PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Yordanova, MM; Wu, C; Andreev, DE; Sachs, MS; Atkins, JF				Yordanova, Martina M.; Wu, Cheng; Andreev, Dmitry E.; Sachs, Matthew S.; Atkins, John F.			A Nascent Peptide Signal Responsive to Endogenous Levels of Polyamines Acts to Stimulate Regulatory Frameshifting on Antizyme mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORNITHINE-DECARBOXYLASE ANTIZYME; OPEN READING FRAME; RIBOSOMAL-RNA; MAMMALIAN ANTIZYME; NEUROSPORA-CRASSA; TRANSLATIONAL REGULATION; ESCHERICHIA-COLI; E-SITE; EXPRESSION; SYSTEM	The protein antizyme is a negative regulator of cellular polyamine concentrations from yeast to mammals. Synthesis of functional antizyme requires programmed + 1 ribosomal frameshifting at the 3' end of the first of two partially overlapping ORFs. The frameshift is the sensor and effector in an autoregulatory circuit. Except for Saccharomyces cerevisiae antizyme mRNA, the frameshift site alone only supports low levels of frameshifting. The high levels usually observed depend on the presence of cis-acting stimulatory elements located 5' and 3' of the frameshift site. Antizyme genes from different evolutionary branches have evolved different stimulatory elements. Prior and new multiple alignments of fungal antizyme mRNA sequences from the Agaricomycetes class of Basidiomycota show a distinct pattern of conservation 5' of the frameshift site consistent with a function at the amino acid level. As shown here when tested in Schizosaccharomyces pombe and mammalian HEK293T cells, the 5' part of this conserved sequence acts at the nascent peptide level to stimulate the frameshifting, without involving stalling detectable by toe-printing. However, the peptide is only part of the signal. The 3' part of the stimulator functions largely independently and acts at least mostly at the nucleotide level. When polyamine levels were varied, the stimulatory effect was seen to be especially responsive in the endogenous polyamine concentration range, and this effect may be more general. A conserved RNA secondary structure 3' of the frameshift site has weaker stimulatory and polyamine sensitizing effects on frameshifting.	[Yordanova, Martina M.; Atkins, John F.] Natl Univ Ireland Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland; [Wu, Cheng; Sachs, Matthew S.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Andreev, Dmitry E.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119991, Russia; [Atkins, John F.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA	University College Cork; Texas A&M University System; Texas A&M University College Station; Lomonosov Moscow State University; Utah System of Higher Education; University of Utah	Atkins, JF (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland.	j.atkins@ucc.ie	Andreev, Dmitry/I-6346-2012; Regan, Clinton/E-6250-2012	Andreev, Dmitry/0000-0001-5320-3045; Sachs, Matthew/0000-0001-9891-9223; Atkins, John/0000-0001-7933-0165; Yordanova, Martina/0000-0001-9693-3857	Science Foundation Ireland; National Institutes of Health [GM068087]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM068087] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Science Foundation Ireland grant (to J. F. A.). This work was also supported in part by National Institutes of Health Grant GM068087 (to M. M. S). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson JB, 2014, MYCOLOGIA, V106, P642, DOI 10.3852/13-367; Arenz S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4501; Atkins JF, 2010, NUCLEIC ACIDS MOL BI, V24, P1, DOI 10.1007/978-0-387-89382-2; ATKINS JF, 1975, J BIOL CHEM, V250, P5688; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; BALASUNDARAM D, 1994, J BACTERIOL, V176, P7126, DOI 10.1128/JB.176.22.7126-7128.1994; Baranov PV, 2002, EMBO REP, V3, P373, DOI 10.1093/embo-reports/kvf065; Cao JH, 1996, MOL CELL BIOL, V16, P7109; Chen J, 2014, NATURE, V512, P328, DOI 10.1038/nature13428; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dmitriev SE, 2003, FEBS LETT, V533, P99, DOI 10.1016/S0014-5793(02)03776-6; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Fixsen SM, 2010, J MOL BIOL, V399, P385, DOI 10.1016/j.jmb.2010.04.033; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; FUJITA K, 1982, BIOCHEM J, V204, P647, DOI 10.1042/bj2040647; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; Grentzmann G, 1998, RNA, V4, P479; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Gupta P, 2013, MOL CELL, V52, P629, DOI 10.1016/j.molcel.2013.10.013; Gurvich OL, 2011, NUCLEIC ACIDS RES, V39, P3079, DOI 10.1093/nar/gkq1272; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Hayashi S, 1996, TRENDS BIOCHEM SCI, V21, P27, DOI 10.1016/0968-0004(96)80882-6; Howard MT, 2001, GENES CELLS, V6, P931, DOI 10.1046/j.1365-2443.2001.00477.x; Ivanov IP, 2000, P NATL ACAD SCI USA, V97, P4808, DOI 10.1073/pnas.070055897; Ivanov IP, 1998, GENOMICS, V52, P119, DOI 10.1006/geno.1998.5434; Ivanov IP, 2004, J MOL BIOL, V339, P495, DOI 10.1016/j.jmb.2004.03.082; Ivanov IP, 2000, EMBO J, V19, P1907, DOI 10.1093/emboj/19.8.1907; Ivanov IP, 1998, RNA, V4, P1230, DOI 10.1017/S1355838298980864; Ivanov IP, 2008, P NATL ACAD SCI USA, V105, P10079, DOI 10.1073/pnas.0801590105; Ivanov IP, 2007, NUCLEIC ACIDS RES, V35, P1842, DOI 10.1093/nar/gkm035; Ivanov IP, 2010, J MOL EVOL, V70, P289, DOI 10.1007/s00239-010-9331-5; Ivanov IP, 2010, NUCLEIC ACIDS MOL BI, V24, P281, DOI 10.1007/978-0-387-89382-2_13; Kahana C, 2009, ESSAYS BIOCHEM, V46, P47, DOI [10.1042/BSE0460004, 10.1042/bse0460004]; Kramer DL, 2001, CANCER RES, V61, P7754; Kurian L, 2011, NATURE, V477, P490, DOI 10.1038/nature10393; LARSEN B, 1994, J BACTERIOL, V176, P6842, DOI 10.1128/JB.176.22.6842-6851.1994; Leger M, 2007, NUCLEIC ACIDS RES, V35, P5581, DOI 10.1093/nar/gkm578; Li YH, 2014, P NATL ACAD SCI USA, V111, pE2172, DOI 10.1073/pnas.1321930111; Lightfoot HL, 2014, NUCLEIC ACIDS RES, V42, P11275, DOI 10.1093/nar/gku837; Loughran G, 2011, P NATL ACAD SCI USA, V108, pE1111, DOI 10.1073/pnas.1102932108; LUO ZG, 1995, MOL CELL BIOL, V15, P5235; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Matsufuji S, 1996, EMBO J, V15, P1360, DOI 10.1002/j.1460-2075.1996.tb00478.x; Mitrasinovic PM, 2006, J STRUCT BIOL, V153, P207, DOI 10.1016/j.jsb.2005.12.001; Murakami Y, 2014, AMINO ACIDS, V46, P575, DOI 10.1007/s00726-013-1598-6; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pegg AE, 2011, METHODS MOL BIOL, V720, P3, DOI 10.1007/978-1-61779-034-8_1; POULIN R, 1993, J BIOL CHEM, V268, P4690; Rato C, 2011, NUCLEIC ACIDS RES, V39, P4587, DOI 10.1093/nar/gkq1349; Ray RM, 2014, AMINO ACIDS, V46, P2231, DOI 10.1007/s00726-014-1777-0; Ray RM, 2012, J BIOL CHEM, V287, P3674, DOI 10.1074/jbc.M111.232561; Ruan HJ, 1996, J BIOL CHEM, V271, P29576, DOI 10.1074/jbc.271.47.29576; Sakata K, 2000, BIOCHEM J, V347, P297, DOI 10.1042/0264-6021:3470297; Sanders CL, 2007, RNA, V13, P1483, DOI 10.1261/rna.638707; Seiler N, 2005, J CELL MOL MED, V9, P623, DOI 10.1111/j.1582-4934.2005.tb00493.x; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Tosaka Y, 2000, GENES CELLS, V5, P265, DOI 10.1046/j.1365-2443.2000.00324.x; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180; Wang Z, 1997, J BIOL CHEM, V272, P255; Wang Z, 1997, MOL CELL BIOL, V17, P4904, DOI 10.1128/MCB.17.9.4904; Wei JJ, 2012, MOL CELL BIOL, V32, P2396, DOI 10.1128/MCB.00136-12; WEISS RB, 1988, EMBO J, V7, P1503, DOI 10.1002/j.1460-2075.1988.tb02969.x; Wilson DN, 2011, CURR OPIN STRUC BIOL, V21, P274, DOI 10.1016/j.sbi.2011.01.007; Wu C, 2007, METHOD ENZYMOL, V429, P203, DOI 10.1016/S0076-6879(07)29010-X; Wu C, 2012, J MOL BIOL, V416, P518, DOI 10.1016/j.jmb.2011.12.064; Yusupova G, 2014, ANNU REV BIOCHEM, V83, P467, DOI 10.1146/annurev-biochem-060713-035445	69	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17863	17878		10.1074/jbc.M115.647065	http://dx.doi.org/10.1074/jbc.M115.647065			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	25998126	hybrid, Green Published			2022-12-26	WOS:000358511700022
J	Rahaman, MM; Reinders, FG; Koes, D; Nguyen, AT; Mutchler, SM; Sparacino-Watkins, C; Alvarez, RA; Miller, MP; Cheng, DM; Chen, BB; Jackson, EK; Camacho, CJ; Straub, AC				Rahaman, Md. Mizanur; Reinders, Fabio G.; Koes, David; Nguyen, Anh T.; Mutchler, Stephanie M.; Sparacino-Watkins, Courtney; Alvarez, Roger A.; Miller, Megan P.; Cheng, Dongmei; Chen, Bill B.; Jackson, Edwin K.; Camacho, Carlos J.; Straub, Adam C.			Structure Guided Chemical Modifications of Propylthiouracil Reveal Novel Small Molecule Inhibitors of Cytochrome b(5) Reductase 3 That Increase Nitric Oxide Bioavailability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE HEREDITARY METHEMOGLOBINEMIA; SMOOTH-MUSCLE-CELLS; ANGIOTENSIN-II; B5; PARTICIPATION; MITOCHONDRIAL; EXPRESSION; CULTURE; PROTEIN; ZINC	NADH cytochrome b(5) reductase 3 (CYB5R3) is critical for reductive reactions such as fatty acid elongation, cholesterol biosynthesis, drug metabolism, and methemoglobin reduction. Although the physiological and metabolic importance of CYB5R3 has been established in hepatocytes and erythrocytes, emerging investigations suggest that CYB5R3 is critical for nitric oxide signaling and vascular function. However, advancement toward fully understanding CYB5R3 function has been limited due to a lack of potent small molecule inhibitors. Because of this restriction, we modeled the binding mode of propylthiouracil, a weak inhibitor of CYB5R3(IC50 = similar to 275 mu M), and used it as a guide to predict thiouracil-biased inhibitors from the set of commercially available compounds in the ZINC database. Using this approach, we validated two new potent derivatives of propylthiouracil, ZINC05626394 (IC50 = 10.81 mu M) and ZINC39395747 (IC50 = 9.14 mu M), both of which inhibit CYB5R3 activity in cultured cells. Moreover, we found that ZINC39395747 significantly increased NO bioavailability in renal vascular cells, augmented renal blood flow, and decreased systemic blood pressure in response to vasoconstrictors in spontaneously hypertensive rats. These compounds will serve as a new tool to examine the biological functions of CYB5R3 in physiology and disease and also as a platform for new drug development.	[Rahaman, Md. Mizanur; Nguyen, Anh T.; Mutchler, Stephanie M.; Sparacino-Watkins, Courtney; Alvarez, Roger A.; Miller, Megan P.; Straub, Adam C.] Univ Pittsburgh, Heart Lung Blood & Vasc Med Inst, Pittsburgh, PA 15213 USA; [Reinders, Fabio G.; Koes, David; Camacho, Carlos J.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15213 USA; [Mutchler, Stephanie M.; Cheng, Dongmei; Jackson, Edwin K.; Straub, Adam C.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Alvarez, Roger A.; Chen, Bill B.] Univ Pittsburgh, Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Straub, AC (corresponding author), Univ Pittsburgh, Sch Med, Heart Lung Blood & Vasc Med Inst, E1254 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15216 USA.	astraub@pitt.edu	Regan, Clinton/E-6250-2012; Alvarez, Roger A./AAZ-3730-2020; Rahaman, Md Mizanur/ABC-7163-2021; Koes, David Ryan/M-4523-2018	Alvarez, Roger A./0000-0001-7819-6486; Rahaman, Md Mizanur/0000-0001-6939-0500; Koes, David Ryan/0000-0002-6892-6614; Straub, Adam/0000-0003-0542-9466; Mutchler, Stephanie/0000-0002-4288-4452; Jackson, Edwin/0000-0002-8101-6009; Sparacino-Watkins, Courtney/0000-0002-2954-9633	National Institutes of Health [R00 HL11290402, R01 HL116472, P30 DK079307, R01 GM097082]; Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania (Straub); American Heart Association Postdoctoral Fellowship [14POST20490112]; National Institutes of Health Post Doctoral Fellowship [T32 DK 06129611]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307, T32DK061296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania (Straub); American Heart Association Postdoctoral Fellowship(American Heart Association); National Institutes of Health Post Doctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R00 HL11290402 (to A. C. S.), R01 HL116472 (to B. B. C.), P30 DK079307 (to E. K. J.), and R01 GM097082 (to C. J. C.). This work was also supported by the Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania (Straub). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of training support by American Heart Association Postdoctoral Fellowship 14POST20490112.; Recipient of National Institutes of Health Post Doctoral Fellowship T32 DK 06129611.	Altuve A, 2004, BIOCHEM BIOPH RES CO, V314, P602, DOI 10.1016/j.bbrc.2003.12.138; Bando S, 2004, ACTA CRYSTALLOGR D, V60, P1929, DOI 10.1107/S0907444904020645; Deng Z, 1999, NAT STRUCT BIOL, V6, P847; DUBEY RK, 1992, CIRC RES, V71, P1143, DOI 10.1161/01.RES.71.5.1143; Ewenczyk C, 2008, BRAIN, V131, P760, DOI 10.1093/brain/awm337; Fermo E, 2008, BLOOD CELL MOL DIS, V41, P50, DOI 10.1016/j.bcmd.2008.02.002; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Frye CA, 2002, IN VITRO CELL DEV-AN, V38, P208; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Halligan KE, 2009, J BIOL CHEM, V284, P8539, DOI 10.1074/jbc.M808231200; Heberlein KR, 2010, CIRC RES, V106, P1092, DOI 10.1161/CIRCRESAHA.109.215723; HILDEBRANDT A, 1971, ARCH BIOCHEM BIOPHYS, V143, P66, DOI 10.1016/0003-9861(71)90186-X; HULTQUIST DE, 1971, NATURE-NEW BIOL, V229, P252, DOI 10.1038/newbio229252a0; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Isakson BE, 2005, CIRC RES, V97, P44, DOI 10.1161/01.RES.0000173461.36221.2e; KITAO T, 1974, BLOOD, V44, P879, DOI 10.1182/blood.V44.6.879.879; Koes DR, 2013, J CHEM INF MODEL, V53, P1893, DOI 10.1021/ci300604z; Koes DR, 2012, NUCLEIC ACIDS RES, V40, pW409, DOI 10.1093/nar/gks378; LEE E, 1986, FEBS LETT, V209, P49, DOI 10.1016/0014-5793(86)81082-1; MAGLIOLA L, 1990, J PHYSIOL-LONDON, V421, P411, DOI 10.1113/jphysiol.1990.sp017952; Mokkapatti R, 1998, J PHARMACOL EXP THER, V287, P223; OSHINO N, 1971, J BIOCHEM, V69, P155, DOI 10.1093/oxfordjournals.jbchem.a129444; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Parekh N, 1996, AM J PHYSIOL-REG I, V270, pR630, DOI 10.1152/ajpregu.1996.270.3.R630; PASSON PG, 1972, BIOCHIM BIOPHYS ACTA, V275, P62, DOI 10.1016/0005-2728(72)90024-2; Percy MJ, 2008, BRIT J HAEMATOL, V141, P298, DOI 10.1111/j.1365-2141.2008.07017.x; REDDY VVR, 1977, J BIOL CHEM, V252, P2797; Sacco JC, 2010, PHARMACOGENET GENOM, V20, P26, DOI 10.1097/FPC.0b013e3283343296; SHIRABE K, 1989, BIOCHIM BIOPHYS ACTA, V1008, P189, DOI 10.1016/0167-4781(80)90007-X; Siendones E, 2014, ANTIOXID REDOX SIGN, V21, P1708, DOI 10.1089/ars.2013.5479; Sparacino-Watkins CE, 2014, J BIOL CHEM, V289, P10345, DOI 10.1074/jbc.M114.555177; Straub AC, 2012, NATURE, V491, P473, DOI 10.1038/nature11626; STRITTMATTER P, 1957, BIOCHIM BIOPHYS ACTA, V25, P228, DOI 10.1016/0006-3002(57)90462-6; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; TSUNODA R, 1994, J CARDIOVASC PHARM, V24, P87, DOI 10.1097/00005344-199407000-00015	36	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16861	16872		10.1074/jbc.M114.629964	http://dx.doi.org/10.1074/jbc.M114.629964			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	26001785	Green Published, hybrid			2022-12-26	WOS:000357572800031
J	Liu, H; Sun, M; Du, DL; Pan, HT; Cheng, TR; Wang, J; Zhang, QX				Liu, Hua; Sun, Ming; Du, Dongliang; Pan, Huitang; Cheng, Tangren; Wang, Jia; Zhang, Qixiang			Whole-Transcriptome Analysis of Differentially Expressed Genes in the Vegetative Buds, Floral Buds and Buds of Chrysanthemum morifolium	PLOS ONE			English	Article							MOLECULAR-CLONING; ARABIDOPSIS; SUPERFAMILY; PROFILES; PROTEIN	Background Chrysanthemum morifolium is an important floral crop that is cultivated worldwide. However, due to a lack of genomic resources, very little information is available concerning the molecular mechanisms of flower development in chrysanthemum. Results The transcriptomes of chrysanthemum vegetative buds, floral buds and buds were sequenced using Illumina paired-end sequencing technology. A total of 15.4 Gb of reads were assembled into 91,367 unigenes with an average length of 739 bp. A total of 43,137 unigenes showed similarity to known proteins in the Swissprot or NCBI non-redundant protein databases. Additionally, 25,424, 24,321 and 13,704 unigenes were assigned to 56 gene ontology (GO) categories, 25 EuKaryotic Orthologous Groups (KOG) categories, and 285 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, respectively. A total of 1,876 differentially expressed genes (DEGs) (1,516 up-regulated, 360 down-regulated) were identified between vegetative buds and floral buds, and 3,300 DEGs (1,277 up-regulated, 1,706 down-regulated) were identified between floral buds and buds. Many genes encoding important transcription factors (e.g., AP2, MYB, MYC, WRKY, NAC and CRT) as well as proteins involved in carbohydrate metabolism, protein kinase activity, plant hormone signal transduction, and the defense responses, among others, were considerably up-regulated in floral buds. Genes involved in the photoperiod pathway and flower organ determination were also identified. These genes represent important candidate genes for molecular cloning and functional analysis to study flowering regulation in chrysanthemum. Conclusion This comparative transcriptome analysis revealed significant differences in gene expression and signaling pathway components between the vegetative buds, floral buds and buds of Chrysanthemum morifolium. A wide range of genes was implicated in regulating the phase transition from vegetative to reproductive growth. These results should aid researchers in the study of flower-time regulation, breeding and molecular biology in chrysanthemum.	[Liu, Hua; Sun, Ming; Du, Dongliang; Pan, Huitang; Cheng, Tangren; Wang, Jia; Zhang, Qixiang] Beijing Forestry Univ, Beijing Lab Urban & Rural Ecol Environm, Beijing Key Lab Ornamental Germplasm Innovat & Mo, Natl Engn Res Ctr Floriculture,Coll Landscape Arc, Beijing 100083, Peoples R China	Beijing Forestry University	Zhang, QX (corresponding author), Beijing Forestry Univ, Beijing Lab Urban & Rural Ecol Environm, Beijing Key Lab Ornamental Germplasm Innovat & Mo, Natl Engn Res Ctr Floriculture,Coll Landscape Arc, Beijing 100083, Peoples R China.	zqxbjfu@126.com	du, dongliang/N-4308-2015; Cheng, Tangren/HDM-6455-2022		12th Five Years Key Programs for Science and Technology Development of China [2012BAD01B07, 2013BAD01B07]; Special Fund for Beijing Common Construction Project	12th Five Years Key Programs for Science and Technology Development of China(Chinese Academy of Sciences); Special Fund for Beijing Common Construction Project	This research was supported by the 12th Five Years Key Programs for Science and Technology Development of China (2012BAD01B07,2013BAD01B07), Special Fund for Beijing Common Construction Project.	Agarwal PK, 2010, BIOL PLANTARUM, V54, P201, DOI 10.1007/s10535-010-0038-7; [Anonymous], 2002, DEV GENETICS PLANT E; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BODSON M, 1977, PLANTA, V135, P19, DOI 10.1007/BF00387970; Broholm SK, 2010, J EXP BOT, V61, P75, DOI 10.1093/jxb/erp279; Chen SM, 2009, PLANT MOL BIOL REP, V27, P503, DOI 10.1007/s11105-009-0103-6; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549; Gu CS, 2011, MOL BIOTECHNOL, V49, P192, DOI 10.1007/s12033-011-9394-6; Hu JX, 2010, J AM STAT ASSOC, V105, P1215, DOI 10.1198/jasa.2010.tm09329; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; IRISH VF, 1990, PLANT CELL, V2, P741, DOI 10.1105/tpc.2.8.741; Irish VF, 2010, PLANT J, V61, P1014, DOI 10.1111/j.1365-313X.2009.04065.x; Jaworski K, 2003, PHYTOCHEMISTRY, V62, P1047, DOI 10.1016/S0031-9422(02)00677-5; Lee J, 2008, PLANT J, V55, P832, DOI 10.1111/j.1365-313X.2008.03552.x; Lenartowski R, 2014, PLANTA, V239, P437, DOI 10.1007/s00425-013-1971-4; Litt A, 2010, SEMIN CELL DEV BIOL, V21, P129, DOI 10.1016/j.semcdb.2009.11.019; Liu ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057338; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Shchennikova AV, 2004, PLANT PHYSIOL, V134, P1632, DOI 10.1104/pp.103.036665; Urao T, 1996, PLANT MOL BIOL, V32, P571, DOI 10.1007/BF00019112; Wagner D, 1999, SCIENCE, V285, P582, DOI 10.1126/science.285.5427.582; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Wang Y, 2014, PLANT CELL TISS ORG, V116, P297, DOI 10.1007/s11240-013-0404-1; Wilmowicz E, 2011, BIOL PLANTARUM, V55, P757, DOI 10.1007/s10535-011-0182-8; Wu XL, 2003, DEVELOPMENT, V130, P3735, DOI 10.1242/dev.00577; Xie XL, 2014, MOL BIOL REP, V41, P4261, DOI 10.1007/s11033-014-3297-0; Xu YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-662	30	41	43	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128009	10.1371/journal.pone.0128009	http://dx.doi.org/10.1371/journal.pone.0128009			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009891	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900182
J	Ohkubo, T; Tamiya, M; Abe, K; Ishiguro, M				Ohkubo, Takayuki; Tamiya, Minoru; Abe, Keiko; Ishiguro, Masaji			Structural Basis of pH Dependence of Neoculin, a Sweet Taste-Modifying Protein	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; PURIFICATION; CURCULIN; RECEPTOR; FRUIT	Among proteins utilized as sweeteners, neoculin and miraculin are taste-modifying proteins that exhibit pH-dependent sweetness. Several experiments on neoculin have shown that His11 of neoculin is responsible for pH dependence. We investigated the molecular mechanism of the pH dependence of neoculin by molecular dynamics (MD) calculations. The MD calculations for the dimeric structures of neoculin and His11 mutants showed no significant structural changes for each monomer at neutral and acidic pH levels. The dimeric structure of neoculin dissociated to form isolated monomers under acidic conditions but was maintained at neutral pH. The dimeric structure of the His11Ala mutant, which is sweet at both neutral and acidic pH, showed dissociation at both pH 3 and 7. The His11 residue is located at the interface of the dimer in close proximity to the Asp91 residue of the other monomer. The MD calculations for His11Phe and His11Tyr mutants demonstrated the stability of the dimeric structures at neutral pH and the dissociation of the dimers to isolated monomers. The dissociation of the dimer caused a flexible backbone at the surface that was different from the dimeric interface at the point where the other monomer interacts to form an oligomeric structure. Further MD calculations on the tetrameric structure of neoculin suggested that the flexible backbone contributed to further dissociation of other monomers under acidic conditions. These results suggest that His11 plays a role in the formation of oligomeric structures at pH 7 and that the isolated monomer of neoculin at acidic pH is responsible for sweetness.	[Ohkubo, Takayuki; Tamiya, Minoru; Ishiguro, Masaji] Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Akiha Ku, Niigata, Japan; [Abe, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo, Japan	Niigata University; University of Tokyo	Ishiguro, M (corresponding author), Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Akiha Ku, Niigata, Japan.	ishiguro@nupals.ac.jp			Grants-in-Aid for Scientific Research [26242007] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		[Anonymous], 2010, AMBER 11 USERS MANUA; IGETA H, 1991, BIOCHIM BIOPHYS ACTA, V1079, P303, DOI 10.1016/0167-4838(91)90073-9; Koizumi A, 2007, BIOCHEM BIOPH RES CO, V358, P585, DOI 10.1016/j.bbrc.2007.04.171; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; KURIHARA K, 1968, SCIENCE, V161, P1241, DOI 10.1126/science.161.3847.1241; Kurimoto E, 2007, J BIOL CHEM, V282, P33252, DOI 10.1074/jbc.C700174200; LIU XZ, 1993, EUR J BIOCHEM, V211, P281, DOI 10.1111/j.1432-1033.1993.tb19896.x; MING D, 1994, FEBS LETT, V355, P106, DOI 10.1016/0014-5793(94)01184-2; MORRIS JA, 1972, BIOCHIM BIOPHYS ACTA, V261, P114, DOI 10.1016/0304-4165(72)90320-0; Nakajima KI, 2008, FASEB J, V22, P2323, DOI 10.1096/fj.07-100289; Nakajima K, 2011, BIOSCI BIOTECH BIOCH, V75, P1600, DOI 10.1271/bbb.110081; Nakajima K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019448; Shimizu-Ibuka A, 2006, J MOL BIOL, V359, P148, DOI 10.1016/j.jmb.2006.03.030; Shirasuka Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1403, DOI 10.1271/bbb.68.1403; VANDERWEL H, 1972, EUR J BIOCHEM, V31, P221; YAMASHITA H, 1990, J BIOL CHEM, V265, P15770	16	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126921	10.1371/journal.pone.0126921	http://dx.doi.org/10.1371/journal.pone.0126921			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010443	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900047
J	Orhan, E; Dalkara, D; Neuille, M; Lechauve, C; Michiels, C; Picaud, S; Leveillard, T; Sahel, JA; Naash, MI; Lavail, MM; Zeitz, C; Audo, I				Orhan, Elise; Dalkara, Deniz; Neuille, Marion; Lechauve, Christophe; Michiels, Christelle; Picaud, Serge; Leveillard, Thierry; Sahel, Jose-Alain; Naash, Muna I.; Lavail, Matthew M.; Zeitz, Christina; Audo, Isabelle			Genotypic and Phenotypic Characterization of P23H Line 1 Rat Model	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; INDUCED RETINAL DEGENERATION; RESTORES VISUAL RESPONSES; RHODOPSIN GENE; TRANSGENIC RAT; PHOTORECEPTOR DEGENERATION; RIBOZYME RESCUE; MUTATIONS; OPSIN; MICE	Rod-cone dystrophy, also known as retinitis pigmentosa (RP), is the most common inherited degenerative photoreceptor disease, for which no therapy is currently available. The P23H rat is one of the most commonly used autosomal dominant RP models. It has been created by incorporation of a mutated mouse rhodopsin (Rho) transgene in the wild-type (WT) Sprague Dawley rat. Detailed genetic characterization of this transgenic animal has however never been fully reported. Here we filled this knowledge gap on P23H Line 1 rat (P23H-1) and provide additional phenotypic information applying non-invasive and state-of-the-art in vivo techniques that are relevant for preclinical therapeutic evaluations. Transgene sequence was analyzed by Sanger sequencing. Using quantitative PCR, transgene copy number was calculated and its expression measured in retinal tissue. Full field electroretinography (ERG) and spectral domain optical coherence tomography (SD-OCT) were performed at 1-, 2-, 3-and 6-months of age. Sanger sequencing revealed that P23H-1 rat carries the mutated mouse genomic Rho sequence from the promoter to the 3' UTR. Transgene copy numbers were estimated at 9 and 18 copies in the hemizygous and homozygous rats respectively. In 1-month-old hemizygous P23H-1 rats, transgene expression represented 43% of all Rho expressed alleles. ERG showed a progressive rod-cone dysfunction peaking at 6 months-of-age. SD-OCT confirmed a progressive thinning of the photoreceptor cell layer leading to the disappearance of the outer retina by 6 months with additional morphological changes in the inner retinal cell layers in hemizygous P23H-1 rats. These results provide precise genotypic information of the P23H-1 rat with additional phenotypic characterization that will serve basis for therapeutic interventions, especially for those aiming at gene editing.	[Orhan, Elise; Dalkara, Deniz; Neuille, Marion; Lechauve, Christophe; Michiels, Christelle; Picaud, Serge; Leveillard, Thierry; Sahel, Jose-Alain; Zeitz, Christina; Audo, Isabelle] INSERM, U968, Paris, France; [Orhan, Elise; Dalkara, Deniz; Neuille, Marion; Lechauve, Christophe; Michiels, Christelle; Picaud, Serge; Leveillard, Thierry; Sahel, Jose-Alain; Zeitz, Christina; Audo, Isabelle] CNRS, UMR 7210, Paris, France; [Orhan, Elise; Dalkara, Deniz; Neuille, Marion; Lechauve, Christophe; Michiels, Christelle; Picaud, Serge; Leveillard, Thierry; Sahel, Jose-Alain; Zeitz, Christina; Audo, Isabelle] Sorbonne Univ, Univ Paris 06, UMR S 968, Inst Vis, Paris, France; [Sahel, Jose-Alain; Audo, Isabelle] Ctr Hosp Natl Ophtalmol Quinze Vingts, DHU ViewMaintain, INSERM DHOS CIC 1423, Paris, France; [Sahel, Jose-Alain; Audo, Isabelle] UCL, Inst Ophthalmol, London, England; [Sahel, Jose-Alain] Fdn Ophtalmol Adolphe Rothschild, Paris, France; [Sahel, Jose-Alain] Acad Sci, Inst France, Paris, France; [Naash, Muna I.] Univ Oklahoma Hlth Sci, Dept Cell Biol, Oklahoma City, OK USA; [Lavail, Matthew M.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA; [Lavail, Matthew M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; Fondation Adolphe de Rothschild; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Audo, I (corresponding author), INSERM, U968, Paris, France.	isabelle.audo@inserm.fr	Léveillard, Thierry/AAR-1804-2020; Dalkara, Deniz/D-5057-2017; Picaud, Serge/H-4012-2014; Zeitz, Christina/F-2757-2017; Sahel, Jose-Alain/F-3172-2017; Lechauve, Christophe/AAH-8873-2019	Léveillard, Thierry/0000-0001-5692-8770; Dalkara, Deniz/0000-0003-4112-9321; Picaud, Serge/0000-0002-0548-5145; Zeitz, Christina/0000-0002-3510-1712; Sahel, Jose-Alain/0000-0002-4831-1153; Orhan, Elise/0000-0002-8306-5250; Audo, Isabelle/0000-0003-0698-5309	Fondation Valentin Hauy; Retina France; e-rare RHORCOD; Fondation de l'Oeil - Fondation de France; Foundation Voir et Entendre; Foundation Fighting Blindness (FFB) [CD-CL-0808-0466-CHNO]; FFB center grant [CD-CL-0808-0466-CHNO]; Ville de Paris; Region Ile de France; Labex Lifesenses [ANR-10-LABX-65]; ANR within the Investissements d'Avenir programme [ANR-11-IDEX-0004-0]; Regional Council of Ile de France [I09 - 1727/R]; National Institute of Health [EY10609, EY001919, EY006842]; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R56EY010609, R37EY001919, R55EY010609, R01EY010609, R01EY001919, U01EY006842, R01EY006842] Funding Source: NIH RePORTER	Fondation Valentin Hauy; Retina France; e-rare RHORCOD; Fondation de l'Oeil - Fondation de France; Foundation Voir et Entendre; Foundation Fighting Blindness (FFB); FFB center grant; Ville de Paris; Region Ile de France(Region Ile-de-France); Labex Lifesenses; ANR within the Investissements d'Avenir programme(French National Research Agency (ANR)); Regional Council of Ile de France(Region Ile-de-France); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Fondation Valentin Hauy (IA, EO), Retina France (IA, EO), e-rare RHORCOD (IA), Fondation de l'Oeil - Fondation de France (IA), Foundation Voir et Entendre (CZ), Foundation Fighting Blindness (FFB) (CD-CL-0808-0466-CHNO) (IA), and the FFB center grant (CD-CL-0808-0466-CHNO), Ville de Paris and Region Ile de France, Labex Lifesenses (reference ANR-10-LABX-65) supported by French state funds managed by the ANR within the Investissements d'Avenir programme (ANR-11-IDEX-0004-0), the Regional Council of Ile de France (I09 - 1727/R) (EO), the National Institute of Health grants EY10609 (MIN), EY001919 (MML) and EY006842 (MML) and the Foundation Fighting Blindness (MIN and MML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguila M, 2014, HUM MOL GENET, V23, P2164, DOI 10.1093/hmg/ddt613; Aleman TS, 2008, INVEST OPHTH VIS SCI, V49, P1580, DOI 10.1167/iovs.07-1110; Aleman TS, 2001, INVEST OPHTH VIS SCI, V42, P1873; ALUBAIDI MR, 1990, J BIOL CHEM, V265, P20563; Audo I, 2010, INVEST OPHTH VIS SCI, V51, P3687, DOI 10.1167/iovs.09-4766; Ballester M, 2004, BIOTECHNIQUES, V37, P610, DOI 10.2144/04374ST06; Berger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096494; BERSON EL, 1991, ARCH OPHTHALMOL-CHIC, V109, P92, DOI 10.1001/archopht.1991.01080010094039; Berson EL, 1976, T SECTION OPHTHALM 1, V81, pOP659; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Cuenca N, 2004, NEUROSCIENCE, V127, P301, DOI 10.1016/j.neuroscience.2004.04.042; Cuenca N, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00151; Dryja TP, 2000, INVEST OPHTH VIS SCI, V41, P3124; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1990, NEW ENGL J MED, V323, P1302, DOI 10.1056/NEJM199011083231903; Fernandez-Sanchez L, 2012, HUM GENE THER, V23, P1290, DOI 10.1089/hum.2012.067; Fernandez-Sanchez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043074; Fernandez-Sanchez L, 2011, INVEST OPHTH VIS SCI, V52, P4998, DOI 10.1167/iovs.11-7496; Garcia-Ayuso D, 2010, EXP EYE RES, V91, P800, DOI 10.1016/j.exer.2010.10.003; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Gorbatyuk M, 2007, EXP EYE RES, V84, P44, DOI 10.1016/j.exer.2006.08.014; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HECKENLIVELY JR, 1991, ARCH OPHTHALMOL-CHIC, V109, P84, DOI 10.1001/archopht.1991.01080010086038; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; INGLEHEARN CF, 1991, AM J HUM GENET, V48, P26; Ishikawa F, 2006, INVEST OPHTH VIS SCI, V47, P5204, DOI 10.1167/iovs.05-1149; Jayaram H, 2014, STEM CELL TRANSL MED, V3, P323, DOI 10.5966/sctm.2013-0112; Jelcick AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021858; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kolomiets B, 2010, NEUROBIOL DIS, V38, P47, DOI 10.1016/j.nbd.2009.12.025; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; LaVail MM, 2000, P NATL ACAD SCI USA, V97, P11488, DOI 10.1073/pnas.210319397; LAVAIL MM, 1987, CURR EYE RES, V6, P825, DOI 10.3109/02713688709034850; Lax P, 2014, EXP EYE RES, V120, P175, DOI 10.1016/j.exer.2014.01.019; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; Mace E, 2015, MOL THER, V23, P7, DOI 10.1038/mt.2014.154; Machida S, 2000, INVEST OPHTH VIS SCI, V41, P3200; Mohand-Said S, 2000, ARCH OPHTHALMOL-CHIC, V118, P807, DOI 10.1001/archopht.118.6.807; Montagutelli X, 2000, J AM SOC NEPHROL, V11, pS101; Moriguchi K, 2003, EXP EYE RES, V77, P167, DOI 10.1016/S0014-4835(03)00114-3; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; Naash ML, 1996, INVEST OPHTH VIS SCI, V37, P775; Parfitt DA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.214; Saliba RS, 2002, J CELL SCI, V115, P2907; Steinberg R. H., 1996, Investigative Ophthalmology and Visual Science, V37, pS698; Stenkamp RE, 2005, ARCH PHARM, V338, P209, DOI 10.1002/ardp.200400995; STONE EM, 1991, OPHTHALMOLOGY, V98, P1806; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P3052, DOI 10.1167/iovs.05-1443; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Vasireddy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021193; Wang M, 1997, VISUAL NEUROSCI, V14, P55, DOI 10.1017/S0952523800008750; Yang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013469; Zrenner E, 2002, SCIENCE, V295, P1022, DOI 10.1126/science.1067996	58	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127319	10.1371/journal.pone.0127319	http://dx.doi.org/10.1371/journal.pone.0127319			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009893	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900082
J	Wagage, S; Pritchard, GH; Dawson, L; Buza, EL; Sonnenberg, GF; Hunter, CA				Wagage, Sagie; Pritchard, Gretchen Harms; Dawson, Lucas; Buza, Elizabeth L.; Sonnenberg, Gregory F.; Hunter, Christopher A.			The Group 3 Innate Lymphoid Cell Defect in Aryl Hydrocarbon Receptor Deficient Mice Is Associated with T Cell Hyperactivation during Intestinal Infection	PLOS ONE			English	Article							TOXOPLASMA-GONDII; COMMENSAL BACTERIA; IMMUNE-RESPONSE; ORAL INFECTION; GAMMA; PROMOTE; GUT; DIFFERENTIATION; ACTIVATION; MICROBIOTA	Intestinal infection with the intracellular parasite Toxoplasma gondii results in the translocation of commensal bacteria to peripheral organs and the development of a T cell response specific to the microbiota. In naive mice, the recently described ROR gamma t(+) group 3 innate lymphoid cell (ILC) population plays a critical role in promoting intestinal barrier function and limiting responses to gut-resident commensal bacteria. Given this role for group 3 ILCs, studies were performed to evaluate whether these cells might influence the immune response to mucosal infection with T. gondii. Phenotypic characterization of ROR gamma t(+) ILCs in T. gondii infected mice revealed that this population decreased following challenge but the population that remained expressed costimulatory molecules and IL-22. One factor that influences the maintenance of ROR gamma t(+) ILCs is the aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor, and Ahr(-/-) mice have a marked defect in the lamina propria group 3 ILC population. When Ahr(-/-) mice were challenged with T. gondii, they lost more weight than wild type controls. This disease course in Ahr(-/-) animals was associated with increased T cell responses to Toxoplasma antigen and crude commensal antigen preparations. Together, these data suggest that group 3 ILCs have a role in limiting T cell activation during intestinal infection.	[Wagage, Sagie; Pritchard, Gretchen Harms; Dawson, Lucas; Buza, Elizabeth L.; Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Sonnenberg, Gregory F.] Univ Penn, Div Gastroenterol, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Sonnenberg, Gregory F.] Univ Penn, Div Gastroenterol, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Hunter, CA (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	chunter@vet.upenn.edu			 [NIHR01AI-110201]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007532, R01AI110201] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported ny the NIHR01AI-110201 (http://www.niaid.nih.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt MC, 2013, CURR OPIN MICROBIOL, V16, P4, DOI 10.1016/j.mib.2012.12.002; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Bannenberg GL, 2004, J EXP MED, V199, P515, DOI 10.1084/jem.20031325; Benson A, 2012, J IMMUNOL, V188, P800, DOI 10.4049/jimmunol.1100769; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Dubey JP, 2012, PARASITOLOGY, V139, P1, DOI 10.1017/S0031182011001673; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Gregg B, 2013, INFECT IMMUN, V81, P1635, DOI 10.1128/IAI.01126-12; Hall AO, 2012, IMMUNITY, V37, P511, DOI 10.1016/j.immuni.2012.06.014; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Molloy MJ, 2013, CELL HOST MICROBE, V14, P318, DOI 10.1016/j.chom.2013.08.003; Moura-Alves P, 2014, NATURE, V512, P387, DOI 10.1038/nature13684; Munoz M, 2015, IMMUNITY, V42, P321, DOI 10.1016/j.immuni.2015.01.011; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Sanchez Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/505694; Schreiner M, 2009, MEM I OSWALDO CRUZ, V104, P221, DOI 10.1590/S0074-02762009000200015; Silva NM, 2002, INFECT IMMUN, V70, P859, DOI 10.1128/IAI.70.2.859-868.2002; Silver JS, 2011, J IMMUNOL, V187, P350, DOI 10.4049/jimmunol.1004144; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Villeret B, 2013, AM J CLIN EXP IMMUNO, V2, P107; von Burg N, 2014, P NATL ACAD SCI USA, V111, P12835, DOI 10.1073/pnas.1406908111; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wagage S, 2015, CURRENT IMM IN PRESS; Wagage S, 2014, J IMMUNOL, V192, P1661, DOI 10.4049/jimmunol.1300497; Wilson MS, 2010, J IMMUNOL, V184, P4378, DOI 10.4049/jimmunol.0903416; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016	47	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128335	10.1371/journal.pone.0128335	http://dx.doi.org/10.1371/journal.pone.0128335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010337	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900226
J	Kari, L; Hill, KA; Sayem, AS; Karamichalis, R; Bryans, N; Davis, K; Dattani, NS				Kari, Lila; Hill, Kathleen A.; Sayem, Abu S.; Karamichalis, Rallis; Bryans, Nathaniel; Davis, Katelyn; Dattani, Nikesh S.			Mapping the Space of Genomic Signatures	PLOS ONE			English	Article							CHAOS GAME REPRESENTATION; 3D GRAPHICAL REPRESENTATION; DNA-SEQUENCES; VISUALIZATION; PHYLOGENY; CLASSIFICATION; FREQUENCY; BARCODE	We propose a computational method to measure and visualize interrelationships among any number of DNA sequences allowing, for example, the examination of hundreds or thousands of complete mitochondrial genomes. An "image distance" is computed for each pair of graphical representations of DNA sequences, and the distances are visualized as a Molecular Distance Map: Each point on the map represents a DNA sequence, and the spatial proximity between any two points reflects the degree of structural similarity between the corresponding sequences. The graphical representation of DNA sequences utilized, Chaos Game Representation (CGR), is genome-and species-specific and can thus act as a genomic signature. Consequently, Molecular Distance Maps could inform species identification, taxonomic classifications and, to a certain extent, evolutionary history. The image distance employed, Structural Dissimilarity Index (DSSIM), implicitly compares the occurrences of oligomers of length up to k (herein k = 9) in DNA sequences. We computed DSSIM distances for more than 5 million pairs of complete mitochondrial genomes, and used Multi-Dimensional Scaling (MDS) to obtain Molecular Distance Maps that visually display the sequence relatedness in various subsets, at different taxonomic levels. This general-purpose method does not require DNA sequence alignment and can thus be used to compare similar or vastly different DNA sequences, genomic or computer-generated, of the same or different lengths. We illustrate potential uses of this approach by applying it to several taxonomic subsets: phylum Vertebrata, (super) kingdom Protista, classes Amphibia-Insecta-Mammalia, class Amphibia, and order Primates. This analysis of an extensive dataset confirms that the oligomer composition of full mtDNA sequences can be a source of taxonomic information. This method also correctly finds the mtDNA sequences most closely related to that of the anatomically modern human (the Neanderthal, the Denisovan, and the chimp), and that the sequence most different from it in this dataset belongs to a cucumber.	[Kari, Lila; Hill, Kathleen A.; Sayem, Abu S.; Karamichalis, Rallis; Bryans, Nathaniel] Univ Western Ontario, Dept Comp Sci, London, ON, Canada; [Hill, Kathleen A.; Davis, Katelyn] Univ Western Ontario, Dept Biol, London, ON, Canada; [Dattani, Nikesh S.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Oxford	Kari, L (corresponding author), Univ Western Ontario, Dept Comp Sci, London, ON, Canada.	lila.kari@uwo.ca		Hill, Kathleen/0000-0002-7788-5105	Natural Sciences and Engineering Research Council of Canada [R2824A01, R3511A12]; Natural Sciences and Engineering Research Council of Canada Undergraduate Student Research Award; Oxford University Press Clarendon Fund	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council of Canada Undergraduate Student Research Award(Natural Sciences and Engineering Research Council of Canada (NSERC)); Oxford University Press Clarendon Fund	This research was funded by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) Discovery Grant no. R2824A01 to LK; Natural Sciences and Engineering Research Council of Canada Discovery Grant no. R3511A12 to KAH; Natural Sciences and Engineering Research Council of Canada Undergraduate Student Research Award (http://www.nserc-crsng.gc.ca/students-etudiants/ug-pc/usra-brpc_eng.asp) to NB; Oxford University Press Clarendon Fund and Natural Sciences and Engineering Research Council of Canada Undergraduate Student Research Award to NSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Beadell JS, 2005, J PARASITOL, V91, P683, DOI 10.1645/GE-3412RN; Borg I, 2010, MODERN MULTIDIMENSIO; Chatterjee HJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-259; Dattani N, 2014, OPENMDM COMPUTER PRO; Deschavanne P, 2000, IEEE INTERNATIONAL SYMPOSIUM ON BIO-INFORMATICS AND BIOMEDICAL ENGINEERING, PROCEEDINGS, P161, DOI 10.1109/BIBE.2000.889603; Deschavanne P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-163; Deschavanne PJ, 1999, MOL BIOL EVOL, V16, P1391, DOI 10.1093/oxfordjournals.molbev.a026048; Edwards SV, 2002, SYST BIOL, V51, P599, DOI 10.1080/10635150290102285; GATES MA, 1986, J THEOR BIOL, V119, P319, DOI 10.1016/S0022-5193(86)80144-8; GOLDMAN N, 1993, NUCLEIC ACIDS RES, V21, P2487, DOI 10.1093/nar/21.10.2487; Hall BK, 2001, BIOSCIENCE, V51, P399, DOI 10.1641/0006-3568(2001)051[0399:JSBIPO]2.0.CO;2; Hao BL, 2000, CHAOS SOLITON FRACT, V11, P825, DOI 10.1016/S0960-0779(98)00182-9; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILL KA, 1992, J MOL EVOL, V35, P261; Hill KA, 1997, GENOME, V40, P342, DOI 10.1139/g97-047; Hillis DM, 2005, SYST BIOL, V54, P471, DOI 10.1080/10635150590946961; Hoef-Emden K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043652; Hu J, 2012, AQUACULTURE, V364, P157, DOI 10.1016/j.aquaculture.2012.08.025; Jameson NM, 2011, J HUM EVOL, V61, P295, DOI 10.1016/j.jhevol.2011.04.004; JEFFREY HJ, 1992, COMPUT GRAPH, V16, P25, DOI 10.1016/0097-8493(92)90067-6; JEFFREY HJ, 1990, NUCLEIC ACIDS RES, V18, P2163, DOI 10.1093/nar/18.8.2163; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; LEONG PM, 1995, COMPUT APPL BIOSCI, V11, P503; LESSA EP, 1990, SYST ZOOL, V39, P242, DOI 10.2307/2992184; Li M, 2004, IEEE T INFORM THEORY, V50, P3250, DOI 10.1109/TIT.2004.838101; Liao B, 2005, CHEM PHYS LETT, V401, P196, DOI 10.1016/j.cplett.2004.11.059; Makula M, 2009, COMPUT INFORM, V28, P695; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; NANDY A, 1994, CURR SCI INDIA, V66, P309; Pandit A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S26; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Pride DT, 2003, GENOME RES, V13, P145, DOI 10.1101/gr.335003; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Qi ZH, 2011, J COMPUT CHEM, V32, P3233, DOI 10.1002/jcc.21906; Randic M, 2000, J CHEM INF COMP SCI, V40, P1235, DOI 10.1021/ci000034q; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Shoshani J, 1996, MOL PHYLOGENET EVOL, V5, P102, DOI 10.1006/mpev.1996.0009; Sirovich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009266; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; Valkiunas G, 2010, J PARASITOL, V96, P783, DOI 10.1645/GE-2442.1; Wang YW, 2005, GENE, V346, P173, DOI 10.1016/j.gene.2004.10.021; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Yao YH, 2004, CHEM PHYS LETT, V398, P318, DOI 10.1016/j.cplett.2004.09.087; Yu CL, 2010, DNA RES, V17, P155, DOI 10.1093/dnares/dsq008; Yu JF, 2009, J THEOR BIOL, V261, P459, DOI 10.1016/j.jtbi.2009.08.005; Yuan CX, 2003, CHEM PHYS LETT, V379, P412, DOI 10.1016/j.cplett.2003.07.023; Zhang ZJ, 2012, MATCH-COMMUN MATH CO, V68, P621	50	17	17	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0119815	10.1371/journal.pone.0119815	http://dx.doi.org/10.1371/journal.pone.0119815			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000734	Green Published, gold, Green Submitted			2022-12-26	WOS:000354931700002
J	Qiu, F; Yang, JC; Ma, XY; Xu, JJ; Yang, QL; Zhou, X; Xiao, YS; Hu, HS; Xia, LH				Qiu, Feng; Yang, Jin-Cheng; Ma, Xiang-Yang; Xu, Jun-Jie; Yang, Qing-Lei; Zhou, Xin; Xiao, Yao-Sheng; Hu, Hai-Sheng; Xia, Li-Hui			Relationship between Spinal Cord Volume and Spinal Cord Injury due to Spinal Shortening	PLOS ONE			English	Article							VERTEBRAL COLUMN RESECTION; SINGLE POSTERIOR APPROACH; IDIOPATHIC SCOLIOSIS; EVOKED-POTENTIALS; SURGERY; DEFORMITY; OSTEOTOMY; KYPHOSCOLIOSIS; RECORDINGS; ANESTHESIA	Vertebral column resection is associated with a risk of spinal cord injury. In the present study, using a goat model, we aimed to investigate the relationship between changes in spinal cord volume and spinal cord injury due to spinal shortening, and to quantify the spinal cord volume per 1-mm height in order to clarify a safe limit for shortening. Vertebral column resection was performed at T10 in 10 goats. The spinal cord was shortened until the somatosensory-evoked potential was decreased by 50% from the baseline amplitude or delayed by 10% relative to the baseline peak latency. A wake-up test was performed, and the goats were observed for two days postoperatively. Magnetic resonance imaging was used to measure the spinal cord volume, T10 height, disc height, osteotomy segment height, and spinal segment height pre- and postoperatively. Two of the 10 goats were excluded, and hence, only data from eight goats were analyzed. The somatosensory-evoked potential of these eight goats demonstrated meaningful changes. With regard to neurologic function, five and three goats were classified as Tarlov grades 5 and 4 at two days postoperatively. The mean shortening distance was 23.6 +/- 1.51 mm, which correlated with the d-value (post-pre) of the spinal cord volume per 1-mm height of the osteotomy segment (r = 0.95, p < 0.001) and with the height of the T10 body (r = 0.79, p = 0.02). The mean d-value (post-pre) of the spinal cord volume per 1-mm height of the osteotomy segment was 142.87 +/- 0.59 mm(3) (range, 142.19-143.67 mm(3)). The limit for shortening was approximately 106% of the vertebral height. The mean volumes of the osteotomy and spinal segments did not significantly change after surgery (t = 0.310, p = 0.765 and t = 1.241, p = 0.255, respectively). Thus, our results indicate that the safe limit for shortening can be calculated using the change in spinal cord volume per 1-mm height.	[Qiu, Feng; Yang, Jin-Cheng; Ma, Xiang-Yang; Xu, Jun-Jie; Yang, Qing-Lei; Zhou, Xin; Xiao, Yao-Sheng; Hu, Hai-Sheng; Xia, Li-Hui] Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Orthoped, Guangzhou 510010, Guangdong, Peoples R China	Southern Theater Command General Hospital	Ma, XY (corresponding author), Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Orthoped, 111 Liuhua Ave,POB 510010, Guangzhou 510010, Guangdong, Peoples R China.	spinemaxy2014@126.com			National Natural Science Foundation of China [NO:81171768]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Foundation funds were received in support of this work from the National Natural Science Foundation of China (NO:81171768).	Alemdaroglu KB, 2007, EUR SPINE J, V16, P1451, DOI 10.1007/s00586-007-0325-y; BOHLMAN HH, 1979, JOHNS HOPKINS MED J, V145, P115; Braun JT, 2006, SPINE, V31, P1314, DOI 10.1097/01.brs.0000218662.78165.b1; Bridwell KH, 2006, SPINE, V31, pS171, DOI 10.1097/01.brs.0000231963.72810.38; Chandanwale A S, 2008, J Orthop Surg (Hong Kong), V16, P277; Dabney KW, 2004, SPINE, V29, P2357, DOI 10.1097/01.brs.0000143108.65385.74; DAWSON EG, 1991, SPINE, V16, pS361; Gunnarsson T, 2004, SPINE, V29, P677, DOI 10.1097/01.BRS.0000115144.30607.E9; Hamzaoglu A, 2011, SPINE, V36, pE340, DOI 10.1097/BRS.0b013e3182015712; Hermanns H, 2007, BRIT J ANAESTH, V98, P362, DOI 10.1093/bja/ael365; Hilibrand AS, 2004, J BONE JOINT SURG AM, V86A, P1248, DOI 10.2106/00004623-200406000-00018; Kawahara N, 2005, SPINE, V30, P613, DOI 10.1097/01.brs.0000155407.87439.a2; Lenke LG, 2010, CLIN ORTHOP RELAT R, V468, P687, DOI 10.1007/s11999-009-1037-x; Lenke LG, 2009, SPINE, V34, P2213, DOI 10.1097/BRS.0b013e3181b53cba; Liljenqvist UR, 2000, SPINE, V25, P1247, DOI 10.1097/00007632-200005150-00008; LIN HC, 1993, CORNELL VET, V83, P117; Metzler P, 2014, J ORAL MAXILLOFAC SU; Modi HN, 2011, J BONE JOINT SURG AM, V93A, P1781, DOI [10.2106/JBJS.J.01794, 10.2106/JBJS.I.01794]; Qin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052910; Qiu Y, 2008, SPINE, V33, P519, DOI 10.1097/BRS.0b013e3181657d93; Schwartz DM, 2007, J BONE JOINT SURG AM, V89A, P2440, DOI 10.2106/Jl3JS.F01476; Shimode M, 2002, SPINE, V27, P2260, DOI 10.1097/00007632-200210150-00015; Strahm C, 2003, SPINAL CORD, V41, P483, DOI 10.1038/sj.sc.3101493; Suk SI, 2005, SPINE, V30, pE703, DOI 10.1097/01.brs.0000188190.90034.be; Suk SI, 2005, SPINE, V30, P1682, DOI 10.1097/01.brs.0000170590.21071.c1; TARLOV IM, 1954, AMA ARCH NEUROL PSY, V71, P271, DOI 10.1001/archneurpsyc.1954.02320390001001; Wang Y, 2008, EUR SPINE J, V17, P361, DOI 10.1007/s00586-007-0566-9; WEINSTEIN JN, 1992, CLIN ORTHOP RELAT R, P34; Weinstein SL, 2000, J BONE JOINT SURG AM, V82A, P1517, DOI 10.2106/00004623-200010000-00041; Yang JH, 2014, CLIN ORTHOP SURG, V6, P290, DOI 10.4055/cios.2014.6.3.290; Yang JC, 2011, INT ORTHOP, V35, P1827, DOI 10.1007/s00264-010-1155-9; Zhang HQ, 2013, ARCH ORTHOP TRAUM SU, V133, P1211, DOI 10.1007/s00402-013-1794-6	32	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127624	10.1371/journal.pone.0127624	http://dx.doi.org/10.1371/journal.pone.0127624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001196	gold, Green Published, Green Submitted			2022-12-26	WOS:000354931700069
J	Lin, WT; Wu, CD; Cheng, SC; Chiu, CC; Tseng, CC; Chan, HT; Chen, PY; Chao, CM				Lin, Wei-Ting; Wu, Chung-Da; Cheng, Shun-Chien; Chiu, Chong-Chi; Tseng, Chi-Chou; Chan, Huan-Tee; Chen, Po-Yih; Chao, Chien-Ming			High Prevalence of Methicillin-Resistant Staphylococcus aureus among Patients with Septic Arthritis Caused by Staphylococcus aureus	PLOS ONE			English	Article							INFECTIONS	Background This study investigated the clinical characteristics of patients with septic arthritis caused by Staphylococcus aureus and tried to identify the risk factors for methicillin-resistant S. aureus (MRSA) arthritis. Methods Between January 2008 and December 2011, patients with septic arthritis caused by S. aureus were identified from the computerized databases of a regional hospital and a medical center in southern Taiwan. The medical records of these patients were retrospectively reviewed. Results A total of 93 patients with S. aureus arthritis were identified, and MRSA arthritis was found in 38 (40.9%) cases. The mean age of the patients was 58 years, and 86 (92.5%) episodes were classified as community-acquired infections. Diabetes mellitus (n = 41, 44.1%) was the most common underlying disease, followed by chronic kidney disease and liver cirrhosis. Patients with MRSA arthritis were more frequently elderly and found in the setting of healthcare-associated infection than patients with methicillin-susceptible S. aureus (MSSA) infections. No other significant differences in clinical manifestations and outcomes were noted between these two groups of patients. Overall, the in-hospital mortality rate was 5.4%, and diabetes mellitus was the only risk factor for mortality. Conclusions MRSA is emerging in the setting of community-acquired septic arthritis. MRSA septic arthritis is more likely to develop in the elderly and in healthcare-associated infections than MSSA septic arthritis.	[Lin, Wei-Ting; Wu, Chung-Da; Cheng, Shun-Chien] Chi Mei Med Ctr, Dept Orthopaed, Tainan, Taiwan; [Lin, Wei-Ting] Shu Zen Jr Coll Med & Management, Dept Phys Therapy, Tainan, Taiwan; [Chiu, Chong-Chi] Chi Mei Med Ctr, Dept Gen Surg, Tainan, Taiwan; [Chiu, Chong-Chi] Southern Taiwan Univ Sci & Technol, Dept Elect Engn, Tainan, Taiwan; [Tseng, Chi-Chou; Chan, Huan-Tee; Chen, Po-Yih] Chi Mei Med Ctr, Dept Orthopaed, Tainan, Taiwan; [Chao, Chien-Ming] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan; [Chao, Chien-Ming] Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan	Chi Mei Hospital; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Chi Mei Hospital; Chi Mei Hospital	Chao, CM (corresponding author), Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan.	ccm870958@yahoo.com.tw						Al-Nammari SS, 2007, ARCH ORTHOP TRAUM SU, V127, P537, DOI 10.1007/s00402-007-0285-z; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Byrne PAC, 1998, CLIN RHEUMATOL, V17, P407, DOI 10.1007/BF01450904; Chen Chih-Jung, 2005, Journal of Microbiology Immunology and Infection, V38, P376; Chuang YC, 2009, J MICROBIOL IMMUNOL, V42, P258; Clerc O, 2011, J ANTIMICROB CHEMOTH, V66, P1168, DOI 10.1093/jac/dkr047; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Frazee BW, 2009, ANN EMERG MED, V54, P695, DOI 10.1016/j.annemergmed.2009.06.511; GOLDENBERG DL, 1985, NEW ENGL J MED, V312, P764, DOI 10.1056/NEJM198503213121206; Gupta MN, 2003, ANN RHEUM DIS, V62, P327, DOI 10.1136/ard.62.4.327; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hsueh PR, 2002, EMERG INFECT DIS, V8, P63, DOI 10.3201/eid0801.000454; Mathews CJ, 2008, CURR OPIN RHEUMATOL, V20, P457, DOI 10.1097/BOR.0b013e3283036975; Mathews CJ, 2010, LANCET, V375, P846, DOI 10.1016/S0140-6736(09)61595-6; Okano T, 2011, J INFECT CHEMOTHER, V17, P666, DOI 10.1007/s10156-011-0244-z; Pioro MH, 1997, RHEUM DIS CLIN N AM, V23, P239, DOI 10.1016/S0889-857X(05)70328-8; Ross JJ, 2005, RHEUMATOLOGY, V44, P1197, DOI 10.1093/rheumatology/kei035; Ryan MJ, 1997, BRIT J RHEUMATOL, V36, P370; Shirtliff ME, 2002, CLIN MICROBIOL REV, V15, P527, DOI 10.1128/CMR.15.4.527-544.2002	19	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127150	10.1371/journal.pone.0127150	http://dx.doi.org/10.1371/journal.pone.0127150			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996145	Green Published, Green Submitted, gold			2022-12-26	WOS:000356444000045
J	Tanaka, K; Watanabe, N				Tanaka, Kazuya; Watanabe, Naoko			Study on the Coordination Structure of Pt Sorbed on Bacterial Cells Using X-Ray Absorption Fine Structure Spectroscopy	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; AQUEOUS-SOLUTION; PRECIOUS METALS; PLATINUM; BIOSORPTION; RECOVERY; PALLADIUM(II); ADSORPTION; SORPTION; BIOMASS	Biosorption has been intensively investigated as a promising technology for the recovery of precious metals from solution. However, the detailed mechanism responsible for the biosorption of Pt on a biomass is not fully understood because of a lack of spectroscopic studies. We applied X-ray absorption fine structure spectroscopy to elucidate the coordination structure of Pt sorbed on bacterial cells. We examined the sorption of Pt(II) and Pt(IV) species on bacterial cells of Bacillus subtilis and Shewanella putrefaciens in NaCl solutions. X-ray absorption near-edge structure and extended X-ray absorption fine structure (EXAFS) of Pt-sorbed bacteria suggested that Pt(IV) was reduced to Pt(II) on the cell's surface, even in the absence of an organic material as an exogenous electron donor. EXAFS spectra demonstrated that Pt sorbed on bacterial cells has a fourfold coordination of chlorine ions, similar to PtCl42-, which indicated that sorption on the protonated amine groups of the bacterial cells. This work clearly demonstrated the coordination structure of Pt sorbed on bacterial cells. The findings of this study will contribute to the understanding of Pt biosorption on biomass, and facilitate the development of recovery methods for rare metals using biosorbent materials.	[Tanaka, Kazuya; Watanabe, Naoko] Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 724, Japan	Hiroshima University	Tanaka, K (corresponding author), Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 724, Japan.	kt0830@hiroshima-u.ac.jp						Ankudinov AL, 1997, PHYS REV B, V56, pR1712, DOI 10.1103/PhysRevB.56.R1712; Bera P, 2003, CHEM MATER, V15, P2049, DOI 10.1021/cm0204775; Cobelo-Garcia A, 2007, ANAL CHIM ACTA, V585, P202, DOI 10.1016/j.aca.2006.12.029; Cosden JM, 2003, GEOCHIM COSMOCHIM AC, V67, P1331, DOI 10.1016/S0016-7037(02)01271-1; Das N, 2010, HYDROMETALLURGY, V103, P180, DOI 10.1016/j.hydromet.2010.03.016; de Vargas I, 2004, J CHEM TECHNOL BIOT, V79, P49, DOI 10.1002/jctb.928; Deng SB, 2005, ENVIRON SCI TECHNOL, V39, P8490, DOI 10.1021/es050697u; Dobson RS, 2007, MINER ENG, V20, P519, DOI 10.1016/j.mineng.2006.10.011; DOYLE RJ, 1980, J BACTERIOL, V143, P471, DOI 10.1128/JB.143.1.471-480.1980; Dziwulska U, 2004, ANAL LETT, V37, P2189, DOI 10.1081/AL-200026696; Fein JB, 1997, GEOCHIM COSMOCHIM AC, V61, P3319, DOI 10.1016/S0016-7037(97)00166-X; Guibal E, 1999, IND ENG CHEM RES, V38, P4011, DOI 10.1021/ie990165k; HANCOCK RD, 1977, J INORG NUCL CHEM, V39, P1031, DOI 10.1016/0022-1902(77)80258-3; HOFFMANN JE, 1988, JOM-J MIN MET MAT S, V40, P40, DOI 10.1007/BF03258173; Itai T, 2006, CHEM LETT, V35, P866, DOI 10.1246/cl.2006.866; Kim HJ, 2011, APPL CATAL B-ENVIRON, V101, P366, DOI 10.1016/j.apcatb.2010.10.005; KUYUCAK N, 1989, Biorecovery, V1, P189; Lloyd JR, 1998, APPL ENVIRON MICROB, V64, P4607; Mack C, 2007, BIOTECHNOL ADV, V25, P264, DOI 10.1016/j.biotechadv.2007.01.003; Mack CL, 2008, MINER ENG, V21, P31, DOI 10.1016/j.mineng.2007.07.001; MANCEAU A, 1987, GEOCHIM COSMOCHIM AC, V51, P105, DOI 10.1016/0016-7037(87)90011-1; Nomura M, 1998, J SYNCHROTRON RADIAT, V5, P851, DOI 10.1107/S090904959800003X; Ramesh A, 2008, BIORESOURCE TECHNOL, V99, P3801, DOI 10.1016/j.biortech.2007.07.008; Rashamuse KJ, 2007, APPL MICROBIOL BIOT, V75, P1429, DOI 10.1007/s00253-007-0963-3; Takahashi Y, 2007, GEOCHIM COSMOCHIM AC, V71, P984, DOI 10.1016/j.gca.2006.11.016; Takahashi Y, 2010, GEOCHIM COSMOCHIM AC, V74, P5443, DOI 10.1016/j.gca.2010.07.001; Tanaka K, 2013, GEOMICROBIOL J, V30, P874, DOI 10.1080/01490451.2013.791352; Tanaka K, 2010, GEOCHIM COSMOCHIM AC, V74, P5463, DOI 10.1016/j.gca.2010.07.010; Vijayaraghavan K, 2008, BIOTECHNOL ADV, V26, P266, DOI 10.1016/j.biotechadv.2008.02.002; Won SW, 2010, BIORESOURCE TECHNOL, V101, P1135, DOI 10.1016/j.biortech.2009.09.056; ZAVINSKY SI, 1995, PHYS REV B, V52, P2995	31	12	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127417	10.1371/journal.pone.0127417	http://dx.doi.org/10.1371/journal.pone.0127417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996945	Green Submitted, Green Published, gold			2022-12-26	WOS:000356444000064
J	Viguier, M; Rist, S; Aubin, F; Leccia, MT; Richard, MA; Esposito-Farese, M; Gaudin, P; Pham, T; Richette, P; Wendling, D; Sibilia, J; Tubach, F				Viguier, Manuelle; Rist, Stephanie; Aubin, Franois; Leccia, Marie-Therese; Richard, Marie-Aleth; Esposito-Farese, Marina; Gaudin, Philippe; Thao Pham; Richette, Pascal; Wendling, Daniel; Sibilia, Jean; Tubach, Florence		Club Rhumatismes & Inflammation	Online Training on Skin Cancer Diagnosis in Rheumatologists: Results from a Nationwide Randomized Web-Based Survey	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; THERAPY	Patients with inflammatory rheumatisms, such as rheumatoid arthritis, are more prone to develop skin cancers than the general population, with an additional increased incidence when receiving TNF blockers. There is therefore a need that physicians treating patients affected with inflammatory rheumatisms with TNF blockers recognize malignant skin lesions, requiring an urgent referral to the dermatologist and a potential withdrawal or modification of the immunomodulatory treatment. We aimed to demonstrate that an online training dedicated to skin tumors increase the abilities of rheumatologists to discriminate skin cancers from benign skin tumors. A nationwide randomized web-based survey involving 141 French rheumatologists was conducted. The baseline evaluation included short cases with skin lesion pictures and multiple choice questions assessing basic knowledge on skin cancers. For each case, rheumatologists had to indicate the nature of skin lesion (benign; premalignant/ malignant), their level of confidence in this diagnosis (10-points Likert scale), and the precise dermatological diagnosis among 5 propositions. Different scores were established. After randomization, only one group had access to the online formation consisting in 4 elearning modules on skin tumors, of 15 minutes each (online training group). After reevaluation, the trained and the non-trained group (control group) were compared. The primary end-point was the number of adequate diagnoses of the nature of the skin lesions. The mean number of adequate diagnosis for the benign versus premalignant/malignant nature of the lesions was higher in the online training group (13.4 vs. 11.2 points; p value <0.0001). While the other knowledge scores were also significantly higher, no statistical difference was observed on the level of self-confidence between the 2 groups. In conclusion, the online formation was effective to improve the rheumatologists' ability to diagnose skin cancer.	[Viguier, Manuelle] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Viguier, Manuelle] Hop St Louis, AP HP, Paris, France; [Rist, Stephanie] CHR, Serv Rhumatol, Orleans, France; [Aubin, Franois] Univ Franche Comte, CHU Besancon, Serv Dermatol, EA3181,SFR4234, F-25030 Besancon, France; [Richard, Marie-Aleth] CHU Grenoble, Clin Dermatol Allergol & Photobiol, F-38043 Grenoble, France; [Richard, Marie-Aleth] Univ Aix Marseille, Hop Enfants La Timone, Ctr Rech Oncol Biol & Oncopharmacol, Assistance Publ Hop Marseille,Serv Dermatol, Marseille, France; [Esposito-Farese, Marina; Tubach, Florence] Univ Paris Diderot, Sorbonne Paris Cite, UMR 1123, Paris, France; [Esposito-Farese, Marina; Tubach, Florence] Hop Bichat Claude Bernard, AP HP, Ctr Pharmacoepidemiol Cephepi, Dept Epidemiol & Rech Clin, F-75877 Paris, France; [Esposito-Farese, Marina; Tubach, Florence] INSERM, CIC EC 1425, UMR 1123, Paris, France; [Gaudin, Philippe] Clin Univ Rhumatol, CHU Grenoble, Hop Sud, F-38043 Grenoble, France; [Thao Pham] CHU, APHM, Serv Rhumatol, Marseille, France; [Richette, Pascal] Univ Paris Diderot, Hop Lariboisiere, AP HP, Serv Rhumatol, Paris, France; [Wendling, Daniel] Univ Franche Comte, CHU Besancon, Serv Rhumatol, F-25030 Besancon, France; [Sibilia, Jean] Univ Strasbourg, Fed Med Translat, Ctr Rech Immunol & Hematol, INSERM UMR S1109, Strasbourg, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre Hospitalier Regional d'Orleans; Universite de Franche-Comte; CHU Besancon; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; CHU Besancon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Viguier, M (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Paris, France.	manuelle.viguier@sls.aphp.fr	Aubin, François/ABE-1236-2021; Aubin, François/AAB-5824-2022; Pham, Thao/GYA-5092-2022	Aubin, François/0000-0002-1421-4996; Aubin, François/0000-0002-1421-4996; Sibilia, Jean/0000-0002-1601-4795; Leccia, M.Therese/0000-0003-1222-0396; Richette, Pascal/0000-0003-2132-4074; Sempe, Christine/0000-0001-6903-1575; durez, patrick/0000-0002-7156-2356	Abbvie Ltd.	Abbvie Ltd.(AbbVie)	The study was supported by an unrestricted grant from Abbvie Ltd. The funder had no role in study design, analysis, decision to publish or preparation of the manuscript.	Askling J, 2005, ANN RHEUM DIS, V64, P1421, DOI 10.1136/ard.2004.033993; Askling J, 2009, ANN RHEUM DIS     S3, V68, P423; Askling J, 2011, PHARMACOEPIDEM DR S, V20, P119, DOI 10.1002/pds.2046; Dougados M, 2014, ANN RHEUM DIS, V73, P62, DOI 10.1136/annrheumdis-2013-204223; Grange F, 2014, BRIT J DERMATOL, V170, P123, DOI 10.1111/bjd.12585; Koh HK, 2011, J AM ACAD DERMATOL, V65, pS3, DOI 10.1016/j.jaad.2011.02.036; Mariette X, 2012, ANN RHEUM DIS, V71, pE2, DOI 10.1136/annrheumdis-2012-202478; Mariette X, 2011, ANN RHEUM DIS, V70, P1895, DOI 10.1136/ard.2010.149419; Mellemkjaer L, 1996, EUR J CANCER, V32A, P1753, DOI 10.1016/0959-8049(96)00210-9; Mercer LK, 2012, ANN RHEUM DIS, V71, P869, DOI 10.1136/annrheumdis-2011-200622; Pham T, 2011, JOINT BONE SPINE, V78, P15, DOI 10.1016/S1297-319X(11)70001-X; Wolfe F, 2007, ARTHRITIS RHEUM, V56, P2886, DOI 10.1002/art.22864	12	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127564	10.1371/journal.pone.0127564	http://dx.doi.org/10.1371/journal.pone.0127564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996152	Green Published, Green Submitted, gold			2022-12-26	WOS:000356444000075
J	Cirkovic, I; Stepanovic, S; Skov, R; Trajkovic, J; Grgurevic, A; Larsen, AR				Cirkovic, Ivana; Stepanovic, Srdjan; Skov, Robert; Trajkovic, Jasmina; Grgurevic, Anita; Larsen, Anders Rhod			Carriage and Genetic Diversity of Methicillin-Resistant Staphylococcus aureus among Patients and Healthcare Workers in a Serbian University Hospital	PLOS ONE			English	Article							CHROMOGENIC MEDIUM; CHROMAGAR MRSA; NASAL; COLONIZATION; PERFORMANCE; INFECTIONS; PREVALENCE; MEDIA; AGAR	Objectives There is a paucity of data on methicillin-resistant Staphylococcus aureus (MRSA) epidemiology among Balkan countries. The aim of our study was to determine the prevalence of nasal and pharyngeal carriages and diversity of MRSA among patients and healthcare workers (HCWs) in the major referral centre in Serbia, and to evaluate performance of three different media for MRSA screening. Methods Nasal and pharyngeal swabs were obtained from 195 patients and 105 HCWs in Emergency Department (ED), Surgical Department (SD) and Medical Department (MD). After broth enrichment, samples were inoculated onto MRSA-ID, ORSA and oxacillin-MSA and incubated for 24/48 hours. Characterisation of isolated MRSA strains was determined by MLVA, spa, SCCmec and agr typing, PVL genes detection and antimicrobial susceptibility. Results MRSA carriage prevalence was 11.8% in patients and 7.6% in HCWs. Introduction of pharyngeal swabs in screening procedure increased MRSA carriage rate by over 30%. Variable found to be independently associated with an increased risk for MRSA carriage was ED (odd ratio (OR) = 4.45, 95% confidence interval (CI) 1.78-11.14). A higher risk of multidrug-resistant MRSA carriage was observed among patients (OR = 22; 95% CI 1.92-251.54). CC5-MRSA-SCCmecI was the dominant clone among patients and HCWs in ED and MD, while high genetic diversity of community-associated MRSA (CA-MRSA) was shown in SD especially among HCWs. MRSA-ID was superior to the other tested media with a sensitivity/specificity of 95.2% and 99.6% after 48 hours of incubation. Conclusions These results indicate high MRSA carriage rate in the hospital and emergence of CA-MRSA through HCWs in these settings. MRSA-ID was the optimal available choice for MRSA screening.	[Cirkovic, Ivana; Stepanovic, Srdjan; Trajkovic, Jasmina] Univ Belgrade, Fac Med, Inst Microbiol & Immunol, Belgrade, Serbia; [Skov, Robert; Larsen, Anders Rhod] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark; [Grgurevic, Anita] Univ Belgrade, Fac Med, Inst Epidemiol, Belgrade, Serbia	University of Belgrade; Statens Serum Institut; University of Belgrade	Cirkovic, I (corresponding author), Univ Belgrade, Fac Med, Inst Microbiol & Immunol, Belgrade, Serbia.	cirkoviciv@yahoo.com	Skov, Robert/ABB-3105-2020	Skov, Robert/0000-0002-6079-5381; Cirkovic, Ivana/0000-0003-1515-1824; Larsen, Anders Rhod/0000-0002-1713-8765				Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; Amorim ML, 2009, MICROB DRUG RESIST, V15, P19, DOI 10.1089/mdr.2009.0881; Bignardi GE, 1996, J ANTIMICROB CHEMOTH, V37, P53, DOI 10.1093/jac/37.1.53; Bogut A, 2007, NEW MICROBIOL, V30, P149; Boye K, 2007, CLIN MICROBIOL INFEC, V13, P725, DOI 10.1111/j.1469-0691.2007.01720.x; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Budimir A, 2010, CLIN MICROBIOL INFEC, V16, P1077, DOI 10.1111/j.1469-0691.2009.03042.x; Cirkovic I, 2013, J MED MICROBIOL, V62, P342, DOI 10.1099/jmm.0.051219-0; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; den Heijer CDJ, 2013, LANCET INFECT DIS, V13, P409, DOI 10.1016/S1473-3099(13)70036-7; Diederen BMW, 2006, J CLIN MICROBIOL, V44, P586, DOI 10.1128/JCM.44.2.586-588.2006; Dulon M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-138; Fiolic Z, 2012, CHEMOTHERAPY, V58, P330, DOI 10.1159/000343454; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Lina G, 2003, APPL ENVIRON MICROB, V69, P18, DOI 10.1128/AEM.69.1.18-23.2003; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Malhotra-Kumar S, 2010, J CLIN MICROBIOL, V48, P1040, DOI 10.1128/JCM.01745-09; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Nahimana I, 2006, CLIN MICROBIOL INFEC, V12, P1168, DOI 10.1111/j.1469-0691.2006.01534.x; Nilsson P, 2006, J CLIN MICROBIOL, V44, P3334, DOI 10.1128/JCM.00880-06; Nonhoff C, 2009, EUR J CLIN MICROBIOL, V28, P363, DOI 10.1007/s10096-008-0637-9; Pan A, 2013, J HOSP INFECT, V83, P107, DOI 10.1016/j.jhin.2012.09.020; Perry JD, 2004, J CLIN MICROBIOL, V42, P4519, DOI 10.1128/JCM.42.10.4519-4523.2004; Sabat A, 2003, J CLIN MICROBIOL, V41, P1801, DOI 10.1128/JCM.41.4.1801-1804.2003; Shittu A, 2007, DIAGN MICR INFEC DIS, V57, P93, DOI 10.1016/j.diagmicrobio.2006.05.004; Van Vaerenbergh K, 2010, J CLIN MICROBIOL, V48, P1450, DOI 10.1128/JCM.02103-09; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Verkade E, 2011, J MED MICROBIOL, V60, P905, DOI 10.1099/jmm.0.021964-0; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4	29	31	31	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127347	10.1371/journal.pone.0127347	http://dx.doi.org/10.1371/journal.pone.0127347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993538	Green Submitted, Green Published, gold			2022-12-26	WOS:000354921400109
J	Jayanti, A; Foden, P; Wearden, A; Morris, J; Brenchley, P; Mitra, S				Jayanti, Anuradha; Foden, Philip; Wearden, Alison; Morris, Julie; Brenchley, Paul; Mitra, Sandip		BASIC-HHD Study Grp	Self-Cannulation for Haemodialysis: Patient Attributes, Clinical Correlates and Self-Cannulation Predilection Models	PLOS ONE			English	Article							NOCTURNAL HOME HEMODIALYSIS; BUTTONHOLE CANNULATION; TECHNIQUE SURVIVAL; DIALYSIS; COHORT; BARRIERS; OUTCOMES; TRIAL	Background and Objectives With emerging evidence in support of home haemodialysis (HHD), patient factors which determine uptake of the modality need to be better understood. Self-cannulation (SC) is a major step towards enabling self-care 'in-centre' and at home and remains the foremost barrier to its uptake. Human factors governing this aspect of HD practice are poorly understood. The aim of this study is to better understand self-cannulation preferences and factors which define them in end stage renal disease (ESRD). Design In this multicentre study, 508 of 535 patients from predialysis (Group A: n = 222), in-centre (Group B: n = 213), and home HD (Group C: n = 100) responded to a questionnaire with 3 self-cannulation questions. Simultaneously, data on clinical, cognitive and psychosocial variables were ascertained. The primary outcome measure was 'perceived ability to self-cannulate AV access'. Predictive models were developed using logistic regression analysis. Results 36.6% of predialysis patients (A) and 29.1% of the 'in-centre' haemodialysis patients (B) felt able to consider SC for HD. Technical-skills related apprehension was highest in Group B (14.4%) patients. Response to routine venepuncture and the types of SC concerns were significant predictors of perceived ability to self-cannulate. There was no significant difference in concern for pain across the groups. In multivariable regression analysis, age, education level, 3MS score, hypoalbuminemia in Groups B & C and additionally, attitude to routine phlebotomy and the nature of specific concern for self-cannulation in Groups A, B and C, are significant predictors of SC preference. The unadjusted c-statistics of models 1 (derived from Group A and validated on A) and 2 (derived from B+C and validated on B), are 0.76(95% CI 0.69, 0.83) and 0.80 (95% CI 0.74, 0.87) respectively. Conclusions There is high prevalence of perceived ability to self-cannulate. Modifiable SC concerns exist in ESRD. The use of predictive models to objectively define and target education and training strategies could potentially impact on HD self-management and future uptake of home HD.	[Jayanti, Anuradha; Brenchley, Paul; Mitra, Sandip] Cent Manchester Hosp NHS Trust, Dept Nephrol, Manchester, Lancs, England; [Foden, Philip; Morris, Julie] Univ Manchester, Dept Biostat, Manchester M13 9PL, Lancs, England; [Wearden, Alison] Univ Manchester, Dept Psychol, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester	Jayanti, A (corresponding author), Cent Manchester Hosp NHS Trust, Dept Nephrol, Manchester, Lancs, England.	anu_5577@yahoo.co.in		Brenchley, Paul/0000-0003-1290-9919	Baxter Clinical Evidence Council; NIHR-CLAHRC for Greater Manchester, UK	Baxter Clinical Evidence Council; NIHR-CLAHRC for Greater Manchester, UK	The research is funded by Baxter Clinical Evidence Council and NIHR-CLAHRC for Greater Manchester, UK. This funding has been secured through open competition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brouwer D., 2011, NDT PLUS S3, V4; Cafazzo JA, 2009, CLIN J AM SOC NEPHRO, V4, P784, DOI 10.2215/CJN.05501008; Castledine C, 2011, NEPHRON CLIN PRACT, V119, pC255, DOI 10.1159/000331783; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; CRAVEN JL, 1988, INT J PSYCHIAT MED, V18, P365; Culleton BF, 2007, JAMA-J AM MED ASSOC, V298, P1291, DOI 10.1001/jama.298.11.1291; Efron B., 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; ENDE J, 1989, J GEN INTERN MED, V4, P23, DOI 10.1007/BF02596485; Figueiredo AE, 2008, J RENAL CARE, V34, P169, DOI 10.1111/j.1755-6686.2008.00041.x; Grudzinski A, 2013, SEMIN DIALYSIS, V26, P465, DOI 10.1111/sdi.12116; Jayanti A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-197; Jayanti A, 2013, NEPHROL DIAL TRANSPL, V28, P2612, DOI 10.1093/ndt/gft294; Kim MK, 2013, HEMODIAL INT, V17, P294, DOI 10.1111/j.1542-4758.2012.00753.x; Kjellstrand C, 2010, HEMODIAL INT, V14, P464, DOI 10.1111/j.1542-4758.2010.00475.x; Klusmann V, 2011, AGING MENT HEALTH, V15, P1052, DOI 10.1080/13607863.2011.583624; McFarlane P, 2011, SEMIN DIALYSIS, V24, P678, DOI 10.1111/j.1525-139X.2011.01007.x; Muir CA, 2014, CLIN J AM SOC NEPHRO, V9, P110, DOI 10.2215/CJN.03930413; Pauly RP, 2010, CLIN J AM SOC NEPHRO, V5, P1815, DOI 10.2215/CJN.00300110; Pipkin M, 2010, CLIN J AM SOC NEPHRO, V5, P1614, DOI 10.2215/CJN.02440310; Ravani P, 2013, J AM SOC NEPHROL, V24, P1; SPIELBERGER CD, 1987, ANXIETY, V19, P2009; Strauss E., 2006, COMPENDIUM NEUROPSYC; Teng EL, 1987, PSYCHIATRY, V48, P314, DOI DOI 10.1093/GERONA/GLT064; Van Eps CL, 2010, HEMODIAL INT, V14, P451, DOI 10.1111/j.1542-4758.2010.00463.x	24	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0125606	10.1371/journal.pone.0125606	http://dx.doi.org/10.1371/journal.pone.0125606			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992775	Green Published, gold, Green Submitted			2022-12-26	WOS:000354918600016
J	Song, ZC; Wang, Y; Li, C; Zhang, DH; Wang, XL				Song, Zhenchuan; Wang, Yong; Li, Chao; Zhang, Donghong; Wang, Xinle			Molecular Modification of Metadherin/MTDH Impacts the Sensitivity of Breast Cancer to Doxorubicin	PLOS ONE			English	Article							ASTROCYTE ELEVATED GENE-1; PROGRESSION; RESISTANCE; AEG-1	Background Breast cancer is a leading cause of death in women and with an increasing worldwide incidence. Doxorubicin, as a first-line anthracycline-based drug is conventional used on breast cancer clinical chemotherapy. However, the drug resistances limited the curative effect of the doxorubicin therapy in breast cancer patients, but the molecular mechanism determinants of breast cancer resistance to doxorubicin chemotherapy are not fully understood. In order to explore the association between metadherin (MTDH) and doxorubicin sensitivity, the differential expressions of MTDH in breast cancer cell lines and the sensitivity to doxorubicin of breast cancer cell lines were investigated. Methods The mRNA and protein expression of MTDH were determined by real-time PCR and Western blot in breast cancer cells such as MDA-MB-231, MCF-7, MDA-MB-435S, MCF-7/ADR cells. Once MTDH gene was knocked down by siRNA in MCF-7/ADR cells and overexpressed by MTDH plasmid transfection in MDA-MB-231 cells, the cell growth and therapeutic sensitivity of doxorubicin were evaluated using MTT and the Cell cycle assay and apoptosis rate was determined by flow cytometry. Results MCF-7/ADR cells revealed highly expressed MTDH and MDA-MB-231 cells had the lowest expression of MTDH. After MTDH gene was knocked down, the cell proliferation was inhibited, and the inhibitory rate of cell growth and apoptosis rate were enhanced, and the cell cycle arrest during the G0/G1 phase in the presence of doxorubicin treatment. On the other hand, the opposite results were observed in MDA-MB-231 cells with overexpressed MTDH gene. Conclusion MTDH gene plays a promoting role in the proliferation of breast cancer cells and its high expression may be associated with doxorubicin sensitivity of breast cancer.	[Song, Zhenchuan; Wang, Yong; Li, Chao; Zhang, Donghong; Wang, Xinle] Hebei Med Univ, Hosp 4, Dept Breast Ctr, Shijiazhuang 050035, Peoples R China	Hebei Medical University	Song, ZC (corresponding author), Hebei Med Univ, Hosp 4, Dept Breast Ctr, 169 Tian Shan St, Shijiazhuang 050035, Peoples R China.	songzhenchuan@medmail.com.cn			Hebei Province Natural Science Foundation [H2012206169]; Wu Jieping Medical Foundation for Clinical Scientific Research [320.6750.13295]	Hebei Province Natural Science Foundation(Natural Science Foundation of Hebei Province); Wu Jieping Medical Foundation for Clinical Scientific Research	This study was supported by Hebei Province Natural Science Foundation (H2012206169) and Wu Jieping Medical Foundation for Clinical Scientific Research (320.6750.13295).	Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Haug S, 2014, INT J CANCER, V2014, P29289; Hickman JA, 1996, EUR J CANCER, V32A, P921, DOI 10.1016/0959-8049(96)00080-9; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Kong XL, 2012, CANCER BIOL THER, V13, P43, DOI 10.4161/cbt.13.1.18868; Li C, 2011, J SURG ONCOL, V103, P184, DOI 10.1002/jso.21788; Li J, 2009, ONCOGENE, V28, P3188, DOI 10.1038/onc.2009.171; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Liu WJ, 2010, CHIN J CANCER, V1, P66; Liu XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017582; Su P, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-38; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Wang S, 2012, ASIAN PAC J CANCER P, V13, P2813, DOI 10.7314/APJCP.2012.13.6.2813; Xin FX, 2009, BIOINFORMATICS, V25, P430, DOI 10.1093/bioinformatics/btn646; Xu JB, 2011, MED ONCOL, V28, P455, DOI 10.1007/s12032-010-9475-6; Yoo BK, 2009, P NATL ACAD SCI USA, V106, P12938, DOI 10.1073/pnas.0901451106; Yu CP, 2009, CARCINOGENESIS, V30, P894, DOI 10.1093/carcin/bgp064; Zhang N, 2013, J BIOL CHEM, V288, P9396, DOI 10.1074/jbc.M112.395913; Zhao YH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015816, 10.1371/journal.pone.0016470]	22	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127599	10.1371/journal.pone.0127599	http://dx.doi.org/10.1371/journal.pone.0127599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993398	Green Published, gold, Green Submitted			2022-12-26	WOS:000354918600069
J	Suzuki, M; Aki, A; Mizuki, T; Maekawa, T; Usami, R; Morimoto, H				Suzuki, Masashi; Aki, Atsushi; Mizuki, Toru; Maekawa, Toru; Usami, Ron; Morimoto, Hisao			Encouragement of Enzyme Reaction Utilizing Heat Generation from Ferromagnetic Particles Subjected to an AC Magnetic Field	PLOS ONE			English	Article							THERMOSENSITIVE POLYMER GELS; IRON-OXIDE; NANOPARTICLES; LIPASE; IMMOBILIZATION; STABILITY; SURFACE	We propose a method of activating an enzyme utilizing heat generation from ferromagnetic particles under an ac magnetic field. We immobilize alpha-amylase on the surface of ferromagnetic particles and analyze its activity. We find that when alpha-amylase/ferromagnetic particle hybrids, that is, ferromagnetic particles, on which alpha-amylase molecules are immobilized, are subjected to an ac magnetic field, the particles generate heat and as a result, alpha-amylase on the particles is heated up and activated. We next prepare a solution, in which alpha-amylase/ferromagnetic particle hybrids and free, nonimmobilized chitinase are dispersed, and analyze their activities. We find that when the solution is subjected to an ac magnetic field, the activity of alpha-amylase immobilized on the particles increases, whereas that of free chitinase hardly changes; in other words, only alpha-amylase immobilized on the particles is selectively activated due to heat generation from the particles.	[Suzuki, Masashi; Mizuki, Toru; Maekawa, Toru; Usami, Ron; Morimoto, Hisao] Toyo Univ, Grad Sch Interdisciplinary New Sci, Kawagoe, Saitama, Japan; [Aki, Atsushi; Mizuki, Toru; Maekawa, Toru; Usami, Ron; Morimoto, Hisao] Toyo Univ, Bionano Elect Res Ctr, Kawagoe, Saitama, Japan	Toyo University; Toyo University	Morimoto, H (corresponding author), Toyo Univ, Grad Sch Interdisciplinary New Sci, Kawagoe, Saitama, Japan.	morimoto@toyo.jp		Mizuki, Toru/0000-0003-2744-881X	Grant for Program for Strategic Research Foundation at Private Universities [S1101017]; Japanese Society for the Promotion of Science [22560209]	Grant for Program for Strategic Research Foundation at Private Universities; Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant for the Program for the Strategic Research Foundation at Private Universities S1101017 organized by the Ministry of Education, Culture, Sports, Science and Technology in Japan (http://www.mext.go.jp/english/) and a Grant-in-Aid for Scientific Research, 22560209, organized by the Japanese Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki A, 2008, J APPL PHYS, V104, DOI 10.1063/1.3010307; Asuri P, 2007, LANGMUIR, V23, P12318, DOI 10.1021/la702091c; Bae S, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2420769; Baker I, 2006, J APPL PHYS, V99, DOI 10.1063/1.2171960; Baraban L, 2013, ACS NANO, V7, P1360, DOI 10.1021/nn305726m; Chien LJ, 2008, BIOTECHNOL BIOENG, V100, P223, DOI 10.1002/bit.21750; Deng HT, 2004, LANGMUIR, V20, P10168, DOI 10.1021/la0484624; Dias JT, 2013, ANGEW CHEM INT EDIT, V52, P11526, DOI 10.1002/anie.201305835; Fortin JP, 2007, J AM CHEM SOC, V129, P2628, DOI 10.1021/ja067457e; Gerday C, 2000, TRENDS BIOTECHNOL, V18, P103, DOI 10.1016/S0167-7799(99)01413-4; Groudieva T, 2004, EXTREMOPHILES, V8, P475, DOI 10.1007/s00792-004-0409-0; Guardia P, 2012, ACS NANO, V6, P3080, DOI 10.1021/nn2048137; HABERDIT.W, 1967, NATURE, V213, P72, DOI 10.1038/213072a0; Jayhooni SMH, 2013, SUPERLATTICE MICROST, V58, P205, DOI 10.1016/j.spmi.2013.03.004; Kalkan NA, 2012, J APPL POLYM SCI, V123, P707, DOI 10.1002/app.34504; Kato N, 1998, MAT SCI ENG C-BIO S, V6, P291, DOI 10.1016/S0928-4931(98)00065-4; Klyachko NL, 2012, ANGEW CHEM INT EDIT, V51, P12016, DOI 10.1002/anie.201205905; Kuo CH, 2012, CARBOHYD POLYM, V87, P2538, DOI 10.1016/j.carbpol.2011.11.026; Lide D. R., 1995, CRC HDB CHEM PHYS; Lund AH, 1996, NUCLEIC ACIDS RES, V24, P800, DOI 10.1093/nar/24.4.800; Ma M, 2004, J MAGN MAGN MATER, V268, P33, DOI 10.1016/S0304-8853(03)00426-8; Maciel JC, 2012, J MAGN MAGN MATER, V324, P1312, DOI 10.1016/j.jmmm.2011.11.017; Marshall CJ, 1997, TRENDS BIOTECHNOL, V15, P359, DOI 10.1016/S0167-7799(97)01086-X; Mary APR, 2010, NANOSCALE RES LETT, V5, P1706, DOI 10.1007/s11671-010-9729-4; Matsumoto M, 2003, BIOCHEM ENG J, V14, P75, DOI 10.1016/S1369-703X(02)00138-9; Matsune H, 2006, CHEM LETT, V35, P1356, DOI 10.1246/cl.2006.1356; Mizuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066528; Mizuki T, 2010, BIOCHEM BIOPH RES CO, V393, P779, DOI 10.1016/j.bbrc.2010.02.081; Morimoto H, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.021403; Mukhopadhyay K, 2003, LANGMUIR, V19, P3858, DOI 10.1021/la0268202; Nakagawa T, 2003, LETT APPL MICROBIOL, V37, P154, DOI 10.1046/j.1472-765X.2003.01369.x; Park HJ, 2011, COLLOID SURFACE B, V83, P198, DOI 10.1016/j.colsurfb.2010.11.006; Peyer KE, 2013, NANOSCALE, V5, P1259, DOI 10.1039/c2nr32554c; Ranjbakhsh E, 2012, CHEM ENG J, V179, P272, DOI 10.1016/j.cej.2011.10.097; Riedinger A, 2013, NANO LETT, V13, P2399, DOI 10.1021/nl400188q; Shahsavarani H, 2012, BIOTECHNOL ADV, V30, P1289, DOI 10.1016/j.biotechadv.2011.09.002; Sing CE, 2010, P NATL ACAD SCI USA, V107, P535, DOI 10.1073/pnas.0906489107; Skumiel A, 2013, INT J THERMOPHYS, V34, P655, DOI 10.1007/s10765-012-1380-0; Takahashi F, 1997, J FERMENT BIOENG, V83, P152, DOI 10.1016/S0922-338X(97)83574-X; Tierno P, 2008, J PHYS CHEM B, V112, P16525, DOI 10.1021/jp808354n; Tsang SC, 2006, J PHYS CHEM B, V110, P16914, DOI 10.1021/jp062275s; Uygun DA, 2012, J APPL POLYM SCI, V123, P2574, DOI 10.1002/app.33879	43	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127673	10.1371/journal.pone.0127673	http://dx.doi.org/10.1371/journal.pone.0127673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993268	gold, Green Submitted, Green Published			2022-12-26	WOS:000354918600073
J	Salas, Y; Marquez, A; Diaz, D; Romero, L				Salas, Yaritza; Marquez, Adelys; Diaz, Daniel; Romero, Laura			Epidemiological Study of Mammary Tumors in Female Dogs Diagnosed during the Period 2002-2012: A Growing Animal Health Problem	PLOS ONE			English	Article							CANCER DEVELOPMENT; 17-BETA-ESTRADIOL; POPULATION; CARCINOMAS; SURVIVAL	Epidemiological studies enable us to analyze disease behavior, define risk factors and establish fundamental prognostic criteria, with the purpose of studying different types of diseases. The aim of this study was to determine the epidemiological characteristics of canine mammary tumors diagnosed during the period 2002-2012. The study was based on a retrospective study consisting of 1,917 biopsies of intact dogs that presented mammary gland lesions. Biopsies were sent to the Department of Pathology FMVZ-UNAM diagnostic service. The annual incidence of mammary tumors was 16.8%: 47.7%(benign) and 47.5%(malignant). The highest number of cases was epithelial, followed by mixed tumors. The most commonly diagnosed tumors were tubular adenoma, papillary adenoma, tubular carcinoma, papillary carcinoma, solid carcinoma, complex carcinoma and carcinosarcoma. Pure breeds accounted for 80% of submissions, and the Poodle, Cocker Spaniel and German Shepherd were consistently affected. Adult female dogs (9 to 12 years old) were most frequently involved, followed by 5- to 8-year-old females. Some association between breeds with histological types of malignant tumors was observed, but no association was found between breeds and BN. Mammary tumors in intact dogs had a high incidence. Benign and malignant tumors had similar frequencies, with an increase in malignant tumors in the past four years of the study. Epithelial tumors were more common, and the most affected were old adult females, purebreds and small-sized dogs. Mammary tumors in dogs are an important animal health problem that needs to be solved by improving veterinary oncology services in Mexico.	[Salas, Yaritza; Marquez, Adelys] Univ Nacl Autonoma Mexico, FMVZ, Doctoral Program Prod Sci & Anim Hlth, Mexico City, DF, Mexico; [Salas, Yaritza] UCLA, Dept Pathol, Barquisimeto, Lara, Venezuela; [Marquez, Adelys] UCLA, Dept Physiol, Barquisimeto, Lara, Venezuela; [Diaz, Daniel] Univ Nacl Autonoma Mexico, Biol Cellular & Physiol Dept, Inst Invest Biomed, Mexico City, DF, Mexico; [Romero, Laura] Univ Nacl Autonoma Mexico, FMVZ, Dept Pathol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Salas, Y (corresponding author), Univ Nacl Autonoma Mexico, FMVZ, Doctoral Program Prod Sci & Anim Hlth, Mexico City, DF, Mexico.	ysalas@ucla.edu.ve	Diaz, Daniel/P-1916-2018	Diaz, Daniel/0000-0003-2302-1982				Andrade FHE, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-45; Blanchard DK, 2003, AM J SURG, V186, P359, DOI 10.1016/S0002-9610(03)00269-1; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Bronden LB, 2010, VET REC, V166, P586, DOI 10.1136/vr.b4808; COFFEY DS, 1990, UROL CLIN N AM, V17, P461; COHEN D, 1974, CANCER RES, V34, P2859; Corro A, 2005, 3 JORN EST INV DES U; Egenvall A, 2005, PREV VET MED, V69, P109, DOI 10.1016/j.prevetmed.2005.01.014; Environmental Protection Agency-EPA, 2006, INFORMATIVE, P49; Fonseca CS, 2000, CIENCIA RURAL, P731; Goldschmidt M, 2011, VET PATHOL, V48, P117, DOI 10.1177/0300985810393258; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Klopfleisch R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-618; Kuldip G, 2012, IOSR PHR, P322; Misdorp W., 1999, HISTOLOGIC CLASSIFIC, V7; Moe L, 2001, J REP FER S, P439; Nitin T, 1997, EPH S3; Oliveira LO, 2003, ACT SCI VET, P105; Rivera P, 2009, CANCER RES, V69, P8770, DOI 10.1158/0008-5472.CAN-09-1725; Rodriguez-Lara V, 2014, ARCH MED RES, V45, P158, DOI 10.1016/j.arcmed.2014.01.001; Sassi F, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-5; SCHNEIDER R, 1969, JNCI-J NATL CANCER I, V43, P1249; Sontasa Ozyogurtcub H, 2009, ARCH MED VET, P53; Sosa I, PERROS CALLEJEROS IN; Wey N, 2000, KLEINTIERPRAXIS, V45, P19; Yu FL, 2002, ASIA PAC J CLIN NUTR, V11, pS460, DOI 10.1046/j.1440-6047.11.s.7.4.x	26	98	100	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127381	10.1371/journal.pone.0127381	http://dx.doi.org/10.1371/journal.pone.0127381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992997	Green Submitted, Green Published, gold			2022-12-26	WOS:000354917300120
J	van den Boogaard, FE; Hofstra, JJ; Veer, CVT; Levi, MM; Roelofs, JJTH; van der Poll, T; Schultz, MJ				van den Boogaard, Florry E.; Hofstra, Jorrit J.; Veer, Cornelis van t; Levi, Marcel M.; Roelofs, Joris J. T. H.; van der Poll, Tom; Schultz, Marcus J.			Feasibility and Safety of Local Treatment with Recombinant Human Tissue Factor Pathway Inhibitor in a Rat Model of Streptococcus pneumoniae Pneumonia	PLOS ONE			English	Article							ACUTE LUNG INJURY; MURINE PNEUMOCOCCAL PNEUMONIA; RESPIRATORY-DISTRESS-SYNDROME; RANDOMIZED CONTROLLED-TRIAL; COLI SEPTIC SHOCK; ESCHERICHIA-COLI; SEVERE SEPSIS; NEBULIZED ANTICOAGULANTS; PROCOAGULANT ACTIVITY; ALVEOLAR COAGULATION	Pulmonary coagulopathy is intrinsic to pulmonary injury including pneumonia. Anticoagulant strategies could benefit patients with pneumonia, but systemic administration of anticoagulant agents may lead to suboptimal local levels and may cause systemic hemorrhage. We hypothesized nebulization to provide a safer and more effective route for local administration of anticoagulants. Therefore, we aimed to examine feasibility and safety of nebulization of recombinant human tissue factor pathway inhibitor (rh-TFPI) in a well-established rat model of Streptococcus (S.) pneumoniae pneumonia. Thirty minutes before and every 6 hours after intratracheal instillation of S. pneumonia causing pneumonia, rats were subjected to local treatment with rh-TFPI or placebo, and sacrificed after 42 hours. Pneumonia was associated with local as well as systemic activation of coagulation. Nebulization of rh-TFPI resulted in high levels of rh-TFPI in bronchoalveolar lavage fluid, which was accompanied by an attenuation of pulmonary coagulation. Systemic rh-TFPI levels remained undetectable, and systemic TFPI activity and systemic coagulation were not affected. Histopathology revealed no bleeding in the lungs. We conclude that nebulization of rh-TFPI seems feasible and safe; local anticoagulant treatment with rh-TFPI attenuates pulmonary coagulation, while not affecting systemic coagulation in a rat model of S. pneumoniae pneumonia.	[van den Boogaard, Florry E.; Hofstra, Jorrit J.; Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, LEICA, NL-1105 AZ Amsterdam, Netherlands; [Schultz, Marcus J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, NL-1105 AZ Amsterdam, Netherlands; [van den Boogaard, Florry E.; Veer, Cornelis van t; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, CEMM, NL-1105 AZ Amsterdam, Netherlands; [Levi, Marcel M.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [van den Boogaard, Florry E.; Veer, Cornelis van t; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Roelofs, Joris J. T. H.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Dept Infect Dis, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van den Boogaard, FE (corresponding author), Univ Amsterdam, Acad Med Ctr, LEICA, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	f.e.vandenboogaard@amc.uva.nl	Schultz, Marcus/AAB-6379-2021; Levi, Marcel/AAZ-8559-2020	Schultz, Marcus/0000-0003-3969-7792; Roelofs, Joris/0000-0001-9595-6571	Novartis, Switzerland; Netherlands Organization for Health Research and Development (ZonMW), NWO-VENI grant [016.056.001]	Novartis, Switzerland; Netherlands Organization for Health Research and Development (ZonMW), NWO-VENI grant	This work was supported by Novartis, Switzerland; Netherlands Organization for Health Research and Development (ZonMW), NWO-VENI grant 2004 to MJS (project number 016.056.001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, JAMA-J AM MED ASSOC, V290, P238, DOI 10.1001/jama.290.2.238; Bastarache JA, 2008, AM J PHYSIOL-LUNG C, V294, pL874, DOI 10.1152/ajplung.00372.2007; Bastarache JA, 2012, THORAX, V67, P1032, DOI 10.1136/thoraxjnl-2012-201781; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Camerota AJ, 1998, J INFECT DIS, V177, P668, DOI 10.1086/514246; CARR C, 1994, CIRC SHOCK, V44, P126; Choi G, 2007, EUR RESPIR J, V30, P423, DOI 10.1183/09031936.00165606; Choi G, 2004, EUR RESPIR J, V24, P786, DOI 10.1183/09031936.04.00140703; Choi G, 2008, CRIT CARE MED, V36, P204, DOI 10.1097/01.CCM.0000292012.87482.F4; Choi G, 2006, ANESTHESIOLOGY, V105, P689, DOI 10.1097/00000542-200610000-00013; Cornet AD, 2011, SHOCK, V36, P417, DOI 10.1097/SHK.0b013e31822bcef0; CREASEY AA, 1993, J CLIN INVEST, V91, P2850, DOI 10.1172/JCI116529; de Jonge E, 2000, BLOOD, V95, P1124, DOI 10.1182/blood.V95.4.1124.002k20_1124_1129; DEMOERLOOSE P, 1992, THROMB RES, V65, P507, DOI 10.1016/0049-3848(92)90202-L; Dixon B, 2010, CRIT CARE, V14, DOI 10.1186/cc9269; Dixon B, 2008, CRIT CARE, V12, DOI 10.1186/cc6894; Enkhbaatar P, 2000, AM J RESP CRIT CARE, V162, P1752, DOI 10.1164/ajrccm.162.5.9911018; Glas GJ, 2013, J THROMB HAEMOST, V11, P17, DOI 10.1111/jth.12047; Gunther A, 2000, AM J RESP CRIT CARE, V161, P454; Hofstra JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055262; Hofstra JJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8040; Honeybourne D, 1997, Curr Opin Pulm Med, V3, P170, DOI 10.1097/00063198-199703000-00014; Kipnis E, 2004, SHOCK, V21, P444, DOI 10.1097/00024382-200405000-00008; LEVI M, 1994, J CLIN INVEST, V93, P114, DOI 10.1172/JCI116934; LEVI M, 1992, THROMB HAEMOSTASIS, V67, P111; Levi M, 2010, SEMIN THROMB HEMOST, V36, P550, DOI 10.1055/s-0030-1255449; Lwaleed BA, 2006, J PATHOL, V208, P327, DOI 10.1002/path.1871; Milbrandt EB, 2009, MOL MED, V15, P438, DOI 10.2119/molmed.2009.00091; Miller DL, 2002, AM J RESP CELL MOL, V26, P650, DOI 10.1165/ajrcmb.26.6.4688; Moons AHM, 2002, THROMB HAEMOSTASIS, V88, P627, DOI 10.1055/s-0037-1613266; Papareddy P, 2010, J BIOL CHEM; Papareddy P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003803; Rijneveld AW, 2006, CRIT CARE MED, V34, P1725, DOI 10.1097/01.CCM.0000218807.20570.C2; Rijneveld AW, 2003, BLOOD, V102, P934, DOI 10.1182/blood-2003-01-0227; SANDSET PM, 1987, THROMB RES, V47, P389, DOI 10.1016/0049-3848(87)90454-3; Schirm S, 2009, J INFECT DIS, V199, P1807, DOI 10.1086/599097; Schultz MJ, 2004, THORAX, V59, P130, DOI 10.1136/thorax.2003.013888; TAYLOR FB, 1991, CIRC SHOCK, V33, P127; Tuinman PR, 2012, CRIT CARE, V16, DOI 10.1186/cc11325; van den Boogaard FE, 2011, J THROMB HAEMOST, V9, P122, DOI 10.1111/j.1538-7836.2010.04089.x; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; van der Poll T, 2008, CRIT CARE, V12, DOI 10.1186/cc7026; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Welty-Wolf KE, 2001, AM J RESP CRIT CARE, V164, P1988, DOI 10.1164/ajrccm.164.10.2105027; Welty-Wolf KE, 2006, AM J PHYSIOL-LUNG C, V290, pL21, DOI 10.1152/ajplung.00155.2005; Welty-Wolf KE, 2001, SEMIN HEMATOL, V38, P35, DOI 10.1016/S0037-1963(01)90145-3; Wunderink RG, 2011, AM J RESP CRIT CARE, V183, P1561, DOI 10.1164/rccm.201007-1167OC; Wygrecka M, 2008, THROMB HAEMOSTASIS, V99, P494, DOI 10.1160/TH07-11-0666	48	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127261	10.1371/journal.pone.0127261	http://dx.doi.org/10.1371/journal.pone.0127261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992779	gold, Green Submitted, Green Published			2022-12-26	WOS:000354917300107
J	Mei, YW; Xu, L; Mowrey, DD; Giraldez, RM; Wang, Y; Pasek, DA; Dokholyan, NV; Meissner, G				Mei, Yingwu; Xu, Le; Mowrey, David D.; Giraldez, Raul Mendez; Wang, Ying; Pasek, Daniel A.; Dokholyan, Nikolay V.; Meissner, Gerhard			Channel Gating Dependence on Pore Lining Helix Glycine Residues in Skeletal Muscle Ryanodine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; DISCRETE MOLECULAR-DYNAMICS; AMINO-ACID-RESIDUES; SARCOPLASMIC-RETICULUM; POTASSIUM CHANNELS; PROTEIN STABILITY; DISEASE; HINGE; RYR1; CONDUCTANCE	Type 1 ryanodine receptors (RyR1s) release Ca2+ from the sarcoplasmic reticulum to initiate skeletal muscle contraction. The role of RyR1-G4934 and -G4941 in the pore-lining helix in channel gating and ion permeation was probed by replacing them with amino acid residues of increasing side chain volume. RyR1-G4934A, -G4941A, and -G4941V mutant channels exhibited a caffeine-induced Ca2+ release response in HEK293 cells and bound the RyR-specific ligand [H-3] ryanodine. In single channel recordings, significant differences in the number of channel events and mean open and close times were observed between WT and RyR1-G4934A and -G4941A. RyR1-G4934A had reduced K+ conductance and ion selectivity compared with WT. Mutations further increasing the side chain volume at these positions (G4934V and G4941I) resulted in reduced caffeine-induced Ca2+ release in HEK293 cells, low [ 3H] ryanodine binding levels, and channels that were not regulated by Ca2+ and did not conduct Ca2+ in single channel measurements. Computational predictions of the thermodynamic impact of mutations on protein stability indicated that although the G4934A mutation was tolerated, the G4934V mutation decreased protein stability by introducing clashes with neighboring amino acid residues. In similar fashion, the G4941A mutation did not introduce clashes, whereas the G4941I mutation resulted in intersubunit clashes among the mutated isoleucines. Co-expression of RyR1-WT with RyR1-G4934V or -G4941I partially restored the WT phenotype, which suggested lessening of amino acid clashes in heterotetrameric channel complexes. The results indicate that both glycines are important for RyR1 channel function by providing flexibility and minimizing amino acid clashes.	[Mei, Yingwu; Xu, Le; Mowrey, David D.; Giraldez, Raul Mendez; Wang, Ying; Pasek, Daniel A.; Dokholyan, Nikolay V.; Meissner, Gerhard] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Meissner, G (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	meissner@med.unc.edu	Regan, Clinton/E-6250-2012; Xu, Le/HDN-9623-2022; Dokholyan, Nikolay/D-8081-2018	Dokholyan, Nikolay/0000-0002-8225-4025	National Institutes of Health [AR018687]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR018687, R01AR018687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR018687.	Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Dirksen RT, 2002, TRENDS CARDIOVAS MED, V12, P189, DOI 10.1016/S1050-1738(02)00163-9; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; Euden J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066542; Euden J, 2013, J BIOL CHEM, V288, P16671, DOI 10.1074/jbc.M113.465310; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; Gao L, 1997, FEBS LETT, V412, P223, DOI 10.1016/S0014-5793(97)00781-3; Hamilton SL, 2009, J BIOL CHEM, V284, P4047, DOI 10.1074/jbc.R800054200; Hardman RM, 2007, J BIOL CHEM, V282, P31972, DOI 10.1074/jbc.M705835200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Lanner JT, 2012, ADV EXP MED BIOL, V740, P217, DOI 10.1007/978-94-007-2888-2_9; LIU QY, 1989, BIOPHYS J, V55, P415, DOI 10.1016/S0006-3495(89)82835-8; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; LYU PC, 1991, P NATL ACAD SCI USA, V88, P5317, DOI 10.1073/pnas.88.12.5317; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; Meissner G, 2002, FRONT BIOSCI, V7, pD2072, DOI 10.2741/meissner; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; Ramachandran S, 2013, J BIOL CHEM, V288, P6154, DOI 10.1074/jbc.M112.433789; Rosenhouse-Dantsker A, 2006, BIOPHYS J, V91, P2860, DOI 10.1529/biophysj.105.080242; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; SERYSHEVA II, 1995, NAT STRUCT BIOL, V2, P18, DOI 10.1038/nsb0195-18; Shirvanyants D, 2012, J PHYS CHEM B, V116, P8375, DOI 10.1021/jp2114576; SMITH JS, 1988, J GEN PHYSIOL, V92, P1, DOI 10.1085/jgp.92.1.1; TINKER A, 1992, J GEN PHYSIOL, V100, P479, DOI 10.1085/jgp.100.3.479; Wang RW, 2004, J BIOL CHEM, V279, P3635, DOI 10.1074/jbc.M311367200; Wang Y, 2005, BIOPHYS J, V89, P256, DOI 10.1529/biophysj.104.056002; Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521; Xiao BL, 2002, J BIOL CHEM, V277, P41778, DOI 10.1074/jbc.M208210200; Xu L, 2006, BIOPHYS J, V90, P443, DOI 10.1529/biophysj.105.072538; Xu L, 2008, J BIOL CHEM, V283, P6321, DOI 10.1074/jbc.M707353200; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Yin S, 2007, STRUCTURE, V15, P1567, DOI 10.1016/j.str.2007.09.024; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971	42	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17535	17545		10.1074/jbc.M115.659672	http://dx.doi.org/10.1074/jbc.M115.659672			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25998124	Green Published, hybrid			2022-12-26	WOS:000357730900044
J	Wang, L; Lee, SJ; Verdine, GL				Wang, Lan; Lee, Seung-Joo; Verdine, Gregory L.			Structural Basis for Avoidance of Promutagenic DNA Repair by MutY Adenine DNA Glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; FREE R-VALUE; ESCHERICHIA-COLI; EXCISION-REPAIR; 8-OXOGUANINE; MUTATIONS; HOMOLOG; PROTEIN; GENE; SPECIFICITY	The highly mutagenic A: oxoG (8-oxoguanine) base pair in DNA most frequently arises by aberrant replication of the primary oxidative lesion C:oxoG. This lesion is particularly insidious because neither of its constituent nucleobases faithfully transmit genetic information from the original C:G base pair. Repair of A: oxoG is initiated by adenine DNA glycosylase, which catalyzes hydrolytic cleavage of the aberrant A nucleobase from the DNA backbone. These enzymes, MutY in bacteria and MUTYH in humans, scrupulously avoid processing of C: oxoG because cleavage of the C residue in C: oxoG would actually promote mutagenic conversion to A: oxoG. Here we analyze the structural basis for rejection of C: oxoG by MutY, using a synthetic crystallography approach to capture the enzyme in the process of inspecting the C: oxoG anti-substrate, with which it ordinarily binds only fleetingly. We find that MutY uses two distinct strategies to avoid presentation of C to the enzyme active site. Firstly, MutY possesses an exo-site that serves as a decoy for C, and secondly, repulsive forces with a key active site residue prevent stable insertion of C into the nucleobase recognition pocket within the enzyme active site.	[Wang, Lan; Lee, Seung-Joo; Verdine, Gregory L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Verdine, GL (corresponding author), Harvard Univ, 12 Oxford St, Cambridge, MA 02138 USA.	gregory_verdine@harvard.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [CA100742]; NATIONAL CANCER INSTITUTE [R01CA100742] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by National Institutes of Health Grant CA100742. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Barrett TE, 1999, EMBO J, V18, P6599, DOI 10.1093/emboj/18.23.6599; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI 10.1038/hr.2014.17; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Guan Y, 1998, NAT STRUCT BIOL, V5, P1058, DOI 10.1038/4168; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Labahn J, 1996, CELL, V86, P321, DOI 10.1016/S0092-8674(00)80103-8; Lee S, 2009, P NATL ACAD SCI USA, V106, P18497, DOI 10.1073/pnas.0902908106; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lu AL, 1998, J BIOL CHEM, V273, P25098, DOI 10.1074/jbc.273.39.25098; MICHAELS ML, 1992, P NATL ACAD SCI USA, V89, P7022, DOI 10.1073/pnas.89.15.7022; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; MORIYA M, 1993, MOL GEN GENET, V239, P72, DOI 10.1007/BF00281603; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; NGHIEM Y, 1988, P NATL ACAD SCI USA, V85, P2709, DOI 10.1073/pnas.85.8.2709; Noll DM, 1999, BIOCHEMISTRY-US, V38, P6374, DOI 10.1021/bi990335x; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Parker A, 2000, NUCLEIC ACIDS RES, V28, P3206, DOI 10.1093/nar/28.17.3206; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Slupska MM, 1996, J BACTERIOL, V178, P3885, DOI 10.1128/jb.178.13.3885-3892.1996; THAYER MM, 1995, EMBO J, V14, P4108, DOI 10.1002/j.1460-2075.1995.tb00083.x; Verdine GL, 2003, ANNU REV BIOCHEM, V72, P337, DOI 10.1146/annurev.biochem.72.121801.161447; Volk DE, 2000, BIOCHEMISTRY-US, V39, P7331, DOI 10.1021/bi000416p; Werner RM, 2000, BIOCHEMISTRY-US, V39, P14054, DOI 10.1021/bi0018178	32	18	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17096	17105		10.1074/jbc.M115.657866	http://dx.doi.org/10.1074/jbc.M115.657866			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25995449	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000357730900005
J	Valencia-Sama, I; Zhao, YL; Lai, D; van Rensburg, HJJ; Hao, YW; Yang, XL				Valencia-Sama, Ivette; Zhao, Yulei; Lai, Dulcie; van Rensburg, Helena J. Janse; Hao, Yawei; Yang, Xiaolong			Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates Delta Np63 Transcription through TEA Domain (TEAD) Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; BREAST-CANCER; CELL-PROLIFERATION; SIGNALING PATHWAY; P63 EXPRESSION; TISSUE-GROWTH; SIZE CONTROL; YAP; PROTEIN; COACTIVATOR	Transcriptional co-activator with a PDZ binding domain (TAZ) is a WW domain-containing transcriptional co-activator and a core component of an emerging Hippo signaling pathway that regulates organ size, tumorigenesis, metastasis, and drug resistance. TAZ regulates these biological functions by up-regulating downstream cellular genes through transactivation of transcription factors such as TEAD and TTF1. To understand the molecular mechanisms underlying TAZ-induced tumorigenesis, we have recently performed a gene expression profile analysis by overexpressing TAZ in mammary cells. In addition to the TAZ-up-regulated genes that were confirmed in our previous studies, we identified a large number of cellular genes that were down-regulated by TAZ. In this study, we have confirmed these down-regulated genes (including cytokines, chemokines, and p53 gene family members) as bona fide downstream transcriptional targets of TAZ. By using human breast and lung epithelial cells, we have further characterized Delta Np63, a p53 gene family member, and shown that TAZ suppresses Delta Np63 mRNA, protein expression, and promoter activity through interaction with the transcription factor TEAD. We also show that TEAD can inhibit Delta Np63 promoter activity and that TAZ can directly interact with Delta Np63 promoter-containing TEAD binding sites. Finally, we provide functional evidence that down-regulation of Delta Np63 by TAZ may play a role in regulating cell migration. Altogether, this study provides novel evidence that the Hippo component TAZ can function as a co-repressor and regulate biological functions by negatively regulating downstream cellular genes.	[Valencia-Sama, Ivette; Zhao, Yulei; Lai, Dulcie; van Rensburg, Helena J. Janse; Hao, Yawei; Yang, Xiaolong] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada	McMaster University; Queens University - Canada	Yang, XL (corresponding author), Queens Univ, Dept Pathol & Mol Med, Richardson Lab 201,88 Stuart St, Kingston, ON K7L 3N6, Canada.	yang@path.queensu.ca	van Rensburg, Helena Janse/AAF-8548-2019; zhao, Yulei/M-8667-2018	Valencia-Sama, Ivette/0000-0003-2706-7435; Janse van Rensburg, Helena/0000-0002-4066-7489	Canadian Institute of Health Research (CIHR) [119325]; Canadian Breast Cancer Foundation, Canada; CIHR/Terry Fox Foundation Training Program in Transdisciplinary Cancer Research; Queen's graduate studentship; Ontario Trillium graduate scholarship	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation, Canada; CIHR/Terry Fox Foundation Training Program in Transdisciplinary Cancer Research(Canadian Institutes of Health Research (CIHR)); Queen's graduate studentship; Ontario Trillium graduate scholarship	This work was supported in part by Canadian Institute of Health Research (CIHR) Grant 119325 and Canadian Breast Cancer Foundation, Canada (to X. Y.).; Supported by the CIHR/Terry Fox Foundation Training Program in Transdisciplinary Cancer Research and a Queen's graduate studentship.; Supported by an Ontario Trillium graduate scholarship.	Avruch J, 2012, SEMIN CELL DEV BIOL, V23, P770, DOI 10.1016/j.semcdb.2012.07.002; Badouel C, 2011, CELL, V145, P484, DOI 10.1016/j.cell.2011.04.009; Barron DA, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-25; Bartucci M, 2015, ONCOGENE, V34, P681, DOI 10.1038/onc.2014.5; Basu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062478; Bergholz J, 2014, ONCOGENE, V33, P212, DOI 10.1038/onc.2012.564; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; de Cristofaro T, 2011, EUR J CANCER, V47, P926, DOI 10.1016/j.ejca.2010.11.008; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Di Palma T, 2009, EXP CELL RES, V315, P162, DOI 10.1016/j.yexcr.2008.10.016; Diepenbruck M, 2014, J CELL SCI, V127, P1523, DOI 10.1242/jcs.139865; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Gao YJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5629; Gomez M, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-22; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hildmann C, 2007, APPL MICROBIOL BIOT, V75, P487, DOI 10.1007/s00253-007-0911-2; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Jang EJ, 2012, MOL CELL BIOL, V32, P4925, DOI 10.1128/MCB.00392-12; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Koker MM, 2004, AM J SURG PATHOL, V28, P1506, DOI 10.1097/01.pas.0000138183.97366.fd; Koontz LM, 2013, DEV CELL, V25, P388, DOI 10.1016/j.devcel.2013.04.021; Lai D, 2013, CELL SIGNAL, V25, P1720, DOI 10.1016/j.cellsig.2013.05.002; Lai D, 2012, BIOSCIENCE REP, V32, P361, DOI 10.1042/BSR20110125; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Lindsay J, 2011, J BIOL CHEM, V286, P3915, DOI 10.1074/jbc.M110.162511; Liu Chenying, 2011, Int J Biochem Mol Biol, V2, P247; Liu H, 2012, PROTEIN CELL, V3, P291, DOI 10.1007/s13238-012-2919-3; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Oh H, 2013, CELL REP, V3, P309, DOI 10.1016/j.celrep.2013.01.008; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Qing Y, 2014, ELIFE, V3, DOI 10.7554/eLife.02564; Reis JS, 2003, CANCER CYTOPATHOL, V99, P172, DOI 10.1002/cncr.11061; Skibinski A, 2014, CELL REP, V6, P1059, DOI 10.1016/j.celrep.2014.02.038; Stefanou D, 2004, HISTOL HISTOPATHOL, V19, P465, DOI 10.14670/HH-19.465; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang Xiaojuan, 2002, Breast Cancer, V9, P216, DOI 10.1007/BF02967592; Wu J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.239; Xie M, 2012, J THORAC ONCOL, V7, P799, DOI 10.1097/JTO.0b013e318248240b; Xu JX, 2013, GENES CELLS, V18, P1082, DOI 10.1111/gtc.12102; Yang XL, 2011, CELL RES, V21, P715, DOI 10.1038/cr.2011.63; Yuen HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054211; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang WJ, 2014, CELL RES, V24, P331, DOI 10.1038/cr.2014.10; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2009, CANCER RES, V69, P1089, DOI 10.1158/0008-5472.CAN-08-2997; Zhao YL, 2015, INT J CANCER, V137, P2767, DOI 10.1002/ijc.29293; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606; Zhou Z, 2011, MOL MED REP, V4, P1075, DOI 10.3892/mmr.2011.543	60	30	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16906	16917		10.1074/jbc.M115.642363	http://dx.doi.org/10.1074/jbc.M115.642363			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25995450	hybrid, Green Published			2022-12-26	WOS:000357572800035
J	Scobie, HM; Ray, A; Routray, S; Bose, A; Bahl, S; Sosler, S; Wannemuehler, K; Kumar, R; Haldar, P; Anand, A				Scobie, Heather M.; Ray, Arindam; Routray, Satyabrata; Bose, Anindya; Bahl, Sunil; Sosler, Stephen; Wannemuehler, Kathleen; Kumar, Rakesh; Haldar, Pradeep; Anand, Abhijeet			Cluster Survey Evaluation of a Measles Vaccination Campaign in Jharkhand, India, 2012	PLOS ONE			English	Article							ROUTINE IMMUNIZATION; POLIO ERADICATION; COVERAGE; ELIMINATION	Introduction India was the last country in the world to implement a two-dose strategy for measles-containing vaccine (MCV) in 2010. As part of measles second-dose introduction, phased measles vaccination campaigns were conducted during 2010-2013, targeting 131 million children 9 months to < 10 years of age. We performed a post-campaign coverage survey to estimate measles vaccination coverage in Jharkhand state. Methods A multi-stage cluster survey was conducted 2 months after the phase 2 measles campaign occurred in 19 of 24 districts of Jharkhand during November 2011-March 2012. Vaccination status of children 9 months to < 10 years of age was documented based on vaccination card or mother's recall. Coverage estimates and 95% confidence intervals (95% CI) for 1,018 children were calculated using survey methods. Results In the Jharkhand phase 2 campaign, MCV coverage among children aged 9 months to < 10 years was 61.0% (95% CI: 54.4-67.7%). Significant differences in coverage were observed between rural (65.0%; 95% CI: 56.8-73.2%) and urban areas (45.6%; 95% CI: 37.3-53.9%). Campaign awareness among mothers was low (51.5%), and the most commonly reported reason for non-vaccination was being unaware of the campaign (69.4%). At the end of the campaign, 53.7% (95% CI: 46.5-60.9%) of children 12 months to < 10 years of age received >= 2 MCV doses, while a large proportion of children remained under-vaccinated (34.0%, 95% CI: 28.0-40.0%) or unvaccinated (12.3%, 95% CI: 9.3-16.2%). Conclusions Implementation of the national measles campaign was a significant achievement towards measles elimination in India. In Jharkhand, campaign performance was below the target coverage of >= 90% set by the Government of India, and challenges in disseminating campaign messages were identified. Efforts towards increasing two-dose MCV coverage are needed to achieve the recently adopted measles elimination goal in India and the South-East Asia region.	[Scobie, Heather M.; Wannemuehler, Kathleen; Anand, Abhijeet] Ctr Dis Control & Prevent, Global Immunizat Div, Atlanta, GA 30332 USA; [Scobie, Heather M.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Ray, Arindam; Routray, Satyabrata; Bose, Anindya; Bahl, Sunil; Sosler, Stephen] WHO, Country Off, Natl Polio Surveillance Project, New Delhi, India; [Kumar, Rakesh; Haldar, Pradeep] Govt India, Minist Hlth & Family Welf, New Delhi, India	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; World Health Organization	Scobie, HM (corresponding author), Ctr Dis Control & Prevent, Global Immunizat Div, Atlanta, GA 30332 USA.	hscobie@cdc.gov	Ray, Arindam/AAN-1525-2020	Ray, Arindam/0000-0002-5955-0352; Wannemuehler, Kathleen/0000-0001-9535-6277; Bose, Anindya Sekhar/0000-0002-7657-8648	National Polio Surveillance Project; World Health Organization Country Office; U.S. Centers for Disease Control and Prevention (CDC)	National Polio Surveillance Project; World Health Organization Country Office(World Health Organization); U.S. Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding was provided by the National Polio Surveillance Project, World Health Organization Country Office and U.S. Centers for Disease Control and Prevention (CDC). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U.S. CDC or other organizations.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P349; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P1321; Bagonza J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-202; Bahl S, 2014, MMWR-MORBID MORTAL W, V63, pCOVER1; BALRAJ V, 1986, B WORLD HEALTH ORGAN, V64, P861; Burton A, 2009, B WORLD HEALTH ORGAN, V87, P535, DOI 10.2471/BLT.08.053819; Closser S, 2014, J INFECT DIS, V210, pS504, DOI 10.1093/infdis/jit232; Fields R, 2013, VACCINE, V31, pB115, DOI 10.1016/j.vaccine.2012.11.094; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Government of India, 2011, VILLAGE TOWN WISE PR; Government of India Ministry of Health and Family Welfare, 2015, MEASL SUPPL IMM ACT; Government of India Ministry of Health and Family Welfare, 2010, MEASL CATCH IMM CAMP; Gupta SK, 2011, INDIAN PEDIATR, V48, P379, DOI 10.1007/s13312-011-0066-1; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; Kish L, 1965, SURVEY SAMPLING; Miles M, 2013, VACCINE, V31, P1560, DOI 10.1016/j.vaccine.2012.10.089; Obregon R, 2009, B WORLD HEALTH ORGAN, V87, P624, DOI 10.2471/BLT.08.060863; Perry RT, 2014, MMWR-MORBID MORTAL W, V63, P103; Sosler Stephen, 2011, Morbidity and Mortality Weekly Report, V60, P1315; United Nations Population Division, 2011, STAT ANN NUMB BIRTHS; Vashishtha VM, 2013, INDIAN PEDIATR, V50, P561, DOI 10.1007/s13312-013-0165-2; *WHO, 2004, IMM COV CLUST SURV R; World Health Organization (WHO) and United Nations Children's Fund (UNICEF), 2012, WHO UNICEF EST NAT I; Zuber PLF, 2003, J INFECT DIS, V187, pS86, DOI 10.1086/368052	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127105	10.1371/journal.pone.0127105	http://dx.doi.org/10.1371/journal.pone.0127105			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010084	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900063
J	Mah, V; Alavi, M; Marquez-Garban, DC; Maresh, EL; Kim, SR; Horvath, S; Bagryanova, L; Huerta-Yepez, S; Chia, D; Pietras, R; Goodglick, L				Mah, Vei; Alavi, Mohammad; Marquez-Garban, Diana C.; Maresh, Erin L.; Kim, Sara R.; Horvath, Steve; Bagryanova, Lora; Huerta-Yepez, Sara; Chia, David; Pietras, Richard; Goodglick, Lee			Ribonucleotide Reductase Subunit M2 Predicts Survival in Subgroups of Patients with Non-Small Cell Lung Carcinoma: Effects of Gender and Smoking Status	PLOS ONE			English	Article							DNA-DAMAGE; PROGNOSTIC BIOMARKER; COLORECTAL-CANCER; GENOME INTEGRITY; NEVER-SMOKERS; EXPRESSION; REPAIR; GEMCITABINE; RESISTANCE; P53R2	Background Ribonucleotide reductase catalyzes the conversion of ribonucleotide diphosphates to deoxyribonucleotide diphosphates. The functional enzyme consists of two subunits - one large (RRM1) and one small (RRM2 or RRM2b) subunit. Expression levels of each subunit have been implicated in prognostic outcomes in several different types of cancers. Experimental Design Immunohistochemistry for RRM1 and RRM2 was performed on a lung cancer tissue microarray (TMA) and analyzed. 326 patients from the microarray were included in this study. Results In non-small cell lung cancer (NSCLC), RRM2 expression was strongly predictive of disease-specific survival in women, non-smokers and former smokers who had quit at least 10 years prior to being diagnosed with lung cancer. Higher expression was associated with worse survival. This was not the case for men, current smokers and those who had stopped smoking for shorter periods of time. RRM1 was not predictive of survival outcomes in any subset of the patient group. Conclusion RRM2, but not RRM1, is a useful predictor of survival outcome in certain subsets of NSCLC patients.	[Mah, Vei; Alavi, Mohammad; Maresh, Erin L.; Kim, Sara R.; Bagryanova, Lora; Chia, David; Goodglick, Lee] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Marquez-Garban, Diana C.; Pietras, Richard] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Horvath, Steve] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90095 USA; [Horvath, Steve] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Marquez-Garban, Diana C.; Horvath, Steve; Chia, David; Pietras, Richard; Goodglick, Lee] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Huerta-Yepez, Sara] Hosp Infantil Mexico Dr Federico Gomez, Unidad Invest Enfermedades Oncol, Federico Gomez, Ssa, Mexico	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Hospital Infantil de Mexico Federico Gomez	Mah, V (corresponding author), Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	vmah@mednet.ucla.edu		Pietras, Richard/0000-0002-2846-3192	Early Detection Research Network NCI [CA86366]; National Lung Cancer Partnership; Specialized Programs of Research Excellence in Lung Cancer [P50-CA90388]; NCI; Stiles Program in Oncology; Hickey Foundation; Prostate SPORE NIH [P50CA092131]; NATIONAL CANCER INSTITUTE [U24CA086366, P50CA090388, P50CA092131] Funding Source: NIH RePORTER	Early Detection Research Network NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Lung Cancer Partnership; Specialized Programs of Research Excellence in Lung Cancer; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stiles Program in Oncology; Hickey Foundation; Prostate SPORE NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Early Detection Research Network NCI CA86366 (LG, DC), the National Lung Cancer Partnership (LG), the Specialized Programs of Research Excellence in Lung Cancer grant P50-CA90388, NCI (RP, LG), the Stiles Program in Oncology (RP), the Hickey Foundation (LG, RP), and Prostate SPORE NIH P50CA092131 (SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad MF, 2012, MOL CANCER THER, V11, P2077, DOI 10.1158/1535-7163.MCT-12-0199; American Cancer Society, CANCER FACTS FIGURES; Aye Y, 2015, ONCOGENE, V34, P2011, DOI 10.1038/onc.2014.155; Bagryanova L, PROGNOSTIC GEN UNPUB; Cerqueira NMFSA, 2007, CHEM-EUR J, V13, P8507, DOI 10.1002/chem.200700260; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Chapman TR, 2012, FRONT ONCOL, V1, DOI 10.3389/fonc.2011.00056; Couraud S, 2012, EUR J CANCER, V48, P1299, DOI 10.1016/j.ejca.2012.03.007; D'Angiolella V, 2012, CELL, V149, P1023, DOI 10.1016/j.cell.2012.03.043; Dalla Pozza E, 2012, BBA-MOL CELL RES, V1823, P1856, DOI 10.1016/j.bbamcr.2012.06.007; Davidson JD, 2004, CANCER RES, V64, P3761, DOI 10.1158/0008-5472.CAN-03-3363; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Dogan S, 2012, CLIN CANCER RES, V18, P6169, DOI 10.1158/1078-0432.CCR-11-3265; Duxbury MS, 2007, BIOCHEM BIOPH RES CO, V354, P190, DOI 10.1016/j.bbrc.2006.12.177; ENGSTROM Y, 1985, J BIOL CHEM, V260, P9114; ERIKSSON S, 1984, J BIOL CHEM, V259, P1695; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; Furuta E, 2010, BBA-REV CANCER, V1805, P141, DOI 10.1016/j.bbcan.2010.01.005; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hsu NY, 2011, ANTICANCER RES, V31, P3475; Hsu NY, 2010, ONCOL LETT, V1, P609, DOI 10.3892/ol_00000108; Jordheim LP, 2011, LANCET ONCOL, V12, P693, DOI 10.1016/S1470-2045(10)70244-8; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lee JJ, 2010, LUNG CANCER, V70, P205, DOI 10.1016/j.lungcan.2010.02.005; Liu XY, 2013, CLIN SCI, V124, P567, DOI 10.1042/CS20120240; Liu XY, 2011, CANCER RES, V71, P3202, DOI 10.1158/0008-5472.CAN-11-0054; Lu AG, 2012, WORLD J GASTROENTERO, V18, P4704, DOI 10.3748/wjg.v18.i34.4704; Mah V, 2007, CANCER RES, V67, P10484, DOI 10.1158/0008-5472.CAN-07-2607; Mah V, 2011, LUNG CANCER, V74, P318, DOI 10.1016/j.lungcan.2011.03.009; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Matsushita S, 2012, J DERMATOL SCI, V68, P19, DOI 10.1016/j.jdermsci.2012.07.005; Morikawa T, 2010, HUM PATHOL, V41, P1742, DOI 10.1016/j.humpath.2010.06.001; Niida H, 2010, CANCER SCI, V101, P2505, DOI 10.1111/j.1349-7006.2010.01719.x; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109; Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105; Rosell R, 2004, CLIN CANCER RES, V10, p4215S, DOI 10.1158/1078-0432.CCR-040006; Rosell R, 2004, CLIN CANCER RES, V10, P1318, DOI 10.1158/1078-0432.CCR-03-0156; Sakurai H, 2010, J THORAC ONCOL, V5, P1594, DOI 10.1097/JTO.0b013e3181f1923b; Shetty SK, 2012, BIOCHEMISTRY-US, V51, P205, DOI 10.1021/bi201293x; Subramanian J, 2008, LANCET ONCOL, V9, P676, DOI 10.1016/S1470-2045(08)70174-8; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tang H, 2013, CLIN CANCER RES, V19, P1577, DOI 10.1158/1078-0432.CCR-12-2321; Tang LY, 2007, MOL CELL PROTEOMICS, V6, P1952, DOI 10.1074/mcp.M700120-MCP200; Wang LJ, 2013, PSYCHIAT INVEST, V10, P1, DOI 10.4306/pi.2013.10.1.1; Xu X, 2008, CANCER RES, V68, P2652, DOI 10.1158/0008-5472.CAN-07-5873; Zhou B, 2001, CYTOGENET CELL GENET, V95, P34, DOI 10.1159/000057014; Zhou B, 2001, CYTOGENET CELL GENET, V95, P52, DOI 10.1159/000057017	49	26	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127600	10.1371/journal.pone.0127600	http://dx.doi.org/10.1371/journal.pone.0127600			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001082	gold, Green Published			2022-12-26	WOS:000354931700068
J	Marcar, L; Ihrig, B; Hourihan, J; Bray, SE; Quinlan, PR; Jordan, LB; Thompson, AM; Hupp, TR; Meek, DW				Marcar, Lynnette; Ihrig, Bianca; Hourihan, John; Bray, Susan E.; Quinlan, Philip R.; Jordan, Lee B.; Thompson, Alastair M.; Hupp, Ted R.; Meek, David W.			MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4	PLOS ONE			English	Article							P53 ACTIVITY; PROTEIN; RING; FAMILY; CANCER; APOPTOSIS; RECEPTOR; TARGETS; UBIQUITINATION; IDENTIFICATION	Melanoma antigen A (MAGE-A) proteins comprise a structurally and biochemically similar sub-family of Cancer/Testis antigens that are expressed in many cancer types and are thought to contribute actively to malignancy. MAGE-A proteins are established regulators of certain cancer-associated transcription factors, including p53, and are activators of several RING finger-dependent ubiquitin E3 ligases. Here, we show that MAGE-A2 associates with MDM2, a ubiquitin E3 ligase that mediates ubiquitylation of more than 20 substrates including mainly p53, MDM2 itself, and MDM4, a potent p53 inhibitor and MDM2 partner that is structurally related to MDM2. We find that MAGE-A2 interacts with MDM2 via the N-terminal p53-binding pocket and the RING finger domain of MDM2 that is required for homo/heterodimerization and for E2 ligase interaction. Consistent with these data, we show that MAGE-A2 is a potent inhibitor of the E3 ubiquitin ligase activity of MDM2, yet it does not have any significant effect on p53 turnover mediated by MDM2. Strikingly, however, increased MAGE-A2 expression leads to reduced ubiquitylation and increased levels of MDM4. Similarly, silencing of endogenous MAGE-A expression diminishes MDM4 levels in a manner that can be rescued by the proteasomal inhibitor, bortezomid, and permits increased MDM2/MDM4 association. These data suggest that MAGE-A proteins can: (i) uncouple the ubiquitin ligase and degradation functions of MDM2; (ii) act as potent inhibitors of E3 ligase function; and (iii) regulate the turnover of MDM4. We also find an association between the presence of MAGE-A and increased MDM4 levels in primary breast cancer, suggesting that MAGE-A-dependent control of MDM4 levels has relevance to cancer clinically.	[Marcar, Lynnette; Ihrig, Bianca; Hourihan, John; Bray, Susan E.; Jordan, Lee B.; Meek, David W.] Univ Dundee, Div Canc Res, Clin Res Ctr, Dundee, Scotland; [Marcar, Lynnette; Ihrig, Bianca; Hourihan, John; Bray, Susan E.; Jordan, Lee B.; Meek, David W.] Ninewells Hosp, Jacqui Wood Canc Ctr, Dundee DD1 9SY, Scotland; [Quinlan, Philip R.] Univ Nottingham, Sch Vet Med & Sci, Nottingham, Leics, England; [Quinlan, Philip R.] Univ Nottingham, Sch Comp Sci, Nottingham NG7 2RD, England; [Quinlan, Philip R.] Univ Nottingham, Adv Data Anal Ctr, Nottingham NG7 2RD, England; [Thompson, Alastair M.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Hupp, Ted R.] Univ Edinburgh, Edinburgh Canc Res UK Ctr, Signal Transduct Lab P53, Edinburgh, Midlothian, Scotland	University of Dundee; University of Dundee; University of Nottingham; University of Nottingham; University of Nottingham; University of Texas System; UTMD Anderson Cancer Center; University of Edinburgh	Meek, DW (corresponding author), Univ Dundee, Div Canc Res, Clin Res Ctr, James Arrott Dr, Dundee, Scotland.	d.w.meek@dundee.ac.uk		Quinlan, Philip/0000-0002-3012-6646; Hupp, Ted/0000-0003-0391-0352	 [2008NovPR32];  [2001NovPhD07]	; 	This study was supported by grant numbers: 2008NovPR32 and 2001NovPhD07, URL: http://www.breastcancercampaign.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew EB, 2010, J BIOL CHEM, V285, P21824, DOI 10.1074/jbc.M110.120600; Askew EB, 2009, J BIOL CHEM, V284, P34793, DOI 10.1074/jbc.M109.065979; Barboza JA, 2008, MOL CANCER RES, V6, P947, DOI 10.1158/1541-7786.MCR-07-2079; Blattner C, 2002, MOL CELL BIOL, V22, P6170, DOI 10.1128/MCB.22.17.6170-6182.2002; Burch LR, 2004, J MOL BIOL, V337, P115, DOI 10.1016/j.jmb.2003.10.081; Carrillo AM, 2015, ONCOGENE, V34, P846, DOI 10.1038/onc.2014.27; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Chomez P, 2001, CANCER RES, V61, P5544; de Graaf P, 2003, J BIOL CHEM, V278, P38315, DOI 10.1074/jbc.M213034200; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Espantman KC, 2010, MOL CELL, V39, P835, DOI 10.1016/j.molcel.2010.09.006; Feng Y, 2011, PROTEIN CELL, V2, P7, DOI 10.1007/s13238-011-1002-9; Gembarska A, 2012, NAT MED, V18, P1239, DOI 10.1038/nm.2863; Hadad SM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-307; Hock AK, 2014, BBA-MOL CELL RES, V1843, P137, DOI 10.1016/j.bbamcr.2013.05.022; Hu Wenwei, 2012, Genes Cancer, V3, P199, DOI 10.1177/1947601912454734; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; King SI, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3136; Kostic M, 2006, J MOL BIOL, V363, P433, DOI 10.1016/j.jmb.2006.08.027; Kulikov R, 2010, P NATL ACAD SCI USA, V107, P10038, DOI 10.1073/pnas.0911716107; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Laduron S, 2004, NUCLEIC ACIDS RES, V32, P4340, DOI 10.1093/nar/gkh735; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Liu W, 2008, CANCER RES, V68, P8104, DOI 10.1158/0008-5472.CAN-08-2132; Love Ian M, 2012, Genes Cancer, V3, P249, DOI 10.1177/1947601912455198; Marcar L, 2010, CANCER RES, V70, P10362, DOI 10.1158/0008-5472.CAN-10-1341; Meek DW, 2012, CANCER LETT, V324, P126, DOI 10.1016/j.canlet.2012.05.011; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; Nardiello T, 2011, CLIN CANCER RES, V17, P4309, DOI 10.1158/1078-0432.CCR-10-1820; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Pant V, 2011, P NATL ACAD SCI USA, V108, P11995, DOI 10.1073/pnas.1102241108; Peche LY, 2012, CELL DEATH DIFFER, V19, P926, DOI 10.1038/cdd.2011.173; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Sang MX, 2011, CANCER LETT, V302, P85, DOI 10.1016/j.canlet.2010.10.021; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Shloush J, 2011, J BIOL CHEM, V286, P4796, DOI 10.1074/jbc.M110.157669; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wade M, 2008, CELL CYCLE, V7, P1973, DOI 10.4161/cc.7.13.6072; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wang XJ, 2011, J BIOL CHEM, V286, P23725, DOI 10.1074/jbc.M110.213868; Wilson EM, 2010, THER ADV UROL, V2, P105, DOI 10.1177/1756287210372380; Wong PP, 2014, ONCOGENE, V33, P4579, DOI 10.1038/onc.2014.45; Xiao TZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023747; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478	54	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127713	10.1371/journal.pone.0127713	http://dx.doi.org/10.1371/journal.pone.0127713			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001071	Green Submitted, Green Published, gold			2022-12-26	WOS:000354931700075
J	Jang, BG; Lee, BL; Kim, WH				Jang, Bo Gun; Lee, Byung Lan; Kim, Woo Ho			Intestinal Stem Cell Markers in the Intestinal Metaplasia of Stomach and Barrett's Esophagus	PLOS ONE			English	Article							HELICOBACTER-PYLORI ERADICATION; GASTRIC-CARCINOMA; RANDOMIZED-TRIAL; CANCER; CDX2; EXPRESSION	Gastric intestinal metaplasia (IM) is a highly prevalent preneoplastic lesion; however, the molecular mechanisms regulating its development remain unclear. We have previously shown that a population of cells expressing the intestinal stem cell (ISC) marker LGR5 increases remarkably in IM. In this study, we further investigated the molecular characteristics of these LGR5(+) cells in IM by examining the expression profile of several ISC markers. Notably, we found that ISC markers-including OLFM4 and EPHB2-are positively associated with the CDX2 expression in non-tumorous gastric tissues. This finding was confirmed in stomach lesions with or without metaplasia, which demonstrated that OLFM4 and EPHB2 expression gradually increased with metaplastic progression. Moreover, RNA in situ hybridization revealed that LGR5+ cells coexpress several ISC markers and remained confined to the base of metaplastic glands, reminiscent to that of normal intestinal crypts, whereas those in normal antral glands expressed none of these markers. Furthermore, a large number of ISC marker-expressing cells were diffusely distributed in gastric adenomas, suggesting that these markers may facilitate gastric tumorigenesis. In addition, Barrett's esophagus (BE)-which is histologically similar to intestinal metaplasia-exhibited a similar distribution of ISC markers, indicating the presence of a stem cell population with intestinal differentiation potential. In conclusion, we identified that LGR5(+) cells in gastric IM and BE coexpress ISC markers, and exhibit the same expression profile as those found in normal intestinal crypts. Taken together, these results implicate an intestinal-like stem cell population in the pathogenesis of IM, and provide an important basis for understanding the development and maintenance of this disease.	[Jang, Bo Gun] Jeju Natl Univ Hosp, Dept Pathol, Jeju, South Korea; [Lee, Byung Lan] Seoul Natl Univ, Coll Med, Dept Anat, Seoul, South Korea; [Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea	Jeju National University; Seoul National University (SNU); Seoul National University (SNU)	Kim, WH (corresponding author), Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea.	woohokim@snu.ac.kr			Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1277]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1277). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichler M, 2014, J PATHOL, V232, P383, DOI 10.1002/path.4300; Almeida R, 2003, J PATHOL, V199, P36, DOI 10.1002/path.1246; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barros R, 2011, GUT, V60, P290, DOI 10.1136/gut.2010.222323; Bonin S, 2010, VIRCHOWS ARCH, V457, P309, DOI 10.1007/s00428-010-0917-5; Correa P, 2000, JNCI-J NATL CANCER I, V92, P1881, DOI 10.1093/jnci/92.23.1881; CORREA P, 1995, AM J SURG PATHOL, V19, pS37; Goldenring JR, 2014, DIGEST DIS SCI, V59, P1078, DOI 10.1007/s10620-014-3088-4; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; Jang BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082390; JASS JR, 1979, HISTOPATHOLOGY, V3, P191, DOI 10.1111/j.1365-2559.1979.tb02996.x; Lavery DL, 2014, GUT; Leung WK, 2004, GUT, V53, P1244, DOI 10.1136/gut.2003.034629; Malfertheiner P, 2005, AM J GASTROENTEROL, V100, P2100, DOI 10.1111/j.1572-0241.2005.41688.x; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Marques-Silva L, 2014, EUR J GASTROEN HEPAT, V26, P378, DOI 10.1097/MEG.0000000000000065; MATSUKURA N, 1980, JNCI-J NATL CANCER I, V65, P231; Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Mills JC, 2011, GASTROENTEROLOGY, V140, P412, DOI 10.1053/j.gastro.2010.12.001; Mizoshita T, 2001, Gastric Cancer, V4, P185, DOI 10.1007/PL00011741; Mutoh H, 2004, CANCER RES, V64, P7740, DOI 10.1158/0008-5472.CAN-04-1617; Mutoh H, 2004, GUT, V53, P1416, DOI 10.1136/gut.2003.032482; Mutoh H, 2002, BIOCHEM BIOPH RES CO, V294, P470, DOI 10.1016/S0006-291X(02)00480-1; Nam K T, 2011, GUT; Nam KT, 2010, GASTROENTEROLOGY, V139, P2028, DOI 10.1053/j.gastro.2010.09.005; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Quante M, 2012, CANCER CELL, V21, P36, DOI 10.1016/j.ccr.2011.12.004; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Silberg DG, 2002, GASTROENTEROLOGY, V122, P689, DOI 10.1053/gast.2002.31902; Sugano K, 2013, J GASTROEN HEPATOL, V28, P906, DOI 10.1111/jgh.12209; Tatematsu M, 2003, CANCER SCI, V94, P135, DOI 10.1111/j.1349-7006.2003.tb01409.x; Tsukamoto Tetsuya, 2006, Gastric Cancer, V9, P156, DOI 10.1007/s10120-006-0375-6; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wang J, 2011, DIGESTION, V83, P253, DOI 10.1159/000280318; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	37	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127300	10.1371/journal.pone.0127300	http://dx.doi.org/10.1371/journal.pone.0127300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996368	gold, Green Published, Green Submitted			2022-12-26	WOS:000356444000056
J	Ronfani, L; Brumatti, LV; Mariuz, M; Tognin, V; Bin, M; Ferluga, V; Knowles, A; Montico, M; Barbone, F				Ronfani, Luca; Brumatti, Liza Vecchi; Mariuz, Marika; Tognin, Veronica; Bin, Maura; Ferluga, Valentina; Knowles, Alessandra; Montico, Marcella; Barbone, Fabio			The Complex Interaction between Home Environment, Socioeconomic Status, Maternal IQ and Early Child Neurocognitive Development: A Multivariate Analysis of Data Collected in a Newborn Cohort Study	PLOS ONE			English	Article							PRENATAL MERCURY EXPOSURE; COGNITIVE-DEVELOPMENT; FISH CONSUMPTION; MOTOR DEVELOPMENT; YOUNG-CHILDREN; MENTAL-HEALTH; INTELLIGENCE; AFFORDANCES; ASSOCIATIONS; PRESCHOOL	Background The relative role of socioeconomic status (SES), home environment and maternal intelligence, as factors affecting child cognitive development in early childhood is still unclear. The aim of this study is to analyze the association of SES, home environment and maternal IQ with child neurodevelopment at 18 months. Methods The data were collected prospectively in the PHIME study, a newborn cohort study carried out in Italy between 2007 and 2010. Maternal nonverbal abilities (IQ) were evaluated using the Standard Progressive Matrices, a version of the Raven's Progressive Matrices; a direct evaluation of the home environment was carried out with the AIRE instrument, designed using the HOME (Home Observation for Measurement of the Environment) model; the socioeconomic characteristics were evaluated using the SES index which takes into account parents occupation, type of employment, educational level, homeownership. The study outcome was child neurodevelopment evaluated at 18 months, with the Bayley Scales of Infant and Toddler Development Third Edition (BSID III). Linear regression analyses and mediation analyses were carried out to evaluate the association between the three exposures, and the scaled scores of the three main scales of BSID III (cognitive, language and motor scale), with adjustment for a wide range of potential explanatory variables. Results Data from 502 mother-child pairs were analyzed. Mediation analysis showed a relationship between SES and maternal IQ, with a complete mediation effect of home environment in affecting cognitive and language domains. A direct significant effect of maternal IQ on the BSID III motor development scale and the mediation effect of home environment were found. Conclusions Our results show that home environment was the variable with greater influence on neurodevelopment at 18 months. The observation of how parents and children interact in the home context is crucial to adequately evaluate early child development.	[Ronfani, Luca; Tognin, Veronica; Bin, Maura; Ferluga, Valentina; Knowles, Alessandra; Montico, Marcella] IRCCS Burlo Garofolo, Inst Maternal & Child Health, Clin Epidemiol & Publ Hlth Res Unit, Trieste, Italy; [Brumatti, Liza Vecchi] IRCCS Burlo Garofolo, Inst Maternal & Child Health, Sci Direct, Trieste, Italy; [Mariuz, Marika; Barbone, Fabio] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy; [Barbone, Fabio] Univ Trieste, Dept Med Sci, Trieste, Italy; [Barbone, Fabio] Univ Hosp Udine, Inst Hyg & Clin Epidemiol, Udine, Italy	IRCCS Burlo Garofolo; IRCCS Burlo Garofolo; University of Udine; University of Trieste; University of Udine; University Hospital of Udine	Ronfani, L (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Health, Clin Epidemiol & Publ Hlth Res Unit, Trieste, Italy.	luca.ronfani@burlo.trieste.it	Knowles, Alessandra/AAB-7765-2020; Vecchi Brumatti, Liza/J-4968-2016; Ronfani, Luca/B-6668-2013; Tognin, Veronica/K-5953-2016; Barbone, Fabio/K-1755-2014; Montico, Marcella/B-5290-2013	Knowles, Alessandra/0000-0003-4504-6371; Vecchi Brumatti, Liza/0000-0001-8149-1873; Ronfani, Luca/0000-0001-5710-3914; Tognin, Veronica/0000-0002-1056-3363; Barbone, Fabio/0000-0001-8795-9959; Montico, Marcella/0000-0003-0377-8232; Bin, Maura/0000-0001-7042-9927; Barbone, Fabio/0000-0003-1337-5111	European Union [FOOD-CT-2006-016253]; Institute for Maternal and Child Health-IRCCS Burlo Garofolo, Trieste, Italy [63/12]	European Union(European Commission); Institute for Maternal and Child Health-IRCCS Burlo Garofolo, Trieste, Italy	The study was supported by the European Union through its Sixth Framework Programme for RTD (contract PHIME no. FOOD-CT-2006-016253), and by grant No. 63/12 from the Institute for Maternal and Child Health-IRCCS Burlo Garofolo, Trieste, Italy. The European Union is not liable for any use that may be made of the information contained herein, and the study reflects only the views of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SA, 2005, REV SAUDE PUBL, V39, P606, DOI 10.1590/S0034-89102005000400014; [Anonymous], 2006, SCALES INFANT TODDLE; Bacharach VR, 1998, J PEDIATR PSYCHOL, V23, P197, DOI 10.1093/jpepsy/23.3.197; Bala G, 2010, COLLEGIUM ANTROPOL, V34, P953; Barlow J., 1999, SYSTEMATIC REV EFFEC, DOI [10.1002/ebch.1905, DOI 10.1002/EBCH.1905]; Bennett GG, 2007, OBESITY, V15, P172, DOI 10.1038/oby.2007.522; Borkowski J, 2002, PARENTING CHILDS WOR, P99; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; BRADLEY RH, 1984, CHILD DEV, V55, P803, DOI 10.2307/1130131; Brumatti LV, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-53; Cacola P, 2011, PEDIATR INT, V53, P820, DOI 10.1111/j.1442-200X.2011.03386.x; Capotorti L., 1987, MED BAMBINO, V9, P16; Deroma L, 2013, EPIDEMIOL PREV, V37, P297; Espy KA, 2001, MERRILL PALMER QUART, V47, P42, DOI 10.1353/mpq.2001.0001; Forns J, 2012, GAC SANIT, V26, P397, DOI 10.1016/j.gaceta.2011.10.011; Freitas TCB, 2013, BRAZ J PHYS THER, V17, P319, DOI 10.1590/S1413-35552013005000096; Gomez-Sanchiz M, 2004, CLIN PEDIATR, V43, P753, DOI 10.1177/000992280404300811; GOTTFRIED AW, 1984, HOME ENV EARLY COGNI, P57, DOI DOI 10.1016/B978-0-12-293460-5.50008-0; Gwynne K, 2009, J PAEDIATR CHILD H, V45, P118, DOI 10.1111/j.1440-1754.2008.01439.x; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Hanscombe KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030320; Hart B., 1995, MEANINGFUL DIFFERENC; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; Hoff E, 2003, CHILD DEV, V74, P1368, DOI 10.1111/1467-8624.00612; Jednorog K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042486; Johnson DL, 1996, PSYCHOL REP, V79, P1179, DOI 10.2466/pr0.1996.79.3f.1179; Kendrick D, 2000, ARCH DIS CHILD, V82, P443, DOI 10.1136/adc.82.6.443; Lederman SA, 2008, ENVIRON HEALTH PERSP, V116, P1085, DOI 10.1289/ehp.10831; Lung FW, 2011, CHILD CARE HLTH DEV, V37, P211, DOI 10.1111/j.1365-2214.2010.01163.x; LUSTER T, 1992, MERRILL PALMER QUART, V38, P151; McPhillips M, 2007, J CHILD PSYCHOL PSYC, V48, P1214, DOI 10.1111/j.1469-7610.2007.01814.x; Miquelote AF, 2012, INFANT BEHAV DEV, V35, P329, DOI 10.1016/j.infbeh.2012.02.002; Myers GJ, 2009, NEUROTOXICOLOGY, V30, P338, DOI 10.1016/j.neuro.2009.01.005; Raven J. C., 2008, STANDARD PROGR MATRI; Saccani R, 2013, PEDIATR INT, V55, P197, DOI 10.1111/ped.12042; Spurgeon A, 2006, ENVIRON HEALTH PERSP, V114, P307, DOI 10.1289/ehp.7859; Sternberg RJ, 2001, FAMILY ENVIRONMENT AND INTELLECTUAL FUNCTIONING: A LIFE-SPAN PERSPECTIVE, P243; Stiles J, 2005, TRENDS COGN SCI, V9, P136, DOI 10.1016/j.tics.2005.01.002; Tamburlini G, 2007, LANCET, V369, P1166, DOI 10.1016/S0140-6736(07)60558-3; Tong S, 2007, J PEDIATR-US, V151, P284, DOI 10.1016/j.jpeds.2007.03.020; Trahan LH, 2014, PSYCHOL BULL, V140, P1332, DOI 10.1037/a0037173; Valent F, 2013, J EPIDEMIOL, V23, P360, DOI 10.2188/jea.JE20120168; Valent F, 2013, J EPIDEMIOL, V23, P146, DOI 10.2188/jea.JE20120030; Van der Elst W, 2013, ASSESSMENT, V20, P48, DOI 10.1177/1073191111415999; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; *WHO, 1991, DIV DIARRH AC RESP D	47	92	99	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127052	10.1371/journal.pone.0127052	http://dx.doi.org/10.1371/journal.pone.0127052			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK7VW	25996934	gold, Green Published, Green Submitted			2022-12-26	WOS:000356444000042
J	Rroji, O; van Kuyck, K; Nuttin, B; Wenderoth, N				Rroji, Orjon; van Kuyck, Kris; Nuttin, Bart; Wenderoth, Nicole			Anodal tDCS over the Primary Motor Cortex Facilitates Long-Term Memory Formation Reflecting Use-Dependent Plasticity	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; EARLY CONSOLIDATION; PREMOTOR CORTEX; EXCITABILITY; MODULATION; IMPLICIT; POLARIZATION; MECHANISMS	Previous research suggests that anodal transcranial direct current stimulation (tDCS) over the primary motor cortex (M1) modulates NMDA receptor dependent processes that mediate synaptic plasticity. Here we test this proposal by applying anodal versus sham tDCS while subjects practiced to flex the thumb as fast as possible (ballistic movements). Repetitive practice of this task has been shown to result in performance improvements that reflect use-dependent plasticity resulting from NMDA receptor mediated, long-term potentiation (LTP)-like processes. Using a double-blind within-subject cross-over design, subjects (n=14) participated either in an anodal or a sham tDCS session which were at least 3 months apart. Sham or anodal tDCS (1 mA) was applied for 20 min during motor practice and retention was tested 30 min, 24 hours and one week later. All subjects improved performance during each of the two sessions (p < 0.001) and learning gains were similar. Our main result is that long term retention performance (i.e. 1 week after practice) was significantly better when practice was performed with anodal tDCS than with sham tDCS (p < 0.001). This effect was large (Cohen's d=1.01) and all but one subject followed the group trend. Our data strongly suggest that anodal tDCS facilitates long-term memory formation reflecting use-dependent plasticity. Our results support the notion that anodal tDCS facilitates synaptic plasticity mediated by an LTP-like mechanism, which is in accordance with previous research.	[Rroji, Orjon; Wenderoth, Nicole] Katholieke Univ Leuven, Res Ctr Movement Control & Neuroplast, Dept Kinesiol, Leuven, Belgium; [van Kuyck, Kris; Nuttin, Bart] Katholieke Univ Leuven, Dept Neurosci, Res Grp Expt Neurosurg & Neuroanat, Leuven, Belgium; [Wenderoth, Nicole] ETH, Dept Hlth Sci & Technol, Neural Control Movement Lab, Zurich, Switzerland	KU Leuven; KU Leuven; Swiss Federal Institutes of Technology Domain; ETH Zurich	Wenderoth, N (corresponding author), Katholieke Univ Leuven, Res Ctr Movement Control & Neuroplast, Dept Kinesiol, Leuven, Belgium.	nicole.wenderoth@hest.ethz.ch	Wenderoth, Nicole/D-7262-2015	Wenderoth, Nicole/0000-0002-3246-9386	Flanders Fund for Scientific Research [G.0401.12]; KU Leuven	Flanders Fund for Scientific Research(FWO); KU Leuven(KU Leuven)	Support for this study was provided through grant G.0401.12 from the Flanders Fund for Scientific Research (http://www.fwo.be). OR was supported by a DBOF PhD fellowship from KU Leuven (http://www.kuleuven.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2009, CORTEX, V45, P1148, DOI 10.1016/j.cortex.2008.10.005; Alonzo A, 2012, BRAIN STIMUL, V5, P208, DOI 10.1016/j.brs.2011.04.006; Antal A, 2004, EUR J NEUROSCI, V19, P2888, DOI 10.1111/j.1460-9568.2004.03367.x; Bisio A, 2015, CLIN NEUROPHYSIOL, V126, P1212, DOI 10.1016/j.clinph.2014.08.024; Boggio PS, 2006, NEUROSCI LETT, V404, P232, DOI 10.1016/j.neulet.2006.05.051; Bortoletto M, 2015, BRAIN STIMUL, V8, P269, DOI 10.1016/j.brs.2014.11.006; Brasil-Neto Joaquim P, 2012, Front Psychiatry, V3, P80, DOI 10.3389/fpsyt.2012.00080; Butefisch CM, 2000, P NATL ACAD SCI USA, V97, P3661, DOI 10.1073/pnas.050350297; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Convento S, 2014, CORTEX, V57, P51, DOI 10.1016/j.cortex.2014.03.006; de Xivry JJO, 2014, EXP BRAIN RES, V232, P3379, DOI 10.1007/s00221-014-4087-6; de Xivry JJO, 2011, J NEUROSCI, V31, P7102, DOI 10.1523/JNEUROSCI.0273-11.2011; Floyer-Lea A, 2006, J NEUROPHYSIOL, V95, P1639, DOI 10.1152/jn.00346.2005; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Furuya S, 2014, J NEUROSCI, V34, P13834, DOI 10.1523/JNEUROSCI.1170-14.2014; Galea JM, 2011, CEREB CORTEX, V21, P1761, DOI 10.1093/cercor/bhq246; Galea JM, 2009, J NEUROPHYSIOL, V102, P294, DOI 10.1152/jn.00184.2009; Hummel FC, 2010, NEUROBIOL AGING, V31, P2160, DOI 10.1016/j.neurobiolaging.2008.12.008; Javadi AH, 2013, BRAIN STIMUL, V6, P668, DOI 10.1016/j.brs.2012.10.007; Kantak SS, 2012, EUR J NEUROSCI, V36, P2710, DOI 10.1111/j.1460-9568.2012.08175.x; Karok S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085693; Marquez CMS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00333; Meinzer M, 2014, CORTEX, V50, P137, DOI 10.1016/j.cortex.2013.07.013; Missitzi J, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.188; Monte-Silva K, 2013, BRAIN STIMUL, V6, P424, DOI 10.1016/j.brs.2012.04.011; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Muller-Dahlhaus F, 2015, NEUROSCIENTIST, V21, P185, DOI 10.1177/1073858414526645; Nitsche MA, 2004, NEUROPSYCHOPHARMACOL, V29, P1573, DOI 10.1038/sj.npp.1300517; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parikh PJ, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.255; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; Paulus W, 2003, SUPPL CLIN NEUROPHYS, V56, P249; Pavlova E, 2014, BRAIN RES, V1576, P52, DOI 10.1016/j.brainres.2014.06.023; Peters MAK, 2013, NEUROPSYCHOLOGIA, V51, P1234, DOI 10.1016/j.neuropsychologia.2013.03.013; Reis Janine, 2015, Cereb Cortex, V25, P109, DOI 10.1093/cercor/bht208; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; RICKHAM PP, 1964, BRIT MED J, V2, P173; Rosenkranz K, 2007, J NEUROSCI, V27, P12058, DOI 10.1523/JNEUROSCI.2663-07.2007; Rosenkranz K, 2007, J NEUROSCI, V27, P5200, DOI 10.1523/JNEUROSCI.0836-07.2007; Schambra HM, 2011, J NEUROPHYSIOL, V106, P652, DOI 10.1152/jn.00210.2011; Schwartz AB, 2007, J PHYSIOL-LONDON, V579, P581, DOI 10.1113/jphysiol.2006.126698; Soekadar SR, 2015, CEREB CORTEX, V25, P2409, DOI 10.1093/cercor/bhu043; Stagg CJ, 2011, CURR BIOL, V21, P480, DOI 10.1016/j.cub.2011.01.069; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Tanaka S, 2009, EXP BRAIN RES, V196, P459, DOI 10.1007/s00221-009-1863-9; Tecchio F, 2010, J NEUROPHYSIOL, V104, P1134, DOI 10.1152/jn.00661.2009; Vines BW, 2008, EUR J NEUROSCI, V28, P1667, DOI 10.1111/j.1460-9568.2008.06459.x; Wiestler T, 2013, ELIFE, V2, DOI 10.7554/eLife.00801; Zhang X, 2011, J NEUROSCI, V31, P11515, DOI 10.1523/JNEUROSCI.6759-10.2011; Ziemann U, 1998, J NEUROSCI, V18, P7000	54	40	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127270	10.1371/journal.pone.0127270	http://dx.doi.org/10.1371/journal.pone.0127270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996937	gold, Green Published, Green Submitted			2022-12-26	WOS:000356444000052
J	Shambharkar, PB; Bittinger, M; Latario, B; Xiong, ZH; Bandyopadhyay, S; Davis, V; Lin, V; Yang, Y; Valdez, R; Labow, MA				Shambharkar, Prashant B.; Bittinger, Mark; Latario, Brian; Xiong, ZhaoHui; Bandyopadhyay, Somnath; Davis, Vanessa; Lin, Victor; Yang, Yi; Valdez, Reginald; Labow, Mark A.			TMEM203 Is a Novel Regulator of Intracellular Calcium Homeostasis and Is Required for Spermatogenesis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; SEMINIFEROUS EPITHELIUM; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; CA2+; BAX; CHANNELS; MOUSE; FERTILITY; APOPTOSIS	Intracellular calcium signaling is critical for initiating and sustaining diverse cellular functions including transcription, synaptic signaling, muscle contraction, apoptosis and fertilization. Trans-membrane 203 (TMEM203) was identified here in cDNA overexpression screens for proteins capable of modulating intracellular calcium levels using activation of a calcium/calcineurin regulated transcription factor as an indicator. Overexpression of TMEM203 resulted in a reduction of Endoplasmic Reticulum (ER) calcium stores and elevation in basal cytoplasmic calcium levels. TMEM203 protein was localized to the ER and found associated with a number of ER proteins which regulate ER calcium entry and efflux. Mouse Embryonic Fibroblasts (MEFs) derived from Tmem203 deficient mice had reduced ER calcium stores and altered calcium homeostasis. Tmem203 deficient mice were viable though male knockout mice were infertile and exhibited a severe block in spermiogenesis and spermiation. Expression profiling studies showed significant alternations in expression of calcium channels and pumps in testes and concurrently Tmem203 deficient spermatocytes demonstrated significantly altered calcium handling. Thus Tmem203 is an evolutionarily conserved regulator of cellular calcium homeostasis, is required for spermatogenesis and provides a causal link between intracellular calcium regulation and spermiogenesis.	[Shambharkar, Prashant B.; Bittinger, Mark; Latario, Brian; Xiong, ZhaoHui; Bandyopadhyay, Somnath; Davis, Vanessa; Lin, Victor; Yang, Yi; Valdez, Reginald; Labow, Mark A.] Novartis Inst Biomed Res, Dev & Mol Pathways, Cambridge, MA 02139 USA	Novartis	Labow, MA (corresponding author), Novartis Inst Biomed Res, Dev & Mol Pathways, 100 Technology Sq, Cambridge, MA 02139 USA.	mark.labow@novartis.com			Novartis Institutes for Biomedical Research	Novartis Institutes for Biomedical Research	Novartis Institutes for Biomedical Research provided support in the form of salaries for authors Prashant B. Shambharkar, Mark Bittinger, Brian Latario, ZhaoHui Xiong, Somnath Bandyopadhyay, Vanessa Davis, Victor Lin, Yi Yang, Reginald Valdez and Mark A. Labow, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Bailey S, 2006, J IMMUNOL METHODS, V311, P220, DOI 10.1016/j.jim.2006.02.005; Bandyopadhyay J, 2002, MOL BIOL CELL, V13, P3281, DOI 10.1091/mbc.E02-01-0005; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Bultynck G, 2012, J BIOL CHEM, V287, P2544, DOI 10.1074/jbc.M111.275354; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Cheng CY, 2010, PHILOS T R SOC B, V365, P1459, DOI 10.1098/rstb.2010.0024; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Coultas L, 2005, EMBO J, V24, P3963, DOI 10.1038/sj.emboj.7600857; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; Ferdek PE, 2012, CURR BIOL, V22, P1241, DOI 10.1016/j.cub.2012.05.002; Gorczynska-Fjalling Eleonora, 2004, Reprod Biol, V4, P219; Hewavitharana T, 2007, CELL CALCIUM, V42, P173, DOI 10.1016/j.ceca.2007.03.009; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; Katz S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-464; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Latendresse JR, 2002, TOXICOL PATHOL, V30, P524, DOI 10.1080/01926230290105721; Lopez JJ, 2008, BIOCHEM PHARMACOL, V75, P2157, DOI 10.1016/j.bcp.2008.03.010; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; MacLean JA, 2005, CURR TOP DEV BIOL, V71, P131, DOI 10.1016/S0070-2153(05)71005-X; Manjarres IM, 2010, CELL CALCIUM, V47, P412, DOI 10.1016/j.ceca.2010.03.001; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Navarro B, 2008, INT J DEV BIOL, V52, P607, DOI 10.1387/ijdb.072554bn; Naz RK, 2009, FRONT BIOSCI-LANDMRK, V14, P3994, DOI 10.2741/3507; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Ohta H, 2007, HUM REPROD, V22, P1612, DOI 10.1093/humrep/dem064; Pan Z, 2001, J BIOL CHEM, V276, P32257, DOI 10.1074/jbc.M100178200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park BJ, 2001, MOL BIOL CELL, V12, P2835, DOI 10.1091/mbc.12.9.2835; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rong Y, 2008, ANNU REV PHYSIOL, V70, P73, DOI 10.1146/annurev.physiol.70.021507.105852; RUSSELL LB, 1990, PROG CLIN BIOL RES, V340, P101; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Szegezdi E, 2009, AM J PHYSIOL-CELL PH, V296, pC941, DOI 10.1152/ajpcell.00612.2008; Tosti E, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-26; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Wakai T, 2011, COLD SPRING HARB PER, V3; Waser M, 1997, J CELL BIOL, V138, P547, DOI 10.1083/jcb.138.3.547; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; White C, 2006, J BIOL CHEM, V281, P20825, DOI 10.1074/jbc.M602175200; Yuan W, 2006, MOL CELL BIOL, V26, P8507, DOI 10.1128/MCB.01488-06; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	54	20	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127480	10.1371/journal.pone.0127480	http://dx.doi.org/10.1371/journal.pone.0127480			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996873	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000070
J	Zhu, YT; Wei, YT; Yang, XJ; Deng, SF; Li, ZH; Li, F; Zhuo, YH				Zhu, Yingting; Wei, Yantao; Yang, Xuejiao; Deng, Shuifeng; Li, Zuohong; Li, Fei; Zhuo, Yehong			Clinical Outcomes of FP-7/8 Ahmed Glaucoma Valves in the Management of Refractory Glaucoma in the Mainland Chinese Population	PLOS ONE			English	Article							DRAINAGE DEVICES; NEOVASCULAR GLAUCOMA; BAERVELDT SHUNT; SINGLE-SURGEON; TERM OUTCOMES; RISK-FACTORS; FOLLOW-UP; IMPLANTATION; EYES; TRABECULECTOMY	Background To evaluate the efficacy and safety of the Ahmed glaucoma valve (AGV) and the risk factors associated with AGV implantation failure in a population of Chinese patients with refractory glaucoma. Method In total, 79 eyes with refractory glaucoma from 79 patients treated in our institution from November 2007 to November 2010 were enrolled in this retrospective study. The demographic data, preoperative and postoperative intraocular pressures (IOPs), best corrected visual acuity (BCVA), number of anti-glaucoma medications used, completed and qualified surgery success rates and postoperative complications were recorded to evaluate the outcomes of AGV implantation. Factors that were associated with implant failure were determined using Cox proportional hazard regression model analysis and multiple linear regression analysis. Principle Findings The average follow-up time was 12.7 +/- 5.8 months (mean +/- SD). We observed a significant reduction in the mean IOP from 39.9 +/- 12.6 mm Hg before surgery to 19.3 +/- 9.6 mm Hg at the final follow-up. The complete success rate was 59.5%, and the qualified success rate was 83.5%. The number of previous surgeries was negatively correlated with qualified success rate (P<0.05, OR=0.736, 95% CI 0.547-0.99). Patients with previous trabeculectomy were more likely to use multiple anti-glaucoma drugs to control IOP (P<0.01). The primary complication was determined to be a flat anterior chamber (AC). Conclusion AGV implantation was safe and effective for the management of refractory glaucoma. Patients with a greater number of previous surgeries were more likely to experience surgical failure, and patients with previous trabeculectomy were more likely to use multiple anti-glaucoma drugs to control postoperative IOP.	[Zhu, Yingting; Wei, Yantao; Yang, Xuejiao; Deng, Shuifeng; Li, Zuohong; Li, Fei; Zhuo, Yehong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhuo, YH (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhuoyh@mail.sysu.edu.cn	Yang, Xuejiao/GPG-4151-2022	Yang, Xuejiao/0000-0002-5347-1071	Specialized Research Fund for the Doctoral Program of Higher Education [20130171110089]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20130171110089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyala RS, 2002, OPHTHALMIC SURG LAS, V33, P94; Bai Yu-jing, 2011, Zhonghua Yan Ke Za Zhi, V47, P893; Bai YJ, 2011, CHINESE MED J-PEKING, V124, P1128, DOI 10.3760/cma.j.issn.0366-6999.2011.08.002; Broadway DC, 2001, J GLAUCOMA, V10, P237, DOI 10.1097/00061198-200106000-00017; Budenz DL, 2011, OPHTHALMOLOGY, V118, P443, DOI 10.1016/j.ophtha.2010.07.016; Christakis PG, 2013, OPHTHALMOLOGY; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Da MA, 1999, OPHTHALMOLOGY, V106, P2168; Desai Manishi A, 2011, Ophthalmic Surg Lasers Imaging, V42, P202, DOI [10.3928/15428877-20110224-94, 10.3928/15428877-20110224-04]; Desai RU, 2013, CLIN EXP OPHTHALMOL, V41, P155, DOI 10.1111/j.1442-9071.2012.02836.x; Doe EA, 2001, OPHTHALMOLOGY, V108, P1789, DOI 10.1016/S0161-6420(01)00725-4; Foster PJ, 2001, BRIT J OPHTHALMOL, V85, P1277, DOI 10.1136/bjo.85.11.1277; Gedde SJ, 2012, AM J OPHTHALMOL, V153, P789, DOI 10.1016/j.ajo.2011.10.026; Hong CH, 2005, SURV OPHTHALMOL, V50, P48, DOI 10.1016/j.survophthal.2004.10.006; Ishida K, 2006, OPHTHALMOLOGY, V113, P1320, DOI 10.1016/j.ophtha.2006.04.020; Kotecha A, 2011, ARCH OPHTHALMOL-CHIC, V129, P145, DOI 10.1001/archophthalmol.2010.350; Lai JSM, 2000, BRIT J OPHTHALMOL, V84, P718, DOI 10.1136/bjo.84.7.718; Li Z, 2014, CHINESE MED J-PEKING, V127, P1417, DOI 10.3760/cma.j.issn.0366-6999.20132654; Minckler DS, 2008, OPHTHALMOLOGY, V115, P1089, DOI 10.1016/j.ophtha.2008.03.031; Brasil MVOM, 2007, J GLAUCOMA, V16, P36, DOI 10.1097/01.ijg.0000243477.82779.31; Parihar JKS, 2009, INDIAN J OPHTHALMOL, V57, P345, DOI 10.4103/0301-4738.55068; Park HY, 2009, J GLAUCOMA, V18, P44, DOI 10.1097/IJG.0b013e31816b2fe7; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 1996, NUMBER, V80, P389; Schmier JK, 2009, ARCH OPHTHALMOL-CHIC, V127, P900, DOI 10.1001/archophthalmol.2009.122; Schwartz KS, 2006, CURR OPIN OPHTHALMOL, V17, P181, DOI 10.1097/01.icu.0000193080.55240.7e; Sothornwit N, 2008, J MED ASS THAI, V91, P162; Souza C, 2007, AM J OPHTHALMOL, V144, P893, DOI 10.1016/j.ajo.2007.07.035; Stein JD, 2009, J GLAUCOMA, V18, P638, DOI 10.1097/IJG.0b013e31819aa4e0; Tai MC, 2010, EYE, V24, P547, DOI 10.1038/eye.2009.181; Thieme H, 2012, DTSCH ARZTEBL INT, V109, P659, DOI 10.3238/arztebl.2012.0659; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; Tran DH, 2009, BRIT J OPHTHALMOL, V93, P1504, DOI 10.1136/bjo.2008.150870; Tranos P, 2004, EYE, V18, P673, DOI 10.1038/sj.eye.6701319; Tsai JC, 2006, OPHTHALMOLOGY, V113, P913, DOI 10.1016/j.ophtha.2006.02.029; Tsai JC, 2003, OPHTHALMOLOGY, V110, P1814, DOI 10.1016/S0161-6420(03)00574-8; Wilkie DA, 2004, VET CLIN N AM-SMALL, V34, P801, DOI 10.1016/j.cvsm.2003.12.004; Yalvac IS, 2007, EYE, V21, P65, DOI 10.1038/sj.eye.6702125; Zhou MW, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-107	39	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127658	10.1371/journal.pone.0127658	http://dx.doi.org/10.1371/journal.pone.0127658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996991	Green Submitted, gold, Green Published			2022-12-26	WOS:000356444000082
J	Cha, GW; Lee, EJ; Lim, EJ; Sin, KS; Park, WW; Jeon, DY; Han, MG; Lee, WJ; Choi, WY; Jeong, YE				Cha, Go-Woon; Lee, Eun Ju; Lim, Eun-Joo; Sin, Kang Suk; Park, Woo Won; Jeon, Doo Young; Han, Myung Guk; Lee, Won-Ja; Choi, Woo-Young; Jeong, Young Eui			A Novel Immunochromatographic Test Applied to a Serological Survey of Japanese Encephalitis Virus on Pig Farms in Korea	PLOS ONE			English	Article							IMMUNOFLUORESCENCE ASSAY; ENVELOPE PROTEIN; RAPID DETECTION; ANTIBODIES; INFECTION; SWINE; STRIP; VACCINATION; FRAGMENT; DOMAIN	Among vertebrate species, pigs are a major amplifying host of Japanese encephalitis virus (JEV) and measuring their seroconversion is a reliable indicator of virus activity. Traditionally, the hemagglutination inhibition test has been used for serological testing in pigs; however, it has several limitations and, thus, a more efficient and reliable replacement test is required. In this study, we developed a new immunochromatographic test for detecting antibodies to JEV in pig serum within 15 min. Specifically, the domain III region of the JEV envelope protein was successfully expressed in soluble form and used for developing the immunochromatographic test. The test was then applied to the surveillance of Japanese encephalitis (JE) in Korea. We found that our immunochromatographic test had good sensitivity (84.8%) and specificity (97.7%) when compared with an immunofluorescence assay used as a reference test. During the surveillance of JE in Korea in 2012, the new immunochromatographic test was used to test the sera of 1,926 slaughtered pigs from eight provinces, and 228 pigs (11.8%) were found to be JEV-positive. Based on these results, we also produced an activity map of JEV, which marked the locations of pig farms in Korea that tested positive for the virus. Thus, the immunochromatographic test reported here provides a convenient and effective tool for real-time monitoring of JEV activity in pigs.	[Cha, Go-Woon; Lee, Eun Ju; Han, Myung Guk; Lee, Won-Ja; Choi, Woo-Young] Korea Ctr Dis Control & Prevent, Natl Inst Hlth, Div Arboviruses, Cheongju, Chungcheongbuk, South Korea; [Lim, Eun-Joo] Gangwon Inst Hlth & Environm, Chuncheon Si, Gangwon Do, South Korea; [Sin, Kang Suk] Chungbuk Inst Hlth & Environm, Cheongju, Chungcheongbuk, South Korea; [Park, Woo Won] Gyeongbuk Inst Hlth & Environm, Yeongcheon Si, Gyeongsangbuk D, South Korea; [Jeon, Doo Young] Jeonnam Inst Hlth & Environm, Muan Gun, Jeollanam Do, South Korea; [Jeong, Young Eui] Hallym Univ, Grad Sch, Dept Biomed Sci, Chuncheon Si, Gangwon Do, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology; Hallym University	Jeong, YE (corresponding author), Korea Ctr Dis Control & Prevent, Natl Inst Hlth, Div Arboviruses, Cheongju, Chungcheongbuk, South Korea.	yougeui58@gmail.com			National Institute of Health, Korea Centers for Disease Control and Prevention [4847-311-210-13]	National Institute of Health, Korea Centers for Disease Control and Prevention(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was undertaken with a grant from the National Institute of Health, Korea Centers for Disease Control and Prevention (Code: 4847-311-210-13).	Arai S, 2008, JPN J INFECT DIS, V61, P333; Borah J, 2013, EPIDEMIOL INFECT, V141, P74, DOI 10.1017/S0950268812000258; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; Cha Go Woon, 2014, Osong Public Health Res Perspect, V5, P286, DOI 10.1016/j.phrp.2014.08.003; Chia SC, 2001, MICROB PATHOGENESIS, V31, P9, DOI 10.1006/mpat.2001.0442; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561; Duong V, 2011, ACTA TROP, V120, P146, DOI 10.1016/j.actatropica.2011.07.008; Endy TP, 2002, CURR TOP MICROBIOL, V267, P11; GEEVARGHESE G, 1987, INDIAN J MED RES, V86, P413; Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040; Jia XL, 2005, VET RES COMMUN, V29, P159, DOI 10.1023/B:VERC.0000047485.85866.6e; Jia XL, 2002, VET RES COMMUN, V26, P495, DOI 10.1023/A:1020546626694; Jin QY, 2012, J VET DIAGN INVEST, V24, P1151, DOI 10.1177/1040638712462374; Koraka P, 2002, MICROBES INFECT, V4, P1209, DOI 10.1016/S1286-4579(02)01647-7; Li XS, 2011, J VIROL METHODS, V176, P46, DOI 10.1016/j.jviromet.2011.05.034; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Litzba N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000883; MASON PW, 1989, J GEN VIROL, V70, P2037, DOI 10.1099/0022-1317-70-8-2037; Nidaira M, 2007, JPN J INFECT DIS, V60, P70; Niedrig M, 2008, CLIN VACCINE IMMUNOL, V15, P177, DOI 10.1128/CVI.00078-07; Peng FH, 2008, CLIN VACCINE IMMUNOL, V15, P569, DOI 10.1128/CVI.00273-07; Pyke AT, 2001, AM J TROP MED HYG, V65, P747; Rajendran R, 2003, TROP MED INT HEALTH, V8, P174, DOI 10.1046/j.1365-3156.2003.01003.x; Saito M, 2011, FLAVIVIRUS ENCEPHALI, P427; SCHERER WF, 1959, J IMMUNOL, V83, P620; Sohn YM, 2000, EMERG INFECT DIS, V6, P17; Wu SC, 2003, VACCINE, V21, P2516, DOI 10.1016/S0264-410X(03)00042-2; Yamanaka A, 2010, JPN J INFECT DIS, V63, P58; Yang DK, 2006, J VET SCI, V7, P271, DOI 10.4142/jvs.2006.7.3.271	29	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127313	10.1371/journal.pone.0127313	http://dx.doi.org/10.1371/journal.pone.0127313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992769	gold, Green Published, Green Submitted			2022-12-26	WOS:000354921400106
J	Lee, WS; Gudimella, R; Wong, GR; Tammi, MT; Khalid, N; Harikrishna, JA				Lee, Wan Sin; Gudimella, Ranganath; Wong, Gwo Rong; Tammi, Martti Tapani; Khalid, Norzulaani; Harikrishna, Jennifer Ann			Transcripts and MicroRNAs Responding to Salt Stress in Musa acuminata Colla (AAA Group) cv. Berangan Roots	PLOS ONE			English	Article							NONCODING RNAS; OSMOTIC-STRESS; PROTEIN-KINASE; FACTOR GENE; TOLERANCE; DROUGHT; SALINITY; IDENTIFICATION; EXPRESSION; OVEREXPRESSION	Physiological responses to stress are controlled by expression of a large number of genes, many of which are regulated by microRNAs. Since most banana cultivars are salt-sensitive, improved understanding of genetic regulation of salt induced stress responses in banana can support future crop management and improvement in the face of increasing soil salinity related to irrigation and climate change. In this study we focused on determining miRNA and their targets that respond to NaCl exposure and used transcriptome sequencing of RNA and small RNA from control and NaCl-treated banana roots to assemble a cultivar-specific reference transcriptome and identify orthologous and Musa-specific miRNA responding to salinity. We observed that, banana roots responded to salinity stress with changes in expression for a large number of genes (9.5% of 31,390 expressed unigenes) and reduction in levels of many miRNA, including several novel miRNA and banana-specific miRNA-target pairs. Banana roots expressed a unique set of orthologous and Musa-specific miRNAs of which 59 respond to salt stress in a dose-dependent manner. Gene expression patterns of miRNA compared with those of their predicted mRNA targets indicated that a majority of the differentially expressed miRNAs were down-regulated in response to increased salinity, allowing increased expression of targets involved in diverse biological processes including stress signaling, stress defence, transport, cellular homeostasis, metabolism and other stress-related functions. This study may contribute to the understanding of gene regulation and abiotic stress response of roots and the high-throughput sequencing data sets generated may serve as important resources related to salt tolerance traits for functional genomic studies and genetic improvement in banana.	[Lee, Wan Sin; Gudimella, Ranganath; Wong, Gwo Rong; Khalid, Norzulaani; Harikrishna, Jennifer Ann] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Lee, Wan Sin; Gudimella, Ranganath; Wong, Gwo Rong; Tammi, Martti Tapani; Khalid, Norzulaani; Harikrishna, Jennifer Ann] Univ Malaya, Ctr Res Biotechnol Agr, Kuala Lumpur, Malaysia; [Tammi, Martti Tapani] Sime Darby Technol Ctr Sdn Bhd, Bioinformat, Serdang, Selangor, Malaysia	Universiti Malaya; Universiti Malaya	Harikrishna, JA (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.	jennihari@um.edu.my	KHALID, NORZULAANI/B-9405-2010; Harikrishna, Jennifer Ann/B-2778-2010	Harikrishna, Jennifer Ann/0000-0002-4687-709X	High Impact Research Chancellory Grant [UM.C/625/1/HIR/MOHE/SCI/14, IRPA 01-99-06-0101EA001, FRGS-FP005/2011A, RG006-09BIO, PS126/2008A]; SLAI fellowship; University of Malaya [PV109/2011A]; Sime Darby Technology Centre Sdn Bhd	High Impact Research Chancellory Grant; SLAI fellowship; University of Malaya(Universiti Malaya); Sime Darby Technology Centre Sdn Bhd	This research was supported by High Impact Research Chancellory Grant UM.C/625/1/HIR/MOHE/SCI/14 (JAH), and Grants IRPA 01-99-06-0101EA001 (JAH), FRGS-FP005/2011A (JAH, NK), RG006-09BIO (JAH, NK), PS126/2008A (WSL), SLAI fellowship (WSL) and PV109/2011A (RG) through the University of Malaya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author MTT is employed by Sime Darby Technology Centre Sdn Bhd. Sime Darby Technology Centre Sdn Bhd provided support in the form of salary for author MTT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Alvarez C, 2012, NEW PHYTOL, V193, P165, DOI 10.1111/j.1469-8137.2011.03889.x; Amir R, 2010, AMINO ACIDS, V39, P917, DOI 10.1007/s00726-010-0482-x; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Belamkar V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-950; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhardwaj AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092456; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Bottino MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059423; Claeys H, 2013, PLANT PHYSIOL, V162, P1768, DOI 10.1104/pp.113.220921; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dang ZH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-29; Davey MW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-683; Davy A, 2000, PLANT PHYSIOL, V122, P425, DOI 10.1104/pp.122.2.425; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; FAO, 2011, STAT WORLDS LAND WAT; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Galvan-Ampudia CS, 2013, CURR BIOL, V23, P2044, DOI 10.1016/j.cub.2013.08.042; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo W, 2014, J EXP BOT, V65, P1205, DOI 10.1093/jxb/ert484; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hu JP, 2012, PLANT CELL, V24, P2279, DOI 10.1105/tpc.112.096586; Hu T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066090; ISRAELI Y, 1986, FRUITS, V41, P297; Janz D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-150; Kiefer E, 2000, PLANT MOL BIOL REP, V18, P33, DOI 10.1007/BF02825291; Kosova K, 2014, FRONT PLANT SCI, V5, DOI [10.3389/fpls.2014.00711, 10.3389/fpls.2014.00343]; Kramer Martha F, 2011, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1510s95; Kumar R, 2014, APPL BIOCHEM BIOTECH, V174, P93, DOI 10.1007/s12010-014-0914-2; Lan P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-210; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee J, 2011, CANCER INFORM, V10, P205, DOI 10.4137/CIN.S7473; Li BS, 2013, PLANT MOL BIOL, V81, P525, DOI 10.1007/s11103-013-0010-y; Li Chun-Yu, 2012, BMC Genomics, V13, P374, DOI 10.1186/1471-2164-13-374; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Lynch JP, 2013, ANN BOT-LONDON, V112, P347, DOI 10.1093/aob/mcs293; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Misic D, 2012, J PLANT PHYSIOL, V169, P1281, DOI 10.1016/j.jplph.2012.04.018; Mizuno H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-683; Mobley EM, 1999, GENE, V240, P115, DOI 10.1016/S0378-1119(99)00423-0; Ouyang B, 2007, J EXP BOT, V58, P507, DOI 10.1093/jxb/erl258; Pierik R, 2014, PLANT PHYSIOL, V166, P5, DOI 10.1104/pp.114.239160; Ramakrishna A, 2011, PLANT SIGNAL BEHAV, V6, P1720, DOI 10.4161/psb.6.11.17613; Rigo G, 2013, PLANT CELL, V25, P1592, DOI 10.1105/tpc.113.110452; Rogers K, 2013, PLANT CELL, V25, P2383, DOI 10.1105/tpc.113.113159; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Secco D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-230; Sun XL, 2013, J PLANT PHYSIOL, V170, P505, DOI 10.1016/j.jplph.2012.11.017; Tang MJ, 2011, PLANT SCI, V181, P623, DOI 10.1016/j.plantsci.2011.06.014; Tian HY, 2014, PLANT CELL REP, V33, P745, DOI 10.1007/s00299-014-1575-x; Torre S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112487; Vanhove AC, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00176; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Villarino GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094651; Wang B, 2014, PLANT PHYSIOL BIOCH, V80, P90, DOI 10.1016/j.plaphy.2014.03.020; Wang JB, 2014, PLANTA, V240, P103, DOI 10.1007/s00425-014-2066-6; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang M, 2013, GENE, V530, P26, DOI 10.1016/j.gene.2013.08.009; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wawer I, 2010, BIOCHEM J, V429, P73, DOI 10.1042/BJ20100492; Wu ZJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-564; Xie FL, 2014, PLANT BIOTECHNOL J, V12, P354, DOI 10.1111/pbi.12142; Xu M, 2012, BIOCHEM BIOPH RES CO, V424, P239, DOI 10.1016/j.bbrc.2012.06.083; Yano-Melo AM, 2003, AGR ECOSYST ENVIRON, V95, P343, DOI 10.1016/S0167-8809(02)00044-0; Yoo H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3833; Zhang J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-337; Zhang JY, 2005, PLANT J, V42, P689, DOI 10.1111/j.1365-313X.2005.02405.x; Zhang XH, 2011, BIOTECHNOL LETT, V33, P403, DOI 10.1007/s10529-010-0436-0; Zhang ZH, 2010, NUCLEIC ACIDS RES, V38, pD806, DOI 10.1093/nar/gkp818; Zhao Q, 2013, J PROTEOMICS, V82, P230, DOI 10.1016/j.jprot.2013.01.024	74	32	34	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127526	10.1371/journal.pone.0127526	http://dx.doi.org/10.1371/journal.pone.0127526			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993649	Green Published, gold, Green Submitted			2022-12-26	WOS:000354921400124
J	Liao, XY; Yuan, ZY; Lai, QF; Guo, JX; Zheng, Q; Yu, SJ; Tong, QQ; Si, WX; Sun, MG				Liao, Xiangyun; Yuan, Zhiyong; Lai, Qianfeng; Guo, Jiaxiang; Zheng, Qi; Yu, Sijiao; Tong, Qianqian; Si, Weixin; Sun, Mingui			Modeling and Predicting Tissue Movement and Deformation for High Intensity Focused Ultrasound Therapy	PLOS ONE			English	Article							ACTIVE CONTOURS; SOLID TUMORS; ABLATION; FEASIBILITY; HIFU; EXPERIENCE; CANCER; ENERGY; FLUIDS; LIVER	Purpose In ultrasound-guided High Intensity Focused Ultrasound (HIFU) therapy, the target tissue (such as a tumor) often moves and/or deforms in response to an external force. This problem creates difficulties in treating patients and can lead to the destruction of normal tissue. In order to solve this problem, we present a novel method to model and predict the movement and deformation of the target tissue during ultrasound-guided HIFU therapy. Methods Our method computationally predicts the position of the target tissue under external force. This prediction allows appropriate adjustments in the focal region during the application of HIFU so that the treatment head is kept aligned with the diseased tissue through the course of therapy. To accomplish this goal, we utilize the cow tissue as the experimental target tissue to collect spatial sequences of ultrasound images using the HIFU equipment. A Geodesic Localized Chan-Vese (GLCV) model is developed to segment the target tissue images. A 3D target tissue model is built based on the segmented results. A versatile particle framework is constructed based on Smoothed Particle Hydrodynamics (SPH) to model the movement and deformation of the target tissue. Further, an iterative parameter estimation algorithm is utilized to determine the essential parameters of the versatile particle framework. Finally, the versatile particle framework with the determined parameters is used to estimate the movement and deformation of the target tissue. Results To validate our method, we compare the predicted contours with the ground truth contours. We found that the lowest, highest and average Dice Similarity Coefficient (DSC) values between predicted and ground truth contours were, respectively, 0.9615, 0.9770 and 0.9697. Conclusion Our experimental result indicates that the proposed method can effectively predict the dynamic contours of the moving and deforming tissue during ultrasound-guided HIFU therapy.	[Liao, Xiangyun; Yuan, Zhiyong; Lai, Qianfeng; Guo, Jiaxiang; Zheng, Qi; Yu, Sijiao; Tong, Qianqian] Wuhan Univ, Sch Comp, Wuhan 430072, Hubei, Peoples R China; [Si, Weixin] Chinese Univ Hong Kong, Dept Comp Sci & Engn, Hong Kong, Hong Kong, Peoples R China; [Sun, Mingui] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA	Wuhan University; Chinese University of Hong Kong; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yuan, ZY (corresponding author), Wuhan Univ, Sch Comp, Wuhan 430072, Hubei, Peoples R China.	zhiyongyuan@whu.edu.cn			National Basic Research Program of China [2011CB707904]; National Natural Science Foundation of China [61372107, 61272276, 61190125]; open funding project of State Key Laboratory of Virtual Technology and Systems, Beihang University [BUAA-VR-13KF-15]; National Institutes of Health of the United States [R01EB013174]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013174] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); open funding project of State Key Laboratory of Virtual Technology and Systems, Beihang University; National Institutes of Health of the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by a grant from the National Basic Research Program of China (Grant No. 2011CB707904), grants from the National Natural Science Foundation of China (Grant No. 61372107, No. 61272276, No. 61190125), the open funding project of State Key Laboratory of Virtual Technology and Systems, Beihang University (Grant No. BUAA-VR-13KF-15), and the National Institutes of Health grant No. R01EB013174 of the United States. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinci N, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2185520.2185558; Benedict SH, 2011, MED PHYS, V38, P3909, DOI 10.1118/1.3561500; Bernard O, 2009, IEEE T IMAGE PROCESS, V18, P1179, DOI 10.1109/TIP.2009.2017343; Caselles V, 1997, INT J COMPUT VISION, V22, P61, DOI 10.1023/A:1007979827043; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Chongqing Haifu Medical Technology Co. Ltd, 2014, MOD JC200 FOC ULTR T, V11, P20; Comaniciu D, 2003, IEEE T PATTERN ANAL, V25, P564, DOI 10.1109/TPAMI.2003.1195991; Coon J, 2012, INT J HYPERTHER, V28, P799, DOI 10.3109/02656736.2012.738846; Cornelis J, 2014, COMPUT GRAPH FORUM, V33, P255, DOI 10.1111/cgf.12324; Dietenbeck T, 2010, IEEE IMAGE PROC, P665, DOI 10.1109/ICIP.2010.5652991; Ge HY, 2014, ULTRASOUND MED BIOL, V40, P947, DOI 10.1016/j.ultrasmedbio.2013.11.020; Gerszewski D., 2009, S COMP AN, P133, DOI DOI 10.1145/1599470.1599488; Goldberg SN, 2000, AM J ROENTGENOL, V174, P323, DOI 10.2214/ajr.174.2.1740323; Goldberg SN, 2005, J VASC INTERV RADIOL, V16, P765, DOI 10.1097/01.RVI.0000170858.46668.65; Ihmsen M, 2014, IEEE T VIS COMPUT GR, V20, P426, DOI 10.1109/TVCG.2013.105; Illing RO, 2005, BRIT J CANCER, V93, P890, DOI 10.1038/sj.bjc.6602803; Jiang N, 2014, CARDIOVASC INTERVENT, P1, DOI [10.1007/s00270-014-0919-9, DOI 10.1007/S00270-014-0919-9]; Khokhlova TD, 2014, P NATL ACAD SCI USA, V111, P8161, DOI 10.1073/pnas.1318355111; LANCASTER P, 1981, MATH COMPUT, V37, P141, DOI 10.1090/S0025-5718-1981-0616367-1; Lankton S, 2008, IEEE T IMAGE PROCESS, V17, P2029, DOI 10.1109/TIP.2008.2004611; Lee SH, 2011, INVEST RADIOL, V46, P77, DOI 10.1097/RLI.0b013e3181f23fcd; LI C, 2007, P IEEE C COMP VIS PA, V1, P1, DOI DOI 10.1109/CVPR.2007.383014; Li CM, 2008, IEEE T IMAGE PROCESS, V17, P1940, DOI 10.1109/TIP.2008.2002304; Liao XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103334; Liu GR, 2003, SMOOTHED PARTICLE HY, DOI DOI 10.1142/9789812564405; Long C, 2011, T EDUTAINMENT, P237; Morita Y, 2008, EUR J OBSTET GYN R B, V139, P199, DOI 10.1016/j.ejogrb.2007.10.018; Muller M., 2004, PROC ACM SIGGRAPHEUR, P141, DOI 10.1145/1028523.1028542; Orsi F, 2010, J CANCER RES THER, V6, P414, DOI 10.4103/0973-1482.77064; Orsi F, 2010, AM J ROENTGENOL, V195, pW245, DOI 10.2214/AJR.09.3321; Stam J, 1999, COMP GRAPH, P121, DOI 10.1145/311535.311548; Tempany CMC, 2003, RADIOLOGY, V226, P897, DOI 10.1148/radiol.2271020395; Weibin Z, 1995, J HUAQIAO U, P16; Wu F, 2005, RADIOLOGY, V236, P1034, DOI 10.1148/radiol.2362041105; Wu F, 2004, ULTRASON SONOCHEM, V11, P149, DOI 10.1016/j.ultsonch.2004.01.011; Wu F, 2001, ULTRASOUND MED BIOL, V27, P1099, DOI 10.1016/S0301-5629(01)00389-1; Zhang L, 2010, EUR J RADIOL, V73, P396, DOI 10.1016/j.ejrad.2008.11.002; Zhu H, 2009, EUR J RADIOL, V72, P160, DOI 10.1016/j.ejrad.2008.07.003	38	0	0	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127873	10.1371/journal.pone.0127873	http://dx.doi.org/10.1371/journal.pone.0127873			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993644	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000354921400138
J	Madejczyk, MS; Baer, CE; Dennis, WE; Minarchick, VC; Leonard, SS; Jackson, DA; Stallings, JD; Lewis, JA				Madejczyk, Michael S.; Baer, Christine E.; Dennis, William E.; Minarchick, Valerie C.; Leonard, Stephen S.; Jackson, David A.; Stallings, Jonathan D.; Lewis, John A.			Temporal Changes in Rat Liver Gene Expression after Acute Cadmium and Chromium Exposure	PLOS ONE			English	Article							URINARY LIPID METABOLITES; INDUCED OXIDATIVE STRESS; DNA-DAMAGE RESPONSE; NF-KAPPA-B; ANTIOXIDANT ENZYMES; HYDROGEN-PEROXIDE; MOLECULAR-MECHANISMS; HEXAVALENT CHROMIUM; INDUCED EXCRETION; STRAND BREAKAGE	U. S. Service Members and civilians are at risk of exposure to a variety of environmental health hazards throughout their normal duty activities and in industrial occupations. Metals are widely used in large quantities in a number of industrial processes and are a common environmental toxicant, which increases the possibility of being exposed at toxic levels. While metal toxicity has been widely studied, the exact mechanisms of toxicity remain unclear. In order to further elucidate these mechanisms and identify candidate biomarkers, rats were exposed via a single intraperitoneal injection to three concentrations of CdCl2 and Na2Cr2O7, with livers harvested at 1, 3, or 7 days after exposure. Cd and Cr accumulated in the liver at 1 day post exposure. Cd levels remained elevated over the length of the experiment, while Cr levels declined. Metal exposures induced ROS, including hydroxyl radical (center dot OH), resulting in DNA strand breaks and lipid peroxidation. Interestingly, ROS and cellular damage appeared to increase with time post-exposure in both metals, despite declines in Cr levels. Differentially expressed genes were identified via microarray analysis. Both metals perturbed gene expression in pathways related to oxidative stress, metabolism, DNA damage, cell cycle, and inflammatory response. This work provides insight into the temporal effects and mechanistic pathways involved in acute metal intoxication, leading to the identification of candidate biomarkers.	[Madejczyk, Michael S.; Minarchick, Valerie C.; Leonard, Stephen S.] US Army Ctr Environm Hlth Res, Ft Detrick, MD 21702 USA; [Baer, Christine E.] Excet Inc, Ft Detrick, MD USA; [Minarchick, Valerie C.; Leonard, Stephen S.] NIOSH, Morgantown, WV USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Lewis, JA (corresponding author), US Army Ctr Environm Hlth Res, Ft Detrick, MD 21702 USA.	john.a.lewis5.civ@mail.mil	Stallings, Jonathan D/H-7779-2013	Stallings, Jonathan D/0000-0002-6430-5888; Madejczyk, Michael/0000-0002-6000-2599	U.S. Army Medical Research and Materiel Command, Military Operational Medicine Research Program	U.S. Army Medical Research and Materiel Command, Military Operational Medicine Research Program(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	The research described herein was sponsored by the U.S. Army Medical Research and Materiel Command, Military Operational Medicine Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 1996, BIOCELL, V20, P339; AbdulHameed MDM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112193; Adams LA, 2011, J GASTROEN HEPATOL, V26, P802, DOI 10.1111/j.1440-1746.2010.06612.x; [Anonymous], 2008, COMBINED EXPOSURES T; [Anonymous], 2012, AGENCY TOXIC SUBSTAN; Ates I, 2004, BIOMETALS, V17, P371, DOI 10.1023/B:BIOM.0000029416.95488.5f; Badisa VLD, 2007, ENVIRON TOXICOL, V22, P144, DOI 10.1002/tox.20248; BAGCHI D, 1995, COMP BIOCHEM PHYS C, V110, P177, DOI 10.1016/0742-8413(94)00093-P; Bagchi D, 2002, TOXICOLOGY, V175, P73, DOI 10.1016/S0300-483X(02)00062-8; Bagchi D, 1996, BIOL TRACE ELEM RES, V52, P143, DOI 10.1007/BF02789456; Bagchi D, 2002, TOXICOLOGY, V180, P5, DOI 10.1016/S0300-483X(02)00378-5; Ballatori N, 2010, CELLULAR AND MOLECULAR BIOLOGY OF METALS, P79, DOI 10.1201/9781420059984-c3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y; Bode JG, 2012, EUR J CELL BIOL, V91, P496, DOI 10.1016/j.ejcb.2011.09.008; Borkham-Kamphorst E, 2013, BBA-MOL BASIS DIS, V1832, P660, DOI 10.1016/j.bbadis.2013.01.014; Botta C, 2006, ENVIRON MOL MUTAGEN, V47, P284, DOI 10.1002/em.20205; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; Buzard Gregory S., 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P179; Casalino E, 2006, TOXICOLOGY, V217, P240, DOI 10.1016/j.tox.2005.09.020; Casalino E, 2002, TOXICOLOGY, V179, P37, DOI 10.1016/S0300-483X(02)00245-7; Chen F, 2002, ENVIRON HEALTH PERSP, V110, P807, DOI 10.1289/ehp.02110s5807; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Cousineau I, 2005, CANCER RES, V65, P11384, DOI 10.1158/0008-5472.CAN-05-2156; COUSINS RJ, 1985, PHYSIOL REV, V65, P238, DOI 10.1152/physrev.1985.65.2.238; Curis E, 2005, AMINO ACIDS, V29, P177, DOI 10.1007/s00726-005-0235-4; Das UN, 2011, MOLECULAR BASIS OF HEALTH AND DISEASE, P1, DOI 10.1007/978-94-007-0495-4; DAY FA, 1984, CHEM-BIOL INTERACT, V50, P159, DOI 10.1016/0009-2797(84)90093-0; Ding M, 2002, MOL CELL BIOCHEM, V234, P293, DOI 10.1023/A:1015975218920; Dote E, 2007, J OCCUP HEALTH, V49, P17, DOI 10.1539/joh.49.17; DUDLEY RE, 1982, TOXICOL APPL PHARM, V65, P302, DOI 10.1016/0041-008X(82)90013-8; Ehrenfried JA, 1997, SURGERY, V122, P927, DOI 10.1016/S0039-6060(97)90334-2; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; Fang JY, 2013, CLIN CHIM ACTA, V423, P23, DOI 10.1016/j.cca.2013.04.012; Faraonio R, 2006, J BIOL CHEM, V281, P39776, DOI 10.1074/jbc.M605707200; Faroon O., 2012, TOXICOLOGICAL PROFIL; FOX RB, 1984, J CLIN INVEST, V74, P1456, DOI 10.1172/JCI111558; Galan A, 2001, EUR J CELL BIOL, V80, P312, DOI 10.1078/0171-9335-00159; Ghibelli L, 1998, FASEB J, V12, P479, DOI 10.1096/fasebj.12.6.479; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Halliwell Barry, 1993, American Journal of Clinical Nutrition, V57, p715S, DOI 10.1093/ajcn/57.5.715S; Hammond CL, 2007, J BIOL CHEM, V282, P14337, DOI 10.1074/jbc.M611019200; Hammond CL, 2004, TOXICOL APPL PHARM, V195, P12, DOI 10.1016/j.taap.2003.10.008; Harris GK, 2003, MUTAT RES-FUND MOL M, V533, P183, DOI 10.1016/j.mrfmmm.2003.08.025; Hartwig A, 2001, ANTIOXID REDOX SIGN, V3, P625, DOI 10.1089/15230860152542970; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; Horiguchi H, 2000, TOXICOL APPL PHARM, V163, P231, DOI 10.1006/taap.1999.8877; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hussainzada N, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-15; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; JANZEN EG, 1968, J AM CHEM SOC, V90, P5909, DOI 10.1021/ja01023a051; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jemai H, 2007, J TRACE ELEM MED BIO, V21, P269, DOI 10.1016/j.jtemb.2007.08.001; Jin SQ, 2000, J BIOL CHEM, V275, P16602, DOI 10.1074/jbc.M000284200; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Kerger BD, 1996, TOXICOL APPL PHARM, V141, P145, DOI 10.1006/taap.1996.0271; KIM E, 1990, ARCH TOXICOL, V64, P644, DOI 10.1007/BF01974692; Koch KA, 1997, CHEM BIOL, V4, P549, DOI 10.1016/S1074-5521(97)90241-6; KOTSONIS FN, 1977, TOXICOL APPL PHARM, V41, P667, DOI 10.1016/S0041-008X(77)80020-3; Kotyzova D, 2015, TOXICOL IND HEALTH, V31, P1044, DOI 10.1177/0748233713487244; Kuester RK, 2002, TOXICOL SCI, V65, P151, DOI 10.1093/toxsci/65.1.151; Lal MA, 2009, CELL CYCLE, V8, P1589, DOI 10.4161/cc.8.10.8547; Lehne B, 2012, PHARMACOGENOMICS, V13, P1967, DOI [10.2217/pgs.12.170, 10.2217/PGS.12.170]; Leonard SS, 2004, FREE RADICAL BIO MED, V37, P1921, DOI 10.1016/j.freeradbiomed.2004.09.010; Leonard SS, 2004, MOL CELL BIOCHEM, V255, P3, DOI 10.1023/B:MCBI.0000007255.72746.a6; Leonard SS, 2002, MOL CELL BIOCHEM, V234, P369, DOI 10.1023/A:1015919101174; Leonard SS, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-32; Liu J, 2008, FREE RADICAL BIO MED, V45, P475, DOI 10.1016/j.freeradbiomed.2008.04.041; Lou JL, 2013, FOOD CHEM TOXICOL, V55, P533, DOI 10.1016/j.fct.2013.01.053; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Mackenzie EL, 2008, ANTIOXID REDOX SIGN, V10, P997, DOI 10.1089/ars.2007.1893; Makia NL, 2011, CHEM-BIOL INTERACT, V191, P278, DOI 10.1016/j.cbi.2011.01.013; MANCA D, 1991, TOXICOLOGY, V67, P303, DOI 10.1016/0300-483X(91)90030-5; MIKALSEN A, 1991, PHARMACOL TOXICOL, V68, P456, DOI 10.1111/j.1600-0773.1991.tb01270.x; Morgan DO, 2007, THE CELL CYCLE PRINC; Newairy AA, 2007, TOXICOLOGY, V242, P23, DOI 10.1016/j.tox.2007.09.001; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Odewumi CO, 2011, INT J MOL MED, V27, P243, DOI 10.3892/ijmm.2010.564; OSHINO N, 1973, ARCH BIOCHEM BIOPHYS, V154, P117, DOI 10.1016/0003-9861(73)90040-4; Ossola JO, 1995, TOXICOLOGY, V104, P141, DOI 10.1016/0300-483X(95)03157-B; Passalaris TM, 1999, MOL CELL BIOL, V19, P5872, DOI 10.1128/mcb.19.9.5872; Permenter MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083751; Permenter MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027730; Qian Y, 2003, J INORG BIOCHEM, V96, P271, DOI 10.1016/S0162-0134(03)00235-6; Saplakoglu U, 1997, MUTAT RES-GEN TOX EN, V394, P133, DOI 10.1016/S1383-5718(97)00134-4; SATO M, 1983, LIFE SCI, V33, P903, DOI 10.1016/0024-3205(83)90745-2; Sauer JM, 1997, TOXICOLOGY, V121, P155, DOI 10.1016/S0300-483X(97)00062-0; Schiopu A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/828354; SHI XL, 1994, CARCINOGENESIS, V15, P2475, DOI 10.1093/carcin/15.11.2475; SNYDER RD, 1988, MUTAT RES, V193, P237, DOI 10.1016/0167-8817(88)90034-X; STANDEVEN AM, 1991, CARCINOGENESIS, V12, P1733, DOI 10.1093/carcin/12.9.1733; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Straif K B-TL, 2011, IARC MONOGRAPHS ON T; Tawa GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107230; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tisserand J, 2011, J BIOL CHEM, V286, P33369, DOI 10.1074/jbc.M111.225680; TSAPAKOS MJ, 1983, CANCER RES, V43, P5662; Uchida K, 2013, REDOX BIOL, V1, P94, DOI 10.1016/j.redox.2012.12.005; UENO S, 1995, MUTAT RES LETT, V346, P247, DOI 10.1016/0165-7992(95)90041-1; Ueno S, 2001, TOXICOL APPL PHARM, V170, P56, DOI 10.1006/taap.2000.9081; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Vallyathan V, 1997, MOL CELL BIOCHEM, V168, P125, DOI 10.1023/A:1006850920080; Villalobos A, 2013, FASEB J, V27; Voet D., 1995, BIOCHEMISTRY; Wang F, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-30; Wang SJ, 2002, ENVIRON RES, V88, P116, DOI 10.1006/enrs.2001.4319; Wang SW, 2000, AM J PHYSIOL-CELL PH, V279, pC868, DOI 10.1152/ajpcell.2000.279.3.C868; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; Weese Coleen Baird, 2009, US Army Med Dep J, P10; Wu KC, 2012, TOXICOL APPL PHARM, V263, P14, DOI 10.1016/j.taap.2012.05.017; Xie JX, 2006, TOXICOLOGY, V224, P56, DOI 10.1016/j.tox.2006.04.026; Yalin S, 2006, ECOTOX ENVIRON SAFE, V65, P140, DOI 10.1016/j.ecoenv.2005.06.006; Yamano T, 2000, TOXICOL APPL PHARM, V162, P68, DOI 10.1006/taap.1999.8833; Yoval-Sanchez B, 2012, CHEM RES TOXICOL, V25, P722, DOI 10.1021/tx2005184; Yu Ri-An, 2007, Biomed Environ Sci, V20, P146; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zhang Z, 2001, MOL CELL BIOCHEM, V222, P77, DOI 10.1023/A:1017963307358; Zhitkovich A, 2005, CHEM RES TOXICOL, V18, P3, DOI 10.1021/tx049774+; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	121	28	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127327	10.1371/journal.pone.0127327	http://dx.doi.org/10.1371/journal.pone.0127327			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993096	Green Submitted, gold, Green Published			2022-12-26	WOS:000354918600058
J	Rawlings, SA; Alonzo, F; Kozhaya, L; Torres, VJ; Unutmaz, D				Rawlings, Stephen A.; Alonzo, Francis, III; Kozhaya, Lina; Torres, Victor J.; Unutmaz, Derya			Elimination of HIV-1-Infected Primary T Cell Reservoirs in an In Vitro Model of Latency	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1; INFECTION; INTERLEUKIN-7; EXPRESSION; BCL-2; CYTOKINES; NAIVE; CCR5; CURE	Establishment of long-lived cellular reservoirs of HIV-1 represents a major therapeutic challenge to virus eradication. In this study, we utilized a human primary cell model of HIV-1 latency to evaluate the requirements for efficient virus reactivation from, and the selective elimination of, latently infected human T cells. Ectopic expression of BCL2 supported the replication and spread of R5-tropic HIV-1 in activated CD4(+) T cells. After IL-2 withdrawal, the HIV1-infected T cells survived as resting cells for several months. Unexpectedly, these resting T cells continue to produce detectable levels of infectious virus, albeit at a lower frequency than cells maintained in IL-2. In the presence of HIV-1 inhibitors, reactivation of the resting T cells with gamma c-cytokines and allogeneic dendritic cells completely extinguished HIV-1 infectivity. We also evaluated the ability of the bacterial LukED cytotoxin to target and kill CCR5-expressing cells. After gamma c-cytokine stimulation, LukED treatment eliminated both HIV-1-infected resting cells and the non-infected CCR5(+) cells. Importantly, complete clearance of in vitro HIV-1 reservoirs by LukED required a lower threshold of cytokine signals relative to HIV-1 inhibitors. Thus, the primary T cell-based HIV-1 latency model could facilitate the development of novel agents and therapeutic strategies that could effectively eradicate HIV-1.	[Rawlings, Stephen A.; Alonzo, Francis, III; Kozhaya, Lina; Torres, Victor J.; Unutmaz, Derya] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Unutmaz, Derya] NYU, Sch Med, Dept Pathol, New York, NY USA; [Unutmaz, Derya] NYU, Sch Med, Dept Med, New York, NY USA	New York University; New York University; New York University	Unutmaz, D (corresponding author), Jackson Lab Genom Med, Farmington, CT 06117 USA.	Derya@mac.com	Rawlings, Stephen/ABA-6797-2020	Rawlings, Stephen/0000-0003-3637-1447; Torres, Victor/0000-0002-7126-0489	American Heart Association [09SDG2060036]; National Institute of Health [5T32 AI007180];  [F32-AI098395];  [R01AI065303];  [R21AI087973]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087973, F32AI098395, R01AI065303, T32AI007180] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funds from the American Heart Association, www.americanheart.org (09SDG2060036) to VJT, the National Institute of Health (NIH.gov) Training Grants (5T32 AI007180) to SAR and FA, and postdoctoral fellowships (F32-AI098395) to FA and (R01AI065303, R21AI087973) to DU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas W, 2012, ADV VIROL, V2012, DOI 10.1155/2012/574967; Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Akbar AN, 1996, EUR J IMMUNOL, V26, P294, DOI 10.1002/eji.1830260204; Alonzo F, 2013, NATURE, V493, P51, DOI 10.1038/nature11724; Alonzo F, 2012, MOL MICROBIOL, V83, P423, DOI 10.1111/j.1365-2958.2011.07942.x; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Blazkova J, 2012, J INFECT DIS, V206, P765, DOI 10.1093/infdis/jis412; Chen BK, 1996, J VIROL, V70, P6044, DOI 10.1128/JVI.70.9.6044-6053.1996; Chun TW, 1997, J VIROL, V71, P4436, DOI 10.1128/JVI.71.6.4436-4444.1997; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1999, NAT MED, V5, P651, DOI 10.1038/9498; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Durand CM, 2012, TRENDS IMMUNOL, V33, P554, DOI 10.1016/j.it.2012.07.001; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Jamieson BD, 1998, J VIROL, V72, P6520, DOI 10.1128/JVI.72.8.6520-6526.1998; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554; Marsden MD, 2013, BIOORG MED CHEM LETT, V23, P4003, DOI 10.1016/j.bmcl.2013.05.032; Oswald-Richter K, 2004, EUR J IMMUNOL, V34, P1705, DOI 10.1002/eji.200424892; Oswald-Richter K, 2007, PLOS PATHOG, V3, P553, DOI 10.1371/journal.ppat.0030058; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Shan L, 2013, BIOESSAYS, V35, P544, DOI 10.1002/bies.201200170; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; UNUTMAZ D, 1994, J EXP MED, V180, P1159, DOI 10.1084/jem.180.3.1159; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Unutmaz D, 2000, J IMMUNOL, V165, P3284, DOI 10.4049/jimmunol.165.6.3284; Xing SF, 2012, J ANTIMICROB CHEMOTH, V67, P398, DOI 10.1093/jac/dkr496; Yang HC, 2009, J CLIN INVEST, V119, P3473, DOI 10.1172/JCI39199	37	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0126917	10.1371/journal.pone.0126917	http://dx.doi.org/10.1371/journal.pone.0126917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993666	Green Submitted, Green Published, gold			2022-12-26	WOS:000354918600044
J	Khan, YA; Umar, S; Abidi, SMA				Khan, Yasir Akhtar; Umar, Sadiq; Abidi, Syed M. A.			Somatic Antigens of Tropical Liver Flukes Ameliorate Collagen-Induced Arthritis in Wistar Rats	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HUMAN SYNOVIAL FIBROBLASTS; RHEUMATOID-ARTHRITIS; FASCIOLA-HEPATICA; NITRIC-OXIDE; MATRIX METALLOPROTEINASES; INTERFERON-GAMMA; FACTOR-ALPHA; BORDETELLA-PERTUSSIS; CARTILAGE AGGRECAN	Parasitic helminths polarize immune response of their vertebrate hosts towards antiinflammatory Th2 type and therefore it is hypothesized that they may suppress the inflammatory conditions in autoimmune disorders. The present study was undertaken to investigate in vivo immunomodulatory and therapeutic potential of somatic antigens (Ag) of liver infecting digenetic trematodes [ Fasciola gigantica (Fg) and Gigantocotyle explanatum (Ge)] in collagen-induced arthritic (CIA) Wistar rats. The CIA rats were administered subcutaneously with different doses (50 mu g,100 mu g and 150 mu g) of somatic antigens of Fg and Ge, daily for 21 days, the time period required to establish infection in natural host (Bubalus bubalis). Thereafter, the control, diseased and treated rats were compared for different parameters viz. hind paw thickness; serum interleukins, IL-4 and IL-10, tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma); expression level of matrix metalloproteinases (MMPs) -2, -9, -13 and nitric oxide (NO) in knee joints and patellar morphology. The CIA rats treated with different antigens, Fg-Ag and Ge-Ag, show significant amelioration of the disease by down regulation of serum TNF-alpha and IFN-gamma (p< 0.05) and upregulation of IL-4 and IL-10 cytokines (p< 0.05); inhibition (p< 0.05) of MMPs (-2,-9,-13) and NO in knee joints and improved patellar morphology with decreased synovial hypertrophy and reduced infiltration of ploymorphonuclear cells. The activity of pro as well as active MMPs (-2 and -9) and active MMP-13 in knee joints of CIA rats was very high compared to the control and treatment groups, suggesting the extent of collagen degradation in CIA rats. Interestingly, the highest dose (150 mu g) of Ge-Ag almost wiped out MMP-13 expression. The overall findings suggest that the somatic proteins of Ge-Ag appeared to be therapeutically more effective than Fg-Ag, reflecting interspecific molecular differences which could contribute to the ability of these worms to successfully ameliorate the pathology of CIA.	[Khan, Yasir Akhtar; Abidi, Syed M. A.] Aligarh Muslim Univ, Dept Zool, Sect Parasitol, Aligarh 202002, Uttar Pradesh, India; [Umar, Sadiq] Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, Spokane, WA USA	Aligarh Muslim University; Washington State University	Abidi, SMA (corresponding author), Aligarh Muslim Univ, Dept Zool, Sect Parasitol, Aligarh 202002, Uttar Pradesh, India.	abbasabidi92@hotmail.com	Umar, Sadiq/H-3769-2019	Umar, Sadiq/0000-0002-4733-5751; Khan, Yasir Akhtar/0000-0001-9277-7164	University Grant Commission New Delhi, India	University Grant Commission New Delhi, India(University Grants Commission, India)	The authors received no specific fund for this work, however YAK received fellowship grant by University Grant Commission New Delhi, India during his PhD Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter E, 2011, RHEUMATOL INT, V31, P849, DOI 10.1007/s00296-011-1820-3; Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453; Borghaei RC, 1998, ARTHRITIS RHEUM-US, V41, P1398, DOI 10.1002/1529-0131(199808)41:8<1398::AID-ART8>3.0.CO;2-B; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brady MT, 1999, INFECT IMMUN, V67, P5372, DOI 10.1128/IAI.67.10.5372-5378.1999; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Brown WC, 1999, INFECT IMMUN, V67, P155, DOI 10.1128/IAI.67.1.155-164.1999; Chambers M, 2013, EXP CELL RES, V319, P1398, DOI 10.1016/j.yexcr.2013.04.010; Clery D, 1996, VET PARASITOL, V62, P71, DOI 10.1016/0304-4017(95)00858-6; Cooke A, 1999, PARASITE IMMUNOL, V21, P169, DOI 10.1046/j.1365-3024.1999.00213.x; DAYER JM, 1985, J EXP MED, V162, P2163, DOI 10.1084/jem.162.6.2163; DOHERTY TM, 1993, J IMMUNOL, V151, P7151; DRAPIER JC, 1988, EUR J IMMUNOL, V18, P1587, DOI 10.1002/eji.1830181018; Elkayam O, 2003, ANN RHEUM DIS, V62, P440, DOI 10.1136/ard.62.5.440; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Flynn RJ, 2009, TRANSBOUND EMERG DIS, V56, P269, DOI 10.1111/j.1865-1682.2009.01075.x; FOSANG AJ, 1992, J BIOL CHEM, V267, P19470; Fosang AJ, 1996, FEBS LETT, V380, P17, DOI 10.1016/0014-5793(95)01539-6; Fournier C, 2005, JOINT BONE SPINE, V72, P527, DOI 10.1016/j.jbspin.2004.12.012; Gatto C, 1999, CLIN CANCER RES, V5, P3603; Gierut A, 2010, RHEUM DIS CLIN N AM, V36, P271, DOI 10.1016/j.rdc.2010.03.004; Haqqi TM, 1999, P NATL ACAD SCI USA, V96, P4524, DOI 10.1073/pnas.96.8.4524; Hernett W, 2009, PATHOGEN DERIVED IMM, P89; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; HIBBS JB, 1992, J CLIN INVEST, V89, P867, DOI 10.1172/JCI115666; Kamanh A, 2004, CELL BIOCHEM FUNCT, V22, P53, DOI 10.1002/cbf.1055; Kang SG, 2014, SCI REP-UK, V4, DOI 10.1038/srep04775; Khalifeh MS, 2010, LAB ANIM-UK, V44, P143, DOI 10.1258/la.2009.0080132; KILBOURN RG, 1990, J NATL CANCER I, V82, P772, DOI 10.1093/jnci/82.9.772; La Flamme AC, 2003, INFECT IMMUN, V71, P4996, DOI 10.1128/IAI.71.9.4996-5004.2003; LACRAZ S, 1995, J CLIN INVEST, V96, P2304, DOI 10.1172/JCI118286; MACNAUL KL, 1990, J BIOL CHEM, V265, P17238; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; Matsuno H, 2002, RHEUMATOLOGY, V41, P329, DOI 10.1093/rheumatology/41.3.329; MCCALL TB, 1992, BIOCHEM BIOPH RES CO, V186, P680, DOI 10.1016/0006-291X(92)90800-Z; McInnes IB, 2003, J IMMUNOL, V171, P2127, DOI 10.4049/jimmunol.171.4.2127; Mo HM, 2007, EXP PARASITOL, V116, P385, DOI 10.1016/j.exppara.2007.02.009; Moore BA, 2000, BBA-MOL BASIS DIS, V1502, P307, DOI 10.1016/S0925-4439(00)00056-9; Mtairag E, 2001, CARDIOVASC RES, V49, P882; NGUYEN Q, 1993, BIOCHEM J, V295, P595, DOI 10.1042/bj2950595; O'Neill SM, 2001, PARASITE IMMUNOL, V23, P541, DOI 10.1046/j.1365-3024.2001.00411.x; O'Neill SM, 2000, PARASITE IMMUNOL, V22, P147, DOI 10.1046/j.1365-3024.2000.00290.x; Osada Y, 2009, INT J PARASITOL, V39, P457, DOI 10.1016/j.ijpara.2008.08.007; OSWALD IP, 1992, J IMMUNOL, V148, P3578; Pincus T, 1995, BRIT J RHEUMATOL, V34, P59; Reynolds SL, 2012, BRIT J PHARMACOL, V167, P505, DOI 10.1111/j.1476-5381.2012.01988.x; Roth I, 1999, DEV BIOL, V205, P194, DOI 10.1006/dbio.1998.9122; Sajad M, 2009, MOL CELL BIOCHEM, V328, P183, DOI 10.1007/s11010-009-0088-3; Schulze-Koops H, 2001, BEST PRACT RES CL RH, V15, P677, DOI 10.1053/berh.2001.0187; Scott DL, 2000, RHEUMATOLOGY, V39, P122, DOI 10.1093/rheumatology/39.2.122; Sewell DL, 2002, IMMUNOL LETT, V82, P101, DOI 10.1016/S0165-2478(02)00025-1; Shalinsky DR, 1999, ANN NY ACAD SCI, V878, P236, DOI 10.1111/j.1749-6632.1999.tb07689.x; Song XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023453; SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5; Spellberg B, 2001, CLIN INFECT DIS, V32, P76, DOI 10.1086/317537; Thomas NV, 2010, BIOCHEM RES INT, V2010, DOI 10.1155/2010/845975; Vukman KV, 2013, J IMMUNOL, V190, P2873, DOI 10.4049/jimmunol.1203011; Walsh KP, 2009, J IMMUNOL, V183, P1577, DOI 10.4049/jimmunol.0803803; Wang LY, 2012, BIOORGAN MED CHEM, V20, P4164, DOI 10.1016/j.bmc.2012.04.063; Yasuda Tadashi, 2006, Mod Rheumatol, V16, P197	61	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126429	10.1371/journal.pone.0126429	http://dx.doi.org/10.1371/journal.pone.0126429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992888	Green Published, Green Submitted, gold			2022-12-26	WOS:000354917300040
J	Yao, JW; Cherian, PT; Frank, MW; Rock, CO				Yao, Jiangwei; Cherian, Philip T.; Frank, Matthew W.; Rock, Charles O.			Chlamydia trachomatis Relies on Autonomous Phospholipid Synthesis for Membrane Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBLIGATE INTRACELLULAR PATHOGEN; ENDOCYTIC MULTIVESICULAR BODIES; FATTY-ACID SYNTHESIS; HOST-CELL; DEVELOPMENTAL CYCLE; ENDOPLASMIC-RETICULUM; ESCHERICHIA-COLI; EPITHELIAL-CELLS; LIPID-METABOLISM; BINDING PROTEIN	The obligate intracellular parasite Chlamydia trachomatis has a reduced genome and is thought to rely on its mammalian host cell for nutrients. Although several lines of evidence suggest C. trachomatis utilizes host phospholipids, the bacterium encodes all the genes necessary for fatty acid and phospholipid synthesis found in free living Gram-negative bacteria. Bacterially derived phospholipids significantly increased in infected HeLa cell cultures. These new phospholipids had a distinct molecular species composition consisting of saturated and branched-chain fatty acids. Biochemical analysis established the role of C. trachomatis-encoded acyltransferases in producing the new disaturated molecular species. There was no evidence for the remodeling of host phospholipids and no change in the size or molecular species composition of the phosphatidylcholine pool in infected HeLa cells. Host sphingomyelin was associated with C. trachomatis isolated by detergent extraction, but it may represent contamination with detergent-insoluble host lipids rather than being an integral bacterial membrane component. C. trachomatis assembles its membrane systems from the unique phospholipid molecular species produced by its own fatty acid and phospholipid biosynthetic machinery utilizing glucose, isoleucine, and serine.	[Yao, Jiangwei; Frank, Matthew W.; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Cherian, Philip T.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org	Regan, Clinton/E-6250-2012	Yao, Jiangwei/0000-0001-7088-3468; Frank, Matthew/0000-0002-4914-1440; Cherian, Philip/0000-0002-1070-6483	National Institutes of Health [GM034496]; Cancer Center Support Grant [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034496, R01GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM034496 (to C.O.R.). This work was also supported by Cancer Center Support Grant CA21765 and the American Lebanese Syrian Associated Charities. The authors declare that they have no conflicts of interest with the contents of this article.	Al-Zeer MA, 2014, MOL MICROBIOL, V94, P1285, DOI 10.1111/mmi.12829; ALVAREZ JG, 1992, J CHROMATOGR-BIOMED, V577, P142, DOI 10.1016/0378-4347(92)80609-T; Babiychuk EB, 2006, BIOCHEM J, V397, P407, DOI 10.1042/BJ20060056; Bastidas RJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010256; Beatty WL, 2008, INFECT IMMUN, V76, P2872, DOI 10.1128/IAI.00129-08; Beatty WL, 2006, J CELL SCI, V119, P350, DOI 10.1242/jcs.02733; BECKER Y, 1978, MICROBIOL REV, V42, P274, DOI 10.1128/MMBR.42.2.274-306.1978; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; BIDAWID S, 1989, A VAN LEEUW J MICROB, V55, P123, DOI 10.1007/BF00404752; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Casadei BR, 2014, MOL MEMBR BIOL, V31, P195, DOI 10.3109/09687688.2014.949319; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; COLEMAN J, 1992, MOL GEN GENET, V232, P295, DOI 10.1007/BF00280009; Cox JV, 2012, CELL MICROBIOL, V14, P1497, DOI 10.1111/j.1462-5822.2012.01823.x; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Dumoux M, 2015, CURR OPIN MICROBIOL, V23, P1, DOI 10.1016/j.mib.2014.09.019; Dumoux M, 2012, TRAFFIC, V13, P1612, DOI 10.1111/tra.12002; Elwell CA, 2012, CELL MICROBIOL, V14, P1010, DOI 10.1111/j.1462-5822.2012.01794.x; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Fields KA, 2002, ANNU REV CELL DEV BI, V18, P221, DOI 10.1146/annurev.cellbio.18.012502.105845; Fukuda EY, 2005, INFECT IMMUN, V73, P4017, DOI 10.1128/IAI.73.7.4017-4024.2005; Giles DK, 2008, MICROBES INFECT, V10, P1494, DOI 10.1016/j.micinf.2008.09.001; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Hatch GM, 1998, INFECT IMMUN, V66, P3727, DOI 10.1128/IAI.66.8.3727-3735.1998; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; HOWARD L, 1974, APPL MICROBIOL, V27, P102, DOI 10.1128/AEM.27.1.102-106.1974; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; JACKOWSKI S, 1986, J BIOL CHEM, V261, P1328; Koumanov KS, 2004, SUB CELL BIOCHEM, V37, P153; Krank J, 2007, METHOD ENZYMOL, V432, P1, DOI 10.1016/S0076-6879(07)32001-6; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Lu YH, 2011, J BIOL CHEM, V286, P5506, DOI 10.1074/jbc.M110.199265; MacKenzie A, 2009, J AM OIL CHEM SOC, V86, P757, DOI 10.1007/s11746-009-1403-6; Nans A, 2014, CELL MICROBIOL, V16, P1457, DOI 10.1111/cmi.12310; Nicholson TL, 2003, J BACTERIOL, V185, P3179, DOI 10.1128/JB.185.10.3179-3189.2003; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; PETERSON EM, 1988, J BACTERIOL, V170, P1389, DOI 10.1128/jb.170.3.1389-1392.1988; Pilhofer M, 2014, ENVIRON MICROBIOL, V16, P417, DOI 10.1111/1462-2920.12299; Robertson DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000664; Rock C O, 1981, Methods Enzymol, V71 Pt C, P341; ROCK CO, 1979, J BIOL CHEM, V254, P7123; Rockey DD, 1997, MOL MICROBIOL, V24, P217, DOI 10.1046/j.1365-2958.1997.3371700.x; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Soupene E, 2015, MICROBIOLOGYOPEN, V4, P235, DOI 10.1002/mbo3.234; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; SWANSON J, 1975, J INFECT DIS, V131, P678, DOI 10.1093/infdis/131.6.678; Turnbull AP, 2001, STRUCTURE, V9, P347, DOI 10.1016/S0969-2126(01)00595-0; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Vignola MJ, 2010, J BIOL CHEM, V285, P21625, DOI 10.1074/jbc.M110.103010; Vromman F, 2014, CURR OPIN MICROBIOL, V17, P38, DOI 10.1016/j.mib.2013.11.003; Wang GQ, 2007, MICROBIOL-SGM, V153, P1935, DOI 10.1099/mic.0.2006/003491-0; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997; Yao JW, 2014, J BIOL CHEM, V289, P22365, DOI 10.1074/jbc.M114.584185; Yao JW, 2013, BBA-MOL CELL BIOL L, V1831, P495, DOI 10.1016/j.bbalip.2012.08.018; ZEICHNER SL, 1983, INFECT IMMUN, V40, P956, DOI 10.1128/IAI.40.3.956-966.1983; Zhang L, 1998, INFECT IMMUN, V66, P1167, DOI 10.1128/IAI.66.3.1167-1173.1998; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	64	32	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					18874	18888		10.1074/jbc.M115.657148	http://dx.doi.org/10.1074/jbc.M115.657148			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	25995447	hybrid, Green Published			2022-12-26	WOS:000358781100001
J	Fujimaki, K; Ogihara, T; Morris, DL; Oda, H; Iida, H; Fujitani, Y; Mirmira, RG; Evans-Molina, C; Watada, H				Fujimaki, Kyoko; Ogihara, Takeshi; Morris, David L.; Oda, Hisanobu; Iida, Hitoshi; Fujitani, Yoshio; Mirmira, Raghavendra G.; Evans-Molina, Carmella; Watada, Hirotaka			SET7/9 Enzyme Regulates Cytokine-induced Expression of Inducible Nitric-oxide Synthase through Methylation of Lysine 4 at Histone 3 in the Islet beta Cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SIGNAL-TRANSDUCTION; INSULIN-SECRETION; METHYLTRANSFERASE; ACTIVATION; INTERLEUKIN-1-BETA; TRANSCRIPTION; LANGERHANS; CHROMATIN; INFLAMMATION	SET7/9 is an enzyme that methylates histone 3 at lysine 4 (H3K4) to maintain euchromatin architecture. Although SET7/9 is enriched in islets and contributes to the transactivation of beta cell-specific genes, including Ins1 and Slc2a, SET7/9 has also been reported to bind the p65 subunit of nuclear factor kappa B in non-beta cells and modify its transcriptional activity. Given that inflammation is a central component of beta cell dysfunction in Type 1 and Type 2 diabetes, the aim of this study was to elucidate the role of SET7/9 in proinflammatory cytokine signaling in beta cells. To induce inflammation, beta TC3 insulinoma cells were treated with IL-1 beta, TNF-alpha, and IFN-gamma. Cytokine treatment led to increased expression of inducible nitric-oxide synthase, which was attenuated by the diminution of SET7/9 using RNA interference. Consistent with previous reports, SET7/9 was co-immunoprecipitated with p65 and underwent cytosolic to nuclear translocation in response to cytokines. ChIP analysis demonstrated augmented H3K4 mono-and dimethylation of the proximal Nos2 promoter with cytokine exposure. SET7/9 was found to occupy this same region, whereas SET7/9 knockdown attenuated cytokine-induced histone methylation of the Nos2 gene. To test this relationship further, islets were isolated from SET7/9-deficient and wild-type mice and treated with IL-1 beta, TNF-alpha, and IFN-gamma. Cytokine-induced Nos2 expression was reduced in the islets from SET7/9 knock-out mice. Together, our findings suggest that SET7/9 contributes to Nos2 transcription and proinflammatory cytokine signaling in the pancreatic beta cell through activating histone modifications.	[Fujimaki, Kyoko; Ogihara, Takeshi; Iida, Hitoshi; Fujitani, Yoshio; Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Dept Metab & Endocrinol, Tokyo 1138421, Japan; [Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Ctr Mol Diabetol, Tokyo 1138421, Japan; [Fujitani, Yoshio; Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Ctr Therapeut Innovat Diabet, Tokyo 1138421, Japan; [Fujitani, Yoshio] Juntendo Univ, Grad Sch Med, Japan Sci & Technol Agcy, Core Res Evolutionary Sci & Technol Program, Tokyo 1138421, Japan; [Mirmira, Raghavendra G.; Evans-Molina, Carmella] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Morris, David L.; Mirmira, Raghavendra G.; Evans-Molina, Carmella] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.; Evans-Molina, Carmella] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.; Evans-Molina, Carmella] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Oda, Hisanobu] Natl Hosp Org Kyushu Canc Ctr, Dept Gastrointestinal & Med Oncol, Fukuoka 8111395, Japan	Juntendo University; Juntendo University; Juntendo University; Japan Science & Technology Agency (JST); Juntendo University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Kyushu Cancer Center	Ogihara, T (corresponding author), Juntendo Univ, Grad Sch Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	take@juntendo.ac.jp; cevansmo@iu.edu	Mirmira, Raghavendra G/AAD-7592-2020; Regan, Clinton/E-6250-2012	Mirmira, Raghavendra G/0000-0002-5013-6075; Watada, Hirotaka/0000-0001-5961-1816	National Institutes of Health [R01 DK093954, F32 DK091976, K01 DK100515]; Japan Society for the Promotion of Science KAKENHI [23591324, 26461345]; Suzuken Memorial Foundation; Veterans Affairs Merit Award [I01BX001733]; Asteras; Astrazeneca; Boehringer Ingelheim; Daiichi Sankyo Inc.; Eli Lilly and Co.; Kissei Pharmaceutical Co.; Kowa Pharmaceutical Co.; Kyowa Hakko Kirin Co.; Merck Sharp and Dohme; Novartis Pharmaceuticals; Novo Nordisk Pharma; Ono Pharmaceutical Co.; Mitsubishi Tanabe Pharma; Sanofi-Aventis; Sanwakagaku Kenkyusho; Takeda Pharmaceutical Co.; Bristol-Myers Squibb; Dainippon Sumitomo Pharma; Eli Lilly; Johnson and Johnson; Mochida Pharmaceutical Co.; Pfizer; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093954, F32DK091976, R01DK083583, K01DK100515, P30DK097512] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001733] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26461345] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Suzuken Memorial Foundation; Veterans Affairs Merit Award(US Department of Veterans Affairs); Asteras; Astrazeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Daiichi Sankyo Inc.(Daiichi Sankyo Company Limited); Eli Lilly and Co.(Eli Lilly); Kissei Pharmaceutical Co.(Kissei Pharmaceutical Co Ltd); Kowa Pharmaceutical Co.; Kyowa Hakko Kirin Co.(Kyowa Kirin Ltd); Merck Sharp and Dohme(Merck & Company); Novartis Pharmaceuticals(Novartis); Novo Nordisk Pharma(Novo Nordisk); Ono Pharmaceutical Co.; Mitsubishi Tanabe Pharma(Mitsubishi Tanabe Pharma Corporation); Sanofi-Aventis(Sanofi-Aventis); Sanwakagaku Kenkyusho; Takeda Pharmaceutical Co.(Takeda Pharmaceutical Company Ltd); Bristol-Myers Squibb(Bristol-Myers Squibb); Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); Eli Lilly(Eli Lilly); Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Mochida Pharmaceutical Co.; Pfizer(Pfizer); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK093954 (to C. E.-M.) and F32 DK091976 and K01 DK100515 (to D. L. M.). This work was also supported by Japan Society for the Promotion of Science KAKENHI Grants 23591324 and 26461345 and the Suzuken Memorial Foundation (both to T. O.) and Veterans Affairs Merit Award I01BX001733 (to C. E.-M.). H. W. has received lecture fees from Asteras, Astrazeneca, Boehringer Ingelheim, Daiichi Sankyo Inc., Eli Lilly and Co., Kissei Pharmaceutical Co., Kowa Pharmaceutical Co., Kyowa Hakko Kirin Co., Merck Sharp and Dohme, Novartis Pharmaceuticals, Novo Nordisk Pharma, Ono Pharmaceutical Co., Mitsubishi Tanabe Pharma, Sanofi-Aventis, Sanwakagaku Kenkyusho, and Takeda Pharmaceutical Co. and research funds from Asteras, Astrazeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Daiichi Sankyo Inc., Dainippon Sumitomo Pharma, Eli Lilly, Johnson and Johnson, Kissei Pharmaceutical Co., Kowa Pharmaceutical Co., Kyowa Hakko Kirin Co., Merck Sharp and Dohme, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical Co., Novartis Pharmaceuticals, Novo Nordisk Pharma, Pfizer, Sanwakagaku Kenkyusho, Sanofi-Aventis, and Takeda Pharmaceutical Co.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Barsyte-Lovejoy D, 2014, P NATL ACAD SCI USA, V111, P12853, DOI 10.1073/pnas.1407358111; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Chan JY, 2011, DIABETOLOGIA, V54, P1766, DOI 10.1007/s00125-011-2139-z; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; COMENS PG, 1987, DIABETES, V36, P963, DOI 10.2337/diabetes.36.8.963; CORBETT JA, 1992, BIOCHEM J, V287, P229, DOI 10.1042/bj2870229; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129; CORBETT JA, 1994, AM J PHYSIOL, V267, pC48, DOI 10.1152/ajpcell.1994.267.1.C48; Deering TG, 2009, DIABETES, V58, P185, DOI 10.2337/db08-1150; Donath MY, 2013, CELL METAB, V17, P860, DOI 10.1016/j.cmet.2013.05.001; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; EIZIRIK DL, 1992, FEBS LETT, V308, P249, DOI 10.1016/0014-5793(92)81285-T; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; EIZIRIK DL, 1989, ENDOCRINOLOGY, V125, P752, DOI 10.1210/endo-125-2-752; Evans-Molina C, 2013, DIABETES OBES METAB, V15, P159, DOI 10.1111/dom.12163; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; Francis J, 2005, J BIOL CHEM, V280, P36244, DOI 10.1074/jbc.M505741200; Gysemans C, 2008, BIOCHEM SOC T, V36, P328, DOI 10.1042/BST0360328; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Ko S, 2011, MOL ENDOCRINOL, V25, P433, DOI 10.1210/me.2010-0482; Kono T, 2012, MOL ENDOCRINOL, V26, P257, DOI 10.1210/me.2011-1181; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Maganti AV, 2015, J BIOL CHEM, V290, P9812, DOI 10.1074/jbc.M114.616219; Munro S, 2010, ONCOGENE, V29, P2357, DOI 10.1038/onc.2009.511; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Ogihara T, 2009, ISLETS, V1, P269, DOI 10.4161/isl.1.3.9779; Okabe J, 2012, CIRC RES, V110, P1067, DOI 10.1161/CIRCRESAHA.112.266171; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Roep BO, 2014, NAT REV ENDOCRINOL, V10, P229, DOI 10.1038/nrendo.2014.2; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; Shimabukuro M, 1997, J CLIN INVEST, V100, P290, DOI 10.1172/JCI119534; Stassi G, 1997, J EXP MED, V186, P1193, DOI 10.1084/jem.186.8.1193; Stull ND, 2012, JOVE-J VIS EXP, DOI 10.3791/4137; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Xu L, 2008, J BIOL CHEM, V283, P3077, DOI 10.1074/jbc.M705709200; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55	45	20	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16607	16618		10.1074/jbc.M115.661777	http://dx.doi.org/10.1074/jbc.M115.661777			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25995453	hybrid, Green Published			2022-12-26	WOS:000357572800013
J	Alvarez, FJ; Revuelta, M; Santaolalla, F; Alvarez, A; Lafuente, H; Arteaga, O; Alonso-Alconada, D; Sanchez-del-Rey, A; Hilario, E; Martinez-Ibarguen, A				Jose Alvarez, Francisco; Revuelta, Miren; Santaolalla, Francisco; Alvarez, Antonia; Lafuente, Hector; Arteaga, Olatz; Alonso-Alconada, Daniel; Sanchez-del-Rey, Ana; Hilario, Enrique; Martinez-Ibargueen, Agustin			Effect of Neonatal Asphyxia on the Impairment of the Auditory Pathway by Recording Auditory Brainstem Responses in Newborn Piglets: A New Experimentation Model to Study the Perinatal Hypoxic-Ischemic Damage on the Auditory System	PLOS ONE			English	Article							INDUCED NEURONAL LOSS; CELL-DEATH; EVOKED-POTENTIALS; PRETERM LAMBS; INJURY; TERM; INFANTS; CANNABIDIOL; CAT	Introduction Hypoxia-ischemia (HI) is a major perinatal problem that results in severe damage to the brain impairing the normal development of the auditory system. The purpose of the present study is to study the effect of perinatal asphyxia on the auditory pathway by recording auditory brain responses in a novel animal experimentation model in newborn piglets. Method Hypoxia-ischemia was induced to 1.3 day-old piglets by clamping 30 minutes both carotid arteries by vascular occluders and lowering the fraction of inspired oxygen. We compared the Auditory Brain Responses (ABRs) of newborn piglets exposed to acute hypoxia/ischemia (n = 6) and a control group with no such exposure (n = 10). ABRs were recorded for both ears before the start of the experiment (baseline), after 30 minutes of HI injury, and every 30 minutes during 6 h after the HI injury. Results Auditory brain responses were altered during the hypoxic-ischemic insult but recovered 30-60 minutes later. Hypoxia/ischemia seemed to induce auditory functional damage by increasing I-V latencies and decreasing wave I, III and V amplitudes, although differences were not significant. Conclusion The described experimental model of hypoxia-ischemia in newborn piglets may be useful for studying the effect of perinatal asphyxia on the impairment of the auditory pathway.	[Jose Alvarez, Francisco; Lafuente, Hector] Cruces Univ Hosp, Res Unit Expt Perinatal Physiopathol, Baracaldo 48080, Bizkaia, Spain; [Revuelta, Miren; Alvarez, Antonia; Arteaga, Olatz; Alonso-Alconada, Daniel; Hilario, Enrique] Univ Basque Country, Fac Med & Dent, Dept Cell Biol & Histol, Leioa 48940, Bizkaia, Spain; [Santaolalla, Francisco; Sanchez-del-Rey, Ana; Martinez-Ibargueen, Agustin] Univ Basque Country, Fac Med, Basurto Univ Hosp, Dept Otorhinolaryngol, Leioa 48940, Bizkaia, Spain	Hospital Universitario Cruces; University of Basque Country; Basurto Hospital; University of Basque Country	Santaolalla, F (corresponding author), Univ Basque Country, Fac Med, Basurto Univ Hosp, Dept Otorhinolaryngol, Barrio Sarriena S-N, Leioa 48940, Bizkaia, Spain.	francisco.santaolalla@ehu.es; enrique.hilario@ehu.es	Martinez, Agustin/T-6004-2019; Alvarez, Francisco/GZL-1953-2022; Alvarez, Francisco J./K-8951-2017; José, Antonio/H-3024-2015; Revuelta, Miren/AAH-2410-2019	Martinez, Agustin/0000-0002-6468-5606; Alvarez, Francisco J./0000-0002-8690-0506; José, Antonio/0000-0003-2851-0400; Revuelta, Miren/0000-0001-8126-2050; arteaga, olatz/0000-0002-4328-4408; Alonso-Alconada, Daniel/0000-0002-9874-2947; Hilario, Enrique/0000-0002-8876-8131; santaolalla, francisco/0000-0003-1813-4069; ALVAREZ DIAZ, ANTONIA ANGELES/0000-0002-1730-7565; Ana, Sanchez-del-Rey/0000-0002-8930-1832	ISCIII-General SubDirectorate for Research Assessment and Promotion [PS120852, PI061085, PS091900]; European Regional Development Funds; Basque Country Government [IT773/13]; Fundacion Jesus de Gangoiti Barrera	ISCIII-General SubDirectorate for Research Assessment and Promotion; European Regional Development Funds(European Commission); Basque Country Government(Basque Government); Fundacion Jesus de Gangoiti Barrera	This research has been supported by grants PS120852, PI061085, PS091900 from ISCIII-General SubDirectorate for Research Assessment and Promotion and the European Regional Development Funds and by grants from the Basque Country Government (IT773/13) and Fundacion Jesus de Gangoiti Barrera. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alconada D, 2011, NEUROSCI BULL, V27, P275, DOI 10.1007/s12264-011-1008-6; Alonso-Alconada D, 2010, BRAIN RES, V1362, P150, DOI 10.1016/j.brainres.2010.09.050; Alvarez FJ, 2008, PEDIATR RES, V64, P653, DOI 10.1203/PDR.0b013e318186e5dd; Alvarez-Diaz A, 2007, NEONATOLOGY, V92, P227, DOI 10.1159/000103741; Appler JM, 2011, PROG NEUROBIOL, V93, P488, DOI 10.1016/j.pneurobio.2011.01.004; Cao F, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-115; du Plessis AJ, 2002, CURR OPIN NEUROL, V15, P151, DOI 10.1097/00019052-200204000-00005; Echteler SM, 2005, DEV BRAIN RES, V157, P192, DOI 10.1016/j.devbrainres.2005.04.004; Foster KA, 2001, BRAIN RES, V919, P122, DOI 10.1016/S0006-8993(01)03011-6; Goni-de-Cerio F, 2007, BRAIN RES, V1151, P161, DOI 10.1016/j.brainres.2007.03.013; Hilario E, 2005, ACTA PAEDIATR, V94, P903, DOI 10.1080/08035250510031151; Inder T E, 2000, Semin Neonatol, V5, P3, DOI 10.1053/siny.1999.0112; Jiang ZD, 2000, PEDIATR RES, V48, P639, DOI 10.1203/00006450-200011000-00015; Jiang ZD, 2003, PEDIATR RES, V54, P680, DOI 10.1203/01.PDR.0000084084.62571.12; JIANG ZD, 2008, NEW TRENDS BRAIN HYP, P203; Jiang ZD, 2006, ACTA PAEDIATR, V95, P1400, DOI 10.1080/08035250600615143; Jiang ZD, 2009, J NEUROL SCI, V287, P172, DOI 10.1016/j.jns.2009.07.029; Kishan AU, 2011, OPEN J NEUROSCI, V1, P1; Lafuente H, 2011, PEDIATR RES, V70, P272, DOI 10.1203/PDR.0b013e3182276b11; Lefebvre PP, 2002, AUDIOL NEURO-OTOL, V7, P165, DOI 10.1159/000058304; Martinez Ibarguen A, 1993, ACTA OTORRINOLARINGO, V44, P36; Meyer C, 1999, PEDIATRICS, V104, P900, DOI 10.1542/peds.104.4.900; Newton V, 2001, Semin Neonatol, V6, P543, DOI 10.1053/siny.2001.0076; Peeters-Scholte C, 2003, PEDIATR RES, V54, P516, DOI 10.1203/01.PDR.0000081297.53793.C6; Perlman JM, 2004, SEMIN PERINATOL, V28, P415, DOI 10.1053/j.semperi.2004.10.003; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Schubert S, 2005, BRAIN RES, V1058, P129, DOI 10.1016/j.brainres.2005.07.061; Smit AL, 2013, PEDIATR RES, V74, P34, DOI 10.1038/pr.2013.64; Soehle M, 2003, NEUROL RES, V25, P411, DOI 10.1179/016164103101201580; Todd KJ, 2006, J PHYSIOLOGY-PARIS, V99, P75, DOI 10.1016/j.jphysparis.2005.12.002; Volpe JJ., 2001, NEUROLOGY NEWBORN, V4; ZAAROOR M, 1991, ELECTROEN CLIN NEURO, V80, P436, DOI 10.1016/0168-5597(91)90092-C; ZAAROOR M, 1991, ELECTROEN CLIN NEURO, V80, P422, DOI 10.1016/0168-5597(91)90091-B	33	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126885	10.1371/journal.pone.0126885	http://dx.doi.org/10.1371/journal.pone.0126885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010092	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900043
J	Azizi, P; Rafii, MY; Mahmood, M; Abdullah, SNA; Hanafi, MM; Nejat, N; Latif, MA; Sahebi, M				Azizi, Parisa; Rafii, Mohd Y.; Mahmood, Maziah; Abdullah, Siti N. A.; Hanafi, Mohamed M.; Nejat, Naghmeh; Latif, Muhammad A.; Sahebi, Mahbod			Differential Gene Expression Reflects Morphological Characteristics and Physiological Processes in Rice Immunity against Blast Pathogen Magnaporthe oryzae	PLOS ONE			English	Article							PLANT-DISEASE RESISTANCE; NUCLEOTIDE-BINDING; BROAD-SPECTRUM; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; PRIMARY METABOLISM; FUNGAL BIOMASS; POWDERY MILDEW; REPEAT CLASS; WRKY GENE	The rice blast fungus Magnaporthe oryzae is a serious pathogen that jeopardises the world's most important food-security crop. Ten common Malaysian rice varieties were examined for their morphological, physiological and genomic responses to this rice blast pathogen. qPCR quantification was used to assess the growth of the pathogen population in resistant and susceptible rice varieties. The chlorophyll content and photosynthesis were also measured to further understand the disruptive effects that M. oryzae has on infected plants of these varieties. Real-time PCR was used to explore the differential expression of eight blast resistance genes among the ten local varieties. Blast disease has destructive effects on the growth of rice, and the findings of our study provide evidence that the Pikh, Pi9, Pi21, and Osw45 genes are involved in defence responses in the leaves of Malaysian rice at 31 h after inoculation with M. oryzae pathotype P7.2. Both the chlorophyll content and photosynthesis were reduced, but the levels of Pikh gene expression remained constant in susceptible varieties, with a developed pathogen population and mild or severe symptoms. The Pi9, Pi21, and Osw45 genes, however, were simultaneously upregulated in infected rice plants. Therefore, the presence of the Pikh, Pi9, Pi21, and Osw45 genes in the germ-plasm is useful for improving the resistance of rice varieties.	[Azizi, Parisa; Rafii, Mohd Y.; Mahmood, Maziah] Univ Putra Malaysia, Inst Trop Agr, Lab Food Crops, Serdang 43400, Selangor, Malaysia; [Rafii, Mohd Y.; Latif, Muhammad A.] Univ Putra Malaysia, Fac Agr, Dept Crop Sci, Serdang 43400, Selangor, Malaysia; [Mahmood, Maziah] Univ Putra Malaysia, Dept Biochem, Fac Biotechnol & Biomol Sci, Serdang 43400, Selangor, Malaysia; [Abdullah, Siti N. A.; Hanafi, Mohamed M.; Nejat, Naghmeh; Sahebi, Mahbod] Univ Putra Malaysia, Lab Plantat Crop, Inst Trop Agr, Serdang 43400, Selangor, Malaysia; [Latif, Muhammad A.] Bangladesh Rice Res Inst, Plant Pathol Div, Gazipur 1701, Bangladesh	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Bangladesh Rice Research Institute (BRRI)	Rafii, MY (corresponding author), Univ Putra Malaysia, Inst Trop Agr, Lab Food Crops, Serdang 43400, Selangor, Malaysia.	mrafii@upm.edu.my	Rafii, M.Y./G-9925-2015; Azizi, Parisa/AAH-3817-2021	Rafii, M.Y./0000-0003-4763-6367; Latif, Mohammad Abdul/0000-0002-4289-575X; Abdullah, Siti Nor Akmar/0000-0002-3611-6094	Ministry of Higher Education, Malaysia [5525001,]	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	The Long-Term Research Grant Scheme (LRGS), Food Security project, grant number 5525001, Ministry of Higher Education, Malaysia. The funders had no role in study design, data collection and analysis, but they are the authors' financial supporter.	Abbruscato P, 2012, MOL PLANT PATHOL, V13, P828, DOI 10.1111/j.1364-3703.2012.00795.x; Ashikawa I, 2008, GENETICS, V180, P2267, DOI 10.1534/genetics.108.095034; Ballini E, 2008, MOL PLANT MICROBE IN, V21, P859, DOI 10.1094/MPMI-21-7-0859; Barriuso J, 2008, PHYTOPATHOLOGY, V98, P666, DOI 10.1094/PHYTO-98-6-0666; BASTIAANS L, 1993, NETH J PLANT PATHOL, V99, P197, DOI 10.1007/BF01974664; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; BERMINGHAM S, 1995, MYCOL RES, V99, P479, DOI 10.1016/S0953-7562(09)80650-3; Blayles D.F., 1971, EXPT PLANT PHYSL, P55; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Bryan GT, 2000, PLANT CELL, V12, P2033, DOI 10.1105/tpc.12.11.2033; Chen XW, 2006, PLANT J, V46, P794, DOI 10.1111/j.1365-313X.2006.02739.x; Correa Victoria FJ, 1993, PLANT DIS, V77, P1029; Diedhiou Abdala Gamby, 2014, Acta Scientiarum Biological Sciences, V36, P433, DOI 10.4025/actascibiolsci.v36i4.21689; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; GARDNER RM, 1993, J MICROBIOL METH, V17, P49, DOI 10.1016/0167-7012(93)90078-V; Gohre V, 2012, MOL PLANT MICROBE IN, V25, P1083, DOI 10.1094/MPMI-11-11-0301; GRETENKORT MA, 1993, J PHYTOPATHOL, V138, P217, DOI 10.1111/j.1439-0434.1993.tb01379.x; Hammond Kosack KE, 2007, ENCYCL LIFE SCI, V40, P1; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hittalmani S, 2000, THEOR APPL GENET, V100, P1121, DOI 10.1007/s001220051395; HU X, 1993, PHYSIOL MOL PLANT P, V42, P23, DOI 10.1006/pmpp.1993.1003; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; Ishiga Y, 2009, NEW PHYTOL, V181, P147, DOI 10.1111/j.1469-8137.2008.02639.x; Jia YL, 2004, PHYTOPATHOLOGY, V94, P296, DOI 10.1094/PHYTO.2004.94.3.296; Kalde M, 2003, MOL PLANT MICROBE IN, V16, P295, DOI 10.1094/MPMI.2003.16.4.295; Kato H., 2001, Pesticide Outlook, V12, P23, DOI 10.1039/b100803j; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Kuyek D, 2000, BIOTECH AND BIG BUSI; Liu G, 2002, MOL GENET GENOMICS, V267, P472, DOI 10.1007/s00438-002-0677-2; Liu XQ, 2007, GENETICS, V176, P2541, DOI 10.1534/genetics.107.075465; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; MALESZKA R, 1993, YEAST, V9, P53, DOI 10.1002/yea.320090107; Marsh E, 2010, PROTEOMICS, V10, P2057, DOI 10.1002/pmic.200900712; Okuyama Y, 2011, PLANT J, V66, P467, DOI 10.1111/j.1365-313X.2011.04502.x; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Parker D, 2008, NAT PROTOC, V3, P435, DOI 10.1038/nprot.2007.499; Pieterse CMJ, 1999, TRENDS PLANT SCI, V4, P52, DOI 10.1016/S1360-1385(98)01364-8; Pineda M, 2010, PHOTOSYNTH RES, V103, P31, DOI 10.1007/s11120-009-9499-y; PLASSARD CS, 1982, PHYTOCHEMISTRY, V21, P345, DOI 10.1016/S0031-9422(00)95263-4; Qi M, 2002, PHYTOPATHOLOGY, V92, P870, DOI 10.1094/PHYTO.2002.92.8.870; Qu SH, 2006, GENETICS, V172, P1901, DOI 10.1534/genetics.105.044891; Rice INfGEo, 1996, STANDARD EVALUATION; Rushton PJ, 1996, EMBO J, V15, P5690, DOI 10.1002/j.1460-2075.1996.tb00953.x; Ryu HS, 2006, PLANT CELL REP, V25, P836, DOI 10.1007/s00299-006-0138-1; SANDHU GS, 1995, J CLIN MICROBIOL, V33, P2913, DOI 10.1128/JCM.33.11.2913-2919.1995; Sharma TR, 2010, J PLANT BIOCHEM BIOT, V19, P87, DOI 10.1007/BF03323441; Shimono M, 2012, MOL PLANT PATHOL, V13, P83, DOI 10.1111/j.1364-3703.2011.00732.x; Shinoda H., 1971, ANN REV CHUGOKU NATL, V20, P1; Simms D., 1993, FOCUS, V15, P532, DOI DOI 10.1016/0003-267061)80041-X; Staskawicz BJ, 2001, PLANT PHYSIOL, V125, P73, DOI 10.1104/pp.125.1.73; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Swarbrick PJ, 2006, PLANT CELL ENVIRON, V29, P1061, DOI 10.1111/j.1365-3040.2005.01472.x; Taj G, 2014, MAPK SIGNALING CASCA, P297; Viraktamath MS, 2010, INT RICE RES NOTES, V117, P4185; Wang ZX, 1999, PLANT J, V19, P55, DOI 10.1046/j.1365-313X.1999.00498.x; Wen N, 2003, MOL GENET GENOMICS, V269, P331, DOI 10.1007/s00438-003-0839-x; Yang H, 2011, MOL BIOL REP, V38, P511, DOI 10.1007/s11033-010-0135-x; Young ND, 1996, ANNU REV PHYTOPATHOL, V34, P479, DOI 10.1146/annurev.phyto.34.1.479; Zeigler RS, 1994, RICE BLAST DISEASE	61	12	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126188	10.1371/journal.pone.0126188	http://dx.doi.org/10.1371/journal.pone.0126188			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001124	Green Submitted, Green Published, gold			2022-12-26	WOS:000354931700013
J	Goldschmidt, Y; Yurkovsky, E; Reif, A; Rosner, R; Akiva, A; Nachman, I				Goldschmidt, Yifat; Yurkovsky, Evgeny; Reif, Amit; Rosner, Roni; Akiva, Amit; Nachman, Iftach			Control of Relative Timing and Stoichiometry by a Master Regulator	PLOS ONE			English	Article							MEIOSIS-SPECIFIC GENES; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; TRANSCRIPTION FACTOR; EXPRESSION KINETICS; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; GLOBAL ANALYSIS; PROTEIN; IME1	Developmental processes in cells require a series of complex steps. Often only a single master regulator activates genes in these different steps. This poses several challenges: some targets need to be ordered temporally, while co-functional targets may need to be synchronized in both time and expression level. Here we study in single cells the dynamic activation patterns of early meiosis genes in budding yeast, targets of the meiosis master regulator Ime1. We quantify the individual roles of the promoter and protein levels in expression pattern control, as well as the roles of individual promoter elements. We find a consistent expression pattern difference between a non-cofunctional pair of genes, and a highly synchronized activation of a co-functional pair. We show that dynamic control leading to these patterns is distributed between promoter, gene and external regions. Through specific reciprocal changes to the promoters of pairs of genes, we show that different genes can use different promoter elements to reach near identical activation patterns.	[Goldschmidt, Yifat; Yurkovsky, Evgeny; Reif, Amit; Rosner, Roni; Akiva, Amit; Nachman, Iftach] Tel Aviv Univ, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Nachman, I (corresponding author), Tel Aviv Univ, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel.	iftachn@post.tau.ac.il	Nachman, Iftach/AAK-2051-2020; Nachman, Iftach/E-6750-2010	Nachman, Iftach/0000-0002-4667-0398	Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Israeli Science Foundation [ISF 1499/10]	Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Israeli Science Foundation(Israel Science Foundation)	This study was supported in part by a fellowship from the Edmond J. Safra Center for Bioinformatics at Tel Aviv University (EY and RR) and by the Israeli Science Foundation (ISF 1499/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Bishop DK, 2012, CELL CYCLE, V11, P4105, DOI 10.4161/cc.22396; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Brar GA, 2009, MOL BIOL CELL, V20, P1030, DOI 10.1091/mbc.E08-06-0637; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Dadiani M, 2013, GENOME RES, V23, P966, DOI 10.1101/gr.149096.112; Eser U, 2011, MOL CELL, V43, P515, DOI 10.1016/j.molcel.2011.06.024; Ferrari SR, 2009, J BIOL CHEM; Fujita M, 2005, J BACTERIOL, V187, P1357, DOI 10.1128/JB.187.4.1357-1368.2005; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GRANOT D, 1989, MOL GEN GENET, V218, P308, DOI 10.1007/BF00331283; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; Kassir Y, 2003, INT REV CYTOL, V224, P111, DOI 10.1016/S0074-7696(05)24004-4; Kim HD, 2008, NAT STRUCT MOL BIOL, V15, P1192, DOI 10.1038/nsmb.1500; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Leem SH, 1998, NUCLEIC ACIDS RES, V26, P3154, DOI 10.1093/nar/26.13.3154; Lin ZG, 2012, MOL BIOL EVOL, V29, P81, DOI 10.1093/molbev/msr143; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; MacIsaac KD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000773; MANDEL S, 1994, DEV GENET, V15, P139, DOI 10.1002/dvg.1020150204; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Pnueli L, 2004, MOL CELL BIOL, V24, P5197, DOI 10.1128/MCB.24.12.5197-5208.2004; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; RubinBejerano I, 1996, MOL CELL BIOL, V16, P2518; Sagee S, 1998, MOL CELL BIOL, V18, P1985, DOI 10.1128/MCB.18.4.1985; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Tsankov A, 2011, GENOME RES, V21, P1851, DOI 10.1101/gr.122267.111; VANSINDEREN D, 1995, MOL MICROBIOL, V15, P455; Williams RM, 2002, P NATL ACAD SCI USA, V99, P13431, DOI 10.1073/pnas.202495299; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348; Zeevi D, 2011, GENOME RES, V21, P2114, DOI 10.1101/gr.119669.110	39	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127339	10.1371/journal.pone.0127339	http://dx.doi.org/10.1371/journal.pone.0127339			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000862	Green Published, Green Submitted, gold			2022-12-26	WOS:000354931700052
J	Schwingshackl, A; Roan, E; Teng, B; Waters, CM				Schwingshackl, Andreas; Roan, Esra; Teng, Bin; Waters, Christopher M.			TREK-1 Regulates Cytokine Secretion from Cultured Human Alveolar Epithelial Cells Independently of Cytoskeletal Rearrangements	PLOS ONE			English	Article							POTASSIUM CHANNEL TREK-1; TNF-ALPHA; DNA-DAMAGE; MECHANISMS; EXPRESSION; HYPEROXIA; VESICLES; PROTEIN; A549; DEGRADATION	Background TREK-1 deficient alveolar epithelial cells (AECs) secrete less IL-6, more MCP-1, and contain less F-actin. Whether these alterations in cytokine secretion and F-actin content are related remains unknown. We now hypothesized that cytokine secretion from TREK-1-deficient AECs was regulated by cytoskeletal rearrangements. Methods We determined F-actin and a-tubulin contents of control, TREK-1-deficient and TREK-1-overexpressing human A549 cells by confocal microscopy and western blotting, and measured IL-6 and MCP-1 levels using real-time PCR and ELISA. Results Cytochalasin D decreased the F-actin content of control cells. Jasplakinolide increased the F-actin content of TREK-1 deficient cells, similar to the effect of TREK-1 overexpression in control cells. Treatment of control and TREK-1 deficient cells with TNF-alpha, a strong stimulus for IL-6 and MCP-1 secretion, had no effect on F-actin structures. The combination of TNF-alpha+cytochalasin D or TNF-alpha+jasplakinolide had no additional effect on the F-actin content or architecture when compared to cytochalasin D or jasplakinolide alone. Although TREK-1 deficient AECs contained less F-actin at baseline, quantified biochemically, they contained more a-tubulin. Exposure to nocodazole disrupted a-tubulin filaments in control and TREK1 deficient cells, but left the overall amount of a-tubulin unchanged. Although TNF-alpha had no effect on the F-actin or a-tubulin contents, it increased IL-6 and MCP-1 production and secretion from control and TREK-1 deficient cells. IL-6 and MCP-1 secretions from control and TREK-1 deficient cells after TNF-alpha+jasplakinolide or TNF-alpha+nocodazole treatment was similar to the effect of TNF-alpha alone. Interestingly, cytochalasin D decreased TNF-alpha-induced IL-6 but not MCP-1 secretion from control but not TREK-1 deficient cells. Conclusion Although cytochalasin D, jasplakinolide and nocodazole altered the F-actin and a-tubulin structures of control and TREK-1 deficient AEC, the changes in cytokine secretion from TREK-1 deficient cells cannot be explained by cytoskeletal rearrangements in these cells.	[Schwingshackl, Andreas] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Memphis, TN 38163 USA; [Schwingshackl, Andreas; Teng, Bin; Waters, Christopher M.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN USA; [Roan, Esra] Univ Memphis, Dept Biomed Engn, Memphis, TN 38152 USA; [Waters, Christopher M.] Univ Tennessee, Dept Med, Hlth Sci Ctr, Memphis, TN 38104 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; University of Tennessee System; University of Tennessee Health Science Center	Schwingshackl, A (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Memphis, TN 38163 USA.	aschwingshackl@gmail.com	Waters, Christopher/V-2759-2019		American Lung Association (ALA) [: RG-260120-N]; NIH [NIH HL118118-01A1];  [K01 HL120912-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL120912, K08HL118118, R01HL123540] Funding Source: NIH RePORTER	American Lung Association (ALA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the American Lung Association (ALA): RG-260120-N (AS) and the NIH: NIH HL118118-01A1 (AS). The study was also supported by a K01 HL120912-02 grant (ER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belperio JA, 2006, SEMIN RESP CRIT CARE, V27, P350, DOI 10.1055/s-2006-948289; Benado A, 2009, IMMUNOBIOLOGY, V214, P507, DOI 10.1016/j.imbio.2008.11.011; BENGTSSON T, 1991, J LEUKOCYTE BIOL, V49, P236, DOI 10.1002/jlb.49.3.236; Bittner S, 2013, NAT MED, V19, P1161, DOI 10.1038/nm.3303; Brown ACN, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001152; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Chang B, 2004, MICROB PATHOGENESIS, V37, P295, DOI 10.1016/j.micpath.2004.10.002; Chanteloup NK, 2011, VET MICROBIOL, V147, P435, DOI 10.1016/j.vetmic.2010.07.013; Chapman KE, 2005, AM J PHYSIOL-LUNG C, V289, pL834, DOI 10.1152/ajplung.00069.2005; Chemin K, 2012, J IMMUNOL, V189, P2159, DOI 10.4049/jimmunol.1200156; Cordell PA, 2010, BLOOD, V115, P2674, DOI 10.1182/blood-2009-08-231316; Corsini E, 2013, ARCH TOXICOL, V87, P2187, DOI 10.1007/s00204-013-1071-z; Desai LP, 2008, AM J PHYSIOL-LUNG C, V295, pL958, DOI 10.1152/ajplung.90218.2008; Desai LP, 2007, AM J PHYSIOL-LUNG C, V293, pL769, DOI 10.1152/ajplung.00127.2007; DiPaolo BC, 2010, AM J PHYSIOL-CELL PH, V299, pC345, DOI 10.1152/ajpcell.00379.2009; Garcia-Perez BE, 2008, MICROB PATHOGENESIS, V45, P1, DOI 10.1016/j.micpath.2008.01.009; Fedorko ME, 2004, MED HYPOTHESES, V62, P911, DOI 10.1016/j.mehy.2004.01.007; Goel M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023070; Granger E, 2014, SEMIN CELL DEV BIOL, V31, P20, DOI 10.1016/j.semcdb.2014.04.011; Guadiz G, 1997, AM J RESP CELL MOL, V17, P60, DOI 10.1165/ajrcmb.17.1.2730; Guo FY, 2012, TOXICOL APPL PHARM, V260, P183, DOI 10.1016/j.taap.2012.02.010; Han CF, 2009, J IMMUNOL, V182, P2986, DOI 10.4049/jimmunol.0802002; Hayot C, 2006, TOXICOL APPL PHARM, V211, P30, DOI 10.1016/j.taap.2005.06.006; Huang FY, 2013, ONCOL REP, V30, P478, DOI 10.3892/or.2013.2423; Islam MN, 2014, AM J PHYSIOL-LUNG C, V306, pL50, DOI 10.1152/ajplung.00252.2013; Ito S, 2010, AM J RESP CELL MOL, V43, P26, DOI 10.1165/rcmb.2009-0073OC; Jacquemet G, 2013, J CELL BIOL, V202, P917, DOI 10.1083/jcb.201302041; Kermorgant S, 2003, J BIOL CHEM, V278, P28921, DOI 10.1074/jbc.M302116200; Kimura K, 2013, INVEST OPHTH VIS SCI, V54, P2752, DOI 10.1167/iovs.12-11294; Kohwiwattanagun J, 2007, MICROBIOL IMMUNOL, V51, P253, DOI 10.1111/j.1348-0421.2007.tb03897.x; Lacherade JC, 2001, AM J PHYSIOL-LUNG C, V281, pL134, DOI 10.1152/ajplung.2001.281.1.L134; Lagrue K, 2013, IMMUNOL REV, V256, P203, DOI 10.1111/imr.12107; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; Liu D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012870; McAdams RM, 2006, AM J PHYSIOL-LUNG C, V291, pL166, DOI 10.1152/ajplung.00160.2005; MEDURI GU, 1995, CHEST, V107, P1062, DOI 10.1378/chest.107.4.1062; Mong PY, 2008, J IMMUNOL, V180, P550, DOI 10.4049/jimmunol.180.1.550; Muroya M, 2012, BIOSCI TRENDS, V6, P70, DOI 10.5582/bst.2012.v6.2.70; Ni JX, 2013, FREE RADICAL BIO MED, V61, P26, DOI 10.1016/j.freeradbiomed.2013.03.012; Rahat MA, 2006, J LEUKOCYTE BIOL, V79, P706, DOI 10.1189/jlb.0605302; Rak GD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001151; Regueiro V, 2006, MICROBIOL-SGM, V152, P555, DOI 10.1099/mic.0.28285-0; Roan E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089429; Sasaki S, 2014, BBA-BIOMEMBRANES, V1838, P514, DOI 10.1016/j.bbamem.2013.06.004; Schwingshackl A, 2014, CRIT CARE MED, V42, pE692, DOI 10.1097/CCM.0000000000000603; Schwingshackl A, 2013, AM J TRANSL RES, V5, P530; Schwingshackl A, 2013, AM J PHYSIOL-LUNG C, V304, pL276, DOI 10.1152/ajplung.00299.2012; Schwingshackl A, 2012, AM J PHYSIOL-LUNG C, V302, pL93, DOI 10.1152/ajplung.00078.2011; Smith AJ, 2003, TRAFFIC, V4, P302, DOI 10.1034/j.1600-0854.2003.00084.x; Stanley AC, 2012, J LEUKOCYTE BIOL, V92, P1227, DOI 10.1189/jlb.0412191; Stanley AC, 2010, PHYSIOLOGY, V25, P218, DOI 10.1152/physiol.00017.2010; Suzuki M, 2003, J ALLERGY CLIN IMMUN, V112, P126, DOI 10.1067/mai.2003.1515; Szczygiel AM, 2012, PFLUG ARCH EUR J PHY, V463, P487, DOI 10.1007/s00424-011-1051-1; Tsakini N, 2008, MOL CELL NEUROSCI, V37, P110, DOI 10.1016/j.mcn.2007.09.001; Tu LN, 2007, INFECT IMMUN, V75, P2996, DOI 10.1128/IAI.01716-06; Uronen-Hansson H, 2004, IMMUNOLOGY, V111, P173, DOI 10.1111/j.0019-2805.2003.01803.x; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; WISPE JR, 1990, J CLIN INVEST, V86, P1954, DOI 10.1172/JCI114929; Wu LG, 2014, ANNU REV PHYSIOL, V76, P301, DOI 10.1146/annurev-physiol-021113-170305; Xie JS, 2009, EXP EYE RES, V88, P467, DOI 10.1016/j.exer.2008.10.023; Zoncu R, 2011, SCIENCE, V332, P923, DOI 10.1126/science.1207552	61	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126781	10.1371/journal.pone.0126781	http://dx.doi.org/10.1371/journal.pone.0126781			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001192	gold, Green Published, Green Submitted			2022-12-26	WOS:000354931700027
J	Bode, GH; Pickl, KE; Sanchez-Purra, M; Albaiges, B; Borros, S; Poetgens, AJG; Schmitz, C; Sinner, FM; Losen, M; Steinbusch, HWM; Frank, HG; Martinez-Martinez, P				Bode, Gerard H.; Pickl, Karin E.; Sanchez-Purra, Maria; Albaiges, Berta; Borros, Salvador; Poetgens, Andy J. G.; Schmitz, Christoph; Sinner, Frank M.; Losen, Mario; Steinbusch, Harry W. M.; Frank, Hans-Georg; Martinez-Martinez, Pilar		European NanoBioPharmaceutics Res	Detection of Peptide-Based Nanoparticles in Blood Plasma by ELISA	PLOS ONE			English	Article							DRUG-DELIVERY; NANOMEDICINE; ATHEROSCLEROSIS; CANCER; NAP	Aims The aim of the current study was to develop a method to detect peptide-linked nanoparticles in blood plasma. Materials & Methods A convenient enzyme linked immunosorbent assay (ELISA) was developed for the detection of peptides functionalized with biotin and fluorescein groups. As a proof of principle, polymerized pentafluorophenyl methacrylate nanoparticles linked to biotin-carboxyfluorescein labeled peptides were intravenously injected in Wistar rats. Serial blood plasma samples were analyzed by ELISA and by liquid chromatography mass spectrometry (LC/MS) technology. Results The ELISA based method for the detection of FITC labeled peptides had a detection limit of 1 ng/mL. We were able to accurately measure peptides bound to pentafluorophenyl methacrylate nanoparticles in blood plasma of rats, and similar results were obtained by LC/MS. Conclusions We detected FITC-labeled peptides on pentafluorophenyl methacrylate nanoparticles after injection in vivo. This method can be extended to detect nanoparticles with different chemical compositions.	[Bode, Gerard H.; Losen, Mario; Steinbusch, Harry W. M.; Martinez-Martinez, Pilar] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci, Dept Neurosci, NL-6200 MD Maastricht, Netherlands; [Pickl, Karin E.] Joanneum Res Forsch Gesell MbH, HLTH Inst Biomed & Hlth Sci, Graz, Austria; [Sanchez-Purra, Maria; Albaiges, Berta; Borros, Salvador] Univ Ramon Llull, Inst Quim Sarria, Grp Enginyeria Mat GEMAT, Barcelona, Spain; [Poetgens, Andy J. G.; Frank, Hans-Georg] AplaGen GmbH, Baesweiler, Germany; [Schmitz, Christoph; Frank, Hans-Georg] Univ Munich, Dept Neuroanat, Munich, Germany; [Sinner, Frank M.] Med Univ Graz, Dept Internal Med, Div Endocrinol & Metab, Graz, Austria	Maastricht University; Universitat Ramon Llull; Institut Quimic de Sarria; University of Munich; Medical University of Graz	Martinez-Martinez, P (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci, Dept Neurosci, NL-6200 MD Maastricht, Netherlands.	p.martinez@maastrichtuniversity.nl	Frank, Hans-Georg/G-6038-2012; Borrós, Salvador/A-3950-2016; Steinbusch, Heinrich/L-6950-2017	Frank, Hans-Georg/0000-0002-3562-138X; Borrós, Salvador/0000-0002-4003-0381; Losen, Mario/0000-0002-9761-0002; Martinez Martinez, Pilar/0000-0002-5990-3373	EC-FP6; AplaGen GmbH	EC-FP6(European CommissionEuropean Commission Joint Research Centre); AplaGen GmbH	This work was supported by a grant from the EC-FP6 (to the European NanoBioPharmaceutics research initiative). AplaGen GmbH provided support in the form of salaries for authors Andy J.G. Potgens and Hans-Georg Frank, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arosio D, 2012, CURR MED CHEM, V19, P3128; Bassan M, 1999, J NEUROCHEM, V72, P1283, DOI 10.1046/j.1471-4159.1999.0721283.x; Brasnjevic I, 2009, PROG NEUROBIOL, V87, P212, DOI 10.1016/j.pneurobio.2008.12.002; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Lobatto ME, 2011, NAT REV DRUG DISCOV, V10, P835, DOI 10.1038/nrd3578; Magen I, 2013, NEUROPEPTIDES, V47, P489, DOI 10.1016/j.npep.2013.10.011; Pearce TR, 2012, ADV MATER, V24, P3803, DOI 10.1002/adma.201200832; Psarros C, 2012, NANOMED-NANOTECHNOL, V8, pS59, DOI 10.1016/j.nano.2012.05.006; Quraishe S, 2013, MOL PSYCHIATR, V18, P834, DOI 10.1038/mp.2013.32; Re F, 2012, NANOMED-NANOTECHNOL, V8, pS51, DOI 10.1016/j.nano.2012.05.007; Spuch Carlos, 2012, Recent Pat Drug Deliv Formul, V6, P2; Svensen N, 2012, TRENDS PHARMACOL SCI, V33, P186, DOI 10.1016/j.tips.2012.02.002; Wei H, 2009, PROG POLYM SCI, V34, P893, DOI 10.1016/j.progpolymsci.2009.05.002; Zhang XX, 2012, J CONTROL RELEASE, V159, P2, DOI 10.1016/j.jconrel.2011.10.023	14	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0126136	10.1371/journal.pone.0126136	http://dx.doi.org/10.1371/journal.pone.0126136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996618	Green Submitted, Green Published, gold			2022-12-26	WOS:000356444000018
J	Brand, M; Sommer, M; Ellmann, S; Wuest, W; May, MS; Eller, A; Vogt, S; Lell, MM; Kuefner, MA; Uder, M				Brand, Michael; Sommer, Matthias; Ellmann, Stephan; Wuest, Wolfgang; May, Matthias S.; Eller, Achim; Vogt, Sabine; Lell, Michael M.; Kuefner, Michael A.; Uder, Michael			Influence of Different Antioxidants on X-Ray Induced DNA Double-Strand Breaks (DSBs) Using gamma-H2AX Immunofluorescence Microscopy in a Preliminary Study	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; BLOOD-LYMPHOCYTES; IONIZING-RADIATION; OMEGA CLASS; REPAIR; CT; PROTECTION; CYSTEINE; IMPACT; DAMAGE	Background Radiation exposure occurs in X-ray guided interventional procedures or computed tomography (CT) and gamma-H2AX-foci are recognized to represent DNA double-strand breaks (DSBs) as a biomarker for radiation induced damage. Antioxidants may reduce the induction of gamma-H2AX-foci by binding free radicals. The aim of this study was to establish a dose-effect relationship and a time-effect relationship for the individual antioxidants on DSBs in human blood lymphocytes. Materials and Methods Blood samples from volunteers were irradiated with 10 mGy before and after pre-incubation with different antioxidants (zinc, trolox, lipoic acid, beta-carotene, selenium, vitamin E, vitamin C, N-acetyl-L-cysteine (NAC) and Q 10). Thereby, different pre-incubation times, concentrations and combinations of drugs were evaluated. For assessment of DSBs, lymphocytes were stained against the phosphorylated histone variant gamma-H2AX. Results For zinc, trolox and lipoic acid regardless of concentration or pre-incubation time, no significant decrease of gamma-H2AX-foci was found. However, beta-carotene (15%), selenium (14%), vitamin E (12%), vitamin C (25%), NAC (43%) and Q 10 (18%) led to a significant reduction of gamma-H2AX-foci at a pre-incubation time of 1 hour. The combination of different antioxidants did not have an additive effect. Conclusion Antioxidants administered prior to irradiation demonstrated the potential to reduce gamma-H2AX-foci in blood lymphocytes.	[Brand, Michael; Sommer, Matthias; Ellmann, Stephan; Wuest, Wolfgang; May, Matthias S.; Eller, Achim; Vogt, Sabine; Lell, Michael M.; Kuefner, Michael A.; Uder, Michael] Univ Hosp Erlangen Nuremberg, Dept Radiol, Erlangen, Germany	University of Erlangen Nuremberg	Brand, M (corresponding author), Univ Hosp Erlangen Nuremberg, Dept Radiol, Erlangen, Germany.	michael.brand@uk-erlangen.de	May, Matthias/AAZ-4877-2021; Ellmann, Stephan/P-3824-2016	May, Matthias/0000-0002-2540-850X; Ellmann, Stephan/0000-0003-2737-5526				Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; Beels L, 2009, CIRCULATION, V120, P1903, DOI 10.1161/CIRCULATIONAHA.109.880385; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Bhabak KP, 2010, ACCOUNTS CHEM RES, V43, P1408, DOI 10.1021/ar100059g; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Brand M, 2012, EUR J RADIOL, V81, pE357, DOI 10.1016/j.ejrad.2011.11.027; Dardano A, 2007, J CLIN ENDOCR METAB, V92, P4286, DOI 10.1210/jc.2007-0597; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Dilger RN, 2007, J ANIM SCI, V85, P1712, DOI 10.2527/jas.2006-835; Eaton DL, 1999, TOXICOL SCI, V49, P156, DOI 10.1093/toxsci/49.2.156; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Kuefner MA, 2010, EUR RADIOL, V20, P2917, DOI 10.1007/s00330-010-1873-9; Kuefner MA, 2012, RADIOLOGY, V264, P59, DOI 10.1148/radiol.12111730; Kuefner MA, 2010, INVEST RADIOL, V45, P182, DOI 10.1097/RLI.0b013e3181d3eddf; Kuefner MA, 2009, INVEST RADIOL, V44, P440, DOI 10.1097/RLI.0b013e3181a654a5; Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x; Lobrich M, 2005, P NATL ACAD SCI USA, V102, P8984, DOI 10.1073/pnas.0501895102; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Oakley AJ, 2005, CURR OPIN STRUC BIOL, V15, P716, DOI 10.1016/j.sbi.2005.10.005; Reliene R, 2009, MUTAT RES-FUND MOL M, V665, P37, DOI 10.1016/j.mrfmmm.2009.02.016; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rothkamm K, 2007, RADIOLOGY, V242, P244, DOI 10.1148/radiol.2421060171; Rube CE, 2008, CLIN CANCER RES, V14, P6546, DOI 10.1158/1078-0432.CCR-07-5147; Traber MG, 2011, FREE RADICAL BIO MED, V51, P1000, DOI 10.1016/j.freeradbiomed.2011.05.017; Wan XS, 2006, INT J RADIAT ONCOL, V64, P1475, DOI 10.1016/j.ijrobp.2005.11.024; Weiss JF, 2003, TOXICOLOGY, V189, P1, DOI 10.1016/S0300-483X(03)00149-5; Whitbread AK, 2005, METHOD ENZYMOL, V401, P78, DOI 10.1016/S0076-6879(05)01005-0	31	29	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127142	10.1371/journal.pone.0127142	http://dx.doi.org/10.1371/journal.pone.0127142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996998	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000044
J	Macconi, D; Perico, L; Longaretti, L; Morigi, M; Cassis, P; Buelli, S; Perico, N; Remuzzi, G; Benigni, A				Macconi, Daniela; Perico, Luca; Longaretti, Lorena; Morigi, Marina; Cassis, Paola; Buelli, Simona; Perico, Norberto; Remuzzi, Giuseppe; Benigni, Ariela			Sirtuin3 Dysfunction Is the Key Determinant of Skeletal Muscle Insulin Resistance by Angiotensin II	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; METABOLIC SYNDROME; L-CARNITINE; GLUT4 TRANSLOCATION; OXIDATIVE STRESS; GLUCOSE-UPTAKE; NADPH OXIDASE; MITOCHONDRIAL; EXPRESSION; AMPK	Background Angiotensin II promotes insulin resistance. The mechanism underlying this abnormality, however, is still poorly defined. In a different setting, skeletal muscle metabolism and insulin signaling are regulated by Sirtuin3. Objective Here, we investigate whether angiotensin II-induced insulin resistance in skeletal muscle is associated with Sirtuin3 dysregulation and whether pharmacological manipulation of Sirtuin3 confers protection. Study Design Parental and GLUT4-myc L6 rat skeletal muscle cells exposed to angiotensin II are used as in vitro models of insulin resistance. GLUT4 translocation, glucose uptake, intracellular molecular signals such as mitochondrial reactive oxygen species, Sirtuin3 protein expression and activity, along with its downstream targets and upstream regulators, are analyzed both in the absence and presence of acetyl-L-carnitine. The role of Sirtuin3 in GLUT4 translocation and intracellular molecular signaling is also studied in Sirtuin3-silenced as well as overexpressing cells. Results Angiotensin II promotes insulin resistance in skeletal muscle cells via mitochondrial oxidative stress, resulting in a two-fold increase in superoxide generation. In this context, reactive oxygen species open the mitochondrial permeability transition pore and significantly lower Sirtuin3 levels and activity impairing the cell antioxidant defense. Angiotensin II-induced Sirtuin3 dysfunction leads to the impairment of AMP-activated protein kinase/nicotinamide phosphoribosyltransferase signaling. Acetyl-L-carnitine, by lowering angiotensin II-induced mitochondrial superoxide formation, prevents Sirtuin3 dysfunction. This phenomenon implies the restoration of manganese superoxide dismutase antioxidant activity and AMP-activated protein kinase activation. Acetyl-L-carnitine protection is abrogated by specific Sirtuin3 siRNA. Conclusions Our data demonstrate that angiotensin II-induced insulin resistance fosters mitochondrial superoxide generation, in turn leading to Sirtuin3 dysfunction. The present results also highlight Sirtuin3 as a therapeutic target for the insulin-sensitizing effects of acetyl-L-carnitine.	[Macconi, Daniela; Perico, Luca; Longaretti, Lorena; Morigi, Marina; Buelli, Simona; Remuzzi, Giuseppe; Benigni, Ariela] IRCCS, Ist Ric Farmacol Mario Negri, Ctr Anna Maria Astori, I-24126 Bergamo, Italy; [Cassis, Paola; Perico, Norberto] IRCCS, Ist Ric Farmacol Mario Negri, Clin Res Ctr Rare Dis Aldo & Cele Dacco, I-24020 Bergamo, Italy; [Remuzzi, Giuseppe] Azienda Osped Papa Giovanni XXIII, Unit Nephrol & Dialysis, I-24127 Bergamo, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; ASST Papa Giovanni XXIII	Macconi, D (corresponding author), IRCCS, Ist Ric Farmacol Mario Negri, Ctr Anna Maria Astori, Sci & Technol Pk Kilometro Rosso,Via Stezzano 87, I-24126 Bergamo, Italy.	daniela.macconi@marionegri.it	Morigi, Marina/ABH-3131-2020; Longaretti, Lorena/ABG-1258-2020; Perico, Luca/ABH-3224-2020; Ariela, Benigni/ABH-3492-2020; Buelli, Simona/AAB-1847-2020; Macconi, Daniela/ABH-3534-2020; Perico, Norberto/ABH-3222-2020; Remuzzi, Giuseppe/V-9766-2017	Morigi, Marina/0000-0001-8029-7382; Longaretti, Lorena/0000-0002-4366-4152; Perico, Luca/0000-0003-3470-1721; Ariela, Benigni/0000-0002-4721-5485; Buelli, Simona/0000-0002-2508-7793; Macconi, Daniela/0000-0002-2208-9646; Perico, Norberto/0000-0002-3147-4327; Remuzzi, Giuseppe/0000-0002-6194-3446	fiRSt Srl, Rome, Italy	fiRSt Srl, Rome, Italy	The study was supported by a grant from fiRSt Srl, Rome, Italy.	BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Bell EL, 2011, MOL CELL, V42, P561, DOI 10.1016/j.molcel.2011.05.008; Benigni A, 2009, J CLIN INVEST, V119, P524, DOI 10.1172/JCI36703; Brandauer J, 2013, J PHYSIOL-LONDON, V591, P5207, DOI 10.1113/jphysiol.2013.259515; Calabrese V, 2006, ANTIOXID REDOX SIGN, V8, P404, DOI 10.1089/ars.2006.8.404; Calabrese V, 2009, BIOFACTORS, V35, P146, DOI 10.1002/biof.22; Cassano P, 2006, BBA-BIOENERGETICS, V1757, P1421, DOI 10.1016/j.bbabio.2006.05.019; Costford SR, 2010, AM J PHYSIOL-ENDOC M, V298, pE117, DOI 10.1152/ajpendo.00318.2009; Decleves AE, 2014, NEPHRON EXP NEPHROL; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Diamond-Stanic Maggie K., 2010, Archives of Physiology and Biochemistry, V116, P88, DOI 10.3109/13813451003758703; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fisher Jonathan S, 2006, Cellscience, V2, P68; Fryer LGD, 2002, FEBS LETT, V531, P189, DOI 10.1016/S0014-5793(02)03501-9; Gallagher EJ, 2011, MED CLIN N AM, V95, P855, DOI 10.1016/j.mcna.2011.06.001; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Imai S, 2009, CURR PHARM DESIGN, V15, P20, DOI 10.2174/138161209787185814; James AM, 2012, TRENDS ENDOCRIN MET, V23, P429, DOI 10.1016/j.tem.2012.06.008; Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108; Karalliedde J., 2014, NEPHROL DIAL TRANSPL, ppii; KATZ LD, 1983, DIABETES, V32, P675, DOI 10.2337/diabetes.32.7.675; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lastra G, 2013, CARDIORENAL MED, V3, P154, DOI 10.1159/000353155; Lin LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085636; Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299; Marcovina SM, 2013, TRANSL RES, V161, P73, DOI 10.1016/j.trsl.2012.10.006; Martin SD, 2014, BBA-GEN SUBJECTS, V1840, P1303, DOI 10.1016/j.bbagen.2013.09.019; Mingorance C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034268; Mitsuishi M, 2009, DIABETES, V58, P710, DOI 10.2337/db08-0949; MITSUMOTO Y, 1992, J BIOL CHEM, V267, P4957; Olivares-Reyes JA, 2009, MOL CELL ENDOCRINOL, V302, P128, DOI 10.1016/j.mce.2008.12.011; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Pehmoller C, 2009, AM J PHYSIOL-ENDOC M, V297, pE665, DOI 10.1152/ajpendo.00115.2009; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Rebouche CJ, 2004, ANN NY ACAD SCI, V1033, P30, DOI 10.1196/annals.1320.003; Rosca MG, 2009, ADV DRUG DELIVER REV, V61, P1332, DOI 10.1016/j.addr.2009.06.009; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Ruggenenti P, 2009, HYPERTENSION, V54, P567, DOI 10.1161/HYPERTENSIONAHA.109.132522; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Shinshi Y, 2007, J AM SOC HYPERTENS, V1, P251, DOI 10.1016/j.jash.2007.04.007; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Ueyama A, 1999, AM J PHYSIOL-ENDOC M, V277, pE572, DOI 10.1152/ajpendo.1999.277.3.E572; Underwood PC, 2013, CURR HYPERTENS REP, V15, P59, DOI 10.1007/s11906-012-0323-2; Vajapey R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00439; Wang QH, 1998, FEBS LETT, V427, P193, DOI 10.1016/S0014-5793(98)00423-2; Wei Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE345, DOI 10.1152/ajpendo.00456.2007; Wei YZ, 2006, J BIOL CHEM, V281, P35137, DOI 10.1074/jbc.M601320200; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Yonemitsu S, 2001, DIABETES, V50, P1093, DOI 10.2337/diabetes.50.5.1093; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang ZF, 2009, FEBS LETT, V583, P470, DOI 10.1016/j.febslet.2008.12.053; Zinkevich NS, 2011, AM J PHYSIOL-HEART C, V301, pH647, DOI 10.1152/ajpheart.01271.2010	59	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127172	10.1371/journal.pone.0127172	http://dx.doi.org/10.1371/journal.pone.0127172			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993470	Green Published, Green Submitted, gold			2022-12-26	WOS:000354918600052
J	Kreinin, A; Lisson, S; Nesher, E; Schneider, J; Bergman, J; Farhat, K; Farah, J; Lejbkowicz, F; Yadid, G; Raskin, L; Koman, I; Pinhasov, A				Kreinin, Anatoly; Lisson, Serah; Nesher, Elimelech; Schneider, Jenny; Bergman, Josef; Farhat, Kamal; Farah, Joseph; Lejbkowicz, Flavio; Yadid, Gal; Raskin, Leon; Koman, Igor; Pinhasov, Albert			Blood BDNF Level Is Gender Specific in Severe Depression	PLOS ONE			English	Article							NEUROTROPHIC FACTOR BDNF; VAL66MET POLYMORPHISM; MAJOR DEPRESSION; MET ALLELE; SERUM; DISORDER; GENE; ASSOCIATION; FLUOXETINE; NEUROPLASTICITY	Though the role of brain derived neurotrophic factor (BDNF) as a marker for major depressive disorder (MDD) and antidepressant efficacy has been widely studied, the role of BDNF in distinct groups of patients remains unclear. We evaluated the diagnostic value of BDNF as a marker of disease severity measured by HAM-D scores and antidepressants efficacy among MDD patients. Fifty-one patients who met DSM-IV criteria for MDD and were prescribed antidepressants and 38 controls participated in this study. BDNF in serum was measured at baseline, 1st, 2nd and 8th treatment weeks. Depression severity was evaluated using the Hamilton Rating Scale for Depression (HAM-D). BDNF polymorphism rs6265 (val66met) was genotyped. We found a positive correlation between blood BDNF levels and severity of depression only among untreated women with severe MDD (HAM-D>24). Serum BDNF levels were lower in untreated MDD patients compared to control group. Anti-depressants increased serum BDNF levels and reduced between-group differences after two weeks of treatment. No correlations were observed between BDNF polymorphism, depression severity, duration of illness, age and BDNF serum levels. Further supporting the role of BDNF in the pathology and treatment of MDD, we suggest that it should not be used as a universal biomarker for diagnosis of MDD in the general population. However, it has diagnostic value for the assessment of disease progression and treatment efficacy in individual patients.	[Kreinin, Anatoly; Bergman, Josef] Technion Israel Inst Technol, Maale HaCarmel Mental Hlth Ctr, Rappaport Fac Med, Haifa, Israel; [Kreinin, Anatoly; Bergman, Josef] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Lisson, Serah; Nesher, Elimelech; Schneider, Jenny; Koman, Igor; Pinhasov, Albert] Ariel Univ, Dept Mol Biol, Ariel, Israel; [Lisson, Serah; Yadid, Gal] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; [Farhat, Kamal; Farah, Joseph] Bar Ilan Univ, Fac Med, Nazareth Hosp, EMMS, Nazareth, Israel; [Lejbkowicz, Flavio] Carmel Hosp, Dept Community Med & Epidemiol, Haifa, Israel; [Lejbkowicz, Flavio] Natl Canc Control Ctr, Clalit Hlth Serv, Haifa, Israel; [Raskin, Leon] Vanderbilt Univ, Div Epidemiol, Dept Med, Nashville, TN USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Ariel University; Bar Ilan University; Bar Ilan University; Clalit Health Services; Carmel Medical Center; Clalit Health Services; Vanderbilt University	Pinhasov, A (corresponding author), Ariel Univ, Dept Mol Biol, Ariel, Israel.	albertpi@ariel.ac.il	Pinhasov, Albert/X-5304-2019; Raskin, Leon/P-5765-2015; Schneider, Jenny/I-9497-2019; Kreinin, Anatoly/AAN-8803-2021	Pinhasov, Albert/0000-0001-8116-4565; Raskin, Leon/0000-0003-1195-7214; Schneider, Jenny/0000-0001-7315-7269; Nesher, Elimelech/0000-0002-8326-5535				American Psychiatric Association, 2000, DIAGNOSTIC CRITERIA, Vxii; Aydemir C, 2006, PROG NEURO-PSYCHOPH, V30, P1256, DOI 10.1016/j.pnpbp.2006.03.025; Aydemir O, 2005, PROG NEURO-PSYCHOPH, V29, P261, DOI 10.1016/j.pnpbp.2004.11.009; Basterzi AD, 2009, PROG NEURO-PSYCHOPH, V33, P281, DOI 10.1016/j.pnpbp.2008.11.016; Bath KG, 2006, COGN AFFECT BEHAV NE, V6, P79, DOI 10.3758/CABN.6.1.79; Benton CS, 2012, PSYCHOPHARMACOLOGY, V221, P297, DOI 10.1007/s00213-011-2574-z; Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098; Bocchio-Chiavetto L, 2010, WORLD J BIOL PSYCHIA, V11, P763, DOI 10.3109/15622971003611319; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Bus BAA, 2012, NEUROPSYCHOBIOLOGY, V65, P183, DOI 10.1159/000336997; Cardoso TD, 2014, NEUROCHEM RES, V39, P1571, DOI 10.1007/s11064-014-1349-4; Cattaneo A, 2010, INT J NEUROPSYCHOPH, V13, P103, DOI 10.1017/S1461145709990812; Choi MJ, 2006, BRAIN RES, V1118, P176, DOI 10.1016/j.brainres.2006.08.012; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Conti AC, 2002, J NEUROSCI, V22, P3262, DOI 10.1523/JNEUROSCI.22-08-03262.2002; Culpepper Larry, 2011, J Clin Psychiatry, V72, pe19, DOI 10.4088/JCP.10126tx1c; Cusin C, 2010, CURR CLIN PSYCHIAT, P7, DOI 10.1007/978-1-59745-387-5_2; Czira ME, 2012, AGE, V34, P1529, DOI 10.1007/s11357-011-9313-6; Dell'Osso L, 2010, NEUROPSYCHOBIOLOGY, V62, P207, DOI 10.1159/000319946; Ebmeier KP, 2006, LANCET, V367, P153, DOI 10.1016/S0140-6736(06)67964-6; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Gonul AS, 2005, EUR ARCH PSY CLIN N, V255, P381, DOI 10.1007/s00406-005-0578-6; Gorski JA, 2003, J NEUROSCI, V23, P6856; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Hong CJ, 2003, NEUROPSYCHOBIOLOGY, V48, P186, DOI 10.1159/000074636; Hwang JP, 2006, NEUROBIOL AGING, V27, P1834, DOI 10.1016/j.neurobiolaging.2005.10.013; Ising M, 2007, BIOL PSYCHIAT, V62, P47, DOI 10.1016/j.biopsych.2006.07.039; Jevtovic S, 2011, PSYCHIAT DANUB, V23, P363; Karege F, 2005, BIOL PSYCHIAT, V57, P1068, DOI 10.1016/j.biopsych.2005.01.008; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; Karlovic D, 2013, J PSYCHIATR RES, V47, P162, DOI 10.1016/j.jpsychires.2012.09.017; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Labelle C, 2000, DEV BRAIN RES, V123, P1, DOI 10.1016/S0165-3806(00)00069-9; Ladea M, 2013, PSYCHIAT DANUB, V25, P128; Lang UE, 2009, MOL PSYCHIATR, V14, P120, DOI 10.1038/mp.2008.80; Lee HY, 2008, NEUROPSYCHOBIOLOGY, V57, P194, DOI 10.1159/000149817; Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174; Levinson DF, 2006, BIOL PSYCHIAT, V60, P84, DOI 10.1016/j.biopsych.2005.08.024; Lim JY, 2008, J NEUROSCI RES, V86, P2168, DOI 10.1002/jnr.21669; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Maier W, 1999, J AFFECT DISORDERS, V53, P241, DOI 10.1016/S0165-0327(98)00131-1; Moner R, 2007, WORLD J BIOL PSYCHIA, V8, P141, DOI 10.1080/15622970701263303; Molendijk ML, 2011, MOL PSYCHIATR, V16, P1088, DOI 10.1038/mp.2010.98; Oswald P, 2005, EUR NEUROPSYCHOPHARM, V15, P491, DOI 10.1016/j.euroneuro.2005.01.001; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Park YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091061; Reichenstein M, 2008, J MOL NEUROSCI, V36, P330, DOI 10.1007/s12031-008-9116-0; Ribeiro L, 2007, NEUROREPORT, V18, P1291, DOI 10.1097/WNR.0b013e328273bcb0; Ristevska-Dimitrovska G, 2013, PSYCHIAT DANUB, V25, P123; Saveanu RV, 2012, PSYCHIAT CLIN N AM, V35, P51, DOI 10.1016/j.psc.2011.12.001; Schumacher J, 2005, BIOL PSYCHIAT, V58, P307, DOI 10.1016/j.biopsych.2005.04.006; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Studd J, 2004, CLIMACTERIC, V7, P338, DOI 10.1080/13697130400012262; Subbarao A, 2008, J ABNORM CHILD PSYCH, V36, P433, DOI 10.1007/s10802-007-9189-1; Surtees PG, 2007, J PSYCHIATR RES, V41, P404, DOI 10.1016/j.jpsychires.2006.01.004; Tardito D, 2006, PHARMACOL REV, V58, P115, DOI 10.1124/pr.58.1.7; Taylor WD, 2007, AM J GERIAT PSYCHIAT, V15, P850, DOI 10.1097/JGP.0b013e318050c9d5; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109; Wolkowitz OM, 2011, PROG NEURO-PSYCHOPH, V35, P1623, DOI 10.1016/j.pnpbp.2011.06.013; Yoshida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042676; Zou YF, 2010, NEUROPSYCHOBIOLOGY, V61, P71, DOI 10.1159/000265132	64	53	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127643	10.1371/journal.pone.0127643	http://dx.doi.org/10.1371/journal.pone.0127643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010085	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900123
J	Kuznik, A; Muhumuza, C; Komakech, H; Marques, EMR; Lamorde, M				Kuznik, Andreas; Muhumuza, Christine; Komakech, Henry; Marques, Elsa M. R.; Lamorde, Mohammed			Antenatal Syphilis Screening Using Point-Of-Care Testing in Low- and Middle-Income Countries in Asia and Latin America: A Cost-Effectiveness Analysis	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; HIV; PREGNANCY	Background Untreated syphilis in pregnancy is associated with adverse clinical outcomes to the infant. In low- and middle-income countries in Asia and Latin America, 20%-30% of women are not tested for syphilis during pregnancy. We evaluated the cost-effectiveness of increasing the coverage for antenatal syphilis screening in 11 Asian and 20 Latin American countries, using a point-of-care immunochromatographic strip (ICS) test. Methods The decision analytical cost-effectiveness models reported incremental costs per disability-adjusted life years (DALYs) averted from the perspectives of the national health care payer. Clinical outcomes were stillbirths, neonatal deaths, and congenital syphilis. DALYs were computed using WHO disability weights. Costs included the ICS test, three injections of benzathine penicillin, and nurse wages. Country-specific inputs included the antenatal prevalence of syphilis and the proportion of women in the antenatal care setting that are screened for syphilis infection as reported in the 2014 WHO baseline report on global sexually transmitted infection surveillance. Country-specific data on the annual number of live births, proportion of women with at least one antenatal care visit, and per capita gross national income were also included in the model. Results The incremental cost/DALY averted of syphilis screening is US$53 (range: US$10-US$332; Prob<1*per capita GDP=99.71%) in Asia and US$ 60 (range: US$5-US$225; Prob<1*per capita GDP=99.77%) in Latin America. Universal screening may reduce the annual number of stillbirths by 20,344 and 4,270, neonatal deaths by 8,201 and 1,721, cases of congenital syphilis by 10,952 and 2,298, and avert 925,039 and 197,454 DALYs in the aggregate Asian and Latin American panel, respectively. Conclusion Antenatal syphilis screening is highly cost-effective in all the 11 Asian and 20 Latin American countries assessed. Our findings support the decision to expand syphilis screening in countries with currently low screening rates or continue national syphilis screening programs in countries with high rates.	[Kuznik, Andreas; Lamorde, Mohammed] Makerere Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Kuznik, Andreas] Celgene Corp, Summit, NJ USA; [Muhumuza, Christine; Komakech, Henry] Makerere Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Marques, Elsa M. R.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	Bristol-Myers Squibb; Celgene Corporation; University of Bristol	Lamorde, M (corresponding author), Makerere Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.	mlamorde@idi.co.ug		Marques, Elsa/0000-0003-1360-5677; Lamorde, Mohammed/0000-0003-2218-6822; Komakech, Henry/0000-0001-7137-5940; Kuznik, Andreas/0000-0002-8634-8360	European and Developing Countries Clinical Trials Partnership [TA_11_40200_047]; Celgene Corporation	European and Developing Countries Clinical Trials Partnership; Celgene Corporation(Bristol-Myers SquibbCelgene Corporation)	ML is supported through a grant awarded by the European and Developing Countries Clinical Trials Partnership (TA_11_40200_047). Celgene Corporation provided support in the form of salaries for author AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Tran BX, 2013, GLOBAL HEALTH ACTION, V6, P142, DOI 10.3402/gha.v6i0.18619; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Futures Group, 2002, MAT NEON PROGR EFF I; Gloyd S, 2001, HEALTH POLICY PLANN, V16, P29, DOI 10.1093/heapol/16.1.29; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Hawkes S, 2011, LANCET INFECT DIS, V11, P684, DOI 10.1016/S1473-3099(11)70104-9; Indian Council of Medical Research, 2010, ICMR NURS STAFF CADR; International Labour Organization, LABORSTA LAB STAT DA; Jafari Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054695; Kuznik A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001545; Montoya PJ, 2006, B WORLD HEALTH ORGAN, V84, P97, DOI 10.2471/BLT.04.018663; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; National Bureau of Economics Research, OCC WAG AR WORLD OWW; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Owusu-Edusei K, 2014, SEX TRANSM DIS, V41, P103, DOI 10.1097/OLQ.0000000000000085; Pai NP, 2012, INT J STD AIDS, V23, P319, DOI 10.1258/ijsa.2011.011139; Rydzak CE, 2008, SEX TRANSM DIS, V35, P775, DOI 10.1097/OLQ.0b013e318176196d; Schackman BR, 2007, PLOS MED, V4, P937, DOI 10.1371/journal.pmed.0040183; Strasser S, 2012, JAIDS-J ACQ IMM DEF, V61, pE40, DOI 10.1097/QAI.0b013e318267bc94; Tang W. M., 2012, INT J NURS SCI, V2, P29, DOI [DOI 10.5923/J.NURSING.20120204.01, 10.5923/j.nursing.20120204.01]; The Asia Pacific Prevention of Parent to Child Transmission Task Force, VIETN COUNTR FACT SH; Dinh TH, 2013, SEX TRANSM DIS, V40, P846, DOI 10.1097/OLQ.0000000000000042; Tucker JD, 2010, LANCET INFECT DIS, V10, P381, DOI 10.1016/S1473-3099(10)70092-X; United Nations Children's Fund, 2012, STAT MONT; World Bank, 2010, 58018LA WORLD BANK; World Health Organization, 2019, CHOOSING INT AR COST; World Health Organization, 2006, NEON PER MORT COUNTR; World Health Organization, 2014, GLOB GUID CRIT PROC; World Health Organization, 2014, BAS REP GLOB SEX TRA	30	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127379	10.1371/journal.pone.0127379	http://dx.doi.org/10.1371/journal.pone.0127379			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010366	gold, Green Published, Green Submitted			2022-12-26	WOS:000355183900086
J	Li, X; Xiao, J; Frohlich, H; Tu, XM; Li, LL; Xu, Y; Cao, HT; Qu, J; Rappold, GA; Chen, JG				Li, Xue; Xiao, Jian; Froehlich, Henning; Tu, Xiaomeng; Li, Lianlian; Xu, Yue; Cao, Huateng; Qu, Jia; Rappold, Gudrun A.; Chen, Jie-Guang			Foxp1 Regulates Cortical Radial Migration and Neuronal Morphogenesis in Developing Cerebral Cortex	PLOS ONE			English	Article							IN-VIVO ELECTROPORATION; DEVELOPING HUMAN BRAIN; DE-NOVO MUTATIONS; INTELLECTUAL DISABILITY; DEVELOPING NEOCORTEX; MENTAL-RETARDATION; PYRAMIDAL NEURONS; PROTEIN; EXPRESSION; DISORDERS	FOXP1 is a member of FOXP subfamily transcription factors. Mutations in FOXP1 gene have been found in various development-related cognitive disorders. However, little is known about the etiology of these symptoms, and specifically the function of FOXP1 in neuronal development. Here, we report that suppression of Foxp1 expression in mouse cerebral cortex led to a neuronal migration defect, which was rescued by overexpression of Foxp1. Mice with Foxp1 knockdown exhibited ectopic neurons in deep layers of the cortex postnatally. The neuronal differentiation of Foxp1-downregulated cells was normal. However, morphological analysis showed that the neurons with Foxp1 deficiency had an inhibited axonal growth in vitro and a weakened transition from multipolar to bipolar in vivo. Moreover, we found that the expression of Foxp1 modulated the dendritic maturation of neurons at a late postnatal date. Our results demonstrate critical roles of Foxp1 in the radial migration and morphogenesis of cortical neurons during development. This study may shed light on the complex relationship between neuronal development and the related cognitive disorders.	[Li, Xue; Xiao, Jian; Tu, Xiaomeng; Li, Lianlian; Xu, Yue; Cao, Huateng; Qu, Jia; Chen, Jie-Guang] Wenzhou Med Univ, Natl Minist Hlth, Key Lab Visual Sci, Wenzhou 325027, Peoples R China; [Li, Xue; Xiao, Jian; Tu, Xiaomeng; Li, Lianlian; Xu, Yue; Cao, Huateng; Qu, Jia; Chen, Jie-Guang] Wenzhou Med Univ, Sch Optometry & Ophthalmol, Wenzhou 325027, Peoples R China; [Froehlich, Henning; Rappold, Gudrun A.] Heidelberg Univ, Dept Human Mol Genet, D-69120 Heidelberg, Germany	Wenzhou Medical University; Wenzhou Medical University; Ruprecht Karls University Heidelberg	Chen, JG (corresponding author), Wenzhou Med Univ, Natl Minist Hlth, Key Lab Visual Sci, Wenzhou 325027, Peoples R China.	jiesbooks@gmail.com			Natural Science Foundation of Zhejiang Province of China [Z2110700, LQ14C090005]; National Natural Science Foundation of China [31070951]; Scientific Research Fund of Wenzhou Science and Technology Bureau [Y20140363]	Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Fund of Wenzhou Science and Technology Bureau	This work was supported by the Natural Science Foundation of Zhejiang Province of China (Grants Z2110700 to J.-G Chen and LQ14C090005 to Xue Li) (http://www.zjnsf.gov.cn/1/xm/lx.aspx), the National Natural Science Foundation of China (Grant 31070951 J.-G Chen) (http://www.nsfc.gov.cn/), and by the Scientific Research Fund of Wenzhou Science and Technology Bureau (Grant Y20140363 to Xue Li) (http://www.wzkj.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackman JB, 2009, J NEUROSCI, V29, P313, DOI 10.1523/JNEUROSCI.4093-08.2009; Adams RH, 1996, MECH DEVELOP, V57, P33, DOI 10.1016/0925-4773(96)00525-4; Bacon C, 2014, MOL PSYCHIAT; Bacon C, 2012, HUM GENET, V131, P1687, DOI 10.1007/s00439-012-1193-z; Baek ST, 2014, NEURON, V82, P1255, DOI 10.1016/j.neuron.2014.04.036; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Carr CW, 2010, EUR J HUM GENET, V18, P1216, DOI 10.1038/ejhg.2010.96; Cascio CJ, 2010, J NEURODEV DISORD, V2, P62, DOI 10.1007/s11689-010-9046-3; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Gabut M, 2011, CELL, V147, P132, DOI 10.1016/j.cell.2011.08.023; Grundmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070873; Guerrini R, 2005, J CHILD NEUROL, V20, P287, DOI 10.1177/08830738050200040401; Guerrini R, 2014, LANCET NEUROL, V13, P710, DOI 10.1016/S1474-4422(14)70040-7; GUIJARRO P, 2013, J PEDIATR ONCOL NURS, V30, P871, DOI DOI 10.1002/dneu.22107; Hamdan FF, 2010, AM J HUM GENET, V87, P671, DOI 10.1016/j.ajhg.2010.09.017; Hatanaka Y, 2013, CEREB CORTEX, V23, P105, DOI 10.1093/cercor/bhr383; Horn D, 2010, HUM MUTAT, V31, pE1851, DOI 10.1002/humu.21362; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Jossin Y, 2011, NAT NEUROSCI, V14, P697, DOI 10.1038/nn.2816; Konstantoulas CJ, 2010, J NEUROCHEM, V113, P836, DOI 10.1111/j.1471-4159.2010.06650.x; LaBerge D, 2006, CONSCIOUS COGN, V15, P235, DOI 10.1016/j.concog.2005.09.007; Le Fevre AK, 2013, AM J MED GENET A, V161, P3166, DOI 10.1002/ajmg.a.36174; Lett RLM, 2009, CEREB CORTEX, V19, P1408, DOI 10.1093/cercor/bhn179; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Miyoshi G, 2012, NEURON, V74, P1045, DOI 10.1016/j.neuron.2012.04.025; Morikawa Y, 2009, DEV NEUROSCI-BASEL, V31, P511, DOI 10.1159/000243715; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Nishimura YV, 2010, J BIOL CHEM, V285, P5878, DOI 10.1074/jbc.M109.033761; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; Pacary E, 2011, NEURON, V69, P1069, DOI 10.1016/j.neuron.2011.02.018; Palmesino E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000446; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rubenstein JLR, 2011, J CHILD PSYCHOL PSYC, V52, P339, DOI 10.1111/j.1469-7610.2010.02307.x; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shi C, 2004, J CLIN INVEST, V114, P408, DOI 10.1172/jci200421100; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Sin C, 2014, J MOL NEUROSCIENCE M; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; Straub C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105584; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Wang B, 2004, DEVELOPMENT, V131, P4477, DOI 10.1242/dev.01287; Washington SD, 2014, HUM BRAIN MAPP, V35, P1284, DOI 10.1002/hbm.22252; Watanabe K, 2011, DEVELOPMENT, V138, P4979, DOI 10.1242/dev.068155; Zhang C, 2013, NEURON, V78, P986, DOI 10.1016/j.neuron.2013.04.021; Zheng W, 2012, CEREB CORTEX, V22, P2587, DOI 10.1093/cercor/bhr330	61	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127671	10.1371/journal.pone.0127671	http://dx.doi.org/10.1371/journal.pone.0127671			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010426	gold, Green Published, Green Submitted			2022-12-26	WOS:000355183900127
J	Maufroy, A; Chassot, E; Joo, R; Kaplan, DM				Maufroy, Alexandra; Chassot, Emmanuel; Joo, Rocio; Kaplan, David Michael			Large-Scale Examination of Spatio-Temporal Patterns of Drifting Fish Aggregating Devices (dFADs) from Tropical Tuna Fisheries of the Indian and Atlantic Oceans	PLOS ONE			English	Article							CLASSIFICATION; MODELS; BEHAVIOR	Since the 1990s, massive use of drifting Fish Aggregating Devices (dFADs) to aggregate tropical tunas has strongly modified global purse-seine fisheries. For the first time, a large data set of GPS positions from buoys deployed by French purse-seiners to monitor dFADs is analysed to provide information on spatio-temporal patterns of dFAD use in the Atlantic and Indian Oceans during 2007-2011. First, we select among four classification methods the model that best separates "at sea" from "on board" buoy positions. A random forest model had the best performance, both in terms of the rate of false "at sea" predictions and the amount of over-segmentation of "at sea" trajectories (i.e., artificial division of trajectories into multiple, shorter pieces due to misclassification). Performance is improved via post-processing removing unrealistically short "at sea" trajectories. Results derived from the selected model enable us to identify the main areas and seasons of dFAD deployment and the spatial extent of their drift. We find that dFADs drift at sea on average for 39.5 days, with time at sea being shorter and distance travelled longer in the Indian than in the Atlantic Ocean. 9.9% of all trajectories end with a beaching event, suggesting that 1,500-2,000 may be lost onshore each year, potentially impacting sensitive habitat areas, such as the coral reefs of the Maldives, the Chagos Archipelago, and the Seychelles.	[Maufroy, Alexandra; Joo, Rocio; Kaplan, David Michael] CNRS, Inst Rech Dev, UMR MARBEC, IRD Ifremer UM2, Sete, France; [Chassot, Emmanuel] CNRS, Inst Rech Dev, UMR MARBEC, SFA,IRD Ifremer UM2, Victoria, Seychelles; [Joo, Rocio] IMARPE, Lima, Peru; [Kaplan, David Michael] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Ifremer; Institut de Recherche pour le Developpement (IRD); Instituto del Mar del Peru; William & Mary; Virginia Institute of Marine Science	Maufroy, A (corresponding author), CNRS, Inst Rech Dev, UMR MARBEC, IRD Ifremer UM2, Ave Jean Monnet, Sete, France.	alexandra.maufroy@gmail.com	Joo, Rocio/H-8238-2019; Kaplan, David/G-5230-2010	Kaplan, David/0000-0001-6087-359X; CHASSOT, Emmanuel/0000-0002-6779-4955; Maufroy, Alexandra/0000-0002-4814-6522	French National Research Agency (ANR) [ANR-08-STRA-03]; France Filiere Peche; IRD; EU [(EC) 1543/2000, 199/2008]	French National Research Agency (ANR)(French National Research Agency (ANR)); France Filiere Peche; IRD; EU(European Commission)	The work of DMK and AM was supported by the AMPED project (www.amped.ird.fr) through a grant from the French National Research Agency (ANR, www.agence-nationale-recherche.fr), Systerra Programme, grant number ANR-08-STRA-03. AM also benefited from a grant of France Filiere Peche (www.francefilierepeche.fr). R. J. was financially supported by an ARTS grant from IRD (www.ird.fr) and managed by Campus France (www.campusfrance.org). The fisheries data analysed in this publication were collected by the Mixed Research Unit 212 'Exploited Marine Ecosystems' of the Institut de Recherche pour le Developpement (IRD) through the EU-funded Data Collection Framework [DCF, Reg (EC) 1543/2000 and 199/2008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2009, ENTANGLEMENT OLIVE R; Ariz Telleria J, 1999, P INT WORKSH EC FISH, P21; Baske A, 2012, ESTIMATING USE DRIFT; Bertrand S, 2008, PROG OCEANOGR, V79, P379, DOI 10.1016/j.pocean.2008.10.009; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bromhead D, 2003, FINAL REPORT FISHERI; Castro JJ, 2001, REV FISH BIOL FISHER, V11, P255, DOI 10.1023/A:1020302414472; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dagorn L, 2013, FISH FISH, V14, P391, DOI 10.1111/j.1467-2979.2012.00478.x; Dempster T, 2004, REV FISH BIOL FISHER, V14, P21, DOI 10.1007/s11160-004-3151-x; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; Filmalter JD, 2013, FRONT ECOL ENVIRON, V11, P291, DOI 10.1890/130045; Floch L, 2012, STAT FRENCH PURSE SE, P858; Floch L, 2012, P 14 SESS IOTC WORK, P14; Fonteneau A, 2000, AQUAT LIVING RESOUR, V13, P253, DOI 10.1016/S0990-7440(00)01054-8; Fonteneau A., 2000, PECHE THONIERE DISPO, V28, P15; Fonteneau A, 2013, AQUAT LIVING RESOUR, V26, P37, DOI 10.1051/alr/2013046; Fossette S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3065; Franco J, 2012, COLLECT VOL SCI PAP, V68, P1754; Freon P, 2000, REV FISH BIOL FISHER, V10, P183, DOI 10.1023/A:1016666108540; Gilman EL, 2011, MAR POLICY, V35, P590, DOI 10.1016/j.marpol.2011.01.021; Graham Nicholas A.J., 2013, P253; GREENBLATT PR, 1979, FISH B-NOAA, V77, P147; Hallier JP, 2008, MAR ECOL PROG SER, V353, P255, DOI 10.3354/meps07180; IOTC, 2012, 1208 IOTC, P3; ISSF, 2012, ISSF GUID NON FADS; ISSF, 2012, 2012 ISSF STOCK ASS; Jaquemet S, 2011, FISH RES, V107, P283, DOI 10.1016/j.fishres.2010.11.011; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Joo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071246; Kaplan DM, 2014, ICES J MAR SCI, V71, P1728, DOI 10.1093/icesjms/fst233; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lee JW, 2005, COMPUT STAT DATA AN, V48, P869, DOI 10.1016/j.csda.2004.03.017; Marsac F, 1999, PECHE THONIERE DISPO; Menard F, 2000, AQUAT LIVING RESOUR, V13, P233, DOI 10.1016/S0990-7440(00)01066-4; Meynard CN, 2013, J BIOGEOGR, V40, P1, DOI 10.1111/jbi.12006; Moron J, 2001, 14 STAND COMM TUN BI; Nicodemus KK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-110; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Picaut J, 1984, CALCOFI REP, V25, P41; R Core Team, 2021, R LANGUAGE ENV STAT; Ramos ML, 2010, IOTC2010WPTT22; Schott FA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000245; Scott MD, 1992, P INT WORKSH EC FISH; Strobl C, 2009, R J, V1, P14; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; The MathWorks Inc., 2012, MATL STAT TOOLB REL; Venables WN., 2002, MODERN APPL STAT S, V4	48	39	42	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128023	10.1371/journal.pone.0128023	http://dx.doi.org/10.1371/journal.pone.0128023			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010151	gold, Green Submitted, Green Published			2022-12-26	WOS:000355183900184
J	Romanenko, SA; Perelman, PL; Trifonov, VA; Serdyukova, NA; Li, TL; Fu, BY; O'Brien, PCM; Ng, BL; Nie, WH; Liehr, T; Stanyon, R; Graphodatsky, AS; Yang, FT				Romanenko, Svetlana A.; Perelman, Polina L.; Trifonov, Vladimir A.; Serdyukova, Natalia A.; Li, Tangliang; Fu, Beiyuan; O'Brien, Patricia C. M.; Ng, Bee L.; Nie, Wenhui; Liehr, Thomas; Stanyon, Roscoe; Graphodatsky, Alexander S.; Yang, Fengtang			A First Generation Comparative Chromosome Map between Guinea Pig (Cavia porcellus) and Humans	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; GENOME ORGANIZATION; MOLECULAR SYSTEMATICS; PAINTING SHOWS; EVOLUTION; RODENTIA; PHYLOGENY; SCIURIDAE; KARYOTYPES; HOMOLOGY	The domesticated guinea pig, Cavia porcellus (Hystricomorpha, Rodentia), is an important laboratory species and a model for a number of human diseases. Nevertheless, genomic tools for this species are lacking; even its karyotype is poorly characterized. The guinea pig belongs to Hystricomorpha, a widespread and important group of rodents; so far the chromosomes of guinea pigs have not been compared with that of other hystricomorph species or with any other mammals. We generated full sets of chromosome-specific painting probes for the guinea pig by flow sorting and microdissection, and for the first time, mapped the chromosomal homologies between guinea pig and human by reciprocal chromosome painting. Our data demonstrate that the guinea pig karyotype has undergone extensive rearrangements: 78 synteny-conserved human autosomal segments were delimited in the guinea pig genome. The high rate of genome evolution in the guinea pig may explain why the HSA7/16 and HSA16/19 associations presumed ancestral for eutherians and the three syntenic associations (HSA1/10, 3/19, and 9/11) considered ancestral for rodents were not found in C. porcellus. The comparative chromosome map presented here is a starting point for further development of physical and genetic maps of the guinea pig as well as an aid for genome assembly assignment to specific chromosomes. Furthermore, the comparative mapping will allow a transfer of gene map data from other species. The probes developed here provide a genomic toolkit, which will make the guinea pig a key species to unravel the evolutionary biology of the Hystricomorph rodents.	[Romanenko, Svetlana A.; Perelman, Polina L.; Trifonov, Vladimir A.; Serdyukova, Natalia A.; Graphodatsky, Alexander S.] SB RAS, Inst Mol & Cellular Biol, Novosibirsk, Russia; [Romanenko, Svetlana A.; Perelman, Polina L.; Trifonov, Vladimir A.; Graphodatsky, Alexander S.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Romanenko, Svetlana A.; Perelman, Polina L.; Li, Tangliang; Nie, Wenhui] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Fu, Beiyuan; Ng, Bee L.; Yang, Fengtang] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [O'Brien, Patricia C. M.] Univ Cambridge, Ctr Vet Sci, Dept Vet Med, Cambridge, England; [Liehr, Thomas] Jena Univ Hosp, Inst Human Genet & Anthropol, Jena, Germany; [Stanyon, Roscoe] Univ Florence, Dept Biol, Florence, Italy	Russian Academy of Sciences; Novosibirsk State University; Chinese Academy of Sciences; Kunming Institute of Zoology; Wellcome Trust Sanger Institute; University of Cambridge; Friedrich Schiller University of Jena; University of Florence	Romanenko, SA (corresponding author), SB RAS, Inst Mol & Cellular Biol, Novosibirsk, Russia.	rosa@mcb.nsc.ru; fy1@sanger.ac.uk	Li, Tangliang/AAN-6866-2020; Liehr, Thomas/H-2852-2019; Yang, Fan/GYU-4249-2022; Perelman, Polina/N-8088-2015; Serdyukova, Natalia/AAU-6393-2021; Trifonov, Vladimir/E-4907-2012; Li, Tangliang/A-6087-2009; Romanenko, Svetlana/N-2500-2015; Perelman, Polina/AAD-9030-2019; Graphodatsky, Alexander/B-4922-2010; Serdyukova, Natalia/N-6476-2015	Li, Tangliang/0000-0003-0671-9166; Liehr, Thomas/0000-0003-1672-3054; Perelman, Polina/0000-0002-0982-5100; Serdyukova, Natalia/0000-0002-0409-1371; Trifonov, Vladimir/0000-0003-0454-8359; Li, Tangliang/0000-0003-0671-9166; Romanenko, Svetlana/0000-0002-0951-5209; Perelman, Polina/0000-0002-0982-5100; Graphodatsky, Alexander/0000-0002-8282-1085; Yang, Fengtang/0000-0002-3573-2354; Stanyon, Roscoe/0000-0002-7229-1092	MCB; SB RAS; Russian Fund for Basic Research; Wellcome Trust [WT098051]; PRIN; DFG [LI 820/32-1]	MCB; SB RAS(Russian Academy of Sciences); Russian Fund for Basic Research(Russian Foundation for Basic Research (RFBR)); Wellcome Trust(Wellcome Trust); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); DFG(German Research Foundation (DFG))	This study was funded in part by programs MCB and SB RAS Programs and research grants of the Russian Fund for Basic Research. BF, BLN and FY were supported by Wellcome Trust (grant number WT098051), RS was supported by PRIN grant 2012, MURST, ThL and VAT were supported by DFG (LI 820/32-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2003, MOL PHYLOGENET EVOL, V26, P409, DOI 10.1016/S1055-7903(02)00304-4; AWA AKIO, 1959, JAPANESE JOUR ZOOL, V12, P257; Badenhorst D, 2011, CHROMOSOME RES, V19, P709, DOI 10.1007/s10577-011-9227-2; Beklemisheva VR, 2011, CHROMOSOME RES, V19, P549, DOI 10.1007/s10577-011-9210-y; BIANCHI NO, 1971, CHROMOSOMA, V34, P254, DOI 10.1007/BF00286151; British cavi council, 2009, BREED STANDARDS FOR; Broad Institute, GUINEA PIG GENOME PR; Broad Institute, 29 MAMMALS PROJECT; CAO Y, 1994, MOL BIOL EVOL, V11, P593; Chowdhary BP, 1998, GENOME RES, V8, P577, DOI 10.1101/gr.8.6.577; Deuve JL, 2008, CHROMOSOME RES, V16, P57, DOI 10.1007/s10577-007-1200-8; Deuve JL, 2006, CHROMOSOME RES, V14, P681, DOI 10.1007/s10577-006-1080-3; Dunnum JL, 2010, J ZOOL SYST EVOL RES, V48, P376, DOI 10.1111/j.1439-0469.2009.00561.x; Ferguson-Smith MA, 2007, NAT REV GENET, V8, P950, DOI 10.1038/nrg2199; FergusonSmith MA, 1997, EUR J HUM GENET, V5, P253, DOI 10.1159/000484775; Fronicke L, 2003, P ROY SOC B-BIOL SCI, V270, P1331, DOI 10.1098/rspb.2003.2383; Gava A, 1998, GENETICS AND MOLECUL, V21; Genome Bioinformatics Group, 2008, GENOME BROWSER; GEORGE W, 1972, J ZOOL, V168, P81, DOI 10.1111/j.1469-7998.1972.tb01339.x; Graphodatsky A, 2012, CYTOGENET GENOME RES, V137, P83, DOI 10.1159/000341502; Graphodatsky AS, 2008, CHROMOSOME RES, V16, P261, DOI 10.1007/s10577-007-1191-5; Graphodatsky AS, 2000, CYTOGENET CELL GENET, V88, P296, DOI 10.1159/000015513; Graphodatsky AS, 1988, CHROMOSOMES OF AGRIC; Graphodatsky S, 2006, ATLAS OF MAMMALIAN C, P324; Honeycutt RL, 2003, MOL PHYLOGENET EVOL, V26, P476, DOI 10.1016/S1055-7903(02)00368-8; HSU TC, 1953, J HERED, V44, P23, DOI 10.1093/oxfordjournals.jhered.a106344; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Huchon D, 2001, MOL PHYLOGENET EVOL, V20, P238, DOI 10.1006/mpev.2001.0961; IJDO JW, 1991, NUCLEIC ACIDS RES, V19, P4780, DOI 10.1093/nar/19.17.4780; Kosyakova N, 2013, MOLECULAR CYTOGENETI, V6; Li T, 2006, CYTOGENET GENOME RES, V112, P270, DOI 10.1159/000089881; Li TL, 2004, CHROMOSOME RES, V12, P317, DOI 10.1023/B:CHRO.0000034131.73620.48; LI WH, 1990, P NATL ACAD SCI USA, V87, P6703, DOI 10.1073/pnas.87.17.6703; Lomholt B, 2002, HEREDITAS, V136, P104, DOI 10.1034/j.1601-5223.2002.1360203.x; MADEN BEH, 1987, BIOCHEM J, V246, P519, DOI 10.1042/bj2460519; MAIA V, 1984, EXPERIENTIA, V40, P564, DOI 10.1007/BF01982332; Makino S, 1947, J FAC SCI HOKKAIDO 6, V9, P345; MANNA GK, 1964, EXPERIENTIA, V20, P324, DOI 10.1007/BF02171074; MEYNE J, 1990, CHROMOSOMA, V99, P3, DOI 10.1007/BF01737283; Mlynarski EE, 2008, CYTOGENET GENOME RES, V121, P288, DOI 10.1159/000138900; MOORE DE, 1982, J NATL CANCER I, V69, P591; NATARAJAN AT, 1974, HEREDITAS, V76, P145; Nie WH, 2009, CHROMOSOME RES, V17, P99, DOI 10.1007/s10577-009-9021-6; Ohi Y, 2014, BRAIN RES, V1581, P12, DOI 10.1016/j.brainres.2014.04.031; OHNO S, 1961, EXP CELL RES, V25, P498, DOI 10.1016/0014-4827(61)90185-9; POPESCU NC, 1976, CANCER RES, V36, P1404; Richard F, 2012, CYTOGENET GENOME RES, V137, P218, DOI 10.1159/000341379; Richard F, 2003, CHROMOSOME RES, V11, P597, DOI 10.1023/A:1024905018685; Romanenko SA, 2012, HEREDITY, V108, P4, DOI 10.1038/hdy.2011.110; Romanenko SA, 2006, MAMM GENOME, V17, P1183, DOI 10.1007/s00335-006-0081-z; Saidullah Bano, 2014, J Smooth Muscle Res, V50, P29; Sannier J, 2011, CYTOGENET GENOME RES, V134, P51, DOI 10.1159/000324691; SCHMID W, 1967, Archiv der Julius Klaus-Stiftung fuer Vererbungsforschung Sozialanthropologie und Rassenhygiene, V42, P1; SEABRIGH.M, 1971, LANCET, V2, P971; Sitnikova NA, 2007, CHROMOSOME RES, V15, P447, DOI 10.1007/s10577-007-1137-y; Spotorno AE, 2004, REV CHIL HIST NAT, V77, P243; Stanyon R, 1999, CYTOGENET CELL GENET, V84, P150, DOI 10.1159/000015244; Stanyon R, 2003, GENOMICS, V82, P245, DOI 10.1016/S0888-7543(03)00109-5; STANYON R, 1991, B ZOOL, V58, P81, DOI 10.1080/11250009109355732; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Svartman M, 2005, GENOMICS, V85, P425, DOI 10.1016/j.ygeno.2004.12.004; TELENIUS H, 1991, CYTOGENET CELL GENET, V58, P2154; Ventura K, 2009, CHROMOSOME RES, V17, P1063, DOI 10.1007/s10577-009-9083-5; Veyrunes F, 2006, P ROY SOC B-BIOL SCI, V273, P2925, DOI 10.1098/rspb.2006.3670; Weimer J, 2000, CYTOGENET CELL GENET, V88, P114, DOI 10.1159/000015502; WHANGPENG J, 1976, J NATL CANCER I, V57, P897; Yang F, 1999, GENOMICS, V62, P189, DOI 10.1006/geno.1999.5989; YANG F, 1995, CHROMOSOMA, V103, P642, DOI 10.1007/BF00357691; Yang F, 2000, CHROMOSOME RES, V8, P219, DOI 10.1023/A:1009200912436; ZENZES MT, 1977, CYTOGENET CELL GENET, V19, P368, DOI 10.1159/000130830	70	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127937	10.1371/journal.pone.0127937	http://dx.doi.org/10.1371/journal.pone.0127937			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010445	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900167
J	Zhang, L; Li, Y; Xie, XJ; Xu, HP; Xu, ZQ; Ma, JG; Li, BX; Lin, SD; Nie, QH; Luo, QB; Zhang, XQ				Zhang, Li; Li, Ying; Xie, Xiujuan; Xu, Haiping; Xu, Zhenqiang; Ma, Jinge; Li, Bixiao; Lin, Shudai; Nie, Qinghua; Luo, Qingbin; Zhang, Xiquan			A Systematic Analysis on mRNA and MicroRNA Expression in Runting and Stunting Chickens	PLOS ONE			English	Article							BROILER LINES; MALABSORPTION-SYNDROME; MIR-30; SUSCEPTIBILITY; FAMILY; GROWTH; GENE; BEHAVIOR; DELETION; DIFFER	Runting and stunting syndrome (RSS), which is characterized by lower body weight, widely occurs in broilers. Some RSS chickens simply exhibit slow growth without pathological changes. An increasing number of studies indicate that broiler strains differ in susceptibility to infectious diseases, most likely due to their genetic differences. The objective of this study was to detect the differentially expressed miRNAs and mRNAs in RSS and normal chickens. By integrating miRNA with mRNA expression profiling, potential molecular mechanisms involved in RSS could be further explored. Twenty-two known miRNAs and 1,159 genes were differentially expressed in RSS chickens compared with normal chickens (P < 0.05). qPCR validation results displayed similar patterns. The differentially expressed genes were primarily involved in energy metabolism pathways. The antisense transcripts were extensively expressed in chicken liver albeit with reduced abundance. Dual-luciferase reporter assay indicated that gga-miR-30b/c directly target CARS through binding to its 30UTR. The miR-30b/c: CARS regulation mainly occurred in liver. In thigh muscle and the hypothalamus, miR-30b/c are expressed at higher levels in RSS chickens compared with normal chickens from 2 to 6 w of age, and notably significant differences are observed at 4 w of age.	[Zhang, Li; Li, Ying; Xie, Xiujuan; Xu, Haiping; Xu, Zhenqiang; Ma, Jinge; Li, Bixiao; Lin, Shudai; Nie, Qinghua; Luo, Qingbin; Zhang, Xiquan] South China Agr Univ, Minist Agr, Guangdong Prov Key Lab Agroanim Genom & Mol Bree, Guangzhou 510642, Guangdong, Peoples R China; [Zhang, Li; Li, Ying; Xie, Xiujuan; Xu, Haiping; Xu, Zhenqiang; Ma, Jinge; Li, Bixiao; Lin, Shudai; Nie, Qinghua; Luo, Qingbin; Zhang, Xiquan] South China Agr Univ, Minist Agr, Key Lab Chicken Genet,Breeding & Reprod, Guangzhou 510642, Guangdong, Peoples R China; [Zhang, Li] Guangdong Ocean Univ, Coll Agr, Zhanjiang 524088, Peoples R China; [Li, Ying] Guangdong Acad Agr Sci, Inst Anim Sci, Guangzhou 510640, Guangdong, Peoples R China	Ministry of Agriculture & Rural Affairs; South China Agricultural University; Ministry of Agriculture & Rural Affairs; South China Agricultural University; Guangdong Ocean University; Guangdong Academy of Agricultural Sciences	Zhang, XQ (corresponding author), South China Agr Univ, Minist Agr, Guangdong Prov Key Lab Agroanim Genom & Mol Bree, Guangzhou 510642, Guangdong, Peoples R China.	xqzhang@scau.edu.cn	xu, haiping/GSJ-1374-2022		Chinese Postdoctoral Science Foundation [2012M521611, 2013T60808]; National Natural Science Foundation [31301958]; Guangdong Provincial Natural Science Foundation [S2013010013382]; China Agriculture Research System [CARS-42-G05]	Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province); China Agriculture Research System	This work was supported by the Chinese Postdoctoral Science Foundation (2012M521611, 2013T60808), the National Natural Science Foundation (31301958), the Guangdong Provincial Natural Science Foundation (S2013010013382) and the China Agriculture Research System (CARS-42-G05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bolisetty MT, 2009, J VIROL, V83, P12009, DOI 10.1128/JVI.01182-09; Bridge G, 2012, BLOOD, V120, P5063, DOI 10.1182/blood-2012-04-423004; Choufani S, 2013, AM J MED GENET C, V163C, P131, DOI 10.1002/ajmg.c.31363; Costa V, 2013, EUR J HUM GENET, V21, P134, DOI 10.1038/ejhg.2012.129; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Gu LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086150; Hu J, 2013, AM J MED GENET A, V161A, P179, DOI 10.1002/ajmg.a.35658; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Kaiser MG, 1998, POULTRY SCI, V77, P271, DOI 10.1093/ps/77.2.271; Kang KI, 2012, AVIAN PATHOL, V41, P41, DOI 10.1080/03079457.2011.632402; Kort YH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-12; KOUWENHOVEN B, 1978, AVIAN PATHOL, V7, P183, DOI 10.1080/03079457808418269; Li JC, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1000795, 10.1186/1746-4811-6-1]; Li JT, 2008, NUCLEIC ACIDS RES, V36, P4833, DOI 10.1093/nar/gkn470; LILBURN MS, 1982, POULTRY SCI, V61, P608, DOI 10.3382/ps.0610608; Lin SM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-306; Ma Q, 2008, CELL SIGNAL, V20, P1044, DOI 10.1016/j.cellsig.2008.01.015; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Otto P, 2006, AVIAN DIS, V50, P411, DOI 10.1637/7511-020106R.1; Pfisterer L, 2015, CIRCULATION, V132; Rebel JMJ, 2005, BRIT POULTRY SCI, V46, P679, DOI 10.1080/00071660500395541; Rebel JMJ, 2004, BRIT POULTRY SCI, V45, P201, DOI 10.1080/00071660410001715803; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Sissler M, 1999, P NATL ACAD SCI USA, V96, P8985, DOI 10.1073/pnas.96.16.8985; Songserm T, 2002, VET IMMUNOL IMMUNOP, V85, P51, DOI 10.1016/S0165-2427(01)00411-1; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Toyomizu M, 2011, COMP BIOCHEM PHYS A, V159, P75, DOI 10.1016/j.cbpa.2011.01.020; van Hemert S, 2004, POULTRY SCI, V83, P1675, DOI 10.1093/ps/83.10.1675; Wang Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-278; WINSTEAD CS, 1985, POULTRY SCI, V64, P499, DOI 10.3382/ps.0640499; Wu TT, 2012, J BIOL CHEM, V287, P7503, DOI 10.1074/jbc.M111.292722; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167; Zaragosi LE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r64; Zekarias B, 2002, POULTRY SCI, V81, P1283, DOI 10.1093/ps/81.9.1283; Zhang L, 2013, GENE, V519, P77, DOI 10.1016/j.gene.2013.01.043; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224	38	7	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127342	10.1371/journal.pone.0127342	http://dx.doi.org/10.1371/journal.pone.0127342			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010155	gold, Green Published, Green Submitted			2022-12-26	WOS:000355183900084
J	Dalwani, MS; McMahon, MA; Mikulich-Gilbertson, SK; Young, SE; Regner, MF; Raymond, KM; McWilliams, SK; Banich, MT; Tanabe, JL; Crowley, TJ; Sakai, JT				Dalwani, Manish S.; McMahon, Mary Agnes; Mikulich-Gilbertson, Susan K.; Young, Susan E.; Regner, Michael F.; Raymond, Kristen M.; McWilliams, Shannon K.; Banich, Marie T.; Tanabe, Jody L.; Crowley, Thomas J.; Sakai, Joseph T.			Female Adolescents with Severe Substance and Conduct Problems Have Substantially Less Brain Gray Matter Volume	PLOS ONE			English	Article							ENVIRONMENTAL RISK-FACTORS; USE DISORDERS; DEVELOPMENTAL PSYCHOPATHOLOGY; BEHAVIORAL DISINHIBITION; DIAGNOSTIC INTERVIEW; RESPONSE-INHIBITION; ALCOHOL DEPENDENCE; GENDER-DIFFERENCES; VIRGINIA TWIN; CHILDHOOD	Objective Structural neuroimaging studies have demonstrated lower regional gray matter volume in adolescents with severe substance and conduct problems. These research studies, including ours, have generally focused on male-only or mixed-sex samples of adolescents with conduct and/or substance problems. Here we compare gray matter volume between female adolescents with severe substance and conduct problems and female healthy controls of similar ages. Hypotheses: Female adolescents with severe substance and conduct problems will show significantly less gray matter volume in frontal regions critical to inhibition (i.e. dorsolateral prefrontal cortex and ventrolateral prefrontal cortex), conflict processing (i.e., anterior cingulate), valuation of expected outcomes(i.e., medial orbitofrontal cortex) and the dopamine reward system(i.e. striatum). Methods We conducted whole-brain voxel-based morphometric comparison of structural MR images of 22 patients(14-18 years) with severe substance and conduct problems and 21 controls of similar age using statistical parametric mapping(SPM) and voxel-based morphometric (VBM8) toolbox. We tested group differences in regional gray matter volume with analyses of covariance, adjusting for age and IQ at p<0.05, corrected for multiple comparisons at whole-brain cluster-level threshold. Results Female adolescents with severe substance and conduct problems compared to controls showed significantly less gray matter volume in right dorsolateral prefrontal cortex, left ventrolateral prefrontal cortex, medial orbitofrontal cortex, anterior cingulate, bilateral somatosensory cortex, left supramarginal gyrus, and bilateral angular gyrus. Considering the entire brain, patients had 9.5% less overall gray matter volume compared to controls. Conclusions Female adolescents with severe substance and conduct problems in comparison to similarly aged female healthy controls showed substantially lower gray matter volume in brain regions involved in inhibition, conflict processing, valuation of outcomes, decision-making, reward, risk-taking, and rule-breaking antisocial behavior.	[Dalwani, Manish S.; McMahon, Mary Agnes; Mikulich-Gilbertson, Susan K.; Young, Susan E.; Raymond, Kristen M.; McWilliams, Shannon K.; Banich, Marie T.; Tanabe, Jody L.; Crowley, Thomas J.; Sakai, Joseph T.] Univ Colorado, Sch Med, Dept Psychiat, Denver, CO 80262 USA; [Regner, Michael F.; Tanabe, Jody L.] Univ Colorado, Sch Med, Dept Radiol, Denver, CO 80262 USA; [Banich, Marie T.] Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA; [Banich, Marie T.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Dalwani, MS (corresponding author), Univ Colorado, Sch Med, Dept Psychiat, Denver, CO 80262 USA.	manish.dalwani@ucdenver.edu	Sakai, Joseph/AAH-5984-2020	Regner, Michael/0000-0002-5777-5996; BANICH, MARIE/0000-0001-9373-9194; Sakai, Joseph/0000-0003-1600-6100	National Institute of Drug Abuse (NIDA) [DA009842, DA011015, DA034604, DA031761]; Kane Family Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031761, R01DA034604, P60DA011015, R37DA009842, R01DA009842] Funding Source: NIH RePORTER	National Institute of Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Kane Family Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the National Institute of Drug Abuse (NIDA) grants DA009842, DA011015, DA034604, DA031761 and the Kane Family Foundation.	Achenbach T. M., 1991, CHILD BEHAV CHECKLIS; American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; Bardone AM, 1998, J AM ACAD CHILD PSY, V37, P594, DOI 10.1097/00004583-199806000-00009; Belfer ML, 2008, J CHILD PSYCHOL PSYC, V49, P226, DOI 10.1111/j.1469-7610.2007.01855.x; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; CARROLL BJ, 1981, BRIT J PSYCHIAT, V138, P194, DOI 10.1192/bjp.138.3.194; Chong MY, 1999, PSYCHOL MED, V29, P1387, DOI 10.1017/S0033291799001257; Clark DB, 1998, ADDICT BEHAV, V23, P561, DOI 10.1016/S0306-4603(98)00038-0; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; COTTLER LB, 1995, DRUG ALCOHOL DEPEN, V38, P59, DOI 10.1016/0376-8716(94)01091-X; Crowley T J, 1995, NIDA Res Monogr, V156, P49; Crowley TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012835; Crowley TJ, 2006, J AM ACAD CHILD PSY, V45, P175, DOI 10.1097/01.chi.0000188893.60551.31; Crowley TJ, 2001, J AM ACAD CHILD PSY, V40, P265, DOI 10.1097/00004583-200103000-00005; Dalwani M, 2011, DRUG ALCOHOL DEPEN, V118, P295, DOI 10.1016/j.drugalcdep.2011.04.006; De Brito SA, 2009, BRAIN, V132, P843, DOI 10.1093/brain/awp011; Disney ER, 1999, AM J PSYCHIAT, V156, P1515, DOI 10.1176/ajp.156.10.1515; Eaves LJ, 1997, J CHILD PSYCHOL PSYC, V38, P965, DOI 10.1111/j.1469-7610.1997.tb01614.x; EAVES LJ, 1993, BEHAV GENET, V23, P5, DOI 10.1007/BF01067550; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; Fairchild G, 2013, J CHILD PSYCHOL PSYC, V54, P86, DOI 10.1111/j.1469-7610.2012.02617.x; Fein G, 2013, PSYCHIAT RES-NEUROIM, V214, P1, DOI 10.1016/j.pscychresns.2013.06.001; Fergusson DM, 2007, DRUG ALCOHOL DEPEN, V88, pS14, DOI 10.1016/j.drugalcdep.2006.12.011; Foster EM, 2005, AM J PUBLIC HEALTH, V95, P1767, DOI 10.2105/AJPH.2004.061424; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Grella CE, 2001, J NERV MENT DIS, V189, P384, DOI 10.1097/00005053-200106000-00006; Harris CR, 2006, JUDGM DECIS MAK, V1, P48; Harrison PA, 1998, AM J PSYCHIAT, V155, P486, DOI 10.1176/ajp.155.4.486; Heath AC, 1997, PSYCHOL MED, V27, P1381, DOI 10.1017/S0033291797005643; Hewitt JK, 1997, J CHILD PSYCHOL PSYC, V38, P943, DOI 10.1111/j.1469-7610.1997.tb01613.x; Hicks BM, 2004, ARCH GEN PSYCHIAT, V61, P922, DOI 10.1001/archpsyc.61.9.922; Hicks BM, 2011, BEHAV GENET, V41, P459, DOI 10.1007/s10519-010-9417-2; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Hopfer CJ, 2003, J AM ACAD CHILD PSY, V42, P710, DOI 10.1097/01.CHI.0000046848.56865.54; Huebner T, 2008, J AM ACAD CHILD PSY, V47, P540, DOI 10.1097/CHI.0b013e3181676545; Iacono WG, 2008, ANNU REV CLIN PSYCHO, V4, P325, DOI 10.1146/annurev.clinpsy.4.022007.141157; Kalivas PW, 2011, MOL PSYCHIATR, V16, P974, DOI 10.1038/mp.2011.46; Kendler KS, 2003, ARCH GEN PSYCHIAT, V60, P929, DOI 10.1001/archpsyc.60.9.929; Krueger RF, 2002, J ABNORM PSYCHOL, V111, P411, DOI 10.1037//0021-843X.111.3.411; Krueger RF, 1999, ARCH GEN PSYCHIAT, V56, P921, DOI 10.1001/archpsyc.56.10.921; Kuperman S, 2001, AM J PSYCHIAT, V158, P2022, DOI 10.1176/appi.ajp.158.12.2022; Lahat A, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.87; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Marmorstein NR, 2001, J AM ACAD CHILD PSY, V40, P299, DOI 10.1097/00004583-200103000-00009; Matthews JS, 2009, J EDUC PSYCHOL, V101, P689, DOI 10.1037/a0014240; Medina KL, 2008, ALCOHOL CLIN EXP RES, V32, P386, DOI 10.1111/j.1530-0277.2007.00602.x; MOFFITT TE, 1993, DEV PSYCHOPATHOL, V5, P135, DOI 10.1017/S0954579400004302; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Myers MG, 1995, ALCOHOL CLIN EXP RES, V19, P1528, DOI 10.1111/j.1530-0277.1995.tb01019.x; Pajer Kathleen, 2008, Child Adolesc Psychiatry Ment Health, V2, P28, DOI 10.1186/1753-2000-2-28; PFEFFERBAUM A, 1995, ALCOHOL CLIN EXP RES, V19, P1177, DOI 10.1111/j.1530-0277.1995.tb01598.x; Raine A, 2006, SOC COGN AFFECT NEUR, V1, P203, DOI 10.1093/scan/nsl033; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Rose RJ, 1998, ALCOHOL HEALTH RES W, V22, P131; Schneider S, 2012, AM J PSYCHIAT, V169, P39, DOI 10.1176/appi.ajp.2011.11030489; Shaffer D, 2000, J AM ACAD CHILD PSY, V39, P28, DOI 10.1097/00004583-200001000-00014; Silberg J, 2003, J CHILD PSYCHOL PSYC, V44, P664, DOI 10.1111/1469-7610.00153; Silberg J, 1996, J CHILD PSYCHOL PSYC, V37, P803, DOI 10.1111/j.1469-7610.1996.tb01476.x; Slutske WS, 1998, J ABNORM PSYCHOL, V107, P363, DOI 10.1037/0021-843X.107.3.363; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stallings MC, 2003, DRUG ALCOHOL DEPEN, V70, P295, DOI 10.1016/S0376-8716(03)00031-0; Steinberg L, 2010, DEV PSYCHOBIOL, V52, P216, DOI 10.1002/dev.20445; Sterzer P, 2007, NEUROIMAGE, V37, P335, DOI 10.1016/j.neuroimage.2007.04.043; Steven MC, 2007, BEHAV BRAIN RES, V181, P12, DOI 10.1016/j.bbr.2007.03.023; Substance Abuse and Mental Health Services Administration, 2013, HHS PUBLICATION NO S; Tanabe J, 2009, BIOL PSYCHIAT, V65, P160, DOI 10.1016/j.biopsych.2008.07.030; Tarter RE, 2003, AM J PSYCHIAT, V160, P1078, DOI 10.1176/appi.ajp.160.6.1078; Thompson LL, 2006, ASSESSMENT, V13, P3, DOI 10.1177/1073191105282247; Tully EC, 2014, THE OXFORD HANDBOOK, V2, DOI [10.1093/oxfordhb/9780199381708.013.20, DOI 10.1093/OXFORDHB/9780199381708.013.20]; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Weinberg NZ, 1998, J AM ACAD CHILD PSY, V37, P252, DOI 10.1097/00004583-199803000-00009; Wilke M, 2008, NEUROIMAGE, V41, P903, DOI 10.1016/j.neuroimage.2008.02.056; YOUNG SE, 1995, DRUG ALCOHOL DEPEN, V37, P149, DOI 10.1016/0376-8716(94)01069-W; Young SE, 2009, J ABNORM PSYCHOL, V118, P117, DOI 10.1037/a0014657; ZOCCOLILLO M, 1991, J AM ACAD CHILD PSY, V30, P973, DOI 10.1097/00004583-199111000-00016	76	17	17	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126368	10.1371/journal.pone.0126368	http://dx.doi.org/10.1371/journal.pone.0126368			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000879	Green Submitted, Green Published, gold			2022-12-26	WOS:000354931700017
J	Guard, BC; Barr, JW; Reddivari, L; Klemashevich, C; Jayaraman, A; Steiner, JM; Vanamala, J; Suchodolski, JS				Guard, Blake C.; Barr, James W.; Reddivari, Lavanya; Klemashevich, Cory; Jayaraman, Arul; Steiner, Joerg M.; Vanamala, Jairam; Suchodolski, Jan S.			Characterization of Microbial Dysbiosis and Metabolomic Changes in Dogs with Acute Diarrhea	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CHAIN FATTY-ACIDS; MOLECULAR-PHYLOGENETIC CHARACTERIZATION; BACTERIAL MICROBIOTA; MASS-SPECTROMETRY; ESCHERICHIA-COLI; SMALL-INTESTINE; GUT MICROBIOME; HEALTHY DOGS; RNA	Limited information is available regarding the metabolic consequences of intestinal dysbiosis in dogs with acute onset of diarrhea. The aim of this study was to evaluate the fecal microbiome, fecal concentrations of short-chain fatty acids (SCFAs), as well as serum and urine metabolites in healthy dogs (n=13) and dogs with acute diarrhea (n=13). The fecal microbiome, SCFAs, and serum/urine metabolite profiles were characterized by 454-pyrosequencing of the 16S rRNA genes, GC/MS, and untargeted and targeted metabolomics approach using UPLC/MS and HPLC/MS, respectively. Significantly lower bacterial diversity was observed in dogs with acute diarrhea in regards to species richness, chao1, and Shannon index (p=0.0218, 0.0176, and 0.0033; respectively). Dogs with acute diarrhea had significantly different microbial communities compared to healthy dogs (unweighted Unifrac distances, ANOSIM p=0.0040). While Bacteroidetes, Faecalibacterium, and an unclassified genus within Ruminococcaceae were underrepresented, the genus Clostridium was overrepresented in dogs with acute diarrhea. Concentrations of fecal propionic acid were significantly decreased in acute diarrhea (p=0.0033), and were correlated to a decrease in Faecalibacterium (rho=0.6725, p=0.0332). The predicted functional gene content of the microbiome (PICRUSt) revealed overrepresentations of genes for transposase enzymes as well as methyl accepting chemotaxis proteins in acute diarrhea. Serum concentrations of kynurenic acid and urine concentrations of 2-methyl-1H-indole and 5-Methoxy-1H-indole-3-carbaldehyde were significantly decreased in acute diarrhea (p=0.0048, 0.0185, and 0.0330, respectively). These results demonstrate that the fecal dysbiosis present in acute diarrhea is associated with altered systemic metabolic states.	[Guard, Blake C.; Steiner, Joerg M.; Suchodolski, Jan S.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, Gastrointestinal Lab, College Stn, TX 77843 USA; [Barr, James W.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, Emergency & Crit Care, College Stn, TX USA; [Reddivari, Lavanya] Penn State Univ, Dept Plant Sci, University Pk, PA 16802 USA; [Klemashevich, Cory; Jayaraman, Arul] Texas A&M Univ, Artie McFerrin Dept Chem Engn, College Stn, TX USA; [Jayaraman, Arul] Texas A&M Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, College Stn, TX USA; [Vanamala, Jairam] Penn State Univ, Dept Food Sci, University Pk, PA 16802 USA; [Vanamala, Jairam] Penn State Hershey Canc Inst, Hershey, PA USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Suchodolski, JS (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Small Anim Clin Sci, Gastrointestinal Lab, College Stn, TX 77843 USA.	jsuchodolski@cvm.tamu.edu		Suchodolski, Jan/0000-0002-2176-6932				Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Bell Julia A, 2008, Interdiscip Perspect Infect Dis, V2008, P149694, DOI 10.1155/2008/149694; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benov L, 1996, P NATL ACAD SCI USA, V93, P4999, DOI 10.1073/pnas.93.10.4999; Berg DE, 1989, MOBILE DNA; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Broeckling CD, 2013, METABOLOMICS, V9, P33, DOI 10.1007/s11306-012-0426-4; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cook SI, 1998, ALIMENT PHARM THER, V12, P499, DOI 10.1046/j.1365-2036.1998.00337.x; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Foster M Lauren, 2013, Vet Med Int, V2013, P658373, DOI 10.1155/2013/658373; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; Garcia-Mazcorro JF, 2012, FEMS MICROBIOL ECOL, V80, P624, DOI 10.1111/j.1574-6941.2012.01331.x; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gupta NK, 2012, INFLAMM BOWEL DIS, V18, P1214, DOI 10.1002/ibd.21849; Handl S, 2013, FEMS MICROBIOL ECOL, V84, P332, DOI 10.1111/1574-6941.12067; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Hinnebusch BF, 2002, J NUTR, V132, P1012, DOI 10.1093/jn/132.5.1012; Inness VL, 2007, J ANIM PHYSIOL AN N, V91, P48, DOI 10.1111/j.1439-0396.2006.00640.x; Janeczko S, 2008, VET MICROBIOL, V128, P178, DOI 10.1016/j.vetmic.2007.10.014; Keszthelyi D, 2013, J PSYCHOSOM RES, V74, P501, DOI 10.1016/j.jpsychores.2013.01.008; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; KONDOH H, 1979, P NATL ACAD SCI USA, V76, P260, DOI 10.1073/pnas.76.1.260; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lynch SV, 2013, GUT MICROBES, V4, P41, DOI 10.4161/gmic.22430; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Minamoto Y, 2015, GUT MICROBES, V6, P33, DOI 10.1080/19490976.2014.997612; Minamoto Y, 2014, VET MICROBIOL, V174, P463, DOI 10.1016/j.vetmic.2014.10.005; Mogi C, 2009, J IMMUNOL, V182, P3243, DOI 10.4049/jimmunol.0803466; Moreau NM, 2003, J CHROMATOGR B, V784, P395, DOI 10.1016/S1570-0232(02)00827-9; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Pilotte L, 2012, P NATL ACAD SCI USA, V109, P2497, DOI 10.1073/pnas.1113873109; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Rossi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094699; Schott T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-534; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Suchodolski JS, 2011, J ANIM SCI, V89, P1520, DOI 10.2527/jas.2010-3377; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Suchodolski JS, 2010, VET MICROBIOL, V142, P394, DOI 10.1016/j.vetmic.2009.11.002; Suchodolski JS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-210; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xenoulis PG, 2008, FEMS MICROBIOL ECOL, V66, P579, DOI 10.1111/j.1574-6941.2008.00556.x; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Zhu WT, 2011, ANAL BIOANAL CHEM, V401, P3249, DOI 10.1007/s00216-011-5436-y; Zoetendal EG, 2004, J NUTR, V134, P465, DOI 10.1093/jn/134.2.465	61	100	104	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127259	10.1371/journal.pone.0127259	http://dx.doi.org/10.1371/journal.pone.0127259			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000959	Green Submitted, Green Published, gold			2022-12-26	WOS:000354931700046
J	Hung, CI; Liu, CY; Yang, CH; Wang, SJ				Hung, Ching-I; Liu, Chia-Yih; Yang, Ching-Hui; Wang, Shuu-Jiun			The Impacts of Migraine among Outpatients with Major Depressive Disorder at a Two-Year Follow-Up	PLOS ONE			English	Article							SOMATIC SYMPTOMS SCALE; QUALITY-OF-LIFE; ANXIETY DISORDERS; COMORBIDITY; REMISSION; ASSOCIATION	Background No study has investigated the impacts of migraine on depression, anxiety, and somatic symptoms and remission at the two-year follow-up point among patients with major depressive disorder (MDD). This study aimed to investigate the above issues. Methods Psychiatric outpatients with MDD recruited at baseline were investigated at a two-year follow-up (N = 106). The Hamilton Depression Rating Scale, Hospital Anxiety and Depression Scale, and Depression and Somatic Symptoms Scale were used. Migraine was diagnosed according to the International Classification of Headache Disorders, 2nd edition. The patients were divided into no migraine, inactive migraine, and active migraine subgroups. Multiple logistic regressions were used to investigate the significant factors related to full remission of depression. Results Among patients without pharmacotherapy at the follow-up, patients with active migraine had significantly greater severities of anxiety and somatic symptoms as compared with patients without migraine; moreover, patients with active migraine had the lowest improvement percentage and full remission rate. There were no significant differences in depression, anxiety, and somatic symptoms between patients with inactive migraine and those without migraine. Active headache at follow-up was a significant factor related to a lower full remission rate. Conclusions Active headache at follow-up was associated with a lower rate of full remission and more residual anxiety and somatic symptoms at follow-up among patients with migraine. Physicians should integrate a treatment plan for depression and migraine for the treatment of patients with MDD.	[Hung, Ching-I; Liu, Chia-Yih] Chang Gung Mem Hosp Linkou, Dept Psychiat, Taoyuan, Taiwan; [Hung, Ching-I; Liu, Chia-Yih] Chang Gung Univ, Sch Med, Taoyuan, Taiwan; [Yang, Ching-Hui] Chang Gung Univ Sci & Technol, Dept Nursing, Taoyuan, Taiwan; [Wang, Shuu-Jiun] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Wang, Shuu-Jiun] Taipei Vet Gen Hosp, Neurol Inst, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Wang, SJ (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan.	sjwang@vghtpe.gov.tw		Wang, Shuu-Jiun/0000-0001-5179-5358	National Science Council of Taiwan [NSC 93-2314-B-182A-200, NSC 94-2314-B-182A-207]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	Funding for this study was provided by grants from the National Science Council of Taiwan (NSC 93-2314-B-182A-200 and NSC 94-2314-B-182A-207). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashina S, 2012, J HEADACHE PAIN, V13, P615, DOI 10.1007/s10194-012-0479-9; Baskin SM, 2011, NEUROL SCI, V32, pS9, DOI 10.1007/s10072-011-0549-9; Beghi E, 2010, J HEADACHE PAIN, V11, P141, DOI 10.1007/s10194-010-0187-2; Breslau N, 2012, HEADACHE, V52, P723, DOI 10.1111/j.1526-4610.2012.02117.x; Brietzke E, 2012, COMPR PSYCHIAT, V53, P809, DOI 10.1016/j.comppsych.2011.10.006; Bruti G, 2012, NEUROL SCI, V33, pS107, DOI 10.1007/s10072-012-1053-6; Cripe SM, 2010, J AFFECT DISORDERS, V122, P149, DOI 10.1016/j.jad.2009.07.014; First MB, 2002, STRUCTURED CLIN INTE; Gudmundsson LS, 2013, NEUROLOGY, V80, P2138, DOI 10.1212/WNL.0b013e318295d69e; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Heckman BD, 2009, PAIN, V146, P56, DOI 10.1016/j.pain.2009.06.019; Hung CI, 2008, J PSYCHOSOM RES, V65, P135, DOI 10.1016/j.jpsychores.2008.04.011; Hung CI, 2006, PSYCHIAT CLIN NEUROS, V60, P700, DOI 10.1111/j.1440-1819.2006.01585.x; Hung CI, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-73; Hung CI, 2014, PSYCHOPATHOLOGY, V47, P51, DOI 10.1159/000348583; Hung CI, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-19; Hung CI, 2012, INT J PSYCHIAT CLIN, V16, P33, DOI 10.3109/13651501.2011.617456; Hung CI, 2012, PSYCHIAT CLIN NEUROS, V66, P8, DOI 10.1111/j.1440-1819.2011.02286.x; Hung CI, 2010, J AFFECT DISORDERS, V125, P134, DOI 10.1016/j.jad.2009.12.010; Hung CI, 2009, J AFFECT DISORDERS, V117, P108, DOI 10.1016/j.jad.2008.12.015; Karp JF, 2005, J CLIN PSYCHIAT, V66, P591, DOI 10.4088/JCP.v66n0508; Ligthart L, 2010, CEPHALALGIA, V30, P1073, DOI 10.1177/0333102410363492; McIntyre RS, 2006, HEADACHE, V46, P973, DOI 10.1111/j.1526-4610.2006.00469.x; Novick D, 2013, J AFFECT DISORDERS, V149, P182, DOI 10.1016/j.jad.2013.01.020; Oedegaard KJ, 2005, J AFFECT DISORDERS, V84, P233, DOI 10.1016/j.jad.2003.11.007; Paykel E S, 2008, Dialogues Clin Neurosci, V10, P431; Pompili M, 2009, J HEADACHE PAIN, V10, P283, DOI 10.1007/s10194-009-0134-2; Ratcliffe GE, 2009, GEN HOSP PSYCHIAT, V31, P14, DOI 10.1016/j.genhosppsych.2008.09.006; Samaan Z, 2009, BRIT J PSYCHIAT, V194, P350, DOI 10.1192/bjp.bp.108.054049; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Smitherman TA, 2008, CURR PAIN HEADACHE R, V12, P224, DOI 10.1007/s11916-008-0039-9; Tietjen GE, 2009, HEADACHE, V49, P1333, DOI 10.1111/j.1526-4610.2009.01521.x; Torta R, 2012, NEUROL SCI, V33, pS117, DOI 10.1007/s10072-012-1055-4; Nguyen TV, 2013, HEADACHE, V53, P498, DOI 10.1111/j.1526-4610.2012.02264.x; Victor TW, 2010, CEPHALALGIA, V30, P567, DOI 10.1111/j.1468-2982.2009.01944.x; Yavuz BG, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-53; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	17	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0128087	10.1371/journal.pone.0128087	http://dx.doi.org/10.1371/journal.pone.0128087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7GR	26000962	Green Published, Green Submitted, gold			2022-12-26	WOS:000354931700102
J	Rieckher, M; Kyparissidis-Kokkinidis, I; Zacharopoulos, A; Kourmoulakis, G; Tavernarakis, N; Ripoll, J; Zacharakis, G				Rieckher, Matthias; Kyparissidis-Kokkinidis, Ilias; Zacharopoulos, Athanasios; Kourmoulakis, Georgios; Tavernarakis, Nektarios; Ripoll, Jorge; Zacharakis, Giannis			A Customized Light Sheet Microscope to Measure Spatio-Temporal Protein Dynamics in Small Model Organisms	PLOS ONE			English	Article							OPTICAL PROJECTION TOMOGRAPHY; GENE-EXPRESSION; P-BODIES; ELEGANS; EMBRYOS; TOOL	We describe a customizable and cost-effective light sheet microscopy (LSM) platform for rapid three-dimensional imaging of protein dynamics in small model organisms. The system is designed for high acquisition speeds and enables extended time-lapse in vivo experiments when using fluorescently labeled specimens. We demonstrate the capability of the setup to monitor gene expression and protein localization during ageing and upon starvation stress in longitudinal studies in individual or small groups of adult Caenorhabditis elegans nematodes. The system is equipped to readily perform fluorescence recovery after photobleaching (FRAP), which allows monitoring protein recovery and distribution under low photobleaching conditions. Our imaging platform is designed to easily switch between light sheet microscopy and optical projection tomography (OPT) modalities. The setup permits monitoring of spatio-temporal expression and localization of ageing biomarkers of subcellular size and can be conveniently adapted to image a wide range of small model organisms and tissue samples.	[Rieckher, Matthias; Tavernarakis, Nektarios] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece; [Kyparissidis-Kokkinidis, Ilias; Zacharopoulos, Athanasios; Kourmoulakis, Georgios; Zacharakis, Giannis] Fdn Res & Technol Hellas, Inst Elect Struct & Laser, Iraklion, Greece; [Ripoll, Jorge] Univ Carlos III Madrid, Dept Bioengn & Aerosp Engn, Madrid, Spain; [Ripoll, Jorge] Inst Invest Sanit Hosp Gregorio Maranon, Madrid, Spain; [Tavernarakis, Nektarios] Univ Crete, Fac Med, Dept Basic Sci, Iraklion, Greece	Foundation for Research & Technology - Hellas (FORTH); Foundation for Research & Technology - Hellas (FORTH); Universidad Carlos III de Madrid; University of Crete	Rieckher, M (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece.	mrieckh1@uni-koeln.de; jorge.ripoll@uc3m.es; zahari@iesl.forth.gr	Zacharakis, Giannis/A-2544-2014; Tavernarakis, Nektarios/B-9684-2013; Ripoll, Jorge/J-8134-2012; Zacharopoulos, Athanasios/B-8063-2010; Kourmoulakis, Giorgos/AAG-9243-2019; Ripoll, Jorge/AAW-2245-2020	Zacharakis, Giannis/0000-0002-6438-0773; Tavernarakis, Nektarios/0000-0002-5253-1466; Ripoll, Jorge/0000-0001-8856-7738; Zacharopoulos, Athanasios/0000-0003-3700-6898; Ripoll, Jorge/0000-0001-8856-7738; Rieckher, Matthias/0000-0002-1945-9474	Project "Skin-DOCTor" [1778]; Project "Neureka!" [LSF7-341]; European Social Fund; National Resources; EU Marie Curie Initial Training Network "OILTEBIA" [PITN-GA-2012-317526]; EC [HIGH-THROUGHPUT TOMO PICIG12-GA-2012-333632]; Spanish MINECO [MESO-IMAGING FIS2013-41802-R]	Project "Skin-DOCTor"; Project "Neureka!"; European Social Fund(European Social Fund (ESF)); National Resources; EU Marie Curie Initial Training Network "OILTEBIA"; EC(European CommissionEuropean Commission Joint Research Centre); Spanish MINECO(Spanish Government)	MR, GZ and AZ acknowledge funding from the Projects "Skin-DOCTor" Grant No. 1778 and "Neureka!" Grant No. LSF7-341 implemented under the "ARISTEIA" and "Supporting Postdoctoral Researchers" Actions respectively, of the "OPERATIONAL PROGRAMME EDUCATION AND LIFELONG LEARNING", (http://www.espa.gr/en/pages/staticOPEducationandLifelongLearning.aspx), which is co-funded by the European Social Fund and National Resources and from the EU Marie Curie Initial Training Network "OILTEBIA", Grant No. PITN-GA-2012-317526 (http://ec.europa.eu/research/mariecurieactions/, http://gdo.uc3m.es/oiltebia/index.php?option = com_content&view = frontpage). JR acknowledges support from EC FP7 CIG grant HIGH-THROUGHPUT TOMO PICIG12-GA-2012-333632, (http://cordis.europa.eu/projects/333632), and Spanish MINECO grant MESO-IMAGING FIS2013-41802-R, (https://sede.micinn.gob.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birk UJ, 2010, BIOMED OPT EXPRESS, V1, P87, DOI 10.1364/BOE.1.000087; BRENNER S, 1974, GENETICS, V77, P71; Day Charles A, 2012, Curr Protoc Cytom, VChapter 2, DOI 10.1002/0471142956.cy0219s62; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fickentscher R, 2013, BIOPHYS J, V105, P1805, DOI 10.1016/j.bpj.2013.09.005; FIRE A, 1989, EMBO J, V8, P4359; Golden TR, 2004, AGING CELL, V3, P111, DOI 10.1111/j.1474-9728.2004.00095.x; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Huisken J, 2012, BIOESSAYS, V34, P406, DOI 10.1002/bies.201100120; Huisken J, 2009, DEVELOPMENT, V136, P1963, DOI 10.1242/dev.022426; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kaufmann A, 2012, DEVELOPMENT, V139, P3242, DOI 10.1242/dev.082586; Keller Philipp J, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.top78; Kim E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053419; Kourtis N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004547; Lee K, 2006, PLANT CELL, V18, P2145, DOI 10.1105/tpc.106.043042; Lee S, 1997, IEEE T VIS COMPUT GR, V3, P228, DOI 10.1109/2945.620490; McGinty J, 2011, BIOMED OPT EXPRESS, V2, P1340, DOI 10.1364/BOE.2.001340; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]; Ntziachristos V, 2002, NAT MED, V8, P757, DOI 10.1038/nm729; Reeves GT, 2012, DEV CELL, V22, P544, DOI 10.1016/j.devcel.2011.12.007; Rieckher M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018963; Ripoll J, 2004, MOD PHYS LETT B, V18, P1403, DOI 10.1142/S0217984904007864; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sarma S, 2005, BRAIN RES BULL, V66, P449, DOI 10.1016/j.brainresbull.2005.05.022; Sharpe J, 2003, J ANAT, V202, P175, DOI 10.1046/j.1469-7580.2003.00155.x; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Sun YY, 2011, PROTEIN CELL, V2, P918, DOI 10.1007/s13238-011-1119-x; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Vinegoni C, 2008, NAT METHODS, V5, P45, DOI 10.1038/NMETH1149; Wu YC, 2011, P NATL ACAD SCI USA, V108, P17708, DOI 10.1073/pnas.1108494108; Zhu SP, 2012, IEEE T MED IMAGING, V31, P1358, DOI 10.1109/TMI.2012.2188836	35	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127869	10.1371/journal.pone.0127869	http://dx.doi.org/10.1371/journal.pone.0127869			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000610	gold, Green Published, Green Submitted			2022-12-26	WOS:000354931700091
J	Pacheco, JM; Smoliga, GR; O'Donnell, V; Brito, BP; Stenfeldt, C; Rodriguez, LL; Arzt, J				Pacheco, Juan M.; Smoliga, George R.; O'Donnell, Vivian; Brito, Barbara P.; Stenfeldt, Carolina; Rodriguez, Luis L.; Arzt, Jonathan			Persistent Foot-and-Mouth Disease Virus Infection in the Nasopharynx of Cattle; Tissue-Specific Distribution and Local Cytokine Expression	PLOS ONE			English	Article							IMMUNE-RESPONSES; CARRIER STATE; GAMMA-INTERFERON; RNA; INNATE; CELLS; PATHOGENESIS; REPLICATION; SWINE; LOCALIZATION	Tissues obtained post-mortem from cattle persistently infected with foot-and-mouth disease virus (FMDV) were analyzed to characterize the tissue-specific localization of FMDV and partial transcriptome profiles for selected immunoregulatory cytokines. Analysis of 28 distinct an-atomic sites from 21 steers infected with FMDV serotype A, O or SAT2, had the highest prevalence of overall viral detection in the dorsal nasopharynx (80.95%) and dorsal soft palate (71.43%). FMDV was less frequently detected in laryngeal mucosal tissues, oropharyngeal mucosal sites, and lymph nodes draining the pharynx. Immunomicroscopy indicated that within persistently infected mucosal tissues, FMDV antigens were rarely detectable within few epithelial cells in regions of mucosa-associated lymphoid tissue (MALT). Transcriptome analysis of persistently infected pharyngeal tissues by qRT-PCR for 14 cytokine genes indicated a general trend of decreased mRNA levels compared to uninfected control animals. Although, statistically significant differences were not observed, greatest suppression of relative expression (RE) was identified for IP-10 (RE = 0.198), IFN-beta (RE = 0.269), IL-12 (RE = 0.275), and IL-2 (RE = 0.312). Increased relative expression was detected for IL-6 (RE = 2.065). Overall, this data demonstrates that during the FMDV carrier state in cattle, viral persistence is associated with epithelial cells of the nasopharynx in the upper respiratory tract and decreased levels of mRNA for several immunoregulatory cytokines in the infected tissues.	[Pacheco, Juan M.; Smoliga, George R.; O'Donnell, Vivian; Stenfeldt, Carolina; Rodriguez, Luis L.; Arzt, Jonathan] USDA ARS, Foreign Anim Dis Res Unit, Plum Isl Anim Dis Ctr, Plum Isl, NY USA; [O'Donnell, Vivian] Univ Connecticut, Dept Pathobiol & Vet Sci, Storrs, CT USA; [Brito, Barbara P.] Univ Calif Davis, Ctr Anim Dis Modeling & Surveillance, Davis, CA 95616 USA	United States Department of Agriculture (USDA); University of Connecticut; University of California System; University of California Davis	Arzt, J (corresponding author), USDA ARS, Foreign Anim Dis Res Unit, Plum Isl Anim Dis Ctr, Plum Isl, NY USA.	jonathan.arzt@ars.usda.gov	Brito, Barbara P/H-5467-2017; O'Donnell, Vivian/ACY-4611-2022; Ibrahim, Essam Hassan/G-1960-2018; Stenfeldt, Carolina/AAG-7940-2021	Brito, Barbara P/0000-0001-6122-2596; Ibrahim, Essam Hassan/0000-0003-0130-2257; Pacheco, Juan/0000-0001-5477-0201; Stenfeldt, Carolina/0000-0002-2074-3886; Arzt, Jonathan/0000-0002-7517-7893	USDA-ARS CRIS [8064-32000-057-00D]; Science and Technology Directorate of the U.S. Department of Homeland Security [HSHQPM-13-X-00131]; Plum Island Animal Disease Center Research Participation Program fellowship	USDA-ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Science and Technology Directorate of the U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); Plum Island Animal Disease Center Research Participation Program fellowship	This project was funded by USDA-ARS CRIS project 8064-32000-057-00D and by the Science and Technology Directorate of the U.S. Department of Homeland Security under Award Number HSHQPM-13-X-00131. CS is a recipient of a Plum Island Animal Disease Center Research Participation Program fellowship, administered by the Oak Ridge Institute for Science and Education (ORISE) through an inter-agency agreement with the U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aich P, 2007, J GEN VIROL, V88, P2749, DOI 10.1099/vir.0.82861-0; Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Alexandersen S, 2002, MICROBES INFECT, V4, P1099, DOI 10.1016/S1286-4579(02)01634-9; Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P291, DOI 10.1111/j.1865-1682.2011.01204.x; Arzt J, 2010, VET PATHOL, V47, P1048, DOI 10.1177/0300985810372509; Arzt J, 2014, VIROLOGY, V452, P12, DOI 10.1016/j.virol.2014.01.001; Arzt J, 2009, J VET DIAGN INVEST, V21, P779, DOI 10.1177/104063870902100604; BAXT B, 1989, J VIROL, V63, P2143, DOI 10.1128/JVI.63.5.2143-2151.1989; BURROWS R, 1981, J COMP PATHOL, V91, P599, DOI 10.1016/0021-9975(81)90089-X; BURROWS R, 1968, VET REC, V82, P387; BURROWS R, 1966, J HYG-CAMB, V64, P81, DOI 10.1017/S0022172400040365; BURROWS R, 1971, J HYG-CAMB, V69, P307, DOI 10.1017/S0022172400021537; Chinsangaram J, 2003, J VIROL, V77, P1621, DOI 10.1128/JVI.77.2.1621-1625.2003; Chinsangaram J, 2001, J VIROL, V75, P5498, DOI 10.1128/JVI.75.12.5498-5503.2001; Chinsangaram J, 1999, J VIROL, V73, P9891, DOI 10.1128/JVI.73.12.9891-9898.1999; CONDY JB, 1985, COMP IMMUNOL MICROB, V8, P259, DOI 10.1016/0147-9571(85)90004-9; Cook PC, 2012, P NATL ACAD SCI USA, V109, P9977, DOI 10.1073/pnas.1121231109; Dash P, 2010, J VIROL, V84, P9149, DOI 10.1128/JVI.00642-10; de los Santos T, 2006, J VIROL, V80, P1906, DOI 10.1128/JVI.80.4.1906-1914.2006; Diaz-San Segundo F, 2014, VIROLOGY; Diaz-San Segundo F, 2011, VIROLOGY, V413, P283, DOI 10.1016/j.virol.2011.02.023; DONN A, 1994, J VIROL METHODS, V49, P179, DOI 10.1016/0166-0934(94)90042-6; Golde WT, 2011, TRANSBOUND EMERG DIS, V58, P283, DOI 10.1111/j.1865-1682.2011.01223.x; Grubman MJ, 2008, FEMS IMMUNOL MED MIC, V53, P8, DOI 10.1111/j.1574-695X.2008.00409.x; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Horsington J, 2007, VIRUS RES, V125, P114, DOI 10.1016/j.virusres.2006.12.008; Howey R, 2012, EPIDEMICS-NETH, V4, P93, DOI 10.1016/j.epidem.2012.04.001; Iannello A, 2006, J LEUKOCYTE BIOL, V79, P16, DOI 10.1189/jlb.0705397; Juleff N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003434; Lacy P, 2011, BLOOD, V118, P9, DOI 10.1182/blood-2010-08-265892; LaRocco M, 2013, J CLIN MICROBIOL, V51, P1714, DOI 10.1128/JCM.03370-12; Lemon SM, 2010, J BIOL CHEM, V285, P22739, DOI 10.1074/jbc.R109.099556; Liebler-Tenorio EM, 2006, VET RES, V37, P257, DOI 10.1051/vetres:2006001; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; MCVICAR JW, 1976, J HYG-CAMBRIDGE, V76, P467, DOI 10.1017/S0022172400055406; Mogensen TH, 2004, J VIROL, V78, P5883, DOI 10.1128/JVI.78.11.5883-5890.2004; MOHANTY GC, 1971, ARCH GES VIRUSFORSCH, V34, P1, DOI 10.1007/BF01250240; MOHANTY GC, 1970, AM J VET RES, V31, P1187; Moraes MP, 2007, J VIROL, V81, P7124, DOI 10.1128/JVI.02775-06; Moraes MP, 2003, VACCINE, V22, P268, DOI 10.1016/S0264-410X(03)00560-7; Murphy MLP, 1999, VIRUS RES, V62, P67, DOI 10.1016/S0168-1702(99)00050-7; O'Donnell V, 2014, VIROLOGY, V468, P185, DOI 10.1016/j.virol.2014.08.004; Office of International des Epizootics (OIE), 2012, FOOT MOUTH DIS MAN D, V7th, P145; Oh Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044365; Pacheco JM, 2010, VET J, V183, P46, DOI 10.1016/j.tvjl.2008.08.023; Perez-Martin E, 2012, J VIROL, V86, P4477, DOI 10.1128/JVI.06683-11; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Salt J, 2004, FOOT AND MOUTH DISEASE: CURRENT PERSPECTIVES, P103; Segundo FDS, 2012, J VIROL, V86, P1316, DOI 10.1128/JVI.05941-11; SELLERS RF, 1968, VET REC, V83, P303, DOI 10.1136/vr.83.12.303; Stenfeldt C, 2012, J COMP PATHOL, V146, P243, DOI 10.1016/j.jcpa.2011.06.005; Stenfeldt C, 2012, VET MICROBIOL, V154, P230, DOI 10.1016/j.vetmic.2011.07.007; Stenfeldt C, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-66; SUTMOLLE.P, 1967, ARCH GES VIRUSFORSCH, V21, P170, DOI 10.1007/BF01241441; SUTMOLLER P, 1968, ARCH GES VIRUSFORSCH, V23, P227, DOI 10.1007/BF01241895; SUTMOLLER P, 1965, VET REC, V77, P968, DOI 10.1136/vr.77.33.968; Sutterwala FS, 1999, J LEUKOCYTE BIOL, V65, P543, DOI 10.1002/jlb.65.5.543; Thimme R, 2012, FEMS MICROBIOL REV, V36, P663, DOI 10.1111/j.1574-6976.2011.00319.x; Toka FN, 2013, IMMUNOL LETT, V152, P135, DOI 10.1016/j.imlet.2013.05.007; Toka FN, 2009, CLIN VACCINE IMMUNOL, V16, P1738, DOI 10.1128/CVI.00280-09; Van Bekkum JG, 1959, B INT EPIZOOT, V51, P917; Weaver GV, 2013, J WILDLIFE DIS, V49, P759, DOI 10.7589/2012-11-276; Yang M, 2007, J IMMUNOL METHODS, V321, P174, DOI 10.1016/j.jim.2007.01.016; Zhang Z, 2006, J COMP PATHOL, V134, P56, DOI 10.1016/j.jcpa.2005.06.011; Zhang ZD, 2004, J GEN VIROL, V85, P2567, DOI 10.1099/vir.0.80011-0; Zhang ZD, 2004, J GEN VIROL, V85, P415, DOI 10.1099/vir.0.19538-0; Zhang ZD, 2002, ARCH VIROL, V147, P2157, DOI 10.1007/s00705-002-0867-6; Zhang ZD, 2001, J COMP PATHOL, V124, P89, DOI 10.1053/jcpa.2000.0431; Zhang ZD, 2009, VET J, V179, P85, DOI 10.1016/j.tvjl.2007.08.012; Zhu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064119	71	51	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0125698	10.1371/journal.pone.0125698	http://dx.doi.org/10.1371/journal.pone.0125698			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996935	Green Published, Green Submitted, gold			2022-12-26	WOS:000356444000012
J	Pingel, J; Petersen, MCH; Fredberg, U; Kjaer, SG; Quistorff, B; Langberg, H; Hansen, JB				Pingel, Jessica; Petersen, M. Christine H.; Fredberg, Ulrich; Kjaer, Soren G.; Quistorff, Bjorn; Langberg, Henning; Hansen, Jacob B.			Inflammatory and Metabolic Alterations of Kager's Fat Pad in Chronic Achilles Tendinopathy	PLOS ONE			English	Article							ADIPOSE-TISSUE; RETINOBLASTOMA PROTEIN; ANATOMY; ADIPOKINES; CYTOKINES; JOINT; OSTEOARTHRITIS; PATHOLOGY; OBESITY	Background Achilles tendinopathy is a painful inflammatory condition characterized by swelling, stiffness and reduced function of the Achilles tendon. Kager's fat pad is an adipose tissue located in the area anterior to the Achilles tendon. Observations reveal a close physical interplay between Kager's fat pad and its surrounding structures during movement of the ankle, suggesting that Kager's fat pad may stabilize and protect the mechanical function of the ankle joint. Aim The aim of this study was to characterize whether Achilles tendinopathy was accompanied by changes in expression of inflammatory markers and metabolic enzymes in Kager's fat pad. Methods A biopsy was taken from Kager's fat pad from 31 patients with chronic Achilles tendinopathy and from 13 healthy individuals. Gene expression was measured by reverse transcription-quantitative PCR. Focus was on genes related to inflammation and lipid metabolism. Results Expression of the majority of analyzed inflammatory marker genes was increased in patients with Achilles tendinopathy compared to that in healthy controls. Expression patterns of the patient group were consistent with reduced lipolysis and increased fatty acid beta-oxidation. In the fat pad, the pain-signaling neuropeptide substance P was found to be present in one third of the subjects in the Achilles tendinopathy group but in none of the healthy controls. Conclusion Gene expression changes in Achilles tendinopathy patient samples were consistent with Kager's fat pad being more inflamed than in the healthy control group. Additionally, the results indicate an altered lipid metabolism in Kager's fat pad of Achilles tendinopathy patients.	[Pingel, Jessica] Univ Copenhagen, Dept Exercise & Nutr, Copenhagen, Denmark; [Petersen, M. Christine H.; Hansen, Jacob B.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Petersen, M. Christine H.; Quistorff, Bjorn] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Fredberg, Ulrich; Kjaer, Soren G.] Silkeborg Reg Hosp, Ctr Diagnost, Silkeborg, Denmark; [Langberg, Henning] Univ Copenhagen, Dept Publ Hlth, CopenRehab, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Aarhus University; Silkeborg Central Hospital; University of Copenhagen	Hansen, JB (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	jacob.hansen@bio.ku.dk	Hansen, Jacob B/F-3775-2010; Pingel, Jessica/E-2812-2015	Hansen, Jacob B/0000-0001-5249-2586; Petersen, Christine/0000-0002-6129-4220; Langberg, Henning/0000-0001-8454-6534; Fredberg, Ulrich/0000-0002-7181-1113; Pingel, Jessica/0000-0002-9977-094X	EU [HEALTH-F2-2011-278373]; Danish Diabetes Academy; Novo Nordisk Foundation	EU(European Commission); Danish Diabetes Academy; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by a grant to JBH from the EU FP7 project DIABAT (HEALTH-F2-2011-278373). MCHP was funded in part by The Danish Diabetes Academy supported by The Novo Nordisk Foundation.	ASTROM M, 1995, CLIN ORTHOP RELAT R, P151; Bastiaansen-Jenniskens YM, 2013, ARTHRITIS RHEUM-US, V65, P2070, DOI 10.1002/art.37996; Bohnsack M, 2005, ARCH ORTHOP TRAUM SU, V125, P592, DOI 10.1007/s00402-005-0796-4; Clockaerts S, 2010, OSTEOARTHR CARTILAGE, V18, P876, DOI 10.1016/j.joca.2010.03.014; Coppack SW, 2001, P NUTR SOC, V60, P349, DOI 10.1079/PNS2001110; Culvenor AG, 2011, SCAND J MED SCI SPOR, V21, pE405, DOI 10.1111/j.1600-0838.2011.01334.x; Dali-Youcef N, 2007, P NATL ACAD SCI USA, V104, P10703, DOI 10.1073/pnas.0611568104; DosRemedios E T, 2000, J Foot Ankle Surg, V39, P194; Fain JN, 2006, VITAM HORM, V74, P443, DOI 10.1016/S0083-6729(06)74018-3; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Fredberg U, 2008, SCAND J MED SCI SPOR, V18, P3, DOI 10.1111/j.1600-0838.2007.00746.x; Gallagher J, 2005, KNEE SURG SPORT TR A, V13, P268, DOI 10.1007/s00167-004-0592-7; Gomez R, 2009, J MOL ENDOCRINOL, V43, P11, DOI 10.1677/JME-08-0131; Hansen JB, 2004, CELL CYCLE, V3, P774; Hart Lawrence, 2011, Clin J Sport Med, V21, P540, DOI 10.1097/01.jsm.0000407929.35973.b9; Hirai S, 2014, AM J PHYSIOL-ENDOC M, V306, pE247, DOI 10.1152/ajpendo.00056.2013; Hoffa A, 1904, J AMER MED ASSOC, V43, P0795; Ioan-Facsinay A, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4422; Jacobs E, 2014, J FOOT ANKLE SURG, V53, P208, DOI 10.1053/j.jfas.2013.12.001; Khan KM, 1999, SPORTS MED, V27, P393, DOI 10.2165/00007256-199927060-00004; KOHN D, 1995, ARCH ORTHOP TRAUM SU, V114, P72, DOI 10.1007/BF00422828; Ly JQ, 2004, AM J ROENTGENOL, V182, P147, DOI 10.2214/ajr.182.1.1820147; MACCONAILL MA, 1950, J BONE JOINT SURG BR, V32, P244, DOI 10.1302/0301-620X.32B2.244; MAGI M, 1991, Italian Journal of Orthopaedics and Traumatology, V17, P211; McLaughlin T, 2014, ARTERIOSCL THROM VAS, V34, P2637, DOI 10.1161/ATVBAHA.114.304636; Murholm M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008458; Nielsen AR, 2008, J CLIN ENDOCR METAB, V93, P4486, DOI 10.1210/jc.2007-2561; Pang J, 2009, CLIN ANAT, V22, P371, DOI 10.1002/ca.20770; Pingel J, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-53; Pingel J, 2013, EUR J APPL PHYSIOL, V113, P2101, DOI 10.1007/s00421-013-2638-3; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Sebastian D, 2009, J LIPID RES, V50, P1789, DOI 10.1194/jlr.M800535-JLR200; Shaw HM, 2007, J ANAT, V211, P436, DOI 10.1111/j.1469-7580.2007.00791.x; Singh VK, 2009, SINGAP MED J, V50, pE189; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Tang CH, 2007, J IMMUNOL, V179, P5483, DOI 10.4049/jimmunol.179.8.5483; Theobald P, 2006, J ANAT, V208, P91, DOI 10.1111/j.1469-7580.2006.00510.x; Toussirot E, 2007, CURR MED CHEM, V14, P1095, DOI 10.2174/092986707780362826; Ushiyama T, 2003, ANN RHEUM DIS, V62, P108, DOI 10.1136/ard.62.2.108; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Witonski D, 1999, KNEE SURG SPORT TR A, V7, P177, DOI 10.1007/s001670050144; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200	42	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127811	10.1371/journal.pone.0127811	http://dx.doi.org/10.1371/journal.pone.0127811			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996876	gold, Green Published, Green Submitted			2022-12-26	WOS:000356444000090
J	Sevigny, JL; Kirouac, LE; Thomas, WK; Ramsdell, JS; Lawlor, KE; Sharifi, O; Grewal, S; Baysdorfer, C; Curr, K; Naimie, AA; Okamoto, K; Murray, JA; Newcomb, JM				Sevigny, Joseph L.; Kirouac, Lauren E.; Thomas, William Kelley; Ramsdell, Jordan S.; Lawlor, Kayla E.; Sharifi, Osman; Grewal, Simarvir; Baysdorfer, Christopher; Curr, Kenneth; Naimie, Amanda A.; Okamoto, Kazufusa; Murray, James A.; Newcomb, James M.			The Mitochondrial Genomes of the Nudibranch Mollusks, Melibe leonina and Tritonia diomedea, and Their Impact on Gastropod Phylogeny	PLOS ONE			English	Article							OPISTHOBRANCHIA MOLLUSCA; EUTHYNEURAN GASTROPODS; MOLECULAR PHYLOGENY; COMPLETE SEQUENCE; GENE ORDER; EVOLUTION; SUPPORTS; ORIGIN; STEPS; 18S	The phylogenetic relationships among certain groups of gastropods have remained unresolved in recent studies, especially in the diverse subclass Opisthobranchia, where nudibranchs have been poorly represented. Here we present the complete mitochondrial genomes of Melibe leonina and Tritonia diomedea (more recently named T. tetraquetra), two nudibranchs from the unrepresented Cladobranchia group, and report on the resulting phylogenetic analyses. Both genomes coded for the typical thirteen protein-coding genes, twenty-two transfer RNAs, and two ribosomal RNAs seen in other species. The twelve-nucleotide deletion previously reported for the cytochrome oxidase 1 gene in several other Melibe species was further clarified as three separate deletion events. These deletions were not present in any opisthobranchs examined in our study, including the newly sequenced M. leonina or T. diomedea, suggesting that these previously reported deletions may represent more recently divergent taxa. Analysis of the secondary structures for all twenty-two tRNAs of both M. leonina and T. diomedea indicated truncated d arms for the two serine tRNAs, as seen in some other heterobranchs. In addition, the serine 1 tRNA in T. diomedea contained an anticodon not yet reported in any other gastropod. For phylogenetic analysis, we used the thirteen protein-coding genes from the mitochondrial genomes of M. leonina, T. diomedea, and seventy-one other gastropods. Phylogenetic analyses were performed for both the class Gastropoda and the subclass Opisthobranchia. Both Bayesian and maximum likelihood analyses resulted in similar tree topologies. In the Opisthobranchia, the five orders represented in our study were monophyletic (Anaspidea, Cephalaspidea, Notaspidea, Nudibranchia, Sacoglossa). In Gastropoda, two of the three traditional subclasses, Opisthobranchia and Pulmonata, were not monophyletic. In contrast, four of the more recently named gastropod clades (Vetigastropoda, Neritimorpha, Caenogastropoda, and Heterobranchia) were all monophyletic, and thus appear to be better classifications for this diverse group.	[Sevigny, Joseph L.; Kirouac, Lauren E.; Lawlor, Kayla E.; Naimie, Amanda A.; Newcomb, James M.] New England Coll, Dept Biol & Hlth Sci, Henniker, NH 03242 USA; [Thomas, William Kelley; Ramsdell, Jordan S.; Okamoto, Kazufusa] Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA; [Sharifi, Osman; Grewal, Simarvir; Baysdorfer, Christopher; Curr, Kenneth; Murray, James A.] Calif State Univ Hayward, Dept Biol Sci, Hayward, CA 94542 USA	University System Of New Hampshire; University of New Hampshire; California State University System; California State University East Bay	Newcomb, JM (corresponding author), New England Coll, Dept Biol & Hlth Sci, Henniker, NH 03242 USA.	jnewcomb@nec.edu		Murray, James/0000-0002-1983-9100	NIH [P20GM103506]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103506] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This publication was made possible by the IDeA Program, NIH Grant No. P20GM103506 (National Institute of General Medical Sciences). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktipis Stephanie W., 2008, P201; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bandyopadhyay PK, 2006, TOXICON, V48, P29, DOI 10.1016/j.toxicon.2006.04.013; BIELER R, 1992, ANNU REV ECOL SYST, V23, P311, DOI 10.1146/annurev.es.23.110192.001523; Boore JL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-182; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 2005, METHOD ENZYMOL, V395, P311, DOI 10.1016/S0076-6879(05)95019-2; Bouchet P, 2005, MALACOLOGIA, V47, P1; Broughton RE, 2001, GENOME RES, V11, P1958, DOI 10.1101/gr.156801; Castro LR, 2010, MOL PHYLOGENET EVOL, V57, P918, DOI 10.1016/j.ympev.2010.08.030; Colgan DJ, 2007, MOL PHYLOGENET EVOL, V42, P717, DOI 10.1016/j.ympev.2006.10.009; Colgan D. J., 2003, Molluscan Research, V23, P123, DOI 10.1071/MR03002; Cunha RL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-210; Dayrat B, 2002, ZOOL J LINN SOC-LOND, V135, P403, DOI 10.1046/j.1096-3642.2002.00018.x; Dayrat B, 2011, MOL PHYLOGENET EVOL, V59, P425, DOI 10.1016/j.ympev.2011.02.014; Gaitan-Espitia JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067299; Espinoza E, 2013, ZOOKEYS, P55, DOI 10.3897/zookeys.316.5452; Gosliner Terrence M., 2003, Proceedings of the California Academy of Sciences, V54, P302; Grande C, 2004, MOL PHYLOGENET EVOL, V33, P378, DOI 10.1016/j.ympev.2004.06.008; Grande C, 2002, MOL BIOL EVOL, V19, P1672, DOI 10.1093/oxfordjournals.molbev.a003990; Grande C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-61; Hassanin A, 2006, MOL PHYLOGENET EVOL, V38, P100, DOI 10.1016/j.ympev.2005.09.012; HASZPRUNAR G, 1988, J MOLLUS STUD, V54, P367, DOI 10.1093/mollus/54.4.367; Jorger KM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-323; Kocot KM, 2013, MOL PHYLOGENET EVOL, V69, P764, DOI 10.1016/j.ympev.2013.07.001; Kurabayashi A, 2000, MOL BIOL EVOL, V17, P266, DOI 10.1093/oxfordjournals.molbev.a026306; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Liu G, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042712, DOI 10.1371/JOURNAL.PONE.0042712]; Martynov AV, 2006, MARINE BRACKISH WATE, P267; Mayden RL, 2009, MOL PHYLOGENET EVOL, V51, P500, DOI 10.1016/j.ympev.2008.12.015; Medina M, 2011, MAR GENOM, V4, P51, DOI 10.1016/j.margen.2010.12.006; Plazzi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027147; Pola M, 2010, MOL PHYLOGENET EVOL, V56, P931, DOI 10.1016/j.ympev.2010.05.003; Ponder WF, 1997, ZOOL J LINN SOC-LOND, V119, P83, DOI 10.1111/j.1096-3642.1997.tb00137.x; REID DG, 1989, PHILOS T R SOC B, V324, P1, DOI 10.1098/rstb.1989.0040; SANKOFF D, 1992, P NATL ACAD SCI USA, V89, P6575, DOI 10.1073/pnas.89.14.6575; Schander C, 2001, SYST BIOL, V50, P136, DOI 10.1080/106351501750107576; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stoger I, 2013, MOL PHYLOGENET EVOL, V69, P376, DOI 10.1016/j.ympev.2012.11.017; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tillier S, 1994, NAUTILUS S, V2, P122; Vonnemann V, 2005, J MOLLUS STUD, V71, P113, DOI 10.1093/mollus/eyi014; White TR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-295; Williams ST, 2014, GENE, V533, P38, DOI 10.1016/j.gene.2013.10.005; Wollscheid E, 1999, MOL PHYLOGENET EVOL, V13, P215, DOI 10.1006/mpev.1999.0664; Wollscheid-Lengeling E, 2001, ORG DIVERS EVOL, V1, P241, DOI 10.1078/1439-6092-00022; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Yamazaki N, 1997, GENETICS, V145, P749; Zapata F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1739; Zhu HC, 2012, MITOCHONDR DNA, V23, P379, DOI 10.3109/19401736.2012.696633	50	18	19	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127519	10.1371/journal.pone.0127519	http://dx.doi.org/10.1371/journal.pone.0127519			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996944	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000073
J	Behrouzvaziri, A; Fu, D; Tan, P; Yoo, Y; Zaretskaia, MV; Rusyniak, DE; Molkov, YI; Zaretsky, DV				Behrouzvaziri, Abolhassan; Fu, Daniel; Tan, Patrick; Yoo, Yeonjoo; Zaretskaia, Maria V.; Rusyniak, Daniel E.; Molkov, Yaroslav I.; Zaretsky, Dmitry V.			Orexinergic Neurotransmission in Temperature Responses to Methamphetamine and Stress: Mathematical Modeling as a Data Assimilation Approach	PLOS ONE			English	Article							BODY-TEMPERATURE; 3,4-METHYLENEDIOXYMETHAMPHETAMINE ECSTASY; DORSOMEDIAL HYPOTHALAMUS; RAPHE PALLIDUS; AMPHETAMINE; NEURONS; HYPERTHERMIA; RECEPTOR; RAT; STIMULATION	Experimental Data Orexinergic neurotransmission is involved in mediating temperature responses to methamphetamine (Meth). In experiments in rats, SB-334867 (SB), an antagonist of orexin receptors (OX1R), at a dose of 10 mg/kg decreases late temperature responses (t>60 min) to an intermediate dose of Meth (5 mg/kg). A higher dose of SB (30 mg/kg) attenuates temperature responses to low dose (1 mg/kg) of Meth and to stress. In contrast, it significantly exaggerates early responses (t<60 min) to intermediate and high doses (5 and 10 mg/kg) of Meth. As pretreatment with SB also inhibits temperature response to the stress of injection, traditional statistical analysis of temperature responses is difficult. Mathematical Modeling We have developed a mathematical model that explains the complexity of temperature responses to Meth as the interplay between excitatory and inhibitory nodes. We have extended the developed model to include the stress of manipulations and the effects of SB. Stress is synergistic with Meth on the action on excitatory node. Orexin receptors mediate an activation of on both excitatory and inhibitory nodes by low doses of Meth, but not on the node activated by high doses (HD). Exaggeration of early responses to high doses of Meth involves disinhibition: low dose of SB decreases tonic inhibition of HD and lowers the activation threshold, while the higher dose suppresses the inhibitory component. Using a modeling approach to data assimilation appears efficient in separating individual components of complex response with statistical analysis unachievable by traditional data processing methods.	[Behrouzvaziri, Abolhassan; Yoo, Yeonjoo; Molkov, Yaroslav I.] Indiana Univ Purdue Univ, Dept Math Sci, Indianapolis, IN 46202 USA; [Fu, Daniel] Pk Tudor Sch, Indianapolis, IN 46240 USA; [Tan, Patrick] Carmel High Sch, Carmel, IN 46032 USA; [Zaretskaia, Maria V.; Rusyniak, Daniel E.; Zaretsky, Dmitry V.] Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington	Zaretsky, DV (corresponding author), Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA.	dzaretsk@iu.edu	Molkov, Yaroslav/C-6336-2012; Zaretsky, Dmitry/AAK-1236-2021	Molkov, Yaroslav/0000-0002-0862-1974; Fu, Daniel/0000-0002-2500-2577; Rusyniak, Daniel/0000-0002-6199-0840; Zaretsky, Dmitry/0000-0003-2454-8620	National Institute on Drug Abuse of the NIH [R01DA026867]; IM2CS-GEIRE grant; RSFG grant; National Center for Research Resources, of the NIH [C06 RR015481-010]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026867] Funding Source: NIH RePORTER	National Institute on Drug Abuse of the NIH; IM2CS-GEIRE grant; RSFG grant; National Center for Research Resources, of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Research reported in this publication was supported by the National Institute on Drug Abuse of the NIH under award number R01DA026867 to DER, and IM2CS-GEIRE and RSFG grants to YIM and DVZ. Furthermore, this work was conducted in a facility constructed under support from the National Center for Research Resources, of the NIH under award number C06 RR015481-010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baimel C, 2015, BRIT J PHARMACOL, V172, P334, DOI 10.1111/bph.12639; Blessing WW, 2006, NEUROSCIENCE, V141, P2067, DOI 10.1016/j.neuroscience.2006.05.050; Blessing WW, 2003, J NEUROSCI, V23, P6385; Cruickshank CC, 2009, ADDICTION, V104, P1085, DOI 10.1111/j.1360-0443.2009.02564.x; De Letter EA, 2006, MED SCI LAW, V46, P37, DOI 10.1258/rsmmsl.46.1.37; DiMicco JA, 2007, AM J PHYSIOL-REG I, V292, pR47, DOI 10.1152/ajpregu.00498.2006; DiMicco JA, 2006, AUTON NEUROSCI-BASIC, V126, P106, DOI 10.1016/j.autneu.2006.02.010; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; Fadel J, 2002, J NEUROSCI, V22, P6742; Feigin A. M., 2001, Radiophysics and Quantum Electronics, V44, P348, DOI 10.1023/A:1017988912081; GINSBERG MD, 1970, ANN INTERN MED, V73, P81, DOI 10.7326/0003-4819-73-1-81; Johnson PL, 2010, NAT MED, V16, P111, DOI 10.1038/nm.2075; JORDAN SC, 1960, BRIT MED J, V2, P844, DOI 10.1136/bmj.2.5202.844; KALANT H, 1975, CAN MED ASSOC J, V112, P299; KENDRICK WC, 1977, ANN INTERN MED, V86, P381, DOI 10.7326/0003-4819-86-4-381; Kerman IA, 2006, J NEUROSCI, V26, P3423, DOI 10.1523/JNEUROSCI.5283-05.2006; Kerman IA, 2007, J COMP NEUROL, V505, P586, DOI 10.1002/cne.21511; Khoo SYS, 2014, CNS DRUGS, V28, P713, DOI 10.1007/s40263-014-0179-x; KOJIMA T, 1984, FORENSIC SCI INT, V24, P87, DOI 10.1016/0379-0738(84)90156-7; Kukkonen JP, 2014, BRIT J PHARMACOL, V171, P314, DOI 10.1111/bph.12324; Loskutov EM, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.066214; Molkov YI, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036215; Molkov Yaroslav I, 2014, Temperature (Austin), V1, P154, DOI 10.4161/2167549X.2014.968483; Molkov YI, 2014, AM J PHYSIOL-REG I, V306, pR552, DOI 10.1152/ajpregu.00365.2013; Monda M, 2007, REGUL PEPTIDES, V139, P39, DOI 10.1016/j.regpep.2006.10.002; Mukhin DN, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036211; Myles BJ, 2008, PSYCHOPHARMACOLOGY, V198, P301, DOI 10.1007/s00213-007-1061-z; Nishino S, 2010, EXPERT OPIN EMERG DR, V15, P139, DOI 10.1517/14728210903559852; O'Connor AD, 2005, MED CLIN N AM, V89, P1343, DOI 10.1016/j.mcna.2005.06.010; Pedersen NP, 2001, J NEUROSCI, V21, P8648, DOI 10.1523/JNEUROSCI.21-21-08648.2001; Peyron C, 1998, J NEUROSCI, V18, P9996; Rusyniak DE, 2008, BRAIN RES, V1226, P116, DOI 10.1016/j.brainres.2008.06.011; Rusyniak DE, 2012, PHYSIOL BEHAV, V107, P743, DOI 10.1016/j.physbeh.2012.02.010; Sakurai T, 2013, CURR OPIN NEUROBIOL, V23, P760, DOI 10.1016/j.conb.2013.04.007; Samson WK, 2007, AM J PHYSIOL-REG I, V292, pR382, DOI 10.1152/ajpregu.00496.2006; Samson WK, 1999, BRAIN RES, V831, P248, DOI 10.1016/S0006-8993(99)01457-2; Shirasaka T, 2002, REGUL PEPTIDES, V104, P91, DOI 10.1016/S0167-0115(01)00352-4; Sprague JE, 2004, BIOCHEM PHARMACOL, V68, P1339, DOI 10.1016/j.bcp.2004.03.049; Tupone D, 2011, J NEUROSCI, V31, P15944, DOI 10.1523/JNEUROSCI.3909-11.2011; UNODC, 2008, ANN REP 2008; Verschraagen M, 2007, FORENSIC SCI INT, V170, P163, DOI 10.1016/j.forsciint.2007.03.030; WELLMAN PJ, 1983, RES COMMUN CHEM PATH, V41, P173; Westover AN, 2008, DRUG ALCOHOL DEPEN, V96, P49, DOI 10.1016/j.drugalcdep.2008.01.027; Yoshimichi G, 2001, EXP BIOL MED, V226, P468, DOI 10.1177/153537020122600513; Zaretsky DV, 2003, AM J PHYSIOL-REG I, V285, pR110, DOI 10.1152/ajpregu.00016.2003	45	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126719	10.1371/journal.pone.0126719	http://dx.doi.org/10.1371/journal.pone.0126719			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993564	Green Published, Green Submitted, gold			2022-12-26	WOS:000354921400073
J	Frades, I; Andreasson, E; Mato, JM; Alexandersson, E; Matthiesen, R; Martinez-Chantar, ML				Frades, Itziar; Andreasson, Erik; Maria Mato, Jose; Alexandersson, Erik; Matthiesen, Rune; Martinez-Chantar, Ma Luz			Integrative Genomic Signatures Of Hepatocellular Carcinoma Derived from Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							GENE-EXPRESSION; LIPID-ACCUMULATION; HUMAN HEPATOCYTES; DOWN-REGULATION; STEATOHEPATITIS; STEATOSIS; BOOTSTRAP; MICE; PROGRESSION; PHYLOGENIES	Nonalcoholic fatty liver disease (NAFLD) is a risk factor for Hepatocellular carcinoma (HCC), but he transition from NAFLD to HCC is poorly understood. Feature selection algorithms in human and genetically modified mice NAFLD and HCC microarray data were applied to generate signatures of NAFLD progression and HCC differential survival. These signatures were used to study the pathogenesis of NAFLD derived HCC and explore which subtypes of cancers that can be investigated using mouse models. Our findings show that: (I) HNF4 is a common potential transcription factor mediating the transcription of NAFLD progression genes (II) mice HCC derived from NAFLD co-cluster with a less aggressive human HCC subtype of differential prognosis and mixed etiology (III) the HCC survival signature is able to correctly classify 95% of the samples and gives Fgf20 and Tgfb1i1 as the most robust genes for prediction (IV) the expression values of genes composing the signature in an independent human HCC dataset revealed different HCC subtypes showing differences in survival time by a Logrank test. In summary, we present marker signatures for NAFLD derived HCC molecular pathogenesis both at the gene and pathway level.	[Frades, Itziar; Maria Mato, Jose; Martinez-Chantar, Ma Luz] Ctr Invest Cooperat Biociencias, CIC BioGUNE, Metabol Unit, Derio, Bizkaia, Spain; [Frades, Itziar; Andreasson, Erik; Alexandersson, Erik] Swedish Univ Agr Sci, Dept Plant Protect Biol, Alnarp, Sweden; [Matthiesen, Rune] Natl Hlth Inst Doutor Ricardo Jorge, Dept Human Genet, Lisbon, Portugal	CIC bioGUNE; Swedish University of Agricultural Sciences; Instituto Nacional de Saude Dr. Ricardo Jorge	Frades, I (corresponding author), Ctr Invest Cooperat Biociencias, CIC BioGUNE, Metabol Unit, Bizkaia Technol Pk, Derio, Bizkaia, Spain.	maria.iciar.frades@slu.se	Chantar, Maria Luz Martinez/F-5190-2011; MATO, JOSE/A-5187-2011; Frades, Itziar/AAB-6041-2019; Matthiesen, Rune/AAF-2167-2020	Chantar, Maria Luz Martinez/0000-0002-6446-9911; MATO, JOSE/0000-0003-1264-3153; Frades, Itziar/0000-0003-2968-2984; Matthiesen, Rune/0000-0002-6353-2616; Andreasson, Erik/0000-0003-0666-7204	National Institutes of Health [AT-1576]; Fundacion "La Caixa"; Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas; ETORTEK; Educacion Gobierno Vasco; Proyectos en Investigacion en Salud [PI11/01588]; Swedish foundation for strategic environmental research [Mistra Biotech]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacion "La Caixa"(La Caixa Foundation); Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas; ETORTEK; Educacion Gobierno Vasco; Proyectos en Investigacion en Salud; Swedish foundation for strategic environmental research [Mistra Biotech]	This study was supported by grants from National Institutes of Health [AT-1576 to M.L.M.-C]; Fundacion "La Caixa"; Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas; ETORTEK-2011 to M.L.M.-C; Educacion Gobierno Vasco 2011 to M.L.M.-C; Proyectos en Investigacion en Salud [PI11/01588 to M.L.M.-C]; and Swedish foundation for strategic environmental research [Mistra Biotech]. Funding for open access charge: Proyectos en Investigacion en Salud [PI11/01588 to M.L.M.-C]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek J.H., 1997, KOREAN J PHYSIOL PHA, V107, P107; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bonzo JA, 2012, J BIOL CHEM, V2; Cogliano VJ, 2011, J NATL CANC I, P103; Copaci Ionel, 2006, J Gastrointestin Liver Dis, V15, P363; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; De Preter K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn114; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Ding C, 2003, J BIOINFORMATICS COM; Donato MT, 2006, DRUG METAB DISPOS, V34, P1556, DOI 10.1124/dmd.106.009670; Dunne K, 2002, J MACHINE LEARNING R; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; FELSENSTEIN J, 1993, SYST BIOL, V42, P193, DOI 10.2307/2992541; FISHER RA, 1959, STAT METHODS SCI INF; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Hayhurst GP, 2001, MOL CELLULAR BIOL, V21; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Huang S, ADV BIOINFORMATICS C, V3, pP247; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson KA, 2008, BIOCHEM SOC T, V36, P1262, DOI 10.1042/BST0361262; Jayasooriya AP, 2008, P NATL ACAD SCI USA, V105, P6531, DOI 10.1073/pnas.0802690105; Jinjuvadia R, 2014, J CLIN GASTROENTEROL, V48; Jou J, 2008, SEMIN LIVER DIS, V28, P370, DOI 10.1055/s-0028-1091981; Jover R, 2001, HEPATOLOGY, V33, P668, DOI 10.1053/jhep.2001.22176; Kalousis A, 2007, KNOWL INF SYST, V12, P95, DOI 10.1007/s10115-006-0040-8; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; La Vecchia C, 1998, EUROPEAN J CANC PREV, P4; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Lee YJ, 2012, P NATL ACAD SCI USA, V109, P13656, DOI 10.1073/pnas.1203218109; Li G, 2009, FEDERATION AM SOC EX, V23, P117; Liang Y, 2012, HEPATOLOGY, V56, P1409, DOI 10.1002/hep.25788; Liu Zhenqi, 2007, Curr Diab Rep, V7, P34, DOI 10.1007/s11892-007-0007-5; Lu SC, 2001, P NATL ACAD SCI USA, V98, P5560, DOI 10.1073/pnas.091016398; Martinez-Chantar ML, 2008, HEPATOLOGY; Meligi AA, 2004, SCI MED J, V16; MILLS JJ, 1995, CANCER RES, V55, P979; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Ning BF, 2010, CANC RES; Olson JM, 2004, TRENDS MOL MED, V10, P125, DOI 10.1016/j.molmed.2004.01.007; Panasiuk A, 2006, WORLD J GASTROENTERO, V12, P6198, DOI 10.3748/wjg.v12.i38.6198; Park PJ, 2001, PACIFIC S BIOCOMPUTI; Parkin DM, 2011, BRIT J CANCER, V105, pS77, DOI 10.1038/bjc.2011.489; Parkin DM, 2006, INT J CANC, P118; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; Pavel K, 2008, FEATURE SELECTION ST; Rubio A, 2007, J HEPATOL, V46, P708, DOI 10.1016/j.jhep.2006.10.021; Sanderson MJ, 2000, SYST BIOL, V49, P671, DOI 10.1080/106351500750049761; Sayers EW, 2008, DATABASE RESOURCES N; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Shibata K, 2008, ONCOLOGY-BASEL, V74, P104, DOI 10.1159/000139138; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Shimodaira H, 2004, ANN STAT, V32, P2616, DOI 10.1214/009053604000000823; Shiota G, 2007, J GASTROEN HEPATOL, V22, pS101, DOI 10.1111/j.1440-1746.2006.04668.x; Silverman GA, 2005, OVALBUMIN SERPINS; Stickel F, 2010, GUT, V59, P1303, DOI 10.1136/gut.2009.199661; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Suzuki R, 2004, 15 INT C GEN INF; Szabo G, 2005, ALCOHOL CLIN EXP RES, V29, p140S, DOI 10.1097/01.alc.0000189287.83544.33; Turati F, 2014, ANN ONCOLOGY; Varela-Rey M, 2010, HEPATOLOGY, V52; Vecchini A, 2004, J LIPID RES, V45, P308, DOI 10.1194/jlr.M300396-JLR200; Videla LA, 2004, FREE RADICAL BIO MED, V37, P1499, DOI 10.1016/j.freeradbiomed.2004.06.033; Vinciguerra M, 2008, GASTROENTEROLOGY, V134, P268, DOI 10.1053/j.gastro.2007.10.010; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; Yang K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-228; Yang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021481; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Yu JX, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-182; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; ZHARKIKH A, 1992, MOL BIOL EVOL, V9, P1119	74	46	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0124544	10.1371/journal.pone.0124544	http://dx.doi.org/10.1371/journal.pone.0124544			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993042	Green Published, Green Submitted, gold			2022-12-26	WOS:000354921400019
J	Jankowiak, W; Kruszewski, K; Flachsbarth, K; Skevas, C; Richard, G; Ruther, K; Braulke, T; Bartsch, U				Jankowiak, Wanda; Kruszewski, Katharina; Flachsbarth, Kai; Skevas, Christos; Richard, Gisbert; Ruether, Klaus; Braulke, Thomas; Bartsch, Udo			Sustained Neural Stem Cell-Based Intraocular Delivery of CNTF Attenuates Photoreceptor Loss in the nclf Mouse Model of Neuronal Ceroid Lipofuscinosis	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; LYSOSOMAL STORAGE DISEASE; RAT MODEL; RETINAL DEGENERATION; MEMBRANE-PROTEIN; PROGENITOR CELLS; GENE-THERAPY; OUTER SEGMENTS; ANIMAL-MODELS; MUTANT MICE	A sustained intraocular administration of neurotrophic factors is among the strategies aimed at establishing treatments for currently untreatable degenerative retinal disorders. In the present study we have analyzed the neuroprotective effects of a continuous neural stem (NS) cell-based intraocular delivery of ciliary neurotrophic factor (CNTF) on photoreceptor cells in the nclf mouse, an animal model of the neurodegenerative lysosomal storage disorder variant late infantile neuronal ceroid lipofuscinosis (vLINCL). To this aim, we genetically modified adherently cultivated NS cells with a polycistronic lentiviral vector encoding a secretable variant of CNTF together with a Venus reporter gene (CNTF-NS cells). NS cells for control experiments (control-NS cells) were modified with a vector encoding the reporter gene tdTomato. Clonal CNTF-NS and control-NS cell lines were established using fluorescent activated cell sorting and intravitreally grafted into 14 days old nclf mice at the onset of retinal degeneration. The grafted cells preferentially differentiated into astrocytes that were attached to the posterior side of the lenses and the vitreal side of the retinas and stably expressed the transgenes for at least six weeks, the latest post-transplantation time point analyzed. Integration of donor cells into host retinas, ongoing proliferation of grafted cells or adverse effects of the donor cells on the morphology of the host eyes were not observed. Quantitative analyses of host retinas two, four and six weeks after cell transplantation revealed the presence of significantly more photoreceptor cells in eyes with grafted CNTF-NS cells than in eyes with grafted control-NS cells. This is the first demonstration that a continuous intraocular administration of a neurotrophic factor attenuates retinal degeneration in an animal model of neuronal ceroid lipofuscinosis.	[Jankowiak, Wanda; Kruszewski, Katharina; Flachsbarth, Kai; Skevas, Christos; Richard, Gisbert; Bartsch, Udo] Univ Med Ctr Hamburg Eppendorf, Dept Ophthalmol, Hamburg, Germany; [Ruether, Klaus] Sankt Gertrauden Krankenhaus, Dept Ophthalmol, Berlin, Germany; [Braulke, Thomas] Childrens Hosp, Univ Med Ctr Hamburg Eppendorf, Dept Biochem, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Bartsch, U (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Ophthalmol, Hamburg, Germany.	ubartsch@uke.uni-hamburg.de	Braulke, Thomas/AAV-9121-2020	Braulke, Thomas/0000-0002-2336-8532	European Union Seventh Framework Programme (FP7) [281234]	European Union Seventh Framework Programme (FP7)	This work was supported by the European Union Seventh Framework Programme (FP7/2007-2013) under Grant 281234 to UB (http://ec.europa.eu/research/fp7/index_en.cfm).	Ajmone-Cat MA, 2012, J NEUROSCI RES, V90, P575, DOI 10.1002/jnr.22783; Anderson GW, 2013, BBA-MOL BASIS DIS, V1832, P1807, DOI 10.1016/j.bbadis.2012.11.014; Arsov T, 2011, AM J HUM GENET, V88, P566, DOI 10.1016/j.ajhg.2011.04.004; Banin E, 2006, STEM CELLS, V24, P246, DOI 10.1634/stemcells.2005-0009; Bartsch U, 2013, INVEST OPHTH VIS SCI, V54, P6952, DOI 10.1167/iovs.13-12945; Bauer S, 2007, NAT REV NEUROSCI, V8, P221, DOI 10.1038/nrn2054; Birch DG, 2013, AM J OPHTHALMOL, V156, P283, DOI 10.1016/j.ajo.2013.03.021; Bond M, 2013, BBA-MOL BASIS DIS, V1832, P1842, DOI 10.1016/j.bbadis.2013.01.009; Bronson RT, 1998, AM J MED GENET, V77, P289, DOI 10.1002/(SICI)1096-8628(19980526)77:4<289::AID-AJMG8>3.0.CO;2-I; BRONSON RT, 1993, ANN NEUROL, V33, P381, DOI 10.1002/ana.410330408; Buch PK, 2007, CURR GENE THER, V7, P434, DOI 10.2174/156652307782793531; Bush RA, 2004, INVEST OPHTH VIS SCI, V45, P2420, DOI 10.1167/iovs.03-1342; CHANG B, 1994, INVEST OPHTH VIS SCI, V35, P1071; Jin CY, 2007, ACTA PHARMACOL SIN, V28, P1645, DOI 10.1111/j.1745-7254.2007.00651.x; Chong NHV, 1999, INVEST OPHTH VIS SCI, V40, P1298; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Cuenca N, 2013, INVEST OPHTH VIS SCI, V54, P6745, DOI 10.1167/iovs.13-12860; Ebert S, 2009, J NEUROCHEM, V110, P1863, DOI 10.1111/j.1471-4159.2009.06286.x; Flachsbarth K, 2014, INVEST OPHTH VIS SCI, V55, P7029, DOI 10.1167/iovs.14-15266; Gamm DM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000338; Gao HL, 2002, AM J HUM GENET, V70, P324, DOI 10.1086/338190; Getty AL, 2011, CELL MOL LIFE SCI, V68, P453, DOI 10.1007/s00018-010-0468-6; Glaser T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000298; Gregory-Evans K, 2009, MOL VIS, V15, P962; Griffey M, 2005, MOL THER, V12, P413, DOI 10.1016/j.ymthe.2005.04.018; Haltia M, 2013, BBA-MOL BASIS DIS, V1832, P1795, DOI 10.1016/j.bbadis.2012.08.012; Hawkins-Salsbury JA, 2013, BBA-MOL BASIS DIS, V1832, P1906, DOI 10.1016/j.bbadis.2013.05.026; Heine C, 2004, J BIOL CHEM, V279, P22347, DOI 10.1074/jbc.M400643200; Inoue Y, 2007, EXP EYE RES, V85, P234, DOI 10.1016/j.exer.2007.04.007; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Jung GL, 2013, STEM CELL TRANSL MED, V2, P1001, DOI 10.5966/sctm.2013-0013; Jung KK, 2006, LIFE SCI, V79, P2022, DOI 10.1016/j.lfs.2006.06.048; Kauper K, 2012, INVEST OPHTH VIS SCI, V53, P7484, DOI 10.1167/iovs.12-9970; Kohan R, 2011, CURR PHARM BIOTECHNO, V12, P867, DOI 1389-2010/11 $58.00+.00; Kollmann K, 2013, BBA-MOL BASIS DIS, V1832, P1866, DOI 10.1016/j.bbadis.2013.01.019; Kousi M, 2012, HUM MUTAT, V33, P42, DOI 10.1002/humu.21624; Kurze AK, 2010, HUM MUTAT, V31, pE1163, DOI 10.1002/humu.21184; Lawrence JM, 2004, INVEST OPHTH VIS SCI, V45, P267, DOI 10.1167/iovs.03-0093; Lawrence JM, 2000, INVEST OPHTH VIS SCI, V41, P518; Li YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009495; Liang FQ, 2001, MOL THER, V4, P461, DOI 10.1006/mthe.2001.0473; Lonka L, 2000, HUM MOL GENET, V9, P1691, DOI 10.1093/hmg/9.11.1691; Lu B, 2013, TRANSL VIS SCI TECHN, V2, DOI 10.1167/tvst.2.1.1; Machalinska A, 2013, INVEST OPHTH VIS SCI, V54, P8292, DOI 10.1167/iovs.13-12221; McGill TJ, 2007, INVEST OPHTH VIS SCI, V48, P5756, DOI 10.1167/iovs.07-0054; McGill TJ, 2012, EUR J NEUROSCI, V35, P468, DOI 10.1111/j.1460-9568.2011.07970.x; MESSER A, 1993, EXP EYE RES, V57, P637, DOI 10.1006/exer.1993.1169; Meyer JS, 2006, STEM CELLS, V24, P274, DOI 10.1634/stemcells.2005-0059; Mirza M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075963; Mole SE, 2004, EXP CELL RES, V298, P399, DOI 10.1016/j.yexcr.2004.04.042; Morgan JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078694; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Ranta S, 1999, NAT GENET, V23, P233, DOI 10.1038/13868; Schlichtenbrede FC, 2003, GENE THER, V10, P523, DOI 10.1038/sj.gt.3301929; Schulz A, 2013, BBA-MOL BASIS DIS, V1832, P1801, DOI 10.1016/j.bbadis.2013.04.008; Seigel GM, 2005, EYE, V19, P1306, DOI 10.1038/sj.eye.6701770; Shacka JJ, 2012, BRAIN RES BULL, V88, P43, DOI 10.1016/j.brainresbull.2012.03.003; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; Talcott KE, 2011, INVEST OPHTH VIS SCI, V52, P2219, DOI 10.1167/iovs.10-6479; Tao W, 2002, INVEST OPHTH VIS SCI, V43, P3292; Thelen M, 2012, J NEUROSCI RES, V90, P568, DOI 10.1002/jnr.22773; Tzameret A, 2014, EXP EYE RES, V118, P135, DOI 10.1016/j.exer.2013.10.023; Unsicker K, 2013, CELL TISSUE RES, V353, P205, DOI 10.1007/s00441-013-1585-y; Van Hoffelen SJ, 2003, INVEST OPHTH VIS SCI, V44, P426, DOI 10.1167/iovs.02-0269; Wang SM, 2008, INVEST OPHTH VIS SCI, V49, P3201, DOI 10.1167/iovs.08-1831; Wang SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009200; Warrier V, 2013, BBA-MOL BASIS DIS, V1832, P1827, DOI 10.1016/j.bbadis.2013.03.017; Wen R, 2006, J NEUROSCI, V26, P13523, DOI 10.1523/JNEUROSCI.4021-06.2006; Wen R, 2012, PROG RETIN EYE RES, V31, P136, DOI 10.1016/j.preteyeres.2011.11.005; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wheeler RB, 2002, AM J HUM GENET, V70, P537, DOI 10.1086/338708; Wong AMS, 2010, BIOCHEM SOC T, V38, P1484, DOI 10.1042/BST0381484; Young MJ, 2000, MOL CELL NEUROSCI, V16, P197, DOI 10.1006/mcne.2000.0869; Zhang K, 2011, P NATL ACAD SCI USA, V108, P6241, DOI 10.1073/pnas.1018987108; Zhang Y, 2010, INVEST OPHTH VIS SCI, V51, P3742, DOI 10.1167/iovs.08-3314	76	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127204	10.1371/journal.pone.0127204	http://dx.doi.org/10.1371/journal.pone.0127204			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992714	gold, Green Published, Green Submitted			2022-12-26	WOS:000354921400102
J	Liu, CC; Lai, CY; Yen, WF; Lin, YH; Chang, HH; Tai, TS; Lu, YJ; Tsao, HW; Ho, IC; Miaw, SC				Liu, Chih-Chun; Lai, Chen-Yen; Yen, Wei-Feng; Lin, Yu-Hsien; Chang, Hui-Hsin; Tai, Tzong-Shyuan; Lu, Yu-Jung; Tsao, Hsiao-Wei; Ho, I-Cheng; Miaw, Shi-Chuen			Reciprocal Regulation of C-Maf Tyrosine Phosphorylation by Tec and Ptpn22	PLOS ONE			English	Article							T-CELLS; EXPRESSION; KINASE; DIFFERENTIATION; PHOSPHATASE; DOMAIN; IDENTIFICATION; PROMOTE; IL-21; ICOS	C-Maf plays an important role in regulating cytokine production in T-H cells. Its transactivation of IL-4 is optimized by phosphorylation at Tyr21, Tyr92, and Tyr131. However, the molecular mechanism regulating its tyrosine phosphorylation remains unknown. In this study, we demonstrate that Tec kinase family member Tec, but not Rlk or Itk, is a tyrosine kinase of c-Maf and that Tec enhances c-Maf-dependent IL-4 promoter activity. This effect of Tec is counteracted by Ptpn22, which physically interacts with and facilitates tyrosine dephosphorylation of c-Maf thereby attenuating its transcriptional activity. We further show that phosphorylation of Tyr21/92/131 of c-Maf is also critical for its recruitment to the IL-21 promoter and optimal production of this cytokine by T(H)17 cells. Thus, manipulating tyrosine phosphorylation of c-Maf through its kinases and phosphatases can have significant impact on T-H cell-mediated immune responses.	[Liu, Chih-Chun; Lai, Chen-Yen; Yen, Wei-Feng; Lin, Yu-Hsien; Lu, Yu-Jung; Tsao, Hsiao-Wei; Miaw, Shi-Chuen] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan; [Chang, Hui-Hsin; Tai, Tzong-Shyuan; Ho, I-Cheng] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy,Dept Med, Boston, MA USA	National Taiwan University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Miaw, SC (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan.	smiaw@ntu.edu.tw		MIAW, SHI-CHUEN/0000-0003-1347-9367	Ministry of Science and Technology (MOST) [103-2320-B-002 -035]; National Health Research Institutes [NHRI-EX100-9941SI]; Excellent translational Medicine Research of NTUCM; Excellent translational Medicine Research of NTUH; Department of Defense, USA [W81XWH-11-1-0492]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); National Health Research Institutes(National Health Research Institutes, Japan); Excellent translational Medicine Research of NTUCM; Excellent translational Medicine Research of NTUH; Department of Defense, USA(United States Department of Defense)	This work is supported by grants from Ministry of Science and Technology (MOST 103-2320-B-002 -035), National Health Research Institutes (NHRI-EX100-9941SI) and Excellent translational Medicine Research of NTUCM and NTUH to SCM. Additional funding comes from an award (W81XWH-11-1-0492) from the Department of Defense, USA to ICH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ministry of Science and Technology: http://www.most.gov.tw/. National Health Research Institutes: http://english.nhri.org.tw/NHRI_WEB/nhriw001Action.do.	Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Boucheron N, 2012, INT REV IMMUNOL, V31, P133, DOI 10.3109/08830185.2012.664798; Boucheron N, 2010, J IMMUNOL, V185, P5111, DOI 10.4049/jimmunol.1001734; Chang HH, 2013, J IMMUNOL, V191, P2134, DOI 10.4049/jimmunol.1203363; Chang HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033067; Chung SA, 2007, AUTOIMMUNITY, V40, P582, DOI 10.1080/08916930701510848; Davidson D, 2010, IMMUNITY, V33, P167, DOI 10.1016/j.immuni.2010.08.001; Ghose R, 2001, NAT STRUCT BIOL, V8, P998, DOI 10.1038/nsb1101-998; Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; HU Q, 1995, J BIOL CHEM, V270, P1928, DOI 10.1074/jbc.270.4.1928; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; Lai CY, 2012, J IMMUNOL, V189, P1545, DOI 10.4049/jimmunol.1200405; Lin BS, 2010, EUR J IMMUNOL, V40, P1174, DOI 10.1002/eji.200939788; MATTHEWS RJ, 1992, MOL CELL BIOL, V12, P2396, DOI 10.1128/MCB.12.5.2396; Miller AT, 2004, IMMUNITY, V21, P67, DOI 10.1016/j.immuni.2004.06.009; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Rutz S, 2011, NAT IMMUNOL, V12, P1238, DOI 10.1038/ni.2134; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Schaeffer EM, 2001, NAT IMMUNOL, V2, P1183, DOI 10.1038/ni734; Tanaka S, 2014, J EXP MED, V211, P1857, DOI 10.1084/jem.20130791; Tomlinson MG, 2004, MOL CELL BIOL, V24, P2455, DOI 10.1128/MCB.24.6.2455-2466.2004; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Xu JN, 2009, J IMMUNOL, V182, P6226, DOI 10.4049/jimmunol.0900123; Yang WC, 2001, J IMMUNOL, V166, P387, DOI 10.4049/jimmunol.166.1.387; Yang WC, 1999, J BIOL CHEM, V274, P607, DOI 10.1074/jbc.274.2.607	32	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127617	10.1371/journal.pone.0127617	http://dx.doi.org/10.1371/journal.pone.0127617			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993510	Green Submitted, gold, Green Published			2022-12-26	WOS:000354921400127
J	Rudolph, DL; Sullivan, V; Owen, SM; Curtis, KA				Rudolph, Donna L.; Sullivan, Vickie; Owen, S. Michele; Curtis, Kelly A.			Detection of Acute HIV-1 Infection by RT-LAMP	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; COMBO RAPID TEST; REVERSE-TRANSCRIPTION; VISUAL DETECTION; UNITED-STATES; VIRUS; DIAGNOSIS; SEROCONVERSION; IMMUNOASSAY; PERFORMANCE	A rapid, cost-effective diagnostic test for the detection of acute HIV-1 infection is highly desired. Isothermal amplification techniques, such as reverse-transcription loop-mediated isothermal amplification (RT-LAMP), exhibit characteristics that are ideal for the development of a rapid nucleic acid amplification test (NAAT) because they are quick, easy to perform and do not require complex, dedicated equipment and laboratory space. In this study, we assessed the ability of the HIV-1 RT-LAMP assay to detect acute HIV infection as compared to a representative rapid antibody test and several FDA-approved laboratory-based assays. The HIV-1 RT-LAMP assay detected seroconverting individuals one to three weeks earlier than a rapid HIV antibody test and up to two weeks earlier than a lab-based antigen/antibody (Ag/Ab) combo enzyme immunoassay (EIA). RT-LAMP was not as sensitive as a lab-based qualitative RNA assay, which could be attributed to the significantly smaller nucleic acid input volume. To our knowledge, this is the first demonstration of detecting acute HIV infection using the RT-LAMP assay. The availability of a rapid NAAT, such as the HIV-1 RT-LAMP assay, at the point of care (POC) or in laboratories that do not have access to large platform NAAT could increase the percentage of individuals who receive an acute HIV infection status or confirmation of their HIV status, while immediately linking them to counseling and medical care. In addition, early knowledge of HIV status could lead to reduced high-risk behavior at a time when individuals are at a higher risk for transmitting the virus.	[Rudolph, Donna L.; Sullivan, Vickie; Owen, S. Michele; Curtis, Kelly A.] Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Hepatitis STD & TB Prevent, Div HIV AIDS Prevent, Branch Lab, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Curtis, KA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr HIV AIDS Hepatitis STD & TB Prevent, Div HIV AIDS Prevent, Branch Lab, Atlanta, GA 30329 USA.	czv2@cdc.gov						APHL C, 2014, LAB TEST DIAGN HIV I; Beelaert G, 2010, J VIROL METHODS, V168, P218, DOI 10.1016/j.jviromet.2010.06.002; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Branson BM, 2012, J INFECT DIS, V205, P521, DOI 10.1093/infdis/jir793; Brauer M, 2013, J VIROL METHODS, V189, P180, DOI 10.1016/j.jviromet.2013.01.017; BUTERA ST, 1991, J VIROL, V65, P4645, DOI 10.1128/JVI.65.9.4645-4653.1991; Centers for Disease Control and Prevention (US), 2013, HIV SURV REP, V18, P1; Chetty V, 2012, J CLIN VIROL, V54, P180, DOI 10.1016/j.jcv.2012.02.021; Curtis KA, 2008, J VIROL METHODS, V151, P264, DOI 10.1016/j.jviromet.2008.04.011; Curtis KA, 2014, J CLIN MICROBIOL, V52, P2674, DOI 10.1128/JCM.00935-14; Curtis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031432; Curtis KA, 2009, J MED VIROL, V81, P966, DOI 10.1002/jmv.21490; Faraoni S, 2013, J CLIN VIROL, V57, P84, DOI 10.1016/j.jcv.2013.01.007; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Fox J, 2011, SEX TRANSM INFECT, V87, P178, DOI 10.1136/sti.2010.042564; Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; Iwamoto T, 2003, J CLIN MICROBIOL, V41, P2616, DOI 10.1128/JCM.41.6.2616-2622.2003; Jangam SR, 2013, BIOSENS BIOELECTRON, V42, P69, DOI 10.1016/j.bios.2012.10.024; Jones CB, 2012, J INFECT DIS, V206, P1947, DOI 10.1093/infdis/jis617; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Kilembe W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037154; Kurosaki Y, 2007, J VIROL METHODS, V141, P78, DOI 10.1016/j.jviromet.2006.11.031; Laperche S, 2012, J INFECT DIS, V206, P1946, DOI 10.1093/infdis/jis616; Liu CC, 2011, ANALYST, V136, P2069, DOI 10.1039/c1an00007a; Louie B, 2006, J CLIN MICROBIOL, V44, P1856, DOI 10.1128/JCM.44.5.1856-1858.2006; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Masciotra S, 2013, J CLIN VIROL, V58, pE54, DOI 10.1016/j.jcv.2013.07.002; Mori Y, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-3; Nasrullah M, 2013, AIDS, V27, P731, DOI 10.1097/QAD.0b013e32835bc535; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Owen SM, 2008, J CLIN MICROBIOL, V46, P1588, DOI 10.1128/JCM.02196-07; Patel P, 2012, J CLIN VIROL, V54, P42, DOI 10.1016/j.jcv.2012.01.022; Pierce VM, 2011, J CLIN MICROBIOL, V49, P1642, DOI 10.1128/JCM.02183-10; Rosenberg NE, 2012, J INFECT DIS, V205, P528, DOI 10.1093/infdis/jir789; Schito ML, 2010, J INFECT DIS, V201, pS1, DOI 10.1086/650394; Scott L, 2009, J CLIN MICROBIOL, V47, P3400, DOI 10.1128/JCM.00727-09; Soliman H, 2006, VET MICROBIOL, V114, P205, DOI 10.1016/j.vetmic.2005.11.063; Taegtmeyer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028019; Thai HTC, 2004, J CLIN MICROBIOL, V42, P1956, DOI 10.1128/JCM.42.5.1956-1961.2004; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wesolowski LG, 2013, J CLIN VIROL, V58, P240, DOI 10.1016/j.jcv.2013.06.019; Yoshida N, 2007, VACCINE, V25, P1281, DOI 10.1016/j.vaccine.2006.09.093	45	19	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126609	10.1371/journal.pone.0126609	http://dx.doi.org/10.1371/journal.pone.0126609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993381	Green Submitted, Green Published, gold			2022-12-26	WOS:000354921400068
J	Wende, CZ; Zoubaa, S; Blak, A; Echevarria, D; Martinez, S; Guillemot, F; Wurst, W; Guimera, J				Wende, Clara-Zoe; Zoubaa, Saida; Blak, Alexandra; Echevarria, Diego; Martinez, Salvador; Guillemot, Francois; Wurst, Wolfgang; Guimera, Jordi			Hairy/Enhancer-of-Split MEGANE and Proneural MASH1 Factors Cooperate Synergistically in Midbrain GABAergic Neurogenesis	PLOS ONE			English	Article							MOUSE SUPERIOR COLLICULUS; NEURONS; GENES; DIFFERENTIATION; MECHANISMS; EXPRESSION; CELLS; MODEL; ASCL1; HELT	GABAergic neurons are the primary inhibitory cell type in the mature brain and their dysfunction is associated with important neurological conditions like schizophrenia and anxiety. We aimed to discover the underlying mechanisms for dorsal/ventral midbrain GABAergic neurogenesis. Previous work by us and others has provided crucial insights into the key function of Mgn and Mash1 genes in determining GABAergic neurotransmitter fate. Induction of dorsal midbrain GABAergic neurons does not take place at any time during development in either of the single mutant mice. However, GABAergic neurons in the ventral midbrain remained unchanged. Thus, the similarities in MB-GABAergic phenotype observed in the Mgn and Mash1 single mutants suggest the existence of other factors that take over the function of MGN and MASH1 in the ventral midbrain or the existence of different molecular mechanisms. We show that this process essentially depends on heterodimers and homodimers formed by MGN and MASH1 and deciphered the in vivo relevance of the interaction by phenotypic analysis of Mgn/Mash1 double knockout and compound mice. Furthermore, the combination of gain- and loss-of-function experiments in the developing midbrain showed co-operative roles for Mgn and Mash1 genes in determining GABAergic identity. Transcription factors belonging to the Enhancer-of-split-related and proneural families have long been believed to counterpart each other's function. This work uncovers a synergistic cooperation between these two families, and provides a novel paradigm for how these two families cooperate for the acquisition of MB-GABAergic neuronal identity. Understanding their molecular mechanisms is essential for cell therapy strategies to amend GABAergic deficits.	[Wende, Clara-Zoe; Blak, Alexandra; Wurst, Wolfgang; Guimera, Jordi] Deutsch Forsch Zentrum Gesundheit & Umwelt Gmb, Helmholtz zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Zoubaa, Saida] Regensburg Univ Hosp, Dept Neuropathol, Regensburg, Germany; [Echevarria, Diego; Martinez, Salvador] Univ Miguel Hernandez, Inst Neurociencias, Expt Embryol Lab, Alicante, Spain; [Guillemot, Francois] Natl Inst Med Res, MRC, Div Mol Neurobiol, London NW7 1AA, England	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Regensburg; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); MRC National Institute for Medical Research	Guimera, J (corresponding author), Deutsch Forsch Zentrum Gesundheit & Umwelt Gmb, Helmholtz zentrum Munchen, Inst Dev Genet, Neuherberg, Germany.	guimera@helmholtz-muenchen.de	Echevarria, Diego/E-6386-2016; Echevarria, Diego/P-7391-2019; Guillemot, Francois/AAV-1482-2021	Echevarria, Diego/0000-0002-0938-7470; Echevarria, Diego/0000-0002-0938-7470; Wurst, Wolfgang/0000-0003-4422-7410; Martinez, Salvador/0000-0002-2910-8926	Collaborative Research Center grant [(SFB) 870]	Collaborative Research Center grant	This work was supported by a Collaborative Research Center (SFB) 870 grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achim K, 2014, CELL MOL LIFE SCI, V71, P1395, DOI 10.1007/s00018-013-1501-3; Achim K, 2013, BIOL OPEN, V2, P990, DOI 10.1242/bio.20135041; Achim K, 2012, DEVELOPMENT, V139, P2360, DOI 10.1242/dev.076380; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Echevarria D, 2005, DEV BIOL, V277, P114; Golemis E A, 1997, Methods Mol Biol, V63, P197; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Guimera J, 2006, DEVELOPMENT, V133, P3847, DOI 10.1242/dev.02557; Guimera J, 2006, GENE, V377, P65, DOI 10.1016/j.gene.2006.02.026; Kageyama R, 2008, DEV GROWTH DIFFER, V50, pS97, DOI 10.1111/j.1440-169X.2008.00993.x; Kim EJ, 2008, MOL CELL NEUROSCI, V38, P595, DOI 10.1016/j.mcn.2008.05.008; Miyoshi G, 2004, J NEUROSCI, V24, P3672, DOI 10.1523/JNEUROSCI.5327-03.2004; Monyer H, 2004, TRENDS NEUROSCI, V27, P90, DOI 10.1016/j.tins.2003.12.008; Nakatani T, 2004, J BIOL CHEM, V279, P16356, DOI 10.1074/jbc.M311740200; Nakatani T, 2007, DEVELOPMENT, V134, P2783, DOI 10.1242/dev.02870; Peltopuro P, 2010, DEV BIOL, V343, P63, DOI 10.1016/j.ydbio.2010.04.015; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puelles L, 2003, TRENDS NEUROSCI, V26, P469, DOI 10.1016/S0166-2236(03)00234-0; Tan SS, 2002, DEV BIOL, V241, P117, DOI 10.1006/dbio.2001.0505; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Watson C, 2012, MOUSE NERVOUS SYSTEM, P1	22	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127681	10.1371/journal.pone.0127681	http://dx.doi.org/10.1371/journal.pone.0127681			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993409	Green Published, Green Submitted, gold			2022-12-26	WOS:000354921400130
J	Esteve-Altava, B; Boughner, JC; Diogo, R; Villmoare, BA; Rasskin-Gutman, D				Esteve-Altava, Borja; Boughner, Julia C.; Diogo, Rui; Villmoare, Brian A.; Rasskin-Gutman, Diego			Anatomical Network Analysis Shows Decoupling of Modular Lability and Complexity in the Evolution of the Primate Skull	PLOS ONE			English	Article							SUTURE CLOSURE; EVOLVABILITY; CONSTRAINTS; INTEGRATION; PATTERNS; INSIGHTS	Modularity and complexity go hand in hand in the evolution of the skull of primates. Because analyses of these two parameters often use different approaches, we do not know yet how modularity evolves within, or as a consequence of, an also-evolving complex organization. Here we use a novel network theory-based approach (Anatomical Network Analysis) to assess how the organization of skull bones constrains the co-evolution of modularity and complexity among primates. We used the pattern of bone contacts modeled as networks to identify connectivity modules and quantify morphological complexity. We analyzed whether modularity and complexity evolved coordinately in the skull of primates. Specifically, we tested Herbert Simon's general theory of near-decomposability, which states that modularity promotes the evolution of complexity. We found that the skulls of extant primates divide into one conserved cranial module and up to three labile facial modules, whose composition varies among primates. Despite changes in modularity, statistical analyses reject a positive feedback between modularity and complexity. Our results suggest a decoupling of complexity and modularity that translates to varying levels of constraint on the morphological evolvability of the primate skull. This study has methodological and conceptual implications for grasping the constraints that underlie the developmental and functional integration of the skull of humans and other primates.	[Rasskin-Gutman, Diego] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Theoret Biol Res Grp, Valencia 46071, Spain; [Esteve-Altava, Borja; Rasskin-Gutman, Diego] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Theoret Biol Res Grp, Valencia 46071, Spain; [Boughner, Julia C.] Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK, Canada; [Diogo, Rui] Howard Univ, Dept Anat, Coll Med, Washington, DC USA; [Villmoare, Brian A.] Univ Nevada, Dept Anthropol, Las Vegas, NV 89154 USA; [Villmoare, Brian A.] UCL, Dept Anthropol, London, England	University of Valencia; University of Valencia; University of Saskatchewan; Howard University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of London; University College London	Rasskin-Gutman, D (corresponding author), Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Theoret Biol Res Grp, Valencia 46071, Spain.	diego.rasskin@uv.es	Esteve-Altava, Borja/S-3092-2016; Villmoare, Brian/W-4391-2019	Esteve-Altava, Borja/0000-0002-6645-4684; 	Cavanilles Institute of Biodiversity and Evolutionary Biology; Directorate For Geosciences [1258878] Funding Source: National Science Foundation	Cavanilles Institute of Biodiversity and Evolutionary Biology; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank A. Lieverse and E. Walker for access to the zoology collection in the Dept. of Archaeology of the Univ. of Saskatchewan. DR-G and BE-A thank the Cavanilles Institute of Biodiversity and Evolutionary Biology for its support.	Abouheif E, 1999, EVOL ECOL RES, V1, P895; Adams DC, 2013, HYSTRIX, V24, P7, DOI 10.4404/hystrix-24.1-6283; Barbeito-Andrés Jimena, 2012, Rev Arg Antrop Biol, V14, P79; Bastir M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1593; Bonner JT., 1988, EVOLUTION COMPLEXITY; Brigandt I, 2007, BIOL PHILOS, V22, P709, DOI 10.1007/s10539-007-9089-3; Callebaut W, 2005, MODULARITY UNDERSTAN; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Di Ieva A, 2013, CHILD NERV SYST, V29, P893, DOI 10.1007/s00381-013-2061-4; Diogo R., 2012, COMP ANATOMY PHYLOGE; Diogo R, 2014, BIOL REV; Esteve-Altava B, 2015, J ANTHROPOL SCI, V93, P103, DOI 10.4436/JASS.93001; Esteve-Altava B, 2015, SCI REP-UK, V5, DOI 10.1038/srep08298; Esteve-Altava B, 2014, EVOL BIOL, V41, P52, DOI 10.1007/s11692-013-9245-4; Esteve-Altava B, 2013, J EXP ZOOL PART B, V320, P489, DOI 10.1002/jez.b.22524; Esteve-Altava B, 2013, EVOL BIOL, V40, P209, DOI 10.1007/s11692-012-9200-9; Gomulkiewicz R, 2009, AM NAT, V174, pE218, DOI 10.1086/645086; Goswami A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009517; Gregory WAK, 1934, P NATL ACAD SCI USA, V20, P1, DOI 10.1073/pnas.20.1.1; Gregory WK, 1935, AM J PHYS ANTHROPOL, V20, P123, DOI 10.1002/ajpa.1330200202; Hansen TF, 2003, BIOSYSTEMS, V69, P83, DOI 10.1016/S0303-2647(02)00132-6; Hendrikse JL, 2007, EVOL DEV, V9, P393, DOI 10.1111/j.1525-142X.2007.00176.x; Herbert S., 1962, P AM PHILOS SOC, V106, P467, DOI DOI 10.1080/14759550302804; Herring Susan W., 2008, V12, P41, DOI 10.1159/000115031; Heuze Y, 2012, J EXP ZOOL PART B, V318B, P109, DOI 10.1002/jezb.21449; Heuze Y, 2010, J ANAT, V217, P85, DOI 10.1111/j.1469-7580.2010.01258.x; Klingenberg Christian Peter, 2005, P219, DOI 10.1016/B978-012088777-4/50013-2; Krogman WM, 1930, AM J ANAT, V46, P315, DOI 10.1002/aja.1000460206; Laurin M, 2010, SYST BIOL, V59, P689, DOI 10.1093/sysbio/syq059; Lieberman DE, 2011, EVOLUTION HUMAN HEAD; Makedonska J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040398; Marroig G, 2001, EVOLUTION, V55, P2576; Marroig G, 2009, EVOL BIOL, V36, P136, DOI 10.1007/s11692-009-9051-1; Martinez-Abadias N, 2012, EVOL BIOL, V39, P554, DOI 10.1007/s11692-012-9210-7; Martinez-Abadias N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026425; McShea DW, 2013, EVOL BIOL, V40, P504, DOI 10.1007/s11692-013-9227-6; MCSHEA DW, 1993, EVOLUTION, V47, P730, DOI 10.1111/j.1558-5646.1993.tb01229.x; Moore W.J., 1981, MAMMALIAN SKULL; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Orr HA, 2008, AM NAT, V172, P160, DOI 10.1086/589460; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Porto A, 2013, EVOLUTION, V67, P3305, DOI 10.1111/evo.12177; Porto A, 2009, EVOL BIOL, V36, P118, DOI 10.1007/s11692-008-9038-3; Quarto N, 2005, CELLS TISSUES ORGANS, V181, P109, DOI 10.1159/000091100; Raff R. A., 1996, SHAPE LIFE GENES DEV; Rasskin-Gutman Diego, 2014, Biological Theory, V9, P178, DOI 10.1007/s13752-014-0175-x; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Revell LJ, 2013, METHODS ECOL EVOL, V4, P754, DOI 10.1111/2041-210X.12066; Rosenberger AL, 2008, ANAT REC, V291, P308, DOI 10.1002/ar.20647; Ross CF, 2013, J HUM EVOL, V64, P56, DOI 10.1016/j.jhevol.2012.08.010; Schlosser G., 2004, MODULARITY DEV EVOLU; Sidor CA, 2001, EVOLUTION, V55, P1419; Simon HA, 2005, MODULARITY UNDERSTAN, pix; Singh N, 2012, J HUM EVOL, V62, P155, DOI 10.1016/j.jhevol.2011.11.006; Villmoare BA, 2014, J HUM EVOL; Wagner GP, 1996, AM ZOOL, V36, P36; West-Eberhard Mary Jane, 2003, pi; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22	59	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127653	10.1371/journal.pone.0127653	http://dx.doi.org/10.1371/journal.pone.0127653			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7BT	25992690	Green Submitted, Green Published, gold			2022-12-26	WOS:000354918600071
J	Muff, R; Rath, P; Kumar, RMR; Husmann, K; Born, W; Baudis, M; Fuchs, B				Muff, Roman; Rath, Prisni; Kumar, Ram Mohan Ram; Husmann, Knut; Born, Walter; Baudis, Michael; Fuchs, Bruno			Genomic Instability of Osteosarcoma Cell Lines in Culture: Impact on the Prediction of Metastasis Relevant Genes	PLOS ONE			English	Article							PHENOTYPIC INSTABILITY; MURINE OSTEOSARCOMA; ORTHOTOPIC MODEL; EXPRESSION; CANCER; ESTABLISHMENT; PATHWAY; WNT; STABILITY; CATENIN	Background Osteosarcoma is a rare but highly malignant cancer of the bone. As a consequence, the number of established cell lines used for experimental in vitro and in vivo osteosarcoma research is limited and the value of these cell lines relies on their stability during culture. Here we investigated the stability in gene expression by microarray analysis and array genomic hybridization of three low metastatic cell lines and derivatives thereof with increased metastatic potential using cells of different passages. Principal Findings The osteosarcoma cell lines showed altered gene expression during in vitro culture, and it was more pronounced in two metastatic cell lines compared to the respective parental cells. Chromosomal instability contributed in part to the altered gene expression in SAOS and LM5 cells with low and high metastatic potential. To identify metastasis-relevant genes in a background of passage-dependent altered gene expression, genes involved in "Pathways in cancer" that were consistently regulated under all passage comparisons were evaluated. Genes belonging to "Hedgehog signaling pathway" and "Wnt signaling pathway" were significantly up-regulated, and IHH, WNT10B and TCF7 were found up-regulated in all three metastatic compared to the parental cell lines. Conclusions Considerable instability during culture in terms of gene expression and chromosomal aberrations was observed in osteosarcoma cell lines. The use of cells from different passages and a search for genes consistently regulated in early and late passages allows the analysis of metastasis-relevant genes despite the observed instability in gene expression in osteosarcoma cell lines during culture.	[Muff, Roman; Kumar, Ram Mohan Ram; Husmann, Knut; Born, Walter; Fuchs, Bruno] Balgrist Univ Hosp, Lab Orthoped Res, Zurich, Switzerland; [Rath, Prisni; Baudis, Michael] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland	University of Zurich; University of Zurich	Fuchs, B (corresponding author), Balgrist Univ Hosp, Lab Orthoped Res, Zurich, Switzerland.	research@balgrist.ch	RamKumar, RamMohan/P-1762-2018; Baudis, Michael/J-4602-2012	RamKumar, RamMohan/0000-0002-0689-2957; Baudis, Michael/0000-0002-9903-4248; Rath, Prisni/0000-0002-6080-6079	Swiss Institute for Bioinformatics; Swiss National Science Foundation [31003A-120403]; Zurcher Krebsliga; Schweizerischer Verein Balgrist; Walter L. & Johanna Wolf Foundation (Alte Landstrasse, Zollikon, Switzerland); Program for Highly Specialized Medicine of the Kanton Zurich; University of Zurich	Swiss Institute for Bioinformatics; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Zurcher Krebsliga; Schweizerischer Verein Balgrist; Walter L. & Johanna Wolf Foundation (Alte Landstrasse, Zollikon, Switzerland); Program for Highly Specialized Medicine of the Kanton Zurich; University of Zurich	P. Rath was supported by a fellowship from the Swiss Institute for Bioinformatics (http://www.isbsib.ch/). This research was supported in part by grants from the Swiss National Science Foundation (31003A-120403), the Zurcher Krebsliga (http://www.krebsligazuerich.ch/), the Schweizerischer Verein Balgrist (http://www.balgrist.ch/), the Walter L. & Johanna Wolf Foundation (Alte Landstrasse 101, 8702 Zollikon, Switzerland), the Program for Highly Specialized Medicine of the Kanton Zurich (http://www.gdk-cds.ch/) and the University of Zurich (http://www.uzh.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai T, 1998, INT J CANCER, V76, P418, DOI 10.1002/(SICI)1097-0215(19980504)76:3<418::AID-IJC21>3.3.CO;2-E; BERKELHAMMER J, 1986, CANCER RES, V46, P2923; Boukamp P, 1997, GENE CHROMOSOME CANC, V19, P201, DOI 10.1002/(SICI)1098-2264(199708)19:4<201::AID-GCC1>3.0.CO;2-0; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Brun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055034; Cai H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-82; Cai HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036944; Cai Y, 2014, J CELL BIOCHEM, V115, P625, DOI 10.1002/jcb.24708; Chen K, 2008, PEDIATR BLOOD CANCER, V51, P349, DOI 10.1002/pbc.21595; Chen X, 2009, CYTOTECHNOLOGY, V61, P37, DOI 10.1007/s10616-009-9239-3; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; Day TF, 2008, J BONE JOINT SURG AM, V90A, P19, DOI 10.2106/JBJS.G.01174; Dieudonne FX, 2012, J BONE MINER RES, V27, P2118, DOI 10.1002/jbmr.1650; DUNN TB, 1963, J NATL CANCER I, V31, P873; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Guo Y, 2008, CLIN ORTHOP RELAT R, V466, P2039, DOI 10.1007/s11999-008-0344-y; Hausser HJ, 2005, BIOCHEM BIOPH RES CO, V333, P216, DOI 10.1016/j.bbrc.2005.05.097; Hirotsu M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-5; Hoang BH, 2004, INT J CANCER, V109, P106, DOI 10.1002/ijc.11677; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Husmann K, 2008, MOL CARCINOGEN, V47, P66, DOI 10.1002/mc.20362; Jia SF, 1999, CLIN EXP METASTAS, V17, P501, DOI 10.1023/A:1006623001465; Khanna C, 2000, CLIN EXP METASTAS, V18, P261, DOI 10.1023/A:1006767007547; Kim W, 2013, BIOCHEM J, V450, P9, DOI 10.1042/BJ20121284; Kimura K, 2002, CLIN EXP METASTAS, V19, P477, DOI 10.1023/A:1020395816633; Kresse SH, 2012, CANCER-AM CANCER SOC, V118, P558, DOI 10.1002/cncr.26276; Lagarde P, 2013, J CLIN ONCOL, V31, P608, DOI 10.1200/JCO.2012.46.0147; Lo Winnie W., 2014, Sarcoma, V2014, P261804, DOI 10.1155/2014/261804; Lo WW, 2014, CANCER-AM CANCER SOC, V120, P537, DOI 10.1002/cncr.28439; Lu BJ, 2012, MOL MED REP, V5, P1033, DOI 10.3892/mmr.2012.772; Luu HH, 2005, CLIN EXP METASTAS, V22, P319, DOI 10.1007/s10585-005-0365-9; Martin B, 2002, J CELL BIOL, V159, P113, DOI 10.1083/jcb.200202075; McQueen P, 2011, EXPERT REV ANTICANC, V11, P1223, DOI [10.1586/era.11.94, 10.1586/ERA.11.94]; Mikami I, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-53; Muff Roman, 2012, Sarcoma, V2012, P937506, DOI 10.1155/2012/937506; Nagao H, 2011, J PATHOL, V224, P169, DOI 10.1002/path.2880; Nakamura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069466; Nakano T, 2003, CLIN EXP METASTAS, V20, P665, DOI 10.1023/A:1027355610603; NIELSEN KV, 1994, CANCER GENET CYTOGEN, V78, P189, DOI 10.1016/0165-4608(94)90089-2; PEISER C, 1993, MUTAT RES, V289, P281, DOI 10.1016/0027-5107(93)90079-U; RHIM JS, 1975, INT J CANCER, V15, P23, DOI 10.1002/ijc.2910150104; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ruutu M, 2004, ANTICANCER RES, V24, P2627; Selvarajah S, 2007, CANCER GENET CYTOGEN, V179, P52, DOI 10.1016/j.cancergencyto.2007.08.003; Shi XB, 2005, CHINESE MED J-PEKING, V118, P687; SMITH A, 1989, CANCER GENET CYTOGEN, V38, P13, DOI 10.1016/0165-4608(89)90160-X; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Su YX, 2009, CLIN EXP METASTAS, V26, P599, DOI 10.1007/s10585-009-9259-6; Szuhai K, 2012, CANCER GENET-NY, V205, P193, DOI 10.1016/j.cancergen.2012.04.001; Weiss KR, 2006, CLIN ORTHOP RELAT R, P111, DOI 10.1097/01.blo.0000229333.98781.56; Yang W, 2013, J ORTHOP RES, V31, P502, DOI 10.1002/jor.22230; Zanazzi C, 2007, GENE CHROMOSOME CANC, V46, P895, DOI 10.1002/gcc.20475; Zhang KL, 2008, J PROTEOMICS, V71, P160, DOI 10.1016/j.jprot.2008.04.001; Zou CY, 2008, ACTA PHARMACOL SIN, V29, P325, DOI 10.1111/j.1745-7254.2008.00756.x	54	25	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0125611	10.1371/journal.pone.0125611	http://dx.doi.org/10.1371/journal.pone.0125611			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992885	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000354918600017
J	Wu, JL; Kang, XJ; Guo, MS; Mu, SM; Zhang, ZH				Wu, Jiang-Li; Kang, Xian-Jiang; Guo, Ming-Shen; Mu, Shu-Mei; Zhang, Zhao-Hui			Cloning and Functional Analysis of Histones H3 and H4 in Nuclear Shaping during Spermatogenesis of the Chinese Mitten Crab, Eriocheir sinensis	PLOS ONE			English	Article							PALAEMON-SERRATUS; SPERM; CRUSTACEA; SPERMATOZOA; PROTEINS; CELLS; CYTOCHIMIQUE; MATURATION; PATTERNS; FINE	During spermatogenesis in most animals, the basic proteins associated with DNA are continuously changing and somatic-typed histones are partly replaced by sperm-specific histones, which are then successively replaced by transition proteins and protamines. With the replacement of sperm nuclear basic proteins, nuclei progressively undergo chromatin condensation. The Chinese Mitten Crab (Eriocheir sinensis) is also known as the hairy crab or river crab (phylum Arthropoda, subphylum Crustacea, order Decapoda, and family Grapsidae). The spermatozoa of this species are aflagellate, and each has a spherical acrosome surrounded by a cup-shaped nucleus, peculiar to brachyurans. An interesting characteristic of the E. sinensis sperm nucleus is its lack of electron-dense chromatin. However, its formation is not clear. In this study, sequences encoding histones H3 and H4 were cloned by polymerase chain reaction amplification. Western blotting indicated that H3 and H4 existed in the sperm nuclei. Immunofluorescence and ultrastructural immunocytochemistry demonstrated that histones H3 and H4 were both present in the nuclei of spermatogonia, spermatocytes, spermatids and mature spermatozoa. The nuclear labeling density of histone H4 decreased in sperm nuclei, while histone H3 labeling was not changed significantly. Quantitative real-time PCR showed that the mRNA expression levels of histones H3 and H4 were higher at mitotic and meiotic stages than in later spermiogenesis. Our study demonstrates that the mature sperm nuclei of E. sinensis contain histones H3 and H4. This is the first report that the mature sperm nucleus of E. sinensis contains histones H3 and H4. This finding extends the study of sperm histones of E. sinensis and provides some basic data for exploring how decapod crustaceans form uncondensed sperm chromatin.	[Wu, Jiang-Li; Kang, Xian-Jiang; Guo, Ming-Shen; Mu, Shu-Mei; Zhang, Zhao-Hui] Hebei Univ, Coll Life Sci, Baoding 071002, Peoples R China	Hebei University	Kang, XJ (corresponding author), Hebei Univ, Coll Life Sci, Baoding 071002, Peoples R China.	xjkang@hbu.edu.cn	zhang, zh/GWV-4677-2022		Natural Science Foundation of China [31272309, 31202000]; Natural Science Foundation of Heibei Province P. R. China [C2011201028]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heibei Province P. R. China	This research was supported by Natural Science Foundation of China (31272309 and 31202000) and Natural Science Foundation of Heibei Province P. R. China (C2011201028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE SI, 1987, INT REV CYTOL, V109, P159, DOI 10.1016/S0074-7696(08)61722-2; ALFERT M, 1953, P NATL ACAD SCI USA, V39, P991, DOI 10.1073/pnas.39.10.991; Baxevanis AD, 1996, NUCLEIC ACIDS RES, V24, P245, DOI 10.1093/nar/24.1.245; BIGGIOGERA M, 1992, MICROSC RES TECHNIQ, V20, P259, DOI 10.1002/jemt.1070200305; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; Bloch D.P., 1976, P139; BOLS NC, 1973, CAN J ZOOL, V51, P203, DOI 10.1139/z73-029; Braun RE, 2001, NAT GENET, V28, P10, DOI 10.1038/88194; CHEVAILL.P, 1966, J MICROSC-PARIS, V5, P739; CHEVAILL.P, 1965, J MICROSC-PARIS, V4, P679; CHEVAILLIER P, 1967, J CELL BIOL, V32, P547, DOI 10.1083/jcb.32.3.547; CHEVAILLIER P, 1968, J MICROSC-PARIS, V7, P107; COURTENS JL, 1995, REPROD NUTR DEV, V35, P569, DOI 10.1051/rnd:19950509; GARCIARAMIREZ M, 1995, J BIOL CHEM, V270, P17923, DOI 10.1074/jbc.270.30.17923; Ge Shao-qin, 2008, Journal of Hebei University Natural Science Edition, V28, P187; GOUDEAU M, 1986, DEV BIOL, V118, P361, DOI 10.1016/0012-1606(86)90005-9; HINSCH GW, 1986, INT J INVER REP DEV, V10, P79, DOI 10.1080/01688170.1986.10510227; HINSCH GW, 1969, J ULTRA MOL STRUCT R, V29, P525, DOI 10.1016/S0022-5320(69)90071-9; KLEVE MG, 1980, TISSUE CELL, V12, P29, DOI 10.1016/0040-8166(80)90050-6; Kurtz K, 2009, TISSUE CELL, V41, P334, DOI 10.1016/j.tice.2009.02.003; Kurtz K, 2008, J CELL BIOCHEM, V105, P574, DOI 10.1002/jcb.21857; LIU TJ, 1989, MOL CELL BIOL, V9, P3499, DOI 10.1128/MCB.9.8.3499; MANN M, 1982, J EXP ZOOL, V222, P173, DOI 10.1002/jez.1402220209; MARUSHIGE K, 1971, J BIOL CHEM, V246, P5799; MATSUMURA T, 1970, NEPHRON, V7, P165, DOI 10.1159/000179818; Medina A, 2006, ZOOMORPHOLOGY, V125, P39, DOI 10.1007/s00435-005-0013-6; OLIVA R, 1982, NUCLEIC ACIDS RES, V10, P8049, DOI 10.1093/nar/10.24.8049; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Piontkivska H, 2002, MOL BIOL EVOL, V19, P689, DOI 10.1093/oxfordjournals.molbev.a004127; Pochon-Masson J., 1983, REPRODUCTIVE BIOL IN, V2, P407; Poljaroen J, 2010, ZOOL ANZ, V249, P81, DOI 10.1016/j.jcz.2010.03.002; Rang X.J., 2001, ACTA ZOOL SINICA, V47, P82; RISLEY MS, 1981, DEV BIOL, V84, P79, DOI 10.1016/0012-1606(81)90372-9; SCHUMPERLI D, 1986, CELL, V45, P471, DOI 10.1016/0092-8674(86)90277-1; SELLOS D, 1981, CELL DIFFER DEV, V10, P69, DOI 10.1016/0045-6039(81)90014-2; Stewart MJ, 2010, TISSUE CELL, V42, P137, DOI 10.1016/j.tice.2010.03.002; Subirana JA, 1975, BIOL MALE GAMETE, P239; Tudge Christopher, 2009, Crustacean Issues, V18, P101; Tudge Christopher C., 2001, Zoosystema, V23, P117; Van Holde KE, 1988, SPRINGER SERIES MOL; VAUGHN JC, 1969, EXP CELL RES, V54, P362, DOI 10.1016/0014-4827(69)90215-8; VAUGHN JC, 1969, J HISTOCHEM CYTOCHEM, V17, P591, DOI 10.1177/17.9.591; Wang Yilei, 1996, Journal of Xiamen University Natural Science, V35, P947; WOLFFE AP, 1989, NUCLEIC ACIDS RES, V17, P767, DOI 10.1093/nar/17.2.767; Zweidler A., 1980, DEV BIOCHEM, V15, P47; 费仁仁, 1997, 解剖学报, V28, P388	46	22	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0126623	10.1371/journal.pone.0126623	http://dx.doi.org/10.1371/journal.pone.0126623			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993499	Green Published, gold, Green Submitted			2022-12-26	WOS:000354918600036
J	Jansen, MAE; van den Heuvel, D; van Zelm, MC; Jaddoe, VWV; Hofman, A; de Jongste, JC; Hooijkaas, H; Moll, HA				Jansen, Michelle A. E.; van den Heuvel, Diana; van Zelm, Menno C.; Jaddoe, Vincent W. V.; Hofman, Albert; de Jongste, Johan C.; Hooijkaas, Herbert; Moll, Henriette A.			Decreased Memory B Cells and Increased CD8 Memory T Cells in Blood of Breastfed Children: The Generation R Study	PLOS ONE			English	Article							LYMPHOCYTE SUBSETS; IMMUNE-RESPONSE; IGA RESPONSES; INFANTS; CHILDHOOD; ANTIBODY; MILK; TRANSMISSION; IMMUNOLOGY; MODULATION	Background Breastfeeding provides a protective effect against infectious diseases in infancy. Still, immunological evidence for enhanced adaptive immunity in breastfed children remains inconclusive. Objective To determine whether breastfeeding affects B-and T-cell memory in the first years of life. Methods We performed immunophenotypic analysis on blood samples within a population-based prospective cohort study. Participants included children at 6 months (n=258), 14 months (n=166), 25 months (n=112) and 6 years of age (n=332) with both data on breastfeeding and blood lymphocytes. Total B-and T-cell numbers and their memory subsets were determined with 6-color flow cytometry. Mothers completed questionnaires on breastfeeding when their children were aged 2, 6, and 12 months. Multiple linear regression models with adjustments for potential confounders were performed. Results Per month continuation of breastfeeding, a 3% (95% CI -6, -1) decrease in CD27+IgM+,a 2% (95 CI % -5, -1) decrease in CD27+IgA+and a 2% (95% CI -4, -1) decrease in CD27IgG+ memory B cell numbers were observed at 6 months of age. CD8 T-cell numbers at 6 months of age were 20% (95% CI 3, 37) higher in breastfed than in non-breastfed infants. This was mainly found for central memory CD8 T cells and associated with exposure to breast milk, rather than duration. The same trend was observed at 14 months, but associations disappeared at older ages. Conclusions Longer breastfeeding is associated with increased CD8 T-cell memory, but not B-cell memory numbers in the first 6 months of life. This transient skewing towards T cell memory might contribute to the protective effect against infectious diseases in infancy.	[Jansen, Michelle A. E.; Jaddoe, Vincent W. V.] Univ Med Ctr, Erasmus MC, Generat R Study Grp, Rotterdam, Netherlands; [Jansen, Michelle A. E.; Jaddoe, Vincent W. V.; de Jongste, Johan C.; Moll, Henriette A.] Univ Med Ctr, Erasmus MC, Sophia Childrens Hosp, Dept Pediat, Rotterdam, Netherlands; [Jansen, Michelle A. E.; van den Heuvel, Diana; van Zelm, Menno C.; Hooijkaas, Herbert] Univ Med Ctr, Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Jaddoe, Vincent W. V.; Hofman, Albert] Univ Med Ctr, Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van Zelm, MC (corresponding author), Univ Med Ctr, Erasmus MC, Dept Immunol, Rotterdam, Netherlands.	m.vanzelm@erasmusmc.nl	van den Heuvel, Diana/Q-5930-2017; van Zelm, Menno C/O-4404-2015	van Zelm, Menno C/0000-0003-4161-1919	Erasmus Medical Centre, Rotterdam, Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw); Europe Container Terminals; Netherlands Organization for Health Research and Development [ZonMw 907.00303, ZonMw 916.10159]; Erasmus MC fellowship	Erasmus Medical Centre, Rotterdam, Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Europe Container Terminals; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Erasmus MC fellowship	The first phase of the Generation R Study is made possible by financial support from Erasmus Medical Centre, Rotterdam, Erasmus University Rotterdam and the Netherlands Organization for Health Research and Development (ZonMw) and an unrestricted grant from Europe Container Terminals B.V. The present study was supported by an additional grant from the Netherlands Organization for Health Research and Development, ZonMw 907.00303, ZonMw 916.10159, URL: http://www.zonmw.nl/. MCvZ and DvdH were supported by an Erasmus MC fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admyre C, 2007, J ALLERGY CLIN IMMUN, V120, P1418, DOI 10.1016/j.jaci.2007.06.040; Andersson Y, 2009, J IMMUNOL, V183, P4322, DOI 10.4049/jimmunol.0900829; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Berkowska MA, 2011, BLOOD, V118, P2150, DOI 10.1182/blood-2011-04-345579; Bunders MJ, 2012, BLOOD, V120, P4383, DOI 10.1182/blood-2012-06-437566; CARVER JD, 1991, J CLIN LAB ANAL, V5, P54, DOI 10.1002/jcla.1860050110; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; Driessen GJ, 2013, HAEMATOLOGICA, V98, P1617, DOI 10.3324/haematol.2013.085076; Duijts L, 2009, MATERN CHILD NUTR, V5, P199, DOI 10.1111/j.1740-8709.2008.00176.x; Freud AG, 2006, IMMUNOL REV, V214, P56, DOI 10.1111/j.1600-065X.2006.00451.x; Groome MJ, 2014, B WORLD HEALTH ORGAN, V92, P238, DOI 10.2471/BLT.13.128066; HAHNZORIC M, 1990, ACTA PAEDIATR SCAND, V79, P1137; Hanson LA, 2003, ANN NY ACAD SCI, V987, P199, DOI 10.1111/j.1749-6632.2003.tb06049.x; Hanson LA, 2002, ADV EXP MED BIOL, V503, P99; Hawkes JS, 1999, PEDIATR RES, V45, P648, DOI 10.1203/00006450-199905010-00006; Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1; JAIN L, 1989, ARCH DIS CHILD-FETAL, V64, P930, DOI 10.1136/adc.64.7_Spec_No.930; Jeppesen DL, 2004, PEDIATR ALLERGY IMMU, V15, P127, DOI 10.1111/j.1399-3038.2004.00032.x; Kiefte-de Jong JC, 2010, AM J GASTROENTEROL, V105, P940, DOI 10.1038/ajg.2010.96; KRAMER DR, 1995, J IMMUNOL, V154, P2051; KRAMER DR, 1995, INT IMMUNOL, V7, P911, DOI 10.1093/intimm/7.6.911; Lawrence Robert M, 2007, Curr Probl Pediatr Adolesc Health Care, V37, P7, DOI 10.1016/j.cppeds.2006.10.002; Li RW, 2005, NUTR REV, V63, P103, DOI 10.1111/j.1753-4887.2005.tb00128.x; Lonnerdal B, 2013, J PAEDIATR CHILD H, V49, P1, DOI 10.1111/jpc.12104; M'Rabet L, 2008, J NUTR, V138, p1782S, DOI 10.1093/jn/138.9.1782S; Mackay CR, 1999, NATURE, V401, P659, DOI 10.1038/44309; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; MOHR JA, 1972, LANCET, V1, P688; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Pabst HF, 1997, ACTA PAEDIATR, V86, P1291, DOI 10.1111/j.1651-2227.1997.tb14900.x; PABST HF, 1989, LANCET, V1, P295, DOI 10.1016/S0140-6736(89)91307-X; PABST HF, 1990, LANCET, V336, P269, DOI 10.1016/0140-6736(90)91802-H; Pabst O, 2012, NAT REV IMMUNOL, V12, P821, DOI 10.1038/nri3322; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rennels MB, 1996, J INFECT DIS, V174, pS107, DOI 10.1093/infdis/174.Supplement_1.S107; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; SCHLESINGER JJ, 1977, LANCET, V2, P529; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Silfverdal SA, 1997, INT J EPIDEMIOL, V26, P443, DOI 10.1093/ije/26.2.443; Statistics N, 2008, DUTCH STAND CLASS ED; Statistics Netherlands, 2012, WELF NETH INC WELF S; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tosato F, 2015, CYTOM PART A, V87A, P81, DOI 10.1002/cyto.a.22520; Tuaillon E, 2009, J IMMUNOL, V182, P7155, DOI 10.4049/jimmunol.0803107; van Gent R, 2009, CLIN IMMUNOL, V133, P95, DOI 10.1016/j.clim.2009.05.020; van Rossem L, 2009, PEDIATRICS, V123, pE1017, DOI 10.1542/peds.2008-2663; Walker A, 2010, J PEDIATR-US, V156, pS3, DOI 10.1016/j.jpeds.2009.11.021; Wilson AC, 1998, BMJ-BRIT MED J, V316, P21, DOI 10.1136/bmj.316.7124.21; Wold AE, 1998, ACTA PAEDIATR, V87, P19, DOI 10.1080/08035259850157804; Zinkernagel RM, 2001, NEW ENGL J MED, V345, P1331, DOI 10.1056/NEJMra012493; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	54	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126019	10.1371/journal.pone.0126019	http://dx.doi.org/10.1371/journal.pone.0126019			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993335	Green Submitted, gold, Green Published			2022-12-26	WOS:000354917300033
J	Moul, C; Dobson-Stone, C; Brennan, J; Hawes, DJ; Dadds, MR				Moul, Caroline; Dobson-Stone, Carol; Brennan, John; Hawes, David J.; Dadds, Mark R.			Serotonin 1B Receptor Gene (HTR1B) Methylation as a Risk Factor for Callous-Unemotional Traits in Antisocial Boys	PLOS ONE			English	Article							PSYCHOPATHIC TRAITS; CONDUCT PROBLEMS; 5-HT1B RECEPTOR; EXPRESSION; CHILDREN; BEHAVIOR; POLYMORPHISMS; ENVIRONMENT; MODULATION; CHILDHOOD	The serotonin system is thought to play a role in the aetiology of callous-unemotional (CU) traits in children. Previous research identified a functional single nucleotide polymorphism (SNP) from the promoter region of the serotonin 1B receptor gene as being associated with CU traits in boys with antisocial behaviour problems. This research tested the hypothesis that CU traits are associated with reduced methylation of the promoter region of the serotonin 1B receptor gene due to the influence of methylation on gene expression. Participants (N = 117) were boys with antisocial behaviour problems aged 3-16 years referred to University of New South Wales Child Behaviour Research Clinics. Participants volunteered a saliva sample from which the genotype of a SNP from the promoter region of the serotonin 1B receptor gene and the methylation levels of 30 CpG sites from 3 CpG regions surrounding the location of this polymorphism were assayed. Lower levels of serotonin 1B receptor gene methylation were associated with higher levels of CU traits. This relationship, however, was found to be moderated by genotype and carried exclusively by two CpG sites for which levels of methylation were negatively associated with overall methylation levels in this region of the gene. Results provide support to the emerging literature that argues for a genetically-driven system-wide alteration in serotonin function in the aetiology of CU traits. Furthermore, the results suggest that there may be two pathways to CU traits that involve methylation of the serotonin 1B receptor gene; one that is driven by a genotypic risk and another that is associated with risk for generally increased levels of methylation. Future research that aims to replicate and further investigate these results is required.	[Moul, Caroline; Brennan, John; Hawes, David J.; Dadds, Mark R.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Dobson-Stone, Carol] Neurosci Res Australia, Sydney, NSW, Australia; [Dobson-Stone, Carol] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia	University of New South Wales Sydney; Neuroscience Research Australia; University of New South Wales Sydney	Moul, C (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	cmoul@psy.unsw.edu.au	Hawes, David/AAE-6800-2021	Dobson-Stone, Carol/0000-0002-2211-0257; Dadds, Mark/0000-0002-2900-1715; Hawes, David/0000-0003-3260-1225; Moul, Caroline/0000-0003-2632-1067	National Health and Medical Research Council [455439]; Australian Research Council [DP120102296, LP100200150]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	National Health and Medical Research Council #455439 (http://www.nhmrc.gov.au/) MD JB DH. Australian Research Council DP120102296 (http://www.arc.gov.au/) MD JB DH. Australian Research Council LP100200150 MD JB DH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2001, INF PAP CENS POP HOU; Beaver KM, 2011, CRIM JUSTICE BEHAV, V38, P896, DOI 10.1177/0093854811411153; Cecil CAM, 2014, MOL PSYCHIATR, V19, P1071, DOI 10.1038/mp.2014.95; Clark MS, 2004, BRAIN RES, V1007, P86, DOI 10.1016/j.brainres.2004.01.070; Conner TS, 2010, AM J MED GENET B, V153B, P67, DOI 10.1002/ajmg.b.30955; Contini V, 2012, DRUG ALCOHOL DEPEN, V122, P100, DOI 10.1016/j.drugalcdep.2011.09.020; Dadds MR, 2008, J AM ACAD CHILD PSY, V47, P455, DOI 10.1097/CHI.0b013e31816407f1; Dadds MR, 2014, DEV PSYCHOPATHOL, V26, P33, DOI 10.1017/S0954579413000497; Dadds MR, 2009, J CHILD PSYCHOL PSYC, V50, P599, DOI 10.1111/j.1469-7610.2008.02058.x; Dammann G, 2011, EPIGENETICS-US, V6, P1454, DOI 10.4161/epi.6.12.18363; Dolan MC, 2003, J PSYCHOPHARMACOL, V17, P216, DOI 10.1177/0269881103017002011; Drago A, 2010, EUR J CLIN PHARMACOL, V66, P5, DOI 10.1007/s00228-009-0724-6; Duan J, 2003, MOL PSYCHIATR, V8, P901, DOI 10.1038/sj.mp.4001403; Frick PJ, 2003, J ABNORM CHILD PSYCH, V31, P457, DOI 10.1023/A:1023899703866; Frick PJ, 2001, TORONTO MULTIHEALTH; Frick PJ, 2010, PROPOSAL DSM 5 CHILD; Glenn AL, 2011, NEUROSCI BIOBEHAV R, V35, P612, DOI 10.1016/j.neubiorev.2010.07.005; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gunter TD, 2010, BEHAV SCI LAW, V28, P148, DOI 10.1002/bsl.923; Hawes DJ, 2005, J CONSULT CLIN PSYCH, V73, P737, DOI 10.1037/0022-006X.73.4.737; Jensen KP, 2009, MOL PSYCHIATR, V14, P381, DOI 10.1038/mp.2008.15; Johnson S, 1999, BEHAV CHANGE, V16, P155, DOI 10.1375/bech.16.3.155; Koglin U, 2012, KINDH ENTWICKL, V21, P141, DOI 10.1026/0942-5403/a000080; Lappalainen J, 1998, ARCH GEN PSYCHIAT, V55, P989, DOI 10.1001/archpsyc.55.11.989; Moul C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056619; Moul C, 2012, PSYCHOL REV, V119, P789, DOI 10.1037/a0029342; Murrough JW, 2011, ARCH GEN PSYCHIAT, V68, P892, DOI 10.1001/archgenpsychiatry.2011.91; Orabona GM, 2009, BRAIN RES, V1250, P14, DOI 10.1016/j.brainres.2008.11.007; Pasalich DS, 2012, J CHILD PSYCHOL PSYC, V53, P838, DOI 10.1111/j.1469-7610.2012.02544.x; PATRICK CJ, 1993, J ABNORM PSYCHOL, V102, P82, DOI 10.1037/0021-843X.102.1.82; Rey JM, 1997, ARCH GEN PSYCHIAT, V54, P817; Rowe R, 2010, J CHILD PSYCHOL PSYC, V51, P688, DOI 10.1111/j.1469-7610.2009.02199.x; Sadeh N, 2010, J ABNORM PSYCHOL, V119, P604, DOI 10.1037/a0019709; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; Szyf M, 2011, J NEURODEV DISORD, V3, P238, DOI 10.1007/s11689-011-9079-2; Takai D, 2001, ONCOGENE, V20, P7505, DOI 10.1038/sj.onc.1204940; Viding E, 2005, J CHILD PSYCHOL PSYC, V46, P592, DOI 10.1111/j.1469-7610.2004.00393.x; Viding E, 2008, DEVELOPMENTAL SCI, V11, P17, DOI 10.1111/j.1467-7687.2007.00648.x; Vollm B, 2010, J PSYCHIATR RES, V44, P123, DOI 10.1016/j.jpsychires.2009.07.005; Watakabe A, 2009, CEREB CORTEX, V19, P1915, DOI 10.1093/cercor/bhn219; Zhang H, 2013, PLOS ONE, V8; Zhuang XX, 1999, NEUROPSYCHOPHARMACOL, V21, pS52, DOI 10.1016/S0893-133X(99)00047-0; Zouk H, 2007, AM J MED GENET B, V144B, P996, DOI 10.1002/ajmg.b.30521	43	25	25	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126903	10.1371/journal.pone.0126903	http://dx.doi.org/10.1371/journal.pone.0126903			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993020	gold, Green Published, Green Submitted			2022-12-26	WOS:000354917300063
J	Yu, Q; Mei, XQ; Ding, XF; Dong, TT; Dong, WW; Li, HG				Yu, Qiong; Mei, Xiao-Qin; Ding, Xiao-Fang; Dong, Ting-Ting; Dong, Wei-Wei; Li, Hong-Gang			Construction of a Catsper1 DNA Vaccine and Its Antifertility Effect on Male Mice	PLOS ONE			English	Article							MALE CONTRACEPTION; IMMUNE-RESPONSE; MALE-FERTILITY; SPERM ANTIBODIES; PLASMID DNA; IMMUNIZATION; PROTEIN; SPERMATOZOA; CHANNEL; IMMUNOCONTRACEPTION	Cation channel of sperm 1 (CATSPER1) is a unique sperm cation channel protein, and essential for sperm function and male fertility. CATSPER1 exclusively expresses in meiotic and postmeiotic spermatogenic cells, thus belongs to the spermatogenesis-specific antigen that escape central tolerance. We have previously demonstrated the immunocontraceptive potential of its transmembrane domains and pore region, and reported the antifertility effects of its B-cell epitopes on male mice. Aiming to develop DNA vaccine targeting CATSPER1 for male contraception, here the whole open reading frame of mouse Catsper1 was cloned into the plasmid pEGFP-N1 to obtain a DNA vaccine pEGFP-N1-Catsper1. The vaccine was confirmed to be transcribed and translated in mouse N2a cell in vitro and mouse muscle tissue in vivo. Intramuscular injection with the vaccine on male mice induced specific immune reaction and caused significant inhibition on sperm hyperactivated motility and progressive motility (P<0.001 for both), and consequently reduced male fertility. The fertility rate of experimental group was 40.9%, which was significant lower (P=0.012) than control group (81.8%). No significant change in mating behavior, sperm production and histology of testis/epididymis was observed. Given that Catsper1 exhibits a high degree of homology among different species, Catsper1 DNA vaccine might be a good strategy for developing an immunocontraceptive vaccine for human and animal use.	[Yu, Qiong; Mei, Xiao-Qin; Dong, Ting-Ting; Dong, Wei-Wei; Li, Hong-Gang] Huazhong Univ Sci & Technol, Tongji Med Coll, Ctr Reprod Med, Family Planning Res Inst, Wuhan 430074, Peoples R China; [Ding, Xiao-Fang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Ctr Reprod Med, Wuhan 430074, Peoples R China; [Li, Hong-Gang] Wuhan Tongji Reprod Med Hosp, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Li, HG (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Ctr Reprod Med, Family Planning Res Inst, Wuhan 430074, Peoples R China.	lhgyx@hotmail.com			Science and Technology Department of China [2004BA720A33-01]; Health Department of Hubei Province [JX2B03]	Science and Technology Department of China; Health Department of Hubei Province	Grant sponsor: Science and Technology Department of China (http://www.most.gov.cn/), Grant number: 2004BA720A33-01, Grant recipient: HGL. Grant sponsor: Health Department of Hubei Province (http://www.hbwsjs.gov.cn/), Grant number: JX2B03, Grant recipient: HGL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An G, 2009, AM J REPROD IMMUNOL, V61, P227, DOI 10.1111/j.1600-0897.2009.00685.x; Avenarius MR, 2009, AM J HUM GENET, V84, P505, DOI 10.1016/j.ajhg.2009.03.004; Boyle JS, 1997, P NATL ACAD SCI USA, V94, P14626, DOI 10.1073/pnas.94.26.14626; BRONSON R, 1984, FERTIL STERIL, V42, P171; BRONSON RA, 1982, AM J REPROD IMMUNOL, V2, P222, DOI 10.1111/j.1600-0897.1982.tb00170.x; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Carlson AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006844; Chang HX, 2011, BIOL REPROD, V85, P296, DOI 10.1095/biolreprod.110.089789; Chen Y, 2008, SCI CHINA SER C, V51, P308, DOI 10.1007/s11427-008-0035-7; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Davis HL, 1996, VACCINE, V14, P910, DOI 10.1016/0264-410X(95)00255-Y; Deck RR, 1997, VACCINE, V15, P71, DOI 10.1016/S0264-410X(96)00101-6; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Eade JA, 2009, REPRODUCTION, V137, P913, DOI 10.1530/REP-08-0471; Ellerman DA, 1998, BIOL REPROD, V59, P1029, DOI 10.1095/biolreprod59.5.1029; Ellerman DA, 2008, FERTIL STERIL, V89, P199, DOI 10.1016/j.fertnstert.2007.02.025; Ferro VA, 2004, CURR OPIN MOL THER, V6, P83; Ferro VA, 2011, EXPERT OPIN THER PAT, V21, P1473, DOI 10.1517/13543776.2011.594042; HAAS GG, 1991, FERTIL STERIL, V55, P377; Heinemann K, 2005, HUM REPROD, V20, P549, DOI 10.1093/humrep/deh574; JOHNSON MH, 1968, J REPROD FERTIL, V17, P403, DOI 10.1530/jrf.0.0170403; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Knee RA, 2005, BIOL REPROD, V73, P688, DOI 10.1095/biolreprod.105.041079; Laylor R, 1999, CLIN EXP IMMUNOL, V117, P106; Li HG, 2007, MOL HUM REPROD, V13, P299, DOI 10.1093/molehr/gam009; Li HG, 2012, FERTIL STERIL, V97, P445, DOI 10.1016/j.fertnstert.2011.11.043; Li HG, 2009, FERTIL STERIL, V92, P1141, DOI 10.1016/j.fertnstert.2008.07.1751; LINNET L, 1982, J REPROD IMMUNOL, V4, P133, DOI 10.1016/0165-0378(82)90031-6; Liu T, 2010, FERTIL STERIL, V93, P1556, DOI 10.1016/j.fertnstert.2009.03.056; Luo J, 2012, AM J REPROD IMMUNOL, V68, P47, DOI 10.1111/j.1600-0897.2012.01117.x; McLaughlin EA, 2011, MOL CELL ENDOCRINOL, V335, P78, DOI 10.1016/j.mce.2010.04.004; Moore HDM, 1997, REPROD FERT DEVELOP, V9, P125, DOI 10.1071/R96053; Naz RK, 2006, MOL REPROD DEV, V73, P1473, DOI 10.1002/mrd.20591; Naz RK, 2011, AM J REPROD IMMUNOL, V66, P5, DOI 10.1111/j.1600-0897.2011.01000.x; Naz RK, 2005, HUM REPROD, V20, P3271, DOI 10.1093/humrep/dei256; Nielsen CH, 2000, IMMUNOLOGY, V100, P4, DOI 10.1046/j.1365-2567.2000.00009.x; Nieschlag E, 2005, LANCET, V365, P554; O'Rand MG, 2004, SCIENCE, V306, P1189, DOI 10.1126/science.1099743; Page ST, 2008, ENDOCR REV, V29, P465, DOI 10.1210/er.2007-0041; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Restrepo B, 2013, ACTAS UROL ESP; Shen ZG, 2011, REPRODUCTION, V142, P659, DOI 10.1530/REP-11-0161; Sun ZY, 2010, AM J REPROD IMMUNOL, V63, P282, DOI 10.1111/j.1600-0897.2009.00785.x; Suri A, 2005, EXPERT OPIN BIOL TH, V5, P381, DOI 10.1517/14712598.5.3.381; Tighe H, 1998, IMMUNOL TODAY, V19, P89, DOI 10.1016/S0167-5699(97)01201-2; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Wang XL, 2006, J GENE MED, V8, P498, DOI 10.1002/jgm.871; WEININGER RB, 1982, J REPROD FERTIL, V66, P251; YANAGIMA.R, 1970, J REPROD FERTIL, V23, P193, DOI 10.1530/jrf.0.0230193	50	11	11	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127508	10.1371/journal.pone.0127508	http://dx.doi.org/10.1371/journal.pone.0127508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993432	Green Published, gold, Green Submitted			2022-12-26	WOS:000354917300128
J	Szpila, BE; Ozrazgat-Baslanti, T; Zhang, JY; Lanz, J; Davis, R; Rebel, A; Vanzant, E; Gentile, LF; Cuenca, AG; Ang, DN; Liu, HZ; Lottenberg, L; Marker, P; Zumberg, M; Bihorac, A; Moore, FA; Brakenridge, S; Efron, PA				Szpila, Benjamin E.; Ozrazgat-Baslanti, Tezcan; Zhang, Jianyi; Lanz, Jennifer; Davis, Ruth; Rebel, Annette; Vanzant, Erin; Gentile, Lori F.; Cuenca, Alex G.; Ang, Darwin N.; Liu, Huazhi; Lottenberg, Lawrence; Marker, Peggy; Zumberg, Marc; Bihorac, Azra; Moore, Frederick A.; Brakenridge, Scott; Efron, Philip A.			Successful Implementation of a Packed Red Blood Cell and Fresh Frozen Plasma Transfusion Protocol in the Surgical Intensive Care Unit	PLOS ONE			English	Article							PROTHROMBIN TIME; CARDIAC-SURGERY; CRITICALLY-ILL; INCREASED MORTALITY; ELDERLY-PATIENTS; REQUIREMENTS; MORBIDITY; TRAUMA; TRIAL	Background Blood product transfusions are associated with increased morbidity and mortality. The purpose of this study was to determine if implementation of a restrictive protocol for packed red blood cell (PRBC) and fresh frozen plasma (FFP) transfusion safely reduces blood product utilization and costs in a surgical intensive care unit (SICU). Study Design We performed a retrospective, historical control analysis comparing before (PRE) and after (POST) implementation of a restrictive PRBC/FFP transfusion protocol for SICU patients. Univariate analysis was utilized to compare patient demographics and blood product transfusion totals between the PRE and POST cohorts. Multivariate logistic regression models were developed to determine if implementation of the restrictive transfusion protocol is an independent predictor of adverse outcomes after controlling for age, illness severity, and total blood products received. Results 829 total patients were included in the analysis (PRE, n=372; POST, n=457). Despite higher mean age (56 vs. 52 years, p=0.01) and APACHE II scores (12.5 vs. 11.2, p=0.006), mean units transfused per patient were lower for both packed red blood cells (0.7 vs. 1.2, p=0.03) and fresh frozen plasma (0.3 vs. 1.2, p=0.007) in the POST compared to the PRE cohort, respectively. There was no difference in inpatient mortality between the PRE and POST cohorts (7.5% vs. 9.2%, p=0.39). There was a decreased risk of urinary tract infections (OR 0.47, 95% CI 0.28-0.80) in the POST cohort after controlling for age, illness severity and amount of blood products transfused. Conclusions Implementation of a restrictive transfusion protocol can effectively reduce blood product utilization in critically ill surgical patients with no increase in morbidity or mortality.	[Szpila, Benjamin E.; Zhang, Jianyi; Lanz, Jennifer; Davis, Ruth; Vanzant, Erin; Gentile, Lori F.; Cuenca, Alex G.; Lottenberg, Lawrence; Moore, Frederick A.; Brakenridge, Scott; Efron, Philip A.] Univ Florida, Coll Med, Dept Surg, Gainesville, FL 32610 USA; [Ozrazgat-Baslanti, Tezcan; Bihorac, Azra] Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL 32610 USA; [Marker, Peggy] Univ Florida, Coll Med, Dept Nursing, Gainesville, FL 32610 USA; [Zumberg, Marc] Univ Florida, Coll Med, Dept Med, Gainesville, FL 32610 USA; [Rebel, Annette] Univ Kentucky, Coll Med, Dept Anesthesia, Lexington, KY 40506 USA; [Ang, Darwin N.; Liu, Huazhi] Univ S Florida, Dept Surg, Tampa, FL 33612 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Kentucky; State University System of Florida; University of South Florida	Efron, PA (corresponding author), Univ Florida, Coll Med, Dept Surg, Gainesville, FL 32610 USA.	philip.efron@surgery.ufl.edu	Brakenridge, Scott/AAD-6691-2019; Bihorac, Azra/Q-6500-2016; Ang, Darwin/AIA-3852-2022	Brakenridge, Scott/0000-0002-7327-3718; Bihorac, Azra/0000-0002-5745-2863; Zhang, Jianyi/0000-0002-1501-4822	NIGMS [T32 GM-008721, R01 GM-40586-24, R01 GM-80576-06]; NIH NIGMS [K23 GM087709]; P50 NIH grant [P50GM111152-01]; NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM111152, R01GM040586, T32GM008721, K23GM087709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); P50 NIH grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	BES, AGC, and LFG were supported by a T32 training grant (T32 GM-008721) in burns and trauma from the NIGMS. AB is supported by NIH NIGMS Grant K23 GM087709. Other support was provided by R01 GM-40586-24 and R01 GM-80576-06 awarded by the NIGMS. AB, FM, SB, and PE were supported by a P50 NIH grant P50GM111152-01. NIH funding had a role in the collection, management, analysis, and interpretation of the data; and preparation and review of the manuscript.	Abdel-Wahab OI, 2006, TRANSFUSION, V46, P1279, DOI 10.1111/j.1537-2995.2006.00891.x; Bauer DF, 2011, J TRAUMA, V70, P1112, DOI 10.1097/TA.0b013e3181e7c2ae; Corwin HL, 2007, NEW ENGL J MED, V356, P1667, DOI 10.1056/NEJMe078019; Davis JW, 2004, J TRAUMA, V57, P1173, DOI 10.1097/01.TA.0000151257.79108.FB; Gerber DR, 2008, CRIT CARE MED, V36, P1068, DOI 10.1097/CCM.0b013e318169251f; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 2004, VOX SANG, V87, P209, DOI 10.1111/j.1741-6892.2004.00497.x; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; Juffermans NP, 2011, SHOCK, V35, P355, DOI 10.1097/SHK.0b013e3182086094; Kiraly LN, 2009, J TRAUMA, V67, P29, DOI 10.1097/TA.0b013e3181af6a8c; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Marik PE, 2008, CRIT CARE MED, V36, P3134; Matevosyan K, 2011, J NEUROSURG, V114, P3, DOI 10.3171/2010.7.JNS091699; Mica Ladislav, 2013, J Trauma Manag Outcomes, V7, P6, DOI 10.1186/1752-2897-7-6; Murad MH, 2010, TRANSFUSION, V50, P1370, DOI 10.1111/j.1537-2995.2010.02630.x; Murphy GJ, 2007, CIRCULATION, V116, P2544, DOI 10.1161/CIRCULATIONAHA.107.698977; Napolitano LM, 2009, J TRAUMA, V67, P1439, DOI 10.1097/TA.0b013e3181ba7074; Pita-Ramirez L, 1999, REV INVEST CLIN, V51, P89; Qiao Q, 2012, J INT MED RES, V40, P1114, DOI 10.1177/147323001204000331; Raghavan M, 2005, CHEST, V127, P295, DOI 10.1378/chest.127.1.295; Robinson WP, 2005, J TRAUMA, V58, P437, DOI 10.1097/01.TA.0000153935.18997.14; Stanworth SJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10129; Stanworth SJ, 2004, BRIT J HAEMATOL, V126, P139, DOI 10.1111/j.1365-2141.2004.04973.x; Tavares M, 2011, TRANSFUSION, V51, P754, DOI 10.1111/j.1537-2995.2010.02900.x; Taylor RW, 2002, CRIT CARE MED, V30, P2249, DOI 10.1097/00003246-200210000-00012; Tinmouth AT, 2011, CRIT CARE, V15, DOI 10.1186/cc10215; Wu WC, 2001, NEW ENGL J MED, V345, P1230, DOI 10.1056/NEJMoa010615; [No title captured]	29	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126895	10.1371/journal.pone.0126895	http://dx.doi.org/10.1371/journal.pone.0126895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010247	gold, Green Published, Green Submitted			2022-12-26	WOS:000355183900045
J	Calcott, RD; Berkman, ET				Calcott, Rebecca D.; Berkman, Elliot T.			Neural Correlates of Attentional Flexibility during Approach and Avoidance Motivation	PLOS ONE			English	Article							COGNITIVE CONTROL; POSITIVE AFFECT; REWARD; DOPAMINE; ACTIVATION; GOALS	Dynamic, momentary approach or avoidance motivational states have downstream effects on eventual goal success and overall well being, but there is still uncertainty about how those states affect the proximal neurocognitive processes (e.g., attention) that mediate the longer-term effects. Attentional flexibility, or the ability to switch between different attentional foci, is one such neurocognitive process that influences outcomes in the long run. The present study examined how approach and avoidance motivational states affect the neural processes involved in attentional flexibility using fMRI with the aim of determining whether flexibility operates via different neural mechanisms under these different states. Attentional flexibility was operationalized as subjects' ability to switch between global and local stimulus features. In addition to subjects' motivational state, the task context was manipulated by varying the ratio of global to local trials in a block in light of recent findings about the moderating role of context on motivation-related differences in attentional flexibility. The neural processes involved in attentional flexibility differ under approach versus avoidance states. First, differences in the preparatory activity in key brain regions suggested that subjects' preparedness to switch was influenced by motivational state (anterior insula) and the interaction between motivation and context (superior temporal gyrus, inferior parietal lobule). Additionally, we observed motivation-related differences the anterior cingulate cortex during switching. These results provide initial evidence that motivation-induced behavioral changes may arise via different mechanisms in approach versus avoidance motivational states.	[Calcott, Rebecca D.; Berkman, Elliot T.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	University of Oregon	Calcott, RD (corresponding author), Univ Oregon, Dept Psychol, Eugene, OR 97403 USA.	rcalcott@uoregon.edu	Berkman, Elliot T./Q-5233-2016	Berkman, Elliot T./0000-0002-7113-5792	Natural Sciences and Engineering Research Council of Canada (NSERC); NIH [P50 DA035763, R01 AG048840, R21 CA175241]; NATIONAL CANCER INSTITUTE [R21CA175241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG048840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA035763] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	RDC was supported by a Postgraduate Scholarship (PGS-D) from the Natural Sciences and Engineering Research Council of Canada (NSERC http://www.nserc-crsng.gc.ca/). ETB received support from NIH grants P50 DA035763, R01 AG048840, and R21 CA175241 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts E, 2010, NEUROPSYCHOPHARMACOL, V35, P1943, DOI 10.1038/npp.2010.68; Avila C, 2012, SOC COGN AFFECT NEUR, V7, P423, DOI 10.1093/scan/nsr028; Berkman ET, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040334; Berkman ET, 2010, J COGNITIVE NEUROSCI, V22, P1970, DOI 10.1162/jocn.2009.21317; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Calcott RD, 2014, J EXP PSYCHOL GEN, V143, P1393, DOI 10.1037/a0035060; Chartrand TL, 1996, J PERS SOC PSYCHOL, V71, P464, DOI 10.1037/0022-3514.71.3.464; Chiew KS, 2014, COGN AFFECT BEHAV NE, V14, P509, DOI 10.3758/s13415-014-0280-0; Chiew KS, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00015; Elliot AJ, 1997, J PERS SOC PSYCHOL, V72, P218, DOI 10.1037/0022-3514.72.1.218; Elliot AJ, 2011, J PERS, V79, P643, DOI 10.1111/j.1467-6494.2011.00694.x; Falk E, 2009, EMS STIMULUS SOFTWAR; Fraley RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109019; Friedman RS, 2000, J PERS SOC PSYCHOL, V79, P477, DOI 10.1037//0022-3514.79.4.477; Frober K, 2014, COGN AFFECT BEHAV NE, V14, P530, DOI 10.3758/s13415-014-0259-x; Gable P, 2010, PSYCHOL SCI, V21, P211, DOI 10.1177/0956797609359622; Gable PA, 2008, PSYCHOL SCI, V19, P476, DOI 10.1111/j.1467-9280.2008.02112.x; Giuliani NR, 2013, APPETITE, V64, P56, DOI 10.1016/j.appet.2012.12.020; Harmon-Jones E, 2013, EMOT REV, V5, P291, DOI 10.1177/1754073913477509; Harmon-Jones E, 2011, BIOL PSYCHOL, V87, P311, DOI 10.1016/j.biopsycho.2011.03.009; Harmon-Jones E, 2009, PSYCHOL SCI, V20, P1209, DOI 10.1111/j.1467-9280.2009.02416.x; Hedden T, 2010, NEUROIMAGE, V51, P421, DOI 10.1016/j.neuroimage.2010.01.089; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Koch S, 2008, COGNITION, V109, P133, DOI 10.1016/j.cognition.2008.07.014; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Leber AB, 2008, P NATL ACAD SCI USA, V105, P13592, DOI 10.1073/pnas.0805423105; Liu Y, 2014, PSYCHOL SCI, V25, P1116, DOI 10.1177/0956797614525213; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Palmiter R. D., 2011, ANN NY ACAD SCI, V1129, P35; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Roskes M, 2014, CURR DIR PSYCHOL SCI, V23, P133, DOI 10.1177/0963721414524224; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007	32	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127203	10.1371/journal.pone.0127203	http://dx.doi.org/10.1371/journal.pone.0127203			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7GR	26000735	gold, Green Published, Green Submitted			2022-12-26	WOS:000354931700044
J	Chojnacka, A; Szczesny, P; Blaszczyk, MK; Zielenkiewicz, U; Detman, A; Salamon, A; Sikora, A				Chojnacka, Aleksandra; Szczesny, Pawel; Blaszczyk, Mieczyslaw K.; Zielenkiewicz, Urszula; Detman, Anna; Salamon, Agnieszka; Sikora, Anna			Noteworthy Facts about a Methane-Producing Microbial Community Processing Acidic Effluent from Sugar Beet Molasses Fermentation	PLOS ONE			English	Article							COENZYME-M-REDUCTASE; 2-STAGE ANAEROBIC-DIGESTION; A MCRA GENES; METHANOGENIC ARCHAEA; ELECTRON-TRANSFER; BIOGAS REACTOR; SLUDGE BED; FOOD WASTE; HYDROGEN; BACTERIAL	Anaerobic digestion is a complex process involving hydrolysis, acidogenesis, acetogenesis and methanogenesis. The separation of the hydrogen-yielding (dark fermentation) and methane-yielding steps under controlled conditions permits the production of hydrogen and methane from biomass. The characterization of microbial communities developed in bioreactors is crucial for the understanding and optimization of fermentation processes. Previously we developed an effective system for hydrogen production based on long-term continuous microbial cultures grown on sugar beet molasses. Here, the acidic effluent from molasses fermentation was used as the substrate for methanogenesis in an upflow anaerobic sludge blanket bioreactor. This study focused on the molecular analysis of the methaneyielding community processing the non-gaseous products of molasses fermentation. The substrate for methanogenesis produces conditions that favor the hydrogenotrophic pathway of methane synthesis. Methane production results from syntrophic metabolism whose key process is hydrogen transfer between bacteria and methanogenic Archaea. High-throughput 454 pyrosequencing of total DNA isolated from the methanogenic microbial community and bioinformatic sequence analysis revealed that the domain Bacteria was dominated by Firmicutes (mainly Clostridia), Bacteroidetes, delta- and gamma-Proteobacteria, Cloacimonetes and Spirochaetes. In the domain Archaea, the order Methanomicrobiales was predominant, with Methanoculleus as the most abundant genus. The second and third most abundant members of the Archaeal community were representatives of the Methanomassiliicoccales and the Methanosarcinales. Analysis of the methanogenic sludge by scanning electron microscopy with Energy Dispersive X-ray Spectroscopy and X-ray diffraction showed that it was composed of small highly heterogeneous mineral-rich granules. Mineral components of methanogenic granules probably modulate syntrophic metabolism and methanogenic pathways. A rough functional analysis from shotgun data of the metagenome demonstrated that our knowledge of methanogenesis is poor and/or the enzymes responsible for methane production are highly effective, since despite reasonably good sequencing coverage, the details of the functional potential of the microbial community appeared to be incomplete.	[Chojnacka, Aleksandra; Zielenkiewicz, Urszula; Detman, Anna; Sikora, Anna] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Szczesny, Pawel] Warsaw Univ, Fac Biol, Warsaw, Poland; [Blaszczyk, Mieczyslaw K.] Warsaw Univ Life Sci, Fac Agr & Biol, Warsaw, Poland; [Salamon, Agnieszka] Inst Agr & Food Biotechnol, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw; Warsaw University of Life Sciences	Sikora, A (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	annaw@ibb.waw.pl	Detman, Anna/ABE-8013-2020; Sikora, Anna/Y-4216-2019; Chojnacka, Aleksandra/HGA-7394-2022	Detman, Anna/0000-0001-9579-7523; Sikora, Anna/0000-0002-9464-6851; Chojnacka, Aleksandra/0000-0001-7802-1678; Zielenkiewicz, Urszula/0000-0003-0615-7546; Szczesny, Pawel/0000-0001-8442-0157	Polish Ministry of Science and Higher Education, Poland [IP2011006571]; National Centre for Research and Development, Poland [PBS1/B9/9/2012]	Polish Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); National Centre for Research and Development, Poland	This work was supported by Grant IP2011006571 awarded for the years 2012-2014, Polish Ministry of Science and Higher Education, Poland; and Grant PBS1/B9/9/2012 awarded for the years 2012-2015, The National Centre for Research and Development, Poland.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Bal A S, 2001, Indian J Environ Health, V43, P1; Bertoldo C, 2006, THE PROKARYOTES A HA, P69; Blume F, 2010, J APPL MICROBIOL, V109, P441, DOI 10.1111/j.1365-2672.2010.04682.x; Borrel G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-679; Buckel W, 2001, APPL MICROBIOL BIOT, V57, P263, DOI 10.1007/s002530100773; Cardinali-Rezende J, 2009, APPL MICROBIOL BIOT, V84, P777, DOI 10.1007/s00253-009-2071-z; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Cheng XY, 2012, BIORESOURCE TECHNOL, V114, P327, DOI 10.1016/j.biortech.2012.03.038; Cho SK, 2013, BIORESOURCE TECHNOL, V131, P210, DOI 10.1016/j.biortech.2012.12.100; Chojnacka A, 2011, BIORESOURCE TECHNOL, V102, P10057, DOI 10.1016/j.biortech.2011.08.063; Demirel Burak, 2008, Reviews in Environmental Science and Bio/Technology, V7, P173, DOI 10.1007/s11157-008-9131-1; Diaz EE, 2006, APPL ENVIRON MICROB, V72, P4942, DOI 10.1128/AEM.02985-05; Fang C, 2011, BIORESOURCE TECHNOL, V102, P1005, DOI 10.1016/j.biortech.2010.09.077; Goenrich M, 2005, J BIOL INORG CHEM, V10, P333, DOI 10.1007/s00775-005-0636-6; Goubeaud M, 1997, EUR J BIOCHEM, V243, P110, DOI 10.1111/j.1432-1033.1997.00110.x; Guwy AJ, 2011, BIORESOURCE TECHNOL, V102, P8534, DOI 10.1016/j.biortech.2011.04.051; Hallam SJ, 2003, APPL ENVIRON MICROB, V69, P5483, DOI 10.1128/AEM.69.9.5483-5491.2003; Hartzell P, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P82, DOI 10.1007/0-387-30743-5_6; Hatamoto M, 2008, APPL ENVIRON MICROB, V74, P3610, DOI 10.1128/AEM.00045-08; Hedderich R, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P1050, DOI 10.1007/0-387-30742-7_34; Huber H, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P101, DOI 10.1007/0-387-30743-5_7; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Ito T, 2011, ISME J, V5, P1844, DOI 10.1038/ismej.2011.59; Jablonski S, 2015, INT J SYST EVOL MICR, DOI [10.1099/ijs.0.000065-0, DOI 10.1099/IJS.0.000065-0]; Jaenicke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014519; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kendal M, 2006, PROKARYOTES, V3, P244, DOI DOI 10.1007/0-387-30743-5_; Kovacs E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077265; Kvesitadze G, 2012, ENERGY, V37, P94, DOI 10.1016/j.energy.2011.08.039; Li A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-3; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Limam RD, 2014, MICROBIOLOGYOPEN, V3, P157, DOI 10.1002/mbo3.144; Liu DW, 2006, WATER RES, V40, P2230, DOI 10.1016/j.watres.2006.03.029; Liu PF, 2011, APPL ENVIRON MICROB, V77, P3884, DOI 10.1128/AEM.00190-11; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Lu XY, 2013, BIORESOURCE TECHNOL, V148, P517, DOI 10.1016/j.biortech.2013.09.017; Meyer B, 2013, J BACTERIOL, V195, P990, DOI 10.1128/JB.01959-12; Miller J. H., 1972, EXPT MOL GENETICS, P431; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; Nasr N, 2012, BIORESOURCE TECHNOL, V111, P122, DOI 10.1016/j.biortech.2012.02.019; Nettmann E, 2008, J APPL MICROBIOL, V105, P1835, DOI 10.1111/j.1365-2672.2008.03949.x; Nishio N, 2004, ADV BIOCHEM ENG BIOT, V90, P63; Oren A, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P113, DOI 10.1007/0-387-30743-5_8; Park MJ, 2010, INT J HYDROGEN ENERG, V35, P6194, DOI 10.1016/j.ijhydene.2010.03.135; Pelletier E, 2008, J BACTERIOL, V190, P2572, DOI 10.1128/JB.01248-07; Rademacher A, 2012, FEMS MICROBIOL ECOL, V79, P785, DOI 10.1111/j.1574-6941.2011.01265.x; Rastogi G, 2008, BIORESOURCE TECHNOL, V99, P5317, DOI 10.1016/j.biortech.2007.11.024; Regueiro L, 2012, MICROBIOL RES, V167, P581, DOI 10.1016/j.micres.2012.06.002; ROUVIERE PE, 1988, J BACTERIOL, V170, P3946, DOI 10.1128/jb.170.9.3946-3952.1988; Sakai S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022898; Schink B, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P309, DOI 10.1007/0-387-30742-7_11; Schluter A, 2008, J BIOTECHNOL, V136, P77, DOI 10.1016/j.jbiotec.2008.05.008; Shin HS, 2001, WATER RES, V35, P3441, DOI 10.1016/S0043-1354(01)00041-0; Shmidt A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056905, DOI 10.1371/JOURNAL.PONE.0056905]; Sieber JR, 2012, ANNU REV MICROBIOL, V66, P429, DOI 10.1146/annurev-micro-090110-102844; Sikora A., 2013, LACTIC ACID BACTERIA; Sikora A, 2011, J MICROBIOL BIOTECHN, V21, P305, DOI 10.4014/jmb.1006.06022; Stams AJM, 2009, NAT REV MICROBIOL, V7, P568, DOI 10.1038/nrmicro2166; Struchtemeyer CG, 2011, FEMS MICROBIOL ECOL, V76, P289, DOI 10.1111/j.1574-6941.2011.01046.x; Sundberg C, 2013, FEMS MICROBIOL ECOL, V85, P612, DOI 10.1111/1574-6941.12148; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Ueno Y, 2007, ENVIRON SCI TECHNOL, V41, P1413, DOI 10.1021/es062127f; Wirth R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-41; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595; Zheng X, 2013, ENVIRON SCI TECHNOL, V47, P4262, DOI 10.1021/es400210v; Zhu CG, 2011, MICROBIOL RES, V166, P27, DOI 10.1016/j.micres.2010.01.004	68	44	46	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0128008	10.1371/journal.pone.0128008	http://dx.doi.org/10.1371/journal.pone.0128008			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000448	Green Published, gold, Green Submitted			2022-12-26	WOS:000354931700098
J	Chou, CL; Lee, WR; Yeh, CC; Shih, CC; Chen, TL; Liao, CC				Chou, Chia-Lun; Lee, Woan-Ruoh; Yeh, Chun-Chieh; Shih, Chun-Chuan; Chen, Ta-Liang; Liao, Chien-Chang			Adverse Outcomes after Major Surgery in Patients with Pressure Ulcer: A Nationwide Population-Based Retrospective Cohort Study	PLOS ONE			English	Article							RISK-FACTORS; DIABETES-MELLITUS; PREVENTION; INFECTION; INJURY; CARE; ATHEROSCLEROSIS; DETERMINANTS; INFLAMMATION; MORTALITY	Background Postoperative adverse outcomes in patients with pressure ulcer are not completely understood. This study evaluated the association between preoperative pressure ulcer and adverse events after major surgeries. Methods Using reimbursement claims from Taiwan's National Health Insurance Research Database, we conducted a nationwide retrospective cohort study of 17391 patients with preoperative pressure ulcer receiving major surgery in 2008-2010. With a propensity score matching procedure, 17391 surgical patients without pressure ulcer were selected for comparison. Eight major surgical postoperative complications and 30-day postoperative mortality were evaluated among patients with pressure ulcer of varying severity. Results Patients with preoperative pressure ulcer had significantly higher risk than controls for postoperative adverse outcomes, including septicemia, pneumonia, stroke, urinary tract infection, and acute renal failure. Surgical patients with pressure ulcer had approximately 1.83-fold risk (95% confidence interval 1.54-2.18) of 30-day postoperative mortality compared with control group. The most significant postoperative mortality was found in those with serious pressure ulcer, such as pressure ulcer with local infection, cellulitis, wound or treatment by change dressing, hospitalized care, debridement or antibiotics. Prolonged hospital or intensive care unit stay and increased medical expenditures were also associated with preoperative pressure ulcer. Conclusion This nationwide propensity score-matched retrospective cohort study showed increased postoperative complications and mortality in patients with preoperative pressure ulcer. Our findings suggest the urgency of preventing and managing preoperative pressure ulcer by a multidisciplinary medical team for this specific population.	[Chou, Chia-Lun; Lee, Woan-Ruoh] Taipei Med Univ, Coll Med, Sch Med, Dept Dermatol, Taipei, Taiwan; [Chou, Chia-Lun; Lee, Woan-Ruoh] Taipei Med Univ, Shuang Ho Hosp, Dept Dermatol, New Taipei City, Taiwan; [Lee, Woan-Ruoh] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Yeh, Chun-Chieh] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Yeh, Chun-Chieh] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Shih, Chun-Chuan] I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Ctr Hlth Policy Res, Taipei, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Taipei, Taiwan; [Liao, Chien-Chang] China Med Univ, Sch Chinese Med, Taichung, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; I Shou University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; China Medical University Taiwan	Liao, CC (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan.	ccliao@tmu.edu.tw	Yeh, Chun Chieh/Y-3304-2019; Yeh, Chun Chieh/I-4893-2019	Yeh, Chun Chieh/0000-0001-6753-7564	National Science Council, Taiwan [NSC102-2314-B-038-021-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the National Science Council, Taiwan (NSC102-2314-B-038-021-MY3). No other funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, Decubitus, V2, P24; Bergstrom N, 2005, J AM GERIATR SOC, V53, P1721, DOI 10.1111/j.1532-5415.2005.53506.x; Bower WF, 2010, SURGERY, V147, P670, DOI 10.1016/j.surg.2009.10.070; Braga IA, 2013, J HOSP INFECT, V83, P314, DOI 10.1016/j.jhin.2012.11.008; Brem H, 2010, AM J SURG, V200, P473, DOI 10.1016/j.amjsurg.2009.12.021; Bronneberg D, 2007, EXP DERMATOL, V16, P567, DOI 10.1111/j.1600-0625.2007.00566.x; BROOKE OG, 1970, BMJ-BRIT MED J, V4, P218, DOI 10.1136/bmj.4.5729.218; BRYAN CS, 1983, ARCH INTERN MED, V143, P2093, DOI 10.1001/archinte.143.11.2093; Chou R, 2013, ANN INTERN MED, V159, P28, DOI 10.7326/0003-4819-159-1-201307020-00006; Cushing CA, 2013, PLAST RECONSTR SURG, V132, P1720, DOI 10.1097/PRS.0b013e3182a808ba; Daley J, 1997, J AM COLL SURGEONS, V185, P328, DOI 10.1016/S1072-7515(01)00939-5; Feuchtinger J, 2005, HEART LUNG, V34, P375, DOI 10.1016/j.hrtlng.2005.04.004; Frankel H, 2007, AM SURGEON, V73, P1215; Garcia AD, 2006, MED CLIN N AM, V90, P925, DOI 10.1016/j.mcna.2006.05.018; Graves N, 2005, INFECT CONT HOSP EP, V26, P293, DOI 10.1086/502542; Hanan K, 1991, Ostomy Wound Manage, V33, P22; HOSHOWSKY VM, 1994, RES NURS HEALTH, V17, P333, DOI 10.1002/nur.4770170504; Kanj LF, 1998, J AM ACAD DERMATOL, V38, P517, DOI 10.1016/S0190-9622(98)70113-6; Khor HM, 2014, ARCH GERONTOL GERIAT, V59, P536, DOI 10.1016/j.archger.2014.07.011; Khuri SF, 2005, ANN SURG, V242, P326, DOI 10.1097/01.sla.0000179621.33268.83; Lardenoye JWHP, 2009, DERMATOL SURG, V35, P1797, DOI 10.1111/j.1524-4725.2009.01293.x; Liao CC, 2014, DIABETES CARE, V37, P2246, DOI 10.2337/dc13-2957; Liao CC, 2013, ANN SURG, V257, P433, DOI 10.1097/SLA.0b013e31827b9b25; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin CS, 2013, BRIT J SURG, V100, P1784, DOI 10.1002/bjs.9312; Lindgren M, 2005, J ADV NURS, V50, P605, DOI 10.1111/j.1365-2648.2005.03441.x; Lindsberg PJ, 2003, STROKE, V34, P2518, DOI 10.1161/01.STR.0000089015.51603.CC; Lyder CH, 2003, JAMA-J AM MED ASSOC, V289, P223, DOI 10.1001/jama.289.2.223; Marchant MH, 2009, J BONE JOINT SURG AM, V91A, P1621, DOI 10.2106/JBJS.H.00116; Mashour GA, 2011, ANESTHESIOLOGY, V114, P1289, DOI 10.1097/ALN.0b013e318216e7f4; Mattila KJ, 1998, CLIN INFECT DIS, V26, P719, DOI 10.1086/514570; Medical Advisory Secretariat, 2009, Ont Health Technol Assess Ser, V9, P1; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sabate S, 2011, BRIT J ANAESTH, V107, P879, DOI 10.1093/bja/aer268; Saito Y, 2008, J INVEST DERMATOL, V128, P1838, DOI 10.1038/sj.jid.5701258; Schoonhoven L, 2002, J CLIN NURS, V11, P479, DOI 10.1046/j.1365-2702.2002.00621.x; Smith MEB, 2013, ANN INTERN MED, V159, P39, DOI 10.7326/0003-4819-159-1-201307020-00007; SUGARMAN B, 1982, JAMA-J AM MED ASSOC, V248, P66, DOI 10.1001/jama.248.1.66; Tarnuzzer Roy W., 1996, Wound Repair and Regeneration, V4, P321, DOI 10.1046/j.1524-475X.1996.40307.x; TEASELL R, 1993, CAN FAM PHYSICIAN, V39, P1440; Thomas DR, 1996, J AM GERIATR SOC, V44, P1435, DOI 10.1111/j.1532-5415.1996.tb04067.x; Tschannen D, 2012, AM J CRIT CARE, V21, P116, DOI 10.4037/ajcc2012716; WOOLSEY RM, 1991, NEUROL CLIN, V9, P797, DOI 10.1016/S0733-8619(18)30280-9; Yeh CC, 2013, DIABETES CARE, V36, P3216, DOI 10.2337/dc13-0770	45	23	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127731	10.1371/journal.pone.0127731	http://dx.doi.org/10.1371/journal.pone.0127731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7GR	26000606	Green Submitted, Green Published, gold			2022-12-26	WOS:000354931700077
J	Zhang, M; Harashima, N; Moritani, T; Huang, WD; Harada, M				Zhang, Min; Harashima, Nanae; Moritani, Tamami; Huang, Weidong; Harada, Mamoru			The Roles of ROS and Caspases in TRAIL-Induced Apoptosis and Necroptosis in Human Pancreatic Cancer Cells	PLOS ONE			English	Article							DEPENDENT NECROSIS; DNA-DAMAGE; TNF-ALPHA; AUTOPHAGY; DEATH; RECEPTOR; RESISTANCE; KINASE; MITOCHONDRIA; ACTIVATION	Death signaling provided by tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) can induce death in cancer cells with little cytotoxicity to normal cells; this cell death has been thought to involve caspase-dependent apoptosis. Reactive oxygen species (ROS) are also mediators that induce cell death, but their roles in TRAIL-induced apoptosis have not been elucidated fully. In the current study, we investigated ROS and caspases in human pancreatic cancer cells undergoing two different types of TRAIL-induced cell death, apoptosis and necroptosis. TRAIL treatment increased ROS in two TRAIL-sensitive pancreatic cancer cell lines, MiaPaCa-2 and BxPC-3, but ROS were involved in TRAIL-induced apoptosis only in MiaPaCa-2 cells. Unexpectedly, inhibition of ROS by either N-acetyl-L-cysteine (NAC), a peroxide inhibitor, or Tempol, a superoxide inhibitor, increased the annexin V-/propidium iodide (PI)(+) early necrotic population in TRAIL-treated cells. Additionally, both necrostatin-1, an inhibitor of receptor-interacting protein kinase 1 (RIP1), and siRNA-mediated knockdown of RIP3 decreased the annexin V-/PI+ early necrotic population after TRAIL treatment. Furthermore, an increase in early apoptosis was induced in TRAIL-treated cancer cells under inhibition of either caspase-2 or -9. Caspase-2 worked upstream of caspase-9, and no crosstalk was observed between ROS and caspase-2/-9 in TRAIL-treated cells. Together, these results indicate that ROS contribute to TRAIL-induced apoptosis in MiaPaCa-2 cells, and that ROS play an inhibitory role in TRAIL-induced necroptosis of MiaPaCa-2 and BxPC-3 cells, with caspase-2 and -9 playing regulatory roles in this process.	[Zhang, Min; Huang, Weidong] Ningxia Med Univ, Dept Biochem & Mol Biol, Yinchuan, Peoples R China; [Zhang, Min; Harashima, Nanae; Moritani, Tamami; Harada, Mamoru] Shimane Univ, Fac Med, Dept Immunol, Izumi, Shimane, Japan	Ningxia Medical University; Shimane University	Harada, M (corresponding author), Shimane Univ, Fac Med, Dept Immunol, Izumi, Shimane, Japan.	haramamo@med.shimane-u.ac.jp			Ministry of Education, Science, Sport, Culture, and Technology of Japan [25430150, 24501331]; Shimane University "SUIGANN" Project; Grants-in-Aid for Scientific Research [25430150] Funding Source: KAKEN	Ministry of Education, Science, Sport, Culture, and Technology of Japan; Shimane University "SUIGANN" Project; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by grants from the Ministry of Education, Science, Sport, Culture, and Technology of Japan (no. 25430150 to N. H., and no. 24501331 to M. H.) and from the Shimane University "SUIGANN" Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasan A, 2003, CYTOKINE GROWTH F R, V14, P337, DOI 10.1016/S1359-6101(03)00029-7; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Delhalle S, 2002, ONCOGENE, V21, P3917, DOI 10.1038/sj.onc.1205489; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Ebrahimi B, 2004, CANCER-AM CANCER SOC, V101, P2727, DOI 10.1002/cncr.20672; Gewirtz DA, 2014, CANCER RES, V74, P647, DOI 10.1158/0008-5472.CAN-13-2966; Goossens V, 1999, BIOFACTORS, V10, P145, DOI 10.1002/biof.5520100210; Green DR, 2011, MOL CELL, V44, P9, DOI 10.1016/j.molcel.2011.09.003; Han J, 2008, J BIOL CHEM, V283, P19665, DOI 10.1074/jbc.M710169200; Harashima N, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-217; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Herbst RS, 2010, J CLIN ONCOL, V28, P2839, DOI 10.1200/JCO.2009.25.1991; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jouan-Lanhouet S, 2012, CELL DEATH DIFFER, V19, P2003, DOI 10.1038/cdd.2012.90; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Karl I, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.404; Kim BM, 2012, APOPTOSIS, V17, P200, DOI 10.1007/s10495-011-0665-2; Konopleva M, 1999, ADV EXP MED BIOL, V457, P217; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Liu Y, 2014, CANCER SCI, V105, P520, DOI 10.1111/cas.12395; Mellier G, 2012, FREE RADICAL RES, V46, P996, DOI 10.3109/10715762.2012.690514; Meurette O, 2007, CANCER RES, V67, P218, DOI 10.1158/0008-5472.CAN-06-1610; Monma H, 2013, MOL CANCER THER, V12, P341, DOI 10.1158/1535-7163.MCT-12-0954; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Nagaraj NS, 2011, CLIN CANCER RES, V17, P483, DOI 10.1158/1078-0432.CCR-10-1670; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Park KJ, 2012, J BIOL CHEM, V287, P3313, DOI 10.1074/jbc.M111.309021; Perez-Cruz I, 2003, BLOOD, V102, P336, DOI 10.1182/blood-2002-11-3559; Prasad V, 2006, FREE RADICAL BIO MED, V41, P431, DOI 10.1016/j.freeradbiomed.2006.03.009; Puccini J, 2013, CELL DEATH DIFFER, V20, P1133, DOI 10.1038/cdd.2013.87; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Shimojo Y, 2013, CLIN EXP METASTAS, V30, P143, DOI 10.1007/s10585-012-9519-8; Shin S, 2005, EMBO J, V24, P3532, DOI 10.1038/sj.emboj.7600827; Singh KK, 2006, ANN NY ACAD SCI, V1067, P182, DOI 10.1196/annals.1354.022; Soria JC, 2011, J CLIN ONCOL, V29, P4442, DOI 10.1200/JCO.2011.37.2623; Suzuki-Karasaki Y, 2014, FRONTIERS IN ONCOL, V4, P1; Temkin V, 2006, MOL CELL BIOL, V26, P2215, DOI 10.1128/MCB.26.6.2215-2225.2006; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Tiwari M, 2014, AUTOPHAGY, V10, P1054, DOI 10.4161/auto.28528; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Wagner KW, 2004, J BIOL CHEM, V279, P35047, DOI 10.1074/jbc.M400708200; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhivotovsky B, 2005, BIOCHEM BIOPH RES CO, V331, P859, DOI 10.1016/j.bbrc.2005.03.191	52	71	78	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127386	10.1371/journal.pone.0127386	http://dx.doi.org/10.1371/journal.pone.0127386			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000607	Green Submitted, gold, Green Published			2022-12-26	WOS:000354931700056
J	Koepfli, C; Robinson, LJ; Rarau, P; Salib, M; Sambale, N; Wampfler, R; Betuela, I; Nuitragool, W; Barry, AE; Siba, P; Felger, I; Mueller, I				Koepfli, Cristian; Robinson, Leanne J.; Rarau, Patricia; Salib, Mary; Sambale, Naomi; Wampfler, Rahel; Betuela, Inoni; Nuitragool, Wang; Barry, Alyssa E.; Siba, Peter; Felger, Ingrid; Mueller, Ivo			Blood-Stage Parasitaemia and Age Determine Plasmodium falciparum and P-vivax Gametocytaemia in Papua New Guinea	PLOS ONE			English	Article							RISK-FACTORS; INFECTIOUS RESERVOIR; HUMAN-POPULATIONS; ENDEMIC REGION; CARRIAGE; MALARIA; TIME; TRANSMISSION; CHILDREN; EPIDEMIOLOGY	A better understanding of human-to-mosquito transmission is crucial to control malaria. In order to assess factors associated with gametocyte carriage, 2083 samples were collected in a cross-sectional survey in Papua New Guinea. Plasmodium species were detected by light microscopy and qPCR and gametocytes by detection of pfs25 and pvs25mRNA transcripts by reverse-transcriptase PCR (qRT-PCR). The parasite prevalence by PCR was 18.5% for Plasmodium falciparum and 13.0% for P. vivax. 52.5% of all infections were submicroscopic. Gametocytes were detected in 60% of Plasmodium falciparum-positive and 51% of P. vivax-positive samples. Each 10-fold increase in parasite density led to a 1.8-fold and 3.3-fold increase in the odds of carrying P. falciparum and P. vivax gametocytes. Thus the proportion of gametocyte positive and gametocyte densities was highest in young children carrying high asexual parasite densities and in symptomatic individuals. Dilution series of gametocytes allowed absolute quantification of gametocyte densities by qRT-PCR and showed that pvs25expression is 10-20 fold lower than pfs25expression. Between 2006 and 2010 parasite prevalence in the study site has decreased by half. 90% of the remaining infections were asymptomatic and likely constitute an important reservoir of transmission. However, mean gametocyte densities were low (approx. 1-2 gametocyte/mu L) and it remains to be determined to what extent low-density gametocyte positive individuals are infective to mosquitos.	[Koepfli, Cristian; Robinson, Leanne J.; Barry, Alyssa E.; Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun Div, Parkville, Vic, Australia; [Koepfli, Cristian; Robinson, Leanne J.; Barry, Alyssa E.; Mueller, Ivo] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Robinson, Leanne J.; Rarau, Patricia; Salib, Mary; Sambale, Naomi; Betuela, Inoni; Siba, Peter] Papua New Guinea Inst Med Res, Vector Borne Dis Unit, Madang, Papua N Guinea; [Wampfler, Rahel; Felger, Ingrid] Swiss Trop & Publ Hlth Inst, Med Parasitol & Infect Biol, Basel, Switzerland; [Wampfler, Rahel; Felger, Ingrid] Univ Basel, Basel, Switzerland; [Nuitragool, Wang] Mahidol Univ, Fac Trop Med, Bangkok 10700, Thailand; [Mueller, Ivo] ISGlobal, Barcelona Ctr Int Hlth Res, Barcelona, Spain	Walter & Eliza Hall Institute; University of Melbourne; PNG Institute Of Medical Research; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Mahidol University; ISGlobal; CRESIB	Mueller, I (corresponding author), Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun Div, Parkville, Vic, Australia.	ivomueller@fastmail.fm	Koepfli, Cristian/H-8772-2019	Koepfli, Cristian/0000-0002-9354-0414; Felger, Ingrid/0000-0003-1255-2606; Rarau, Patricia/0000-0003-0795-4686; Nguitragool, Wang/0000-0002-5484-7130; Barry, Alyssa/0000-0002-1189-2310	TransEPI consortium - Bill & Melinda Gates Foundation; NHMRC project grant [1021455]; Swiss National Science Foundation grant [310030_134889]; NIH International Centers of Excellence in Malaria Research grant [U19 AI089686]; NHMRC Early Career Fellowship [1016443]; NHMRC Senior Research Fellowship [1043345]; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089686] Funding Source: NIH RePORTER	TransEPI consortium - Bill & Melinda Gates Foundation; NHMRC project grant(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation grant(Swiss National Science Foundation (SNSF)); NIH International Centers of Excellence in Malaria Research grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the TransEPI consortium funded by the Bill & Melinda Gates Foundation (www.gatesfoundation.org), and an NHMRC project grant (#1021455, www.nhmrc.gov.au), Swiss National Science Foundation grant (310030_134889, www.snf.ch), and NIH International Centers of Excellence in Malaria Research grant (U19 AI089686, www.niaid.nih.gov). Samples were collected as part of the Bill & Melinda Gates Foundation funded PNG IPTi study. This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. LJ Robinson is supported by an NHMRC Early Career Fellowship (#1016443). IM is supported by an NHMRC Senior Research Fellowship (#1043345). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2014, BLOOD, V123, P959, DOI 10.1182/blood-2013-08-520767; Arnott A, 2013, AM J TROP MED HYG; Beurskens M, 2009, AM J TROP MED HYG, V81, P366, DOI 10.4269/ajtmh.2009.81.366; Bharti AR, 2006, AM J TROP MED HYG, V75, P610, DOI 10.4269/ajtmh.2006.75.610; Bousema JT, 2006, J INFECT DIS, V193, P1151, DOI 10.1086/503051; Bousema JT, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-18; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Bousema T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-136; Carter R., 1988, MALARIA PRINCIPLES P, P253; CATTANI JA, 1986, AM J TROP MED HYG, V35, P3, DOI 10.4269/ajtmh.1986.35.3; CLEMENTS AN, 2000, BIOL MOSQUITOES, V1; Coleman RE, 2004, J MED ENTOMOL, V41, P201, DOI 10.1603/0022-2585-41.2.201; Douglas NM, 2013, J INFECT DIS, V208, P801, DOI 10.1093/infdis/jit261; El-Sayed B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001311; GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P479, DOI 10.4269/ajtmh.1991.45.479; Garnham PCC., 1966, MALARIA PARASITES OT; Gneme A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-67; GRAVES PM, 1988, PARASITOLOGY, V96, P251, DOI 10.1017/S003118200005825X; Hasugian AR, 2007, CLIN INFECT DIS, V44, P1067, DOI 10.1086/512677; Hetzel MW, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-192; Huh AJ, 2011, J KOREAN MED SCI, V26, P42, DOI 10.3346/jkms.2011.26.1.42; Koepfli C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001424; Kuamsab N, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-190; Laman M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-145; Lima NF, 2012, EXP PARASITOL, V132, P348, DOI 10.1016/j.exppara.2012.08.010; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; Mawili-Mboumba DP, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-375; McCarthy JS, 2013, J INFECT DIS; McKenzie FE, 2006, J PARASITOL, V92, P1281, DOI 10.1645/GE-911R.1; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Ouedraogo AL, 2007, AM J TROP MED HYG, V76, P626, DOI 10.4269/ajtmh.2007.76.626; Ouedraogo AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008410; Pain A, 2001, P NATL ACAD SCI USA, V98, P1805, DOI 10.1073/pnas.98.4.1805; Pethleart A, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-34; Price R, 1999, AM J TROP MED HYG, V60, P1019, DOI 10.4269/ajtmh.1999.60.1019; Rosanas-Urgell A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-361; SATTABONGKOT J, 1991, PARASITOLOGY, V102, P27, DOI 10.1017/S0031182000060303; Sattabongkot J, 2003, AM J TROP MED HYG, V69, P529, DOI 10.4269/ajtmh.2003.69.529; Schneider P, 2007, AM J TROP MED HYG, V76, P470, DOI 10.4269/ajtmh.2007.76.470; Schoepflin S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-250; Schultz L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-336; Shekalaghe SA, 2007, TROP MED INT HEALTH, V12, P547, DOI 10.1111/j.1365-3156.2007.01821.x; SMALLEY ME, 1977, PARASITOLOGY, V74, P1, DOI 10.1017/S0031182000047478; Sowunmi A, 2004, PARASITOLOGY, V129, P255, DOI 10.1017/S0031182004005669; von Seidlein L, 2001, AM J TROP MED HYG, V65, P523, DOI 10.4269/ajtmh.2001.65.523; Wampfler R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076316	46	68	68	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0126747	10.1371/journal.pone.0126747	http://dx.doi.org/10.1371/journal.pone.0126747			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996916	Green Published, Green Accepted, gold			2022-12-26	WOS:000356444000031
J	Ntwenya, JE; Kinabo, J; Msuya, J; Mamiro, P; Majili, ZS				Ntwenya, Julius Edward; Kinabo, Joyce; Msuya, John; Mamiro, Peter; Majili, Zahara Saidi			Dietary Patterns and Household Food Insecurity in Rural Populations of Kilosa District, Tanzania	PLOS ONE			English	Article							ASSOCIATION; ADULTS	Introduction Few studies have investigated the relationship between dietary pattern and household food insecurity. The objective of the present analysis was to describe the food consumption patterns and to relate these with the prevalence of food insecurity in the context of a rural community. Methodology Three hundred and seven (307) randomly selected households in Kilosa district participated in the study. Data were collected during the rainy season (February-May) and post harvest season (September-October) in the year 2011. Food consumption pattern was determined using a 24-h dietary recall method. Food insecurity data were based on the 30 day recall experience to food insecurity in the household. Factor analysis method using Principal Components extraction function was used to derive the dietary patterns and correlation analysis was used to establish the existing relationship between household food insecurity and dietary patterns factor score. Results Four food consumption patterns namely (I) Meat and milk; (II) Pulses, legumes, nuts and cooking oils; (III) fish (and other sea foods), roots and tubers; (IV) Cereals, vegetables and fruits consumption patterns were identified during harvest season. Dietary patterns identified during the rainy season were as follows: (I) Fruits, cooking oils, fats, roots and tubers (II) Eggs, meat, milk and milk products (III) Fish, other sea foods, vegetables, roots and tubers and (IV) Pulses, legumes, nuts, cereals and vegetables. Household food insecurity was 80% and 69% during rainy and harvest-seasons, respectively (P = 0.01). Household food insecurity access scale score was negatively correlated with the factor scores on household dietary diversity. Conclusion Food consumption patterns and food insecurity varied by seasons with worst scenarios most prevalent during the rainy season. The risk for inadequate dietary diversity was higher among food insecure households compared to food secure households. Effort geared at alleviating household food insecurity could contribute to consumption of a wide range of food items at the household level.	[Ntwenya, Julius Edward] Univ Dodoma, Dept Publ Hlth, Dodoma, Tanzania; [Kinabo, Joyce; Msuya, John; Mamiro, Peter; Majili, Zahara Saidi] Sokoine Univ Agr, Dept Food Sci & Technol, Morogoro, Tanzania	Sokoine University of Agriculture	Ntwenya, JE (corresponding author), Univ Dodoma, Dept Publ Hlth, POB 395, Dodoma, Tanzania.	julyfather@yahoo.com		NTWENYA, JULIUS/0000-0002-4719-1970; MAJILI, ZAHRA SAIDI/0000-0002-0499-1310	International Development Research Centre (IDRC) [106025]	International Development Research Centre (IDRC)	The project was funded by International Development Research Centre (IDRC) grant number 106025, URL www.idrc.ca, Author JK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimond M, 2009, DIETARY DIVERSITY ME, P210; Becquey E, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-13; Coates J, 2007, HOUSEHOLD FOOD INSEC, P32; Denova-Gutierrez E, 2010, J NUTR, V140, P1855, DOI 10.3945/jn.110.122671; FAO, 2013, STAT FOOD AGR, P114; FAO, 2013, STATE HUNGER BUILDIN; FAO, 2011, GLOBAL FOOD LOSSES F; Johnson JS, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.17345; Kesse-Guyot E, 2012, J NUTR, V142, P909, DOI 10.3945/jn.111.156257; Moore LL, 2012, NUTRIENTS, V4, P1692, DOI 10.3390/nu4111692; National Bureau of Statistics, 2012, 2012 POP HOUS CENS, P264; Nie N H, 1968, SPSS COMPUTER PROGRA; Quirk SE, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-175; Smith ADAC, 2011, EUR J CLIN NUTR, V65, P1102, DOI 10.1038/ejcn.2011.96; Swindale A, 2006, J NUTR, V136, P1449, DOI 10.1093/jn/136.5.1449S; United Republic of Tanzania, 2012, NAT SAMPL CENS AGR 2, P345	16	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0126038	10.1371/journal.pone.0126038	http://dx.doi.org/10.1371/journal.pone.0126038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996146	Green Published, Green Submitted, gold			2022-12-26	WOS:000356444000015
J	Ciaccio, C; Ocana-Calahorro, F; Droghetti, E; Tundo, GR; Sanz-Luque, E; Polticelli, F; Visca, P; Smulevich, G; Ascenzi, P; Coletta, M				Ciaccio, Chiara; Ocana-Calahorro, Francisco; Droghetti, Enrica; Tundo, Grazia R.; Sanz-Luque, Emanuel; Polticelli, Fabio; Visca, Paolo; Smulevich, Giulietta; Ascenzi, Paolo; Coletta, Massimo			Functional and Spectroscopic Characterization of Chlamydomonas reinhardtii Truncated Hemoglobins	PLOS ONE			English	Article							AUTOMATED PROTEIN-STRUCTURE; NITRITE REDUCTASE-ACTIVITY; KINETIC EVIDENCE; I-TASSER; LIGAND; OXIDE; HEMOPROTEINS; DIVERSITY; BACTERIAL; BINDING	The single-cell green alga Chlamydomonas reinhardtii harbors twelve truncated hemoglobins (Cr-TrHbs). Cr-TrHb1-1 and Cr-TrHb1-8 have been postulated to be parts of the nitrogen assimilation pathway, and of a NO-dependent signaling pathway, respectively. Here, spectroscopic and reactivity properties of Cr-TrHb1-1, Cr-TrHb1-2, and Cr-TrHb1-4, all belonging to clsss 1 (previously known as group N or group I), are reported. The ferric form of Cr-TrHb1-1, Cr-TrHb1-2, and Cr-TrHb1-4 displays a stable 6cLS heme-Fe atom, whereas the hexa-coordination of the ferrous derivative appears less strongly stabilized. Accordingly, kinetics of azide binding to ferric Cr-TrHb1-1, Cr-TrHb1-2, and Cr-TrHb1-4 are independent of the ligand concentration. Conversely, kinetics of CO or NO2- binding to ferrous CrTrHb1- 1, Cr-TrHb1-2, and Cr-TrHb1-4 are ligand-dependent at low CO or NO2- concentrations, tending to level off at high ligand concentrations, suggesting the presence of a ratelimiting step. In agreement with the different heme-Fe environments, the pH-dependent kinetics for CO and NO2-binding to ferrous Cr-TrHb1-1, Cr-TrHb1-2, and Cr-TrHb1-4 are characterized by different ligand-linked protonation events. This raises the question of whether the simultaneous presence in C. reinhardtii of multiple TrHb1s may be related to different regulatory roles.	[Ciaccio, Chiara; Tundo, Grazia R.; Coletta, Massimo] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy; [Ciaccio, Chiara; Tundo, Grazia R.; Coletta, Massimo] Interuniv Consortium Res Chem Met Biol Syst, Bari, Italy; [Ocana-Calahorro, Francisco; Sanz-Luque, Emanuel] Univ Cordoba, Fac Sci, Dept Biochem & Mol Biol, E-14004 Cordoba, Spain; [Droghetti, Enrica; Smulevich, Giulietta] Univ Firenze, Dept Chem Ugo Schiff, Sesto Fiorentino, FI, Italy; [Polticelli, Fabio; Visca, Paolo] Univ Rome Tre, Dept Sci, I-00146 Rome, Italy; [Polticelli, Fabio] Roma Tre Univ Sect, Natl Inst Nucl Phys, Rome, Italy; [Ascenzi, Paolo] Univ Rome Tre, Interdept Lab Elect Microscopy, I-00146 Rome, Italy	University of Rome Tor Vergata; Universidad de Cordoba; University of Florence; Italfarmaco; Roma Tre University; Istituto Nazionale di Fisica Nucleare (INFN); Roma Tre University	Coletta, M (corresponding author), Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy.	coletta@seneca.uniroma2.it	Polticelli, Fabio/A-4573-2009; Coletta, Massimo/N-9049-2015; Sanz-Luque, Emanuel/Z-2166-2019; Coletta, Massimiliano/GSN-5927-2022	Polticelli, Fabio/0000-0002-7657-2019; Sanz-Luque, Emanuel/0000-0002-7300-9730; Smulevich, Giulietta/0000-0003-3021-8919; TUNDO, Grazia Raffaella/0000-0002-3866-3171; COLETTA, Massimiliano/0000-0002-5489-9467; Visca, Paolo/0000-0002-6128-7039	MINECO (Ministerio de Economia y Competitividad, Spain) [BFU2011-29338]; European FEDER program; Junta de Andalucia [P08-CVI-04157, BIO-502]; Plan Propio de la Universidad de Cordoba	MINECO (Ministerio de Economia y Competitividad, Spain); European FEDER program(European Commission); Junta de Andalucia(Junta de Andalucia); Plan Propio de la Universidad de Cordoba	Part of this work was funded by MINECO (Ministerio de Economia y Competitividad, Spain, Grant no. BFU2011-29338) with support of the European FEDER program, by the Junta de Andalucia (P08-CVI-04157 and BIO-502) and Plan Propio de la Universidad de Cordoba. F.O-C thanks MINECO for a Formacion de Personal Investigador fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascenzi P, 2008, METHOD ENZYMOL, V436, P317, DOI 10.1016/S0076-6879(08)36018-2; Ascenzi P, 2007, GENE, V398, P42, DOI 10.1016/j.gene.2007.02.043; Ascenzi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095391; Ascenzi P, 2013, J BIOL INORG CHEM, V18, P939, DOI 10.1007/s00775-013-1040-2; Blaby IK, 2014, TRENDS PLANT SCI, V19, P672, DOI 10.1016/j.tplants.2014.05.008; Coletta M, 1996, EUR J BIOCHEM, V235, P49, DOI 10.1111/j.1432-1033.1996.00049.x; COLETTA M, 1985, J BIOL CHEM, V260, P4151; COLETTA M, 1988, J BIOL CHEM, V263, P18286; Droghetti E, 2010, BIOCHEMISTRY-US, V49, P10394, DOI 10.1021/bi101452k; Egawa T, 2005, J INORG BIOCHEM, V99, P72, DOI 10.1016/j.jinorgbio.2004.10.017; Feis A, 2008, BIOCHEMISTRY-US, V47, P902, DOI 10.1021/bi701297f; Gardner PR, 2008, METHOD ENZYMOL, V436, P217, DOI 10.1016/S0076-6879(08)36012-1; Giordano D, 2011, IUBMB LIFE, V63, P566, DOI 10.1002/iub.492; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363; Hemschemeier A, 2013, P NATL ACAD SCI USA, V110, P10854, DOI 10.1073/pnas.1302592110; HORI H, 1980, J AM CHEM SOC, V102, P3608, DOI 10.1021/ja00530a049; Igarashi J, 2011, J BIOL INORG CHEM, V16, P599, DOI 10.1007/s00775-011-0761-3; Johnson EA, 2014, BIOCHEMISTRY-US, V53, P4573, DOI 10.1021/bi5005206; KITAGAWA T, 1988, BIOL APPL RAMAN SPEC, P97; Li HT, 2012, J BIOL CHEM, V287, P36623, DOI 10.1074/jbc.M112.342378; Ouellet H, 2007, BIOCHEMISTRY-US, V46, P11440, DOI 10.1021/bi7010288; Pesce A, 2000, EMBO J, V19, P2424, DOI 10.1093/emboj/19.11.2424; Pesce A, 2013, ADV MICROB PHYSIOL, V63, P49, DOI 10.1016/B978-0-12-407693-8.00002-9; Reeder BJ, 2011, BIOCHEM J, V434, P483, DOI 10.1042/BJ20101136; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sanz-Luque E, 2013, J EXP BOT, V64, P3373, DOI 10.1093/jxb/ert175; Spiro TG, 2005, J INORG BIOCHEM, V99, P34, DOI 10.1016/j.jinorgbio.2004.09.026; Spiro TG, 1988, BIOL APPL RAMAN SPEC, V3, P1; STEIN P, 1980, J AM CHEM SOC, V102, P7795, DOI 10.1021/ja00546a035; Sturms R, 2011, BIOCHEMISTRY-US, V50, P3873, DOI 10.1021/bi2004312; Tiso M, 2012, BIOCHEMISTRY-US, V51, P5285, DOI 10.1021/bi300570v; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Vinogradov SN, 2008, J BIOL CHEM, V283, P8773, DOI 10.1074/jbc.R700029200; Vinogradov SN, 2007, GENE, V398, P132, DOI 10.1016/j.gene.2007.02.041; Vinogradov SN, 2013, BBA-PROTEINS PROTEOM, V1834, P1789, DOI 10.1016/j.bbapap.2013.03.021; Vinogradov SN, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-31; Vinogradov SN, 2005, P NATL ACAD SCI USA, V102, P11385, DOI 10.1073/pnas.0502103102; Vuletich DA, 2006, J MOL EVOL, V62, P196, DOI 10.1007/s00239-005-0077-4; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200; Woody R. W., 1994, CIRCULAR DICHROISM P, P473; Xu D, 2011, PROTEINS, V79, P147, DOI 10.1002/prot.23111	41	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125005	10.1371/journal.pone.0125005	http://dx.doi.org/10.1371/journal.pone.0125005			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993270	Green Published, gold, Green Submitted			2022-12-26	WOS:000354921400022
J	Estallo, EL; Luduena-Almeida, FF; Introini, MV; Zaidenberg, M; Almiron, WR				Estallo, Elizabet L.; Luduena-Almeida, Francisco F.; Introini, Maria V.; Zaidenberg, Mario; Almiron, Walter R.			Weather Variability Associated with Aedes (Stegomyia) aegypti (Dengue Vector) Oviposition Dynamics in Northwestern Argentina	PLOS ONE			English	Article							SUBPOPULATIONS DIPTERA-CULICIDAE; BUENOS-AIRES; POPULATION-DYNAMICS; BIONOMICS; FEVER; MODEL; CITY; VARIABLES; OUTBREAK; CLIMATE	This study aims to develop a forecasting model by assessing the weather variability associated with seasonal fluctuation of Aedes aegypti oviposition dynamic at a city level in Oran, in northwestern Argentina. Oviposition dynamics were assessed by weekly monitoring of 90 ovitraps in the urban area during 2005-2007. Correlations were performed between the number of eggs collected weekly and weather variables (rainfall, photoperiod, vapor pressure of water, temperature, and relative humidity) with and without time lags (1 to 6 weeks). A stepwise multiple linear regression analysis was performed with the set of meteorological variables from the first year of study with the variables in the time lags that best correlated with the oviposition. Model validation was conducted using the data from the second year of study (October 2006-2007). Minimum temperature and rainfall were the most important variables. No eggs were found at temperatures below 10 degrees C. The most significant time lags were 3 weeks for minimum temperature and rains, 3 weeks for water vapor pressure, and 6 weeks for maximum temperature. Aedes aegypti could be expected in Oran three weeks after rains with adequate min temperatures. The best-fit forecasting model for the combined meteorological variables explained 70 % of the variance (adj. R-2). The correlation between Ae. aegypti oviposition observed and estimated by the forecasting model resulted in r(s) = 0.80 (P < 0.05). The forecasting model developed would allow prediction of increases and decreases in the Ae. aegypti oviposition activity based on meteorological data for Oran city and, according to the meteorological variables, vector activity can be predicted three or four weeks in advance.	[Estallo, Elizabet L.; Luduena-Almeida, Francisco F.; Almiron, Walter R.] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, CONICET, Ctr Invest Entomol Cordoba,Inst Invest Biol & Tec, RA-5000 Cordoba, Argentina; [Introini, Maria V.; Zaidenberg, Mario] Minist Salud Nac, Coordinac Nacl Control Vectores, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Estallo, EL (corresponding author), Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, CONICET, Ctr Invest Entomol Cordoba,Inst Invest Biol & Tec, Av Velez Sarsfield 1611,Ciudad Univ,X5016GCA, RA-5000 Cordoba, Argentina.	eelizabet@gmail.com		Estallo, Elizabet/0000-0002-6723-6929	Red Latinoamericana de Control de Vectores (RELCOV); VIGIA of the Ministerio de Salud de la Nacion (National Health Ministry); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); CONICET	Red Latinoamericana de Control de Vectores (RELCOV); VIGIA of the Ministerio de Salud de la Nacion (National Health Ministry); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was partially funded by Red Latinoamericana de Control de Vectores (RELCOV), VIGIA of the Ministerio de Salud de la Nacion (National Health Ministry), and the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET). WRA and ELE are CONICET researchers. This paper was part of the PhD of ELE (April 2010), who was supported by CONICET as doctoral student. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2011, INFOSTAT VERS 2011; [Anonymous], 2014, R LANG ENV STAT COMP; Arroyo AR, 2004, INTA DIAGNOSTICO PRO; Azil AH, 2010, TROP MED INT HEALTH, V15, P1190, DOI 10.1111/j.1365-3156.2010.02592.x; Campos Raul E., 1996, Revista de la Sociedad Entomologica Argentina, V55, P67; Carbajo AE, 2006, MED VET ENTOMOL, V20, P209, DOI 10.1111/j.1365-2915.2006.00625.x; Carbajo AE, 2004, MEDICINA-BUENOS AIRE, V64, P231; Christophers, 1960, AEDES AEGYPTI L YELL; de Garin AB, 2000, INT J BIOMETEOROL, V44, P148, DOI 10.1007/s004840000051; Dibo MR, 2008, MEM I OSWALDO CRUZ, V103, P554, DOI 10.1590/S0074-02762008000600008; Dominguez Martha C., 2000, Revista de la Sociedad Entomologica Argentina, V59, P41; Estallo EL, 2014, ACTA TROP, V136, P129, DOI 10.1016/j.actatropica.2014.04.024; Estallo EL, 2008, J AM MOSQUITO CONTR, V24, P368, DOI 10.2987/5705.1; Estallo EL, 2011, VECTOR-BORNE ZOONOT, V11, P543, DOI 10.1089/vbz.2009.0165; Tejerina EF, 2009, ACTA TROP, V109, P45, DOI 10.1016/j.actatropica.2008.09.014; Grech MG, 2010, J VECTOR ECOL, V35, P277, DOI 10.1111/j.1948-7134.2010.00083.x; Grech M, 2012, REV SAUDE PUBL, V46, P387, DOI 10.1590/S0034-89102012005000007; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263; INDEC, 2001, CENS NAC POBL HOG VI; Estallo EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054167; Estallo EL, 2012, INT J REMOTE SENS, V33, P4254, DOI 10.1080/01431161.2011.640962; Micieli MV, 2006, REV BIOL TROP, V54, P979; Micieli MV, 2003, MEM I OSWALDO CRUZ, V98, P659, DOI 10.1590/S0074-02762003000500013; Ministerio de Salud de la Nacion, 2009, B EP PER SIT DENG AR; Otero M, 2008, B MATH BIOL, V70, P1297, DOI 10.1007/s11538-008-9300-y; Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y; Reiter P., 2001, GUIDELINES ASSESSING; Reiter Paul, 1997, P425; Rodhain Francois, 1997, P45; Seijo A, 2009, MEDICINA-BUENOS AIRE, V69, P593; Service M. W., 1993, FIELD SAMPLING METHO; Vezzani D, 2004, MEM I OSWALDO CRUZ, V99, P351, DOI 10.1590/S0074-02762004000400002; Vezzani D, 2008, MEM I OSWALDO CRUZ, V103, P66, DOI 10.1590/S0074-02762008005000003; WHO, 2014, STAT ART PREV CONTR; WHO, 2012, GLOB STRAT DENG PREV, DOI [10.1371/journal.pntd.0003396, DOI 10.1371/JOURNAL.PNTD.0003396]; WHO, 2014, NUMB REP CAS SEV DEN; Wu PC, 2007, ACTA TROP, V103, P50, DOI 10.1016/j.actatropica.2007.05.014	39	27	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127820	10.1371/journal.pone.0127820	http://dx.doi.org/10.1371/journal.pone.0127820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993415	gold, Green Published			2022-12-26	WOS:000354921400137
J	Gonzalez, EB; Aritaki, M; Knutsen, H; Taniguchi, N				Gonzalez, Enrique Blanco; Aritaki, Masato; Knutsen, Halvor; Taniguchi, Nobuhiko			Effects of Large-Scale Releases on the Genetic Structure of Red Sea Bream (Pagrus major, Temminck et Schlegel) Populations in Japan	PLOS ONE			English	Article							FALSE DISCOVERY RATE; ACANTHOPAGRUS-SCHLEGELII; MATURITY CLASSIFICATION; LINKAGE DISEQUILIBRIUM; HIROSHIMA BAY; FRESH-WATER; DIVERSITY; MARINE; FISH; WILD	Large-scale hatchery releases are carried out for many marine fish species worldwide; nevertheless, the long-term effects of this practice on the genetic structure of natural populations remains unclear. The lack of knowledge is especially evident when independent stock enhancement programs are conducted simultaneously on the same species at different geographical locations, as occurs with red sea bream (Pagrus major, Temminck et Schlegel) in Japan. In this study, we examined the putative effects of intensive offspring releases on the genetic structure of red sea bream populations along the Japanese archipelago by genotyping 848 fish at fifteen microsatellite loci. Our results suggests weak but consistent patterns of genetic divergence (F-ST = 0.002, p < 0.001). Red sea bream in Japan appeared spatially structured with several patches of distinct allelic composition, which corresponded to areas receiving an important influx of fish of hatchery origin, either released intentionally or from unintentional escapees from aquaculture operations. In addition to impacts upon local populations inhabiting semi-enclosed embayments, large-scale releases (either intentionally or from unintentional escapes) appeared also to have perturbed genetic structure in open areas. Hence, results of the present study suggest that independent large-scale marine stock enhancement programs conducted simultaneously on one species at different geographical locations may compromise native genetic structure and lead to patchy patterns in population genetic structure.	[Gonzalez, Enrique Blanco; Taniguchi, Nobuhiko] Fukuyama Univ, Res Inst Marine Bioresources, Onomichi 7222101, Japan; [Gonzalez, Enrique Blanco; Knutsen, Halvor] Univ Agder, N-4604 Kristiansand, Norway; [Gonzalez, Enrique Blanco; Knutsen, Halvor] Inst Marine Res, N-4817 His, Norway; [Aritaki, Masato] Fisheries Res Agcy, Seikai Natl Fisheries Res Inst, Coastal Fisheries & Aquaculture Div, Nagasaki 8512213, Japan; [Knutsen, Halvor] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, N-0316 Oslo, Norway	Fukuyama University; University of Agder; Institute of Marine Research - Norway; Japan Fisheries Research & Education Agency (FRA); University of Oslo	Gonzalez, EB (corresponding author), Fukuyama Univ, Res Inst Marine Bioresources, Onomichi 7222101, Japan.	enrique.blanco@uia.no	Knutsen, Halvor/A-4261-2009; Gonzalez, Enrique Blanco/O-7721-2019	Knutsen, Halvor/0000-0002-7627-7634; Gonzalez, Enrique Blanco/0000-0002-2631-2331	Japan Society for the Promotion of Science (JSPS) [18380111]; Ministry of Agriculture, Forestry, and Fisheries, Japan	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Agriculture, Forestry, and Fisheries, Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This study was supported by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (JSPS) to Nobuhiko Taniguchi (No. 18380111) and was conducted as part of the research project "Research and Development Projects for Application in Promoting New Policy of Agriculture, Forestry, and Fisheries", funded by the Ministry of Agriculture, Forestry, and Fisheries, Japan.	Ab Ghani NI, 2012, BIOL J LINN SOC, V107, P521, DOI 10.1111/j.1095-8312.2012.01956.x; Ambe D, 2004, J OCEANOGR, V60, P375, DOI 10.1023/B:JOCE.0000038343.31468.fe; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Araki H, 2010, AQUACULTURE, V308, pS2, DOI 10.1016/j.aquaculture.2010.05.036; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Fisheries Agency Fisheries Research Agency National Association for the Promotion of Productive Seas, 1984, ANNUAL STATISTICS OF; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Fraser DJ, 2008, EVOL APPL, V1, P535, DOI 10.1111/j.1752-4571.2008.00036.x; FUKUHARA O, 1991, AQUACULTURE, V95, P117, DOI 10.1016/0044-8486(91)90078-L; Gonzalez EB, 2009, J APPL ICHTHYOL, V25, P407, DOI 10.1111/j.1439-0426.2009.01249.x; Gonzalez EB, 2008, AQUACULTURE, V276, P36, DOI 10.1016/j.aquaculture.2008.02.004; Gonzalez EB, 2013, MAR BIOTECHNOL, V15, P206, DOI 10.1007/s10126-012-9479-7; Gonzalez EB, 2012, FISHERIES SCI, V78, P603, DOI 10.1007/s12562-012-0469-5; Gonzalez EB, 2010, AQUACULTURE, V308, pS12, DOI 10.1016/j.aquaculture.2010.06.031; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J, 1999, PCAGEN 1 2 1; Hamasaki K, 2010, J FISH BIOL, V77, P2123, DOI 10.1111/j.1095-8649.2010.02826.x; Hansen MM, 2012, MOL ECOL, V21, P1311, DOI 10.1111/j.1365-294X.2011.05463.x; Hansen MM, 2009, MOL ECOL, V18, P2549, DOI 10.1111/j.1365-294X.2009.04198.x; Hess MA, 2012, MOL ECOL, V21, P5236, DOI 10.1111/mec.12046; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; HINDAR K, 1991, CAN J FISH AQUAT SCI, V48, P945, DOI 10.1139/f91-111; HORIKI N, 1992, NIPPON SUISAN GAKK, V58, P1007; Iida Mirodi, 2010, Coastal Marine Science, V34, P42; Imai T, 2005, B KANAGAWA PREFECTUR, V10, P65; Isobe A, 2012, OCEAN DYNAM, V62, P633, DOI 10.1007/s10236-011-0519-z; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kinoshita I, 2000, ENVIRON BIOL FISH, V57, P305, DOI 10.1023/A:1007613015063; Kitada S, 2006, FISH RES, V80, P101, DOI 10.1016/j.fishres.2006.03.019; Kitada S, 2009, AQUACULTURE, V290, P69, DOI 10.1016/j.aquaculture.2009.02.011; Knutsen H, 2007, CAN J FISH AQUAT SCI, V64, P857, DOI 10.1139/F07-070; Kojima K, 1981, B SEIKAI REG FISH RE, V56, P71; Kojima S, 1997, MAR ECOL PROG SER, V150, P149, DOI 10.3354/meps150149; Laikre L, 2010, TRENDS ECOL EVOL, V25, P520, DOI 10.1016/j.tree.2010.06.013; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Masuda H, 1984, THE FISHES OF THE JA; Matsuura H, 1980, B SEIKAI REG FISH RE, V55, P65; MATSUURA S, 1987, MAR BIOL, V96, P169, DOI 10.1007/BF00427016; MATSUYAMA M, 1987, MAR BIOL, V96, P163, DOI 10.1007/BF00427015; Mori K, 1980, B SEIKAI REG FISH RE, V54, P59; Nakajima K, 2014, CAN J FISH AQUAT SCI, V71, P301, DOI 10.1139/cjfas-2013-0418; NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x; Ogoh K, 2005, MOL BIOL EVOL, V22, P1543, DOI 10.1093/molbev/msi155; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Perez-Enriquez R, 1999, FISHERIES SCI, V65, P23, DOI 10.2331/fishsci.65.23; Perez-Enriquez R, 2001, FISHERIES SCI, V67, P71, DOI 10.1046/j.1444-2906.2001.00201.x; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ryman N, 2001, MOL ECOL, V10, P2361, DOI 10.1046/j.0962-1083.2001.01345.x; Ryman N, 1988, POPULATION GENETICS; Sekino M, 2001, MAR BIOTECHNOL, V3, P572, DOI 10.1007/s10126-001-0064-8; Shishidou H, 2008, NIPPON SUISAN GAKK, V74, P183, DOI 10.2331/suisan.74.183; Shoji J, 2007, FISHERIES SCI, V73, P1281, DOI 10.1111/j.1444-2906.2007.01466.x; Sobajima N, 1986, B KYOTO OCEA FISH SC, V10, P35; Sugaya T, 2008, FISHERIES SCI, V74, P579, DOI 10.1111/j.1444-2906.2008.01561.x; Tabata K, 1997, FISHERIES SCI, V63, P211, DOI 10.2331/fishsci.63.211; Takaba M, 1999, NIPPON SUISAN GAKK, V65, P200; Takeoka H., 1988, J OCEANOGR SOC JAP, V44, P6, DOI DOI 10.1007/BF02303146; TANIGUCHI N, 1990, NIPPON SUISAN GAKK, V56, P1069; Taniguchi N, 2004, STOCK ENHANCEMENT SE, P329; Tojima T, 2000, KYOTO INST OCEAN FIS, V6, P1; Umino T, 2011, GLOBAL CHANGE: MANKIND-MARINE ENVIRONMENT INTERACTIONS, P37, DOI 10.1007/978-90-481-8630-3_7; Umino T, 2009, FISHERIES SCI, V75, P909, DOI 10.1007/s12562-009-0118-9; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; Ward RD, 2006, FISH RES, V80, P9, DOI 10.1016/j.fishres.2006.03.009; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zenitani H, 2009, FISHERIES SCI, V75, P55, DOI 10.1007/s12562-008-0005-9	81	20	21	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125743	10.1371/journal.pone.0125743	http://dx.doi.org/10.1371/journal.pone.0125743			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993089	Green Submitted, Green Published, gold			2022-12-26	WOS:000354921400045
J	Keller, T; Kalt, R; Raab, I; Schachner, H; Mayrhofer, C; Kerjaschki, D; Hantusch, B				Keller, Thomas; Kalt, Romana; Raab, Ingrid; Schachner, Helga; Mayrhofer, Corina; Kerjaschki, Dontscho; Hantusch, Brigitte			Selection of scFv Antibody Fragments Binding to Human Blood versus Lymphatic Endothelial Surface Antigens by Direct Cell Phage Display	PLOS ONE			English	Article							ANTI-CD146 MONOCLONAL-ANTIBODY; IN-VIVO; INHIBITS ANGIOGENESIS; TUMOR-GROWTH; BRAIN-BARRIER; LIBRARY; CD146; MARKER; IDENTIFICATION; EPITOPES	The identification of marker molecules specific for blood and lymphatic endothelium may provide new diagnostic tools and identify new targets for therapy of immune, microvascular and cancerous diseases. Here, we used a phage display library expressing human randomized single-chain Fv (scFv) antibodies for direct panning against live cultures of blood (BECs) and lymphatic (LECs) endothelial cells in solution. After six panning rounds, out of 944 sequenced antibody clones, we retrieved 166 unique/diverse scFv fragments, as indicated by the V-region sequences. Specificities of these phage clone antibodies for respective compartments were individually tested by direct cell ELISA, indicating that mainly panendothelial cell (EC) binders had been selected, but also revealing a subset of BEC-specific scFv antibodies. The specific staining pattern was recapitulated by twelve phage-independently expressed scFv antibodies. Binding capacity to BECs and LECs and differential staining of BEC versus LEC by a subset of eight scFv antibodies was confirmed by immunofluorescence staining. As one antigen, CD146 was identified by immunoprecipitation with phage-independent scFv fragment. This antibody, B6-11, specifically bound to recombinant CD146, and to native CD146 expressed by BECs, melanoma cells and blood vessels. Further, binding capacity of B6-11 to CD146 was fully retained after fusion to a mouse Fc portion, which enabled eukaryotic cell expression. Beyond visualization and diagnosis, this antibody might be used as a functional tool. Overall, our approach provided a method to select antibodies specific for endothelial surface determinants in their native configuration. We successfully selected antibodies that bind to antigens expressed on the human endothelial cell surfaces in situ, showing that BECs and LECs share a majority of surface antigens, which is complemented by cell-type specific, unique markers.	[Keller, Thomas; Kalt, Romana; Raab, Ingrid; Schachner, Helga; Kerjaschki, Dontscho; Hantusch, Brigitte] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Mayrhofer, Corina] Univ Vet Med, Inst Anim Breeding & Genet, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna	Hantusch, B (corresponding author), Med Univ Vienna, Clin Inst Pathol, Vienna, Austria.	brigitte.hantusch@meduniwien.ac.at	Hantusch, Brigitte/AAM-9822-2021	Hantusch, Brigitte/0000-0002-9126-003X	PhD Program CCHD, "Cell Communication in Health and Disease" - Austrian Science Fund FWF [W1205-B09]	PhD Program CCHD, "Cell Communication in Health and Disease" - Austrian Science Fund FWF	Thomas Keller was funded within the PhD Program CCHD, "Cell Communication in Health and Disease" (http://www.meduniwien.ac.at/phd-cchd/), supported by the Austrian Science Fund FWF (https://www.fwf.ac.at/) (Project Nr. W1205-B09).	ADEY NB, 1995, GENE, V156, P27, DOI 10.1016/0378-1119(95)00058-E; Amatschek S, 2007, BLOOD, V109, P4777, DOI 10.1182/blood-2006-10-053280; Abengozar MA, 2012, BLOOD, V119, P4565, DOI 10.1182/blood-2011-09-380006; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Bidlingmaier S, 2009, CANCER RES, V69, P1570, DOI 10.1158/0008-5472.CAN-08-1363; Boldicke T, 2001, STEM CELLS, V19, P24, DOI 10.1634/stemcells.19-1-24; Bowes T, 2011, J BIOMOL SCREEN, V16, P744, DOI 10.1177/1087057111407067; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; Bu PC, 2006, MOL CANCER THER, V5, P2872, DOI 10.1158/1535-7163.MCT-06-0260; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chan CEZ, 2011, J IMMUNOL METHODS, V373, P79, DOI 10.1016/j.jim.2011.08.005; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; Cooley LS, 2011, BIOCHEM SOC T, V39, P1639, DOI 10.1042/BST20110723; Dantas-Barbosa C, 2012, INT J MOL SCI, V13, P5420, DOI 10.3390/ijms13055420; Dantas-Barbosa C, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/157531; Deramchia K, 2012, AM J PATHOL, V180, P2576, DOI 10.1016/j.ajpath.2012.02.013; Durr E, 2004, NAT BIOTECHNOL, V22, P985, DOI 10.1038/nbt993; Edwards BM, 2000, J IMMUNOL METHODS, V245, P67, DOI 10.1016/S0022-1759(00)00275-1; Eisenhardt SU, 2007, NAT PROTOC, V2, P3063, DOI 10.1038/nprot.2007.455; Giordano RJ, 2001, NAT MED, V7, P1249, DOI 10.1038/nm1101-1249; Goenaga AL, 2007, MOL IMMUNOL, V44, P3777, DOI 10.1016/j.molimm.2007.03.023; Haemmerle M, 2013, DIABETES; Hafner C, 2002, J INVEST DERMATOL, V119, P865, DOI 10.1046/j.1523-1747.2002.00171.x; HALLMANN R, 1995, DEV DYNAM, V202, P325, DOI 10.1002/aja.1002020402; Hida K, 2013, CANCER SCI, V104, P1391, DOI 10.1111/cas.12251; Hoogenboom HR, 1999, EUR J BIOCHEM, V260, P774, DOI 10.1046/j.1432-1327.1999.00214.x; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Huie MA, 2001, P NATL ACAD SCI USA, V98, P2682, DOI 10.1073/pnas.051631798; Jiang TX, 2012, BLOOD, V120, P2330, DOI 10.1182/blood-2012-01-406108; Jones AR, 2014, BIOTECHNOL J, V9, P664, DOI 10.1002/biot.201300550; Kennel SJ, 2004, HYBRIDOMA HYBRIDOM, V23, P205, DOI 10.1089/1536859041651295; Ki MK, 2013, ONCOGENE, V32, P5449, DOI 10.1038/onc.2013.156; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Laakkonen P, 2002, NAT MED, V8, P751, DOI 10.1038/nm720; Lee M, 2014, NAT IMMUNOL, V15, P982, DOI 10.1038/ni.2983; Liang WC, 2007, J MOL BIOL, V366, P815, DOI 10.1016/j.jmb.2006.11.021; Lin Y, 2007, ANTICANCER RES, V27, P4219; Lu D, 1999, J IMMUNOL METHODS, V230, P159, DOI 10.1016/S0022-1759(99)00135-0; Matsuo AL, 2011, MOL CANC RES; Mazur A, 2003, ENDOTHELIUM-J ENDOTH, V10, P277, DOI 10.1080/713715236; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Moutel S, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-14; Mutuberria R, 2004, J IMMUNOL METHODS, V287, P31, DOI 10.1016/j.jim.2004.01.011; Mutuberria R, 1999, J IMMUNOL METHODS, V231, P65, DOI 10.1016/S0022-1759(99)00141-6; Orecchia P, 2013, EUR J CANCER, V49, P2022, DOI 10.1016/j.ejca.2012.12.019; Palmer DB, 1997, IMMUNOLOGY, V91, P473, DOI 10.1046/j.1365-2567.1997.00262.x; Park C, 2013, CIRC RES, V112, P1380, DOI 10.1161/CIRCRESAHA.113.301078; Pereira S, 1997, J IMMUNOL METHODS, V203, P11, DOI 10.1016/S0022-1759(97)00005-7; Pini A, 1998, J BIOL CHEM, V273, P21769, DOI 10.1074/jbc.273.34.21769; Rinderknecht M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011941; Robert R, 2006, J BIOL CHEM, V281, P40135, DOI 10.1074/jbc.M609344200; Ronca R, 2010, MOL CANC THER; SCHLINGEMANN RO, 1985, LAB INVEST, V52, P71; Schofield DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r254; SERS C, 1993, P NATL ACAD SCI USA, V90, P8514, DOI 10.1073/pnas.90.18.8514; Silacci M, 2005, PROTEOMICS, V5, P2340, DOI 10.1002/pmic.200401273; Smith J, 2005, FASEB J, V19, P331, DOI 10.1096/fj.04-2863rev; St Croix B, 2000, SCIENCE, V289, P1197; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tomlinson IM, 1996, J MOL BIOL, V256, P813, DOI 10.1006/jmbi.1996.0127; Trepel M, 2002, CURR OPIN CHEM BIOL, V6, P399, DOI 10.1016/S1367-5931(02)00336-8; Valadon P, 2006, P NATL ACAD SCI USA, V103, P407, DOI 10.1073/pnas.0506938103; Wang ZQ, 2013, CANCER LETT, V330, P150, DOI 10.1016/j.canlet.2012.11.049; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Wick N, 2008, AM J PATHOL, V173, P1202, DOI 10.2353/ajpath.2008.080101; Wick N, 2007, PHYSIOL GENOMICS, V28, P179, DOI 10.1152/physiolgenomics.00037.2006; Wu GQ, 2010, BIOTECHNOL APPL BIOC, V56, P95, DOI 10.1042/BA20100031; Yan XY, 2003, BLOOD, V102, P184, DOI 10.1182/blood-2002-04-1004; Zeng QQ, 2014, PROTEIN CELL, V5, P445, DOI 10.1007/s13238-014-0047-y; Zhang Y, 2008, HYBRIDOMA, V27, P345, DOI 10.1089/hyb.2008.0034; Zheng CG, 2009, INT J BIOCHEM CELL B, V41, P2163, DOI 10.1016/j.biocel.2009.03.014	71	13	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127169	10.1371/journal.pone.0127169	http://dx.doi.org/10.1371/journal.pone.0127169			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993332	Green Submitted, Green Published, gold			2022-12-26	WOS:000354921400101
J	Aguiar, B; Vieira, J; Cunha, AE; Fonseca, NA; Iezzoni, A; van Nocker, S; Vieira, CP				Aguiar, Bruno; Vieira, Jorge; Cunha, Ana E.; Fonseca, Nuno A.; Iezzoni, Amy; van Nocker, Steve; Vieira, Cristina P.			Convergent Evolution at the Gametophytic Self-Incompatibility System in Malus and Prunus	PLOS ONE			English	Article							F-BOX PROTEIN; S-LOCUS REGION; POSITIVELY SELECTED SITES; MUME-SIEB.; POLLEN; RNASE; GENE; GENOME; IDENTIFICATION; SFB	S-RNase-based gametophytic self-incompatibility (GSI) has evolved once before the split of the Asteridae and Rosidae. This conclusion is based on the phylogenetic history of the S-RNase that determines pistil specificity. In Rosaceae, molecular characterizations of Prunus species, and species from the tribe Pyreae (i.e., Malus, Pyrus, Sorbus) revealed different numbers of genes determining S-pollen specificity. In Prunus only one pistil and pollen gene determine GSI, while in Pyreae there is one pistil but multiple pollen genes, implying different specificity recognition mechanisms. It is thus conceivable that within Rosaceae the genes involved in GSI in the two lineages are not orthologous but possibly paralogous. To address this hypothesis we characterised the S-RNase lineage and S-pollen lineage genes present in the genomes of five Rosaceae species from three genera: M. x domestica (apple, self-incompatible (SI); tribe Pyreae), P. persica (peach, self-compatible (SC); Amygdaleae), P. mume (mei, SI; Amygdaleae), Fragaria vesca (strawberry, SC; Potentilleae), and F. nipponica (mori-ichigo, SI; Potentilleae). Phylogenetic analyses revealed that the Malus and Prunus S-RNase and S-pollen genes belong to distinct gene lineages, and that only Prunus S-RNase and SFB-lineage genes are present in Fragaria. Thus, S-RNase based GSI system of Malus evolved independently from the ancestral system of Rosaceae. Using expression patterns based on RNA-seq data, the ancestral S-RNase lineage gene is inferred to be expressed in pistils only, while the ancestral S-pollen lineage gene is inferred to be expressed in tissues other than pollen.	[Aguiar, Bruno; Vieira, Jorge; Cunha, Ana E.; Vieira, Cristina P.] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Porto, Portugal; [Aguiar, Bruno; Vieira, Jorge; Cunha, Ana E.; Vieira, Cristina P.] Univ Porto, Inst Biol Mol & Celular, P-4100 Porto, Portugal; [Fonseca, Nuno A.] CRACS INESC Porto, P-4169007 Porto, Portugal; [Fonseca, Nuno A.] European Bioinformat Inst EMBL EBI, Cambridge CB10 1SD, England; [Iezzoni, Amy; van Nocker, Steve] Michigan State Univ, E Lansing, MI 48824 USA	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; INESC TEC; Universidade do Porto; European Molecular Biology Laboratory (EMBL); Michigan State University	Vieira, CP (corresponding author), Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Porto, Portugal.	cgvieira@ibmc.up.pt	Vieira, Cristina P./K-1775-2013; Fonseca, Nuno A./B-7801-2009; Vieira, Jorge/J-7477-2013	Vieira, Cristina P./0000-0002-7139-2107; Fonseca, Nuno A./0000-0003-4832-578X; Vieira, Jorge/0000-0001-7032-5220; Cunha, Ana Estefania/0000-0002-7651-5858	FEDER funds through the Operational Competitiveness Programme - COMPETE; National Funds through FCT Fundacao para a Ciencia e a Tecnologia [FCOMP-01-0124-FEDER-028299, PTDC/BIA-BIC/3830/2012]; FCT [SFRH/BD/69207/2010]	FEDER funds through the Operational Competitiveness Programme - COMPETE; National Funds through FCT Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by FEDER funds through the Operational Competitiveness Programme - COMPETE and by National Funds through FCT Fundacao para a Ciencia e a Tecnologia under the project FCOMP-01-0124-FEDER-028299 (PTDC/BIA-BIC/3830/2012). Bruno Aguiar is the recipient of a PhD grant (SFRH/BD/69207/2010) from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar B, 2013, J EXP BOT, V64, P2423, DOI 10.1093/jxb/ert098; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Boskovic RI, 2010, J EXP BOT, V61, P755, DOI 10.1093/jxb/erp340; BROOTHAERTS W, 1995, PLANT MOL BIOL, V27, P499, DOI 10.1007/BF00019317; Busch JW, 2008, GENETICS, V178, P2055, DOI 10.1534/genetics.107.083204; Busch JW, 2011, EVOL BIOL, V38, P15, DOI 10.1007/s11692-010-9104-5; Chagne D, 2008, GENOMICS, V92, P353, DOI 10.1016/j.ygeno.2008.07.008; Chantha SC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001560; Cheng JH, 2006, SEX PLANT REPROD, V19, P175, DOI 10.1007/s00497-006-0034-4; De Franceschi P, 2012, J EXP BOT, V63, P4015, DOI 10.1093/jxb/ers108; De Nettancourt D, 1977, INCOMPATIBILITY IN A; Dirlewanger E, 2004, P NATL ACAD SCI USA, V101, P9891, DOI 10.1073/pnas.0307937101; Entani T, 2003, GENES CELLS, V8, P203, DOI 10.1046/j.1365-2443.2003.00626.x; EVANS WD, 1967, CAN J GENET CYTOL, V9, P831, DOI 10.1139/g67-088; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goldberg EE, 2010, SCIENCE, V330, P493, DOI 10.1126/science.1194513; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Habu T, 2014, J JPN SOC HORTIC SCI, V83, P95, DOI 10.2503/jjshs1.CH-086; Herman AC, 2012, EVOLUTION, V66, P1849, DOI 10.1111/j.1558-5646.2011.01564.x; Hirakawa H, 2013, DNA RES, P1, DOI [10.1093/dnares/dst035, DOI 10.1093/DNARES/DST035]; Hua ZH, 2007, PLANT CELL, V19, P3593, DOI 10.1105/tpc.107.055426; Hua ZH, 2006, PLANT CELL, V18, P2531, DOI 10.1105/tpc.106.041061; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Igic B, 2006, P NATL ACAD SCI USA, V103, P1359, DOI 10.1073/pnas.0506283103; Igic B, 2001, P NATL ACAD SCI USA, V98, P13167, DOI 10.1073/pnas.231386798; Igic B, 2008, INT J PLANT SCI, V169, P93, DOI 10.1086/523362; Igic B, 2013, NEW PHYTOL, V198, P386, DOI 10.1111/nph.12182; Ikeda K, 2004, SEX PLANT REPROD, V16, P235, DOI 10.1007/s00497-003-0200-x; Illa E, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-9; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jung S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-129; Kakui H, 2007, PLANT CELL REP, V26, P1619, DOI 10.1007/s00299-007-0386-8; Kakui H, 2011, PLANT J, V68, P1028, DOI 10.1111/j.1365-313X.2011.04752.x; Kubo K, 2010, SCIENCE, V330, P796, DOI 10.1126/science.1195243; Luu DT, 2001, GENETICS, V159, P329; Maliepaard C, 1998, THEOR APPL GENET, V97, P60, DOI 10.1007/s001220050867; Matsumoto D, 2008, SEX PLANT REPROD, V21, P113, DOI 10.1007/s00497-008-0069-9; Minamikawa M, 2010, PLANT MOL BIOL, V74, P143, DOI 10.1007/s11103-010-9662-z; Njuguna W, 2013, MOL PHYLOGENET EVOL, V66, P17, DOI 10.1016/j.ympev.2012.08.026; Nowak MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021019; Nunes MDS, 2006, NEW PHYTOL, V172, P577, DOI 10.1111/j.1469-8137.2006.01838.x; Okada K, 2011, J EXP BOT, V62, P1887, DOI 10.1093/jxb/erq381; Reboiro-Jato D, 2012, J INTEGR BIOINFORMAT, V9, DOI 10.2390/biecoll-jib-2012-200; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roalson EH, 2003, MOL PHYLOGENET EVOL, V29, P490, DOI 10.1016/S1055-7903(03)00195-7; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Rojas HJ, 2013, ANN BOT, P1, DOI [10.1093/aob/mct244, DOI 10.1093/A0B/MCT244]; Romero C, 2004, PLANT MOL BIOL, V56, P145, DOI 10.1007/s11103-004-2651-3; Sargent DJ, 2006, THEOR APPL GENET, V112, P1349, DOI 10.1007/s00122-006-0237-y; Sassa H, 2007, GENETICS, V175, P1869, DOI 10.1534/genetics.106.068858; Sassa H, 2010, SEX PLANT REPROD, V23, P39, DOI 10.1007/s00497-009-0111-6; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Sonneveld T, 2005, PLANT CELL, V17, P37, DOI 10.1105/tpc.104.026963; Steinbachs JE, 2002, MOL BIOL EVOL, V19, P825, DOI 10.1093/oxfordjournals.molbev.a004139; Sun LD, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-98; Tao R, 2007, PLANT MOL BIOL, V63, P109, DOI 10.1007/s11103-006-9076-0; Tao R, 2010, SCI HORTIC-AMSTERDAM, V124, P423, DOI 10.1016/j.scienta.2010.01.025; Ushijima K, 2004, PLANT J, V39, P573, DOI 10.1111/j.1365-313X.2004.02154.x; Ushijima K, 2003, PLANT CELL, V15, P771, DOI 10.1105/tpc.009290; Ushijima K, 2001, GENETICS, V158, P379; Uyenoyama MK, 2005, NEW PHYTOL, V165, P63, DOI 10.1111/j.1469-8137.2004.01246.x; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Vieira CP, 2002, HEREDITY, V88, P172, DOI 10.1038/sj.hdy.6800024; Vieira J, 2008, HEREDITY, V101, P351, DOI 10.1038/hdy.2008.60; Vieira J, 2008, J MOL EVOL, V67, P179, DOI 10.1007/s00239-008-9137-x; Vieira J, 2007, J MOL EVOL, V65, P175, DOI 10.1007/s00239-006-0285-6; Vieira J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-200; Vieira J, 2009, J MOL EVOL, V69, P32, DOI 10.1007/s00239-009-9249-y; Vilanova S, 2006, PLANT PHYSIOL, V142, P629, DOI 10.1104/pp.106.083865; Wang L, 2004, PLANT MOL BIOL, V56, P929, DOI 10.1007/s11103-004-6236-y; Wheeler D, 2007, GENETICS, V177, P2171, DOI 10.1534/genetics.107.076885; Yamane H, 2003, THEOR APPL GENET, V107, P1357, DOI 10.1007/s00122-003-1389-7; Yamane H, 2003, J EXP BOT, V54, P2431, DOI 10.1093/jxb/erg271; Yamane H, 2003, MOL GENET GENOMICS, V269, P90, DOI 10.1007/s00438-003-0815-5; Zhang QX, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2290; Zuriaga E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053947	79	38	39	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0126138	10.1371/journal.pone.0126138	http://dx.doi.org/10.1371/journal.pone.0126138			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993016	gold, Green Published, Green Submitted			2022-12-26	WOS:000354918600027
J	Ding, Y; Caberoy, NB; Guo, FY; LeBlanc, ME; Zhang, CM; Wang, WW; Wang, F; Chen, R; Li, W				Ding, Ying; Caberoy, Nora B.; Guo, Feiye; LeBlanc, Michelle E.; Zhang, Chenming; Wang, Weiwen; Wang, Feng; Chen, Rui; Li, Wei			Reticulocalbin-1 Facilitates Microglial Phagocytosis	PLOS ONE			English	Article							ORF PHAGE DISPLAY; MULTIPLE EF-HAND; EAT-ME SIGNALS; EFFICIENT IDENTIFICATION; ENDOTHELIAL-CELLS; SECRETORY PATHWAY; BINDING PROTEINS; APOPTOTIC CELLS; CLEARANCE; EXPRESSION	Phagocytosis is critical to the clearance of apoptotic cells, cellular debris and deleterious metabolic products for tissue homeostasis. Phagocytosis ligands directly recognizing deleterious cargos are the key to defining the functional roles of phagocytes, but are traditionally identified on a case-by-case basis with technical challenges. As a result, extrinsic regulation of phagocytosis is poorly defined. Here we demonstrate that microglial phagocytosis ligands can be systematically identified by a new approach of functional screening. One of the identified ligands is reticulocalbin-1 (Rcn1), which was originally reported as a Ca2+-binding protein with a strict expression in the endoplasmic reticulum. Our results showed that Rcn1 can be secreted from healthy cells and that secreted Rcn1 selectively bound to the surface of apoptotic neurons, but not healthy neurons. Independent characterization revealed that Rcn1 stimulated microglial phagocytosis of apoptotic but not healthy neurons. Ingested apoptotic cells were targeted to phagosomes and co-localized with phagosome marker Rab7. These data suggest that Rcn1 is a genuine phagocytosis ligand. The new approach described in this study will enable systematic identification of microglial phagocytosis ligands with broad applicability to many other phagocytes.	[Ding, Ying; Guo, Feiye; LeBlanc, Michelle E.; Zhang, Chenming; Wang, Weiwen; Li, Wei] Univ Miami, Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Li, Wei] Univ Miami, Sch Med, Neurosci Program, Miami, FL 33136 USA; [Caberoy, Nora B.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Zhang, Chenming] Jinan 2nd Peoples Hosp, Jinan 250001, Peoples R China; [Wang, Feng; Chen, Rui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Bascom Palmer Eye Institute; University of Miami; University of Miami; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Baylor College of Medicine	Li, W (corresponding author), Univ Miami, Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	w.li@med.miami.edu	GUO, FEIYE/O-2729-2018; Wang, Feng/G-4847-2015; GUO, FEIYE/AAH-2350-2019; Ding, Ying/M-8060-2017	Ding, Ying/0000-0001-8600-9740	NIH [R01GM094449, R21HD075372]; BrightFocus Foundation [M2012026]; Special Scholar Award from Research to Prevent Blindness (RPB) [K99EY020865]; American Heart Association [14PRE18310014, P30-EY014801]; Research to Prevent Blindness; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD075372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094449] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BrightFocus Foundation(BrightFocus Foundation); Special Scholar Award from Research to Prevent Blindness (RPB); American Heart Association(American Heart Association); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by NIH R01GM094449 (W.L.), R21HD075372 (WL), BrightFocus Foundation M2012026 (W.L.), Special Scholar Award from Research to Prevent Blindness (RPB) (W.L.), K99EY020865 (N.B.C.), American Heart Association 14PRE18310014 (M.E.L), P30-EY014801 and an institutional grant from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Caberoy NB, 2012, J NEUROIMMUNOL, V252, P40, DOI 10.1016/j.jneuroim.2012.07.009; Caberoy NB, 2012, J CELL PHYSIOL, V227, P401, DOI 10.1002/jcp.22955; Caberoy NB, 2010, EMBO J, V29, P3898, DOI 10.1038/emboj.2010.265; Caberoy NB, 2010, J MOL RECOGNIT, V23, P74, DOI 10.1002/jmr.983; Caberoy NB, 2010, EXP CELL RES, V316, P245, DOI 10.1016/j.yexcr.2009.10.008; Caberoy NB, 2009, J BIOMOL SCREEN, V14, P653, DOI 10.1177/1087057109335679; Caberoy NB, 2009, BIOCHEM BIOPH RES CO, V386, P197, DOI 10.1016/j.bbrc.2009.06.010; Cooper CR, 2008, J CELL BIOCHEM, V104, P2298, DOI 10.1002/jcb.21785; Fukuda T, 2007, J HISTOCHEM CYTOCHEM, V55, P335, DOI 10.1369/jhc.6A6943.2006; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Honore B, 2000, FEBS LETT, V466, P11, DOI 10.1016/S0014-5793(99)01780-9; Honore B, 2009, BIOESSAYS, V31, P262, DOI 10.1002/bies.200800186; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Jeon H, 2010, J BIOMOL SCREEN, V15, P949, DOI 10.1177/1087057110376090; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kent J, 1997, GENOMICS, V42, P260, DOI 10.1006/geno.1997.4706; Kramann N, 2014, CARDIOVASC RES, V102, P88, DOI 10.1093/cvr/cvu024; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Li W, 2013, AGEING RES REV, V12, P1005, DOI 10.1016/j.arr.2013.05.006; Li W, 2012, METHODS, V58, P2, DOI 10.1016/j.ymeth.2012.07.013; Li W, 2012, J CELL PHYSIOL, V227, P1291, DOI 10.1002/jcp.22815; Li W, 2010, APPL MICROBIOL BIOT, V85, P909, DOI 10.1007/s00253-009-2277-0; Linehan SA, 2005, HISTOCHEM CELL BIOL, V123, P365, DOI 10.1007/s00418-005-0767-4; Liu ZD, 1997, BIOCHEM BIOPH RES CO, V231, P283, DOI 10.1006/bbrc.1997.6083; Morgan D, 2009, CNS NEUROL DISORD-DR, V8, P7, DOI 10.2174/187152709787601821; Nakai Y, 2005, EXP CELL RES, V309, P137, DOI 10.1016/j.yexcr.2005.05.006; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Napoli I, 2010, EXP NEUROL, V225, P24, DOI 10.1016/j.expneurol.2009.04.024; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Neumann H, 2007, J NEUROIMMUNOL, V184, P92, DOI 10.1016/j.jneuroim.2006.11.032; Nimmrich I, 2000, CANCER LETT, V160, P37, DOI 10.1016/S0304-3835(00)00553-X; OZAWA M, 1993, J BIOL CHEM, V268, P699; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Schlegelmilch T, 2011, CURR OPIN NEUROBIOL, V21, P5, DOI 10.1016/j.conb.2010.08.004; Sierra A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00006; Sorensen KK, 2012, AM J PHYSIOL-REG I, V303, pR1217, DOI 10.1152/ajpregu.00686.2011; TYEDMERS J, 2005, J BIOL SCI, V5, P70; Zhang Y, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-53	43	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126993	10.1371/journal.pone.0126993	http://dx.doi.org/10.1371/journal.pone.0126993			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992960	Green Submitted, Green Published, gold			2022-12-26	WOS:000354917300074
J	Wang, J; Barbuskaite, D; Tozzi, M; Giannuzzo, A; Sorensen, CE; Novak, I				Wang, Jing; Barbuskaite, Dagne; Tozzi, Marco; Giannuzzo, Andrea; Sorensen, Christiane E.; Novak, Ivana			Proton Pump Inhibitors Inhibit Pancreatic Secretion: Role of Gastric and Non-Gastric H+/K+-ATPases	PLOS ONE			English	Article							H-K-ATPASE; ACID-BASE TRANSPORT; BICARBONATE SECRETION; BETA-SUBUNIT; INTERLOBULAR DUCTS; DYNAMIC REGULATION; FLUID SECRETION; CYSTIC-FIBROSIS; ALPHA-SUBUNIT; PH REGULATION	The mechanism by which pancreas secretes high HCO3- has not been fully resolved. This alkaline secretion, formed in pancreatic ducts, can be achieved by transporting HCO3- from serosa to mucosa or by moving H+ in the opposite direction. The aim of the present study was to determine whether H+/K+-ATPases are expressed and functional in human pancreatic ducts and whether proton pump inhibitors (PPIs) have effect on those. Here we show that the gastric HK alpha 1 and HK beta subunits (ATP4A;ATP4B) and non-gastric HK alpha 2 subunits (ATP12A) of H+/K+-ATPases are expressed in human pancreatic cells. Pumps have similar localizations in duct cell monolayers (Capan-1) and human pancreas, and notably the gastric pumps are localized on the luminal membranes. In Capan-1 cells, PPIs inhibited recovery of intracellular pH from acidosis. Furthermore, in rats treated with PPIs, pancreatic secretion was inhibited but concentrations of major ions in secretion follow similar excretory curves in control and PPI treated animals. In addition to HCO3-, pancreas also secretes K+. In conclusion, this study calls for a revision of the basic model for HCO3- secretion. We propose that proton transport is driving secretion, and that in addition it may provide a protective pH buffer zone and K+ recirculation. Furthermore, it seems relevant to re-evaluate whether PPIs should be used in treatment therapies where pancreatic functions are already compromised.	[Wang, Jing; Barbuskaite, Dagne; Tozzi, Marco; Giannuzzo, Andrea; Sorensen, Christiane E.; Novak, Ivana] Univ Copenhagen, Dept Biol, Sect Mol Integrat Physiol, Copenhagen, Denmark	University of Copenhagen	Novak, I (corresponding author), Univ Copenhagen, Dept Biol, Sect Mol Integrat Physiol, August Krogh Bldg, Copenhagen, Denmark.	inovak@bio.ku.dk	Novak, Ivana/M-2791-2014	Novak, Ivana/0000-0002-8917-8010; Tozzi, Marco/0000-0002-2576-0183; Soerensen, Christiane/0000-0001-6814-1166	Danish Council for Independent Research\Natural Sciences (FNU) [0602-01527B, 4002-00162]; Novo Nordisk Foundation [10723001001]; Lundbeck Foundation [R173-2014-1462]; FNU; Department of Biology; Lundbeck Foundation; Erasmus exchange program stipend; FP7 Marie Curie Initial Training Network "IonTraC"; Novo Nordisk Fonden [NNF13OC0007353] Funding Source: researchfish	Danish Council for Independent Research\Natural Sciences (FNU)(Det Frie Forskningsrad (DFF)Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); FNU(Danish Natural Science Research Council); Department of Biology; Lundbeck Foundation(Lundbeckfonden); Erasmus exchange program stipend; FP7 Marie Curie Initial Training Network "IonTraC"; Novo Nordisk Fonden(Novo Nordisk Foundation)	The project was supported by The Danish Council for Independent Research vertical bar Natural Sciences (FNU grant number 0602-01527B and 4002-00162), the Novo Nordisk Foundation (grant number 10723001001) and the Lundbeck Foundation (grant number R173-2014-1462). JW had a co-financed Ph.D. stipend from FNU; Department of Biology and the Lundbeck Foundation. MT was the recipient of Erasmus exchange program stipend and AG was supported by the FP7 Marie Curie Initial Training Network "IonTraC". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A, 2005, AM J PHYSIOL-CELL PH, V288, pC1, DOI 10.1152/ajpcell.00102.2004; Asano S, 2000, J BIOL CHEM, V275, P8324, DOI 10.1074/jbc.275.12.8324; CAFLISCH CR, 1979, PFLUG ARCH EUR J PHY, V380, P121, DOI 10.1007/BF00582146; Caplan MJ, 2001, KIDNEY INT, V60, P427, DOI 10.1046/j.1523-1755.2001.060002427.x; Cheng HS, 1998, J MEMBRANE BIOL, V164, P155, DOI 10.1007/s002329900401; Christoffersen BC, 1998, PFLUG ARCH EUR J PHY, V436, P33, DOI 10.1007/s004240050601; Chu SY, 1999, J CLIN INVEST, V103, P605, DOI 10.1172/JCI5217; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Codina J, 1998, J BIOL CHEM, V273, P7894, DOI 10.1074/jbc.273.14.7894; Crouch MA, 2012, J AM BOARD FAM MED, V25, P50, DOI 10.3122/jabfm.2012.01.100161; DeOndarza J, 1997, AM J PHYSIOL-GASTR L, V272, pG124, DOI 10.1152/ajpgi.1997.272.1.G124; EKMAN L, 1985, SCAND J GASTROENTERO, V20, P53, DOI 10.3109/00365528509095819; Fischer H, 2006, J MEMBRANE BIOL, V211, P139, DOI 10.1007/s00232-006-0861-0; Forte JG, 2010, ANNU REV PHYSIOL, V72, P273, DOI 10.1146/annurev-physiol-021909-135744; Grishin AV, 1998, J BIOL CHEM, V273, P27772, DOI 10.1074/jbc.273.43.27772; Gumz ML, 2010, AM J PHYSIOL-RENAL, V298, pF12, DOI 10.1152/ajprenal.90723.2008; Hayashi M, 2013, CHANNELS, V7, P432, DOI 10.4161/chan.26100; Hayashi M, 2012, AM J PHYSIOL-CELL PH, V303, pC151, DOI 10.1152/ajpcell.00089.2012; Hove KD, 2010, DIABETES RES CLIN PR, V90, pE72, DOI 10.1016/j.diabres.2010.09.007; Inglis SK, 2003, AM J PHYSIOL-LUNG C, V284, pL855, DOI 10.1152/ajplung.00348.2002; Ishiguro H, 1998, J PHYSIOL-LONDON, V511, P407, DOI 10.1111/j.1469-7793.1998.407bh.x; Ishiguro H, 1996, J PHYSIOL-LONDON, V495, P179, DOI 10.1113/jphysiol.1996.sp021583; Ishiguro H, 2009, J GEN PHYSIOL, V133, P315, DOI 10.1085/jgp.200810122; Jaisser F, 1999, AM J PHYSIOL-RENAL, V276, pF812, DOI 10.1152/ajprenal.1999.276.6.F812; Johansson M, 2004, PLACENTA, V25, P505, DOI 10.1016/j.placenta.2003.11.008; Jonckheere Nicolas, 2010, Cancers (Basel), V2, P1794, DOI 10.3390/cancers2041794; Kong SC, 2014, BIOCHEM CELL BIOL, V92, P449, DOI 10.1139/bcb-2014-0078; Kraut JA, 1998, KIDNEY INT, V53, P958, DOI 10.1111/j.1523-1755.1998.00841.x; Krouse ME, 2004, AM J PHYSIOL-LUNG C, V287, pL1274, DOI 10.1152/ajplung.00036.2004; Laine L, 2008, GASTROENTEROLOGY, V135, P41, DOI 10.1053/j.gastro.2008.05.030; LARSSON H, 1985, SCAND J GASTROENTERO, V20, P23, DOI 10.3109/00365528509095817; Lecain E, 2000, HEARING RES, V149, P147, DOI 10.1016/S0378-5955(00)00174-X; Lee MG, 2012, PHYSIOL REV, V92, P39, DOI 10.1152/physrev.00011.2011; Lerner M, 2006, CELL PHYSIOL BIOCHEM, V18, P75, DOI 10.1159/000095169; Litalien C, 2005, CLIN PHARMACOKINET, V44, P441, DOI 10.2165/00003088-200544050-00001; LONG JF, 1983, J PHARMACOL EXP THER, V226, P114; Moniaux N, 2004, BRIT J CANCER, V91, P1633, DOI 10.1038/sj.bjc.6602163; NOVAK I, 1988, PFLUG ARCH EUR J PHY, V411, P58, DOI 10.1007/BF00581647; NOVAK I, 1991, PFLUG ARCH EUR J PHY, V419, P76, DOI 10.1007/BF00373750; Novak I, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00380; Novak I, 2011, J BIOL CHEM, V286, P280, DOI 10.1074/jbc.M110.136382; Novak I, 2010, J PHYSIOL-LONDON, V588, P3615, DOI 10.1113/jphysiol.2010.190017; Park HW, 2010, GASTROENTEROLOGY, V139, P620, DOI 10.1053/j.gastro.2010.04.004; Pestov NB, 2002, AM J PHYSIOL-CELL PH, V282, pC907, DOI 10.1152/ajpcell.00258.2001; Pestov NB, 2006, AM J PHYSIOL-CELL PH, V291, pC366, DOI 10.1152/ajpcell.00042.2006; Phillipson M, 2002, AM J PHYSIOL-GASTR L, V282, pG211, DOI 10.1152/ajpgi.00223.2001; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; Reinhardt J, 2000, AM J PHYSIOL-RENAL, V279, pF417, DOI 10.1152/ajprenal.2000.279.3.F417; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Sachs G, 2007, J CLIN GASTROENTEROL, V41, pS226, DOI 10.1097/MCG.0b013e31803233b7; Sachs George, 2010, Curr Gastroenterol Rep, V12, P437, DOI 10.1007/s11894-010-0149-5; Sangan P, 2000, AM J PHYSIOL-CELL PH, V278, pC182, DOI 10.1152/ajpcell.2000.278.1.C182; SEGAWA K, 1987, Gastroenterologia Japonica, V22, P413; SEOW KTFP, 1991, PANCREAS, V6, P385, DOI 10.1097/00006676-199107000-00002; SEWELL WA, 1975, J PHYSIOL-LONDON, V252, P379, DOI 10.1113/jphysiol.1975.sp011149; Shan JJ, 2012, J PHYSIOL-LONDON, V590, P5273, DOI 10.1113/jphysiol.2012.236893; Shibata T, 2006, AM J PHYSIOL-CELL PH, V291, pC1038, DOI 10.1152/ajpcell.00266.2006; SMITH JJ, 1993, J CLIN INVEST, V91, P1590, DOI 10.1172/JCI116365; Steward MC, 2005, ANNU REV PHYSIOL, V67, P377, DOI 10.1146/annurev.physiol.67.031103.153247; Swarts HGP, 2005, J BIOL CHEM, V280, P33115, DOI 10.1074/jbc.M504535200; Vagin O, 2004, J BIOL CHEM, V279, P39026, DOI 10.1074/jbc.M405453200; Vagin O, 2003, AM J PHYSIOL-CELL PH, V285, pC968, DOI 10.1152/ajpcell.00068.2003; VILLANGER O, 1995, GASTROENTEROLOGY, V108, P850, DOI 10.1016/0016-5085(95)90460-3; Wang J, 2013, AM J PHYSIOL-CELL PH, V304, pC673, DOI 10.1152/ajpcell.00196.2012; Wang J, 2013, PANCREAS, V42, P452, DOI 10.1097/MPA.0b013e318264c302; Wieczorek H, 2009, J EXP BIOL, V212, P1611, DOI 10.1242/jeb.030007; Wilschanski M, 2013, COLD SPRING HARB PER, V3, DOI [10.1101/cshperspect.a015560, DOI 10.1101/CSHPERSPECT.A015560]; Wood CM, 2010, J EXP BIOL, V213, P2681, DOI 10.1242/jeb.039164; ZHAO H, 1994, J GEN PHYSIOL, V104, P57, DOI 10.1085/jgp.104.1.57	69	32	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126432	10.1371/journal.pone.0126432	http://dx.doi.org/10.1371/journal.pone.0126432			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993003	Green Published, gold, Green Submitted			2022-12-26	WOS:000354917300041
J	Xu, MX; Cooper, EC				Xu, Mingxuan; Cooper, Edward C.			An Ankyrin-G N-terminal Gate and Protein Kinase CK2 Dually Regulate Binding of Voltage-gated Sodium and KCNQ2/3 Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXON INITIAL SEGMENT; NEURONAL POLARITY; PYRAMIDAL NEURONS; BIPOLAR DISORDER; ANION-EXCHANGER; MOTIF; ASSOCIATION; SPECTRIN; EPILEPSY; RANVIER	In many mammalian neurons, fidelity and robustness of action potential generation and conduction depends on the colocalization of voltage-gated sodium (Na-v) and KCNQ2/3 potassium channel conductance at the distal axon initial segment (AIS) and nodes of Ranvier in a ratio of similar to 40 to 1. Analogous "anchor" peptides within intracellular domains of vertebrate KCNQ2, KCNQ3, and Na-v channel alpha-subunits bind Ankyrin-G (AnkG), thereby mediating concentration of those channels at AISs and nodes of Ranvier. Here, we show that the channel anchors bind at overlapping but distinct sites near the AnkG N terminus. In pulldown assays, the rank order of AnkG binding strength is Na(v)1.2 >> KCNQ3 > KCNQ2. Phosphorylation of KCNQ2 and KCNQ3 anchor domains by protein kinase CK2 (CK2) augments binding, as previously shown for Na(v)1.2. An AnkG fragment comprising ankyrin repeats 1 through 7 (R1-7) binds phosphorylated Na-v or KCNQ anchors robustly. However, mutational analysis of R1-7 reveals differences in binding mechanisms. A smaller fragment, R1-6, exhibits much-diminished KCNQ3 binding but binds Na(v)1.2 well. Two lysine residues at the tip of repeat 2-3 beta-hairpin (residues 105-106) are critical for Na(v)1.2 but not KCNQ3 channel binding. Another dibasic motif (residues Arg-47, Arg-50) in the repeat 1 front alpha-helix is crucial for KCNQ2/3 but not Na(v)1.2 binding. AnkG's alternatively spliced N terminus selectively gates access to those sites, blocking KCNQ but not Na-v channel binding. These findings suggest that the 40:1 Na-v:KCNQ channel conductance ratio at the distal AIS and nodes arises from the relative strength of binding to AnkG.	[Xu, Mingxuan; Cooper, Edward C.] Baylor Coll Med, Dept Neurol, Mol Neuropharmacol Lab, Houston, TX 77030 USA; [Cooper, Edward C.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Cooper, Edward C.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Xu, MX (corresponding author), Baylor Coll Med, Dept Neurol, 1 Baylor Plaza,MS NB302, Houston, TX 77030 USA.	mingxuax@bcm.edu; ecc1@bcm.edu	Cooper, Edward/X-6659-2019; Regan, Clinton/E-6250-2012	Cooper, Edward/0000-0003-3672-8442; 	National Institutes of Health [RO1 NS049119, T32NS043124]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049119, T32NS043124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 NS049119 (NINDS; to E. C. C. and M. X.) and T32NS043124 (to M. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdi KM, 2006, J BIOL CHEM, V281, P5741, DOI 10.1074/jbc.M506697200; Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; Barlow AL, 2010, MICROSC MICROANAL, V16, P710, DOI 10.1017/S143192761009389X; Barry J, 2014, DEV CELL, V28, P117, DOI 10.1016/j.devcel.2013.11.023; Battefeld A, 2014, J NEUROSCI, V34, P3719, DOI 10.1523/JNEUROSCI.4206-13.2014; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bi C, 2012, HUM MUTAT, V33, P1635, DOI 10.1002/humu.22174; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Brachet A, 2010, J CELL BIOL, V191, P383, DOI 10.1083/jcb.201003042; Brechet A, 2008, J CELL BIOL, V183, P1101, DOI 10.1083/jcb.200805169; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cai XJ, 2006, MOL BIOL EVOL, V23, P550, DOI 10.1093/molbev/msj056; Chang KJ, 2014, NAT NEUROSCI, V17, P1673, DOI 10.1038/nn.3858; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cooper EC, 2003, ARCH NEUROL-CHICAGO, V60, P496, DOI 10.1001/archneur.60.4.496; Cunha SR, 2008, J BIOL CHEM, V283, P31968, DOI 10.1074/jbc.M806050200; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; DAVIS JQ, 1990, J BIOL CHEM, V265, P17252; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Gasser A, 2012, J NEUROSCI, V32, P7232, DOI 10.1523/JNEUROSCI.5434-11.2012; Hallermann S, 2012, NAT NEUROSCI, V15, P1007, DOI 10.1038/nn.3132; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Hien YE, 2014, FEBS LETT, V588, P3403, DOI 10.1016/j.febslet.2014.07.032; Hill AS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000317; Ho TSY, 2014, NAT NEUROSCI, V17, P1664, DOI 10.1038/nn.3859; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; Kang S, 2014, J BIOL CHEM, V289, P11536, DOI 10.1074/jbc.M113.528497; Kato M, 2013, EPILEPSIA, V54, P1282, DOI 10.1111/epi.12200; Lemaillet G, 2003, J BIOL CHEM, V278, P27333, DOI 10.1074/jbc.M303327200; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Michaely P, 1995, J BIOL CHEM, V270, P31298, DOI 10.1074/jbc.270.52.31298; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; Pagano MA, 2007, CHEMBIOCHEM, V8, P129, DOI 10.1002/cbic.200600293; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; ROPER J, 1989, J PHYSIOL-LONDON, V416, P93; Rueckert EH, 2013, MOL PSYCHIATR, V18, P922, DOI 10.1038/mp.2012.104; Sanchez-Ponce D, 2011, MOL CELL NEUROSCI, V46, P222, DOI 10.1016/j.mcn.2010.09.005; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Schwarz JR, 2006, J PHYSIOL-LONDON, V573, P17, DOI 10.1113/jphysiol.2006.106815; Shah MM, 2008, P NATL ACAD SCI USA, V105, P7869, DOI 10.1073/pnas.0802805105; Wang C, 2014, ELIFE, V3, DOI 10.7554/eLife.04353; Weckhuysen S, 2013, NEUROLOGY, V81, P1697, DOI 10.1212/01.wnl.0000435296.72400.a1; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Zakon HH, 2012, P NATL ACAD SCI USA, V109, P10619, DOI 10.1073/pnas.1201884109; Zhang X, 1998, J CELL BIOL, V142, P1571, DOI 10.1083/jcb.142.6.1571; Zhang X, 1998, J BIOL CHEM, V273, P30785, DOI 10.1074/jbc.273.46.30785; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	58	40	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16619	16632		10.1074/jbc.M115.638932	http://dx.doi.org/10.1074/jbc.M115.638932			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25998125	Green Published, hybrid			2022-12-26	WOS:000357572800014
J	Yoo, JY; Ko, KS; Seo, HK; Park, S; Fanata, WID; Harmoko, R; Ramasamy, NK; Thulasinathan, T; Mengiste, T; Lim, JM; Lee, SY; Lee, KO				Yoo, Jae Yong; Ko, Ki Seong; Seo, Hyun-Kyeong; Park, Seongha; Fanata, Wahyu Indra Duwi; Harmoko, Rikno; Ramasamy, Nirmal Kumar; Thulasinathan, Thiyagarajan; Mengiste, Tesfaye; Lim, Jae-Min; Lee, Sang Yeol; Lee, Kyun Oh			Limited Addition of the 6-Arm beta 1,2-linked N-Acetylglucosamine (GlcNAc) Residue Facilitates the Formation of the Largest N-Glycan in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-MANNOSIDASE-II; CORE ALPHA-1,3-LINKED FUCOSE; ENDOPLASMIC-RETICULUM; ARABIDOPSIS-THALIANA; LINKED OLIGOSACCHARIDES; SECRETORY PATHWAY; MOLECULAR-CLONING; GOLGI-APPARATUS; IN-VIVO; COMPLEX	The most abundant N-glycan in plants is the paucimannosidic N-glycan with core beta 1,2-xylose and alpha 1,3-fucose residues (Man(3)XylFuc(GlcNAc)(2)). Here, we report a mechanism in Arabidopsis thaliana that efficiently produces the largest-N-glycan in plants. Genetic and biochemical evidence indicates that the addition of the 6-arm beta 1,2-GlcNAc residue by N-acetylglucosaminyltransferase II (GnTII) is less effective than additions of the core beta 1,2-xylose and alpha 1,3-fucose residues by XylT, FucTA, and FucTB in Arabidopsis. Furthermore, analysis of gnt2 mutant and 35S:GnTII transgenic plants shows that the addition of the 6-arm non-reducing GlcNAc residue to the common N-glycan acceptor GlcNAcMan(3)(GlcNAc)(2) inhibits additions of the core beta 1,2-xylose and alpha 1,3-fucose residues. Our findings indicate that plants limit the rate of the addition of the 6-arm GlcNAc residue to the common N-glycan acceptor as a mechanism to facilitate formation of the prevalent N-glycans with Man(3)XylFuc(GlcNAc)(2) and (GlcNAc)(2)Man(3)XylFuc(GlcNAc)(2) structures.	[Yoo, Jae Yong; Ko, Ki Seong; Fanata, Wahyu Indra Duwi; Harmoko, Rikno; Ramasamy, Nirmal Kumar; Thulasinathan, Thiyagarajan; Lee, Sang Yeol; Lee, Kyun Oh] Gyeongsang Natl Univ, Div Appl Life Sci, Jinju 660701, South Korea; [Yoo, Jae Yong; Ko, Ki Seong; Fanata, Wahyu Indra Duwi; Harmoko, Rikno; Ramasamy, Nirmal Kumar; Thulasinathan, Thiyagarajan; Lee, Sang Yeol; Lee, Kyun Oh] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Jinju 660701, South Korea; [Seo, Hyun-Kyeong; Park, Seongha; Lim, Jae-Min] Changwon Natl Univ, Dept Chem, Chang Won 641773, South Korea; [Mengiste, Tesfaye] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	Gyeongsang National University; Gyeongsang National University; Changwon National University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Lee, KO (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci, 501 Jinju Daero, Jinju 660701, South Korea.	leeko@gnu.ac.kr	Ramasamy, NirmalKumar/ABG-2032-2020; Harmoko, Rikno/Q-3783-2018; Fanata, Wahyu Indra Duwi/GPK-6251-2022	Harmoko, Rikno/0000-0003-3166-2966; Fanata, Wahyu Indra Duwi/0000-0002-4992-9799; Ramasamy, NirmalKumar/0000-0002-6500-311X; Mengiste, Tesfaye/0000-0001-8865-994X	Next-Generation BioGreen Program [PJ01137901]; Technology Innovation Program - Ministry of Trade, Industry and Energy [10048311]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology, Republic of Korea [2012R1A1A2001074]; Basic Science Research Program through the NRF - Ministry of Education, Science and Technology [NRF 2011-0013961, NRF 2010-0029634]; Priority Research Centers Program through the NRF - Ministry of Education, Science and Technology [NRF 2011-0013961, NRF 2010-0029634]; BK21 program; NRF Postdoctoral Fellowship Program for Foreign Researchers	Next-Generation BioGreen Program; Technology Innovation Program - Ministry of Trade, Industry and Energy; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology, Republic of Korea(National Research Foundation of Korea); Basic Science Research Program through the NRF - Ministry of Education, Science and Technology(National Research Foundation of Korea); Priority Research Centers Program through the NRF - Ministry of Education, Science and Technology(National Research Foundation of Korea); BK21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); NRF Postdoctoral Fellowship Program for Foreign Researchers(National Research Foundation of Korea)	This work was supported in part by grants from the Next-Generation BioGreen Program (Grant PJ01137901); the Technology Innovation Program funded by the Ministry of Trade, Industry and Energy (Grant 10048311); the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (Grant 2012R1A1A2001074), Republic of Korea; and the Basic Science Research Program and the Priority Research Centers Program through the NRF funded by the Ministry of Education, Science and Technology (Grants NRF 2011-0013961 and NRF 2010-0029634). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by scholarships from the BK21 program.; Supported by the 2013 NRF Postdoctoral Fellowship Program for Foreign Researchers. Present address: Center for Development of Advanced Science and Technology (CDAST) and Faculty of Agriculture, University of Jember, Jember 68121, Indonesia.	AALBERSE RC, 1981, J ALLERGY CLIN IMMUN, V68, P356, DOI 10.1016/0091-6749(81)90133-0; ALTMANN F, 1995, GLYCOCONJUGATE J, V12, P150, DOI 10.1007/BF00731359; Bione HM, 1998, AUST DENT J, V43, P181, DOI 10.1111/j.1834-7819.1998.tb00162.x; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; Castilho A, 2008, PLANT PHYSIOL, V147, P331, DOI 10.1104/pp.108.117572; Castilho A, 2010, J BIOL CHEM, V285, P15923, DOI 10.1074/jbc.M109.088401; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Fanata WID, 2013, PLANT J, V73, P966, DOI 10.1111/tpj.12087; FIEDLER K, 1995, CELL, V81, P309, DOI 10.1016/0092-8674(95)90380-1; Frank J, 2008, PLANT PHYSIOL, V148, P1354, DOI 10.1104/pp.108.127027; Ghaderi D, 2010, NAT BIOTECHNOL, V28, P863, DOI 10.1038/nbt.1651; Gomord V, 1997, PLANT J, V11, P313, DOI 10.1046/j.1365-313X.1997.11020313.x; Gutternigg M, 2007, J BIOL CHEM, V282, P27825, DOI 10.1074/jbc.M704235200; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Henquet M, 2008, PLANT CELL, V20, P1652, DOI 10.1105/tpc.108.060731; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Kajiura H, 2012, J BIOSCI BIOENG, V113, P48, DOI 10.1016/j.jbiosc.2011.09.011; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; Kaulfurst-Soboll H, 2011, J BIOL CHEM, V286, P22955, DOI 10.1074/jbc.M110.196097; Liebminger E, 2011, J BIOL CHEM, V286, P10793, DOI 10.1074/jbc.M110.178020; Manduzio H, 2012, PLANT BIOTECHNOL J, V10, P184, DOI 10.1111/j.1467-7652.2011.00654.x; Martina JA, 2000, NEUROCHEM RES, V25, P725, DOI 10.1023/A:1007527523734; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; NILSSON T, 1993, FEBS LETT, V330, P1, DOI 10.1016/0014-5793(93)80906-B; Pagny S, 2003, PLANT J, V33, P189, DOI 10.1046/j.0960-7412.2002.01604.x; Paschinger K, 2006, J BIOL CHEM, V281, P28265, DOI 10.1074/jbc.M602878200; Raju TS, 2014, CURR OPIN BIOTECH, V30, P147, DOI 10.1016/j.copbio.2014.06.014; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Saint-Jore-Dupas C, 2006, PLANT CELL, V18, P3182, DOI 10.1105/tpc.105.036400; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Spiro RG, 2004, CELL MOL LIFE SCI, V61, P1025, DOI 10.1007/s00018-004-4037-8; Strasser R, 1999, GLYCOCONJUGATE J, V16, P787, DOI 10.1023/A:1007127815012; Strasser R, 2006, PLANT J, V45, P789, DOI 10.1111/j.1365-313X.2005.02648.x; Strasser R, 2004, FEBS LETT, V561, P132, DOI 10.1016/S0014-5793(04)00150-4; van Ree R, 2000, J BIOL CHEM, V275, P11451, DOI 10.1074/jbc.275.15.11451; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; VONSCHAEWEN A, 1993, PLANT PHYSIOL, V102, P1109, DOI 10.1104/pp.102.4.1109; Wilson IBH, 1998, GLYCOBIOLOGY, V8, P651, DOI 10.1093/glycob/8.7.651; Wilson IBH, 2002, CURR OPIN STRUC BIOL, V12, P569, DOI 10.1016/S0959-440X(02)00367-6; Wilson IBH, 1998, GLYCOCONJUGATE J, V15, P1055, DOI 10.1023/A:1006960401562; Yip B, 1997, BIOCHEM J, V321, P465, DOI 10.1042/bj3210465; Yoo JY, 2014, PLANT BIOTECHNOL REP, V8, P357, DOI 10.1007/s11816-014-0328-1	45	14	14	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16560	16572		10.1074/jbc.M115.653162	http://dx.doi.org/10.1074/jbc.M115.653162			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	26001781	Green Published, hybrid			2022-12-26	WOS:000357572800009
J	Ordano, M; Engelhard, I; Rempoulakis, P; Nemny-Lavy, E; Blum, M; Yasin, S; Lensky, IM; Papadopoulos, NT; Nestel, D				Ordano, Mariano; Engelhard, Izhar; Rempoulakis, Polychronis; Nemny-Lavy, Esther; Blum, Moshe; Yasin, Sami; Lensky, Itamar M.; Papadopoulos, Nikos T.; Nestel, David			Olive Fruit Fly (Bactrocera oleae) Population Dynamics in the Eastern Mediterranean: Influence of Exogenous Uncertainty on a Monophagous Frugivorous Insect	PLOS ONE			English	Article							NORTH-ATLANTIC OSCILLATION; DIPTERA TEPHRITIDAE; DACUS-OLEAE; DENSITY-DEPENDENCE; CLIMATE-CHANGE; HEAT-STRESS; INFESTATION; PATTERNS; ROSSI; TIME	Despite of the economic importance of the olive fly (Bactrocera oleae) and the large amount of biological and ecological studies on the insect, the factors driving its population dynamics (i.e., population persistence and regulation) had not been analytically investigated until the present study. Specifically, our study investigated the autoregressive process of the olive fly populations, and the joint role of intrinsic and extrinsic factors molding the population dynamics of the insect. Accounting for endogenous dynamics and the influences of exogenous factors such as olive grove temperature, the North Atlantic Oscillation and the presence of potential host fruit, we modeled olive fly populations in five locations in the Eastern Mediterranean region. Our models indicate that the rate of population change is mainly shaped by first and higher order non-monotonic, endogenous dynamics (i.e., density-dependent population feedback). The olive grove temperature was the main exogenous driver, while the North Atlantic Oscillation and fruit availability acted as significant exogenous factors in one of the five populations. Seasonal influences were also relevant for three of the populations. In spite of exogenous effects, the rate of population change was fairly stable along time. We propose that a special reproductive mechanism, such as reproductive quiescence, allows populations of monophagous fruit flies such as the olive fly to remain stable. Further, we discuss how weather factors could impinge constraints on the population dynamics at the local level. Particularly, local temperature dynamics could provide forecasting cues for management guidelines. Jointly, our results advocate for establishing monitoring programs and for a major focus of research on the relationship between life history traits and populations dynamics.	[Ordano, Mariano] Fdn Miguel Lillo, San Miguel De Tucuman, Argentina; [Engelhard, Izhar; Rempoulakis, Polychronis; Nemny-Lavy, Esther; Nestel, David] Agr Res Org, Volcani Ctr, Inst Plant Protect, IL-50250 Bet Dagan, Israel; [Blum, Moshe; Lensky, Itamar M.] Bar Ilan Univ, Dept Geog & Environm, Ramat Gan, Israel; [Yasin, Sami] Agro Nippon Int Cooperat Community Dev NICCOD, Zababdeh Off, Tubas, Israel; [Papadopoulos, Nikos T.] Univ Thessaly, Lab Entomol & Agr Zool, Volos, Greece; [Ordano, Mariano] Consejo Nacl Invest Cient & Tecn, FML, CCT Tucuman, Unidad Ejecutora Lillo, San Miguel De Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Miguel Lillo Foundation; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Bar Ilan University; University of Thessaly; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Nestel, D (corresponding author), Agr Res Org, Volcani Ctr, Inst Plant Protect, IL-50250 Bet Dagan, Israel.	nestel@volcani.agri.gov.il	Papadopoulos, Nikos/AAJ-1721-2020; Ordano, Mariano/H-8437-2019; Rempoulakis, Polychronis/P-2731-2019; Papadopoulos, Nikos T./B-9156-2011; Lensky, Itamar/B-5285-2014	Papadopoulos, Nikos/0000-0003-2480-8189; Ordano, Mariano/0000-0003-0962-973X; Rempoulakis, Polychronis/0000-0002-3947-0064; Papadopoulos, Nikos T./0000-0003-2480-8189; Lensky, Itamar/0000-0001-7594-5277; Nestel, 0000-0002-4042-9210 Other IDs Loop profile: 123122/0000-0003-4322-4648	Nippon International Cooperation for Community Development [131-1631]	Nippon International Cooperation for Community Development	This work was supported by the Nippon International Cooperation for Community Development (grant no. 131-1631 to DN). The funders have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aluja M, 2012, J ECON ENTOMOL, V105, P823, DOI 10.1603/EC11353; Aluja M, 2009, J INSECT PHYSIOL, V55, P231, DOI 10.1016/j.jinsphys.2008.11.013; AVIDOV Z., 1954, Ktavim, V4, P39; Baldoni L, 2009, HANDB PLANT BREED, V4, P397, DOI 10.1007/978-0-387-77594-4_13; Berryman A, 2001, OIKOS, V92, P265, DOI 10.1034/j.1600-0706.2001.920208.x; Berryman A., 1999, PRINCIPLES POPULATIO; Blum M, 2013, AGR FOREST METEOROL, V176, P90, DOI 10.1016/j.agrformet.2013.03.007; Brook BW, 2006, ECOLOGY, V87, P1445, DOI 10.1890/0012-9658(2006)87[1445:SOEFDD]2.0.CO;2; Burrack HJ, 2011, CALIF AGR, V65, P14, DOI 10.3733/ca.v065n01p14; COOK JR, 1994, J AM STAT ASSOC, V89, P1314, DOI 10.2307/2290994; Cowpertwait PSP, 2009, USE R, P1, DOI 10.1007/978-0-387-88698-5_1; Delrio G., 1985, INTEGRATED PEST CONT, P394; ECONOMOPOULOS AP, 1982, Z ANGEW ENTOMOL, V93, P463; Engelhard I, 2012, THESIS HEBREW U JERU, P40; Estay SA, 2014, OIKOS, V123, P131, DOI 10.1111/j.1600-0706.2013.00607.x; Estay SA, 2010, POPUL ECOL, V52, P289, DOI 10.1007/s10144-009-0179-8; Fletcher B.S., 1989, World Crop Pests, V3A, P273; FLETCHER BS, 1978, ECOL ENTOMOL, V3, P99, DOI 10.1111/j.1365-2311.1978.tb00908.x; Fornaciari M, 2000, PLANT BIOSYST, V134, P199, DOI 10.1080/11263500012331358474; Freckleton RP, 2006, J ANIM ECOL, V75, P837, DOI 10.1111/j.1365-2656.2006.01121.x; Galecki A, 2013, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-1-4614-3900-4; Giannini A, 2001, J CLIMATE, V14, P2867, DOI 10.1175/1520-0442(2001)014<2867:ICITET>2.0.CO;2; Goncalves F, 2013, INT J PEST MANAGE, V59, P279, DOI 10.1080/09670874.2013.851428; Gordo O, 2010, GLOBAL CHANGE BIOL, V16, P1082, DOI 10.1111/j.1365-2486.2009.02084.x; Gutierrez AP, 2009, CLIMATIC CHANGE, V95, P195, DOI 10.1007/s10584-008-9528-4; Haniotakis GE, 1982, P M EEC ETAT AVANCEM, P46; Hodar JA, 2012, CLIMATIC CHANGE, V113, P699, DOI 10.1007/s10584-011-0371-7; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Israely N, 1997, ENVIRON ENTOMOL, V26, P1263, DOI 10.1093/ee/26.6.1263; K?chenhoff H., 2006, R NEWS, V6, P26; Katsoyannos P, 1992, FAO PLANT PRODUCTION, V115; Kiritani K, 2013, APPL ENTOMOL ZOOL, V48, P97, DOI 10.1007/s13355-012-0158-y; Knape J, 2012, ECOL LETT, V15, P17, DOI 10.1111/j.1461-0248.2011.01702.x; Kounatidis I, 2008, J APPL ENTOMOL, V132, P722, DOI 10.1111/j.1439-0418.2008.01349.x; KOVEOS DS, 1990, ENTOMOL EXP APPL, V55, P161, DOI 10.1007/BF00352577; Lima M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030569; Nardi F, 2005, MOL ECOL, V14, P2729, DOI 10.1111/j.1365-294X.2005.02610.x; National Weather Service. Climate Prediction Center, TEL IND CALC PROC; Nestel D, 2004, INSECT PEST MANAGEMENT, FIELD AND PROTECTED CROPS, P45; NEUENSCHWANDER P, 1978, Z ANGEW ENTOMOL, V86, P420; NICHOLSON AJ, 1958, ANNU REV ENTOMOL, V3, P107, DOI 10.1146/annurev.en.03.010158.000543; Papadopoulos NT, 2003, PHYTOMA ESPANA, V153, P149; Papanastasiou SA, 2011, J INSECT PHYSIOL, V57, P83, DOI 10.1016/j.jinsphys.2010.09.008; Pappas ML, 2011, J APPL ENTOMOL, V135, P359, DOI 10.1111/j.1439-0418.2010.01579.x; Parry M. L., 2007, CLIMATE CHANGE 2007; Pinheiro J, 2020, R PACKAGE VERSION 31; Pinheiro J, 2000, MIXED EFFECTS MODELS; Podgornik M, 2013, ENTOMOL NEWS, V123, P15, DOI 10.3157/021.123.0106; R Development Core Team, 2014, R LANG ENV STAT COMP; Ramos P, 1983, P CEC IBOC INT S FRU, p[16, 38]; Royama T., 1992, Analytical population dynamics.; SOLOMON ME, 1957, ANNU REV ENTOMOL, V2, P121, DOI 10.1146/annurev.en.02.010157.001005; Stavrakis G.N., 1980, Mededelingen van de Faculteit Landbouwwetenschappen Rijksuniversiteit Gent, V45, P587; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Tzanakakis ME, 2003, NETH J ZOOL, V52, P87, DOI 10.1163/156854203764817670; Varikou K, 2013, PHYTOPARASITICA, V41, P105, DOI 10.1007/s12600-012-0270-0; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Volakakis NG, 2012, J SUSTAIN AGR, V36, P683, DOI 10.1080/10440046.2012.672377; Wang XG, 2009, ENVIRON ENTOMOL, V38, P1496, DOI 10.1603/022.038.0518; Wang XG, 2009, ANN ENTOMOL SOC AM, V102, P727, DOI 10.1603/008.102.0418; Weissman Z, 2009, DESERT OLIVE OIL CUL; Yasin S, 2014, CROP PROT, V57, P63, DOI 10.1016/j.cropro.2013.12.020; Yokoyama VY, 2012, J ECON ENTOMOL, V105, P186, DOI 10.1603/EC11255; Zuur Alain F., 2009, P1	64	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127798	10.1371/journal.pone.0127798	http://dx.doi.org/10.1371/journal.pone.0127798			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010332	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900146
J	Si, W; Wu, ZW; Wang, LL; Yang, MM; Zhao, X				Si, Wei; Wu, ZhaoWei; Wang, LiangLiang; Yang, MingMing; Zhao, Xin			Enzymological Characterization of Atm, the First Laccase from Agrobacterium sp. S5-1, with the Ability to Enhance In Vitro digestibility of Maize Straw	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; WHEAT-STRAW; ENZYMES; POLYSACCHARIDES; PURIFICATION; FUNGAL	Laccase is an enzyme that catalyzes oxidation of phenolic compounds, diamines and aromatic amines. In this study, a novel laccase-like gene (atm) in a ligninolyitic isolate Agrobacterium sp. S5-1 from soil humus was identified and heterologously expressed in Escherichia coli. Atm exhibited its maximal activity at pH 4.5 and at 50 degrees C. This enzyme was tolerant to high temperature, a broad range of pH, heavy metal ions (Co3+, Mn2+, Cu2+ and Ni2+, 20 mM) and all tested organic solvents. Furthermore, Atm significantly (p<0.05) increased dry matter digestibility of maize straw from 23.44% to 27.96% and from 29.53% to 37.10% after 8 or 24 h of digestion and improved acid detergent fiber digestibility from 5.81% to 10.33% and from 12.80% to 19.07% after 8 or 24 h of digestion, respectively. The combination of Atm and fibrolytic enzymes significantly (p<0.05) enhanced neutral detergent fiber digestibility from 19.02% to 24.55% after 24 h of digestion respectively. Results showed treatment with Atm effectively improved in vitro digestibility of maize straw, thus suggesting that Atm has an application potential for bioconversion of lignin rich agricultural byproducts into animal feed and cellulosic ethanol.	[Si, Wei; Wu, ZhaoWei; Wang, LiangLiang; Yang, MingMing; Zhao, Xin] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi Provinc, Peoples R China; [Zhao, Xin] McGill Univ, Dept Anim Sci, Montreal, PQ H3A 2T5, Canada	Northwest A&F University - China; McGill University	Zhao, X (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi Provinc, Peoples R China.	biodna@126.com; xin.zhao@mcgill.ca	Zhao, Xin/M-4312-2015; Wang, Liangliang/ADF-9017-2022	Zhao, Xin/0000-0002-1078-7332; 	China Thousand Talents program; National Science Foundation of China [31372343]	China Thousand Talents program; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the China Thousand Talents program and a grant from the National Science Foundation of China (31372343).	Arora DS, 2009, BIORESOURCES, V4, P909; Ausec L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025724; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen M, 2008, CARBOHYD POLYM, V71, P411, DOI 10.1016/j.carbpol.2007.06.011; Claus H, 2003, ARCH MICROBIOL, V179, P145, DOI 10.1007/s00203-002-0510-7; DESCHAMPS AM, 1980, EUR J APPL MICROBIOL, V9, P45, DOI 10.1007/BF00500001; Endo K, 2003, J BIOCHEM, V133, P671, DOI 10.1093/jb/mvg086; Graminha EBN, 2008, ANIM FEED SCI TECH, V144, P1, DOI 10.1016/j.anifeedsci.2007.09.029; Hullo MF, 2001, J BACTERIOL, V183, P5426, DOI 10.1128/JB.183.18.5426-5430.2001; Johannes C, 2000, J BIOTECHNOL, V78, P193, DOI 10.1016/S0168-1656(00)00208-X; Komori H, 2009, FEBS LETT, V583, P1189, DOI 10.1016/j.febslet.2009.03.008; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; Krueger NA, 2008, ANIM FEED SCI TECH, V145, P95, DOI 10.1016/j.anifeedsci.2007.05.042; Krueger NA, 2008, ANIM FEED SCI TECH, V145, P84, DOI 10.1016/j.anifeedsci.2007.05.041; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Martins LO, 2015, CELL MOL LIFE SCI, V72, P911, DOI 10.1007/s00018-014-1822-x; MENKE KH, 1979, J AGR SCI, V93, P217, DOI 10.1017/S0021859600086305; Miyazaki K, 2005, EXTREMOPHILES, V9, P415, DOI 10.1007/s00792-005-0458-z; Morozova V, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1136, DOI 10.1134/S0006297907100112; Nakamura K, 2003, FEBS LETT, V553, P239, DOI 10.1016/S0014-5793(03)01000-7; Parshetti GK, 2011, J ENVIRON SCI, V23, P1384, DOI 10.1016/S1001-0742(10)60547-5; Reiss R, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-9; Rivera-Hoyos CM, 2013, FUNGAL BIOL REV, V27, P67, DOI 10.1016/j.fbr.2013.07.001; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; Ruijssenaars HJ, 2004, APPL MICROBIOL BIOT, V65, P177, DOI 10.1007/s00253-004-1571-0; Sharma P, 2007, WORLD J MICROB BIOT, V23, P823, DOI 10.1007/s11274-006-9305-3; Sharma RK, 2010, BIORESOURCE TECHNOL, V101, P9248, DOI 10.1016/j.biortech.2010.07.042; Shrivastava B, 2011, BIODEGRADATION, V22, P823, DOI 10.1007/s10532-010-9408-2; Singh G, 2007, ENZYME MICROB TECH, V41, P794, DOI 10.1016/j.enzmictec.2007.07.001; SUNDMAN V, 1964, J GEN MICROBIOL, V36, P185, DOI 10.1099/00221287-36-2-185; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Widsten P, 2008, ENZYME MICROB TECH, V42, P293, DOI 10.1016/j.enzmictec.2007.12.003; Wu YR, 2010, BIORESOURCE TECHNOL, V101, P9772, DOI 10.1016/j.biortech.2010.07.091; Yu P, 2005, J ANIM SCI, V83, P1133	34	10	10	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128204	10.1371/journal.pone.0128204	http://dx.doi.org/10.1371/journal.pone.0128204			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010258	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900205
J	Zeng, C; Li, H; Wei, J; Yang, T; Deng, ZH; Yang, Y; Zhang, Y; Yang, TB; Lei, GH				Zeng, Chao; Li, Hui; Wei, Jie; Yang, Tuo; Deng, Zhen-han; Yang, Ye; Zhang, Yi; Yang, Tu-bao; Lei, Guang-hua			Association between Dietary Magnesium Intake and Radiographic Knee Osteoarthritis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; METABOLIC SYNDROME; RISK-FACTORS; WOMEN; DISEASE; INFLAMMATION; PREVALENCE; DEFICIENCY; CALCIUM; METAANALYSIS	Objective To examine the cross-sectional associations between dietary magnesium (Mg) intake and radiographic knee osteoarthritis (OA), joint space narrowing (JSN), and osteophytes (OST) respectively. Methods A total of 1626 subjects were included in the study. Dietary intake was assessed using a validated semi-quantitative food frequency questionnaire. Radiographic knee OA was defined as Kellgren-Lawrence (K-L) Grade 2 in at least one leg. JSN and OST were assessed individually according to the Osteoarthritis Research Society International (OARSI) atlas. A multivariable logistic analysis model was applied to test the various associations after adjusting for potentially confounding factors. Results The relative odds of radiographic knee OA were decreased by 0.53 times in the third quintile of Mg intake [odds ratio (OR) 0.53, 95% confidence interval (CI) 0.28-1.01], 0.40 times in the fourth quintile (OR 0.40, 95% CI 0.17-0.94) and 0.34 times in the fifth quintile (OR 0.34, 95% CI 0.11-1.00) compared with those in the lowest quintile, while P for trend was 0.111. The relative odds of JSN were decreased by 0.49 times in the third quintile of Mg intake (OR 0.49, 95% CI 0.28-0.88) and 0.37 times in the fifth quintile (OR 0.37, 95% CI 0.14-0.98) compared with those in the lowest quintile, while P for trend was 0.088. There was no significant relationship between dietary Mg intake and the presence of OST. Conclusions The findings of this cross-sectional study indicate that Mg intake is inversely associated with radiographic knee OA and JSN. It supports potential role of Mg in the prevention of knee OA.	[Zeng, Chao; Li, Hui; Yang, Tuo; Deng, Zhen-han; Yang, Ye; Zhang, Yi; Lei, Guang-hua] Cent S Univ, Xiangya Hosp, Dept Orthopaed, Changsha, Hunan, Peoples R China; [Wei, Jie; Yang, Tu-bao] Cent S Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China	Central South University; Central South University	Lei, GH (corresponding author), Cent S Univ, Xiangya Hosp, Dept Orthopaed, Changsha, Hunan, Peoples R China.	lgh9640@sina.cn	Wei, Jie/ACR-8087-2022; Deng, Zhenhan/AAB-4968-2021; Deng, Zhenhan/AAR-2420-2021	Wei, Jie/0000-0003-3510-8241; Deng, Zhenhan/0000-0003-0522-8269	Hunan Provincial Innovation Foundation for Postgraduate [CX2014A005]; Fundamental Research Funds for the Central Universities of Central South University; National Natural Science Foundation of China [81201420, 81272034, 81472130]; Provincial Science Foundation of Hunan [14JJ3032]; Scientific Research Project of the Development and Reform Commission of Hunan Province [[2013]1199]; Scientific Research Project of Science and Technology Office of Hunan Province [2013SK2018]; Ministry of Education of China [20120162110036]	Hunan Provincial Innovation Foundation for Postgraduate; Fundamental Research Funds for the Central Universities of Central South University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Science Foundation of Hunan; Scientific Research Project of the Development and Reform Commission of Hunan Province; Scientific Research Project of Science and Technology Office of Hunan Province; Ministry of Education of China(Ministry of Education, China)	This work was supported by Hunan Provincial Innovation Foundation for Postgraduate (CX2014A005), the Fundamental Research Funds for the Central Universities of Central South University, the National Natural Science Foundation of China (No. 81201420, 81272034, 81472130), the Provincial Science Foundation of Hunan (No. 14JJ3032), the Scientific Research Project of the Development and Reform Commission of Hunan Province ([2013]1199), the Scientific Research Project of Science and Technology Office of Hunan Province (2013SK2018), and the Doctoral Scientific Fund Project of the Ministry of Education of China (20120162110036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; Berenbaum F, 2011, ANN RHEUM DIS, V70, P1354, DOI 10.1136/ard.2010.146399; Bonnet CS, 2005, RHEUMATOLOGY, V44, P7, DOI 10.1093/rheumatology/keh344; Conaghan PG, 2005, ANN RHEUM DIS, V64, P1539, DOI 10.1136/ard.2005.039263; Dibaba DT, 2014, EUR J CLIN NUTR, V68, P510, DOI 10.1038/ejcn.2014.7; Du H, 2005, RHEUMATOL INT, V25, P585, DOI 10.1007/s00296-004-0492-7; Egerbacher M, 2001, VET PATHOL, V38, P143, DOI 10.1354/vp.38-2-143; Engstrom G, 2009, OSTEOARTHR CARTILAGE, V17, P168, DOI 10.1016/j.joca.2008.07.003; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Feyerabend F, 2006, TISSUE ENG, V12, P3545, DOI 10.1089/ten.2006.12.3545; FINCHAM JE, 1986, S AFR MED J, V70, P740; Gruber HE, 2004, BIOTECH HISTOCHEM, V79, P45, DOI 10.1080/10520290410001697913; Hejazi J, 2011, WOMENS HEALTH, V7, P599, DOI [10.2217/WHE.11.41, 10.2217/whe.11.41]; Ho-Pham LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094563; Hruby A, 2014, DIABETES CARE, V37, P419, DOI 10.2337/dc13-1397; Hunter DJ, 2003, RHEUMATOLOGY, V42, P1311, DOI 10.1093/rheumatology/keg373; Jin XZ, 2015, ANN RHEUM DIS, V74, P703, DOI 10.1136/annrheumdis-2013-204494; Kellgren JH, 1963, THE EPIDEMIOLOGY OF; King DE, 2007, MAGNESIUM RES, V20, P32; King DE, 2005, J AM COLL NUTR, V24, P166, DOI 10.1080/07315724.2005.10719461; Kremer JM, 1996, J RHEUMATOL, V23, P990; Lee CH, 2009, OSTEOARTHR CARTILAGE, V17, P1485, DOI 10.1016/j.joca.2009.05.006; Lopez-Ridaura R, 2004, DIABETES CARE, V27, P134, DOI 10.2337/diacare.27.1.134; Mak IT, 1997, MOL CELL BIOCHEM, V176, P35, DOI 10.1023/A:1006814609769; Malpuech-Brugere C, 2000, BBA-MOL BASIS DIS, V1501, P91, DOI 10.1016/S0925-4439(00)00018-1; Marks Ray, 2002, Med Sci Monit, V8, pCR305; Morgan S L, 1993, Arthritis Care Res, V6, P4, DOI 10.1002/art.1790060103; Nanri A, 2010, EUR J CLIN NUTR, V64, P1244, DOI 10.1038/ejcn.2010.138; Nielsen FH, 2010, NUTR REV, V68, P333, DOI 10.1111/j.1753-4887.2010.00293.x; Puenpatom RA, 2009, POSTGRAD MED, V121, P9, DOI 10.3810/pgm.2009.11.2073; Qin B, 2012, ARTHRIT CARE RES, V64, P1306, DOI 10.1002/acr.21708; Salve Harshal, 2010, Indian J Public Health, V54, P155, DOI 10.4103/0019-557X.75739; Song YQ, 2007, AM J CLIN NUTR, V85, P1068, DOI 10.1093/ajcn/85.4.1068; Song YQ, 2004, DIABETES CARE, V27, P59, DOI 10.2337/diacare.27.1.59; Song YQ, 2005, DIABETES CARE, V28, P1438, DOI 10.2337/diacare.28.6.1438; Tam M, 2003, EUR J CLIN NUTR, V57, P1193, DOI 10.1038/sj.ejcn.1601689; Tangney CC, 2004, J NUTR, V134, P927, DOI 10.1093/jn/134.4.927; van Dam RM, 2006, DIABETES CARE, V29, P2238, DOI 10.2337/dc06-1014; WEGLICKI WB, 1992, MOL CELL BIOCHEM, V110, P169, DOI 10.1007/BF02454195; Yang YX., 2009, CHINA FOOD COMPOSITI; Yoshimura N, 2011, J RHEUMATOL, V38, P921, DOI 10.3899/jrheum.100569; Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8; Zeng C, 2014, OSTEOARTHR CARTILAGE, V22, P1947, DOI 10.1016/j.joca.2014.06.039; Zeng QY, 2006, CHINESE MED J-PEKING, V119, P1522, DOI 10.1097/00029330-200609020-00004; Zhang Y, 2015, RHEUMATOL INT; Zheng JM, 2014, BIOL TRACE ELEM RES, V159, P8, DOI 10.1007/s12011-014-9961-3; Zhuo Q, 2012, NAT REV RHEUMATOL, V8, P729, DOI 10.1038/nrrheum.2012.135	47	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127666	10.1371/journal.pone.0127666	http://dx.doi.org/10.1371/journal.pone.0127666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010333	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900126
J	Du, F; Ding, Y; Zou, J; Li, ZL; Tian, JJ; She, RP; Wang, DS; Wang, HJ; Lv, DQ; Chang, LL				Du, Fang; Ding, Ye; Zou, Jun; Li, Zhili; Tian, Jijing; She, Ruiping; Wang, Desheng; Wang, Huijuan; Lv, Dongqiang; Chang, Lingling			Morphology and Molecular Mechanisms of Hepatic Injury in Rats under Simulated Weightlessness and the Protective Effects of Resistance Training	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SOLEUS MUSCLE; BONE LOSS; APOPTOSIS; MICROGRAVITY; HUMANS; METABOLISM; EXPRESSION; VIBRATION; ATROPHY	This study investigated the effects of long-term simulated weightlessness on liver morphology, enzymes, glycogen, and apoptosis related proteins by using two-month rat-tail suspension model (TS), and liver injury improvement by rat-tail suspension with resistance training model (TS&RT). Microscopically the livers of TS rats showed massive granular degeneration, chronic inflammation, and portal fibrosis. Mitochondrial and endoplasmic reticulum swelling and loss of membrane integrity were observed by transmission electron microscopy (TEM). The similar, but milder, morphological changes were observed in the livers of TS&RT rats. Serum biochemistry analysis revealed that the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were significantly higher (p<0.05) in TS rats than in controls. The levels of ALT and AST in TS&RT rats were slightly lower than in RT rats, but they were insignificantly higher than in controls. However, both TS and TS&RT rats had significantly lower levels (p<0.05) of serum glucose and hepatic glycogen than in controls. Immunohistochemistry demonstrated that the expressions of Bax, Bcl-2, and active caspase-3 were higher in TS rats than in TS&RT and control rats. Real-time polymerase chain reaction (real-time PCR) showed that TS rats had higher mRNA levels (P<0.05) of glucose-regulated protein 78 (GRP78) and caspase-12 transcription than in control rats; whereas mRNA expressions of C/EBP homologous protein (CHOP) and c-Jun N-terminal kinase (JNK) were slightly higher in TS rats. TS&RT rats showed no significant differences of above 4 mRNAs compared with the control group. Our results demonstrated that long-term weightlessness caused hepatic injury, and may trigger hepatic apoptosis. Resistance training slightly improved hepatic damage.	[Du, Fang; Ding, Ye; Tian, Jijing; She, Ruiping; Lv, Dongqiang; Chang, Lingling] China Agr Univ, Dept Vet Pathol, Lab Vet Pathol & Publ Hlth, Coll Vet Med, Beijing 100094, Peoples R China; [Zou, Jun] China Agr Univ, Natl Anim Protozoa Lab, Coll Vet Med, Beijing 100094, Peoples R China; [Li, Zhili; Wang, Desheng; Wang, Huijuan] China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China	China Agricultural University; China Agricultural University	She, RP (corresponding author), China Agr Univ, Dept Vet Pathol, Lab Vet Pathol & Publ Hlth, Coll Vet Med, Beijing 100094, Peoples R China.	sheruiping@126.com; wangds64@tom.com	ZOU, JUN/AAD-3904-2019; wang, huimin/HDM-8421-2022; wang, hui/GRS-4730-2022		Advanced Space Medico-Engineering Research Project of China [SJ200802]	Advanced Space Medico-Engineering Research Project of China	This work was supported by Advanced Space Medico-Engineering Research Project of China (grant NO. SJ200802).	Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Banhegyi G, 2007, ANN NY ACAD SCI, V1113, P58, DOI 10.1196/annals.1391.007; Bederman IR, 2013, EXP PHYSIOL, V98, P278, DOI 10.1113/expphysiol.2012.067074; Ding Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020008; Ferreira R, 2008, PHYSIOL RES, V57, P601, DOI 10.33549/physiolres.931272; Fitts RH, 2000, J APPL PHYSIOL, V89, P823, DOI 10.1152/jappl.2000.89.2.823; Grimm D, 2002, FASEB J, V16, P604, DOI 10.1096/fj.01-0673fje; Hwang S, 2007, J APPL PHYSIOL, V102, P1595, DOI 10.1152/japplphysiol.01020.2006; Kahraman A, 2008, HEPATOLOGY, V47, P1317, DOI 10.1002/hep.22136; Kijima K, 2004, TOXICOL APPL PHARM, V200, P103, DOI 10.1016/j.taap.2004.03.015; Li ZL, 2012, EUR J APPL PHYSIOL, V112, P3743, DOI 10.1007/s00421-012-2355-3; Liu GG, 2008, BIOCHEM BIOPH RES CO, V370, P651, DOI 10.1016/j.bbrc.2008.04.031; MACHO L, 1982, ACTA ASTRONAUT, V9, P385, DOI 10.1016/0094-5765(82)90066-2; MERRILL AH, 1992, J APPL PHYSIOL, V73, pS142, DOI 10.1152/jappl.1992.73.2.S142; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Nakamura H, 2003, ANN NY ACAD SCI, V1010, P143, DOI 10.1196/annals.1299.023; Norsk P, 2005, CURR PHARM BIOTECHNO, V6, P325, DOI 10.2174/1389201054553734; Oxlund BS, 2003, BONE, V32, P69, DOI 10.1016/S8756-3282(02)00916-X; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Perez MJ, 2005, J HEPATOL, V43, P324, DOI 10.1016/j.jhep.2005.02.028; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Shahraki Mohammad Reza, 2014, Int J High Risk Behav Addict, V3, pe21076, DOI 10.5812/ijhrba.21076; Sharma CS, 2008, MOL CELL BIOCHEM, V313, P71, DOI 10.1007/s11010-008-9743-3; Stein TP, 2005, J NUTR, V135, p1824S, DOI 10.1093/jn/135.7.1824S; Stein TP, 2005, J NUTR BIOCHEM, V16, P9, DOI 10.1016/j.jnutbio.2004.07.003; Sun XQ, 2009, BEHAV BRAIN RES, V199, P197, DOI 10.1016/j.bbr.2008.11.035; Sun YY, 2008, ACTA BIOCHIM POL, V55, P511, DOI 10.18388/abp.2008_3057; Swift JM, 2010, J BONE MINER RES, V25, P564, DOI 10.1359/jbmr.090811; Symons TB, 2009, J APPL PHYSIOL, V107, P34, DOI 10.1152/japplphysiol.91137.2008; THOMASON DB, 1990, J APPL PHYSIOL, V68, P1, DOI 10.1152/jappl.1990.68.1.1; Trappe T, 2006, J APPL PHYSIOL, V100, P951, DOI 10.1152/japplphysiol.01083.2005; Turner R T, 1979, Physiologist, V22, pS73; VETROVA EG, 1981, KOSM BIOL AVIAK MED+, V15, P34; Wade CE, 2002, NUTRITION, V18, P829, DOI 10.1016/S0899-9007(02)00914-0; Wang XD, 2001, GENE DEV, V15, P2922; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; Widrick JJ, 1999, J PHYSIOL-LONDON, V516, P915, DOI 10.1111/j.1469-7793.1999.0915u.x; Wilkerson MK, 2002, AM J PHYSIOL-HEART C, V282, pH328, DOI 10.1152/ajpheart.00727.2001; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653	40	21	25	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127047	10.1371/journal.pone.0127047	http://dx.doi.org/10.1371/journal.pone.0127047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000905	Green Published, gold, Green Submitted			2022-12-26	WOS:000354931700038
J	Galactionova, K; Tediosi, F; de Savigny, D; Smith, T; Tanner, M				Galactionova, Katya; Tediosi, Fabrizio; de Savigny, Don; Smith, Thomas; Tanner, Marcel			Effective Coverage and Systems Effectiveness for Malaria Case Management in Sub-Saharan African Countries	PLOS ONE			English	Article							LUMEFANTRINE TREATMENT POLICY; ARTEMETHER-LUMEFANTRINE; UNCOMPLICATED MALARIA; HEALTH-WORKERS; ANTIMALARIAL TREATMENT; CONCEPTUAL-FRAMEWORK; COMBINATION THERAPY; FALCIPARUM-MALARIA; 6-DOSE REGIMEN; ADHERENCE	Scale-up of malaria preventive and control interventions over the last decade resulted in substantial declines in mortality and morbidity from the disease in sub-Saharan Africa and many other parts of the world. Sustaining these gains will depend on the health system performance. Treatment provides individual benefits by curing infection and preventing progression to severe disease as well as community-level benefits by reducing the infectious reservoir and averting emergence and spread of drug resistance. However many patients with malaria do not access care, providers do not comply with treatment guidelines, and hence, patients do not necessarily receive the correct regimen. Even when the correct regimen is administered some patients will not adhere and others will be treated with counterfeit or substandard medication leading to treatment failures and spread of drug resistance. We apply systems effectiveness concepts that explicitly consider implications of health system factors such as treatment seeking, provider compliance, adherence, and quality of medication to estimate treatment outcomes for malaria case management. We compile data for these indicators to derive estimates of effective coverage for 43 high-burden Sub-Saharan African countries. Parameters are populated from the Demographic and Health Surveys and other published sources. We assess the relative importance of these factors on the level of effective coverage and consider variation in these health systems indicators across countries. Our findings suggest that effective coverage for malaria case management ranges from 8% to 72% in the region. Different factors account for health system inefficiencies in different countries. Significant losses in effectiveness of treatment are estimated in all countries. The patterns of inter-country variation suggest that these are system failures that are amenable to change. Identifying the reasons for the poor health system performance and intervening to tackle them become key priority areas for malaria control and elimination policies in the region.	[Galactionova, Katya; Tediosi, Fabrizio; de Savigny, Don; Smith, Thomas; Tanner, Marcel] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Galactionova, Katya; Tediosi, Fabrizio; de Savigny, Don; Smith, Thomas; Tanner, Marcel] Univ Basel, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Smith, T (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	thomas-a.smith@unibas.ch	Tediosi, Fabrizio/ABC-7880-2020; Tediosi, Fabrizio/AAD-4805-2022; Smith, Thomas/B-5569-2015	Tediosi, Fabrizio/0000-0001-8671-9400; Smith, Thomas/0000-0002-3650-9381; Galactionova, Katya/0000-0002-5743-7647	Malaria Vaccine Initiative at PATH; Bill & Melinda Gates Foundation [1032350]	Malaria Vaccine Initiative at PATH; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The funding was from the Malaria Vaccine Initiative at PATH (http://www.malariavaccine.org/), and the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org/), Grant number 1032350. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreha T, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-292; Ajayi IO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-190; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000397; [Anonymous], LANCENT; [Anonymous], SPMAP STATA MODULE T; [Anonymous], DHS MODEL QUESTIONNA; [Anonymous], THE GLOBAL MALARIA A; [Anonymous], PLOS ONE; [Anonymous], ARE WE ACHIEVING SUF; [Anonymous], TRANSACTIONS OF THE; [Anonymous], DEMOGRAPHIC AND HEAL; [Anonymous], SURVEY OF THE QUALIT; [Anonymous], CLINICAL PHARMACOKIN; [Anonymous], DHS RECODE MANUAL; [Anonymous], ANTIMALARIAL QUALITY; [Anonymous], GLOBAL REPORT ON ANT; [Anonymous], MALARIA JOURNAL; [Anonymous], GUIDELINES FOR TREAT; [Anonymous], NIGERIAN JOURNAL OF; [Anonymous], SURVEY OF THE QUALIT; [Anonymous], 2012 SURVEY REPORT; [Anonymous], PLOS MEDICINE; [Anonymous], AMERICAN JOURNAL OF; [Anonymous], 2010 SURVEY REPORT; [Anonymous], THE MARKET FOR FAKE; [Anonymous], MALARIA DRUG RESISTA; [Anonymous], MULTIPLE INDICATOR C; [Anonymous], 2011 SURVEY REPORT; Bate R, 2012, RES REP TROP MED, V3, P63, DOI 10.2147/RRTM.S33690; Bate R, 2011, J HEALTH ECON, V30, P1150, DOI 10.1016/j.jhealeco.2011.08.006; Bate R, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-157; Beer N, 2009, TROP MED INT HEALTH, V14, P766, DOI 10.1111/j.1365-3156.2009.02289.x; Berendes S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000433; Brasseur P, 2009, TROP MED INT HEALTH, V14, P79, DOI 10.1111/j.1365-3156.2008.02190.x; Briet OJT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-401; Cohen JL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-83; Colvin CJ, 2013, SOC SCI MED, V86, P66, DOI 10.1016/j.socscimed.2013.02.031; Crowell V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057297; Eisele TP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001417; Eisele TP, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-93; Ezzet F, 2000, ANTIMICROB AGENTS CH, V44, P697, DOI 10.1128/AAC.44.3.697-704.2000; Fabic MS, 2012, B WORLD HEALTH ORGAN, V90, P604, DOI 10.2471/BLT.11.095513; Fogg C, 2004, AM J TROP MED HYG, V71, P525, DOI 10.4269/ajtmh.2004.71.525; Hancioglu A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001391; Juma E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-1; Kabanywanyi AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-48; Kalyango JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060481; Kangwana BP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000437; Karunamoorthi K, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-209; Khatib RA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-155; Klein EY, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-110; Lemma H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-349; Littrell M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-371; Mace KE, 2011, CLIN INFECT DIS, V53, P772, DOI 10.1093/cid/cir498; Mangham LJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-155; Masanja IM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-446; McPake B, 1999, SOC SCI MED, V49, P849, DOI 10.1016/S0277-9536(99)00144-6; Mikkelsen-Lopez I, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-444; Minzi O, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-267; Mumba M, 2003, TROP MED INT HEALTH, V8, P544, DOI 10.1046/j.1365-3156.2003.01064.x; Newton PN, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-352; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Ogolla JO, 2013, IRAN J PUBLIC HEALTH, V42, P129; Palafox B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093763; Rao VB, 2013, TRENDS PARASITOL, V29, P164, DOI 10.1016/j.pt.2013.01.005; Shengelia B, 2005, SOC SCI MED, V61, P97, DOI 10.1016/j.socscimed.2004.11.055; Simba DO, 2012, T ROY SOC TROP MED H, V106, P3, DOI 10.1016/j.trstmh.2011.09.006; Stratton L, 2008, SOC SCI MED, V67, P854, DOI 10.1016/j.socscimed.2008.05.013; Sumba PO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-245; Tambo E, 2012, INFECT DIS POVERTY, V1, DOI 10.1186/2049-9957-1-7; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; Tanner M, 1998, SOC SCI MED, V46, P523, DOI 10.1016/S0277-9536(97)00195-0; Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419; Watsierah CA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-290; Webster J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-261; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Zurovac D, 2008, TROP MED INT HEALTH, V13, P99, DOI 10.1111/j.1365-3156.2007.01980.x; Zurovac D, 2006, ANN TROP MED PARASIT, V100, P283, DOI 10.1179/136485906X105633; Zurovac D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-31; Zurovac D, 2011, LANCET, V378, P795, DOI 10.1016/S0140-6736(11)60783-6; Zurovac D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-181	82	53	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127818	10.1371/journal.pone.0127818	http://dx.doi.org/10.1371/journal.pone.0127818			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7GR	26000856	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000354931700087
J	Cho, Y; Jang, M; Srivastava, A; Jang, JH; Soung, NK; Ko, SK; Kang, DO; Ahn, JS; Kim, BY				Cho, Yangrae; Jang, Mina; Srivastava, Akhil; Jang, Jae-Hyuk; Soung, Nak-Kyun; Ko, Sung-Kyun; Kang, Dae-Ook; Ahn, Jong Seog; Kim, Bo Yeon			A Pectate Lyase-Coding Gene Abundantly Expressed during Early Stages of Infection Is Required for Full Virulence in Alternaria brassicicola	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; JAPANESE PEAR PATHOTYPE; HOST-SELECTIVE TOXINS; TRANSCRIPTION FACTOR; GERMINATING SPORES; BOTRYTIS-CINEREA; OXALIC-ACID; AK-TOXIN; PLANT; PATHOGENICITY	Alternaria brassicicola causes black spot disease of Brassica species. The functional importance of pectin digestion enzymes and unidentified phytotoxins in fungal pathogenesis has been suspected but not verified in A. brassicicola. The fungal transcription factor AbPf2 is essential for pathogenicity and induces 106 genes during early pathogenesis, including the pectate lyase-coding gene, PL1332. The aim of this study was to test the importance and roles of PL1332 in pathogenesis. We generated deletion strains of the PL1332 gene, produced heterologous PL1332 proteins, and evaluated their association with virulence. Deletion strains of the PL1332 gene were approximately 30% less virulent than wild-type A. brassicicola, without showing differences in colony expansion on solid media and mycelial growth in nutrient-rich liquid media or minimal media with pectins as a major carbon source. Heterologous PL1332 expressed as fusion proteins digested polygalacturons in vitro. When the fusion proteins were injected into the apoplast between leaf veins of host plants the tissues turned dark brown and soft, resembling necrotic leaf tissue. The PL1332 gene was the first example identified as a general toxin-coding gene and virulence factor among the 106 genes regulated by the transcription factor, AbPf2. It was also the first gene to have its functions investigated among the 19 pectate lyase genes and several hundred putative cell-wall degrading enzymes in A. brassicicola. These results further support the importance of the AbPf2 gene as a key pathogenesis regulator and possible target for agrochemical development.	[Cho, Yangrae; Soung, Nak-Kyun; Kim, Bo Yeon] Incurable Dis Res Ctr WCI, Biotherapeut Res Inst, Korea Res Inst Biosci & Biotechnol, Ochang 363883, Chungbuk, South Korea; [Jang, Mina; Jang, Jae-Hyuk; Ko, Sung-Kyun; Ahn, Jong Seog] Chem Biol Res Ctr, Biotherapeut Res Inst, Korea Res Inst Biosci & Biotechnol, Ochang 363883, Chungbuk, South Korea; [Jang, Mina; Kang, Dae-Ook] Changwon Natl Univ, Dept Bio Hlth Sci, Changwon Si 641773, Gyeongsangnam D, South Korea; [Srivastava, Akhil] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Oklahoma City, OK 73104 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Changwon National University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Ahn, JS (corresponding author), Chem Biol Res Ctr, Biotherapeut Res Inst, Korea Res Inst Biosci & Biotechnol, Ochang 363883, Chungbuk, South Korea.	jsahn@kribb.re.kr; bykim@kribb.re.kr		Ko, Sung-Kyun/0000-0002-8202-1205; Kang, Dae-Ook/0000-0002-7671-7572	World Class Institute (WCI) [NRF-2009-002]; global R&D center (GRDC) program [NRF-2010-0079]; Bio & Medical Technology Development Program - Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea [NRF-2014M3A9B5073938]; Chuncheongbuk-do; KRIBB Research Initiative Program	World Class Institute (WCI); global R&D center (GRDC) program; Bio & Medical Technology Development Program - Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea; Chuncheongbuk-do; KRIBB Research Initiative Program	This research was supported by the World Class Institute ((WCI) NRF-2009-002) program, global R&D center (GRDC) program (NRF-2010-0079), Bio & Medical Technology Development Program (NRF-2014M3A9B5073938), and KRIBB Research Initiative Program funded by the Ministry of Science, ICT and Future Planning (MSIP), Republic of Korea. The research was also supported by grants from the Chuncheongbuk-do and the KRIBB Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandwagt BF, 2000, P NATL ACAD SCI USA, V97, P4961, DOI 10.1073/pnas.97.9.4961; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cho Y, 2015, EUKARYOT CE IN PRESS; Cho Y, 2014, MOLECULES, V19, P10717, DOI 10.3390/molecules190810717; Cho YR, 2013, PLANT J, V75, P498, DOI 10.1111/tpj.12217; Cho Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002974; Cho Y, 2009, MOL MICROBIOL, V72, P1316, DOI 10.1111/j.1365-2958.2009.06689.x; Cho YR, 2006, MOL PLANT MICROBE IN, V19, P7, DOI 10.1094/MPMI-19-0007; Churchill A, 1995, FUNGAL GENET NEWSL A, V42A, P41; Ciuffetti LM, 2010, NEW PHYTOL, V187, P911, DOI 10.1111/j.1469-8137.2010.03362.x; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Daebeler F., 1986, Wissenschaftliche Zeitschrift der Wilhelm-Pieck-Universitat Rostock, Naturwissenschaftliche Reihe, V35, P52; DAVIS KR, 1984, PLANT PHYSIOL, V74, P52, DOI 10.1104/pp.74.1.52; Djamei A, 2011, NATURE, V478, P395, DOI 10.1038/nature10454; Doehlemann G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000290; Errakhi R, 2008, J EXP BOT, V59, P3121, DOI 10.1093/jxb/ern166; Friesen TL, 2006, NAT GENET, V38, P953, DOI 10.1038/ng1839; Hashimoto M, 2009, BIOORG MED CHEM LETT, V19, P5640, DOI 10.1016/j.bmcl.2009.08.026; HUMPHERSONJONES FM, 1989, ANN APPL BIOL, V114, P449, DOI 10.1111/j.1744-7348.1989.tb03360.x; Ito K, 2004, MOL MICROBIOL, V52, P399, DOI 10.1111/j.1365-2958.2004.04004.x; Johnson RD, 2000, MOL PLANT MICROBE IN, V13, P742, DOI 10.1094/MPMI.2000.13.7.742; Kale SD, 2011, CELL MICROBIOL, V13, P1839, DOI 10.1111/j.1462-5822.2011.01659.x; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Kim KS, 2008, MOL PLANT MICROBE IN, V21, P605, DOI 10.1094/MPMI-21-5-0605; KOHMOTO K, 1991, EXPERIENTIA, V47, P755, DOI 10.1007/BF01922454; Lawrence CB, 2008, PLANT PATHOLOGY J, V24, P101, DOI 10.5423/PPJ.2008.24.2.101; Lehner A, 2008, PLANT SIGNAL BEHAV, V3, P746, DOI 10.4161/psb.3.9.6634; Neergaard P, 1945, DANISH SPECIES ALTER; Noda J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-38; Oeser B, 2002, FUNGAL GENET BIOL, V36, P176, DOI 10.1016/S1087-1845(02)00020-8; Ohm RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003037; Oka K, 2005, PHYSIOL MOL PLANT P, V66, P12, DOI 10.1016/j.pmpp.2005.03.005; Oliver RP, 2008, MOL PLANT MICROBE IN, V21, P287, DOI 10.1094/MPMI-21-3-0287; Otani H, 1998, PHYSIOL MOL PLANT P, V52, P285, DOI 10.1006/pmpp.1998.0147; Pandelova I, 2009, MOL PLANT, V2, P1067, DOI 10.1093/mp/ssp045; Pedras MSC, 2009, PHYTOCHEMISTRY, V70, P394, DOI 10.1016/j.phytochem.2009.01.005; Shieh MT, 1997, APPL ENVIRON MICROB, V63, P3548, DOI 10.1128/AEM.63.9.3548-3552.1997; Sigareva MA, 1999, THEOR APPL GENET, V98, P164, DOI 10.1007/s001220051053; Spassieva SD, 2002, PLANT J, V32, P561, DOI 10.1046/j.1365-313X.2002.01444.x; Srivastava A, 2012, MOL PLANT MICROBE IN, V25, P443, DOI 10.1094/MPMI-10-11-0275; STARR MP, 1977, J CLIN MICROBIOL, V6, P379; Tanaka A, 1999, MOL PLANT MICROBE IN, V12, P691, DOI 10.1094/MPMI.1999.12.8.691; Tanaka A, 2000, MOL PLANT MICROBE IN, V13, P975, DOI 10.1094/MPMI.2000.13.9.975; ten Have A, 1998, MOL PLANT MICROBE IN, V11, P1009, DOI 10.1094/MPMI.1998.11.10.1009; Thomma BPHJ, 1999, PLANT J, V19, P163, DOI 10.1046/j.1365-313X.1999.00513.x; Tonukari NJ, 2000, PLANT CELL, V12, P237, DOI 10.1105/tpc.12.2.237; Tsuge T, 2013, FEMS MICROBIOL REV, V37, P44, DOI 10.1111/j.1574-6976.2012.00350.x; Warwick SI, 1994, AGR CAN RES BRANCH T, V1994, p2E; Westman AL, 1999, EUPHYTICA, V106, P253, DOI 10.1023/A:1003544025146; Wight WD, 2009, MOL PLANT MICROBE IN, V22, P1258, DOI 10.1094/MPMI-22-10-1258; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; Yun SH, 1998, PHYSIOL MOL PLANT P, V52, P53, DOI 10.1006/pmpp.1997.0134	52	13	16	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127140	10.1371/journal.pone.0127140	http://dx.doi.org/10.1371/journal.pone.0127140			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996954	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000043
J	Fontoura, NF; Rodrigues, LR; Batista, CB; Persch, TSP; Janowicz, ME				Fontoura, Nelson F.; Rodrigues, Lucia R.; Batista, Cibele B.; Persch, Tanilene S. P.; Janowicz, Mariola E.			Integrating Ontogenetic Shift, Growth and Mortality to Determine a Species' Ecological Role from Isotopic Signatures	PLOS ONE			English	Article							DISCRIMINATION FACTORS DELTA-N-15; TROPHIC POSITION; STABLE-ISOTOPES; DIET; DELTA-C-13; CONSUMER; MODELS	Understanding species linkages and energy transfer is a basic goal underlying any attempt at ecosystem analysis. Although the first food-web studies were based on gut contents of captured specimens, the assessment of stable isotopes, mainly delta C-13 and delta N-15, has become a standard methodology for wide-range analyses in the last 30 years. Stable isotopes provide information on the trophic level of species, food-web length, and origin of organic matter ingested by consumers. In this study, we analyzed the ontogenetic variability of delta C-13 and delta N-15 obtained from samples of three Neotropical fish species: silver sardine (Lycengraulis grossidens, n=46), white lambari (Cyanocharax alburnus, n=26), and the red-tail lambari (Astyanax fasciatus, n=23) in Pinguela Lagoon, southern Brazil. We developed a new metric, called the Weighted Isotopic Signature (phi N-15 or phi C-13, %), that incorporates ontogenetic variability, body growth, and natural mortality into a single number.	[Fontoura, Nelson F.; Batista, Cibele B.; Persch, Tanilene S. P.] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil; [Rodrigues, Lucia R.] Univ Fed Rio Grande do Sul, Inst Pesquisas Hidraul, Porto Alegre, RS, Brazil; [Janowicz, Mariola E.] Concordia Univ, Coll Alberta, Dept Biol & Environm Sci, Edmonton, AB, Canada	Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal do Rio Grande do Sul; Concordia University - Canada	Fontoura, NF (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil.	nfontoura@pucrs.br	Fontoura, Nelson F/I-6397-2012; Rodrigues, Lucia R./F-3136-2013	Fontoura, Nelson F/0000-0001-9978-2812; Rodrigues, Lucia R./0000-0003-2915-3185	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; www.cnpq.br). Research founding to NFF, process 302211/2008-0.	Artioli Luiz Guilherme Schultz, 2003, Biociencias (Porto Alegre), V11, P115; Auerswald K, 2010, J APPL ECOL, V47, P936, DOI 10.1111/j.1365-2664.2009.01764.x; Bervian G, 2006, J FISH BIOL, V68, P196, DOI 10.1111/j.0022-1112.2006.00890.x; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Caut S, 2008, FUNCT ECOL, V22, P255, DOI 10.1111/j.1365-2435.2007.01360.x; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Fontoura NF, 1996, J FISH BIOL, V48, P569, DOI 10.1006/jfbi.1996.0058; Froese R, 2006, J APPL ICHTHYOL, V22, P241, DOI 10.1111/j.1439-0426.2006.00805.x; Fry B, 1999, CAN J FISH AQUAT SCI, V56, P590, DOI 10.1139/cjfas-56-4-590; Kenchington TJ, 2014, FISH FISH, V15, P533, DOI 10.1111/faf.12027; Oliveira AG, 1997, THESIS PONTIFICIA U; Persaud AD, 2012, AQUAT SCI, V74, P203, DOI 10.1007/s00027-011-0212-9; Persch TSP, 2011, THESIS PONTIFICIA U; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Pinnegar JK, 2000, OECOLOGIA, V122, P399, DOI 10.1007/s004420050046; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Post DM, 2003, ECOLOGY, V84, P1298, DOI 10.1890/0012-9658(2003)084[1298:IVITTO]2.0.CO;2; Resco V, 2010, BIOL LETTERS, V6, P287, DOI 10.1098/rsbl.2009.0950; RICKER W E, 1975, P382; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Williams DG, 2007, TERR ECOL SER, V1, P383; WINEMILLER KO, 1989, ENVIRON BIOL FISH, V26, P177, DOI 10.1007/BF00004815; Wolff LL, 2009, NEOTROP ICHTHYOL, V7, P257, DOI 10.1590/S1679-62252009000200018	26	4	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0125059	10.1371/journal.pone.0125059	http://dx.doi.org/10.1371/journal.pone.0125059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996777	Green Submitted, Green Published, gold			2022-12-26	WOS:000356444000009
J	Hamaya, Y; Guarinos, C; Tseng-Rogenski, SS; Iwaizumi, M; Das, R; Jover, R; Castells, A; Llor, X; Andreu, M; Carethers, JM				Hamaya, Yasushi; Guarinos, Carla; Tseng-Rogenski, Stephanie S.; Iwaizumi, Moriya; Das, Ritabrata; Jover, Rodrigo; Castells, Antoni; Llor, Xavier; Andreu, Montserrat; Carethers, John M.			Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer	PLOS ONE			English	Article							MISMATCH REPAIR PROFICIENCY; MICROSATELLITE-INSTABILITY; COLON-CANCER; TETRANUCLEOTIDE REPEATS; CHEMOTHERAPY; DNA; SURVIVAL; BENEFIT; CELLS	Elevated Microsatellite Alterations at Selected Tetranucleotide repeats (EMAST) is a genetic signature found in up to 60% of colorectal cancers (CRCs) that is caused by somatic dysfunction of the DNA mismatch repair (MMR) protein hMSH3. We have previously shown in vitro that recognition of 5-fluorouracil (5-FU) within DNA and subsequent cytotoxicity was most effective when both hMutS alpha (hMSH2-hMSH6 heterodimer) and hMutS beta (hMSH2-hMSH3 heterodimer) MMR complexes were present, compared to hMutS alpha > hMutS beta alone. We tested if patients with EMAST CRCs (hMutS beta defective) had diminished response to adjuvant 5-FU chemotherapy, paralleling in vitro findings. We analyzed 230 patients with stage II/III sporadic colorectal cancers for which we had 5-FU treatment and survival data. Archival DNA was analyzed for EMAST (>2 of 5 markers mutated among UT5037, D8S321, D9S242, D20S82, D20S85 tetranucleotide loci). Kaplan-Meier survival curves were generated and multivariate analysis was used to determine contribution to risk. We identified 102 (44%) EMAST cancers. Ninety-four patients (41%) received adjuvant 5-FU chemotherapy, and median follow-up for all patients was 51 months. Patients with EMAST CRCs demonstrated improved survival with adjuvant 5FU to the same extent as patients with non-EMAST CRCs (P<0.05). We observed no difference in survival between patients with stage II/III EMAST and non-EMAST cancers (P = 0.36). There is improved survival for stage II/III CRC patients after adjuvant 5-FU-based chemotherapy regardless of EMAST status. The loss of contribution of hMSH3 for 5-FU cytotoxicity may not adversely affect patient outcome, contrasting patients whose tumors completely lack DNA MMR function (MSI-H).	[Hamaya, Yasushi; Guarinos, Carla; Tseng-Rogenski, Stephanie S.; Iwaizumi, Moriya; Carethers, John M.] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Guarinos, Carla; Jover, Rodrigo] Hosp Gen Univ Alicante, Unidad Gastroenterol, Alicante, Spain; [Das, Ritabrata] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Castells, Antoni] Univ Barcelona, IDIBAPS, CIBERehd, Hosp Clin,Dept Gastroenterol, Barcelona, Spain; [Llor, Xavier] Yale Univ, Dept Med, Div Gastroenterol, New Haven, CT 06520 USA; [Andreu, Montserrat] Hosp Mar, IMIM Inst Hosp Mar Invest Med, Dept Gastroenterol, Barcelona, Catalonia, Spain	University of Michigan System; University of Michigan; General University Hospital of Alicante; University of Michigan System; University of Michigan; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Yale University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Carethers, JM (corresponding author), Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA.	jcarethe@umich.edu	Castells, Antoni/ABC-1002-2021; Jover, Rodrigo/ABC-3258-2021; Iwaizumi, Moriya/AAG-3173-2019; Hamaya, Yasushi/ABA-8280-2021	Castells, Antoni/0000-0001-8431-2033; Jover, Rodrigo/0000-0003-3742-3413; Iwaizumi, Moriya/0000-0002-2629-0830; Hamaya, Yasushi/0000-0002-1355-6687	United States Public Health Service [DK067287, CA162147]; A. Alfred Taubman Medical Research Institute of the University of Michigan; NATIONAL CANCER INSTITUTE [U01CA162147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067287, P30DK034933] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); A. Alfred Taubman Medical Research Institute of the University of Michigan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the United States Public Health Service (DK067287 and CA162147) and the A. Alfred Taubman Medical Research Institute of the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boland CR, 2000, GASTROENTEROLOGY, V118, pS115, DOI 10.1016/S0016-5085(00)70010-2; Campregher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050541; Cappel WHDN, 2004, INT J CANCER, V109, P468, DOI 10.1002/ijc.11712; Carethers JM, 1999, GASTROENTEROLOGY, V117, P123, DOI 10.1016/S0016-5085(99)70558-5; Carethers JM, 2004, GASTROENTEROLOGY, V126, P394, DOI 10.1053/j.gastro.2003.12.023; Carethers John M, 2013, J Dig Cancer Rep, V1, P78; Carethers JM, 2015, GENES-BASEL, V6, P185, DOI 10.3390/genes6020185; Carethers JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100461; Carethers JM, 2014, GASTROENTEROLOGY, V146, P602, DOI 10.1053/j.gastro.2014.01.041; Carethers John M, 2008, Therap Adv Gastroenterol, V1, P33, DOI 10.1177/1756283X08093607; Chung H, 2010, CANCER BIOL THER, V10, P1148, DOI 10.4161/cbt.10.11.13447; Devaraj B, 2010, J GASTROINTEST SURG, V14, P1521, DOI 10.1007/s11605-010-1340-6; Garcia M, 2012, GASTROENTEROLOGY, V143, P48, DOI 10.1053/j.gastro.2012.03.034; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Graham JS, 2012, EXPERT REV ANTICANC, V12, P99, DOI [10.1586/ERA.11.189, 10.1586/era.11.189]; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; Hile SE, 2013, MUTAT RES-FUND MOL M, V743, P67, DOI 10.1016/j.mrfmmm.2012.11.003; Iwaizumi M, 2011, CANCER BIOL THER, V12, P756, DOI 10.4161/cbt.12.8.17169; Jo Won-Seok, 2006, Cancer Biomarkers, V2, P51; Jover R, 2006, GUT, V55, P848, DOI 10.1136/gut.2005.073015; Jover R, 2009, EUR J CANCER, V45, P365, DOI 10.1016/j.ejca.2008.07.016; Lee SY, 2010, GASTROENTEROLOGY, V139, P1519, DOI 10.1053/j.gastro.2010.08.001; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Tajima A, 2004, GASTROENTEROLOGY, V127, P1678, DOI 10.1053/j.gastro.2004.10.001; Tajima A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028117; Tseng-Rogenski SS, 2015, GASTROENTEROLOGY, V148, P579, DOI 10.1053/j.gastro.2014.11.027; Tseng-Rogenski SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050616; Yamada K, 2010, ONCOL REP, V23, P551, DOI 10.3892/or_00000669	31	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127591	10.1371/journal.pone.0127591	http://dx.doi.org/10.1371/journal.pone.0127591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996601	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000078
J	Swift, AJ; Capener, D; Hammerton, C; Thomas, SM; Elliot, C; Condliffe, R; Wild, JM; Kiely, DG				Swift, Andrew J.; Capener, Dave; Hammerton, Charlotte; Thomas, Steven M.; Elliot, Charlie; Condliffe, Robin; Wild, Jim M.; Kiely, David G.			Right Ventricular Sex Differences in Patients with Idiopathic Pulmonary Arterial Hypertension Characterised by Magnetic Resonance Imaging: Pair-Matched Case Controlled Study	PLOS ONE			English	Article							DIASTOLIC FUNCTION; ASPIRE REGISTRY; SURVIVAL; GENDER; DYSFUNCTION; MANAGEMENT; AGE	Purpose Sex differences exist in both the prevalence and survival of patients with idiopathic pulmonary arterial hypertension (IPAH). Men are less frequently affected by the condition but have worse outcome as compared to females. We sought to characterise the sex related differences in right ventricular remodelling in age matched male and female patients with IPAH using cardiac magnetic resonance imaging (MRI). Methods A case controlled pair-matched study was conducted with patients matched by age and sex. Steady state free precession (SSFP) MRI of the heart was performed at 1.5T. Cardiac volume, function and mass measurements were corrected for age, sex and BSA according to reference data. Results 40 age and sex matched patients with IPAH were identified. The mean age was 57 (SD 17) in both male and female cohorts. Men had proportionally lower right ventricular (RV) ejection fraction, RV stroke volume and LV stroke volume than females, p=0.028, p=0.007 and p=0.013, respectively. However, there was no significant difference in RV mass or haemodynamic indices of mPAP and PVR between males and females. Conclusion Male patients with IPAH have proportionally worse RV function despite similar afterload. We hypothesise that adaptive remodelling of the RV in response to increased afterload in IPAH is more effective in females.	[Swift, Andrew J.; Capener, Dave; Hammerton, Charlotte; Wild, Jim M.] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Swift, Andrew J.; Wild, Jim M.; Kiely, David G.] Univ Sheffield, Inst Silico Med, INSIGNEO, Sheffield, S Yorkshire, England; [Thomas, Steven M.] Sheffield Teaching Hosp NHS Fdn Trust, Dept Radiol, Sheffield, S Yorkshire, England; [Elliot, Charlie; Condliffe, Robin; Kiely, David G.] Royal Hallamshire Hosp, Sheffield Teaching Hosp NHS Fdn Trust, Sheffield Pulm Vasc Dis Unit, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield	Swift, AJ (corresponding author), Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England.	a.j.swift@shef.ac.uk	Swift, Andy/GYU-3283-2022	Wild, Jim/0000-0002-7246-8660; Condliffe, Robin/0000-0002-3492-4143; Capener, Dave/0000-0003-2394-8729	National Institute for Health Research (NIHR); Engineering and Physical Sciences Research Council (EPSRC); Bayer Schering; British Heart Foundation [SP/14/6/31350] Funding Source: researchfish; Medical Research Council [MR/M008894/1] Funding Source: researchfish; National Institute for Health Research [CL-2012-04-004, NIHR-RP-R3-12-027] Funding Source: researchfish; MRC [MR/M008894/1] Funding Source: UKRI	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Bayer Schering(Bayer AG); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AJS, RC, CE, JMW, and DGK have received funding from the National Institute for Health Research (NIHR). JMW is also funded by the Engineering and Physical Sciences Research Council (EPSRC). DC receives funding from Bayer Schering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badesch DB, 2010, CHEST, V137, P376, DOI 10.1378/chest.09-1140; Dent MR, 2010, J CARD FAIL, V16, P439, DOI 10.1016/j.cardfail.2009.12.017; Gardner JD, 2002, J CARD FAIL, V8, P101, DOI 10.1054/jcaf.2002.32195; Grothues F, 2004, AM HEART J, V147, P218, DOI 10.1016/j.ahj.2003.10.005; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Hurdman J, 2012, EUR RESPIR J, V39, P945, DOI 10.1183/09031936.00078411; Jacobs W, 2014, CHEST, V145, P1230, DOI 10.1378/chest.13-1291; Kawut SM, 2011, CIRCULATION, V123, P2542, DOI 10.1161/CIRCULATIONAHA.110.985515; Lahm T, 2007, AM J PHYSIOL-ENDOC M, V293, pE865, DOI 10.1152/ajpendo.00201.2007; Lahm T, 2014, AM J PHYSIOL-LUNG C, V307, pL7, DOI 10.1152/ajplung.00337.2013; Ling Y, 2012, AM J RESP CRIT CARE, V186, P790, DOI 10.1164/rccm.201203-0383OC; Luchner A, 2002, CARDIOVASC RES, V53, P720, DOI 10.1016/S0008-6363(01)00510-7; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; Maceira AM, 2006, EUR HEART J, V27, P2879, DOI 10.1093/eurheartj/ehl336; Mauritz GJ, 2012, CHEST, V141, P935, DOI 10.1378/chest.10-3277; Pugh ME, 2010, WOMENS HEALTH, V6, P285, DOI [10.2217/whe.09.88, 10.2217/WHE.09.88]; Schulz-Menger J, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-35; Shapiro S, 2012, CHEST, V141, P363, DOI 10.1378/chest.10-3114; Swift AJ, 2014, JACC-CARDIOVASC IMAG, V7, P1209, DOI 10.1016/j.jcmg.2014.08.014; Swift AJ, 2014, CIRC-CARDIOVASC IMAG, V7, P100, DOI 10.1161/CIRCIMAGING.113.000338; Swift AJ, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-40; van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068; Ventetuolo CE, 2014, EUR RESPIR J, V43, P523, DOI 10.1183/09031936.00027613	23	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127415	10.1371/journal.pone.0127415	http://dx.doi.org/10.1371/journal.pone.0127415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996939	Green Accepted, Green Published, gold			2022-12-26	WOS:000356444000063
J	Watanabe-Takano, H; Takano, K; Hatano, M; Tokuhisa, T; Endo, T				Watanabe-Takano, Haruko; Takano, Kazunori; Hatano, Masahiko; Tokuhisa, Takeshi; Endo, Takeshi			DA-Raf-Mediated Suppression of the Ras-ERK Pathway Is Essential for TGF-beta 1-Induced Epithelial-Mesenchymal Transition in Alveolar Epithelial Type 2 Cells	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; GROWTH-FACTOR-BETA; TGF-BETA; SIGNALING PATHWAYS; KINASE; INDUCTION; SPROUTY; MECHANISMS; PLASTICITY; PROTEINS	Myofibroblasts play critical roles in the development of idiopathic pulmonary fibrosis by depositing components of extracellular matrix. One source of lung myofibroblasts is thought to be alveolar epithelial type 2 cells that undergo epithelial-mesenchymal transition (EMT). Rat RLE-6TN alveolar epithelial type 2 cells treated with transforming growth factor-beta 1 (TGF-beta 1) are converted into myofibroblasts through EMT. TGF-beta induces both canonical Smad signaling and non-canonical signaling, including the Ras-induced ERK pathway (Raf-MEK-ERK). However, the signaling mechanisms regulating TGF-beta 1-induced EMT are not fully understood. Here, we show that the Ras-ERK pathway negatively regulates TGF-beta 1-induced EMT in RLE-6TN cells and that DA-Raf1 (DA-Raf), a splicing isoform of A-Raf and a dominant-negative antagonist of the Ras-ERK pathway, plays an essential role in EMT. Stimulation of the cells with fibroblast growth factor 2 (FGF2), which activated the ERK pathway, prominently suppressed TGF-beta 1-induced EMT. An inhibitor of MEK, but not an inhibitor of phosphatidylinositol 3-kinase, rescued the TGF-beta 1-treated cells from the suppression of EMT by FGF2. Overexpression of a constitutively active mutant of a component of the Ras-ERK pathway, i.e., H-Ras, B-Raf, or MEK1, interfered with EMT. Knockdown of DA-Raf expression with siRNAs facilitated the activity of MEK and ERK, which were only weakly and transiently activated by TGF-beta 1. Although DA-Raf knockdown abrogated TGF-beta 1-induced EMT, the abrogation of EMT was reversed by the addition of the MEK inhibitor. Furthermore, DA-Raf knockdown impaired the TGF-beta 1-induced nuclear translocation of Smad2, which mediates the transcription required for EMT. These results imply that intrinsic DA-Raf exerts essential functions for EMT by antagonizing the TGF-beta 1-induced Ras-ERK pathway in RLE-6TN cells.	[Watanabe-Takano, Haruko; Takano, Kazunori; Endo, Takeshi] Chiba Univ, Grad Sch Sci, Dept Biol, Inage Ku, Chiba, Japan; [Takano, Kazunori; Endo, Takeshi] Chiba Univ, Grad Sch Adv Integral Sci, Dept Nanobiol, Inage Ku, Chiba, Japan; [Watanabe-Takano, Haruko; Hatano, Masahiko] Chiba Univ, Biomed Res Ctr, Chuo Ku, Chiba, Japan; [Tokuhisa, Takeshi] Chiba Univ, Grad Sch Sci, Dept Dev Genet, Chuo Ku, Chiba, Japan; [Tokuhisa, Takeshi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan	Chiba University; Chiba University; Chiba University; Chiba University; Japan Society for the Promotion of Science	Endo, T (corresponding author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Cell Biol, Suita, Osaka, Japan.	t.endo@faculty.chiba-u.jp			Japan Society for the Promotion of Science [23659428]; Ministry of Education, Culture, Sports, Science, and Technology [20013007, 25117706]; Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry [23-5, 26-8]; Kato Memorial Trust for Nambyo Research;  [22790688];  [24-5613]; Grants-in-Aid for Scientific Research [15H04348, 15H05646] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry; Kato Memorial Trust for Nambyo Research(Kato Memorial Trust for Nambyo Research); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Young Scientists (B) (22790688) (HW-T), for the Japan Society for the Promotion of Science Fellows (24-5613) (HW-T), and for Challenging Exploratory Research (23659428) (MH) from the Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research on Priority Areas (20013007) (TE) and for Scientific Research on Innovative Areas (25117706) (TE) from the Ministry of Education, Culture, Sports, Science, and Technology; Intramural Research Grant (23-5 and 26-8) for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry (TE); and grants from Kato Memorial Trust for Nambyo Research (HW-T). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Chapman HA, 2011, ANNU REV PHYSIOL, V73, P413, DOI 10.1146/annurev-physiol-012110-142225; Cox Adrienne D, 2010, Small GTPases, V1, P2; Davies M, 2005, J CELL BIOCHEM, V95, P918, DOI 10.1002/jcb.20458; Dhomen N, 2007, CURR OPIN GENET DEV, V17, P31, DOI 10.1016/j.gde.2006.12.005; DRISCOLL KE, 1995, IN VITRO CELL DEV-AN, V31, P516; Fujimura L, 2009, NEUROSCI LETT, V467, P6, DOI 10.1016/j.neulet.2009.09.050; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Jain R, 2007, AM J RESP CELL MOL, V37, P38, DOI 10.1165/rcmb.2006-0353OC; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Koizumi K, 2012, MOL BIOL CELL, V23, P4647, DOI 10.1091/mbc.E12-04-0315; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marmai C, 2011, AM J PHYSIOL-LUNG C, V301, pL71, DOI 10.1152/ajplung.00212.2010; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Matheny SA, 2009, J BIOL CHEM, V284, P11007, DOI 10.1074/jbc.R800082200; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Odabaei G, 2004, ADV CANCER RES, V91, P169, DOI 10.1016/S0065-230X(04)91005-6; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Ramos C, 2010, AM J PHYSIOL-LUNG C, V299, pL222, DOI 10.1152/ajplung.00070.2010; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Selman M, 2008, PLOS MED, V5, P373, DOI 10.1371/journal.pmed.0050062; Shin EHH, 2012, MOL MED, V18, P861, DOI 10.2119/molmed.2012.00111; Shukla MN, 2009, AM J RESP CELL MOL, V40, P643, DOI 10.1165/rcmb.2008-0217OC; Takano K, 2010, SCIENCE, V330, P1536, DOI 10.1126/science.1197767; Tanjore H, 2009, AM J RESP CRIT CARE, V180, P657, DOI 10.1164/rccm.200903-0322OC; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Watanabe-Takano H, 2014, P NATL ACAD SCI USA, V111, pE2291, DOI 10.1073/pnas.1321574111; Watanabe-Takano H, 2010, EXP CELL RES, V316, P477, DOI 10.1016/j.yexcr.2009.09.028; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; YAN MH, 1994, J BIOL CHEM, V269, P19067; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yokoyama T, 2007, J CELL BIOL, V177, P781, DOI 10.1083/jcb.200703195; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	52	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127888	10.1371/journal.pone.0127888	http://dx.doi.org/10.1371/journal.pone.0127888			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996975	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000094
J	Cabanes, D; Shahack-Gross, R				Cabanes, Dan; Shahack-Gross, Ruth			Understanding Fossil Phytolith Preservation: The Role of Partial Dissolution in Paleoecology and Archaeology	PLOS ONE			English	Article							OLDUVAI GORGE; BIOGEOCHEMICAL CYCLE; RICE; SILICON; CAVE; IDENTIFICATION; ASSEMBLAGES; SOLUBILITY; REACTIVITY; CHEMISTRY	Opaline phytoliths are important microfossils used for paleoecological and archaeological reconstructions that are primarily based on relative ratios of specific morphotypes. Recent studies have shown that phytolith assemblages are prone to post-depositional alteration involving partial dissolution, however, the manner in which partial dissolution affects morphotype composition is poorly understood. Here we show that morphotype assemblages from four different plant species subjected to controlled partial dissolution are significantly different from the original assemblages, indicating that the stability of various morphotypes differs, mainly depending on their surface area to bulk ratios. This underlying mechanism produces distorted morphotype compositions in partially dissolved phytolith assemblages, bearing vast implications for morphotype-based paleoecological and archaeological interpretation. Together with analyses of phytolith assemblages from a variety of archaeological sites, our results establish criteria by which well-preserved phytolith assemblages can be selected for accurate paleoecological and archaeological reconstructions.	[Cabanes, Dan] Univ Barcelona, Dept Prehist Ancient Hist & Archaeol, ERAAUB, Barcelona 08001, Spain; [Shahack-Gross, Ruth] Weizmann Inst Sci, Kimmel Ctr Archaeol Sci, IL-76100 Rehovot, Israel	University of Barcelona; Weizmann Institute of Science	Cabanes, D (corresponding author), Univ Barcelona, Dept Prehist Ancient Hist & Archaeol, ERAAUB, C Montalegre 6-8, Barcelona 08001, Spain.	dancabanes@ub.edu		Cabanes, Dan/0000-0001-6347-2513	European Research Council [229418]; Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya	European Research Council(European Research Council (ERC)European Commission); Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya	This research has been carried out with the support of European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no 229418 to S. Weiner and I. Finkelstein where R. S-G. acted as track leader. This contribution is part of the activities of the Equip de Recerca Arqueologica i Arqueometrica de la Universitat de Barcelona (ERAAUB), Consolidated Group (2014 SGR 845), thanks to the support of the Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert RM, 2006, QUATERN INT, V148, P78, DOI 10.1016/j.quaint.2005.11.026; Albert RM, 2003, J ARCHAEOL SCI, V30, P461, DOI 10.1006/jasc.2002.0854; Albert RM, 2001, PHYTOLITHS: APPLICATIONS IN EARTH SCIENCES AND HUMAN HISTORY, P251; Albert RM, 2008, J ARCHAEOL SCI, V35, P57, DOI 10.1016/j.jas.2007.02.015; Alexandre A, 1997, GEOCHIM COSMOCHIM AC, V61, P677, DOI 10.1016/S0016-7037(97)00001-X; Alexandre A, 2012, CLIM PAST, V8, P307, DOI 10.5194/cp-8-307-2012; Ball TB, 1999, AM J BOT, V86, P1615, DOI 10.2307/2656798; Bamford MK, 2006, QUATERN INT, V148, P95, DOI 10.1016/j.quaint.2005.11.027; BARTOLI F, 1980, SOIL SCI SOC AM J, V44, P873, DOI 10.2136/sssaj1980.03615995004400040043x; Blecker SW, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002690; Bremond L, 2005, J BIOGEOGR, V32, P311, DOI 10.1111/j.1365-2699.2004.01162.x; Bremond L, 2008, GLOBAL PLANET CHANGE, V61, P209, DOI 10.1016/j.gloplacha.2007.08.016; BROWN DA, 1984, J ARCHAEOL SCI, V11, P345, DOI 10.1016/0305-4403(84)90016-5; Cabanes D, 2012, J ARCHAEOL SCI, V39, P2697, DOI 10.1016/j.jas.2012.04.008; Cabanes D, 2011, J ARCHAEOL SCI, V38, P2480, DOI 10.1016/j.jas.2011.05.020; Cabanes D, 2010, J ARCHAEOL SCI, V37, P2947, DOI 10.1016/j.jas.2010.07.010; Derry LA, 2005, NATURE, V433, P728, DOI 10.1038/nature03299; EPSTEIN E, 1994, P NATL ACAD SCI USA, V91, P11, DOI 10.1073/pnas.91.1.11; Farmer VC, 2005, GEODERMA, V127, P71, DOI 10.1016/j.geoderma.2004.11.014; Fishman M. J., 1989, US GEOLOGICAL SURVEY, P545; Fraysse F, 2006, J GEOCHEM EXPLOR, V88, P202, DOI 10.1016/j.gexplo.2005.08.039; Fraysse F, 2006, GEOCHIM COSMOCHIM AC, V70, P1939, DOI 10.1016/j.gca.2005.12.025; Fraysse F, 2009, CHEM GEOL, V258, P197, DOI 10.1016/j.chemgeo.2008.10.003; Fredlund GG, 1997, PALAEOGEOGR PALAEOCL, V136, P199, DOI 10.1016/S0031-0182(97)00040-0; Goldberg P, 2006, PRACTICAL THEORETICA; Gu YS, 2013, QUATERN INT, V287, P141, DOI 10.1016/j.quaint.2012.02.013; Gur-Arieh S, 2013, J ARCHAEOL SCI, V40, P4331, DOI 10.1016/j.jas.2013.06.001; Harvey EL, 2005, J ARCHAEOL SCI, V32, P739, DOI 10.1016/j.jas.2004.12.010; Holst I, 2007, P NATL ACAD SCI USA, V104, P17608, DOI 10.1073/pnas.0708736104; Jenkins E, 2009, J ARCHAEOL SCI, V36, P2402, DOI 10.1016/j.jas.2009.06.028; Loucaides S, 2010, GEOCHIM COSMOCHIM AC, V74, P517, DOI 10.1016/j.gca.2009.10.038; Ma JF, 2006, TRENDS PLANT SCI, V11, P392, DOI 10.1016/j.tplants.2006.06.007; Madella M, 2005, ANN BOT-LONDON, V96, P253, DOI 10.1093/aob/mci172; Madella M, 2012, QUATERN INT, V275, P76, DOI 10.1016/j.quaint.2011.09.008; Albert RM, 2009, QUATERN INT, V193, P41, DOI 10.1016/j.quaint.2007.06.008; McInerney FA, 2011, PALEOBIOLOGY, V37, P23, DOI 10.1666/09068.1; Meunier JD, 2014, GEODERMA, V216, P30, DOI 10.1016/j.geoderma.2013.10.014; Nguyen MN, 2014, J PLANT NUTR SOIL SC, V177, P349, DOI 10.1002/jpln.201300056; Osterrieth M, 2009, QUATERN INT, V193, P70, DOI 10.1016/j.quaint.2007.09.002; Piperno D.R., 2006, PHYTOLITH COMPREHENS; Piperno DR, 2002, P NATL ACAD SCI USA, V99, P10923, DOI 10.1073/pnas.152275499; PIPERNO DR, 1985, J ARCHAEOL SCI, V12, P247, DOI 10.1016/0305-4403(85)90032-9; Power RC, 2014, J ANTHROPOL ARCHAEOL, V33, P49, DOI 10.1016/j.jaa.2013.11.002; Rapp G.R., 1992, ADV ARCHAEOL METH TH, Vfirst, DOI [10.1007/978-1-4899-1155-1, DOI 10.1007/978-1-4899-1155-1]; ROSEN AM, 1994, J ARCHAEOL SCI, V21, P125, DOI 10.1006/jasc.1994.1013; Rovner I., 1971, QUAT RES, V1, P343, DOI [10.1016/0033-5894(71)90070-6, DOI 10.1016/0033-5894(71)90070-6]; Shahack-Gross R, 2014, J ARCHAEOL SCI, V44, P12, DOI 10.1016/j.jas.2013.11.015; Shahack-Gross R, 2014, LEVANT, V46, P98, DOI 10.1179/0075891413Z.00000000034; Shillito LM, 2013, ANTIQUITY, V87, P684, DOI 10.1017/S0003598X00049395; Shillito LM, 2013, VEG HIST ARCHAEOBOT, V22, P71, DOI 10.1007/s00334-011-0341-z; TWISS PC, 1969, SOIL SCI SOC AM PRO, V33, P109, DOI 10.2136/sssaj1969.03615995003300010030x; Wadley L, 2011, SCIENCE, V334, P1388, DOI 10.1126/science.1213317; WILDING LP, 1974, CLAY CLAY MINER, V22, P295, DOI 10.1346/CCMN.1974.0220311; Zhao ZJ, 1998, ECON BOT, V52, P134, DOI 10.1007/BF02861201	54	88	90	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125532	10.1371/journal.pone.0125532	http://dx.doi.org/10.1371/journal.pone.0125532			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993338	Green Published, gold, Green Submitted			2022-12-26	WOS:000354921400034
J	Huang, CH; Hsiao, WR; Huang, CW; Chen, KC; Lin, SS; Chen, TC; Raja, JAJ; Wu, HW; Yeh, SD				Huang, Chung-Hao; Hsiao, Weng-Rong; Huang, Ching-Wen; Chen, Kuan-Chun; Lin, Shih-Shun; Chen, Tsung-Chi; Raja, Joseph A. J.; Wu, Hui-Wen; Yeh, Shyi-Dong			Two Novel Motifs of Watermelon Silver Mottle Virus NSs Protein Are Responsible for RNA Silencing Suppression and Pathogenicity	PLOS ONE			English	Article							SPOTTED-WILT-VIRUS; YELLOW-MOSAIC-VIRUS; SMALL INTERFERING RNA; COMPLETE GENOME SEQUENCE; VIRAL SUPPRESSOR; NONSTRUCTURAL PROTEIN; CROSS-PROTECTION; GENUS TOSPOVIRUS; TSW GENE; IDENTIFICATION	The NSs protein of Watermelon silver mottle virus (WSMoV) is the RNA silencing suppressor and pathogenicity determinant. In this study, serial deletion and point-mutation mutagenesis of conserved regions (CR) of NSs protein were performed, and the silencing suppression function was analyzed through agroinfiltration in Nicotiana benthamiana plants. We found two amino acid (aa) residues, H113 and Y398, are novel functional residues for RNA silencing suppression. Our further analyses demonstrated that H113 at the common epitope (CE) ((109)KFTMHNQ(117)), which is highly conserved in Asia type tospoviruses, and the benzene ring of Y398 at the C-terminal beta-sheet motif ((IYFL400)-I-397) affect NSs mRNA stability and protein stability, respectively, and are thus critical for NSs RNA silencing suppression. Additionally, protein expression of other six deleted (Delta CR1-Delta CR6) and five point-mutated (Y15A, Y27A, G180A, R181A and R212A) mutants were hampered and their silencing suppression ability was abolished. The accumulation of the mutant mRNAs and proteins, except Y398A, could be rescued or enhanced by co-infiltration with potyviral suppressor HC-Pro. When assayed with the attenuated Zucchini yellow mosaic virus vector in squash plants, the recombinants carrying individual seven point-mutated NSs proteins displayed symptoms much milder than the recombinant carrying the wild type NSs protein, suggesting that these aa residues also affect viral pathogenicity by suppressing the host silencing mechanism.	[Huang, Chung-Hao; Hsiao, Weng-Rong; Huang, Ching-Wen; Chen, Kuan-Chun; Raja, Joseph A. J.; Wu, Hui-Wen; Yeh, Shyi-Dong] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan; [Lin, Shih-Shun] Natl Taiwan Univ, Inst Biotechnol, Taipei 106, Taiwan; [Chen, Tsung-Chi] Asia Univ, Dept Biotechnol, Taichung 41354, Taiwan; [Raja, Joseph A. J.; Yeh, Shyi-Dong] Natl Chung Hsing Univ, NCHU UCD Plant & Food Biotechnol Ctr, Taichung 40227, Taiwan	National Chung Hsing University; National Taiwan University; Asia University Taiwan; National Chung Hsing University	Yeh, SD (corresponding author), Natl Chung Hsing Univ, Dept Plant Pathol, Taichung 40227, Taiwan.	sdyeh@nchu.edu.tw	Lin, Shih-Shun/HCH-9241-2022		Ministry of Science and Technology, Taiwan, Republic of China [NSC-101-2321-B-005-010, NSC-102-2321-B-005-006, NSC-103-2911-I-005-301]	Ministry of Science and Technology, Taiwan, Republic of China	This study was supported by the grants NSC-101-2321-B-005-010 and NSC-102-2321-B-005-006 and NSC-103-2911-I-005-301 from the Ministry of Science and Technology, Taiwan, Republic of China (http://www.most.gov.tw/mp.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; Bhushan L, 2015, ARCH VIROL; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Burgyan J, 2011, TRENDS PLANT SCI, V16, P265, DOI 10.1016/j.tplants.2011.02.010; Canizares MC, 2013, MOL PLANT MICROBE IN, V26, P1004, DOI 10.1094/MPMI-02-13-0037-R; Carrington JC, 1998, CURR OPIN PLANT BIOL, V1, P336, DOI 10.1016/1369-5266(88)80056-6; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chen TC, 2006, PHYTOPATHOLOGY, V96, P1296, DOI 10.1094/PHYTO-96-1296; Cheng HW, 2013, J BIOTECHNOL, V164, P510, DOI 10.1016/j.jbiotec.2013.02.002; Cheng YH, 2014, ANN APPL BIOL, V164, P107, DOI 10.1111/aab.12084; Chu FH, 2001, PHYTOPATHOLOGY, V91, P361, DOI 10.1094/PHYTO.2001.91.4.361; Chu FH, 1998, PHYTOPATHOLOGY, V88, P351, DOI 10.1094/PHYTO.1998.88.4.351; Collins RE, 2005, FEBS LETT, V579, P5841, DOI 10.1016/j.febslet.2005.07.072; CRONIN S, 1995, PLANT CELL, V7, P549, DOI 10.1105/tpc.7.5.549; Csorba T, 2009, ADV VIRUS RES, V75, P35, DOI 10.1016/S0065-3527(09)07502-2; Curaba JL, 2008, J BIOL CHEM, V283, P3059, DOI 10.1074/jbc.M708983200; de Ronde D, 2014, MOL PLANT PATHOL, V15, P185, DOI 10.1111/mpp.12082; De Ronde D, 2013, MOL PLANT PATHOL, V14, P405, DOI 10.1111/mpp.12016; DING SW, 1995, EMBO J, V14, P5762, DOI 10.1002/j.1460-2075.1995.tb00265.x; Dong JH, 2013, VIRUS GENES, V46, P567, DOI 10.1007/s11262-012-0873-z; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; English JJ, 1997, PLANT J, V12, P597, DOI 10.1046/j.1365-313X.1997.00597.x; Fukunaga R, 2009, EMBO J, V28, P545, DOI 10.1038/emboj.2009.2; Garcia S, 2006, J GEN VIROL, V87, P1985, DOI 10.1099/vir.0.81827-0; Hsu CH, 2004, J ALLERGY CLIN IMMUN, V113, P1079, DOI 10.1016/j.jaci.2004.02.047; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; KAMEYAIWAKI M, 1984, PLANT DIS, V68, P1006; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; KORMELINK R, 1991, VIROLOGY, V181, P459, DOI 10.1016/0042-6822(91)90878-F; Kung YJ, 2014, MOL PLANT MICROBE IN, V27, P944, DOI 10.1094/MPMI-04-14-0116-R; Lewsey M, 2007, PLANT J, V50, P240, DOI 10.1111/j.1365-313X.2007.03042.x; Lin SS, 2007, PHYTOPATHOLOGY, V97, P287, DOI 10.1094/PHYTO-97-3-0287; Lin Shih-Shun, 1998, Plant Protection Bulletin (Taichung), V40, P163; Lin SS, 2001, BOT BULL ACAD SINICA, V42, P243; Lokesh B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009757; Mallory AC, 2002, P NATL ACAD SCI USA, V99, P15228, DOI 10.1073/pnas.232434999; Margaria P, 2007, MOL PLANT MICROBE IN, V20, P547, DOI 10.1094/MPMI-20-5-0547; Margaria P, 2014, J VIROL, V88, P5788, DOI 10.1128/JVI.00079-14; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; Peng JC, 2011, EUR J PLANT PATHOL, V130, P205, DOI 10.1007/s10658-011-9746-x; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Rao XQ, 2013, VIRUS GENES, V46, P576, DOI 10.1007/s11262-013-0885-3; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Schnettler E, 2010, J VIROL, V84, P11542, DOI 10.1128/JVI.00595-10; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; vanTilbeurgh H, 1997, EMBO J, V16, P5030, DOI 10.1093/emboj/16.16.5030; Wu HW, 2010, MOL PLANT MICROBE IN, V23, P17, DOI 10.1094/MPMI-23-1-0017; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xu AX, 2013, MOL PLANT PATHOL, V14, P803, DOI 10.1111/mpp.12051; Yang XL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002329; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213; YEH SD, 1992, PLANT DIS, V76, P835, DOI 10.1094/PD-76-0835; YEH SD, 1995, PHYTOPATHOLOGY, V85, P58, DOI 10.1094/Phyto-85-58; Zhai Y, 2014, ARCH VIROL, V159, P1499, DOI 10.1007/s00705-013-1928-8; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506	58	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126161	10.1371/journal.pone.0126161	http://dx.doi.org/10.1371/journal.pone.0126161			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993336	Green Submitted, Green Published, gold			2022-12-26	WOS:000354921400056
J	Spinney, R; Smith, L; Ucci, M; Fisher, A; Konstantatou, M; Sawyer, A; Wardle, J; Marmot, A				Spinney, Richard; Smith, Lee; Ucci, Marcella; Fisher, Abigail; Konstantatou, Marina; Sawyer, Alexia; Wardle, Jane; Marmot, Alexi			Indoor Tracking to Understand Physical Activity and Sedentary Behaviour: Exploratory Study in UK Office Buildings	PLOS ONE			English	Article							ACTIVITY MONITOR; SITTING TIME; RELIABILITY; WORKPLACE; VALIDITY; POSTURE; STEP; SIT	Little is known of the patterns of physical activity, standing and sitting by office workers. However, insight into these behaviours is of growing interest, notably in regard to public health priorities to reduce non-communicable disease risk factors associated with high levels of sitting time and low levels of physical activity. With the advent and increasing availability of indoor tracking systems it is now becoming possible to build detailed pictures of the usage of indoor spaces. This paper reports initial results of indoor tracking used in conjunction with the Activ-PAL activity monitoring device. In this paper we give an overview of the usage of the tracking system and its installation and illustrate some of the resultant data. We also provide preliminary results that investigate the relationship between location, light physical activity and sitting in a small sample of office workers (n=33) from two separate office environments in order to demonstrate the relevance and explanatory power of the technique.	[Spinney, Richard; Ucci, Marcella; Konstantatou, Marina; Marmot, Alexi] UCL, Bartlett Fac Built Environm, UCL Inst Environm Design & Engn, Cent House,14 Upper Woburn Pl, London WC1H 0NN, England; [Smith, Lee; Fisher, Abigail; Sawyer, Alexia; Wardle, Jane] UCL, Dept Epidemiol & Publ Hlth, Hlth Behav Res Ctr, London WC1E 7HB, England	University of London; University College London; University of London; University College London	Spinney, R (corresponding author), UCL, Bartlett Fac Built Environm, UCL Inst Environm Design & Engn, Cent House,14 Upper Woburn Pl, London WC1H 0NN, England.	r.spinney@ucl.ac.uk; lee.smith@ucl.ac.uk; m.ucci@ucl.ac.uk; abigail.fisher@ucl.ac.uk		Smith, Lee/0000-0002-5340-9833; Sawyer, Alexia/0000-0002-9079-4814; Ucci, Marcella/0000-0001-5618-7247	National Institute for Health Research's School for Public Health Research; EPSRC [EP/I02929X/1] Funding Source: UKRI; Cancer Research UK [14133] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I02929X/1] Funding Source: researchfish	National Institute for Health Research's School for Public Health Research; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The funder was the National Institute for Health Research's School for Public Health Research (http://sphr.nihr.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, HEALTH PSYCHOL REV, V3, P108, DOI 10.1080/17437190903151096; Alexi Marmot JE. Office Space Planning, 2000, OFFICE SPACE PLANNIN; Alkhajah TA, 2012, AM J PREV MED, V43, P298, DOI 10.1016/j.amepre.2012.05.027; Aminian S, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-119; Anastasi G, 2003, 23RD INTERNATIONAL CONFERENCE ON DISTRIBUTED COMPUTING SYSTEMS WORKSHOPS, P480; Bauman A E, 2004, J Sci Med Sport, V7, P6, DOI 10.1016/S1440-2440(04)80273-1; Busse M. E., 2009, Journal of Medical Engineering & Technology, V33, P33, DOI 10.1080/03091900701682606; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Chau JY, 2010, PREV MED, V51, P352, DOI 10.1016/j.ypmed.2010.08.012; Chloe B, 2014, P 17 ACM C COMP SUPP; Conn VS, 2009, AM J PREV MED, V37, P330, DOI 10.1016/j.amepre.2009.06.008; Curran K, 2011, J LOCAT BASED SERV, V5, P61, DOI 10.1080/17489725.2011.562927; Dahlgren G, 2010, GAIT POSTURE, V32, P386, DOI 10.1016/j.gaitpost.2010.06.022; Dall PM, 2010, APPL ERGON, V41, P58, DOI 10.1016/j.apergo.2009.04.005; Dhruv P, 2003, 2003 PIMRC 2003 14TH; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Evans RE, 2012, AM J PREV MED, V43, P293, DOI 10.1016/j.amepre.2012.05.010; Godfrey A, 2007, MED ENG PHYS, V29, P930, DOI 10.1016/j.medengphy.2006.10.001; Grant PM, 2006, BRIT J SPORT MED, V40, P992, DOI 10.1136/bjsm.2006.030262; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Harrington DM, 2011, J SPORT SCI, V29, P627, DOI 10.1080/02640414.2010.549499; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2013, PREV MED, V57, P43, DOI 10.1016/j.ypmed.2013.04.004; Isella L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017144; Kerstin Sailer RP, 2013, P 9 INT SPAC SYNT S; Liu H, 2007, IEEE T SYST MAN CY C, V37, P1067, DOI 10.1109/TSMCC.2007.905750; Oliver M, 2011, OPEN J PREV MED, V1, P1, DOI [10.4236/ojpm.2011.11001, DOI 10.4236/0JPM.2011.11001]; Oliver M, 2010, PREV MED, V51, P357, DOI 10.1016/j.ypmed.2010.08.010; Panisson A, 2013, PERV COMP COMM WORKS; Pronk NP, 2011, PREV CHRONIC DIS, P9; Ryan CG, 2006, BRIT J SPORT MED, V40, P779, DOI 10.1136/bjsm.2006.027276; Smith L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004103; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Tanz O, 2005, LECT NOTES COMPUT SC, V3345, P248; Thorp AA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-128; Troped PJ, 2010, AM J PREV MED, V38, P429, DOI 10.1016/j.amepre.2009.12.032; Van den Broeck W., 2010, P 8 ANN IEEE INT C P, P226, DOI [10.1109/PERCOMW.2010.5470665, DOI 10.1109/PERCOMW.2010.5470665]	38	33	33	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127688	10.1371/journal.pone.0127688	http://dx.doi.org/10.1371/journal.pone.0127688			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993515	Green Submitted, Green Published, gold			2022-12-26	WOS:000354921400131
J	Stich, S; Stolk, M; Girod, PP; Thome, C; Sittinger, M; Ringe, J; Seifert, M; Hegewald, AA				Stich, Stefan; Stolk, Meaghan; Girod, Pierre Pascal; Thome, Claudius; Sittinger, Michael; Ringe, Jochen; Seifert, Martina; Hegewald, Aldemar Andres			Regenerative and Immunogenic Characteristics of Cultured Nucleus Pulposus Cells from Human Cervical Intervertebral Discs	PLOS ONE			English	Article							FAS LIGAND; AUTOIMMUNE PROPERTIES; IMMUNE PRIVILEGE; PROGENITOR CELLS; GENE-EXPRESSION; ANIMAL-MODELS; NITRIC-OXIDE; IN-VITRO; DEGENERATION; TRANSPLANTATION	Cell-based regenerative approaches have been suggested as primary or adjuvant procedures for the treatment of degenerated intervertebral disc (IVD) diseases. Our aim was to evaluate the regenerative and immunogenic properties of mildly and severely degenerated cervical nucleus pulposus (NP) cells with regard to cell isolation, proliferation and differentiation, as well as to cell surface markers and co-cultures with autologous or allogeneic peripheral blood mononuclear cells (PBMC) including changes in their immunogenic properties after 3-dimensional (3D)-culture. Tissue from the NP compartment of 10 patients with mild or severe grades of IVD degeneration was collected. Cells were isolated, expanded with and without basic fibroblast growth factor and cultured in 3D fibrin/poly (lactic-coglycolic) acid transplants for 21 days. Real-time reverse-transcription polymerase chain reaction (RT-PCR) showed the expression of characteristic NP markers ACAN, COL1A1 and COL2A1 in 2D- and 3D-culture with degeneration-and culture-dependent differences. In a 5,6-carboxyfluorescein diacetate N-succinimidyl ester-based proliferation assay, NP cells in monolayer, regardless of their grade of degeneration, did not provoke a significant proliferation response in T cells, natural killer (NK) cells or B cells, not only with donor PBMC, but also with allogeneic PBMC. In conjunction with low inflammatory cytokine expression, analyzed by Cytometric Bead Array and fluorescence-activated cell sorting (FACS), a low immunogenicity can be assumed, facilitating possible therapeutic approaches. In 3D-culture, however, we found elevated immune cell proliferation levels, and there was a general trend to higher responses for NP cells from severely degenerated IVD tissue. This emphasizes the importance of considering the specific immunological alterations when including biomaterials in a therapeutic concept. The overall expression of Fas receptor, found on cultured NP cells, could have disadvantageous implications on their potential therapeutic applications because they could be the targets of cytotoxic T-cell activity acting by Fas ligand-induced apoptosis.	[Stich, Stefan; Sittinger, Michael; Ringe, Jochen] Charite, Dept Rheumatol & Clin Immunol, Tissue Engn Lab, D-13353 Berlin, Germany; [Stich, Stefan; Sittinger, Michael; Ringe, Jochen] Charite, Dept Rheumatol & Clin Immunol, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Stolk, Meaghan; Seifert, Martina] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Stolk, Meaghan; Seifert, Martina] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Girod, Pierre Pascal; Thome, Claudius] Med Univ Innsbruck, Dept Neurosurg, A-6020 Innsbruck, Austria; [Hegewald, Aldemar Andres] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neurosurg, Mannheim, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Medical University of Innsbruck; Ruprecht Karls University Heidelberg	Hegewald, AA (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neurosurg, Mannheim, Germany.	aldemar.hegewald@medma.uni-heidelberg.de	, Hegewald/H-2847-2019	, Hegewald/0000-0002-2022-2060; , Martina/0000-0002-6372-9769	Berlin-Brandenburg Center for Regenerative Therapies-BCRT [1315848A]	Berlin-Brandenburg Center for Regenerative Therapies-BCRT	This study was supported by the Berlin-Brandenburg Center for Regenerative Therapies-BCRT (Bundesministerium fur Bildung und Forschung-1315848A), http://www.b-crt.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Akyol S, 2010, TURK NEUROSURG, V20, P492, DOI 10.5137/1019-5149.JTN.3394-10.1; Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y; Conde J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052533; Fujita N, 2005, BIOCHEM BIOPH RES CO, V338, P1890, DOI 10.1016/j.bbrc.2005.10.166; Gabr MA, 2011, J ORTHOP RES, V29, P1, DOI 10.1002/jor.21206; Geiss A, 2007, SPINE, V32, P168, DOI 10.1097/01.brs.0000251651.61844.2d; Geiss A, 2009, J ORTHOP RES, V27, P97, DOI 10.1002/jor.20691; Goldschlager T, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1050; Gruber HE, 2005, SPINE, V30, P625, DOI 10.1097/01.brs.0000155420.01444.c6; Gruber HE, 2000, SPINE, V25, P2153, DOI 10.1097/00007632-200009010-00002; Gruber Helen E, 2006, Spine J, V6, P120, DOI 10.1016/j.spinee.2005.05.383; Gruber HE, 2010, SPINE, V35, P1033, DOI 10.1097/BRS.0b013e3181bc3e04; Gruber HE, 2009, SPINE, V34, P4, DOI 10.1097/BRS.0b013e31818f8c02; Han DF, 2009, ACTA BIOCH BIOPH SIN, V41, P938, DOI 10.1093/abbs/gmp087; Hastreiter D, 2001, J ORTHOP RES, V19, P597, DOI 10.1016/S0736-0266(00)00069-3; Hegewald AA, 2011, J NEUROSURG-SPINE, V14, P273, DOI 10.3171/2010.10.SPINE10223; Hegewald AA, 2008, FRONT BIOSCI-LANDMRK, V13, P1507, DOI 10.2741/2777; Hegewald AA, 2011, J TISSUE ENG REGEN M, V5, P275, DOI 10.1002/term.312; Hohaus C, 2008, EUR SPINE J, V17, pS492, DOI 10.1007/s00586-008-0750-6; ISHII T, 1991, J ORTHOP RES, V9, P78, DOI 10.1002/jor.1100090111; Johnson WEB, 2007, BIOCHEM SOC T, V35, P680, DOI 10.1042/BST0350680; Johnson WEB, 2001, CONNECT TISSUE RES, V42, P197, DOI 10.3109/03008200109005650; Kaneyama S, 2008, J ORTHOP SCI, V13, P130, DOI 10.1007/s00776-007-1204-4; KANG JD, 1995, SPINE, V20, P2373, DOI 10.1097/00007632-199511001-00001; Kang JD, 1997, SPINE, V22, P1065, DOI 10.1097/00007632-199705150-00003; Kepler CK, 2013, SPINE J, V13, P318, DOI 10.1016/j.spinee.2012.12.003; Kienzle G, 1998, ARTHRITIS RHEUM-US, V41, P1296, DOI 10.1002/1529-0131(199807)41:7<1296::AID-ART21>3.0.CO;2-8; Kluba T, 2005, SPINE, V30, P2743, DOI 10.1097/01.brs.0000192204.89160.6d; Kokubo Y, 2008, J NEUROSURG-SPINE, V9, P285, DOI 10.3171/SPI/2008/9/9/285; Kraychete DC, 2010, SAO PAULO MED J, V128, P259, DOI 10.1590/S1516-31802010000500003; Lee S, 2009, CLIN BIOCHEM, V42, P1504, DOI 10.1016/j.clinbiochem.2009.06.017; Liebscher T, 2011, SPINE, V36, P153, DOI 10.1097/BRS.0b013e3181cd588c; Liu ZH, 2013, INT J MED SCI, V10, P1053, DOI 10.7150/ijms.6223; Lotz JC, 2004, SPINE, V29, P2742, DOI 10.1097/01.brs.0000146498.04628.f9; Luk KDK, 2003, SPINE, V28, P864, DOI 10.1097/00007632-200305010-00005; Mauth C, 2009, EUR CELLS MATER, V18, P27, DOI 10.22203/eCM.v018a03; Mehrkens A, 2012, OSTEOARTHR CARTILAGE, V20, P1316, DOI 10.1016/j.joca.2012.06.001; Mern DS, 2014, J TISSUE ENG REGEN M, V8, P925, DOI 10.1002/term.1583; Millward-Sadler SJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2693; Miyazaki M, 2008, J SPINAL DISORD TECH, V21, P288, DOI 10.1097/BSD.0b013e31813c0e59; Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3; Murai K, 2010, EUR CELLS MATER, V19, P13, DOI 10.22203/eCM.v019a02; NAYLOR A, 1962, Ann R Coll Surg Engl, V31, P91; Park JB, 2001, SPINE, V26, P142, DOI 10.1097/00007632-200101150-00006; Park JB, 2001, SPINE, V26, P618, DOI 10.1097/00007632-200103150-00011; Pfaffl MW, 2001, BIOTECHNOL LETT, V23, P275, DOI 10.1023/A:1005658330108; Pratsinis H, 2007, EUR SPINE J, V16, P1858, DOI 10.1007/s00586-007-0408-9; Risbud MV, 2007, SPINE, V32, P2537, DOI 10.1097/BRS.0b013e318158dea6; Ruan DK, 2007, LANCET, V369, P993, DOI 10.1016/S0140-6736(07)60496-6; SCOTT JE, 1994, J ANAT, V184, P73; Stern S, 2004, CLIN ORTHOP RELAT R, P238, DOI 10.1097/01.blo.0000116310.84600.37; Studer RK, 2011, SPINE, V36, P593, DOI 10.1097/BRS.0b013e3181da38d5; Sun Z, 2013, INT J CLIN EXP PATHO, V6, P1009; Takada T, 2004, SPINE, V29, P1089, DOI 10.1097/00007632-200405150-00007; Takada T, 2002, SPINE, V27, P1526, DOI 10.1097/00007632-200207150-00009; Tang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052020; Tsai TT, 2007, SPINE, V32, P495, DOI 10.1097/01.brs.0000257341.88880.f1; Vadala G, 2008, SPINE, V33, P870, DOI 10.1097/BRS.0b013e31816b4619; Vadala G, 2015, J TISSUE ENG REGEN M, V9, P679, DOI 10.1002/term.1719; Wallach CJ, 2003, SPINE, V28, P2331, DOI 10.1097/01.BRS.0000085303.67942.94; Wang J, 2007, J NEUROSURG-SPINE, V6, P425, DOI 10.3171/spi.2007.6.5.425; Yamamoto J, 2013, J ORTHOP RES, V31, P608, DOI 10.1002/jor.22274; Zhang YG, 2010, J BONE MINER METAB, V28, P209, DOI 10.1007/s00774-009-0120-4	64	18	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0126954	10.1371/journal.pone.0126954	http://dx.doi.org/10.1371/journal.pone.0126954			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993467	Green Submitted, gold, Green Published			2022-12-26	WOS:000354918600046
J	Suchodolski, JS; Foster, ML; Sohail, MU; Leutenegger, C; Queen, EV; Steiner, JM; Marks, SL				Suchodolski, Jan S.; Foster, Mary L.; Sohail, Muhammad U.; Leutenegger, Christian; Queen, Erica V.; Steiner, Joerg M.; Marks, Stanley L.			The Fecal Microbiome in Cats with Diarrhea	PLOS ONE			English	Article							CLOSTRIDIUM-PERFRINGENS ENTEROTOXIN; INFLAMMATORY-BOWEL-DISEASE; BACTERIAL; RNA; HEALTHY; DOGS; COMMUNITIES; PREVALENCE; DYSBIOSIS; COLITIS	Recent studies have revealed that microbes play an important role in the pathogenesis of gastrointestinal (GI) diseases in various animal species, but only limited data is available about the microbiome in cats with GI disease. The aim of this study was to evaluate the fecal microbiome in cats with diarrhea. Fecal samples were obtained from healthy cats (n = 21) and cats with acute (n = 19) or chronic diarrhea (n = 29) and analyzed by sequencing of 16S rRNA genes, and PICRUSt was used to predict the functional gene content of the microbiome. Linear discriminant analysis (LDA) effect size (LEfSe) revealed significant differences in bacterial groups between healthy cats and cats with diarrhea. The order Burkholderiales, the families Enterobacteriaceae, and the genera Streptococcus and Collinsella were significantly increased in diarrheic cats. In contrast the order Campylobacterales, the family Bacteroidaceae, and the genera Megamonas, Helicobacter, and Roseburia were significantly increased in healthy cats. Phylum Bacteroidetes was significantly decreased in cats with chronic diarrhea (>21 days duration), while the class Erysipelotrichi and the genus Lactobacillus were significantly decreased in cats with acute diarrhea. The observed changes in bacterial groups were accompanied by significant differences in functional gene contents: metabolism of fatty acids, biosynthesis of glycosphingolipids, metabolism of biotin, metabolism of tryptophan, and ascorbate and aldarate metabolism, were all significantly (p < 0.001) altered in cats with diarrhea. In conclusion, significant differences in the fecal microbiomes between healthy cats and cats with diarrhea were identified. This dysbiosis was accompanied by changes in bacterial functional gene categories. Future studies are warranted to evaluate if these microbial changes correlate with changes in fecal concentrations of microbial metabolites in cats with diarrhea for the identification of potential diagnostic or therapeutic targets.	[Suchodolski, Jan S.; Foster, Mary L.; Steiner, Joerg M.] Texas A&M Univ, Gastrointestinal Lab, College Stn, TX 77843 USA; [Sohail, Muhammad U.] Govt Coll Univ, Dept Physiol, Faisalabad, Pakistan; [Leutenegger, Christian] IDEXX Reference Labs, West Sacramento, CA USA; [Queen, Erica V.] MarQueen Anim Clin, Roseville, CA USA; [Marks, Stanley L.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA	Texas A&M University System; Texas A&M University College Station; Government College University Faisalabad; University of California System; University of California Davis	Suchodolski, JS (corresponding author), Texas A&M Univ, Gastrointestinal Lab, College Stn, TX 77843 USA.	jsuchodolski@cvm.tamu.edu		Suchodolski, Jan/0000-0002-2176-6932; Sohail, Muhammad Umar/0000-0003-3250-3174	Texas AM University; University Libraries; Office of the Vice President for Research	Texas AM University; University Libraries; Office of the Vice President for Research	The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research. IDEXX Laboratories provided support in the form of salaries for authors [CL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Abecia L., 2010, International Journal of Probiotics and Prebiotics, V5, P61; Barry KA, 2012, J PROTEOME RES, V11, P5924, DOI 10.1021/pr3006809; Bell ET, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108729; Bell Julia A, 2008, Interdiscip Perspect Infect Dis, V2008, P149694, DOI 10.1155/2008/149694; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Busch K, 2015, VET REC, V176, P253, DOI 10.1136/vr.102738; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Costa Marcio C., 2012, Animal Health Research Reviews, V13, P121, DOI 10.1017/S1466252312000035; Craven M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041594; Erickson AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049138; Foster M Lauren, 2013, Vet Med Int, V2013, P658373, DOI 10.1155/2013/658373; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Handl S, 2013, FEMS MICROBIOL ECOL, V84, P332, DOI 10.1111/1574-6941.12067; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Honneffer JB, 2014, WORLD J GASTROENTERO, V20, P16489, DOI 10.3748/wjg.v20.i44.16489; Hooda Seema, 2012, Animal Health Research Reviews, V13, P78, DOI 10.1017/S1466252312000059; Inness VL, 2007, J ANIM PHYSIOL AN N, V91, P48, DOI 10.1111/j.1439-0396.2006.00640.x; Janeczko S, 2008, VET MICROBIOL, V128, P178, DOI 10.1016/j.vetmic.2007.10.014; Jia J, 2011, LETT APPL MICROBIOL, V53, P288, DOI 10.1111/j.1472-765X.2011.03105.x; Jia J, 2011, FEMS MICROBIOL ECOL, V78, P395, DOI 10.1111/j.1574-6941.2011.01172.x; Kommedal O, 2014, J CLIN MICROBIOL, V52, P1990, DOI 10.1128/JCM.00346-14; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Machiels Kathleen, 2014, Gut, V63, P1275, DOI 10.1136/gutjnl-2013-304833; Mapes S, 2008, VET REC, V162, P857, DOI 10.1136/vr.162.26.857; Milani C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068739; Minamoto Y, 2015, GUT MICROBES, V6, P33, DOI 10.1080/19490976.2014.997612; Minamoto Y, 2014, VET MICROBIOL, V174, P463, DOI 10.1016/j.vetmic.2014.10.005; Minamoto Yasushi, 2012, Animal Health Research Reviews, V13, P64, DOI 10.1017/S1466252312000060; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Queen EV, 2012, J VET INTERN MED, V26, P54, DOI 10.1111/j.1939-1676.2011.00843.x; Ramadan Z, 2014, J VET INTERN MED, V28, P59, DOI 10.1111/jvim.12261; Ritchie LE, 2008, FEMS MICROBIOL ECOL, V66, P590, DOI 10.1111/j.1574-6941.2008.00609.x; Rooks MG, 2014, ISME J, V8, P1403, DOI 10.1038/ismej.2014.3; Rossi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094699; Salipante SJ, 2014, APPL ENVIRON MICROB, V80, P7583, DOI 10.1128/AEM.02206-14; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333	41	71	73	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127378	10.1371/journal.pone.0127378	http://dx.doi.org/10.1371/journal.pone.0127378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992741	Green Submitted, Green Published, gold			2022-12-26	WOS:000354918600060
J	Basavanhally, A; Viswanath, S; Madabhushi, A				Basavanhally, Ajay; Viswanath, Satish; Madabhushi, Anant			Predicting Classifier Performance with Limited Training Data: Applications to Computer-Aided Diagnosis in Breast and Prostate Cancer	PLOS ONE			English	Article							GRADE; BIAS	Clinical trials increasingly employ medical imaging data in conjunction with supervised classifiers, where the latter require large amounts of training data to accurately model the system. Yet, a classifier selected at the start of the trial based on smaller and more accessible datasets may yield inaccurate and unstable classification performance. In this paper, we aim to address two common concerns in classifier selection for clinical trials: (1) predicting expected classifier performance for large datasets based on error rates calculated from smaller datasets and (2) the selection of appropriate classifiers based on expected performance for larger datasets. We present a framework for comparative evaluation of classifiers using only limited amounts of training data by using random repeated sampling (RRS) in conjunction with a cross-validation sampling strategy. Extrapolated error rates are subsequently validated via comparison with leave-one-out cross-validation performed on a larger dataset. The ability to predict error rates as dataset size increases is demonstrated on both synthetic data as well as three different computational imaging tasks: detecting cancerous image regions in prostate histopathology, differentiating high and low grade cancer in breast histopathology, and detecting cancerous metavoxels in prostate magnetic resonance spectroscopy. For each task, the relationships between 3 distinct classifiers (k-nearest neighbor, naive Bayes, Support Vector Machine) are explored. Further quantitative evaluation in terms of interquartile range (IQR) suggests that our approach consistently yields error rates with lower variability (mean IQRs of 0.0070, 0.0127, and 0.0140) than a traditional RRS approach (mean IQRs of 0.0297, 0.0779, and 0.305) that does not employ cross-validation sampling for all three datasets.	[Basavanhally, Ajay; Viswanath, Satish; Madabhushi, Anant] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	Case Western Reserve University	Madabhushi, A (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	anantm@case.edu	Madabhushi, Anant/AAG-2908-2019	Madabhushi, Anant/0000-0002-5741-0399; Basavanhally, Ajay/0000-0002-4713-815X; Viswanath, Satish/0000-0003-4550-8337	National Cancer Institute of the National Institutes of Health [R01CA136535-01, R01CA140772-01, R21CA167811-01, R21CA179327-01, R21CA195152-01]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK098503-02]; DOD Prostate Cancer Synergistic Idea Development Award [PC120857]; DOD Lung Cancer Idea Development New Investigator Award [LC130463]; DOD Prostate Cancer Idea Development Award; Ohio Third Frontier Technology development Grant; CTSC Coulter Annual Pilot Grant; Case Comprehensive Cancer Center Pilot Grant; VelaSano Grant Cleveland Clinic; Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University; NATIONAL CANCER INSTITUTE [R21CA167811, R21CA195152, R01CA136535, R21CA179327, R01CA140772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098503] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DOD Prostate Cancer Synergistic Idea Development Award; DOD Lung Cancer Idea Development New Investigator Award; DOD Prostate Cancer Idea Development Award; Ohio Third Frontier Technology development Grant; CTSC Coulter Annual Pilot Grant; Case Comprehensive Cancer Center Pilot Grant; VelaSano Grant Cleveland Clinic; Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award numbers R01CA136535-01, R01CA140772-01, R21CA167811-01, R21CA179327-01, R21CA195152-01, the National Institute of Diabetes and Digestive and Kidney Diseases under award number R01DK098503-02, the DOD Prostate Cancer Synergistic Idea Development Award (PC120857); the DOD Lung Cancer Idea Development New Investigator Award (LC130463), the DOD Prostate Cancer Idea Development Award; the Ohio Third Frontier Technology development Grant, the CTSC Coulter Annual Pilot Grant, the Case Comprehensive Cancer Center Pilot Grant, VelaSano Grant from the Cleveland Clinic, the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adcock CJ, 1997, J ROY STAT SOC D-STA, V46, P261; Al-Kadi OS, 2010, PATTERN RECOGN, V43, P2043, DOI 10.1016/j.patcog.2010.01.005; Basavanhally A, 2013, IEEE T BIO-MED ENG, V60, P2089, DOI 10.1109/TBME.2013.2245129; Basavanhally A, 2010, I S BIOMED IMAGING, P229, DOI 10.1109/ISBI.2010.5490373; Berrar D, 2006, BIOINFORMATICS, V22, P1245, DOI 10.1093/bioinformatics/btl066; Breiman L, 1996, ANN STAT, V24, P2350; Brooks FJ, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-7; Didaci L, 2005, PATTERN RECOGN, V38, P2188, DOI 10.1016/j.patcog.2005.02.010; Doyle S, 2012, IEEE T BIO-MED ENG, V59, P1205, DOI 10.1109/TBME.2010.2053540; Doyle S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-424; Duda R.O., 2006, PATTERN CLASSIFICATI; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Evans AC, 1997, ANN NEUROL, V41, P125, DOI 10.1002/ana.410410123; Freund Y, 1997, MACH LEARN, V28, P133, DOI 10.1023/A:1007330508534; Good P, 1994, PERMUTATION TESTS A; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Kurhanewicz J, 2002, J MAGN RESON IMAGING, V16, P451, DOI 10.1002/jmri.10172; Madabhushi A, 2011, COMPUT MED IMAG GRAP, V35, P506, DOI 10.1016/j.compmedimag.2011.01.008; Meyer JS, 2005, MODERN PATHOL, V18, P1067, DOI 10.1038/modpathol.3800388; Mukherjee S, 2003, J COMPUT BIOL, V10, P119, DOI 10.1089/106652703321825928; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Scheidler J, 1999, RADIOLOGY, V213, P473, DOI 10.1148/radiology.213.2.r99nv23473; Sertel O, 2009, PATTERN RECOGN, V42, P1093, DOI 10.1016/j.patcog.2008.08.027; Shin DS, 1999, OPHTHALMOLOGY, V106, P1119, DOI 10.1016/S0161-6420(99)90257-9; Tiwari P, 2012, NMR BIOMED, V25, P607, DOI 10.1002/nbm.1777; Vasanji A, 2013, APPLIED CLINICAL TRI, V22, P38; Wickenberg-Bolin U, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-127; Wu G, 2003, ICML 2003 WORKSH LEA, P49, DOI DOI 10.5753/SBRC.2019.7416; Xu Y, 2006, ACAD RADIOL, V13, P969, DOI 10.1016/j.acra.2006.04.017	30	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0117900	10.1371/journal.pone.0117900	http://dx.doi.org/10.1371/journal.pone.0117900			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993029	Green Published, gold, Green Submitted			2022-12-26	WOS:000354917300001
J	Avaldi, VM; Lenzi, J; Castaldini, I; Urbinati, S; Di Pasquale, G; Morini, M; Protonotari, A; Maggioni, AP; Fantini, MP				Avaldi, Vera Maria; Lenzi, Jacopo; Castaldini, Ilaria; Urbinati, Stefano; Di Pasquale, Giuseppe; Morini, Mara; Protonotari, Adalgisa; Maggioni, Aldo Pietro; Fantini, Maria Pia			Hospital Readmissions of Patients with Heart Failure: The Impact of Hospital and Primary Care Organizational Factors in Northern Italy	PLOS ONE			English	Article							DISEASE MANAGEMENT PROGRAM; IMPROVING PRIMARY-CARE; MYOCARDIAL-INFARCTION; RANDOMIZED TRIAL; ELDERLY-PATIENTS; HIGH-RISK; INTERVENTION; METAANALYSIS; ADMISSION; EPIDEMIOLOGY	Background Primary health care is essential for an appropriate management of heart failure (HF), a disease which is a major clinical and public health issue and a leading cause of hospitalization. The aim of this study was to evaluate the impact of different organizational factors on readmissions of patients with HF. Methods The study population included elderly resident in the Local Health Authority of Bologna (Northern Italy) and discharged with a diagnosis of HF from January to December 2010. Unplanned hospital readmissions were measured in four timeframes: 30 (short-term), 90 (medium-term), 180 (mid-long-term), and 365 days (long-term). Using multivariable multilevel Poisson regression analyses, we investigated the association between readmissions and organizational factors (discharge from a cardiology department, general practitioners' monodisciplinary organizational arrangement, and implementation of a specific HF care pathway). Results The 1873 study patients had a median age of 83 years (interquartile range 77-87) and 55.5% were females; 52.0% were readmitted to the hospital for any reason after a year, while 20.1% were readmitted for HF. The presence of a HF care pathway was the only factor significantly associated with a lower risk of readmission for HF in the short-, medium-, mid-long-and long-term period (short-term: IRR [incidence rate ratio] = 0.57, 95% CI [confidence interval] = 0.35-0.92; medium-term: IRR = 0.70, 95% CI = 0.51-0.96; mid-long-term: IRR= 0.79, 95% CI= 0.64-0.98; long-term: IRR = 0.82, 95% CI = 0.67-0.99), and with a lower risk of all-cause readmission in the short-term period (IRR= 0.73, 95% CI = 0.57-0.94). Conclusion Our study shows that the HF care specific pathway implemented at the primary care level was associated with lower readmission rate for HF in each timeframe, and also with lower readmission rate for all causes in the short-term period. Our results suggest that the engagement of primary care professionals starting from the early post-discharge period may be relevant in the management of patients with HF.	[Avaldi, Vera Maria; Lenzi, Jacopo; Fantini, Maria Pia] Univ Bologna, Alma Mater Studiorum, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Castaldini, Ilaria; Protonotari, Adalgisa] Bologna Local Healthcare Author, Dept Programming & Control, Bologna, Italy; [Urbinati, Stefano] Bellaria Hosp, Dept Cardiol, Bologna, Italy; [Di Pasquale, Giuseppe] Maggiore Hosp, Dept Cardiol, Bologna, Italy; [Morini, Mara] Bologna Local Healthcare Author, Dept Primary Care, Bologna, Italy; [Maggioni, Aldo Pietro] ANMCO Res Ctr, Florence, Italy	University of Bologna; AUSL di Bologna; AUSL di Bologna; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO)	Fantini, MP (corresponding author), Univ Bologna, Alma Mater Studiorum, Dept Biomed & Neuromotor Sci, Bologna, Italy.	mariapia.fantini@unibo.it	Lenzi, Jacopo/W-4835-2017; Maggioni, Aldo Pietro/AAL-5334-2020	Lenzi, Jacopo/0000-0003-2882-4223; Maggioni, Aldo Pietro/0000-0003-2764-6779; Avaldi, Vera Maria/0000-0003-0609-2439				Armeni P, 2014, MED CARE RES REV, V71, P315, DOI 10.1177/1077558714536618; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Blue L, 2001, BRIT MED J, V323, P715, DOI 10.1136/bmj.323.7315.715; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Bottle A, 2014, EUR J HEART FAIL, V16, P846, DOI 10.1002/ejhf.129; Bradley EH, 2013, CIRC-CARDIOVASC QUAL, V6, P444, DOI 10.1161/CIRCOUTCOMES.111.000101; Capomolla S, 2002, J AM COLL CARDIOL, V40, P1259, DOI 10.1016/S0735-1097(02)02140-X; Clark AM, 2008, LANCET, V372, P784, DOI 10.1016/S0140-6736(08)61317-3; Clark RA, 2007, BMJ-BRIT MED J, V334, P942, DOI 10.1136/bmj.39156.536968.55; Coleman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75; Del Sindaco D, 2007, J CARDIOVASC MED, V8, P324, DOI 10.2459/JCM.0b013e32801164cb; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Ducharme A, 2005, CAN MED ASSOC J, V173, P40, DOI 10.1503/cmaj.1041137; Fantini MP, 2012, HEALTH CARE MANAGE R, V37, P67, DOI 10.1097/HMR.0b013e31822241cf; Garin N, 2012, EUR J INTERN MED, V23, P760, DOI 10.1016/j.ejim.2012.06.006; Gonseth J, 2004, EUR HEART J, V25, P1570, DOI 10.1016/j.ehj.2004.04.022; Ham C, 2010, HEALTH ECON POLICY L, V5, P71, DOI 10.1017/S1744133109990120; Hansen LO, 2011, ANN INTERN MED, V155, P520, DOI 10.7326/0003-4819-155-8-201110180-00008; Inglis SC, 2011, EUR J HEART FAIL, V13, P1028, DOI 10.1093/eurjhf/hfr039; Jaarsma T, 2013, EUR J CARDIOVASC NUR, V12, P230, DOI [10.1177/1474515113476605, 10.1177/1474515112449539]; Kasper EK, 2002, J AM COLL CARDIOL, V39, P471, DOI 10.1016/S0735-1097(01)01761-2; Kirchmayer U, 2012, J CLIN PHARM THER, V37, P37, DOI 10.1111/j.1365-2710.2010.01242.x; Kirchmayer U, 2013, PHARMACOEPIDEM DR S, V22, P649, DOI 10.1002/pds.3430; Klersy C, 2009, J AM COLL CARDIOL, V54, P1683, DOI 10.1016/j.jacc.2009.08.017; Krumholz HM, 2002, J AM COLL CARDIOL, V39, P83, DOI 10.1016/S0735-1097(01)01699-0; Kul S, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-81; Lenzi J, 2015, EUR J CLIN PHARMACOL, V71, P243, DOI 10.1007/s00228-014-1793-8; Linden A, 2014, AM J MANAG CARE, V20; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; McAlister FA, 2013, CAN MED ASSOC J, V185, pE681, DOI 10.1503/cmaj.130048; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Michalsen A, 1998, HEART, V80, P437, DOI 10.1136/hrt.80.5.437; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Panella M, 2009, QUAL SAF HEALTH CARE, V18, P369, DOI 10.1136/qshc.2008.026559; Profili S., 2009, HLTH SYST TRANSIT, V11, P1; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Takeda A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002752.pub3; Tsuyuki RT, 2004, J CARD FAIL, V10, P473, DOI 10.1016/j.cardfail.2004.02.005; Tuppin P, 2014, ARCH CARDIOVASC DIS, V107, P158, DOI 10.1016/j.acvd.2014.01.012; Visca M, 2013, HEALTH POLICY, V113, P188, DOI 10.1016/j.healthpol.2013.05.016; Wagner E H, 1998, Eff Clin Pract, V1, P2; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206	44	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127796	10.1371/journal.pone.0127796	http://dx.doi.org/10.1371/journal.pone.0127796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010223	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900145
J	Kotani, H; Taimatsu, K; Ohga, R; Ota, S; Kawahara, A				Kotani, Hirohito; Taimatsu, Kiyohito; Ohga, Rie; Ota, Satoshi; Kawahara, Atsuo			Efficient Multiple Genome Modifications Induced by the crRNAs, tracrRNA and Cas9 Protein Complex in Zebrafish	PLOS ONE			English	Article							TARGET DNA; KNOCK-IN; RNA; SYSTEM; CRISPR; NUCLEASES; TALEN; CELL; IDENTIFICATION; GENERATION	The type II clustered regularly interspaced short palindromic repeats (CRISPR) associated with Cas9 endonuclease (CRISPR/Cas9) has become a powerful genetic tool for understanding the function of a gene of interest. In zebrafish, the injection of Cas9 mRNA and guide-RNA (gRNA), which are prepared using an in vitro transcription system, efficiently induce DNA double-strand breaks (DSBs) at the targeted genomic locus. Because gRNA was originally constructed by fusing two short RNAs CRISPR RNA (crRNA) and trans-activating crRNA (tracrRNA), we examined the effect of synthetic crRNAs and tracrRNA with Cas9 mRNA or Cas9 protein on the genome editing activity. We previously reported that the disruption of tyrosinase (tyr) by tyr-gRNA/Cas9 mRNA causes a retinal pigment defect, whereas the disruption of spns2 by spns2-gRNA1/Cas9 mRNA leads to a cardiac progenitor migration defect in zebrafish. Here, we found that the injection of spns2-crRNA1, tyr-crRNA and tracrRNA with Cas9 mRNA or Cas9 protein simultaneously caused a migration defect in cardiac progenitors and a pigment defect in retinal epithelial cells. A time course analysis demonstrated that the injection of crRNAs and tracrRNA with Cas9 protein rapidly induced genome modifications compared with the injection of crRNAs and tracrRNA with Cas9 mRNA. We further show that the crRNA-tracrRNA-Cas9 protein complex is functional for the visualization of endogenous gene expression; therefore, this is a very powerful, ready-to-use system in zebrafish.	[Kotani, Hirohito; Taimatsu, Kiyohito; Ohga, Rie; Ota, Satoshi; Kawahara, Atsuo] Univ Yamanashi, Grad Sch Med Sci, Dev Biol Lab, Ctr Med Educ & Sci, Chuo, Yamanashi, Japan	University of Yamanashi	Kawahara, A (corresponding author), Univ Yamanashi, Grad Sch Med Sci, Dev Biol Lab, Ctr Med Educ & Sci, Shimokato 1110, Chuo, Yamanashi, Japan.	akawahara@yamanashi.ac.jp			Japan Society for the Promotion of Science KAKENHI [26640064]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by the Japan Society for the Promotion of Science KAKENHI Grant Number 26640064, http://www.jsps.go.jp/english/index.html.	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Ansai S, 2014, BIOL OPEN, V3, P362, DOI 10.1242/bio.20148177; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Fujita T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103084; Fujita T, 2013, BIOCHEM BIOPH RES CO, V439, P132, DOI 10.1016/j.bbrc.2013.08.013; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Hisano Y, 2014, DEV GROWTH DIFFER, V56, P26, DOI 10.1111/dgd.12094; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Kawahara A, 2002, DEV BIOL, V248, P107, DOI 10.1006/dbio.2002.0709; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kimura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06545; Kupperman E, 2000, NATURE, V406, P192, DOI 10.1038/35018092; Lee JS, 2014, G3-GENES GENOM GENET, V4, P1291, DOI 10.1534/g3.114.012179; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Mashimo T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01253; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Osborne N, 2008, CURR BIOL, V18, P1882, DOI 10.1016/j.cub.2008.10.061; Ota S, 2014, GENES CELLS, V19, P555, DOI 10.1111/gtc.12154; Ota S, 2013, GENES CELLS, V18, P450, DOI 10.1111/gtc.12050; Page-McCaw PS, 2004, NAT NEUROSCI, V7, P1329, DOI 10.1038/nn1344; Sakuma T, 2013, GENES CELLS, V18, P315, DOI 10.1111/gtc.12037; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Yoshimi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5240; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	36	64	65	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128319	10.1371/journal.pone.0128319	http://dx.doi.org/10.1371/journal.pone.0128319			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010089	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900223
J	Jo, SR; Joh, JY; Jeong, JR; Kim, S; Kim, YP				Jo, So-Ra; Joh, Ju-Youn; Jeong, Ju-Ri; Kim, Sun; Kim, Yeon-Pyo			Health Behaviors of Korean Gastric Cancer Survivors with Hypertension: A Propensity Analysis of KNHANES III-V (2005-2012)	PLOS ONE			English	Article							ALCOHOL-CONSUMPTION; PHYSICAL-ACTIVITY; BREAST-CANCER; ADHERENCE; DIAGNOSIS; RISK; LIFE; CARE; RECOMMENDATIONS; SOCIETY	Objective This study provides a comparison of health behaviors between gastric cancer survivors with hypertension and non-cancer subjects in Korea. Methods Data from the Korean National Health and Nutrition Examination Survey (KNHANES) for the period of 2005-2012 were used in this study. A propensity score matching method was used to compare health behaviors. Before the matching of propensity scores, the number of participants was 11034 (102 gastric cancer survivors and 10932 non-cancer participants). A 1:5 propensity score matching procedure yielded a total of 480 participants (80 gastric cancer survivors and 400 non-cancer participants) for the final analysis. Drinking, smoking, physical activity, antihypertensive medication adherence, self-reported diet control, and sodium intake accordance in the two groups were compared. A complex samples logistic regression analysis was conducted to assess any differences between the two groups. Results The group of hypertensive gastric cancer survivors had lower alcohol consumption (OR = 0.30; 95% CI: 0.14-0.66; p-value = 0.003). They were more likely to be on dietary control than the control group (OR = 3.12; 95% CI: 1.60-6.10; p-value = 0.001). However, there was no significant (p > 0.05) difference in sodium intake accordance or other health behaviors (including medication adherence, smoking, and physical activity) between the two groups. Conclusions Our results revealed that gastric cancer survivors with hypertension were more likely to be on dietary control with lower alcohol consumption than the control group. However, there was no significant difference in sodium intake accordance or other health behaviors between the two groups. Therefore, primary care physicians should inform cancer survivors about the appropriate health behaviors to reduce their risk of cardiovascular disease and improve their overall survival rate, even though they say they have been doing health behaviors.	[Jo, So-Ra; Joh, Ju-Youn; Jeong, Ju-Ri; Kim, Sun; Kim, Yeon-Pyo] Hwasun Chonnam Natl Univ Hosp, Dept Family Med, Hwasun Eup, Hwasun Gun Chon, South Korea; [Jo, So-Ra; Joh, Ju-Youn; Jeong, Ju-Ri; Kim, Sun] Hwasun Chonnam Natl Univ Hosp, Clin Life Canc Treatment LACT Clin, Hwasun Eup, Hwasun Gun Chon, South Korea	Chonnam National University; Chonnam National University Hospital; Chonnam National University; Chonnam National University Hospital	Kim, YP (corresponding author), Hwasun Chonnam Natl Univ Hosp, Dept Family Med, Hwasun Eup, Hwasun Gun Chon, South Korea.	ypkim@jnu.ac.kr		Jeong, Ju Ri/0000-0003-3544-2522				Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Blanchard CM, 2008, J CLIN ONCOL, V26, P2198, DOI 10.1200/JCO.2007.14.6217; Blanchard CM, 2003, AM J HEALTH BEHAV, V27, P246, DOI 10.5993/AJHB.27.3.6; Caliendo M., 2005, 1588 IZA; Cooley M, 2007, ONCOL NURS FORUM, V34, P228; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; D'Elia L, 2012, CLIN NUTR, V31, P489, DOI 10.1016/j.clnu.2012.01.003; DuGoff EH, 2014, HEALTH SERV RES, V49, P284, DOI 10.1111/1475-6773.12090; Eakin EG, 2007, CANCER CAUSE CONTROL, V18, P881, DOI 10.1007/s10552-007-9033-5; Eckel RH, 2013, J AM COLL CARDIOL; Frobisher C, 2010, CANCER EPIDEM BIOMAR, V19, P1174, DOI 10.1158/1055-9965.EPI-10-0006; Hawkins NA, 2010, J CANCER SURVIV, V4, P20, DOI 10.1007/s11764-009-0104-3; Holmes MD, 2005, JAMA-J AM MED ASSOC, V293, P2479, DOI 10.1001/jama.293.20.2479; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kim HI, 2012, SUPPORT CARE CANCER, V20, P2041, DOI 10.1007/s00520-011-1313-7; Kwan ML, 2010, J CLIN ONCOL, V28, P4410, DOI 10.1200/JCO.2010.29.2730; Lee DR, 2014, KOREAN J FAM MED, V35, P28, DOI 10.4082/kjfm.2014.35.1.28; Ligibel JA, 2013, J NATL COMPR CANC NE, V11, P640, DOI 10.6004/jnccn.2013.0191; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Ogle KS, 2000, CANCER, V88, P653, DOI 10.1002/(SICI)1097-0142(20000201)88:3<653::AID-CNCR24>3.0.CO;2-1; Oh K, 2007, KOREAN J EPIDEMIOL, V29, P139; Oh MG, 2013, JPN J CLIN ONCOL, V43, P981, DOI 10.1093/jjco/hyt118; Palli D, 2000, CANCER, V89, P1205, DOI 10.1002/1097-0142(20000915)89:6&lt;1205::AID-CNCR3&gt;3.0.CO;2-5; Park CL, 2008, J HEALTH PSYCHOL, V13, P1198, DOI 10.1177/1359105308095978; Patterson RE, 2003, J AM DIET ASSOC, V103, P323, DOI 10.1053/jada.2003.50045; Pearl J, 2009, STAT MED, V28, P1415, DOI 10.1002/sim.3521; Petrelli NJ, 2009, J CLIN ONCOL, V27, P6052, DOI 10.1200/JCO.2009.26.6171; Rausch SM, 2012, AM J CLIN ONCOL-CANC, V35, P22, DOI 10.1097/COC.0b013e318200598e; Ronksley P. E., 2011, BMJ-BRIT MED J, Vd671, P342; Seo HG, 2012, CANC FACTS FIGURES 2; Shadish W., 2001, EXPT QUASIEXPERIMENT; Shin DW, 2011, SUPPORT CARE CANCER, V19, P211, DOI 10.1007/s00520-009-0802-4; Shin DW, 2010, CANCER CAUSE CONTROL, V21, P919, DOI 10.1007/s10552-010-9521-x; Shin DW, 2013, PSYCHOONCOLOGY; Takachi R, 2010, AM J CLIN NUTR, V91, P456, DOI 10.3945/ajcn.2009.28587; Thoemmes F, 2012, PROPENSITY SCORE MTC; Underwood J. Michael, 2012, Morbidity and Mortality Weekly Report, V61, P1; Weaver KE, 2013, J CANCER SURVIV, V7, P253, DOI 10.1007/s11764-013-0267-9; Williams K, 2013, BRIT J CANCER, V108, P2407, DOI 10.1038/bjc.2013.254	39	3	3	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126927	10.1371/journal.pone.0126927	http://dx.doi.org/10.1371/journal.pone.0126927			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000609	gold, Green Published, Green Submitted			2022-12-26	WOS:000354931700035
J	Pan, WC; Yan, QG; Qin, MX; Jin, G; Sun, J; Ning, X; Zhuang, W; Peng, B; Li, G				Pan, Wencai; Yan, Qingguang; Qin, Mingxin; Jin, Gui; Sun, Jian; Ning, Xu; Zhuang, Wei; Peng, Bin; Li, Gen			Detection of Cerebral Hemorrhage in Rabbits by Time-Difference Magnetic Inductive Phase Shift Spectroscopy	PLOS ONE			English	Article							BRAIN EDEMA; INTRACEREBRAL HEMORRHAGE; TOMOGRAPHY	Cerebral hemorrhage, a difficult issue in clinical practice, is often detected and studied with computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET). However, these expensive devices are not readily available in economically underdeveloped regions, and hence are unable to provide bedside and emergency on-site monitoring. The magnetic inductive phase shift (MIPS) is an emerging technology that may become a new tool to detect cerebral hemorrhage and to serve as an inexpensive partial substitute to medical imaging. In order to study a wider band of cerebral hemorrhage MIPS and to provide more useful information for measuring cerebral hemorrhage, we established a cerebral hemorrhage magnetic induction phase shift spectroscopy (MIPSS) detection system. Thirteen rabbits with five cerebral hemorrhage states were studied using a single coil-coil within a 1 MHz-200 MHz frequency range in linear sweep. A feature band (FB) with the highest detection sensitivity and the greatest stability was selected for further analysis and processing. In addition, a maximum conductivity cerebrospinal fluid (CSF) MRI was performed to verify and interpret the MIPSS result. The average phase shift change induced by a 3 ml injection of autologous blood under FB was -7.7503 degrees +/- 1.4204 degrees, which was considerably larger than our previous work. Data analysis with a non-parametric statistical Friedman M test showed that in the FB, MIPSS could distinguish the five states of cerebral hemorrhage in rabbits, with a statistical significance of p < 0.05. A B-F distribution profile was designed according to the MIPSS under FB that can provide instantaneous diagnostic information about the cerebral hemorrhage severity from a single set of measurements. The results illustrate that the MIPSS detection method is able to provide a new possibility for real-time monitoring and diagnosis of the severity of cerebral hemorrhage.	[Pan, Wencai; Yan, Qingguang; Qin, Mingxin; Jin, Gui; Sun, Jian; Ning, Xu; Zhuang, Wei] Third Mil Med Univ, Coll Biomed Engn, Chongqing, Peoples R China; [Yan, Qingguang] Third Mil Med Univ, Surg Inst, Daping Hosp, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China; [Peng, Bin; Li, Gen] Chongqing Univ, Dept Biomed Engn, Chongqing 630044, Peoples R China	Army Medical University; Army Medical University; Chongqing University	Qin, MX (corresponding author), Third Mil Med Univ, Coll Biomed Engn, Chongqing, Peoples R China.	jellyhuang415@163.com	SUN, Jian/HGV-0337-2022	Gen, Li/0000-0002-4183-4242	National Natural Science Foundation of China [61372065]; Science and Technology Research Projects of Chongqing [cstc2012gg-yyjs10013]; Foundation of the Third Military Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research Projects of Chongqing; Foundation of the Third Military Medical University	This work was supported by the National Natural Science Foundation of China (61372065), the Science and Technology Research Projects of Chongqing (cstc2012gg-yyjs10013) and the Foundation of the Third Military Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, BRIT MED J, V313, P1448; [Anonymous], 1926, 3 CIRCULATION STUDIE; Gonzalez CA, 2007, P ANN INT IEEE EMBS, P2346, DOI 10.1109/IEMBS.2007.4352797; Gonzalez CA, 2007, IEEE T BIO-MED ENG, V54, P953, DOI 10.1109/TBME.2006.889183; Gonzalez CA, 2006, PHYSIOL MEAS, V27, P829, DOI 10.1088/0967-3334/27/9/006; Gonzalez CA, 2006, PHYSIOL MEAS, V27, P539, DOI 10.1088/0967-3334/27/6/007; Gonzalez CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063223; Griffiths H, 2001, MEAS SCI TECHNOL, V12, P1126, DOI 10.1088/0957-0233/12/8/319; Griffiths H, 1999, ANN NY ACAD SCI, V873, P335, DOI 10.1111/j.1749-6632.1999.tb09481.x; Grimnes S., 2008, BIOIMPEDANCE BIOELEC, V2nd ed, DOI [10.1016/B978-0-12-374004-5.X0001-3, DOI 10.1016/B978-0-12-374004-5.X0001-3]; Jiao M, 2008, BIOINF BIOM ENG 2008, P2345, DOI [10.1109/ICBBE.2008.919, DOI 10.1109/ICBBE.2008.919]; Jin G, 2011, COMMUNICATION SYSTEM, V4, P361, DOI [10.1007/978-3-642-21762-3_47, DOI 10.1007/978-3-642-21762-3_]; Jin G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097179; Jin G, 2014, BIOSENS BIOELECTRON, V52, P374, DOI 10.1016/j.bios.2013.09.019; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kidwell CS, 2004, JAMA-J AM MED ASSOC, V292, P1823, DOI 10.1001/jama.292.15.1823; Liang WW, 2008, INT CONF BIOMED, P638, DOI 10.1109/BMEI.2008.103; Lin Xu, 2011, 2011 4th International Congress on Image and Signal Processing (CISP 2011), P266, DOI 10.1109/CISP.2011.6099912; Liu RG, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/6/065402; Mingxin Qin, 2007, 2007 1st International Conference on Bioinformatics and Biomedical Engineering, P660; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P725, DOI 10.1001/archneur.1984.04050180047016; SCHURER L, 1988, ACTA NEUROCHIR, V94, P150, DOI 10.1007/BF01435869; Sun J, 2014, BRAZ J MED BIOL RES, V47, P144, DOI 10.1590/1414-431X20132978; Sun JF, 2012, ADV MECH ENG, DOI 10.1155/2012/427386; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Wang ZZ, 2005, NEUROSURGERY; Watson S, 2004, PHYSIOL MEAS, V25, P271, DOI 10.1088/0967-3334/25/1/031; YANG GY, 1994, J NEUROSURG, V81, P93, DOI 10.3171/jns.1994.81.1.0093; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zolgharni M, 2010, PHYSIOL MEAS, V31, pS111, DOI 10.1088/0967-3334/31/8/S09; Zolgharni M, 2009, PHYSIOL MEAS, V30, pS187, DOI 10.1088/0967-3334/30/6/S13	32	22	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0128127	10.1371/journal.pone.0128127	http://dx.doi.org/10.1371/journal.pone.0128127			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001112	Green Published, Green Submitted, gold			2022-12-26	WOS:000354931700104
J	Rato, C; Harris, DJ; Perera, A; Carvalho, SB; Carretero, MA; Rodder, D				Rato, Catarina; Harris, David James; Perera, Ana; Carvalho, Silvia B.; Carretero, Miguel A.; Roedder, Dennis			A Combination of Divergence and Conservatism in the Niche Evolution of the Moorish Gecko, Tarentola mauritanica (Gekkota: Phyllodactylidae)	PLOS ONE			English	Article							SPECIES DELIMITATION; MITOCHONDRIAL GENOME; CLIMATIC ZONATION; ECOLOGY; GEKKONIDAE; REPTILIA; SPECIATION; MODELS; POPULATION; DIVERSIFICATION	The quantification of realized niche overlap and the integration of species distribution models (SDMs) with calibrated phylogenies to study niche evolution are becoming not only powerful tools to understand speciation events, but can also be used as proxies regarding the delimitation of cryptic species. We applied these techniques in order to unravel how the fundamental niche evolved during cladogenesis within the Tarentola mauritanica species-complex. Our results suggest that diversification within this complex, during the Miocene and Pleistocene, is associated with both niche divergence and niche conservatism, with a pattern that varies depending on whether the variables involved are related to the mean or seasonality of temperature and humidity. Moreover, climatic variables related to humidity and temperature seasonality were involved in the niche shift and genetic diversification of the European/North African clade during the Pleistocene and in its maintenance in a fundamental niche distinct from that of the remaining members of the group. This study further highlights the need for a taxonomic revision of the T. mauritanica species-complex.	[Rato, Catarina; Harris, David James; Perera, Ana; Carvalho, Silvia B.; Carretero, Miguel A.] Univ Porto, InBIO, CIBIO Res Ctr Biodivers & Genet Resources, Vairao, Vila Do Conde, Portugal; [Roedder, Dennis] Zool Forsch Museum Alexander Koenig, Bonn, Germany	Universidade do Porto; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Rato, C (corresponding author), Univ Porto, InBIO, CIBIO Res Ctr Biodivers & Genet Resources, Campus Agr Vairao,Rua Padre Armando Quintas, Vairao, Vila Do Conde, Portugal.	catarina.rato@cibio.up.pt	Carvalho, Silvia B/J-3343-2013; Perera, Ana/I-3021-2012; Rato, Catarina CS/F-5784-2012; Perera, Ana/S-9399-2019; Carvalho, Silvia/AAE-9566-2020; Rödder, Dennis/AAT-8644-2021; Carretero, Miguel A/A-1472-2013	Carvalho, Silvia B/0000-0003-4368-4708; Perera, Ana/0000-0002-7466-4753; Rato, Catarina CS/0000-0002-8292-2433; Perera, Ana/0000-0002-7466-4753; Carvalho, Silvia/0000-0003-4368-4708; Rödder, Dennis/0000-0002-6108-1639; Carretero, Miguel A/0000-0002-2335-7198	Fundacao para a Ciencia e a Tecnologia (FCT) under the Programa Operacional Potencial Humano Quadro de Referencia Estrategico Nacional funds from the European Social Fund [IF/01257/2012]; Portuguese Ministerio da Educacao e Ciencia; Project "Genomics and EvolutionaryBiology"; North Portugal Regional Operational Programme under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF); FEDER funds through the Operational Programme for Competitiveness Factors - COMPETE; National Funds through FCT [PTDC/BIA-BEC/105327/2008, FCOMP-01-0124-FEDER-008970, PTDC/BIA-BIC/118624/2010, FCOMP-01-0124-FEDER-019676];  [SFRH/BPD/92343/2013];  [SFRH/BPD/74423/2010]	Fundacao para a Ciencia e a Tecnologia (FCT) under the Programa Operacional Potencial Humano Quadro de Referencia Estrategico Nacional funds from the European Social Fund; Portuguese Ministerio da Educacao e Ciencia(Portuguese Foundation for Science and Technology); Project "Genomics and EvolutionaryBiology"; North Portugal Regional Operational Programme under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF); FEDER funds through the Operational Programme for Competitiveness Factors - COMPETE; National Funds through FCT(Portuguese Foundation for Science and Technology); ; 	Both CR and SBC are funded through a Post-Doctoral grant (SFRH/BPD/92343/2013 and SFRH/BPD/74423/2010, respectively) and AP by an IF contract (IF/01257/2012) supported by the Fundacao para a Ciencia e a Tecnologia (FCT) under the Programa Operacional Potencial Humano Quadro de Referencia Estrategico Nacional funds from the European Social Fund and Portuguese Ministerio da Educacao e Ciencia. DJH was supported by the Project "Genomics and EvolutionaryBiology", co-financed by North Portugal Regional Operational Programme 2007/2013 (ON.2 - O Novo Norte), under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF). Research was funded by FEDER funds through the Operational Programme for Competitiveness Factors - COMPETE and by National Funds through FCT - under the projects PTDC/BIA-BEC/105327/2008 and FCOMP-01-0124-FEDER-008970 (to AP) and PTDC/BIA-BIC/118624/2010 and FCOMP-01-0124-FEDER-019676 (to SBC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080563; Ahmadzadeh F, 2013, J BIOGEOGR, V40, P1807, DOI 10.1111/jbi.12121; Arnold EN, 2002, FIELD GUIDE REPTILES, P272; Beukema W, 2010, BIOL J LINN SOC, V101, P626, DOI 10.1111/j.1095-8312.2010.01506.x; Blain Hugues-Alexandre, 2006, Treballs del Museu de Geologia de Barcelona, V14, P61; Bowman A, 2010, SM SMOOTHING METHODS; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Carranza S, 2002, MOL PHYLOGENET EVOL, V23, P244, DOI 10.1016/S1055-7903(02)00024-6; Carranza S, 2000, P ROY SOC B-BIOL SCI, V267, P637, DOI 10.1098/rspb.2000.1050; Cleugh HA, 2007, REMOTE SENS ENVIRON, V106, P285, DOI 10.1016/j.rse.2006.07.007; Costa GC, 2008, J BIOGEOGR, V35, P637, DOI 10.1111/j.1365-2699.2007.01809.x; Coyne J.A., 2004, SPECIATION; Cunningham CW, 1998, TRENDS ECOL EVOL, V13, P361, DOI 10.1016/S0169-5347(98)01382-2; Cadena CD, 2012, P ROY SOC B-BIOL SCI, V279, P194, DOI 10.1098/rspb.2011.0720; Donoghue MJ, 1996, PHILOS T R SOC B, V351, P1241, DOI 10.1098/rstb.1996.0107; Downes S, 2002, ANIM BEHAV, V63, P1037, DOI 10.1006/anbe.2002.3022; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duggen S, 2003, NATURE, V422, P602, DOI 10.1038/nature01553; Evans MEK, 2009, AM NAT, V173, P225, DOI 10.1086/595757; Funk Daniel J., 2009, P195; Godsoe W, 2012, ECOGRAPHY, V35, P769, DOI 10.1111/j.1600-0587.2012.07456.x; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Harris DJ, 2009, NORTH-WEST J ZOOL, V5, P197; Harris DJ, 2004, AMPHIBIA-REPTILIA, V25, P451; Harris DJ, 2004, MOL PHYLOGENET EVOL, V30, P855, DOI 10.1016/S1055-7903(03)00260-4; Heibl C., 2012, PHYLOCLIM INTEGRATIN; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans RJ, 2012, DISMO SEPCIES DISTRI; Hijmans RJ., 2012, RASTER GEOGRAPHIC AN; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hof C, 2011, GLOBAL CHANGE BIOL, V17, P2987, DOI 10.1111/j.1365-2486.2011.02418.x; Hof C, 2010, ECOGRAPHY, V33, P242, DOI 10.1111/j.1600-0587.2010.06309.x; HSU KJ, 1974, NATURWISSENSCHAFTEN, V61, P137; Hua X, 2013, AM NAT, V182, P1, DOI 10.1086/670690; Huete AR, 1997, REMOTE SENS ENVIRON, V59, P440, DOI 10.1016/S0034-4257(96)00112-5; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jakob SS, 2010, MOL ECOL, V19, P1423, DOI 10.1111/j.1365-294X.2010.04582.x; Jimenez-Moreno G, 2010, REV PALAEOBOT PALYNO, V162, P403, DOI 10.1016/j.revpalbo.2009.08.001; Juan C, 2000, TRENDS ECOL EVOL, V15, P104, DOI 10.1016/S0169-5347(99)01776-0; Kozak KH, 2007, P ROY SOC B-BIOL SCI, V274, P2995, DOI 10.1098/rspb.2007.1106; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Lisicic D, 2012, ECOL RES, V27, P551, DOI 10.1007/s11284-011-0921-5; Luo YJ, 2008, MITOCHONDRION, V8, P352, DOI 10.1016/j.mito.2008.07.005; MANI GS, 1990, PROC R SOC SER B-BIO, V240, P29, DOI 10.1098/rspb.1990.0025; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; McCormack JE, 2010, EVOLUTION, V64, P1231, DOI 10.1111/j.1558-5646.2009.00900.x; Meco J, 2007, GLOBAL PLANET CHANGE, V57, P222, DOI 10.1016/j.gloplacha.2006.11.040; Nix H.A., 1986, ATLAS ELAPID SNAKES, P4; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Perera A, 2008, AMPHIBIA-REPTILIA, V29, P583, DOI 10.1163/156853808786230352; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Rato C, 2013, GENE, V512, P166, DOI 10.1016/j.gene.2012.09.032; Rato C, 2010, MOL PHYLOGENET EVOL, V56, P962, DOI 10.1016/j.ympev.2010.04.033; Rato C, PHYSL BIOCH ZOOL; Rato C, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-14; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Rodder D, 2011, GLOBAL ECOL BIOGEOGR, V20, P915, DOI 10.1111/j.1466-8238.2011.00659.x; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Sanchez-Fernandez D, 2011, BIOL J LINN SOC, V103, P891, DOI 10.1111/j.1095-8312.2011.01668.x; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D, 2009, P NATL ACAD SCI USA, V106, P9955, DOI 10.1073/pnas.0901264106; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Smith SA, 2010, SYST BIOL, V59, P322, DOI 10.1093/sysbio/syq011; Stanner D, 1995, EUROPES ENV DOBRIS A, P616; Stockman AK, 2007, MOL ECOL, V16, P3374, DOI 10.1111/j.1365-294X.2007.03389.x; Sun YB, 2011, MOL BIOL EVOL, V28, P39, DOI 10.1093/molbev/msq256; Thorpe RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000929; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Wielstra B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095504; Wielstra B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046671; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wooten JA, 2013, CAN J ZOOL, V91, P883, DOI 10.1139/cjz-2013-0097; Yu L, 2011, MITOCHONDRION, V11, P497, DOI 10.1016/j.mito.2011.01.004	88	31	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127980	10.1371/journal.pone.0127980	http://dx.doi.org/10.1371/journal.pone.0127980			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000981	Green Submitted, gold, Green Published			2022-12-26	WOS:000354931700095
J	Abeni, F; Petrera, F; Capelletti, M; Dal Pra, A; Bontempo, L; Tonon, A; Camin, F				Abeni, Fabio; Petrera, Francesca; Capelletti, Maurizio; Dal Pra, Aldo; Bontempo, Luana; Tonon, Agostino; Camin, Federica			Hydrogen and Oxygen Stable Isotope Fractionation in Body Fluid Compartments of Dairy Cattle According to Season, Farm, Breed, and Reproductive Stage	PLOS ONE			English	Article							HEAT-STRESS; WATER; COWS; TEMPERATURE; MILK; QUALITY; RATIOS; CARBON; DRY	Environmental temperature affects water turnover and isotope fractionation by causing water evaporation from the body in mammals. This may lead to rearrangement of the water stable isotope equilibrium in body fluids. We propose an approach to detect possible variations in the isotope ratio in different body fluids on the basis of different homoeothermic adaptations in varying reproductive stages. Three different reproductive stages (pregnant heifer, primiparous lactating cow, and pluriparous lactating cow) of two dairy cattle breeds (Italian Friesian and Modenese) were studied in winter and summer. Blood plasma, urine, faecal water, and milk were sampled and the isotope ratios of H (H-2/H-1) and O (O-18/O-16) were determined. Deuterium excess and isotope-fractionation factors were calculated for each passage from plasma to faeces, urine and milk. The effects of the season, reproductive stages and breed on delta H-2 and delta O-18 were significant in all the fluids, with few exceptions. Deuterium excess was affected by season in all the analysed fluids. The correlations between water isotope measurements in bovine body fluids ranged between 0.6936 (urine-milk) and 0.7848 (urine-plasma) for delta H-2, and between 0.8705 (urine-milk) and 0.9602 (plasma-milk) for delta O-18. The increase in both isotopic delta values in all body fluids during summer is representative of a condition in which fractionation took place as a consequence of a different ratio between ingested and excreted water, which leads to an increased presence of the heavy isotopes. The different body water turnover between adult lactating cattle and non-lactating heifers was confirmed by the higher isotopic d for the latter, with a shift in the isotopic equilibrium towards values more distant from those of drinking water.	[Abeni, Fabio; Petrera, Francesca; Capelletti, Maurizio; Dal Pra, Aldo] Ctr Ric Prod Foraggere & Lattiero Casearie, Consiglio Ric Sperimentazione Agr, I-26100 Cremona, Italy; [Bontempo, Luana; Tonon, Agostino; Camin, Federica] Fdn Edmund Mach, Ctr Ric Ist Agrario San Michele allAdige, Dipartimento Qualita Alimentare Nutr, I-38010 San Michele All Adige, TN, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Fondazione Edmund Mach	Abeni, F (corresponding author), Ctr Ric Prod Foraggere & Lattiero Casearie, Consiglio Ric Sperimentazione Agr, Via Porcellasco 7, I-26100 Cremona, Italy.	fabiopalmiro.abeni@entecra.it	Bontempo, Luana/B-7777-2011; PETRERA, FRANCESCA/AAY-3309-2020	Bontempo, Luana/0000-0001-7583-1501; PETRERA, FRANCESCA/0000-0003-3066-7618; Camin, Federica/0000-0003-0509-6745; Dal Pra, Aldo/0000-0002-8882-5650	Italian Ministry of Agricultural, Food and Forestry Policy; "Accordo di Programma FEM" (Fondazione Edmund Mach)	Italian Ministry of Agricultural, Food and Forestry Policy; "Accordo di Programma FEM" (Fondazione Edmund Mach)	This research was supported by the "Improvement of Italian livestock through the use of innovative biotechnologies: functional genomics, transcriptomics and proteomics (GENZOOT)" programme, funded by the Italian Ministry of Agricultural, Food and Forestry Policy (coordinator B. Moioli) and by "Accordo di Programma FEM" (Fondazione Edmund Mach). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abeni F, 2007, INT J BIOMETEOROL, V52, P87, DOI 10.1007/s00484-007-0098-3; Auerswald K, 2011, RAPID COMMUN MASS SP, V25, P3741, DOI 10.1002/rcm.5284; Beauchemin KA, 2008, J DAIRY SCI, V91, P2077, DOI 10.3168/jds.2007-0726; Berman A, 2006, J DAIRY SCI, V89, P3817, DOI 10.3168/jds.S0022-0302(06)72423-7; Bontempo L, 2012, INT DAIRY J, V23, P99, DOI 10.1016/j.idairyj.2011.10.005; BRYANT JD, 1995, GEOCHIM COSMOCHIM AC, V59, P4523; Camin F, 2008, RAPID COMMUN MASS SP, V22, P1690, DOI 10.1002/rcm.3506; Camin F, 2012, ANAL CHIM ACTA, V711, P54, DOI 10.1016/j.aca.2011.10.047; Chesson LA, 2010, J AGR FOOD CHEM, V58, P2358, DOI 10.1021/jf904151c; D'Ambrosia AR, 2014, PALAEOGEOGR PALAEOCL, V414, P310, DOI 10.1016/j.palaeo.2014.09.014; DANSGAARD W, 1964, TELLUS, V16, P436; Dikmen S, 2009, J DAIRY SCI, V92, P109, DOI 10.3168/jds.2008-1370; EPSTEIN S, 1953, GEOCHIM COSMOCHIM AC, V4, P213, DOI 10.1016/0016-7037(53)90051-9; European Commission, 2010, OFFICIAL JOURNAL OF, V276, P33; FINCH VA, 1986, J ANIM SCI, V62, P531, DOI 10.2527/jas1986.622531x; Fry B., 2006, STABLE ISOTOPE ECOLO; HOLTER JB, 1992, J DAIRY SCI, V75, P1472, DOI 10.3168/jds.S0022-0302(92)77904-1; Kadzere CT, 2002, LIVEST PROD SCI, V77, P59, DOI 10.1016/S0301-6226(01)00330-X; Khelil-Arfa H, 2014, J DAIRY SCI, V97, P2305, DOI 10.3168/jds.2013-7079; Kornexl BE, 1997, Z LEBENSM UNTERS F A, V205, P19, DOI 10.1007/s002170050117; Kuo TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032137; Mader TL, 2006, J ANIM SCI, V84, P712, DOI 10.2527/2006.843712x; MCDOWELL RE, 1969, J DAIRY SCI, V52, P188, DOI 10.3168/jds.S0022-0302(69)86528-8; MURPHY MR, 1992, J DAIRY SCI, V75, P326, DOI 10.3168/jds.S0022-0302(92)77768-6; MURPHY MR, 1983, J DAIRY SCI, V66, P35, DOI 10.3168/jds.S0022-0302(83)81750-0; National Research Council, 2001, NUTRIENT REQUIREMENT; O'Grady SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011699; ODWONGO WO, 1985, J DAIRY SCI, V68, P1155, DOI 10.3168/jds.S0022-0302(85)80942-5; OLSSON K, 1995, COMP BIOCHEM PHYS A, V110, P309, DOI 10.1016/0300-9629(94)00186-W; Osborne VR, 2006, ADV DAIRY TECHNOL, V18, P197; Petrera F, 2015, J ANIM PHYSIOL AN N, V99, P962, DOI 10.1111/jpn.12270; Podlesak DW, 2008, GEOCHIM COSMOCHIM AC, V72, P19, DOI 10.1016/j.gca.2007.10.003; RICHARDS JI, 1985, TROP ANIM HEALTH PRO, V17, P209, DOI 10.1007/BF02356978; SILANIKOVE N, 1992, LIVEST PROD SCI, V30, P175, DOI 10.1016/S0301-6226(06)80009-6; Silanikove N, 2000, LIVEST PROD SCI, V67, P1, DOI 10.1016/S0301-6226(00)00162-7; West JW, 2003, J DAIRY SCI, V86, P2131, DOI 10.3168/jds.S0022-0302(03)73803-X; WONG WW, 1988, AM J CLIN NUTR, V47, P1; WOODFORD ST, 1984, J DAIRY SCI, V67, P2336, DOI 10.3168/jds.S0022-0302(84)81582-9	38	20	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127391	10.1371/journal.pone.0127391	http://dx.doi.org/10.1371/journal.pone.0127391			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996911	gold, Green Published, Green Submitted			2022-12-26	WOS:000356444000061
J	Farcal, L; Andon, FT; Di Cristo, L; Rotoli, BM; Bussolati, O; Bergamaschi, E; Mech, A; Hartmann, NB; Rasmussen, K; Riego-Sintes, J; Ponti, J; Kinsner-Ovaskainen, A; Rossi, F; Oomen, A; Bos, P; Chen, R; Bai, R; Chen, CY; Rocks, L; Fulton, N; Ross, B; Hutchison, G; Tran, L; Mues, S; Ossig, R; Schnekenburger, J; Campagnolo, L; Vecchione, L; Pietroiusti, A; Fadeel, B				Farcal, Lucian; Andon, Fernando Torres; Di Cristo, Luisana; Rotoli, Bianca Maria; Bussolati, Ovidio; Bergamaschi, Enrico; Mech, Agnieszka; Hartmann, Nanna B.; Rasmussen, Kirsten; Riego-Sintes, Juan; Ponti, Jessica; Kinsner-Ovaskainen, Agnieszka; Rossi, Francois; Oomen, Agnes; Bos, Peter; Chen, Rui; Bai, Ru; Chen, Chunying; Rocks, Louise; Fulton, Norma; Ross, Bryony; Hutchison, Gary; Tran, Lang; Mues, Sarah; Ossig, Rainer; Schnekenburger, Juergen; Campagnolo, Luisa; Vecchione, Lucia; Pietroiusti, Antonio; Fadeel, Bengt			Comprehensive In Vitro Toxicity Testing of a Panel of Representative Oxide Nanomaterials: First Steps towards an Intelligent Testing Strategy	PLOS ONE			English	Article							ENGINEERED NANOMATERIALS; NANOPARTICLE UPTAKE; HUMAN HEALTH; CYTOTOXICITY; NANO; CONTAMINATION; VALIDATION; CELLS; ASSAY	Nanomaterials (NMs) display many unique and useful physico-chemical properties. However, reliable approaches are needed for risk assessment of NMs. The present study was performed in the FP7-MARINA project, with the objective to identify and evaluate in vitro test methods for toxicity assessment in order to facilitate the development of an intelligent testing strategy (ITS). Six representative oxide NMs provided by the EC-JRC Nanomaterials Repository were tested in nine laboratories. The in vitro toxicity of NMs was evaluated in 12 cellular models representing 6 different target organs/systems (immune system, respiratory system, gastrointestinal system, reproductive organs, kidney and embryonic tissues). The toxicity assessment was conducted using 10 different assays for cytotoxicity, embryotoxicity, epithelial integrity, cytokine secretion and oxidative stress. Thorough physico-chemical characterization was performed for all tested NMs. Commercially relevant NMs with different physico-chemical properties were selected: two TiO2 NMs with different surface chemistry -hydrophilic (NM-103) and hydrophobic (NM-104), two forms of ZnO - uncoated (NM-110) and coated with triethoxycapryl silane (NM-111) and two SiO2 NMs produced by two different manufacturing techniques - precipitated (NM-200) and pyrogenic (NM-203). Cell specific toxicity effects of all NMs were observed; macrophages were the most sensitive cell type after short-term exposures (24-72h) (ZnO>SiO2>TiO2). Longer term exposure (7 to 21 days) significantly affected the cell barrier integrity in the presence of ZnO, but not TiO2 and SiO2, while the embryonic stem cell test (EST) classified the TiO2 NMs as potentially 'weak-embryotoxic' and ZnO and SiO2 NMs as 'non-embryotoxic'. A hazard ranking could be established for the representative NMs tested (ZnO NM-110 > ZnO NM-111 > SiO2 NM-203 > SiO2 NM-200 > TiO2 NM-104 > TiO2 NM-103). This ranking was different in the case of embryonic tissues, for which TiO2 displayed higher toxicity compared with ZnO and SiO2. Importantly, the in vitro methodology applied could identify cell-and NM-specific responses, with a low variability observed between different test assays. Overall, this testing approach, based on a battery of cellular systems and test assays, complemented by an exhaustive physico-chemical characterization of NMs, could be deployed for the development of an ITS suitable for risk assessment of NMs. This study also provides a rich source of data for modeling of NM effects.	[Farcal, Lucian; Andon, Fernando Torres; Fadeel, Bengt] Karolinska Inst, Inst Environm Med, Div Mol Toxicol, S-10401 Stockholm, Sweden; [Di Cristo, Luisana; Bergamaschi, Enrico] Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy; [Rotoli, Bianca Maria; Bussolati, Ovidio] Univ Parma, Dept Biomed Biotechnol & Translat Sci, Parma, Italy; [Mech, Agnieszka; Hartmann, Nanna B.; Rasmussen, Kirsten; Riego-Sintes, Juan; Ponti, Jessica; Kinsner-Ovaskainen, Agnieszka; Rossi, Francois] European Commiss Joint Res Ctr, Inst Hlth & Consumer Protect, Nanobiosci Unit, Ispra, Italy; [Hartmann, Nanna B.] Tech Univ Denmark, Kongens Lyngby, Denmark; [Oomen, Agnes; Bos, Peter] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Chen, Rui; Bai, Ru; Chen, Chunying] Chinese Acad Sci, Natl Ctr Nanosci & Technol China, Key Lab Biomed Effects Nanomat & Nanosafety, Beijing, Peoples R China; [Rocks, Louise] Univ Coll Dublin, Sch Chem & Chem Biol, Ctr BioNano Interact, Dublin 2, Ireland; [Fulton, Norma; Ross, Bryony; Hutchison, Gary] Edinburgh Napier Univ, Ctr Nano Safety, Edinburgh, Midlothian, Scotland; [Ross, Bryony; Tran, Lang] Inst Occupat Med, Edinburgh EH8 9SV, Midlothian, Scotland; [Mues, Sarah; Ossig, Rainer; Schnekenburger, Juergen] Univ Munster, Biomed Technol Zentrum, Munster, Germany; [Campagnolo, Luisa; Vecchione, Lucia; Pietroiusti, Antonio] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy	Karolinska Institutet; University of Parma; University Hospital of Parma; University of Parma; European Commission Joint Research Centre; EC JRC ISPRA Site; Technical University of Denmark; Netherlands National Institute for Public Health & the Environment; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; University College Dublin; Edinburgh Napier University; University of Munster; University of Rome Tor Vergata	Fadeel, B (corresponding author), Karolinska Inst, Inst Environm Med, Div Mol Toxicol, S-10401 Stockholm, Sweden.	bengt.fadeel@ki.se	Chen, Rui/AAD-6700-2019; Bussolati, Ovidio/B-7589-2013; Chen, Rui/D-4733-2017; Chen, Chunying/AAA-2891-2021; Hartmann, Nanna B./AAB-5093-2022; FT, Andón/D-5184-2009; BAI, Ru/Y-8577-2018; Hartmann, Nanna B./A-1678-2009; Campagnolo, Luisa/K-3520-2018; Farcal, Lucian/B-7339-2011	Chen, Rui/0000-0002-6488-6133; Bussolati, Ovidio/0000-0002-4301-2939; Chen, Rui/0000-0002-6488-6133; Chen, Chunying/0000-0002-6027-0315; Hartmann, Nanna B./0000-0002-0442-245X; FT, Andón/0000-0001-9235-1278; BAI, Ru/0000-0001-7312-7086; Hartmann, Nanna B./0000-0002-0442-245X; Campagnolo, Luisa/0000-0003-3928-0276; PIETROIUSTI, Antonio/0000-0002-4056-1801; Farcal, Lucian/0000-0001-5773-2024; Ponti, Jessica/0000-0002-4961-8405; SFItest, Louise/0000-0002-5504-0582; Oomen, Agnes/0000-0002-7754-8643; Rocks, Louise/0000-0002-1870-4212; Schnekenburger, Juergen/0000-0002-0199-2908; Rasmussen, Kirsten/0000-0002-7254-3325	European Commission [263215]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The study was supported by the European Commission Seventh Framework Programme Project FP7-MARINA (Grant No. 263215; www.marina-fp7.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, EP7 NANOMMUNE QUALIT; [Anonymous], 2014, COMPENDIUM PROJECTS; [Anonymous], 2011, NANOGENOTOX FINAL PR; Aschberger K, 2011, ENVIRON INT, V37, P1143, DOI 10.1016/j.envint.2011.02.005; Buerki-Thurnherr T, 2013, NANOTOXICOLOGY, V7, P402, DOI 10.3109/17435390.2012.666575; Cho WS, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-55; Cohen JM, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-20; Fadeel B, 2013, NAT NANOTECHNOL, V8, P71, DOI 10.1038/nnano.2013.2; Genschow E, 2004, ATLA-ALTERN LAB ANIM, V32, P209, DOI 10.1177/026119290403200305; Guadagnini R, 2013, NANOTOXICOLOGY; Han XL, 2011, TOXICOLOGY, V287, P99, DOI 10.1016/j.tox.2011.06.011; Hartung T, 2011, WILEY INTERDISCIP RE; Hirsch C, 2011, NANOMEDICINE-UK, V6, P837, DOI [10.2217/nnm.11.88, 10.2217/NNM.11.88]; Hole P, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-2101-8; Johnston HJ, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-33; Karlsson H.L., 2014, HDB TOXICOLOGY METAL, P75; Kroll A, 2012, ARCH TOXICOL, V86, P1123, DOI 10.1007/s00204-012-0837-z; Kroll A, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-9; Krug HF, 2011, ANGEW CHEM INT EDIT, V50, P1260, DOI 10.1002/anie.201001037; Lesniak A, 2013, J AM CHEM SOC, V135, P1438, DOI 10.1021/ja309812z; Lesniak A, 2012, ACS NANO, V6, P5845, DOI 10.1021/nn300223w; Love SA, 2012, ANNU REV ANAL CHEM, V5, P181, DOI 10.1146/annurev-anchem-062011-143134; Manke A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/942916; MATHER JP, 1980, BIOL REPROD, V23, P243, DOI 10.1095/biolreprod23.1.243; Monteiro-Riviere NA, 2009, TOXICOL APPL PHARM, V234, P222, DOI 10.1016/j.taap.2008.09.030; Napierska D, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-39; Nel AE, 2013, J INTERN MED; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Neun BW, 2011, METHODS MOL BIOL, V697, P121, DOI 10.1007/978-1-60327-198-1_12; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Oberdorster G, 2010, J INTERN MED, V267, P89, DOI 10.1111/j.1365-2796.2009.02187.x; OECD, 2009, ENVJMMONO200920REV O; Olmedo DG, 2008, J BIOMED MATER RES A, V84A, P1087, DOI 10.1002/jbm.a.31514; Park MVDZ, 2009, TOXICOL APPL PHARM, V240, P108, DOI 10.1016/j.taap.2009.07.019; Pietroiusti A, 2011, ACS NANO, V5, P4624, DOI 10.1021/nn200372g; Pizzolon J.P., 2013, JRS SCI POLICY REPOR; Rasmussen JW, 2010, EXPERT OPIN DRUG DEL, V7, P1063, DOI 10.1517/17425247.2010.502560; Rasmussen K., 2014, JRC SCI POLICY REPOR, DOI 10.2788/79554; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Roebben G, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1455-2; Savolainen K, 2013, NANOSAFETY EUROPE 20, DOI [10.3389/ fphar. 2015.00055, DOI 10.3389/FPHAR.2015.00055]; Scholz G, 1999, CELLS TISSUES ORGANS, V165, P203, DOI 10.1159/000016700; Schrurs F, 2012, NAT NANOTECHNOL, V7, P546, DOI 10.1038/nnano.2012.148; Shi JW, 2012, ACS NANO, V6, P1925, DOI 10.1021/nn2021056; Singh C., 2011, EUR SCI TECHNICAL RE; Smulders S, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-41; Stone V, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-9; Tuomela S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068415; US Pharmacopeia, 2011, US PHARMACOPEIA TRAN; Vermeire T, 2013, REGUL TOXICOL PHARM, V67, P136, DOI 10.1016/j.yrtph.2013.01.007; Winkler DA, 2013, TOXICOLOGY, V313, P15, DOI 10.1016/j.tox.2012.11.005; Xia T, 2013, ENVIRON HEALTH PERSP, V121, P683, DOI 10.1289/ehp.1306561; Yin H, 2010, LANGMUIR, V26, P15399, DOI 10.1021/la101033n; Zhang JY, 2013, TOXICOL IND HEALTH, V29, P523, DOI 10.1177/0748233712442708	54	116	119	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127174	10.1371/journal.pone.0127174	http://dx.doi.org/10.1371/journal.pone.0127174			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996496	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000047
J	Noda, S; Shirai, T; Mochida, K; Matsuda, F; Oyama, S; Okamoto, M; Kondo, A				Noda, Shuhei; Shirai, Tomokazu; Mochida, Keiichi; Matsuda, Fumio; Oyama, Sachiko; Okamoto, Mami; Kondo, Akihiko			Evaluation of Brachypodium distachyon L-Tyrosine Decarboxylase Using L-Tyrosine Over-Producing Saccharomyces cerevisiae	PLOS ONE			English	Article							TERT-BUTYLDIMETHYLSILYL DERIVATIVES; GAS-LIQUID-CHROMATOGRAPHY; ARABIDOPSIS-THALIANA; ESCHERICHIA-COLI; AMINO-ACIDS; EXPRESSION; GENES; YEAST; BIOSYNTHESIS; PRECURSOR	To demonstrate that herbaceous biomass is a versatile gene resource, we focused on the model plant Brachypodium distachyon, and screened the B. distachyon for homologs of tyrosine decarboxylase (TDC), which is involved in the modification of aromatic compounds. A total of 5 candidate genes were identified in cDNA libraries of B. distachyon and were introduced into Saccharomyces cerevisiae to evaluate TDC expression and tyramine production. It is suggested that two TDCs encoded in the transcripts Bradi2g51120.1 and Bradi2g51170.1 have L-tyrosine decarboxylation activity. Bradi2g51170.1 was introduced into the L-tyrosine over-producing strain of S. cerevisiae that was constructed by the introduction of mutant genes that promote deregulated feedback inhibition. The amount of tyramine produced by the resulting transformant was 6.6-fold higher (approximately 200 mg/L) than the control strain, indicating that B. distachyon TDC effectively converts L-tyrosine to tyramine. Our results suggest that B. distachyon possesses enzymes that are capable of modifying aromatic residues, and that S. cerevisiae is a suitable host for the production of L-tyrosine derivatives.	[Noda, Shuhei; Shirai, Tomokazu; Mochida, Keiichi; Matsuda, Fumio; Oyama, Sachiko; Okamoto, Mami; Kondo, Akihiko] RIKEN, Biomass Engn Program, Yokohama, Kanagawa, Japan; [Matsuda, Fumio] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka, Japan; [Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Kobe, Hyogo 657, Japan	RIKEN; Osaka University; Kobe University	Kondo, A (corresponding author), RIKEN, Biomass Engn Program, Yokohama, Kanagawa, Japan.	akihiko.kondo@riken.jp	Mochida, Keiichi/N-9052-2014; Kondo, Akihiko/A-2130-2015; Noda, Shuhei/D-4815-2017; Mochida, Keiichi/T-2866-2019; Shirai, Tomokazu/C-7986-2017	Mochida, Keiichi/0000-0003-1299-0024; Mochida, Keiichi/0000-0003-1299-0024; 	RIKEN Biomass Engineering Program	RIKEN Biomass Engineering Program	The authors were supported by the RIKEN Biomass Engineering Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chen H, 2007, PHYTOCHEMISTRY, V68, P306, DOI 10.1016/j.phytochem.2006.10.018; Chen Y, 2014, METAB ENG, V22, P104, DOI 10.1016/j.ymben.2014.01.005; Davin LB, 2005, CURR OPIN BIOTECH, V16, P407, DOI 10.1016/j.copbio.2005.06.011; Gosset G, 2009, CURR OPIN BIOTECH, V20, P651, DOI 10.1016/j.copbio.2009.09.012; Gray J, 2012, PLANT SCI, V184, P112, DOI 10.1016/j.plantsci.2011.12.008; Helmstaedt K, 2005, P NATL ACAD SCI USA, V102, P9784, DOI 10.1073/pnas.0504238102; Ishii J, 2009, J BIOCHEM, V145, P701, DOI 10.1093/jb/mvp028; Jiang HX, 2005, APPL ENVIRON MICROB, V71, P2962, DOI 10.1128/AEM.71.6.2962-2969.2005; Karkonen A, 2010, J INTEGR PLANT BIOL, V52, P176, DOI 10.1111/j.1744-7909.2010.00913.x; Kim B, 2014, BIOTECHNOL BIOENG, V111, P115, DOI 10.1002/bit.24993; Kirby J, 2008, FEBS J, V275, P1852, DOI 10.1111/j.1742-4658.2008.06343.x; Koma D, 2012, APPL MICROBIOL BIOT, V93, P815, DOI 10.1007/s00253-011-3735-z; Koopman F, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-155; Kutchan TM, 1996, GENE, V179, P73, DOI 10.1016/S0378-1119(96)00426-X; Lan XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075459; Lehmann T, 2009, FEBS LETT, V583, P1895, DOI 10.1016/j.febslet.2009.05.017; Luttik MAH, 2008, METAB ENG, V10, P141, DOI 10.1016/j.ymben.2008.02.002; MACKENZIE SL, 1987, J CHROMATOGR, V387, P241, DOI 10.1016/S0021-9673(01)94528-5; MAWHINNEY TP, 1986, J CHROMATOGR, V358, P231, DOI 10.1016/S0021-9673(01)90333-4; Minami H, 2008, P NATL ACAD SCI USA, V105, P7393, DOI 10.1073/pnas.0802981105; Mochida K, 2013, PLANT CELL PHYSIOL, V54, P1931, DOI 10.1093/pcp/pct163; Mochida K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075265; Olsen KM, 2008, J PLANT PHYSIOL, V165, P1491, DOI 10.1016/j.jplph.2007.11.005; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; Stephanopoulos G, 1998, METABOLIC ENG PRINCI, P68; Vannelli T, 2007, METAB ENG, V9, P142, DOI 10.1016/j.ymben.2006.11.001; VERDUYN C, 1990, J GEN MICROBIOL, V136, P405, DOI 10.1099/00221287-136-3-405; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; WANNER LA, 1995, PLANT MOL BIOL, V27, P327, DOI 10.1007/BF00020187; Westfall PJ, 2012, P NATL ACAD SCI USA, V109, P111, DOI 10.1073/pnas.1110740109; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Yamada R, 2010, APPL MICROBIOL BIOT, V85, P1491, DOI 10.1007/s00253-009-2198-y; Yazaki K, 2009, PHYTOCHEMISTRY, V70, P1739, DOI 10.1016/j.phytochem.2009.08.023	34	1	1	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0125488	10.1371/journal.pone.0125488	http://dx.doi.org/10.1371/journal.pone.0125488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996877	Green Submitted, Green Published, gold			2022-12-26	WOS:000356444000010
J	Otero-Rodino, C; Libran-Perez, M; Velasco, C; Lopez-Patino, MA; Miguez, JM; Soengas, JL				Otero-Rodino, Cristina; Libran-Perez, Marta; Velasco, Cristina; Lopez-Patino, Marcos A.; Miguez, Jesus M.; Soengas, Jose L.			Evidence for the Presence of Glucosensor Mechanisms Not Dependent on Glucokinase in Hypothalamus and Hindbrain of Rainbow Trout (Oncorhynchus mykiss)	PLOS ONE			English	Article							LIVER X RECEPTOR; FOOD-INTAKE; BROCKMANN BODIES; GENE-EXPRESSION; SENSING APPARATUS; PROTEIN-KINASE; IN-VIVO; METABOLISM; FISH; CAPACITY	We hypothesize that glucosensor mechanisms other than that mediated by glucokinase (GK) operate in hypothalamus and hindbrain of the carnivorous fish species rainbow trout and stress affected them. Therefore, we evaluated in these areas changes in parameters which could be related to putative glucosensor mechanisms based on liver X receptor (LXR), mitochondrial activity, sweet taste receptor, and sodium/glucose co-transporter 1 (SGLT-1) 6h after intraperitoneal injection of 5 mL.Kg(-1) of saline solution alone (normoglycaemic treatment) or containing insulin (hypoglycaemic treatment, 4 mg bovine insulin.Kg(-1) body mass), or D-glucose (hyperglycaemic treatment, 500 mg.Kg(-1) body mass). Half of tanks were kept at a 10 Kg fish mass.m(-3) and denoted as fish under normal stocking density (NSD) whereas the remaining tanks were kept at a stressful high stocking density (70 kg fish mass.m(-3)) denoted as HSD. The results obtained in non-stressed rainbow trout provide evidence, for the first time in fish, that manipulation of glucose levels induce changes in parameters which could be related to putative glucosensor systems based on LXR, mitochondrial activity and sweet taste receptor in hypothalamus, and a system based on SGLT-1 in hindbrain. Stress altered the response of parameters related to these systems to changes in glycaemia.	[Otero-Rodino, Cristina; Libran-Perez, Marta; Velasco, Cristina; Lopez-Patino, Marcos A.; Miguez, Jesus M.; Soengas, Jose L.] Univ Vigo, Fac Biol, Dept Biol Func & Ciencias, Lab Fisiol Anim, Vigo 36310, Spain	Universidade de Vigo	Soengas, JL (corresponding author), Univ Vigo, Fac Biol, Dept Biol Func & Ciencias, Lab Fisiol Anim, Vigo 36310, Spain.	jsoengas@uvigo.es	Soengas, José L/M-1898-2014; Velasco, Cristina/AAE-4604-2021; Miguez, J.M./M-3705-2014	Soengas, José L/0000-0002-6847-3993; Miguez, J.M./0000-0002-3474-2139; Velasco Rubial, Cristina/0000-0001-7440-8998; Lopez-Patino, Marcos A./0000-0002-1038-7419	European Fund for Regional Development (FEDER) [AGL2013-46448-C3-1-R]; Ministerio de Economia y Competitividad [BES-2011-043394, BES-2014-068040]	European Fund for Regional Development (FEDER)(European Commission); Ministerio de Economia y Competitividad(Spanish Government)	This study was supported by a research grant from Ministerio de Economia y Competitividad and European Fund for Regional Development (AGL2013-46448-C3-1-R and FEDER) to JLS; predoctoral fellowship from Ministerio de Economia y Competitividad (BES-2011-043394) to MLP; predoctoral fellowship from Ministerio de Economia y Competitividad (BES-2014-068040) to COR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthonisen EH, 2010, J BIOL CHEM, V285, P1607, DOI 10.1074/jbc.M109.082685; Archer A, 2014, AM J PHYSIOL-ENDOC M, V306, pE494, DOI 10.1152/ajpendo.00410.2013; Batchelor DJ, 2011, AM J PHYSIOL-REG I, V300, pR67, DOI 10.1152/ajpregu.00262.2010; Beall C, 2012, DIABETOLOGIA, V55, P2432, DOI 10.1007/s00125-012-2617-y; Bermejo-Nogales A, 2010, J COMP PHYSIOL B, V180, P685, DOI 10.1007/s00360-009-0441-6; Bernier NJ, 2008, J ENDOCRINOL, V196, P637, DOI 10.1677/JOE-07-0568; de Morentin PBM, 2011, REV ENDOCR METAB DIS, V12, P127, DOI 10.1007/s11154-011-9165-5; Blouet C, 2010, BEHAV BRAIN RES, V209, P1, DOI 10.1016/j.bbr.2009.12.024; Carmona-Antonanzas G, 2014, GENE, V534, P1, DOI 10.1016/j.gene.2013.10.040; Conde-Sieira M, 2013, J EXP BIOL, V216, P554, DOI 10.1242/jeb.076505; Conde-Sieira M, 2012, J EXP BIOL, V215, P3112, DOI 10.1242/jeb.069740; Conde-Sieira M, 2011, J EXP BIOL, V214, P3887, DOI 10.1242/jeb.061564; Conde-Sieira M, 2010, J EXP BIOL, V213, P3858, DOI 10.1242/jeb.048439; Conde-Sieira M, 2010, PHYSIOL BEHAV, V101, P483, DOI 10.1016/j.physbeh.2010.07.016; Coulibaly I, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-203; Craig PM, 2013, COMP BIOCHEM PHYS B, V166, P23, DOI 10.1016/j.cbpb.2013.06.005; Craig PM, 2013, BRIT J NUTR, V109, P402, DOI 10.1017/S0007114512001663; Cruz-Garcia L, 2012, COMP BIOCHEM PHYS A, V163, P120, DOI 10.1016/j.cbpa.2012.05.193; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Elo B, 2007, J MOL ENDOCRINOL, V38, P433, DOI 10.1677/JME-06-0037; Festuccia WT, 2014, AM J PHYSIOL-ENDOC M, V306, pE1046, DOI 10.1152/ajpendo.00683.2013; Fioramonti X, 2004, DIABETES, V53, P2767, DOI 10.2337/diabetes.53.11.2767; Gonzalez JA, 2009, J PHYSIOL-LONDON, V587, P41, DOI 10.1113/jphysiol.2008.163410; Higuchi N, 2011, J CELL BIOCHEM, V112, P30, DOI 10.1002/jcb.22688; Jensen VFH, 2014, J NEUROENDOCRINOL, V26, P123, DOI 10.1111/jne.12133; Keppler D., 1974, METHOD ENZYMAT AN, V3, P1127, DOI DOI 10.1242/JEB.037275; Kim H, 2004, DIABETES, V53, pS60, DOI 10.2337/diabetes.53.2007.S60; Kolditz C, 2008, AM J PHYSIOL-REG I, V294, pR1154, DOI 10.1152/ajpregu.00766.2007; Kong D, 2010, CELL METAB, V12, P545, DOI 10.1016/j.cmet.2010.09.013; Kyriazis GA, 2014, ENDOCRINOLOGY, V155, P2112, DOI 10.1210/en.2013-2015; Lansard M, 2009, BRIT J NUTR, V102, P1564, DOI 10.1017/S000711450999095X; Leder EH, 2006, J ENDOCRINOL, V188, P355, DOI 10.1677/joe.1.06283; Libran-Perez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059507; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; Nakagawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005106; Panserat S, 2001, J EXP BIOL, V204, P2351; Panserat S, 2000, AM J PHYSIOL-REG I, V278, pR1164, DOI 10.1152/ajpregu.2000.278.5.R1164; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfannkuche H, 2009, J ANIM PHYSIOL AN N, V93, P277, DOI 10.1111/j.1439-0396.2008.00847.x; Polakof S, 2011, LIPIDS, V46, P189, DOI 10.1007/s11745-010-3521-1; Polakof S, 2010, DOMEST ANIM ENDOCRIN, V39, P26, DOI 10.1016/j.domaniend.2010.01.003; Polakof S, 2008, AM J PHYSIOL-REG I, V295, pR1077, DOI 10.1152/ajpregu.90476.2008; Polakof S, 2008, J COMP PHYSIOL A, V194, P829, DOI 10.1007/s00359-008-0354-y; Polakof S, 2008, AM J PHYSIOL-REG I, V295, pR478, DOI 10.1152/ajpregu.00176.2008; Polakof S, 2007, AM J PHYSIOL-REG I, V293, pR1410, DOI 10.1152/ajpregu.00283.2007; Polakof S, 2007, AM J PHYSIOL-REG I, V292, pR1657, DOI 10.1152/ajpregu.00525.2006; Polakof S, 2013, COMP BIOCHEM PHYS B, V166, P58, DOI 10.1016/j.cbpb.2013.07.003; Polakof S, 2012, J COMP PHYSIOL B, V182, P1015, DOI 10.1007/s00360-012-0658-7; Polakof S, 2011, COMP BIOCHEM PHYS B, V160, P123, DOI 10.1016/j.cbpb.2011.07.006; Polakof S, 2010, AM J PHYSIOL-REG I, V299, pR19, DOI 10.1152/ajpregu.00005.2010; Ren XY, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.012.2009; Sala-Rabanal M, 2004, J MEMBRANE BIOL, V201, P85, DOI 10.1007/s00232-004-0710-y; Sanchez-Gurmaches J, 2012, J EXP BIOL, V215, P1373, DOI 10.1242/jeb.061697; Soengas J.L, 2013, TROUT PHYSL CONSERVA, P155; Soengas JL, 2014, GEN COMP ENDOCR, V205, P36, DOI 10.1016/j.ygcen.2014.01.015; Steffensen KR, 2004, DIABETES, V53, pS36, DOI 10.2337/diabetes.53.2007.S36; Sugiura SH, 2003, AM J PHYSIOL-REG I, V285, pR770, DOI 10.1152/ajpregu.00127.2003; Sukardi H, 2012, BBA-GEN SUBJECTS, V1820, P33, DOI 10.1016/j.bbagen.2011.10.009; Tang ZG, 2013, MOL CELL ENDOCRINOL, V376, P114, DOI 10.1016/j.mce.2013.06.020; Tine M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-62; Wauson EM, 2013, MOL ENDOCRINOL, V27, P1188, DOI 10.1210/me.2013-1100	63	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0128603	10.1371/journal.pone.0128603	http://dx.doi.org/10.1371/journal.pone.0128603			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996158	Green Submitted, Green Published, gold			2022-12-26	WOS:000356444000105
J	Riera, H; Afonso, V; Collin, P; Lomri, A				Riera, Humberto; Afonso, Valery; Collin, Pascal; Lomri, Abderrahim			A Central Role for JNK/AP-1 Pathway in the Pro-Oxidant Effect of Pyrrolidine Dithiocarbamate through Superoxide Dismutase 1 Gene Repression and Reactive Oxygen Species Generation in Hematopoietic Human Cancer Cell Line U937	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN ENDOTHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; TERMINAL KINASE JNK; BREAST-CANCER; ACTIVATION; APOPTOSIS; EXPRESSION; ANTIOXIDANTS; INHIBITION	Pyrrolidine dithiocarbamate (PDTC) known as antioxidant and specific inhibitor of NF-kappa B was also described as pro-oxidant by inducing cell death and reactive oxygen species (ROS) accumulation in cancer. However, the mechanism by which PDTC indices its pro-oxidant effect is unknown. Therefore, we aimed to evaluate the effect of PDTC on the human Cu/Zn superoxide dismutase 1 (SOD1) gene transcription in hematopoietic human cancer cell line U937. We herein show for the first time that PDTC decreases SOD1 transcripts, protein and promoter activity. Furthermore, SOD1 repression by PDTC was associated with an increase in oxidative stress as evidenced by ROS production. Electrophoretic mobility-shift assays (EMSA) show that PDTC increased binding of activating protein-1 (AP-1) in dose dependent-manner suggesting that the MAPkinase up-stream of AP-1 is involved. Ectopic NF-kappa B p65 subunit overexpression had no effect on SOD1 transcription. In contrast, in the presence of JNK inhibitor (SP600125), p65 induced a marked increase of SOD1 promoter, suggesting that JNK pathway is up-stream of NF-kappa B signaling and controls negatively its activity. Indeed, using JNK deficient cells, PDTC effect was not observed nether on SOD1 transcription or enzymatic activity, nor on ROS production. Finally, PDTC represses SOD1 in U937 cells through JNK/c-Jun phosphorylation. Taken together, these results suggest that PDTC acts as pro-oxidant compound in JNK/AP-1 dependent-manner by repressing the superoxide dismutase 1 gene leading to intracellular ROS accumulation.	[Riera, Humberto] Univ Los Andes, Nivel Plaza Inst Autonomo Hosp, Unidad Reumatol, Merida, Venezuela; [Afonso, Valery; Lomri, Abderrahim] INSERM, Lab Angiogenese & Microenvironn Canc, U1029, Pessac, France; [Collin, Pascal] Lab Chim & Biochim Pharmacol, UMR 8601, Paris, France	University of Los Andes Venezuela; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Lomri, A (corresponding author), INSERM, Lab Angiogenese & Microenvironn Canc, U1029, Pessac, France.	rahim.lomri@inserm.fr		Lomri, Abderrahim/0000-0001-9847-026X	INSERM (Institut National de la Sante et la Recherche Medicale)	INSERM (Institut National de la Sante et la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This study was sponsored and funded by the INSERM (Institut National de la Sante et la Recherche Medicale); AL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso V, 2006, FREE RADICAL BIO MED, V41, P709, DOI 10.1016/j.freeradbiomed.2006.05.014; Ambrosone CB, 2000, ANTIOXID REDOX SIGN, V2, P903, DOI 10.1089/ars.2000.2.4-903; Burkitt MJ, 1998, ARCH BIOCHEM BIOPHYS, V353, P73, DOI 10.1006/abbi.1998.0618; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen M, 2010, EXP EYE RES, V90, P437, DOI 10.1016/j.exer.2009.12.004; Chen YR, 2000, INT J ONCOL, V16, P651; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Chinery R, 1997, NAT MED, V3, P1233, DOI 10.1038/nm1197-1233; Chung KC, 2000, J NEUROSCI RES, V59, P117, DOI 10.1002/(SICI)1097-4547(20000101)59:1<117::AID-JNR14>3.0.CO;2-Q; Di Nicuolo F, 2001, FREE RADICAL BIO MED, V31, P1424; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fuchs D, 1997, OXIDATIVE STRESS MOL, P139; Glasauer A, 2014, J CLIN INVEST, V124, P117, DOI 10.1172/JCI71714; Gu JW, 2009, CANCER BIOL THER, V8, P514, DOI 10.4161/cbt.8.6.7689; Herrmann JL, 1997, EXP CELL RES, V237, P101, DOI 10.1006/excr.1997.3737; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jacobson MD, 1996, TRENDS BIOCHEM SCI, V21, P83, DOI 10.1016/0968-0004(96)20008-8; Karihtala P, 2006, EUR J CANCER, V42, P2653, DOI 10.1016/j.ejca.2006.05.037; Kong JM, 1998, J NEUROSCI, V18, P3241; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Lehmann TG, 2003, TRANSPLANTATION, V76, P28, DOI 10.1097/01.TP.0000065299.29900.17; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin SJ, 2005, ARTERIOSCL THROM VAS, V25, P334, DOI 10.1161/01.ATV.0000152114.00114.d8; Liu SF, 1999, CIRCULATION, V100, P1330, DOI 10.1161/01.CIR.100.12.1330; Maggirwar SB, 2000, J NEUROCHEM, V74, P527, DOI 10.1046/j.1471-4159.2000.740527.x; Malaguarnera L, 2003, APOPTOSIS, V8, P539, DOI 10.1023/A:1025550726803; Matroule JY, 2001, ONCOGENE, V20, P4070, DOI 10.1038/sj.onc.1204546; Meisner M, 2000, INT J IMMUNOPHARMACO, V22, P83, DOI 10.1016/S0192-0561(99)00071-5; Minc E, 1999, J BIOL CHEM, V274, P503, DOI 10.1074/jbc.274.1.503; Munoz C, 1996, BLOOD, V88, P3482, DOI 10.1182/blood.V88.9.3482.bloodjournal8893482; Nemeth ZH, 1998, SHOCK, V10, P49, DOI 10.1097/00024382-199807000-00009; NOBEL CSI, 1995, J BIOL CHEM, V270, P26202, DOI 10.1074/jbc.270.44.26202; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Papa L, 2014, J BIOL CHEM, V289, P5412, DOI 10.1074/jbc.C113.526475; Portakal O, 2000, CLIN BIOCHEM, V33, P279, DOI 10.1016/S0009-9120(00)00067-9; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rossner P, 2006, CANCER EPIDEM BIOMAR, V15, P639, DOI 10.1158/1055-9965.EPI-05-0554; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Sanchez-Perez I, 1998, ONCOGENE, V16, P533, DOI 10.1038/sj.onc.1201578; Sanchez-Perez I, 2002, MOL BIOL CELL, V13, P2933, DOI 10.1091/mbc.E02-01-0022; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; SMAELE ED, 2001, NATURE, V414, P308; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; TAYLOR KL, 1987, BIOCHEM PHARMACOL, V36, P141, DOI 10.1016/0006-2952(87)90391-1; Tzagarakis-Foster C, 2002, J BIOL CHEM, V277, P44772, DOI 10.1074/jbc.M205355200; VERHAEGEN S, 1995, BIOCHEM PHARMACOL, V50, P1021, DOI 10.1016/0006-2952(95)00233-P; Verrecchia F, 2003, J BIOL CHEM, V278, P1585, DOI 10.1074/jbc.M206927200; Wheeler MD, 2003, J BIOL CHEM, V278, P8435, DOI 10.1074/jbc.M212076200; Wheeler MD, 2001, HUM GENE THER, V12, P2167, DOI 10.1089/10430340152710513; Wheeler MD, 2001, GASTROENTEROLOGY, V120, P1241, DOI 10.1053/gast.2001.23253; Zhou JB, 2008, BREAST CANCER RES TR, V111, P419, DOI 10.1007/s10549-007-9798-y; ZIEGLERHEITBROCK HWL, 1993, J IMMUNOL, V151, P6986	53	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127571	10.1371/journal.pone.0127571	http://dx.doi.org/10.1371/journal.pone.0127571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996379	Green Submitted, Green Published, gold			2022-12-26	WOS:000356444000076
J	Toth, M; Doorduin, J; Haggkvist, J; Varrone, A; Amini, N; Halldin, C; Gulyas, B				Toth, Miklos; Doorduin, Janine; Haggkvist, Jenny; Varrone, Andrea; Amini, Nahid; Halldin, Christer; Gulyas, Balazs			Positron Emission Tomography studies with [C-11]PBR28 in the Healthy Rodent Brain: Validating SUV as an Outcome Measure of Neuroinflammation	PLOS ONE			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTOR; PROTEIN 18 KDA; PERFORMANCE EVALUATION; RADIOLIGAND	Molecular imaging of the 18 kD Translocator protein (TSPO) with positron emission tomography (PET) is of great value for studying neuroinflammation in rodents longitudinally. Quantification of the TSPO in rodents is, however, quite challenging. There is no suitable reference region and the use of plasma-derived input is not an option for longitudinal studies. The aim of this study was therefore to evaluate the use of the standardized uptake value (SUV) as an outcome measure for TSPO imaging in rodent brain PET studies, using [C-11]PBR28. In the first part of the study, healthy male Wistar rats (n = 4) were used to determine the correlation between the distribution volume (V-T, calculated with Logan graphical analysis) and the SUV. In the second part, healthy male Wistar rats (n = 4) and healthy male C57BL/6J mice (n = 4), were used to determine the test-retest variability of the SUV, with a 7-day interval between measurements. Dynamic PET scans of 63 minutes were acquired with a nanoScan PET/MRI and nanoScan PET/CT. An MRI scan was made for anatomical reference with each measurement. The whole brain V-T of [C-11]PBR28 in rats was 42.9 +/- 1.7. A statistically significant correlation (r(2) = 0.96; p < 0.01) was found between the V-T and the SUV. The test-retest variability in 8 brain region ranged from 8 to 20% in rats and from 7 to 23% in mice. The interclass correlation coefficient (ICC) was acceptable to excellent for rats, but poor to acceptable for mice. In conclusion: The SUV of [C-11]PBR28 showed a high correlation with V-T as well as good test-retest variability. For future longitudinal small animal PET studies the SUV can thus be used to describe [C-11]PBR28 uptake in healthy brain tissue. Based on the present observations, further studies are needed to explore the applicability of this approach in small animal disease models, with special regard to neuroinflammatory models.	[Toth, Miklos; Doorduin, Janine; Haggkvist, Jenny; Varrone, Andrea; Amini, Nahid; Halldin, Christer; Gulyas, Balazs] Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden; [Doorduin, Janine] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands; [Halldin, Christer; Gulyas, Balazs] Nanyang Technol Univ, Lee Chian Kong Sch Med, Imperial Coll NTU, Singapore 639798, Singapore	Karolinska Institutet; University of Groningen; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Toth, M (corresponding author), Karolinska Inst, Ctr Psychiat Res, Dept Clin Neurosci, Stockholm, Sweden.	miklos.toth@ki.se	Gulyas, Balazs/F-9508-2015	Doorduin, Janine/0000-0003-2925-9959; Toth, Miklos/0000-0002-1652-7136	European Union [GA 278850]; European Cooperation in Science and Technology COST Action [TD1007]	European Union(European Commission); European Cooperation in Science and Technology COST Action(European Cooperation in Science and Technology (COST))	CH, BG, and MT received funding from European Union's Seventh Framework Program FP7/2007-2013, GA 278850, Imaging of Neuroinflammation in Neurodegenerative Diseases (http://www.uni-muenster.de/InMind/). CH and BG recieved funding from European Cooperation in Science and Technology COST Action TD1007 (http://www.pet-mri.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briard E, 2008, J MED CHEM, V51, P17, DOI 10.1021/jm0707370; Doorduin J, 2009, MOL IMAGING BIOL, V11, P386, DOI 10.1007/s11307-009-0211-6; Doorduin J, 2008, CURR PHARM DESIGN, V14, P3297, DOI 10.2174/138161208786549443; Fujita M, 2008, NEUROIMAGE, V40, P43, DOI 10.1016/j.neuroimage.2007.11.011; Hashimoto K, 1989, Ann Nucl Med, V3, P63; Hirvonen J, 2012, J NUCL MED, V53, P234, DOI 10.2967/jnumed.111.091694; Imaizumi M, 2007, NEUROSCI LETT, V411, P200, DOI 10.1016/j.neulet.2006.09.093; Kreisl WC, 2013, BRAIN, V136, P2228, DOI 10.1093/brain/awt145; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Logan J, 2000, NUCL MED BIOL, V27, P661, DOI 10.1016/S0969-8051(00)00137-2; Nagy K, 2013, J NUCL MED, V54, P1825, DOI 10.2967/jnumed.112.119065; Papadopoulos V, 1997, J BIOL CHEM, V272, P32129, DOI 10.1074/jbc.272.51.32129; Papadopoulos V, 2004, ENDOCR RES, V30, P677, DOI 10.1081/ERC-200043971; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Szanda I, 2011, J NUCL MED, V52, P1741, DOI 10.2967/jnumed.111.088260; Turkheimer FE, 2007, J NUCL MED, V48, P158; Venneti S, 2006, PROG NEUROBIOL, V80, P308, DOI 10.1016/j.pneurobio.2006.10.002; Wang M, 2009, BIOORG MED CHEM LETT, V19, P5636, DOI 10.1016/j.bmcl.2009.08.051; Yoder KK, 2014, INT S FUNCT NEUR MAP, P87	20	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0125917	10.1371/journal.pone.0125917	http://dx.doi.org/10.1371/journal.pone.0125917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996996	Green Published, gold			2022-12-26	WOS:000356444000014
J	Soma, M; Mori, C				Soma, Masayo; Mori, Chihiro			The Songbird as a Percussionist: Syntactic Rules for Non-Vocal Sound and Song Production in Java Sparrows	PLOS ONE			English	Article							VOCAL-TRACT; COURTSHIP; DISPLAY; DANCE; CHOREOGRAPHY; PERFORMANCE; EVOLUTION	Music and dance are two remarkable human characteristics that are closely related. Communication through integrated vocal and motional signals is also common in the courtship displays of birds. The contribution of songbird studies to our understanding of vocal learning has already shed some light on the cognitive underpinnings of musical ability. Moreover, recent pioneering research has begun to show how animals can synchronize their behaviors with external stimuli, like metronome beats. However, few studies have applied such perspectives to unraveling how animals can integrate multimodal communicative signals that have natural functions. Additionally, studies have rarely asked how well these behaviors are learned. With this in mind, here we cast a spotlight on an unusual animal behavior: nonvocal sound production associated with singing in the Java sparrow (Lonchura oryzivora), a songbird. We show that male Java sparrows coordinate their bill-click sounds with the syntax of their song-note sequences, similar to percussionists. Analysis showed that they produced clicks frequently toward the beginning of songs and before/after specific song notes. We also show that bill-clicking patterns are similar between social fathers and their sons, suggesting that these behaviors might be learned from models or linked to learning-based vocalizations. Individuals untutored by conspecifics also exhibited stereotypical bill-clicking patterns in relation to song-note sequence, indicating that while the production of bill clicking itself is intrinsic, its syncopation appears to develop with songs. This paints an intriguing picture in which non-vocal sounds are integrated with vocal courtship signals in a songbird, a model that we expect will contribute to the further understanding of multimodal communication.	[Soma, Masayo] Hokkaido Univ, Fac Sci, Dept Biol, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Mori, Chihiro] Hokkaido Univ, Grad Sch Life Sci, Biosyst Sci Course, Kita Ku, Sapporo, Hokkaido 0600810, Japan	Hokkaido University; Hokkaido University	Soma, M (corresponding author), Hokkaido Univ, Fac Sci, Dept Biol, Kita Ku, Kita 10,Nishi 8, Sapporo, Hokkaido 0600810, Japan.	masayo.soma@sci.hokudai.ac.jp			Japan Society for the Promotion of Science [22800002, 23680027]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The work was supported by Japan Society for the Promotion of Science Grants-in-Aid for Young Scientists (Nos. 22800002, 23680027), http://www.jsps.go.jp/english/index.html.	Beecher MD, 2005, TRENDS ECOL EVOL, V20, P143, DOI 10.1016/j.tree.2005.01.004; Bostwick KS, 2005, SCIENCE, V309, P736, DOI 10.1126/science.1111701; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; Charif RA, 2010, RAVEN PRO 1 4 USERS; Cook P, 2013, J COMP PSYCHOL, V127, P412, DOI 10.1037/a0032345; Cooper BG, 2004, SCIENCE, V303, P544, DOI 10.1126/science.1091099; Dalziell AH, 2013, CURR BIOL, V23, P1132, DOI 10.1016/j.cub.2013.05.018; Freeberg TM, 2000, BEHAV PROCESS, V51, P177, DOI 10.1016/S0376-6357(00)00127-3; Fusani L, 1997, BEHAVIOUR, V134, P321, DOI 10.1163/156853997X00566; Fusani L, 2007, ETHOLOGY, V113, P964, DOI 10.1111/j.1439-0310.2007.01395.x; Garcia M, 2012, CONDOR, V114, P500, DOI 10.1525/cond.2012.110158; Geissmann T, 2000, ANIM BEHAV, V60, P805, DOI 10.1006/anbe.2000.1540; Goodwin, 1982, ESTRILDID FINCHES WO; Hasegawa A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00120; Hasegawa A, 2011, ORNITHOL SCI, V10, P73, DOI 10.2326/osj.10.73; Hattori Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01566; Hile AG, 2000, ANIM BEHAV, V59, P1209, DOI 10.1006/anbe.1999.1438; Hingee M, 2009, P ROY SOC B-BIOL SCI, V276, P4173, DOI 10.1098/rspb.2009.1110; Kagawa H, 2013, BEHAV PROCESS, V99, P138, DOI 10.1016/j.beproc.2013.07.012; Nelson BS, 2005, J EXP BIOL, V208, P297, DOI 10.1242/jeb.01378; Ota N, 2014, J AVIAN BIOL, V45, P566, DOI 10.1111/jav.00383; Patel AD, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001821; Prum RO, 1998, ANIM BEHAV, V55, P977, DOI 10.1006/anbe.1997.0647; Restall R., 1996, MUNIAS AND MANNIKINS; Riede T, 2006, P NATL ACAD SCI USA, V103, P5543, DOI 10.1073/pnas.0601262103; Romero T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105963; Romero T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071365; Schachner A, 2009, CURR BIOL, V19, P831, DOI 10.1016/j.cub.2009.03.061; SOMA M, 2015, FRONT ECOL EVOL, V3, DOI DOI 10.3389/FEV0.2015.00004; Soma MF, 2011, ORNITHOL SCI, V10, P89, DOI 10.2326/osj.10.89; Stark RD, 1998, CONDOR, V100, P350, DOI 10.2307/1370276; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Williams H, 2001, J EXP BIOL, V204, P3497	33	19	19	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0124876	10.1371/journal.pone.0124876	http://dx.doi.org/10.1371/journal.pone.0124876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992841	Green Published, gold, Green Submitted			2022-12-26	WOS:000354921400021
J	Wang, DD; Ma, LC; Wong, MP; Lee, VHF; Yan, H				Wang, Debby D.; Ma, Lichun; Wong, Maria P.; Lee, Victor H. F.; Yan, Hong			Contribution of EGFR and ErbB-3 Heterodimerization to the EGFR Mutation-Induced Gefitinib- and Erlotinib-Resistance in Non-Small-Cell Lung Carcinoma Treatments	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITOR; BREAST-CANCER; FACTOR-I; C-MET; STRUCTURAL-ANALYSIS; CLINICAL-RESPONSE; EXON 19; ACTIVATION; MECHANISM	EGFR mutation-induced drug resistance has become a major threat to the treatment of non-small-cell lung carcinoma. Essentially, the resistance mechanism involves modifications of the intracellular signaling pathways. In our work, we separately investigated the EGFR and ErbB-3 heterodimerization, regarded as the origin of intracellular signaling pathways. On one hand, we combined the molecular interaction in EGFR heterodimerization with that between the EGFR tyrosine kinase and its inhibitor. For 168 clinical subjects, we characterized their corresponding EGFR mutations using molecular interactions, with three potential dimerization partners (ErbB-2, IGF-1R and c-Met) of EGFR and two of its small molecule inhibitors (gefitinib and erlotinib). Based on molecular dynamics simulations and structural analysis, we modeled these mutant-partner or mutant-inhibitor interactions using binding free energy and its components. As a consequence, the mutant-partner interactions are amplified for mutants L858R and L858R_T790M, compared to the wild type EGFR. Mutant delL747_P753insS represents the largest difference between the mutant-IGF-1R interaction and the mutant-inhibitor interaction, which explains the shorter progression-free survival of an inhibitor to this mutant type. Besides, feature sets including different energy components were constructed, and efficient regression trees were applied to map these features to the progression-free survival of an inhibitor. On the other hand, we comparably examined the interactions between ErbB-3 and its partners (EGFR mutants, IGF-1R, ErbB-2 and c-Met). Compared to others, c-Met shows a remarkably-strong binding with ErbB-3, implying its significant role in regulating ErbB-3 signaling. Moreover, EGFR mutants corresponding to poor clinical outcomes, such as L858R_T790M, possess lower binding affinities with ErbB-3 than c-Met does. This may promote the communication between ErbB-3 and c-Met in these cancer cells. The analysis verified the important contribution of IGF-1R or c-Met in the drug resistance mechanism developed in lung cancer treatments, which may bring many benefits to specialized therapy design and innovative drug discovery.	[Wang, Debby D.; Ma, Lichun; Yan, Hong] City Univ Hong Kong, Dept Elect Engn, Kowloon, Hong Kong, Peoples R China; [Wong, Maria P.; Lee, Victor H. F.] Univ Hong Kong, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China	City University of Hong Kong; University of Hong Kong	Wang, DD (corresponding author), City Univ Hong Kong, Dept Elect Engn, Kowloon, Hong Kong, Peoples R China.	danwang6-c@my.cityu.edu.hk		Lee, Victor/0000-0002-6283-978X; Ma, Lichun/0000-0001-9809-775X	Hong Kong Health and Medical Research Fund [01121986]; City University of Hong Kong [9610308]	Hong Kong Health and Medical Research Fund; City University of Hong Kong(City University of Hong Kong)	This work is supported by the Hong Kong Health and Medical Research Fund (Project 01121986) and City University of Hong Kong (Project 9610308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Rehim DM, 2004, BRIT J CANCER, V91, P1532, DOI 10.1038/sj.bjc.6602184; Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; Ahmad T, 2004, J BIOL CHEM, V279, P1713, DOI 10.1074/jbc.M306156200; Akhoon BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110041; Al-Lazikani B, 2001, CURR OPIN CHEM BIOL, V5, P51, DOI 10.1016/S1367-5931(00)00164-2; Arteaga CL, 2001, J CLIN ONCOL, V19, p32S; Bae JH, 2010, MOL CELLS, V29, P443, DOI 10.1007/s10059-010-0080-5; Bartova I, 2004, PROTEIN SCI, V13, P1449, DOI 10.1110/ps.03578504; Becker OM, 2003, CURR OPIN DRUG DISC, V6, P353; Berasain Carmen, 2011, Cancers (Basel), V3, P2444, DOI 10.3390/cancers3022444; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bill A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041179; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Buyya R., 1999, HIGH PERFORMANCE CLU; Chakravarti A, 2002, CANCER RES, V62, P200; Chung KP, 2012, CLIN CANCER RES, V18, P3470, DOI 10.1158/1078-0432.CCR-11-2353; Croasdale R, 2012, ARCH BIOCHEM BIOPHYS, V526, P206, DOI 10.1016/j.abb.2012.03.016; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Frolov A, 2007, CANCER BIOL THER, V6, P548, DOI 10.4161/cbt.6.4.3849; Gandhi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004576; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Groenen LC, 1997, BIOCHEMISTRY-US, V36, P3826, DOI 10.1021/bi9614141; Gullick WJ, 2001, ENDOCR-RELAT CANCER, V8, P75, DOI 10.1677/erc.0.0080075; Haley J. D., 2009, EGFR SIGNALING NETWO; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Jones HE, 2004, ENDOCR-RELAT CANCER, V11, P793, DOI 10.1677/erc.1.00799; KALLIONIEMI OP, 1992, P NATL ACAD SCI USA, V89, P5321, DOI 10.1073/pnas.89.12.5321; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Lee JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048532; Lee VHF, 2013, J THORAC ONCOL, V8, P1148, DOI 10.1097/JTO.0b013e31829f684a; Littlefield P, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005786; Lu D, 2005, J BIOL CHEM, V280, P19665, DOI 10.1074/jbc.M500815200; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Meek K, 2007, MOL CELL BIOL, V27, P3881, DOI 10.1128/MCB.02366-06; Moore T, 2012, CANCER PREV RES, V5, P1236, DOI 10.1158/1940-6207.CAPR-12-0234; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Moulder SL, 2001, CANCER RES, V61, P8887; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Normanno N, 2003, ENDOCR-RELAT CANCER, V10, P1, DOI 10.1677/erc.0.0100001; Normanno N, 2005, CURR DRUG TARGETS, V6, P243, DOI 10.2174/1389450053765879; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5; Roengvoraphoj M, 2013, CANCER TREAT REV, V39, P839, DOI 10.1016/j.ctrv.2013.05.001; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Santos GD, 2011, ANNU REV PATHOL-MECH, V6, P49, DOI 10.1146/annurev-pathol-011110-130206; Schiering N, 2003, P NATL ACAD SCI USA, V100, P12654, DOI 10.1073/pnas.1734128100; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SHENKIN PS, 1987, BIOPOLYMERS, V26, P2053, DOI 10.1002/bip.360261207; Soto CS, 2008, PROTEINS, V70, P834, DOI 10.1002/prot.21612; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Sutherland RL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2878; Tam IYS, 2006, CLIN CANCER RES, V12, P1647, DOI 10.1158/1078-0432.CCR-05-1981; Tanizaki J, 2011, BRIT J CANCER, V105, P807, DOI 10.1038/bjc.2011.322; van der Meel R, 2013, MOL PHARMACEUT, V10, P3717, DOI 10.1021/mp400212v; van der Veeken J, 2009, CURR CANCER DRUG TAR, V9, P748; Wang DD, 2013, SCI REPORTS, P3; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033709; Wang Y, 2013, ADV CIV ENG, V2013, DOI 10.1155/2013/189105; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865; Xu H, 2011, CLIN CANCER RES, V17, P4425, DOI 10.1158/1078-0432.CCR-10-3339; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	76	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0128360	10.1371/journal.pone.0128360	http://dx.doi.org/10.1371/journal.pone.0128360			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993617	Green Published, Green Submitted, gold			2022-12-26	WOS:000354921400144
J	Wang, Y; Ran, M; Wang, J; Ouyang, Q; Luo, CX				Wang, Ying; Ran, Min; Wang, Jun; Ouyang, Qi; Luo, Chunxiong			Studies of Antibiotic Resistance of Beta-Lactamase Bacteria under Different Nutrition Limitations at the Single-Cell Level	PLOS ONE			English	Article							FLOW-CYTOMETRY; ESCHERICHIA-COLI; PERSISTENCE; PDMS	Drug resistance involves many biological processes, including cell growth, cell communication, and cell cooperation. In the last few decades, bacterial drug resistance studies have made substantial progress. However, a major limitation of the traditional resistance study still exists: most of the studies have concentrated on the average behavior of enormous amounts of cells rather than surveying single cells with different phenotypes or genotypes. Here, we report our study of beta-lactamase bacterial drug resistance in a well-designed microfluidic device, which allows us to conduct more controllable experiments, such as controlling the nutrient concentration, switching the culture media, performing parallel experiments, observing single cells, and acquiring time-lapse images. By using GFP as a beta-lactamase indicator and acquiring time-lapse images at the single-cell level, we observed correlations between the bacterial heterogeneous phenotypes and their behavior in different culture media. The feedback loop between the growth rate and the beta-lactamase production suggests that the beta-lactamase bacteria are more resistant in a rich medium than in a relatively poor medium. In the poorest medium, the proportion of dormant cells may increase, which causes a lower death rate in the same generation. Our work may contribute to assaying the antibiotic resistance of pathogenic bacteria in heterogeneous complex media.	[Wang, Ying; Ran, Min; Ouyang, Qi; Luo, Chunxiong] Peking Univ, Sch Phys, State Key Lab Artificial Microstruct & Mesoscop P, Beijing 100871, Peoples R China; [Wang, Jun; Ouyang, Qi; Luo, Chunxiong] Peking Univ, Acad Adv Interdisciplinary Studies, Ctr Quantitat Biol, Beijing 100871, Peoples R China; [Ouyang, Qi] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Ouyang, Q (corresponding author), Peking Univ, Sch Phys, State Key Lab Artificial Microstruct & Mesoscop P, Beijing 100871, Peoples R China.	qi@pku.edu.cn; pkuluocx@pku.edu.cn		Luo, Chunxiong/0000-0001-8974-7693	National Natural Science Foundation of China [10721403, 11074009, 11174012, 11434001]; Ministry of Science and technology of the People's Republic of China [2009CB918500, 2012AA02A702]; National Fund for Fostering Talents of Basic Science [J0630311]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and technology of the People's Republic of China(Ministry of Science and Technology, China); National Fund for Fostering Talents of Basic Science	This work is partially supported by the National Natural Science Foundation of China (10721403, 11074009, 11174012, 11434001), the Ministry of Science and technology of the People's Republic of China (2009CB918500, 2012AA02A702), the National Fund for Fostering Talents of Basic Science (J0630311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; Andersson DI, 1995, CURR OPIN MICROBIOL, V2, P489; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; Bhattacharya S, 2005, J MICROELECTROMECH S, V14, P590, DOI 10.1109/JMEMS.2005.844746; Bjorkman J, 2000, DRUG RESIST UPDATE, V3, P237, DOI 10.1054/drup.2000.0147; Brenwald NP, 2003, J ANTIMICROB CHEMOTH, V51, P195, DOI 10.1093/jac/dkg051; Brook I, 2004, CLIN MICROBIOL INFEC, V10, P777, DOI 10.1111/j.1198-743X.2004.00962.x; Brook I, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-202; BROWN MRW, 1988, J ANTIMICROB CHEMOTH, V22, P777, DOI 10.1093/jac/22.6.777; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; COZENS RM, 1986, ANTIMICROB AGENTS CH, V29, P797, DOI 10.1128/AAC.29.5.797; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Hansen C, 2003, CURR OPIN STRUC BIOL, V13, P538, DOI 10.1016/j.sbi.2003.09.010; Jiang XD, 2014, INTEGR BIOL-UK, V6, P143, DOI 10.1039/c3ib40164b; Jo BH, 2000, J MICROELECTROMECH S, V9, P76, DOI 10.1109/84.825780; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Luo CX, 2009, BIOMED MICRODEVICES, V11, P981, DOI 10.1007/s10544-009-9315-7; Maisonneuve E, 2014, CELL, V157, P539, DOI 10.1016/j.cell.2014.02.050; Morrissey I, 2013, PHARMACEUTICALS-BASE, V6, P1335, DOI 10.3390/ph6111335; Nebe-von-Caron G, 2000, J MICROBIOL METH, V42, P97, DOI 10.1016/S0167-7012(00)00181-0; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Shapiro HH, 2000, J MICROBIOL METH, V42, P3, DOI 10.1016/S0167-7012(00)00167-6; SKARSTAD K, 1985, J BACTERIOL, V163, P661, DOI 10.1128/JB.163.2.661-668.1985; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Thomson KS, 2010, J CLIN MICROBIOL, V48, P1019, DOI 10.1128/JCM.00219-10; TUOMANEN E, 1986, J GEN MICROBIOL, V132, P1297; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Wang XR, 2014, MBIO, V5, DOI 10.1128/mBio.00942-13; Zhang MY, 2010, LAB CHIP, V10, P1199, DOI 10.1039/b923101c	33	6	6	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127115	10.1371/journal.pone.0127115	http://dx.doi.org/10.1371/journal.pone.0127115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993008	Green Submitted, Green Published, gold			2022-12-26	WOS:000354921400098
J	Wiener, DJ; Wiedemar, N; Welle, MM; Drogemuller, C				Wiener, Dominique Judith; Wiedemar, Natalie; Welle, Monika Maria; Droegemueller, Cord			Novel Features of the Prenatal Horn Bud Development in Cattle (Bos taurus)	PLOS ONE			English	Article							POLLED CONDITION; GENE; INHERITANCE; LOCUS	Whereas the genetic background of horn growth in cattle has been studied extensively, little is known about the morphological changes in the developing fetal horn bud. In this study we histologically analyzed the development of horn buds of bovine fetuses between similar to 70 and similar to 268 days of pregnancy and compared them with biopsies taken from the frontal skin of the same fetuses. In addition we compared the samples from the wild type (horned) fetuses with samples taken from the horn bud region of age-matched genetically hornless (polled) fetuses. In summary, the horn bud with multiple layers of vacuolated keratinocytes is histologically visible early in fetal life already at around day 70 of gestation and can be easily differentiated from the much thinner epidermis of the frontal skin. However, at the gestation day (gd) 212 the epidermis above the horn bud shows a similar morphology to the epidermis of the frontal skin and the outstanding layers of vacuolated keratinocytes have disappeared. Immature hair follicles are seen in the frontal skin at gd 115 whereas hair follicles below the horn bud are not present until gd 155. Interestingly, thick nerve bundles appear in the dermis below the horn bud at gd 115. These nerve fibers grow in size over time and are prominent shortly before birth. Prominent nerve bundles are not present in the frontal skin of wild type or in polled fetuses at any time, indicating that the horn bud is a very sensitive area. The samples from the horn bud region from polled fetuses are histologically equivalent to samples taken from the frontal skin in horned species. This is the first study that presents unique histological data on bovine prenatal horn bud differentiation at different developmental stages which creates knowledge for a better understanding of recent molecular findings.	[Wiener, Dominique Judith; Welle, Monika Maria] Univ Bern, Vetsuisse Fac, Inst Anim Pathol, Bern, Switzerland; [Wiener, Dominique Judith; Wiedemar, Natalie; Welle, Monika Maria; Droegemueller, Cord] Univ Bern, Vetsuisse Fac, DermFocus, Bern, Switzerland; [Wiedemar, Natalie; Droegemueller, Cord] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland	University of Bern; University of Bern; University of Bern	Drogemuller, C (corresponding author), Univ Bern, Vetsuisse Fac, DermFocus, Bern, Switzerland.	cord.droegemueller@vetsuisse.unibe.ch	Welle, Monika Maria/ABF-6113-2021; Wiedemar, Natalie/AAR-3199-2021; Wiener, Dominique Judith/AAN-3313-2021	Wiedemar, Natalie/0000-0001-9470-4284; Drogemuller, Cord/0000-0001-9773-522X	Swiss National Science Foundation [31003A_141228]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by grant no. 31003A_141228 from the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allais-Bonnet A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063512, DOI 10.1371/J0URNAL.P0NE.0063512]; Alsaaod M, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-35; Brem G., 1982, Bayerisches Landwirtschaftliches Jahrbuch, V59, P688; Brenneman RA, 1996, J HERED, V87, P156, DOI 10.1093/oxfordjournals.jhered.a022975; Capitan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049084; Capitan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022242; Dove WF, 1935, J EXP ZOOL, V69, P347, DOI 10.1002/jez.1400690302; Drogemuller C, 2005, MAMM GENOME, V16, P613, DOI 10.1007/s00335-005-0016-0; Dyce KM, 2002, TXB VET ANATOMY, P359; GEORGES M, 1993, NAT GENET, V4, P206, DOI 10.1038/ng0693-206; Graf B, 1999, APPL ANIM BEHAV SCI, V62, P153, DOI 10.1016/S0168-1591(98)00218-4; Harlizius B, 1997, MAMM GENOME, V8, P255, DOI 10.1007/s003359900404; LONG CR, 1978, J HERED, V69, P395, DOI 10.1093/oxfordjournals.jhered.a108980; Medugorac I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039477; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; Reese S, 2011, ANATOMIE HAUSSAUGETI; Rothammer S, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-44; SCHMUTZ SM, 1995, MAMM GENOME, V6, P710, DOI 10.1007/BF00354293; Schnorr B, 2011, EMBRYOLOGIE HAUSTIER; Seichter D, 2012, ANIM GENET, V43, P595, DOI 10.1111/j.1365-2052.2011.02302.x; Sinowatz F., 1991, LEHRBUCH EMBRYOLOGIE; Strouhal E., 1997, LIFE ANCIENT EGYPTIA; White WT, 1936, J GENET, V32, P33, DOI 10.1007/BF02982500; Wiedemar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093435	24	18	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127691	10.1371/journal.pone.0127691	http://dx.doi.org/10.1371/journal.pone.0127691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993643	Green Published, Green Submitted, gold			2022-12-26	WOS:000354921400132
J	Zhang, H; Huang, CX; Wang, Y; Lu, Z; Zhuang, NT; Zhao, DJ; He, JQ; Shi, LY				Zhang, Hang; Huang, Changxin; Wang, Yan; Lu, Zhe; Zhuang, Ningtong; Zhao, Dongjiu; He, Jianqin; Shi, Liyun			Hepatitis B Virus X Protein Sensitizes TRAIL-Induced Hepatocyte Apoptosis by Inhibiting the E3 Ubiquitin Ligase A20	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED HEPATOCELLULAR-CARCINOMA; CELL-DEATH; HBV INFECTION; EXPRESSION; LIVER; MICRORNAS; CASPASE-8; NECROSIS; POLYUBIQUITINATION	Hepatitis B virus (HBV) infection causes hepatocyte death and liver damage, which may eventually lead to cirrhosis and liver cancer. Hepatitis B virus X protein (HBx) is a key antigen that is critically involved in HBV-associated liver diseases. However, the molecular basis for its pathogenesis, particularly in liver damage, has not been well defined. Herein, we report that HBx was able to enhance the susceptibility of hepatocytes to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. Increased sensitivity to TRAIL was associated with HBx-induced upregulation of miR-125a, which, in turn, suppressed the expression of its putative target gene, A20 E3 ligase. Importantly, we demonstrate that the defective expression of A20 impaired the K63-linked polyubiquitination of caspase-8, which reciprocally enhanced the activation of caspase-8, the recruitment of Fas-associated death domain (FADD), and the formation of death-inducing signaling complex (DISC), thereby promoting HBx-mediated apoptotic signaling. Accordingly, antagonizing miR-125a or ectopically expressing A20 in hepatocytes abolished the pro-apoptotic effect of HBx. Conversely, the overexpression of miR-125a or knockdown of A20 mimicked HBx to enhance TRAIL susceptibility in hepatocytes. Thus, we establish, for the first time, a miR-125a/A20-initiated and caspase-8-targeted mechanism by which HBx modulates apoptotic signaling and increases hepatic susceptibility to the damaging agent, which might provide novel insight into HBV-related liver pathology.	[Zhang, Hang; Wang, Yan; Lu, Zhe; Zhuang, Ningtong; Zhao, Dongjiu; Shi, Liyun] Hangzhou Normal Univ, Sch Med, Dept Basic Med Sci, Key Lab Immunol & Mol Med, Hangzhou 310036, Zhejiang, Peoples R China; [Huang, Changxin] Hangzhou Normal Univ, Sch Med, Affiliated Hosp, Dept Oncol, Hangzhou 310036, Zhejiang, Peoples R China; [He, Jianqin] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China	Hangzhou Normal University; Hangzhou Normal University; Zhejiang University	Shi, LY (corresponding author), Hangzhou Normal Univ, Sch Med, Dept Basic Med Sci, Key Lab Immunol & Mol Med, Hangzhou 310036, Zhejiang, Peoples R China.	shi_liyun@msn.com		Shi, Liyun/0000-0003-3538-1571	National Key Scientific Research Project [2012CB911200]; National Natural Science Foundation of China [81270066, 81470210, 81000956]; Natural Science Foundation of Zhejiang Province [LY15C070006]; provincial and municipal government funds [20100633B11, 2013R421025]	National Key Scientific Research Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); provincial and municipal government funds	This work was supported by the National Key Scientific Research Project (2012CB911200), the National Natural Science Foundation of China (81270066, 81470210 and 81000956), the Natural Science Foundation of Zhejiang Province (LY15C070006) and the provincial and municipal government funds (20100633B11 and 2013R421025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellail AC, 2012, CANCER DISCOV, V2, P140, DOI 10.1158/2159-8290.CD-11-0172; Bi Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040169; Chen GY, 2005, WORLD J GASTROENTERO, V11, P4090, DOI 10.3748/wjg.v11.i26.4090; Coppola N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065336; Criollo A, 2007, APOPTOSIS, V12, P3, DOI 10.1007/s10495-006-0328-x; Dong BF, 2012, BIOCHEM BIOPH RES CO, V418, P433, DOI 10.1016/j.bbrc.2012.01.056; Doukas T, 2011, J VIROL, V85, P10101, DOI 10.1128/JVI.00575-11; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Geng X, 2012, P NATL ACAD SCI USA, V109, P18471, DOI 10.1073/pnas.1204668109; Hu L, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-43; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kanduri M, 2010, BLOOD, V115, P296, DOI 10.1182/blood-2009-07-232868; Kang YH, 2013, J IMMUNOL, V191, P386, DOI 10.4049/jimmunol.1300481; Kim JK, 2013, HEPATOLOGY, V57, P1055, DOI 10.1002/hep.26101; Kim KI, 2003, BRIT J CANCER, V88, P910, DOI 10.1038/sj.bjc.6600795; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Kondo T, 1997, NAT MED, V3, P409, DOI 10.1038/nm0497-409; Lee SM, 2014, P NATL ACAD SCI USA, V111, P9555, DOI 10.1073/pnas.1400604111; Li CF, 2013, J VIROL, V87, P2193, DOI 10.1128/JVI.02831-12; Li Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.464; Liang XH, 2007, J IMMUNOL, V178, P503, DOI 10.4049/jimmunol.178.1.503; Liu FW, 2013, CLIN RES HEPATOL GAS, V37, P269, DOI 10.1016/j.clinre.2012.09.009; Lopez-Serra P, 2012, ONCOGENE, V31, P1609, DOI 10.1038/onc.2011.354; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Mosca N, 2014, BIOCHEM BIOPH RES CO, V449, P141, DOI 10.1016/j.bbrc.2014.05.009; Mundt B, 2005, GUT, V54, P1590, DOI 10.1136/gut.2004.056929; Potenza N, 2011, NUCLEIC ACIDS RES, V39, P5157, DOI 10.1093/nar/gkr067; Ramsey HE, 2009, LIVER TRANSPLANT, V15, P1613, DOI 10.1002/lt.21879; Schulze-Bergkamen H, 2006, J HEPATOL, V44, P984, DOI 10.1016/j.jhep.2006.02.004; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015; Tian Y, 2013, MOL CELL BIOL, V33, P2810, DOI 10.1128/MCB.00205-13; Tomar D, 2013, BBA-MOL CELL RES, V1833, P3134, DOI 10.1016/j.bbamcr.2013.08.021; Tong HV, 2013, J VIRAL HEPATITIS, V20, P687, DOI 10.1111/jvh.12089; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Wang CM, 2011, BIOCHEM BIOPH RES CO, V411, P586, DOI 10.1016/j.bbrc.2011.06.191; Wei XF, 2013, CELL SIGNAL, V25, P1037, DOI 10.1016/j.cellsig.2013.01.019; Xu C, 2014, CANCER LETT, V345, P216, DOI 10.1016/j.canlet.2013.08.035; Xu F, 2013, J INFECT DIS, V208, P528, DOI 10.1093/infdis/jit177; Xu RZ, 2007, HEPATOLOGY, V46, P1810, DOI 10.1002/hep.21893; Zhang H, 2012, ONCOL REP, V28, P2083, DOI 10.3892/or.2012.2022; Zhang Xiaoyong, 2013, Frontiers in Genetics, V4, P202, DOI 10.3389/fgene.2013.00202	43	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127329	10.1371/journal.pone.0127329	http://dx.doi.org/10.1371/journal.pone.0127329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993287	gold, Green Published, Green Submitted			2022-12-26	WOS:000354921400107
J	De Melo, J; Tang, DM				De Melo, Jason; Tang, Damu			Elevation of SIPL1 (SHARPIN) Increases Breast Cancer Risk	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION PATTERNS; ESTROGEN PLUS PROGESTIN; E3 UBIQUITIN LIGASE; LINEAR UBIQUITINATION; PREMENOPAUSAL WOMEN; SEX STEROIDS; INFLAMMATION; ACTIVATION; DENSITY	SIPL1 (Sharpin) or Sharpin plays a role in tumorigenesis. However, its involvement in breast cancer tumorigenesis remains largely unknown. To investigate this issue, we have systemically analyzed SIPL1 gene amplification and expression data available from Oncomine datasets, which were derived from 17 studies and contained approximately 20,000 genes, 3438 breast cancer cases, and 228 normal individuals. We found a SIPL1 gene amplification in invasive ductal breast cancers compared to normal breast tissues and a significant elevation of SIPL1 mRNA in breast cancers in comparison to non-tumor breast tissues. These results collectively reveal that increases in SIPL1 expression occur during breast cancer tumorigenesis. To further investigate this association, we observed increases in the SIPL1 gene and mRNA in the breast cancer subtypes of estrogen receptor (ER)+, progesterone receptor (PR)+, HER2+, or triple negative. Additionally, a gain of the SIPL1 gene correlated with breast cancer grade and the levels of SIPL1 mRNA associated with both breast cancer stages and grades. Elevation of SIPL1 gene copy and mRNA is linked to a decrease in patient survival, especially for those with PR+, ER+, or HER2-breast cancers. These results are supported by our analysis of SIPL1 protein expression using a tissue microarray containing 224 breast cancer cases, in which higher levels of SIPL1 relate to ER+ and PR+ tumors and AKT activation. Furthermore, we were able to show that progesterone significantly reduced SIPL1 mRNA and protein expression in MCF7 cells. As progesterone enhances breast cancer tumorigenesis in a context dependent manner, inhibition of SIPL1 expression may contribute to progesterone's non-tumorigenic function which might be countered by SIPL1 upregulation. Taken together, we demonstrate a positive correlation of SIPL1 with BC tumorigenesis.	[De Melo, Jason; Tang, Damu] McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada; [De Melo, Jason; Tang, Damu] Father Sean Osullivan Res Inst, Hamilton, ON, Canada; [De Melo, Jason; Tang, Damu] St Josephs Hosp, Hamilton Ctr Kidney Res, Hamilton, ON, Canada	McMaster University; McGill University; McMaster University	Tang, DM (corresponding author), McMaster Univ, Dept Med, Div Nephrol, Hamilton, ON, Canada.	damut@mcmaster.ca	Tang, Damu/AAQ-1786-2021	Tang, Damu/0000-0002-3282-9521; De Melo, Jason/0000-0001-6519-4879	Canadian Institute of Health Research (CIHR) [COP 107971]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institute of Health Research (CIHR) grant (COP 107971) to D. Tang.	Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Belgnaoui SM, 2012, CELL HOST MICROBE, V12, P211, DOI 10.1016/j.chom.2012.06.009; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Benson JR, 2009, LANCET, V373, P1463, DOI 10.1016/S0140-6736(09)60316-0; Bonnefoi Herve, 2007, Lancet Oncol, V8, P1071, DOI 10.1016/S1470-2045(07)70345-5; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Brisken C, 2013, NAT REV CANCER, V13, P385, DOI 10.1038/nrc3518; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Daigo Y, 2003, J GASTROEN HEPATOL, V18, P712, DOI 10.1046/j.1440-1746.2003.03046.x; De Melo J, 2014, INT J MOL MED, V34, P835, DOI 10.3892/ijmm.2014.1840; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Dong LA, 1999, J BIOL CHEM, V274, P32099, DOI 10.1074/jbc.274.45.32099; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Emmerich CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002187; Esserman LJ, 2012, BREAST CANCER RES TR, V132, P1049, DOI 10.1007/s10549-011-1895-2; Fujita H, 2014, MOL CELL BIOL, V34, P1322, DOI 10.1128/MCB.01538-13; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Glass AG, 2001, CLIN CANCER RES, V7, P1843; Hagan CR, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-32; He LZ, 2010, J CLIN INVEST, V120, P2094, DOI 10.1172/JCI40778; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hofseth LJ, 1999, J CLIN ENDOCR METAB, V84, P4559, DOI 10.1210/jc.84.12.4559; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Iwai K, 2011, CELL CYCLE, V10, P3095, DOI 10.4161/cc.10.18.17437; Jung J, 2010, MOL CELL BIOCHEM, V340, P161, DOI 10.1007/s11010-010-0413-x; Kaaks R, 2005, JNCI-J NATL CANCER I, V97, P755, DOI 10.1093/jnci/dji132; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Li C., 2013, J MAT, V2013, P1, DOI DOI 10.1155/2013/547271; Liang Y, 2011, J DERMATOL SCI, V63, P148, DOI 10.1016/j.jdermsci.2011.04.012; Lim S, 2001, MOL CELL NEUROSCI, V17, P385, DOI 10.1006/mcne.2000.0940; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; MacKay C, 2014, CANCER RES, V74, P2246, DOI 10.1158/0008-5472.CAN-13-2131; Mannella P, 2006, J NEUROSCI, V26, P9439, DOI 10.1523/JNEUROSCI.1443-06.2006; MASTERS JRW, 1977, J NATL CANCER I, V58, P1263, DOI 10.1093/jnci/58.5.1263; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; Micheli A, 2004, INT J CANCER, V112, P312, DOI 10.1002/ijc.20403; Moore MR, 1997, J STEROID BIOCHEM, V62, P243, DOI 10.1016/S0960-0760(97)00036-8; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nikolsky Y, 2008, CANCER RES, V68, P9532, DOI 10.1158/0008-5472.CAN-08-3082; O'Lone R, 2004, MOL ENDOCRINOL, V18, P1859, DOI 10.1210/me.2003-0044; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Pouwels J, 2013, CELL REP, V5, P619, DOI 10.1016/j.celrep.2013.10.011; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Rennstam K, 2003, CANCER RES, V63, P8861; Rivenbark AG, 2013, AM J PATHOL, V183, P1113, DOI 10.1016/j.ajpath.2013.08.002; Rocha A, 2008, J CELL BIOCHEM, V103, P607, DOI 10.1002/jcb.21432; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schernhammer ES, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3438; Seute A, 2001, INT J CANCER, V93, P80, DOI 10.1002/ijc.1296; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Sieber S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029993; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Stieglitz B, 2012, J BIOL CHEM, V287, P20823, DOI 10.1074/jbc.M112.359547; Tabchy A, 2010, CLIN CANCER RES, V16, P5351, DOI 10.1158/1078-0432.CCR-10-1265; Tirkkonen M, 1998, GENE CHROMOSOME CANC, V21, P177, DOI 10.1002/(SICI)1098-2264(199803)21:3<177::AID-GCC1>3.3.CO;2-C; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tomonaga M, 2012, INT J ONCOL, V40, P409, DOI 10.3892/ijo.2011.1209; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Wang AT, 2014, MAYO CLIN PROC, V89, P548, DOI 10.1016/j.mayocp.2013.12.014; Wang Z, 2012, ELEKTRON ELEKTROTECH, V18, P7, DOI 10.5755/j01.eee.18.9.2795; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786; Zheng AP, 2007, ENDOCRINOLOGY, V148, P2764, DOI 10.1210/en.2006-1269; Zhou W, 2014, NAT REV CANCER, V14, P26, DOI 10.1038/nrc3622	75	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127546	10.1371/journal.pone.0127546	http://dx.doi.org/10.1371/journal.pone.0127546			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992689	Green Submitted, Green Published, gold			2022-12-26	WOS:000354918600066
J	Dogra, P; Martin, EB; Williams, A; Richardson, RL; Foster, JS; Hackenback, N; Kennel, SJ; Sparer, TE; Wall, JS				Dogra, Pranay; Martin, Emily B.; Williams, Angela; Richardson, Raphael L.; Foster, James S.; Hackenback, Nicole; Kennel, Stephen J.; Sparer, Tim E.; Wall, Jonathan S.			Novel Heparan Sulfate-Binding Peptides for Blocking Herpesvirus Entry	PLOS ONE			English	Article							RESISTANT CYTOMEGALOVIRUS DISEASE; SIMPLEX-VIRUS; IN-VIVO; TRANSPLANT RECIPIENTS; PROTEIN TRANSDUCTION; INFECTION; CELLS; GLYCOSAMINOGLYCANS; PROTEOGLYCANS; MICE	Human cytomegalovirus (HCMV) infection can lead to congenital hearing loss and mental retardation. Upon immune suppression, reactivation of latent HCMV or primary infection increases morbidity in cancer, transplantation, and late stage AIDS patients. Current treatments include nucleoside analogues, which have significant toxicities limiting their usefulness. In this study we screened a panel of synthetic heparin-binding peptides for their ability to prevent CMV infection in vitro. A peptide designated, p5+14 exhibited similar to 90% reduction in murine CMV (MCMV) infection. Because negatively charged, cell-surface heparan sulfate proteoglycans (HSPGs), serve as the attachment receptor during the adsorption phase of the CMV infection cycle, we hypothesized that p5+14 effectively competes for CMV adsorption to the cell surface resulting in the reduction in infection. Positively charged Lys residues were required for peptide binding to cell-surface HSPGs and reducing viral infection. We show that this inhibition was not due to a direct neutralizing effect on the virus itself and that the peptide blocked adsorption of the virus. The peptide also inhibited infection of other herpesviruses: HCMV and herpes simplex virus 1 and 2 in vitro, demonstrating it has broadspectrum antiviral activity. Therefore, this peptide may offer an adjunct therapy for the treatment of herpes viral infections and other viruses that use HSPGs for entry.	[Dogra, Pranay; Sparer, Tim E.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Martin, Emily B.; Williams, Angela; Foster, James S.; Hackenback, Nicole; Kennel, Stephen J.; Wall, Jonathan S.] Univ Tennessee, Dept Med, Grad Sch Med, Knoxville, TN 37996 USA; [Kennel, Stephen J.; Wall, Jonathan S.] Univ Tennessee, Dept Radiol, Grad Sch Med, Knoxville, TN 37996 USA; [Richardson, Raphael L.] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Sparer, TE (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	tsparer@utk.edu		Sparer, Tim/0000-0002-5543-6691; Dogra, Pranay/0000-0003-2031-9855; Hackenbrack, Nicole/0000-0001-9155-5711; Wall, Jonathan/0000-0002-5516-8578; Hackenbrack, Nicky/0000-0002-2344-1533	Physicians Medical, Education and Research Foundation (PMERF) at the University of Tennessee Medical Center, Knoxville; Scholarly and Research Incentive Fund (SARIF) award from the Office of Research Engagement at the University of Tennessee, Knoxville	Physicians Medical, Education and Research Foundation (PMERF) at the University of Tennessee Medical Center, Knoxville; Scholarly and Research Incentive Fund (SARIF) award from the Office of Research Engagement at the University of Tennessee, Knoxville	Funding came from Physicians Medical, Education and Research Foundation (PMERF) at the University of Tennessee Medical Center, Knoxville and a Scholarly and Research Incentive Fund (SARIF) award from the Office of Research Engagement at the University of Tennessee, Knoxville.	Ali MM, 2012, J VIROL, V86, P6434, DOI 10.1128/JVI.00433-12; Biron KK, 2006, ANTIVIR RES, V71, P154, DOI 10.1016/j.antiviral.2006.05.002; Borst EM, 2013, ANTIMICROB AGENTS CH, V57, P4751, DOI 10.1128/AAC.00854-13; COMPTON T, 1993, VIROLOGY, V193, P834, DOI 10.1006/viro.1993.1192; Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200; Crough T, 2009, CLIN MICROBIOL REV, V22, P76, DOI 10.1128/CMR.00034-08; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Fang SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057318; Gerna G, 2004, HUM IMMUNOL, V65, P381, DOI 10.1016/j.humimm.2004.02.009; Griffiths P, 2013, VACCINE, V31, pB197, DOI 10.1016/j.vaccine.2012.10.074; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; Herold BC, 1996, J VIROL, V70, P3461, DOI 10.1128/JVI.70.6.3461-3469.1996; Inoue S, 2005, AMYLOID, V12, P157, DOI 10.1080/13506120500232010; Jaishankar D, 2015, J VIROL, V89, P1932, DOI 10.1128/JVI.02979-14; Jayaraman G, 2000, FEBS LETT, V482, P154, DOI 10.1016/S0014-5793(00)01964-5; KATO M, 1994, J BIOL CHEM, V269, P18881; Le Page AK, 2013, CLIN INFECT DIS, V56, P1018, DOI 10.1093/cid/cis1035; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; Li F, 2007, CLIN INFECT DIS, V45, P439, DOI 10.1086/519941; Limaye AP, 2000, LANCET, V356, P645, DOI 10.1016/S0140-6736(00)02607-6; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026; Lurain NS, 2010, CLIN MICROBIOL REV, V23, P689, DOI 10.1128/CMR.00009-10; Martin EB, 2013, BIOCHEM BIOPH RES CO, V436, P85, DOI 10.1016/j.bbrc.2013.05.063; Merton B, 1999, ANNU REV BIOCHEM, V68, DOI [10.1146/annurev.biochem.68.1.729, DOI 10.1146/ANNUREV.BIOCHEM.68.1.729]; Miller WE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050524; Mocarski Jr E, 2013, FIELDS VIROLOGY, V2, P1960; O'Connor CM, 2011, J VIROL, V85, P3700, DOI 10.1128/JVI.02442-10; Payne CK, 2007, TRAFFIC, V8, P389, DOI 10.1111/j.1600-0854.2007.00540.x; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; Ramanan P, 2013, INFECT CHEMOTHER, V45, P260, DOI 10.3947/ic.2013.45.3.260; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rullo A, 2010, BIOPOLYMERS, V93, P290, DOI 10.1002/bip.21339; Saederup N, 2001, J VIROL, V75, P9966, DOI 10.1128/JVI.75.20.9966-9976.2001; Sampaio KL, 2005, J VIROL, V79, P2754, DOI 10.1128/JVI.79.5.2754-2767.2005; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; Schleiss MR, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/501801; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; Smits NC, 2010, J BIOL CHEM, V285, P41143, DOI 10.1074/jbc.M110.153791; Sung H, 2010, EXPERT REV VACCINES, V9, P1303, DOI [10.1586/erv.10.125, 10.1586/ERV.10.125]; Tiwari V, 2011, J BIOL CHEM, V286, P25406, DOI 10.1074/jbc.M110.201103; Vanarsdall AL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002905; Vanarsdall AL, 2012, CURR OPIN VIROL, V2, P37, DOI 10.1016/j.coviro.2012.01.001; Vaux DL, 2014, ANNU REV CELL DEV BI, V30, P23, DOI 10.1146/annurev-cellbio-100913-013303; Vaux DL, 2012, EMBO REP, V13, P291, DOI 10.1038/embor.2012.36; Wadstrom T, 1999, J MED MICROBIOL, V48, P223, DOI 10.1099/00222615-48-3-223; Wall Jonathan S, 2011, Tijdschr Nucl Geneeskd, V33, P807; Wall JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066181; Wall JS, 2012, MOL IMAGING BIOL, V14, P402, DOI 10.1007/s11307-011-0524-0; Wall JS, 2012, NUCL MED BIOL, V39, P65, DOI 10.1016/j.nucmedbio.2011.06.007; Wall JS, 2011, P NATL ACAD SCI USA, V108, pE586, DOI 10.1073/pnas.1103247108; Watanabe N, 2004, FASEB J, V18, P1013, DOI 10.1096/fj.03-1040fje; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	55	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126239	10.1371/journal.pone.0126239	http://dx.doi.org/10.1371/journal.pone.0126239			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992785	Green Published, Green Submitted, gold			2022-12-26	WOS:000354917300035
J	Honda, JR; Hess, T; Malcolm, KC; Ovrutsky, AR; Bai, XY; Irani, VR; Dobos, KM; Chan, ED; Flores, SC				Honda, Jennifer R.; Hess, Tamara; Malcolm, Kenneth C.; Ovrutsky, Alida R.; Bai, Xiyuan; Irani, Vida R.; Dobos, Karen M.; Chan, Edward D.; Flores, Sonia C.			Pathogenic Nontuberculous Mycobacteria Resist and Inactivate Cathelicidin: Implication of a Novel Role for Polar Mycobacterial Lipids	PLOS ONE			English	Article							AVIUM COMPLEX; CELL-WALL; LUNG-DISEASE; ANTIMICROBIAL PEPTIDES; COLONY MORPHOLOGY; EPITHELIAL-CELLS; TUBERCULOSIS; EXPRESSION; SURFACE; GLYCOPEPTIDOLIPIDS	Nontuberculous mycobacteria (NTM) are a large group of environmental organisms with worldwide distribution, but only a relatively few are known to be pathogenic. Chronic, debilitating lung disease is the most common manifestation of NTM infection, which is often refractory to treatment. The incidence and prevalence of NTM lung disease are increasing in the United States and in many parts of the world. Hence, a more complete understanding of NTM pathogenesis will provide the foundation to develop innovative approaches to treat this recalcitrant disease. Herein, we demonstrate that several species of NTM show broad resistance to the antimicrobial peptide, cathelicidin (LL-37). Resistance to LL-37 was not significantly different between M. avium that contain serovar-specific glycopeptidolipid (GPL, M. avium(ssGPL)) and M. avium that do not (M. avium(Delta ssGPL)). Similarly, M. abscessus containing non-specific GPL (M. abscessus(nsGPL(+))) or lacking nsGPL (M. abscessus(nsGPL(-))) remained equally resistant to LL-37. These findings would support the notion that GPL are not the components responsible for NTM resistance to LL-37. Unexpectedly, the growth of M. abscessus(nsGPL(-)) increased with LL-37 or scrambled LL-37 peptide in a dose-dependent fashion. We also discovered that LL-37 exposed to NTM had reduced antimicrobial activity, and initial work indicates that this is likely due to inactivation of LL-37 by lipid component(s) of the NTM cell envelope. We conclude that pathogenic NTM resist and inactivate LL-37. The mechanism by which NTM circumvent the antimicrobial activity of LL-37 remains to be determined.	[Honda, Jennifer R.; Malcolm, Kenneth C.; Chan, Edward D.; Flores, Sonia C.] Univ Colorado, Div Pulm Sci & Crit Care Med, Dept Med, Aurora, CO USA; [Honda, Jennifer R.; Malcolm, Kenneth C.; Ovrutsky, Alida R.; Bai, Xiyuan; Chan, Edward D.] Natl Jewish Hlth, Denver, CO USA; [Hess, Tamara] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Irani, Vida R.] Indiana Univ Penn, Dept Biol, Indiana, PA USA; [Honda, Jennifer R.; Ovrutsky, Alida R.; Bai, Xiyuan; Chan, Edward D.] Denver Vet Affairs Med Ctr, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; Colorado State University; Pennsylvania State System of Higher Education (PASSHE); Indiana University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Honda, JR (corresponding author), Univ Colorado, Div Pulm Sci & Crit Care Med, Anschutz Med Campus, Aurora, CO 80045 USA.	Jennifer.Honda@ucdenver.edu	Dobos, Karen/D-1170-2017	Dobos, Karen/0000-0001-7115-8524	National Institutes of Health (NIH) [3R01HL059785-09S1]; University of Colorado Anschutz Medical Campus Pulmonary and Critical Care Division; NIH NRSA Infectious Disease Training Award [T32-AI007447-19]; Tim Gill Endowment for AIDS Research, NIH NRSA Pulmonary and Critical Care Medicine Training Award [T32 HL 7085-83]; Potts Memorial Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007085, R01HL059785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007447] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado Anschutz Medical Campus Pulmonary and Critical Care Division; NIH NRSA Infectious Disease Training Award; Tim Gill Endowment for AIDS Research, NIH NRSA Pulmonary and Critical Care Medicine Training Award; Potts Memorial Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Study support was provided in part by Institutional Funds and the National Institutes of Health (NIH) Supplement 3R01HL059785-09S1 for SCF, University of Colorado Anschutz Medical Campus Pulmonary and Critical Care Division. JRH is supported by a NIH NRSA Infectious Disease Training Award (T32-AI007447-19), the Tim Gill Endowment for AIDS Research, NIH NRSA Pulmonary and Critical Care Medicine Training Award (T32 HL 7085-83), and the Potts Memorial Foundation.	Adjemian J, 2012, AM J RESP CRIT CARE, V185, P881, DOI 10.1164/rccm.201111-2016OC; Agerberth B, 2006, CURR TOP MICROBIOL, V306, P67; Bai XY, 2011, INT IMMUNOL, V23, P679, DOI 10.1093/intimm/dxr075; BARNES PF, 1989, J IMMUNOL, V143, P2656; BELISLE JT, 1993, J BIOL CHEM, V268, P10517; BESRA GS, 1995, BIOCHEMISTRY-US, V34, P4257, DOI 10.1021/bi00013a015; Billman-Jacobe H, 2004, CURR SCI INDIA, V86, P111; BRENNAN PJ, 1982, J CLIN MICROBIOL, V15, P447, DOI 10.1128/JCM.15.3.447-455.1982; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Chatterjee D, 2001, CELL MOL LIFE SCI, V58, P2018, DOI 10.1007/PL00000834; Chick JFB, 2013, INTERN EMERG MED, V8, P83, DOI 10.1007/s11739-012-0870-1; Collier SA, 2012, EPIDEMIOL INFECT, V140, P2003, DOI 10.1017/S0950268811002858; Falkinham JO, 2002, CLIN CHEST MED, V23, P529, DOI 10.1016/S0272-5231(02)00014-X; Falkinham JO, 2011, EMERG INFECT DIS, V17, P419, DOI 10.3201/eid1703.101510; Freeman R, 2006, APPL ENVIRON MICROB, V72, P7554, DOI 10.1128/AEM.01633-06; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Griffith DE, 2010, CURR OPIN INFECT DIS, V23, P185, DOI 10.1097/QCO.0b013e328336ead6; Henzler-Wildman KA, 2004, BIOCHEMISTRY-US, V43, P8459, DOI 10.1021/bi036284s; Howard ST, 2006, MICROBIOL-SGM, V152, P1581, DOI 10.1099/mic.0.28625-0; Irani Vida R, 2004, Ann Clin Microbiol Antimicrob, V3, P18, DOI 10.1186/1476-0711-3-18; Kansal RG, 1998, MICROB PATHOGENESIS, V25, P203, DOI 10.1006/mpat.1998.0227; Kocincova D, 2008, TUBERCULOSIS, V88, P390, DOI 10.1016/j.tube.2008.02.005; Lai CC, 2010, EMERG INFECT DIS, V16, P294, DOI 10.3201/eid1602.090675; LARRICK JW, 1995, IMMUNOTECHNOLOGY, V1, P65, DOI 10.1016/1380-2933(95)00006-2; Layre E, 2013, BIOCHIMIE, V95, P109, DOI 10.1016/j.biochi.2012.08.012; Layre E, 2011, CHEM BIOL, V18, P1537, DOI 10.1016/j.chembiol.2011.10.013; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; LOPEZMARIN LM, 1994, BIOCHEMISTRY-US, V33, P7056, DOI 10.1021/bi00189a006; Lytle D, 2004, APPL ENVIRON MICROB, V70, P5667, DOI 10.1128/AEM.70.9.5667-5671.2004; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; Mawuenyega KG, 2005, MOL BIOL CELL, V16, P396, DOI 10.1091/mbc.e04-04-0329; McGrath EE, 2010, LUNG, V188, P269, DOI 10.1007/s00408-010-9240-9; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; Moore JE, 2006, BMC PUBLIC HEALTH, V10, P612, DOI DOI 10.1186/1471-2458-10-612; Motamedi N, 2014, J MED MICROBIOL, V63, P923, DOI 10.1099/jmm.0.072744-0; Nizet V, 2006, CURR ISSUES MOL BIOL, V8, P11; OrtaloMagne A, 1996, J BACTERIOL, V178, P456, DOI 10.1128/jb.178.2.456-461.1996; Recht J, 2001, J BACTERIOL, V183, P5718, DOI 10.1128/JB.183.19.5718-5724.2001; Reddy VM, 1996, MICROB PATHOGENESIS, V21, P97, DOI 10.1006/mpat.1996.0046; Rhoades ER, 2009, J IMMUNOL, V183, P1997, DOI 10.4049/jimmunol.0802181; Ripoll F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-114; Rivas-Santiago B, 2008, INFECT IMMUN, V76, P935, DOI 10.1128/IAI.01218-07; Rodrigues L, 2009, INT J ANTIMICROB AG, V34, P529, DOI 10.1016/j.ijantimicag.2009.07.010; Sartain MJ, 2011, J LIPID RES, V52, P861, DOI 10.1194/jlr.M010363; Schmalstieg AM, 2012, ANTIMICROB AGENTS CH, V56, P4806, DOI 10.1128/AAC.05546-11; Schorey JS, 2008, GLYCOBIOLOGY, V18, P832, DOI 10.1093/glycob/cwn076; Somoskovi A, 2014, CLIN LAB MED, V34, P271, DOI 10.1016/j.cll.2014.03.001; Sorensen O, 1997, J IMMUNOL METHODS, V206, P53, DOI 10.1016/S0022-1759(97)00084-7; Thomson RM, 2010, EMERG INFECT DIS, V16, P1576, DOI 10.3201/eid1610.091201; Torrelles JB, 2002, TUBERCULOSIS, V82, P293, DOI 10.1054/tube.2002.0373; Travis SM, 2001, CURR OPIN IMMUNOL, V13, P89, DOI 10.1016/S0952-7915(00)00187-4; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Weiss CH, 2012, EXPERT REV RESP MED, V6, P597, DOI [10.1586/ERS.12.58, 10.1586/ers.12.58]; Wolfe LM, 2010, J PROTEOME RES, V9, P5816, DOI 10.1021/pr1005873	54	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126994	10.1371/journal.pone.0126994	http://dx.doi.org/10.1371/journal.pone.0126994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993058	Green Published, gold			2022-12-26	WOS:000354917300075
J	Sebeson, A; Xi, LQ; Zhang, QW; Sigmund, A; Wang, JP; Widom, J; Wang, XZ				Sebeson, Amy; Xi, Liqun; Zhang, Quanwei; Sigmund, Audrey; Wang, Ji-Ping; Widom, Jonathan; Wang, Xiaozhong			Differential Nucleosome Occupancies across Oct4-Sox2 Binding Sites in Murine Embryonic Stem Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; HIGH-RESOLUTION; GENOME-WIDE; IN-VIVO; COLLABORATIVE COMPETITION; SEQUENCE PREFERENCES; CHROMATIN-STRUCTURE; DNA INTERACTIONS; GENE-EXPRESSION; YEAST	The binding sequence for any transcription factor can be found millions of times within a genome, yet only a small fraction of these sequences encode functional transcription factor binding sites. One of the reasons for this dichotomy is that many other factors, such as nucleosomes, compete for binding. To study how the competition between nucleosomes and transcription factors helps determine a functional transcription factor site from a predicted transcription factor site, we compared experimentally-generated in vitro nucleosome occupancy with in vivo nucleosome occupancy and transcription factor binding in murine embryonic stem cells. Using a solution hybridization enrichment technique, we generated a high-resolution nucleosome map from targeted regions of the genome containing predicted sites and functional sites of Oct4/Sox2 regulation. We found that at Pax6 and Nes, which are bivalently poised in stem cells, functional Oct4 and Sox2 sites show high amounts of in vivo nucleosome displacement compared to in vitro. Oct4 and Sox2, which are active, show no significant displacement of in vivo nucleosomes at functional sites, similar to nonfunctional Oct4/Sox2 binding. This study highlights a complex interplay between Oct4 and Sox2 transcription factors and nucleosomes among different target genes, which may result in distinct patterns of stem cell gene regulation.	[Sebeson, Amy; Sigmund, Audrey; Widom, Jonathan; Wang, Xiaozhong] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Xi, Liqun; Zhang, Quanwei; Wang, Ji-Ping] Northwestern Univ, Dept Stat, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Wang, JP (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	jzwang@northwestern.edu; awang@northwestern.edu			National Institutes of Health [R01GM058617, U54CA143869, R01GM107177]; American Heart Association; NATIONAL CANCER INSTITUTE [U54CA143869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058617, R01GM107177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the National Institutes of Health under Awards R01GM058617, U54CA143869 and R01GM107177 and by a predoctoral grant from the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Carr A, 2000, NUCLEIC ACIDS RES, V28, P2839, DOI 10.1093/nar/28.14.2839; Charoensawan V, 2012, MOL CELL, V47, P183, DOI 10.1016/j.molcel.2012.06.028; Cheng Q, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003571; Chung HR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015754; Deniz O, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-489; Ercan S, 2011, GENOME RES, V21, P237, DOI 10.1101/gr.115931.110; FENG HP, 1993, BIOCHEMISTRY-US, V32, P7824, DOI 10.1021/bi00081a030; Goke J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002304; Holmqvist PH, 2005, EXP CELL RES, V304, P593, DOI 10.1016/j.yexcr.2004.12.002; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kaplan T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001290; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Liber D, 2010, CELL STEM CELL, V7, P114, DOI 10.1016/j.stem.2010.05.020; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Makeev VJ, 2003, NUCLEIC ACIDS RES, V31, P6016, DOI 10.1093/nar/gkg799; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller JA, 2003, MOL CELL BIOL, V23, P1623, DOI 10.1128/MCB.23.5.1623-1632.2003; Moyle-Heyrman G, 2013, P NATL ACAD SCI USA, V110, P20158, DOI 10.1073/pnas.1315809110; Moyle-Heyrman G, 2011, J MOL BIOL, V412, P634, DOI 10.1016/j.jmb.2011.07.032; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nalabothula N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-391; Nili EL, 2010, GENOME RES, V20, P1361, DOI 10.1101/gr.103945.109; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Poirier MG, 2009, NAT STRUCT MOL BIOL, V16, P938, DOI 10.1038/nsmb.1650; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Raveh-Sadka T, 2012, NAT GENET, V44, P743, DOI 10.1038/ng.2305; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Sekiya T, 2009, GENE DEV, V23, P804, DOI 10.1101/gad.1775509; Smale ST, 2010, CURR OPIN GENET DEV, V20, P519, DOI 10.1016/j.gde.2010.06.010; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Teif VB, 2012, NAT STRUCT MOL BIOL, V19, P1185, DOI 10.1038/nsmb.2419; Tillo D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009129; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Vashee S, 1998, CURR BIOL, V8, P452, DOI 10.1016/S0960-9822(98)70179-4; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003; Yigit E, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt081; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	58	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127214	10.1371/journal.pone.0127214	http://dx.doi.org/10.1371/journal.pone.0127214			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992972	Green Published, Green Submitted, gold			2022-12-26	WOS:000354917300102
J	Lindert, U; Weis, MA; Rai, J; Seeliger, F; Hausser, I; Leeb, T; Eyre, D; Rohrbach, M; Giunta, C				Lindert, Uschi; Weis, Mary Ann; Rai, Jyoti; Seeliger, Frank; Hausser, Ingrid; Leeb, Tosso; Eyre, David; Rohrbach, Marianne; Giunta, Cecilia			Molecular Consequences of the SERPINH1/HSP47 Mutation in the Dachshund Natural Model of Osteogenesis Imperfecta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EHLERS-DANLOS-SYNDROME; ENDOPLASMIC-RETICULUM; CROSS-LINKS; I COLLAGEN; BONE-COLLAGEN; ALPHA-CHAINS; PROCOLLAGEN; CHAPERONE; HSP47; PROTEIN	Osteogenesis imperfecta (OI) is a heritable connective tissue disease characterized by bone fragility and increased risk of fractures. Up to now, mutations in at least 18 genes have been associated with dominant and recessive forms of OI that affect the production or post-translational processing of procollagen or alter bone homeostasis. Among those, SERPINH1 encoding heat shock protein 47 (HSP47), a chaperone exclusive for collagen folding in the ER, was identified to cause a severe form of OI in dachshunds (L326P) as well as in humans (one single case with a L78P mutation). To elucidate the disease mechanism underlying OI in the dog model, we applied a range of biochemical assays to mutant and control skin fibroblasts as well as on bone samples. These experiments revealed that type I collagen synthesized by mutant cells had decreased electrophoretic mobility. Procollagen was retained intracellularly with concomitant dilation of ER cisternae and activation of the ER stress response markers GRP78 and phospho-eIF2 alpha, thus suggesting a defect in procollagen processing. In line with the migration shift detected on SDS-PAGE of cell culture collagen, extracts of bone collagen from the OI dog showed a similar mobility shift, and on tandem mass spectrometry, the chains were post-translationally over-modified. The bone collagen had a higher content of pyridinoline than control dog bone. We conclude that the SERPINH1 mutation in this naturally occurring model of OI impairs how HSP47 acts as a chaperone in the ER. This results in abnormal post-translational modification and cross-linking of the bone collagen.	[Lindert, Uschi; Rohrbach, Marianne; Giunta, Cecilia] Univ Childrens Hosp Zurich, Connect Tissue Unit, Div Metab, Childrens Res Ctr, CH-8032 Zurich, Switzerland; [Weis, Mary Ann; Rai, Jyoti; Eyre, David] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Seeliger, Frank] AstraZeneca, Drug Safety & Metab, S-43183 Molndal, Sweden; [Hausser, Ingrid] Univ Heidelberg Hosp, Inst Pathol, D-69120 Heidelberg, Germany; [Hausser, Ingrid] Heidelberg Univ, Electron Microscopy Core Facil, D-69120 Heidelberg, Germany; [Leeb, Tosso] Univ Bern, Inst Genet, Vetsuisse Fac, CH-3001 Bern, Switzerland	University Children's Hospital Zurich; University of Washington; University of Washington Seattle; AstraZeneca; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Bern	Giunta, C (corresponding author), Univ Childrens Hosp Zurich, Connect Tissue Unit, Div Metab, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	Cecilia.Giunta@kispi.uzh.ch	Giunta, Cecilia/T-8222-2019; Leeb, Tosso/G-3187-2014	Giunta, Cecilia/0000-0002-9313-8257; Leeb, Tosso/0000-0003-0553-4880; Rohrbach, Marianne/0000-0002-4013-6012	Swiss National Foundation (SNF) [310030_138288]; Gottfried und Julia Bangerter-Rhyner-Stiftung; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR037318, R01AR036794] Funding Source: NIH RePORTER	Swiss National Foundation (SNF)(Swiss National Science Foundation (SNSF)); Gottfried und Julia Bangerter-Rhyner-Stiftung; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by the Swiss National Foundation (SNF-Grant 310030_138288) and the Gottfried und Julia Bangerter-Rhyner-Stiftung. The authors declare that they have no conflicts of interest with the contents of this article.	Banse X, 2003, J BONE MINER RES, V18, P1247, DOI 10.1359/jbmr.2003.18.7.1247; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Cabral WA, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.040493; Cabral WA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004465; Cabral WA, 2012, GENET MED, V14, P543, DOI 10.1038/gim.2011.44; CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; Eyre DR, 2013, CALCIFIED TISSUE INT, V93, P338, DOI 10.1007/s00223-013-9723-9; Forlino A, 2007, PROTEOMICS, V7, P1877, DOI 10.1002/pmic.200600919; Garbes L, 2015, AM J HUM GENET, V96, P432, DOI 10.1016/j.ajhg.2015.01.002; Giunta C, 2008, AM J HUM GENET, V82, P1290, DOI 10.1016/j.ajhg.2008.05.001; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Kraenzlin ME, 2008, CLIN CHEM, V54, P1546, DOI 10.1373/clinchem.2008.105262; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Lisse TS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040007; Makareeva E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001029; Makareeva E, 2011, TRENDS CELL BIOL, V21, P168, DOI 10.1016/j.tcb.2010.11.007; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Nagata K, 1996, TRENDS BIOCHEM SCI, V21, P23, DOI 10.1016/0968-0004(96)80881-4; Nagata K, 1998, MATRIX BIOL, V16, P379, DOI 10.1016/S0945-053X(98)90011-7; NAKAI A, 1992, J CELL BIOL, V117, P903, DOI 10.1083/jcb.117.4.903; Rauch F, 2015, AM J HUM GENET, V96, P425, DOI 10.1016/j.ajhg.2014.12.027; Risteli J., 1994, J BONE MINER RES, V9, pS186; Rohrbach M, 2012, AM J MED GENET C, V160C, P175, DOI 10.1002/ajmg.c.31334; Satoh T, 1996, J BIOL CHEM, V271, P27919, DOI 10.1074/jbc.271.44.27919; Schwarze U, 2013, HUM MOL GENET, V22, P1, DOI 10.1093/hmg/dds371; Seeliger F, 2003, VET PATHOL, V40, P530, DOI 10.1354/vp.40-5-530; SMITH T, 1995, J BIOL CHEM, V270, P18323, DOI 10.1074/jbc.270.31.18323; STEINMANN B, 1995, AM J HUM GENET, V57, P1505; Thomson CA, 2000, BIOCHEM J, V349, P877, DOI 10.1042/bj3490877; Van Dijk FS, 2014, AM J MED GENET A, V164, P1470, DOI 10.1002/ajmg.a.36545; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; WU JJ, 1992, J BIOL CHEM, V267, P23007	38	34	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17679	17689		10.1074/jbc.M115.661025	http://dx.doi.org/10.1074/jbc.M115.661025			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26004778	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000358511700004
J	Basile, LFH; Sato, JR; Pasquini, HA; Lozano, MD; Nucci, MP; Velasques, B; Ribeiro, P; Ramos, RT; Anghina, R				Basile, Luis F. H.; Sato, Joao R.; Pasquini, Henrique A.; Lozano, Mirna D.; Nucci, Mariana P.; Velasques, Bruna; Ribeiro, Pedro; Ramos, Renato T.; Anghina, Renato			Individual Topographic Variability Is Inherent to Cortical Physiology but Task-Related Differences May Be Noise	PLOS ONE			English	Article							INCIDENTAL FINDINGS; FUNCTIONAL MRI; BRAIN; GENERATION; ATTENTION; CORTEX; FMRI; POTENTIALS; NETWORK; AREAS	The observation of highly variable sets of association neocortical areas across individuals, containing the estimated generators of Slow Potentials (SPs) and beta oscillations, lead to the persistence in individual analyses. This brought to notice an unexpected within individual topographic similarity between task conditions, despite our original interest in task-related differences. A recent related work explored the quantification of the similarity in beta topography between largely differing tasks. In this article, we used Independent Component Analysis (ICA) for the decomposition of beta activity from a visual attention task, and compared it with quiet resting, recorded by 128-channel EEG in 62 subjects. We statistically tested whether each ICA component obtained in one condition could be explained by a linear regression model based on the topographic patterns from the other condition, in each individual. Results were coherent with the previous report, showing a high topographic similarity between conditions. From an average of 12 beta component maps obtained for each task, over 80% were satisfactorily explained by the complementary task. Once more, the component maps including those considered unexplained, putatively "task-specific", had their scalp distribution and estimated cortical sources highly variable across subjects. These findings are discussed along with other studies based on individual data and the present fMRI results, reinforcing the increasingly accepted view that individual variability in sets of active neocortical association areas is not noise, but intrinsic to cortical physiology. Actual 'noise', mainly stemming from group "brain averaging" and the emphasis on statistical differences as opposed to similarities, may explain the overall hardship in replication of the vast literature on supposed task-specific forms of activity, and the ever inconclusive status of a universal functional mapping of cortical association areas. A new hypothesis, that individuals may use the same idiosyncratic sets of areas, at least by their fraction of activity in the sub-delta and beta range, in various non-sensory-motor forms of conscious activities, is a corollary of the discussed variability.	[Basile, Luis F. H.; Pasquini, Henrique A.; Lozano, Mirna D.] UMESP, Fac Saude, Psychophysiol Lab, Sao Paulo, SP, Brazil; [Basile, Luis F. H.] Univ Sao Paulo, Sch Med, Dept Neurol, Div Neurosurg, Sao Paulo, SP, Brazil; [Sato, Joao R.] Fed Univ ABC, Ctr Math Computat & Cognit, Santo Andre, SP, Brazil; [Nucci, Mariana P.] Univ Sao Paulo, Sch Med, Dept Radiol, Sao Paulo, SP, Brazil; [Velasques, Bruna; Ribeiro, Pedro] Univ Fed Rio de Janeiro, Dept Psychiat, Rio De Janeiro, RJ, Brazil; [Ramos, Renato T.] Univ Sao Paulo, Sch Med, Dept Psychiat, Sao Paulo, SP, Brazil; [Anghina, Renato] Univ Sao Paulo, Sch Med, Dept Neurol, Sao Paulo, SP, Brazil	Universidade Metodista de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade de Sao Paulo	Basile, LFH (corresponding author), UMESP, Fac Saude, Psychophysiol Lab, Sao Paulo, SP, Brazil.	lbasile@usp.br	Ramos, Renato T/G-1566-2013; Nucci, Mariana/AAM-6841-2021; Nucci, Mariana/AAC-4990-2020	Nucci, Mariana/0000-0002-1502-9215; Sato, Joao Ricardo/0000-0002-7503-9781	FAPESP, Sao Paulo, Brazil [2013/07236-0]	FAPESP, Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grant 2013/07236-0 from FAPESP, Sao Paulo, Brazil.	Aziz-Zadeh L, 2008, SOC NEUROSCI-UK, V3, P229, DOI 10.1080/17470910701414604; Barbas H, 1992, Adv Neurol, V57, P91; Basile LFH, 2003, INT J PSYCHOPHYSIOL, V48, P55, DOI 10.1016/S0167-8760(03)00004-7; Basile LFH, 2002, INT J PSYCHOPHYSIOL, V45, P227, DOI 10.1016/S0167-8760(02)00014-4; Basile LFH, 2007, INT J PSYCHOPHYSIOL, V65, P238, DOI 10.1016/j.ijpsycho.2007.05.001; Basile LFH, 2006, INT J PSYCHOPHYSIOL, V61, P149, DOI 10.1016/j.ijpsycho.2005.09.004; Basile LFH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059595; Basile LFH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015022; Bibbig A, 2002, J NEUROPHYSIOL, V88, P1634, DOI 10.1152/jn.2002.88.4.1634; Brannen JH, 2001, AM J NEURORADIOL, V22, P1711; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Davis KD, 1998, J NEUROPHYSIOL, V80, P1533, DOI 10.1152/jn.1998.80.3.1533; Devlin JT, 2007, NEUROIMAGE, V37, P1033, DOI 10.1016/j.neuroimage.2006.09.055; Duffau H, 2012, Adv Tech Stand Neurosurg, V38, P3, DOI 10.1007/978-3-7091-0676-1_1; Duffau H, 2012, CORTEX, V48, P120, DOI 10.1016/j.cortex.2011.04.029; Ekstrom A, 2010, BRAIN RES REV, V62, P233, DOI 10.1016/j.brainresrev.2009.12.004; Epstein RA, 2006, NEUROPSYCHOLOGIA, V44, P1145, DOI 10.1016/j.neuropsychologia.2005.10.009; Eskandary H, 2005, SURG NEUROL, V63, P550, DOI 10.1016/j.surneu.2004.07.049; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; Fuster J.M., 1989, PREFRONTAL CORTEX; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; Haist F, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00181; He BJ, 2009, TRENDS COGN SCI, V13, P302, DOI 10.1016/j.tics.2009.04.004; Herholz K, 1996, NEUROIMAGE, V3, P185, DOI 10.1006/nimg.1996.0020; Hinterberger T, 2003, EXP BRAIN RES, V152, P113, DOI 10.1007/s00221-003-1515-4; Hudson AJ, 2000, CAN J NEUROL SCI, V27, P2, DOI 10.1017/S0317167100051908; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kaminski J, 2012, INT J PSYCHOPHYSIOL, V85, P125, DOI 10.1016/j.ijpsycho.2011.11.006; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36; Khader P, 2008, INT J PSYCHOPHYSIOL, V67, P252, DOI 10.1016/j.ijpsycho.2007.05.018; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Macko K A, 1985, Res Publ Assoc Res Nerv Ment Dis, V63, P73; Mazoyer, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; McCallum W., 1988, HDB ELECTROENCEPHALO, V3, P427; Mechelli A, 2002, NEUROIMAGE, V17, P1459, DOI 10.1006/nimg.2002.1231; Naito E, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00594; Noppency U, 2004, J ANATOMY, V205, P6; Onton J, 2006, NEUROSCI BIOBEHAV R, V30, P808, DOI 10.1016/j.neubiorev.2006.06.007; Pandya D.N., 1988, P39; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Ranganath C, 2004, COGNITIVE BRAIN RES, V20, P37, DOI 10.1016/j.cogbrainres.2003.11.017; Seghier ML, 2007, NEUROIMAGE, V36, P594, DOI 10.1016/j.neuroimage.2007.03.021; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Xu YD, 2007, J NEUROSCI, V27, P5981, DOI 10.1523/JNEUROSCI.5527-06.2007; Zilles K, 2013, TRENDS COGN SCI, V17, P153, DOI 10.1016/j.tics.2013.02.003; [No title captured]	52	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128343	10.1371/journal.pone.0128343	http://dx.doi.org/10.1371/journal.pone.0128343			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010428	Green Published, gold			2022-12-26	WOS:000355183900227
J	Dosedelova, H; Dumkova, J; Lesot, H; Glocova, K; Kunova, M; Tucker, AS; Vesela, I; Krejci, P; Tichy, F; Hampl, A; Buchtova, M				Dosedelova, Hana; Dumkova, Jana; Lesot, Herve; Glocova, Kristyna; Kunova, Michaela; Tucker, Abigail S.; Vesela, Iva; Krejci, Pavel; Tichy, Frantisek; Hampl, Ales; Buchtova, Marcela			Fate of the Molar Dental Lamina in the Monophyodont Mouse	PLOS ONE			English	Article							STEM-CELLS; TOOTH REPLACEMENT; BASAL LAMINA; PROLIFERATION; HEDGEHOG; TEETH; MORPHOGENESIS; SOX2; INITIATION; DENTITION	The successional dental lamina (SDL) plays an essential role in the development of replacement teeth in diphyodont and polyphyodont animals. A morphologically similar structure, the rudimental successional dental lamina (RSDL), has been described in monophyodont (only one tooth generation) lizards on the lingual side of the developing functional tooth. This rudimentary lamina regresses, which has been proposed to play a role in preventing the formation of future generations of teeth. A similar rudimentary lingual structure has been reported associated with the first molar in the monophyodont mouse, and we show that this structure is common to all murine molars. Intriguingly, a lingual lamina is also observed on the non-replacing molars of other diphyodont mammals (pig and hedgehog), initially appearing very similar to the successional dental lamina on the replacing teeth. We have analyzed the morphological as well as ultrastructural changes that occur during the development and loss of this molar lamina in the mouse, from its initiation at late embryonic stages to its disappearance at postnatal stages. We show that loss appears to be driven by a reduction in cell proliferation, down-regulation of the progenitor marker Sox2, with only a small number of cells undergoing programmed cell death. The lingual lamina was associated with the dental stalk, a short epithelial connection between the tooth germ and the oral epithelium. The dental stalk remained in contact with the oral epithelium throughout tooth development up to eruption when connective tissue and numerous capillaries progressively invaded the dental stalk. The buccal side of the dental stalk underwent keratinisation and became part of the gingival epithelium, while most of the lingual cells underwent programmed cell death and the tissue directly above the erupting tooth was shed into the oral cavity.	[Dosedelova, Hana; Glocova, Kristyna; Vesela, Iva; Tichy, Frantisek; Buchtova, Marcela] Univ Vet & Pharmaceut Sci, Fac Vet Med, Dept Anat Histol & Embryol, Brno, Czech Republic; [Dosedelova, Hana; Vesela, Iva; Buchtova, Marcela] Acad Sci Czech Republ, Vvi, Inst Anim Physiol & Genet, Brno, Czech Republic; [Dumkova, Jana; Hampl, Ales] Masaryk Univ, Fac Med, Dept Histol & Embryol, Brno, Czech Republic; [Lesot, Herve] Univ Strasbourg, INSERM, Team Osteoarticular & Dent Regenerat NanoMed, UMR1109, Strasbourg, France; [Lesot, Herve] Univ Strasbourg, Fac Chirurg Dent, Strasbourg, France; [Kunova, Michaela; Krejci, Pavel] Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic; [Tucker, Abigail S.] Kings Coll London, Dept Craniofacial Dev & Stem Cell Biol, London, England; [Tucker, Abigail S.] Kings Coll London, Inst Dent, Dept Orthodont, London, England; [Buchtova, Marcela] Masaryk Univ, Fac Sci, Dept Expt Biol, Brno, Czech Republic	University of Veterinary Sciences Brno; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Masaryk University Brno; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Masaryk University Brno; University of London; King's College London; University of London; King's College London; Masaryk University Brno	Buchtova, M (corresponding author), Univ Vet & Pharmaceut Sci, Fac Vet Med, Dept Anat Histol & Embryol, Brno, Czech Republic.	buchtova@iach.cz	Hampl, Ales/N-1632-2016; Krejčí, Pavel/I-4285-2014; Lesot, Herve/AAM-4523-2021; Tucker, Abigail S/K-1788-2016	Hampl, Ales/0000-0002-8963-9235; Tucker, Abigail S/0000-0001-8871-6094; Krejci, Pavel/0000-0003-0618-9134; Dumkova, Jana/0000-0002-2834-6316; Vesela, Iva/0000-0001-5751-0130; Bosakova, Michaela/0000-0002-7627-0344	Internal Grant Agency UVPS [96/2014/FVL]; Czech Science Foundation/GACR [14-37368G, 14-29273P]; Ministry of Education, Youth and Sports/OPVK [CZ.1.074/2.3.00/30.0053]; IRP IPAG [AVOZ 5045015]; Academy of Sciences of the Czech Republic [M200451201]	Internal Grant Agency UVPS; Czech Science Foundation/GACR(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports/OPVK; IRP IPAG; Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	The research was supported by Internal Grant Agency UVPS (96/2014/FVL), Czech Science Foundation/GACR (14-37368G to MB lab, 14-29273P to IV), Ministry of Education, Youth and Sports/OPVK (CZ.1.074/2.3.00/30.0053) and the labs run under IRP IPAG (No. AVOZ 5045015). International cooperation between the labs was supported by Academy of Sciences of the Czech Republic (M200451201).	Alibardi L, 2013, ACTA HISTOCHEM, V115, P879, DOI 10.1016/j.acthis.2013.04.008; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Avery JK, 1994, ORAL DEVELOPMENT AND; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Buchtova M, 2012, J DENT RES, V91, P491, DOI 10.1177/0022034512442896; Buchtova M, 2008, DEV BIOL, V319, P132, DOI 10.1016/j.ydbio.2008.03.004; Buchtova M, 2007, ZOOLOGY, V110, P231, DOI 10.1016/j.zool.2007.01.006; Buchtova M, 2013, ARCH ORAL BIOL, V58, P118, DOI 10.1016/j.archoralbio.2012.10.019; COOPER JS, 1970, J ZOOL, V162, P85; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; Fan YX, 2013, GENET MOL RES, V12, P6067, DOI 10.4238/2013.December.2.5; Gaete M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074484; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Handrigan GR, 2010, DEV BIOL, V348, P130, DOI 10.1016/j.ydbio.2010.09.003; Handrigan GR, 2010, DEVELOPMENT, V137, P3545, DOI 10.1242/dev.052415; Heo JS, 2007, STEM CELLS, V25, P3069, DOI 10.1634/stemcells.2007-0550; Huysseune A, 2004, BIOESSAYS, V26, P665, DOI 10.1002/bies.20039; Jarvinen E, 2009, J EXP ZOOL PART B, V312B, P281, DOI 10.1002/jez.b.21275; Jernvall J, 2012, DEVELOPMENT, V139, P3487, DOI 10.1242/dev.085084; Jussila M, 2014, DIFFERENTIATION, V87, P32, DOI 10.1016/j.diff.2013.11.004; Juuri E, 2013, EUR J ORAL SCI, V121, P509, DOI 10.1111/eos.12095; Juuri E, 2013, DEVELOPMENT, V140, P1424, DOI 10.1242/dev.089599; Juuri E, 2012, DEV CELL, V23, P317, DOI 10.1016/j.devcel.2012.05.012; KARCHERDJURICIC V, 1978, J BIOL BUCCALE, V6, P257; KHAEJORNBUT J, 1991, J ANAT, V179, P85; Lesot H, 1999, INT J DEV BIOL, V43, P245; Lesot H, 2002, CONNECT TISSUE RES, V43, P191, DOI 10.1080/03008200290000529; Martinez C, 2011, J DENT RES, V90, P483, DOI 10.1177/0022034510391797; Matalova E, 2004, J DENT RES, V83, P11, DOI 10.1177/154405910408300103; MEYER JM, 1995, CELL TISSUE RES, V279, P135, DOI 10.1007/BF00300700; MOSKOW BS, 1983, J CLIN PERIODONTOL, V10, P119, DOI 10.1111/j.1600-051X.1983.tb02200.x; Nadiri A, 2006, CELL TISSUE RES, V324, P33, DOI 10.1007/s00441-005-0120-1; Numakura C, 2010, AM J MED GENET A, V152A, P2355, DOI 10.1002/ajmg.a.33556; OSMAN M, 1981, J DENT RES, V60, P1015, DOI 10.1177/00220345810600060301; Peterkova R, 2014, AUST DENT J, V59, P55, DOI 10.1111/adj.12130; Richman JM, 2011, GENESIS, V49, P247, DOI 10.1002/dvg.20721; Rothova M, 2012, DEV BIOL, V366, P244, DOI 10.1016/j.ydbio.2012.03.018; RUCH JV, 1983, J BIOL BUCCALE, V11, P173; RUCH JV, 1995, INT J DEV BIOL, V39, P51; Setkova J, 2006, INT J DEV BIOL, V50, P481, DOI 10.1387/ijdb.052067js; Sire JY, 2002, MICROSC RES TECHNIQ, V59, P408, DOI 10.1002/jemt.10220; Smith MM, 2009, J EXP ZOOL PART B, V312B, P260, DOI 10.1002/jez.b.21272; Steinert PM, 1999, MOL BIOL CELL, V10, P4247, DOI 10.1091/mbc.10.12.4247; Stembirek J, 2010, EUR J ORAL SCI, V118, P547, DOI 10.1111/j.1600-0722.2010.00772.x; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Ungar P.S., 2010, MAMMAL TEETH ORIGIN; Vaahtokari A, 1996, DEVELOPMENT, V122, P121; Wu P, 2013, P NATL ACAD SCI USA, V110, pE2009, DOI 10.1073/pnas.1213202110; Zahradnicek O, 2012, J ANAT, V221, P195, DOI 10.1111/j.1469-7580.2012.01531.x	50	21	21	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127543	10.1371/journal.pone.0127543	http://dx.doi.org/10.1371/journal.pone.0127543			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010446	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900107
J	Wang, LM; Lu, HB; Brown, PL; Rea, W; Vaupel, B; Yang, YH; Stein, E; Shepard, PD				Wang, Leiming; Lu, Hanbing; Brown, P. Leon; Rea, William; Vaupel, Bruce; Yang, Yihong; Stein, Elliot; Shepard, Paul D.			Manganese-Enhanced MRI Reflects Both Activity-Independent and Activity-Dependent Uptake within the Rat Habenulomesencephalic Pathway	PLOS ONE			English	Article							CEREBRAL GLUCOSE-UTILIZATION; RESONANCE-IMAGING MEMRI; HABENULO-INTERPEDUNCULAR PATHWAY; IN-VIVO; GLUTAMATE RECEPTORS; CALCIUM-CHANNELS; TRANSFERRIN RECEPTOR; CA2+ PERMEABILITY; NEURONAL-ACTIVITY; BRAIN ACTIVATION	Manganese-enhanced magnetic resonance imaging (MEMRI) is a powerful technique for assessing the functional connectivity of neurons within the central nervous system. Despite the widely held proposition that MEMRI signal is dependent on neuronal activity, few studies have directly tested this implicit hypothesis. In the present series of experiments, MnCl2 was injected into the habenula of urethane-anesthetized rats alone or in combination with drugs known to alter neuronal activity by modulating specific voltage-and/or ligand-gated ion channels. Continuous quantitative T1 mapping was used to measure Mn2+ accumulation in the interpeduncular nucleus, a midline structure in which efferents from the medial habenula terminate. Microinjection of MnCl2 into the habenular complex using a protocol that maintained spontaneous neuronal activity resulted in a time-dependent increase in MEMRI signal intensity in the interpeduncular nucleus consistent with fast axonal transport of Mn2+ between these structures. Co-injection of the excitatory amino-acid agonist AMPA, increased the Mn2+-enhanced signal intensity within the interpeduncular nucleus. AMPA-induced increases in MEMRI signal were attenuated by co-injection of either the sodium channel blocker, TTX, or broad-spectrum Ca2+ channel blocker, Ni2+, and were occluded in the presence of both channel blockers. However, neither Ni2+ nor TTX, alone or in combination, attenuated the increase in signal intensity following injection of Mn2+ into the habenula. These results support the premise that changes in neuronal excitability are reflected by corresponding changes in MEMRI signal intensity. However, they also suggest that basal rates of Mn2+ uptake by neurons in the medial habenula may also occur via activity-independent mechanisms.	[Wang, Leiming; Lu, Hanbing; Rea, William; Vaupel, Bruce; Yang, Yihong; Stein, Elliot] Natl Inst Drug Abuse, Neuroimaging Res Branch, IRP, Baltimore, MD 21224 USA; [Wang, Leiming; Brown, P. Leon; Shepard, Paul D.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21228 USA; [Wang, Leiming; Brown, P. Leon; Shepard, Paul D.] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Baltimore, MD 21228 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Shepard, PD (corresponding author), Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21228 USA.	shepard.paul@gmail.com	Brown, P. Leon/ABD-6581-2021; Shepard, Paul/AAF-1533-2021	Brown, P. Leon/0000-0001-5778-3921	Intramural Research Program of the National Institute on Drug Abuse, NIDA Residential Research Support Services [N01DA-5-9909]; National Institute of Mental Health [MH-094489]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000597, ZIADA000545] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Drug Abuse, NIDA Residential Research Support Services; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the Intramural Research Program of the National Institute on Drug Abuse, NIDA Residential Research Support Services Contract N01DA-5-9909 and a grant from the National Institute of Mental Health (MH-094489).	Aoki I, 2002, MAGNET RESON MED, V48, P927, DOI 10.1002/mrm.10320; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; Bearer EL, 2007, NEUROIMAGE, V37, pS37, DOI 10.1016/j.neuroimage.2007.04.053; Bock NA, 2009, NMR BIOMED, V22, P730, DOI 10.1002/nbm.1384; Bowie D, 1998, J NEUROSCI, V18, P8175; Canals S, 2008, NEUROIMAGE, V40, P458, DOI 10.1016/j.neuroimage.2007.12.007; CONTESTABILE A, 1981, J COMP NEUROL, V196, P253; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Duong TQ, 2000, MAGN RESON MED, V43, P383, DOI 10.1002/(SICI)1522-2594(200003)43:3<383::AID-MRM10>3.0.CO;2-Q; FORNASIERO D, 1987, INVEST RADIOL, V22, P322, DOI 10.1097/00004424-198704000-00008; Fowler JH, 2004, J CEREBR BLOOD F MET, V24, P1098, DOI 10.1097/01.WCB.0000138665.25305.7C; Fuchs RA, 2002, PSYCHOPHARMACOLOGY, V160, P425, DOI 10.1007/s00213-001-0997-7; Gao M, 2007, J NEUROSCI, V27, P5414, DOI 10.1523/JNEUROSCI.5347-06.2007; GARLAND JC, 1983, BRAIN RES, V263, P33, DOI 10.1016/0006-8993(83)91197-6; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gunter TE, 2013, NEUROTOXICOLOGY, V34, P118, DOI 10.1016/j.neuro.2012.10.018; Haacke E. M., 1999, MAGNETIC RESONANCE I; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; HERKENHAM M, 1981, BRAIN RES, V210, P461, DOI 10.1016/0006-8993(81)90927-6; HODES JE, 1985, ANESTHESIOLOGY, V63, P633, DOI 10.1097/00000542-198512000-00013; Hsu YH, 2007, BRAIN, V130, P3124, DOI 10.1093/brain/awm207; Inoue T, 2011, REV NEUROSCIENCE, V22, P675, DOI 10.1515/RNS.2011.048; Ito M, 1984, No To Shinkei, V36, P1191; Kaku T, 2003, JPN J PHYSIOL, V53, P165, DOI 10.2170/jjphysiol.53.165; KANG YS, 1984, INVEST RADIOL, V19, P399, DOI 10.1097/00004424-198409000-00012; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; KITA H, 1981, BRAIN RES, V205, P111, DOI 10.1016/0006-8993(81)90723-X; Koretsky AP, 2004, NMR BIOMED, V17, P527, DOI 10.1002/nbm.940; Leergaard TB, 2003, NEUROIMAGE, V20, P1591, DOI 10.1016/j.neuroimage.2003.07.009; Lenz C, 1998, ANESTHESIOLOGY, V89, P1480, DOI 10.1097/00000542-199812000-00026; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; Lowe AS, 2008, NMR BIOMED, V21, P859, DOI 10.1002/nbm.1272; Lu HB, 2007, P NATL ACAD SCI USA, V104, P2489, DOI 10.1073/pnas.0606983104; MARCHAND ER, 1980, BRAIN RES, V193, P339; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MCQUEEN JK, 1984, BRAIN RES, V300, P19, DOI 10.1016/0006-8993(84)91336-2; MENDONCADIAS MH, 1983, SEMIN NUCL MED, V13, P364, DOI 10.1016/S0001-2998(83)80048-8; Moldovan N, 2013, BIOMETALS, V26, P179, DOI 10.1007/s10534-012-9605-z; Moos T, 1999, MOL BRAIN RES, V72, P231, DOI 10.1016/S0169-328X(99)00226-0; Moos T, 1998, J COMP NEUROL, V398, P420; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Paxinos G., 2007, THE RAT BRAIN IN STE; Paxinos G., 1986, THE RAT BRAIN IN STE; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Robertson SJ, 1999, J PHYSIOL-LONDON, V518, P539, DOI 10.1111/j.1469-7793.1999.0539p.x; Roth JA, 2003, BIOCHEM PHARMACOL, V66, P1, DOI 10.1016/S0006-2952(03)00145-X; Sakhi K, 2014, J PHYSIOL-LONDON, V592, P5025, DOI 10.1113/jphysiol.2014.280065; Saleem KS, 2002, NEURON, V34, P685, DOI 10.1016/S0896-6273(02)00718-3; SAVAKI HE, 1983, J COMP NEUROL, V213, P36, DOI 10.1002/cne.902130104; Shin WY, 2009, MAGN RESON MED, V61, P899, DOI 10.1002/mrm.21836; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Silva AC, 2008, SCHIZOPHRENIA BULLET, V34, P7; SLOOT WN, 1994, BRAIN RES, V657, P124, DOI 10.1016/0006-8993(94)90959-8; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; SUZUKI S, 1989, P NATL ACAD SCI USA, V86, P7228, DOI 10.1073/pnas.86.18.7228; Swerdlow NR, 2002, BRAIN RES, V953, P246, DOI 10.1016/S0006-8993(02)03298-5; Takeda A, 1998, BRAIN RES BULL, V45, P149, DOI 10.1016/S0361-9230(97)00330-4; Watanabe T, 2006, MAGN RESON IMAGING, V24, P209, DOI 10.1016/j.mri.2005.10.034; Weng JC, 2007, NEUROIMAGE, V36, P1179, DOI 10.1016/j.neuroimage.2007.04.010; Yu X, 2005, NAT NEUROSCI, V8, P961, DOI 10.1038/nn1477; Zhao H, 2005, NEUROSCIENCE, V132, P519, DOI 10.1016/j.neuroscience.2005.01.012	62	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127773	10.1371/journal.pone.0127773	http://dx.doi.org/10.1371/journal.pone.0127773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009889	gold, Green Published, Green Submitted			2022-12-26	WOS:000355183900142
J	Xu, Y; Hu, B; Alnajm, SS; Lu, Y; Huang, YX; Allen-Gipson, D; Cheng, F				Xu, Yan; Hu, Brian; Alnajm, Sammy S.; Lu, Yin; Huang, Yangxin; Allen-Gipson, Diane; Cheng, Feng			SEGEL: A Web Server for Visualization of Smoking Effects on Human Lung Gene Expression	PLOS ONE			English	Article							CIGARETTE-SMOKE; INTERLEUKIN-8 RELEASE; ALVEOLAR MACROPHAGES; ADENOSINE; RECEPTOR; OVEREXPRESSION; PATHOGENESIS; INFLAMMATION; ACTIVATION; EPITHELIUM	Cigarette smoking is a major cause of death worldwide resulting in over six million deaths per year. Cigarette smoke contains complex mixtures of chemicals that are harmful to nearly all organs of the human body, especially the lungs. Cigarette smoking is considered the major risk factor for many lung diseases, particularly chronic obstructive pulmonary diseases (COPD) and lung cancer. However, the underlying molecular mechanisms of smoking- induced lung injury associated with these lung diseases still remain largely unknown. Expression microarray techniques have been widely applied to detect the effects of smoking on gene expression in different human cells in the lungs. These projects have provided a lot of useful information for researchers to understand the potential molecular mechanism (s) of smoke-induced pathogenesis. However, a user-friendly web server that would allow scientists to fast query these data sets and compare the smoking effects on gene expression across different cells had not yet been established. For that reason, we have integrated eight public expression microarray data sets from trachea epithelial cells, large airway epithelial cells, small airway epithelial cells, and alveolar macrophage into an online web server called SEGEL (Smoking Effects on Gene Expression of Lung). Users can query gene expression patterns across these cells from smokers and nonsmokers by gene symbols, and find the effects of smoking on the gene expression of lungs from this web server. Sex difference in response to smoking is also shown. The relationship between the gene expression and cigarette smoking consumption were calculated and are shown in the server. The current version of SEGEL web server contains 42,400 annotated gene probe sets represented on the Affymetrix Human Genome U133 Plus 2.0 platform. SEGEL will be an invaluable resource for researchers interested in the effects of smoking on gene expression in the lungs. The server also provides useful information for drug development against smoking-related diseases. The SEGEL web server is available online at http://www.chengfeng.info/smoking_database.html.	[Xu, Yan; Hu, Brian; Lu, Yin; Allen-Gipson, Diane; Cheng, Feng] Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL 33620 USA; [Alnajm, Sammy S.] Univ Cologne, Fac Math & Nat Sci, Dept Biol, D-50931 Cologne, Germany; [Huang, Yangxin; Cheng, Feng] Univ S Florida, Coll Publ Hlth, Dept Dept Epidemiol & Biostat, Tampa, FL USA; [Allen-Gipson, Diane] Univ S Florida, Coll Med, Div Allergy & Clin Immunol, Tampa, FL USA	State University System of Florida; University of South Florida; University of Cologne; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Cheng, F (corresponding author), Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL 33620 USA.	fcheng1@health.usf.edu	Cheng, Feng/A-9760-2009	Cheng, Feng/0000-0003-3619-8090; Allen-Gipson, Diane/0000-0001-6976-3960	University of South Florida (USF) System Internal Awards Program under USF Women's Health Collaborative Grant [0095058]	University of South Florida (USF) System Internal Awards Program under USF Women's Health Collaborative Grant	The project was supported by the University of South Florida (USF) System Internal Awards Program under USF Women's Health Collaborative Grant No. 0095058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beukers MW, 2000, MOL PHARMACOL, V58, P1349, DOI 10.1124/mol.58.6.1349; Carolan BJ, 2008, J IMMUNOL, V181, P5760, DOI 10.4049/jimmunol.181.8.5760; Caruso M, 2006, CURR OPIN PHARMACOL, V6, P251, DOI 10.1016/j.coph.2006.02.002; Chunn JL, 2006, AM J PHYSIOL-LUNG C, V290, pL579, DOI 10.1152/ajplung.00258.2005; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; DUBAR V, 1993, EXP LUNG RES, V19, P345, DOI 10.3109/01902149309064351; Edwards R, 2004, BRIT MED J, V328, P217, DOI 10.1136/bmj.328.7433.217; Feoktistov I, 1997, PHARMACOL REV, V49, P381; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Fredholm BB, 2001, BIOCHEM PHARMACOL, V61, P443, DOI 10.1016/S0006-2952(00)00570-0; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Heguy A, 2006, J MOL MED, V84, P318, DOI 10.1007/s00109-005-0008-2; Ito K, 2002, P NATL ACAD SCI USA, V99, P8921, DOI 10.1073/pnas.132556899; Johnson Bankole A, 2011, Front Psychiatry, V2, P2, DOI 10.3389/fpsyt.2011.00002; Kazeros A, 2008, AM J RESP CELL MOL, V39, P747, DOI 10.1165/rcmb.2007-0306OC; King Brian A, 2012, Am J Public Health, V102, pe93, DOI 10.2105/AJPH.2012.301002; Mio T, 1997, AM J RESP CRIT CARE, V155, P1770, DOI 10.1164/ajrccm.155.5.9154890; Mohsenin A, 2006, CURR OPIN PULM MED, V12, P54, DOI 10.1097/01.mcp.0000199002.46038.cb; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; Poliska S, 2011, RESPIRATION, V81, P499, DOI 10.1159/000324297; Rennard SI, 1999, AM J RESP CRIT CARE, V160, pS12, DOI 10.1164/ajrccm.160.supplement_1.5; Richter A, 2002, AM J RESP CELL MOL, V27, P85, DOI 10.1165/ajrcmb.27.1.4789; Richter P, 2008, PUBLIC HEALTH REP, V123, P30, DOI 10.1177/003335490812300105; Shapiro SD, 1999, AM J RESP CRIT CARE, V160, pS29, DOI 10.1164/ajrccm.160.supplement_1.9; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; SHOJI S, 1995, CLIN SCI, V88, P337, DOI 10.1042/cs0880337; Sorheim IC, 2010, THORAX, V65, P480, DOI 10.1136/thx.2009.122002; Spicuzza L, 2006, EUR J PHARMACOL, V533, P77, DOI 10.1016/j.ejphar.2005.12.056; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Tuder Rubin M, 2006, Proc Am Thorac Soc, V3, P503, DOI 10.1513/pats.200603-054MS; Turetz ML, 2009, CTS-CLIN TRANSL SCI, V2, P260, DOI 10.1111/j.1752-8062.2009.00129.x; Vanni H, 2009, CHEST, V135, P1197, DOI 10.1378/chest.08-1024; Vogelmeier C, 2007, AM J RESP CRIT CARE, V175, P1217, DOI 10.1164/rccm.200703-513ED; Wang R, 2012, J IMMUNOL, V189, P2217, DOI 10.4049/jimmunol.1101895	34	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128326	10.1371/journal.pone.0128326	http://dx.doi.org/10.1371/journal.pone.0128326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010234	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900225
J	Lai, YS; Chen, WC; Huang, CH; Cheng, CK; Chan, KK; Chang, TK				Lai, Yu-Shu; Chen, Wen-Chuan; Huang, Chang-Hung; Cheng, Cheng-Kung; Chan, Kam-Kong; Chang, Ting-Kuo			The Effect of Graft Strength on Knee Laxity and Graft In-Situ Forces after Posterior Cruciate Ligament Reconstruction	PLOS ONE			English	Article							SURGERY EXPERIENCE; POSTEROLATERAL STRUCTURES; COMPUTATIONAL SIMULATION; NATURAL-HISTORY; FINITE-ELEMENT; MUSCLE LOAD; ANTERIOR; JOINT; KINEMATICS; BIOMECHANICS	Surgical reconstruction is generally recommended for posterior cruciate ligament (PCL) injuries; however, the use of grafts is still a controversial problem. In this study, a three-dimensional finite element model of the human tibiofemoral joint with articular cartilage layers, menisci, and four main ligaments was constructed to investigate the effects of graft strengths on knee kinematics and in-situ forces of PCL grafts. Nine different graft strengths with stiffness ranging from 0% (PCL rupture) to 200%, in increments of 25%, of an intact PCL's strength were used to simulate the PCL reconstruction. A 100 N posterior tibial drawer load was applied to the knee joint at full extension. Results revealed that the maximum posterior translation of the PCL rupture model (0% stiffness) was 6.77 mm in the medial compartment, which resulted in tibial internal rotation of about 3.01 degrees. After PCL reconstruction with any graft strength, the laxity of the medial tibial compartment was noticeably improved. Tibial translation and rotation were similar to the intact knee after PCL reconstruction with graft strengths ranging from 75% to 125% of an intact PCL. When the graft's strength surpassed 150%, the medial tibia moved forward and external tibial rotation greatly increased. The in-situ forces generated in the PCL grafts ranged from 13.15 N to 75.82 N, depending on the stiffness. In conclusion, the strength of PCL grafts have has a noticeable effect on anterior-posterior translation of the medial tibial compartment and its in-situ force. Similar kinematic response may happen in the models when the PCL graft's strength lies between 75% and 125% of an intact PCL.	[Lai, Yu-Shu; Chen, Wen-Chuan] Natl Yang Ming Univ, Orthopaed Device Res Ctr, Taipei 112, Taiwan; [Huang, Chang-Hung] Mackay Mem Hosp, Dept Med Res, New Taipei City, Taiwan; [Cheng, Cheng-Kung] Natl Yang Ming Univ, Dept Biomed Engn, Taipei 112, Taiwan; [Chan, Kam-Kong] Cardinal Tien Hosp, Dept Orthopaed, New Taipei City, Taiwan; [Chang, Ting-Kuo] Mackay Mem Hosp, Dept Orthoped, Taipei, Taiwan; [Chang, Ting-Kuo] Mackay Med Coll, New Taipei City, Taiwan	National Yang Ming Chiao Tung University; Mackay Memorial Hospital; National Yang Ming Chiao Tung University; Cardinal Tien Hospital; Mackay Memorial Hospital; Mackay Medical College	Chang, TK (corresponding author), Mackay Med Coll, New Taipei City, Taiwan.	tommy.tkchang@gmail.com						BACH BR, 1992, AM J SPORT MED, V20, P67, DOI 10.1177/036354659202000116; Bendjaballah M., 1995, KNEE, V2, P69, DOI [10.1016/0968-0160(95)00018-K, DOI 10.1016/0968-0160(95)00018-K]; Bendjaballah MZ, 1998, CLIN BIOMECH, V13, P625, DOI 10.1016/S0268-0033(98)00035-7; BURNS WC, 1995, AM J SPORT MED, V23, P424, DOI 10.1177/036354659502300409; BUTLER DL, 1980, J BONE JOINT SURG AM, V62, P259, DOI 10.2106/00004623-198062020-00013; Chen CH, 2004, KNEE SURG SPORT TR A, V12, P371, DOI 10.1007/s00167-003-0457-5; CLANCY WG, 1983, J BONE JOINT SURG AM, V65, P310, DOI 10.2106/00004623-198365030-00004; Cosgarea A J, 2001, J Am Acad Orthop Surg, V9, P297; Covey DC, 1996, AM J SPORT MED, V24, P740, DOI 10.1177/036354659602400607; DEJOUR H, 1988, REV CHIR ORTHOP, V74, P35; Fox RJ, 1998, AM J SPORT MED, V26, P395, DOI 10.1177/03635465980260030901; FUKUBAYASHI T, 1982, J BONE JOINT SURG AM, V64, P258, DOI 10.2106/00004623-198264020-00018; GOLLEHON DL, 1987, J BONE JOINT SURG AM, V69A, P233, DOI 10.2106/00004623-198769020-00010; GROOD ES, 1988, J BONE JOINT SURG AM, V70A, P88, DOI 10.2106/00004623-198870010-00014; Harner CD, 1998, AM J SPORT MED, V26, P669, DOI 10.1177/03635465980260051201; HUGHSTON JC, 1982, CLIN ORTHOP RELAT R, P59; Jilani A, 1997, KNEE, V4, P203, DOI 10.1016/S0968-0160(97)00266-4; Johnson DL, 1996, CLIN ORTHOP RELAT R, P100; KELLER PM, 1993, AM J SPORT MED, V21, P132, DOI 10.1177/036354659302100122; Lenschow S, 2006, ARCH ORTHOP TRAUM SU, V126, P253, DOI 10.1007/s00402-005-0062-9; Li G, 2002, ANN BIOMED ENG, V30, P713, DOI 10.1114/1.1484219; LIPSCOMB AB, 1993, AM J SPORT MED, V21, P490, DOI 10.1177/036354659302100402; Logan M, 2004, AM J SPORT MED, V32, P1915, DOI 10.1177/0363546504265005; Markolf KL, 1997, J BONE JOINT SURG AM, V79A, P381, DOI 10.2106/00004623-199703000-00010; Moglo KE, 2003, CLIN BIOMECH, V18, P751, DOI 10.1016/S0268-0033(03)00140-2; NOYES FR, 1994, J BONE JOINT SURG AM, V76A, P1019, DOI 10.2106/00004623-199407000-00010; Race A, 1996, J BIOMECH, V29, P873, DOI 10.1016/0021-9290(95)00161-1; Ramaniraka NA, 2005, CLIN BIOMECH, V20, P434, DOI 10.1016/j.clinbiomech.2004.11.014; Richter M, 1996, AM J SPORT MED, V24, P298, DOI 10.1177/036354659602400309; Suggs J, 2003, CLIN BIOMECH, V18, P35, DOI 10.1016/S0268-0033(02)00137-7; TORG JS, 1989, CLIN ORTHOP RELAT R, P208; Uribe JW, 1996, CLIN ORTHOP RELAT R, P91, DOI 10.1097/00003086-199604000-00010; Vogrin TM, 2000, KNEE SURG SPORT TR A, V8, P93, DOI 10.1007/s001670050193; Weiler A, 2002, ARTHROSCOPY, V18, P113, DOI 10.1053/jars.2002.30656; Wilson TW, 1999, AM J SPORT MED, V27, P202, DOI 10.1177/03635465990270021501; Wirth CJ, 1996, CLIN ORTHOP RELAT R, P110; WISMANS J, 1980, J BIOMECH, V13, P677, DOI 10.1016/0021-9290(80)90354-1	37	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127293	10.1371/journal.pone.0127293	http://dx.doi.org/10.1371/journal.pone.0127293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001045	Green Submitted, Green Published, gold			2022-12-26	WOS:000354931700047
J	Meng, YH; Zhang, WL; Zhou, JH; Liu, MY; Chen, JH; Tian, S; Zhuo, M; Zhang, Y; Zhong, Y; Du, HL; Wang, XN				Meng, Yuhuan; Zhang, Wenlu; Zhou, Jinghui; Liu, Mingyu; Chen, Junhui; Tian, Shuai; Zhuo, Min; Zhang, Yu; Zhong, Yang; Du, Hongli; Wang, Xiaoning			Genome-Wide Analysis of Positively Selected Genes in Seasonal and Non-Seasonal Breeding Species	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; SEQUENCE ALIGNMENT; EVOLUTION; REPRODUCTION; CELLS; SCANS; PROLIFERATION; ANNOTATION; INVERSIN; ECOLOGY	Some mammals breed throughout the year, while others breed only at certain times of year. These differences in reproductive behavior can be explained by evolution. We identified positively-selected genes in two sets of species with different degrees of relatedness including seasonal and non-seasonal breeding species, using branch-site models. After stringent filtering by sum of pairs scoring, we revealed that more genes underwent positive selection in seasonal compared with non-seasonal breeding species. Positively-selected genes were verified by cDNA mapping of the positive sites with the corresponding cDNA sequences. The design of the evolutionary analysis can effectively lower the false-positive rate and thus identify valid positive genes. Validated, positively-selected genes, including CGA, DNAH1, INVS, and CD151, were related to reproductive behaviors such as spermatogenesis and cell proliferation in non-seasonal breeding species. Genes in seasonal breeding species, including THRAP3, TH1L, and CMTM6, may be related to the evolution of sperm and the circadian rhythm system. Identification of these positively-selected genes might help to identify the molecular mechanisms underlying seasonal and non-seasonal reproductive behaviors.	[Meng, Yuhuan; Zhang, Wenlu; Zhou, Jinghui; Liu, Mingyu; Chen, Junhui; Tian, Shuai; Zhuo, Min; Du, Hongli; Wang, Xiaoning] S China Univ Technol, Sch Biosci & Bioengn, Guangdong Prov Key Lab Fermentat & Enzyme Engn, Guangzhou 510641, Guangdong, Peoples R China; [Zhang, Yu] Guangdong Lab Anim Monitoring Inst, Guangdong Key Lab Lab Anim, Guangzhou, Guangdong, Peoples R China; [Wang, Xiaoning] Chinese Peoples Liberat Army Gen Hosp, Beijing 100853, Peoples R China; [Zhong, Yang] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Zhong, Yang] Tibet Univ, Inst Biodivers Sci, Lhasa, Peoples R China	South China University of Technology; Chinese People's Liberation Army General Hospital; Fudan University; Tibet University	Du, HL (corresponding author), S China Univ Technol, Sch Biosci & Bioengn, Guangdong Prov Key Lab Fermentat & Enzyme Engn, Guangzhou 510641, Guangdong, Peoples R China.	hldu@scut.edu.cn		junhui, chen/0000-0002-5938-0760	National Science and Technology Support Program [2014BAI03B01, 2015BAI07B01]; Science and Technology Planning Project of Guangzhou [1561000294]; Science and Technology Planning Project of Guangdong Province [2013B060300025]; BGI-SCUT Innovation Fund Project [SW20130802]	National Science and Technology Support Program; Science and Technology Planning Project of Guangzhou; Science and Technology Planning Project of Guangdong Province; BGI-SCUT Innovation Fund Project	This study was funded by the National Science and Technology Support Program (2014BAI03B01, 2015BAI07B01), the Science and Technology Planning Project of Guangzhou (1561000294), the Science and Technology Planning Project of Guangdong Province(2013B060300025), and BGI-SCUT Innovation Fund Project (SW20130802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1989, J THEOR BIOL, V138, P297, DOI 10.1016/S0022-5193(89)80196-1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arbiza L, 2006, PLOS COMPUT BIOL, V2, P288, DOI 10.1371/journal.pcbi.0020038; Bakewell MA, 2007, P NATL ACAD SCI USA, V104, P7489, DOI 10.1073/pnas.0701705104; Ben Khelifa M, 2014, AM J HUM GENET, V94, P95, DOI 10.1016/j.ajhg.2013.11.017; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benzing T, 2007, J AM SOC NEPHROL, V18, P1389, DOI 10.1681/ASN.2006121355; Brambell FWR, 1944, P ZOOL SOC LOND, V114, P1; BRONSON FH, 1979, Q REV BIOL, V54, P265, DOI 10.1086/411295; Carneiro M, 2012, MOL BIOL EVOL, V29, P1837, DOI 10.1093/molbev/mss025; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Fujii-Hanamoto H, 2011, AM J PRIMATOL, V73, P570, DOI 10.1002/ajp.20930; Furuno M, 2003, GENOME RES, V13, P1478, DOI 10.1101/gr.1060303; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gupta S K, 1995, J Comput Biol, V2, P459, DOI 10.1089/cmb.1995.2.459; Gupta VA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003583; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; Hou JH, 1998, CHINESE J ECOL, V17, P22; Hut RA, 2011, CURR BIOL, V21, pR22, DOI 10.1016/j.cub.2010.11.060; IMS RA, 1990, TRENDS ECOL EVOL, V5, P135, DOI 10.1016/0169-5347(90)90218-3; Jang You-Na, 2013, JAKSTAT, V2, pe23282, DOI 10.4161/jkst.23282; JOHNSON L, 1987, J REPROD FERTIL, V81, P227, DOI 10.1530/jrf.0.0810227; Katano-Toki A, 2013, MOL ENDOCRINOL, V27, P769, DOI 10.1210/me.2012-1332; Kim DS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-427; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Lande-Diner L, 2013, P NATL ACAD SCI USA, V110, P16021, DOI 10.1073/pnas.1305980110; Laurie S, 2012, GENOME RES, V22, P478, DOI 10.1101/gr.121897.111; Lienkamp S, 2012, DIFFERENTIATION, V83, pS49, DOI 10.1016/j.diff.2011.11.012; Lincoln GA, 2003, J ENDOCRINOL, V179, P1, DOI 10.1677/joe.0.1790001; Liu DZ, 2009, CHINESE SCI BULL, V54, P1050, DOI 10.1007/s11434-009-0092-8; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Villanueva-Canas JL, 2013, GENOME BIOL EVOL, V5, P457, DOI 10.1093/gbe/evt017; Mallick S, 2009, GENOME RES, V19, P922, DOI 10.1101/gr.086512.108; Markova-Raina P, 2011, GENOME RES, V21, P863, DOI 10.1101/gr.115949.110; Mitani JC, 2002, EVOL ANTHROPOL, V11, P9, DOI 10.1002/evan.10008; Neesen J, 2001, HUM MOL GENET, V10, P1117, DOI 10.1093/hmg/10.11.1117; Nurnberger J, 2006, CELL TISSUE RES, V323, P147, DOI 10.1007/s00441-005-0012-4; Orth JM., 1993, CELL MOL BIOL TESTIS, P3; Pal SK, 1998, APPL ANIM BEHAV SCI, V61, P123, DOI 10.1016/S0168-1591(98)00185-3; PERRY JS, 1945, P ZOOL SOC LOND, V115, P19; Prendergast BJ, 2005, HORM BEHAV, V48, P503, DOI 10.1016/j.yhbeh.2005.05.013; Prorocic MM, 2011, NUCLEIC ACIDS RES, V39, P9316, DOI 10.1093/nar/gkr652; Rebers FEM, 1997, FISH PHYSIOL BIOCHEM, V17, P99, DOI 10.1023/A:1007725321061; Rijksen H. D., 1978, FIELDSTUDY SUMATRAN; Schneider A, 2009, GENOME BIOL EVOL, V1, P114, DOI 10.1093/gbe/evp012; Singleton I, 2002, FOLIA PRIMATOL, V73, P1, DOI 10.1159/000060415; Sousa MBC, 1999, PRIMATES, V40, P327, DOI 10.1007/BF02557556; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Sun YB, 2013, GENOME BIOL EVOL, V5, P130, DOI 10.1093/gbe/evs123; Sun Z, 2008, CHINESE J COMP MED, V11, P33; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Toll-Riera M, 2011, MOL BIOL EVOL, V28, P383, DOI 10.1093/molbev/msq206; Torgerson DG, 2002, MOL BIOL EVOL, V19, P1973, DOI 10.1093/oxfordjournals.molbev.a004021; Uenishi H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-581; Veland IR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060193; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; WATTS DP, 1991, AM J PRIMATOL, V24, P211, DOI 10.1002/ajp.1350240307; Weber-Nordt RM, 1998, LEUKEMIA LYMPHOMA, V28, P459, DOI 10.3109/10428199809058353; Werner ME, 2013, AM J PHYSIOL-CELL PH, V305, pC36, DOI 10.1152/ajpcell.00279.2012; Wich SA, 2004, J HUM EVOL, V47, P385, DOI 10.1016/j.jhevol.2004.08.006; Yan GM, 2011, NAT BIOTECHNOL, V29, P1019, DOI 10.1038/nbt.1992; Yang WX, 2012, J HUAZHONG U SCI-MED, V32, P383, DOI 10.1007/s11596-012-0066-y; Yang YZ, 2010, J CELL BIOCHEM, V109, P1013, DOI 10.1002/jcb.22484; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Yoshimura T, 2010, ANIM SCI J, V81, P403, DOI 10.1111/j.1740-0929.2010.00777.x; Yue SJ, 2013, EUR J CANCER, V49, P2934, DOI 10.1016/j.ejca.2013.03.032; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; [钟惟德 Zhong Weide], 2003, [中华实验外科杂志, Chinese Journal of Experimental Surgery], V20, P1027	74	4	4	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126736	10.1371/journal.pone.0126736	http://dx.doi.org/10.1371/journal.pone.0126736			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000771	gold, Green Published, Green Submitted			2022-12-26	WOS:000354931700023
J	Zhang, YJ; Wang, ZS; Li, L; Zhou, Q; Xiao, Y; Wei, X; Zhou, MY				Zhang, Yajie; Wang, Zhensheng; Li, Lei; Zhou, Qun; Xiao, Yao; Wei, Xing; Zhou, Mingyao			Short-Term Complete Submergence of Rice at the Tillering Stage Increases Yield	PLOS ONE			English	Article							DEEP-WATER RICE; LOWLAND RICE; ELONGATION; RESPONSES; PLANTS; CHLOROPHYLL; IRRIGATION; RESISTANCE; SEEDLINGS; AERATION	Flooding is a major threat to agricultural production. Most studies have focused on the lower water storage limit in rice fields, whereas few studies have examined the upper water storage limit. This study aimed to explore the effect of waterlogging at the rice tillering stage on rice growth and yield. The early-ripening late japonica variety Yangjing 4227 was selected for this study. The treatments included different submergence depths (submergence depth/plant height: 1/2 (waist submergence), 2/3 (neck submergence), and 1/1 (complete submergence)) and durations (1, 3, and 5 d). The control group was treated with the conventional alternation of drying and wetting. The effects of waterlogging at the tillering stage on root characteristics, dry matter production, nitrogen and phosphorus accumulation, yield, yield components, and 1-aminocyclopropane-1-carboxylic acid synthase (ACS) gene expression were explored. Compared with the control group, the 1/1 group showed significant increases in yield, seed-setting rate, photosynthetically efficient leaf area, and OS-ACS3 gene expression after 1 d of submergence. The grain number per panicle, dry weight of the aboveground and belowground parts, and number of adventitious roots also increased. Correlation analysis revealed a significant positive correlation between the panicle number and nitrogen content; however, no significant correlation was found for phosphorus content. If a decrease in rice yield of less than 10% is acceptable, half, 2/3, and complete submergence of the plants can be performed at the tillering stage for 1-3 d; this treatment will increase the space available for rice field water management/control and will improve rainfall resource utilization.	[Zhang, Yajie; Wang, Zhensheng; Zhou, Qun; Xiao, Yao; Wei, Xing] Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Coinnovat Ctr Modern Prod Technol Grain Crops, Yangzhou 225009, Jiangsu, Peoples R China; [Li, Lei; Zhou, Mingyao] Yangzhou Univ, Sch Hydraul Energy & Power Engn, Yangzhou 225009, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University	Zhou, MY (corresponding author), Yangzhou Univ, Sch Hydraul Energy & Power Engn, Yangzhou 225009, Jiangsu, Peoples R China.	myzhou123@yeah.net			Ministry of Water Resources of the People's Republic China [201201005]; Three New Agricultural Projects of Jiangsu [SXGC[2013]262]; Industry-education-academy Cooperative Innovation Funds of Jiangsu (Prospective Cooperative Projects) [BY2014117-05]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Ministry of Water Resources of the People's Republic China; Three New Agricultural Projects of Jiangsu; Industry-education-academy Cooperative Innovation Funds of Jiangsu (Prospective Cooperative Projects); Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by the Public Industry Research Special Funds of the Ministry of Water Resources of the People's Republic China (201201005), Three New Agricultural Projects of Jiangsu (SXGC[2013]262), Industry-education-academy Cooperative Innovation Funds of Jiangsu (Prospective Cooperative Projects; BY2014117-05), and Projects Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandan A, 2012, FUNCT PLANT BIOL, V39, P137, DOI 10.1071/FP11184; ARMSTRONG W, 1994, ACTA BOT NEERL, V43, P307; Bremner JM, 1982, AGRONOMY, P595, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C31; Colmer TD, 2009, FUNCT PLANT BIOL, V36, P665, DOI 10.1071/FP09144; Colmer TD, 2003, PLANT CELL ENVIRON, V26, P17, DOI 10.1046/j.1365-3040.2003.00846.x; Costa JM, 2007, J INTEGR PLANT BIOL, V49, P1421, DOI 10.1111/j.1672-9072.2007.00556.x; Crawford RMM, 2003, CAN J BOT, V81, P1224, DOI [10.1139/B03-127, 10.1139/b03-127]; Guo XiangPing, 2006, Journal of Shanghai Jiaotong University - Agricultural Science, V24, P307; Huang JY, 2005, CHINA RURAL WATER HY, V7, P11; Iwai T, 2006, PLANT PHYSIOL, V142, P1202, DOI 10.1104/pp.106.085258; Jackson MB, 2008, ANN BOT-LONDON, V101, P229, DOI 10.1093/aob/mcm237; Kaelke CM, 2003, PLANT SOIL, V254, P167, DOI 10.1023/A:1024903912325; Kawano N, 2009, ANN BOT-LONDON, V103, P161, DOI 10.1093/aob/mcn171; Kende H, 1998, PLANT PHYSIOL, V118, P1105, DOI 10.1104/pp.118.4.1105; [李永和 Li Yonghe], 2004, [自然灾害学报, Journal of Natural Disasters], V13, P83; Lin W., 1997, J HUNAN AGR U, V23, P50; Lu R.K., 1999, METHODS AGR CHEM ANA; Mao Z, 2005, CHINA WATER RESOUR, V15, P14; McDonald MP, 2002, PLANT CELL ENVIRON, V25, P441, DOI 10.1046/j.0016-8025.2001.00817.x; Mergemann H, 2000, PLANT PHYSIOL, V124, P609, DOI 10.1104/pp.124.2.609; Mommer L, 2005, PLANT PHYSIOL, V139, P497, DOI 10.1104/pp.105.064725; Panda D, 2008, AQUAT BOT, V88, P127, DOI 10.1016/j.aquabot.2007.08.012; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qu X., 2014, CHINA RICE, V20, P68; Sakagami JI, 2011, TROPICS, V20, P55; Sarkar RK, 1996, J PLANT PHYSIOL, V149, P623, DOI 10.1016/S0176-1617(96)80344-0; Sasidharan R, 2013, NEW PHYTOL, V197, P1029, DOI 10.1111/nph.12148; SETTER TL, 1989, AUST J PLANT PHYSIOL, V16, P251, DOI 10.1071/PP9890251; Shan L, 2000, REV CHINA AGR SCI TE, V2, P66; Sone C, 2012, J AGRON CROP SCI, V198, P152, DOI 10.1111/j.1439-037X.2011.00494.x; TROUGHT MCT, 1981, J EXP BOT, V32, P509, DOI 10.1093/jxb/32.3.509; Turner NC, 1997, ADV AGRON, V58, P293; Vico G, 2011, ADV WATER RESOUR, V34, P263, DOI 10.1016/j.advwatres.2010.11.010; Voesenek LACJ, 2006, NEW PHYTOL, V170, P213, DOI 10.1111/j.1469-8137.2006.01692.x; Vriezen WH, 2003, ANN BOT-LONDON, V91, P263, DOI 10.1093/aob/mcf121; Wang B, 2014, CHINA RICE, V20, P75; Wu LiQuan, 2006, Journal of Anhui Agricultural University, V33, P537; Wu XY, 1998, PLANT PHYSL MOL BIOL, P150; Yang JC, 2007, J INTEGR PLANT BIOL, V49, P1445, DOI 10.1111/j.1672-9072.2007.00555.x; Yu S.E., 1997, J IRRIGATION DRAINAG, V12, P20; ZAREMBINSKI TI, 1993, MOL BIOL CELL, V4, P363, DOI 10.1091/mbc.4.4.363; Zhou ZY, 2001, EUPHYTICA, V121, P137, DOI 10.1023/A:1012059425624	42	11	12	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127982	10.1371/journal.pone.0127982	http://dx.doi.org/10.1371/journal.pone.0127982			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001084	Green Published, Green Submitted, gold			2022-12-26	WOS:000354931700096
J	He, GX; Li, Y; Zhao, F; Wang, LX; Cheng, SM; Guo, H; Klena, JD; Fan, HY; Gao, FF; Gao, F; Han, GX; Ren, LP; Song, YD; Xiong, YC; Geng, MJ; Hou, YY; He, GM; Li, JB; Guo, SF; Yang, J; Yan, DQ; Wang, YL; Gao, HY; An, J; Duan, XY; Wu, CR; Duan, FM; Hu, DM; Lu, K; Zhao, YL; Rao, CY; Wang, Y				He, Guangxue; Li, Yuan; Zhao, Fei; Wang, Lixia; Cheng, Shiming; Guo, Hui; Klena, John D.; Fan, Haiying; Gao, Fangfang; Gao, Fei; Han, Guoxin; Ren, Liping; Song, Yudan; Xiong, Yongchao; Geng, Mengjie; Hou, Yueyun; He, Guoming; Li, Jianbo; Guo, Shufang; Yang, Jun; Yan, Daiqin; Wang, Yali; Gao, Haiyan; An, Jing; Duan, Xiaoyan; Wu, Chunru; Duan, Fengming; Hu, Dongmei; Lu, Kai; Zhao, Yanlin; Rao, Carol Y.; Wang, Yu			The Prevalence and Incidence of Latent Tuberculosis Infection and Its Associated Factors among Village Doctors in China	PLOS ONE			English	Article							HEALTH-CARE WORKERS; GAMMA RELEASE ASSAYS; RISK-FACTORS	Background China is a high tuberculosis (TB) burden country. More than half of acute TB cases first seek medical care in village doctors' clinics or community health centers. Despite being responsible for patient referral and management, village doctors are not systematically evaluated for TB infection or disease. We assessed prevalence and incidence of latent TB infection (LTBI) among village doctors in China. Methods and Findings A longitudinal study was conducted in Inner Mongolia Autonomous Region. We administered a questionnaire on demographics and risk factors for TB exposure and disease; Tuberculin skin testing (TST) and QuantiFERON-TB Gold in-tube assay (QFT-GIT) was conducted at baseline and repeated 12 months later. We used a logistic regression model to calculate adjusted odds ratios (ORs) for risk factors for TST and QFT-GIT prevalence and incidence. At the time of follow up, 19.5% of the 880 participating village doctors had a positive TST and 46.0% had a positive QFT-GIT result. Factors associated with TST prevalence included having a BCG scar (OR = 1.45, 95% CI 1.03-2.04) and smoking (OR = 1.69, 95% CI 1.17-2.44). Risk factors associated with QFT-GIT prevalence included being male (OR = 2.17, 95% CI 1.63-2.89), below college education (OR = 1.42, 95% CI 1.01-1.97), and working for >= 25 years as a village doctor (OR = 1.64, 95% CI 1.12-2.39). The annual incidence of LTBI was 11.4% by TST and 19.1% by QFT-GIT. QFT-GIT conversion was associated with spending 15 minutes or more per patient on average (OR = 2.62, 95% CI1.39-4.97) and having BCG scar (OR = 0.53, 95% CI0.28-1.00). Conclusions Prevalence and incidence of LTBI among Chinese village doctors is high. TB infection control measures should be strengthened among village doctors and at village healthcare settings.	[He, Guangxue; Zhao, Fei; Wang, Lixia; Cheng, Shiming; Guo, Hui; Fan, Haiying; Song, Yudan; Xiong, Yongchao; Geng, Mengjie; Hu, Dongmei; Lu, Kai; Zhao, Yanlin; Wang, Yu] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Li, Yuan; Klena, John D.; Rao, Carol Y.] US Ctr Dis Control & Prevent Atlanta, Div Global Hlth Protect, Global Dis Detect Branch, Atlanta, GA 30333 USA; [Gao, Fangfang; Gao, Fei; Han, Guoxin; Ren, Liping] Inner Mongolia Ctr TB Control & Prevent, Hohhot, Peoples R China; [Hou, Yueyun] Tongzhou Maternal & Child Hlth Hosp, Beijing, Peoples R China; [He, Guoming; Li, Jianbo; Guo, Shufang; Yang, Jun] Ulanqab Ctr TB Control & Prevent, Jining, Peoples R China; [Yan, Daiqin; Wang, Yali; Gao, Haiyan] Bayannur TB Control & Prevent, Bayannur, Peoples R China; [An, Jing; Duan, Xiaoyan] Linhe Dist Ctr Dis Control & Prevent, Bayannur, Peoples R China; [Wu, Chunru; Duan, Fengming] Hanggin Rear Banner Ctr Dis Control & Prevent, Bayannur, Peoples R China	Chinese Center for Disease Control & Prevention; Centers for Disease Control & Prevention - USA	Rao, CY (corresponding author), US Ctr Dis Control & Prevent Atlanta, Div Global Hlth Protect, Global Dis Detect Branch, Atlanta, GA 30333 USA.	crao@cdc.gov; wangyu@chinacdc.cn		Rao, Carol/0000-0001-7187-2189; Zhao, Fei/0000-0001-7952-4517	U.S. Centers for Disease Control and Prevention [5U2GGH000018]	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This publication was supported by the Cooperative Agreement Number 5U2GGH000018 from The U.S. Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centers for Disease Control and Prevention (CDC), CDC HUM RES PROT POL; Drobniewski F, 2007, PLOS MED, V4, P273, DOI 10.1371/journal.pmed.0040055; Du X, 2013, J CHINESE ANTITUBERC, V35, P337; Fang Tao, 2011, Chongqing Medicine, V40, P2351; He GX, 2012, INT J TUBERC LUNG D, V16, P1485, DOI 10.5588/ijtld.12.0193; He GX, 2003, CHINA J PUBLIC HLTH, V19, P865; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Lien Luu Thi, 2009, PLoS One, V4, pe6798, DOI 10.1371/journal.pone.0006798; Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Ministry of Health China, 2008, 2882008 WS MIN HLTH; Ministry of Health of the People's Republic of China, 2010, NAT ANT DRUG RES BAS; Mirtskhulava V, 2008, INT J TUBERC LUNG D, V12, P513; Moon HW, 2013, ANN CLIN LAB SCI, V43, P221; National Bureau of Statistics of China, 2011, CHINA POPULATION TOD; National Technic Steering Group Of The Epidemiological Sampling Survey For Tuberculosis, 2002, Zhonghua Jie He He Hu Xi Za Zhi, V25, P3; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Styblo K, 1969, Bull Int Union Tuberc, V42, P1; Wang Y, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/621414; Wang ZL, 2003, CHINESE RURAL HLTH C, V23, P25; WHO, 2011, WHO GLOBAL TUBERCULO; Xu HW, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-17; Xu WG, 2008, J CHINESE ANTITUBERC, V30, P1; Yang JX, 2008, CHINESE RURAL HLTH S, V28, P791; Zhang W, 2008, CHIN J HLTH ED, V24, P572; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	28	25	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0124097	10.1371/journal.pone.0124097	http://dx.doi.org/10.1371/journal.pone.0124097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996960	gold, Green Submitted, Green Published			2022-12-26	WOS:000356444000002
J	Viollet, L; Glusman, G; Murphy, KJ; Newcomb, TM; Reyna, SP; Sweney, M; Nelson, B; Andermann, F; Andermann, E; Acsadi, G; Barbano, RL; Brown, C; Brunkow, ME; Chugani, HT; Cheyette, SR; Collins, A; DeBrosse, SD; Galas, D; Friedman, J; Hood, L; Huff, C; Jorde, LB; King, MD; LaSalle, B; Leventer, RJ; Lewelt, AJ; Massart, MB; Merida, MR; Ptacek, LJ; Roach, JC; Rust, RS; Renault, F; Sanger, TD; de Menezes, MAS; Tennyson, R; Uldall, P; Zhang, Y; Zupanc, M; Xin, WN; Silver, K; Swoboda, KJ				Viollet, Louis; Glusman, Gustavo; Murphy, Kelley J.; Newcomb, Tara M.; Reyna, Sandra P.; Sweney, Matthew; Nelson, Benjamin; Andermann, Frederick; Andermann, Eva; Acsadi, Gyula; Barbano, Richard L.; Brown, Candida; Brunkow, Mary E.; Chugani, Harry T.; Cheyette, Sarah R.; Collins, Abigail; DeBrosse, Suzanne D.; Galas, David; Friedman, Jennifer; Hood, Lee; Huff, Chad; Jorde, Lynn B.; King, Mary D.; LaSalle, Bernie; Leventer, Richard J.; Lewelt, Aga J.; Massart, Mylynda B.; Merida, Mario R., II; Ptacek, Louis J.; Roach, Jared C.; Rust, Robert S.; Renault, Francis; Sanger, Terry D.; de Menezes, Marcio A. Sotero; Tennyson, Rachel; Uldall, Peter; Zhang, Yue; Zupanc, Mary; Xin, Winnie; Silver, Kenneth; Swoboda, Kathryn J.			Alternating Hemiplegia of Childhood: Retrospective Genetic Study and Genotype-Phenotype Correlations in 187 Subjects from the US AHCF Registry	PLOS ONE			English	Article							ONSET DYSTONIA-PARKINSONISM; GLUTAMATE TRANSPORTER EAAT1; DE-NOVO MUTATIONS; ATP1A3 MUTATION; CLINICAL-MANIFESTATIONS; ALPHA-3 ISOFORM; NA+ INTERACTION; K+-ATPASE; SPECTRUM; AFFINITY	Mutations in ATP1A3 cause Alternating Hemiplegia of Childhood (AHC) by disrupting function of the neuronal Na+/K+ ATPase. Published studies to date indicate 2 recurrent mutations, D801N and E815K, and a more severe phenotype in the E815K cohort. We performed mutation analysis and retrospective genotype-phenotype correlations in all eligible patients with AHC enrolled in the US AHC Foundation registry from 1997-2012. Clinical data were abstracted from standardized caregivers' questionnaires and medical records and confirmed by expert clinicians. We identified ATP1A3 mutations by Sanger and whole genome sequencing, and compared phenotypes within and between 4 groups of subjects, those with D801N, E815K, other ATP1A3 or no ATP1A3 mutations. We identified heterozygous ATP1A3 mutations in 154 of 187 (82%) AHC patients. Of 34 unique mutations, 31 (91%) are missense, and 16 (47%) had not been previously reported. Concordant with prior studies, more than 2/3 of all mutations are clustered in exons 17 and 18. Of 143 simplex occurrences, 58 had D801N (40%), 38 had E815K (26%) and 11 had G937R (8%) mutations. Patients with an E815K mutation demonstrate an earlier age of onset, more severe motor impairment and a higher prevalence of status epilepticus. This study further expands the number and spectrum of ATP1A3 mutations associated with AHC and confirms a more deleterious effect of the E815K mutation on selected neurologic outcomes. However, the complexity of the disorder and the extensive phenotypic variability among subgroups merits caution and emphasizes the need for further studies.	[Viollet, Louis; Murphy, Kelley J.; Newcomb, Tara M.; Reyna, Sandra P.; Sweney, Matthew; Nelson, Benjamin; Tennyson, Rachel; Swoboda, Kathryn J.] Univ Utah, Dept Neurol, Pediat Motor Disorders Res Program, Salt Lake City, UT 84112 USA; [Viollet, Louis; Murphy, Kelley J.; Newcomb, Tara M.; Reyna, Sandra P.; Sweney, Matthew; Nelson, Benjamin; Tennyson, Rachel; Swoboda, Kathryn J.] Univ Utah, Dept Pediat, Pediat Motor Disorders Res Program, Salt Lake City, UT USA; [Glusman, Gustavo; Brunkow, Mary E.; Hood, Lee; Roach, Jared C.] Inst Syst Biol, Seattle, WA USA; [Andermann, Frederick; Andermann, Eva] McGill Univ, Montreal Neurol Inst & Hosp, Neurogenet Unit, Montreal, PQ, Canada; [Acsadi, Gyula] Connecticut Childrens Med Ctr, Dept Pediat, Hartford, CT USA; [Acsadi, Gyula] Connecticut Childrens Med Ctr, Dept Neurol, Hartford, CT USA; [Barbano, Richard L.] Univ Connecticut, Sch Med, Hartford, CT 06112 USA; [Brown, Candida] Univ Rochester, Sch Med, Dept Neurol, Rochester, NY USA; [Chugani, Harry T.] Affiliate Stanford Hlth Alliance, Diablo Valley Child Neurol, Pleasant Hill, CA USA; [Cheyette, Sarah R.] Wayne State Univ, Childrens Hosp Michigan, Div Pediat Neurol, Detroit, MI USA; [Collins, Abigail] Palo Alto Med Fdn Redwood City Clin, Dept Child Neurol, Redwood City, CA USA; [DeBrosse, Suzanne D.] Univ Colorado Hosp, Childrens Hosp Colorado, Dept Pediat Neurol, Aurora, CO USA; [DeBrosse, Suzanne D.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Galas, David] Case Western Reserve Univ, Dept Genome Sci Pediat & Neurol, Cleveland, OH 44106 USA; [Friedman, Jennifer] Pacific Northwest Diabet Res Inst, Seattle, WA USA; [Friedman, Jennifer] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Huff, Chad] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; [Jorde, Lynn B.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [King, Mary D.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [King, Mary D.] Univ Coll Dublin, Sch Med & Med Sci, Dept Pediat, Dublin 2, Ireland; [LaSalle, Bernie] Univ Coll Dublin, Sch Med & Med Sci, Dept Neurol, Dublin 2, Ireland; [Leventer, Richard J.] Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT USA; [Lewelt, Aga J.] Univ Melbourne, Royal Childrens Hosp, Childrens Neurosci Ctr, Murdoch Childrens Res Inst,Dept Paediat, Parkville, Vic 3052, Australia; [Massart, Mylynda B.] Univ Florida, Coll Med, Dept Pediat, Jacksonville, FL USA; [Merida, Mario R., II] Univ Pittsburgh, Sch Med, Dept Family Med, Pittsburgh, PA USA; [Ptacek, Louis J.] Stevens Henager Coll, Salt Lake City, UT USA; [Rust, Robert S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Renault, Francis] Univ Virginia UVA Hlth Syst, Ctr Med Eth & Humanities Med, Charlottesville, VA USA; [Sanger, Terry D.] Hop Armand Trousseau, AP HP, Dept Neurophysiol, Paris, France; [de Menezes, Marcio A. Sotero] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Uldall, Peter] Swedish Neurosci Inst, Swedish Med Ctr, Seattle, WA USA; [Zhang, Yue] Univ Copenhagen, Rigshosp, Juliane Marie Ctr, Dept Paediat & Adolescent Med, DK-2100 Copenhagen, Denmark; [Zupanc, Mary] Univ Utah, Study Design & Biostat Ctr, Salt Lake City, UT USA; [Zupanc, Mary] Univ Calif, Childrens Hosp, Dept Neurol, Orange, CA USA; [Xin, Winnie] Univ Calif, Dept Pediat, Orange, CA USA; [Xin, Winnie] Massachusetts Gen Hosp, Ctr Human Genet Res, Dept Neurol, Boston, MA 02114 USA; [Silver, Kenneth] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Silver, Kenneth] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Silver, Kenneth] Comer Childrens Hosp, Chicago, IL USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Institute for Systems Biology (ISB); McGill University; Connecticut Children's Medical Center; Connecticut Children's Medical Center; University of Connecticut; University of Rochester; Children's Hospital of Michigan; Wayne State University; Children's Hospital Colorado; University of Colorado System; University of Colorado Hospital; Case Western Reserve University; Case Western Reserve University; Pacific Northwest Diabetes Research Institute (PNDRI); University of California System; University of California San Diego; University of California System; University of California San Diego; University of Texas System; UTMD Anderson Cancer Center; Utah System of Higher Education; University of Utah; University College Dublin; University College Dublin; Utah System of Higher Education; University of Utah; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Southern California; Swedish Medical Center; Rigshospitalet; University of Copenhagen; Utah System of Higher Education; University of Utah; Children's Hospital Los Angeles; Harvard University; Massachusetts General Hospital; University of Chicago; University of Chicago	Swoboda, KJ (corresponding author), Univ Utah, Dept Neurol, Pediat Motor Disorders Res Program, Salt Lake City, UT 84112 USA.	swoboda@genetics.utah.edu	Zupanc, Mary Lynn/AAW-5956-2021; Massart, Mylynda/ABC-6861-2021	Massart, Mylynda/0000-0002-8835-7957; Swoboda, Kathryn/0000-0002-4593-6342; Glusman, Gustavo/0000-0001-8060-5955	Alternating Hemiplegia of Childhood Foundation; University of Luxembourg-Institute for Systems Biology Strategic Partnership; Luxembourg Centre for Systems Biomedicine; National Institute of General Medical Sciences Center for Systems Biology [P50 GM076547]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER	Alternating Hemiplegia of Childhood Foundation; University of Luxembourg-Institute for Systems Biology Strategic Partnership; Luxembourg Centre for Systems Biomedicine; National Institute of General Medical Sciences Center for Systems Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Alternating Hemiplegia of Childhood Foundation (http://ahckids.org/). Funds were received by KJS. The association Genetique Actions (http://www.genetique-actions.fr/). Funds were received by LV. The University of Luxembourg-Institute for Systems Biology Strategic Partnership (http://www.partnerships.systemsbiology.net/517/). Funds were received by LH. The Luxembourg Centre for Systems Biomedicine (http://wwwfr.uni.lu/lcsb). Funds were received by LH. The National Institute of General Medical Sciences Center for Systems Biology (http://www.nigms.nih.gov/research/specificareas/sysbio/Pages/default.aspx) P50 GM076547. Funds were received by LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Barbano RL, 2012, PARKINSONISM RELAT D, V18, P737, DOI 10.1016/j.parkreldis.2012.03.020; Bassi MT, 2004, J MED GENET, V41, P621, DOI 10.1136/jmg.2003.017863; Blanco-Arias P, 2009, HUM MOL GENET, V18, P2370, DOI 10.1093/hmg/ddp170; BOURGEOIS M, 1993, J PEDIATR-US, V122, P673, DOI 10.1016/S0022-3476(06)80003-X; Brashear A, 2007, BRAIN, V130, P828, DOI 10.1093/brain/awl340; Brashear A, 2012, DEV MED CHILD NEUROL, V54, P1065, DOI 10.1111/j.1469-8749.2012.04421.x; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; de Vries B, 2008, CEPHALALGIA, V28, P887, DOI 10.1111/j.1468-2982.2008.01596.x; de Vries B, 2006, NEUROPEDIATRICS, V37, P302, DOI 10.1055/s-2006-924609; Demos MK, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-15; Di Michele M, 2013, J PROTEOMICS, V86, P53, DOI 10.1016/j.jprot.2013.05.005; Einholm AP, 2010, J BIOL CHEM, V285, P26245, DOI 10.1074/jbc.M110.123976; Glusman G, 2011, BIOINFORMATICS, V27, P3216, DOI 10.1093/bioinformatics/btr540; Heinzen EL, 2014, LANCET NEUROL, V13, P503, DOI 10.1016/S1474-4422(14)70011-0; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Hoei-Hansen CE, 2014, EUR J PAEDIATR NEURO, V18, P50, DOI 10.1016/j.ejpn.2013.08.007; Ishii A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056120; Jen JC, 2005, NEUROLOGY, V65, P529, DOI 10.1212/01.WNL.0000172638.58172.5a; Kamm C, 2008, NEUROLOGY, V70, P1501, DOI 10.1212/01.wnl.0000310431.41036.e0; Kamphuis DJ, 2006, MOVEMENT DISORD, V21, P118, DOI 10.1002/mds.20695; Kanavakis E, 2003, DEV MED CHILD NEUROL, V45, P833, DOI 10.1017/S0012162203001543; Lee JY, 2007, MOVEMENT DISORD, V22, P1808, DOI 10.1002/mds.21638; Li M, 2015, NEUROBIOL DIS, V77, P88, DOI 10.1016/j.nbd.2015.02.002; Linazasoro G, 2002, MOVEMENT DISORD, V17, P608, DOI 10.1002/mds.10103; MIKATI MA, 1992, NEUROLOGY, V42, P2251, DOI 10.1212/WNL.42.12.2251; Mikati MA, 2000, PEDIATR NEUROL, V23, P134, DOI 10.1016/S0887-8994(00)00157-0; Ozelius LJ, 2012, LANCET NEUROL, V11, P741, DOI 10.1016/S1474-4422(12)70185-0; Panagiotakaki E, 2010, BRAIN, V133, P3598, DOI 10.1093/brain/awq295; Pittock SJ, 2000, NEUROLOGY, V55, P991, DOI 10.1212/WNL.55.7.991; Rodacker V, 2006, J BIOL CHEM, V281, P18539, DOI 10.1074/jbc.M601780200; Rosewich H, 2014, NEUROLOGY, V83, P861, DOI 10.1212/WNL.0000000000000735; Rosewich H, 2014, J NEUROL SCI, V341, P133, DOI 10.1016/j.jns.2014.03.034; Rosewich H, 2014, NEUROLOGY, V82, P945, DOI 10.1212/WNL.0000000000000212; Rosewich H, 2012, LANCET NEUROL, V11, P764, DOI 10.1016/S1474-4422(12)70182-5; Saito Y, 2010, EPILEPSY RES, V90, P248, DOI 10.1016/j.eplepsyres.2010.05.013; SAKURAGAWA N, 1992, BRAIN DEV-JPN, V14, P283, DOI 10.1016/S0387-7604(12)80144-6; Sasaki M, 2014, NEUROLOGY, V82, P482, DOI 10.1212/WNL.0000000000000102; Svetel M, 2010, J NEUROL, V257, P472, DOI 10.1007/s00415-009-5385-y; Sweney MT, 2009, PEDIATRICS, V123, pe534, DOI 10.1542/peds.2008-2027; Swoboda KJ, 2004, ANN NEUROL, V55, P884, DOI 10.1002/ana.20134; Tarsy D, 2010, NEW ENGL J MED, V362, P2213, DOI 10.1056/NEJMcpc1002112; Toustrup-Jensen MS, 2014, J BIOL CHEM, V289, P3186, DOI 10.1074/jbc.M113.543272; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; Ulate-Campos A, 2014, MED CLIN-BARCELONA, V143, P25, DOI 10.1016/j.medcli.2014.01.036; Vedovato N, 2014, J GEN PHYSIOL, V143, P449, DOI 10.1085/jgp.201311148; VERRETT S, 1971, PEDIATRICS, V47, P675; Vila-Pueyo M, 2014, J NEUROL SCI, V344, P37, DOI 10.1016/j.jns.2014.06.014; Vuillaumier-Barrot S, 2010, NEUROPEDIATRICS, V41, DOI 10.1055/s-0031-1271767; Weigand KM, 2014, BBA-MOL BASIS DIS, V1842, P1010, DOI 10.1016/j.bbadis.2014.03.002; Yang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097274; Zanotti-Fregonara P, 2008, J NEUROL SCI, V273, P148, DOI 10.1016/j.jns.2008.06.033	52	45	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127045	10.1371/journal.pone.0127045	http://dx.doi.org/10.1371/journal.pone.0127045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996915	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000356444000041
J	Yu, Z; Lu, HJ; Si, HZ; Liu, SH; Li, XC; Gao, CH; Cui, LH; Li, C; Yang, X; Yao, XJ				Yu, Zhuang; Lu, Haijiao; Si, Hongzong; Liu, Shihai; Li, Xianchao; Gao, Caihong; Cui, Lianhua; Li, Chuan; Yang, Xue; Yao, Xiaojun			A Highly Efficient Gene Expression Programming (GEP) Model for Auxiliary Diagnosis of Small Cell Lung Cancer	PLOS ONE			English	Article							C-REACTIVE PROTEIN; TUMOR-MARKERS; BIOMARKERS; HYPONATREMIA; PREDICTION; TOOLS; PANEL; SCC; CEA	Background Lung cancer is an important and common cancer that constitutes a major public health problem, but early detection of small cell lung cancer can significantly improve the survival rate of cancer patients. A number of serum biomarkers have been used in the diagnosis of lung cancers; however, they exhibit low sensitivity and specificity. Methods We used biochemical methods to measure blood levels of lactate dehydrogenase (LDH), Creactive protein (CRP), Na+, Cl-, carcino-embryonic antigen (CEA), and neuron specific enolase (NSE) in 145 small cell lung cancer (SCLC) patients and 155 non-small cell lung cancer and 155 normal controls. A gene expression programming (GEP) model and Receiver Operating Characteristic (ROC) curves incorporating these biomarkers was developed for the auxiliary diagnosis of SCLC. Results After appropriate modification of the parameters, the GEP model was initially set up based on a training set of 115 SCLC patients and 125 normal controls for GEP model generation. Then the GEP was applied to the remaining 60 subjects (the test set) for model validation. GEP successfully discriminated 281 out of 300 cases, showing a correct classification rate for lung cancer patients of 93.75% (225/240) and 93.33% (56/60) for the training and test sets, respectively. Another GEP model incorporating four biomarkers, including CEA, NSE, LDH, and CRP, exhibited slightly lower detection sensitivity than the GEP model, including six biomarkers. We repeat the models on artificial neural network (ANN), and our results showed that the accuracy of GEP models were higher than that in ANN. GEP model incorporating six serum biomarkers performed by NSCLC patients and normal controls showed low accuracy than SCLC patients and was enough to prove that the GEP model is suitable for the SCLC patients. Conclusion We have developed a GEP model with high sensitivity and specificity for the auxiliary diagnosis of SCLC. This GEP model has the potential for the wide use for detection of SCLC in less developed regions.	[Yu, Zhuang; Lu, Haijiao; Gao, Caihong; Yang, Xue] Qingdao Univ, Affiliated Hosp, Dept Oncol, Qingdao 266071, Shandong, Peoples R China; [Si, Hongzong] Qingdao Univ, Lab New Fibrous Mat & Modern Text, Inst Computat Sci & Engn, Growing Base State Key Lab,Dept Pharm, Qingdao 266071, Shandong, Peoples R China; [Liu, Shihai] Qingdao Univ, Affiliated Hosp, Cent Lab, Qingdao 266071, Shandong, Peoples R China; [Li, Xianchao] Qingdao Univ, Dept Pharm, Qingdao 266071, Shandong, Peoples R China; [Cui, Lianhua] Qingdao Univ, Coll Med, Dept Publ Hlth, Qingdao 266071, Shandong, Peoples R China; [Li, Chuan] Qingdao Univ, Affiliated Hosp, Dept Thorac Surg, Qingdao 266071, Shandong, Peoples R China; [Yao, Xiaojun] Lanzhou Univ, Dept Chem, Lanzhou 730000, Gansu, Peoples R China	Qingdao University; Qingdao University; Qingdao University; Qingdao University; Qingdao University; Qingdao University; Lanzhou University	Yu, Z (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Oncol, Qingdao 266071, Shandong, Peoples R China.	yuzhuang2002@163.com			Jieping Wu foundation [320.6750.13210, 320.6753.1219]	Jieping Wu foundation	This work was supported by Jieping Wu foundation: 320.6750.13210 and Jieping Wu foundation: 320.6753.1219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Adetiba E, 2011, INT J COMPUTER APPL, V20, P39; Bajtarevic A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-348; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Bucher C, 2014, CLIN BIOCHEM, V47, P618, DOI 10.1016/j.clinbiochem.2013.12.021; Chanin TD, 2004, CURR OPIN PULM MED, V10, P242, DOI 10.1097/01.mcp.0000130321.11513.13; Chaturvedi AK, 2010, J CLIN ONCOL, V28, P2719, DOI 10.1200/JCO.2009.27.0454; Cheng J, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P101; Cho WCS, 2007, BIOMED PHARMACOTHER, V61, P515, DOI 10.1016/j.biopha.2007.08.005; Chu XY, 2011, CANCER BIOL THER, V11, P995, DOI 10.4161/cbt.11.12.15526; Chute JP, 2006, CLIN CANCER RES, V12, P888, DOI 10.1158/1078-0432.CCR-05-1536; Cruz JA, 2006, CANCER INFORM, V2, P59; Erbaycu AE, 2010, ARCH BRONCONEUMOL, V46, P364, DOI 10.1016/j.arbres.2010.04.005; Feng FF, 2012, J MED SYST, V36, P2973, DOI 10.1007/s10916-011-9775-1; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fernandez A, 2007, QUIMICA CLIN, V26, P77; Ferreira C, 2002, SOFT COMPUTING AND INDUSTRY, P635; GEPSOFT, 2013, GENEXPROTOOLS; Ghosal R, 2009, POSTGRAD MED J, V85, P358, DOI 10.1136/pgmj.2008.076307; Grondin SC, 2002, SURG ONCOL, V11, P181, DOI 10.1016/S0960-7404(02)00050-6; Han XR, 2014, ADV MATER RES-SWITZ, V850-851, P1291, DOI 10.4028/www.scientific.net/AMR.850-851.1291; Hannon MJ, 2010, EUR J ENDOCRINOL, V162, pS5, DOI 10.1530/EJE-09-1063; Heikkila K, 2007, J EPIDEMIOL COMMUN H, V61, P824, DOI 10.1136/jech.2006.051292; Hermes A, 2010, RESP MED, V104, P1937, DOI 10.1016/j.rmed.2010.07.013; Casillas CEH, 2014, FUTURE ONCOL, V10, P1501, DOI [10.2217/FON.14.21, 10.2217/fon.14.21]; Hirsch FR, 1998, RESP PHARM & PHARMAC, P1; Hosseinzadeh F, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-238; Kayaer K, 2003, MED DIAGNOSIS PIMA I, P181; Koza JR, 1992, GENETIC PROGRAMMING; Kusy M, 2013, MED BIOL ENG COMPUT, V51, P1357, DOI 10.1007/s11517-013-1108-8; Lee S, 2011, J EPIDEMIOL, V21, P161, DOI 10.2188/jea.JE20100128; Lekic M, 2012, RADIOL ONCOL, V46, P54, DOI 10.2478/v10019-012-0007-1; Marshall E, 2008, SCIENCE, V320, P600, DOI 10.1126/science.320.5876.600; Flores-Fernandez JM, 2012, EXPERT SYST APPL, V39, P10851, DOI 10.1016/j.eswa.2012.03.008; Molina R, 2008, TUMOR BIOL, V29, P371, DOI 10.1159/000181180; Muller-Hermelink H.K., 2004, PATHOLOGY GENETICS T; Nolen BM, 2011, CANCER BIOMARK, V10, P3, DOI 10.3233/CBM-2012-0229; Patz EF, 2007, J CLIN ONCOL, V25, P5578, DOI 10.1200/JCO.2007.13.5392; Pieterman RM, 2000, NEW ENGL J MED, V343, P254, DOI 10.1056/NEJM200007273430404; Pine SR, 2011, JNCI-J NATL CANCER I, V103, P1112, DOI 10.1093/jnci/djr216; Reich JM, 2008, THORAX, V63, P377, DOI 10.1136/thx.2007.079673; Salomon R, 1996, BIOSYSTEMS, V39, P263, DOI 10.1016/0303-2647(96)01621-8; Schneider J, 2006, ADV CLIN CHEM, V42, P1, DOI 10.1016/S0065-2423(06)42001-1; Sesen MB, 2012, SURVIVAL PREDICTION, P838; Seute T, 2004, CANCER-AM CANCER SOC, V100, P801, DOI 10.1002/cncr.20043; Si H.Z., 2011, J COMPUT SCI ENG, V1, P22, DOI DOI 10.1186/1753-6561-8-S6-S4; Sone S, 2001, BRIT J CANCER, V84, P25, DOI 10.1054/bjoc.2000.1531; Sun T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063559; Sun ZH, 2004, ANTICANCER RES, V24, P1159; Tureci O, 2006, CANCER LETT, V236, P64, DOI 10.1016/j.canlet.2005.05.008; Vantyghem MC, 2011, ANN ENDOCRINOL-PARIS, V72, P500, DOI 10.1016/j.ando.2011.10.001; Wahbah M, 2007, ANN DIAGN PATHOL, V11, P89, DOI 10.1016/j.anndiagpath.2006.04.006; Welch HG, 2007, ARCH INTERN MED, V167, P2289, DOI 10.1001/archinte.167.21.2289; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P956, DOI 10.1164/rccm.200802-336OC; Wu YJ, 2011, EXPERT SYST APPL, V38, P11329, DOI 10.1016/j.eswa.2011.02.183; Yang XQ, 2011, CELL BIOCHEM BIOPHYS, V59, P113, DOI 10.1007/s12013-010-9121-0; Yokosuka K, 2008, INTERNAL MED, V47, P109, DOI 10.2169/internalmedicine.47.0441; Yu Z, 2014, ASIAN PAC J CANCER P, V15, P9367, DOI 10.7314/APJCP.2014.15.21.9367; Zhou C, 2003, IEEE T EVOLUT COMPUT, V7, P519, DOI 10.1109/TEVC.2003.819261	60	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0125517	10.1371/journal.pone.0125517	http://dx.doi.org/10.1371/journal.pone.0125517			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996920	Green Published, Green Submitted, gold			2022-12-26	WOS:000356444000011
J	Bi, K; Huang, K; Zeng, LY; Zhou, MH; Wang, QM; Wang, YG; Lei, M				Bi, K.; Huang, K.; Zeng, L. Y.; Zhou, M. H.; Wang, Q. M.; Wang, Y. G.; Lei, M.			Tunable Dielectric Properties of Ferrite-Dielectric Based Metamaterial	PLOS ONE			English	Article							MIE RESONANCE; THIN-FILMS	A ferrite-dielectric metamaterial composed of dielectric and ferrite cuboids has been investigated by experiments and simulations. By interacting with the electromagnetic wave, the Mie resonance can take place in the dielectric cuboids and the ferromagnetic precession will appear in the ferrite cuboids. The magnetic field distributions show the electric Mie resonance of the dielectric cuboids can be influenced by the ferromagnetic precession of ferrite cuboids when a certain magnetic field is applied. The effective permittivity of the metamaterial can be tuned by modifying the applied magnetic field. A good agreement between experimental and simulated results is demonstrated, which confirms that these metamaterials can be used for tunable microwave devices.	[Lei, M.] Beijing Univ Posts & Telecommun, State Key Lab Informat Photon & Opt Commun, Beijing 100876, Peoples R China; Beijing Univ Posts & Telecommun, Sch Sci, Beijing 100876, Peoples R China	Beijing University of Posts & Telecommunications; Beijing University of Posts & Telecommunications	Lei, M (corresponding author), Beijing Univ Posts & Telecommun, State Key Lab Informat Photon & Opt Commun, Beijing 100876, Peoples R China.	minglei@bupt.edu.cn	Lei, Ming/D-8847-2013; Bi, Ke/C-1175-2011	Bi, Ke/0000-0002-3357-5754	National Natural Science Foundation of China [51402163, 61376018, 51032003, 11274198, 51102148, 51221291]; China Postdoctoral Science Foundation [2013M530042, 2014T70075]; Fundamental Research Funds for the Central Universities [2015RC18]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China under Grant Nos. 51402163, 61376018, 51032003, 11274198, 51102148 and 51221291; the China Postdoctoral Science Foundation under Grant Nos. 2013M530042 and 2014T70075; and the Fundamental Research Funds for the Central Universities under Grant No. 2015RC18. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi K, 2014, SCI REP-UK, V4, DOI 10.1038/srep07001; Bi K, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4823598; Castel V, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2943153; Chen PY, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.105503; Chen XD, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.016608; Chen YJ, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3095498; Cole MW, 2000, THIN SOLID FILMS, V374, P34, DOI 10.1016/S0040-6090(00)01059-2; Cole MW, 2003, J APPL PHYS, V93, P9218, DOI 10.1063/1.1569392; Croenne C, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.125333; Fu YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2538; Kang L, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.195125; Kim KT, 2002, THIN SOLID FILMS, V420, P544, DOI 10.1016/S0040-6090(02)00849-0; KOBAYASHI Y, 1985, IEEE T MICROW THEORY, V33, P586, DOI 10.1109/TMTT.1985.1133033; Kuznetsov AI, 2012, SCI REP-UK, V2, DOI 10.1038/srep00492; Peng L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.157403; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Smith DR, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.195104; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; Somiya Y, 2001, INT J INORG MATER, V3, P709, DOI 10.1016/S1466-6049(01)00187-8; Stingaciu M, 2014, J MATER CHEM C, V2, P325, DOI 10.1039/c3tc31737d; Tsang L, 2000, SCATTERING ELECTROMA, V141; Wu Y, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.105506; Zhang FL, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4900757; Zhang FL, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4870647; Zhang FL, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033031; Zhao HJ, 2009, OPT EXPRESS, V17, P13373, DOI 10.1364/OE.17.013373; Zhao Q, 2008, CHINESE SCI BULL, V53, P3272, DOI 10.1007/s11434-008-0475-2; Zhao Q, 2009, MATER TODAY, V12, P60, DOI 10.1016/S1369-7021(09)70318-9; Zhao Q, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.027402	29	3	3	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127331	10.1371/journal.pone.0127331	http://dx.doi.org/10.1371/journal.pone.0127331			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993433	Green Published, Green Submitted, gold			2022-12-26	WOS:000354921400108
J	Denk, J; Boelmans, K; Siegismund, C; Lassner, D; Arlt, S; Jahn, H				Denk, Johannes; Boelmans, Kai; Siegismund, Christine; Lassner, Dirk; Arlt, Soenke; Jahn, Holger			MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; NATIONAL INSTITUTE; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; CEREBROSPINAL-FLUID; PHOSPHORYLATED TAU; EXPRESSION; RECOMMENDATIONS; BRAIN; STABILITY	The miRBase-21 database currently lists 1881 microRNA (miRNA) precursors and 2585 unique mature human miRNAs. Since their discovery, miRNAs have proved to present a new level of epigenetic post-transcriptional control of protein synthesis. Initial results point to a possible involvement of miRNA in Alzheimer's disease (AD). We applied OpenArray technology to profile the expression of 1178 unique miRNAs in cerebrospinal fluid (CSF) samples of AD patients (n = 22) and controls (n = 28). Using a Cq of 34 as cut-off, we identified positive signals for 441 miRNAs, while 729 miRNAs could not be detected, indicating that at least 37% of miRNAs are present in the brain. We found 74 miRNAs being down- and 74 miRNAs being up-regulated in AD using a 1.5 fold change threshold. By applying the new explorative "Measure of relevance" method, 6 reliable and 9 informative biomarkers were identified. Confirmatory MANCOVA revealed reliable miR-100, miR-146a and miR-1274a as differentially expressed in AD reaching Bonferroni corrected significance. MANCOVA also confirmed differential expression of informative miR-103, miR-375, miR-505#, miR-708, miR-4467, miR-219, miR-296, miR-766 and miR-3622b-3p. Discrimination analysis using a combination of miR-100, miR-103 and miR-375 was able to detect AD in CSF by positively classifying controls and AD cases with 96.4% and 95.5% accuracy, respectively. Referring to the Ingenuity database we could identify a set of AD associated genes that are targeted by these miRNAs. Highly predicted targets included genes involved in the regulation of tau and amyloid pathways in AD like MAPT, BACE1 and mTOR.	[Denk, Johannes; Boelmans, Kai; Arlt, Soenke; Jahn, Holger] Univ Hosp Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Hamburg, Germany; [Siegismund, Christine; Lassner, Dirk] Inst Cardiac Diagnost & Therapy IKDT, Berlin, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Jahn, H (corresponding author), Univ Hosp Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Hamburg, Germany.	jahn@uke.de	Jahn, Holger/A-9255-2008; Denk, Johannes/X-4513-2018; Denk, Johannes/R-3740-2019	Jahn, Holger/0000-0003-3607-7651; Denk, Johannes/0000-0002-1759-148X; Denk, Johannes/0000-0002-1759-148X; Lassner, Dirk/0000-0003-0815-7013; Siegismund, Christine Sabine/0000-0001-7909-1694				Abdelmohsen K, 2010, MOL CELL BIOL, V30, P4197, DOI 10.1128/MCB.00316-10; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alexandrov Peter N, 2012, Int J Biochem Mol Biol, V3, P365; Antony JM, 2011, BBA-MOL BASIS DIS, V1812, P162, DOI 10.1016/j.bbadis.2010.07.016; Baker M, 2010, NAT METHODS, V7, P687, DOI 10.1038/nmeth0910-687; Bekris LM, 2013, BIOMARKERS, V18, P455, DOI 10.3109/1354750X.2013.814073; Blennow K, 2001, MOL NEUROBIOL, V24, P87, DOI 10.1385/MN:24:1-3:087; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caccamo A, 2013, AGING CELL, V12, P370, DOI 10.1111/acel.12057; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Cheng Lesley, 2013, Frontiers in Genetics, V4, P150, DOI [10.3389/fgene.2013.00150, 10.3389/fimmu.2013.00388]; Chouliaras L, 2010, PROG NEUROBIOL, V90, P498, DOI 10.1016/j.pneurobio.2010.01.002; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Coolen M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00220; De Strooper B, 2010, MACROROLES MICRORNAS; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Frigerio CS, 2013, NEUROLOGY, V81, P2103, DOI 10.1212/01.wnl.0000437306.37850.22; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hulstaert F, 1999, NEUROLOGY, V52, P1555, DOI 10.1212/WNL.52.8.1555; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jung M, 2010, CLIN CHEM, V56, P998, DOI 10.1373/clinchem.2009.141580; Kiko T, 2014, J ALZHEIMERS DIS, V39, P253, DOI 10.3233/JAD-130932; Koberle V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075184; Lau P, 2014, AGEING RES REV, V17, P43, DOI 10.1016/j.arr.2014.02.006; Le Carre J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00413; Leidinger P, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r78; Lewczuk P, 2006, J NEURAL TRANSM, V113, P1075, DOI 10.1007/s00702-006-0511-9; Li YY, 2011, NEUROSCI LETT, V487, P94, DOI 10.1016/j.neulet.2010.09.079; Liu W, 2012, NEUROBIOL AGING, V33, P522, DOI 10.1016/j.neurobiolaging.2010.04.034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Lukiw WJ, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt150; Machida Akira, 2013, Methods Mol Biol, V1024, P203, DOI 10.1007/978-1-62703-453-1_16; Maciotta S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00265; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Migliore L, 2009, MUTAT RES-FUND MOL M, V667, P82, DOI 10.1016/j.mrfmmm.2008.10.011; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Moldovan L, 2014, J CELL MOL MED, V18, P371, DOI 10.1111/jcmm.12236; Mulder C, 2010, CLIN CHEM, V56, P248, DOI 10.1373/clinchem.2009.130518; Muller M, 2014, NEUROBIOL AGING, V35, P152, DOI 10.1016/j.neurobiolaging.2013.07.005; Sheinerman KS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00150; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Rosa-Neto P, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt223; Schonrock N, 2012, EXP NEUROL, V235, P447, DOI 10.1016/j.expneurol.2011.11.013; Schopman NCT, 2010, RNA BIOL, V7, P573, DOI [10.4161/rna.7.5.13141, 10.4161/rna.7.4.13141]; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Vanderstichele H, 2012, ALZHEIMERS DEMENT, V8, P65, DOI 10.1016/j.jalz.2011.07.004; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wilcock Donna M, 2012, Curr Gerontol Geriatr Res, V2012, P170276, DOI 10.1155/2012/170276; World Health Organization, 1992, ICD 10 INT STAT CLAS; Yassouridis A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035741; Zaits MN, 2014, MOL PSYCHIATR, V19, P848, DOI 10.1038/mp.2013.93; Zawia NH, 2009, FREE RADICAL BIO MED, V46, P1241, DOI 10.1016/j.freeradbiomed.2009.02.006	71	154	157	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126423	10.1371/journal.pone.0126423	http://dx.doi.org/10.1371/journal.pone.0126423			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992776	Green Published, gold, Green Submitted			2022-12-26	WOS:000354921400063
J	Jacquet, L; Neueder, A; Foldes, G; Karagiannis, P; Hobbs, C; Jolinon, N; Mioulane, M; Sakai, T; Harding, SE; Ilic, D				Jacquet, Laureen; Neueder, Andreas; Foeldes, Gabor; Karagiannis, Panagiotis; Hobbs, Carl; Jolinon, Nelly; Mioulane, Maxime; Sakai, Takao; Harding, Sian E.; Ilic, Dusko			Three Huntington's Disease Specific Mutation-Carrying Human Embryonic Stem Cell Lines Have Stable Number of CAG Repeats upon In Vitro Differentiation into Cardiomyocytes	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; GENE; DERIVATION; INSTABILITY; EXPRESSION; BRAIN; PROPAGATION; DYSFUNCTION; GENERATION; PHENOTYPES	Huntington disease (HD; OMIM 143100), a progressive neurodegenerative disorder, is caused by an expanded trinucleotide CAG (polyQ) motif in the HTT gene. Cardiovascular symptoms, often present in early stage HD patients, are, in general, ascribed to dysautonomia. However, cardio-specific expression of polyQ peptides caused pathological response in murine models, suggesting the presence of a nervous system-independent heart phenotype in HD patients. A positive correlation between the CAG repeat size and severity of symptoms observed in HD patients has also been observed in in vitro HD cellular models. Here, we test the suitability of human embryonic stem cell (hESC) lines carrying HD-specific mutation as in vitro models for understanding molecular mechanisms of cardiac pathology seen in HD patients. We have differentiated three HD-hESC lines into cardiomyocytes and investigated CAG stability up to 60 days after starting differentiation. To assess CAG stability in other tissues, the lines were also subjected to in vivo differentiation into teratomas for 10 weeks. Neither directed differentiation into cardiomyocytes in vitro nor in vivo differentiation into teratomas, rich in immature neuronal tissue, led to an increase in the number of CAG repeats. Although the CAG stability might be cell line-dependent, induced pluripotent stem cells generated from patients with larger numbers of CAG repeats could have an advantage as a research tool for understanding cardiac symptoms of HD patients.	[Jacquet, Laureen; Ilic, Dusko] Kings Coll London, Guys Hosp, Div Womens Hlth, Stem Cell Lab,Assisted Concept Unit, London SE1 9RT, England; [Neueder, Andreas; Karagiannis, Panagiotis; Jolinon, Nelly] Kings Coll London, Guys Hosp, Div Genet & Mol Med, London SE1 9RT, England; [Foeldes, Gabor; Mioulane, Maxime; Harding, Sian E.] Univ London Imperial Coll Sci Technol & Med, ICTEM, Natl Heart & Lung Inst, London W12 0NN, England; [Hobbs, Carl] Kings Coll London, Wolfson Ctr Age Related Dis, Histol Lab, London SE1 1UL, England; [Sakai, Takao] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool L69 3GE, Merseyside, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Imperial College London; University of London; King's College London; University of Liverpool	Ilic, D (corresponding author), Kings Coll London, Guys Hosp, Div Womens Hlth, Stem Cell Lab,Assisted Concept Unit, London SE1 9RT, England.	dusko.ilic@kcl.ac.uk	Neueder, Andreas/K-4319-2015	Neueder, Andreas/0000-0002-2389-5236; ILIC, DUSKO/0000-0003-1647-0026; Harding, Sian/0000-0002-3651-6354; Karagiannis, Panagiotis/0000-0001-6459-7561	UK Medical Research Council (MRC) [G0701172, G0801061]; MRC studentship; MRC [G0701172, MR/L012618/1, G0801061] Funding Source: UKRI; British Heart Foundation [RG/14/1/30588] Funding Source: researchfish; Medical Research Council [G0701172, G0801061, MR/L012618/1] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council (MRC) grants G0701172 and G0801061. L.J. had MRC studentship.	Abildtrup M, 2013, J HUNTINGTONS DIS, V2, P251, DOI 10.3233/JHD-130054; Andrich J, 2002, J NEUROL NEUROSUR PS, V72, P726, DOI 10.1136/jnnp.72.6.726; Bar KJ, 2008, EUR J NEUROL, V15, P869, DOI 10.1111/j.1468-1331.2008.02173.x; Bradley CK, 2011, STEM CELLS DEV, V20, P495, DOI 10.1089/scd.2010.0120; Bustin SA, 2011, CLIN CHEM, V57, P919, DOI 10.1373/clinchem.2011.162958; Camnasio S, 2012, NEUROBIOL DIS, V46, P41, DOI 10.1016/j.nbd.2011.12.042; Campos PF, 2012, METHODS MOL BIOL, V840, P81, DOI 10.1007/978-1-61779-516-9_11; Chae JI, 2012, BIOCHEM J, V446, P359, DOI 10.1042/BJ20111495; Cooke MJ, 2006, STEM CELLS DEV, V15, P254, DOI 10.1089/scd.2006.15.254; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Epping EA, 2011, NEURODEGENER DIS MAN, V1, P407, DOI 10.2217/NMT.11.45; Feyeux M, 2012, HUM MOL GENET, V21, P3883, DOI 10.1093/hmg/dds216; Gu A, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010067, 10.1371/currents.RRN1193]; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Ilic D, 2012, CYTOTHERAPY, V14, P122, DOI 10.3109/14653249.2011.623692; Jacobsen JC, 2011, HUM MOL GENET, V20, P2846, DOI 10.1093/hmg/ddr195; Jacquet L, 2013, EMBO MOL MED, V5, P10, DOI 10.1002/emmm.201201973; Jeon I, 2012, STEM CELLS, V30, P2054, DOI 10.1002/stem.1135; Jonson I, 2013, STEM CELL RES, V11, P1264, DOI 10.1016/j.scr.2013.08.010; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Kiriazis H, 2012, J PHYSIOL-LONDON, V590, P5845, DOI 10.1113/jphysiol.2012.238113; Kobal J, 2004, EUR J NEUROL, V11, P842, DOI 10.1111/j.1468-1331.2004.00894.x; Kobal J, 2010, ACTA NEUROL SCAND, V121, P392, DOI 10.1111/j.1600-0404.2009.01251.x; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laowtammathron C, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-12; Lee JM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-29; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; Lorincz MT, 2009, MOL CELL NEUROSCI, V40, P1, DOI 10.1016/j.mcn.2008.06.004; Lu BX, 2013, FASEB J, V27, P1820, DOI 10.1096/fj.12-219220; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Manley K, 1999, BRAIN RES, V835, P74, DOI 10.1016/S0006-8993(99)01451-1; Marti M, 2013, NAT PROTOC, V8, P223, DOI 10.1038/nprot.2012.154; Mihm MJ, 2007, NEUROBIOL DIS, V25, P297, DOI 10.1016/j.nbd.2006.09.016; Niclis JC, 2009, REPROD BIOMED ONLINE, V19, P106, DOI 10.1016/S1472-6483(10)60053-3; Niclis JC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00037; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pattison JS, 2008, CIRCULATION, V117, P2743, DOI 10.1161/CIRCULATIONAHA.107.750232; Pickering SJ, 2005, REPROD BIOMED ONLINE, V10, P390, DOI 10.1016/S1472-6483(10)61801-9; Prokhorova TA, 2009, STEM CELLS DEV, V18, P47, DOI 10.1089/scd.2007.0266; Putkhao K, 2013, STEM CELLS DEV, V22, P1198, DOI 10.1089/scd.2012.0469; Ritch JJ, 2012, MOL CELL NEUROSCI, V50, P70, DOI 10.1016/j.mcn.2012.03.011; Sassone J, 2009, EXP NEUROL, V219, P385, DOI 10.1016/j.expneurol.2009.05.012; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Seriola A, 2011, HUM MOL GENET, V20, P176, DOI 10.1093/hmg/ddq456; Sharma KR, 1999, ARCH NEUROL-CHICAGO, V56, P1248, DOI 10.1001/archneur.56.10.1248; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Squitieri F, 2003, BRAIN, V126, P946, DOI 10.1093/brain/awg077; Stephenson E, 2012, NAT PROTOC, V7, P1366, DOI 10.1038/nprot.2012.080; Stephenson E, 2010, J R SOC INTERFACE, V7, pS677, DOI 10.1098/rsif.2010.0343.focus; Stephenson EL, 2010, IN VITRO CELL DEV-AN, V46, P178, DOI 10.1007/s11626-010-9276-4; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409; TROTTIER Y, 1994, J MED GENET, V31, P377, DOI 10.1136/jmg.31.5.377; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Wood NI, 2012, J HUNTINGTONS DIS, V1, P57, DOI 10.3233/JHD-2012-120004	58	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126860	10.1371/journal.pone.0126860	http://dx.doi.org/10.1371/journal.pone.0126860			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993131	Green Published, Green Submitted, gold			2022-12-26	WOS:000354921400080
J	Legrain, A; Berenschot, EJW; Tas, NR; Abelmann, L				Legrain, Antoine; Berenschot, Erwin J. W.; Tas, Niels R.; Abelmann, Leon			Elasto-Capillary Folding Using Stop-Programmable Hinges Fabricated by 3D Micro-Machining	PLOS ONE			English	Article							NANOSTRUCTURES; MICROORIGAMI; FILMS	We show elasto-capillary folding of silicon nitride objects with accurate folding angles between flaps of (70.6 +/- 0.1)degrees and demonstrate the feasibility of such accurate micro-assembly with a final folding angle of 90 degrees. The folding angle is defined by stop-programmable hinges that are fabricated starting from silicon molds employing accurate three-dimensional corner lithography. This nano-patterning method exploits the conformal deposition and the subsequent timed isotropic etching of a thin film in a 3D shaped silicon template. The technique leaves a residue of the thin film in sharp concave corners which can be used as an inversion mask in subsequent steps. Hinges designed to stop the folding at 70.6 degrees were fabricated batchwise by machining the V-grooves obtained by KOH etching in (110) silicon wafers; 90 degrees stop-programmable hinges were obtained starting from silicon molds obtained by dry etching on (100) wafers. The presented technique has potential to achieve any folding angle and opens a new route towards creating structures with increased complexity, which will ultimately lead to a novel method for device fabrication.	[Legrain, Antoine; Berenschot, Erwin J. W.; Tas, Niels R.; Abelmann, Leon] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Abelmann, Leon] KIST Europe, Saarbrucken, Germany	University of Twente	Legrain, A (corresponding author), Univ Twente, MESA Inst Nanotechnol, POB 217, NL-7500 AE Enschede, Netherlands.	a.b.h.legrain@utwente.nl		Berenschot, Erwin J.W./0000-0002-4721-2997				Ariga K, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/1/014109; Arora WJ, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2168516; Berenschot E, 2008, INT CONF NANO MICRO, P729; Berenschot EJW, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/5/055024; Berenschot EJW, 2012, SMALL, V8, P3823, DOI 10.1002/smll.201201446; Boncheva M, 2005, P NATL ACAD SCI USA, V102, P3924, DOI 10.1073/pnas.0500807102; Brittain ST, 2001, J PHYS CHEM B, V105, P347, DOI 10.1021/jp002556e; Burouni N, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/28/285303; Cho JH, 2010, ADV MATER, V22, P2320, DOI 10.1002/adma.200904410; Cho JH, 2009, NANO LETT, V9, P4049, DOI 10.1021/nl9022176; Chua CL, 2003, J MICROELECTROMECH S, V12, P989, DOI 10.1109/JMEMS.2003.820274; Filipiak DJ, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/7/075012; Gagler R, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/5/055025; Gardeniers JGE, 1996, J VAC SCI TECHNOL A, V14, P2879, DOI 10.1116/1.580239; Gattass RR, 2008, NAT PHOTONICS, V2, P219, DOI 10.1038/nphoton.2008.47; Guan JJ, 2005, J PHYS CHEM B, V109, P23134, DOI 10.1021/jp054341g; Ionov L, 2013, MACROMOL CHEM PHYS, V214, P1178, DOI 10.1002/macp.201200246; Ionov L, 2011, SOFT MATTER, V7, P6786, DOI 10.1039/c1sm05476g; Iwase E, 2006, SENSOR ACTUAT A-PHYS, V127, P310, DOI 10.1016/j.sna.2006.01.025; Jansen HV, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/3/033001; Judy JW, 1997, J MICROELECTROMECH S, V6, P249, DOI 10.1109/84.623114; Kaajakari V, 2003, J MICROELECTROMECH S, V12, P425, DOI 10.1109/JMEMS.2003.811747; Kim GM, 2002, J NANOSCI NANOTECHNO, V2, P55, DOI 10.1166/jnn.2002.073; Kim SJ, 2005, SMART MATER STRUCT, V14, P511, DOI 10.1088/0964-1726/14/4/008; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Legrain A, 2014, J APPL PHYS, V115, DOI 10.1063/1.4878460; Leong TG, 2008, SMALL, V4, P1605, DOI 10.1002/smll.200800280; Leong TG, 2007, LANGMUIR, V23, P8747, DOI 10.1021/la700913m; Leong TG, 2010, SMALL, V6, P792, DOI 10.1002/smll.200901704; Liu Y, 2012, SOFT MATTER, V8, P1764, DOI 10.1039/c1sm06564e; Lu YW, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2362602; Luo JK, 2006, SENSOR ACTUAT A-PHYS, V132, P346, DOI 10.1016/j.sna.2006.03.004; Madou MJ, 1997, FUNDAMENTALS OF MICR; Mastrangeli M, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/8/083001; Nichol AJ, 2006, J VAC SCI TECHNOL B, V24, P3128, DOI 10.1116/1.2375084; Pilkey W.D., 2020, PETERSONS STRESS CON; Py C, 2009, EUR PHYS J-SPEC TOP, V166, P67, DOI 10.1140/epjst/e2009-00880-4; Py C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.156103; Randall CL, 2012, TRENDS BIOTECHNOL, V30, P138, DOI 10.1016/j.tibtech.2011.06.013; Roman B, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/49/493101; Sarajlic E, 2005, Transducers '05, Digest of Technical Papers, Vols 1 and 2, P27; Schmidt OG, 2001, NATURE, V410, P168, DOI 10.1038/35065525; SHANKOFF TA, 1980, J ELECTROCHEM SOC, V127, P216, DOI 10.1149/1.2129621; Shenoy VB, 2012, MRS BULL, V37, P847, DOI 10.1557/mrs.2012.184; Shin C, 2014, IEICE ELECT EXPRESS, V11; SINCLAIR GB, 1984, INT J MECH SCI, V26, P477, DOI 10.1016/0020-7403(84)90002-X; Stoychev G, 2011, SOFT MATTER, V7, P3277, DOI 10.1039/c1sm05109a; Sugioka K, 2014, LAB CHIP, V14, P3447, DOI 10.1039/c4lc00548a; Syms RRA, 2000, IEEE PHOTONIC TECH L, V12, P1519, DOI 10.1109/68.887729; Syms RRA, 2003, J MICROELECTROMECH S, V12, P387, DOI 10.1109/JMEMS.2003.811724; SYMS RRA, 1993, ELECTRON LETT, V29, P662, DOI 10.1049/el:19930444; Tas N, 1996, J MICROMECH MICROENG, V6, P385, DOI 10.1088/0960-1317/6/4/005; van Honschoten JW, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3462302; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Yu XD, 2009, NANO LETT, V9, P4424, DOI 10.1021/nl9027236	55	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0125891	10.1371/journal.pone.0125891	http://dx.doi.org/10.1371/journal.pone.0125891			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992886	gold, Green Published, Green Submitted			2022-12-26	WOS:000354918600019
J	D'Aquila, T; Sirohi, D; Grabowski, JM; Hedrick, VE; Paul, LN; Greenberg, AS; Kuhn, RJ; Buhman, KK				D'Aquila, Theresa; Sirohi, Devika; Grabowski, Jeffrey M.; Hedrick, Victoria E.; Paul, Lake N.; Greenberg, Andrew S.; Kuhn, Richard J.; Buhman, Kimberly K.			Characterization of the Proteome of Cytoplasmic Lipid Droplets in Mouse Enterocytes after a Dietary Fat Challenge	PLOS ONE			English	Article							COA SYNTHETASE 5; A-IV EXPRESSION; DIACYLGLYCEROL ACYLTRANSFERASE-2; TRIACYLGLYCEROL SYNTHESIS; TRIGLYCERIDE SECRETION; PROTEINS; IDENTIFICATION; OVEREXPRESSION; CHYLOMICRONS; ASSOCIATION	Dietary fat absorption by the small intestine is a multistep process that regulates the uptake and delivery of essential nutrients and energy. One step of this process is the temporary storage of dietary fat in cytoplasmic lipid droplets (CLDs). The storage and mobilization of dietary fat is thought to be regulated by proteins that associate with the CLD; however, mechanistic details of this process are currently unknown. In this study we analyzed the proteome of CLDs isolated from enterocytes harvested from the small intestine of mice following a dietary fat challenge. In this analysis we identified 181 proteins associated with the CLD fraction, of which 37 are associated with known lipid related metabolic pathways. We confirmed the localization of several of these proteins on or around the CLD through confocal and electron microscopy, including perilipin 3, apolipoprotein A-IV, and acyl-CoA synthetase long-chain family member 5. The identification of the enterocyte CLD proteome provides new insight into potential regulators of CLD metabolism and the process of dietary fat absorption.	[D'Aquila, Theresa; Buhman, Kimberly K.] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA; [Sirohi, Devika; Grabowski, Jeffrey M.; Kuhn, Richard J.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Sirohi, Devika; Hedrick, Victoria E.; Paul, Lake N.; Kuhn, Richard J.] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Grabowski, Jeffrey M.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Greenberg, Andrew S.] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Tufts University; United States Department of Agriculture (USDA)	Buhman, KK (corresponding author), Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA.	kbuhman@purdue.edu	Buhman, Kimberly/AAV-3111-2021; Kuhn, Richard/AAR-2722-2021; Sirohi, Devika/I-7136-2019	Buhman, Kimberly/0000-0002-3784-1028; Kuhn, Richard/0000-0003-4148-1026; Sirohi, Devika/0000-0001-8601-6211	Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [UL1TR001108]; American Diabetes Association, Innovation Award [7-13-IN-05]; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01 DK098606]; National Institutes of Health, NIDDK [P30 DK046200]; National Institutes of Health, National Institute of Environmental Health Science [U01 ES020958]; Purdue Research Foundation, Graduate Fellowship Award; U.S. Department of Agriculture [58-1950-4-003]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, R01DK098606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES020958] Funding Source: NIH RePORTER	Indiana Clinical and Translational Sciences Institute; National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award; American Diabetes Association, Innovation Award(American Diabetes Association); National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health, National Institute of Environmental Health Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Purdue Research Foundation, Graduate Fellowship Award; U.S. Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was supported by the Indiana Clinical and Translational Sciences Institute, by Grant # UL1TR001108 from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award (KKB), Grant # 7-13-IN-05 by the American Diabetes Association, Innovation Award (KKB), Grant # R01 DK098606 from the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (KKB, ASG), Grant # P30 DK046200 National Institutes of Health, NIDDK (ASG), Grant # U01 ES020958 National Institutes of Health, National Institute of Environmental Health Science (ASG), and the Purdue Research Foundation, Graduate Fellowship Award (KKB, TD). This material is based upon work supported by the U.S. Department of Agriculture, under agreement No. 58-1950-4-003 (ASG). Any opinions, findings, conclusion, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the view of the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumrad NA, 2012, PHYSIOL REV, V92, P1061, DOI 10.1152/physrev.00019.2011; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Arrese Estela L, 2014, Lipid Insights, V7, P7; Bartzt R, 2007, J PROTEOME RES, V6, P3256, DOI 10.1021/pr070158j; Beilstein F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053017; Bouchoux J, 2011, BIOL CELL, V103, P499, DOI 10.1042/BC20110024; Brasaemle Dawn L, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0315s29; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Bu SY, 2010, J LIPID RES, V51, P3270, DOI 10.1194/jlr.M009407; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crunk AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067631; Demignot S, 2014, BIOCHIMIE, V96, P48, DOI 10.1016/j.biochi.2013.07.009; Ding YB, 2012, ACTA BIOCH BIOPH SIN, V44, P394, DOI 10.1093/abbs/gms008; Duez H, 2008, ATHEROSCLEROSIS SUPP, V9, P33, DOI 10.1016/j.atherosclerosissup.2008.05.013; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Goodman JM, 2009, J LIPID RES, V50, P2148, DOI 10.1194/jlr.R001446; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hussain MM, 2014, CURR OPIN LIPIDOL, V25, P200, DOI 10.1097/MOL.0000000000000084; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kaemmerer E, 2011, WORLD J GASTROENTERO, V17, P4883, DOI 10.3748/wjg.v17.i44.4883; Kassan A, 2013, J CELL BIOL, V203, P985, DOI 10.1083/jcb.201305142; Kiss RS, 2014, J BIOMED RES, V28, P169, DOI 10.7555/JBR.28.20140029; Klaus C, 2014, WORLD J GASTROENTERO, V20, P14855, DOI 10.3748/wjg.v20.i40.14855; Kohan AB, 2012, AM J PHYSIOL-GASTR L, V302, pG628, DOI 10.1152/ajpgi.00225.2011; Lambert JE, 2012, BBA-MOL CELL BIOL L, V1821, P721, DOI 10.1016/j.bbalip.2012.01.006; Larsson S, 2012, J PROTEOME RES, V11, P1264, DOI 10.1021/pr200957p; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lee B, 2009, BBA-MOL CELL BIOL L, V1791, P1173, DOI 10.1016/j.bbalip.2009.08.002; Li ZH, 2014, CURR BIOL, V24, P1485, DOI 10.1016/j.cub.2014.05.022; Li ZH, 2012, CURR BIOL, V22, P2104, DOI 10.1016/j.cub.2012.09.018; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Lu S, 2006, J BIOL CHEM, V281, P3473, DOI 10.1074/jbc.M502501200; Lu S, 2002, J BIOL CHEM, V277, P31929, DOI 10.1074/jbc.M201418200; Luchoomun J, 1999, J BIOL CHEM, V274, P19565, DOI 10.1074/jbc.274.28.19565; Mashek DG, 2006, J BIOL CHEM, V281, P945, DOI 10.1074/jbc.M507646200; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; McFie PJ, 2014, BBA-MOL CELL BIOL L, V1841, P1318, DOI 10.1016/j.bbalip.2014.06.004; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; Obrowsky S, 2013, J LIPID RES, V54, P425, DOI 10.1194/jlr.M031716; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Orban T, 2011, J BIOL CHEM, V286, P17248, DOI 10.1074/jbc.M110.195198; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Seyer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058224; Simon T, 2011, J LIPID RES, V52, P1984, DOI 10.1194/jlr.M017418; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Tan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063213; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; VerHague MA, 2013, ARTERIOSCL THROM VAS, V33, P2501, DOI 10.1161/ATVBAHA.113.301948; Vowinkel T, 2004, J CLIN INVEST, V114, P260, DOI 10.1172/JCI200421233; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang F, 2015, J LIPID RES, V56, P1403, DOI 10.1194/jlr.R052753; Wang F, 2013, PHYSIOL BEHAV, V120, P136, DOI 10.1016/j.physbeh.2013.07.010; Warnakula S, 2011, CAN J CARDIOL, V27, P183, DOI 10.1016/j.cjca.2010.12.020; Weinberg RB, 2012, J LIPID RES, V53, P736, DOI 10.1194/jlr.M019992; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Wong DM, 2009, PROTEOMICS, V9, P3698, DOI 10.1002/pmic.200800914; Xie P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091652; Xie Y, 2003, AM J PHYSIOL-GASTR L, V285, pG735, DOI 10.1152/ajpgi.00202.2003; Zhang HN, 2011, J PROTEOME RES, V10, P4757, DOI 10.1021/pr200553c; Zhu JB, 2009, J LIPID RES, V50, P1080, DOI 10.1194/jlr.M800555-JLR200	66	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126823	10.1371/journal.pone.0126823	http://dx.doi.org/10.1371/journal.pone.0126823			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992653	gold, Green Published, Green Submitted			2022-12-26	WOS:000354917300055
J	Gu, BW; Apicella, M; Mills, J; Fan, JM; Reeves, DA; French, D; Podsakoff, GM; Bessler, M; Mason, PJ				Gu, Bai-Wei; Apicella, Marisa; Mills, Jason; Fan, Jian-Meng; Reeves, Dara A.; French, Deborah; Podsakoff, Gregory M.; Bessler, Monica; Mason, Philip J.			Impaired Telomere Maintenance and Decreased Canonical WNT Signaling but Normal Ribosome Biogenesis in Induced Pluripotent Stem Cells from X-Linked Dyskeratosis Congenita Patients	PLOS ONE			English	Article							SMALL NUCLEOLAR RNA; CRYSTAL-STRUCTURE; SELF-RENEWAL; MUTATIONS; CANCER; LGR5; ELONGATION; EXPRESSION; DEFECTS; COMPLEX	Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome characterized by the presence of short telomeres at presentation. Mutations in ten different genes, whose products are involved in the telomere maintenance pathway, have been shown to cause DC. The X-linked form is the most common form of the disease and is caused by mutations in the gene DKC1, encoding the protein dyskerin. Dyskerin is required for the assembly and stability of telomerase and is also involved in ribosomal RNA (rRNA) processing where it converts specific uridines to pseudouridine. DC is thought to result from failure to maintain tissues, like blood, that are renewed by stem cell activity, but research into pathogenic mechanisms has been hampered by the difficulty of obtaining stem cells from patients. We reasoned that induced pluripotent stem (iPS) cells from X-linked DC patients may provide information about the mechanisms involved. Here we describe the production of iPS cells from DC patients with DKC1mutations Q31E, A353Vand Delta L37. In addition we constructed "corrected" lines with a copy of the wild type dyskerin cDNA expressed from the AAVS1 safe harbor locus. We show that in iPS cells with DKC1mutations telomere maintenance is compromised with short telomere lengths and decreased telomerase activity. The degree to which telomere lengths are affected by expression of telomerase during reprograming, or with ectopic expression of wild type dyskerin, is variable. The recurrent mutation A353Vshows the most severe effect on telomere maintenance. A353Vcells but not Q31Eor Delta L37cells, are refractory to correction by expression of wild type DKC1 cDNA. Because dyskerin is involved in both telomere maintenance and ribosome biogenesis it has been postulated that defective ribosome biogenesis and translation may contribute to the disease phenotype. Evidence from mouse and zebra fish models has supported the involvement of ribosome biogenesis but primary cells from human patients have so far not shown defects in pseudouridylation or ribosomal RNA processing. None of the mutant iPS cells presented here show decreased pseudouridine levels in rRNA or defective rRNA processing suggesting telomere maintenance defects account for most of the phenotype of X-linked DC. Finally gene expression analysis of the iPS cells shows that WNT signaling is significantly decreased in all mutant cells, raising the possibility that defective WNT signaling may contribute to disease pathogenesis.	[Gu, Bai-Wei; Apicella, Marisa; Fan, Jian-Meng; Reeves, Dara A.; Bessler, Monica; Mason, Philip J.] Childrens Hosp Philadelphia, Dept Pediat, Div Hematol, Philadelphia, PA 19104 USA; [Mills, Jason; French, Deborah] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Podsakoff, Gregory M.] Childrens Hosp Philadelphia, Ctr Cellular & Mol Therapeut, Div Hematol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Mason, PJ (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, Div Hematol, Philadelphia, PA 19104 USA.	masonp@email.chop.edu			National Cancer Institute, National Institutes of Health [2R01CA106995, 2R01 CA105312]; American Society of Hematology Scholar Awards (BWG); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [P30 DK090969]; NATIONAL CANCER INSTITUTE [R01CA105312, R01CA106995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090969] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Society of Hematology Scholar Awards (BWG); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Cancer Institute, National Institutes of Health grants 2R01CA106995 (PJM) and 2R01 CA105312 (MB) (http://grants.nih.gov/grants/oer.htm) and American Society of Hematology Scholar Awards (BWG) (http://www.hematology.org/). The project was also supported by the The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) P30 DK090969 (DF) (http://www.niddk.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Austinat M, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-21; Ballew BJ, 2013, EXPERT REV HEMATOL, V6, P327, DOI [10.1586/EHM.13.23, 10.1586/ehm.13.23]; Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084; Bellodi C, 2010, EMBO J, V29, P1865, DOI 10.1038/emboj.2010.83; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dokal I, 2011, HEMATOL-AM SOC HEMAT, P480, DOI 10.1182/asheducation-2011.1.480; DRACHTMAN RA, 1995, DERMATOL CLIN, V13, P33, DOI 10.1016/S0733-8635(18)30104-9; Fatica A, 2002, RNA, V8, P1502, DOI 10.1017/S1355838202022094; Garcon L, 2013, BLOOD, V122, P912, DOI 10.1182/blood-2013-01-478321; Ge JP, 2010, MOL CELL BIOL, V30, P413, DOI 10.1128/MCB.01128-09; Grozdanov PN, 2009, HUM MOL GENET, V18, P4546, DOI 10.1093/hmg/ddp416; Gu BW, 2008, P NATL ACAD SCI USA, V105, P10173, DOI 10.1073/pnas.0803559105; Gu BW, 2013, FEBS LETT, V587, P2112, DOI 10.1016/j.febslet.2013.05.028; Gu BW, 2009, FEBS LETT, V583, P3086, DOI 10.1016/j.febslet.2009.08.038; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; He J, 2009, GENESIS, V47, P366, DOI 10.1002/dvg.20509; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004; Kiss T, 2010, MOL CELL, V37, P597, DOI 10.1016/j.molcel.2010.01.032; Knight SW, 1999, AM J HUM GENET, V65, P50, DOI 10.1086/302446; Leushacke M, 2012, ONCOGENE, V31, P3009, DOI 10.1038/onc.2011.479; Li L, 2006, NATURE, V443, P302, DOI 10.1038/nature05151; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; Mills JA, 2013, BLOOD, V122, P2047, DOI 10.1182/blood-2013-02-484444; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Mochizuki Y, 2004, P NATL ACAD SCI USA, V101, P10756, DOI 10.1073/pnas.0402560101; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Nelson ND, 2012, MUTAT RES-FUND MOL M, V730, P43, DOI 10.1016/j.mrfmmm.2011.06.008; Pereboom TC, 2011, BLOOD, V118, P5458, DOI 10.1182/blood-2011-04-351460; Podlevsky JD, 2008, NUCLEIC ACIDS RES, V36, pD339, DOI 10.1093/nar/gkm700; Pogacic V, 2000, MOL CELL BIOL, V20, P9028, DOI 10.1128/MCB.20.23.9028-9040.2000; Rashid R, 2006, MOL CELL, V21, P249, DOI 10.1016/j.molcel.2005.11.017; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; Sommer AG, 2012, JOVE-J VIS EXP, DOI 10.3791/4327; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2013, DEVELOPMENT, V140, P2457, DOI 10.1242/dev.092551; Thumati NR, 2013, HUM MUTAT, V34, P1698, DOI 10.1002/humu.22447; Trahan C, 2009, RNA, V15, P235, DOI 10.1261/rna.1354009; Vulliamy TJ, 2006, BLOOD, V107, P2680, DOI 10.1182/blood-2005-07-2622; Winkler T, 2013, J CLIN INVEST, V123, P1952, DOI 10.1172/JCI67146; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030188	49	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127414	10.1371/journal.pone.0127414	http://dx.doi.org/10.1371/journal.pone.0127414			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992652	Green Published, gold, Green Submitted			2022-12-26	WOS:000354917300123
J	Harding, JMS; Segal, MR; Reynolds, JD				Harding, Joel M. S.; Segal, Michelle R.; Reynolds, John D.			Location Is Everything: Evaluating the Effects of Terrestrial and Marine Resource Subsidies on an Estuarine Bivalve	PLOS ONE			English	Article							SOFT-SHELL CLAM; MYA-ARENARIA; ORGANIC-MATTER; SPAWNING SALMON; PACIFIC SALMON; RHONE RIVER; MERCENARIA-MERCENARIA; DISSOLVED NUTRIENTS; SUSPENDED PARTICLES; CERASTODERMA-EDULE	Estuaries are amongst the world's most productive ecosystems, lying at the intersection between terrestrial and marine environments. They receive substantial inputs from adjacent landscapes but the importance of resource subsidies is not well understood. Here, we test hypotheses for the effects of both terrestrial- and salmon-derived resource subsidies on the diet (inferred from stable isotopes of muscle tissue), size and percent nitrogen of the soft-shell clam (Mya arenaria), a sedentary estuarine consumer. We examine how these relationships shift across natural gradients among 14 estuaries that vary in upstream watershed size and salmon density on the central coast of British Columbia, Canada. We also test how assimilation and response to subsidies vary at smaller spatial scales within estuaries. The depletion and enrichment of stable isotope ratios in soft-shell clam muscle tissue correlated with increasing upstream watershed size and salmon density, respectively. The effects of terrestrial- and salmon-derived subsidies were also strongest at locations near stream outlets. When we controlled for age of individual clams, there were larger individuals with higher percent nitrogen content in estuaries below larger watersheds, though this effect was limited to the depositional zones below river mouths. Pink salmon exhibited a stronger effect on isotope ratios of clams than chum salmon, which could reflect increased habitat overlap as spawning pink salmon concentrate in lower stream reaches, closer to intertidal clam beds. However, there were smaller clams in estuaries that had higher upstream pink salmon densities, possibly due to differences in habitat requirements. Our study highlights the importance of upstream resource subsidies to this bivalve species, but that individual responses to subsidies can vary at smaller scales within estuaries.	[Harding, Joel M. S.; Segal, Michelle R.; Reynolds, John D.] Simon Fraser Univ, Earth Ocean Res Grp, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Harding, Joel M. S.; Reynolds, John D.] Hakai Inst, Heriot Bay, BC, Canada	Simon Fraser University; Hakai Institute	Harding, JMS (corresponding author), Simon Fraser Univ, Earth Ocean Res Grp, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	joelmsharding@gmail.com	Reynolds, John D/L-6345-2015	Reynolds, John D/0000-0002-0459-0074	Natural Sciences and Engineering Research Council; Tom Buell BC Leadership Chair endowment - Pacific Salmon Foundation; BC Leading Edge Endowment Fund; Tula Foundation through Hakai Network for Coastal Peoples, Ecosystems and Management	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Tom Buell BC Leadership Chair endowment - Pacific Salmon Foundation; BC Leading Edge Endowment Fund; Tula Foundation through Hakai Network for Coastal Peoples, Ecosystems and Management	This research was supported by the Natural Sciences and Engineering Research Council and the Tom Buell BC Leadership Chair endowment funded by the Pacific Salmon Foundation and the BC Leading Edge Endowment Fund. Support was also received from the Tula Foundation, including a scholarship to Joel Harding through the Hakai Network for Coastal Peoples, Ecosystems and Management. Funding sources did not have any role in study design, data collection, analysis, decision to publish or manuscript preparation.	Alliot E, 2003, ESTUAR COAST SHELF S, V57, P357, DOI 10.1016/S0272-7714(02)00361-X; Anderson WB, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P82; Anderson WB, 2008, ECOLOGY, V89, P660, DOI 10.1890/07-0234.1; ANDRE C, 1991, MAR ECOL PROG SER, V71, P227, DOI 10.3354/meps071227; [Anonymous], 2002, MODEL SELECTION MULT; Bain MB, 1999, AQUATIC HABITAT ASSE, P1; Banaru D, 2007, MAR POLLUT BULL, V54, P1385, DOI 10.1016/j.marpolbul.2007.05.022; Banaru D, 2009, MAR FRESHWATER RES, V60, P529, DOI 10.1071/MF08005; Barton K, 2012, MULTIMODEL INFERENCE, P37; Beal BF, 2002, AQUACULTURE, V208, P81, DOI 10.1016/S0044-8486(01)00900-0; Bilby RE, 2003, T AM FISH SOC, V132, P733, DOI 10.1577/T02-089; Bowes RE, 2014, FRESHWATER BIOL, V59, P1926, DOI 10.1111/fwb.12396; BROUSSEAU DJ, 1979, MAR BIOL, V51, P221, DOI 10.1007/BF00386801; Cak AD, 2008, AQUAT SCI, V70, P169, DOI 10.1007/s00027-008-8090-5; Carleton SA, 2010, FUNCT ECOL, V24, P805, DOI 10.1111/j.1365-2435.2010.01700.x; Carmichael RH, 2004, J EXP MAR BIOL ECOL, V313, P75, DOI 10.1016/j.jembe.2004.08.006; Carmichael RH, 2012, J SHELLFISH RES, V31, P1, DOI 10.2983/035.031.0101; Carr MH, 2003, ECOL APPL, V13, pS90; Chanton J, 2002, LIMNOL OCEANOGR, V47, P683, DOI 10.4319/lo.2002.47.3.0683; CHESTER AJ, 1981, ESTUARIES, V4, P42, DOI 10.2307/1351541; Connolly RM, 2009, MAR BIOL RES, V5, P164, DOI 10.1080/17451000802266625; CORRELL DL, 1992, ESTUARIES, V15, P431, DOI 10.2307/1352388; Darnaude AM, 2005, J ANIM ECOL, V74, P864, DOI 10.1111/j.1365-2656.2005.00978.x; Darnaude AM, 2004, MAR ECOL PROG SER, V275, P47, DOI 10.3354/meps275047; de la Huz R, 2002, J SEA RES, V47, P85, DOI 10.1016/S1385-1101(02)00108-9; Deegan LA, 1997, MAR ECOL PROG SER, V147, P31, DOI 10.3354/meps147031; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; Elliott M, 2011, ESTUAR COAST SHELF S, V94, P306, DOI 10.1016/j.ecss.2011.06.016; EMERSON CW, 1990, CAN J FISH AQUAT SCI, V47, P1655, DOI 10.1139/f90-189; Fry B, 2002, ESTUARIES, V25, P264, DOI 10.1007/BF02691313; FRY B, 1977, GEOCHIM COSMOCHIM AC, V41, P1875, DOI 10.1016/0016-7037(77)90218-6; Fujiwara M, 1997, MAR ECOL PROG SER, V158, P205, DOI 10.3354/meps158205; Fulweiler RW, 2005, BIOGEOCHEMISTRY, V76, P567, DOI 10.1007/s10533-005-0444-7; Galster JC, 2007, GEOSPHERE, V3, P260, DOI 10.1130/GES00065.1; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gende SM, 2004, J FRESHWATER ECOL, V19, P149, DOI 10.1080/02705060.2004.9664522; Gende SM, 2002, BIOSCIENCE, V52, P917, DOI 10.1641/0006-3568(2002)052[0917:PSIAAT]2.0.CO;2; Government of British Columbia, 2006, IMAPBC; Groot C, 1991, PACIFIC SALMON LIFE, P1; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Harding JMS, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00029.1; Harmelin-Vivien M, 2010, BIOGEOCHEMISTRY, V100, P139, DOI 10.1007/s10533-010-9411-z; Hocking MD, 2011, SCIENCE, V331, P1609, DOI 10.1126/science.1201079; Hoffman JC, 2007, ESTUAR COAST, V30, P1034, DOI 10.1007/BF02841394; Honkoop PJC, 1997, J EXP MAR BIOL ECOL, V212, P277, DOI 10.1016/S0022-0981(96)02757-8; Hopkinson CS, 1999, ESTUARIES, V22, P863, DOI 10.2307/1353067; HUNTER JG, 1959, J FISH RES BOARD CAN, V16, P835, DOI 10.1139/f59-061; Huxel GR, 1998, AM NAT, V152, P460, DOI 10.1086/286182; Janetski DJ, 2009, OECOLOGIA, V159, P583, DOI 10.1007/s00442-008-1249-x; Jauquet J, 2003, AM FISH S S, V34, P71; Jonsson B, 2003, FRESHWATER BIOL, V48, P21, DOI 10.1046/j.1365-2427.2003.00964.x; Kasai A, 2005, FISHERIES SCI, V71, P151, DOI 10.1111/j.1444-2906.2005.00942.x; KLINE TC, 1993, CAN J FISH AQUAT SCI, V50, P2350, DOI 10.1139/f93-259; Kohler AE, 2013, CAN J FISH AQUAT SCI, V70, P502, DOI 10.1139/cjfas-2012-0347; Leroux SJ, 2008, ECOL LETT, V11, P1147, DOI 10.1111/j.1461-0248.2008.01235.x; Lovelock CE, 2011, FUNCT PLANT BIOL, V38, P514, DOI 10.1071/FP11027; MacDonald BA, 1998, J EXP MAR BIOL ECOL, V219, P127, DOI 10.1016/S0022-0981(97)00178-0; MACDONALD BA, 1980, MAR BIOL, V58, P105, DOI 10.1007/BF00396121; Marcarelli AM, 2011, ECOLOGY, V92, P1215, DOI 10.1890/10-2240.1; Marczak LB, 2007, ECOLOGY, V88, P140, DOI 10.1890/0012-9658(2007)88[140:MTLHAP]2.0.CO;2; MILLIMAN JD, 1992, J GEOL, V100, P525, DOI 10.1086/629606; Mitchell NL, 2005, LIMNOL OCEANOGR, V50, P217, DOI 10.4319/lo.2005.50.1.0217; Moore JW, 2007, ECOLOGY, V88, P1278, DOI 10.1890/06-0782; Moore JW, 2004, OECOLOGIA, V139, P298, DOI 10.1007/s00442-004-1509-3; Morse BL, 2013, J EXP MAR BIOL ECOL, V448, P57, DOI 10.1016/j.jembe.2013.06.016; Naiman RJ, 2002, ECOSYSTEMS, V5, P399, DOI 10.1007/s10021-001-0083-3; NEAVE FERRIS, 1966, INT N PACIFIC FEH COMM, V18, P71; NEWELL CR, 1982, J EXP MAR BIOL ECOL, V65, P285, DOI 10.1016/0022-0981(82)90060-0; Nowlin WH, 2008, ECOLOGY, V89, P647, DOI 10.1890/07-0303.1; Oczkowski AJ, 2011, ESTUAR COAST, V34, P993, DOI 10.1007/s12237-011-9383-9; Palardy JE, 2014, ECOLOGY, V95, P286, DOI 10.1890/12-1612.1; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Pojar J., 1991, ECOSYSTEMS BRIT COLU, V6, P95; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Polis GA, 2004, FOOD WEBS LANDSCAPE, P1; Price K, 2009, FOREST ECOL MANAG, V258, P495, DOI 10.1016/j.foreco.2008.10.010; R Core Team, 2012, R LANG ENV STAT COMP; Reimchen TE., 1994, FURTHER STUDIES PRED; Richardson JS, 2010, RIVER RES APPL, V26, P55, DOI 10.1002/rra.1283; Rip JMK, 2011, ECOL LETT, V14, P733, DOI 10.1111/j.1461-0248.2011.01636.x; Rossi F, 2004, LIMNOL OCEANOGR, V49, P408, DOI 10.4319/lo.2004.49.2.0408; Sakamaki T, 2008, MAR ECOL PROG SER, V360, P13, DOI 10.3354/meps07388; Sakamaki T, 2008, CAN J FISH AQUAT SCI, V65, P38, DOI 10.1139/F07-151; Sakamaki T, 2013, J APPL ECOL, V50, P1019, DOI 10.1111/1365-2664.12099; Sakamaki T, 2010, ECOSYSTEMS, V13, P328, DOI 10.1007/s10021-010-9321-x; Sanchez-Pinero F, 2000, ECOLOGY, V81, P3117, DOI 10.1890/0012-9658(2000)081[3117:BUDOAI]2.0.CO;2; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Shurin JB, 2006, P ROY SOC B-BIOL SCI, V273, P1, DOI 10.1098/rspb.2005.3377; Slaney TL, 1996, FISHERIES, V21, P20, DOI 10.1577/1548-8446(1996)021<0020:SOASAT>2.0.CO;2; Spiller DA, 2010, ECOLOGY, V91, P1424, DOI 10.1890/09-0715.1; Stapp P, 2003, OECOLOGIA, V134, P496, DOI 10.1007/s00442-002-1146-7; Swain NR, 2014, CAN J FISH AQUAT SCI, V71, P521, DOI 10.1139/cjfas-2013-0159; Tiegs SD, 2011, ECOSYSTEMS, V14, P598, DOI 10.1007/s10021-011-9431-0; Valiela I, 2014, ECOSYSTEMS, V17, P96, DOI 10.1007/s10021-013-9709-5; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Vinagre C, 2011, ESTUAR COAST, V34, P663, DOI 10.1007/s12237-010-9315-0; Weiss ET, 2002, AQUACULTURE, V211, P275, DOI 10.1016/S0044-8486(02)00018-2; Wipfli MS, 2004, HYDROBIOLOGIA, V520, P153, DOI 10.1023/B:HYDR.0000027734.95586.24; Yamanaka T, 2013, ESTUAR COAST SHELF S, V126, P87, DOI 10.1016/j.ecss.2013.04.011; Yang LH, 2010, ECOL MONOGR, V80, P125, DOI 10.1890/08-1996.1; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	105	3	3	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0125167	10.1371/journal.pone.0125167	http://dx.doi.org/10.1371/journal.pone.0125167			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993002	gold, Green Published			2022-12-26	WOS:000354917300015
J	Long, M; Zhou, JY; Li, DD; Zheng, L; Xu, ZH; Zhou, SW				Long, Min; Zhou, Jiyin; Li, Dandan; Zheng, Lu; Xu, Zihui; Zhou, Shiwen			Long-Term Over-Expression of Neuropeptide Y in Hypothalamic Paraventricular Nucleus Contributes to Adipose Tissue Insulin Resistance Partly via the Y5 Receptor	PLOS ONE			English	Article							GLUCOSE-METABOLISM; IN-VIVO; INDIVIDUAL TISSUES; 3T3-L1 ADIPOCYTES; SKELETAL-MUSCLES; INDUCED OBESITY; CHRONIC STRESS; NPY; RATS; DIET	Intracerebroventricular injection and overexpression of Neuropeptide Y (NPY) in the paraventricular nucleus (PVN) has been shown to induce obesity and glucose metabolism disorder in rodents; however, the underlying mechanisms are still unclear. The aim of this study was to investigate the mechanism contributing to glucose metabolic disturbance induced by NPY. Recombinant lentiviral NPY vectors were injected into the PVN of rats fed a high fat (HFD) or low-fat diet. 8 weeks later, in vivo intravenous glucose tolerance tests and euglycemic-hyperinsulinemic clamp revealed that insulin resistance of adipose tissue were induced by NPY overexpression with or without HFD. NPY increased food intake, but did not change blood glucose, glycated hemoglobin A1c (HbA1c) or lipid levels. However, NPY decreased the expression of pGSK3 beta, PI3K p85 and pAKT(Ser473)in adipose tissue of rats. In vitro, 3T3-L1 adipocytes were treated with NPY, NPY Y1 and Y5 receptor antagonists. Glucose consumption and 2-deoxy-D-[H-3] glucose uptake were partly inhibited by NPY, while a decrease in PI3K-AKT pathway signaling and a decreased expression of pGSK3 alpha and pGSK3 beta were observed. Nevertheless, a Y5 receptor antagonist (L-152,804) reversed the effects of NPY on glucose uptake and consumption. These data suggest that long-term over-expression of NPY in PVN contributes to the establishment of adipose tissue insulin resistance, at least partly via the Y5 Receptor.	[Long, Min; Xu, Zihui] Third Mil Med Univ, Xinqiao Hosp, Dept Endocrinol, Chongqing 400037, Peoples R China; [Long, Min; Zhou, Jiyin; Li, Dandan; Zhou, Shiwen] Third Mil Med Univ, Xinqiao Hosp, Base Drug Clin Trial, Chongqing 400037, Peoples R China; [Zheng, Lu] Third Mil Med Univ, Xinqiao Hosp, Dept Hepatobiliary Surg, Chongqing 400037, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Zhou, SW (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Base Drug Clin Trial, Chongqing 400037, Peoples R China.	shiwenzhou2000@163.com	zheng, lu/GXH-7035-2022	Long, Min/0000-0003-1071-8131	Natural Science Foundation Project of Chongqing Science and Technology Commission [2009BA5012]; State Scholarship Fund of China [201207610022]; Chongqing Science Foundation [cstc2013jcsfC10001-5]	Natural Science Foundation Project of Chongqing Science and Technology Commission(Natural Science Foundation of Chongqing); State Scholarship Fund of China; Chongqing Science Foundation	This study was supported by a Natural Science Foundation Project of Chongqing Science and Technology Commission (No. 2009BA5012), the State Scholarship Fund of China (No. 201207610022 to M.L.), and Chongqing Science Foundation (No. cstc2013jcsfC10001-5 to M.L.).	Bamshad M, 1998, AM J PHYSIOL-REG I, V275, pR291, DOI 10.1152/ajpregu.1998.275.1.R291; Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; BERNARDIS LL, 1968, J ENDOCRINOL, V40, P527, DOI 10.1677/joe.0.0400527; Chronwall BA, 2004, PEPTIDES, V25, P359, DOI 10.1016/j.peptides.2004.02.013; Drira R, 2013, BIOCHEM BIOPH RES CO, V440, P576, DOI 10.1016/j.bbrc.2013.09.106; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Gericke MT, 2012, MOL CELL ENDOCRINOL, V348, P27, DOI 10.1016/j.mce.2011.07.028; HARFSTRAND A, 1986, ACTA PHYSIOL SCAND, V128, P121, DOI 10.1111/j.1748-1716.1986.tb07957.x; Hirsch D, 2012, CELL MOL NEUROBIOL, V32, P645, DOI 10.1007/s10571-011-9793-z; Hughey CC, 2011, J VIS EXP, V7; Ishihara A, 2006, P NATL ACAD SCI USA, V103, P7154, DOI 10.1073/pnas.0510320103; JAMES DE, 1986, J BIOL CHEM, V261, P6366; JAMES DE, 1985, AM J PHYSIOL, V248, pE567, DOI 10.1152/ajpendo.1985.248.5.E567; Kamon J, 2001, CELL SIGNAL, V13, P105, DOI 10.1016/S0898-6568(00)00137-6; Kanatani A, 2000, BIOCHEM BIOPH RES CO, V272, P169, DOI 10.1006/bbrc.2000.2696; Kim WK, 2013, NUTR RES PRACT, V7, P160, DOI 10.4162/nrp.2013.7.3.160; Kohno D, 2012, NEUROPEPTIDES, V46, P315, DOI 10.1016/j.npep.2012.09.004; Kos K, 2009, DIABETES OBES METAB, V11, P285, DOI 10.1111/j.1463-1326.2008.00909.x; KRAEGEN EW, 1985, AM J PHYSIOL, V248, pE353; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Kuo LE, 2008, ANN NY ACAD SCI, V1148, P232, DOI 10.1196/annals.1410.035; Lee JS, 2007, DIABETES RES CLIN PR, V77, pS49, DOI 10.1016/j.diabres.2007.01.033; Leng SH, 2010, J ENDOCRINOL, V206, P171, DOI 10.1677/JOE-09-0456; Macedo IC, 2012, PEPTIDES, V38, P189, DOI 10.1016/j.peptides.2012.08.007; Mashiko S, 2003, ENDOCRINOLOGY, V144, P1793, DOI 10.1210/en.2002-0119; Mashiko S, 2008, OBESITY, V16, P1510, DOI 10.1038/oby.2008.223; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Park S, 2014, FASEB J, V28, P5337, DOI 10.1096/fj.14-258384; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pedragosa-Badia Xavier, 2013, Front Endocrinol (Lausanne), V4, P5, DOI 10.3389/fendo.2013.00005; Qiu J, 2008, PEPTIDES, V29, P2052, DOI 10.1016/j.peptides.2008.06.024; Rosmaninho-Salgado J, 2012, NEUROPEPTIDES, V46, P359, DOI 10.1016/j.npep.2012.08.006; Ruzzin J, 2005, DIABETOLOGIA, V48, P2119, DOI 10.1007/s00125-005-1886-0; Shiuchi T, 2002, HYPERTENSION, V40, P329, DOI 10.1161/01.HYP.0000028979.98877.0C; Shiuchi T, 2004, HYPERTENSION, V43, P1003, DOI 10.1161/01.HYP.0000125142.41703.64; STRACK AM, 1989, BRAIN RES, V491, P156, DOI 10.1016/0006-8993(89)90098-X; Tiesjema B, 2007, J NEUROSCI, V27, P14139, DOI 10.1523/JNEUROSCI.3280-07.2007; Tiesjema B, 2007, OBESITY, V15, P2424, DOI 10.1038/oby.2007.288; Tiesjema B, 2009, OBESITY, V17, P1448, DOI 10.1038/oby.2008.670; Timmers S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014503; van den Hoek AM, 2008, DIABETES, V57, P2304, DOI 10.2337/db07-1658; Wan Y, 2015, PEPTIDES, V63, P126, DOI 10.1016/j.peptides.2014.10.018; Wang C, 2007, HORM METAB RES, V39, P262, DOI 10.1055/s-2007-973073; Wang F, 2014, PHARM BIOL, V52, P68, DOI 10.3109/13880209.2013.814691; Wasan KM, 2006, J TRACE ELEM MED BIO, V19, P251, DOI 10.1016/j.jtemb.2005.10.001; Wynne K, 2005, J ENDOCRINOL, V184, P291, DOI 10.1677/joe.1.05866; Yin J, 2002, METABOLISM, V51, P1439, DOI 10.1053/meta.2002.34715; Yin J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1275, DOI 10.1152/ajpendo.00092.2009; Yulyaningsih E, 2011, BRIT J PHARMACOL, V163, P1170, DOI 10.1111/j.1476-5381.2011.01363.x; Zhang CH, 2013, PHYTOMEDICINE, V20, P221, DOI 10.1016/j.phymed.2012.11.002; Zhang W, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-27; ZUKOWSKAGROJEC Z, 1987, AM J PHYSIOL, V253, pH1234, DOI 10.1152/ajpheart.1987.253.5.H1234	53	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126714	10.1371/journal.pone.0126714	http://dx.doi.org/10.1371/journal.pone.0126714			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993471	Green Submitted, gold, Green Published			2022-12-26	WOS:000354917300049
J	Oksanen, SM; Ahola, MP; Oikarinen, J; Kunnasranta, M				Oksanen, Sari M.; Ahola, Markus P.; Oikarinen, Jyrki; Kunnasranta, Mervi			A Novel Tool to Mitigate By-Catch Mortality of Baltic Seals in Coastal Fyke Net Fishery	PLOS ONE			English	Article							HALICHOERUS-GRYPUS; PHOCA-HISPIDA; GEAR DAMAGE; GREY SEALS; TRAP-NET; BYCATCH; SALMON; DISTRIBUTIONS; POPULATION; PATTERNS	Developing methods to reduce the incidental catch of non-target species is important, as by-catch mortality poses threats especially to large aquatic predators. We examined the effectiveness of a novel device, a "seal sock", in mitigating the by-catch mortality of seals in coastal fyke net fisheries in the Baltic Sea. The seal sock developed and tested in this study was a cylindrical net attached to the fyke net, allowing the seals access to the surface to breathe while trapped inside fishing gear. The number of dead and live seals caught in fyke nets without a seal sock (years 2008-2010) and with a sock (years 2011-2013) was recorded. The seals caught in fyke nets were mainly juveniles. Of ringed seals (Phoca hispida botnica) both sexes were equally represented, while of grey seals (Halichoerus grypus) the ratio was biased (71%) towards males. All the by-caught seals were dead in the fyke nets without a seal sock, whereas 70% of ringed seals and 11% of grey seals survived when the seal sock was used. The seal sock proved to be effective in reducing the by-catch mortality of ringed seals, but did not perform as well with grey seals.	[Oksanen, Sari M.; Kunnasranta, Mervi] Univ Eastern Finland, Dept Biol, Joensuu, Finland; [Ahola, Markus P.] Nat Resources Inst Finland, Turku, Finland; [Oikarinen, Jyrki] Perameren Kalatalousyhteisojen Liitto Ry, Oulu, Finland	University of Eastern Finland; Natural Resources Institute Finland (Luke)	Oksanen, SM (corresponding author), Univ Eastern Finland, Dept Biol, Joensuu, Finland.	sari.oksanen@uef.fi			European Fisheries Fund award by ELY-Centre of Kainuu [1000862, 1001767]; Maj and Tor Nessling Foundation [201200171, 201300044, 201400081, 201500146]	European Fisheries Fund award by ELY-Centre of Kainuu; Maj and Tor Nessling Foundation	This study was partly funded from the European Fisheries Fund (http://ec.europa.eu/fisheries/cfp/eff/index_en.htm) awarded to the Finnish Game and Fisheries Research Institute by the ELY-Centre of Kainuu (#1000862, #1001767) and the Maj and Tor Nessling Foundation (http://www.nessling.fi/en/, #201200171, 201300044, 201400081, 201500146 to SMO, MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backlin BM, 2011, ICES J MAR SCI, V68, P183, DOI 10.1093/icesjms/fsq131; Bjorge A, 2002, MAR MAMMAL SCI, V18, P963, DOI 10.1111/j.1748-7692.2002.tb01085.x; Bowen WD, 2013, MAMMAL REV, V43, P207, DOI 10.1111/j.1365-2907.2012.00217.x; Bruckmeier K, 2008, MAR POLICY, V32, P201, DOI 10.1016/j.marpol.2007.09.005; Finnish Game and Fisheries Research Institute, 2014, IT HALL KASV ED; Fjalling A, 2005, ICES J MAR SCI, V62, P1630, DOI 10.1016/j.icesjms.2005.02.015; Hamilton S, 2015, FISH RES, V161, P200, DOI 10.1016/j.fishres.2014.07.010; Harding Karin C., 2007, NAMMCO Scientific Publications, V6, P33; Harding KC, 1999, AMBIO, V28, P619; Hemmingsson M, 2008, FISH RES, V93, P357, DOI 10.1016/j.fishres.2008.06.013; Kauhala K, 2015, ANN ZOOL FE IN PRESS, P52; Kauhala K, 2012, ANN ZOOL FENN, V49, P287, DOI 10.5735/086.049.0502; Kauppinen T, 2005, FISH RES, V73, P99, DOI 10.1016/j.fishres.2005.01.003; Kirby DS, 2014, MAR POLICY, V44, P419, DOI 10.1016/j.marpol.2013.10.008; Konigson S, 2013, FISH RES, V148, P117, DOI 10.1016/j.fishres.2013.07.014; Lehtonen E, 2004, ICES J MAR SCI, V61, P1195, DOI 10.1016/j.icesjms.2004.06.012; Lehtonen E, 2010, FISH RES, V102, P214, DOI 10.1016/j.fishres.2009.10.007; Lewison RL, 2014, P NATL ACAD SCI USA, V111, P5271, DOI 10.1073/pnas.1318960111; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lunneryd SG, 2003, ICES J MAR SCI, V60, P1194, DOI 10.1016/S1054-3139(03)00145-0; Meier HEM, 2004, AMBIO, V33, P249, DOI 10.1639/0044-7447(2004)033[0249:SDOBSI]2.0.CO;2; Ministry of Agriculture and Forestry, 2007, MAN PLAN FINN SEAL P; Morner T, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-79; Niemi M, 2013, MAR MAMMAL SCI, V29, P1, DOI 10.1111/j.1748-7692.2011.00521.x; Oksanen SM, 2014, MAR ECOL PROG SER, V507, P297, DOI 10.3354/meps10846; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Sipila T., 2003, THESIS U HELSINKI FI; SMITH TG, 1975, CAN J ZOOL, V53, P1297, DOI 10.1139/z75-155; Soykan Candan U., 2008, Endangered Species Research, V5, P91, DOI 10.3354/esr00175; Storm A, 2007, HYLJEPUHETTA ALUEELL; Sundqvist L, 2012, AMBIO, V41, P865, DOI 10.1007/s13280-012-0334-x; Suuronen P, 2006, FISH RES, V79, P129, DOI 10.1016/j.fishres.2006.02.014; Vanhatalo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113836; Varjopuro R, 2011, MAR POLICY, V35, P450, DOI 10.1016/j.marpol.2010.10.023	34	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127510	10.1371/journal.pone.0127510	http://dx.doi.org/10.1371/journal.pone.0127510			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993534	Green Published, gold, Green Submitted			2022-12-26	WOS:000354917300129
J	Zhang, Y; Wang, L; Hu, Y; Xi, XF; Tang, YS; Chen, JH; Fu, XH; Sun, Y				Zhang, Yue; Wang, Lei; Hu, Yu; Xi, Xuefei; Tang, Yushu; Chen, Jinhai; Fu, Xiaohua; Sun, Ying			Water Organic Pollution and Eutrophication Influence Soil Microbial Processes, Increasing Soil Respiration of Estuarine Wetlands: Site Study in Jiuduansha Wetland	PLOS ONE			English	Article							QINGHAI-TIBETAN PLATEAU; YANGTZE-RIVER ESTUARY; ALPINE WETLAND; CONSTRUCTED WETLAND; COMMUNITY STRUCTURE; CHONGMING DONGTAN; TIDAL WETLANDS; NITROGEN; CHINA; NITRIFICATION	Undisturbed natural wetlands are important carbon sinks due to their low soil respiration. When compared with inland alpine wetlands, estuarine wetlands in densely populated areas are subjected to great pressure associated with environmental pollution. However, the effects of water pollution and eutrophication on soil respiration of estuarine and their mechanism have still not been thoroughly investigated. In this study, two representative zones of a tidal wetland located in the upstream and downstream were investigated to determine the effects of water organic pollution and eutrophication on soil respiration of estuarine wetlands and its mechanism. The results showed that eutrophication, which is a result of there being an excess of nutrients including nitrogen and phosphorus, and organic pollutants in the water near Shang shoal located upstream were higher than in downstream Xia shoal. Due to the absorption and interception function of shoals, there to be more nitrogen, phosphorus and organic matter in Shang shoal soil than in Xia shoal. Abundant nitrogen, phosphorus and organic carbon input to soil of Shang shoal promoted reproduction and growth of some highly heterotrophic metabolic microorganisms such as beta-Proteobacteria, gamma-Proteobacteria and Acidobacteria which is not conducive to carbon sequestration. These results imply that the performance of pollutant interception and purification function of estuarine wetlands may weaken their carbon sequestration function to some extent.	[Zhang, Yue; Wang, Lei; Hu, Yu; Xi, Xuefei; Tang, Yushu; Chen, Jinhai; Fu, Xiaohua] Tongji Univ, Sch Environm Sci & Engn, Minist Educ, Key Lab Yangtze River Water Environm, Shanghai 200092, Peoples R China; [Sun, Ying] Shanghai Jiuduansha Wetland Nat Reserve Adm, Shanghai, Peoples R China	Tongji University	Wang, L (corresponding author), Tongji Univ, Sch Environm Sci & Engn, Minist Educ, Key Lab Yangtze River Water Environm, Shanghai 200092, Peoples R China.	celwang@tongji.edu.cn			National Natural Science Foundation of China [21177093, 21307093]; China Postdoctoral Science Foundation [2013M531220, 2014T70430]; Major Project of the Shanghai Scientific and Technological Committee [10dz1200803]; Ministry of Education of China [20130072110025]; Collaborative Innovation Center for Regional Environmental Quality in Beijing	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Major Project of the Shanghai Scientific and Technological Committee; Ministry of Education of China(Ministry of Education, China); Collaborative Innovation Center for Regional Environmental Quality in Beijing	LW received the fundings including: National Natural Science Foundation of China (No. 21177093 and No. 21307093, URL:www.nsfc.gov.cn), China Postdoctoral Science Foundation (No. 2013M531220 and No. 2014T70430, URL: http://jj.chinapostdoctor.org.cn/V1/Program1/Default.aspx), Major Project of the Shanghai Scientific and Technological Committee (No. 10dz1200803, URL: http://www.stcsm.gov.cn/info/nIndex.jsp?isSd = false&node_id=GKxxgk&cat_id=10152) and the Ph.D. Programs Foundation of Ministry of Education of China (No. 20130072110025, URL: http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm). Additional support was received from the Collaborative Innovation Center for Regional Environmental Quality in Beijing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, GLOBAL BIOGEOCHEM CY, DOI DOI 10.1029/2002GB001917; Barlett MA, 2010, CAN J MICROBIOL, V56, P32, DOI [10.1139/W09-099, 10.1139/w09-099]; Bernal B, 2008, ECOL ENG, V34, P311, DOI 10.1016/j.ecoleng.2008.09.005; Bernal B, 2012, GLOBAL CHANGE BIOL, V18, P1636, DOI 10.1111/j.1365-2486.2011.02619.x; BROSIUS J, 1978, P NATL ACAD SCI USA, V75, P4801, DOI 10.1073/pnas.75.10.4801; Calheiros CSC, 2007, WATER RES, V41, P1790, DOI 10.1016/j.watres.2007.01.012; Chen JR, 2013, EUR J SOIL BIOL, V56, P65, DOI 10.1016/j.ejsobi.2013.02.007; Chipps SR, 2006, WETLANDS, V26, P497, DOI 10.1672/0277-5212(2006)26[497:ABWDAB]2.0.CO;2; D'Arcy BJ, 2007, WATER SCI TECHNOL, V56, P49, DOI 10.2166/wst.2007.435; Du S, 2006, CRITERION OF SOIL AN; Galicia L, 2004, APPL SOIL ECOL, V26, P31, DOI 10.1016/j.apsoil.2003.10.006; Gao C, 2013, QUATERN INT, V304, P13, DOI 10.1016/j.quaint.2013.03.001; Gao JQ, 2011, CHINESE GEOGR SCI, V21, P27, DOI 10.1007/s11769-011-0439-3; Gomez-Casanovas N, 2012, GLOBAL CHANGE BIOL, V18, P2532, DOI 10.1111/j.1365-2486.2012.02721.x; Gude A, 2012, SOIL BIOL BIOCHEM, V47, P209, DOI 10.1016/j.soilbio.2012.01.003; Guo P, 2011, PLANT SOIL, V338, P355, DOI 10.1007/s11104-010-0550-8; Gurnell A, 2005, FRONT ECOL ENVIRON, V3, P377, DOI 10.1890/1540-9295(2005)003[0377:EODWOB]2.0.CO;2; Hirota M, 2007, LIMNOLOGY, V8, P161, DOI 10.1007/s10201-007-0205-5; Hu Y, 2012, J ENVIRON SCI, V24, P1053, DOI 10.1016/S1001-0742(11)60877-2; Hugler M, 2001, ANNU REV MAR SCI, V3, P261; Jana BB, 2001, J APPL MICROBIOL, V90, P733, DOI 10.1046/j.1365-2672.2001.01299.x; Joo HS, 2005, J BIOSCI BIOENG, V100, P184, DOI 10.1263/jbb.100.184; Kraigher B, 2006, SOIL BIOL BIOCHEM, V38, P2762, DOI 10.1016/j.soilbio.2006.04.031; Li M, 2006, ACTA GEOGRAPHICA SIN, V3, P008; Liang LZ, 2013, SOIL USE MANAGE, V29, P161, DOI 10.1111/sum.12035; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061188; Lutz A, 2000, MAR POLLUT BULL, V41, P255; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; ORCHARD VA, 1983, SOIL BIOL BIOCHEM, V15, P447, DOI 10.1016/0038-0717(83)90010-X; Qiao JL, 2012, J ENVIRON SCI HEAL A, V47, P319, DOI 10.1080/10934529.2012.640912; Ren ZM, 2013, ECOL MODEL, V252, P97, DOI 10.1016/j.ecolmodel.2012.08.025; Tang YS, 2011, SOIL BIOL BIOCHEM, V43, P638, DOI 10.1016/j.soilbio.2010.11.035; Tang YS, 2011, DESALIN WATER TREAT, V32, P277, DOI 10.5004/dwt.2011.2711; Tang YS, 2011, ECOL ENG, V37, P1638, DOI 10.1016/j.ecoleng.2011.06.004; Wakelin SA, 2007, FEMS MICROBIOL ECOL, V59, P661, DOI 10.1111/j.1574-6941.2006.00235.x; Wang GX, 2002, SCI TOTAL ENVIRON, V291, P207, DOI 10.1016/S0048-9697(01)01100-7; Wang QK, 2013, AGR FOREST METEOROL, V178, P152, DOI 10.1016/j.agrformet.2013.04.021; Weaver RW, METHODS OF SOIL ANAL; Xi XF, 2012, ECOL ENG, V49, P104, DOI 10.1016/j.ecoleng.2012.08.011; Xu DF, 2013, CHEMOSPHERE, V92, P201, DOI 10.1016/j.chemosphere.2013.03.016; Yao H.Y., 2006, SOIL MICROBIAL ECOLO; Zaman M, 1999, BIOL FERT SOILS, V29, P178, DOI 10.1007/s003740050542; Zhang J, 2010, PEDOSPHERE, V20, P557, DOI 10.1016/S1002-0160(10)60045-8; Zhang LF, 2013, ENVIRON POLLUT, V181, P159, DOI 10.1016/j.envpol.2013.06.033; Zhang YN, 2013, ECOL ENG, V52, P308, DOI 10.1016/j.ecoleng.2012.10.002; Zhao L, 2010, BIOGEOSCIENCES, V7, P1207, DOI 10.5194/bg-7-1207-2010	46	18	19	9	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126951	10.1371/journal.pone.0126951	http://dx.doi.org/10.1371/journal.pone.0126951			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993326	gold, Green Published, Green Submitted			2022-12-26	WOS:000354917300070
J	Kim, SW; Hasanuzzaman, M; Cho, M; Heo, YR; Ryu, MJ; Ha, NY; Park, HJ; Park, HY; Shin, JG				Kim, So Won; Hasanuzzaman, Md.; Cho, Munju; Heo, Ye Rang; Ryu, Min-Jung; Ha, Na-Young; Park, Hyun June; Park, Hyung-Yeon; Shin, Jae-Gook			Casein Kinase 2 (CK2)-mediated Phosphorylation of Hsp90 beta as a Novel Mechanism of Rifampin-induced MDR1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-GLYCOPROTEIN; NUCLEAR RECEPTORS; GENE-EXPRESSION; PROTEIN; CK2; CANCER; RESISTANCE; PXR; LOCALIZATION; APOPTOSIS	The P-glycoprotein (P-gp) encoded by the MDR1 gene is a drug-exporting transporter located in the cellular membrane. P-gp induction is regarded as one of the main mechanisms underlying drug-induced resistance. Although there is great interest in the regulation of P-gp expression, little is known about its underlying regulatory mechanisms. In this study, we demonstrate that casein kinase 2 (CK2)-mediated phosphorylation of heat shock protein 90 beta (Hsp90 beta) and subsequent stabilization of PXR is a key mechanism in the regulation of MDR1 expression. Furthermore, we show that CK2 is directly activated by rifampin. Upon exposure to rifampin, CK2 catalyzes the phosphorylation of Hsp90 beta at the Ser-225/254 residues. Phosphorylated Hsp90 beta then interacts with PXR, causing a subsequent increase in its stability, leading to the induction of P-gp expression. In addition, inhibition of CK2 and Hsp90 beta enhances the down-regulation of PXR and P-gp expression. The results of this study may facilitate the development of new strategies to prevent multidrug resistance and provide a plausible mechanism for acquired drug resistance by CK2-mediated regulation of P-gp expression.	[Kim, So Won] Catholic Kwandong Univ, Dept Pharmacol, Coll Med, Kangnung 210701, South Korea; [Kim, So Won] Catholic Kwandong Univ, Inst Clin & Translat Res, Coll Med, Kangnung 210701, South Korea; [Kim, So Won; Hasanuzzaman, Md.; Cho, Munju; Heo, Ye Rang; Ryu, Min-Jung; Ha, Na-Young; Shin, Jae-Gook] Inje Univ, Coll Med, Dept Pharmacol, Busan 614735, South Korea; [Kim, So Won; Hasanuzzaman, Md.; Cho, Munju; Heo, Ye Rang; Ryu, Min-Jung; Ha, Na-Young; Shin, Jae-Gook] Inje Univ, Coll Med, PharmacoGen Res Ctr, Busan 614735, South Korea; [Kim, So Won; Shin, Jae-Gook] Inje Univ, Busan Paik Hosp, Dept Clin Pharmacol, Busan 614735, South Korea; [Park, Hyun June] Seoul Natl Univ, BioMAX Inst, Seoul 151742, South Korea; [Park, Hyung-Yeon] Noroo Holdings Co Ltd, Agr & Biotechnol Dept, Seoul 135983, South Korea	Catholic Kwandong University; Catholic Kwandong University; Inje University; Inje University; Inje University; Seoul National University (SNU)	Shin, JG (corresponding author), Inje Univ, Busan Paik Hosp, Pharmacogen Res Ctr, Coll Med,Clin Trial Ctr, Busan 633165, South Korea.	phshinjg@gmail.com			National Research Foundation of Korea (NRF) - Korean government (MSIP) [R13-2007-023-00000-0]; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI14C0067]	National Research Foundation of Korea (NRF) - Korean government (MSIP); Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by National Research Foundation of Korea (NRF) Grant R13-2007-023-00000-0 funded by the Korean government (MSIP) and Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea, Grant HI14C0067. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; Akten B, 2009, J NEUROSCI, V29, P466, DOI 10.1523/JNEUROSCI.4034-08.2009; Baciewicz AM, 2013, CURR MED RES OPIN, V29, P1, DOI 10.1185/03007995.2012.747952; Battistutta R, 2000, J BIOL CHEM, V275, P29618, DOI 10.1074/jbc.M004257200; Baysarowich J, 2008, P NATL ACAD SCI USA, V105, P4886, DOI 10.1073/pnas.0711939105; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Cowen LE, 2006, EUKARYOT CELL, V5, P2184, DOI 10.1128/EC.00274-06; Enkvist E, 2012, ORG BIOMOL CHEM, V10, P8645, DOI 10.1039/c2ob26022k; Feng S, 2007, PROTEOMICS, V7, P351, DOI 10.1002/pmic.200600045; GANT TW, 1992, NUCLEIC ACIDS RES, V20, P2841, DOI 10.1093/nar/20.11.2841; Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Greiner B, 1999, J CLIN INVEST, V104, P147, DOI 10.1172/JCI6663; Guo CH, 2001, J BIOL CHEM, V276, P5992, DOI 10.1074/jbc.M004862200; Heriche JK, 1998, ONCOGENE, V17, P13, DOI 10.1038/sj.onc.1201900; Huang H, 2007, ONCOGENE, V26, P258, DOI 10.1038/sj.onc.1209788; Kakizaki S, 2011, FRONT BIOSCI-LANDMRK, V16, P2988, DOI 10.2741/3893; Labialle S, 2002, BIOCHEM PHARMACOL, V64, P943, DOI 10.1016/S0006-2952(02)01156-5; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Lu XY, 2012, BIOCHEM PHARMACOL, V83, P995, DOI 10.1016/j.bcp.2011.11.011; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Miyata Y, 2009, CELL MOL LIFE SCI, V66, P1840, DOI 10.1007/s00018-009-9152-0; MIYATA Y, 1992, J BIOL CHEM, V267, P7042; Niemi M, 2003, CLIN PHARMACOKINET, V42, P819, DOI 10.2165/00003088-200342090-00003; Persidis A, 1999, NAT BIOTECHNOL, V17, P94, DOI 10.1038/5289; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Pinna LA, 2012, PROTEIN KINASE CK2; Proia DA, 2012, INVEST NEW DRUG, V30, P2201, DOI 10.1007/s10637-011-9790-6; Schuetz EG, 1996, MOL PHARMACOL, V49, P311; Scotto KW, 2003, ONCOGENE, V22, P7496, DOI 10.1038/sj.onc.1206950; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; Squires EJ, 2004, J BIOL CHEM, V279, P49307, DOI 10.1074/jbc.M407281200; Stolarczyk EI, 2012, MOL PHARMACOL, V82, P488, DOI 10.1124/mol.112.078295; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Yamane K, 2005, CANCER RES, V65, P4362, DOI 10.1158/0008-5472.CAN-04-3941	37	21	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					17029	17040		10.1074/jbc.M114.624106	http://dx.doi.org/10.1074/jbc.M114.624106			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25995454	hybrid, Green Published			2022-12-26	WOS:000357572800045
J	Bi, HS; Guo, ZH; Benfield, MC; Fan, CL; Ford, M; Shahrestani, S; Sieracki, JM				Bi, Hongsheng; Guo, Zhenhua; Benfield, Mark C.; Fan, Chunlei; Ford, Michael; Shahrestani, Suzan; Sieracki, Jeffery M.			A Semi-Automated Image Analysis Procedure for In Situ Plankton Imaging Systems	PLOS ONE			English	Article							CLASSIFICATION; RECOGNITION; ENUMERATION; RESOLUTION; ABUNDANCE; TIME; NET	Plankton imaging systems are capable of providing fine-scale observations that enhance our understanding of key physical and biological processes. However, processing the large volumes of data collected by imaging systems remains a major obstacle for their employment, and existing approaches are designed either for images acquired under laboratory controlled conditions or within clear waters. In the present study, we developed a semi-automated approach to analyze plankton taxa from images acquired by the ZOOplankton VISualization (ZOOVIS) system within turbid estuarine waters, in Chesapeake Bay. When compared to images under laboratory controlled conditions or clear waters, images from highly turbid waters are often of relatively low quality and more variable, due to the large amount of objects and nonlinear illumination within each image. We first customized a segmentation procedure to locate objects within each image and extracted them for classification. A maximally stable extremal regions algorithm was applied to segment large gelatinous zooplankton and an adaptive threshold approach was developed to segment small organisms, such as copepods. Unlike the existing approaches for images acquired from laboratory, controlled conditions or clear waters, the target objects are often the majority class, and the classification can be treated as a multi-class classification problem. We customized a two-level hierarchical classification procedure using support vector machines to classify the target objects (< 5%), and remove the non-target objects (> 95%). First, histograms of oriented gradients feature descriptors were constructed for the segmented objects. In the first step all non-target and target objects were classified into different groups: arrow-like, copepod-like, and gelatinous zooplankton. Each object was passed to a group-specific classifier to remove most non-target objects. After the object was classified, an expert or non-expert then manually removed the non-target objects that could not be removed by the procedure. The procedure was tested on 89,419 images collected in Chesapeake Bay, and results were consistent with visual counts with > 80% accuracy for all three groups.	[Bi, Hongsheng; Shahrestani, Suzan] Univ Maryland, Ctr Environm Sci, Chesapeake Biol Lab, Solomons, MD 20688 USA; [Guo, Zhenhua] Tsinghua Univ, Grad Sch Shenzhen, Shenzhen Key Lab Broadband Network & Multimedia, Shenzhen 518057, Peoples R China; [Benfield, Mark C.] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; [Fan, Chunlei] Morgan State Univ, Dept Biol, Patuxent Environm & Aquat Res Lab, St Leonard, MD 20685 USA; [Ford, Michael] Natl Ocean & Atmospher Adm, Silver Spring, MD 20910 USA; [Sieracki, Jeffery M.] SR2 Grp LLC, Laurel, MD 20707 USA	University System of Maryland; University of Maryland Center for Environmental Science; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Louisiana State University System; Louisiana State University; Morgan State University; National Oceanic Atmospheric Admin (NOAA) - USA	Bi, HS (corresponding author), Univ Maryland, Ctr Environm Sci, Chesapeake Biol Lab, Solomons, MD 20688 USA.	hbi@cbl.umces.edu	Bi, Hongsheng/B-9409-2012; /AAD-1578-2020	Bi, Hongsheng/0000-0003-2595-6271; 	North Pacific Research Board [1419]; BP Exploration and Production Company	North Pacific Research Board; BP Exploration and Production Company	This research was funded by the North Pacific Research Board (project no. 1419). Development of ZOOVIS was supported by a grant from BP Exploration and Production Company to LSU. SR2 Group LLC provided support in the form of salaries for author JMS, but neither the funder or SR2 Group LLC had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Babbar R, 2013, ADV NEUR IN, V26, P1824; Batuwita R, 2013, IMBALANCED LEARNING: FOUNDATIONS, ALGORITHMS, AND APPLICATIONS, P83; Benfield MC, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.63; Benfield MC, 1996, DEEP-SEA RES PT II, V43, P1925, DOI 10.1016/S0967-0645(96)00044-6; Bhutada GG, 2011, DIGIT SIGNAL PROCESS, V21, P118, DOI 10.1016/j.dsp.2010.09.002; Bi HS, 2013, J PLANKTON RES, V35, P270, DOI 10.1093/plankt/fbs094; Buskey EJ, 2006, HARMFUL ALGAE, V5, P685, DOI 10.1016/j.hal.2006.02.003; Chang CY, 2012, CONT SHELF RES, V36, P19, DOI 10.1016/j.csr.2012.01.005; Cowen RK, 2008, LIMNOL OCEANOGR-METH, V6, P126, DOI 10.4319/lom.2008.6.126; Culverhouse PF, 1996, MAR ECOL PROG SER, V139, P281, DOI 10.3354/meps139281; Culverhouse PF, 2003, MAR ECOL PROG SER, V247, P17, DOI 10.3354/meps247017; Culverhouse PF, 2006, MAR ECOL PROG SER, V312, P297, DOI 10.3354/meps312297; Dalal N., 2005, IEEE COMPUTER SOC C, V1, P886, DOI DOI 10.1109/CVPR.2005.177; Davis CS, 1996, DEEP-SEA RES PT II, V43, P1947, DOI 10.1016/S0967-0645(96)00051-3; Fefilatyev S., 2011, 2011 IEEE International Conference on Data Mining Workshops, P741, DOI 10.1109/ICDMW.2011.65; Gorsky G, 2002, J MARINE SYST, V33, P289, DOI 10.1016/S0924-7963(02)00063-5; Gorsky G, 2010, J PLANKTON RES, V32, P285, DOI 10.1093/plankt/fbp124; Grosjean P, 2004, ICES J MAR SCI, V61, P518, DOI 10.1016/j.icesjms.2004.03.012; Hu Q, 2006, MAR ECOL PROG SER, V306, P51, DOI 10.3354/meps306051; Hu Q, 2005, MAR ECOL PROG SER, V295, P21, DOI 10.3354/meps295021; Kohavi R., 1998, MACH LEARN, V30-2, P271, DOI [DOI 10.1023/A:1017181826899, 10.1023/A:1017181826899]; Luo T, 2005, J MACH LEARN RES, V6, P589; Luo T, 2004, IEEE T SYST MAN CY B, V34, P1753, DOI 10.1109/TSMCB.2004.830340; Luo T, 2003, IEEE SYS MAN CYBERN, P888; MacLeod N, 2010, NATURE, V467, P154, DOI 10.1038/467154a; Matas J., 2002, Electronic Proceedings of the 13th British Machine Vision Conference, P384; Nister D, 2008, LECT NOTES COMPUT SC, V5303, P183, DOI 10.1007/978-3-540-88688-4_14; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Panetta K, 2011, IEEE T SYST MAN CY B, V41, P460, DOI 10.1109/TSMCB.2010.2058847; Pang YW, 2011, SIGNAL PROCESS, V91, P773, DOI 10.1016/j.sigpro.2010.08.010; Picheral M, 2010, LIMNOL OCEANOGR-METH, V8, P462, DOI 10.4319/lom.2010.8.462; Samson S, 2001, IEEE J OCEANIC ENG, V26, P671, DOI 10.1109/48.972110; Sauvola J, 2000, PATTERN RECOGN, V33, P225, DOI 10.1016/S0031-3203(99)00055-2; Schulz J, 2010, J EUR OPT SOC-RAPID, V5, DOI 10.2971/jeos.2010.10017s; Shapiro L., 2001, COMPUTER VISION; Sieracki CK, 1998, MAR ECOL PROG SER, V168, P285, DOI 10.3354/meps168285; Trevorrow MV, 2005, J ACOUST SOC AM, V117, P3574, DOI 10.1121/1.1920087; Vapnik V., 2013, NATURE STAT LAERNING; Vapnik V., 1998, STAT LEARNING THEORY; Wiebe PH, 2003, PROG OCEANOGR, V56, P7, DOI 10.1016/S0079-6611(02)00140-4; Ye L, 2011, MAR ECOL PROG SER, V441, P185, DOI 10.3354/meps09387; Zhu XJ, 2013, OPT LETT, V38, P275, DOI 10.1364/OL.38.000275	42	34	35	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127121	10.1371/journal.pone.0127121	http://dx.doi.org/10.1371/journal.pone.0127121			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010260	gold, Green Submitted, Green Published			2022-12-26	WOS:000355183900065
J	Guo, HY; Chamberlain, SA; Elhaik, E; Jalli, I; Lynes, AR; Marczak, L; Sabath, N; Vargas, A; Wieski, K; Zelig, EM; Pennings, SC				Guo, Hongyu; Chamberlain, Scott A.; Elhaik, Eran; Jalli, Inder; Lynes, Alana-Rose; Marczak, Laurie; Sabath, Niv; Vargas, Amy; Wieski, Kazimierz; Zelig, Emily M.; Pennings, Steven C.			Geographic Variation in Plant Community Structure of Salt Marshes: Species, Functional and Phylogenetic Perspectives	PLOS ONE			English	Article							DISTANCE-DECAY; BETA-DIVERSITY; FRESH-WATER; SIMILARITY; ECOLOGY; HETEROGENEITY; MAINTENANCE; DISPERSAL; INSIGHTS; ZONATION	In general, community similarity is thought to decay with distance; however, this view may be complicated by the relative roles of different ecological processes at different geographical scales, and by the compositional perspective (e.g. species, functional group and phylogenetic lineage) used. Coastal salt marshes are widely distributed worldwide, but no studies have explicitly examined variation in salt marsh plant community composition across geographical scales, and from species, functional and phylogenetic perspectives. Based on studies in other ecosystems, we hypothesized that, in coastal salt marshes, community turnover would be more rapid at local versus larger geographical scales; and that community turnover patterns would diverge among compositional perspectives, with a greater distance decay at the species level than at the functional or phylogenetic levels. We tested these hypotheses in salt marshes of two regions: The southern Atlantic and Gulf Coasts of the United States. We examined the characteristics of plant community composition at each salt marsh site, how community similarity decayed with distance within individual salt marshes versus among sites in each region, and how community similarity differed among regions, using species, functional and phylogenetic perspectives. We found that results from the three compositional perspectives generally showed similar patterns: there was strong variation in community composition within individual salt marsh sites across elevation; in contrast, community similarity decayed with distance four to five orders of magnitude more slowly across sites within each region. Overall, community dissimilarity of salt marshes was lowest on the southern Atlantic Coast, intermediate on the Gulf Coast, and highest between the two regions. Our results indicated that local gradients are relatively more important than regional processes in structuring coastal salt marsh communities. Our results also suggested that in ecosystems with low species diversity, functional and phylogenetic approaches may not provide additional insight over a species-based approach.	[Guo, Hongyu; Elhaik, Eran; Jalli, Inder; Lynes, Alana-Rose; Marczak, Laurie; Sabath, Niv; Vargas, Amy; Wieski, Kazimierz; Zelig, Emily M.; Pennings, Steven C.] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [Chamberlain, Scott A.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX USA	University of Houston System; University of Houston; Rice University	Pennings, SC (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.	spennings@uh.edu	Elhaik, Eran/H-6838-2019; Pennings, Steven C/A-8326-2013	Elhaik, Eran/0000-0003-4795-1084; Pennings, Steven C/0000-0003-4757-7125; Marczak, Laurie/0000-0001-5979-4261	Environmental Institute of Houston; NSF [OCE06-20959, OCE12-37140, EF-0553768]; University of California, Santa Barbara; State of California; Division Of Ocean Sciences [1237140] Funding Source: National Science Foundation	Environmental Institute of Houston; NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The authors thank the Environmental Institute of Houston and the NSF (OCE06-20959; OCE12-37140) for funding. This work resulted from a Distributed Graduate Seminar (Ushering in a New Era of Functional Ecology: Dynamics in a Changing Environment), conducted through the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (EF-0553768), the University of California, Santa Barbara, and the State of California.	Adam P., 1990, SALTMARSH ECOLOGY; Astorga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P365, DOI 10.1111/j.1466-8238.2011.00681.x; Bahram M, 2013, J ECOL, V101, P1335, DOI 10.1111/1365-2745.12120; Baraloto C, 2012, J ECOL, V100, P690, DOI 10.1111/j.1365-2745.2012.01966.x; BERTNESS MD, 1991, ECOLOGY, V72, P138, DOI 10.2307/1938909; BERTNESS MD, 1987, ECOL MONOGR, V57, P129, DOI 10.2307/1942621; BERTNESS MD, 1991, ECOLOGY, V72, P125, DOI 10.2307/1938908; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chapman VJ, 1960, SALT MARSHES SALT DE; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Duckworth JC, 2000, PROG PHYS GEOG, V24, P515, DOI 10.1177/030913330002400403; ELEUTERIUS L N, 1976, Chesapeake Science, V17, P289, DOI 10.2307/1350516; ELEUTERIUS LN, 1979, B MAR SCI, V29, P394; Epstein HE, 2001, OIKOS, V95, P239, DOI 10.1034/j.1600-0706.2001.950206.x; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Garcillan PP, 2003, J VEG SCI, V14, P859, DOI 10.1111/j.1654-1103.2003.tb02219.x; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hubbell Stephen P., 2001, V32, pi; Judd FW, 2004, TEX J SCI, V56, P103; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Kunza AE, 2008, ESTUAR COAST, V31, P673, DOI 10.1007/s12237-008-9058-3; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Morlon H, 2008, ECOL LETT, V11, P904, DOI 10.1111/j.1461-0248.2008.01202.x; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; OKSANEN J, 2012, R PACKAGE VERSION, V2, P1, DOI DOI 10.3856/V0L41-ISSUEL-FULLTEXT-11; Pavoine S, 2013, J VEG SCI, V24, P781, DOI 10.1111/jvs.12051; Pennings SC, 2005, J ECOL, V93, P159, DOI 10.1111/j.1365-2745.2004.00959.x; Pennings SC, 2001, MARINE COMMUNITY ECOLOGY, P289; Purschke O, 2013, J ECOL, V101, P857, DOI 10.1111/1365-2745.12098; Rajaniemi TK, 2006, ECOL LETT, V9, P121, DOI 10.1111/j.1461-0248.2005.00855.x; Rasser MK, 2013, WETLANDS, V33, P575, DOI 10.1007/s13157-013-0398-9; Rowe N, 2005, NEW PHYTOL, V166, P61, DOI 10.1111/j.1469-8137.2004.01309.x; Stout J.P., 1984, US FISH WILDLIFE SER; Suchrow S, 2010, WETLANDS, V30, P735, DOI 10.1007/s13157-010-0073-3; Sullivan G, 1999, OIKOS, V84, P246, DOI 10.2307/3546719; Tessier M, 2002, J VEG SCI, V13, P115, DOI 10.1658/1100-9233(2002)013[0115:TROSTH]2.0.CO;2; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; USDA [ US Department of Agriculture], 2014, THE PLANTS DAT; VivianSmith G, 1997, J ECOL, V85, P71, DOI 10.2307/2960628; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Wiegert RG, 1990, US FISH WILDLIFE SER, V85, P1; ZETLER BD, 1970, B MAR SCI, V20, P57	51	7	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127781	10.1371/journal.pone.0127781	http://dx.doi.org/10.1371/journal.pone.0127781			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010135	Green Accepted, Green Published, gold			2022-12-26	WOS:000355183900144
J	Huan, YJ; Xie, BT; Liu, SC; Kong, QR; Liu, ZH				Huan, Yanjun; Xie, Bingteng; Liu, Shichao; Kong, Qingran; Liu, Zhonghua			A Novel Role for DNA Methyltransferase 1 in Regulating Oocyte Cytoplasmic Maturation in Pigs	PLOS ONE			English	Article							IN-VITRO MATURATION; DEVELOPMENTAL COMPETENCE; PREIMPLANTATION DEVELOPMENT; DNA METHYLTRANSFERASE-1; EMBRYONIC LETHALITY; DNMT1; LOCALIZATION; CELLS; METHYLATION; EXPRESSION	Maternal factors are required for oocyte maturation and embryo development. To better understand the role of DNA methyltransferase 1 (Dnmt1) in oocyte maturation and embryo development, small interfering RNA (siRNA) was conducted in porcine oocytes. In this study, our results showed that Dnmt1 localized in oocyte cytoplasm and its expression displayed no obvious change during oocyte maturation. When siRNAs targeting Dnmt1 were injected into germinal vesicle (GV) stage oocytes, Dnmt1 transcripts significantly decreased in matured oocytes (P<0.05). After Dnmt1 knockdown in GV stage oocytes, the significant reduction of glutathione content, mitochondrial DNA copy number, glucose-6-phosphate dehydrogenase activity and expression profiles of maternal factors and the severely disrupted distribution of cortical granules were observed in MII stage oocytes (P<0.05), leading to the impaired oocyte cytoplasm. Further study displayed that Dnmt1 knockdown in GV stage oocytes significantly reduced the development of early embryos generated through parthenogenetic activation, in vitro fertilization and somatic cell nuclear transfer (P< 0.05). In conclusion, Dnmt1 was indispensable for oocyte cytoplasmic maturation, providing a novel role for Dnmt1 in the regulation of oocyte maturation.	[Huan, Yanjun; Xie, Bingteng; Liu, Shichao; Kong, Qingran; Liu, Zhonghua] Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang Pr, Peoples R China; [Huan, Yanjun] Shandong Acad Agr Sci, Dairy Cattle Res Ctr, Jinan, Shandong, Peoples R China	Northeast Agricultural University - China; Shandong Academy of Agricultural Sciences	Liu, ZH (corresponding author), Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang Pr, Peoples R China.	liu086@126.com	Liu, Shichao/J-2954-2019; Liu, Zhonghua/AAO-3590-2021; Liu, Zhunghua/F-2485-2010	Liu, Shichao/0000-0002-4156-3876; Liu, Zhonghua/0000-0002-9199-6493; Liu, Zhunghua/0000-0002-9199-6493; , Yanjun/0000-0001-7334-4582	National Basic Research Program of China, Program 973 [2011CB944202]; National Natural Science Foundation of China, NSFC [31101035]; China Postdoctoral Science Foundation [2014M551943]; special foundation of Postdoctoral Innovation Project in Shandong Province of China [201402044]	National Basic Research Program of China, Program 973(National Basic Research Program of China); National Natural Science Foundation of China, NSFC(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); special foundation of Postdoctoral Innovation Project in Shandong Province of China	National Basic Research Program of China, Program 973 (2011CB944202) to ZHL, http://www.most.gov.cn/; National Natural Science Foundation of China, NSFC (31101035) to ZHL, http://www.nsfc.gov.cn/; China Postdoctoral Science Foundation (2014M551943) to YJH, http://bg.chinapostdoctor.org.cn/; the special foundation of Postdoctoral Innovation Project in Shandong Province of China (201402044) to YJH, http://www.sdhrss.gov.cn/cm/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biniszkiewicz D, 2002, MOL CELL BIOL, V22, P2124, DOI 10.1128/MCB.22.7.2124-2135.2002; Brevini TAL, 2007, ANIM REPROD SCI, V98, P23, DOI 10.1016/j.anireprosci.2006.10.018; Choi JY, 2013, J REPROD DEVELOP, V59, P450, DOI 10.1262/jrd.2012-134; Georgia S, 2013, GENE DEV, V27, P372, DOI 10.1101/gad.207001.112; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Huan YJ, 2013, J REPROD DEVELOP, V59, P442, DOI 10.1262/jrd.2013-026; Huan YJ, 2012, AGR SCI TECHNOLOGY, V13, P1368; Jeong YS, 2009, DEV DYNAM, V238, P1666, DOI 10.1002/dvdy.21975; Laget S, 2014, EPIGENETICS-US, V9, P546, DOI 10.4161/epi.27695; Lee SK, 2014, J REPROD DEVELOP, V60, P128, DOI 10.1262/jrd.2013-098; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lin SB, 2014, NAT CELL BIOL, V16, P129, DOI 10.1038/ncb2914; Lodde V, 2009, EUR J HISTOCHEM, V53, P199, DOI 10.4081/ejh.2009.e24; Luberda Zofia, 2005, Reprod Biol, V5, P5; Martin SE, 2007, ANNU REV GENOM HUM G, V8, P81, DOI 10.1146/annurev.genom.8.080706.092424; McGraw S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003873; Oliveri RS, 2007, REPRODUCTION, V134, P549, DOI 10.1530/REP-06-0315; Petrussa L, 2014, MOL HUM REPROD, V20, P861, DOI 10.1093/molehr/gau049; Ratnam S, 2002, DEV BIOL, V245, P304, DOI 10.1006/dbio.2002.0628; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Turek-Plewa J, 2005, CELL MOL BIOL LETT, V10, P631; Wang Q, 2007, REPROD FERT DEVELOP, V19, P1, DOI 10.1071/RD06103; Watson AJ, 2007, J ANIM SCI, V85, pE1, DOI 10.2527/jas.2006-432; Wei YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020154; Yamanaka K, 2011, J REPROD DEVELOP, V57, P393, DOI 10.1262/jrd.10-181A; Zhang X, 2010, J ANIM SCI, V88, P2604, DOI 10.2527/jas.2009-2714; Zhou P, 2010, BIOL REPROD, V82, P759, DOI 10.1095/biolreprod.109.082206; Zuccotti M, 2011, HUM REPROD UPDATE, V17, P525, DOI 10.1093/humupd/dmr009	29	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127512	10.1371/journal.pone.0127512	http://dx.doi.org/10.1371/journal.pone.0127512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009894	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900102
J	Gonzalez, G; Jimenez-Carretero, D; Rodriguez-Lopez, S; Kumamaru, KK; George, E; Estepar, RSJ; Rybicki, FJ; Ledesma-Carbayo, MJ				Gonzalez, German; Jimenez-Carretero, Daniel; Rodriguez-Lopez, Sara; Kumamaru, Kanako K.; George, Elizabeth; Estepar, Raul San Jose; Rybicki, Frank J.; Ledesma-Carbayo, Maria J.			Automated Axial Right Ventricle to Left Ventricle Diameter Ratio Computation in Computed Tomography Pulmonary Angiography	PLOS ONE			English	Article							HELICAL CT; EMBOLISM; DYSFUNCTION; ENLARGEMENT; PREDICTORS; MANAGEMENT; DEATH; SIGNS	Background and Purpose Right Ventricular to Left Ventricular (RV/LV) diameter ratio has been shown to be a prognostic biomarker for patients suffering from acute Pulmonary Embolism (PE). While Computed Tomography Pulmonary Angiography (CTPA) images used to confirm a clinical suspicion of PE do include information of the heart, a numerical RV/LV diameter ratio is not universally reported, likely because of lack in training, inter-reader variability in the measurements, and additional effort by the radiologist. This study designs and validates a completely automated Computer Aided Detection (CAD) system to compute the axial RV/LV diameter ratio from CTPA images so that the RV/LV diameter ratio can be a more objective metric that is consistently reported in patients for whom CTPA diagnoses PE. Materials and Methods The CAD system was designed specifically for RV/LV measurements. The system was tested in 198 consecutive CTPA patients with acute PE. Its accuracy was evaluated using reference standard RV/LV radiologist measurements and its prognostic value was established for 30-day PE-specific mortality and a composite outcome of 30-day PE-specific mortality or the need for intensive therapies. The study was Institutional Review Board (IRB) approved and HIPAA compliant. Results The CAD system analyzed correctly 92.4%(183/198) of CTPA studies. The mean difference between automated and manually computed axial RV/LV ratios was 0.03+/-0.22. The correlation between the RV/LV diameter ratio obtained by the CAD system and that obtained by the radiologist was high (r=0.81). Compared to the radiologist, the CAD system equally achieved high accuracy for the composite outcome, with areas under the receiver operating characteristic curves of 0.75 vs. 0.78. Similar results were found for 30-days PE-specific mortality, with areas under the curve of 0.72 vs. 0.75. Conclusions An automated CAD system for determining the CT derived RV/LV diameter ratio in patients with acute PE has high accuracy when compared to manual measurements and similar prognostic significance for two clinical outcomes.	[Gonzalez, German] MIT, Elect Res Lab, Madrid MIT M Vis Consortium, Cambridge, MA 02139 USA; [Jimenez-Carretero, Daniel; Rodriguez-Lopez, Sara; Ledesma-Carbayo, Maria J.] Univ Politecn Madrid, Biomed Image Technol, Madrid, Spain; [Jimenez-Carretero, Daniel; Rodriguez-Lopez, Sara; Ledesma-Carbayo, Maria J.] CIBER BBN, Madrid, Spain; [Kumamaru, Kanako K.; George, Elizabeth; Rybicki, Frank J.] Brigham & Womens Hosp, Appl Imaging Sci Lab, Boston, MA 02115 USA; [Gonzalez, German; Estepar, Raul San Jose] Brigham & Womens Hosp, Surg Planning Lab, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Universidad Politecnica de Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Gonzalez, G (corresponding author), MIT, Elect Res Lab, Madrid MIT M Vis Consortium, Cambridge, MA 02139 USA.	ggonzale@mit.edu	San Jose Estepar, Raul/AAQ-5657-2020; George, Elizabeth/J-9008-2017; Gonzalez, Germán/G-8677-2019; Ledesma-Carbayo, Maria J/D-5529-2009	San Jose Estepar, Raul/0000-0002-3677-1996; George, Elizabeth/0000-0003-3141-5738; Gonzalez, Germán/0000-0001-9694-0766; Ledesma-Carbayo, Maria J/0000-0001-6846-3923; Jimenez-Carretero, Daniel/0000-0001-7858-1907	Comunidad de Madrid, Spain through the Madrid-MIT M+Vision Consortium; FPU grant by the Spain's Ministry of Education	Comunidad de Madrid, Spain through the Madrid-MIT M+Vision Consortium(Comunidad de Madrid); FPU grant by the Spain's Ministry of Education	This project has been financially supported by the Comunidad de Madrid, Spain through the Madrid-MIT M+Vision Consortium. Daniel Jimenez was supported by an FPU grant by the Spain's Ministry of Education.	Agnelli G, 2010, NEW ENGL J MED, V363, P266, DOI 10.1056/NEJMra0907731; Breuninger M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106381; Collomb D, 2003, EUR RADIOL, V13, P1508, DOI 10.1007/s00330-002-1804-5; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Felzenszwalb PF, 2010, PROC CVPR IEEE, P2241, DOI 10.1109/CVPR.2010.5539906; George E, 2014, J THORAC IMAG, V29, pW7, DOI 10.1097/RTI.0000000000000048; Ghaye B, 2006, RADIOLOGY, V239, P884, DOI 10.1148/radiol.2392050075; Goldhaber SZ, 2009, J THROMB HAEMOST, V7, P322, DOI 10.1111/j.1538-7836.2009.03415.x; Goldhaber SZ, 2003, CIRCULATION, V108, P2726, DOI 10.1161/01.CIR.0000097829.89204.0C; Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; Jimenez-Carretero D, 2011, IEEE ENG MED BIO, P3419, DOI 10.1109/IEMBS.2011.6090925; Kang DK, 2011, JACC-CARDIOVASC IMAG, V4, P841, DOI 10.1016/j.jcmg.2011.04.013; Kang DK, 2010, AM J ROENTGENOL, V194, P1500, DOI 10.2214/AJR.09.3717; Kumamaru KK, 2013, INT J CARDIOVAS IMAG, V29, P705, DOI 10.1007/s10554-012-0126-1; Kumamaru KK, 2012, J THORAC IMAG, V27, P331, DOI 10.1097/RTI.0b013e3182350a35; Kumamaru KK, 2012, INT J CARDIOVAS IMAG, V28, P965, DOI 10.1007/s10554-011-9903-5; Lu MT, 2012, AM J ROENTGENOL, V198, P1353, DOI 10.2214/AJR.11.7439; Lu MT, 2009, INT J CARDIOVAS IMAG, V25, P101, DOI 10.1007/s10554-008-9342-0; Marx V, 2013, NATURE, V498, P255, DOI 10.1038/498255a; Ozsu S, 2010, THROMB RES, V126, P486, DOI 10.1016/j.thromres.2010.08.021; Reid JH, 1998, CLIN RADIOL, V53, P694, DOI 10.1016/S0009-9260(98)80297-3; Rodriguez-Lopez S, 2015, TO APPEAR ON INT SYM; Santos EMM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101985; Schoepf UJ, 2004, CIRCULATION, V110, P3276, DOI 10.1161/01.CIR.0000147612.59751.4C; Tapson VF, 2013, SEMIN THROMB HEMOST, V39, P452, DOI 10.1055/s-0033-1334145; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; van der Meer RW, 2005, RADIOLOGY, V235, P798, DOI 10.1148/radiol.2353040593; Wake N, 2014, J THORAC IMAG, V29, pW1, DOI 10.1097/RTI.0000000000000047; Wittenberg R, 2012, EUR J RADIOL, V81, P218, DOI 10.1016/j.ejrad.2011.01.041	29	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127797	10.1371/journal.pone.0127797	http://dx.doi.org/10.1371/journal.pone.0127797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000632	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000354931700085
J	Hua, W; Huang, HZ; Tan, LT; Wan, JM; Gui, HB; Zhao, L; Ruan, XZ; Chen, XM; Du, XG				Hua, Wei; Huang, Hui-zhe; Tan, Lan-ting; Wan, Jiang-min; Gui, Hai-bo; Zhao, Liang; Ruan, Xiong-zhong; Chen, Xue-mei; Du, Xiao-gang			CD36 Mediated Fatty Acid-Induced Podocyte Apoptosis via Oxidative Stress	PLOS ONE			English	Article							SCAVENGER RECEPTOR CD36; MEMBRANE-PROTEINS; PROGRESSION; HYPERLIPIDEMIA; EXPRESSION; CELLS	Background Hyperlipidemia-induced apoptosis mediated by fatty acid translocase CD36 is associated with increased uptake of ox-LDL or fatty acid in macrophages, hepatocytes and proximal tubular epithelial cells, leading to atherosclerosis, liver damage and fibrosis in obese patients, and diabetic nephropathy (DN), respectively. However, the specific role of CD36 in podocyte apoptosis in DN with hyperlipidemia remains poorly investigated. Methods The expression of CD36 was measured in paraffin-embedded kidney tissue samples (Ctr = 18, DN = 20) by immunohistochemistry and immunofluorescence staining. We cultured conditionally immortalized mouse podocytes (MPC5) and treated cells with palmitic acid, and measured CD36 expression by real-time PCR, Western blot analysis and immunofluorescence; lipid uptake by Oil red O staining and BODIPY staining; apoptosis by flow cytometry assay, TUNEL assay and Western blot analysis; and ROS production by DCFH-DA fluorescence staining. All statistical analyses were performed using SPSS 21.0 statistical software. Results CD36 expression was increased in kidney tissue from DN patients with hyperlipidemia. Palmitic acid upregulated CD36 expression and promoted its translocation from cytoplasm to plasma membrane in podocytes. Furthermore, palmitic acid increased lipid uptake, ROS production and apoptosis in podocytes, Sulfo-N-succinimidyloleate (SSO), the specific inhibitor of the fatty acid binding site on CD36, decreased palmitic acid-induced fatty acid accumulation, ROS production, and apoptosis in podocytes. Antioxidant 4-hydroxy-2,2,6,6-tetramethylpiperidine -1-oxyl (tempol) inhibited the overproduction of ROS and apoptosis in podocytes induced by palmitic acid. Conclusions CD36 mediated fatty acid-induced podocyte apoptosis via oxidative stress might participate in the process of DN.	[Hua, Wei; Wan, Jiang-min; Du, Xiao-gang] Chongqing Med Univ, Affiliated Hosp 1, Dept Nephrol, Chongqing 400042, Peoples R China; [Huang, Hui-zhe; Zhao, Liang] Chongqing Med Univ, Fac Basic Med Sci, Chongqing 400016, Peoples R China; [Tan, Lan-ting; Gui, Hai-bo; Chen, Xue-mei] Chongqing Med Univ, Affiliated Hosp 1, Emergency Dept, Chongqing 400042, Peoples R China; [Ruan, Xiong-zhong] UCL, Royal Free & Univ Coll Med Sch, Ctr Nephrol, London NW3 2PF, England; [Ruan, Xiong-zhong] Chongqing Med Univ, Minist Educ, Ctr Lipid Res, Key Lab Mol Biol Infect Dis, Chongqing 400042, Peoples R China; [Du, Xiao-gang] Chongqing Med Univ, Affiliated Hosp 1, Lab Lipid & Glucose Metab, Chongqing 400042, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; University of London; University College London; Chongqing Medical University; Chongqing Medical University	Chen, XM (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Emergency Dept, Youyi Rd 1, Chongqing 400042, Peoples R China.	1557451771@qq.com; dxgcxm@163.com	Ruan, Xiong Zhong/GZA-5963-2022	Ruan, Xiong Zhong/0000-0001-5199-4971	National Natural Science Foundation of China [81370816, 81202318]; Natural Science Foundation of Chongqing Science and Technology Commission of China [cstc2012jjA10136]; Chongqing Municipal Health Bureau of China [2011-1-016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing Science and Technology Commission of China; Chongqing Municipal Health Bureau of China	This work was supported by grants from the National Natural Science Foundation of China (No. 81370816), the Natural Science Foundation of Chongqing Science and Technology Commission of China (No. cstc2012jjA10136) and Chongqing Municipal Health Bureau of China (No. 2011-1-016) to X. Du, and the National Natural Science Foundation of China (No. 81202318) to X. Chen.	Abumrad N, 1999, BBA-MOL CELL BIOL L, V1441, P4, DOI 10.1016/S1388-1981(99)00137-7; Affar EB, 2001, J BIOL CHEM, V276, P2935, DOI 10.1074/jbc.M007269200; ARAUJO FB, 1995, ATHEROSCLEROSIS, V117, P61, DOI 10.1016/0021-9150(94)05558-Z; Bechmann LP, 2010, LIVER INT, V30, P850, DOI 10.1111/j.1478-3231.2010.02248.x; Bicu Mihaela, 2010, Rom J Intern Med, V48, P307; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Calcutt NA, 2009, NAT REV DRUG DISCOV, V8, P417, DOI 10.1038/nrd2476; Garini G, 1989, Ann Ital Med Int, V4, P184; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Grauntanu Corina, 2010, Rom J Intern Med, V48, P313; HARMON CM, 1993, J MEMBRANE BIOL, V133, P43; Hoosdally SJ, 2009, J BIOL CHEM, V284, P16277, DOI 10.1074/jbc.M109.007849; Ibrahimi A, 1996, P NATL ACAD SCI USA, V93, P2646, DOI 10.1073/pnas.93.7.2646; Ichikawa L, 2005, CURR OPIN NEPHROL HY, V14, P205; Kashyap SR, 2009, OBESITY, V17, P2142, DOI 10.1038/oby.2009.179; KEESFOLTS D, 1993, AM J NEPHROL, V13, P365, DOI 10.1159/000168651; Kikkawa R, 2003, AM J KIDNEY DIS, V41, pS19, DOI 10.1053/ajkd.2003.50077; Kriz W, 2002, MICROSC RES TECHNIQ, V57, P189, DOI 10.1002/jemt.10072; Kumar PA, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00151; Le Lay S, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/908539; Pohl J, 2005, MOL BIOL CELL, V16, P24, DOI 10.1091/mbc.E04-07-0616; Ruggenenti P, 2010, NAT REV NEPHROL, V6, P319, DOI 10.1038/nrneph.2010.58; Seimon TA, 2010, CELL METAB, V12, P467, DOI 10.1016/j.cmet.2010.09.010; Solano Maria P, 2006, Cardiol Rev, V14, P125, DOI 10.1097/01.crd.0000188034.76283.5e; Srivastava SP, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-12; STENVINKEL P, 1989, J INTERN MED, V226, P183, DOI 10.1111/j.1365-2796.1989.tb01377.x; Susztak K, 2005, PLOS MED, V2, P152, DOI 10.1371/journal.pmed.0020045; THABET MAEH, 1993, PEDIATR NEPHROL, V7, P559; WHEELER DC, 1994, AM J KIDNEY DIS, V23, P331, DOI 10.1016/S0272-6386(12)80994-2; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Xie CH, 2011, IMMUNOL LETT, V137, P15, DOI 10.1016/j.imlet.2011.01.015; Yang ZH, 2011, CARDIOVASC RES, V89, P485, DOI 10.1093/cvr/cvq406; Yasuda M, 2014, BBA-MOL BASIS DIS, V1842, P1097, DOI 10.1016/j.bbadis.2014.04.001; Yukawa S, 1999, KIDNEY INT, V56, pS141	34	86	94	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127507	10.1371/journal.pone.0127507	http://dx.doi.org/10.1371/journal.pone.0127507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000608	Green Published, gold, Green Submitted			2022-12-26	WOS:000354931700063
J	Schemionek, M; Masouleh, BK; Klaile, Y; Krug, U; Hebestreit, K; Schubert, C; Dugas, M; Buchner, T; Wormann, B; Hiddemann, W; Berdel, WE; Brummendorf, TH; Muller-Tidow, C; Koschmieder, S				Schemionek, Mirle; Masouleh, Behzad Kharabi; Klaile, Yvonne; Krug, Utz; Hebestreit, Katja; Schubert, Claudia; Dugas, Martin; Buechner, Thomas; Woermann, Bernhard; Hiddemann, Wolfgang; Berdel, Wolfgang E.; Bruemmendorf, Tim H.; Mueller-Tidow, Carsten; Koschmieder, Steffen			Identification of the Adapter Molecule MTSS1 as a Potential Oncogene-Specific Tumor Suppressor in Acute Myeloid Leukemia	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; METASTASIS; EXPRESSION; GENE; MIM; CONTRIBUTES; MUTATIONS; REMISSION; MIM/MTSS1	The adapter protein metastasis suppressor 1 (MTSS1) is implicated as a tumor suppressor or tumor promoter, depending on the type of solid cancer. Here, we identified Mtss1 expression to be increased in AML subsets with favorable outcome, while suppressed in high risk AML patients. High expression of MTSS1 predicted better clinical outcome of patients with normal-karyotype AML. Mechanistically, MTSS1 expression was negatively regulated by FLT3-ITD signaling but enhanced by the AML1-ETO fusion protein. DNMT3B, a negative regulator of MTSS1, showed strong binding to the MTSS1 promoter in PML-RARA positive but not AML1-ETO positive cells, suggesting that AML1-ETO leads to derepression of MTSS1. Pharmacological treatment of AML cell lines carrying the FLT3-ITD mutation with the specific FLT3 inhibitor PKC-412 caused upregulation of MTSS1. Moreover, treatment of acute promyelocytic cells (APL) with all-trans retinoic acid (ATRA) increased MTSS1 mRNA levels. Taken together, our findings suggest that MTSS1 might have a context-dependent function and could act as a tumor suppressor, which is pharmacologically targetable in AML patients.	[Schemionek, Mirle; Masouleh, Behzad Kharabi; Schubert, Claudia; Bruemmendorf, Tim H.; Koschmieder, Steffen] Rhein Westfal TH Aachen, Fac Med, Dept Hematol Oncol Hemostaseol & Stem Cell Transp, Aachen, Germany; [Klaile, Yvonne] Univ Munster, Dept Urol, D-48149 Munster, Germany; [Krug, Utz; Buechner, Thomas; Berdel, Wolfgang E.; Mueller-Tidow, Carsten] Univ Munster, Dept Med A, Hematol, Oncol,Pneumol, D-48149 Munster, Germany; [Hebestreit, Katja; Dugas, Martin] Univ Munster, Inst Med Informat, D-48149 Munster, Germany; [Hiddemann, Wolfgang] Univ Munich, Dept Internal Med 3, Munich, Germany; [Hiddemann, Wolfgang] Helmholtz Zentrum Munich, Clin Cooperat Grp Acute Myeloid Leukemia, German Res Ctr Environm Hlth, Munich, Germany	RWTH Aachen University; University of Munster; University of Munster; University of Munster; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Koschmieder, S (corresponding author), Rhein Westfal TH Aachen, Fac Med, Dept Hematol Oncol Hemostaseol & Stem Cell Transp, Aachen, Germany.	skoschmieder@ukaachen.de	Müller-Tidow, Carsten/O-7207-2018	Müller-Tidow, Carsten/0000-0002-7166-5232; Koschmieder, Steffen/0000-0002-1011-8171	German Research Foundation (DFG) [KO 2155/2-2]; German Jose Carreras Leukemia Foundation (DJCLS) [10/23]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Jose Carreras Leukemia Foundation (DJCLS)	Steffen Koschmieder has received grant funding from the German Research Foundation (DFG KO 2155/2-2) and the German Jose Carreras Leukemia Foundation (DJCLS grant 10/23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunet S, 2012, J CLIN ONCOL, V30, P735, DOI 10.1200/JCO.2011.36.9868; Corsello SM, 2009, BLOOD, V113, P6193, DOI 10.1182/blood-2008-07-166090; Du Peng, 2012, J Exp Ther Oncol, V10, P91; Fan H, 2012, ONCOGENE, V31, P2298, DOI 10.1038/onc.2011.411; FENAUX P, 1992, BLOOD, V80, P2176; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hayette S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051527; Hebestreit K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039148; Hirata H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055502; Isaksson HS, 2014, ONCOTARGET, V5, P4040, DOI 10.18632/oncotarget.1938; Jost E, 2014, LEUKEMIA, V28, P1227, DOI 10.1038/leu.2013.362; Kihara R, 2014, LEUKEMIA, V28, P1586, DOI 10.1038/leu.2014.55; Krejci O, 2008, BLOOD, V111, P2190, DOI 10.1182/blood-2007-06-093682; Lee YG, 2002, NEOPLASIA, V4, P291, DOI 10.1038/sj.neo.7900231; Liu K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-428; Liu SP, 2012, J HEPATOL, V56, P389, DOI 10.1016/j.jhep.2011.08.008; Liu ZJ, 2012, J PATHOL, V228, P204, DOI 10.1002/path.4000; Loberg RD, 2005, INT J ONCOL, V26, P1699; Machesky LM, 2007, J MOL MED-JMM, V85, P569, DOI 10.1007/s00109-007-0207-0; Mertz KD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4465; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Parr C, 2009, EUR J CANCER, V45, P1673, DOI 10.1016/j.ejca.2009.02.019; Saarikangas J, 2011, J CELL SCI, V124, P1245, DOI 10.1242/jcs.082610; TESTA U, 1994, CANCER RES, V54, P4508; Utikal J, 2006, INT J CANCER, V119, P2287, DOI 10.1002/ijc.22106; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Wang D, 2011, J GASTROINTEST SURG, V15, P1205, DOI 10.1007/s11605-011-1546-2; Wang J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-227; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Wiernik Peter H, 2010, Clin Adv Hematol Oncol, V8, P429; Wu WY, 2014, MOL CELL BIOCHEM, V388, P249, DOI 10.1007/s11010-013-1916-z; Xie F, J TRANSL MED, V9, P95; Xie Fei, 2011, Front Biosci (Schol Ed), V3, P621, DOI 10.2741/s175; Yu D, 2012, ONCOGENE, V31, P3561, DOI 10.1038/onc.2011.509; Zhou WW, 2012, ACTA BIOCH BIOPH SIN, V44, P838, DOI 10.1093/abbs/gms071	37	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0125783	10.1371/journal.pone.0125783	http://dx.doi.org/10.1371/journal.pone.0125783			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996952	Green Published, Green Submitted, gold			2022-12-26	WOS:000356444000013
J	Peecook, BR; Sidor, CA				Peecook, Brandon R.; Sidor, Christian A.			The First Dinosaur from Washington State and a Review of Pacific Coast Dinosaurs from North America	PLOS ONE			English	Article							CRETACEOUS NANAIMO GROUP; BRITISH-COLUMBIA; BAJA-CALIFORNIA; CARCHARODONTOSAURID DINOSAURIA; HADROSAURIAN DINOSAUR; EARLY DIVERSIFICATION; MARINE-SEDIMENTS; FOSSIL BIRDS; THEROPODA; ISLAND	We describe the first diagnostic dinosaur fossil from Washington State. The specimen, which consists of a proximal left femur, was recovered from the shallow marine rocks of the Upper Cretaceous (Campanian) Cedar District Formation (Nanaimo Group) and is interpreted as pertaining to a large theropod on the basis of its hollow medullary cavity and proximally placed fourth trochanter. The Washington theropod represents one of the northernmost occurrences of a Mesozoic dinosaur on the west coast of the United States and one of only a handful from the Pacific coast of Laramidia during the Cretaceous. Its isolated nature and preservation in marine rocks suggest that the element was washed in from a nearby fluvial system. If the femur pertains to a tyrannosauroid, which seems likely given its size and the widespread occurrence of the group across Laramidia during Late Cretaceous times, then it would represent an earlier occurrence of large body size than previously recognized (complete femur length estimated at 1.2 meters). Uncertainty surrounding the latitude of deposition of the Nanaimo Group (i.e., the Baja-British Columbia hypothesis) precludes assigning the Washington theropod to either of the putative northern or southern biogeographic provinces of Laramidia.	[Peecook, Brandon R.; Sidor, Christian A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Peecook, Brandon R.; Sidor, Christian A.] Univ Washington, Burke Museum, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Sidor, CA (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	casidor@uw.edu		Peecook, Brandon/0000-0002-0566-1487	University of Washington Burke Museum	University of Washington Burke Museum(University of Washington)	The University of Washington Burke Museum provided funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell PR, 2010, CAN J EARTH SCI, V47, P1417, DOI 10.1139/E10-062; Brochu CA, 2003, J VERTEBR PALEONTOL, V22, P1, DOI [10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947, 10.2307/3889334, DOI 10.2307/3889334]; Brodkorb P., 1976, Smithsonian Contributions to Paleobiology, VNo. 27, P67; Brusatte SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1815; Brusatte SL, 2010, SCIENCE, V329, P1481, DOI 10.1126/science.1193304; Brusatte SL, 2009, NATURWISSENSCHAFTEN, V96, P1051, DOI 10.1007/s00114-009-0565-2; Bullard T, 1999, BRITISH COLUMBIA PAL, V22, P11; CARPENTER K, 1995, J VERTEBR PALEONTOL, V15, P275, DOI 10.1080/02724634.1995.10011230; Carr TD, 2011, NATURWISSENSCHAFTEN, V98, P241, DOI 10.1007/s00114-011-0762-7; Carr TD, 2010, J VERTEBR PALEONTOL, V30, P1, DOI 10.1080/02724630903413032; Carrano M.T., 1998, THESIS; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; Carrano MT, 2002, J VERTEBR PALEONTOL, V22, P510, DOI 10.1671/0272-4634(2002)022[0510:TOOMKA]2.0.CO;2; Choiniere JN, 2012, J AFR EARTH SCI, V71-72, P1, DOI 10.1016/j.jafrearsci.2012.05.005; Clark JM, 2004, DINOSAURIA, 2ND EDITION, P151; Coombs WP, 1996, J PALEONTOL, V70, P311, DOI 10.1017/S0022336000023404; Coria RA, 2006, GEODIVERSITAS, V28, P71; CORIA RA, 1995, NATURE, V377, P224, DOI 10.1038/377224a0; Cowan DS, 1997, AM J SCI, V297, P117, DOI 10.2475/ajs.297.2.117; Currie PJ, 2005, LIFE O PAST, P367; Currie Philip J., 2000, Geodiversitas, V22, P207; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Dyke G, 2011, CAN J EARTH SCI, V48, P1489, DOI 10.1139/E11-050; Dzik J, 2003, J VERTEBR PALEONTOL, V23, P556, DOI 10.1671/A1097; Enkin RJ, 2001, CAN J EARTH SCI, V38, P1403, DOI 10.1139/e01-031; Farke AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112055; Fiorillo A.R., 1990, Journal of Vertebrate Paleontology, V10, P515; Ford TL, 2001, LIFE O PAST, P239; GANGLOFF RA, 1995, J VERTEBR PALEONTOL, V15, P195, DOI 10.1080/02724634.1995.10011218; Haggart JW, 2005, CAN J EARTH SCI, V42, P2001, DOI 10.1139/E05-066; HAGGART JW, 1989, J PALEONTOL, V63, P218, DOI 10.1017/S0022336000019247; Hernandez-Rivera R., 1997, ENCY DINOSAURS, P433; Hilton R.P., 1999, CALIFORNIA GEOLOGY, V52, P4; Hilton RP, 1997, J VERTEBR PALEONTOL, V17, P557, DOI 10.1080/02724634.1997.10011002; Hilton RP, 2003, DINOSAURS AND OTHER; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; HORNER JR, 1979, J PALEONTOL, V53, P566; Hutchinson JR, 2001, ZOOL J LINN SOC-LOND, V131, P169, DOI 10.1006/zjls.2000.0267; Juárez Valieri Rubén D., 2010, Rev. Mus. Argent. Cienc. Nat., V12, P217; Kellner AWA, 2011, AN ACAD BRAS CIENC, V83, P99, DOI 10.1590/S0001-37652011000100006; Kim BY, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002696; Kirkland JI, 2005, NATURE, V435, P84, DOI 10.1038/nature03468; Kirkland JI, 2001, J VERTEBR PALEONTOL, V21, P410, DOI 10.1671/0272-4634(2001)021[0410:FDTDTF]2.0.CO;2; Lamanna MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092022; Lambe L., 1914, Ottawa Naturalist, V28; Lambe L.M, 1902, GEOLOGICAL SURVEY CA, V3, P25; Lee YN, 2014, NATURE, V515, P257, DOI 10.1038/nature13874; Lehman TM, 1997, DIN INT P S SPONS AR, P233; Liggett Gregory A., 2005, Transactions of the Kansas Academy of Science, V108, P1, DOI 10.1660/0022-8443(2005)108[0001:AROTDF]2.0.CO;2; Loewen MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079420; Longrich NR, 2013, B PEABODY MUS NAT HI, V54, P23, DOI 10.3374/014.054.0102; Ludvigsen Rolf, 1996, P156; Ludvisgen R, 1994, WEST COAST FOSSILS; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P137; Marsh O. C., 1890, American Journal of Science (3), Vxxxix, P81; Marsh O.C., 1872, AM J SCI, V3, P301; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; MOLNAR RE, 1974, J PALEONTOL, V48, P1009; Morris W.J., 1968, NATL GEOGRAPHIC SOC, P195; Morris W. J., 1973, NATL GEOGRAPHIC SOC, P197; MORRIS WJ, 1981, J PALEONTOL, V55, P453; MORRIS WJ, 1972, J PALEONTOL, V46, P777; MORRIS WJ, 1967, SCIENCE, V155, P1539, DOI 10.1126/science.155.3769.1539; MORRIS WJ, 1973, J PALEONTOL, V47, P551; Morris WJ, 1982, LATE CRETACEOUS DEPO, P89; Morrison K, 2005, CAN J EARTH SCI, V42, P2097, DOI 10.1139/E05-081; Muller J.E., 1970, GEOLOGICAL SURVEY CA, V69-25, P1, DOI DOI 10.4095/102353; Mustard P.S., 1994, GEOLOGY GEOLOGIC HAZ, V481, P27, DOI [DOI 10.4095/203246, 10.4095/203246]; Nesbitt SJ, 2010, NATURE, V464, P95, DOI 10.1038/nature08718; Nicholls EL, 2002, CAN J EARTH SCI, V39, P1591, DOI 10.1139/E02-075; Novas FE, 1998, J VERTEBR PALEONTOL, V18, P4, DOI 10.1080/02724634.1998.10011030; Novas FE, 2008, CRETACEOUS RES, V29, P468, DOI 10.1016/j.cretres.2008.01.001; Novas FE, 2013, CRETACEOUS RES, V45, P174, DOI 10.1016/j.cretres.2013.04.001; Orr EL, 2009, OREGON FOSSILS; Ostrom JH., 1970, PEABODY MUSEUM B, V35, P1; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; Pasch AD, 1997, SHORT NOTES ALASKA G, V1997, P99; Pasch Anne D., 2001, P219; Peecook BR, 2014, ACTA PALAEONTOL POL, V59, P71, DOI 10.4202/app.2012.0003; Pol D, 2012, P ROY SOC B-BIOL SCI, V279, P3170, DOI 10.1098/rspb.2012.0660; Prieto-Marquez A, 2015, GEOL MAG, V152, P225, DOI 10.1017/S0016756814000284; Prieto-Marquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038207; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Prieto-Marquez A, 2010, J VERTEBR PALEONTOL, V30, P813, DOI 10.1080/02724631003763508; R Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Rivera-Sylva H., 2014, DINOSAURS OTHER REPT, P156; Rivera-Sylva H., 2014, DINOSAURS OTHER REPT, P143; Rivera-Sylva HE, 2006, STUDIES ON MEXICAN P; Rivera-Sylva HE, 2011, REV MEX CIENC GEOL, V28, P371; Russell D. A., 1970, Publs Palaeont. nat. Mus. Canada, VNo. 1, P1; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Sereno P.C., 2008, PLOS ONE, V3; Stinnesbeck W., 2014, DINOSAURS OTHER REPT, V13-29, P13; STOVALL JW, 1950, AM MIDL NAT, V43, P696, DOI 10.2307/2421859; Stromer E, 1915, MATHEMATISCH PHYSIKA, V28, P1; Tanke D.H., 1984, FOSSILS Q, V3, P19; Tortosa T, 2014, ANN PALEONTOL, V100, P63, DOI 10.1016/j.annpal.2013.10.003; Vavrek MJ, 2010, P NATL ACAD SCI USA, V107, P8265, DOI 10.1073/pnas.0913645107; WARD PD, 1978, CAN J EARTH SCI, V15, P405, DOI 10.1139/e78-045; Ward PD, 1997, SCIENCE, V277, P1642, DOI 10.1126/science.277.5332.1642; WARD PD, 1978, J PALEONTOL, V52, P1143; WARD PD, 1976, J PALEONTOL, V50, P454; Ward PD, 2012, GEOL SOC AM BULL, V124, P957, DOI 10.1130/B30077.1; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P517; Weishampel DB, 1996, DINOSAURS OF THE EAS; Wilson JA, 1999, PALEOBIOLOGY, V25, P252, DOI 10.1017/S0094837300026543; WYNNE PJ, 1995, J GEOPHYS RES-SOL EA, V100, P6073, DOI 10.1029/94JB02643; Xu X, 2007, NATURE, V447, P844, DOI 10.1038/nature05849; Zanno LE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3827; Zanno LE, 2010, J SYST PALAEONTOL, V8, P503, DOI 10.1080/14772019.2010.488045; Zhang Xiao-Hong, 2001, Vertebrata Palasiatica, V39, P282	112	8	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127792	10.1371/journal.pone.0127792	http://dx.doi.org/10.1371/journal.pone.0127792			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993090	Green Submitted, Green Published, gold			2022-12-26	WOS:000354921400136
J	Schwarz, MK; Scherbarth, A; Sprengel, R; Engelhardt, J; Theer, P; Giese, G				Schwarz, Martin K.; Scherbarth, Annemarie; Sprengel, Rolf; Engelhardt, Johann; Theer, Patrick; Giese, Guenter			Fluorescent-Protein Stabilization and HighResolution Imaging of Cleared, Intact Mouse Brains	PLOS ONE			English	Article							EXPRESSION; RECONSTRUCTION; SINGLE; DENATURATION; PROMOTERS; ALCOHOLS; NEURONS; TISSUE; INPUTS	In order to observe and quantify long-range neuronal connections in intact mouse brain by light microscopy, it is first necessary to clear the brain, thus suppressing refractive-index variations. Here we describe a method that clears the brain and preserves the signal from proteinaceous fluorophores using a pH-adjusted non-aqueous index-matching medium. Successful clearing is enabled through the use of either 1-propanol or tert-butanol during dehydration whilst maintaining a basic pH. We show that high-resolution fluorescence imaging of entire, structurally intact juvenile and adult mouse brains is possible at subcellular resolution, even following many months in clearing solution. We also show that axonal longrange projections that are EGFP-labelled by modified Rabies virus can be imaged throughout the brain using a purpose-built light-sheet fluorescence microscope. To demonstrate the viability of the technique, we determined a detailed map of the monosynaptic projections onto a target cell population in the lateral entorhinal cortex. This example demonstrates that our method permits the quantification of whole-brain connectivity patterns at the subcellular level in the uncut brain.	[Schwarz, Martin K.; Scherbarth, Annemarie; Sprengel, Rolf; Giese, Guenter] Max Planck Inst Med Res, D-69120 Heidelberg 1, Germany; [Engelhardt, Johann] German Canc Res Ctr, Heidelberg, Germany; [Theer, Patrick] Heidelberg Univ, Ctr Mol Biol ZMBH, Heidelberg, Germany	Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Giese, G (corresponding author), Max Planck Inst Med Res, Jahnstr 29, D-69120 Heidelberg 1, Germany.	Guenter.Giese@mpimf-heidelberg.mpg.de		Sprengel, Rolf/0000-0003-3370-0970	Deutsche Forschungsgemeinschaft [SCH 15578/1-1, SFB 1089 (P02)]; Max-Plank Society, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Plank Society, Germany(Max Planck Society)	This work was supported by Grants SCH 15578/1-1 and SFB 1089 (P02) by Deutsche Forschungsgemeinschaft (www.dfg.de) to MKS and by general funding by the Max-Plank Society, Germany (www.mpg.de) to GG, AS, MKS, and RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; BULL HB, 1978, BIOPOLYMERS, V17, P2121, DOI 10.1002/bip.1978.360170907; Cetin A, 2006, NAT PROTOC, V1, P3166, DOI 10.1038/nprot.2006.450; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; DENT JA, 1989, DEVELOPMENT, V105, P61; Deshpande A, 2013, P NATL ACAD SCI USA, V110, pE1152, DOI 10.1073/pnas.1218991110; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Enoki S, 2004, BIOCHEMISTRY-US, V43, P14238, DOI 10.1021/bi048733+; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Galster H, 1991, PH MEASUREMENT FUNDA; Goldberg IG, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r47; Halassa MM, 2009, NEUROPHARMACOLOGY, V57, P343, DOI 10.1016/j.neuropharm.2009.06.031; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; HERSKOVI.TT, 1970, J BIOL CHEM, V245, P2588; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Huisken J, 2007, OPT LETT, V32, P2608, DOI 10.1364/OL.32.002608; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Kerr KM, 2007, HIPPOCAMPUS, V17, P697, DOI 10.1002/hipo.20315; Krestel HE, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e39; Krzisch M, 2014, BRAIN STRUCT FUNCT; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Mertz J, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3324890; Moser EIW M. P., 2013, HANDBOOK OF BRAIN MI, P175; Niedworok CJ, 2012, CELL REP, V2, P1375, DOI 10.1016/j.celrep.2012.10.008; Oberto A, 2007, EUR J NEUROSCI, V26, P155, DOI 10.1111/j.1460-9568.2007.05631.x; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Rasband WS, 1997, IMAGEJ; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Schellinger AP, 2004, LC GC N AM, V22, P544; Shevtsova Z, 2005, EXP PHYSIOL, V90, P53, DOI 10.1113/expphysiol.2004.028159; Spalteholz W., 1914, DURCHSICHTIGMACHEN M; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Vettenburg T, 2014, NAT METHODS, V11, P541, DOI [10.1038/NMETH.2922, 10.1038/nmeth.2922]; Vivar C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2101; VOIE AH, 1993, J MICROSC-OXFORD, V170, P229, DOI 10.1111/j.1365-2818.1993.tb03346.x; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Zhu PX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000533; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996	44	116	118	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0124650	10.1371/journal.pone.0124650	http://dx.doi.org/10.1371/journal.pone.0124650			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993380	Green Published, Green Submitted, gold			2022-12-26	WOS:000354921400020
J	van der Kallen, LR; Eggers, R; Ehlert, EM; Verhaagen, J; Smit, AB; van Kesteren, RE				van der Kallen, Loek R.; Eggers, Ruben; Ehlert, Erich M.; Verhaagen, Joost; Smit, August B.; van Kesteren, Ronald E.			Genetic Deletion of the Transcriptional Repressor NFIL3 Enhances Axon Growth In Vitro but Not Axonal Repair In Vivo	PLOS ONE			English	Article							PERIPHERAL-NERVE REGENERATION; FEEDFORWARD LOOP; BIOINFORMATICS; NEURONS; EXPRESSION; SYSTEM; TOOLS; LISTS	Axonal regeneration after injury requires the coordinated expression of genes in injured neurons. We previously showed that either reducing expression or blocking function of the transcriptional repressor NFIL3 activates transcription of regeneration-associated genes Arg1 and Gap43 and strongly promotes axon outgrowth in vitro. Here we tested whether genetic deletion or dominant-negative inhibition of NFIL3 could promote axon regeneration and functional recovery after peripheral nerve lesion in vivo. Contrary to our expectations, we observed no changes in the expression of regeneration-associated genes and a significant delay in functional recovery following genetic deletion of Nfil3. When NFIL3 function was inhibited specifically in dorsal root ganglia prior to sciatic nerve injury, we observed a decrease in regenerative axon growth into the distal nerve segment rather than an increase. Finally, we show that deletion of Nfil3 changes sciatic nerve lesion-induced expression in dorsal root ganglia of genes that are not typically involved in regeneration, including several olfactory receptors and developmental transcription factors. Together our findings show that removal of NFIL3 in vivo does not recapitulate the regeneration-promoting effects that were previously observed in vitro, indicating that in vivo transcriptional control of regeneration is probably more complex and more robust against perturbation than in vitro data may suggest.	[van der Kallen, Loek R.; Smit, August B.; van Kesteren, Ronald E.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands; [Eggers, Ruben; Ehlert, Erich M.; Verhaagen, Joost] Netherlands Inst Neurosci, Dept Neuroregenerat, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	van Kesteren, RE (corresponding author), Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Neurosci Campus Amsterdam, Amsterdam, Netherlands.	ronald.van.kesteren@vu.nl	Eggers, Ruben/N-3619-2019; eggers, ruben/B-8937-2008; van Kesteren, Ronald E/E-2505-2014; Verhaagen, Joost/G-4773-2012	Eggers, Ruben/0000-0001-7017-0791; eggers, ruben/0000-0001-7017-0791; van Kesteren, Ronald/0000-0002-9592-3777	Netherlands Organisation for Health Research and Development [91211043]	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	REvK and LRvdK were funded by The Netherlands Organisation for Health Research and Development (grant number 91211043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PN, 1998, PROG BRAIN RES, V117, P211; Blits B, 2010, J NEUROSCI METH, V185, P257, DOI 10.1016/j.jneumeth.2009.10.009; Carlson M., 2012, ORG MM EG DB GENOME; Cournac A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-29; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Hermens WTJMC, 1999, HUM GENE THER, V10, P1885, DOI 10.1089/10430349950017563; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kamizono S, 2009, J EXP MED, V206, P2977, DOI 10.1084/jem.20092176; Kashiwada M, 2011, EMBO J, V30, P2071, DOI 10.1038/emboj.2011.111; Kashiwada M, 2010, P NATL ACAD SCI USA, V107, P821, DOI 10.1073/pnas.0909235107; Kim Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033664; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; MacGillavry HD, 2011, MOL CELL NEUROSCI, V46, P460, DOI 10.1016/j.mcn.2010.11.011; MacGillavry HD, 2009, J NEUROSCI, V29, P15542, DOI 10.1523/JNEUROSCI.3938-09.2009; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; Mar FM, 2014, EMBO REP, V15, P254, DOI 10.1002/embr.201337723; Mason MRJ, 2010, MOL THER, V18, P715, DOI 10.1038/mt.2010.19; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Pego AP, 2012, J CELL MOL MED, V16, P2564, DOI 10.1111/j.1582-4934.2012.01603.x; Raivich G, 2007, BRAIN RES REV, V53, P287, DOI 10.1016/j.brainresrev.2006.09.005; Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609; Scheib J, 2013, NAT REV NEUROL, V9, P668, DOI 10.1038/nrneurol.2013.227; Schwab ME, 2004, CURR OPIN NEUROBIOL, V14, P118, DOI 10.1016/j.conb.2004.01.004; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stam FJ, 2008, NEURAL DEGENERATION; Sui SJH, 2007, NUCLEIC ACIDS RES, V35, pW245, DOI 10.1093/nar/gkm427; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Tibshirani R., 2011, SAMR SAM SIGNIFICANC; van Kesteren RE, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00046; Warnes GR, 2012, GPLOTS VARIOUS R PRO; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wickham H, 2007, J STAT SOFTW, V21, P1; Zou HY, 2009, J NEUROSCI, V29, P7116, DOI 10.1523/JNEUROSCI.5397-08.2009	38	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127163	10.1371/journal.pone.0127163	http://dx.doi.org/10.1371/journal.pone.0127163			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993115	gold, Green Published, Green Submitted			2022-12-26	WOS:000354921400100
J	Xing, LD; Buckley, LG; McCrea, RT; Lockley, MG; Zhang, JP; Pinuela, L; Klein, H; Wang, FP				Xing, Lida; Buckley, Lisa G.; McCrea, Richard T.; Lockley, Martin G.; Zhang, Jianping; Pinuela, Laura; Klein, Hendrik; Wang, Fengping			Reanalysis of Wupus agilis (Early Cretaceous) of Chongqing, China as a Large Avian Trace: Differentiating between Large Bird and Small Non-Avian Theropod Tracks	PLOS ONE			English	Article							DINOSAUR FOOTPRINTS; JIAGUAN FORMATION; MESOZOIC BIRDS; DISCOVERY; QIJIANG	Trace fossils provide the only records of Early Cretaceous birds from many parts of the world. The identification of traces from large avian track-makers is made difficult given their overall similarity in size and tridactyly in comparison with traces of small non-avian theropods. Reanalysis of Wupus agilis from the Early Cretaceous (Aptian-Albian) Jiaguan Formation, one of a small but growing number of known avian-pterosaur track assemblages, of southeast China determines that these are the traces of a large avian track-maker, analogous to extant herons. Wupus, originally identified as the trace of a small non-avian theropod track-maker, is therefore similar in both footprint and trackway characteristics to the Early Cretaceous (Albian) large avian trace Limiavipes curriei from western Canada, and Wupus is reassigned to the ichnofamily Limiavipedidae. The reanalysis of Wupus reveals that it and Limiavipes are distinct from similar traces of small to medium-sized non-avian theropods (Irenichnites, Columbosauripus, Magnoavipes) based on their relatively large footprint length to pace length ratio and higher mean footprint splay, and that Wupus shares enough characters with Limiavipes to be reassigned to the ichnofamily Limiavipedidae. The ability to discern traces of large avians from those of small non-avian theropods provides more data on the diversity of Early Cretaceous birds. This analysis reveals that, despite the current lack of body fossils, large wading birds were globally distributed in both Laurasia and Gondwana during the Early Cretaceous.	[Xing, Lida; Zhang, Jianping] China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; [Buckley, Lisa G.; McCrea, Richard T.] Peace Reg Palaeontol Res Ctr, Tumbler Ridge, BC, Canada; [Lockley, Martin G.] Univ Colorado, Dinosaur Tracks Museum, Denver, CO 80202 USA; [Pinuela, Laura] Jurass Museum Asturias, Museo Juras Asturias MUJA, Colunga, Spain; [Klein, Hendrik] Saurierwelt Palaontolog Museum, Neumarkt, Germany; [Wang, Fengping] Qijiang Dist Bur Land Resources, Chongqing, Peoples R China	China University of Geosciences; University of Colorado System; University of Colorado Denver	Buckley, LG (corresponding author), Peace Reg Palaeontol Res Ctr, Tumbler Ridge, BC, Canada.	lgbuckley@prprc.com	Piñuela, Laura/ABB-9908-2020		Host Committee of the Qijiang Dinosaur Tracks Symposium, Chongqing; Qijiang People's Government; Qijiang District Bureau of Land Resources	Host Committee of the Qijiang Dinosaur Tracks Symposium, Chongqing; Qijiang People's Government; Qijiang District Bureau of Land Resources	The work was supported by the Host Committee of the Qijiang Dinosaur Tracks Symposium, Chongqing, 2012, the Qijiang People's Government, and the Qijiang District Bureau of Land Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckley LG, 2015, DINOSAUR TR IN PRESS; Chen HX, 2009, RES PALEOENVIRONMENT; Farlow J.O., 2013, TYRANNOSAURID PALEOB, P88; Farlow JO, 2000, AM ZOOL, V40, P640, DOI 10.1668/0003-1569(2000)040[0640:TL]2.0.CO;2; Fiorillo AR, 2011, J SYST PALAEONTOL, V9, P33, DOI 10.1080/14772019.2010.509356; Fuentes Vidarte C., 1996, Estudios Geologicos (Madrid), V52, P63; GATESY SM, 1990, PALEOBIOLOGY, V16, P170, DOI 10.1017/S0094837300009866; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Gou Z.H., 2001, J STRATIGR, V25, P62; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Kim JY, 2012, ICHNOS, V19, P28, DOI 10.1080/10420940.2012.660414; Kordos L., 1985, GEOLOGICA HUNGARIC P, V44-46, P259; Lee YN, 1997, CRETACEOUS RES, V18, P849, DOI 10.1006/cres.1997.0091; Li Y L., 1995, J CHENGDU U TECHNOLO, V22, P11; Lockley M.G., 2001, MOUNTAIN GEOL, V38, P137; Lockley M.G., 2007, NEW MEXICO MUSEUM NA, V42, P67; Lockley M, 2009, CRETACEOUS RES, V30, P1041, DOI 10.1016/j.cretres.2009.04.001; Lockley MG, 2007, NATURWISSENSCHAFTEN, V94, P657, DOI 10.1007/s00114-007-0239-x; Lockley Martin G., 2004, Ichnos, V11, P229, DOI 10.1080/10420940490428625; LOCKLEY MG, 1992, PHILOS T ROY SOC B, V336, P113, DOI 10.1098/rstb.1992.0051; Martakis M. D. Aias, 2013, P 21 EUR C INF SYST, P1, DOI DOI 10.1109/RCIS.2013.6577679; Matsukawa M, 2014, CRETACEOUS RES, V47, P131, DOI 10.1016/j.cretres.2013.10.005; McCrea Richard T., 2014, Bulletin of the New Mexico Museum of Natural History and Science, P5; McCrea Richard T., 2001, P453; McCrea RT, 2000, THESIS U SASKATCHEWA; Panin N., 1962, STUDII CERCETARI GEO, V7, P455; Payros A, 2000, FACIES, V42, P107, DOI 10.1007/BF02562569; Sarjeant W.A.S., 2001, CHANGING FACE E MOJA, P21; Sarjeant William Anthony S., 1994, Bulletin of the Texas Memorial Museum, V36, P1; Thulborn RA., 1990, DINOSAUR TRACKS; Wright JL, 2004, LIFE O PAST, P167; Xing LD, 2013, PALAEOGEOGR PALAEOCL, V392, P177, DOI 10.1016/j.palaeo.2013.09.003; Xing Lida, 2007, Dizhi Xuebao, V81, P1591	34	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0124039	10.1371/journal.pone.0124039	http://dx.doi.org/10.1371/journal.pone.0124039			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993285	Green Submitted, Green Published, gold			2022-12-26	WOS:000354921400013
J	Roznik, EA; Alford, RA				Roznik, Elizabeth A.; Alford, Ross A.			Seasonal Ecology and Behavior of an Endangered Rainforest Frog (Litoria rheocola) Threatened by Disease	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; INFECTIOUS-DISEASE; STREAM FROGS; CHYTRIDIOMYCOSIS; AMPHIBIANS; TRANSMISSION; DESICCATION; PATHOGEN; DECLINES; SURVIVAL	One of the most devastating wildlife diseases ever recorded is chytridiomycosis, a recently emerged amphibian disease that is caused by the chytrid fungus Batrachochytrium dendrobatidis. Understanding, predicting, and managing the impacts of chytridiomycosis on any amphibian species will require detailed information on its ecology and behavior because this pathogen is transmitted by contact with water or other individuals, and pathogen growth rates are thermally sensitive. The commonmistfrog (Litoria rheocola) is an endangered tropical rainforest frog that has declined due to chytridiomycosis. We tracked Litoria rheocola during the winter (cool/dry) and summer (warm/wet) seasons at a low-and high-elevation site. We found that seasonal differences in environmental temperatures and frog behavior should render this species most vulnerable to Batrachochytrium dendrobatidis during cooler months and at higher elevations, which matches observed patterns of infection prevalence in this species. During winter, frogs moved shorter distances than during summer, and they spent less time in vegetation and more time in the stream, which should increase exposure to aquatic Batrachochytrium dendrobatidis zoospores. At a low-elevation site (40m ASL), estimated body temperatures were within the optimal range for Batrchochytrium dendrobatidis growth (15-25 degrees C) most of the time during winter, but they reached temperatures above this threshold frequently in summer. At a higher elevation (750 m ASL), estimated body temperatures were within the range most favorable for Batrachochytrium dendrobatidis year-round, and did not exceed 25 degrees C, even during summer. Our study provides the first detailed information on the ecology and behavior of Litoria rheocola and suggests ecological mechanisms for infection dynamics that have been observed in this endangered species.	[Roznik, Elizabeth A.; Alford, Ross A.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University	Roznik, EA (corresponding author), Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA.	betsy.roznik@gmail.com	Alford, Ross A/H-1577-2011	Alford, Ross A/0000-0002-3010-6768	Australian Research Council [DP0986537, DP130101635]; Australasian Society for the Study of Animal Behaviour; James Cook University	Australian Research Council(Australian Research Council); Australasian Society for the Study of Animal Behaviour; James Cook University	Funding was provided by the Australian Research Council (DP0986537 and DP130101635 to RAA), and the Australasian Society for the Study of Animal Behaviour (to EAR). EAR was supported by a Postgraduate Research Scholarship and a Doctoral Completion Award, both from James Cook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford RA, 2010, ECOTOXICOLOGY OF AMPHIBIANS AND REPTILES, SECOND EDITION, P13, DOI 10.1201/EBK1420064162-c2; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Cade B.S., 2005, USER MANUAL BLOSSOM; Collins J.P., 2009, EXTINCTION OUR TIMES; Curtis Lee K., 2012, P1; Department of Environment and Resource Management, 2010, LAND COV CHANG QUEEN, DOI [10.1007/s00267-008-9117-3, DOI 10.1007/S00267-008-9117-3]; Ezenwa VO, 2004, BEHAV ECOL, V15, P446, DOI 10.1093/beheco/arh028; FOLSTAD I, 1991, CAN J ZOOL, V69, P2423, DOI 10.1139/z91-340; Gourret Arnaud, 2011, Herpetological Review, V42, P522; Han BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016675; Hodgkison S, 2002, P QUEENSL FROG SOC B, P29; Hoskin CJ, 2010, ECOL SOC, V15, DOI 10.5751/es-03272-150315; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; JOHNSON DH, 1995, ECOLOGY, V76, P1998, DOI 10.2307/1940733; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Johnson ML, 2005, DIS AQUAT ORGAN, V65, P181, DOI 10.3354/dao065181; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Langkilde T, 2002, J HERPETOL, V36, P711, DOI 10.2307/1565948; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; McDonald K, 1999, DECLINES DISAPPEARAN, P14; McDonald K. R., 2005, PAC CONSERV BIOL, V11, P114, DOI DOI 10.1071/PC050114; Parris MJ, 2006, CAN J ZOOL, V84, P58, DOI 10.1139/Z05-175; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Rachowicz LJ, 2004, DIS AQUAT ORGAN, V61, P75, DOI 10.3354/dao061075; RETALLICK R, 2002, USING EXPT TRANSLOCA; RICHARDS SJ, 1994, MEASURING MONITORING, P289; Richards Stephen J., 1993, Pacific Conservation Biology, V1, P66; Richards-Zawacki CL, 2010, P ROY SOC B-BIOL SCI, V277, P519, DOI 10.1098/rspb.2009.1656; Rowley JJL, 2007, WILDLIFE RES, V34, P371, DOI 10.1071/WR07014; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Rowley JJL, 2007, AMPHIBIA-REPTILIA, V28, P367, DOI 10.1163/156853807781374755; Rowley JJL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01515; Rowley Jodi J.L., 2010, P387; Roznik EA, 2013, THESIS J COOK U; Roznik EA, 2014, J THERM BIOL, V45, P22, DOI 10.1016/j.jtherbio.2014.07.005; Roznik EA, 2012, J THERM BIOL, V37, P260, DOI 10.1016/j.jtherbio.2012.02.004; Sapsford SJ, 2014, HERPETOLOGICA, V70, P23, DOI 10.1655/HERPETOLOGICA-D-13-0004; Sapsford SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082425; Sapsford SJ, 2012, THESIS J COOK U; Schwarzkopf L, 1996, FUNCT ECOL, V10, P193, DOI 10.2307/2389843; Stevenson LA, 2014, ECOL EVOL, V4, P4053, DOI 10.1002/ece3.1271; Stevenson LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073830; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Venesky MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024991; Venesky MD, 2009, ECOHEALTH, V6, P565, DOI 10.1007/s10393-009-0272-7; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; WINTER J W, 1987, Proceedings of the Royal Society of Queensland, V98, P41; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x	54	19	19	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127851	10.1371/journal.pone.0127851	http://dx.doi.org/10.1371/journal.pone.0127851			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993520	Green Published, Green Accepted, gold			2022-12-26	WOS:000354918600075
J	Alburaki, M; Boutin, S; Mercier, PL; Loublier, Y; Chagnon, M; Derome, N				Alburaki, Mohamed; Boutin, Sebastien; Mercier, Pierre-Luc; Loublier, Yves; Chagnon, Madeleine; Derome, Nicolas			Neonicotinoid-Coated Zea mays Seeds Indirectly Affect Honeybee Performance and Pathogen Susceptibility in Field Trials	PLOS ONE			English	Article							DEFORMED WING VIRUS; APIS-MELLIFERA; MITOCHONDRIAL-DNA; EXPOSURE; PESTICIDES; INSECTICIDES; POLLINATORS; HYMENOPTERA; BEES; DWV	Thirty-two honeybee (Apis mellifera) colonies were studied in order to detect and measure potential in vivo effects of neonicotinoid pesticides used in cornfields (Zea mays spp) on honeybee health. Honeybee colonies were randomly split on four different agricultural cornfield areas located near Quebec City, Canada. Two locations contained cornfields treated with a seed-coated systemic neonicotinoid insecticide while the two others were organic cornfields used as control treatments. Hives were extensively monitored for their performance and health traits over a period of two years. Honeybee viruses (brood queen cell virus BQCV, deformed wing virus DWV, and Israeli acute paralysis virus IAPV) and the brain specific expression of a biomarker of host physiological stress, the Acetylcholinesterase gene AChE, were investigated using RT-qPCR. Liquid chromatography-mass spectrometry (LC-MS) was performed to detect pesticide residues in adult bees, honey, pollen, and corn flowers collected from the studied hives in each location. In addition, general hive conditions were assessed by monitoring colony weight and brood development. Neonicotinoids were only identified in corn flowers at low concentrations. However, honeybee colonies located in neonicotinoid treated cornfields expressed significantly higher pathogen infection than those located in untreated cornfields. AChE levels showed elevated levels among honeybees that collected corn pollen from treated fields. Positive correlations were recorded between pathogens and the treated locations. Our data suggests that neonicotinoids indirectly weaken honeybee health by inducing physiological stress and increasing pathogen loads.	[Alburaki, Mohamed; Boutin, Sebastien; Mercier, Pierre-Luc; Derome, Nicolas] Univ Laval, IBIS, Quebec City, PQ G1K 7P4, Canada; [Derome, Nicolas] Univ Laval, Dept Biol, Fac Sci & Genie, Quebec City, PQ G1K 7P4, Canada; [Alburaki, Mohamed; Mercier, Pierre-Luc] CRSAD, Quebec City, PQ, Canada; [Chagnon, Madeleine] Univ Quebec Montreal, Quebec City, PQ, Canada; [Loublier, Yves] CNRS, LEGS, Gif Sur Yvette, France	Laval University; Laval University; University of Quebec; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Alburaki, M (corresponding author), Univ Tennessee, Entomol & Plant Pathol Dept, West TN Res & Educ Ctr, 605 Airways Blvd, Jackson, TN 38301 USA.	malburak@utk.edu	Boutin, Sébastien/AAX-5334-2021	Boutin, Sébastien/0000-0002-0499-2460; Alburaki, Mohamed/0000-0003-4441-9391	Conseil pour le Developpement de l'Agricuture du Quebec (CDAQ)	Conseil pour le Developpement de l'Agricuture du Quebec (CDAQ)	The funder is Conseil pour le Developpement de l'Agricuture du Quebec (CDAQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Alburaki M, 2011, APIDOLOGIE, V42, P628, DOI 10.1007/s13592-011-0062-4; Arias MC, 1996, MOL PHYLOGENET EVOL, V5, P557, DOI 10.1006/mpev.1996.0050; Atkins EL, 1992, THE HIVE AND THE HON; Aufauvre J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00326; Bacandritsos N, 2010, J INVERTEBR PATHOL, V105, P335, DOI 10.1016/j.jip.2010.08.004; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Boily M, 2013, ENVIRON SCI POLLUT R, V20, P5603, DOI 10.1007/s11356-013-1568-2; BOURKE JB, 1982, AM BEE J, V122, P780; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Charvet R., 2004, Annales Pharmaceutiques Francaises, V62, P29, DOI 10.1016/S0003-4509(04)94278-2; Chen YP, 2006, APPL ENVIRON MICROB, V72, P606, DOI 10.1128/AEM.72.1.606-611.2006; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; COX RL, 1984, ENVIRON ENTOMOL, V13, P375, DOI 10.1093/ee/13.2.375; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; DAVIS AR, 1989, BEE WORLD, V70, P163, DOI 10.1080/0005772X.1989.11099013; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Decourtye A, 2011, ECOTOXICOLOGY, V20, P429, DOI 10.1007/s10646-011-0594-4; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2752; FLAHERTY DL, 1977, AM BEE J, V117, P220; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; FURGALA B, 1966, VIROLOGY, V29, P346, DOI 10.1016/0042-6822(66)90042-0; GARNERY L, 1993, EXPERIENTIA, V49, P1016, DOI 10.1007/BF02125651; Garnery L, 1992, MOL ECOL, V1, P145, DOI 10.1111/j.1365-294X.1992.tb00170.x; Gauthier M, 2010, ADV EXP MED BIOL, V683, P97; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; HAYNES KF, 1988, ANNU REV ENTOMOL, V33, P149, DOI 10.1146/annurev.en.33.010188.001053; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Kremen C, 2000, CONSERV BIOL, V14, P1226, DOI 10.1046/j.1523-1739.2000.00013.x; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Kuznetsova A, 2014, LMERTEST TESTS IN LI, DOI [10.1186/1471-2164-15-862, DOI 10.1186/1471-2164-15-862]; Leonardi MG, 1996, COMP BIOCHEM PHYS B, V113, P361, DOI 10.1016/0305-0491(95)02051-9; Loublier Y, 2003, POLLEN, V13, P363; LOUVEAUX J., 1966, ANN ABEILLE [PARIS], V9, P323, DOI 10.1051/apido:19660402; Louveaux J., 1973, Bee World, V54, P105; MACKENZIE KE, 1989, J ECON ENTOMOL, V82, P75, DOI 10.1093/jee/82.1.75; Martin SJ, 2010, J APICULT RES, V49, P72, DOI 10.3896/IBRA.1.49.1.10; Morse RA, 2000, THE VALUE OF HONEY B; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; NAS, 2007, STATUS OF POLLINATOR; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Pinheiro J, 2000, MIXED EFFECTS MODELS; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; SMIRLE MJ, 1987, J ECON ENTOMOL, V80, P5, DOI 10.1093/jee/80.1.5; Stewart SD, 2014, ENVIRON SCI TECHNOL, V48, P9762, DOI 10.1021/es501657w; Tanner G, 2011, J AGR FOOD CHEM, V59, P12271, DOI 10.1021/jf202775m; Team RDC, 2011, R A LANGUAGE AND ENV, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; Tentcheva D, 2006, APIDOLOGIE, V37, P41, DOI 10.1051/apido:2005057; van der Sluijs JP, 2013, CURR OPIN ENV SUST, V5, P293, DOI 10.1016/j.cosust.2013.05.007; van der Zee R, 2012, J APICULT RES, V51, P91, DOI 10.3896/IBRA.1.51.1.12; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; VANDAME R, 1995, ENVIRON TOXICOL CHEM, V14, P855, DOI 10.1002/etc.5620140517; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang RM, 2012, J SCI FOOD AGR, V92, P1253, DOI 10.1002/jsfa.4691; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Williams GR, 2012, J APICULT RES, V51, P151, DOI 10.3896/IBRA.1.51.2.01; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Withgott J, 1999, BIOSCIENCE, V49, P857, DOI 10.2307/1313643; Wu JY, 2012, J INVERTEBR PATHOL, V109, P326, DOI 10.1016/j.jip.2012.01.005; Zioni N, 2011, VIROLOGY, V417, P106, DOI 10.1016/j.virol.2011.05.009	74	56	59	3	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0125790	10.1371/journal.pone.0125790	http://dx.doi.org/10.1371/journal.pone.0125790			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993642	Green Published, Green Submitted, gold			2022-12-26	WOS:000354917300026
J	Blanco-Prieto, S; Vazquez-Iglesias, L; Rodriguez-Girondo, M; Barcia-Castro, L; Fernandez-Villar, A; Botana-Rial, MI; Rodriguez-Berrocal, FJ; de la Cadena, MP				Blanco-Prieto, Sonia; Vazquez-Iglesias, Lorena; Rodriguez-Girondo, Mar; Barcia-Castro, Leticia; Fernandez-Villar, Alberto; Isabel Botana-Rial, Maria; Javier Rodriguez-Berrocal, Francisco; Paez de la Cadena, Maria			Serum Calprotectin, CD26 and EGF to Establish a Panel for the Diagnosis of Lung Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; DIPEPTIDYL-PEPTIDASE-IV; BIOMARKER; INFLAMMATION; ASSOCIATION; EXPRESSION; S100A8; RISK	Lung cancer is the most lethal neoplasia, and an early diagnosis is the best way for improving survival. Symptomatic patients attending Pulmonary Services could be diagnosed with lung cancer earlier if high-risk individuals are promptly separated from healthy individuals and patients with benign respiratory pathologies. We searched for a convenient noninvasive serum test to define which patients should have more immediate clinical tests. Six cancer-associated molecules (HB-EGF, EGF, EGFR, sCD26, VEGF, and Calprotectin) were investigated in this study. Markers were measured in serum by specific ELISAs, in an unselected population that included 72 lung cancer patients of different histological types and 56 control subjects (healthy individuals and patients with benign pulmonary pathologies). Boosted regression and random forests analysis were conducted for the selection of the best candidate biomarkers. A remarkable discriminatory capacity was observed for EGF, sCD26, and especially for Calprotectin, these three molecules constituting a marker panel boasting a sensitivity of 83% and specificity of 87%, resulting in an associated misclassification rate of 15%. Finally, an algorithm derived by logistic regression and a nomogram allowed generating classification scores in terms of the risk of a patient of suffering lung cancer. In conclusion, we propose a non-invasive test to identify patients at high-risk for lung cancer from a non-selected population attending a Pulmonary Service. The efficacy of this three-marker panel must be tested in a larger population for lung cancer.	[Blanco-Prieto, Sonia; Vazquez-Iglesias, Lorena; Barcia-Castro, Leticia; Javier Rodriguez-Berrocal, Francisco; Paez de la Cadena, Maria] Univ Vigo, Dept Biochem Genet & Immunol, Fac Biol, Vigo 36310, Spain; [Rodriguez-Girondo, Mar] Univ Vigo, Fac Ciencias Econ & Empresariales, SiDOR Res Grp, Vigo 36310, Spain; [Rodriguez-Girondo, Mar] Univ Vigo, Fac Ciencias Econ & Empresariales, Ctr Inves Biomed CINBIO, Vigo 36310, Spain; [Fernandez-Villar, Alberto; Isabel Botana-Rial, Maria] Complejo Hosp Univ Vigo CHUVI, Dept Pneumol, Unit Intervent Broncopleural Pathol, Vigo, Spain	Universidade de Vigo; Universidade de Vigo; Universidade de Vigo; CINBIO; Complexo Hospitalario Universitario de Vigo	de la Cadena, MP (corresponding author), Univ Vigo, Dept Biochem Genet & Immunol, Fac Biol, Vigo 36310, Spain.	mpaez@uvigo.es	de la Cadena, Maria Paez/M-2364-2014; Vázquez-Iglesias, Lorena/M-1837-2014	de la Cadena, Maria Paez/0000-0002-8317-8861; Vázquez-Iglesias, Lorena/0000-0002-0203-3514; FERNANDEZ-VILLAR, ALBERTO/0000-0001-7407-5249; Rodriguez-Girondo, Mar/0000-0003-3126-1003	Instituto de Salud Carlos III, Grouping of Inbiomed [PS09-00405, 2012/273]; FEDER DXPCTSUG-Feder [CN 2011/024]; Programa Nacional de Formacion de Profesorado Universitario (FPU, Spanish Ministry of Science and Innovation); Spanish Ministry of Science and Innovation [MTM2011-23204 (FEDER)]; INBIOMED of the Xunta de Galicia [2009-063]	Instituto de Salud Carlos III, Grouping of Inbiomed; FEDER DXPCTSUG-Feder; Programa Nacional de Formacion de Profesorado Universitario (FPU, Spanish Ministry of Science and Innovation); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); INBIOMED of the Xunta de Galicia	This research was supported by project PS09-00405 from Instituto de Salud Carlos III, Grouping of Inbiomed 2012/273, and funding from FEDER DXPCTSUG-Feder (CN 2011/024). S. Blanco-Prieto was supported by a fellowship from the Programa Nacional de Formacion de Profesorado Universitario (FPU, Spanish Ministry of Science and Innovation). M. Rodriguez-Girondo acknowledges financial support of Grant MTM2011-23204 (FEDER support included) of the Spanish Ministry of Science and Innovation and INBIOMED 2009-063 of the Xunta de Galicia. The samples used in this work belong to the Biobank from the CHUVI (RETIC-FIS-ISCIII RD09/0076/00011).	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Alberg AJ, 2013, CHEST, V143, pE1, DOI 10.1378/chest.12-2345; Baron AT, 2003, CANCER EPIDEM BIOMAR, V12, P103; Baselga J, 2002, ONCOLOGIST, V7, P2; Bigbee WL, 2012, J THORAC ONCOL, V7, P698, DOI 10.1097/JTO.0b013e31824ab6b0; Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bunn PA, 2012, ARCH PATHOL LAB MED, V136, P1478, DOI 10.5858/arpa.2012-0295-SA; Cordero OJ, 2009, CANCER IMMUNOL IMMUN, V58, P1725, DOI 10.1007/s00262-009-0728-1; De Chiara L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-333; De Chiara L, 2009, DIS MARKERS, V27, P311, DOI [10.3233/DMA-2009-0679, 10.1155/2009/986295]; De Meester I, 1999, IMMUNOL TODAY, V20, P367, DOI 10.1016/S0167-5699(99)01486-3; Detterbeck FC, 2007, CHEST, V132, p202S, DOI 10.1378/chest.07-1362; Durinx C, 2001, CLIN CHEM LAB MED, V39, P155, DOI 10.1515/CCLM.2001.026; Farlow EC, 2010, BRIT J CANCER, V103, P1221, DOI 10.1038/sj.bjc.6605865; Field JK, 2013, J SURG ONCOL, V108, P280, DOI 10.1002/jso.23383; Field JK, 2013, LANCET, V382, P732, DOI 10.1016/S0140-6736(13)61614-1; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Ghavami S, 2009, EUR J PHARMACOL, V625, P73, DOI 10.1016/j.ejphar.2009.08.044; Hastie T, 2009, ELEMENTS STAT LEARNI, DOI [10.1016/j.neunet.2009.04.005, DOI 10.1016/J.NEUNET.2009.04.005]; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; HOLM S, 1979, SCAND J STAT, V6, P65; Horeweg N, 2013, AM J RESP CRIT CARE, V187, P848, DOI 10.1164/rccm.201209-1651OC; Izbicka E, 2012, CANCER GENOM PROTEOM, V9, P27; Jantus-Lewintre E, 2012, LUNG CANCER-TARGETS, V3, P21, DOI 10.2147/LCTT.S23424; Javidroozi M, 2012, DIS MARKERS, V32, P309, DOI [10.3233/DMA-2011-0889, 10.1155/2012/706745]; Jett JR, 2014, LUNG CANCER, V83, P51, DOI 10.1016/j.lungcan.2013.10.008; Kasahara K, 2010, CLIN CANCER RES, V16, P4616, DOI 10.1158/1078-0432.CCR-10-0383; Kim JW, 2013, CANCER RES TREAT, V45, P325, DOI 10.4143/crt.2013.45.4.325; Lee HJ, 2012, J THORAC CARDIOV SUR, V143, P421, DOI 10.1016/j.jtcvs.2011.10.046; Lemos-Gonzalez Y, 2007, BRIT J CANCER, V96, P1569, DOI 10.1038/sj.bjc.6603770; Li XJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007013; Morgensztern D, 2010, J THORAC ONCOL, V5, P29, DOI 10.1097/JTO.0b013e3181c5920c; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Perez-Torres M, 2008, EXP CELL RES, V314, P2907, DOI 10.1016/j.yexcr.2008.07.013; Planque C, 2008, CLIN CANCER RES, V14, P1355, DOI 10.1158/1078-0432.CCR-07-4117; Rivera MP, 2013, CHEST, V143, pE142, DOI 10.1378/chest.12-2353; Sanchez-Otero N, 2012, BRIT J CANCER, V107, P1876, DOI 10.1038/bjc.2012.478; Shingu K, 2003, CANCER IMMUNOL IMMUN, V52, P546, DOI 10.1007/s00262-003-0392-9; Silvestri GA, 2007, CHEST, V132, p178S, DOI 10.1378/chest.07-1360; Spiro SG, 2007, CHEST, V132, p149S, DOI 10.1378/chest.07-1358; Su YJ, 2010, CHINESE MED J-PEKING, V123, P2215, DOI 10.3760/cma.j.issn.0366-6999.2010.16.011; Travis WD, 1999, HISTOLOGICAL TYPING; van den Bergh RCN, 2009, CANCER-AM CANCER SOC, V115, P3868, DOI 10.1002/cncr.24446; Wender R, 2013, CA-CANCER J CLIN, V63, P107, DOI 10.3322/caac.21172; Wesley UV, 2004, INT J CANCER, V109, P855, DOI 10.1002/ijc.20091; Zhan P, 2009, J THORAC ONCOL, V4, P1094, DOI 10.1097/JTO.0b013e3181a97e31	49	14	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127318	10.1371/journal.pone.0127318	http://dx.doi.org/10.1371/journal.pone.0127318			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992884	gold, Green Published, Green Submitted			2022-12-26	WOS:000354917300114
J	Larsen, SB; Grove, EL; Neergaard-Petersen, S; Wurtz, M; Hvas, AM; Kristensen, SD				Larsen, Sanne Bojet; Grove, Erik Lerkevang; Neergaard-Petersen, Sos; Wurtz, Morten; Hvas, Anne-Mette; Kristensen, Steen Dalby			Determinants of Reduced Antiplatelet Effect of Aspirin in Patients with Stable Coronary Artery Disease	PLOS ONE			English	Article							PLATELET-AGGREGATION; INTERINDIVIDUAL VARIABILITY; RESISTANCE; AGGREGOMETRY; TURNOVER; DRUGS; RISK; ANTICOAGULANTS; REACTIVITY; THROMBOSIS	Background Aspirin is a cornerstone in management of coronary artery disease (CAD). However, considerable variability in the antiplatelet effect of aspirin has been reported. Aim To investigate independent determinants of reduced antiplatelet effect of aspirin in stable CAD patients. Methods We performed a cross-sectional study including 900 stable, high-risk CAD patients. Among these, 795 (88%) had prior myocardial infarction, 250 (28%) had type 2 diabetes, and 170 (19%) had both. All patients received 75 mg aspirin daily as mono antiplatelet therapy. The antiplatelet effect of aspirin was assessed by measurement of platelet aggregation employing 1) multiple electrode aggregometry (MEA, Multiplate Analyzer) in whole blood anticoagulated with citrate or hirudin using arachidonic acid (AA) or collagen as agonists, and 2) VerifyNow Aspirin Assay. Compliance was assessed by measurement of serum thromboxane B2. Results Platelet count, prior myocardial infarction, type 2 diabetes and body mass index were independent determinants of increased AA-induced MEA platelet aggregation in citrate and hirudin anticoagulated blood (p-values <= 0.045). Similar results were found with VerifyNow. Prior coronary artery bypass grafting, age, smoking (MEA, AA/citrate) and female gender (MEA, AA/hirudin) were also independent determinants of increased platelet aggregation (p-values <= 0.038). Compliance was confirmed by low serum thromboxane B-2 levels in all patients (median [25%; 75%]: 0.97 [0.52; 1.97], range 0.02-26.44 ng/ml). Conclusion Platelet count, prior myocardial infarction, type 2 diabetes and body mass index were independent determinants of increased platelet aggregation, indicating that these characteristics may be key factors in reduced antiplatelet effect of aspirin in stable CAD patients.	[Larsen, Sanne Bojet; Grove, Erik Lerkevang; Neergaard-Petersen, Sos; Wurtz, Morten; Kristensen, Steen Dalby] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark; [Hvas, Anne-Mette] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Hvas, Anne-Mette; Kristensen, Steen Dalby] Aarhus Univ, Fac Hlth Sci, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Kristensen, SD (corresponding author), Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark.	steendk@dadlnet.dk		Grove, Erik/0000-0002-1466-0865	Danish Agency for Science, Technology and Innovation [2101-05-0052]; Faculty of Health Sciences, Aarhus University, Denmark; Danish Heart Foundation; Department of Clinical Medicine, Aarhus University Hospital, Denmark; Eva & Henry Fraenkel's Foundation; Aase & Ejnar Danielsen's Foundation; Sophus Jacobsen & Spouse Astrid Jacobsen's Foundation; Korning Foundation; Physician's assurance association anno 1891; Carl & Ellen Hertz's Grant; Novo Nordisk Fonden [NNF14OC0008817] Funding Source: researchfish	Danish Agency for Science, Technology and Innovation; Faculty of Health Sciences, Aarhus University, Denmark; Danish Heart Foundation; Department of Clinical Medicine, Aarhus University Hospital, Denmark; Eva & Henry Fraenkel's Foundation; Aase & Ejnar Danielsen's Foundation; Sophus Jacobsen & Spouse Astrid Jacobsen's Foundation; Korning Foundation(National Research Foundation of Korea); Physician's assurance association anno 1891; Carl & Ellen Hertz's Grant; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was financially supported by the Danish Agency for Science, Technology and Innovation (grant no. 2101-05-0052, SDK), the Faculty of Health Sciences, Aarhus University, Denmark (SBL); The Danish Heart Foundation (SBL); Department of Clinical Medicine, Aarhus University Hospital, Denmark (SNP); Eva & Henry Fraenkel's Foundation (SBL); Aase & Ejnar Danielsen's Foundation (SBL); Sophus Jacobsen & Spouse Astrid Jacobsen's Foundation (SBL); The Korning Foundation (SBL); The Physician's assurance association anno 1891 (SBL) and Carl & Ellen Hertz's Grant to Danish Medical- and Natural Science (SBL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker DM, 2006, JAMA-J AM MED ASSOC, V295, P1420, DOI 10.1001/jama.295.12.1420; Bonello-Palot N, 2009, AM J CARDIOL, V104, P1511, DOI 10.1016/j.amjcard.2009.07.015; Bordeaux Bryan C, 2010, Prev Cardiol, V13, P56, DOI 10.1111/j.1751-7141.2009.00058.x; Breddin HK, 2005, PLATELETS, V16, P151, DOI 10.1080/09537100400020161; Cesari F, 2008, THROMB HAEMOSTASIS, V99, P930, DOI [10.1160/THOS-01-0002, 10.1160/TH08-01-0002]; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Furman MI, 1998, J AM COLL CARDIOL, V31, P352, DOI 10.1016/S0735-1097(97)00510-X; Grinstein J, 2012, CLIN CARDIOL, V35, P673, DOI 10.1002/clc.22031; Grove EL, 2011, J THROMB HAEMOST, V9, P185, DOI 10.1111/j.1538-7836.2010.04115.x; Grove EL, 2012, CURR VASC PHARMACOL, V10, P494; Grove EL, 2010, THROMB HAEMOSTASIS, V103, P1245, DOI 10.1160/TH09-08-0527; HAMSTEN A, 1985, AM HEART J, V110, P1154, DOI 10.1016/0002-8703(85)90005-5; Hanley MJ, 2010, CLIN PHARMACOKINET, V49, P71, DOI 10.2165/11318100-000000000-00000; Ikonomidis I, 2005, AM HEART J, V149, P832, DOI 10.1016/j.ahj.2004.08.030; Kaiser AFC, 2012, PLATELETS, V23, P359, DOI 10.3109/09537104.2011.624211; Krasopoulos G, 2008, BMJ-BRIT MED J, V336, P195, DOI 10.1136/bmj.39430.529549.BE; Kuliczkowski W, 2009, EUR HEART J, V30, P426, DOI 10.1093/eurheartj/ehn562; Kuzniatsova N, 2012, ANN MED, V44, P773, DOI 10.3109/07853890.2011.605388; Larsen SB, 2013, THROMB HAEMOSTASIS, V109, P920, DOI 10.1160/TH12-09-0666; Larsen SB, 2012, THROMB HAEMOSTASIS, V108, P140, DOI 10.1160/TH12-01-0026; LINDHOUT T, 1990, THROMB HAEMOSTASIS, V64, P464; Lordkipanidze M, 2010, INT J CARDIOL, V143, P43, DOI 10.1016/j.ijcard.2009.01.037; Ferreiro JL, 2012, CURR PHARM DESIGN, V18, P5273; Maree AO, 2005, J AM COLL CARDIOL, V46, P1258, DOI 10.1016/j.jacc.2005.06.058; Mayer K, 2014, PLATELETS IN PRESS; Mirkhel A, 2006, AM J CARDIOL, V98, P577, DOI 10.1016/j.amjcard.2006.03.029; Mortensen SB, 2010, THROMB RES, V126, pE318, DOI 10.1016/j.thromres.2010.03.013; Nakata M, 1999, DIABETES, V48, P426, DOI 10.2337/diabetes.48.2.426; Narvaez I, 2007, THROMB RES, V120, P671, DOI 10.1016/j.thromres.2006.12.020; Patrono C, 2007, NAT CLIN PRACT CARD, V4, P42, DOI 10.1038/ncpcardio0728; Peace A, 2010, J THROMB HAEMOST, V8, P2323, DOI 10.1111/j.1538-7836.2010.03997.x; Qayyum R, 2008, AM J CARDIOL, V101, P1359, DOI 10.1016/j.amjcard.2007.12.038; Rocca B, 2012, THROMBOSIS, V2012, DOI 10.1155/2012/376721; Rocca B, 2013, EXPERT REV CARDIOVAS, V11, P365, DOI [10.1586/erc.12.144, 10.1586/ERC.12.144]; Schmidt Morten, 2010, Clin Epidemiol, V2, P137; Silvain J, 2012, EUR HEART J, V33, P1241, DOI 10.1093/eurheartj/ehr407; Snoep JD, 2007, ARCH INTERN MED, V167, P1593, DOI 10.1001/archinte.167.15.1593; Vaturi M, 2013, AM J CARDIOL, V112, P212, DOI 10.1016/j.amjcard.2013.03.022; Watala C, 2004, THROMB RES, V113, P101, DOI 10.1016/j.thromres.2003.12.016; Wurtz M, 2012, CURR PHARM DESIGN, V18, P5344, DOI 10.2174/138161212803251925; Wurtz M, 2012, THROMB RES, V129, P434, DOI 10.1016/j.thromres.2011.07.019; Wurtz M, 2012, THROMB RES, V129, P56, DOI 10.1016/j.thromres.2011.08.019; Wurtz M, 2010, JACC-CARDIOVASC INTE, V3, P828, DOI 10.1016/j.jcin.2010.05.014; Zhang HZ, 2013, PLATELETS, V24, P339, DOI 10.3109/09537104.2012.698431	44	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126767	10.1371/journal.pone.0126767	http://dx.doi.org/10.1371/journal.pone.0126767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993271	Green Published, gold, Green Submitted			2022-12-26	WOS:000354917300051
J	Sato, M; Matsubara, T; Adachi, J; Hashimoto, Y; Fukamizu, K; Kishida, M; Yang, YA; Wakefield, LM; Tomonaga, T				Sato, Misako; Matsubara, Tsutomu; Adachi, Jun; Hashimoto, Yuuki; Fukamizu, Kazuna; Kishida, Marina; Yang, Yu-an; Wakefield, Lalage M.; Tomonaga, Takeshi			Differential Proteome Analysis Identifies TGF-beta-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MESENCHYMAL TRANSITION; TRANSLATION INITIATION; RECEPTOR KINASE; TISSUE SAMPLES; MAMMARY-TUMOR; SB-431542; EXPRESSION; INHIBITOR; PROLIFERATION	Transforming growth factor-beta (TGF-beta) has a dual role in tumorigenesis, acting as either a tumor suppressor or as a pro-oncogenic factor in a context-dependent manner. Although TGF-beta antagonists have been proposed as anti-metastatic therapies for patients with advanced stage cancer, how TGF-beta mediates metastasis-promoting effects is poorly understood. Establishment of TGF-beta-related protein expression signatures at the metastatic site could provide new mechanistic information and potentially allow identification of novel biomarkers for clinical intervention to discriminate TGF-beta oncogenic effects from tumor suppressive effects. In the present study, we found that systemic administration of the TGF-beta receptor kinase inhibitor, SB-431542, significantly inhibited lung metastasis from transplanted 4T1 mammary tumors in Balb/c mice. The differentially expressed proteins in the comparison of lung metastases from SB-431542 treated and control vehicle-treated groups were analyzed by a quantitative LTQ Orbitrap Velos system coupled with stable isotope dimethyl labeling. A total of 36,239 peptides from 6,694 proteins were identified, out of which 4,531 proteins were characterized as differentially expressed. A subset of upregulated proteins in the control group was validated by western blotting and immunohistochemistry. The eukaryotic initiation factor (eIF) family members constituted the most enriched protein pathway in vehicle-treated compared with SB-43512-treated lung metastases, suggesting that increased protein expression of specific eIF family members, especially eIF4A1 and eEF2, is related to the metastatic phenotype of advanced breast cancer and can be down-regulated by TGF-beta pathway inhibitors. Thus our proteomic approach identified eIF pathway proteins as novel potential mediators of TGF-beta tumor-promoting activity.	[Sato, Misako; Adachi, Jun; Hashimoto, Yuuki; Fukamizu, Kazuna; Kishida, Marina; Tomonaga, Takeshi] Proteome Res Ctr, Natl Inst Biomed Innovat, Lab Proteome Res, Saito, Osaka, Japan; [Sato, Misako] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 558, Japan; [Matsubara, Tsutomu] Osaka City Univ, Grad Sch Med, Dept Anat & Regenerat Biol, Osaka 558, Japan; [Yang, Yu-an; Wakefield, Lalage M.] NIH, Lab Canc Biol & Genet, Bethesda, MD 20892 USA	National Institute of Health Sciences - Japan; Osaka Metropolitan University; Osaka Metropolitan University; National Institutes of Health (NIH) - USA	Sato, M (corresponding author), Proteome Res Ctr, Natl Inst Biomed Innovat, Lab Proteome Res, Saito, Osaka, Japan.	mmatsubara@med.osaka-cu.ac.jp; tomonaga@nibiohn.go.jp	Adachi, Jun/H-2813-2014	Adachi, Jun/0000-0003-1220-3246	JSPS KAKENHI [25871241]; NATIONAL CANCER INSTITUTE [ZIABC010881] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25871241] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	MS; JSPS KAKENHI grant-in-Aid for Young Scientists (B) Grant Number 25871241 (http://www.jsps.go.jp/english/e-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Ali NA, 2011, PROTEOMICS, V11, P3390, DOI 10.1002/pmic.201100036; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Badura M, 2012, P NATL ACAD SCI USA, V109, P18767, DOI 10.1073/pnas.1203853109; Bao LL, 2011, AM J PATHOL, V178, P838, DOI 10.1016/j.ajpath.2010.10.029; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bonafoux D, 2009, EXPERT OPIN THER PAT, V19, P1759, DOI 10.1517/13543770903397400; Das F, 2013, J CELL PHYSIOL, V228, P1617, DOI 10.1002/jcp.24327; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; de la Parra C, 2012, J BIOL CHEM, V287, P41640, DOI 10.1074/jbc.M112.393470; Gilles C, 1999, J CELL SCI, V112, P4615; Halder SK, 2005, NEOPLASIA, V7, P509, DOI 10.1593/neo.04640; Hjelmeland MD, 2004, MOL CANCER THER, V3, P737; Ho J, 2009, J PROTEOME RES, V8, P583, DOI 10.1021/pr8007368; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Issa A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3379; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Konicek BW, 2008, CELL CYCLE, V7, P2466, DOI 10.4161/cc.7.16.6464; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lou YM, 2008, DEV DYNAM, V237, P2755, DOI 10.1002/dvdy.21658; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Matsubara T, 2012, CELL METAB, V16, P634, DOI 10.1016/j.cmet.2012.10.006; Matsuyama S, 2003, CANCER RES, V63, P7791; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Muraoka S, 2012, J PROTEOME RES, V11, P4201, DOI 10.1021/pr300322q; Nagaraja GM, 2012, CANCER PREV RES, V5, P122, DOI 10.1158/1940-6207.CAPR-11-0121; Nam JS, 2008, CANCER RES, V68, P3835, DOI 10.1158/0008-5472.CAN-08-0215; Nam JS, 2006, CANCER RES, V66, P6327, DOI 10.1158/0008-5472.CAN-06-0068; Narumi R, 2012, J PROTEOME RES, V11, P5311, DOI 10.1021/pr3005474; Nasr Z, 2013, ONCOGENE, V32, P861, DOI 10.1038/onc.2012.105; O'Shaughnessy J, 2005, ONCOLOGIST, V10, P20, DOI 10.1634/theoncologist.10-90003-20; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Shiromizu T, 2013, J PROTEOME RES, V12, P2414, DOI 10.1021/pr300825v; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Souchelnytskyi S, 2005, EXPERT REV PROTEOMIC, V2, P925, DOI 10.1586/14789450.2.6.925; Tanaka H, 2010, ONCOL REP, V24, P1637, DOI 10.3892/or_00001028; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Xue T, 2013, J PROTEOME RES; Yellen P, 2013, CANCER LETT, V333, P239, DOI 10.1016/j.canlet.2013.01.041; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580	48	14	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126483	10.1371/journal.pone.0126483	http://dx.doi.org/10.1371/journal.pone.0126483			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993439	Green Published, Green Submitted, gold			2022-12-26	WOS:000354917300043
J	Brar, S; Tsui, CKM; Dhillon, B; Bergeron, MJ; Joly, DL; Zambino, PJ; El-Kassaby, YA; Hamelin, RC				Brar, Simren; Tsui, Clement K. M.; Dhillon, Braham; Bergeron, Marie-Josee; Joly, David L.; Zambino, P. J.; El-Kassaby, Yousry A.; Hamelin, Richard C.			Colonization History, Host Distribution, Anthropogenic Influence and Landscape Features Shape Populations of White Pine Blister Rust, an Invasive Alien Tree Pathogen	PLOS ONE			English	Article							CRONARTIUM-RIBICOLA; NORTH-AMERICA; AERIAL DISPERSAL; LIMBER PINE; GENE; EPIDEMIOLOGY; RESISTANCE; EASTERN; SPECIALIZATION; MANAGEMENT	White pine blister rust is caused by the fungal pathogen Cronartium ribicola J.C. Fisch (Basidiomycota, Pucciniales). This invasive alien pathogen was introduced into North America at the beginning of the 20th century on pine seedlings imported from Europe and has caused serious economic and ecological impacts. In this study, we applied a population and landscape genetics approach to understand the patterns of introduction and colonization as well as population structure and migration of C. ribicola. We characterized 1,292 samples of C. ribicola from 66 geographic locations in North America using single nucleotide polymorphisms (SNPs) and evaluated the effect of landscape features, host distribution, and colonization history on the structure of these pathogen populations. We identified eastern and western genetic populations in North America that are strongly differentiated. Genetic diversity is two to five times higher in eastern populations than in western ones, which can be explained by the repeated accidental introductions of the pathogen into northeastern North America compared with a single documented introduction into western North America. These distinct genetic populations are maintained by a barrier to gene flow that corresponds to a region where host connectivity is interrupted. Furthermore, additional cryptic spatial differentiation was identified in western populations. This differentiation corresponds to landscape features, such as mountain ranges, and also to host connectivity. We also detected genetic differentiation between the pathogen populations in natural stands and plantations, an indication that anthropogenic movement of this pathogen still takes place. These results highlight the importance of monitoring this invasive alien tree pathogen to prevent admixture of eastern and western populations where different pathogen races occur.	[Brar, Simren; Tsui, Clement K. M.; Dhillon, Braham; El-Kassaby, Yousry A.; Hamelin, Richard C.] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada; [Bergeron, Marie-Josee; Hamelin, Richard C.] Nat Resources Canada, Laurentian Forestry Ctr, Quebec City, PQ, Canada; [Joly, David L.] Univ Moncton, Dept Biol, Moncton, NB E1A 3E9, Canada; [Zambino, P. J.] US Forest Serv, USDA, Coeur dAlene Field Off, Coeur Dalene, ID USA	University of British Columbia; Natural Resources Canada; University of Moncton; United States Department of Agriculture (USDA); United States Forest Service	Hamelin, RC (corresponding author), Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada.	Richard.hamelin@ubc.ca	El-Kassaby, Yousry A/K-9856-2016; Joly, David/ABC-5640-2020; Tsui, Clement/F-6416-2013; Hamelin, Richard/F-7006-2010; Joly, David/B-4612-2012	El-Kassaby, Yousry A/0000-0002-4887-8977; Tsui, Clement/0000-0001-5129-1037; Hamelin, Richard/0000-0003-4006-532X; Joly, David/0000-0001-8411-5558	NSERC; Genome Canada	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada(Genome Canada)	This study was funded by an NSERC Discovery grant to RCH that supported a research assistant-ship to SB, and by a Genome Canada Large Scale Applied Genomics grant to RCH that supported BD and CKMT, (http://www.genomecanada.ca/en/portfolio/research/2010-competition.aspx).	ANDERSON R. L., 1955, Forest Science, V1, P38; Archie EA, 2009, TRENDS ECOL EVOL, V24, P21, DOI 10.1016/j.tree.2008.08.008; Arsdel E. P., 2006, P 53 W INT FOR DIS W, P49; Biek R, 2010, MOL ECOL, V19, P3515, DOI 10.1111/j.1365-294X.2010.04679.x; BROWN DH, 1978, PLANT DIS REP, V62, P905; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; CLOSE RC, 1978, INT J BIOMETEOROL, V22, P1, DOI 10.1007/BF01553136; Cummins G, 2003, THE AMERICAN PHYTOPA; Desprez-Loustau ML, 2007, TRENDS ECOL EVOL, V22, P472, DOI 10.1016/j.tree.2007.04.005; DIAMOND JM, 1976, SCIENCE, V193, P1027, DOI 10.1126/science.193.4257.1027; Dong SM, 2014, SCIENCE, V343, P552, DOI 10.1126/science.1246300; DRAPER MA, 1993, PLANT DIS, V77, P952, DOI 10.1094/PD-77-0952C; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Geils BW, 2010, FOREST PATHOL, V40, P147, DOI 10.1111/j.1439-0329.2010.00654.x; Hamelin RC, 2000, PHYTOPATHOLOGY, V90, P1073, DOI 10.1094/PHYTO.2000.90.10.1073; Hamelin RC, 1995, THEOR APPL GENET, V91, P1214, DOI 10.1007/BF00220932; HAWKSWORTH FG, 1990, PLANT DIS, V74, P938, DOI 10.1094/PD-74-0938A; Hunt RS, 2009, FOREST CHRON, V85, P516, DOI 10.5558/tfc85516-4; HUNT RS, 1991, FOREST CHRON, V67, P284, DOI 10.5558/tfc67284-3; Johnson D. W., 2000, Plant Disease, V84, P595, DOI 10.1094/PDIS.2000.84.5.595D; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kinloch BB, 2004, PHYTOPATHOLOGY, V94, P751, DOI 10.1094/PHYTO.2004.94.7.751; Kinloch BB, 2003, PHYTOPATHOLOGY, V93, P1044, DOI 10.1094/PHYTO.2003.93.8.1044; Kinloch BB, 2003, PHYTOPATHOLOGY, V93, P691, DOI 10.1094/PHYTO.2003.93.6.691; KINLOCH BB, 1981, PLANT DIS, V65, P604, DOI 10.1094/PD-65-604; Loo J, 2009, BIOL INVASIONS, V11, P81, DOI 10.1007/s10530-008-9321-3; LUNDQUIST JE, 1992, PLANT DIS, V76, P538, DOI 10.1094/PD-76-0538A; Maloy OC, 1997, ANNU REV PHYTOPATHOL, V35, P87, DOI 10.1146/annurev.phyto.35.1.87; McDonald GI, 2006, FOREST PATHOL, V36, P73, DOI 10.1111/j.1439-0329.2006.00432.x; MIELKE J. L., 1943, Bull. Sch. For. Yale Univ., V52; Milgroom MG, 2003, PLANT DIS, V87, P608, DOI 10.1094/PDIS.2003.87.6.608; MOIR W. S., 1924, Bulletin. United States Department of Agriculture; Mulvey RL, 2011, FOREST PATHOL, V41, P453, DOI 10.1111/j.1439-0329.2010.00702.x; NAGARAJAN S, 1990, ANNU REV PHYTOPATHOL, V28, P139, DOI 10.1146/annurev.py.28.090190.001035; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Richardson BA, 2007, CAN J BOT, V85, P299, DOI 10.1139/B07-031; Santini A, 2013, NEW PHYTOL, V197, P238, DOI 10.1111/j.1469-8137.2012.04364.x; Schoettle AW, 2007, J FOREST RES-JPN, V12, P327, DOI 10.1007/s10310-007-0024-x; Schwandt JW, 2010, FOREST PATHOL, V40, P226, DOI 10.1111/j.1439-0329.2010.00656.x; Smith JA, 2006, PHYTOPATHOLOGY, V96, P171, DOI 10.1094/PHYTO-96-0171; Sniezko RA, 2004, BREEDING AND GENETIC, V2, P203; Spaulding P, 1929, USDA TECHNICAL BULLE, V87, P58; Spaulding P., 1911, USDA BUR PLANT IND B, V206, P88; SPIERS AG, 1994, MYCOL RES, V98, P889, DOI 10.1016/S0953-7562(09)80260-8; Stewart FC, 1906, NY AGR EXP STN TECH, P61; Tanguay P, 2013, PHYTOPATHOLOGY, V103, P143; Tomback DF, 2007, PHYS GEOGR, V28, P397, DOI 10.2747/0272-3646.28.5.397; Vialle A, 2013, MOL PHYLOGENET EVOL, V66, P628, DOI 10.1016/j.ympev.2012.10.021; Washburn LF, 1917, WORK ON PINE BLISTER; Zambino PJ, 2007, PLANT DIS, V91, P467, DOI 10.1094/PDIS-91-4-0467A; Zambino PJ, 2010, FOREST PATHOL, V40, P264, DOI 10.1111/j.1439-0329.2010.00658.x	56	13	13	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127916	10.1371/journal.pone.0127916	http://dx.doi.org/10.1371/journal.pone.0127916			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010250	gold, Green Published, Green Submitted			2022-12-26	WOS:000355183900165
J	de Moraes, ACF; Cassenote, AJF; Leclercq, C; Dallongeville, J; Androutsos, O; Torok, K; Gonzalez-Gross, M; Widhalm, K; Kafatos, A; Carvalho, HB; Moreno, LA				Ferreira de Moraes, Augusto Cesar; Cassenote, Alex Jones Flores; Leclercq, Catherine; Dallongeville, Jean; Androutsos, Odysseas; Toeroek, Katalin; Gonzalez-Gross, Marcela; Widhalm, Kurt; Kafatos, Anthony; Carvalho, Heraclito Barbosa; Alberto Moreno, Luis			Resting Heart Rate Is Not a Good Predictor of a Clustered Cardiovascular Risk Score in Adolescents: The HELENA Study	PLOS ONE			English	Article							SYMPATHETIC NEURAL ACTIVATION; HEALTHY LIFE-STYLE; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; OBESITY; HYPERTENSION; PREVALENCE; OVERWEIGHT; NUTRITION; EUROPE	Background Resting heart rate (RHR) reflects sympathetic nerve activity a significant association between RHR and all-cause and cardiovascular mortality has been reported in some epidemiologic studies. Methods To analyze the predictive power and accuracy of RHR as a screening measure for individual and clustered cardiovascular risk in adolescents. The study comprised 769 European adolescents (376 boys) participating in the HELENA cross-sectional study (2006-2008) were included in this study. Measurements on systolic blood pressure, HOMA index, triglycerides, TC/HDL-c, VO(2)max and the sum of four skinfolds were obtained, and a clustered cardiovascular disease (CVD) risk index was computed. The receiver operating characteristics curve was applied to calculate the power and accuracy of RHR to predict individual and clustered CVD risk factors. Results RHR showed low accuracy for screening CVD risk factors in both sexes (range 38.5%-54.4% in boys and 45.5%-54.3% in girls). Low specificity's (15.6%-19.7% in boys; 18.1%-20.0% in girls) were also found. Nevertheless, the sensitivities were moderate-to-high (61.4%-89.1% in boys; 72.9%-90.3% in girls). Conclusion RHR is a poor predictor of individual CVD risk factors and of clustered CVD and the estimates based on RHR are not accurate. The use of RHR as an indicator of CVD risk in adolescents may produce a biased screening of cardiovascular health in both sexes.	[Ferreira de Moraes, Augusto Cesar; Carvalho, Heraclito Barbosa] Univ Sao Paulo, Sch Med, YCARE Youth Child & cARdiovasc Risk & Environm Re, Sao Paulo, Brazil; [Ferreira de Moraes, Augusto Cesar; Alberto Moreno, Luis] Univ Zaragoza, Fac Ciencias Salud, GENUD Growth Exercise Nutr & Dev Res Grp, Zaragoza, Spain; [Cassenote, Alex Jones Flores] Univ Sao Paulo, Sch Med, Dept Infect & Parasit Dis, Sao Paulo, Brazil; [Ferreira de Moraes, Augusto Cesar; Carvalho, Heraclito Barbosa; Alberto Moreno, Luis] Univ Sao Paulo, Sch Med, Dept Prevent Med, Sao Paulo, Brazil; [Leclercq, Catherine] Natl Inst Food & Nutr Res, Rome, Italy; [Dallongeville, Jean] Inst Pasteur, F-59019 Lille, France; [Androutsos, Odysseas] Harokopio Univ, Dept Nutr & Dietet, Athens, Greece; [Toeroek, Katalin] Univ Pecs, Fac Med, Dept Paediat, Pecs, Hungary; [Gonzalez-Gross, Marcela] Tech Univ Madrid, Fac Phys Act & Sport INEF, Dept Hlth & Human Performance, Madrid, Spain; [Gonzalez-Gross, Marcela] Univ Bonn, Rhein Friedrich Wilhelms, Inst Ernahrungs & Lebensmittelwissensch Humanemah, Dortmund, Germany; [Widhalm, Kurt] Private Med Univ Salzburg, Dept Paediat, Salzburg, Austria; [Kafatos, Anthony] Univ Crete Herakl, Sch Med, Prevent Med & Nutr Unit, Iraklion, NE, Greece	Universidade de Sao Paulo; University of Zaragoza; Universidade de Sao Paulo; Universidade de Sao Paulo; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Harokopio University Athens; University of Pecs; Universidad Politecnica de Madrid; University of Bonn; University of Crete	de Moraes, ACF (corresponding author), Univ Sao Paulo, Sch Med, YCARE Youth Child & cARdiovasc Risk & Environm Re, Sao Paulo, Brazil.	augustocesar.demoraes@usp.br	Gonzalez-Gross, Marcela/W-8000-2018; Cassenote, Alex/C-4220-2013; Androutsos, Odysseas/ABF-8670-2021; Ferreira De Moraes, Augusto César/D-2198-2009; Carvalho, Heráclito/C-1334-2012; Moreno, Luis/S-1780-2019	Ferreira De Moraes, Augusto César/0000-0002-5763-435X; Carvalho, Heráclito/0000-0002-7037-5655; Moreno, Luis/0000-0003-0454-653X; Gonzalez-Gross, Marcela/0000-0001-7757-3235; Leclercq, Catherine/0000-0002-9416-7738	European Community Sixth RTD Framework Programme [FOOD-CT-2005-007034]; Spanish Ministry of Health: Maternal, Child Health and Development Network [RD08/0072]; Spanish Ministry of Education [EX-2008-0641]; Swedish Heart-Lung Foundation [20090635]; Sao Paulo Research Foundation - FAPESP [proc. 2011/11137-1, 2011/20662-2, proc. 2014/13367-2, proc. 2013/18158-1]; Post-Doctoral scholarship from the Brazilian Government from the National Counsel of Technological and Scientific Development - CNPq [proc. 471266/2013-2, 313772/2014-2]; Brazilian government by Science without Borders Program by CNPq (National Counsel of Technological and Scientific Development); CAPES (Coordination of Improvement of Higher Education Personnel) [proc. 007/2012]; European Regional Development Fund (MICINN-FEDER)	European Community Sixth RTD Framework Programme(European Commission); Spanish Ministry of Health: Maternal, Child Health and Development Network(Spanish Government); Spanish Ministry of Education(Spanish Government); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Post-Doctoral scholarship from the Brazilian Government from the National Counsel of Technological and Scientific Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Brazilian government by Science without Borders Program by CNPq (National Counsel of Technological and Scientific Development); CAPES (Coordination of Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); European Regional Development Fund (MICINN-FEDER)	The HELENA Study takes place with the financial support of the European Community Sixth RTD Framework Programme (contract FOOD-CT-2005-007034). The writing group takes sole responsibility for the content of this article. This study was also supported by granta from the Spanish Ministry of Health: Maternal, Child Health and Development Network (number RD08/0072), the Spanish Ministry of Education (EX-2008-0641) and the Swedish Heart-Lung Foundation (20090635). Augusto Cesar F. de Moraes was given a PhD Student scholarship from the Sao Paulo Research Foundation - FAPESP (proc. 2011/11137-1 and 2011/20662-2) and a Post-Doctoral scholarship from the Brazilian Government from the National Counsel of Technological and Scientific Development - CNPq (proc. 471266/2013-2 and 313772/2014-2) and the Sao Paulo Research Foundation - FAPESP (proc. 2014/13367-2). Alex Jones Flores Cassenote was given a PhD Student scholarship from the Sao Paulo Research Foundation - FAPESP (proc. 2013/18158-1). Luis A. Moreno was given a visiting professor scholarship from the Brazilian government by Science without Borders Program by CNPq (National Counsel of Technological and Scientific Development) and CAPES (Coordination of Improvement of Higher Education Personnel) (proc. 007/2012). The GENUD Research Group was co-financed by the European Regional Development Fund (MICINN-FEDER).	Alvarez GE, 2002, CIRCULATION, V106, P2533, DOI 10.1161/01.CIR.0000041244.79165.25; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Beghin L, 2008, INT J OBESITY, V32, pS12, DOI 10.1038/ijo.2008.179; Bemelmans RHH, 2013, INT J CARDIOL, V168, P1410, DOI 10.1016/j.ijcard.2012.12.043; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; Esler M, 2006, HYPERTENSION, V48, P787, DOI 10.1161/01.HYP.0000242642.42177.49; Falkner B, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0449-5; Fernandes RA, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-48; Fernandes RA, 2011, J PEDIATR-US, V158, P634, DOI 10.1016/j.jpeds.2010.10.007; de Moraes ACF, 2009, CAD SAUDE PUBLICA, V25, P1195, DOI 10.1590/S0102-311X2009000600002; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Grassi G, 1998, J HYPERTENS, V16, P1635, DOI 10.1097/00004872-199816110-00010; Guidolin M, 2012, SLEEP MED, V13, P779, DOI 10.1016/j.sleep.2012.03.016; Huggett RJ, 2004, HYPERTENSION, V44, P847, DOI 10.1161/01.HYP.0000147893.08533.d8; Iliescu C, 2008, INT J OBESITY, V32, pS19, DOI 10.1038/ijo.2008.178; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moreno LA, 2008, INT J OBESITY, V32, pS4, DOI 10.1038/ijo.2008.177; Moreno LA, 2008, PUBLIC HEALTH NUTR, V11, P288, DOI 10.1017/S1368980007000535; Ortega FB, 2008, INT J OBESITY, V32, pS49, DOI 10.1038/ijo.2008.183; Ortega FB, 2011, BRIT J SPORT MED, V45, P20, DOI 10.1136/bjsm.2009.062679; Palatini P, 2004, CLIN EXP HYPERTENS, V26, P637, DOI 10.1081/CEH-200031959; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Pocock SJ, 2006, EUR HEART J, V27, P65, DOI 10.1093/eurheartj/ehi555; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Rey-Lopez JP, 2013, NUTR METAB CARDIOVAS, V23, P1017, DOI 10.1016/j.numecd.2012.06.006; Roux AVD, 2008, J EPIDEMIOL COMMUN H, V62, P957, DOI 10.1136/jech.2007.064311; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Syme C, 2008, ARCH PEDIAT ADOL MED, V162, P453, DOI 10.1001/archpedi.162.5.453; Topouchian JA, 2006, BLOOD PRESS MONIT, V11, P165, DOI 10.1097/01.mbp.0000209078.17246.34; Weise M, 2002, J CLIN ENDOCR METAB, V87, P5038, DOI 10.1210/jc.2002-020590	35	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127530	10.1371/journal.pone.0127530	http://dx.doi.org/10.1371/journal.pone.0127530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010248	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900105
J	Kashimshetty, Y; Pelikan, S; Rogstad, SH				Kashimshetty, Yamini; Pelikan, Stephan; Rogstad, Steven H.			Variable Gene Dispersal Conditions and Spatial Deforestation Patterns Can Interact to Affect Tropical Tree Conservation Outcomes	PLOS ONE			English	Article							RAIN-FOREST; SYMPHONIA-GLOBULIFERA; POLLEN DISPERSAL; HABITAT FRAGMENTATION; SEED DISPERSAL; IMPACTS; DYNAMICS; FLOW; POPULATION; DIVERSITY	Tropical lowland rain forest (TLRF) biodiversity is under threat from anthropogenic factors including deforestation which creates forest fragments of different sizes that can further undergo various internal patterns of logging. Such interventions can modify previous equilibrium abundance and spatial distribution patterns of offspring recruitment and/or pollen dispersal. Little is known about how these aspects of deforestation and fragmentation might synergistically affect TLRF tree recovery demographics and population genetics in newly formed forest fragments. To investigate these TLRF anthropogenic disturbance processes we used the computer program NEWGARDEN (NG), which models spatially-explicit, individual-based plant populations, to simulate 10% deforestation in six different spatial logging patterns for the plant functional type of a long-lived TLRF canopy tree species. Further, each logging pattern was analyzed under nine varying patterns of offspring versus pollen dispersal distances that could have arisen post-fragmentation. Results indicated that gene dispersal condition (especially via offspring) had a greater effect on population growth and genetic diversity retention (explaining 98.5% and 88.8% of the variance respectively) than spatial logging pattern (0.2% and 4.7% respectively), with 'Near' distance dispersal maximizing population growth and genetic diversity relative to distant dispersal. Within logged regions of the fragment, deforestation patterns closer to fragment borders more often exhibited lower population recovery rates and founding genetic diversity retention relative to more centrally located logging. These results suggest newly isolated fragments have populations that are more sensitive to the way in which their offspring and pollen dispersers are affected than the spatial pattern in which subsequent logging occurs, and that large variation in the recovery rates of different TLRF tree species attributable to altered gene dispersal regimens will be a likely outcome of fragmentation. Conservation implications include possible manual interventions (manual manipulations of offspring dispersers and/or pollinators) in forest fragments to increase population recovery and genetic diversity retention.	[Kashimshetty, Yamini; Rogstad, Steven H.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45220 USA; [Pelikan, Stephan] Univ Cincinnati, Dept Math Sci, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Rogstad, SH (corresponding author), Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45220 USA.	steven.rogstad@uc.edu			University of Cincinnati - Department of Biological Sciences: Wiemen-Wendel Benedict grant; Ohio Plant Biotechnology Consortium OPBC [2014-008]; Ohio State University Ohio Agricultural Research and Development Center	University of Cincinnati - Department of Biological Sciences: Wiemen-Wendel Benedict grant; Ohio Plant Biotechnology Consortium OPBC; Ohio State University Ohio Agricultural Research and Development Center(Ohio State University)	1. University of Cincinnati - Department of Biological Sciences: Wiemen-Wendel Benedict grant (2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2. Ohio Plant Biotechnology Consortium OPBC 2014-008 (includes funding from The Ohio State University Ohio Agricultural Research and Development Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilee R, 2013, EVOLUTION, V67, P792, DOI 10.1111/j.1558-5646.2012.01816.x; Aldrich PR, 1998, SCIENCE, V281, P103, DOI 10.1126/science.281.5373.103; Allendorf FW, 2001, CONSERV GENET, P124; AlvarezBuylla ER, 1996, ANNU REV ECOL SYST, V27, P387, DOI 10.1146/annurev.ecolsys.27.1.387; Babweteera F, 2010, J TROP ECOL, V26, P193, DOI 10.1017/S026646740999054X; Baraloto C, 2012, J APPL ECOL, V49, P861, DOI 10.1111/j.1365-2664.2012.02164.x; Beckman NG, 2013, BIOTROPICA, V45, P666, DOI 10.1111/btp.12071; Berens DG, 2013, OIKOS, V122, P1616, DOI 10.1111/j.1600-0706.2013.00515.x; BERRYMAN AA, 1991, OECOLOGIA, V86, P140, DOI 10.1007/BF00317401; Blount ZD, 2012, NATURE, V489, P513, DOI 10.1038/nature11514; Budde KB, 2013, HEREDITY, V111, P66, DOI 10.1038/hdy.2013.21; Bugmann H, 2001, CLIMATIC CHANGE, V51, P259, DOI 10.1023/A:1012525626267; Carneiro FS, 2011, FOREST ECOL MANAG, V262, P1758, DOI 10.1016/j.foreco.2011.07.023; Carneiro FD, 2009, FOREST ECOL MANAG, V258, P1260, DOI 10.1016/j.foreco.2009.06.019; CHUDNOFF M, 1980, TROPICAL TIMBERS WOR; Clark DA, 1994, J ECOL, V82, P856; Condit R, 1999, PHILOS T R SOC B, V354, P1739, DOI 10.1098/rstb.1999.0517; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Corlett T, 2010, TROPICAL RAIN FOREST, P33; Da Silva EF, 2008, BIODIVERSITY BIOAVAI, V2, P35; Degen B, 2004, HEREDITY, V93, P585, DOI 10.1038/sj.hdy.6800560; Figueroa-Esquivel EM, 2010, REV MEX BIODIVERS, V81, P789; Forest Research Institute of Malaysia (FRIM), 1993, DISTR TREE SPEC 50 H; Gaveau DLA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101654; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Gill GE, 1998, BIOTROPICA, V30, P139, DOI 10.1111/j.1744-7429.1998.tb00378.x; GRIMES A, 1994, AMBIO, V23, P405; Guariguata MR, 2002, BIOTROPICA, V34, P405, DOI 10.1111/j.1744-7429.2002.tb00554.x; Hamilton MB, 1999, NATURE, V401, P129, DOI 10.1038/43597; Hartl DL, 1997, PRINCIPLES POPULATIO, P257; Haymes KL, 2012, AM J BOT, V99, P640, DOI 10.3732/ajb.1100339; Hill JK, 2011, PHILOS T R SOC B, V366, P3265, DOI 10.1098/rstb.2011.0050; Huth A, 2001, FOREST ECOL MANAG, V142, P33, DOI 10.1016/S0378-1127(00)00338-8; Jennings SB, 2001, FOREST ECOL MANAG, V154, P1, DOI 10.1016/S0378-1127(00)00637-X; Kashimshetty Y, 2012, GENETIC DIVERSITY IN PLANTS, P375; Kettle CJ, 2014, CONSERV GENET, V15, P1265, DOI 10.1007/s10592-014-0673-1; Kircher J, 2011, TROPICAL ECOLOGY, P6; Kohler P, 2000, J TROP ECOL, V16, P591, DOI 10.1017/S0266467400001590; Korfanta NM, 2012, ECOLOGY, V93, P2548, DOI 10.1890/11-1345.1; Landsberg J, 2011, TERR ECOL SER, V4, P221, DOI 10.1016/S1936-7961(11)04008-5; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; LIU JG, 1995, FOREST ECOL MANAG, V73, P157, DOI 10.1016/0378-1127(94)03490-N; Lowe AJ, 2005, HEREDITY, V95, P255, DOI 10.1038/sj.hdy.6800725; Metcalf CJE, 2009, ECOLOGY, V90, P2766, DOI 10.1890/08-1645.1; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Paul J, 2013, CONSERV GENET, V14, P195, DOI 10.1007/s10592-012-0443-x; Pearce D, 2003, FOREST ECOL MANAG, V172, P229, DOI 10.1016/S0378-1127(01)00798-8; Pelikan S, WEED SCI; Pelikan S, 2013, CONSERV GENET RESOUR, V5, P857, DOI 10.1007/s12686-013-9869-9; Putz FE, 2008, FOREST ECOL MANAG, V256, P1427, DOI 10.1016/j.foreco.2008.03.036; Quesada M, 2013, AM J BOT, V100, P1095, DOI 10.3732/ajb.1200542; Reisch C, 2014, PLANT ECOL, V215, P1493, DOI 10.1007/s11258-014-0409-9; Rogstad S. H., 2011, GENETIC DIVERSITY ES; Rogstad SH, 2013, AM J PLANT SCI, V4, P1932; Rogstad SH, 2013, SUSTAINABILITY-BASEL, V5, P1304, DOI 10.3390/su5031304; Rosa IMD, 2014, GLOBAL CHANGE BIOL, V20, P1707, DOI 10.1111/gcb.12523; Rumana R, 2009, TREES-STRUCT FUNCT, V23, P521; Schulke B, 2001, OECOLOGIA, V127, P239, DOI 10.1007/s004420000586; Sist P, 2014, FOREST ECOL MANAG, V318, P103, DOI 10.1016/j.foreco.2014.01.005; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Soria-Carrasco V, 2014, SCIENCE, V344, P738, DOI 10.1126/science.1252136; Vanclay J, 2003, CAN J FOREST RES, V33, P536, DOI [10.1139/x02-117, 10.1139/X02-117]; Vinson CC, 2015, MOL ECOL, V24, P38, DOI 10.1111/mec.13002; Ward M, 2005, HEREDITY, V95, P246, DOI 10.1038/sj.hdy.6800712; West TAP, 2014, FOREST ECOL MANAG, V314, P59, DOI 10.1016/j.foreco.2013.11.022; Zanella CM, 2011, AM J BOT, V98, P1511, DOI 10.3732/ajb.1000458; Zhao L, 2014, SCIENCE, V343, P769, DOI 10.1126/science.1248286	72	4	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127745	10.1371/journal.pone.0127745	http://dx.doi.org/10.1371/journal.pone.0127745			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000951	gold, Green Submitted, Green Published			2022-12-26	WOS:000354931700080
J	Li, JY; Wang, QH; Cui, Y; Yang, XQ; Li, Y; Zhang, XY; Qiu, MS; Zhang, Z; Zhang, ZY				Li, Jianying; Wang, Qihui; Cui, Ying; Yang, Xueqin; Li, Yan; Zhang, Xiaoyun; Qiu, Mengsheng; Zhang, Ze; Zhang, Zunyi			Suppressor of Fused Is Required for Determining Digit Number and Identity via Gli3/Fgfs/Gremlin	PLOS ONE			English	Article							LIMB-BUD; VERTEBRATE LIMB; INDEPENDENT REGULATION; TARGETED DISRUPTION; ACTIVATOR FUNCTION; MOUSE LIMB; GLI3; HEDGEHOG; SHH; REPRESSOR	The anterior-posterior patterning of the vertebrate limb bud requires closely coordinated signaling interactions, including Sonic Hedgehog (Shh)-mediated counteraction of the Gli3 transcription factor in the distal and posterior mesenchyme of the limb bud. Suppressor of Fused (Sufu), an intracellular negative regulator of Shh signaling via Gli2 and Gli3, is implicated in early development of the mouse limb bud. However, how Sufu is involved in the genetic regulation of limb bud patterning still remains elusive. In this study, we show that the conditional deletion of Sufu in the mesenchyme of the early limb bud results in polydactyly with loss of digit identity and supernumerary bones in the wrist and the ankle. These pattern alterations are associated with anterior expansion of HoxD genes located at the 5' end of the cluster. By focusing on gene expression analysis of Shh/Gremlin1/Fgf signaling critical for the establishment and maintenance of anterior-posterior patterning, we show that early response to loss of Sufu involves anterior prolongation of Fgf4 and Fgf8 expression in the apical ectodermal ridge at E10.5. We also reveal the anterior activation of Shh-dependent posterior markers Ptc1, Gli1 and Gremlin in limb buds lacking Sufu. Furthermore, we find that loss of Sufu leads to attenuated levels of repressor Gli2 and repressor Gli3 in the early limb bud. Moreover, expression of Hand2 is activated in the entire limb bud at the early outgrowth stage in the mutant lacking Sufu. Thus, we provide evidence that Sufu is involved in the genetic network that restricts the posterior expression of Gli2/3/Hand2 and Gremlin/Fgf in limb bud patterning.	[Li, Jianying; Wang, Qihui; Cui, Ying; Yang, Xueqin; Li, Yan; Zhang, Xiaoyun; Qiu, Mengsheng; Zhang, Zunyi] Hangzhou Normal Univ, Coll Life & Environm Sci, Inst Dev & Regenerat Biol, Zhejiang Key Lab Organogenesis & Regenerat Techno, Hangzhou 310036, Zhejiang, Peoples R China; [Qiu, Mengsheng] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Zhang, Ze] Tulane Univ, Med Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA	Hangzhou Normal University; University of Louisville; Tulane University	Zhang, ZY (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Inst Dev & Regenerat Biol, Zhejiang Key Lab Organogenesis & Regenerat Techno, Hangzhou 310036, Zhejiang, Peoples R China.	zunyi.zhang@idrbio.org		Li, Jianying/0000-0003-1488-8322	National Natural Science Foundation of China [31201089, 31071287, 31371471]; Natural Science Foundation of Zhejiang Province [LZ12C12002]; Science and Technology Support of Zhejing [2013C37024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Science and Technology Support of Zhejing	This work was supported by the following grants: The National Natural Science Foundation of China (31201089),(31071287) and (31371471); The Natural Science Foundation of Zhejiang Province (LZ12C12002); and Science and Technology Support of Zhejing (2013C37024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CB, 2002, DEVELOPMENT, V129, P4753; Biesecker LG, 1997, NAT GENET, V17, P259, DOI 10.1038/ng1197-259; Boulet AM, 2004, DEV BIOL, V273, P361, DOI 10.1016/j.ydbio.2004.06.012; Bowers M, 2012, DEV BIOL, V370, P110, DOI 10.1016/j.ydbio.2012.07.017; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; DAVIS AP, 1994, DEVELOPMENT, V120, P2187; Fernandez-Teran M, 2008, INT J DEV BIOL, V52, P857, DOI 10.1387/ijdb.072416mf; Hill P, 2007, HUM MOL GENET, V16, P2089, DOI 10.1093/hmg/ddm156; Hill P, 2009, DEV BIOL, V328, P506, DOI 10.1016/j.ydbio.2009.02.017; Hsu SHC, 2012, J BIOL CHEM, V287, P36222, DOI 10.1074/jbc.M112.382275; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Jia JP, 2009, DEV BIOL, V330, P452, DOI 10.1016/j.ydbio.2009.04.009; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Kim JJ, 2011, J NEUROSCI, V31, P1825, DOI 10.1523/JNEUROSCI.2166-10.2011; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Liu JL, 2012, DEV BIOL, V362, P141, DOI 10.1016/j.ydbio.2011.11.022; McGlinn E, 2005, MECH DEVELOP, V122, P1218, DOI 10.1016/j.mod.2005.06.012; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Panman L, 2006, DEVELOPMENT, V133, P3419, DOI 10.1242/dev.02529; Park HL, 2000, DEVELOPMENT, V127, P1593; Pearse RV, 1999, DEV BIOL, V212, P323, DOI 10.1006/dbio.1999.9335; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Ruel L, 2009, GENE DEV, V23, P1843, DOI 10.1101/gad.1838109; Simon-Chazottes D, 2000, MAMM GENOME, V11, P614, DOI 10.1007/s003350010144; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Verheyden JM, 2008, NATURE, V454, P638, DOI 10.1038/nature07085; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang CB, 2007, DEV BIOL, V305, P460, DOI 10.1016/j.ydbio.2007.02.029; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Welscher PT, 2002, GENE DEV, V16, P421, DOI 10.1101/gad.219202; Wild A, 1997, HUM MOL GENET, V6, P1979, DOI 10.1093/hmg/6.11.1979; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhang ZY, 2000, DEV BIOL, V220, P154, DOI 10.1006/dbio.2000.9637; Zhu X, 2014, J DENT RES, V93, P582, DOI 10.1177/0022034514531985; Zhu XJ, 2013, J BIOL CHEM, V288, P12080, DOI 10.1074/jbc.M113.462473; Zhulyn O, 2014, DEV CELL, V29, P241, DOI 10.1016/j.devcel.2014.03.002; Zuniga A, 1999, DEVELOPMENT, V126, P13	42	17	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0128006	10.1371/journal.pone.0128006	http://dx.doi.org/10.1371/journal.pone.0128006			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001200	Green Published, Green Submitted, gold			2022-12-26	WOS:000354931700097
J	Wan, PJ; Yuan, SY; Tang, YH; Li, KL; Yang, L; Fu, Q; Li, GQ				Wan, Pin-Jun; Yuan, San-Yue; Tang, Yao-Hua; Li, Kai-Long; Yang, Lu; Fu, Qiang; Li, Guo-Qing			Pathways of Amino Acid Degradation in Nilaparvata lugens (Stal) with Special Reference to Lysine-Ketoglutarate Reductase/Saccharopine Dehydrogenase (LKR/SDH)	PLOS ONE			English	Article							SYRUP-URINE-DISEASE; RAPESEED LEAF DISCS; YEAST-LIKE SYMBIOTE; BROWN PLANTHOPPER; SACCHAROPINE DEHYDROGENASE; SEMIALDEHYDE SYNTHASE; RT-PCR; REDUCTASE; DELPHACIDAE; CATABOLISM	Nilaparvata lugens harbors yeast-like symbionts (YLSs). In present paper, a genome-wide analysis found 115 genes from Ni. lugens and 90 genes from YLSs that were involved in the metabolic degradation of 20 proteinogenic amino acids. These 205 genes encoded for 77 enzymes. Accordingly, the degradation pathways for the 20 amino acids were manually constructed. It is postulated that Ni. lugens can independently degrade fourteen amino acids (threonine, alanine, glycine, serine, aspartate, asparagine, phenylalanine, tyrosine, glutamate, glutamine, proline, histidine, leucine and lysine). Ni. lugens and YLSs enzymes may work collaboratively to break down tryptophan, cysteine, arginine, isoleucine, methionine and valine. We cloned a lysine-ketoglutarate reductase/saccharopine dehydrogenase gene (Nllkr/sdh) that encoded a bifunctional enzyme catalyzing the first two steps of lysine catabolism. Nllkr/sdh is widely expressed in the first through fifth instar nymphs and adults, and is highly expressed in the fat body, ovary and gut in adults. Ingestion of dsNllkr/sdh by nymphs successfully knocked down the target gene, and caused nymphal/adult mortality, shortened nymphal development stage and reduced adult fresh weight. Moreover, Nllkr/sdh knockdown resulted in three defects: wings were shortened and thickened; cuticles were stretched and thinned; and old nymphal cuticles remained on the tips of legs and abdomen and were not completely shed. These data indicate that impaired lysine degradation negatively affects the survival and development of Ni. lugens.	[Wan, Pin-Jun; Yuan, San-Yue; Tang, Yao-Hua; Li, Kai-Long; Yang, Lu; Fu, Qiang] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China; [Wan, Pin-Jun; Yuan, San-Yue; Yang, Lu; Li, Guo-Qing] Nanjing Agr Univ, Coll Plant Protect, Educ Minist, Key Lab Integrated Management Crop Dis & Pests, Nanjing 210095, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Nanjing Agricultural University	Fu, Q (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou 310006, Zhejiang, Peoples R China.	fuqiang@caas.cn; ligq@njau.edu.cn	Li, Kailong/AGZ-1532-2022	Li, Kailong/0000-0003-2386-6897	National Natural Science Foundation of China [31371939, 30370937]; Zhejiang Provincial Natural Science Foundation of China [LQ15C140005]; China National Rice Institute	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); China National Rice Institute	This research was supported by the National Natural Science Foundation of China (31371939 and 30370937) and Zhejiang Provincial Natural Science Foundation of China (LQ15C140005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors confirm that China National Rice Institute provided support in the form of salaries for authors Pin-Jun Wan, San-Yue Yuan, Yao-Hua Tang, Kai-Long Li, Lu Yang, and Qiang Fu, but did not have any additional role in the study design, data collection and analysis and decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amaral AU, 2010, BRAIN RES, V1324, P75, DOI 10.1016/j.brainres.2010.02.018; Araujo P, 2001, NEUROCHEM INT, V38, P529, DOI 10.1016/S0197-0186(00)00100-5; Bao YY, 2010, J INSECT PHYSIOL, V56, P1087, DOI 10.1016/j.jinsphys.2010.03.004; Battur B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007136; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cakouros D, 2008, J CELL BIOL, V182, P481, DOI 10.1083/jcb.200712169; Chapman RF, THE INSECTS STRUCTUR; CHEN CC, 1981, Z ANGEW ENTOMOL, V92, P440; Cheng DJ, 2001, TISSUE CELL, V33, P273, DOI 10.1054/tice.2001.0173; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Deleu C, 1999, PLANT CELL ENVIRON, V22, P979, DOI 10.1046/j.1365-3040.1999.00471.x; Dong SZ, 2011, CURR MICROBIOL, V62, P1133, DOI 10.1007/s00284-010-9830-z; Epelbaum S, 1997, PLANT MOL BIOL, V35, P735, DOI 10.1023/A:1005808923191; FOSTER AR, 1993, NUTR RES, V13, P1433, DOI 10.1016/S0271-5317(05)80792-4; Fu Q, 2001, APPL ENTOMOL ZOOL, V36, P111, DOI 10.1303/aez.2001.111; Fu Qiang, 2001, Acta Entomologica Sinica, V44, P534; FUKUMORITA T, 1982, PLANT CELL PHYSIOL, V23, P273; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; HIGASHINO K, 1971, ARCH BIOCHEM BIOPHYS, V142, P606, DOI 10.1016/0003-9861(71)90525-X; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; HUTZLER J, 1975, BIOCHIM BIOPHYS ACTA, V377, P42, DOI 10.1016/0005-2744(75)90284-3; Jia S, 2013, GENE, V531, P168, DOI 10.1016/j.gene.2013.09.034; Jia S, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-19; KARCHI H, 1995, PLANT CELL, V7, P1963, DOI 10.1105/tpc.7.11.1963; KARCHI H, 1994, P NATL ACAD SCI USA, V91, P2577, DOI 10.1073/pnas.91.7.2577; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; MARKOVITZ PJ, 1984, J BIOL CHEM, V259, P1643; Mitchell JJ, 2011, GENET MED, V13, P697, DOI 10.1097/GIM.0b013e3182141b48; Moulin M, 2006, PLANT PHYSIOL BIOCH, V44, P474, DOI 10.1016/j.plaphy.2006.08.005; Moulin M, 2000, PLANT PHYSIOL BIOCH, V38, P577, DOI 10.1016/S0981-9428(00)00777-4; NODA C, 1978, BIOCHIM BIOPHYS ACTA, V525, P307, DOI 10.1016/0005-2744(78)90225-5; Papes F, 1999, BIOCHEM J, V344, P555, DOI 10.1042/0264-6021:3440555; Papes F, 2001, FEBS LETT, V488, P34, DOI 10.1016/S0014-5793(00)02401-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Schonberger S, 2004, MOL GENET METAB, V82, P69, DOI 10.1016/j.ymgme.2004.01.016; SHINNO H, 1980, BIOCHIM BIOPHYS ACTA, V633, P310, DOI 10.1016/0304-4165(80)90190-7; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Tavares RG, 2000, J NEUROL SCI, V181, P44, DOI 10.1016/S0022-510X(00)00402-0; Tondo M, 2013, MOL GENET METAB, V110, P231, DOI 10.1016/j.ymgme.2013.06.021; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan PJ, 2014, INSECT MOL BIOL, V23, P152, DOI 10.1111/imb.12069; Wilson ACC, 2010, INSECT MOL BIOL, V19, P249, DOI 10.1111/j.1365-2583.2009.00942.x; Wingglesworth VB, 1967, THE PRINCIPLES OF IN; Xue J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0521-0; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503	49	13	14	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127789	10.1371/journal.pone.0127789	http://dx.doi.org/10.1371/journal.pone.0127789			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000452	Green Published, gold, Green Submitted			2022-12-26	WOS:000354931700084
J	Whay, HR; Dikshit, AK; Hockenhull, J; Parker, RMA; Banerjee, A; Hughes, SI; Pritchard, JC; Reix, CE				Whay, Helen R.; Dikshit, Amit K.; Hockenhull, Jo; Parker, Richard M. A.; Banerjee, Anindo; Hughes, Sue I.; Pritchard, Joy C.; Reix, Christine E.			Evaluation of Changes in Equine Care and Limb-Related Abnormalities in Working Horses in Jaipur, India, as Part of a Two Year Participatory Intervention Study	PLOS ONE			English	Article							QUALITATIVE RESEARCH; DEVELOPING-COUNTRIES; WELFARE; HEALTH; BEHAVIOR; DONKEYS; MULES	Background Previous studies have found the prevalence of lameness in working horses to be 90-100%. Risk factors for lameness in this important equine population, together with risk-reduction strategies adopted by their owners, are poorly understood. The objective was to uncover risk factors for lameness and limb abnormalities in working horses, by associating clinical lameness examination findings on three occasions over two years with owner reported changes in equine management and work practices over this period. Methodology/Principal Findings Twenty-one communities of horse owners in Jaipur, India, took part in a participatory intervention (PI) project aiming to reduce risk factors for poor welfare, particularly lameness and limb problems. Associations between quantitative measures of equine lameness/limb abnormalities and reported changes in management and work practices were compared with 21 control (C) communities of owners where no intervention had taken place. Key findings from 'complete cases', where the same horse stayed with the same owner for the whole study period (PI group = 73 owners of 83 horses, C group = 58 owners of 66 horses), were that more positive statements of change in equine management and work practices were made by PI group owners than C group owners. A mixed picture of potential risk factors emerged: some reported management improvements, for example reducing the weight of the load for cart animals, were associated with improved limbs and lameness, and others, such as making improvements in shoeing and increasing the age at which their animals started work, with negative outcomes. Conclusions/Significance This study illustrates the complexity and interacting nature of risk factors for lameness in working horses, and highlights the importance of longitudinal investigations that recognise and address this. PI group owners found the project useful and requested similar inputs in future. Our findings demonstrate the value of exploratory and participatory research methodology in the field of working horse welfare.	[Whay, Helen R.; Hockenhull, Jo; Parker, Richard M. A.; Hughes, Sue I.; Reix, Christine E.] Univ Bristol, Sch Vet Sci, North Somerset, England; [Dikshit, Amit K.] Help Suffering, Jaipur, Rajasthan, India; [Banerjee, Anindo] Praxis Inst Participatory Practices, New Delhi, India; [Pritchard, Joy C.] Anim Int Dev, Banwell, North Somerset, England; [Pritchard, Joy C.; Reix, Christine E.] Brooke, Friars Bridge Court, London, England	University of Bristol	Whay, HR (corresponding author), Univ Bristol, Sch Vet Sci, Langford House, North Somerset, England.	bec.whay@bristol.ac.uk	Banerjee, Anindo/GVT-8729-2022	Parker, Richard/0000-0002-3933-9728; Hockenhull, Jo/0000-0002-9224-7304	Brooke	Brooke	This study was funded by The Brooke (www.thebrooke.org/).	Abeyasekera S., 2001, SOCIOECONOMIC METHOD; Babbie ER, 2007, PRACTICE SOCIAL RES, P44; Bazeley, 2007, QUALITATIVE DATA ANA; Britten N, 2011, PATIENT EDUC COUNS, V82, P384, DOI 10.1016/j.pec.2010.12.021; Broster CE, 2009, EQUINE VET J, V41, P474, DOI 10.2746/042516409X373907; Broster CE, 2010, P 6 INT C WORK EQ NE, P9; Burn CC, 2010, VET J, V186, P385, DOI 10.1016/j.tvjl.2009.09.016; Christley RM, 2010, EQUINE VET J, V42, P285, DOI 10.1111/j.2042-3306.2010.00074.x; Conroy C, 2005, PARTICIPATORY LIVEST, P58; Forman J, 2008, AM J INFECT CONTROL, V36, P764, DOI 10.1016/j.ajic.2008.03.010; FRANKEL S, 1991, BRIT J GEN PRACT, V41, P428; Jones H., 2011, 330 OV DEV I; Kumar S., 2002, METHODS COMMUNITY PA; Litva A, 2010, EQUINE VET J, V42, P288, DOI 10.1111/j.2042-3306.2009.00025.x; Morgan RE, 2006, INT MARKET REV, V23, P5; Murray RC, 2010, VET J, V184, P27, DOI 10.1016/j.tvjl.2009.03.020; Nagy A, 2010, EQUINE VET J, V42, P637, DOI 10.1111/j.2042-3306.2010.00220.x; Pritchard JC, 2005, PREV VET MED, V69, P265, DOI 10.1016/j.prevetmed.2005.02.002; Rasbash J, 2009, USERS GUIDE MLWIN V2; Rasbash J., 2010, MLWIN VERSION 2 22; Reix CE, PLOS ONE IN PRESS, VIn press; Rogers CW, 2008, EQUINE VET J, V40, P119, DOI 10.2746/042516408X266088; Upjohn MM, 2013, PREV VET MED, V108, P313, DOI 10.1016/j.prevetmed.2012.11.008; Whay HR, 2007, ANIM WELFARE, V16, P117; Whay H. R., 2010, The 6th International Colloquium on Working Equids: learning from others. Proceedings of an International Colloquium, New Delhi, India, 29 November - 2 December 2010, P67; Williams RB, 2001, EQUINE VET J, V33, P478, DOI 10.2746/042516401776254808; Wuest J, 2011, QUAL HEALTH RES, V21, P875, DOI 10.1177/1049732311401424	27	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126160	10.1371/journal.pone.0126160	http://dx.doi.org/10.1371/journal.pone.0126160			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000967	Green Published, gold, Green Submitted			2022-12-26	WOS:000354931700011
J	Alyahya, SA; Nolan, ST; Smith, CMR; Bishai, WR; Sadoff, J; Lamichhane, G				Alyahya, S. Anisah; Nolan, Scott T.; Smith, Cara M. R.; Bishai, William R.; Sadoff, Jerald; Lamichhane, Gyanu			Immunogenicity without Efficacy of an Adenoviral Tuberculosis Vaccine in a Stringent Mouse Model for Immunotherapy during Treatment	PLOS ONE			English	Article							T-CELL EPITOPES; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSES; MURINE MODEL; INFECTION; PROTECTION; LUNGS; MICE; CD4; CHEMOTHERAPY	To investigate if bacterial persistence during TB drug treatment could be overcome by modulation of host immunity, we adapted a clinically-relevant model developed for the evaluation of new drugs and examined if immunotherapy with two adenoviral vaccines, Ad35-TBS (AERAS-402) and Ad26-TBS, could shorten therapy in mice. Even though immunotherapy resulted in strong splenic IFN-gamma responses, no effect on bacterial replication in the lungs was seen. Multiplex assay analysis of lung samples revealed the absence of cytokine augmentation such as IFN-gamma, TNF-alpha and IL-2, suggesting that immunization failed to induce immunity in the lungs. In this model, we show that IFN-gamma levels were not associated with protection against disease relapse. The results obtained from our study raise questions regarding the traits of protective TB immunity that are relevant for the development of future immunotherapeutic and post-exposure vaccination strategies.	[Alyahya, S. Anisah; Sadoff, Jerald] Crucell Holland BV, Janssen Infect Dis & Vaccines, Leiden, Netherlands; [Nolan, Scott T.; Smith, Cara M. R.; Bishai, William R.; Lamichhane, Gyanu] Johns Hopkins Univ, Sch Med, Dept Med, Ctr TB Res, Baltimore, MD 21205 USA; [Bishai, William R.] Johns Hopkins Univ, Sch Med, HHMI, Baltimore, MD 21205 USA	Johnson & Johnson; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Alyahya, SA (corresponding author), Crucell Holland BV, Janssen Infect Dis & Vaccines, Leiden, Netherlands.	anisah.alyahya@gmail.com; JSadoff@its.jnj.com; lamichhane@jhu.edu		Alyahya, S. Anisah/0000-0002-8209-8528; Lamichhane, Gyanu/0000-0002-2214-0114	internal grant from Crucell Holland BV	internal grant from Crucell Holland BV	The study was funded by an internal grant from Crucell Holland BV. JS and SAA are current and former employees of Crucell Holland BV, respectively. Crucell Holland BV provided support in the form of salaries for authors JS and SAA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304; Bold TD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002063; BURKE DS, 1993, VACCINE, V11, P795, DOI 10.1016/0264-410X(93)90354-Z; Cardona PJ, 2005, VACCINE, V23, P1393, DOI 10.1016/j.vaccine.2004.09.008; Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392; Cohn DL, 2000, CLIN INFECT DIS, V31, P120, DOI 10.1086/313891; Coler RN, 2013, J INFECT DIS, V207, P1242, DOI 10.1093/infdis/jis425; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; D'Souza S, 2003, INFECT IMMUN, V71, P483, DOI 10.1128/IAI.71.1.483-493.2003; Darrah PA, 2014, J IMMUNOL, V193, P1799, DOI 10.4049/jimmunol.1400676; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Egen JG, 2011, IMMUNITY, V34, P807, DOI 10.1016/j.immuni.2011.03.022; Gil O, 2006, MICROBES INFECT, V8, P628, DOI 10.1016/j.micinf.2005.08.014; Gonzalez-Juarrero M, 2005, J LEUKOCYTE BIOL, V77, P914, DOI 10.1189/jlb.1204723; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Groschel MI, 2014, VACCINE, V32, P3162, DOI 10.1016/j.vaccine.2014.03.047; Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003; Havenga M, 2006, J GEN VIROL, V87, P2135, DOI 10.1099/vir.0.81956-0; Hoff DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017550; Johnson JL, 2009, AM J RESP CRIT CARE, V180, P558, DOI 10.1164/rccm.200904-0536OC; Kagina BMN, 2014, VACCINE, V32, P5908, DOI 10.1016/j.vaccine.2014.09.001; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Lazarevic V, 2005, J IMMUNOL, V175, P1107, DOI 10.4049/jimmunol.175.2.1107; Lindenstrom T, 2014, EUR J IMMUNOL, V44, P1699, DOI 10.1002/eji.201344358; Lindenstrom T, 2013, J IMMUNOL, V190, P6311, DOI 10.4049/jimmunol.1300248; Nuermberger E, 2008, SEMIN RESP CRIT CARE, V29, P542, DOI 10.1055/s-0028-1085705; Nunes-Alves C, 2014, NAT REV MICROBIOL, V12, P289, DOI 10.1038/nrmicro3230; Orme IM, 2014, TUBERCULOSIS, V94, P8, DOI 10.1016/j.tube.2013.07.004; Pooran A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054587; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Regoes RR, 2005, PLOS MED, V2, P798, DOI 10.1371/journal.pmed.0020249; Rothchild AC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003805; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Silva CL, 2005, GENE THER, V12, P281, DOI 10.1038/sj.gt.3302418; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Tasneen R, 2011, ANTIMICROB AGENTS CH, V55, P5485, DOI 10.1128/AAC.05293-11; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Weichold FF, 2007, GENES IMMUN, V8, P334, DOI 10.1038/sj.gene.6364392; Williams KN, 2009, AM J RESP CRIT CARE, V180, P371, DOI 10.1164/rccm.200904-0611OC	42	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127907	10.1371/journal.pone.0127907	http://dx.doi.org/10.1371/journal.pone.0127907			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996375	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000096
J	Li, HG; Hung, PH; Suarez, SS				Li, Honggang; Hung, Pei-hsuan; Suarez, Susan S.			Ejaculated Mouse Sperm Enter Cumulus-Oocyte Complexes More Efficiently In Vitro than Epididymal Sperm	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; SEMINAL PLASMA; CAPACITATION; SPERMATOZOA; MOTILITY; SVS2; MICE; MECHANISMS; INITIATION; FLAGELLAR	The mouse is an established and popular animal model for studying reproductive biology. Epididymal mouse sperm, which lack exposure to secretions of male accessory glands and do not precisely represent ejaculated sperm for the study of sperm functions, have been almost exclusively used in studies. We compared ejaculated and epididymal sperm in an in vitro fertilization setting to examine whether ejaculated sperm enter cumulus-oocyte complexes more efficiently. In order to prepare sperm for fertilization, they were incubated under capacitating conditions. At the outset of incubation, ejaculated sperm stuck to the glass surfaces of slides and the incidences of sticking decreased with time; whereas, very few epididymal sperm stuck to glass at any time point, indicating differences in surface charge. At the end of the capacitating incubation, when sperm were added to cumulus-oocyte complexes, the form of flagellar movement differed dramatically; specifically, ejaculated sperm predominantly exhibited increased bending on one side of the flagellum (a process termed pro-hook hyperactivation), while epididymal sperm equally exhibited increased bending on one or the other side of the flagellum (pro-hook or anti-hook hyperactivation). This indicates that accessory sex gland secretions might have modified Ca2+ signaling activities in sperm, because the two forms of hyperactivation are reported to be triggered by different Ca2+ signaling patterns. Lastly, over time, more ejaculated than epididymal sperm entered the cumulus oocyte complexes. We concluded that modification of sperm by male accessory gland secretions affects the behavior of ejaculated sperm, possibly providing them with an advantage over epididymal sperm for reaching the eggs in vivo.	[Li, Honggang] Huazhong Univ Sci & Technol, Tongji Med Coll, Family Planning Res Inst, Wuhan 430074, Peoples R China; [Li, Honggang] Wuhan Tongji Reprod Med Hosp, Wuhan, Peoples R China; [Hung, Pei-hsuan; Suarez, Susan S.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA	Huazhong University of Science & Technology; Cornell University	Suarez, SS (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.	sss7@cornell.edu			National Natural Science Foundation of China [31271249]; National Institutes of Health [1R03HD062471]; National Institutes of Child Health and Human Development [T32HD052471]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD052471] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD062471] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Natural Science Foundation of China grant 31271249 to HL, National Institutes of Health Grant 1R03HD062471 to SSS, and National Institutes of Child Health and Human Development grant T32HD052471 to PHH.	BEDFORD JM, 1993, J EXP ZOOL, V265, P321, DOI 10.1002/jez.1402650314; BEDFORD JM, 1992, J ANDROL, V13, P444; Bromfield JJ, 2014, P NATL ACAD SCI USA, V111, P2200, DOI 10.1073/pnas.1305609111; Chang HX, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096578; Chang HX, 2011, BIOL REPROD, V85, P296, DOI 10.1095/biolreprod.110.089789; Chang HX, 2010, BIOL REPROD, V83, P507, DOI 10.1095/biolreprod.109.083113; GalantinoHomer HL, 1997, BIOL REPROD, V56, P707, DOI 10.1095/biolreprod56.3.707; Gwathmey TM, 2006, BIOL REPROD, V75, P501, DOI 10.1095/biolreprod.106.053306; Gwathmey TM, 2003, BIOL REPROD, V69, P809, DOI 10.1095/biolreprod.102.010827; HARRISON RAP, 1982, J EXP ZOOL, V222, P81, DOI 10.1002/jez.1402220111; He Q, 2010, REPRODUCTION, V140, P903, DOI 10.1530/REP-10-0178; Ho HC, 2001, BIOL REPROD, V65, P1606, DOI 10.1095/biolreprod65.5.1606; Hung PH, 2010, SOC REPROD FERTIL, V67, P257; Hung PH, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099721; KALAB P, 1994, J BIOL CHEM, V269, P3810; Kawano N, 2007, BIOL REPROD, V76, P353, DOI 10.1095/biolreprod.106.056887; Kawano N, 2014, P NATL ACAD SCI USA, V111, P4145, DOI 10.1073/pnas.1320715111; Kawano N, 2008, BIOL REPROD, V79, P1153, DOI 10.1095/biolreprod.108.069054; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Songsasen N, 1998, LAB ANIM SCI, V48, P275; Spehr M, 2006, MOL CELL ENDOCRINOL, V250, P128, DOI 10.1016/j.mce.2005.12.035; SUAREZ SS, 1987, BIOL REPROD, V36, P1191, DOI 10.1095/biolreprod36.5.1191; Tecirlioglu RT, 2002, REPROD FERT DEVELOP, V14, P471, DOI 10.1071/RD02050; Tecirlioglu RT, 2002, REPROD FERT DEVELOP, V14, P363, DOI 10.1071/RD02015; Tseng HC, 2013, J CELL BIOCHEM, V114, P888, DOI 10.1002/jcb.24428; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; Wennemuth G, 2003, DEVELOPMENT, V130, P1317, DOI 10.1242/dev.00353; Yamauchi Y, 2007, BIOL REPROD, V76, P1002, DOI 10.1095/biolreprod.106.059881	28	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127753	10.1371/journal.pone.0127753	http://dx.doi.org/10.1371/journal.pone.0127753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996155	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000085
J	Srivastava, A; Arya, P; Goel, S; Kundu, B; Mishra, P; Fnu, A				Srivastava, Ankit; Arya, Prabha; Goel, Surbhi; Kundu, Bishwajit; Mishra, Prashant; Fnu, Ashish			Gelsolin Amyloidogenesis Is Effectively Modulated by Curcumin and Emetine Conjugated PLGA Nanoparticles	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ISLET AMYLOID POLYPEPTIDE; DRUG-DELIVERY; BETA PEPTIDE; AROMATIC INTERACTIONS; ALZHEIMERS-DISEASE; FIBRIL FORMATION; ALPHA-SYNUCLEIN; PROTEIN; MECHANISM	Small molecule based therapeutic intervention of amyloids has been limited by their low solubility and poor pharmacokinetic characteristics. We report here, the use of water soluble poly lactic-co-glycolic acid (PLGA)-encapsulated curcumin and emetine nanoparticles (Cm-NPs and Em-NPs, respectively), as potential modulators of gelsolin amyloidogenesis. Using the amyloid-specific dye Thioflavin T (ThT) as an indicator along with electron microscopic imaging we show that the presence of Cm-NPs augmented amyloid formation in gelsolin by skipping the pre-fibrillar assemblies, while Em-NPs induced non-fibrillar aggregates. These two types of aggregates differed in their morphologies, surface hydrophobicity and secondary structural signatures, confirming that they followed distinct pathways. In spite of differences, both these aggregates displayed reduced toxicity against SH-SY5Y human neuroblastoma cells as compared to control gelsolin amyloids. We conclude that the cytotoxicity of gelsolin amyloids can be reduced by either stalling or accelerating its fibrillation process. In addition, Cm-NPs increased the fibrillar bulk while Em-NPs defibrillated the pre-formed gelsolin amyloids. Moreover, amyloid modulation happened at a much lower concentration and at a faster rate by the PLGA encapsulated compounds as compared to their free forms. Thus, besides improving pharmacokinetic and biocompatible properties of curcumin and emetine, PLGA conjugation elevates the therapeutic potential of both small molecules against amyloid fibrillation and toxicity.	[Srivastava, Ankit; Kundu, Bishwajit] IIT Delhi, Kusuma Sch Biol Sci, New Delhi, India; [Arya, Prabha; Goel, Surbhi; Mishra, Prashant] IIT Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India; [Fnu, Ashish] CSIR, Inst Microbial Technol, Chandigarh 160036, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Kundu, B (corresponding author), IIT Delhi, Kusuma Sch Biol Sci, New Delhi, India.	bkundu@bioschool.iitd.ac.in	Mishra, Prashant/R-4701-2019	Kundu, Bishwajit/0000-0002-5786-3144	Indian Council of Medical Research, Government of India	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	The work was supported by funding from The Indian Council of Medical Research, Government of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad E, 2013, J BIOMOL STRUCT DYN, V31, P630, DOI 10.1080/07391102.2012.706081; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Arya P, 2014, ACS CHEM NEUROSCI, V5, P982, DOI 10.1021/cn500002v; Bao G, 2013, ANNU REV BIOMED ENG, V15, P253, DOI 10.1146/annurev-bioeng-071812-152409; Belluti F, 2013, EXPERT OPIN THER PAT, V23, P581, DOI 10.1517/13543776.2013.772983; Bhatia NK, 2015, BBA-PROTEINS PROTEOM, V1854, P426, DOI 10.1016/j.bbapap.2015.01.014; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen-Sela E, 2009, J CONTROL RELEASE, V133, P90, DOI 10.1016/j.jconrel.2008.09.073; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Gan CW, 2010, BIOMATERIALS, V31, P7748, DOI 10.1016/j.biomaterials.2010.06.053; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Gillmore JD, 2006, NAT CLIN PRACT NEPHR, V2, P263, DOI 10.1038/ncpneph0169; GROLLMAN AP, 1966, P NATL ACAD SCI USA, V56, P1867, DOI 10.1073/pnas.56.6.1867; Jagur-Grodzinski J, 1999, REACT FUNCT POLYM, V39, P99, DOI 10.1016/S1381-5148(98)00054-6; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jayaprabha KN, 2015, RSC ADV, V5, P22117, DOI 10.1039/c4ra16044d; Kato Y, 2013, J BIOL CHEM, V288, P25109, DOI 10.1074/jbc.M113.477695; Khan JM, 2014, SOFT MATTER, V10, P2591, DOI 10.1039/c3sm52435c; Kreuter J, 2013, J MICROENCAPSUL, V30, P49, DOI 10.3109/02652048.2012.692491; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Ladiwala ARA, 2011, J BIOL CHEM, V286, P3209, DOI 10.1074/jbc.M110.173856; Li JY, 2013, NANOTECHNOL REV, V2, P241, DOI 10.1515/ntrev-2012-0084; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Mohd I, 2015, RSC ADV, V5, P18218; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Murakami H, 1999, INT J PHARM, V187, P143, DOI 10.1016/S0378-5173(99)00187-8; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Peddada N, 2013, J BIOL CHEM, V288, P28266, DOI 10.1074/jbc.M113.463224; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Powers ET, 2008, BIOPHYS J, V94, P379, DOI 10.1529/biophysj.107.117168; Prigent S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043273; Rabbani G, 2014, COLLOID SURFACE B, V123, P96, DOI 10.1016/j.colsurfb.2014.08.035; Rabbani G, 2012, CELL BIOCHEM BIOPHYS, V62, P487, DOI 10.1007/s12013-011-9335-9; Rana A, 2009, CHEM-BIOL INTERACT, V181, P282, DOI 10.1016/j.cbi.2009.07.021; Ratnaswamy G, 1999, CHEM BIOL, V6, P293, DOI 10.1016/S1074-5521(99)80075-1; Ridgley DM, 2011, BIOMACROMOLECULES, V12, P3770, DOI 10.1021/bm201005k; Sero L, 2013, MOLECULES, V18, P14320, DOI 10.3390/molecules181114320; Shankarayan R, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1496-6; Shivu B, 2013, BIOCHEMISTRY-US, V52, P5176, DOI 10.1021/bi400625v; Silva GA, 2007, SURG NEUROL, V67, P113, DOI 10.1016/j.surneu.2006.08.033; Singh PK, 2013, ACS CHEM NEUROSCI, V4, P393, DOI 10.1021/cn3001203; Solomon JP, 2012, CRIT REV BIOCHEM MOL, V47, P282, DOI 10.3109/10409238.2012.661401; Solomon JP, 2011, BIOCHEMISTRY-US, V50, P2486, DOI 10.1021/bi101905n; Stewart LA, 2008, NEUROLOGY, V70, P1272, DOI 10.1212/01.wnl.0000308955.25760.c2; Tihanyi K, 2011, SOLUBILITY, DELIVERY AND ADME PROBLEMS OF DRUGS AND DRUG CANDIDATES, P1; Tomar R, 2013, FEBS J, V280, P2688, DOI 10.1111/febs.12271; Tu LH, 2013, BIOCHEMISTRY-US, V52, P333, DOI 10.1021/bi3014278; Wilczewska AZ, 2012, PHARMACOL REP, V64, P1020, DOI 10.1016/S1734-1140(12)70901-5; Williams TL, 2011, FEBS J, V278, P3905, DOI 10.1111/j.1742-4658.2011.08228.x; Wohlfart S, 2012, J CONTROL RELEASE, V161, P264, DOI 10.1016/j.jconrel.2011.08.017; Wu WH, 2008, BIOCHEM BIOPH RES CO, V373, P315, DOI 10.1016/j.bbrc.2008.06.035; Zaman M, 2014, INT J NANOMED, V9, P899, DOI 10.2147/IJN.S54171; Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400	58	20	20	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127011	10.1371/journal.pone.0127011	http://dx.doi.org/10.1371/journal.pone.0127011			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996685	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000039
J	Cao, RY; Rossetti, G; Bauer, A; Carloni, P				Cao, Ruyin; Rossetti, Giulia; Bauer, Andreas; Carloni, Paolo			Binding of the Antagonist Caffeine to the Human Adenosine Receptor hA(2A)R in Nearly Physiological Conditions	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CHOLESTEROL INTERACTION; STRUCTURAL STABILITY; A(2A) RECEPTOR; FORCE-FIELD; ACTIVATION; HYDRATION; MODEL; PHOSPHATIDYLCHOLINE; FLUCTUATIONS	Lipid composition may significantly affect membrane proteins function, yet its impact on the protein structural determinants is not well understood. Here we present a comparative molecular dynamics (MD) study of the human adenosine receptor type 2A (hA(2A)R) in complex with caffeine-a system of high neuro-pharmacological relevance-within different membrane types. These are POPC, mixed POPC/POPE and cholesterol-rich membranes. 0.8-mu s MD simulations unambiguously show that the helical folding of the amphipathic helix 8 depends on membrane contents. Most importantly, the distinct cholesterol binding into the cleft between helix 1 and 2 stabilizes a specific caffeine-binding pose against others visited during the simulation. Hence, cholesterol presence (similar to 33%-50% in synaptic membrane in central nervous system), often neglected in X-ray determination of membrane proteins, affects the population of the ligand binding poses. We conclude that including a correct description of neuronal membranes may be very important for computer-aided design of ligands targeting hA(2A)R and possibly other GPCRs.	[Cao, Ruyin; Rossetti, Giulia; Carloni, Paolo] Joint Venture RWTH Aachen Univ, German Res Sch Simulat Sci, D-52425 Julich, Germany; [Cao, Ruyin; Rossetti, Giulia; Carloni, Paolo] Forschungszentrum Julich GmbH, D-52425 Julich, Germany; [Cao, Ruyin; Rossetti, Giulia; Carloni, Paolo] Forschungszentrum Julich GmbH, Inst Adv Simulat IAS 5, Computat Biomed, D-52425 Julich, Germany; [Rossetti, Giulia; Carloni, Paolo] Forschungszentrum Julich GmbH, Inst Neurosci & Med INM 9, D-52425 Julich, Germany; [Rossetti, Giulia] Forschungszentrum Julich GmbH, Julich Supercomp Ctr, D-52425 Julich, Germany; [Bauer, Andreas] Forschungszentrum Julich GmbH, Inst Neurosci & Med INM 2, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich	Rossetti, G (corresponding author), Joint Venture RWTH Aachen Univ, German Res Sch Simulat Sci, D-52425 Julich, Germany.	g.rossetti@grs-sim.de	Rossetti, Giulia/G-3473-2018; Bauer, Andreas/H-8759-2013; Rossetti, Giulia/U-2448-2019	Rossetti, Giulia/0000-0002-2032-4630; Bauer, Andreas/0000-0002-0117-3793; Rossetti, Giulia/0000-0002-2032-4630; Carloni, Paolo/0000-0002-9010-0149	Julich Supercomputing Centre (JSC)	Julich Supercomputing Centre (JSC)	Julich Supercomputing Centre (JSC) provided support in the form of a salary for author GR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Allen M.P., 1989, PHYS TODAY, V42, P105, DOI [10.1063/1.2810937, DOI 10.1063/1.2810937]; Allen WJ, 2009, J COMPUT CHEM, V30, P1952, DOI 10.1002/jcc.21172; Armentero MT, 2011, PHARMACOL THERAPEUT, V132, P280, DOI 10.1016/j.pharmthera.2011.07.004; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t; Bruno A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042023; Caliandro R, 2012, J CHEM THEORY COMPUT, V8, P4775, DOI 10.1021/ct300610y; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Ciruela F, 2010, BBA-BIOMEMBRANES, V1798, P9, DOI 10.1016/j.bbamem.2009.10.016; Congreve M, 2012, J MED CHEM, V55, P1898, DOI 10.1021/jm201376w; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dibenedetto D, 2013, BIOCHEMISTRY-US, V52, P6672, DOI 10.1021/bi400367r; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Douna H, 2012, OPEN PHARM J, V6, P12, DOI DOI 10.2174/1874143601206010012; Elmore DE, 2006, FEBS LETT, V580, P144, DOI 10.1016/j.febslet.2005.11.064; FINK JS, 1992, MOL BRAIN RES, V14, P186, DOI 10.1016/0169-328X(92)90173-9; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Frisch G. W., 2013, GAUSSIAN 09; Ghahremanpour MM, 2014, BIOINFORMATICS, V30, P439, DOI 10.1093/bioinformatics/btt680; Gomes CV, 2011, BBA-BIOMEMBRANES, V1808, P1380, DOI 10.1016/j.bbamem.2010.12.001; Grossfield A, 2008, J MOL BIOL, V381, P478, DOI 10.1016/j.jmb.2008.05.036; Grossfield A, 2009, ANN REP COMP CHEM, V5, P23, DOI 10.1016/S1574-1400(09)00502-7; Gsandtner I, 2006, MOL PHARMACOL, V70, P447, DOI 10.1124/mol.106.026757; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunenberger P, 2005, ADV POLYM SCI, V173, P105, DOI 10.1007/b99427; Hung WC, 2007, BIOPHYS J, V92, P3960, DOI 10.1529/biophysj.106.099234; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; JACOBSON KA, 1987, J MED CHEM, V30, P211, DOI 10.1021/jm00384a037; Jambeck JPM, 2012, J CHEM THEORY COMPUT, V8, P2938, DOI 10.1021/ct300342n; Jambeck JPM, 2012, J PHYS CHEM B, V116, P3164, DOI 10.1021/jp212503e; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jurkiewicz P, 2012, BBA-BIOMEMBRANES, V1818, P609, DOI 10.1016/j.bbamem.2011.11.033; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Katragadda M, 2004, BBA-BIOMEMBRANES, V1663, P74, DOI 10.1016/j.bbamem.2004.01.012; Khelashvili G, 2009, PROTEINS, V76, P403, DOI 10.1002/prot.22355; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lee JY, 2012, J AM CHEM SOC, V134, P16512, DOI 10.1021/ja307532d; Lee JY, 2012, BIOPHYS J, V102, P2114, DOI 10.1016/j.bpj.2012.03.061; Li JN, 2013, J AM CHEM SOC, V135, P8749, DOI 10.1021/ja404391q; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Liu YL, 2011, J PHYS CHEM B, V115, P13880, DOI 10.1021/jp2022049; Lyman E, 2009, STRUCTURE, V17, P1660, DOI 10.1016/j.str.2009.10.010; Mahmood MI, 2013, CHEM PHARM BULL, V61, P426; McIntosh TJ, 1996, CHEM PHYS LIPIDS, V81, P117, DOI 10.1016/0009-3084(96)02577-7; Mori A, 1996, ADV BEHAV BIOL, V47, P119; Murzyn K, 2005, BIOPHYS J, V88, P1091, DOI 10.1529/biophysj.104.048835; Musiani F, 2013, BIOCHEMISTRY-US, V52, P2949, DOI 10.1021/bi4001744; Nakaso K, 2008, NEUROSCI LETT, V432, P146, DOI 10.1016/j.neulet.2007.12.034; Ng HW, 2013, J CHEM INF MODEL, V53, P1168, DOI 10.1021/ci300610w; Niu SL, 2002, J BIOL CHEM, V277, P20139, DOI 10.1074/jbc.M200594200; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pang XQ, 2013, PROTEINS, V81, P1399, DOI 10.1002/prot.24283; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pfrieger FW, 2003, BBA-BIOMEMBRANES, V1610, P271, DOI 10.1016/S0005-2736(03)00024-5; Postuma RB, 2012, NEUROLOGY, V79, P651, DOI 10.1212/WNL.0b013e318263570d; Pucadyil TJ, 2004, BBA-BIOMEMBRANES, V1663, P188, DOI 10.1016/j.bbamem.2004.03.010; Rivera-Oliver M, 2014, LIFE SCI, V101, P1, DOI 10.1016/j.lfs.2014.01.083; Rodriguez D, 2011, BIOCHEMISTRY-US, V50, P4194, DOI 10.1021/bi200100t; Ross GW, 2000, JAMA-J AM MED ASSOC, V283, P2674, DOI 10.1001/jama.283.20.2674; Sabbadin D, 2014, J CHEM INF MODEL, V54, P169, DOI 10.1021/ci400532b; Serebryany E, 2012, BBA-BIOMEMBRANES, V1818, P225, DOI 10.1016/j.bbamem.2011.07.047; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Soubias O, 2012, BBA-BIOMEMBRANES, V1818, P234, DOI 10.1016/j.bbamem.2011.08.034; Soubias O, 2010, BIOPHYS J, V99, P817, DOI 10.1016/j.bpj.2010.04.068; STONE WL, 1979, EXP EYE RES, V28, P387, DOI 10.1016/0014-4835(79)90114-3; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	75	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126833	10.1371/journal.pone.0126833	http://dx.doi.org/10.1371/journal.pone.0126833			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992797	gold, Green Published, Green Submitted			2022-12-26	WOS:000354921400079
J	Wang, H; Sun, RW; Gu, M; Li, S; Zhang, B; Chi, ZF; Hao, LC				Wang, Hong; Sun, Ruowen; Gu, Min; Li, Shuang; Zhang, Bin; Chi, Zuofei; Hao, Liangchun			shRNA-Mediated Silencing of Y-Box Binding Protein-1 (YB-1) Suppresses Growth of Neuroblastoma Cell SH-SY5Y In Vitro and In Vivo	PLOS ONE			English	Article							TRANSCRIPTION FACTOR YB-1; GENE-EXPRESSION; NUCLEAR EXPRESSION; DRUG-RESISTANCE; CYCLE CONTROL; CANCER; APOPTOSIS; INHIBITION; TARGET; MARKER	Y-box binding protein-1 (YB-1), a member of cold-shock protein superfamily, has been demonstrated to be associated with tumor malignancy, and is proposed as a prognostic marker in multiple carcinomas. However, the role of YB-1 in neuroblastoma has not been well studied. To investigate the functional role of YB-1 in neuroblastoma, we established a YB-1-silenced neuroblastoma cell strain by inhibiting YB-1 expression using a shRNA knockdown approach. YB-1-silenced neuroblastoma SH-SY5Y cells exhibited a pronounced reduction in cell proliferation and an increased rate of apoptosis in vitro and in vivo xenograft tumor model. At molecular level, YB-1 silencing resulted in downregulation of Cyclin A, Cyclin D1 and Bcl-2, as well as upregulated levels of Bax, cleaved caspase-3 and cleaved PARP-1. We further demonstrated that YB-1 transcriptionally regulated Cyclin D1 expression by chromatin-immunoprecipitation and luciferase reporter assays. In addition, xenograft tumors derived from neuroblastoma SH-SY5Y cell line were treated with YB-1 shRNA plasmids by intra-tumor injection, and YB-1 targeting effectively inhibited tumor growth and induced cell death. In summary, our findings suggest that YB-1 plays a critical role in neuroblastoma development, and it may serve as a potential target for neuroblastoma therapy.	[Wang, Hong; Sun, Ruowen; Gu, Min; Li, Shuang; Zhang, Bin; Chi, Zuofei; Hao, Liangchun] China Med Univ, Shengjing Hosp, Hematol Ctr, Dept Pediat Hematol Oncol, Shenyang, Peoples R China	China Medical University	Wang, H (corresponding author), China Med Univ, Shengjing Hosp, Hematol Ctr, Dept Pediat Hematol Oncol, Shenyang, Peoples R China.	hongwang1012@163.com			National Natural Science Foundation of China [81101528]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by a grant from the National Natural Science Foundation of China (No.: 81101528), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astanehe A, 2012, ONCOGENE, V31, P4434, DOI 10.1038/onc.2011.617; Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; BIEDLER JL, 1973, CANCER RES, V33, P2643; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Chatterjee M, 2008, BLOOD, V111, P3714, DOI 10.1182/blood-2007-05-089151; Chen XM, 2012, DNA CELL BIOL, V31, P1107, DOI 10.1089/dna.2011.1521; Das S, 2007, J BIOL CHEM, V282, P28474, DOI 10.1074/jbc.M704672200; Davydova EK, 1997, NUCLEIC ACIDS RES, V25, P2911, DOI 10.1093/nar/25.14.2911; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; En-Nia A, 2005, J BIOL CHEM, V280, P7702, DOI 10.1074/jbc.M413353200; Fujiwara-Okada Y, 2013, BRIT J CANCER, V108, P836, DOI 10.1038/bjc.2012.579; Gao YY, 2009, MOL CANCER THER, V8, P3276, DOI 10.1158/1535-7163.MCT-09-0478; Gautschi O, 2007, LUNG CANCER, V55, P1, DOI 10.1016/j.lungcan.2006.09.024; Geier A, 2003, BIOCHEM BIOPH RES CO, V309, P612, DOI 10.1016/j.bbrc.2003.08.041; Gimenez-Bonafe P, 2004, PROSTATE, V59, P337, DOI 10.1002/pros.20023; Harada M, 2014, GENES CELLS, V19, P504, DOI 10.1111/gtc.12150; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; Homer C, 2005, ONCOGENE, V24, P8314, DOI 10.1038/sj.onc.1208998; Huschka R, 2012, ACS NANO, V6, P7681, DOI 10.1021/nn301135w; Janz M, 2002, INT J CANCER, V97, P278, DOI 10.1002/ijc.1610; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Jurchott K, 2003, J BIOL CHEM, V278, P27988, DOI 10.1074/jbc.M212966200; Kamura T, 1999, CANCER, V85, P2450, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2450::AID-CNCR21>3.0.CO;2-U; Lasham A, 2003, J BIOL CHEM, V278, P35516, DOI 10.1074/jbc.M303920200; Lasham A, 2000, GENE, V252, P1, DOI 10.1016/S0378-1119(00)00220-1; Lasham A, 2013, BIOCHEM J, V449, P11, DOI 10.1042/BJ20121323; Lasham A, 2012, JNCI-J NATL CANCER I, V104, P133, DOI 10.1093/jnci/djr512; Lee C, 2008, CANCER RES, V68, P8661, DOI 10.1158/0008-5472.CAN-08-1082; Lee MH, 2003, CANCER METAST REV, V22, P435, DOI 10.1023/A:1023785332315; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Ohga T, 1996, CANCER RES, V56, P4224; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Ponten J, 1971, Virol Monogr, V8, P1; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Schittek B, 2007, INT J CANCER, V120, P2110, DOI 10.1002/ijc.22512; Seton-Rogers S, 2012, NAT REV CANCER, V12, DOI 10.1038/nrc3281; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Shibahara K, 2001, CLIN CANCER RES, V7, P3151; Shibao K, 1999, INT J CANCER, V83, P732; Shimada H, 1999, CANCER, V86, P364, DOI 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.3.CO;2-Z; Shiota M, 2011, BJU INT, V108, pE142, DOI 10.1111/j.1464-410X.2010.09810.x; Simpson DJ, 2001, CARCINOGENESIS, V22, P1801, DOI 10.1093/carcin/22.11.1801; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Vermes I, 1995, ANNEXIN 5, V184, P39, DOI [DOI 10.1016/0022-1759(95)00072-I), DOI 10.1016/0022-1759(95)00072-I]; Wachowiak R, 2010, ANTICANCER RES, V30, P1239; Yalcin B, 2010, COCHRANE DB SYST REV, DOI [10.1002/1465185.CD006301.pub2, 10.1002/14651858.CD006301.pub2]; Zheng J, 2012, ACTA BIOCH BIOPH SIN, V44, P1006, DOI 10.1093/abbs/gms089; Zheng J, 2009, ACTA BIOCH BIOPH SIN, V41, P980, DOI 10.1093/abbs/gmp092	51	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127224	10.1371/journal.pone.0127224	http://dx.doi.org/10.1371/journal.pone.0127224			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993060	gold, Green Submitted, Green Published			2022-12-26	WOS:000354918600055
J	Nabeka, H; Shimokawa, T; Doihara, T; Saito, S; Wakisaka, H; Hamada, F; Kobayashi, N; Matsuda, S				Nabeka, Hiroaki; Shimokawa, Tetsuya; Doihara, Takuya; Saito, Shouichiro; Wakisaka, Hiroyuki; Hamada, Fumihiko; Kobayashi, Naoto; Matsuda, Seiji			A Prosaposin-Derived Peptide Alleviates Kainic Acid-Induced Brain Injury	PLOS ONE			English	Article							FACIAL-NERVE TRANSECTION; CELL-DEATH PREVENTION; IN-VIVO; QUANTITATIVE-ANALYSIS; NEUROTROPHIC FACTOR; ACTIVATOR PROTEINS; NEURONAL DAMAGE; RAT HIPPOCAMPUS; SCHWANN-CELLS; EXPRESSION	Four sphingolipid activator proteins (i.e., saposins A-D) are synthesized from a single precursor protein, prosaposin (PS), which exerts exogenous neurotrophic effects in vivo and in vitro. Kainic acid (KA) injection in rodents is a good model in which to study neurotrophic factor elevation; PS and its mRNA are increased in neurons and the choroid plexus in this animal model. An 18-mer peptide (LSELIINNATEELLIKGL; PS18) derived from the PS neurotrophic region prevents neuronal damage after ischemia, and PS18 is a potent candidate molecule for use in alleviating ischemia-induced learning disabilities and neuronal loss. KA is a glutamate analog that stimulates excitatory neurotransmitter release and induces ischemia-like neuronal degeneration; it has been used to define mechanisms involved in neurodegeneration and neuroprotection. In the present study, we demonstrate that a subcutaneous injection of 0.2 and 2.0 mg/kg PS18 significantly improved behavioral deficits of Wistar rats (n = 6 per group), and enhanced the survival of hippocampal and cortical neurons against neurotoxicity induced by 12 mg/kg KA compared with control animals. PS18 significantly protected hippocampal synapses against KA-induced destruction. To evaluate the extent of PS18- and KA-induced effects in these hippocampal regions, we performed histological evaluations using semithin sections stained with toluidine blue, as well as ordinal sections stained with hematoxylin and eosin. We revealed a distinctive feature of KA-induced brain injury, which reportedly mimics ischemia, but affects a much wider area than ischemia-induced injury: KA induced neuronal degeneration not only in the CA1 region, where neurons degenerate following ischemia, but also in the CA2, CA3, and CA4 hippocampal regions.	[Nabeka, Hiroaki; Shimokawa, Tetsuya; Doihara, Takuya; Matsuda, Seiji] Ehime Univ, Grad Sch Med, Dept Anat & Embryol, Toon, Ehime, Japan; [Saito, Shouichiro] Gifu Univ, Fac Appl Biol Sci, Lab Vet Anat, Gifu, Japan; [Wakisaka, Hiroyuki] Ehime Prefectural Univ Hlth Sci, Iyo, Ehime, Japan; [Hamada, Fumihiko] Oita Univ, Fuculty Med, Dept Human Anat, Yufu, Oita, Japan; [Kobayashi, Naoto] Ehime Univ, Grad Sch Med, Med Educ Ctr, Toon, Ehime, Japan	Ehime University; Gifu University; Oita University; Ehime University	Nabeka, H (corresponding author), Ehime Univ, Grad Sch Med, Dept Anat & Embryol, Toon, Ehime, Japan.	nabeka@m.ehime-u.ac.jp			Japan Society for the Promotion of Science [22591637, 19659380, 22591979, 25450466]; Ehime University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ehime University	This study was supported in part by Grants-in-Aid for Scientific Research to SM (22591637, 19659380), NK (22591979), TS (25450466) from the Japan Society for the Promotion of Science and in part by a grant to HN from Ehime University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Campana WM, 1996, BIOCHEM BIOPH RES CO, V229, P706, DOI 10.1006/bbrc.1996.1869; Campana WM, 1998, FASEB J, V12, P307, DOI 10.1096/fasebj.12.3.307; Campana WM, 1998, NEUROTOXICOLOGY, V19, P237; Chen J, 2008, NEUROSCI RES, V60, P82, DOI 10.1016/j.neures.2007.09.010; COYLE JT, 1987, CIBA F SYMP, V126, P186; FERKANY JW, 1982, NATURE, V298, P757, DOI 10.1038/298757a0; Gao HL, 2013, NEUROSCIENCE, V236, P373, DOI 10.1016/j.neuroscience.2013.01.007; Gao HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080032; HEGGLI DE, 1981, BRAIN RES, V230, P253, DOI 10.1016/0006-8993(81)90405-4; HINENO T, 1991, BIOCHEM BIOPH RES CO, V176, P668, DOI 10.1016/S0006-291X(05)80236-0; Hiraiwa M, 1997, P NATL ACAD SCI USA, V94, P4778, DOI 10.1073/pnas.94.9.4778; HIRAIWA M, 1992, P NATL ACAD SCI USA, V89, P11254, DOI 10.1073/pnas.89.23.11254; Hiraiwa M, 1999, GLIA, V26, P353, DOI 10.1002/(SICI)1098-1136(199906)26:4<353::AID-GLIA9>3.0.CO;2-G; Hosoda Y, 2007, CELL TISSUE RES, V330, P197, DOI 10.1007/s00441-007-0464-9; Igase K, 1999, J CEREBR BLOOD F MET, V19, P298, DOI 10.1097/00004647-199903000-00008; ISHIZUKA N, 1995, J COMP NEUROL, V362, P17, DOI 10.1002/cne.903620103; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; KONDOH K, 1993, J COMP NEUROL, V334, P590, DOI 10.1002/cne.903340407; Kotani Y, 1996, J NEUROCHEM, V66, P2197; Kotani Y, 1996, J NEUROCHEM, V66, P2019; Li C, 2013, HISTOL HISTOPATHOL, V28, P875, DOI 10.14670/HH-28.875; LOTHMAN EW, 1981, BRAIN RES, V218, P299, DOI 10.1016/0006-8993(81)91308-1; Matsuda S, 2004, NEUROSCI RES, V49, P241, DOI 10.1016/j.neures.2004.03.002; Matsuda S, 1997, BRAIN RES, V769, P321, DOI 10.1016/S0006-8993(97)00724-5; Matsuda S, 1996, NEUROSCI RES, V26, P157, DOI 10.1016/S0168-0102(96)01088-7; Meyer RC, 2013, P NATL ACAD SCI USA, V110, P9529, DOI 10.1073/pnas.1219004110; Misasi R, 2001, FASEB J, V15, P467, DOI 10.1096/fj.00-0217com; Misasi R, 2004, EXP CELL RES, V298, P38, DOI 10.1016/j.yexcr.2004.04.011; Morales CR, 1998, J ANDROL, V19, P156; Nabeka H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110534; NADLER JV, 1981, NEUROSCIENCE, V6, P2505, DOI 10.1016/0306-4522(81)90096-8; NADLER JV, 1980, BRAIN RES, V195, P47; OBRIEN JS, 1995, FASEB J, V9, P681, DOI 10.1096/fasebj.9.8.7768361; OBRIEN JS, 1988, SCIENCE, V241, P1098, DOI 10.1126/science.2842863; OBRIEN JS, 1994, P NATL ACAD SCI USA, V91, P9593, DOI 10.1073/pnas.91.20.9593; OBRIEN JS, 1991, FASEB J, V5, P301, DOI 10.1096/fasebj.5.3.2001789; Ochiai T, 2008, BBA-GEN SUBJECTS, V1780, P1441, DOI 10.1016/j.bbagen.2008.07.010; OLNEY JW, 1978, NATURE, V271, P557, DOI 10.1038/271557a0; Saito S, 2014, CELL TISSUE RES, V356, P231, DOI 10.1007/s00441-013-1773-9; SANO A, 1988, J BIOL CHEM, V263, P19597; SANO A, 1992, BIOCHIM BIOPHYS ACTA, V1120, P75, DOI 10.1016/0167-4838(92)90426-E; SANO A, 1994, BIOCHEM BIOPH RES CO, V204, P994, DOI 10.1006/bbrc.1994.2558; SANO A, 1989, BIOCHEM BIOPH RES CO, V165, P1191, DOI 10.1016/0006-291X(89)92728-9; SCHWOB JE, 1980, NEUROSCIENCE, V5, P991, DOI 10.1016/0306-4522(80)90181-5; Shimokawa T, 2013, CELL TISSUE RES, V352, P685, DOI 10.1007/s00441-013-1575-0; Terashita T, 2007, NEUROSCI RES, V57, P372, DOI 10.1016/j.neures.2006.11.006; Terashita T, 2013, ACTA OTO-LARYNGOL, V133, P462, DOI 10.3109/00016489.2012.750430; Tsuboi K, 1998, DEV BRAIN RES, V110, P249, DOI 10.1016/S0165-3806(98)00109-6; Unuma K, 2005, NEUROSCI RES, V52, P220, DOI 10.1016/j.neures.2005.03.009	51	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126856	10.1371/journal.pone.0126856	http://dx.doi.org/10.1371/journal.pone.0126856			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993033	Green Published, gold, Green Submitted			2022-12-26	WOS:000354917300057
J	Hao, W; Tashiro, S; Hasegawa, T; Sato, Y; Kobayashi, T; Tando, T; Katsuyama, E; Fujie, A; Watanabe, R; Morita, M; Miyamoto, K; Morioka, H; Nakamura, M; Matsumoto, M; Amizuka, N; Toyama, Y; Miyamoto, T				Hao, Wu; Tashiro, Syoichi; Hasegawa, Tomoka; Sato, Yuiko; Kobayashi, Tami; Tando, Toshimi; Katsuyama, Eri; Fujie, Atsuhiro; Watanabe, Ryuichi; Morita, Mayu; Miyamoto, Kana; Morioka, Hideo; Nakamura, Masaya; Matsumoto, Morio; Amizuka, Norio; Toyama, Yoshiaki; Miyamoto, Takeshi			Hyperglycemia Promotes Schwann Cell De-differentiation and De-myelination via Sorbitol Accumulation and Igf1 Protein Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETIC PERIPHERAL NEUROPATHY; POLYOL PATHWAY; VITAMIN-D; HIGH GLUCOSE; CALCIUM-ABSORPTION; ENDOTHELIAL-CELLS; IN-VITRO; COMPLICATIONS; PROLIFERATION; ACTIVATION	Diabetes mellitus (DM) is frequently accompanied by complications, such as peripheral nerve neuropathy. Schwann cells play a pivotal role in regulating peripheral nerve function and conduction velocity; however, changes in Schwann cell differentiation status in DM are not fully understood. Here, we report that Schwann cells de-differentiate into immature cells under hyperglycemic conditions as a result of sorbitol accumulation and decreased Igf1 expression in those cells. We found that dedifferentiated Schwann cells could be re-differentiated in vitro into mature cells by treatment with an aldose reductase inhibitor, to reduce sorbitol levels, or with vitamin D-3, to elevate Igf1 expression. In vivo DM models exhibited significantly reduced nerve function and conduction, Schwann cell de-differentiation, peripheralnervede-myelination, and all conditions were significantly rescued by aldose reductase inhibitor or vitamin D-3 administration. These findings reveal mechanisms underlying pathological changes in Schwann cells seen in DM and suggest ways to treat neurological conditions associated with this condition.	[Hao, Wu; Sato, Yuiko; Kobayashi, Tami; Tando, Toshimi; Katsuyama, Eri; Fujie, Atsuhiro; Watanabe, Ryuichi; Miyamoto, Kana; Morioka, Hideo; Nakamura, Masaya; Matsumoto, Morio; Toyama, Yoshiaki; Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Tashiro, Syoichi] Keio Univ, Sch Med, Dept Rehabil Med, Shinjuku Ku, Tokyo 1608582, Japan; [Sato, Yuiko] Keio Univ, Sch Med, Dept Musculoskeletal Reconstruct & Regenerat Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Kobayashi, Tami; Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Integrated Bone Metab & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Morita, Mayu] Keio Univ, Sch Med, Dept Dent & Oral Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Hasegawa, Tomoka; Amizuka, Norio] Hokkaido Univ, Grad Sch Dent Med, Dept Dev Biol Hard Tissue, Kita Ku, Sapporo, Hokkaido 0608586, Japan	Keio University; Keio University; Keio University; Keio University; Keio University; Hokkaido University	Miyamoto, T (corresponding author), Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	miyamoto@z5.keio.jp	Nakamura, Masaya/K-4111-2013; Tashiro, Syoichi/I-5119-2019; hao, wu/HDM-1705-2022	Tashiro, Syoichi/0000-0002-1430-0552; 				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Ameri P, 2013, EUR J ENDOCRINOL, V169, P767, DOI 10.1530/EJE-13-0510; Berrone E, 2006, J BIOL CHEM, V281, P9307, DOI 10.1074/jbc.M600418200; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; Boulton AJM, 1998, DIABETIC MED, V15, P508, DOI 10.1002/(SICI)1096-9136(199806)15:6<508::AID-DIA613>3.0.CO;2-L; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Christakos S, 2011, MOL CELL ENDOCRINOL, V347, P25, DOI 10.1016/j.mce.2011.05.038; CHRISTIANSEN C, 1981, EUR J CLIN INVEST, V11, P305, DOI 10.1111/j.1365-2362.1981.tb02121.x; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; CLEMENTS RS, 1979, DIABETES, V28, P604, DOI 10.2337/diab.28.6.604; da Silva TF, 2014, J CLIN INVEST, V124, P2560, DOI 10.1172/JCI72063; DAWSONHUGHES B, 1995, J CLIN ENDOCR METAB, V80, P3657, DOI 10.1210/jc.80.12.3657; Felitsyn N, 2007, J NEUROCHEM, V100, P429, DOI 10.1111/j.1471-4159.2006.04248.x; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; Galuppo M, 2014, MOLECULES, V19, P2877, DOI 10.3390/molecules19032877; GREENE DA, 1992, DIABETES CARE, V15, P1902, DOI 10.2337/diacare.15.12.1902; Ho ECM, 2006, DIABETES, V55, P1946, DOI 10.2337/db05-1497; Kachroo Sumesh, 2015, J Manag Care Spec Pharm, V21, P243; KAHN SE, 1994, DIABETES, V43, P587, DOI 10.2337/diabetes.43.4.587; KIKKAWA R, 1987, DIABETES, V36, P240, DOI 10.2337/diabetes.36.2.240; Krajewski KM, 2000, BRAIN, V123, P1516, DOI 10.1093/brain/123.7.1516; Lee HK, 2009, GLIA, V57, P1825, DOI 10.1002/glia.20894; LeRoith D, 1997, NEW ENGL J MED, V336, P633, DOI 10.1056/NEJM199702273360907; Liu GS, 2009, HUM GENE THER, V20, P715, DOI 10.1089/hum.2009.002; NIDDK, 2011, NIH PUBL; Peppa Melpomeni, 2005, Hormones (Athens), V4, P28; Porrello E, 2014, J EXP MED, V211, P29, DOI 10.1084/jem.20130720; Rambhade S., 2010, J CHEM PHARM RES, V2, P7; Said G, 2007, NAT CLIN PRACT NEURO, V3, P331, DOI 10.1038/ncpneuro0504; Sakuma M, 2011, J ORTHOP SCI, V16, P418, DOI 10.1007/s00776-011-0089-4; Sango K, 2006, J NEUROCHEM, V98, P446, DOI 10.1111/j.1471-4159.2006.03885.x; SATO A, 1985, NEUROSCI LETT, V53, P15, DOI 10.1016/0304-3940(85)90090-4; Sharp LL, 2005, NAT IMMUNOL, V6, P73, DOI 10.1038/ni1152; Takamura Y, 2008, INVEST OPHTH VIS SCI, V49, P3216, DOI 10.1167/iovs.07-1643; Tashiro S., 2014, NEUROREHAB NEURAL RE; VINIK AI, 1992, DIABETES CARE, V15, P1926, DOI 10.2337/diacare.15.12.1926	39	39	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17106	17115		10.1074/jbc.M114.631291	http://dx.doi.org/10.1074/jbc.M114.631291			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25998127	Green Published, hybrid			2022-12-26	WOS:000357730900006
J	Munns, JJ; Lee, JYB; Orias, AAE; Takatori, R; Andersson, GBJ; An, HS; Inoue, N				Munns, Justin J.; Lee, Joe Y. B.; Orias, Alejandro A. Espinoza; Takatori, Ryota; Andersson, Gunnar B. J.; An, Howard S.; Inoue, Nozomu			Ligamentum Flavum Hypertrophy in Asymptomatic and Chronic Low Back Pain Subjects	PLOS ONE			English	Article							SEGMENTAL MOTION; SPINAL STENOSIS; LUMBAR; PATHOMECHANISM; TISSUE	Purpose To examine ligamentum flavum thickness using magnetic resonance (MR) images to evaluate its association with low back pain symptoms, age, gender, lumbar level, and disc characteristics. Materials and Methods Sixty-three individuals were part of this IRB-approved study: twenty-seven with chronic low back pain, and thirty-six as asymptomatic. All patients underwent MR imaging and computed tomography (CT) of the lumbar spine. The MR images at the mid-disc level were captured and enlarged 800% using a bilinear interpolation size conversion algorithm that allowed for enhanced image quality. Ligamentum flavum thickness was assessed using bilateral medial and lateral measurements. Disc height at each level was measured by the least-distance measurement method in three-dimensional models created by CT images taken of the same subject. Analysis of variance and t-tests were carried out to evaluate the relationship between ligamentum flavum thickness and patient variables. Results Ligamentum flavum thickness was found to significantly increase with older age, lower lumbar level, and chronic low back pain (p < 0.03). No difference in ligamentum flavum thickness was observed between right and left sided measurements, or between male and female subjects. Disc height and both ligamentum flavum thickness measurements showed low to moderate correlations that reached significance (p < 0.01). Additionally, a moderate and significant correlation between disc degeneration grade and ligamentum flavum thickness does exist (p < 0.001). Conclusion By measuring ligamentum flavum thickness on MR images at two different sites and comparing degrees of disc degeneration, we found that ligamentum flavum thickness may be closely related to the pathogenesis of pain processes in the spine.	[Munns, Justin J.; Lee, Joe Y. B.; Orias, Alejandro A. Espinoza; Takatori, Ryota; Andersson, Gunnar B. J.; An, Howard S.; Inoue, Nozomu] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA	Rush University	Inoue, N (corresponding author), Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA.	Nozomu_Inoue@rush.edu		Takatori, Ryota/0000-0002-0867-3918	National Institutes of Health grant: National Institute for Arthritis and Musculoskeletal and Skin Diseases [P01-AR48152-10]; National Institutes of Health grant: National Center for Complementary and Alternative Medicine [R01-AT006692-01A1]; National Center for Complementary & Integrative Health [R01AT006692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR048152] Funding Source: NIH RePORTER	National Institutes of Health grant: National Institute for Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health grant: National Center for Complementary and Alternative Medicine; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by two National Institutes of Health grants: National Institute for Arthritis and Musculoskeletal and Skin Diseases (www.niams.nih.gov) Grant No. P01-AR48152-10; National Center for Complementary and Alternative Medicine (nccam.nih.gov) Grant No. R01-AT006692-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas J, 2010, SPINE, V35, P1225, DOI 10.1097/BRS.0b013e3181bfca15; Altinkaya N, 2011, SPINE, V36, pE1093, DOI 10.1097/BRS.0b013e318203e2b5; Chen JW, 2014, DIS MARKERS, V2014, P1, DOI 10.1155/2014/786543; Chen YT, 2011, SPINE, V36, pE1193, DOI 10.1097/BRS.0b013e3182053f58; Crane B, 2006, 52 ANN M ORTH RES SO; Cui GY, 2011, J ORTHOP SCI, V16, P785, DOI 10.1007/s00776-011-0135-2; Duan CY, 2011, OSTEOARTHR CARTILAGE, V19, P96, DOI 10.1016/j.joca.2010.10.015; FUKUYAMA S, 1995, J SPINAL DISORD, V8, P126; Hansson T, 2009, EUR SPINE J, V18, P679, DOI 10.1007/s00586-009-0919-7; Kosaka H, 2007, SPINE, V32, P2805, DOI 10.1097/BRS.0b013e31815b650f; Miyamoto Kei, 2006, Spine J, V6, P692, DOI 10.1016/j.spinee.2006.04.014; Moon HJ, 2012, SPINE, V37, pE147, DOI 10.1097/BRS.0b013e3182269b19; NACHEMSON A L, 1968, Journal of Biomechanics, V1, P211, DOI 10.1016/0021-9290(68)90006-7; Ochia RS, 2007, SPINE, V32, P1394, DOI 10.1097/BRS.0b013e318060122b; Ochia RS, 2006, SPINE, V31, P2073, DOI 10.1097/01.brs.0000231435.55842.9e; Okuda T, 2004, SPINE, V29, P1689, DOI 10.1097/01.BRS.0000132510.25378.8C; Park J B, 2001, Spine (Phila Pa 1976), V26, pE492, DOI 10.1097/00007632-200111010-00007; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; POSTACCHINI F, 1994, SPINE, V19, P917, DOI 10.1097/00007632-199404150-00009; Safak AA, 2010, CLIN ANAT, V23, P79, DOI 10.1002/ca.20883; Sairyo K, 2005, SPINE, V30, P2649, DOI 10.1097/01.brs.0000188117.77657.ee; Sairyo K, 2007, SPINE, V32, pE340, DOI 10.1097/01.brs.0000263407.25009.6e; Sakamaki T, 2009, ARCH ORTHOP TRAUM SU, V129, P1415, DOI 10.1007/s00402-009-0849-1; Schrader PK, 1999, EUR SPINE J, V8, P323, DOI 10.1007/s005860050181; Watanabe S, 2012, EUR SPINE J, V21, P946, DOI 10.1007/s00586-011-2090-1; Zhong ZM, 2011, J ORTHOP RES, V29, P1592, DOI 10.1002/jor.21431	26	25	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128321	10.1371/journal.pone.0128321	http://dx.doi.org/10.1371/journal.pone.0128321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010138	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900224
J	Reynolds, KA; Grindler, NM; Rhee, JS; Cooper, AR; Ratts, VS; Carson, KR; Jungheim, ES				Reynolds, Kasey A.; Grindler, Natalia M.; Rhee, Julie S.; Cooper, Amber R.; Ratts, Valerie S.; Carson, Kenneth R.; Jungheim, Emily S.			Variability in the Practice of Fertility Preservation for Patients with Cancer	PLOS ONE			English	Article							BREAST-CANCER; OVARIAN STIMULATION; EMBRYO CRYOPRESERVATION; AMERICAN-SOCIETY; WOMEN; RECOMMENDATIONS; ONCOLOGISTS; TAMOXIFEN; LETROZOLE; LYMPHOMA	Fertility is important to women and men with cancer. While options for fertility preservation (FP) are available, knowledge regarding the medical application of FP is lacking. Therefore we examined FP practices for cancer patients among reproductive endocrinologists (REs). A 36 item survey was sent to board-certified REs. 98% of respondents reported counseling women with cancer about FP options. Oocyte and embryo cryopreservation were universally offered by these providers, but variability was noted in reported management of these cases -particularly for women with breast cancer. 86% of the respondents reported using letrozole during controlled ovarian stimulation (COS) in patients with estrogen receptor positive (ER+) breast cancer to minimize patient exposure to estrogen. 49% of respondents who reported using letrozole in COS for patients with ER+ breast cancer reported that they would also use letrozole in COS for women with ER negative breast cancer. Variability was also noted in the management of FP for men with cancer. 83% of participants reported counseling men about sperm banking with 22% recommending against banking for men previously exposed to chemotherapy. Overall, 79% of respondents reported knowledge of American Society for Clinical Oncology FP guidelines-knowledge that was associated with providers offering gonadal tissue cryopreservation (RR 1.82, 95% CI 1.14-2.90). These findings demonstrate that RE management of FP in cancer patients varies. Although some variability may be dictated by local resources, standardization of FP practices and communication with treating oncologists may help ensure consistent recommendations and outcomes for patients seeking FP.	[Reynolds, Kasey A.; Grindler, Natalia M.; Rhee, Julie S.; Cooper, Amber R.; Ratts, Valerie S.; Jungheim, Emily S.] Washington Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol, St Louis, MO 63110 USA; [Carson, Kenneth R.] Washington Univ, Sch Med, Div Publ Hlth Sci, St Louis, MO USA; [Carson, Kenneth R.] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA; [Carson, Kenneth R.] St Louis Vet Affairs Med Ctr, Res Serv, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Jungheim, ES (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod Endocrinol, St Louis, MO 63110 USA.	jungheime@wustl.edu			National Institutes of Health [T32 HD0040135, K12 HD063086]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD063086, T32HD040135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health Grants: T32 HD0040135 (KAR, JSR), and K12 HD063086 (ESJ, ARC).	Adams E, 2013, BRIT J CANCER, V108, P1602, DOI 10.1038/bjc.2013.139; Amer Soc Reproductive Med, 2008, FERTIL STERIL, V90, pS241, DOI 10.1016/j.fertnstert.2008.08.039; Azim AA, 2008, J CLIN ONCOL, V26, P2630, DOI 10.1200/JCO.2007.14.8700; Cakmak H, 2013, FERTIL STERIL, V99, P1476, DOI 10.1016/j.fertnstert.2013.03.029; Dobson R, 2009, BMJ-BRIT MED J, P339; Forman EJ, 2010, FERTIL STERIL, V94, P1652, DOI 10.1016/j.fertnstert.2009.10.008; Jungheim ES, 2015, SEMIN REPROD MED, V33, P77, DOI 10.1055/s-0035-1546424; Kim SS, 2012, J ASSIST REPROD GEN, V29, P465, DOI 10.1007/s10815-012-9786-y; King JW, 2012, ONCOLOGIST, V17, P910, DOI 10.1634/theoncologist.2012-0064; Lee SJ, 2006, J CLIN ONCOL, V24, P2917, DOI 10.1200/JCO.2006.06.5888; Loren AW, 2013, J CLIN ONCOL, V31, P2500, DOI 10.1200/JCO.2013.49.2678; Oktay K, 2003, HUM REPROD, V18, P90, DOI 10.1093/humrep/deg045; Oktay K, 2005, J CLIN ONCOL, V23, P4347, DOI 10.1200/JCO.2005.05.037; Oktay K, 2010, REPROD BIOMED ONLINE, V20, P783, DOI 10.1016/j.rbmo.2010.03.004; Omurtag K, 2012, FERTIL STERIL, V97, P1095, DOI 10.1016/j.fertnstert.2012.02.026; Partridge AH, 2008, J CLIN ONCOL, V26, P2612, DOI 10.1200/JCO.2008.16.1976; Pfeifer S, 2014, FERTIL STERIL, V101, P1237, DOI 10.1016/j.fertnstert.2014.02.052; Quinn GP, 2011, J NATL COMPR CANC NE, V9, P1219, DOI 10.6004/jnccn.2011.0102; Quinn GP, 2009, J CLIN ONCOL, V27, P5952, DOI 10.1200/JCO.2009.23.0250; Rodriguez-Wallberg KA, 2012, CANCER TREAT REV, V38, P354, DOI 10.1016/j.ctrv.2011.10.002; SART, 2013, 2011 DAT SOC ASS REP; Sheth KR, 2012, J UROLOGY, V187, P979, DOI 10.1016/j.juro.2011.10.154; Sonmezer M, 2011, FERTIL STERIL, V95, DOI 10.1016/j.fertnstert.2011.01.030; Sunderam S, 2012, MMWR SURVEILL SUMM, V61, P1; Vadaparampil ST, 2013, J ONCOL PRACT, V9, P300, DOI 10.1200/JOP.2013.001097; von Wolff M, 2011, ARCH GYNECOL OBSTET, V284, P427, DOI 10.1007/s00404-011-1874-1; Zegers-Hochschild F, 2009, FERTIL STERIL, V92, P1520, DOI 10.1016/j.fertnstert.2009.09.009	27	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127335	10.1371/journal.pone.0127335	http://dx.doi.org/10.1371/journal.pone.0127335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010087	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900083
J	Baym, M; Kryazhimskiy, S; Lieberman, TD; Chung, H; Desai, MM; Kishony, R				Baym, Michael; Kryazhimskiy, Sergey; Lieberman, Tami D.; Chung, Hattie; Desai, Michael M.; Kishony, Roy			Inexpensive Multiplexed Library Preparation for Megabase-Sized Genomes	PLOS ONE			English	Article							EXPERIMENTAL EVOLUTION; LOW-INPUT; PCR	Whole-genome sequencing has become an indispensible tool of modern biology. However, the cost of sample preparation relative to the cost of sequencing remains high, especially for small genomes where the former is dominant. Here we present a protocol for rapid and inexpensive preparation of hundreds of multiplexed genomic libraries for Illumina sequencing. By carrying out the Nextera tagmentation reaction in small volumes, replacing costly reagents with cheaper equivalents, and omitting unnecessary steps, we achieve a cost of library preparation of $ 8 per sample, approximately 6 times cheaper than the standard Nextera XT protocol. Furthermore, our procedure takes less than 5 hours for 96 samples. Several hundred samples can then be pooled on the same HiSeq lane via custom barcodes. Our method will be useful for re-sequencing of microbial or viral genomes, including those from evolution experiments, genetic screens, and environmental samples, as well as for other sequencing applications including large amplicon, open chromosome, artificial chromosomes, and RNA sequencing.	[Baym, Michael; Lieberman, Tami D.; Chung, Hattie; Kishony, Roy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Kryazhimskiy, Sergey; Desai, Michael M.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Kryazhimskiy, Sergey; Desai, Michael M.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Desai, Michael M.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Kishony, Roy] Technion Israel Inst Technol, Fac Biol, Haifa, Israel; [Kishony, Roy] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University; Technion Israel Institute of Technology; Technion Israel Institute of Technology	Desai, MM (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	mmdesai@fas.harvard.edu; roy_kishony@hms.harvard.edu	Kryazhimskiy, Sergey/AAV-1258-2020	Kryazhimskiy, Sergey/0000-0001-9128-8705; Desai, Michael/0000-0002-9581-1150; /0000-0001-5430-3937; Baym, Michael/0000-0003-1303-5598	National Science Foundation [DMS-0903013]; Scientific Interface from the Burroughs Wellcome Foundation; James S. McDonnell Foundation; Alfred P. Sloan Foundation; US National Science Foundation [PHY 1313638]; US National Institutes of Health [R01-GM081617, R01-GM104239]; European Research Council [281891]; Hoffman-LaRoche; Direct For Mathematical & Physical Scien [1313638] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104239, R01GM081617] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Scientific Interface from the Burroughs Wellcome Foundation; James S. McDonnell Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Hoffman-LaRoche; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation Mathematical Sciences Postdoctoral Research Fellowship DMS-0903013 (to MB, http://www.nsf.gov/), Career Award at the Scientific Interface from the Burroughs Wellcome Foundation (to SK, http://www.bwfund.org/), the James S. McDonnell Foundation (to MMD, https://www.jsmf.org/), the Alfred P. Sloan Foundation (to MMD, http://www.sloan.org/), PHY 1313638 from the US National Science Foundation (to MMD, http://www.nsf.gov/), US National Institutes of Health grant R01-GM081617 (to RK) and R01-GM104239 (to MMD, http://www.nih.gov/), European Research Council FP7 ERC Grant 281891 (to RK, http://erc.europa.eu/), and Hoffman-LaRoche (to RK, http://www.rocheusa.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey A, 2012, GENOME RES, V22, P1139, DOI 10.1101/gr.136242.111; Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; Bielecki P, 2012, CHEMBIOCHEM, V13, P2339, DOI 10.1002/cbic.201200479; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; DEANGELIS MM, 1995, NUCLEIC ACIDS RES, V23, P4742, DOI 10.1093/nar/23.22.4742; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; Hegreness M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-201; Kryazhimskiy S, 2014, SCIENCE, V344, P1519, DOI 10.1126/science.1250939; Kuleshov V, 2014, NAT BIOTECHNOL, V32, P261, DOI 10.1038/nbt.2833; Lamble S, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-104; MARDIS ER, 2008, ANN REV GENOMICS HUM; McAdam PR, 2014, CURR OPIN MICROBIOL, V19, P106, DOI 10.1016/j.mib.2014.06.002; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340	16	330	336	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0128036	10.1371/journal.pone.0128036	http://dx.doi.org/10.1371/journal.pone.0128036			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000737	Green Published, gold, Green Submitted			2022-12-26	WOS:000354931700100
J	Dia, N; Fall, A; Ka, R; Fall, A; Kiori, DE; Goudiaby, DG; Fall, AD; Faye, EA; Dosseh, A; Ndiaye, K; Diop, OM; Niang, MN				Dia, Ndongo; Fall, Ameth; Ka, Rouguiyatou; Fall, Amary; Kiori, David E.; Goudiaby, Deborah G.; Fall, Aichatou D.; Faye, El Hadj Abdourahmane; Dosseh, Annick; Ndiaye, Kader; Diop, Ousmane M.; Niang, Mbayame Nd.			Epidemiology and Genetic Characterization of Measles Strains in Senegal, 2004-2013	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GLOBAL DISTRIBUTION; EUROPEAN REGION; VIRUS; GENOTYPES; MORTALITY; UPDATE	Background In Senegal, with the variable routine vaccination coverage, the risk for illness and death from measles still exists as evidenced by the measles epidemic episode in 2009. Since 2002 a laboratory-based surveillance system of measles was established by the Ministry of Health and the Institut Pasteur de Dakar. The present study analysed the data collected over the 10 years inclusive between 2004-2013 in order to define a measles epidemiological profile in Senegal, and we carried out a phylogenetic analysis of measles virus circulating in Senegal over the period 2009-2012. Methodology and Results total number of 4580 samples were collected from suspected cases, with the most cases between 2008 and 2010 (2219/4580; 48.4%). The majority of suspected cases are found in children from 4-6 years old (29%). 981 (21.4%) were measles laboratory-confirmed by IgM ELISA. The measles confirmation rate per year is very high during 2009-2010 periods (48.5% for each year). Regarding age groups, the highest measles IgM-positivity rate occurred among persons aged over 15 years with 39.4%(115/292) followed by 2-3 years old age group with 30.4% (323/1062) and 30% (148/494) in children under one year old group. The majority of suspected cases were collected between February and June and paradoxically confirmed cases rates increased from July (77/270; 28.6%) and reached a peak in November with 60% (93/155). Phylogenetic analysis showed that all the 29 sequences from strains that circulated in Senegal between 2009 and 2012 belong to the B3 genotype and they are clustered in B3.1 (2011-2012) and B3.3 (2009-2011) sub-genotypes according to a temporal parameter. Conclusion Improvements in the measles surveillance in Senegal are required and the introduction of oral fluid and FTA cards as an alternative to transportation of sera should be investigated to improve surveillance. The introduction of a national vaccine database including number of doses of measles-containing vaccine will greatly improve efforts to interrupt and ultimately eliminate measles virus transmission in Senegal.	[Dia, Ndongo; Fall, Ameth; Fall, Amary; Kiori, David E.; Goudiaby, Deborah G.; Fall, Aichatou D.; Faye, El Hadj Abdourahmane; Dosseh, Annick; Ndiaye, Kader; Diop, Ousmane M.; Niang, Mbayame Nd.] Inst Pasteur, Unite Virol Med, Dakar, Senegal; [Ka, Rouguiyatou] Ctr Hosp Natl Univ Fann, Lab Bacteriol, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Niang, MN (corresponding author), Inst Pasteur, Unite Virol Med, Dakar, Senegal.	niang@pasteur.sn	Fall, Amary/AAR-8776-2021	Fall, Amary/0000-0002-6890-7915	Institut Pasteur; WHO Fund	Institut Pasteur(European Commission); WHO Fund	This work was supported by Institut Pasteur and WHO Fund (Assistance to the Measles National Reference Center of Senegal).	[Anonymous], 2001, Wkly Epidemiol Rec, V76, P242; CANTRELLE P, 1968, LENFANT EN MILIEU TR, V52, P37; Cheng WY, 2013, J MED VIROL, V85, P1095, DOI 10.1002/jmv.23563; Dabbagh A., 2008, Morbidity and Mortality Weekly Report, V57, P1303; Fitzpatrick G, 2012, EURO SURVEILL, V17; Goodson JL, 2011, J INFECT DIS, V204, pS205, DOI 10.1093/infdis/jir129; Haddad-Boubaker S, 2010, VIRUS RES, V153, P258, DOI 10.1016/j.virusres.2010.08.011; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Knol MJ, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.36.20580; Mankertz A, 2011, EMERG INFECT DIS, V17, P1396, DOI 10.3201/eid1708.101994; Mankertz A, 2011, J INFECT DIS, V204, pS335, DOI 10.1093/infdis/jir101; Marinova L, 2009, EUROSURVEILLANCE, V14, P9; Mosquera MM, 2010, OPEN VACCINE J, V3, P76; Muscat M, 2014, CLIN MICROBIOL INFEC, V20, P12, DOI 10.1111/1469-0691.12584; Necula G, 2013, EUROSURVEILLANCE, V18, P28, DOI 10.2807/1560-7917.ES2013.18.50.20658; Ramsay ME, 2013, ARCH DIS CHILD, V98, P752, DOI 10.1136/archdischild-2013-304292; Riddell MA, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-87; Rota PA, 2009, CURR TOP MICROBIOL, V330, P129; Rota PA, 2003, J INFECT DIS, V187, pS270, DOI 10.1086/368042; Rota PA, 2011, J INFECT DIS, V204, pS514, DOI 10.1093/infdis/jir118; Sniadack DH, 2011, J INFECT DIS, V204, pS476, DOI 10.1093/infdis/jir092; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wairagkar N, 2011, J INFECT DIS, V204, pS403, DOI 10.1093/infdis/jir150; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X; World Health Organization, MANUAL FOR THE LABOR; World Health Organization and UNICEF, 2005, GLOBAL IMMUNIZATION; Zarocostas J, 2007, BRIT MED J, V335, P1173, DOI 10.1136/bmj.39419.393275.DB	27	6	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0121704	10.1371/journal.pone.0121704	http://dx.doi.org/10.1371/journal.pone.0121704			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000828	Green Published, Green Submitted, gold			2022-12-26	WOS:000354931700003
J	Adler, SA; Purup, S; Hansen-Moller, J; Thuen, E; Steinshamn, H				Adler, Steffen A.; Purup, Stig; Hansen-Moller, Jens; Thuen, Erling; Steinshamn, Havard			Phytoestrogens and Their Metabolites in Bulk-Tank Milk: Effects of Farm Management and Season	PLOS ONE			English	Article							RED-CLOVER; PHYTO-ESTROGENS; DAIRY-COWS; GRASS SILAGES; ISOFLAVONES; FERTILITY; LIGNANS; HERBAGE; FORAGE; FOODS	Phytoestrogens have structures similar to endogenous steroids and may induce or inhibit the response of hormone receptors. The objectives of the present study were to compare the effects of long-term vs. short-term grassland management in organic and conventional dairy production systems, compare organic and conventional production systems and assess seasonal variation on phytoestrogen concentrations in bulk-tank milk. The concentrations of phytoestrogens were analyzed in bulk-tank milk sampled three times in two subsequent years from 28 dairy farms: Fourteen organic (ORG) dairy farms with either short-term or long-term grassland management were paired with 14 conventional (CON) farms with respect to grassland management. Grassland management varied in terms of time since establishment. Short-term grassland management (SG) was defined as establishment or reseeding every fourth year or more often, and long-term grassland management (LG) was defined as less frequent establishment or reseeding. The proportion of red clover (Trifolium pretense L.) in the herbage was positively correlated with milk concentrations of the mammalian isoflavone equol. Therefore, organically produced bulk-tank milk contained more equol than conventionally produced milk, and milk from ORG-SG farms had more equol than milk from ORG-LG farms. Milk produced during the indoor-feeding periods had more equol than milk produced during the outdoor feeding period, because pastures contained less red clover than fields intended for silage production. Organically produced milk had also higher concentrations of the mammalian lignan enterolactone, but in contrast to equol, concentrations increased in the outdoor-feeding periods compared to the indoor-feeding periods. There were no indications of fertility problems on ORG-SG farms who had the highest red clover proportions in the herbage. This study shows that production system, grassland management, and season affect milk concentrations of phytoestrogens. However, compared to soy products, milk concentrations of phytoestrogens are low and future studies are required to investigate if the intake of phytoestrogens from dairy products has physiological effects in humans.	[Adler, Steffen A.; Steinshamn, Havard] Bioforsk, Norwegian Inst Agr & Environm Res, N-6630 Tingvoll, Norway; [Adler, Steffen A.; Thuen, Erling] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, N-1432 As, Norway; [Purup, Stig; Hansen-Moller, Jens] Aarhus Univ, Dept Anim Sci, DK-8830 Tjele, Denmark	Bioforsk; Norwegian University of Life Sciences; Aarhus University	Adler, SA (corresponding author), Bioforsk, Norwegian Inst Agr & Environm Res, N-6630 Tingvoll, Norway.	steffen.adler@bioforsk.no	Steinshamn, Håvard/H-6160-2019	Purup, Stig/0000-0003-0653-4751; Steinshamn, Havard/0000-0003-0052-7294	More and Romsdal County	More and Romsdal County	HS received support from More and Romsdal County, http://www.fylkesmannen.no/Moreog-Romsdal/; TINE Norwegian Dairies SA, www.tine.no, Data and sample collection. TINE SA contributed with data from the Norwegian Dairy Herd Recording System. TINE SA also had a role in collecting milk samples, analysing milk gross composition and freezing samples for further analysis. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	ADAMS NR, 1995, J ANIM SCI, V73, P1509; Adler SA, 2014, LIVEST SCI, V163, P62, DOI 10.1016/j.livsci.2014.02.006; Adler SA, 2013, J DAIRY SCI, V96, P5793, DOI 10.3168/jds.2012-5765; Andersen C, 2009, ANIMAL, V3, P1189, DOI 10.1017/S1751731109004613; Andersen C, 2009, ANIMAL, V3, P617, DOI 10.1017/S1751731108003698; [Anonymous], 2010, PLANT PHYSL 5 EDITIO; Antignac JP, 2004, FOOD CHEM, V87, P275, DOI 10.1016/j.foodchem.2003.12.013; AUSTIN AR, 1982, GRASS FORAGE SCI, V37, P101, DOI 10.1111/j.1365-2494.1982.tb01584.x; BATTERHA.TJ, 1965, NATURE, V206, P509, DOI 10.1038/206509a0; Bennetts H. W., 1946, JOUR DEPT AGRIC WESTERN AUSTRALIA, V23, P1; Booth NL, 2006, J AGR FOOD CHEM, V54, P1277, DOI 10.1021/jf052927u; FRANCOS G, 1992, THERIOGENOLOGY, V38, P385, DOI 10.1016/0093-691X(92)90059-Z; Heinonen S, 2001, J AGR FOOD CHEM, V49, P3178, DOI 10.1021/jf010038a; Hoikkala A, 2007, MOL NUTR FOOD RES, V51, P782, DOI 10.1002/mnfr.200600222; Hojer A, 2012, J DAIRY SCI, V95, P4526, DOI 10.3168/jds.2011-5226; Hwang CS, 2006, J STEROID BIOCHEM, V101, P246, DOI 10.1016/j.jsbmb.2006.06.020; JONES RM, 1979, GRASS FORAGE SCI, V34, P181, DOI 10.1111/j.1365-2494.1979.tb01465.x; KALLELA K, 1984, NORD VET MED, V36, P124; Kuhnle GGC, 2008, J AGR FOOD CHEM, V56, P10099, DOI 10.1021/jf801344x; MANNETJE L.'T., 1963, JOUR BRIT GRASSLAND SOC, V18, P268; Mazur W, 1998, PURE APPL CHEM, V70, P1759, DOI 10.1351/pac199870091759; Milder IEJ, 2005, BRIT J NUTR, V93, P393, DOI 10.1079/BJN20051371; Mustonen EA, 2009, BRIT J NUTR, V102, P1552, DOI 10.1017/S0007114509990857; Njastad KM, 2014, J DAIRY SCI, V97, P7735, DOI 10.3168/jds.2014-8208; Pfitscher A, 2008, J STEROID BIOCHEM, V112, P87, DOI 10.1016/j.jsbmb.2008.08.007; Rafii F, 2003, ARCH MICROBIOL, V180, P11, DOI 10.1007/s00203-003-0551-6; Reksen O, 1999, J DAIRY SCI, V82, P2605, DOI 10.3168/jds.S0022-0302(99)75515-3; Riesinger P, 2008, AGR FOOD SCI, V17, P394, DOI 10.2137/145960608787235522; SAS S., 2009, STAT US GUID VERS 9; Schogor ALB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087949; Setchell KDR, 2003, AM J CLIN NUTR, V78, p593S, DOI 10.1093/ajcn/78.3.593S; Sivesind E, 2005, J AGR FOOD CHEM, V53, P6397, DOI 10.1021/jf0507487; Steinshamn H, 2008, J DAIRY SCI, V91, P2715, DOI 10.3168/jds.2007-0857; Tsao R, 2006, J AGR FOOD CHEM, V54, P5797, DOI 10.1021/jf0614589; Zhou W, 2009, ANIM FEED SCI TECH, V150, P18, DOI 10.1016/j.anifeedsci.2008.07.006	35	15	15	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127187	10.1371/journal.pone.0127187	http://dx.doi.org/10.1371/journal.pone.0127187			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996600	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000356444000048
J	Ahmad, Z; Laughlin, TF; Kady, IO				Ahmad, Zulfiqar; Laughlin, Thomas F.; Kady, Ismail O.			Thymoquinone Inhibits Escherichia coli ATP Synthase and Cell Growth	PLOS ONE			English	Article							CATALYTIC SITES; CANCER-CELLS; MYCOBACTERIUM-TUBERCULOSIS; ANTIBACTERIAL ACTIVITY; F1F0-ATP SYNTHASE; MUTANT STRAINS; NIGELLA-SATIVA; RESVERATROL; POLYPHENOLS; F1-ATPASE	We examined the thymoquinone induced inhibition of purified F-1 or membrane bound F1FO E. coli ATP synthase. Both purified F-1 and membrane bound F1FO were completely inhibited by thymoquinone with no residual ATPase activity. The process of inhibition was fully reversible and identical in both membrane bound F1Fo and purified F-1 preparations. Moreover, thymoquinone induced inhibition of ATP synthase expressing wild-type E. coli cell growth and non-inhibition of ATPase gene deleted null control cells demonstrates that ATP synthase is a molecular target for thymoquinone. This also links the beneficial dietary based antimicrobial and anticancer effects of thymoquinone to its inhibitory action on ATP synthase.	[Ahmad, Zulfiqar; Laughlin, Thomas F.] AT Still Univ Hlth Sci, Kirksville Coll Osteopath Med, Dept Biochem, Kirksville, MO 63501 USA; [Kady, Ismail O.] E Tennessee State Univ, Dept Chem, Johnson City, TN 37614 USA	A.T. Still University of Health Sciences; East Tennessee State University	Ahmad, Z (corresponding author), AT Still Univ Hlth Sci, Kirksville Coll Osteopath Med, Dept Biochem, Kirksville, MO 63501 USA.	zahmad@atsu.edu		Ahmad, Zulfiqar/0000-0001-7306-8151	National Institutes of Health [GM085771]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM085771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health grant GM085771 to ZA.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Ahmad A, 2010, FITOTERAPIA, V81, P1157, DOI 10.1016/j.fitote.2010.07.020; Ahmad I, 2013, TOXICOL APPL PHARM, V270, P70, DOI 10.1016/j.taap.2013.03.027; Ahmad Z, 2005, J BIOL CHEM, V280, P27981, DOI 10.1074/jbc.M503955200; Ahmad Z, 2004, J BIOL CHEM, V279, P31505, DOI 10.1074/jbc.M404621200; Ahmad Z., 2014, SCI WORLD J, V2014, P10, DOI DOI 10.1155/2014/567398; Ahmad Z, 2015, INT J BIOL MACROMOL, V75, P37, DOI 10.1016/j.ijbiomac.2014.12.047; Ahmad Z, 2014, BIOCHEMISTRY-US, V53, P7376, DOI 10.1021/bi5013063; Ahmad Z, 2012, INT J BIOL MACROMOL, V50, P476, DOI 10.1016/j.ijbiomac.2012.01.019; Ahmad Z, 2010, CURR MED CHEM, V17, P2822, DOI 10.2174/092986710791859270; Al-Majed AA, 2006, EUR J PHARMACOL, V543, P40, DOI 10.1016/j.ejphar.2006.05.046; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Athar M, 2009, ARCH BIOCHEM BIOPHYS, V486, P95, DOI 10.1016/j.abb.2009.01.018; Attoub S, 2013, FUND CLIN PHARMACOL, V27, P557, DOI 10.1111/j.1472-8206.2012.01056.x; Banerjee S, 2010, NUTR CANCER, V62, P938, DOI 10.1080/01635581.2010.509832; Burwick NR, 2005, J BIOL CHEM, V280, P1740, DOI 10.1074/jbc.M405947200; Chaieb K, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-29; Chandra S, 2009, EXP BIOL MED, V234, P442, DOI 10.3181/0811-RM-317; Chang HY, 2012, CANCER RES, V72, P4696, DOI 10.1158/0008-5472.CAN-12-0567; Chinnam N, 2010, INT J BIOL MACROMOL, V46, P478, DOI 10.1016/j.ijbiomac.2010.03.009; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Cushnie TPT, 2011, INT J ANTIMICROB AG, V38, P99, DOI 10.1016/j.ijantimicag.2011.02.014; Dadi PK, 2009, INT J BIOL MACROMOL, V45, P72, DOI 10.1016/j.ijbiomac.2009.04.004; Duarte S, 2006, FEMS MICROBIOL LETT, V257, P50, DOI 10.1111/j.1574-6968.2006.00147.x; Fararh KM, 2005, RES VET SCI, V79, P219, DOI 10.1016/j.rvsc.2005.01.001; Gali-Muhtasib H, 2004, INT J ONCOL, V25, P857; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Hong S, 2008, MICROBIOL MOL BIOL R, V72, P590, DOI 10.1128/MMBR.00016-08; Jafri SH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-87; Johnson KM, 2005, CHEM BIOL, V12, P485, DOI 10.1016/j.chembiol.2005.02.012; Ketchum CJ, 1998, BIOCHEM J, V330, P707; Koka PS, 2010, EXP BIOL MED, V235, P751, DOI 10.1258/ebm.2010.009369; Kokoska L, 2008, J FOOD PROTECT, V71, P2475, DOI 10.4315/0362-028X-71.12.2475; Kouidhi B, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-29; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laughlin TF, 2010, INT J BIOL MACROMOL, V46, P367, DOI 10.1016/j.ijbiomac.2010.01.015; Li B, 2012, J NUTR BIOCHEM, V23, P953, DOI 10.1016/j.jnutbio.2011.05.001; Li WZ, 2009, J BIOL CHEM, V284, P10747, DOI 10.1074/jbc.M809209200; Noji H, 2001, J BIOL CHEM, V276, P1665, DOI 10.1074/jbc.R000021200; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P1, DOI 10.1007/s10863-007-9070-5; Piotto S, 2013, EUR J MED CHEM, V68, P178, DOI 10.1016/j.ejmech.2013.07.030; Ragheb A, 2009, SAUDI J KIDNEY DIS T, V20, P741; RAO R, 1987, ARCH BIOCHEM BIOPHYS, V255, P309, DOI 10.1016/0003-9861(87)90398-5; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Salmani JMM, 2014, MOLECULES, V19, P5925, DOI 10.3390/molecules19055925; SENIOR AE, 1983, BIOCHEM J, V210, P395, DOI 10.1042/bj2100395; Senior AE, 2002, BBA-BIOENERGETICS, V1553, P188, DOI 10.1016/S0005-2728(02)00185-8; SENIOR AE, 1984, ARCH BIOCHEM BIOPHYS, V228, P49, DOI 10.1016/0003-9861(84)90045-6; Singh CK, 2014, CELL CYCLE, V13, P1867, DOI 10.4161/cc.29334; Singh CK, 2013, ANN NY ACAD SCI, V1290, P113, DOI 10.1111/nyas.12160; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; WEBER J, 1992, J BIOL CHEM, V267, P1712; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; Woo CC, 2012, BIOCHEM PHARMACOL, V83, P443, DOI 10.1016/j.bcp.2011.09.029; Yavlovich A, 2012, BLOOD, V120, P1246, DOI 10.1182/blood-2011-12-399063; Zheng JB, 2000, BRIT J PHARMACOL, V130, P1115, DOI 10.1038/sj.bjp.0703397	56	33	33	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127802	10.1371/journal.pone.0127802	http://dx.doi.org/10.1371/journal.pone.0127802			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996607	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000088
J	Arsnoe, IM; Hickling, GJ; Ginsberg, HS; McElreath, R; Tsao, JI				Arsnoe, Isis M.; Hickling, Graham J.; Ginsberg, Howard S.; McElreath, Richard; Tsao, Jean I.			Different Populations of Blacklegged Tick Nymphs Exhibit Differences in Questing Behavior That Have Implications for Human Lyme Disease Risk	PLOS ONE			English	Article							IXODES-SCAPULARIS ACARI; AMBLYOMMA-AMERICANUM ACARI; BORRELIA-BURGDORFERI; RELATIVE-HUMIDITY; PACIFICUS ACARI; IXODIDAE NYMPHS; CLIMATE-CHANGE; UNITED-STATES; VECTOR-BORNE; BIODIVERSITY	Animal behavior can have profound effects on pathogen transmission and disease incidence. We studied the questing (= host-seeking) behavior of blacklegged tick (Ixodes scapularis) nymphs, which are the primary vectors of Lyme disease in the eastern United States. Lyme disease is common in northern but not in southern regions, and prior ecological studies have found that standard methods used to collect host-seeking nymphs in northern regions are unsuccessful in the south. This led us to hypothesize that there are behavior differences between northern and southern nymphs that alter how readily they are collected, and how likely they are to transmit the etiological agent of Lyme disease to humans. To examine this question, we compared the questing behavior of I. scapularis nymphs originating from one northern (Lyme disease endemic) and two southern (non-endemic) US regions at field sites in Wisconsin, Rhode Island, Tennessee, and Florida. Laboratory-raised uninfected nymphs were monitored in circular 0.2 m(2) arenas containing wooden dowels (mimicking stems of understory vegetation) for 10 (2011) and 19 (2012) weeks. The probability of observing nymphs questing on these stems (2011), and on stems, on top of leaf litter, and on arena walls (2012) was much greater for northern than for southern origin ticks in both years and at all field sites (19.5 times greater in 2011; 3.6-11.6 times greater in 2012). Our findings suggest that southern origin I. scapularis nymphs rarely emerge from the leaf litter, and consequently are unlikely to contact passing humans. We propose that this difference in questing behavior accounts for observed geographic differences in the efficacy of the standard sampling techniques used to collect questing nymphs. These findings also support our hypothesis that very low Lyme disease incidence in southern states is, in part, a consequence of the type of host-seeking behavior exhibited by southern populations of the key Lyme disease vector.	[Arsnoe, Isis M.; Tsao, Jean I.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Hickling, Graham J.] Univ Tennessee, Inst Agr, Ctr Wildlife Hlth, Knoxville, TN 37901 USA; [Ginsberg, Howard S.] Univ Rhode Isl, US Geol Survey, Patuxent Wildlife Res Ctr, Rhode Isl Field Stn, Kingston, RI 02881 USA; [McElreath, Richard] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [McElreath, Richard] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	Michigan State University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; United States Department of the Interior; United States Geological Survey; University of Rhode Island; University of California System; University of California Davis; University of California System; University of California Davis	Arsnoe, IM (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	kuczajis@msu.edu	Hickling, Graham/AHB-7822-2022	Hickling, Graham/0000-0002-1894-7505; McElreath, Richard/0000-0002-0387-5377	National Science Foundation, Emerging Infectious Disease Award [EF-0914476]; Direct For Biological Sciences [0914397] Funding Source: National Science Foundation; Division Of Environmental Biology [0914476] Funding Source: National Science Foundation	National Science Foundation, Emerging Infectious Disease Award; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was funded by the National Science Foundation, Emerging Infectious Disease Award EF-0914476. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; APPERSON CS, 1993, EXP APPL ACAROL, V17, P719; Arsnoe IM, 2015, THESIS MICHIGAN STAT; Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; BARBOUR AG, 1993, SCIENCE, V260, P1610, DOI 10.1126/science.8503006; Berger KA, 2014, J MED ENTOMOL, V51, P769, DOI 10.1603/ME13186; Bouchard C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-195; Brownstein John S., 2005, EcoHealth, V2, P38, DOI 10.1007/s10393-004-0139-x; Canals M, 1999, MEM I OSWALDO CRUZ, V94, P687, DOI 10.1590/S0074-02761999000500025; Centers for Disease Control and Prevention (CDC), LYM DIS DAT STAT; Conner J. K., 2004, PRIMER ECOLOGICAL GE; Cortinas MR, 2006, J MED ENTOMOL, V43, P810, DOI 10.1603/0022-2585(2006)43[810:CSOWDI]2.0.CO;2; Daniels TJ, 2000, J MED ENTOMOL, V37, P357, DOI 10.1603/0022-2585(2000)037[0357:EPSADS]2.0.CO;2; Dautel H, 2008, INT J MED MICROBIOL, V298, P50, DOI 10.1016/j.ijmm.2008.01.010; Day JF, 2005, J AM MOSQUITO CONTR, V21, P17, DOI 10.2987/8756-971X(2005)21[17:HSOMDV]2.0.CO;2; Dennis DT, 1998, J MED ENTOMOL, V35, P629, DOI 10.1093/jmedent/35.5.629; Diuk-Wasser MA, 2006, J MED ENTOMOL, V43, P166, DOI 10.1603/0022-2585(2006)043[0166:SPOHIS]2.0.CO;2; Diuk-Wasser MA, 2012, AM J TROP MED HYG, V86, P320, DOI 10.4269/ajtmh.2012.11-0395; Durden LA, 2002, EXP APPL ACAROL, V26, P257, DOI 10.1023/A:1021199914816; Falco RC, 1999, AM J EPIDEMIOL, V149, P771, DOI 10.1093/oxfordjournals.aje.a009886; FALCO RC, 1992, EXP APPL ACAROL, V14, P165, DOI 10.1007/BF01219108; Felz MW, 1996, J PARASITOL, V82, P505, DOI 10.2307/3284095; Feria-Arroyo TP, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-199; Gatewood AG, 2009, APPL ENVIRON MICROB, V75, P2476, DOI 10.1128/AEM.02633-08; Gelman A., 2007, DATA ANAL USING REGR; Ginsberg HS, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-394; GINSBERG HS, 1989, EXP APPL ACAROL, V7, P313, DOI 10.1007/BF01197925; Goddard J, 2006, J VECTOR ECOL, V31, P421, DOI 10.3376/1081-1710(2006)31[421:NROIIS]2.0.CO;2; Goddard Jerome, 2002, J Agromedicine, V8, P25, DOI 10.1300/J096v08n02_06; Goltz L, 2013, SYST APPL ACAROL-UK, V18, P212, DOI 10.11158/saa.18.3.2; Hamer SA, 2010, ECOHEALTH, V7, P47, DOI 10.1007/s10393-010-0287-0; Hoen AG, 2009, P NATL ACAD SCI USA, V106, P15013, DOI 10.1073/pnas.0903810106; Horobik V, 2006, ECOHEALTH, V3, P262, DOI 10.1007/s10393-006-0065-1; Humphrey PT, 2010, EVOLUTION, V64, P2653, DOI 10.1111/j.1558-5646.2010.01001.x; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kelly RR, 2014, INFECT GENET EVOL, V27, P543, DOI 10.1016/j.meegid.2014.05.022; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Kollars TM, 1999, J MED ENTOMOL, V36, P720, DOI 10.1093/jmedent/36.6.720; Kruschke JK, 2012, ORGAN RES METHODS, V15, P722, DOI 10.1177/1094428112457829; Lane RS, 2013, TICKS TICK-BORNE DIS, V4, P377, DOI 10.1016/j.ttbdis.2013.02.005; LANE RS, 1995, J MED ENTOMOL, V32, P290, DOI 10.1093/jmedent/32.3.290; Levine JF, 1997, J MED ENTOMOL, V34, P594, DOI 10.1093/jmedent/34.6.594; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Mahande A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-100; Martinez-Ibarra JA, 2001, J AM MOSQUITO CONTR, V17, P209; Mather TN, 1996, AM J EPIDEMIOL, V144, P1066, DOI 10.1093/oxfordjournals.aje.a008879; McElreath R, 2014, RETHINKING STAT RETH; McElreath R, 2014, HUM NATURE-INT BIOS, V25, P100, DOI 10.1007/s12110-014-9193-4; Mejlon HA, 1997, EXP APPL ACAROL, V21, P747, DOI 10.1023/A:1018421105231; Mills JN, 2010, ENVIRON HEALTH PERSP, V118, P1507, DOI 10.1289/ehp.0901389; Moore C. G., 1993, GUIDELINES ARBOVIRUS; NEEDHAM GR, 1991, ANNU REV ENTOMOL, V36, P659, DOI 10.1146/annurev.en.36.010191.003303; Ogden NH, 2009, EPIDEMICS-NETH, V1, P196, DOI 10.1016/j.epidem.2009.06.002; Ogden NH, 2014, ENVIRON HEALTH PERSP, V122, P631, DOI 10.1289/ehp.1307799; Ogden NH, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-24; Oliver JH, 1996, J PARASITOL, V82, P926, DOI 10.2307/3284201; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Ostfeld RS, 2000, CONSERV BIOL, V14, P722, DOI 10.1046/j.1523-1739.2000.99014.x; Pepin KM, 2012, AM J TROP MED HYG, V86, P1062, DOI 10.4269/ajtmh.2012.11-0630; Qiu WG, 2002, GENETICS, V160, P833; Randolph SE, 1999, J MED ENTOMOL, V36, P741, DOI 10.1093/jmedent/36.6.741; Rogers AJ, 1953, THESIS U MARYLAND; Rollend L, 2013, TICKS TICK-BORNE DIS, V4, P46, DOI 10.1016/j.ttbdis.2012.06.008; Schmidt KA, 2001, ECOLOGY, V82, P609, DOI 10.1890/0012-9658(2001)082[0609:BATDEI]2.0.CO;2; Schulze TL, 2003, J MED ENTOMOL, V40, P395, DOI 10.1603/0022-2585-40.4.395; Sonenshine D.E., 1991, BIOL TICKS, V2; Sonenshine DE, 1991, BIOL TICKS, V1; SPIELMAN A, 1985, ANNU REV ENTOMOL, V30, P439, DOI 10.1146/annurev.en.30.010185.002255; Stafford KC, 1998, J CLIN MICROBIOL, V36, P1240, DOI 10.1128/JCM.36.5.1240-1244.1998; Stan Development Team, 2014, STAN A C LIB PROB SA; Stromdahl EY, 2012, ZOONOSES PUBLIC HLTH, V59, P48, DOI 10.1111/j.1863-2378.2012.01475.x; Swei A, 2011, P ROY SOC B-BIOL SCI, V278, P2970, DOI 10.1098/rspb.2010.2402; Talleklint-Eisen L, 2000, J MED ENTOMOL, V37, P484, DOI 10.1603/0022-2585(2000)037[0484:EODSFE]2.0.CO;2; Tsunoda T, 2004, PARASITOLOGY, V128, P503, DOI 10.1017/S0031182004004913; Vail SG, 2002, J MED ENTOMOL, V39, P842, DOI 10.1603/0022-2585-39.6.842; Vail SG, 1998, J MED ENTOMOL, V35, P1025, DOI 10.1093/jmedent/35.6.1025; van Es RP, 1998, B ENTOMOL RES, V88, P567, DOI 10.1017/S0007485300026092; Van Zee J, 2013, TICKS TICK-BORNE DIS, V4, P63, DOI 10.1016/j.ttbdis.2012.07.005; Wang P, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00070; Williamson PC, 2010, EMERG INFECT DIS, V16, P441, DOI 10.3201/eid1603.091333	80	80	80	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127450	10.1371/journal.pone.0127450	http://dx.doi.org/10.1371/journal.pone.0127450			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996603	gold, Green Submitted, Green Published			2022-12-26	WOS:000356444000068
J	Green, SJ; Venkatramanan, R; Naqib, A				Green, Stefan J.; Venkatramanan, Raghavee; Naqib, Ankur			Deconstructing the Polymerase Chain Reaction: Understanding and Correcting Bias Associated with Primer Degeneracies and Primer-Template Mismatches	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; ANNEALING TEMPERATURE; PCR; AMPLIFICATION; SEQUENCES; DIVERSITY; NUMBER	The polymerase chain reaction (PCR) is sensitive to mismatches between primer and template, and mismatches can lead to inefficient amplification of targeted regions of DNA template. In PCRs in which a degenerate primer pool is employed, each primer can behave differently. Therefore, inefficiencies due to different primer melting temperatures within a degenerate primer pool, in addition to mismatches between primer binding sites and primers, can lead to a distortion of the true relative abundance of targets in the original DNA pool. A theoretical analysis indicated that a combination of primer-template and primer-amplicon interactions during PCR cycles 3-12 is potentially responsible for this distortion. To test this hypothesis, we developed a novel amplification strategy, entitled "Polymerase-exonuclease (PEX) PCR", in which primer-template interactions and primer-amplicon interactions are separated. The PEX PCR method substantially and significantly improved the evenness of recovery of sequences from a mock community of known composition, and allowed for amplification of templates with introduced mismatches near the 3' end of the primer annealing sites. When the PEX PCR method was applied to genomic DNA extracted from complex environmental samples, a significant shift in the observed microbial community was detected. Furthermore, the PEX PCR method provides a mechanism to identify which primers in a primer pool are annealing to target gDNA. Primer utilization patterns revealed that at high annealing temperatures in the PEX PCR method, perfect match annealing predominates, while at lower annealing temperatures, primers with up to four mismatches with templates can contribute substantially to amplification. The PEX PCR method is simple to perform, is limited to PCR mixes and a single exonuclease step which can be performed without reaction cleanup, and is recommended for reactions in which degenerate primer pools are used or when mismatches between primers and template are possible.	[Green, Stefan J.; Venkatramanan, Raghavee; Naqib, Ankur] Univ Illinois, Res Resources Ctr, DNA Serv Facil, Chicago, IL 60607 USA; [Green, Stefan J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Venkatramanan, Raghavee; Naqib, Ankur] Univ Illinois, Dept Bioengn, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Green, SJ (corresponding author), Univ Illinois, Res Resources Ctr, DNA Serv Facil, Chicago, IL 60607 USA.	GreenDNA@uic.edu		Green, Stefan/0000-0003-2781-359X	Research Open Access Publishing (ROAAP) Fund of University of Illinois at Chicago	Research Open Access Publishing (ROAAP) Fund of University of Illinois at Chicago	The Research Open Access Publishing (ROAAP) Fund of the University of Illinois at Chicago is kindly acknowledged for financial support towards the open access publishing fee for this article. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Bru D, 2008, APPL ENVIRON MICROB, V74, P1660, DOI 10.1128/AEM.02403-07; Bybee SM, 2011, GENOME BIOL EVOL, V3, P1312, DOI 10.1093/gbe/evr106; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chandler DP, 1997, MOL ECOL, V6, P475, DOI 10.1046/j.1365-294X.1997.00205.x; Chang SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020303; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Crosby LD, 2007, MOL CELL PROBE, V21, P140, DOI 10.1016/j.mcp.2006.09.003; de Carcer DA, 2011, APPL ENVIRON MICROB, V77, P6310, DOI 10.1128/AEM.05146-11; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Green SJ, 2010, APPL ENVIRON MICROB, V76, P3244, DOI 10.1128/AEM.03069-09; Isenbarger TA, 2008, APPL ENVIRON MICROB, V74, P840, DOI 10.1128/AEM.01933-07; Ishii K, 2001, APPL ENVIRON MICROB, V67, P3753, DOI 10.1128/AEM.67.8.3753-3755.2001; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Kostka JE, 2012, J BACTERIOL, V194, P4461, DOI 10.1128/JB.00871-12; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; LOAKES D, 1995, NUCLEIC ACIDS RES, V23, P2361, DOI 10.1093/nar/23.13.2361; Mao DP, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-66; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Moonsamy PV, 2013, TISSUE ANTIGENS, V81, P141, DOI 10.1111/tan.12071; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wu JH, 2009, J MICROBIOL METH, V77, P267, DOI 10.1016/j.mimet.2009.03.001	35	121	122	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0128122	10.1371/journal.pone.0128122	http://dx.doi.org/10.1371/journal.pone.0128122			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996930	Green Submitted, Green Published, gold			2022-12-26	WOS:000356444000102
J	Moscovice, LR; Deschner, T; Hohmann, G				Moscovice, Liza R.; Deschner, Tobias; Hohmann, Gottfried			Welcome Back: Responses of Female Bonobos (Pan paniscus) to Fusions	PLOS ONE			English	Article							FISSION-FUSION; TENSION REGULATION; URINARY CORTISOL; SOCIAL BONDS; BEHAVIOR; CHIMPANZEES; DOMINANCE; WAMBA; AGGRESSION; GREETINGS	In species with a high degree of fission-fusion social dynamics, fusions may trigger social conflict and thus provide an opportunity to identify sources of social tension and mechanisms related to its alleviation. We characterized behavioral and endocrine responses of captive female bonobos (Pan paniscus) to fusions within a zoo facility designed to simulate naturalistic fission-fusion social dynamics. We compared urinary cortisol levels and frequencies of aggression, grooming and socio-sexual interactions between female bonobos while in stable sub-groups and when one "joiner" was reunited with the "residents" of another sub-group. We hypothesized that fusions would trigger increases in aggression and cortisol levels among reunited joiners and resident females. We further predicted that females who face more uncertainty in their social interactions following fusions may use grooming and/or socio-sexual behavior to reduce social tension and aggression. The only aggression on reunion days occurred between reunited females, but frequencies of aggression remained low across non-reunion and reunion days, and there was no effect of fusions on cortisol levels. Fusions did not influence patterns of grooming, but there were increases in socio-sexual solicitations and socio-sexual interactions between joiners and resident females. Joiners who had been separated from residents for longer received the most solicitations, but were also more selective in their acceptance of solicitations and preferred to have socio-sexual interactions with higher-ranking residents. Our results suggest that sociosexual interactions play a role in reintegrating female bonobos into social groups following fusions. In addition, females who receive a high number of solicitations are able to gain more control over their socio-sexual interactions and may use socio-sexual interactions for other purposes, such as to enhance their social standing.	[Moscovice, Liza R.; Deschner, Tobias; Hohmann, Gottfried] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany	Max Planck Society	Moscovice, LR (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany.	liza_moscovice@eva.mpg.de		Moscovice, Liza/0000-0002-1823-7757	VolkswagenStiftung [86 048]; Leakey Foundation; Wenner-Gren Foundation	VolkswagenStiftung(Volkswagen); Leakey Foundation; Wenner-Gren Foundation	Funding for this research was provided by: The VolkswagenStiftung grant #86 048 (http://www.volkswagenstiftung.de/), the Leakey Foundation (http://www.leakeyfoundation.org/) and the Wenner-Gren Foundation (http://www.wennergren.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Amrein M, 2014, INT J PRIMATOL, V35, P509, DOI 10.1007/s10764-014-9765-5; Anestis SF, 2004, HORM BEHAV, V45, P209, DOI 10.1016/j.yhbeh.2003.09.015; [Anonymous], 2014, R LANG ENV STAT COMP; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Aureli F, 2007, BIOL LETTERS, V3, P147, DOI 10.1098/rsbl.2007.0041; Aureli F, 2008, CAM S BIO EVOL ANTHR, V55, P236; Bahr NI, 2000, GEN COMP ENDOCR, V117, P427, DOI 10.1006/gcen.1999.7431; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bauer H.R., 1975, Proceedings int Congr Primatol, V5, P295; Behringer V, 2012, J ENDOCRINOL, V214, P55, DOI 10.1530/JOE-12-0103; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; Clay Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00291; Copeland SR, 2011, NATURE, V474, P76, DOI 10.1038/nature10149; DAHL JF, 1986, J HUM EVOL, V15, P369, DOI 10.1016/S0047-2484(86)80017-3; DEWAAL FBM, 1987, NATL GEOGR RES, V3, P318; Dunbar RIM, 2010, NEUROSCI BIOBEHAV R, V34, P260, DOI 10.1016/j.neubiorev.2008.07.001; EAST ML, 1993, BEHAV ECOL SOCIOBIOL, V33, P355; Fishlock V, 2013, ANIM BEHAV, V85, P357, DOI 10.1016/j.anbehav.2012.11.004; Fox J, 2011, AN R COMPANION APPL; FURUICHI T, 1987, PRIMATES, V28, P309, DOI 10.1007/BF02381014; FURUICHI T, 1989, INT J PRIMATOL, V10, P173, DOI 10.1007/BF02735199; Furuichi T, 1997, INT J PRIMATOL, V18, P855, DOI 10.1023/A:1026327627943; Furuichi T, 2009, PRIMATES, V50, P197, DOI 10.1007/s10329-009-0141-6; Gold Kenneth C., 2001, P90; Hauser B, 2008, J CHROMATOGR B, V862, P100, DOI 10.1016/j.jchromb.2007.11.009; Hill KR, 2011, SCIENCE, V331, P1286, DOI 10.1126/science.1199071; Hohmann G, 2003, BEHAVIOUR, V140, P1389, DOI 10.1163/156853903771980648; Hohmann G, 1999, BEHAVIOUR, V136, P1219, DOI 10.1163/156853999501739; Hohmann G, 2000, ANIM BEHAV, V60, P107, DOI 10.1006/anbe.2000.1451; Hohmann G., 1996, FOOD STATUS QUEST, P47; Hohmann G, 2009, AM J PRIMATOL, V71, P223, DOI 10.1002/ajp.20640; IDANI G, 1991, FOLIA PRIMATOL, V57, P83, DOI 10.1159/000156568; Jaeggi AV, 2010, AM J PHYS ANTHROPOL, V143, P41, DOI 10.1002/ajpa.21288; KANO T, 1980, J HUM EVOL, V9, P243, DOI 10.1016/0047-2484(80)90053-6; Kappeler Peter M., 2008, P225, DOI 10.1007/978-3-540-75957-7_11; KURODA S, 1979, Primates, V20, P161, DOI 10.1007/BF02373371; Mitani JC, 2009, ANIM BEHAV, V77, P633, DOI 10.1016/j.anbehav.2008.11.021; Muller MN, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P112, DOI 10.1017/CBO9780511606397.012; NISHIDA T, 1970, Primates, V11, P47, DOI 10.1007/BF01730675; Okamoto K, 2001, PRIMATES, V42, P161, DOI 10.1007/BF02558143; SAPOLSKY R M, 1992, P287; Schaffner CM, 2005, INT J PRIMATOL, V26, P1093, DOI 10.1007/s10764-005-6460-6; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Silk JB, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P269, DOI 10.1016/B978-0-12-374176-9.00018-X; Smith JE, 2011, ANIM BEHAV, V81, P401, DOI 10.1016/j.anbehav.2010.11.007; Stevens JMG, 2007, INT J PRIMATOL, V28, P1417, DOI 10.1007/s10764-007-9186-9; Surbeck M, 2013, BEHAV ECOL SOCIOBIOL, V67, P1767, DOI 10.1007/s00265-013-1584-8; Surbeck M, 2012, HORM BEHAV, V62, P27, DOI 10.1016/j.yhbeh.2012.04.013; Tan JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051922; TAUSSKY HH, 1954, J BIOL CHEM, V208, P853; Vervaecke H, 2000, INT J PRIMATOL, V21, P47, DOI 10.1023/A:1005471512788	53	11	11	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127305	10.1371/journal.pone.0127305	http://dx.doi.org/10.1371/journal.pone.0127305			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996476	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000057
J	Ye, Q; Shang, SQ; Liu, AM; Zhang, T; Shen, HQ; Chen, XJ; Mao, JH				Ye, Qing; Shang, Shi-qiang; Liu, Ai-min; Zhang, Ting; Shen, Hong-qiang; Chen, Xue-jun; Mao, Jian-hua			24h Urinary Protein Levels and Urine Protein/Creatinine Ratios Could Probably Forecast the Pathological Classification of HSPN	PLOS ONE			English	Article							HENOCH-SCHONLEIN PURPURA; MESANGIAL CELLS; CULTURED RAT; NEPHRITIS; PATHWAY; IGA	This study aimed to assess the relevance of laboratory tests in Henoch-Schonlein purpura nephritis (HSPN) classification, and determine accurate classification factors. This prospective study included 694 HSPN patients who underwent ultrasound-guided percutaneous renal biopsy (PRB). Renal specimens were scored according to International Study of Kidney Disease in Children (ISKDC) classification. Meanwhile, blood samples were immediately collected for laboratory examination. The associations between laboratory parameters and HSPN classification were assessed. Significant differences in levels of serum Th1/Th2 cytokines, immunoglobulins, T-lymphocyte subsets, complement, and coagulation markers were obtained between HSPN patients and healthy children. Interestingly, 24h urinary protein (24h-UPRO) levels and urine protein/urine creatinine ratios could determine HPSN grade IIb, IIIa, and IIIb incidences, with areas under ROC curve of 0.767 and 0.731, respectively. At 24h-UPRO >580.35mg/L, prediction sensitivity and specificity were 75.2% and 70.0%, respectively. These values became 53.0% and 82.3%, respectively, with 24h-UPRO exceeding 1006.25mg/L. At urine protein/urine creatinine >0.97, prediction sensitivity and specificity were 65.5% and 67.2%, respectively, values that became 57.4% and 80.0%, respectively, at ratios exceeding 1.2. Cell and humoral immunity, coagulation and fibrinolytic systems are all involved in the pathogenesis of HSPN, and type I hypersensitivity may be the disease trigger of HSPN. 24h-UPRO levels and urine protein/creatinine ratios could probably forecast the pathological classification of HSPN.	[Ye, Qing; Shang, Shi-qiang; Liu, Ai-min; Shen, Hong-qiang; Chen, Xue-jun; Mao, Jian-hua] Zhejiang Univ, Childrens Hosp, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Ye, Qing] Zhejiang Key Lab Diag & Treatment Neonatal Dis, Hangzhou, Zhejiang, Peoples R China; [Zhang, Ting] Zhejiang Chinese Med Univ, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Chinese Medical University	Mao, JH (corresponding author), Zhejiang Univ, Childrens Hosp, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China.	yeqingkaoyan@163.com	Mao, Jianhua/GOK-2713-2022	Shen, Hongqiang/0000-0001-7188-5289	National Natural Science Foundation of China [81270792, 81470939, 81170664]; Research Fund for the Doctoral Program of Higher Education of China [20120101110018]; Zhejiang Provincial Healthy Science Foundation of China [2012KYA119, 2014KYA123]; Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents; Zhejiang Provincial Natural Science Foundation of China [LH14H050002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Zhejiang Provincial Healthy Science Foundation of China; Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This project was supported by the National Natural Science Foundation of China (grant nos. 81270792, 81470939 and 81170664), the Research Fund for the Doctoral Program of Higher Education of China (20120101110018), the Zhejiang Provincial Healthy Science Foundation of China (2012KYA119, 2014KYA123), the Zhejiang Provincial Program for the Cultivation of High-Level Innovative Health Talents and the Zhejiang Provincial Natural Science Foundation of China (LH14H050002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davin JC, 2001, KIDNEY INT, V59, P823, DOI 10.1046/j.1523-1755.2001.059003823.x; DAVIN JC, 1994, PEDIATR NEPHROL, V8, P169, DOI 10.1007/BF00865470; Davin JC, 2011, CLIN J AM SOC NEPHRO, V6, P679, DOI 10.2215/CJN.06710810; GOMEZGUERRERO C, 1994, J IMMUNOL, V153, P5247; Hisano S, 2005, AM J KIDNEY DIS, V45, P295, DOI 10.1053/j.ajkd.2004.10.020; Johnson EF, 2015, BRIT J DERMATOL, V172, P1358, DOI 10.1111/bjd.13472; Lau KK, 2010, PEDIATR NEPHROL, V25, P19, DOI 10.1007/s00467-009-1230-x; Lin Q, 2012, PEDIATR NEPHROL, V27, P801, DOI 10.1007/s00467-011-2070-z; LopezArmada MJ, 1996, J IMMUNOL, V157, P2136; Noble A, 2001, EUR J IMMUNOL, V31, P2227, DOI 10.1002/1521-4141(200107)31:7<2227::AID-IMMU2227>3.0.CO;2-C; Pan YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115261; Tsuruga K, 2011, PEDIATR NEPHROL, V26, P2253, DOI 10.1007/s00467-011-1996-5; Ye Q, 2015, J MED VIROL, V87, P323, DOI 10.1002/jmv.24047; Ye Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098745; Zaffanello M, 2009, PEDIATR NEPHROL, V24, P1901, DOI 10.1007/s00467-008-1066-9; Zhang Guo-Zhen, 2007, Zhongguo Dang Dai Er Ke Za Zhi, V9, P129	16	14	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127767	10.1371/journal.pone.0127767	http://dx.doi.org/10.1371/journal.pone.0127767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996387	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000086
J	Kasumov, T; Li, L; Li, M; Gulshan, K; Kirwan, JP; Liu, XL; Previs, S; Willard, B; Smith, JD; McCullough, A				Kasumov, Takhar; Li, Ling; Li, Min; Gulshan, Kailash; Kirwan, John P.; Liu, Xiuli; Previs, Stephen; Willard, Belinda; Smith, Jonathan D.; McCullough, Arthur			Ceramide as a Mediator of Non-Alcoholic Fatty Liver Disease and Associated Atherosclerosis	PLOS ONE			English	Article							RECEPTOR KNOCKOUT MICE; INSULIN-RESISTANCE; SPHINGOMYELIN SYNTHESIS; DIETARY-CHOLESTEROL; HEPATIC STEATOSIS; ADIPOSE-TISSUE; RAPID METHOD; LDL; OBESITY; LIPOPROTEINS	Cardiovascular disease (CVD) is a serious comorbidity in nonalcoholic fatty liver disease (NAFLD). Since plasma ceramides are increased in NAFLD and sphingomyelin, a ceramide metabolite, is an independent risk factor for CVD, the role of ceramides in dyslipidemia was assessed using LDLR-/-mice, a diet-induced model of NAFLD and atherosclerosis. Mice were fed a standard or Western diet (WD), with or without myriocin, an inhibitor of ceramide synthesis. Hepatic and plasma ceramides were profiled and lipid and lipoprotein kinetics were quantified. Hepatic and intestinal expression of genes and proteins involved in insulin, lipid and lipoprotein metabolism were also determined. WD caused hepatic oxidative stress, inflammation, apoptosis, increased hepatic long-chain ceramides associated with apoptosis (C16 and C18) and decreased very-long-chain ceramide C24 involved in insulin signaling. The plasma ratio of ApoB/ApoA1 (proteins of VLDL/LDL and HDL) was increased 2-fold due to increased ApoB production. Myriocin reduced hepatic and plasma ceramides and sphingomyelin, and decreased atherosclerosis, hepatic steatosis, fibrosis, and apoptosis without any effect on oxidative stress. These changes were associated with decreased lipogenesis, ApoB production and increased HDL turnover. Thus, modulation of ceramide synthesis may lead to the development of novel strategies for the treatment of both NAFLD and its associated atherosclerosis.	[Kasumov, Takhar; McCullough, Arthur] Cleveland Clin, Dept Gastroenterol & Hepatol, Cleveland, OH 44106 USA; [Li, Ling; Willard, Belinda] Cleveland Clin, Dept Res Core Serv, Cleveland, OH 44106 USA; [Li, Min; Kirwan, John P.; McCullough, Arthur] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44106 USA; [Gulshan, Kailash; Smith, Jonathan D.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Liu, Xiuli] Cleveland Clin, Dept Anat Pathol, Cleveland, OH 44106 USA; [Previs, Stephen] Case Western Reserve Univ, Sch Med, Cleveland Clin, Dept Nutr & Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Kasumov, T (corresponding author), Cleveland Clin, Dept Gastroenterol & Hepatol, Cleveland, OH 44106 USA.	kasumot@ccf.org; MCULLA@ccf.org	Kirwan, John P/G-6942-2012; Smith, Jonathan D./H-9723-2013	Smith, Jonathan D./0000-0002-0415-386X	National Institute of Health [5R21RR025346-03, 1S10RR031537-01]; American Heart Association [13IRG14700011]; Cleveland Clinic Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025346, S10RR031537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582, P01HL098055, R21HL114407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112044] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Cleveland Clinic Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institute of Health (5R21RR025346-03 (TK) and 1S10RR031537-01 (BW)), American Heart Association (13IRG14700011 (TK)) and the Cleveland Clinic Foundation (TK, AM).	Abumrad N A, 2000, Curr Opin Clin Nutr Metab Care, V3, P255, DOI 10.1097/00075197-200007000-00003; Alkhouri N, 2010, DIGEST DIS SCI, V55, P2644, DOI 10.1007/s10620-009-1075-y; Baglione Julie, 2006, V129, P83; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030668; Bikman BT, 2012, CELL MOL LIFE SCI, V69, P2135, DOI 10.1007/s00018-012-0917-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boon J, 2013, DIABETES, V62, P401, DOI 10.2337/db12-0686; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brunengraber DZ, 2003, AM J PHYSIOL-ENDOC M, V285, pE917, DOI 10.1152/ajpendo.00128.2003; Chavez JA, 2014, J BIOL CHEM, V289, P723, DOI 10.1074/jbc.M113.522847; Collins AR, 2009, CIRC RES, V104, pe42, DOI 10.1161/CIRCRESAHA.108.188771; Deevska GM, 2012, BIOSCIENCE REP, V32, P479, DOI 10.1042/BSR20120036; Deevska GM, 2009, J BIOL CHEM, V284, P8359, DOI 10.1074/jbc.M807800200; Dekker MJ, 2013, ATHEROSCLEROSIS, V228, P98, DOI 10.1016/j.atherosclerosis.2013.01.041; Ehehalt R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-45; FUJITA T, 1994, J ANTIBIOT, V47, P208, DOI 10.7164/antibiotics.47.208; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Goldberg IJ, 2008, DIABETES, V57, P1674, DOI 10.2337/db08-0083; Gulshan K, 2013, J BIOL CHEM, V288, P37166, DOI 10.1074/jbc.M113.512244; Gupte AA, 2010, HEPATOLOGY, V52, P2001, DOI 10.1002/hep.23941; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Heneghan HM, 2013, SURG OBES RELAT DIS, V9, P100, DOI 10.1016/j.soard.2011.11.018; HOFF HF, 1990, EUR HEART J, V11, P105, DOI 10.1093/eurheartj/11.suppl_E.105; Hojjati MR, 2005, J BIOL CHEM, V280, P10284, DOI 10.1074/jbc.M412348200; Huang H, 2011, OBESITY, V19, P2235, DOI 10.1038/oby.2011.107; Jiang CT, 2015, J CLIN INVEST, V125, P386, DOI 10.1172/JCI76738; Jiang XC, 2000, ARTERIOSCL THROM VAS, V20, P2614, DOI 10.1161/01.ATV.20.12.2614; Joven J, 2007, ATHEROSCLEROSIS, V195, pE85, DOI 10.1016/j.atherosclerosis.2007.06.012; Kasumov T, 2013, ARTERIOSCL THROM VAS, V33, P1994, DOI 10.1161/ATVBAHA.113.301700; Kasumov T, 2010, ANAL BIOCHEM, V401, P154, DOI 10.1016/j.ab.2010.02.023; Kasumov T, 2009, CARDIOVASC DRUG THER, V23, P459, DOI 10.1007/s10557-009-6208-1; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Li L, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010025, 10.1074/mcp.M111.014209]; Li ZQ, 2009, BBA-MOL CELL BIOL L, V1791, P297, DOI 10.1016/j.bbalip.2009.01.010; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Pagadala M, 2012, TRENDS ENDOCRIN MET, V23, P365, DOI 10.1016/j.tem.2012.04.005; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Park JW, 2013, HEPATOLOGY, V57, P525, DOI 10.1002/hep.26015; Park TS, 2006, ATHEROSCLEROSIS, V189, P264, DOI 10.1016/j.atherosclerosis.2005.12.029; Park TS, 2004, CIRCULATION, V110, P3465, DOI 10.1161/01.CIR.0000148370.60535.22; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Previs SF, 2011, J LIPID RES, V52, P1420, DOI 10.1194/jlr.D014993; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; RAPP JH, 1994, ARTERIOSCLER THROMB, V14, P1767, DOI 10.1161/01.ATV.14.11.1767; Rye KA, 2009, J LIPID RES, V50, pS195, DOI 10.1194/jlr.R800034-JLR200; Scarpa MC, 2013, RESPIRATION, V85, P342, DOI 10.1159/000341185; Shah V, 2010, ANAL BIOCHEM, V404, P235, DOI 10.1016/j.ab.2010.05.010; Siri P, 2001, J BIOL CHEM, V276, P46064, DOI 10.1074/jbc.M108909200; Subramanian S, 2011, J LIPID RES, V52, P1626, DOI 10.1194/jlr.M016246; Summers SA, 2010, CURR OPIN LIPIDOL, V21, P128, DOI 10.1097/MOL.0b013e3283373b66; Targher G, 2005, ARTERIOSCL THROM VAS, V25, P2687, DOI 10.1161/01.ATV.0000189299.61568.79; Targher G, 2004, DIABETES CARE, V27, P2498, DOI 10.2337/diacare.27.10.2498; Teupser D, 2003, ARTERIOSCL THROM VAS, V23, P1907, DOI 10.1161/01.ATV.0000090126.34881.B1; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; Walldius G, 2004, CLIN CHEM LAB MED, V42, P1355, DOI 10.1515/CCLM.2004.254; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Wu L, 2006, J LIPID RES, V47, P2215, DOI 10.1194/jlr.M600146-JLR200; Xue B, 2007, J BIOL CHEM, V282, P23829, DOI 10.1074/jbc.M609680200; Zhang QJ, 2012, DIABETES, V61, P1848, DOI 10.2337/db11-1399; Zhou HH, 2012, J LIPID RES, V53, P1223, DOI 10.1194/jlr.D021295	61	129	132	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126910	10.1371/journal.pone.0126910	http://dx.doi.org/10.1371/journal.pone.0126910			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993337	Green Published, Green Submitted, gold			2022-12-26	WOS:000354921400083
J	Liu, J; Wan, L; Lu, KH; Sun, M; Pan, X; Zhang, P; Lu, BB; Liu, GJ; Wang, ZX				Liu, Jing; Wan, Li; Lu, Kaihua; Sun, Ming; Pan, Xuan; Zhang, Ping; Lu, Binbin; Liu, Guojian; Wang, Zhaoxia			The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma	PLOS ONE			English	Article							CELL-PROLIFERATION; INDUCED APOPTOSIS; CANCER; P53; MDM2; PROMOTES; TRENDS	Long noncoding RNAs (lncRNAs) have been identified as oncogenes or tumor suppressors that are involved in tumorigenesis and chemotherapy drug resistance. Maternally expressed gene 3 (MEG3) is an imprinted gene located at 14q32 that encodes an lncRNA, and decreased MEG3 expression plays an important role in multiple cancers. However, its biological role in the development of the chemoresistance phenotype of human lung adenocarcinoma (LAD) is unknown. This study aimed to observe the expression of MEG3 in LAD and to evaluate its biological role and clinical significance in the resistance of LAD cells to cisplatin. MEG3 expression was markedly decreased in cisplatin-resistant A549/DDP cells compared with parental A549 cells as shown by an lncRNA microarray. MEG3 overexpression in A549/DDP cells increased their chemosensitivity to cisplatin both in vitro and in vivo by inhibiting cell proliferation and inducing apoptosis. By contrast, MEG3 knockdown in A549 cells decreased the chemosensitivity. Moreover, MEG3 was decreased in cisplatin-insensitive LAD tissues while p53 protein levels were decreased and Bcl-xl protein levels increased. Furthermore, patients with lower levels of MEG3 expression showed worse responses to cisplatin-based chemotherapy. These findings demonstrate that MEG3 is significantly downregulated in LAD and partially regulates the cisplatin resistance of LAD cells through the control of p53 and Bcl-xl expression. Thus, MEG3 may represent a new marker of poor response to cisplatin and could be a potential therapeutic target for LAD chemotherapy.	[Liu, Jing; Wan, Li; Lu, Binbin; Liu, Guojian; Wang, Zhaoxia] Nanjing Med Univ, Affiliated Hosp 2, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Lu, Kaihua] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Sun, Ming] Nanjing Med Univ, Dept Biochem & Mol Biol, Nanjing, Jiangsu, Peoples R China; [Pan, Xuan] Nanjing Med Univ, Affiliated Canc Hosp Jiangsu Prov, Canc Inst Jiangsu Prov, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China; [Zhang, Ping] Nanjing Med Univ, Affiliated Hosp 2, Dept Pathol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Wang, ZX (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Dept Oncol, Nanjing, Jiangsu, Peoples R China.	zhaoxiawang88@hotmail.com			National Natural Science Foundation of China [81272601, 81372397, 81472198]; Key Clinical Medicine Technology Foundation of Jiangsu Province [BL2014096]; Medical Key Talented Person Foundation of the Jiangsu Provincial Developing Health Project [RC2011080]; Scientific Research Foundation of Jiangsu Province Health Department [H201310]; 333 high class Talented Man Project [2011-III-2630]; School key Fund of Nanjing Medical University [2013NJMU054]; Innovation Team Project of the Second Affiliated Hospital of Nanjing Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Clinical Medicine Technology Foundation of Jiangsu Province; Medical Key Talented Person Foundation of the Jiangsu Provincial Developing Health Project; Scientific Research Foundation of Jiangsu Province Health Department; 333 high class Talented Man Project; School key Fund of Nanjing Medical University; Innovation Team Project of the Second Affiliated Hospital of Nanjing Medical University	This work was supported by grants from the National Natural Science Foundation of China (No. 81272601,81372397,81472198), the Key Clinical Medicine Technology Foundation of Jiangsu Province (No. BL2014096), the Medical Key Talented Person Foundation of the Jiangsu Provincial Developing Health Project (No. RC2011080), Innovation Team Project of the Second Affiliated Hospital of Nanjing Medical University, the Scientific Research Foundation of Jiangsu Province Health Department (No. H201310),"333 high class Talented Man Project" (No. 2011-III-2630) and the School key Fund of Nanjing Medical University (2013NJMU054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bahlani S, 2011, ONCOGENE, V30, P4219, DOI 10.1038/onc.2011.134; Anwar SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049462; Boni C, 2012, BRIT J CANCER, V106, P658, DOI 10.1038/bjc.2011.606; Brosnan CA, 2009, CURR OPIN CELL BIOL, V21, P416, DOI 10.1016/j.ceb.2009.04.001; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Devesa SS, 2005, INT J CANCER, V117, P294, DOI 10.1002/ijc.21183; Gejman R, 2008, J CLIN ENDOCRINOLOGY; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Lim J, 2013, MOL CELLS, V36, P340, DOI 10.1007/s10059-013-0123-9; Liu ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077293; Lu KH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-461; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Miyoshi N, 2000, GENES CELLS, V5, P211, DOI 10.1046/j.1365-2443.2000.00320.x; Morgensztern D, 2010, J THORAC ONCOL, V5, P29, DOI 10.1097/JTO.0b013e3181c5920c; Orrenius S, 2004, TOXICOL LETT, V149, P19, DOI 10.1016/j.toxlet.2003.12.017; Pei DS, 2012, ONCOTARGET, V3, P228; Redis RS, 2013, ONCOTARGET, V4, P1748, DOI 10.18632/oncotarget.1292; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sculier JP, 2013, EUR RESPIR REV, V22, P33, DOI 10.1183/09059180.00007012; Sun M, 2014, TUMOR BIOL, V35, P1065, DOI 10.1007/s13277-013-1142-z; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Walia V, 2011, FRONT BIOSCI-LANDMRK, V16, P749, DOI 10.2741/3717; Wang H, 2014, BRIT J CANCER, V111, P339, DOI 10.1038/bjc.2014.157; Wang PJ, 2012, J CELL BIOCHEM, V113, P1868, DOI 10.1002/jcb.24055; Wang SZ, 2013, MOL CARCINOGEN, V52, P87, DOI [10.1002/mc.22017, 10.1002/mc.21930]; Wang XF, 2014, MOL MED REP, V9, P39, DOI 10.3892/mmr.2013.1783; Wang XJ, 2012, FEBS LETT, V586, P1390, DOI 10.1016/j.febslet.2012.02.049; Yang H, 2013, BIOCHEM PHARMACOL, V85, P1761, DOI 10.1016/j.bcp.2013.04.020; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065309; Ying L, 2013, MOL BIOSYST, V9, P407, DOI 10.1039/c2mb25386k; Zhang X, 2003, J CLIN ENDOCR METAB, V88, P5119, DOI 10.1210/jc.2003-030222; Zhang X, 2010, CANCER RES, V70, P2350, DOI 10.1158/0008-5472.CAN-09-3885; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200	37	112	120	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0114586	10.1371/journal.pone.0114586	http://dx.doi.org/10.1371/journal.pone.0114586			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992654	Green Submitted, Green Published, gold			2022-12-26	WOS:000354921400002
J	Zhang, J; Liu, Y; Liu, XF; Xu, LZ; Zhou, LL; Tang, LL; Zhuang, J; Guo, WQ; Hu, R				Zhang, Jing; Liu, Ying; Liu, Xiaofang; Xu, Liangzhi; Zhou, Lingling; Tang, Liulin; Zhuang, Jing; Guo, Wenqi; Hu, Rong			High Intake of Energy and Fat in Southwest Chinese Women with PCOS: A Population-Based Case-Control Study	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; FOOD FREQUENCY QUESTIONNAIRE; DIETARY-INTAKE; DIFFERENT PHENOTYPES; PHYSICAL-ACTIVITY; OBESE WOMEN; PREVALENCE; OVERWEIGHT; FEATURES; METABOLISM	Background Polycystic ovary syndrome (PCOS) is a common reproductive endocrinological disease with heterogeneous phenotype. Obesity contributes to the increased prevalence and severity of PCOS. Whether the intakes of major nutrients are higher in Chinese PCOS patients is still unknown. Objectives To study the intakes of total energy, protein, fat and carbohydrate in Southwest Chinese PCOS patients. Methods 1854 women were included in the cross-sectional study. A population-based case-control study was conducted. The dietary habits and nutrients intake status of 169 PCOS patients and 338 age-matched controls were investigated by the method of semi-quantitative food frequency questionnaire. Results The actual intake of total energy (P = 0.01) and fat (P = 0.01) were higher, but carbohydrate was lower (P = 0.01) in PCOS patients as compared with the controls. The energy percentage supplied by protein (12.33%+/- 2.27% vs. 19.26%+/- 5.91%, P<0.001) and carbohydrate (48.72%+/- 6.41% vs. 68.31%+/- 8.37%, P<0.001) were lower in Southwest Chinese PCOS patients than those of control, however, the energy percentage supplied by fat was higher (38.95%+/- 5.71% vs. 12.42%+/- 5.13%, P<0.001) in PCOS. Conclusions Limit the intake of total energy and fat shall be recommended to the Southwest Chinese PCOS patients. Women with PCOS in Southwest China shall consult with the nutritionist for improving the dietary structure.	[Zhang, Jing; Liu, Ying; Liu, Xiaofang; Xu, Liangzhi; Zhou, Lingling; Tang, Liulin; Zhuang, Jing] Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610064, Sichuan, Peoples R China; [Guo, Wenqi] Sichuan Univ, West China Univ Hosp 2, Dept Ultrasound, Chengdu 610064, Sichuan, Peoples R China; [Hu, Rong] Sichuan Univ, West China Univ Hosp 2, Clin Lab Ctr, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Xu, LZ (corresponding author), Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610064, Sichuan, Peoples R China.	liangzxu@aliyun.com			National Natural Science Foundation of China [81270665, 41473097]; Scientific Research Foundation of Health Department of Sichuan province, China [100377, 060020, 090289]; Science and Technology Basic platform foundation of Sichuan Province, China [2012JCPT009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Health Department of Sichuan province, China; Science and Technology Basic platform foundation of Sichuan Province, China	This research was supported by National Natural Science Foundation of China (81270665, 41473097); Scientific Research Foundation of Health Department of Sichuan province (100377, 060020, 090289), China; Science and Technology Basic platform foundation of Sichuan Province (2012JCPT009), China.	Altieri P, 2013, CLIN ENDOCRINOL, V78, P52, DOI 10.1111/j.1365-2265.2012.04355.x; Alvarez-Blasco F, 2011, GYNECOL ENDOCRINOL, V27, P978, DOI 10.3109/09513590.2011.579658; Barr S, 2010, P NUTR SOC, V69, pE126, DOI 10.1017/S0029665109993144; CARMINA E, 1992, AM J OBSTET GYNECOL, V167, P1807, DOI 10.1016/0002-9378(92)91779-A; Colombo O, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-53; Coorperative Mata-Analysis Group China Obesity Task Force, 2002, CHIN J EPIDEMIOL, V23, P5; Douglas CC, 2006, FERTIL STERIL, V86, P411, DOI 10.1016/j.fertnstert.2005.12.054; Eleftheriadou M, 2012, J PEDIATR ADOL GYNEC, V25, P172, DOI 10.1016/j.jpag.2011.11.009; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Friis S, 1997, J CLIN EPIDEMIOL, V50, P303, DOI 10.1016/S0895-4356(96)00379-4; Graff SK, 2013, FERTIL STERIL, V100, P1081, DOI 10.1016/j.fertnstert.2013.06.005; Haffner SM, 1996, DIABETES CARE, V19, P1138, DOI 10.2337/diacare.19.10.1138; Lam P. M., 2005, Hong Kong Medical Journal, V11, P336; Li R, 2013, HUM REPROD, V28, P2562, DOI 10.1093/humrep/det262; Lim SS, 2012, HUM REPROD UPDATE, V18, P618, DOI 10.1093/humupd/dms030; Morales AJ, 1996, J CLIN ENDOCR METAB, V81, P2854, DOI 10.1210/jc.81.8.2854; Moran LJ, 2013, HUM REPROD, V28, P2276, DOI 10.1093/humrep/det256; Ni RM, 2009, EUR J ENDOCRINOL, V161, P411, DOI 10.1530/EJE-09-0298; Panidis D, 2012, FERTIL STERIL, V97, P494, DOI 10.1016/j.fertnstert.2011.11.041; SAMET JM, 1984, AM J EPIDEMIOL, V120, P572, DOI 10.1093/oxfordjournals.aje.a113919; Tang Y, 2015, J HLTH POPU IN PRESS; Teede HJ, 2013, OBESITY, V21, P1526, DOI 10.1002/oby.20213; Teede HJ, 2011, MED J AUSTRALIA, V195, pS69, DOI 10.5694/mja11.10915; Thomson RL, 2009, BJOG-INT J OBSTET GY, V116, P1242, DOI 10.1111/j.1471-0528.2009.02177.x; Tsai YH, 2013, BRIT J NUTR, V109, P2190, DOI 10.1017/S0007114512004369; Wang Ying, 2007, Zhonghua Fu Chan Ke Za Zhi, V42, P756; WILD RA, 1985, J CLIN ENDOCR METAB, V61, P946, DOI 10.1210/jcem-61-5-946; Wright CE, 2004, INT J OBESITY, V28, P1026, DOI 10.1038/sj.ijo.0802661; YANG YX, 2002, CHINA FOOD COMPOSITI, P21; Zhang HY, 2013, ARCH GYNECOL OBSTET, V287, P525, DOI 10.1007/s00404-012-2568-z; Zhou ZY, 2004, ASIA PAC J CLIN NUTR, V13, P273; Zhuang J, 2014, GYNECOL OBSTET INVES, V77, P217, DOI 10.1159/000358485	32	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127094	10.1371/journal.pone.0127094	http://dx.doi.org/10.1371/journal.pone.0127094			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993656	Green Published, Green Submitted, gold			2022-12-26	WOS:000354921400095
J	Henderson, ML; Kreuzer, KN				Henderson, Morgan L.; Kreuzer, Kenneth N.			Functions that Protect Escherichia coli from Tightly Bound DNA-Protein Complexes Created by Mutant EcoRII Methyltransferase	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; REPLICATION FORK; RNA-POLYMERASE; CROSS-LINKS; CYTOSINE METHYLTRANSFERASE; HOLLIDAY JUNCTIONS; TOPOISOMERASE-IV; GENETIC-ANALYSIS; EXCISION-REPAIR; NALIDIXIC-ACID	Expression of mutant EcoRII methyltransferase protein (M. EcoRII-C186A) in Escherichia coli leads to tightly bound DNA-protein complexes (TBCs), located sporadically on the chromosome rather than in tandem arrays. The mechanisms behind the lethality induced by such sporadic TBCs are not well studied, nor is it clear whether very tight binding but non-covalent complexes are processed in the same way as covalent DNA-protein crosslinks (DPCs). Using 2D gel electrophoresis, we found that TBCs induced by M. EcoRII-C186A block replication forks in vivo. Specific bubble molecules were detected as spots on the 2D gel, only when M. EcoRII-C186A was induced, and a mutation that eliminates a specific EcoRII methylation site led to disappearance of the corresponding spot. We also performed a candidate gene screen for mutants that are hypersensitive to TBCs induced by M. EcoRII-C186A. We found several gene products necessary for protection against these TBCs that are known to also protect against DPCs induced with wild-type M. EcoRII (after 5-azacytidine incorporation): RecA, RecBC, RecG, RuvABC, UvrD, FtsK, XerCD and SsrA (tmRNA). In contrast, the RecFOR pathway and Rep helicase are needed for protection against TBCs but not DPCs induced by M. EcoRII. We propose that stalled fork processing by RecFOR and RecA promotes release of tightly bound (but non-covalent) blocking proteins, perhaps by licensing Rep helicase-driven dissociation of the blocking M. EcoRII-C186A. Our studies also argued against the involvement of several proteins that might be expected to protect against TBCs. We took the opportunity to directly compare the sensitivity of all tested mutants to two quinolone antibiotics, which target bacterial type II topoisomerases and induce a unique form of DPC. We uncovered rep, ftsK and xerCD as novel quinolone hypersensitive mutants, and also obtained evidence against the involvement of a number of functions that might be expected to protect against quinolones.	[Henderson, Morgan L.; Kreuzer, Kenneth N.] Duke Univ, Med Ctr, Univ Program Genet & Genom, Durham, NC 27710 USA; [Kreuzer, Kenneth N.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Duke University	Kreuzer, KN (corresponding author), Duke Univ, Med Ctr, Univ Program Genet & Genom, Durham, NC 27710 USA.	kenneth.kreuzer@duke.edu			NIH research grant [GM72089]; NIH training grant [5T32-GM007454]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072089, T32GM007754, T32GM007454] Funding Source: NIH RePORTER	NIH research grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH research grant GM72089. MLH was supported in part by NIH training grant 5T32-GM007454. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aedo S, 2013, ANTIMICROB AGENTS CH, V57, P5116, DOI 10.1128/AAC.00130-13; Atkinson J, 2011, NUCLEIC ACIDS RES, V39, P1351, DOI 10.1093/nar/gkq975; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baharoglu Z, 2006, EMBO J, V25, P596, DOI 10.1038/sj.emboj.7600941; Baharoglu Z, 2010, MOL MICROBIOL, V77, P324, DOI 10.1111/j.1365-2958.2010.07208.x; BANUETT F, 1987, J BACTERIOL, V169, P4076, DOI 10.1128/jb.169.9.4076-4085.1987; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; Becket E, 2010, DNA REPAIR, V9, P949, DOI 10.1016/j.dnarep.2010.06.008; Belle JJ, 2007, J BACTERIOL, V189, P5452, DOI 10.1128/JB.00408-07; Berardini M, 1999, J BACTERIOL, V181, P2878, DOI 10.1128/JB.181.9.2878-2882.1999; BHAGWAT AS, 1987, J BACTERIOL, V169, P1537, DOI 10.1128/jb.169.4.1537-1546.1987; Bidnenko V, 2002, EMBO J, V21, P3898, DOI 10.1093/emboj/cdf369; Bidnenko V, 2006, MOL MICROBIOL, V62, P382, DOI 10.1111/j.1365-2958.2006.05382.x; Bigot S, 2004, MOL MICROBIOL, V54, P876, DOI 10.1111/j.1365-2958.2004.04335.x; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; CHAN GL, 1985, BIOCHEMISTRY-US, V24, P5723, DOI 10.1021/bi00342a006; CHASE JW, 1977, J BACTERIOL, V129, P934, DOI 10.1128/JB.129.2.934-947.1977; Chow KH, 2004, J BIOL CHEM, V279, P3492, DOI 10.1074/jbc.M311012200; Connelly JC, 2003, DNA REPAIR, V2, P795, DOI 10.1016/S1568-7864(03)00063-6; Connelly JC, 1996, GENES CELLS, V1, P285, DOI 10.1046/j.1365-2443.1996.23024.x; Connelly JC, 1998, P NATL ACAD SCI USA, V95, P7969, DOI 10.1073/pnas.95.14.7969; Courcelle CT, 2012, J BACTERIOL, V194, P3977, DOI 10.1128/JB.00290-12; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; Courcelle J, 2003, SCIENCE, V299, P1064, DOI 10.1126/science.1081328; Courcelle J, 1999, MOL GEN GENET, V262, P543, DOI 10.1007/s004380051116; Courcelle J, 1997, P NATL ACAD SCI USA, V94, P3714, DOI 10.1073/pnas.94.8.3714; Courcelle J, 1999, J BACTERIOL, V181, P916, DOI 10.1128/JB.181.3.916-922.1999; Donaldson JR, 2006, J BIOL CHEM, V281, P28811, DOI 10.1074/jbc.M603933200; Drlica K, 2003, CURR TOP MED CHEM, V3, P249, DOI 10.2174/1568026033452537; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Drlica K, 2009, CURR TOP MED CHEM, V9, P981, DOI 10.2174/156802609789630947; Duxin JP, 2014, CELL, V159, P346, DOI 10.1016/j.cell.2014.09.024; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; Epshtein V, 2014, NATURE, V505, P372, DOI 10.1038/nature12928; Flores MJ, 2005, MOL MICROBIOL, V57, P1664, DOI 10.1111/j.1365-2958.2005.04753.x; FRIEDMAN S, 1985, J BIOL CHEM, V260, P5698; GABBARA S, 1995, BIOCHEMISTRY-US, V34, P8914, DOI 10.1021/bi00027a044; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; Gupta MK, 2013, P NATL ACAD SCI USA, V110, P7252, DOI 10.1073/pnas.1303890110; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Gwynn EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078141; Han XL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-35; HIASA H, 1994, J BIOL CHEM, V269, P26959; HILL TM, 1989, P NATL ACAD SCI USA, V86, P1593, DOI 10.1073/pnas.86.5.1593; HORIUCHI T, 1995, J BACTERIOL, V177, P783, DOI 10.1128/jb.177.3.783-791.1995; Ide H, 2011, MUTAT RES-FUND MOL M, V711, P113, DOI 10.1016/j.mrfmmm.2010.12.007; Indiani C, 2013, P NATL ACAD SCI USA, V110, P5410, DOI 10.1073/pnas.1303301110; ISHINO Y, 1992, BIOCHIMIE, V74, P131, DOI 10.1016/0300-9084(92)90036-E; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; KHODURSKY AB, 1995, P NATL ACAD SCI USA, V92, P11801, DOI 10.1073/pnas.92.25.11801; Kihara A, 1996, EMBO J, V15, P6122, DOI 10.1002/j.1460-2075.1996.tb01000.x; KORNBERG T, 1971, P NATL ACAD SCI USA, V68, P761, DOI 10.1073/pnas.68.4.761; Krasich R, 2015, DNA REPAIR, V28, P48, DOI 10.1016/j.dnarep.2015.01.016; Krasilnikova MM, 2001, J MOL BIOL, V313, P271, DOI 10.1006/jmbi.2001.5059; Kuo HK, 2007, CANCER RES, V67, P8248, DOI 10.1158/0008-5472.CAN-07-1038; Kuo HK, 2010, MOL MICROBIOL, V78, P686, DOI 10.1111/j.1365-2958.2010.07355.x; Labib K, 2007, EMBO REP, V8, P346, DOI 10.1038/sj.embor.7400940; LAL D, 1988, MUTAT RES, V193, P229, DOI 10.1016/0167-8817(88)90033-8; Lambert S, 2013, CHROMOSOMA, V122, P33, DOI 10.1007/s00412-013-0398-9; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lestini R, 2008, J BACTERIOL, V190, P5995, DOI 10.1128/JB.00620-08; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; MCDANIEL LS, 1978, J BACTERIOL, V134, P1195, DOI 10.1128/JB.134.3.1195-1198.1978; MENDONCA VM, 1993, J BACTERIOL, V175, P4641, DOI 10.1128/JB.175.15.4641-4651.1993; MI S, 1993, NUCLEIC ACIDS RES, V21, P2459, DOI 10.1093/nar/21.10.2459; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Morimatsu K, 2012, J BIOL CHEM, V287, P35621, DOI 10.1074/jbc.M112.397034; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; Nakano T, 2013, J BIOL CHEM, V288, P4649, DOI 10.1074/jbc.M112.419358; PAVCO PA, 1990, J BIOL CHEM, V265, P9960; Payne BTI, 2006, NUCLEIC ACIDS RES, V34, P5194, DOI 10.1093/nar/gkl682; PELLETIER AJ, 1989, J BACTERIOL, V171, P1739, DOI 10.1128/jb.171.3.1739-1741.1989; Pohlhaus JR, 2005, MOL MICROBIOL, V56, P1416, DOI 10.1111/j.1365-2958.2005.04638.x; Possoz C, 2006, EMBO J, V25, P2596, DOI 10.1038/sj.emboj.7601155; Rangarajan S, 2002, MOL MICROBIOL, V43, P617, DOI 10.1046/j.1365-2958.2002.02747.x; Rangarajan S, 1999, P NATL ACAD SCI USA, V96, P9224, DOI 10.1073/pnas.96.16.9224; Salem AMH, 2009, J BACTERIOL, V191, P5657, DOI 10.1128/JB.00417-09; SANDLER SJ, 1994, MOL GEN GENET, V245, P741, DOI 10.1007/BF00297281; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Schalow BJ, 2012, J BACTERIOL, V194, P2637, DOI 10.1128/JB.06725-11; Seigneur M, 2000, MOL MICROBIOL, V38, P565, DOI 10.1046/j.1365-2958.2000.02152.x; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SETLOW RB, 1963, SCIENCE, V142, P1464, DOI 10.1126/science.142.3598.1464; SHARMA B, 1995, MOL MICROBIOL, V18, P45, DOI 10.1111/j.1365-2958.1995.mmi_18010045.x; Sladewski TE, 2011, MOL MICROBIOL, V80, P524, DOI 10.1111/j.1365-2958.2011.07590.x; Stingele J, 2014, CELL, V158, P327, DOI 10.1016/j.cell.2014.04.053; SUGINO A, 1977, P NATL ACAD SCI USA, V74, P4767, DOI 10.1073/pnas.74.11.4767; Sutherland JH, 2010, J BACTERIOL, V192, P4445, DOI 10.1128/JB.00350-10; Tan KW, 2015, NUCL ACIDS RES; Theodore A, 2013, GENETICS, V195, P1265, DOI 10.1534/genetics.113.152306; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; VALES LD, 1982, J BIOL CHEM, V257, P8799; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Viswanathan M, 1999, GENETICS, V151, P929; Voloshin ON, 2003, J BIOL CHEM, V278, P28284, DOI 10.1074/jbc.M301188200; WHITBY MC, 1994, EMBO J, V13, P5220, DOI 10.1002/j.1460-2075.1994.tb06853.x; WRIGHT DJ, 1989, J BIOL CHEM, V264, P11816; WYSZYNSKI MW, 1992, NUCLEIC ACIDS RES, V20, P319, DOI 10.1093/nar/20.2.319; YARRANTON GT, 1979, P NATL ACAD SCI USA, V76, P1658, DOI 10.1073/pnas.76.4.1658; Yeeles JTP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012815	105	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0128092	10.1371/journal.pone.0128092	http://dx.doi.org/10.1371/journal.pone.0128092			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993347	Green Submitted, Green Published, gold			2022-12-26	WOS:000354918600076
J	Avancini, C; de Oliveira, LF; Menegaldo, LL; Vieira, TM				Avancini, Carolina; de Oliveira, Liliam F.; Menegaldo, Luciano L.; Vieira, Taian M.			Variations in the Spatial Distribution of the Amplitude of Surface Electromyograms Are Unlikely Explained by Changes in the Length of Medial Gastrocnemius Fibres with Knee Joint Angle	PLOS ONE			English	Article							TRICEPS SURAE; FASCICLE LENGTH; MYOELECTRIC ACTIVITY; MUSCLE ACTIVATION; SUBCUTANEOUS FAT; EMG ACTIVITY; ANKLE-JOINT; ULTRASOUND; SYSTEM; CONTRACTION	This study investigates whether knee position affects the amplitude distribution of surface electromyogram (EMG) in the medial gastrocnemius (MG) muscle. Of further concern is understanding whether knee-induced changes in EMG amplitude distribution are associated with regional changes in MG fibre length. Fifteen surface EMGs were acquired proximo-distally from the MG muscle while 22 (13 male) healthy participants (age range: 23-47 years) exerted isometric plantar flexion at 60% of their maximal effort, with knee fully extended and at 90 degrees flexion. The number of channels providing EMGs with greatest amplitude, their relative proximo-distal position and the EMG amplitude averaged over channels were considered to characterise changes in myoelectric activity with knee position. From ultrasound images, collected at rest, fibre length, pennation angle and fat thickness were computed for MG proximo-distal regions. Surface EMGs detected with knee flexed were on average five times smaller than those collected during knee extended. However, during knee flexed, relatively larger EMGs were detected by a dramatically greater number of channels, centred at the MG more proximal regions. Variation in knee position at rest did not affect the proximo-distal values obtained for MG fibre length, pennation angle and fat thickness. Our main findings revealed that, with knee flexion: i) there is a redistribution of activity within the whole MG muscle; ii) EMGs detected locally unlikely suffice to characterise the changes in the neural drive to MG during isometric contractions at knee fully extended and 90 degrees flexed positions; iii) sources other than fibre length may substantially contribute to determining the net, MG activation.	[Avancini, Carolina; de Oliveira, Liliam F.; Menegaldo, Luciano L.] Univ Fed Rio de Janeiro, Programa Engn Biomed COPPE, Rio De Janeiro, RJ, Brazil; [de Oliveira, Liliam F.; Vieira, Taian M.] Univ Fed Rio de Janeiro, Escola Educ Fis & Desportos, Rio De Janeiro, RJ, Brazil; [Vieira, Taian M.] Politecn Torino, Lab Ingn Sistema Neuromuscolare LISiN, Turin, TO, Italy	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Polytechnic University of Turin	Vieira, TM (corresponding author), Univ Fed Rio de Janeiro, Escola Educ Fis & Desportos, Rio De Janeiro, RJ, Brazil.	taian.vieira@polito.it	Menegaldo, Luciano/AAM-3561-2021; Menegaldo, Luciano L/J-3645-2016; Menegaldo, Luciano/C-3463-2013; Vieira, Taian M/A-3818-2013	Menegaldo, Luciano/0000-0002-5855-4650; Menegaldo, Luciano L/0000-0002-5855-4650; Vieira, Taian M/0000-0002-6239-7301	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Financiadora de Estudos e Projetos; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro [INST-110.842/2012]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by three Brazilian funding agencies: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (LM; www.capes.gov.br), Financiadora de Estudos e Projetos (LM; www.finep.gov.br) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (TV; INST-110.842/2012; www.faperj.br). CSA is recipient of a scholarship provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arampatzis A, 2007, J BIOMECH, V40, P3193, DOI 10.1016/j.jbiomech.2007.04.011; Arampatzis A, 2006, J BIOMECH, V39, P1891, DOI 10.1016/j.jbiomech.2005.05.010; Blazevich AJ, 2006, J ANAT, V209, P289, DOI 10.1111/j.1469-7580.2006.00619.x; Botter A, 2013, J APPL PHYSIOL, V115, P1203, DOI 10.1152/japplphysiol.00090.2013; Chow RS, 2000, EUR J APPL PHYSIOL, V82, P236, DOI 10.1007/s004210050677; CRESSWELL AG, 1995, EXP BRAIN RES, V105, P283; Cronin NJ, 2011, J NEUROPHYSIOL, V105, P548, DOI 10.1152/jn.00967.2010; De Monte G, 2006, J ELECTROMYOGR KINES, V16, P413, DOI 10.1016/j.jelekin.2005.10.001; Farcy S, 2014, J APPL PHYSIOL, V116, P259, DOI 10.1152/japplphysiol.00309.2013; Farina D, 2002, BIOL CYBERN, V86, P445, DOI 10.1007/s00422-002-0309-2; FUKUNAGA T, 1992, J ORTHOPAED RES, V10, P926, DOI 10.1002/jor.1100100623; Gallina A, 2013, EUR J APPL PHYSIOL, V113, P887, DOI 10.1007/s00421-012-2498-2; Gallina A, 2011, J ELECTROMYOGR KINES, V21, P929, DOI 10.1016/j.jelekin.2011.08.006; Hahn D, 2011, J BIOMECH, V44, P2059, DOI 10.1016/j.jbiomech.2011.05.011; Herbert RD, 2002, J PHYSIOL-LONDON, V539, P637, DOI 10.1113/jphysiol.2001.012756; Hodson-Tole EF, 2013, J ELECTROMYOGR KINES, V23, P43, DOI 10.1016/j.jelekin.2012.08.003; Hug F, 2011, J ELECTROMYOGR KINES, V21, P1, DOI 10.1016/j.jelekin.2010.08.009; Kawakami Y, 1998, J APPL PHYSIOL, V85, P398, DOI 10.1152/jappl.1998.85.2.398; Kennedy PM, 2001, EXP BRAIN RES, V137, P58, DOI 10.1007/s002210000623; Kinugasa R, 2005, J APPL PHYSIOL, V99, P1149, DOI 10.1152/japplphysiol.01160.2004; Kinugasa R, 2011, EXP PHYSIOL, V96, P938, DOI 10.1113/expphysiol.2011.057562; Kuiken TA, 2003, PROSTHET ORTHOT INT, V27, P48; Lauber B, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12044; Lichtwark GA, 2007, J BIOMECH, V40, P157, DOI 10.1016/j.jbiomech.2005.10.035; Maganaris CN, 2005, J BIOMECH, V38, P9, DOI 10.1016/j.jbiomech.2004.03.024; McLean L, 2004, EUR J APPL PHYSIOL, V91, P204, DOI 10.1007/s00421-003-0967-3; Mesin L, 2011, J BIOMECH, V44, P1096, DOI 10.1016/j.jbiomech.2011.01.031; Miaki H, 1999, EUR J APPL PHYSIOL O, V80, P185, DOI 10.1007/s004210050580; Noorkoiv M, 2010, J APPL PHYSIOL, V109, P1974, DOI 10.1152/japplphysiol.00657.2010; Nordander C, 2003, EUR J APPL PHYSIOL, V89, P514, DOI 10.1007/s00421-003-0819-1; Nourbakhsh MR, 2004, J ELECTROMYOGR KINES, V14, P263, DOI 10.1016/S1050-6411(03)00076-2; Shin DD, 2009, J APPL PHYSIOL, V107, P1276, DOI 10.1152/japplphysiol.91598.2008; Staudenmann D, 2009, J ELECTROMYOGR KINES, V19, P882, DOI 10.1016/j.jelekin.2008.04.013; Tamaki H, 1997, EUR J APPL PHYSIOL O, V75, P1; Vieira TMM, 2011, J PHYSIOL-LONDON, V589, P431, DOI 10.1113/jphysiol.2010.201806; Vieira TMM, 2010, J BIOMECH, V43, P2149, DOI 10.1016/j.jbiomech.2010.03.049; Vieira TMM, 2010, J APPL PHYSIOL, V108, P85, DOI 10.1152/japplphysiol.00070.2009; Wakahara T, 2007, J BIOMECH, V40, P2291, DOI 10.1016/j.jbiomech.2006.10.006; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6	39	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126888	10.1371/journal.pone.0126888	http://dx.doi.org/10.1371/journal.pone.0126888			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001107	Green Published, Green Submitted, gold			2022-12-26	WOS:000354931700034
J	MacGillivray, TJ; Cameron, JR; Zhang, QL; El-Medany, A; Mulholland, C; Sheng, ZY; Dhillon, B; Doubal, FN; Foster, PJ; Trucco, E; Sudlow, C				MacGillivray, Thomas J.; Cameron, James R.; Zhang, Qiuli; El-Medany, Ahmed; Mulholland, Carl; Sheng, Ziyan; Dhillon, Bal; Doubal, Fergus N.; Foster, Paul J.; Trucco, Emmanuel; Sudlow, Cathie		UK Biobank Eye Vision Consortium	Suitability of UK Biobank Retinal Images for Automatic Analysis of Morphometric Properties of the Vasculature	PLOS ONE			English	Article							MICROVASCULAR ABNORMALITIES; ATHEROSCLEROSIS RISK; VESSEL DIAMETERS; HEART-DISEASE; STROKE; TORTUOSITY; SIGNS; COMMUNITIES; RETINOPATHY; FORMULAS	Purpose To assess the suitability of retinal images held in the UK Biobank - the largest retinal data repository in a prospective population-based cohort - for computer assisted vascular morphometry, generating measures that are commonly investigated as candidate biomarkers of systemic disease. Methods Non-mydriatic fundus images from both eyes of 2,690 participants - people with a self-reported history of myocardial infarction (n=1,345) and a matched control group (n=1,345) -were analysed using VAMPIRE software. These images were drawn from those of 68,554 UK Biobank participants who underwent retinal imaging at recruitment. Four operators were trained in the use of the software to measure retinal vascular tortuosity and bifurcation geometry. Results Total operator time was approximately 360 hours (4 minutes per image). 2,252 (84%) of participants had at least one image of sufficient quality for the software to process, i.e. there was sufficient detection of retinal vessels in the image by the software to attempt the measurement of the target parameters. 1,604 (60%) of participants had an image of at least one eye that was adequately analysed by the software, i.e. the measurement protocol was successfully completed. Increasing age was associated with a reduced proportion of images that could be processed (p=0.0004) and analysed (p<0.0001). Cases exhibited more acute arteriolar branching angles (p=0.02) as well as lower arteriolar and venular tortuosity (p<0.0001). Conclusions A proportion of the retinal images in UK Biobank are of insufficient quality for automated analysis. However, the large size of the UK Biobank means that tens of thousands of images are available and suitable for computational analysis. Parametric information measured from the retinas of participants with suspected cardiovascular disease was significantly different to that measured from a matched control group.	[MacGillivray, Thomas J.] Univ Edinburgh, Clin Res Imaging Ctr, VAMPIRE Project, Edinburgh, Midlothian, Scotland; [MacGillivray, Thomas J.; Zhang, Qiuli; Doubal, Fergus N.; Sudlow, Cathie] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [MacGillivray, Thomas J.] Univ Edinburgh, Clin Res Facil, Edinburgh, Midlothian, Scotland; [Cameron, James R.] Univ Edinburgh, Anne Rowling Regenerat Neurol Clin, Edinburgh, Midlothian, Scotland; [El-Medany, Ahmed; Mulholland, Carl; Sheng, Ziyan] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Dhillon, Bal] Univ Edinburgh, Sch Clin Sci, VAMPIRE Project, Edinburgh, Midlothian, Scotland; [Foster, Paul J.] Moorfields Eye Hosp, Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Foster, Paul J.] UCL, Inst Ophthalmol, London, England; [Trucco, Emmanuel] Univ Dundee, Sch Comp, VAMPIRE Project, Dundee, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of Dundee	MacGillivray, TJ (corresponding author), Univ Edinburgh, Clin Res Imaging Ctr, VAMPIRE Project, Edinburgh, Midlothian, Scotland.	T.J.MacGillivray@ed.ac.uk	Cipriani, Valentina/A-8549-2012; Foster, Paul/V-7288-2019; zhang, qiu/GXG-5600-2022; Aslam, Tariq/A-8532-2016	Cipriani, Valentina/0000-0002-0839-9955; Foster, Paul/0000-0002-4755-177X; Sudlow, Cathie/0000-0002-7725-7520; Yip, Jennifer Lai Yee/0000-0003-3788-7170; Yates, Max/0000-0003-3977-8920; Rahi, Jugnoo/0000-0002-5718-9209; Aslam, Tariq/0000-0002-9739-7280; Hammond, Christopher/0000-0002-3227-2620; Trucco, Emanuele/0000-0002-5055-0794; MacGillivray, Tom/0000-0001-5120-0086; Khawaja, Anthony/0000-0001-6802-8585; Bunce, Catey/0000-0002-0935-3713	NIHR Biomedical Research Centre at Moorfields Eye Hospital; UCL Institute of Ophthalmology; Special Trustees of Moorfields Eye Hospital; Medical Research Council [MC_qA137853] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10101, CL-2010-14-004, CL-2010-18-004, CS-2014-14-023] Funding Source: researchfish; Fight for Sight [1507/08] Funding Source: researchfish	NIHR Biomedical Research Centre at Moorfields Eye Hospital; UCL Institute of Ophthalmology; Special Trustees of Moorfields Eye Hospital; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight	This research has been conducted using the UK Biobank Resource. The collection of eye & vision data in UK Biobank was supported in part by a grant from the NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology. The UK Biobank Eye and Vision Consortium is supported by a grant from The Special Trustees of Moorfields Eye Hospital. The main contact for this consortium is Prof Paul Foster (p.foster@ucl.ac.uk) and the list of members is available from the consortium website (http://www.ukbiobankeyeconsortium.org.uk/people). We would like to acknowledge the contributions of our colleagues and collaborators to the work reported: R Annunziata, L Ballerini, S Borooah, L Hughes, E Pellegrini, D Relan, G Robertson, and K Zutis.	Baker ML, 2008, STROKE, V39, P1371, DOI 10.1161/STROKEAHA.107.496091; Bertelsen G, 2013, ACTA OPHTHALMOL, V91, P635, DOI 10.1111/j.1755-3768.2012.02511.x; Centers for Disease Control and Prevention, 2013, CHRON DIS HLTH PROM; Cheung CYL, 2011, OPHTHALMOLOGY, V118, P812, DOI 10.1016/j.ophtha.2010.08.045; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Department of Health, 2012, LOGN TERM COND COMP; Department of Health Social Services and Public Safety Northern Ireland Government, 2012, LIV LONG TERM COND; Doubal FN, 2009, J NEUROL NEUROSUR PS, V80, P158, DOI 10.1136/jnnp.2008.153460; Dougherty G, 2010, MED BIOL ENG COMPUT, V48, P87, DOI 10.1007/s11517-009-0559-4; Giachetti A, 2013, COMPUT MED IMAG GRAP, V37, P369, DOI 10.1016/j.compmedimag.2013.06.005; Habib MS, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-89; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Ikram MK, 2006, HYPERTENSION, V47, P189, DOI 10.1161/01.HYP.0000199104.61945.33; Kawasaki R, 2012, STROKE, V43, P3245, DOI 10.1161/STROKEAHA.112.673335; Kiely AE, 2010, ARCH OPHTHALMOL-CHIC, V128, P847, DOI 10.1001/archophthalmol.2010.133; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Liew G, 2011, REV ESP CARDIOL, V64, P515, DOI [10.1016/j.rec.2011.02.017, 10.1016/j.recesp.2011.02.014]; London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227; Macgillivray T. J., 2012, VAMPIRE VESSEL ASSES; Mitry D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071154; Murdoch IE, 1998, BRIT J OPHTHALMOL, V82, P971, DOI 10.1136/bjo.82.8.971; Niemeijer M, 2011, IEEE T MED IMAGING, V30, P1941, DOI 10.1109/TMI.2011.2159619; Owen CG, 2011, ARTERIOSCL THROM VAS, V31, P1933, DOI 10.1161/ATVBAHA.111.225219; Patton N, 2006, INVEST OPHTH VIS SCI, V47, P1329, DOI 10.1167/iovs.05-1248; Patton N, 2006, PROG RETIN EYE RES, V25, P99, DOI 10.1016/j.preteyeres.2005.07.001; Patton N, 2005, J ANAT, V206, P319, DOI 10.1111/j.1469-7580.2005.00395.x; The Scottish Government, 2013, LONG TERM COND; Trucco E., 2013, P BIOSIGNALS BIOROBO, P1; Trucco E, 2010, IEEE T BIO-MED ENG, V57, P2239, DOI 10.1109/TBME.2010.2050771; Witt N, 2006, HYPERTENSION, V47, P975, DOI 10.1161/01.HYP.0000216717.72048.6c; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P1153, DOI 10.1001/jama.287.9.1153	31	35	37	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127914	10.1371/journal.pone.0127914	http://dx.doi.org/10.1371/journal.pone.0127914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000792	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000354931700093
J	Wu, Q; Wang, GP; Xie, J; Guo, JY; Gong, SS				Wu, Qian; Wang, Guo-Peng; Xie, Jing; Guo, Jing-Ying; Gong, Shu-Sheng			Tumor Necrosis Factor-alpha-Induced Ototoxicity in Mouse Cochlear Organotypic Culture	PLOS ONE			English	Article							INDUCED HEARING-LOSS; AUDITORY HAIR-CELLS; TNF-ALPHA; PROINFLAMMATORY CYTOKINES; EXPRESSION; STEREOCILIA; CISPLATIN; APOPTOSIS; INNER; ORGAN	Tumor necrosis factor (TNF)-alpha is a cytokine involved in acute inflammatory phase reactions, and is the primary upstream mediator in the cochlear inflammatory response. Treatment of the organ of Corti with TNF-alpha can induce hair cell damage. However, the resulting morphological changes have not been systematically examined. In the present study, cochlear organotypic cultures from neonatal mice were treated with various concentrations and durations of TNF-alpha to induce inflammatory responses. Confocal microscopy was used to evaluate the condition of hair cells and supporting cells following immunohistochemical staining. In addition, the ultrastructure of the stereocilia bundle, hair cells, and supporting cells were examined by scanning and transmission electron microscopy. TNF-alpha treatment resulted in a fusion and loss of stereocilia bundles in hair cells, swelling of mitochondria, and vacuolation and degranulation of the endoplasmic reticulum. Disruption of tight junctions between hair cells and supporting cells was also observed at high concentrations. Hair cell loss was preceded by apoptosis of Deiters' and pillar cells. Taken together, these findings detail the morphological changes in the organ of Corti after TNF-alpha treatment, and provide an in vitro model of inflammatory-induced ototoxicity.	[Wu, Qian; Wang, Guo-Peng; Xie, Jing; Gong, Shu-Sheng] Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing 100730, Peoples R China; [Guo, Jing-Ying; Gong, Shu-Sheng] Captital Med Univ, Beijing Friendship Hosp, Dept Otolaryngol Head & Neck Surg, Beijing 100050, Peoples R China	Capital Medical University; Capital Medical University	Gong, SS (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing 100730, Peoples R China.	gongss1962@163.com			National Basic Research Program of China (973 Program) [2011CB504503]; National Natural Science Foundation of China [81271089, 81300831]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program) (No. 2011CB504503) to Shu-Sheng Gong, the National Natural Science Foundation of China (No. 81271089) to Shu-Sheng Gong and (No. 81300831) to Jing Xie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, the authors are not sure whether are they modified in the submission system or in the manuscript.	Abrashkin KA, 2006, HEARING RES, V218, P20, DOI 10.1016/j.heares.2006.04.001; Aminpour S, 2005, OTOL NEUROTOL, V26, P602, DOI 10.1097/01.mao.0000178121.28365.0d; Anttonen T, 2014, JARO-J ASSOC RES OTO, V15, P975, DOI 10.1007/s10162-014-0480-x; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Demirhan E, 2013, LARYNGOSCOPE, V123, P1778, DOI 10.1002/lary.23907; Dinh CT, 2008, NEUROSCIENCE, V157, P405, DOI 10.1016/j.neuroscience.2008.09.012; Fujioka M, 2006, J NEUROSCI RES, V83, P575, DOI 10.1002/jnr.20764; Haake SM, 2009, HEARING RES, V255, P22, DOI 10.1016/j.heares.2009.05.003; He DZZ, 1997, J NEUROSCI, V17, P3634; Jia SP, 2009, J NEUROSCI, V29, P15277, DOI 10.1523/JNEUROSCI.3231-09.2009; Jiang H, 2006, CELL DEATH DIFFER, V13, P20, DOI 10.1038/sj.cdd.4401706; Keithley EM, 2008, OTOL NEUROTOL, V29, P854, DOI 10.1097/MAO.0b013e31818256a9; Lagarde MMM, 2013, J NEUROSCI, V33, P1564, DOI 10.1523/JNEUROSCI.3088-12.2013; LI L, 1995, J COMP NEUROL, V355, P405, DOI 10.1002/cne.903550307; Liu HZ, 2014, J NEUROSCI, V34, P11085, DOI 10.1523/JNEUROSCI.1690-14.2014; Marcotti W, 2014, J NEUROSCI, V34, P5505, DOI 10.1523/JNEUROSCI.4086-13.2014; Monzack EL, 2013, HEARING RES, V303, P20, DOI 10.1016/j.heares.2013.01.008; Moon SK, 2006, ACTA OTO-LARYNGOL, V126, P564, DOI 10.1080/00016480500452525; Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175; Park HY, 2012, LARYNGOSCOPE, V122, P2256, DOI 10.1002/lary.23444; Qi WD, 2008, HEARING RES, V236, P52, DOI 10.1016/j.heares.2007.12.002; Rybak LP, 2007, HEARING RES, V226, P157, DOI 10.1016/j.heares.2006.09.015; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Sakaguchi H, 2008, CELL MOTIL CYTOSKEL, V65, P528, DOI 10.1002/cm.20275; Samavati L, 2008, J BIOL CHEM, V283, P21134, DOI 10.1074/jbc.M801954200; Schacht J, 2012, ANAT REC, V295, P1837, DOI 10.1002/ar.22578; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; So H, 2007, JARO-J ASSOC RES OTO, V8, P338, DOI 10.1007/s10162-007-0084-9; Suzuki M, 2000, GENE THER, V7, P1046, DOI 10.1038/sj.gt.3301180; Viberg A, 2004, HEARING RES, V197, P1, DOI 10.1016/j.heares.2004.04.016; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; Xie J, 2011, HEARING RES, V281, P28, DOI 10.1016/j.heares.2011.05.008; Zou J, 2005, HEARING RES, V202, P13, DOI 10.1016/j.heares.2004.10.008	33	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127703	10.1371/journal.pone.0127703	http://dx.doi.org/10.1371/journal.pone.0127703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000970	Green Published, Green Submitted, gold			2022-12-26	WOS:000354931700074
J	Ji, JC; Pang, W; Zheng, YL; Wang, Z; Ma, ZQ				Ji, Jinchao; Pang, Wei; Zheng, Yanlin; Wang, Zhe; Ma, Zhiqiang			A Novel Artificial Bee Colony Based Clustering Algorithm for Categorical Data	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; K-MODES ALGORITHM	Data with categorical attributes are ubiquitous in the real world. However, existing partitional clustering algorithms for categorical data are prone to fall into local optima. To address this issue, in this paper we propose a novel clustering algorithm, ABC-K-Modes (Artificial Bee Colony clustering based on K-Modes), based on the traditional k-modes clustering algorithm and the artificial bee colony approach. In our approach, we first introduce a one-step k-modes procedure, and then integrate this procedure with the artificial bee colony approach to deal with categorical data. In the search process performed by scout bees, we adopt the multi-source search inspired by the idea of batch processing to accelerate the convergence of ABC-K-Modes. The performance of ABC-K-Modes is evaluated by a series of experiments in comparison with that of the other popular algorithms for categorical data.	[Ji, Jinchao; Zheng, Yanlin; Ma, Zhiqiang] NE Normal Univ, Sch Comp Sci & Informat Technol, Changchun, Peoples R China; [Ji, Jinchao; Zheng, Yanlin; Ma, Zhiqiang] NE Normal Univ, Jilin Univ, Key Lab Intelligent Informat Proc, Changchun, Peoples R China; [Ji, Jinchao; Wang, Zhe] Jilin Univ, Minist Educ, Key Lab Symbol Computat & Knowledge Engn, Changchun 130023, Peoples R China; [Pang, Wei] Univ Aberdeen, Sch Nat & Comp Sci, Aberdeen, Scotland; [Wang, Zhe] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China	Northeast Normal University - China; Jilin University; Northeast Normal University - China; Jilin University; University of Aberdeen; Jilin University	Pang, W (corresponding author), Univ Aberdeen, Sch Nat & Comp Sci, Aberdeen, Scotland.	pang.wei@abdn.ac.uk; mazq0431@gmail.com	Pang, Wei/F-1545-2010	Pang, Wei/0000-0002-1761-6659	National Natural Science Foundation of China (NSFC) [21127010, 61202309]; China Postdoctoral Science Foundation [2013M530956]; UK Economic & Social Research Council (ESRC) [ES/M001628/1]; Science and Technology Development Plan of Jilin province [20140520068JH]; Fundamental Research Funds for the Central Universities [14QNJJ028]; open project program of Key Laboratory of Symbolic Computation andKnowledge Engineering of Ministry of Education, Jilin University [93K172014K07]; Economic and Social Research Council [ES/M001628/1] Funding Source: researchfish	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); UK Economic & Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Science and Technology Development Plan of Jilin province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); open project program of Key Laboratory of Symbolic Computation andKnowledge Engineering of Ministry of Education, Jilin University; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the National Natural Science Foundation of China (NSFC) under Grant Nos. (21127010, 61202309, http://www.nsfc.gov.cn/), China Postdoctoral Science Foundation under Grant No. 2013M530956 (http://res.chinapostdoctor.org.cn), the UK Economic & Social Research Council (ESRC): award reference: ES/M001628/1 (http://www.esrc.ac.uk/), Science and Technology Development Plan of Jilin province under Grant No. 20140520068JH (http://www.jlkjt.gov.cn), Fundamental Research Funds for the Central Universities under No. 14QNJJ028 (http://www.nenu.edu.cn), the open project program of Key Laboratory of Symbolic Computation andKnowledge Engineering of Ministry of Education, Jilin University under Grant No. 93K172014K07 (http://www.jlu.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEZDEK JC, 1984, COMPUT GEOSCI, V10, P191, DOI 10.1016/0098-3004(84)90020-7; Bogner C, 2013, ECOL INFORM, V15, P44, DOI 10.1016/j.ecoinf.2013.03.001; Bordogna G, 2012, KNOWL-BASED SYST, V26, P9, DOI 10.1016/j.knosys.2011.06.012; Celebi ME, 2013, EXPERT SYST APPL, V40, P200, DOI 10.1016/j.eswa.2012.07.021; Chen Luo, 2014, Advances in Knowledge Discovery and Data Mining. 18th Pacific-Asia Conference, PAKDD 2014. Proceedings: LNCS 8444, P548, DOI 10.1007/978-3-319-06605-9_45; Chuang LY, 2011, EXPERT SYST APPL, V38, P14555, DOI 10.1016/j.eswa.2011.05.027; Cura T, 2012, EXPERT SYST APPL, V39, P1582, DOI 10.1016/j.eswa.2011.07.123; Gan GJ, 2005, LECT NOTES ARTIF INT, V3584, P195; Han J, 2012, MOR KAUF D, P1; Huang Z., 1997, DMKD, V3, P34; Huang ZX, 1998, DATA MIN KNOWL DISC, V2, P283, DOI 10.1023/A:1009769707641; Huang ZX, 1999, IEEE T FUZZY SYST, V7, P446, DOI 10.1109/91.784206; IKURA Y, 1986, OPER RES LETT, V5, P61, DOI 10.1016/0167-6377(86)90104-5; Islam MZ, 2011, KNOWL-BASED SYST, V24, P1214, DOI 10.1016/j.knosys.2011.05.011; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jain AK., 1988, TECHNOMETRICS; Kao YT, 2008, EXPERT SYST APPL, V34, P1754, DOI 10.1016/j.eswa.2007.01.028; Karaboga D, 2008, APPL SOFT COMPUT, V8, P687, DOI 10.1016/j.asoc.2007.05.007; Karaboga D, 2011, APPL SOFT COMPUT, V11, P652, DOI 10.1016/j.asoc.2009.12.025; Krishna K, 1999, IEEE T SYST MAN CY B, V29, P433, DOI 10.1109/3477.764879; Lu Y., 2004, P 2004 ACM S APPL CO, P622, DOI DOI 10.1145/967900.968029; Maulik U, 2000, PATTERN RECOGN, V33, P1455, DOI 10.1016/S0031-3203(99)00137-5; Maulik U, 2010, COMPUT OPER RES, V37, P1369, DOI 10.1016/j.cor.2009.02.025; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Saeed F, 2013, MOL INFORM, V32, P591, DOI 10.1002/minf.201300004; SELIM SZ, 1991, PATTERN RECOGN, V24, P1003, DOI 10.1016/0031-3203(91)90097-O; Shelokar PS, 2004, ANAL CHIM ACTA, V509, P187, DOI 10.1016/j.aca.2003.12.032; Sung CS, 2000, PATTERN RECOGN, V33, P849, DOI 10.1016/S0031-3203(99)00090-4; Teodorovic D, 2009, STUD COMPUT INTELL, V248, P39; Wan M, 2012, J INTELL INF SYST, V38, P321, DOI 10.1007/s10844-011-0158-3; Zhang CS, 2010, EXPERT SYST APPL, V37, P4761, DOI 10.1016/j.eswa.2009.11.003; Zhang W, 2010, KNOWL-BASED SYST, V23, P379, DOI 10.1016/j.knosys.2010.01.011; Zhexue Huang, 1997, Proceedings of the First Pacific-Asia Conference on Knowledge Discovery and Data Mining. KDD: Techniques and Applications, P21; 杨云峰, 1999, [西安公路交通大学学报, Journal of Xian Highway University], P67	34	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127125	10.1371/journal.pone.0127125	http://dx.doi.org/10.1371/journal.pone.0127125			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993469	gold, Green Published, Green Submitted			2022-12-26	WOS:000354921400099
J	Kacerovsky, M; Vrbacky, F; Kutova, R; Pliskova, L; Andrys, C; Musilova, I; Menon, R; Lamont, R; Nekvindova, J				Kacerovsky, Marian; Vrbacky, Filip; Kutova, Radka; Pliskova, Lenka; Andrys, Ctirad; Musilova, Ivana; Menon, Ramkumar; Lamont, Ronald; Nekvindova, Jana			Cervical Microbiota in Women with Preterm Prelabor Rupture of Membranes	PLOS ONE			English	Article							FETAL INFLAMMATORY RESPONSE; AMNIOTIC-FLUID; VAGINAL MICROBIOME; PREMATURE RUPTURE; PREGNANT-WOMEN; FLORA; DIVERSITY; BACTERIA; PREVALENCE; INFECTION	Objective To analyze the cervical microbiota in women with preterm prelabor rupture of membranes (PPROM) by pyrosequencing and to document associations between cervical microbiota, cervical inflammatory response, microbial invasion of the amniotic cavity (MIAC), histological chorioamnionitis, and intraamniotic infection (IAI). Study Design Sixty-one women with singleton pregnancies complicated by PPROM were included in the study. Specimens of cervical and amniotic fluid were collected on admission. The cervical microbiota was assessed by 16S rRNA gene sequencing by pyrosequencing. Interleukin (IL)-6 concentration in the cervical fluid and amniotic fluid was measured by ELISA and lateral flow immunoassay, respectively. Results Four bacterial community state types [CST I (Lactobacillus crispatus dominated), CST III (Lactobacillus iners dominated), CST IV-A (non-Lactobacillus bacteria dominated), and CST IV-B (Gardnerella vaginalis and Sneathia sanguinegens dominated)] were observed in the cervical microbiota of women with PPROM. Cervical fluid IL-6 concentrations differed between CSTs (CST I = 145 pg/mL, CST III = 166 pg/mL, CST IV-A = 420 pg/mL, and CST IV-B = 322 pg/mL; p = 0.004). There were also differences in the rates of MIAC, of both MIAC and histological chorioamnionitis, and of IAI among CSTs. No difference in the rate of histological chorioamnionitis was found among CSTs. Conclusions The cervical microbiota in PPROM women in this study was characterized by four CSTs. The presence of non-Lactobacillus CSTs was associated with a strong cervical inflammatory response and higher rates of MIAC, both MIAC and histological chorioamnionitis, and IAI representing a PPROM subtype with pronounced inflammation. CST I represents the dominant type of PPROM with a low rate of MIAC, IAI, and the combination of MIAC and histological chorioamnionitis.	[Kacerovsky, Marian] Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove, Czech Republic; [Kacerovsky, Marian; Musilova, Ivana] Charles Univ Prague, Fac Med Hradec Kralove, Dept Obstet & Gynecol, Hradec Kralove, Czech Republic; [Vrbacky, Filip] Univ Hosp Hradec Kralove, Dept Med 4th, Hematol, Hradec Kralove, Czech Republic; [Vrbacky, Filip] Charles Univ Prague, Fac Med Hradec Kralove, Hradec Kralove, Czech Republic; [Kutova, Radka; Pliskova, Lenka] Univ Hosp Hradec Kralove, Inst Clin Biochem & Diagnost, Hradec Kralove, Czech Republic; [Andrys, Ctirad] Charles Univ Prague, Univ Hosp Hradec Kralove, Dept Clin Immunol & Allergol, Hradec Kralove, Czech Republic; [Menon, Ramkumar] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, Galveston, TX 77555 USA; [Lamont, Ronald] Univ Southern Denmark, Odense Univ, Dept Obstet & Gynecol, Odense, Denmark	University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; University of Texas System; University of Texas Medical Branch Galveston; University of Southern Denmark	Kacerovsky, M (corresponding author), Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove, Czech Republic.	kacermar@fnhk.cz	Kacerovsky, Marian/ABE-3437-2020; Musilová, Ivana Kacerovská/I-6204-2017; Vrbacky, Filip/J-5219-2016; Kacerovsky, Marian/A-7586-2011	Musilová, Ivana Kacerovská/0000-0002-6960-8319; Vrbacky, Filip/0000-0001-9880-117X; Andrys, Ctirad/0000-0001-6489-8786; Kacerovsky, Marian/0000-0001-9858-7900; Nekvindova, Jana/0000-0002-2861-5483	Institutional Resources for Supporting the Research Organization - Ministry of Health of the Czech Republic DRO (UHHK) [00179906]; Ministry of Health of the Czech Republic [NT13461-4/2012]; Charles University in Prague; Faculty of Medicine in Hradec Kralove, Czech Republic, project "PRVOUK" [P37/10]	Institutional Resources for Supporting the Research Organization - Ministry of Health of the Czech Republic DRO (UHHK); Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Charles University in Prague; Faculty of Medicine in Hradec Kralove, Czech Republic, project "PRVOUK"	This work was supported by Institutional Resources for Supporting the Research Organization provided by the Ministry of Health of the Czech Republic DRO (UHHK, 00179906), by a grant from the Ministry of Health of the Czech Republic (NT13461-4/2012) and by Charles University in Prague, the Faculty of Medicine in Hradec Kralove, Czech Republic, project "PRVOUK" P37/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; CHOW AW, 1989, REV INFECT DIS, V11, pS68; Cobo T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043677; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Eade CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050106; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fortner KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083338; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Gao WJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-271; Ghartey JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096659; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; GREISEN K, 1994, J CLIN MICROBIOL, V32, P335, DOI 10.1128/JCM.32.2.335-351.1994; Hyman RW, 2014, REPROD SCI, V21, P32, DOI 10.1177/1933719113488838; JOHNSON SR, 1985, AM J REPROD IM MIC, V9, P1; Kacerovsky M, 2014, J MATERN-FETAL NEO M; Kacerovsky M, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.069; Kacerovsky M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060399; Kacerovsky M, 2013, J MATERN-FETAL NEO M, V26, P795, DOI 10.3109/14767058.2013.765404; Kacerovsky M, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.004; Kacerovsky M, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.028; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kim JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047642; King Caroline C, 2011, Infect Dis Obstet Gynecol, V2011, P319460, DOI 10.1155/2011/319460; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Larsen B, 2001, CLIN INFECT DIS, V32, pE69, DOI 10.1086/318710; Lin J, 1991, IEEE T INFORM THEORY, V37, P6; Markenson GR, 1997, AM J OBSTET GYNECOL, V177, P1471, DOI 10.1016/S0002-9378(97)70093-0; Marrazzo JM, 2002, J INFECT DIS, V185, P1307, DOI 10.1086/339884; Mendz GL, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00058; Menon R, 2014, AM J REPROD IMMUNOL, V72, P75, DOI 10.1111/aji.12220; Menon R, 2014, AM J PATHOL, V184, P1740, DOI 10.1016/j.ajpath.2014.02.011; Menon R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031136; Mercer BM, 2005, OBSTET GYN CLIN N AM, V32, P411, DOI 10.1016/j.ogc.2005.03.003; Michaels JEA, 2007, J PROTEOME RES, V6, P1277, DOI 10.1021/pr060543t; OKA K, 1987, BIOL RES PREG PERIN, V8, P1; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Racicot K, 2013, J IMMUNOL, V191, P934, DOI 10.4049/jimmunol.1300661; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4; SALAFIA CM, 1989, OBSTET GYNECOL, V73, P383; SCHLIEVERT P, 1977, SEMIN PERINATOL, V1, P59; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shipitsyna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060670; Smith BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040425; Team RC, 2014, R LANG ENV STAT COMP; THADEPALLI H, 1977, AM J OBSTET GYNECOL, V127, P250, DOI 10.1016/0002-9378(77)90463-X; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward JH, 1963, J AM STAT ASSOC, V58, P8; Waters TP, 2011, CLIN OBSTET GYNECOL, V54, P307, DOI 10.1097/GRF.0b013e318217d4d3; Zhou X., 2010, Infectious Diseases in Obstetrics and Gynecology, V2010, P737425, DOI 10.1155/2010/737425	56	49	51	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126884	10.1371/journal.pone.0126884	http://dx.doi.org/10.1371/journal.pone.0126884			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993616	Green Published, gold, Green Submitted			2022-12-26	WOS:000354921400082
J	Kallner, HK; Thunell, L; Brynhildsen, J; Lindeberg, M; Danielsson, KG				Kallner, Helena Kopp; Thunell, Louise; Brynhildsen, Jan; Lindeberg, Mia; Danielsson, Kristina Gemzell			Use of Contraception and Attitudes towards Contraceptive Use in Swedish Women - A Nationwide Survey	PLOS ONE			English	Article							UNINTENDED PREGNANCY	Objective To describe contraceptive use and attitudes towards contraceptive use in Sweden which has the highest abortion rate in Western Europe. Secondary objectives were to investigate knowledge of contraceptive methods and outcomes of unplanned and unwanted pregnancies. Design Telephone survey. Setting National survey of women living in Sweden. Population Women between 16 and 49 years. Methods The survey contained 22 questions with free text and multi choice answers on demographics, contraceptive use, knowledge of and attitudes towards contraception, the importance of monthly bleeding and experience of unintended pregnancy. Main Outcome Measures Distribution of use of contraceptive methods and non-use of contraception among Swedish women. Prevalence and outcome of unintended pregnancies. Results A total of 1001 women participated in the survey. Of all women, 721/1001 (72.1%) currently used contraception whereas 268/1001 (26.8%) women did not. Long acting reversible contraception, (LARC; implant and intra uterine contraception) was used by 24.3% of women. The unmet need of contraception in Sweden was estimated at 8.9% (89/1001 women). A total of 781 (78%) women had never experienced an unintended pregnancy whereas 220 (22%) women had had at least one unintended pregnancy. Users and non-users alike stated that one of the most important characteristics of a contraceptive method is its effectiveness. Conclusions Sweden has a large unmet need for contraception. Furthermore, a large proportion of women have experienced at least one unintended pregnancy. Increasing contraceptive use and promotion of LARC is a possible way forward in the effort to reduce the rates of unwanted pregnancies.	[Kallner, Helena Kopp; Danielsson, Kristina Gemzell] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Kallner, Helena Kopp] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden; [Thunell, Louise] Skane Univ Hosp, Dept Obstet & Gynecol, Malmo, Sweden; [Brynhildsen, Jan] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Obstet & Gynecol, Linkoping, Sweden; [Lindeberg, Mia] MSD, Stockholm, Sweden	Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Lund University; Skane University Hospital; Linkoping University	Kallner, HK (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	Helena.kopp-kallner@ki.se	Kallner, Helena Kopp/AAD-4423-2020	Kallner, Helena Kopp/0000-0001-7184-9165	MSD Sweden	MSD Sweden	This study was funded by MSD Sweden. MSD Sweden contributed with knowledge on Telephone surveys but has no influence on the questions asked, analysis or interpretation of results.	[Anonymous], 1983, 19831 SOU; [Anonymous], 2002, FORSLAG TILL HANDLIN; [Anonymous], 1990, FORSL TILL AB PROGR; [Anonymous], 1996, HALS FOR UND EFT GRA; [Anonymous], 2014, SWED NAT REC CONTR U; Bajos N, 2003, HUM REPROD, V18, P994, DOI 10.1093/humrep/deg215; Bitzer J, 2012, EUR J CONTRACEP REPR, V17, P65, DOI 10.3109/13625187.2011.637586; Cameron ST, 2012, BJOG-INT J OBSTET GY, V119, P1074, DOI 10.1111/j.1471-0528.2012.03407.x; Falah-Hassani K, 2009, OBSTET GYNECOL, V114, P79, DOI 10.1097/AOG.0b013e3181a99ddd; Lamvu G, 2006, CONTRACEPTION, V73, P399, DOI 10.1016/j.contraception.2005.10.007; Larsson M, 2007, EUR J CONTRACEP REPR, V12, P119, DOI 10.1080/13625180701217026; Milton A, MILTON INVESTIGATION; Moreau C, 2014, CONTRACEPTION, V89, P314, DOI 10.1016/j.contraception.2013.11.004; Rose SB, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.06.102; Socialstyrelsen, 2010, SOC STAT; Trussell J, 2008, CONTRACEPTION, V77, P1, DOI 10.1016/j.contraception.2007.09.001; Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021; Trussell James, 1999, FAM LIFE MATTERS, P3; Winner B, 2012, NEW ENGL J MED, V366, P1998, DOI 10.1056/NEJMoa1110855	19	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125990	10.1371/journal.pone.0125990	http://dx.doi.org/10.1371/journal.pone.0125990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992901	Green Published, gold, Green Submitted			2022-12-26	WOS:000354921400051
J	Li, LF; Deng, GH; Tang, Y; Mao, Q				Li, Lufeng; Deng, Guohong; Tang, Yi; Mao, Qing			Spectrum of UGT1A1 Variations in Chinese Patients with Crigler-Najjar Syndrome Type II	PLOS ONE			English	Article							ACTIVE METABOLITE; GILBERTS-SYNDROME; BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE-1; GLUCURONOSYLTRANSFERASE GENE; JAPANESE PATIENTS; GLUCURONIDATION; MUTATIONS; HYPERBILIRUBINEMIA; IRINOTECAN; TRANSFERASE	Crigler-Najjar Syndrome type II (CNS-II) is an autosomal recessive hereditary condition of unconjugated hyperbilirubinemia without hemolysis, with bilirubin levels ranging from 102.6 mu mol/L to 342 mu mol/L. CNS-II is caused by a deficiency of UDP-glucuronyl transferase (UGT), which is encoded by the UDP-glucuronyl transferase 1A1 gene (UGT1A1). In East Asian populations, the compound homozygous UGT1A1 G71R and Y486D variants are frequently observed in cases with bilirubin levels exceeding 200 mu mol/L. In this study, we investigated the spectrum of UGT1A1 variations in Chinese CNS-II patients. We sequenced the enhancer, promoter, and coding regions of UGT1A1 in 11 unrelated Chinese CNS-II patients and 80 healthy controls. Nine of these patients carried variations that are here reported for the first time in CNS-II patients, although they have been previously reported for other types of hereditary unconjugated hyperbilirubinemia. These individual variations have less influence on UGT activity than do the compound homozygous variation (combination of homozygous G71R variant and Y486D variant). Therefore, we propose that the spectrum of UGT1A1 variations in CNS-II differs according to the bilirubin levels.	[Li, Lufeng; Deng, Guohong; Tang, Yi; Mao, Qing] Third Mil Med Univ, Southwest Hosp, Dept Infect Dis, Chongqing, Peoples R China; [Deng, Guohong; Mao, Qing] Chongqing Key Lab Res Infect Dis, Chongqing, Peoples R China	Army Medical University	Mao, Q (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Infect Dis, Chongqing, Peoples R China.	qingmao@tmmu.edu.cn			State Key Project [2011ZX09302-005, 2012ZX10002007-002-005]; Third Military Medical University Key Project [2012XLC05]	State Key Project; Third Military Medical University Key Project	The study was supported by the State Key Project (2011ZX09302-005, 2012ZX10002007-002-005) and Third Military Medical University Key Project (2012XLC05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal V, 2010, PEDIATR BLOOD CANCER, V54, P627, DOI 10.1002/pbc.22313; AONO S, 1993, BIOCHEM BIOPH RES CO, V197, P1239, DOI 10.1006/bbrc.1993.2610; ARIAS IM, 1969, AM J MED, V47, P395, DOI 10.1016/0002-9343(69)90224-1; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Canu G, 2013, BLOOD CELL MOL DIS, V50, P273, DOI 10.1016/j.bcmd.2013.01.003; Farheen S, 2006, WORLD J GASTROENTERO, V12, P2269, DOI 10.3748/wjg.v12.i14.2269; Gagne JF, 2002, MOL PHARMACOL, V62, P608, DOI 10.1124/mol.62.3.608; Holstein A, 2005, SCAND J GASTROENTERO, V40, P1124, DOI 10.1080/00365510510025755; Hsieh SY, 2001, AM J GASTROENTEROL, V96, P1188; Huang CS, 2006, J FORMOS MED ASSOC, V105, P950, DOI 10.1016/S0929-6646(09)60182-0; Huang CS, 2001, PHARMACOGENETICS, V11, P639, DOI 10.1097/00008571-200110000-00011; Iijima S, 2011, YONSEI MED J, V52, P369, DOI 10.3349/ymj.2011.52.2.369; Ishihara T, 1999, AM J GASTROENTEROL, V94, P1711, DOI 10.1111/j.1572-0241.1999.1711a.x; Ito M, 2002, EUR J CLIN PHARMACOL, V58, P11, DOI 10.1007/s00228-001-0417-2; Ito T, 2001, J OBSTET GYNAECOL RE, V27, P33, DOI 10.1111/j.1447-0756.2001.tb01212.x; Iyer L, 1999, CLIN PHARMACOL THER, V65, P576, DOI 10.1016/S0009-9236(99)70078-0; Jinno H, 2003, DRUG METAB DISPOS, V31, P108, DOI 10.1124/dmd.31.1.108; Kadakol A, 2000, HUM MUTAT, V16, P297, DOI 10.1002/1098-1004(200010)16:4<297::AID-HUMU2>3.0.CO;2-Z; Ko JS, 2014, PEDIATR GASTROENTERO, V17, P37, DOI 10.5223/pghn.2014.17.1.37; Koiwai O, 1996, HUM MOL GENET, V5, P645, DOI 10.1093/hmg/5.5.645; Korenblat KM, 2005, CLIN GASTROENTEROL H, V3, P303, DOI 10.1016/S1542-3565(05)00083-2; Li Y, 2014, J ZHEJIANG UNIV-SC B, V15, P474, DOI 10.1631/jzus.B1300233; Liu J., 2013, MATH PROBL ENG, V2013, P1; Liu WL, 2012, MOL MED REP, V6, P667, DOI 10.3892/mmr.2012.950; Maruo Y, 2006, J PEDIATR GASTR NUTR, V42, P236, DOI 10.1097/01.mpg.0000184922.09389.0a; Mimura Y, 2011, BASIC CLIN PHARMACOL, V109, P486, DOI 10.1111/j.1742-7843.2011.00754.x; Minucci A, 2012, BLOOD CELL MOL DIS, V49, P118, DOI 10.1016/j.bcmd.2012.05.004; Nong SH, 2005, J PAEDIATR CHILD H, V41, P300, DOI 10.1111/j.1440-1754.2005.00616.x; RITTER JK, 1992, J BIOL CHEM, V267, P3257; Sai K, 2004, CLIN PHARMACOL THER, V75, P501, DOI 10.1016/j.clpt.2004.01.010; SCHMID R, 1956, SCIENCE, V124, P76, DOI 10.1126/science.124.3211.76; Sugatani J, 2002, BIOCHEM BIOPH RES CO, V292, P492, DOI 10.1006/bbrc.2002.6683; Takeuchi K, 2004, J GASTROEN HEPATOL, V19, P1023, DOI 10.1111/j.1440-1746.2004.03370.x; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Udomuksorn W, 2007, PHARMACOGENET GENOM, V17, P1017, DOI 10.1097/FPC.0b013e328256b1b6; Wu JX, 2008, J DIG DIS, V9, P89, DOI 10.1111/j.1751-2980.2008.00328.x; Yamamoto K, 1998, J HUM GENET, V43, P111, DOI 10.1007/s100380050050; Yamamoto K, 1998, BBA-MOL BASIS DIS, V1406, P267, DOI 10.1016/S0925-4439(98)00013-1; Zheng BX, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-267	39	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126263	10.1371/journal.pone.0126263	http://dx.doi.org/10.1371/journal.pone.0126263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993113	gold, Green Published, Green Submitted			2022-12-26	WOS:000354921400060
J	Lin, WY; Liang, FW; Lu, TH				Lin, Wei-Yu; Liang, Fu-Wen; Lu, Tsung-Hsueh			Risk of End-Stage Renal Disease after Cancer Nephrectomy in Taiwan: A Nationwide Population-Based Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RADICAL NEPHRECTOMY; INSUFFICIENCY; SURVIVAL; TUMORS	Background The conclusions of population-based studies examining the risk of developing end-stage renal disease (ESRD) after nephrectomy among patients with renal cell carcinoma (RCC) remain inconclusive. In this study, we sought to examine whether patients with RCC undergoing radical nephrectomy (RN) have higher risk of ESRD compared to those undergoing partial nephrectomy (PN). Methods Nationwide population-based retrospective cohort of 7670 patients with RCC who underwent RN or PN between 2000 and 2011 as recorded in the Taiwan National Health Insurance in-patient claims data were analyzed. The primary outcome of interest was the occurrence of ESRD requiring regular renal hemodialysis. Multivariable Cox proportional hazard regression model was performed to assess the risk. Findings The median follow-up for the post-propensity matched cohort (1212 PN and 2424 RN) was 48 months. Seventy patients (2.9%) developed ESRD among those who underwent RN, for an incidence rate of 6.9 cases per 1000 person-years. In contrast, only 23 patients (1.9%) developed ESRD among patients who underwent PN, for an incidence rate of 5.5 cases per 1000 person-years. Despite the higher incidence rate of ESRD among RN, the aIRR (RN/PN) was 1.26 (95% CI 0.78-2.01), which was not statistically significant. Conclusions This Taiwan nationwide population-based study suggests that patients with RCC undergoing RN do not have significantly higher risk of developing ESRD compared to those undergoing PN.	[Lin, Wei-Yu] Chang Gung Mem Hosp, Div Urol, Dept Surg, Chiayi, Taiwan; [Liang, Fu-Wen; Lu, Tsung-Hsueh] Natl Cheng Kung Univ, NCKU Res Ctr Hlth Data, Tainan 70101, Taiwan; [Liang, Fu-Wen; Lu, Tsung-Hsueh] Natl Cheng Kung Univ, Dept Publ Hlth, Tainan 70101, Taiwan	Chang Gung Memorial Hospital; National Cheng Kung University; National Cheng Kung University	Lu, TH (corresponding author), Natl Cheng Kung Univ, NCKU Res Ctr Hlth Data, Tainan 70101, Taiwan.	robertlu@mail.ncku.edu.tw		Liang, Fu-Wen/0000-0002-3396-037X				Barlow LJ, 2010, BJU INT, V106, P489, DOI 10.1111/j.1464-410X.2009.09147.x; Campbell SC, 2009, J UROLOGY, V182, P1271, DOI 10.1016/j.juro.2009.07.004; Huang WC, 2006, LANCET ONCOL, V7, P735, DOI 10.1016/S1470-2045(06)70803-8; Kim SP, 2012, J UROLOGY, V188, P51, DOI [10.1016/j.juro.2012.10.026, 10.1016/j.juro.2012.03.006]; Klarenbach S, 2011, EUR UROL, V59, P333, DOI 10.1590/S1677-55382011000300026; Lane BR, 2008, J UROLOGY, V180, P2363, DOI 10.1016/j.juro.2008.08.036; Lane BR, 2013, J UROLOGY, V189, P1649, DOI 10.1016/j.juro.2012.11.121; Lane BR, 2010, J UROLOGY, V184, P1286, DOI 10.1016/j.juro.2010.06.011; Li L, 2014, NAT REV NEPHROL, V10, P135, DOI 10.1038/nrneph.2013.273; Malcolm JB, 2009, BJU INT, V104, P476, DOI 10.1111/j.1464-410X.2009.08376.x; McKiernan J, 2002, UROLOGY, V59, P816, DOI 10.1016/S0090-4295(02)01501-7; Miller DC, 2008, CANCER-AM CANCER SOC, V112, P511, DOI 10.1002/cncr.23218; National Health Insurance Administration, CAT ILLN PAT; National Health Insurance Administration, AB NAT HLTH INS; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Scosyrev E, 2014, EUR UROL, V65, P372, DOI 10.1016/j.eururo.2013.06.044; Sun M, 2012, EUR UROL, V62, P696, DOI 10.1016/j.eururo.2012.03.051; Tobert CM, 2014, WORLD J UROL, V32, P573, DOI 10.1007/s00345-014-1275-8; Verhoest G, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2012.10.003; Yap SA, 2015, BJU INT, V115, P897, DOI 10.1111/bju.12883	20	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126965	10.1371/journal.pone.0126965	http://dx.doi.org/10.1371/journal.pone.0126965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993556	Green Published, Green Submitted, gold			2022-12-26	WOS:000354921400086
J	Wada, H; Hirohashi, K; Anayama, T; Nakajima, T; Kato, T; Chan, HHL; Qiu, J; Daly, M; Weersink, R; Jaffray, DA; Irish, JC; Waddell, TK; Keshavjee, S; Yoshino, I; Yasufuku, K				Wada, Hironobu; Hirohashi, Kentaro; Anayama, Takashi; Nakajima, Takahiro; Kato, Tatsuya; Chan, Harley H. L.; Qiu, Jimmy; Daly, Michael; Weersink, Robert; Jaffray, David A.; Irish, Jonathan C.; Waddell, Thomas K.; Keshavjee, Shaf; Yoshino, Ichiro; Yasufuku, Kazuhiro			Minimally Invasive Electro-Magnetic Navigational Bronchoscopy-Integrated Near-Infrared-Guided Sentinel Lymph Node Mapping in the Porcine Lung	PLOS ONE			English	Article							INDOCYANINE GREEN; DOSE-ESCALATION; NECK-CANCER; HEAD; SEGMENTECTOMY; METASTASIS; INJECTION; LOBECTOMY; TRIAL	Background The use of near-infrared (NIR) fluorescence imaging with indocyanine green (ICG) for sentinel lymph node (SN) mapping has been investigated in lung cancer; however, this has not been fully adapted for minimally invasive surgery (MIS). The aim of our study was to develop a minimally invasive SN mapping integrating pre-operative electro-magnetic navigational bronchoscopy (ENB)-guided transbronchial ICG injection and intraoperative NIR thoracoscopic imaging. Methods A NIR thoracoscope was used to visualize ICG fluorescence. ICG solutions in a 96-well plate and ex vivo porcine lungs were examined to optimize ICG concentrations and injection volumes. Transbronchial ICG injection (n=4) was assessed in comparison to a traditional transpleural approach (n=3), where after thoracotomy an ICG solution (100 mu L at 100 mu g/mL) was injected into the porcine right upper lobe for SN identification. For further translation into clinical use, transbronchial ICG injection prior to thoracotomy followed by NIR thoracoscopic imaging was validated (n=3). ENB was used for accurate targeting in two pigs with a pseudo-tumor. Results The ICG fluorescence at 10 mu g/mL was the brightest among various concentrations, unchanged by the distance between the thoracoscope and ICG solutions. Injected ICG of no more than 500 mu L showed a localized fluorescence area. All 7 pigs showed a bright paratracheal lymph node within 15 minutes post-injection, with persistent fluorescence for 60 minutes. The antecedent transbronchial ICG injection succeeded in SN identification in all 3 cases at the first thoracoscopic inspection within 20 minutes post-injection. The ENB system allowed accurate ICG injection surrounding the pseudo-tumors. Conclusions ENB-guided ICG injection followed by NIR thoracoscopy was technically feasible for SN mapping in the porcine lung. This promising platform may be translated into human clinical trials and is suited for MIS.	[Wada, Hironobu; Hirohashi, Kentaro; Anayama, Takashi; Nakajima, Takahiro; Kato, Tatsuya; Waddell, Thomas K.; Keshavjee, Shaf; Yasufuku, Kazuhiro] Univ Hlth Network, Toronto Gen Hosp, Div Thorac Surg, Toronto, ON, Canada; [Chan, Harley H. L.; Qiu, Jimmy; Daly, Michael; Weersink, Robert; Jaffray, David A.; Irish, Jonathan C.; Yasufuku, Kazuhiro] Univ Hlth Network, TECHNA Inst, Guided Therapeut, Toronto, ON, Canada; [Irish, Jonathan C.] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Dept Otolaryngol Head & Neck Surg Surg Oncol, Toronto, ON, Canada; [Wada, Hironobu; Nakajima, Takahiro; Yoshino, Ichiro] Chiba Univ, Grad Sch Med, Dept Gen Thorac Surg, Chiba, Japan	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Chiba University	Yasufuku, K (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Div Thorac Surg, Toronto, ON, Canada.	kazuhiro.yasufuku@uhn.ca	Nakajima, Takahiro/GRX-7909-2022; Weersink, Robert/GOP-3440-2022; Ichiro, Yoshino/HCH-1137-2022	Nakajima, Takahiro/0000-0002-4937-5378; Jaffray, David/0000-0001-7378-7543; Daly, Michael/0000-0002-2217-4146; Keshavjee, Shaf/0000-0003-4547-8094; Weersink, Robert/0000-0002-3411-7288	Intuitive Surgical Technology Research Grant Program; Honjo International Scholarship Foundation	Intuitive Surgical Technology Research Grant Program; Honjo International Scholarship Foundation(Honjo International Scholarship Foundation)	This work was supported by the Intuitive Surgical Technology Research Grant Program 2013 to KY (http://intuitivesurgical.com/company/educational-grants/technology_grants.html). Novadaq Technologies provided the SPY scope and ICG for this work. In-house prototype electro-magnetic navigational bronchoscopy system was developed under collaboration with OLYMPUS MEDICAL SYSTEMS CORP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HW received a research scholarship from the Honjo International Scholarship Foundation.	Allen MS, 2006, ANN THORAC SURG, V81, P1013, DOI 10.1016/j.athoracsur.2005.06.066; Anayama T, ANN THORAC IN PRESS; Bao FC, 2014, EUR J CARDIO-THORAC, V46, P1, DOI 10.1093/ejcts/ezt554; Daly MJ, 2006, MED PHYS, V33, P3767, DOI 10.1118/1.2349687; Daly MJ, 2010, SPIE MED IMAGING, V7625; Gilmore DM, 2013, J THORAC CARDIOV SUR, V146, P562, DOI 10.1016/j.jtcvs.2013.04.010; Gilmore DM, 2013, ANN SURG ONCOL, V20, P2357, DOI 10.1245/s10434-013-2905-x; Gilmore DM, 2012, J THORAC CARDIOV SUR, V144, pS80, DOI 10.1016/j.jtcvs.2012.05.072; Jain R, 2009, J CONTROL RELEASE, V138, P90, DOI 10.1016/j.jconrel.2009.05.010; Kermani AT, 2013, LUNG CANCER, V80, P5, DOI 10.1016/j.lungcan.2013.01.001; Khullar O, 2009, SEMIN THORAC CARDIOV, V21, P309, DOI 10.1053/j.semtcvs.2009.11.009; Khullar OV, 2013, ANN THORAC SURG, V95, P312, DOI 10.1016/j.athoracsur.2012.08.101; Lardinois D, 2003, EUR J CARDIO-THORAC, V23, P824, DOI 10.1016/S1010-7940(03)00077-0; Liptay MJ, 2009, J THORAC ONCOL, V4, P198, DOI 10.1097/JTO.0b013e318194a2c3; Melfi FMA, 2008, EUR J CARDIO-THORAC, V34, P181, DOI 10.1016/j.ejcts.2008.03.059; Nakamura K, 2010, JPN J CLIN ONCOL, V40, P271, DOI 10.1093/jjco/hyp156; National Cancer Institute website, COMP DIFF TYP SURG T; Nomori H, 2012, J THORAC CARDIOV SUR, V144, P87, DOI 10.1016/j.jtcvs.2012.03.034; Oh Y, 2013, J THORAC CARDIOV SUR, V146, P1509, DOI 10.1016/j.jtcvs.2013.02.044; Ono Takashi, 2009, Interact Cardiovasc Thorac Surg, V9, P659, DOI 10.1510/icvts.2009.214197; Riquet M, 2005, ANN THORAC SURG, V79, P225, DOI 10.1016/j.athoracsur.2004.06.081; Takizawa H, 2014, J THORAC CARDIOV SUR, V147, pE50, DOI 10.1016/j.jtcvs.2013.12.058; Takizawa H, 2012, J THORAC CARDIOV SUR, V144, P94, DOI 10.1016/j.jtcvs.2012.03.040; Thompson CF, 2013, EUR ARCH OTO-RHINO-L, V270, P2115, DOI 10.1007/s00405-012-2320-0; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; van der Vorst JR, 2013, ORAL ONCOL, V49, P15, DOI 10.1016/j.oraloncology.2012.07.017; van der Zaag ES, 2012, ANN SURG ONCOL, V19, P3449, DOI 10.1245/s10434-012-2417-0; Van Oostrum NHM, 2012, ACTA OBSTET GYN SCAN, V91, P174, DOI 10.1111/j.1600-0412.2011.01302.x; Yamashita S, 2011, J THORAC CARDIOV SUR, V141, P141, DOI 10.1016/j.jtcvs.2010.01.028	29	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126945	10.1371/journal.pone.0126945	http://dx.doi.org/10.1371/journal.pone.0126945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993006	Green Published, gold, Green Submitted			2022-12-26	WOS:000354921400084
J	Cai, GQ; Mo, CH; Huang, L; Li, J; Wang, YJ				Cai, Guoqing; Mo, Chunheng; Huang, Long; Li, Juan; Wang, Yajun			Characterization of the Two CART Genes (CART1 and CART2) in Chickens (Gallus gallus)	PLOS ONE			English	Article							AMPHETAMINE-REGULATED-TRANSCRIPT; HYPOTHALAMIC SATIETY PEPTIDE; NEUROPEPTIDE-Y NPY; AVIAN LEPTIN GENE; MESSENGER-RNA; FOOD-INTAKE; IMMUNOHISTOCHEMICAL LOCALIZATION; PROHORMONE CONVERTASES; HORMONE-SECRETION; NERVOUS-SYSTEM	Cocaine-and amphetamine-regulated transcript (CART) peptide is implicated in the control of avian energy balance, however, the structure and expression of CART gene(s) remains largely unknown in birds. Here, we cloned and characterized two CART genes (named cCART1 and cCART2) in chickens. The cloned cCART1 is predicted to generate two bioactive peptides, cCART1(42-89) and cCART1(49-89), which share high amino acid sequence identity (94-98%) with their mammalian counterparts, while the novel cCART2 may produce a bioactive peptide cCART2(51-91) with 59% identity to cCART1. Interestingly, quantitative RT-PCR revealed that cCART1 is predominantly expressed in the anterior pituitary and less abundantly in the hypothalamus. In accordance with this finding, cCART1 peptide was easily detected in the anterior pituitary by Western blot, and its secretion from chick pituitaries incubated in vitro was enhanced by ionomycin and forskolin treatment, indicating that cCART1 is a novel peptide hormone produced by the anterior pituitary. Moreover, cCART1 mRNA expression in both the pituitary and hypothalamus is down-regulated by 48-h fasting, suggesting its expression is affected by energy status. Unlike cCART1, cCART2 is only weakly expressed in most tissues examined by RT-PCR, implying a less significant role of cCART2 in chickens. As in chickens, 2 or more CART genes, likely generated by gene and genome duplication event(s), were also identified in other non-mammalian vertebrate species including coelacanth. Collectively, the identification and characterization of CART genes in birds helps to uncover the roles of CART peptide(s) in vertebrates and provides clues to the evolutionary history of vertebrate CART genes.	[Cai, Guoqing; Mo, Chunheng; Huang, Long; Li, Juan; Wang, Yajun] Sichuan Univ, Coll Life Sci, Key Lab Bioresources & Ecoenvironm, Minist Educ, Chengdu 610064, Peoples R China	Sichuan University	Li, J (corresponding author), Sichuan Univ, Coll Life Sci, Key Lab Bioresources & Ecoenvironm, Minist Educ, Chengdu 610064, Peoples R China.	lijuanhk@gmail.com; cdwyjhk@gmail.com			National Natural Science Foundation of China [31272436, 31271325, 31172202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Natural Science Foundation of China to Dr. Juan Li (No. 31272436) and Dr. Yajun Wang (Nos. 31271325, 31172202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 1999, ENDOCRINOLOGY, V140, P4923, DOI 10.1210/en.140.11.4923; Akash G, 2014, J COMP NEUROL, V522, P2266, DOI 10.1002/cne.23532; Banke E, 2013, REGUL PEPTIDES, V182, P35, DOI 10.1016/j.regpep.2012.12.011; Bungo T, 1999, BRAIN RES, V817, P196, DOI 10.1016/S0006-8993(98)01223-2; Couceyro PR, 1997, J CHEM NEUROANAT, V12, P229, DOI 10.1016/S0891-0618(97)00212-3; Dey A, 2003, J BIOL CHEM, V278, P15007, DOI 10.1074/jbc.M212128200; Douglass J, 1996, GENE, V169, P241, DOI 10.1016/0378-1119(96)88651-3; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Elias CF, 2001, J COMP NEUROL, V432, P1, DOI 10.1002/cne.1085; Friedman-Einat M, 2014, ENDOCRINOLOGY, V155, P3376, DOI 10.1210/en.2014-1273; Friedman-Einat M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-551; Gautvik KM, 1996, P NATL ACAD SCI USA, V93, P8733, DOI 10.1073/pnas.93.16.8733; Gertler A, 2014, J EXP BIOL, V217, P180, DOI 10.1242/jeb.095539; Honda K, 2007, NEUROSCI LETT, V423, P153, DOI 10.1016/j.neulet.2007.07.004; Huang GA, 2014, ENDOCRINOLOGY, V155, P4568, DOI 10.1210/en.2014-1331; Huang G, 2014, ENDOCRINOLOGY, V155, P3385, DOI 10.1210/en.2014-1084; Jaworski JN, 2006, PEPTIDES, V27, P1993, DOI 10.1016/j.peptides.2006.03.034; Jensen PB, 1999, FEBS LETT, V447, P139, DOI 10.1016/S0014-5793(99)00291-4; Kehoe AS, 2007, COMP BIOCHEM PHYS A, V146, P451, DOI 10.1016/j.cbpa.2006.12.026; Kobayashi Y, 2004, ENDOCRINOLOGY, V145, P5373, DOI 10.1210/en.2004-0283; Kobayashi Y, 2008, COMP BIOCHEM PHYS A, V151, P219, DOI 10.1016/j.cbpa.2008.06.029; Koylu EO, 1997, J NEUROENDOCRINOL, V9, P823, DOI 10.1046/j.1365-2826.1997.00651.x; Koylu EO, 1998, J COMP NEUROL, V391, P115; Koylu EO, 2006, PEPTIDES, V27, P1956, DOI 10.1016/j.peptides.2006.03.032; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Kuhar MJ, 1999, SYNAPSE, V33, P163, DOI 10.1002/(SICI)1098-2396(19990901)33:3<163::AID-SYN1>3.0.CO;2-T; Kuhar MJ, 2002, NEUROPEPTIDES, V36, P1, DOI 10.1054/npep.2002.0887; Kuriyama G, 2004, ENDOCRINOLOGY, V145, P2542, DOI 10.1210/en.2003-0845; Lambert PD, 1998, SYNAPSE, V29, P293, DOI 10.1002/(SICI)1098-2396(199808)29:4<293::AID-SYN1>3.0.CO;2-0; Ludvigsen S, 2001, BIOCHEMISTRY-US, V40, P9082, DOI 10.1021/bi010433u; Maixnerova J, 2007, PEPTIDES, V28, P1945, DOI 10.1016/j.peptides.2007.07.022; Meng FY, 2014, MOL CELL ENDOCRINOL, V384, P83, DOI 10.1016/j.mce.2014.01.001; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Millar RP, 2014, ENDOCRINOLOGY, V155, P3203, DOI 10.1210/en.2014-1563; Murashita K, 2011, GEN COMP ENDOCR, V170, P494, DOI 10.1016/j.ygcen.2010.11.005; Murashita K, 2009, GEN COMP ENDOCR, V162, P160, DOI 10.1016/j.ygcen.2009.03.015; Murphy KG, 2000, J ENDOCRINOL, V166, P659, DOI 10.1677/joe.0.1660659; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Nishio SI, 2012, MOL ENDOCRINOL, V26, P1316, DOI 10.1210/me.2011-1180; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rogge G, 2008, NAT REV NEUROSCI, V9, P747, DOI 10.1038/nrn2493; SCHWARTZ TW, 1986, FEBS LETT, V200, P1, DOI 10.1016/0014-5793(86)80500-2; Sen A, 2007, ENDOCRINOLOGY, V148, P4400, DOI 10.1210/en.2007-0332; Smith SM, 2006, ENDOCRINOLOGY, V147, P1213, DOI 10.1210/en.2005-1392; Smith SM, 2004, ENDOCRINOLOGY, V145, P5202, DOI 10.1210/en.2004-0708; Song ZG, 2012, GEN COMP ENDOCR, V178, P546, DOI 10.1016/j.ygcen.2012.06.026; Stanek LM, 2006, PEPTIDES, V27, P2005, DOI 10.1016/j.peptides.2006.01.027; Stanley SA, 2004, AM J PHYSIOL-ENDOC M, V287, pE583, DOI 10.1152/ajpendo.00576.2003; Stanley SA, 2001, BRAIN RES, V893, P186, DOI 10.1016/S0006-8993(00)03312-6; Stein J, 2006, PEPTIDES, V27, P1919, DOI 10.1016/j.peptides.2005.10.028; Subhedar NK, 2014, PEPTIDES, V54, P108, DOI 10.1016/j.peptides.2014.01.004; Tachibana T, 2003, NEUROSCI LETT, V337, P131, DOI 10.1016/S0304-3940(02)01321-6; Thim L, 1999, P NATL ACAD SCI USA, V96, P2722, DOI 10.1073/pnas.96.6.2722; Thim L, 1998, FEBS LETT, V428, P263, DOI 10.1016/S0014-5793(98)00543-2; True C, 2013, ENDOCRINOLOGY, V154, P2821, DOI 10.1210/en.2013-1156; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Vicentic A, 2004, ENDOCRINOLOGY, V145, P4119, DOI 10.1210/en.2003-1648; Vicentic A, 2006, PEPTIDES, V27, P1942, DOI 10.1016/j.peptides.2006.01.026; Vicentic A, 2006, PEPTIDES, V27, P1934, DOI 10.1016/j.peptides.2006.03.031; Volkoff H, 2001, ENDOCRINOLOGY, V142, P5076, DOI 10.1210/en.142.12.5076; Volkoff H, 2000, BRAIN RES, V887, P125, DOI 10.1016/S0006-8993(00)03001-8; Vrang N, 2006, PEPTIDES, V27, P1970, DOI 10.1016/j.peptides.2005.10.029; Wierup N, 2004, J HISTOCHEM CYTOCHEM, V52, P169, DOI 10.1177/002215540405200204; Wierup N, 2006, DIABETES, V55, P305, DOI 10.2337/diabetes.55.02.06.db04-1383; Wierup N, 2005, REGUL PEPTIDES, V129, P203, DOI 10.1016/j.regpep.2005.02.016	67	33	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127107	10.1371/journal.pone.0127107	http://dx.doi.org/10.1371/journal.pone.0127107			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992897	Green Published, Green Submitted, gold			2022-12-26	WOS:000354917300092
J	Fezeu, LK; Batty, DG; Gale, CR; Kivimaki, M; Hercberg, S; Czernichow, S				Fezeu, Leopold K.; Batty, David G.; Gale, Catharine R.; Kivimaki, Mika; Hercberg, Serge; Czernichow, Sebastien			Is the Relationship between Common Mental Disorder and Adiposity Bidirectional? Prospective Analyses of a UK General Population-Based Study	PLOS ONE			English	Article							BODY-MASS INDEX; C-REACTIVE PROTEIN; DEPRESSIVE SYMPTOMS; OBESITY; ASSOCIATION; WEIGHT; INFLAMMATION; PROJECTIONS; MORTALITY; ANXIETY	The direction of the association between mental health and adiposity is poorly understood. Our objective was to empirically examine this link in a UK study. This is a prospective cohort study of 3 388 people (men) aged >= 18 years at study induction who participated in both the UK Health and Lifestyle Survey at baseline (HALS-1, 1984/1985) and the re-survey (HALS-2, 1991/1992). At both survey examinations, body mass index, waist circumference and self-reported common mental disorder (the 30-item General Health Questionnaire, GHQ) were measured. Logistic regression models were used to compute odds ratios (OR) and accompanying 95% confidence intervals (CI) for the associations between (1) baseline common mental disorder (QHQ score > 4) and subsequent general and abdominal obesity and (2) baseline general and abdominal obesity and re-survey common mental disorders. After controlling for a range of covariates, participants with common mental disorder at baseline experienced greater odds of subsequently becoming overweight (women, OR: 1.30, 1.03 - 1.64; men, 1.05, 0.81 -1.38) and obese (women, 1.26, 0.82 - 1.94; men, OR: 2.10, 1.23 - 3.55) than those who were free of common mental disorder. Similarly, having baseline common mental health disorder was also related to a greater risk of developing moderate (1.57, 1.21 - 2.04) and severe (1.48, 1.09 - 2.01) abdominal obesity (women only). Baseline general or abdominal obesity was not associated with the risk of future common mental disorder. These findings of the present study suggest that the direction of association between common mental disorders and adiposity is from common mental disorder to increased future risk of adiposity as opposed to the converse.	[Fezeu, Leopold K.; Hercberg, Serge] Univ Paris 07, Univ Paris 05, Univ Paris 13,INSERM,INRA,Cnam, Sorbonne Paris Cite,EREN,Ctr Epidemiol & Biostat, Bobigny, France; [Batty, David G.] Univ Southampton, Epidemiol Resource Ctr, MRC, Southampton, Hants, England; [Batty, David G.; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Gale, Catharine R.] MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Kivimaki, Mika] Finnish Inst Occupat Hlth, Helsinki, Finland; [Hercberg, Serge] Hop Avicenne, AP HP, Dept Sante Publ, F-93009 Bobigny, France; [Czernichow, Sebastien] Hop Ambroise Pare, AP HP, Dept Nutr, Boulogne, France; [Czernichow, Sebastien] Univ Versailles St Quentin Yvelines, Boulogne, France; [Czernichow, Sebastien] INSERM, Populat Based Cohort Unit UMS011, Villejuif, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; University of Southampton; University of London; University College London; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; Finnish Institute of Occupational Health; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm)	Fezeu, LK (corresponding author), Univ Paris 07, Univ Paris 05, Univ Paris 13,INSERM,INRA,Cnam, Sorbonne Paris Cite,EREN,Ctr Epidemiol & Biostat, Bobigny, France.	l.fezeu@uren.smbh.univ-paris13.fr	Serge, Hercberg/F-3038-2017; Kivimaki, Mika/B-3607-2012; HERCBERG, Serge/B-4429-2008; Fezeu, Leopold/F-2804-2017	Serge, Hercberg/0000-0002-3168-1350; Kivimaki, Mika/0000-0002-4699-5627; HERCBERG, Serge/0000-0002-3168-1350; Fezeu, Leopold/0000-0002-7589-3179; Batty, George/0000-0003-1822-5753; Gale, Catharine/0000-0002-3361-8638	UK Health Promotion Trust; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MC_U147585819, MC_UU_12011/2, MC_UP_A620_1015, MC_U147585827, MR/K013351/1, G0400491] Funding Source: UKRI; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [U1475000002, MC_UU_12011/2, MC_U147585819, MR/K013351/1, G0400491, MC_U147585824, MC_UP_A620_1014, MC_UP_A620_1015, MC_UU_12011/1, MC_U147585827, MR/K026992/1, U1475000001] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10085, NF-SI-0508-10082] Funding Source: researchfish	UK Health Promotion Trust; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We are grateful to the original creator and principal investigator of the HALS-1 and HALS-2 studies, Prof. Cox D.B, from the school of clinical medicine, university of Cambridge. We also thank the UK Health Promotion Trust who funded the HALS-1 and HALS-2 studies. The UK Data Archive provided free of charge to us the HALS-1 and HALS-2 databases. The original data creators, depositors or copyright holders, the funders of the Data Collections and the UK Data Archive bear no responsibility for data analyses or interpretation.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; [Anonymous], 1984, CENSUS 1981 EC ACTIV; Aronne LJ, 2003, J CLIN PSYCHIAT, V64, P22; Atlantis E, 2008, INT J OBESITY, V32, P881, DOI 10.1038/ijo.2008.54; Atlantis E, 2008, INT J OBESITY, V32, P715, DOI 10.1038/sj.ijo.0803762; Barefoot JC, 1998, INT J OBESITY, V22, P688, DOI 10.1038/sj.ijo.0800647; Batty GD, 2009, J EPIDEMIOL COMMUN H, V63, P952, DOI 10.1136/jech.2008.086892; Bean MK, 2008, J CLIN PSYCHOL MED S, V15, P214, DOI 10.1007/s10880-008-9124-9; Belanoff JK, 2001, AM J PSYCHIAT, V158, P1612, DOI 10.1176/appi.ajp.158.10.1612; Benhalima K, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/248121; Bermudez EA, 2002, ARTERIOSCL THROM VAS, V22, P1668, DOI 10.1161/01.ATV.0000029781.31325.66; Bjerkeset O, 2008, AM J EPIDEMIOL, V167, P193, DOI 10.1093/aje/kwm280; Bjorntorp P, 1996, INT J OBESITY, V20, P291; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; de Wit L, 2010, PSYCHIAT RES; de Wit LM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-14; Demyttenaere K, 2008, J PSYCHOPHARMACOL, V22, P792, DOI 10.1177/0269881107083798; Hasler G, 2005, MOL PSYCHIATR, V10, P842, DOI 10.1038/sj.mp.4001671; HUPPERT FA, 1995, PSYCHOL MED, V25, P1073, DOI 10.1017/S0033291700037569; Kivimaki M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3765; Kivimaki M, 2009, BRIT J PSYCHIAT, V195, P149, DOI 10.1192/bjp.bp.108.057299; Koponen H, 2008, J CLIN PSYCHIAT, V69, P178, DOI 10.4088/JCP.v69n0202; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Ma YS, 2008, NUTRITION, V24, P941, DOI 10.1016/j.nut.2008.04.005; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mead GE, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub3; Milaneschi Y, 2009, BIOL PSYCHIAT, V65, P973, DOI 10.1016/j.biopsych.2008.11.011; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Pallister E, 2008, CLIN PSYCHOL REV, V28, P366, DOI 10.1016/j.cpr.2007.07.001; Pan A, 2012, INT J OBESITY, V36, P595, DOI 10.1038/ijo.2011.111; Peterson JC, 1998, LANCET, V351, P263, DOI 10.1016/S0140-6736(05)78275-1; Pevalin DJ, 2000, SOC PSYCH PSYCH EPID, V35, P508, DOI 10.1007/s001270050272; Rennie KL, 2005, OBES REV, V6, P11, DOI 10.1111/j.1467-789X.2005.00164.x; Richardson LP, 2003, ARCH PEDIAT ADOL MED, V157, P739, DOI 10.1001/archpedi.157.8.739; Roberts RE, 2003, INT J OBESITY, V27, P514, DOI 10.1038/sj.ijo.0802204; Robinson LE, 2013, LIPIDS, V48, P319, DOI 10.1007/s11745-013-3774-6; Scott KA, 2008, J PSYCHOSOM RES, V64, P97, DOI 10.1016/j.jpsychores.2007.09.006; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; STANSFELD SA, 1992, PSYCHOL MED, V22, P739, DOI 10.1017/S0033291700038186; Stunkard AJ, 2003, BIOL PSYCHIAT, V54, P330, DOI 10.1016/S0006-3223(03)00608-5; Sung KC, 2003, AM J HYPERTENS, V16, P429, DOI 10.1016/S0895-7061(03)00566-1; Sussman N, 2001, J CLIN PSYCHIAT, V62, P256, DOI 10.4088/JCP.v62n0407; van Gool CH, 2007, AM J PUBLIC HEALTH, V97, P2121, DOI [10.2105/AJPH.2004.053199, 10.2105/AJPH.2004.053199e]; Wardle J, 2008, INT J OBESITY, V32, P527, DOI 10.1038/sj.ijo.0803740	45	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0119970	10.1371/journal.pone.0119970	http://dx.doi.org/10.1371/journal.pone.0119970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7BG	25993130	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000354917300002
J	Randall, LA; Smith, DHV; Jones, BL; Prescott, DRC; Moehrenschlager, A				Randall, Lea A.; Smith, Des H. V.; Jones, Breana L.; Prescott, David R. C.; Moehrenschlager, Axel			Seasonal Differences in Extinction and Colonization Drive Occupancy Dynamics of an Imperilled Amphibian	PLOS ONE			English	Article							RANA-PIPIENS SCHREBER; SITE OCCUPANCY; LEOPARD FROGS; ABUNDANCE; MOVEMENTS; DECLINES; TRENDS	A detailed understanding of the population dynamics of many amphibian species is lacking despite concerns about declining amphibian biodiversity and abundance. This paper explores temporal patterns of occupancy and underlying extinction and colonization dynamics in a regionally imperiled amphibian species, the Northern leopard frog (Lithobates pipiens) in Alberta. Our study contributes to elucidating regional occupancy dynamics at northern latitudes, where climate extremes likely have a profound effect on seasonal occupancy. The primary advantage of our study is its wide geographic scale (60,000 km(2)) and the use of repeat visual surveys each spring and summer from 2009-2013. We find that occupancy varied more dramatically between seasons than years, with low spring and higher summer occupancy. Between spring and summer, colonization was high and extinction low; inversely, colonization was low and extinction high over the winter. The dynamics of extinction and colonization are complex, making conservation management challenging. Our results reveal that Northern leopard frog occupancy was constant over the last five years and thus there is no evidence of decline or recovery within our study area. Changes to equilibrium occupancy are most sensitive to increasing colonization in the spring or declining extinction in the summer. Therefore, conservation and management efforts should target actions that are likely to increase spring colonization; this could be achieved through translocations or improving the quality or access to breeding habitat. Because summer occupancy is already high, it may be difficult to improve further. Nevertheless, summer extinction could be reduced by predator control, increasing water quality or hydroperiod of wetlands, or increasing the quality or quantity of summer habitat.	[Randall, Lea A.; Smith, Des H. V.; Jones, Breana L.; Moehrenschlager, Axel] Calgary Zool Soc, Ctr Conservat & Res, Calgary, AB T2M 4R8, Canada; [Smith, Des H. V.] Wildland Consultants Ltd, Christchurch, New Zealand; [Prescott, David R. C.] Fish & Wildlife Div, Environm & Sustainable Resource Dev, Red Deer, AB, Canada		Randall, LA (corresponding author), Calgary Zool Soc, Ctr Conservat & Res, Calgary, AB T2M 4R8, Canada.	lear@calgaryzoo.com		Randall, Lea/0000-0002-6144-855X	Cenovus Energy Ltd.; EnCana; Alberta Conservation Association; Alberta Society of Professional Biologists; Canadian Wildlife Federation; TD Friends of the Environment; Calgary Foundation; Husky Energy; Wildland Consultants Ltd.	Cenovus Energy Ltd.; EnCana; Alberta Conservation Association; Alberta Society of Professional Biologists; Canadian Wildlife Federation; TD Friends of the Environment; Calgary Foundation; Husky Energy; Wildland Consultants Ltd.	This research was funded by Cenovus Energy Ltd. (http://www.cenovus.com), EnCana (http://www.encana.com), the Alberta Conservation Association (http://www.ab-conservation.com), the Alberta Society of Professional Biologists (http://www.aspb.ab.ca), the Canadian Wildlife Federation (http://www.cwf-fcf.org), TD Friends of the Environment (https://fef.td.com), Calgary Foundation (http://www.thecalgaryfoundation.org), and Husky Energy (http://www.huskyenergy.ca). Mike and Sherri Balm also made a significant individual donation. The authors confirm that Wildland Consultants Ltd. provided support in the form of salaries for authors DS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	AESRD, 2012, ALB NO LEOP FROG REC, P34; Alberta Government, 2013, ESRD, P25; ATLAS MEYER, 1935, PHYSIOL ZOOL, V8, P290; Bartzen BA, 2010, ECOL APPL, V20, P525, DOI 10.1890/08-1650.1; BAUER A.M., 2000, HERPETOFAUNA NEW CAL; Blaustein AR, 2011, ANN NY ACAD SCI, V1223, P108, DOI 10.1111/j.1749-6632.2010.05909.x; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Cooch E, 2015, PROGRAM MARK GENTLE, P1038; COSEWIC, 2009, COSEWIC ASS UPD STAT, P69; COSEWIC, 2012, COSEWIC ASS PROC CAT; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; DOLE JW, 1971, COPEIA, P221; DOLE JW, 1965, ECOLOGY, V46, P236, DOI 10.2307/1936327; DOLE JW, 1967, AM MIDL NAT, V78, P167, DOI 10.2307/2423377; Eskew EA, 2012, CONSERV BIOL, V26, P504, DOI 10.1111/j.1523-1739.2012.01842.x; Falke JA, 2012, ECOLOGY, V93, P858, DOI 10.1890/11-1515.1; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; Heard GW, 2012, BIOL CONSERV, V148, P156, DOI 10.1016/j.biocon.2012.01.018; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; IUCN, 2012, IUCN RED LIST CAT CR, VSecond; Jones JPG, 2011, J APPL ECOL, V48, P9, DOI 10.1111/j.1365-2664.2010.01917.x; Kendell K, 2007, ALBERTA NO LEOPARD F, P18; Kendell K, 2002, ALBERTA INVENTORY NO, P29; Link WA, 2002, ECOLOGY, V83, P3299, DOI 10.1890/0012-9658(2002)083[3299:SISA]2.0.CO;2; Lopez JE, 2001, CONSERV BIOL, V15, P1700, DOI 10.1046/j.1523-1739.2001.00140.x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; Marsh DM, 2001, CONSERV BIOL, V15, P40, DOI 10.1046/j.1523-1739.2001.00129.x; Martin J, 2009, ECOLOGY, V90, P10, DOI 10.1109/ARFTG74.2009.5439088; Merrell DJ, 1977, OCCASIONAL PAPERS BE, P22; Miller MW, 2011, J WILDLIFE MANAGE, V75, P836, DOI 10.1002/jwmg.98; Pearl Christopher A., 2009, Diversity, V1, P166; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Rachowicz LJ, 2007, J ANIM ECOL, V76, P711, DOI 10.1111/j.1365-2656.2007.01256.x; Randall Lea A., 2014, Canadian Field-Naturalist, V128, P50; REED JM, 1995, CONSERV BIOL, V9, P1299, DOI 10.1046/j.1523-1739.1995.9051295.x-i1; Riddle JD, 2010, AUK, V127, P94, DOI 10.1525/auk.2009.09062; Russell Anthony P., 2005, P151, DOI 10.1007/3-540-26604-6_7; Schmidt Benedikt R., 2010, P465; Schmidt BR, 2005, J WILDLIFE MANAGE, V69, P884, DOI 10.2193/0022-541X(2005)069[0884:RIOPPA]2.0.CO;2; Shank CC, 2014, CLIMATE CHANGE VULNE, P60; Sinton HM, 2001, PRAIRIE OIL GAS LIGH, P67; Smith DHV, 2014, HERPETOL CONSERV BIO, V9, P267; Smith MA, 2005, ECOGRAPHY, V28, P110; Sparling Donald W., 2010, P105; Stevens SD, 2010, HABITAT SUITABILITY, P16; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Vonesh James R., 2010, P263; Webber AF, 2013, ECOL EVOL, V3, P853, DOI 10.1002/ece3.511	52	2	2	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127059	10.1371/journal.pone.0127059	http://dx.doi.org/10.1371/journal.pone.0127059			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993256	Green Published, Green Submitted, gold			2022-12-26	WOS:000354917300081
J	Sainz-Polo, MA; Gonzalez, B; Menendez, M; Pastor, FIJ; Sanz-Aparicio, J				Angela Sainz-Polo, M.; Gonzalez, Beatriz; Menendez, Margarita; Javier Pastor, F. I.; Sanz-Aparicio, Julia			Exploring Multimodularity in Plant Cell Wall Deconstruction STRUCTURAL AND FUNCTIONAL ANALYSIS OF Xyn10C CONTAINING THE CBM22-1-CBM22-2 TANDEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; THERMOSTABILIZING DOMAINS; MOLECULAR-BASIS; XYLANASE; SPECIFICITY; CELLULOSOMES; BIOCHEMISTRY; RECOGNITION; INSIGHTS; COMPLEX	Elucidating the molecular mechanisms regulating multi-modularity is a challenging task. Paenibacillus barcinonensis Xyn10C is a 120-kDa modular enzyme that presents the CBM22/GH10/CBM9 architecture found in a subset of large xylanases. We report here the three-dimensional structure of the Xyn10C N-terminal region, containing the xylan-binding CBM22-1-CBM22-2 tandem (Xyn10C-XBD), which represents the first solved crystal structure of two contiguous CBM22 modules. Xyn10C-XBD is folded into two separate CBM22 modules linked by a flexible segment that endows the tandem with extraordinary plasticity. Each isolated domain has been expressed and crystallized, and their binding abilities have been investigated. Both domains contain the R(W/Y)YYE motif required for xylan binding. However, crystallographic analysis of CBM22-2 complexes shows Trp-308 as an additional binding determinant. The long loop containing Trp-308 creates a platform that possibly contributes to the recognition of precise decorations at subsite S2. CBM22-2 may thus define a subset of xylan-binding CBM22 modules directed to particular regions of the polysaccharide. Affinity electrophoresis reveals that Xyn10C-XBD binds arabinoxylans more tightly, which is more apparent when CBM22-2 is tested against highly substituted xylan. The crystal structure of the catalytic domain, also reported, shows the capacity of the active site to accommodate xylan substitutions at almost all subsites. The structural differences found at both Xyn10C-XBD domains are consistent with the isothermal titration calorimetry experiments showing two sites with different affinities in the tandem. On the basis of the distinct characteristics of CBM22, a delivery strategy of Xyn10C mediated by Xyn10C-XBD is proposed.	[Angela Sainz-Polo, M.; Gonzalez, Beatriz; Sanz-Aparicio, Julia] CSIC, Inst Quim Fis Rocasolano, Dept Cristalog & Biol Estruct, E-28006 Madrid, Spain; [Menendez, Margarita] CSIC, Inst Quim Fis Rocasolano, Dept Quim Fis Biol, E-28006 Madrid, Spain; [Javier Pastor, F. I.] Univ Barcelona, Fac Biol, Dept Microbiol, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Barcelona	Sanz-Aparicio, J (corresponding author), CSIC, Inst Quim Fis Rocasolano, Dept Cristalog & Biol Estruct, Serrano 119, E-28006 Madrid, Spain.	xjulia@iqfr.csic.es	Menendez, Margarita/M-1795-2014; Gonzalez, Beatriz/M-1219-2014; Sanz-Aparicio, Julia/F-6201-2013; saso, luciano/F-6306-2012; Sainz-Polo, Maria-Angela/F-3947-2016	Menendez, Margarita/0000-0002-3267-4443; Gonzalez, Beatriz/0000-0002-0710-0202; Sanz-Aparicio, Julia/0000-0002-6849-8621; saso, luciano/0000-0003-4530-8706; Sainz-Polo, Maria-Angela/0000-0002-6269-4330	Spanish Ministry of Science and Innovation [BIO2010-20508-C04-03, BIO2013-48779-C4-2-R, CTQ2013-48995-C2-2-R, BFU2012-36825]; Junta de Ampliacion de Estudios predoctoral fellowship from the Spanish National Research Council	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Ampliacion de Estudios predoctoral fellowship from the Spanish National Research Council	This work was supported by Grants BIO2010-20508-C04-03, BIO2013-48779-C4-2-R, CTQ2013-48995-C2-2-R, and BFU2012-36825 from the Spanish Ministry of Science and Innovation. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Junta de Ampliacion de Estudios predoctoral fellowship from the Spanish National Research Council.	Abbott DW, 2008, MOL BIOL EVOL, V25, P155, DOI 10.1093/molbev/msm243; Abbott DW, 2014, CURR OPIN STRUC BIOL, V28, P32, DOI 10.1016/j.sbi.2014.07.004; Andrews SR, 2004, J BIOL CHEM, V279, P54369, DOI 10.1074/jbc.M409044200; Sainz-Polo MA, 2014, J BIOL CHEM, V289, P31088, DOI 10.1074/jbc.M114.597732; Sainz-Polo MA, 2015, ACTA CRYSTALLOGR F, V71, P136, DOI 10.1107/S2053230X14027496; ATKINS EDT, 1992, PROGR BIOTECHNOL, V7, P39; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Blanco A, 1999, MICROBIOL-SGM, V145, P2163, DOI 10.1099/13500872-145-8-2163; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Charnock SJ, 2000, BIOCHEMISTRY-US, V39, P5013, DOI 10.1021/bi992821q; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Correia MAS, 2010, BIOCHEMISTRY-US, V49, P6193, DOI 10.1021/bi1006139; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; FONTES CMGA, 1995, BIOCHEM J, V307, P151, DOI 10.1042/bj3070151; Gallardo O, 2010, J BIOL CHEM, V285, P2721, DOI 10.1074/jbc.M109.064394; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Hogg D, 2003, BIOCHEM J, V371, P1027, DOI 10.1042/BJ20021860; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; McCartney L, 2006, P NATL ACAD SCI USA, V103, P4765, DOI 10.1073/pnas.0508887103; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meissner K, 2000, MOL MICROBIOL, V36, P898, DOI 10.1046/j.1365-2958.2000.01909.x; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Monterroso B, 2008, J BIOL CHEM, V283, P28618, DOI 10.1074/jbc.M802808200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Najmudin S, 2010, J STRUCT BIOL, V172, P353, DOI 10.1016/j.jsb.2010.07.009; Pell G, 2004, J BIOL CHEM, V279, P11777, DOI 10.1074/jbc.M311947200; Pell G, 2004, J BIOL CHEM, V279, P9597, DOI 10.1074/jbc.M312278200; Sanchez MM, 2005, INT J SYST EVOL MICR, V55, P935, DOI 10.1099/ijs.0.63383-0; Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05; Simpson PJ, 1999, STRUCTURE, V7, P853, DOI 10.1016/S0969-2126(99)80108-7; Sunna A, 2000, BIOCHEM J, V346, P583, DOI 10.1042/0264-6021:3460583; Szabo L, 2001, J BIOL CHEM, V276, P49061, DOI 10.1074/jbc.M109558200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valenzuela SV, 2014, APPL MICROBIOL BIOT, V98, P5949, DOI 10.1007/s00253-014-5565-2; Valenzuela SV, 2010, J AGR FOOD CHEM, V58, P4814, DOI 10.1021/jf9045792; Vardakou M, 2005, J MOL BIOL, V352, P1060, DOI 10.1016/j.jmb.2005.07.051; Vazana Y, 2012, METHOD ENZYMOL, V510, P429, DOI 10.1016/B978-0-12-415931-0.00023-9; Xie HF, 2001, BIOCHEMISTRY-US, V40, P9167, DOI 10.1021/bi0106742	47	14	16	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17116	17130		10.1074/jbc.M115.659300	http://dx.doi.org/10.1074/jbc.M115.659300			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26001782	hybrid, Green Published			2022-12-26	WOS:000357730900007
J	Tsai, S; Yen, W; Chavanich, S; Viyakarn, V; Lin, C				Tsai, Sujune; Yen, Wish; Chavanich, Suchana; Viyakarn, Voranop; Lin, Chiahsin			Development of Cryopreservation Techniques for Gorgonian (Junceella juncea) Oocytes through Vitrification	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; ICE-FREE CRYOPRESERVATION; EMBRYOS; CORAL; CRYOPROTECTANT; FRAGILIS; STAGE; TEMPERATURE; PROGRESS; AGENTS	Gorgonian corals are slowly declining due to human interaction and environmental impacts. Cryopreservation of gorgonian corals is an ex-situ method of conservation, ensuring future reproduction. The present study assessed the vitrification properties of cryoprotectant (CPT) mixtures using the cryotop, cryoloop and open pulled straw (OPS) cryopereservation methods prior to experimentation on gorgonian (Junceella juncea) oocytes. Investigations of the equilibration and vitrification solutions' (ES and VS) effect on oocytes throughout different incubation periods were conducted. The cryotop method was found to be the most successful in ensuring vitrification. The most favourable VS was composed of propylene glycol (PG), ethylene glycol (EG) and methanol with concentrations of 3.5M, 1.5M and 2M respectively. Experiments were performed using the cryotop method to cryopreserve Junceella juncea oocytes using VS2, the solution had the least impact on oocytes at 5 degrees C rather than at 26 degrees C. The success of the vitrification procedures was determined by adenosine triphosphate (ATP) levels in cooled-thaw oocytes and the highest viability obtained from the present study was 76.6 +/- 6.2%. This study provides information regarding gorgonian corals' tolerance and viability throughout vitrification to further advance the vitrification protocol on whip corals.	[Tsai, Sujune] Mingdao Univ, Dept Biotechnol, Changhua, Taiwan; [Tsai, Sujune] Mingdao Univ, Dept Post Modern Agr, Peetow, Changhua, Taiwan; [Yen, Wish] Univ Ottawa, Inst Biochem & Environm Sci, Ottawa, ON, Canada; [Lin, Chiahsin] Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan; [Lin, Chiahsin] Natl Dong Hwa Univ, Inst Marine Biol, Checheng, Pingtung, Taiwan; [Chavanich, Suchana; Viyakarn, Voranop] Chulalongkorn Univ, Fac Sci, Dept Marine Sci, Reef Biol Res Grp, Bangkok, Thailand	Mingdao University; Mingdao University; University of Ottawa; National Museum of Marine Biology & Aquarium; National Dong Hwa University; Chulalongkorn University	Lin, C (corresponding author), Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan.	chiahsin@nmmba.gov.tw	Viyakarn, Voranop/Q-9182-2019; Chavanich, Suchana/AAU-8266-2020		National Science Council [NSC 102-2313-B-291 -002]	National Science Council(Ministry of Science and Technology, Taiwan)	Funding was provided by the National Science Council (NSC 102-2313-B-291 -002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI J, 1993, J REPROD FERTIL, V99, P471, DOI 10.1530/jrf.0.0990471; Edashige K, 2006, CRYOBIOLOGY, V53, P96, DOI 10.1016/j.cryobiol.2006.04.002; El-Battawy KA, 2009, REPROD DOMEST ANIM, V44, P718, DOI 10.1111/j.1439-0531.2007.01059.x; GAKHOVA E N, 1988, Ontogenez, V19, P175; Guan M, 2010, CRYOLETTERS, V31, P230; Hajarian H, 2011, J ANIM VET ADV, V10, P2541, DOI 10.3923/javaa.2011.2541.2545; Higaki S, 2010, J REPROD, V56, P12; Isachenko V, 2005, REPROD BIOMED ONLINE, V10, P350, DOI 10.1016/S1472-6483(10)61795-6; Kuiter R.H., 2001, ZOONETICS, V2001, P1; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P300, DOI 10.1016/S1472-6483(10)60837-1; Lin C, 2012, THERIOGENOLOGY, V77, P1257, DOI 10.1016/j.theriogenology.2011.09.021; Lin C, 2011, CRYOLETTERS, V32, P141; Lin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092812; Lin CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057823; Lin CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038689; Lin TT, 2000, CRYOPRESERVATION AQU, P240; MAZUR P, 1993, CRYOBIOLOGY, V30, P45, DOI 10.1006/cryo.1993.1006; O'Neil L, 1998, CRYOBIOLOGY, V37, P59, DOI 10.1006/cryo.1998.2098; Olive PJW, 1997, CRYOBIOLOGY, V34, P284, DOI 10.1006/cryo.1997.2006; Paniagua-Chavez CG, 2001, CRYOBIOLOGY, V43, P211, DOI 10.1006/cryo.2001.2346; PATTON WK, 1972, B MAR SCI, V22, P419; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Robles V, 2005, THERIOGENOLOGY, V64, P1633, DOI 10.1016/j.theriogenology.2005.04.014; Robles V, 2004, THERIOGENOLOGY, V61, P1367, DOI 10.1016/j.theriogenology.2003.08.010; Ruppert EE, 1988, SEASHORE ANIMALS SE, P429; Saragusty J, 2011, REPRODUCTION, V141, P1, DOI 10.1530/REP-10-0236; Song YC, 2000, J INVEST SURG, V13, P279; Tsai S, 2014, CRYOLETTERS, V35, P1; Tsai S, 2012, BRAZ ARCH BIOL TECHN, V55, P425, DOI 10.1590/S1516-89132012000300014; Tsai S, 2011, CRYOLETTERS, V32, P1; Tsai S, 2010, THERIOGENOLOGY, V73, P605, DOI 10.1016/j.theriogenology.2009.10.016; Tsai S, 2009, THERIOGENOLOGY, V71, P1226, DOI 10.1016/j.theriogenology.2009.01.014; Tsai S, 2014, MITOCHONDRIAL DNA; Tsai SJ, 2014, TISSUE CELL, V46, P225, DOI 10.1016/j.tice.2014.05.002; Vrana NE, 2012, J TISSUE ENG REGEN M, V6, P280, DOI 10.1002/term.431; Wowk B, 2000, CRYOBIOLOGY, V40, P228, DOI 10.1006/cryo.2000.2243; Wusteman M, 2004, CRYOBIOLOGY, V48, P179, DOI 10.1016/j.cryobiol.2004.01.002; Yeh Y, 1996, CHEM REV, V96, P601, DOI 10.1021/cr950260c	38	19	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0123409	10.1371/journal.pone.0123409	http://dx.doi.org/10.1371/journal.pone.0123409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010144	Green Published, gold			2022-12-26	WOS:000355183900004
J	Zucca, S; Pasotti, L; Politi, N; Casanova, M; Mazzini, G; De Angelis, MGC; Magni, P				Zucca, Susanna; Pasotti, Lorenzo; Politi, Nicolo; Casanova, Michela; Mazzini, Giuliano; De Angelis, Maria Gabriella Cusella; Magni, Paolo			Multi-Faceted Characterization of a Novel LuxR-Repressible Promoter Library for Escherichia coli	PLOS ONE			English	Article							CELL-CELL COMMUNICATION; TUNING GENETIC-CONTROL; VIBRIO-FISCHERI; LOGIC GATES; QUORUM; EXPRESSION; CONSTRUCTION; BACTERIA; PARTS	The genetic elements regulating the natural quorum sensing (QS) networks of several microorganisms are widely used in synthetic biology to control the behaviour of single cells and engineered bacterial populations via ad-hoc constructed synthetic circuits. A number of novel engineering-inspired biological functions have been implemented and model systems have also been constructed to improve the knowledge on natural QS systems. Synthetic QS-based parts, such as promoters, have been reported in literature, to provide biological components with functions that are not present in nature, like modified induction logic or activation/repression by additional molecules. In this work, a library of promoters that can be repressed by the LuxR protein in presence of the QS autoinducer N-3-oxohexanoyl-L-homoserine lactone (AHL) was reported for Escherichia coli, to expand the toolkit of genetic parts that can be used to engineer novel synthetic QS-based systems. The library was constructed via polymerase chain reaction with highly constrained degenerate oligonucleotides, designed according to the consensus -35 and -10 sequences of a previously reported constitutive promoter library of graded strength, to maximize the probability of obtaining functional clones. All the promoters have a lux box between the -35 and -10 regions, to implement a LuxR-repressible behaviour. Twelve unique library members of graded strength (about 100-fold activity range) were selected to form the final library and they were characterized in several genetic contexts, such as in different plasmids, via different reporter genes, in presence of a LuxR expression cassette in different positions and in response to different AHL concentrations. The new obtained regulatory parts and corresponding data can be exploited by synthetic biologists to implement an artificial AHL-dependent repression of transcription in genetic circuits. The target transcriptional activity can be selected among the available library members to meet the design specifications of the biological system.	[Zucca, Susanna; Pasotti, Lorenzo; Politi, Nicolo; Casanova, Michela; Magni, Paolo] Univ Pavia, Dipartimento Ingn Ind Informaz, I-27100 Pavia, Italy; [Zucca, Susanna; Pasotti, Lorenzo; Politi, Nicolo; Casanova, Michela; De Angelis, Maria Gabriella Cusella; Magni, Paolo] Univ Pavia, Ctr Ingn Tissutale, I-27100 Pavia, Italy; [Mazzini, Giuliano] Univ Pavia, IGM CNR, I-27100 Pavia, Italy	University of Pavia; University of Pavia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Pavia	Magni, P (corresponding author), Univ Pavia, Dipartimento Ingn Ind Informaz, Via Palestro 3, I-27100 Pavia, Italy.	paolo.magni@unipv.it	Pasotti, Lorenzo/AAA-5215-2022; Zucca, Susanna/G-7087-2018	Pasotti, Lorenzo/0000-0002-5431-3083; Zucca, Susanna/0000-0001-8465-632X; Magni, Paolo/0000-0002-8931-4676; Cusella De Angelis, Maria Gabriella/0000-0003-2642-3346	University of Pavia	University of Pavia	This project was supported by the University of Pavia. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BL, 2014, ACS SYNTH BIOL, V3, P210, DOI 10.1021/sb400068z; Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Blount BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033279; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Egland KA, 2000, J BACTERIOL, V182, P805, DOI 10.1128/JB.182.3.805-811.2000; Ellis T, 2009, NATURE PROTOCOL EXCH, DOI [10.1038/nprot.2009.79, DOI 10.1038/NPROT.2009.79]; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Fischer CR, 2006, TRENDS BIOTECHNOL, V24, P55, DOI 10.1016/j.tibtech.2005.12.001; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; GRAY KM, 1994, J BACTERIOL, V176, P3076, DOI 10.1128/JB.176.10.3076-3080.1994; Hammer K, 2006, TRENDS BIOTECHNOL, V24, P53, DOI 10.1016/j.tibtech.2005.12.003; Haseltine EL, 2008, APPL ENVIRON MICROB, V74, P437, DOI 10.1128/AEM.01688-07; Kelly JR, 2009, J BIOL ENG, V3, DOI [10.1186/1754-1611-3-20, DOI 10.1186/1754-1611-3-20]; Knight T., 2003, IDEMPOTENT VECTOR DE; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Martin L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007569; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Mutalik VK, 2013, NAT METHODS, V10, P354, DOI [10.1038/NMETH.2404, 10.1038/nmeth.2404]; Nistala Goutam J, 2010, J Biol Eng, V4, P4, DOI 10.1186/1754-1611-4-4; Pai A, 2014, ACS SYNTH BIOL, V3, P220, DOI 10.1021/sb400069w; Pai A, 2012, P NATL ACAD SCI USA, V109, P19810, DOI 10.1073/pnas.1211072109; Pasotti L, 2013, MODELING METHODOLOGY, P545, DOI [10.1016/B978-0-12-411557-6.00023-9, DOI 10.1016/B978-0-12-411557-6.00023-9]; Pasotti L, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/369681; Pasotti L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039407; Pasotti L, 2011, BIOTECHNOL J, V6, P784, DOI 10.1002/biot.201100080; Pasotti L, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-8; Payne S, 2014, ADV BIOCHEM ENG BIOT, V146, P97, DOI 10.1007/10_2013_249; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Politi N, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-5; Prindle A, 2012, NATURE, V481, P39, DOI 10.1038/nature10722; Riccione KA, 2012, ACS SYNTH BIOL, V1, P389, DOI 10.1021/sb300044r; Salis HM, 2011, METHOD ENZYMOL, V498, P19, DOI 10.1016/B978-0-12-385120-8.00002-4; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Shong J, 2014, ACS SYNTH BIOL, V3, P238, DOI 10.1021/sb4000965; Shong J, 2013, ACS SYNTH BIOL, V2, P568, DOI 10.1021/sb4000433; Sifri CD, 2008, CLIN INFECT DIS, V47, P1070, DOI 10.1086/592072; Solem C, 2002, APPL ENVIRON MICROB, V68, P2397, DOI 10.1128/AEM.68.5.2397-2403.2002; Stevens AM, 1997, J BACTERIOL, V179, P557, DOI 10.1128/jb.179.2.557-562.1997; Swift S, 1996, TRENDS BIOCHEM SCI, V21, P214; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Wang BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1516; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491; Zucca S, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-12; Zucca S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S11	55	14	14	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126264	10.1371/journal.pone.0126264	http://dx.doi.org/10.1371/journal.pone.0126264			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010244	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900025
J	Wagner, S; Liepelt, S; Gerber, S; Petit, RJ				Wagner, Stefanie; Liepelt, Sascha; Gerber, Sophie; Petit, Remy J.			Within-Range Translocations and Their Consequences in European Larch	PLOS ONE			English	Article							GENETIC DIFFERENTIATION; DNA VARIATION; HYBRIDIZATION; CONSERVATION; REINTRODUCTION; INFERENCE; PROGRAM; MARKERS; HYBRIDS; FLOW	In contrast to biological invasions, translocations of individuals within a species range are understudied, due to difficulties in systematically detecting them. This results in limited knowledge about the corresponding processes and uncertainties regarding the status of extant populations. European larch, a forest tree whose fragmented native distribution is restricted to the Alps and to other Central European mountains, has been massively planted for at least 300 years. Here we focus on the genetic characterization of translocations having taken place within its native range. Microsatellite variation at 13 nuclear loci and sequence data of two mitochondrial DNA fragments were analyzed on the basis of a comprehensive range-wide population sample. Two complementary methods (GENECLASS and STRUCTURE) were used to infer translocation events based on nuclear data whereas mitochondrial data were used for validation of these inferences. Using GENECLASS, we found translocation events in a majority of populations. Additional cases of translocation and many instances of admixture were identified using STRUCTURE, thanks to the clear-cut ancestral genetic structure detected in this species. In particular, a strong divide between Alpine and Central European populations, also apparent at mitochondrial markers, helped uncover details on translocation events and related processes. Translocations and associated admixture events were found to be heterogeneously distributed across the species range, with a particularly high frequency in Central Europe. Furthermore, translocations frequently involved multiple geographic sources, some of which were over-represented. Our study illustrates the importance of range-wide investigations for tracing translocations back to their origins and for revealing some of their consequences. It provides some first clues for developing suitable conservation and management strategies.	[Wagner, Stefanie; Gerber, Sophie; Petit, Remy J.] INRA, BIOGECO UMR1202, F-33610 Cestas, France; [Wagner, Stefanie; Gerber, Sophie; Petit, Remy J.] Univ Bordeaux, BIOGECO, UMR 1202, F-33400 Talence, France; [Liepelt, Sascha] Univ Marburg, Fac Biol, Conservat Biol, D-35032 Marburg, Germany	INRAE; UDICE-French Research Universities; Universite de Bordeaux; Philipps University Marburg	Petit, RJ (corresponding author), INRA, BIOGECO UMR1202, F-33610 Cestas, France.	petit@pierroton.inra.fr	Petit, Remy/AAD-9078-2019; Liepelt, Sascha/H-1047-2011	Liepelt, Sascha/0000-0001-6529-2882; Wagner, Stefanie/0000-0003-1737-9021; Petit, Remy J/0000-0002-4809-1453	German Research Foundation (DFG); EU	German Research Foundation (DFG)(German Research Foundation (DFG)); EU(European Commission)	This project was funded by the German Research Foundation (DFG) and by the EU-funded project Trees4Future.	Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; [Anonymous], 2008, CONCISE ENCY STAT, P344; Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Bradshaw RHW, 2004, FOREST ECOL MANAG, V197, P203, DOI 10.1016/j.foreco.2004.05.025; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Deguilloux MF, 2003, MOL ECOL, V12, P1629, DOI 10.1046/j.1365-294X.2003.01836.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fourchy P, 1952, ECOLOGIE MELEZE PART, P137; Geburek T, 1997, BIODIVERS CONSERV, V6, P1639, DOI 10.1023/A:1018330906758; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Gum B, 2006, J FISH BIOL, V69, P115, DOI 10.1111/j.1095-8649.2006.01264.x; Hufford KM, 2003, TRENDS ECOL EVOL, V18, P147, DOI 10.1016/S0169-5347(03)00002-8; Hufford MB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003477; Huntley B., 1983, ATLAS PRESENT POLLEN; International Union for Conservation of Nature (IUCN), 1987, IUCN POS STAT TRANSL; Konig A.O., 2005, CONSERVATION MANAGEM, P275; Konig AO, 2002, FOREST ECOL MANAG, V156, P147, DOI 10.1016/S0378-1127(01)00640-5; Koskela J, 2013, BIOL CONSERV, V157, P39, DOI 10.1016/j.biocon.2012.07.023; Lang G, 1994, QUARTARE VEGETATIONS; Largiader Carlo R., 2007, V193, P275; Lefevre F, 2004, FOREST ECOL MANAG, V197, P257, DOI 10.1016/j.foreco.2004.05.017; Lefevre F, 2002, DOSSIERS ENV INRA, V21, P125, DOI [10.1016/j.annder.2008.07.055, DOI 10.1016/J.ANNDER.2008.07.055]; Lewandowski A, 1997, PLANT SYST EVOL, V204, P65, DOI 10.1007/BF00982532; Lowe A, 2004, FORESTRY, V77, P335, DOI 10.1093/forestry/77.4.335; Marie AD, 2012, CAN J FISH AQUAT SCI, V69, P884, DOI 10.1139/F2012-027; Munch E, 1936, FORSTW CENTR, V58, P641; Neville HM, 2011, N AM J FISH MANAGE, V31, P1163, DOI 10.1080/02755947.2011.647252; Nielsen EE, 2006, MOL ECOL NOTES, V6, P971, DOI 10.1111/j.1471-8286.2006.01433.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pluess AR, 2011, MOL ECOL, V20, P473, DOI 10.1111/j.1365-294X.2010.04972.x; Polezhaeva MA, 2010, MOL ECOL, V19, P1239, DOI 10.1111/j.1365-294X.2010.04552.x; Pons O, 1996, GENETICS, V144, P1237; Pritchard JK, 2000, GENETICS, V155, P945; Rosenthal DM, 2008, MOL ECOL, V17, P4657, DOI 10.1111/j.1365-294X.2008.03844.x; RUBNER K, 1953, PFLANZENGEOGRAPHISCH; Saltonstall K, 2011, CONSERV GENET, V12, P1027, DOI 10.1007/s10592-011-0205-1; Schober R, 1949, LARCHE ERTRAGSKUNDLI, DOI [10.1007/s10147-012-0476-7, DOI 10.1007/S10147-012-0476-7]; Schober R, 1985, NEUE ERGEBNISSE 2 IN, P1; Schober R, 1977, VOM 2 INT LARCHENPRO; Scribner KT, 2000, REV FISH BIOL FISHER, V10, P293, DOI 10.1023/A:1016642723238; Seddon PJ, 2010, RESTOR ECOL, V18, P796, DOI 10.1111/j.1526-100X.2010.00724.x; Semerikov VL, 2006, CONSERV GENET, V7, P621, DOI 10.1007/s10592-005-9059-8; Sjogren P, 2008, REV PALAEOBOT PALYNO, V149, P208, DOI 10.1016/j.revpalbo.2007.12.006; Sjogren P, 2008, REV PALAEOBOT PALYNO, V152, P200, DOI 10.1016/j.revpalbo.2008.05.003; Tschermak L, 1935, NATURLICHE VERBREITU; Wagner S, 2012, MOL ECOL RESOUR, V12, P717, DOI 10.1111/j.1755-0998.2012.03139.x; Winkler KA, 2011, MOL ECOL, V20, P456, DOI 10.1111/j.1365-294X.2010.04961.x	54	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127516	10.1371/journal.pone.0127516	http://dx.doi.org/10.1371/journal.pone.0127516			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000791	Green Published, Green Submitted, gold			2022-12-26	WOS:000354931700065
J	Haley, JM; Thackeray, JT; Thorn, SL; DaSilva, JN				Haley, James M.; Thackeray, James T.; Thorn, Stephanie L.; DaSilva, Jean N.			Cardiac beta-Adrenoceptor Expression Is Reduced in Zucker Diabetic Fatty Rats as Type-2 Diabetes Progresses	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; FAILING HUMAN-HEART; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; DIASTOLIC DYSFUNCTION; DOWN-REGULATION; NERVOUS-SYSTEM; H-3 CGP-12177; RECEPTOR; FAILURE	Objectives Reduced cardiac beta-adrenoceptor (beta-AR) expression and cardiovascular dysfunction occur in models of hyperglycemia and hypoinsulinemia. Cardiac beta-AR expression in type-2 diabetes models of hyperglycemia and hyperinsulinemia, remain less clear. This study investigates cardiac beta-AR expression in type-2 diabetic Zucker diabetic fatty (ZDF) rats. Methods Ex vivo biodistribution experiments with [H-3]CGP12177 were performed in Zucker lean (ZL) and ZDF rats at 10 and 16 weeks of age as diabetes develops. Blood glucose, body mass, and diet consumption were measured. Western blotting of beta-AR subtypes was completed in parallel. Echocardiography was performed at 10 and 16 weeks to assess systolic and diastolic function. Fasted plasma insulin, free fatty acids (FFA), leptin and fed-state insulin were also measured. Results At 10 weeks, myocardial [H-3]CGP12177 was normal in hyperglycemic ZDF (17 +/- 4.1mM) compared to ZL, but reduced 16-25% at 16 weeks of age as diabetes and hyperglycemia (22 +/- 2.4mM) progressed. Reduced beta-AR expression not apparent at 10 weeks also developed by 16 weeks of age in ZDF brown adipose tissue. In the heart, Western blotting at 10 weeks indicated normal beta(1)-AR (98 +/- 9%), reduced beta(2)-AR (76 +/- 10%), and elevated beta(3)-AR (108 +/- 6). At 16 weeks, beta(1)-AR expression became reduced (69 +/- 16%), beta(2)-AR expression decreased further (68 +/- 14%), and beta(3)-AR remained elevated, similar to 10 weeks (112 +/- 9%). While HR was reduced at 10 and 16 weeks in ZDF rats, no significant changes were observed in diastolic or systolic function. Conclusions Cardiac beta-AR are reduced over 6 weeks of sustained hyperglycemia in type-2 diabetic ZDF rats. This indicates cardiac [H-3]CGP12177 retention and beta(1)- and beta(2)-AR expression are inversely correlated with the progression of type-2 diabetes.	[Haley, James M.; Thackeray, James T.; Thorn, Stephanie L.; DaSilva, Jean N.] Univ Ottawa, Cardiac PET Ctr, Inst Heart, Ottawa, ON K1Y 4W7, Canada; [Haley, James M.; Thackeray, James T.; Thorn, Stephanie L.; DaSilva, Jean N.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [DaSilva, Jean N.] Univ Montreal, Univ Montreal Hosp Res Ctr CRCHUM, Dept Radiol Radio Oncol & Nucl Med, Montreal, PQ H2X 0A9, Canada; [Thackeray, James T.] Hannover Med Sch, Dept Nucl Med, D-30625 Hannover, Germany; [Thorn, Stephanie L.] Yale Univ, Sch Med, Yale Translat Res Imaging Ctr, New Haven, CT 06520 USA	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; Universite de Montreal; Hannover Medical School; Yale University	DaSilva, JN (corresponding author), Univ Ottawa, Cardiac PET Ctr, Inst Heart, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.	jean.dasilva@umontreal.ca	Thackeray, James/R-9350-2018; Thorn, Stephanie/AAD-6988-2022		Heart and Stroke Foundation of Canada [NA6477]; Heart and Stroke Foundation of Canada Program Grant in Molecular Function and Imaging [PRG6242]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Heart and Stroke Foundation of Canada Program Grant in Molecular Function and Imaging	Heart and Stroke Foundation of Canada Grant in Aid #NA6477 (http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.2796497/k.BF8B/Home.htm). Heart and Stroke Foundation of Canada Program Grant in Molecular Function and Imaging #PRG6242 (http://www.heartandstroke.com/site/c.ikIQLcMWJtE/b.2796497/k.BF8B/Home.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azad N, 1999, J DIABETES COMPLICAT, V13, P307, DOI 10.1016/S1056-8727(99)00062-8; BRISTOW MR, 1992, J CLIN INVEST, V89, P803, DOI 10.1172/JCI115659; Bugger H, 2009, DIS MODEL MECH, V2, P454, DOI 10.1242/dmm.001941; Carmena R, 2005, AM HEART J, V150, P859, DOI 10.1016/j.ahj.2005.04.027; Chareonthaitawee P, 2007, AM HEART J, V154, P567, DOI 10.1016/j.ahj.2007.04.042; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Daniels A, 2012, EUR J HEART FAIL, V14, P193, DOI 10.1093/eurjhf/hfr166; Diabet Control Complications Trial Res Grp, 1998, DIABETOLOGIA, V41, P416; Dincer UD, 2001, DIABETES, V50, P455, DOI 10.2337/diabetes.50.2.455; Etgen GJ, 2000, METABOLISM, V49, P684, DOI 10.1016/S0026-0495(00)80049-9; Falcao-Pires I, 2012, HEART FAIL REV, V17, P325, DOI 10.1007/s10741-011-9257-z; FOWLER MB, 1986, CIRCULATION, V74, P1290, DOI 10.1161/01.CIR.74.6.1290; Fredersdorf S, 2004, CARDIOVASC PATHOL, V13, P11, DOI 10.1016/S1054-8807(03)00109-1; From AM, 2010, J AM COLL CARDIOL, V55, P300, DOI 10.1016/j.jacc.2009.12.003; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Grueneberger JM, 2013, VIDEOSURGERY MINIINV, V8, P130, DOI 10.5114/wiitm.2011.32925; HADDAD C, 1987, CAN J PHYSIOL PHARM, V65, P1928, DOI 10.1139/y87-300; Hu FB, 2002, DIABETES CARE, V25, P1129, DOI 10.2337/diacare.25.7.1129; Huang L, 2001, J BIOL CHEM, V276, P6343, DOI 10.1074/jbc.M009795200; Jacobson AF, 2010, J AM COLL CARDIOL, V55, P2212, DOI 10.1016/j.jacc.2010.01.014; Lymperopoulos A, 2013, CIRC RES, V113, P739, DOI 10.1161/CIRCRESAHA.113.300308; Marsh SA, 2007, AM J PHYSIOL-HEART C, V293, pH292, DOI 10.1152/ajpheart.01362.2006; Matsuda N, 1999, BIOCHEM PHARMACOL, V58, P881, DOI 10.1016/S0006-2952(99)00164-1; MUZZIN P, 1992, FEBS LETT, V298, P162, DOI 10.1016/0014-5793(92)80046-J; Naya M, 2009, J NUCL MED, V50, P220, DOI 10.2967/jnumed.108.056341; Nemanich S, 2013, OBESITY, V21, P2522, DOI 10.1002/oby.20378; Nikolaev VO, 2010, SCIENCE, V327, P1653, DOI 10.1126/science.1185988; Oltman CL, 2009, DIABETES OBES METAB, V11, P223, DOI 10.1111/j.1463-1326.2008.00924.x; Paolillo S, 2013, DIABETES CARE, V36, P2395, DOI 10.2337/dc12-2147; Puigserver P, 1996, MOL CELL ENDOCRINOL, V117, P7, DOI 10.1016/0303-7207(95)03727-6; Ren J, 2004, J ENDOCRINOL, V181, P1, DOI 10.1677/joe.0.1810001; Rozec B, 2009, J AM COLL CARDIOL, V53, P1532, DOI 10.1016/j.jacc.2008.11.057; Sarkozy M, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-16; Straznicky NE, 2013, J CLIN ENDOCR METAB, V98, pE227, DOI 10.1210/jc.2012-3277; Straznicky NE, 2012, DIABETES, V61, P2506, DOI 10.2337/db12-0138; Thackeray JT, 2013, J NUCL CARDIOL, V20, P845, DOI 10.1007/s12350-013-9759-2; Thackeray JT, 2011, NUCL MED BIOL, V38, P1059, DOI 10.1016/j.nucmedbio.2011.04.002; Timofeyev V, 2013, CIRC RES, V112, P1567, DOI 10.1161/CIRCRESAHA.112.300370; Toblli JE, 2010, J HYPERTENS, V28, P1007, DOI 10.1097/HJH.0b013e328337598c; van den Brom CE, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-39; VANWAARDE A, 1992, EUR J PHARMACOL, V222, P107, DOI 10.1016/0014-2999(92)90469-K; VANWAARDE A, 1995, J CHROMATOGR B, V663, P361, DOI 10.1016/0378-4347(94)00442-8; Young LH, 2009, JAMA-J AM MED ASSOC, V301, P1547, DOI 10.1001/jama.2009.476	43	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127581	10.1371/journal.pone.0127581	http://dx.doi.org/10.1371/journal.pone.0127581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996498	Green Submitted, Green Published, gold			2022-12-26	WOS:000356444000077
J	Liu, ZJ; Zhou, W; Lv, JL; He, P; Liang, GQ; Jin, H				Liu, Zhanjun; Zhou, Wei; Lv, Jialong; He, Ping; Liang, Guoqing; Jin, Hui			A Simple Evaluation of Soil Quality of Waterlogged Purple Paddy Soils with Different Productivities	PLOS ONE			English	Article							CATION-EXCHANGE CAPACITY; MICROBIAL COMMUNITIES; FLY-ASH; INDICATORS; CARBON; RICE; FERTILIZATION; ACIDIFICATION; COMPOST; SYSTEM	Evaluation of soil quality can be crucial for designing efficient farming systems and ensuring sustainable agriculture. The present study aimed at evaluating the quality of waterlogged purple paddy soils with different productivities in Sichuan Basin. The approach involved comprehensive analyses of soil physical and chemical properties, as well as enzyme activities and microbial community structure measured by phospholipid fatty acid analysis (PLFA). A total of 36 soil samples were collected from four typical locations, with 12 samples representing high productivity purple paddy soil (HPPS), medium productivity purple paddy soil (MPPS) and low productivity purple paddy soil (LPPS), respectively. Most measured soil properties showed significant differences (P <= 0.05) among HPPS, MPPS and LPPS. Pearson correlation analysis and principal component analysis were used to identify appropriate soil quality indicators. A minimum data set (MDS) including total nitrogen (TN), available phosphorus (AP), acid phosphatase (ACP), total bacteria (TB) and arbuscular mycorrhizal fungi was established and accounted for 82.1% of the quality variation among soils. A soil quality index (SQI) was developed based on the MDS method, whilst HPPS, MPPS and LPPS received mean SQI scores of 0.725, 0.536 and 0.425, respectively, with a ranking of HPPS > MPPS > LPPS. HPPS showed relatively good soil quality characterized by optimal nutrient availability, enzymatic and microbial activities, but the opposite was true of LPPS. Low levels of TN, AP and soil microbial activities were considered to be the major constraints limiting the productivity in LPPS. All soil samples collected were rich in available N, K, Si and Zn, but deficient in available P, which may be the major constraint for the studied regions. Managers in our study area should employ more appropriate management in the LPPS to improve its rice productivity, and particularly to any potential limiting factor.	[Liu, Zhanjun; Zhou, Wei; He, Ping; Liang, Guoqing] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Crop Nutr & Fertilizat, Minist Agr, Beijing 100081, Peoples R China; [Liu, Zhanjun; Lv, Jialong] Northwest Univ A&F, Coll Resource & Environm Sci, Yangling 712100, Peoples R China; [Jin, Hui] Shanxi Acad Agr Sci, Inst Agr Resources & Econ, Taiyuan 030006, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Shanxi Agricultural University	Zhou, W (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Crop Nutr & Fertilizat, Minist Agr, Beijing 100081, Peoples R China.	wzhou@caas.ac.cn; gqliang@caas.ac.cn	He, Ping/HGD-5389-2022		Special Fund for Agro-scientific Research in the Public Interest [201003016]; Ministry of Agriculture of the People's Republic of China; National Basic Research Program of China [2013CB127405]; Ministry of Science and Technology of the People's Republic of China	Special Fund for Agro-scientific Research in the Public Interest; Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs); National Basic Research Program of China(National Basic Research Program of China); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	The Special Fund for Agro-scientific Research in the Public Interest (201003016); Funding institution: Ministry of Agriculture of the People's Republic of China; WZ received the funding. The earmarked fund for China Agriculture Research System, and the National Basic Research Program of China (2013CB127405); Funding institution: Ministry of Science and Technology of the People's Republic of China; WZ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alef K., 1995, METHODS APPL SOIL MI, DOI DOI 10.1016/B978-0-12-513840-6.X5014-9; Andrews SS, 2001, ECOL APPL, V11, P1573, DOI 10.1890/1051-0761(2001)011[1573:DASQAT]2.0.CO;2; Andrews SS, 2002, AGRON J, V94, P12, DOI 10.2134/agronj2002.0012; Aparicio V, 2007, SOIL TILL RES, V96, P155, DOI 10.1016/j.still.2007.05.006; BEARE MH, 1993, GEODERMA, V56, P87, DOI 10.1016/0016-7061(93)90102-Q; Bhardwaj AK, 2011, AGR ECOSYST ENVIRON, V140, P419, DOI 10.1016/j.agee.2011.01.005; Boluda R, 2014, EUR J SOIL SCI, V65, P286, DOI 10.1111/ejss.12123; Bonanomi G, 2014, AGR ECOSYST ENVIRON, V192, P1, DOI 10.1016/j.agee.2014.03.029; Bonanomi G, 2011, APPL SOIL ECOL, V47, P184, DOI 10.1016/j.apsoil.2010.12.007; Bouma J, 2002, AGR ECOSYST ENVIRON, V88, P129, DOI 10.1016/S0167-8809(01)00248-1; Brejda JJ, 2000, SOIL SCI SOC AM J, V64, P2115, DOI 10.2136/sssaj2000.6462115x; Bruun TB, 2006, AGR ECOSYST ENVIRON, V113, P139, DOI 10.1016/j.agee.2005.09.012; Costa AL, 2007, J SOIL SEDIMENT, V7, P418, DOI 10.1065/jss2007.02.211; Cregan P., 1998, AGR ENV IMPERATIVE, P98; D'Hose T, 2014, APPL SOIL ECOL, V75, P189, DOI 10.1016/j.apsoil.2013.11.013; DeForest JL, 2009, SOIL BIOL BIOCHEM, V41, P1180, DOI 10.1016/j.soilbio.2009.02.029; Dong WY, 2014, APPL SOIL ECOL, V84, P140, DOI 10.1016/j.apsoil.2014.06.007; Doran JW, 2000, APPL SOIL ECOL, V15, P3, DOI 10.1016/S0929-1393(00)00067-6; Doran JW, 2002, AGR ECOSYST ENVIRON, V88, P119, DOI 10.1016/S0167-8809(01)00246-8; DORAN JW, 1994, SSSA SPEC PUBL, P3; Fu B, 2009, PROG NAT SCI-MATER, V19, P1613, DOI 10.1016/j.pnsc.2009.07.001; Gao Y, 2014, J HYDROL, V511, P692, DOI 10.1016/j.jhydrol.2014.02.005; Ge TD, 2012, J FOOD AGRIC ENVIRON, V10, P930; Giacometti C, 2014, APPL SOIL ECOL, V75, P80, DOI 10.1016/j.apsoil.2013.10.009; Giacometti C, 2013, APPL SOIL ECOL, V64, P32, DOI 10.1016/j.apsoil.2012.10.002; Griffiths BS, 2010, APPL SOIL ECOL, V46, P43, DOI 10.1016/j.apsoil.2010.06.012; Gu YunFu, 2008, Agricultural Sciences in China, V7, P1481, DOI 10.1016/S1671-2927(08)60406-X; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hao Q., 2013, ACTA ECOL SIN, V33, P260; He YR, 2003, PURPLE SOIL IN CHINA; Jiang Y. F, 2001, CHINESE J SOIL SCI, V5, P209; Kamprath EJ, 1980, ROLE PHOSPHORUS AGR, P443; Lal R, 2004, GEODERMA, V123, P1, DOI 10.1016/j.geoderma.2004.01.032; Lee H, 2006, BIORESOURCE TECHNOL, V97, P1490, DOI 10.1016/j.biortech.2005.06.020; Li P, 2013, SOIL TILL RES, V126, P112, DOI 10.1016/j.still.2012.07.011; Li ZM, 1991, PURPLE SOIL IN CHINA; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; Liebig MA, 2001, AGRON J, V93, P313, DOI 10.2134/agronj2001.932313x; Lima ACR, 2013, APPL SOIL ECOL, V64, P194, DOI 10.1016/j.apsoil.2012.12.009; Liu ZJ, 2014, SOIL TILL RES, V140, P74, DOI 10.1016/j.still.2014.02.010; Liu Zheng, 1994, Scientia Agricultura Sinica, V27, P30; Lu SG, 2014, CATENA, V114, P37, DOI 10.1016/j.catena.2013.10.014; Ma JF, 2006, TRENDS PLANT SCI, V11, P392, DOI 10.1016/j.tplants.2006.06.007; McLean E., 1983, METHODS SOIL ANAL PA, V9, P199, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C12; Moeskops B, 2010, APPL SOIL ECOL, V45, P112, DOI 10.1016/j.apsoil.2010.03.005; Pajares S, 2011, LAND DEGRAD DEV, V22, P373, DOI 10.1002/ldr.992; Qi YB, 2009, GEODERMA, V149, P325, DOI 10.1016/j.geoderma.2008.12.015; Rahmanipour F, 2014, ECOL INDIC, V40, P19, DOI 10.1016/j.ecolind.2013.12.003; Sinoga JDR, 2012, CATENA, V94, P17, DOI 10.1016/j.catena.2011.06.004; Shukla MK, 2006, SOIL TILL RES, V87, P194, DOI 10.1016/j.still.2005.03.011; State Soil Survey Service of China (SSSC), 1996, DAT NAT SOIL SURV CH, P103; Tang L, 2009, ENVIRON ENG SCI, V26, P137, DOI 10.1089/ees.2007.0238; Tesfahunegn GB, 2011, GEODERMA, V163, P209, DOI 10.1016/j.geoderma.2011.04.016; Tong DL, 2012, J ENVIRON SCI, V24, P682, DOI 10.1016/S1001-0742(11)60832-2; Wang HJ, 2009, SOIL TILL RES, V105, P300, DOI 10.1016/j.still.2008.08.010; Wang ShuYing, 2008, Agricultural Sciences in China, V7, P1235, DOI 10.1016/S1671-2927(08)60170-4; Wang YF, 2013, J SOIL SEDIMENT, V13, P12, DOI 10.1007/s11368-012-0578-x; Willekens K, 2014, APPL SOIL ECOL, V82, P61, DOI 10.1016/j.apsoil.2014.05.009; Wu YP, 2009, GEODERMA, V150, P171, DOI 10.1016/j.geoderma.2009.02.003; Zhou ZF, 2014, EUR J SOIL BIOL, V60, P24, DOI 10.1016/j.ejsobi.2013.10.003; Zhu Qi-qing, 1981, China, Institute of Soil Science, Academia Sinica: Proceedings of Symposium on Paddy Soil., P635	61	8	8	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127690	10.1371/journal.pone.0127690	http://dx.doi.org/10.1371/journal.pone.0127690			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25997107	Green Submitted, Green Published, gold			2022-12-26	WOS:000356444000083
J	Requena-Mendez, A; Aldasoro, E; Munoz, J; Moore, DAJ				Requena-Mendez, Ana; Aldasoro, Edelweiss; Munoz, Jose; Moore, David A. J.			Robust and Reproducible Quantification of the Extent of Chest Radiographic Abnormalities (And It's Free!)	PLOS ONE			English	Article							TUBERCULOSIS; SYSTEM	Rationale Objective, reproducible quantification of the extent of abnormalities seen on a chest radiograph would improve the user-friendliness of a previously proposed severity scoring system for pulmonary tuberculosis and could be helpful in monitoring response to therapy, including in clinical trials. Methods In this study we report the development and evaluation of a simple tool using free image editing software (GIMP) to accurately and reproducibly quantify the area of affected lung on the chest radiograph of tuberculosis patients. As part of a pharmacokinetic study in Lima, Peru, a chest radiograph was performed on patients with pulmonary tuberculosis and this was subsequently photographed using a digital camera. The GIMP software was used by two independent and trained readers to estimate the extent of affected lung (expressed as a percentage of total lung area) in each radiograph and the resulting radiographic SCORE. Results 56 chest radiographs were included in the reading analysis. The Intraclass correlation coefficient (ICC) between the 2 observers was 0.977 (p<0.001) for the area of lung affected and was 0.955 (p<0.001) for the final score; and the kappa coefficient of Interobserver agreement for both the area of lung affected and the score were 0.9 (p<0.001) and 0.86 (p<0.001) respectively. Conclusions This high level of between-observer agreement suggests that this freely available software could constitute a simple and useful tool for robust evaluation of individual and serial chest radiographs.	[Requena-Mendez, Ana; Aldasoro, Edelweiss; Munoz, Jose] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Moore, David A. J.] London Sch Hyg & Trop Med, TB Ctr, London WC1, England	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of London; London School of Hygiene & Tropical Medicine	Requena-Mendez, A (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.	ana.requena@cresib.cat	Gutierrez, Jose Muñoz/AAH-6954-2020; Gutiérrez, José/GSJ-1846-2022; Gutiérrez, Jose Muñoz/X-5917-2018; Aldasoro, Edelweiss/AAV-2048-2020; Mendez, Ana Requena/U-5158-2018	Gutierrez, Jose Muñoz/0000-0002-0945-1735; Gutiérrez, Jose Muñoz/0000-0002-0945-1735; Mendez, Ana Requena/0000-0002-4422-241X; Fernandez, Ivette/0000-0001-5179-0477	British Society of Antimicrobial Chemotherapy [GA2011-04P]	British Society of Antimicrobial Chemotherapy	This work was supported by the British Society of Antimicrobial Chemotherapy (GA2011-04P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balabanova Y, 2005, BMJ-BRIT MED J, V331, P379, DOI 10.1136/bmj.331.7513.379; Breuninger M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106381; Buckens CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071204; Den Boon S, 2005, INT J TUBERC LUNG D, V9, P1088; Jaeger S, 2013, QUANT IMAG MED SURG, V3, P89, DOI 10.3978/j.issn.2223-4292.2013.04.03; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Ralph AP, 2010, THORAX, V65, P863, DOI 10.1136/thx.2010.136242; Schilham AMR, 2006, MED IMAGE ANAL, V10, P247, DOI 10.1016/j.media.2005.09.003; SIMON G, 1966, BMJ-BRIT MED J, V2, P491, DOI 10.1136/bmj.2.5512.491; Zellweger JP, 2006, INT J TUBERC LUNG D, V10, P1123; 1970, CHEST, V58, P57	11	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0128044	10.1371/journal.pone.0128044	http://dx.doi.org/10.1371/journal.pone.0128044			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996917	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000356444000101
J	Rukke, BA; Aak, A; Edgar, KS				Rukke, Bjorn Arne; Aak, Anders; Edgar, Kristin Skarsfjord			Mortality, Temporary Sterilization, and Maternal Effects of Sublethal Heat in Bed Bugs	PLOS ONE			English	Article							CIMEX-LECTULARIUS; CARBON-DIOXIDE; HETEROPTERA CIMICIDAE; SHOCK RESPONSE; CHEMICAL LURE; TEMPERATURE; EVOLUTIONARY; RESISTANCE; TOLERANCE; WOLBACHIA	Adult bed bugs were exposed to the sublethal temperatures 34.0 degrees C, 35.5 degrees C, 37.0 degrees C, 38.5 degrees C, or 40.0 degrees C for 3, 6, or 9 days. The two uppermost temperatures induced 100% mortality within 9 and 2 days, respectively, whereas 34.0 degrees C had no observable effect. The intermediate temperatures interacted with time to induce a limited level of mortality but had distinct effects on fecundity, reflected by decreases in the number of eggs produced and hatching success. Adult fecundity remained low for up to 40 days after heat exposure, and the time until fertility was restored correlated with the temperature-sum experienced during heat exposure. Three or 6 days of parental exposure to 38.5 degrees C significantly lowered their offspring's feeding and moulting ability, which consequently led to a failure to continue beyond the third instar. Eggs that were deposited at 22.0 degrees C before being exposed to 37.0 degrees C for 3 or 6 days died, whereas eggs that were exposed to lower temperatures were not significantly affected. Eggs that were deposited during heat treatment exhibited high levels of mortality also at 34.0 degrees C and 35.5 degrees C. The observed negative effects of temperatures between 34.0 degrees C and 40.0 degrees C may be utilized in pest management, and sublethal temperature exposure ought to be further investigated as an additional tool to decimate or potentially eradicate bed bug populations. The effect of parental heat exposure on progeny demonstrates the importance of including maternal considerations when studying bed bug environmental stress reactions.	[Rukke, Bjorn Arne; Aak, Anders; Edgar, Kristin Skarsfjord] Norwegian Inst Publ Hlth, Dept Pest Control, NO-0456 Oslo, Norway	Norwegian Institute of Public Health (NIPH)	Rukke, BA (corresponding author), Norwegian Inst Publ Hlth, Dept Pest Control, Lovisenberggata 8,POB 4404, NO-0456 Oslo, Norway.	bjorn.arne.rukke@fhi.no						Aak A, 2014, MED VET ENTOMOL, V28, P50, DOI 10.1111/mve.12015; Aak A, 2014, PHYSIOL ENTOMOL, V39, P199, DOI 10.1111/phen.12062; Akhtar Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075626; Anderson JF, 2009, MED VET ENTOMOL, V23, P99, DOI 10.1111/j.1365-2915.2008.00790.x; Anderson JF, 2012, J ECON ENTOMOL, V105, P1789, DOI 10.1603/EC12089; Balvin O, 2012, PARASITOL RES, V111, P457, DOI 10.1007/s00436-012-2862-5; Barbarin AM, 2012, J INVERTEBR PATHOL, V111, P82, DOI 10.1016/j.jip.2012.04.009; Benoit JB, 2009, MED VET ENTOMOL, V23, P418, DOI 10.1111/j.1365-2915.2009.00832.x; Benoit JB, 2007, AM J TROP MED HYG, V76, P987, DOI 10.4269/ajtmh.2007.76.987; Benoit Joshua B., 2011, Insects, V2, P151, DOI 10.3390/insects2020151; Benoit JB, 2011, P NATL ACAD SCI USA, V108, P8026, DOI 10.1073/pnas.1105195108; Benoit JB, 2009, J MED ENTOMOL, V46, P572, DOI 10.1603/033.046.0323; Boggs CL, 2009, FUNCT ECOL, V23, P27, DOI 10.1111/j.1365-2435.2009.01527.x; Bowler K, 2008, BIOL REV, V83, P339, DOI 10.1111/j.1469-185X.2008.00046.x; Chang K. P., 1975, Symposia Soc exp Biol, VNo. 29, P407; CHANG KP, 1974, J INVERTEBR PATHOL, V23, P333, DOI 10.1016/0022-2011(74)90098-6; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Davies TGE, 2012, MED VET ENTOMOL, V26, P241, DOI 10.1111/j.1365-2915.2011.01006.x; Doggett SL, 2012, CLIN MICROBIOL REV, V25, P164, DOI 10.1128/CMR.05015-11; FIELDS PG, 1992, J STORED PROD RES, V28, P89, DOI 10.1016/0022-474X(92)90018-L; Fountain T, 2014, MOL ECOL, V23, P1071, DOI 10.1111/mec.12673; Harrison JF, 2012, ECOL ENVIRON PHYSIOL, P1, DOI 10.1093/acprof:oso/9780199225941.001.0001; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; JANISCH Ernst, 1935, Zeitschrift fur Parasitenkunde, V7, P408, DOI 10.1007/BF02122040; Janisch E., 1933, Zeitschrift fuer Parasitenkunde, V5, P460, DOI 10.1007/BF02121361; Jia FX, 2009, ENVIRON ENTOMOL, V38, P1365, DOI 10.1603/022.038.0503; Johnson CG, 1941, J HYG-CAMBRIDGE, V41, P345, DOI 10.1017/S0022172400012560; Kells Stephen A, 2011, Insects, V2, P412, DOI 10.3390/insects2030412; Kells Stephen A., 2006, American Entomologist, V52, P109; Kilpinen O, 2011, PARASITOL RES, V109, P1461, DOI 10.1007/s00436-011-2423-3; Koganemaru R, 2013, PESTIC BIOCHEM PHYS, V106, P177, DOI 10.1016/j.pestbp.2013.05.005; KREBS RA, 1994, FUNCT ECOL, V8, P730, DOI 10.2307/2390232; Krebs RA, 1997, CELL STRESS CHAPERON, V2, P60, DOI 10.1379/1466-1268(1997)002<0060:DCOHOI>2.3.CO;2; Li YY, 2014, SYMBIOSIS, V62, P1, DOI 10.1007/s13199-014-0267-1; Mahroof R, 2005, J ECON ENTOMOL, V98, P626, DOI 10.1603/0022-0493-98.2.626; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Naylor RA, 2010, J ECON ENTOMOL, V103, P136, DOI 10.1603/EC09288; Nikoh N, 2014, P NATL ACAD SCI USA, V111, P10257, DOI 10.1073/pnas.1409284111; Omori N., 1941, Journal of the Medical Association of Formosa, V60, P555; Pereira RM, 2009, J ECON ENTOMOL, V102, P1182, DOI 10.1603/029.102.0342; Pinto L. J., 2007, BED BUG HDB COMPLETE; Polanco Andrea M., 2011, Insects, V2, P173, DOI 10.3390/insects2020173; Potter MF, 2006, PCT, V34, P44; Puckett RT, 2013, PEST MANAG SCI, V69, P1061, DOI 10.1002/ps.3467; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Reinhardt K, 2009, P NATL ACAD SCI USA, V106, P21743, DOI 10.1073/pnas.0905347106; Rezende EL, 2014, FUNCT ECOL, V28, P799, DOI 10.1111/1365-2435.12268; Salazar R, 2015, AM J TROP MED HYG, V92, P331, DOI 10.4269/ajtmh.14-0483; SAXENA BP, 1992, J STORED PROD RES, V28, P67, DOI 10.1016/0022-474X(92)90031-K; Silbermann R, 2000, EVOLUTION, V54, P2038; SINGH N, 2012, PSYCHE-J ENTOMOL, DOI DOI 10.1155/2012/; Singh N, 2014, J ECON ENTOMOL, V107, P2163, DOI 10.1603/EC14328; Singh N, 2013, J ECON ENTOMOL, V106, P1802, DOI 10.1603/EC13075; Sorensen JG, 2007, J BIOSCIENCES, V32, P447, DOI 10.1007/s12038-007-0044-x; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Suchy James T., 2011, Insects, V2, P22, DOI 10.3390/insects2010022; Susser SR, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000838; Szyndler MW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0174; Terblanche J., 2013, INSECTS STRUCTURE FU, P588; Tsilingiris PT, 2008, ENERG CONVERS MANAGE, V49, P1098, DOI 10.1016/j.enconman.2007.09.015; Usinger R. L., 1966, MONOGRAPH CIMICIDAE; Wang CL, 2013, J ECON ENTOMOL, V106, P347, DOI 10.1603/EC12259; Wang CL, 2009, J ECON ENTOMOL, V102, P1580, DOI 10.1603/029.102.0423; Wang CL, 2009, J MED ENTOMOL, V46, P566, DOI 10.1603/033.046.0322; Wernegreen JJ, 2012, CURR OPIN MICROBIOL, V15, P255, DOI 10.1016/j.mib.2012.02.001; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075923	66	16	17	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127555	10.1371/journal.pone.0127555	http://dx.doi.org/10.1371/journal.pone.0127555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996999	gold, Green Published, Green Submitted			2022-12-26	WOS:000356444000074
J	de Pina-Araujo, IIM; Delatorre, E; Guimaraes, ML; Morgado, MG; Bello, G				de Pina-Araujo, Isabel Ines M.; Delatorre, Edson; Guimaraes, Monick L.; Morgado, Mariza G.; Bello, Gonzalo			Origin and Population Dynamics of a Novel HIV-1 Subtype G Clade Circulating in Cape Verde and Portugal	PLOS ONE			English	Article							NORTH-CENTRAL NIGERIA; NAIVE PREGNANT-WOMEN; DRUG-RESISTANCE; HIGH PREVALENCE; MOLECULAR EPIDEMIOLOGY; OYO-STATE; TYPE-1; SEQUENCES; THERAPY; STRAINS	The human immunodeficiency virus type 1 (HIV-1) subtype G is the most prevalent and second most prevalent HIV-1 clade in Cape Verde and Portugal, respectively; but there is no information about the origin and spatiotemporal dispersal pattern of this HIV-1 clade circulating in those countries. To this end, we used Maximum Likelihood and Bayesian coalescent-based methods to analyze a collection of 578 HIV-1 subtype G pol sequences sampled throughout Portugal, Cape Verde and 11 other countries from West and Central Africa over a period of 22 years (1992 to 2013). Our analyses indicate that most subtype G sequences from Cape Verde (80%) and Portugal (95%) branched together in a distinct monophyletic cluster (here called G(CV-PT)). The G(CV-PT) clade probably emerged after a single migration of the virus out of Central Africa into Cape Verde between the late 1970s and the middle 1980s, followed by a rapid dissemination to Portugal a couple of years later. Reconstruction of the demographic history of the G(CV-PT) clade circulating in Cape Verde and Portugal indicates that this viral clade displayed an initial phase of exponential growth during the 1980s and 1990s, followed by a decline in growth rate since the early 2000s. Our data also indicate that during the exponential growth phase the G(CV-PT) clade recombined with a preexisting subtype B viral strain circulating in Portugal, originating the CRF14_BG clade that was later disseminated to Spain and Cape Verde. Historical and recent human population movements between Angola, Cape Verde and Portugal probably played a key role in the origin and dispersal of the G(CV-PT) and CRF14_BG clades.	[de Pina-Araujo, Isabel Ines M.] Univ Cabo Verde, Dept Ciencia & Tecnol, Praia, Santiago, Cape Verde; [Delatorre, Edson; Guimaraes, Monick L.; Morgado, Mariza G.; Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Bello, G (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, BR-21045900 Rio De Janeiro, Brazil.	gbellobr@gmail.com	Delatorre, Edson/J-8330-2015; Bentancor, Gonzalo Jose Bello/N-7377-2019; Bello, Gonzalo/E-6842-2013	Delatorre, Edson/0000-0002-5746-0820; Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; Monteiro de Pina Araujo, Isabel Ines/0000-0001-7766-1059	CAPES PEC-PG Program; FAPERJ; Public Health Service grant from CNPq [490468/2008-0, E-26/111.758/2012]	CAPES PEC-PG Program(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Public Health Service grant from CNPq	This work was sponsored by Public Health Service grants 490468/2008-0 and E-26/111.758/2012 from the CNPq. IIMPA was supported by a fellowship from the CAPES PEC-PG Program. ED is supported by a fellowship from the FAPERJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2011, AIDS RES HUM RETROV, V27, P803, DOI [10.1089/aid.2010.0312, 10.1089/AID.2010.0312]; Afonso JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042996; Agwale SM, 2002, VACCINE, V20, P2131, DOI 10.1016/S0264-410X(02)00059-2; Ajoge HO, 2012, AIDS RES HUM RETROV, V28, P115, DOI [10.1089/aid.2011.0115, 10.1089/AID.2011.0115]; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Archer J, 2007, AIDS, V21, P1693, DOI 10.1097/QAD.0b013e32825eabd0; Bartolo I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113626; Bartolo I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024130; Bartolo I, 2009, INFECT GENET EVOL, V9, P672, DOI 10.1016/j.meegid.2008.05.003; Bello G, 2012, INFECT GENET EVOL, V12, P1079, DOI 10.1016/j.meegid.2012.03.014; Carling J., 2004, POPUL SPACE PLACE, V10, P113; Chamberland A, 2012, SEX TRANSM INFECT, V88, P179, DOI 10.1136/sextrans-2011-050209; Chaplin B, 2011, AIDS RES HUM RETROV, V27, P71, DOI 10.1089/aid.2010.0050; Charpentier C, 2011, ANTIVIR THER, V16, P429, DOI 10.3851/IMP1754; Dagnra AY, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-30; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; de Pina-Araujo IIM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096201; Delatorre E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098908; Delatorre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072448; Delgado E, 2002, J ACQ IMMUN DEF SYND, V29, P536, DOI 10.1097/00126334-200204150-00016; Dias P, 2014, RELATORIO IMIGRACAO; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Esteves A, 2003, AIDS RES HUM RETROV, V19, P511, DOI 10.1089/088922203766774568; Esteves A, 2002, AIDS RES HUM RETROV, V18, P313, DOI 10.1089/088922202753519089; Faria NR, 2012, J GEN VIROL, V93, P889, DOI 10.1099/vir.0.038638-0; Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Imade GE, 2014, AIDS RES HUM RETROV, V30, P127, DOI [10.1089/aid.2013.0074, 10.1089/AID.2013.0074]; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mamadou S, 2002, AIDS RES HUM RETROV, V18, P723, DOI 10.1089/088922202760072357; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; Ojesina AI, 2006, AIDS RES HUM RETROV, V22, P770, DOI 10.1089/aid.2006.22.770; Oliveira V, 2012, AIDS RES HUM RETROV, V28, P510, DOI [10.1089/aid.2011.0174, 10.1089/AID.2011.0174]; Palma AC, 2007, INFECT GENET EVOL, V7, P391, DOI 10.1016/j.meegid.2007.01.009; Peeters M, 2000, AIDS RES HUM RETROV, V16, P315, DOI 10.1089/088922200309197; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2007, TRACER V1 6; Rambaut A., 2014, FIGTREE V14 TREE FIG; Sankale JL, 2007, AIDS RES HUM RETROV, V23, P1020, DOI 10.1089/aid.2006.0304; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yaotse DA, 2009, INFECT GENET EVOL, V9, P646, DOI 10.1016/j.meegid.2009.04.002	52	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127384	10.1371/journal.pone.0127384	http://dx.doi.org/10.1371/journal.pone.0127384			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993094	Green Submitted, Green Published, gold			2022-12-26	WOS:000354921400111
J	Liou, YR; Wang, YH; Lee, CY; Li, PC				Liou, Yu-Ren; Wang, Yu-Hsin; Lee, Chia-Ying; Li, Pai-Chi			Buoyancy-Activated Cell Sorting Using Targeted Biotinylated Albumin Microbubbles	PLOS ONE			English	Article							RADIATION FORCE; BREAST-CANCER; CD44; ULTRASOUND; SYSTEM; GROWTH; LINES	Cell analysis often requires the isolation of certain cell types. Various isolation methods have been applied to cell sorting, including florescence-activated cell sorting and magnetic-activated cell sorting. However, these conventional approaches involve exerting mechanical forces on the cells, thus risking cell damage. In this study we applied a novel isolation method called buoyancy-activated cell sorting, which involves using biotinylated albumin microbubbles (biotin-MBs) conjugated with antibodies (i.e., targeted biotin-MBs). Albumin MBs are widely used as contrast agents in ultrasound imaging due to their good biocompatibility and stability. For conjugating antibodies, biotin is conjugated onto the albumin MB shell via covalent bonds and the biotinylated antibodies are conjugated using an avidin-biotin system. The albumin microbubbles had a mean diameter of 2 mu m with a polydispersity index of 0.16. For cell separation, the MDA-MB-231 cells are incubated with the targeted biotin-MBs conjugated with anti-CD44 for 10 min, centrifuged at 10g for 1 min, and then allowed 1 hour at 4 degrees C for separation. The results indicate that targeted biotin-MBs conjugated with anti-CD44 antibodies can be used to separate MDA-MB-231 breast cancer cells; more than 90% of the cells were collected in the MB layer when the ratio of the MBs to cells was higher than 70:1. Furthermore, we found that the separating efficiency was higher for targeted biotin-MBs than for targeted avidin-incorporated albumin MBs (avidin-MBs), which is the most common way to make targeted albumin MBs. We also demonstrated that the recovery rate of targeted biotin-MBs was up to 88% and the sorting purity was higher than 84% for a a heterogenous cell population containing MDA-MB-231 cells (CD44(+)) and MDA-MB-453 cells (CD44(-)), which are classified as basal-like breast cancer cells and luminal breast cancer cells, respectively. Knowing that the CD44(+) is a commonly used cancer-stem- cell biomarker, our targeted biotin-MBs could be a potent tool to sort cancer stem cells from dissected tumor tissue for use in preclinical experiments and clinical trials.	[Liou, Yu-Ren; Wang, Yu-Hsin; Lee, Chia-Ying; Li, Pai-Chi] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Li, Pai-Chi] Natl Taiwan Univ, Dept Elect Engn, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Li, PC (corresponding author), Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan.	paichi@ntu.edu.tw		Wang, Yu-Hsin/0000-0001-5580-7766	Ministry of Science and Technology [NSC 100-2221-E-002 -146 -MY3]; National Health Research Institutes [NHRI-EX103- 10137EI]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institutes(National Health Research Institutes, Japan)	This research was supported through grants from Ministry of Science and Technology (NSC 100-2221-E-002 -146 -MY3, (http://www.most.gov.tw/ mp.aspx? mp=7)) and National Health Research Institutes (NHRI-EX103- 10137EI, (http://english.nhri.org.tw/NHRI_WEB/nhriw001Action.do)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter J, 2009, ULTRASOUND MED BIOL, V35, P976, DOI 10.1016/j.ultrasmedbio.2008.12.015; ANDO J, 1987, MICROVASC RES, V33, P62, DOI 10.1016/0026-2862(87)90007-0; Arlymae Rand GG, 2008, OPEN CLIN CHEM J, V1, P75; Bianchi DW, 1996, PRENATAL DIAG, V16, P289, DOI 10.1002/(SICI)1097-0223(199604)16:4<289::AID-PD843>3.3.CO;2-K; Biddle A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057314; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Chen YC, 2014, LAB CHIP, V14, P626, DOI 10.1039/c3lc90136j; Cheng KT, 2004, MOL IMAGING CONTRAST; Chuang YH, 2014, ULTRASOUND MED BIOL, V40, P765, DOI 10.1016/j.ultrasmedbio.2013.10.022; Chuang YH, 2013, IEEE T ULTRASON FERR, V60, P97, DOI 10.1109/TUFFC.2013.2541; Dayton P, 1999, ULTRASOUND MED BIOL, V25, P1195, DOI 10.1016/S0301-5629(99)00062-9; Dayton PA, 1999, IEEE T ULTRASON FERR, V46, P220, DOI 10.1109/58.741536; Feshitan JA, 2009, J COLLOID INTERF SCI, V329, P316, DOI 10.1016/j.jcis.2008.09.066; FRIEDEN E, 1975, J CHEM EDUC, V52, P754, DOI 10.1021/ed052p754; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; GRINSTAFF MW, 1991, P NATL ACAD SCI USA, V88, P7708, DOI 10.1073/pnas.88.17.7708; Grutzkau A, 2010, CYTOM PART A, V77A, P643, DOI 10.1002/cyto.a.20918; Hsu CH, 2010, 14 INT C MIN SYST CH; Klibanov AL, 2009, MED BIOL ENG COMPUT, V47, P875, DOI 10.1007/s11517-009-0498-0; Korpanty G, 2005, ULTRASOUND MED BIOL, V31, P1279, DOI 10.1016/j.ultrasmedbio.2005.06.001; Lindner JR, 1998, CIRCULATION, V98, P2187, DOI 10.1161/01.CIR.98.20.2187; Liu F, 2009, HEPATO-GASTROENTEROL, V56, P1163; Lu B, 1996, ANALYST, V121, pR29, DOI 10.1039/an996210029r; MACEY MG, 1988, MED LAB SCI, V45, P165; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Murohashi M, 2010, BRIT J CANCER, V102, P206, DOI 10.1038/sj.bjc.6605468; Olsson E, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-418; SCHMITZ B, 1994, EUR J HAEMATOL, V52, P267; Sequist LV, 2009, J THORAC ONCOL, V4, P281, DOI 10.1097/JTO.0b013e3181989565; Shi GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058017; Simberg D, 2009, J DRUG TARGET, V17, P392, DOI 10.1080/10611860902902797; Sirsi Shashank, 2009, Bubble Sci Eng Technol, V1, P3, DOI 10.1179/175889709X446507; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Stakenborg T, 2010, IEEE ENG MED BIO, P292, DOI 10.1109/IEMBS.2010.5627655; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Terry VH, 2009, VIROLOGY, V388, P294, DOI 10.1016/j.virol.2009.03.022; Tirino Virginia, 2012, Methods Mol Biol, V879, P513, DOI 10.1007/978-1-61779-815-3_32; Toma C, 2011, TISSUE ENG PT A, V17, P1457, DOI [10.1089/ten.tea.2010.0539, 10.1089/ten.TEA.2010.0539]; Tomlinson MJ, 2013, J TISSUE ENG, V4, DOI 10.1177/2041731412472690; VANKOOTEN TG, 1994, MED ENG PHYS, V16, P506, DOI 10.1016/1350-4533(94)90077-9; Wang YH, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.045001; Wink T, 1997, ANALYST, V122, pR43, DOI 10.1039/a606964i; WU JY, 1995, J BIOTECHNOL, V43, P81, DOI 10.1016/0168-1656(95)00133-7; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	46	13	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125036	10.1371/journal.pone.0125036	http://dx.doi.org/10.1371/journal.pone.0125036			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993512	Green Submitted, gold, Green Published			2022-12-26	WOS:000354921400024
J	Mohamed, HG; Idris, SB; Mustafa, M; Ahmed, MF; Astrom, AN; Mustafa, K; Ibrahim, SO				Mohamed, Hasaan G.; Idris, Shaza B.; Mustafa, Manal; Ahmed, Mutaz F.; Astrom, Anne N.; Mustafa, Kamal; Ibrahim, Salah O.			Impact of Chronic Periodontitis on Levels of Glucoregulatory Biomarkers in Gingival Crevicular Fluid of Adults with and without Type 2 Diabetes	PLOS ONE			English	Article							LEPTIN LEVELS; HEALTH; MELLITUS; INFLAMMATION; SECRETION; VISFATIN; GHRELIN; PLASMA; EXPRESSION; DIAGNOSIS	The relationship between diabetes and periodontal disease is bidirectional, but information about the effect of chronic periodontitis on the levels of the glucoregulatory biomarkers locally in gingival crevicular fluid (GCF) is limited. The aim of this study was to compare the levels of 10 glucoregulatory biomarkers in GCF, firstly in subjects with type 2 diabetes (T2DM) presenting with and without chronic periodontitis and secondly, in subjects without diabetes, with and without chronic periodontitis. The material comprised a total of 152 subjects, stratified as: 54 with T2DM and chronic periodontitis (G1), 24 with T2DM (G2), 30 with chronic periodontitis (G3) and 44 without T2DM or periodontitis (G4). The levels of the biomarkers were measured using multiplex biometric immunoassays. Periodontal pocket depths were recorded in mm. Subsets G1 and G2 and subsets G3 and G4 were compared independently. Among T2DM subjects, GIP, GLP-1 and glucagon were significantly up-regulated in G1 compared to G2. Moreover, there were no statistical differences between the two groups regarding C-peptide, insulin, ghrelin, leptin and PAI-1. Comparisons among individuals without T2DM revealed significantly lower amounts of C-peptide and ghrelin in G3 than in G4. The number of sites with pocket depth >= 4mm correlated negatively with C-peptide (Spearman's correlation co-efficient: -0.240, P < 0.01) and positively with GIP and visfatin (Spearman's correlation co-efficient: 0.255 and 0.241, respectively, P < 0.01). The results demonstrate that chronic periodontitis adversely influences the GCF levels of glucoregulatory biomarkers, as it is associated with disturbed levels of biomarkers related to the onset of T2DM and its medical complications.	[Mohamed, Hasaan G.; Idris, Shaza B.; Astrom, Anne N.; Mustafa, Kamal; Ibrahim, Salah O.] Univ Bergen, Fac Med & Dent, Dept Clin Dent, Bergen, Norway; [Mohamed, Hasaan G.] Univ Khartoum, Fac Dent, Dept Oral Rehabil, Khartoum, Sudan; [Mustafa, Manal] Oral Hlth Competence Ctr Western Norway, Bergen, Norway; [Ahmed, Mutaz F.] Hamad Med Corp, Doha, Qatar	University of Bergen; University of Khartoum; Hamad Medical Corporation	Mohamed, HG (corresponding author), Univ Bergen, Fac Med & Dent, Dept Clin Dent, Bergen, Norway.	hmo003@uib.no	Mustafa, Kamal/ABD-4458-2020		Norwegian State Educational Loan Fund	Norwegian State Educational Loan Fund	This study was funded by the Norwegian State Educational Loan Fund.	AHMED AM, 2012, EGYPT ACAD J BIOL S, V4, P107; Almaghlouth A., 2014, CLIN ORAL INVEST, V18, P1, DOI DOI 10.1007/S00784-014-1333-Z; Alssema M, 2013, EUR J ENDOCRINOL, V169, P421, DOI 10.1530/EJE-13-0487; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; Armitage GC, 2004, PERIODONTOL 2000, V34, P9, DOI 10.1046/j.0906-6713.2002.003421.x; Calanna S, 2013, DIABETOLOGIA, V56, P965, DOI 10.1007/s00125-013-2841-0; Chowta M N, 2010, Indian J Nephrol, V20, P25, DOI 10.4103/0971-4065.62093; Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757; D'Alessio D, 2011, DIABETES OBES METAB, V13, P126, DOI 10.1111/j.1463-1326.2011.01449.x; Demmer RT, 2008, DIABETES CARE, V31, P1373, DOI 10.2337/dc08-0026; Eke PI, 2012, J PERIODONTOL, V83, P1449, DOI 10.1902/jop.2012.110664; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Georgiou HM, 2008, ACTA DIABETOL, V45, P157, DOI 10.1007/s00592-008-0037-8; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Hanes PJ, 2010, EPMA J, V1, P101, DOI 10.1007/s13167-010-0016-3; HOEKSTRA JBL, 1982, DIABETES CARE, V5, P438, DOI 10.2337/diacare.5.4.438; Houser B, 2012, ARCH PHYSIOL BIOCHEM, V118, P192, DOI 10.3109/13813455.2012.705301; Hujoel PP, 2001, J PERIODONTAL RES, V36, P48, DOI 10.1034/j.1600-0765.2001.00011.x; Ide R, 2011, J DENT RES, V90, P41, DOI 10.1177/0022034510381902; International Diabetes Federation, 2014, IDF DIAB ATL UPD POS; Johnson RB, 2001, J PERIODONTOL, V72, P1254, DOI 10.1902/jop.2000.72.9.1254; Kang SM, 2000, YONSEI MED J, V41, P68, DOI 10.3349/ymj.2000.41.1.68; Karmiris K, 2008, MOL NUTR FOOD RES, V52, P855, DOI 10.1002/mnfr.200700050; Karthikeyan BV, 2007, J PERIODONTAL RES, V42, P300, DOI 10.1111/j.1600-0765.2006.00948.x; Katagiri S, 2012, J DIABETES INVEST, V3, P402, DOI 10.1111/j.2040-1124.2012.00209.x; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Lamster IB, 2008, J AM DENT ASSOC, V139, p19S, DOI 10.14219/jada.archive.2008.0363; Lamster IB, 2007, ANN NY ACAD SCI, V1098, P216, DOI 10.1196/annals.1384.027; Leng SX, 2008, J GERONTOL A-BIOL, V63, P879, DOI 10.1093/gerona/63.8.879; Liu MY, 2005, CLIN CHEM, V51, P1102, DOI 10.1373/clinchem.2004.047084; Lopez R, 2011, EUR J ORAL SCI, V119, P455, DOI 10.1111/j.1600-0722.2011.00875.x; Lyon CJ, 2003, AM J MED, V115, P62, DOI 10.1016/j.amjmed.2003.08.014; Mealey BL, 2000, PERIODONTOL, V44, P127, DOI DOI 10.1111/J.1600-0757.2006.00193.X; Merchant AT, 2011, PEDIATR DIABETES, V12, P529, DOI 10.1111/j.1399-5448.2010.00736.x; Mohamed HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082158; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Ohta K, 2011, J DENT RES, V90, P1286, DOI 10.1177/0022034511420431; Petropoulos G, 2004, J CLIN PERIODONTOL, V31, P390, DOI 10.1111/j.1600-051X.2004.00489.x; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Pradeep AR, 2011, J PERIODONTOL, V82, P1314, DOI 10.1902/jop.2011.100690; Pulkkinen L, 2010, INT J PEPTIDES; Schneider DJ, 2012, DIABETES CARE, V35, P1961, DOI 10.2337/dc12-0638; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Sima C, 2013, CURR DIABETES REP, V13, P445, DOI 10.1007/s11892-013-0367-y; Tatti P, 2001, ENDOCRINE, V15, P305, DOI 10.1385/ENDO:15:3:305; Taylor G W, 2001, Ann Periodontol, V6, P99, DOI 10.1902/annals.2001.6.1.99; Thunell DH, 2010, J PERIODONTAL RES, V45, P148, DOI 10.1111/j.1600-0765.2009.01204.x; VAGUE P, 1986, METABOLISM, V35, P250, DOI 10.1016/0026-0495(86)90209-X; Yilmaz G, 2014, ODONTOLOGY, V102, P59, DOI 10.1007/s10266-012-0100-3; Zhong Y, 2007, J CLIN PERIODONTOL, V34, P285, DOI 10.1111/j.1600-051X.2007.01057.x	51	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127660	10.1371/journal.pone.0127660	http://dx.doi.org/10.1371/journal.pone.0127660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993052	Green Published, gold, Green Submitted			2022-12-26	WOS:000354921400129
J	Paradis, EG; Pinilla, LT; Holder, BP; Abed, Y; Boivin, G; Beauchemin, CAA				Paradis, Eric G.; Pinilla, Lady Tatiana; Holder, Benjamin P.; Abed, Yacine; Boivin, Guy; Beauchemin, Catherine A. A.			Impact of the H275Y and I223V Mutations in the Neuraminidase of the 2009 Pandemic Influenza Virus In Vitro and Evaluating Experimental Reproducibility	PLOS ONE			English	Article							A H1N1 VIRUS; OSELTAMIVIR-RESISTANT; UNITED-STATES; FITNESS; INFECTION; CELLS; PHARMACOKINETICS; SENSITIVITY; WIDESPREAD; INHIBITORS	The 2009 pandemic H1N1 (H1N1pdm09) influenza virus is naturally susceptible to neuraminidase (NA) inhibitors, but mutations in the NA protein can cause oseltamivir resistance. The H275Y and I223V amino acid substitutions in the NA of the H1N1pdm09 influenza strain have been separately observed in patients exhibiting oseltamivir-resistance. Here, we apply mathematical modelling techniques to compare the fitness of the wild-type H1N1pdm09 strain relative to each of these two mutants. We find that both the H275Y and I223V mutations in the H1N1pdm09 background significantly lengthen the duration of the eclipse phase (by 2.5 h and 3.6 h, respectively), consistent with these NA mutations delaying the release of viral progeny from newly infected cells. Cells infected by H1N1pdm09 virus carrying the I223V mutation display a disadvantageous, shorter infectious lifespan (17 h shorter) than those infected with the wild-type or MUT-H275Y strains. In terms of compensating traits, the H275Y mutation in the H1N1pdm09 background results in increased virus infectiousness, as we reported previously, whereas the I223V exhibits none, leaving it overall less fit than both its wild-type counterpart and the MUT-H275Y strain. Using computer simulated competition experiments, we determine that in the presence of oseltamivir at doses even below standard therapy, both the MUT-H275Y and MUT-I223V dominate their wild-type counterpart in all aspects, and the MUT-H275Y outcompetes the MUT-I223V. The H275Y mutation should therefore be more commonly observed than the I223V mutation in circulating H1N1pdm09 strains, assuming both mutations have a similar impact or no significant impact on between-host transmission. We also show that mathematical modelling offers a relatively inexpensive and reliable means to quantify inter-experimental variability and assess the reproducibility of results.	[Paradis, Eric G.; Holder, Benjamin P.; Beauchemin, Catherine A. A.] Ryerson Univ, Dept Phys, Toronto, ON, Canada; [Pinilla, Lady Tatiana; Abed, Yacine; Boivin, Guy] CHUQ CHUL, Infect Dis Res Ctr, Quebec City, PQ, Canada; [Pinilla, Lady Tatiana; Abed, Yacine; Boivin, Guy] Univ Laval, Quebec City, PQ, Canada	Toronto Metropolitan University; Laval University; Laval University	Beauchemin, CAA (corresponding author), Ryerson Univ, Dept Phys, Toronto, ON, Canada.	cbeau@ryerson.ca	Beauchemin, Catherine AA/G-4619-2011	Beauchemin, Catherine AA/0000-0003-0599-0069; Boivin, Guy/0000-0003-3027-4662	Canadian Institutes for Health Research [111071]; Ontario Ministry of Research and Innovation (CAAB)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research and Innovation (CAAB)	This study was supported by a grant from the Canadian Institutes for Health Research (www.cihr-irsc.gc.ca; funding reference number 111071) (GB and CAAB) and an Early Researcher Award from the Ontario Ministry of Research and Innovation (CAAB). The computational aspects of this work were made possible by the facilities of the Shared Hierarchical Academic Research Computing Network (SHARCNET, www.sharcnet.ca) and Compute/Calcul Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Brookes DW, 2011, J ANTIMICROB CHEMOTH, V66, P466, DOI 10.1093/jac/dkq486; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Casadevall A, 2010, INFECT IMMUN, V78, P4972, DOI 10.1128/IAI.00908-10; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P969; Drummond Chris, 2009, P 4 WORKSH EV METH M; Eshaghi A, 2011, EMERG INFECT DIS, V17, P1472, DOI 10.3201/eid1708.102004; Florez-Vargas O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101131; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Goodman J, 2010, COMM APP MATH COM SC, V5, P65, DOI 10.2140/camcos.2010.5.65; Graitcer SB, 2011, EMERG INFECT DIS, V17, P255, DOI 10.3201/eid1702.101724; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Handel A, 2007, PLOS COMPUT BIOL, V3, P2456, DOI 10.1371/journal.pcbi.0030240; Hatakeyama S, 2005, J CLIN MICROBIOL, V43, P4139, DOI 10.1128/JCM.43.8.4139-4146.2005; He G, 1999, CLIN PHARMACOKINET, V37, P471, DOI 10.2165/00003088-199937060-00003; Holder BP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S10; Holder BP, 2011, AUTOIMMUNITY, V44, P282, DOI 10.3109/08916934.2011.523267; Hong Seung-Dok, 2011, Chonnam Med J, V47, P127, DOI 10.4068/cmj.2011.47.2.127; Hurt AC, 2012, J INFECT DIS, V206, P148, DOI 10.1093/infdis/jis337; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kelso A, 2012, NAT MED, V18, P1470, DOI 10.1038/nm.2954; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; LeGoff J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037095; Lowenstein PR, 2009, CURR GENE THER, V9, P368, DOI 10.2174/156652309789753392; Lukens S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1019; Marcus PI, 2009, J VIROL, V83, P8122, DOI 10.1128/JVI.02680-08; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Okomo-Adhiambo M, 2010, VIRUSES-BASEL, V2, P2269, DOI 10.3390/v2102269; Pinilla LT, 2012, J VIROL, V86, P10651, DOI 10.1128/JVI.07244-11; Pizzorno A, 2012, ANTIMICROB AGENTS CH, V56, P1208, DOI 10.1128/AAC.05994-11; Pizzorno A, 2011, J INFECT DIS, V203, P25, DOI 10.1093/infdis/jiq010; Renaud C, 2010, TRANSPL INFECT DIS, V12, P513, DOI 10.1111/j.1399-3062.2010.00582.x; Renaud C, 2011, EMERG INFECT DIS, V17, P653, DOI 10.3201/eid1704.101429; ROUX L, 1991, ADV VIRUS RES, V40, P181; Schentag JJ, 2007, J CLIN PHARMACOL, V47, P689, DOI 10.1177/0091270007299761; Smith AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003238; Souza TML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080081; Storms AD, 2012, EMERG INFECT DIS, V18, P308, DOI 10.3201/eid1802.111466; van der Vries E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002276; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; Wang B, 2010, ANTIVIR RES, V87, P16, DOI 10.1016/j.antiviral.2010.04.002; Wong DDY, 2012, J VIROL, V86, P10558, DOI 10.1128/JVI.00985-12; You Y, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl175	48	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126115	10.1371/journal.pone.0126115	http://dx.doi.org/10.1371/journal.pone.0126115			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992792	gold, Green Published, Green Submitted			2022-12-26	WOS:000354921400054
J	Rodriguez-Reyna, TS; Mercado-Velazquez, P; Yu, N; Alosco, S; Ohashi, M; Lebedeva, T; Cruz-Lagunas, A; Nunez-Alvarez, C; Cabiedes-Contreras, J; Vargas-Alarcon, G; Granados, J; Zuniga, J; Yunis, E				Rodriguez-Reyna, Tatiana S.; Mercado-Velazquez, Pamela; Yu, Neng; Alosco, Sharon; Ohashi, Marina; Lebedeva, Tatiana; Cruz-Lagunas, Alfredo; Nunez-Alvarez, Carlos; Cabiedes-Contreras, Javier; Vargas-Alarcon, Gilberto; Granados, Julio; Zuniga, Joaquin; Yunis, Edmond			HLA Class I and II Blocks Are Associated to Susceptibility, Clinical Subtypes and Autoantibodies in Mexican Systemic Sclerosis (SSc) Patients	PLOS ONE			English	Article							DNA TOPOISOMERASE-I; HLA-DQB1 1ST DOMAIN; ANTICENTROMERE ANTIBODY; JAPANESE PATIENTS; DISEASE SEVERITY; ETHNIC-GROUPS; SCLERODERMA; HAPLOTYPES; FEATURES; ALLELES	Introduction Human leukocyte antigen (HLA) polymorphism studies in Systemic Sclerosis (SSc) have yielded variable results. These studies need to consider the genetic admixture of the studied population. Here we used our previously reported definition of genetic admixture of Mexicans using HLA class I and II DNA blocks to map genetic susceptibility to develop SSc and its complications. Methods We included 159 patients from a cohort of Mexican Mestizo SSc patients. We performed clinical evaluation, obtained SSc-associated antibodies, and determined HLA class I and class II alleles using sequence-based, high-resolution techniques to evaluate the contribution of these genes to SSc susceptibility, their correlation with the clinical and autoantibody profile and the prevalence of Amerindian, Caucasian and African alleles, blocks and haplotypes in this population. Results Our study revealed that class I block HLA-C*12:03-B*18:01 was important to map susceptibility to diffuse cutaneous (dc) SSc, HLA-C*07:01-B*08:01 block to map the susceptibility role of HLA-B*08:01 to develop SSc, and the C*07:02-B*39:05 and C*07:02-B*39:06 blocks to map the protective role of C*07: 02 in SSc. We also confirmed previous associations of HLA-DRB1*11:04 and -DRB1*01 to susceptibility to develop SSc. Importantly, we mapped the protective role of DQB1*03:01 using three Amerindian blocks. We also found a significant association for the presence of anti-Topoisomerase I antibody with HLA-DQB1*04:02, present in an Amerindian block (DRB1*08:02-DQB1*04:02), and we found several alleles associated to internal organ damage. The admixture estimations revealed a lower proportion of the Amerindian genetic component among SSc patients. Conclusion This is the first report of the diversity of HLA class I and II alleles and haplotypes Mexican patients with SSc. Our findings suggest that HLA class I and class II genes contribute to the protection and susceptibility to develop SSc and its different clinical presentations as well as different autoantibody profiles in Mexicans.	[Rodriguez-Reyna, Tatiana S.; Mercado-Velazquez, Pamela; Nunez-Alvarez, Carlos; Cabiedes-Contreras, Javier] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico; [Yu, Neng; Alosco, Sharon; Ohashi, Marina; Lebedeva, Tatiana] Amer Red Cross Northeast Div, HLA Lab, Dedham, MA USA; [Cruz-Lagunas, Alfredo; Zuniga, Joaquin] Inst Nacl Enfermedades Respiratorias Ismael Cosio, Dept Immunol, Mexico City, DF, Mexico; [Vargas-Alarcon, Gilberto] Inst Nacl Cardiol Ignacio Chavez, Basic & Technol Res Subdirect, Mexico City, DF, Mexico; [Granados, Julio] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Transplant Dept, Mexico City, DF, Mexico; [Yunis, Edmond] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol, Boston, MA 02115 USA; [Yunis, Edmond] Harvard Univ, Sch Med, Dana Farber Canc Inst, AIDS, Boston, MA 02115 USA; [Yunis, Edmond] Harvard Univ, Sch Med, Boston, MA USA	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; American Red Cross; National Institute of Cardiology - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Zuniga, J (corresponding author), Inst Nacl Enfermedades Respiratorias Ismael Cosio, Dept Immunol, Mexico City, DF, Mexico.	joazu@yahoo.com; eyunis@partners.org	Reyna, Tatiana Sofía Rodríguez/ABB-7864-2020	Reyna, Tatiana Sofía Rodríguez/0000-0002-5799-5016; Vargas-Alarcon, Gilberto/0000-0001-7916-5163; CRUZ-LAGUNAS, ALFREDO/0000-0001-5487-5919; Zuniga, Joaquin/0000-0002-7143-0281	Mexican Council of Science and Technology (CONACYT) [SALUD-2013-1-202576]; Research Funds of the National Institute of Respiratory Diseases Ismael Cosio Villegas, Mexico City, Mexico	Mexican Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Research Funds of the National Institute of Respiratory Diseases Ismael Cosio Villegas, Mexico City, Mexico	This work was supported by the Mexican Council of Science and Technology (CONACYT), [Grant number SALUD-2013-1-202576], www.conacyt.mx; and by the Research Funds of the National Institute of Respiratory Diseases Ismael Cosio Villegas, Mexico City, Mexico, www.iner.salud.gob.mx.	Aggarwal R, 2009, ARTHRITIS RHEUM-US, V60, P1112, DOI 10.1002/art.24409; ALARCONSEGOVIA D, 1989, J RHEUMATOL, V16, P328; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Arnett FC, 1996, ARTHRITIS RHEUM-US, V39, P1151, DOI 10.1002/art.1780390712; Arnett FC, 2010, ANN RHEUM DIS, V69, P822, DOI 10.1136/ard.2009.111906; Azzouz DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036870; Barquera R, 2008, MOL IMMUNOL, V45, P1171, DOI 10.1016/j.molimm.2007.07.042; Beretta L, 2012, RHEUMATOLOGY, V51, P52, DOI 10.1093/rheumatology/ker335; Cao K, 2004, TISSUE ANTIGENS, V63, P293, DOI 10.1111/j.0001-2815.2004.00192.x; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Cavazzana I, 2008, LUPUS, V17, P727, DOI 10.1177/0961203308089442; Domsic RT, 2012, SCLERODERMA: FROM PATHOGENESIS TO COMPREHENSIVE MANAGEMENT, P45, DOI 10.1007/978-1-4419-5774-0_6; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falkner D, 1998, ARTHRITIS RHEUM, V41, P74; Fertig N, 2009, ARTHRIT RHEUM-ARTHR, V61, P958, DOI 10.1002/art.24586; Garcia-Ortiz JE, 2006, TISSUE ANTIGENS, V68, P135, DOI 10.1111/j.1399-0039.2006.00636.x; Gilchrist FC, 2001, GENES IMMUN, V2, P76, DOI 10.1038/sj.gene.6363734; Gladman DD, 2005, J RHEUMATOL, V32, P1481; Gorlova O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002178; He DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106939; Hollenbach JA, 2001, HUM IMMUNOL, V62, P378, DOI 10.1016/S0198-8859(01)00212-9; Hu PQ, 2003, ARTHRITIS RHEUM, V48, P1363, DOI 10.1002/art.10977; Koenig M, 2008, ARTHRITIS RHEUM-US, V58, P3902, DOI 10.1002/art.24038; Kuwana M, 1999, INTERNAL MED, V38, P336, DOI 10.2169/internalmedicine.38.336; KUWANA M, 1995, ANN RHEUM DIS, V54, P983, DOI 10.1136/ard.54.12.983; Kuwana M, 1999, ARTHRITIS RHEUM-US, V42, P465, DOI 10.1002/1529-0131(199904)42:3<465::AID-ANR11>3.0.CO;2-Y; KUWANA M, 1993, J CLIN INVEST, V91, P1399, DOI 10.1172/JCI116343; KUWANA M, 1993, J CLIN INVEST, V92, P1296, DOI 10.1172/JCI116703; Kuwana M, 2003, J RHEUMATOL, V30, P2392; Lebedeva TV, 2011, TISSUE ANTIGENS, V77, P247, DOI 10.1111/j.1399-0039.2010.01616.x; Loubiere LS, 2005, RHEUMATOLOGY, V44, P318, DOI 10.1093/rheumatology/keh489; Louthrenoo W, 2013, RHEUMATOL INT, V33, P2069, DOI 10.1007/s00296-013-2686-3; Mahler M, 2007, AUTOIMMUN REV, V6, P432, DOI 10.1016/j.autrev.2007.01.013; MAYES MD, 2004, SYSTEMIC SCLEROSIS, P1; Medsger TA, 2003, CLIN EXP RHEUMATOL, V21, pS42; Mitri GM, 2003, ARTHRITIS RHEUM-US, V48, P203, DOI 10.1002/art.10760; MOREL PA, 1995, HUM IMMUNOL, V42, P35, DOI 10.1016/0198-8859(94)00078-5; MOREL PA, 1994, HUM IMMUNOL, V40, P101, DOI 10.1016/0198-8859(94)90054-X; OKANO Y, 1993, ANN INTERN MED, V119, P1005, DOI 10.7326/0003-4819-119-10-199311150-00007; REVEILLE JD, 1992, J CLIN INVEST, V89, P1208, DOI 10.1172/JCI115704; REVEILLE JD, 1992, J CLIN INVEST, V90, P973, DOI 10.1172/JCI115974; Reveille JD, 2001, SEMIN ARTHRITIS RHEU, V30, P332, DOI 10.1053/sarh.2001.20268; Robinson J, 2001, NUCLEIC ACIDS RES, V29, P210, DOI 10.1093/nar/29.1.210; Rodriguez-Reyna TS, 2011, AUTOIMMUNITY, V44, P576, DOI 10.3109/08916934.2011.592886; Sharif R, 2011, J RHEUMATOL, V38, P1622, DOI 10.3899/jrheum.110071; Simeon CP, 2009, J RHEUMATOL, V36, P2733, DOI 10.3899/jrheum.090377; Spinola H, 2002, ANN HUM GENET, V66, P285, DOI [10.1046/j.1469-1809.2002.00118.x, 10.1017/S0003480002001185]; TAKEUCHI F, 1994, J RHEUMATOL, V21, P857; Tikly M, 2004, TISSUE ANTIGENS, V63, P487, DOI 10.1111/j.0001-2815.2004.00199.x; Wang J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087451, 10.1371/journal.pone.0107012]; Wang JL, 2003, GENETICS, V164, P747; Williams J, 2005, ARTHRITIS RHEUM-US, V52, pS590; Yunis EJ, 2003, TISSUE ANTIGENS, V62, P1, DOI 10.1034/j.1399-0039.2003.00098.x; Yunis EJ, 2005, ENCY MOL CELL BIOL M, V13, P191; Zhou XD, 2013, INT J IMMUNOPATH PH, V26, P747, DOI 10.1177/039463201302600318; Zuniga J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074442	56	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126727	10.1371/journal.pone.0126727	http://dx.doi.org/10.1371/journal.pone.0126727			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993664	Green Published, Green Submitted, gold			2022-12-26	WOS:000354921400074
J	Saeki, I; Yamasaki, T; Tanabe, N; Iwamoto, T; Matsumoto, T; Urata, Y; Hidaka, I; Ishikawa, T; Takami, T; Yamamoto, N; Uchida, K; Terai, S; Sakaida, I				Saeki, Issei; Yamasaki, Takahiro; Tanabe, Norikazu; Iwamoto, Takuya; Matsumoto, Toshihiko; Urata, Yohei; Hidaka, Isao; Ishikawa, Tsuyoshi; Takami, Taro; Yamamoto, Naoki; Uchida, Koichi; Terai, Shuji; Sakaida, Isao			A New Therapeutic Assessment Score for Advanced Hepatocellular Carcinoma Patients Receiving Hepatic Arterial Infusion Chemotherapy	PLOS ONE			English	Article							GAMMA-CARBOXY PROTHROMBIN; ALPHA-FETOPROTEIN RESPONSE; CLINICAL-OUTCOMES; INTERFERON-ALPHA; STAGING-SYSTEM; TUMOR-MARKERS; 5-FLUOROURACIL; CISPLATIN; JAPAN; CLASSIFICATION	Background & Aims Hepatic arterial infusion chemotherapy (HAIC) is an option for treating advanced hepatocellular carcinoma (HCC). Because of the poor prognosis in HAIC non-responders, it is important to identify patients who may benefit from continuous HAIC treatment; however, there are currently no therapeutic assessment scores for this identification. Therefore, we aimed to establish a new therapeutic assessment score for such patients. Methods We retrospectively analyzed 90 advanced HCC patients with elevated baseline alpha-fetoprotein (AFP) and/or des-gamma-carboxy prothrombin (DCP) levels and analyzed various parameters for their possible use as predictors of response and survival. AFP and DCP responses were assessed after half a course of HAIC (2 weeks); a positive-response was defined as a reduction of >= 20% from baseline. Results Multivariate analysis identified DCP response (odds ratio 16.03, p < 0.001) as an independent predictor of treatment response. In multivariate analysis, Child-Pugh class A (hazard ratio [HR] 1.99, p = 0.018), AFP response (HR 2.17, p = 0.007), and DCP response (HR 1.90, p = 0.030) were independent prognostic predictors. We developed an Assessment for Continuous Treatment with HAIC (ACTH) score, including the above 3 factors, which ranged from 0 to 3. Patients stratified into two groups according to this score showed significantly different prognoses (<= 1 vs. >= 2 points: median survival time, 15.1 vs. 8.7 months; p = 0.003). Conclusions The ACTH score may be useful in the therapeutic assessment of HCC patients receiving HAIC.	[Saeki, Issei; Tanabe, Norikazu; Iwamoto, Takuya; Matsumoto, Toshihiko; Hidaka, Isao; Ishikawa, Tsuyoshi; Takami, Taro; Yamamoto, Naoki; Terai, Shuji; Sakaida, Isao] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Ube, Yamaguchi 755, Japan; [Yamasaki, Takahiro] Yamaguchi Univ, Grad Sch Med, Dept Oncol & Lab Med, Ube, Yamaguchi 755, Japan; [Urata, Yohei] Nagato Gen Hosp, Dept Internal Med, Nagato, Yamaguchi, Japan; [Uchida, Koichi] Yamaguchi Prefectural Univ, Fac Nursing & Human Nutr, Dept Human Nutr, Yamaguchi, Yamaguchi, Japan	Yamaguchi University; Yamaguchi University	Yamasaki, T (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Oncol & Lab Med, Ube, Yamaguchi 755, Japan.	t.yama@yamaguchi-u.ac.jp						Ando E, 2002, CANCER-AM CANCER SOC, V95, P588, DOI 10.1002/cncr.10694; Aoyagi Y, 1996, CANCER, V77, P1781; Arii S, 2010, HEPATOL RES, V40, P667, DOI 10.1111/j.1872-034X.2010.00673.x; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chan SL, 2009, J CLIN ONCOL, V27, P446, DOI 10.1200/JCO.2008.18.8151; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chevret S, 1999, J HEPATOL, V31, P133, DOI 10.1016/S0168-8278(99)80173-1; Ebara M, 2005, J HEPATOL, V43, P458, DOI 10.1016/j.jhep.2005.03.033; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; Huitzil-Melendez FD, 2010, J CLIN ONCOL, V28, P2889, DOI 10.1200/JCO.2009.25.9895; Japan LCSGo, 2009, GEN RUL CLIN PATH ST; Kim BK, 2011, J CANCER RES CLIN, V137, P659, DOI 10.1007/s00432-010-0917-5; Kim BK, 2011, LIVER INT, V31, P369, DOI 10.1111/j.1478-3231.2010.02368.x; Kishi K, 1992, Radiat Med, V10, P189; Kudo M, 2003, J GASTROENTEROL, V38, P207, DOI 10.1007/s005350300038; Lee MH, 2012, J GASTROEN HEPATOL, V27, P313, DOI 10.1111/j.1440-1746.2011.06867.x; Leung TWT, 2002, CANCER, V94, P1760, DOI 10.1002/cncr.10384; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Manghisi G, 1998, HEPATOLOGY, V28, P751; MATSUI O, 1993, RADIOLOGY, V188, P79, DOI 10.1148/radiology.188.1.8390073; Mita Y, 1998, CANCER, V82, P1643, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1643::AID-CNCR8>3.0.CO;2-B; Miyaki D, 2013, J GASTROEN HEPATOL, V28, P1834, DOI 10.1111/jgh.12311; Miyaki D, 2012, J GASTROEN HEPATOL, V27, P1850, DOI 10.1111/j.1440-1746.2012.07276.x; Nagano H, 2011, ONCOLOGY-BASEL, V80, P63, DOI 10.1159/000328281; Nouso K, 2013, BRIT J CANCER, V109, P1904, DOI 10.1038/bjc.2013.542; Obi S, 2006, CANCER-AM CANCER SOC, V106, P1990, DOI 10.1002/cncr.21832; Okita K, 2012, HEPATO-GASTROENTEROL, V59, P533, DOI 10.5754/hge10013; Park H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/310427; Riaz A, 2009, J CLIN ONCOL, V27, P5734, DOI 10.1200/JCO.2009.23.1282; Shao YY, 2012, BRIT J CANCER, V107, P1672, DOI 10.1038/bjc.2012.466; Takaki-Hamabe S, 2009, HEPATOL RES, V39, P223, DOI 10.1111/j.1872-034X.2008.00458.x; Todo S, 2004, ANN SURG, V240, P451, DOI 10.1097/01.sla.0000137129.98894.42; Toyoda H, 2012, J HEPATOL, V57, P1251, DOI 10.1016/j.jhep.2012.07.018; Urayama N, 2011, KANZO, V52, P449; Vora SR, 2009, ONCOLOGIST, V14, P717, DOI 10.1634/theoncologist.2009-0038; Yamamoto K, 2009, ANN SURG ONCOL, V16, P2795, DOI 10.1245/s10434-009-0618-y; Yamasaki T, 2005, J GASTROENTEROL, V40, P70, DOI 10.1007/s00535-004-1494-7; Yamasaki T, 2003, HEPATOL RES, V27, P36, DOI 10.1016/S1386-6346(03)00195-5; Yamasaki T, 2002, HEPATOL RES, V23, P7, DOI 10.1016/S1386-6346(01)00163-2; Yamasaki T, 2012, HEPATOL RES, V42, P340, DOI 10.1111/j.1872-034X.2011.00938.x; Yamashita T, 2011, ONCOLOGY-BASEL, V81, P281, DOI 10.1159/000334439; Zhou L, 2006, WORLD J GASTROENTERO, V12, P1175, DOI 10.3748/wjg.v12.i8.1175	45	17	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126649	10.1371/journal.pone.0126649	http://dx.doi.org/10.1371/journal.pone.0126649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992784	Green Published, Green Submitted, gold			2022-12-26	WOS:000354921400070
J	Salonen, MK; Wasenius, N; Kajantie, E; Lano, A; Lahti, J; Heinonen, K; Raikkonen, K; Eriksson, JG				Salonen, Minna K.; Wasenius, Niko; Kajantie, Eero; Lano, Aulikki; Lahti, Jari; Heinonen, Kati; Raikkonen, Katri; Eriksson, Johan G.			Physical Activity, Body Composition and Metabolic Syndrome in Young Adults	PLOS ONE			English	Article							CARDIOVASCULAR RISK; CARDIORESPIRATORY FITNESS; INSULIN SENSITIVITY; SEDENTARY BEHAVIOR; DISEASE RISK; VISCERAL FAT; EXERCISE; ASSOCIATIONS; PREVALENCE; REDUCTION	Objective Low physical activity (PA) is a major risk factor for cardiovascular and metabolic disorders in all age groups. We measured intensity and volume of PA and examined the associations between PA and the metabolic syndrome (MS), its components and body composition among young Finnish adults. Research Design and Methods The study comprises 991 men and women born 1985-86, who participated in a clinical study during the years 2009-11 which included assessments of metabolism, body composition and PA. Objectively measured (SenseWear Armband) five-day PA data was available from 737 participants and was expressed in metabolic equivalents of task (MET). Results The prevalence of MS ranged between 8-10%. Higher total mean volume (MET-hours) or intensity (MET) were negatively associated with the risk of MS and separate components of MS, while the time spent at sedentary level of PA was positively associated with MS. Conclusions MS was prevalent in approximately every tenth of the young adults at the age of 24 years. Higher total mean intensity and volume rates as well as longer duration spent at moderate and vigorous PA level had a beneficial impact on the risk of MS. Longer time spent at the sedentary level of PA increased the risk of MS.	[Salonen, Minna K.; Lahti, Jari; Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Salonen, Minna K.; Kajantie, Eero; Eriksson, Johan G.] Natl Inst Hlth & Welf, Dept Hlth, Helsinki, Finland; [Wasenius, Niko; Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Kajantie, Eero; Lano, Aulikki] Univ Helsinki, Helsinki Univ Cent Hosp, Childrens Hosp, Helsinki, Finland; [Kajantie, Eero] Oulu Univ Hosp, MRC Oulu, Dept Obstet & Gynaecol, Oulu, Finland; [Kajantie, Eero] Univ Oulu, Oulu, Finland; [Lahti, Jari; Heinonen, Kati; Raikkonen, Katri] Univ Helsinki, Inst Behav Sci, Helsinki, Finland	Folkhalsan Research Center; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Oulu; University of Oulu; University of Helsinki	Salonen, MK (corresponding author), Folkhalsan Res Ctr, Helsinki, Finland.	minna.salonen@thl.fi	Lano, Aulikki/J-6328-2015; Wasenius, Niko/AAE-8927-2020; Lano, Aulikki/HGC-3396-2022; Lahti, Jari/P-2283-2019; Lahti, Jari/P-7987-2018	Lano, Aulikki/0000-0003-1708-4514; Wasenius, Niko/0000-0002-9007-6660; Lahti, Jari/0000-0002-4310-5297; Lahti, Jari/0000-0002-4310-5297; Heinonen, Kati/0000-0002-1262-5599; Raikkonen, Katri/0000-0003-3124-3470; Eriksson, Johan/0000-0002-2516-2060	Samfundet Folkhalsan; National Institute for Health and Welfare; Finska Lakaresallskapet; Academy of Finland; Liv och Halsa; Eemil Aaltonen Foundation; Finnish Foundation for Pediatric Research; Novo Nordisk Foundation; Sigrid Juselius Foundation; Novo Nordisk Fonden [NNF12OC1016374] Funding Source: researchfish	Samfundet Folkhalsan; National Institute for Health and Welfare; Finska Lakaresallskapet; Academy of Finland(Academy of Finland); Liv och Halsa; Eemil Aaltonen Foundation; Finnish Foundation for Pediatric Research; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by Samfundet Folkhalsan, National Institute for Health and Welfare, Finska Lakaresallskapet, Academy of Finland, Liv och Halsa, Eemil Aaltonen Foundation, Finnish Foundation for Pediatric Research, Novo Nordisk Foundation, and Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Borch-Johnsen, 2013, METABOLIC SYNDROME, P7; Boule NG, 2003, DIABETOLOGIA, V46, P1071, DOI 10.1007/s00125-003-1160-2; Cameron AJ, 2004, ENDOCRIN METAB CLIN, V33, P351, DOI 10.1016/j.ecl.2004.03.005; Clarke J, 2014, MED SCI SPORT EXER, V46, P76, DOI 10.1249/MSS.0b013e31829f83a0; Cornelissen VA, 2005, HYPERTENSION, V46, P667, DOI 10.1161/01.HYP.0000184225.05629.51; de Koning L, 2010, DIABETOLOGIA, V53, P1322, DOI 10.1007/s00125-010-1710-3; DiPietro L, 2006, J APPL PHYSIOL, V100, P142, DOI 10.1152/japplphysiol.00474.2005; Drenowatz C, 2011, EUR J APPL PHYSIOL, V111, P883, DOI 10.1007/s00421-010-1695-0; Dumith SC, 2011, PREV MED, V53, P24, DOI 10.1016/j.ypmed.2011.02.017; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fruin ML, 2004, MED SCI SPORT EXER, V36, P1063, DOI 10.1249/01.MSS.0000128144.91337.38; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Hagnas MP, 2012, DIABETES RES CLIN PR, V98, P312, DOI 10.1016/j.diabres.2012.09.009; Hagstromer M, 2007, MED SCI SPORT EXER, V39, P1502, DOI 10.1249/mss.0b013e3180a76de5; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Henson J, 2013, DIABETOLOGIA, V56, P1012, DOI 10.1007/s00125-013-2845-9; ISO, 2004, 8996 EN ISO; Jakicic JM, 2004, MED SCI SPORT EXER, V36, P897, DOI 10.1249/01.MSS.0000126805.32659.43; Kelley George A, 2006, J Cardiopulm Rehabil, V26, P131, DOI 10.1097/00008483-200605000-00002; King GA, 2004, MED SCI SPORT EXER, V36, P1244, DOI 10.1249/01.MSS.0000132379.09364.F8; Klimcakova E, 2006, J CLIN ENDOCR METAB, V91, P5107, DOI 10.1210/jc.2006-0382; Kunst A., 1984, METHOD ENZYMAT AN, VVI, P163; Lano A., 2002, VALUE NEONATAL NEURO; Lee S, 2005, DIABETES CARE, V28, P895, DOI 10.2337/diacare.28.4.895; Mansikkaniemi K, 2012, ANN MED, V44, P733, DOI 10.3109/07853890.2011.590146; Mattsson N, 2007, J INTERN MED, V261, P159, DOI 10.1111/j.1365-2796.2006.01752.x; Ohkawara K, 2007, INT J OBESITY, V31, P1786, DOI 10.1038/sj.ijo.0803683; Parrett AL, 2011, APPL PHYSIOL NUTR ME, V36, P72, DOI 10.1139/H10-083; Sacheck JM, 2010, MED SCI SPORT EXER, V42, P1039, DOI 10.1249/MSS.0b013e3181c9216b; Scheers T, 2013, MED SCI SPORT EXER, V45, P481, DOI 10.1249/MSS.0b013e31827563ba; Sigal RJ, 2007, ANN INTERN MED, V147, P357, DOI 10.7326/0003-4819-147-6-200709180-00005; Snowling NJ, 2006, DIABETES CARE, V29, P2518, DOI 10.2337/dc06-1317; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Wang PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027896; Wasenius N, 2013, J REHABIL MED, V45, P300, DOI 10.2340/16501977-1118; Welk GJ, 2007, OBESITY, V15, P918, DOI 10.1038/oby.2007.624; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1	42	35	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126737	10.1371/journal.pone.0126737	http://dx.doi.org/10.1371/journal.pone.0126737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992848	Green Submitted, Green Published, gold			2022-12-26	WOS:000354921400075
J	Hart, LB; Wells, RS; Kellar, N; Balmer, BC; Hohn, AA; Lamb, SV; Rowles, T; Zolman, ES; Schwacke, LH				Hart, Leslie B.; Wells, Randall S.; Kellar, Nick; Balmer, Brian C.; Hohn, Aleta A.; Lamb, Stephen V.; Rowles, Teri; Zolman, Eric S.; Schwacke, Lori H.			Adrenal Hormones in Common Bottlenose Dolphins (Tursiops truncatus): Influential Factors and Reference Intervals	PLOS ONE			English	Article							CORTISOL CONCENTRATIONS; CIRCULATING LEVELS; STRESS-RESPONSE; BELUGA WHALES; WILD; CAPTURE; GROWTH; BLOOD; AGE	Inshore common bottlenose dolphins (Tursiops truncatus) are exposed to a broad spectrum of natural and anthropogenic stressors. In response to these stressors, the mammalian adrenal gland releases hormones such as cortisol and aldosterone to maintain physiological and biochemical homeostasis. Consequently, adrenal gland dysfunction results in disruption of hormone secretion and an inappropriate stress response. Our objective herein was to develop diagnostic reference intervals (RIs) for adrenal hormones commonly associated with the stress response (i.e., cortisol, aldosterone) that account for the influence of intrinsic (e.g., age, sex) and extrinsic (e.g., time) factors. Ultimately, these reference intervals will be used to gauge an individual's response to chase-capture stress and could indicate adrenal abnormalities. Linear mixed models (LMMs) were used to evaluate demographic and sampling factors contributing to differences in serum cortisol and aldosterone concentrations among bottlenose dolphins sampled in Sarasota Bay, Florida, USA (2000-2012). Serum cortisol concentrations were significantly associated with elapsed time from initial stimulation to sample collection (p<0.05), and RIs were constructed using nonparametric methods based on elapsed sampling time for dolphins sampled in less than 30 minutes following net deployment (95% RI: 0.91-4.21 mu g/dL) and following biological sampling aboard a research vessel (95% RI: 2.32-6.68 mu g/dL). To examine the applicability of the pre-sampling cortisol RI across multiple estuarine stocks, data from three additional southeast U.S. sites were compared, revealing that all of the dolphins sampled from the other sites (N = 34) had cortisol concentrations within the 95th percentile RI. Significant associations between serum concentrations of aldosterone and variables reported in previous studies (i.e., age, elapsed sampling time) were not observed in the current project (p<0.05). Also, approximately 16% of Sarasota Bay bottlenose dolphin aldosterone concentrations were below the assay's detection limit (11 pg/mL), thus hindering the ability to derive 95th percentile RIs. Serum aldosterone concentrations from animals sampled at the three additional sites were compared to the detection limit, and the proportion of animals with low aldosterone concentrations was not significantly different than an expected prevalence of 16%. Although this study relied upon long-term, free-ranging bottlenose dolphin health data from a single site, the objective RIs can be used for future evaluation of adrenal function among individuals sampled during capture-release health assessments.	[Hart, Leslie B.; Balmer, Brian C.; Zolman, Eric S.; Schwacke, Lori H.] NOAA, Natl Ocean Serv, Natl Ctr Coastal Ocean Sci, Hollings Marine Lab, Charleston, SC 29405 USA; [Wells, Randall S.; Balmer, Brian C.] Mote Marine Lab, Chicago Zool Soc, Sarasota, FL 34236 USA; [Kellar, Nick] NOAA, Natl Marine Fisheries Serv, Southwest Fisheries Sci Ctr, La Jolla, CA USA; [Hohn, Aleta A.] NOAA, Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Beaufort, NC USA; [Lamb, Stephen V.] Cornell Univ, Coll Vet Med, Anim Hlth Diagnost Ctr, Ithaca, NY 14853 USA; [Rowles, Teri] NOAA, Natl Marine Fisheries Serv, Off Protected Resources, Silver Spring, MD USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); Mote Marine Laboratory & Aquarium; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Cornell University; National Oceanic Atmospheric Admin (NOAA) - USA	Hart, LB (corresponding author), NOAA, Natl Ocean Serv, Natl Ctr Coastal Ocean Sci, Hollings Marine Lab, Charleston, SC 29405 USA.	leslie.burdett@noaa.gov	Hohn, Aleta A/G-2888-2011; Kellar, Nicholas/AAA-4606-2021	Hohn, Aleta A/0000-0002-9992-7062; Balmer, Brian/0000-0001-9734-4042	Office of Naval Research's Marine Mammals & Biology Program	Office of Naval Research's Marine Mammals & Biology Program(Office of Naval Research)	Funding was received from the Office of Naval Research's Marine Mammals & Biology Program.	Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Fair PA, 2014, GEN COMP ENDOCR, V206, P203, DOI 10.1016/j.ygcen.2014.07.002; Fire SE, 2008, MAR MAMMAL SCI, V24, P831, DOI 10.1111/j.1748-7692.2008.00221.x; Friedrichs KR, 2012, VET CLIN PATH, V41, P441, DOI 10.1111/vcp.12006; Gardiner KJ, 1997, CAN J ZOOL, V75, P1773, DOI 10.1139/z97-806; Gulland FMD, 2012, JAVMA-J AM VET MED A, V241, P943, DOI 10.2460/javma.241.7.943; Gupta S, 2007, VET J, V173, P594, DOI 10.1016/j.tvjl.2006.02.011; Hall AJ, 2007, COMP BIOCHEM PHYS A, V148, P266, DOI 10.1016/j.cbpa.2007.04.017; Hart LB, 2013, AQUAT BIOL, V18, P63, DOI 10.3354/ab00491; Hekman Jessica P, 2014, Animals (Basel), V4, P331, DOI 10.3390/ani4020331; HOHN AA, 1989, MAR MAMMAL SCI, V5, P315, DOI 10.1111/j.1748-7692.1989.tb00346.x; Horn PS, 2003, CLIN CHIM ACTA, V334, P5, DOI 10.1016/S0009-8981(03)00133-5; Houser DS, 2011, J ZOO WILDLIFE MED, V42, P565, DOI 10.1638/2010-0121.1; Izaks GJ, 1999, JAMA-J AM MED ASSOC, V281, P1714, DOI 10.1001/jama.281.18.1714; Loughlin Tom, 2010, P16; ORLOV M M, 1988, Zhurnal Evolyutsionnoi Biokhimii i Fiziologii, V24, P557; Ortiz RM, 2000, COMP BIOCHEM PHYS A, V125, P317, DOI 10.1016/S1095-6433(00)00158-6; READ AJ, 1993, J ZOOL, V231, P107, DOI 10.1111/j.1469-7998.1993.tb05356.x; Rosel PE, 2009, MOL ECOL, V18, P5030, DOI 10.1111/j.1365-294X.2009.04413.x; Schmitt TL, 2010, MAR MAMMAL SCI, V26, P635, DOI 10.1111/j.1748-7692.2009.00366.x; Schwacke LH, 2014, ENVIRON SCI TECHNOL, V48, P93, DOI 10.1021/es403610f; Schwacke LH, 2012, P ROY SOC B-BIOL SCI, V279, P48, DOI 10.1098/rspb.2011.0665; Schwacke LH, 2010, ENVIRON RES, V110, P548, DOI 10.1016/j.envres.2010.05.003; Schwacke LH, 2009, AM J VET RES, V70, P973, DOI 10.2460/ajvr.70.8.973; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; St Aubin DJ, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P165, DOI 10.1201/9781420041637.ch10; St Aubin DJ, 2002, ENCY MARINE MAMMALS, P382; STAUBIN DJ, 1988, PHYSIOL ZOOL, V61, P170, DOI 10.1086/physzool.61.2.30156148; StAubin DJ, 1996, MAR MAMMAL SCI, V12, P1, DOI 10.1111/j.1748-7692.1996.tb00301.x; Suzuki M, 2003, GEN COMP ENDOCR, V132, P427, DOI 10.1016/S0016-6480(03)00100-X; THOMSON CA, 1986, CAN J FISH AQUAT SCI, V43, P1010, DOI 10.1139/f86-125; Twiner MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042974; Wells R.S., 2004, ECOHEALTH, V1, P246, DOI [10.1007/s10393-004-0094-6, DOI 10.1007/S10393-004-0094-6]; Wells RS, 2009, ZOO BIOL, V28, P635, DOI 10.1002/zoo.20252; Yordy JE, 2010, ENVIRON SCI TECHNOL, V44, P4789, DOI 10.1021/es1004158	35	22	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127432	10.1371/journal.pone.0127432	http://dx.doi.org/10.1371/journal.pone.0127432			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993341	Green Published, Green Submitted, gold			2022-12-26	WOS:000354917300124
J	Ke, K; Safder, AM; Sul, OJ; Suh, JH; Joe, Y; Chung, HT; Choi, HS				Ke, Ke; Safder, Ali Muhammad; Sul, Ok-Joo; Suh, Jae-Hee; Joe, Yeonsoo; Chung, Hun-Taeg; Choi, Hye-Seon			Cilostazol Attenuates Ovariectomy-Induced Bone Loss by Inhibiting Osteoclastogenesis	PLOS ONE			English	Article							DIFFERENTIATION; RECEPTOR; MICE; ACTIVATION; CELLS; ATHEROSCLEROSIS; SUPPRESSION; SUPEROXIDE; MODULATION; OSTEOBLAST	Background Cilostazol has been reported to alleviate the metabolic syndrome induced by increased intracellular adenosine 3',5'-cyclic monophosphate (cAMP) levels, which is also associated with osteoclast (OC) differentiation. We hypothesized that bone loss might be attenuated via an action on OC by cilostazol. Methodology and Principal Findings To test this idea, we investigated the effect of cilostazol on ovariectomy (OVX)-induced bone loss in mice and on OC differentiation in vitro, using mu CT and tartrate-resistant acid phosphatase staining, respectively. Cilostazol prevented from OVX-induced bone loss and decreased oxidative stress in vivo. It also decreased the number and activity of OC in vitro. The effect of cilostazol on reactive oxygen species (ROS) occurred via protein kinase A (PKA) and cAMP-regulated guanine nucleotide exchange factor 1, two major effectors of cAMP. Knockdown of NADPH oxidase using siRNA of p47(phox) attenuated the inhibitory effect of cilostazol on OC formation, suggesting that decreased OC formation by cilostazol was partly due to impaired ROS generation. Cilostazol enhanced phosphorylation of nuclear factor of activated T cells, cytoplasmic 1 (NFAT2) at PKA phosphorylation sites, preventing its nuclear translocation to result in reduced receptor activator of nuclear factor-kappa B ligand-induced NFAT2 expression and decreased binding of nuclear factor-kappa B-DNA, finally leading to reduced levels of two transcription factors required for OC differentiation. Conclusions/Significance Our data highlight the therapeutic potential of cilostazol for attenuating bone loss and oxidative stress caused by loss of ovarian function.	[Ke, Ke; Safder, Ali Muhammad; Sul, Ok-Joo; Joe, Yeonsoo; Chung, Hun-Taeg; Choi, Hye-Seon] Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea; [Suh, Jae-Hee] Ulsan Univ Hosp, Dept Pathol, Ulsan 682714, South Korea	University of Ulsan; University of Ulsan; Ulsan University Hospital	Choi, HS (corresponding author), Univ Ulsan, Dept Biol Sci, Ulsan 680749, South Korea.	hschoi@mail.ulsan.ac.kr		Choi, Hye-Seon/0000-0003-2992-2677; Ok Joo, Sul/0000-0002-8517-0898	Korea Healthcare Technology R&D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea - Korean government [A111295]; Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2014R1A1A2008740, 2014R1A6A1030318]	Korea Healthcare Technology R&D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea - Korean government; Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education	This work was supported by the Korea Healthcare Technology R&D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea (A111295) funded by the Korean government. KK (NRF-2014R1A1A2008740), AMS, and OJS (2014R1A6A1030318) were supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education. The funders had no role in study design, data collection and analysis, decision of publish, or preparation of the manuscript.	Bodor J, 2012, EUR J IMMUNOL, V42, P1375, DOI 10.1002/eji.201141578; Dawson DL, 1998, CIRCULATION, V98, P678, DOI 10.1161/01.CIR.98.7.678; Dindyal Shiva, 2009, Recent Pat Cardiovasc Drug Discov, V4, P6; Fang F, 2013, AM J PHYSIOL-RENAL, V304, pF1366, DOI 10.1152/ajprenal.00137.2012; Fuller K, 2006, ENDOCRINOLOGY, V147, P1979, DOI 10.1210/en.2005-1340; Garcia-Barroso C, 2014, J ALZHEIMERS DIS, V42, pS561, DOI 10.3233/JAD-141341; Gerlo S, 2011, CELL MOL LIFE SCI, V68, P3823, DOI 10.1007/s00018-011-0757-8; Idris AI, 2009, CELL METAB, V10, P139, DOI 10.1016/j.cmet.2009.07.006; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Jimi E, 1999, J IMMUNOL, V163, P434; Kambayashi J, 2003, CURR PHARM DESIGN, V9, P2289, DOI 10.2174/1381612033453910; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kim KY, 2002, J PHARMACOL EXP THER, V300, P709, DOI 10.1124/jpet.300.2.709; Kim MS, 2010, J BIOL CHEM, V285, P6913, DOI 10.1074/jbc.M109.051557; Kinoshita T, 2000, BONE, V27, P811, DOI 10.1016/S8756-3282(00)00395-1; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee JH, 2005, J PHARMACOL EXP THER, V313, P502, DOI 10.1124/jpet.104.079780; Lee JE, 2007, EXP HEMATOL, V35, P1100, DOI 10.1016/j.exphem.2007.04.006; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Li JY, 2011, P NATL ACAD SCI USA, V108, P768, DOI 10.1073/pnas.1013492108; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Morel E, 2005, CIRC RES, V97, P1296, DOI 10.1161/01.RES.0000194325.31359.86; Park SY, 2009, J PHARMACOL EXP THER, V329, P571, DOI 10.1124/jpet.108.146456; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Rogers NH, 2009, ENDOCRINOLOGY, V150, P2161, DOI 10.1210/en.2008-1405; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Shin HK, 2004, CIRCULATION, V109, P1022, DOI 10.1161/01.CIR.0000117403.64398.53; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Sun L, 2006, CELL, V125, P247, DOI 10.1016/j.cell.2006.01.051; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Wada T, 2013, EUR J PHARMACOL, V707, P120, DOI 10.1016/j.ejphar.2013.03.016; Wang HD, 2013, BRIT J PHARMACOL, V170, P796, DOI 10.1111/bph.12301; Weitzmann MN, 2006, J CLIN INVEST, V116, P1186, DOI 10.1172/JCI28550; WITTEMAN JCM, 1989, BRIT MED J, V298, P642, DOI 10.1136/bmj.298.6674.642; Yamagami H, 2003, BIOCHEM PHARMACOL, V66, P801, DOI 10.1016/S0006-2952(03)00409-X; Yoon SH, 2011, J BONE MINER RES, V26, P1217, DOI 10.1002/jbmr.310; Zhang X, 2012, NEUROSCIENCE, V220, P191, DOI 10.1016/j.neuroscience.2012.06.027; Zhao HF, 2014, BRIT J NUTR, V111, P836, DOI 10.1017/S0007114513003115	39	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0124869	10.1371/journal.pone.0124869	http://dx.doi.org/10.1371/journal.pone.0124869			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992691	Green Submitted, gold, Green Published			2022-12-26	WOS:000354917300011
J	Kim, H; Kim, Y; Bae, S; Kong, JM; Choi, J; Jang, M; Choi, J; Hong, JM; Hwang, YI; Kang, JS; Lee, WJ				Kim, Hyemin; Kim, Yejin; Bae, Seyeon; Kong, Joo Myoung; Choi, Jiwon; Jang, Mirim; Choi, Jiyea; Hong, Jun-man; Hwang, Young-Il; Kang, Jae Seung; Lee, Wang Jae			Direct Interaction of CD40 on Tumor Cells with CD40L on T Cells Increases the Proliferation of Tumor Cells by Enhancing TGF-beta Production and Th17 Differentiation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BLOOD MONONUCLEAR-CELLS; CARCINOMA-CELLS; B-CELLS; CANCER; LIGAND; INTERLEUKIN-18; STIMULATION; ACTIVATION; CYTOKINES	It has recently been reported that the CD40-CD40 ligand (CD40L) interaction is important in Th17 development. In addition, transforming growth factor-beta (TGF-beta) promotes tumorigenesis as an immunosuppressive cytokine and is crucial in the development of Th17 cells. This study investigated the role of CD40 in breast cancer cells and its role in immunosuppressive function and tumor progression. CD40 was highly expressed in the breast cancer cell line MDA-MB231, and its stimulation with CD40 antibodies caused the up-regulation of TGF-beta. Direct CD40-CD40L interaction between MDA-MB231 cells and activated T cells also increased TGF-beta production and induced the production of IL-17, which accelerated the proliferation of MDA-MB231 cells through the activation of STAT3. Taken together, the direct CD40-CD40L interaction of breast tumor cells and activated T cells increases TGF-beta production and the differentiation of Th17 cells, which promotes the proliferation of breast cancer cells.	[Kim, Hyemin; Kim, Yejin; Bae, Seyeon; Kong, Joo Myoung; Choi, Jiwon; Jang, Mirim; Choi, Jiyea; Hong, Jun-man; Hwang, Young-Il; Kang, Jae Seung; Lee, Wang Jae] Seoul Natl Univ, Coll Med, Dept Anat, Lab Vitamin & Antioxidant Immunol C, Seoul 110799, South Korea; [Kim, Hyemin; Kang, Jae Seung] Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul 110799, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kang, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Anat, Lab Vitamin & Antioxidant Immunol C, Seoul 110799, South Korea.	genius29@snu.ac.kr	Kang, Jae Seung/J-5363-2012		National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1020030]	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	Grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (#1020030).	Abe M, 2002, ENDOTHELIUM-NEW YORK, V9, P25, DOI 10.1080/10623320210710; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Awasthi A, 2009, INT IMMUNOL, V21, P489, DOI 10.1093/intimm/dxp021; Baran J, 2001, CLIN DIAGN LAB IMMUN, V8, P303, DOI 10.1128/CDLI.8.2.303-313.2001; Batrla R, 2002, CANCER RES, V62, P2052; Bishop GA, 2001, IMMUNOL RES, V24, P97, DOI 10.1385/IR:24:2:097; Carbone A, 2005, CANCER BIOL THER, V4, P231; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Cho D, 2000, CANCER RES, V60, P2703; Cotter RL, 2001, J VIROL, V75, P4308, DOI 10.1128/JVI.75.9.4308-4320.2001; Eliopoulos AG, 2000, MOL CELL BIOL, V20, P5503, DOI 10.1128/MCB.20.15.5503-5515.2000; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Fecteau JF, 2003, J IMMUNOL, V171, P4621, DOI 10.4049/jimmunol.171.9.4621; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Hatton RD, 2011, IMMUNITY, V34, P288, DOI 10.1016/j.immuni.2011.03.009; HORIMOTO M, 1995, BRIT J CANCER, V72, P676, DOI 10.1038/bjc.1995.393; Iezzi G, 2009, P NATL ACAD SCI USA, V106, P876, DOI 10.1073/pnas.0810769106; Imamura T, 2012, BREAST CANCER-TOKYO, V19, P118, DOI 10.1007/s12282-011-0321-2; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Johnson-Leger C, 1998, J IMMUNOL, V161, P4618; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Katsuno Y, 2008, ONCOGENE, V27, P6322, DOI 10.1038/onc.2008.232; Kim IY, 2005, J BIOCHEM MOL BIOL, V38, P1; Kim R, 2006, IMMUNOLOGY, V119, P254, DOI 10.1111/j.1365-2567.2006.02430.x; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Lim CK, 2001, IMMUNE NETW, V1, P260; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin F, 2012, TRENDS MOL MED, V18, P742, DOI 10.1016/j.molmed.2012.09.007; Maruo S, 1997, J IMMUNOL, V158, P120; McDyer JF, 1998, J IMMUNOL, V160, P1701; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Moses H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003277; Muhl H, 2004, EUR J PHARMACOL, V500, P63, DOI 10.1016/j.ejphar.2004.07.012; Munger JS, 1997, KIDNEY INT, V51, P1376, DOI 10.1038/ki.1997.188; Neron S, 2005, IMMUNOLOGY, V116, P454, DOI 10.1111/j.1365-2567.2005.02244.x; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Park Hae-Young, 2009, Immune Netw, V9, P122, DOI 10.4110/in.2009.9.4.122; Park J-Y, 2007, IMMUNE NETW, V7, P80; Park S. H., 2014, IMMUNE NETW, V14, P14, DOI [10.4110/in.2014.14.1.14, DOI 10.4110/in.2014.14.1.14, DOI 10.4110/IN.2014.14.1.14]; Pasch MC, 2004, J PATHOL, V203, P839, DOI 10.1002/path.1581; PETERSEN CM, 1992, EXP CELL RES, V201, P160, DOI 10.1016/0014-4827(92)90360-K; Porst M, 2006, NEPHRON EXP NEPHROL, V102, pE99, DOI 10.1159/000089688; Pries R, 2006, IN VIVO, V20, P45; Qian Y, 2002, J INTERF CYTOK RES, V22, P1217, DOI 10.1089/10799900260475740; Randolph DA, 2006, ANNU REV MED, V57, P381, DOI 10.1146/annurev.med.57.121304.131337; Reddy P, 2004, CURR OPIN HEMATOL, V11, P405, DOI 10.1097/01.moh.0000141926.95319.42; Sarawar SR, 2001, P NATL ACAD SCI USA, V98, P6325, DOI 10.1073/pnas.101136898; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Shin H, 2001, IMMUNE NETW, V1, P143; SPRIGGS MK, 1992, J EXP MED, V176, P1543, DOI 10.1084/jem.176.6.1543; Szomolanyi-Tsuda E, 2000, J IMMUNOL, V164, P5877, DOI 10.4049/jimmunol.164.11.5877; Takatsu K, 1997, P SOC EXP BIOL MED, V215, P121; Takatsu Kiyoshi, 2004, Nihon Rinsho, V62, P1941; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; van Mierlo GJD, 2002, P NATL ACAD SCI USA, V99, P5561, DOI 10.1073/pnas.082107699; Wan YY, 2007, IMMUNOL REV, V220, P199, DOI 10.1111/j.1600-065X.2007.00565.x; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Watanabe S, 2003, J IMMUNOL, V171, P5828, DOI 10.4049/jimmunol.171.11.5828; Wingett DG, 1998, BREAST CANCER RES TR, V50, P27, DOI 10.1023/A:1006012607452	61	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0125742	10.1371/journal.pone.0125742	http://dx.doi.org/10.1371/journal.pone.0125742			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992978	Green Published, Green Submitted, gold			2022-12-26	WOS:000354917300024
J	Zhang, S; Mo, F; Luo, Z; Huang, J; Sun, C; Zhang, R				Zhang, Shu; Mo, Fei; Luo, Zhaoxun; Huang, Jian; Sun, Chaoqin; Zhang, Ran			Flavonoid Glycosides of Polygonum capitatum Protect against Inflammation Associated with Helicobacter pylori Infection	PLOS ONE			English	Article							PEPTIC-ULCER DISEASE; INTERFERON-GAMMA; TRIPLE THERAPY; MUCOSAL INFLAMMATION; GASTRIC-CANCER; MALT LYMPHOMA; CLARITHROMYCIN; INTERLEUKIN-4; SOMATOSTATIN; ERADICATION	The antibacterial and anti-inflammatory activities, and protective effects of extracts (flavonoid glycosides) of Polygonum capitatum were investigated to detect the evidence for the utilization of the herb in the clinical therapy of gastritis caused by H. pylori. A mouse gastritis model was established using H. pylori. According to treating methods, model mice were random assigned into a model group (MG group), a triple antibiotics group (TG group, clarithromycin, omeprazole and amoxicillin), low/middle/high concentrations of flavonoid glycosides groups (LF, MF and HF groups) and low/middle/high concentrations of flavonoid glycosides and amoxicillin groups (LFA, MFA and HFA groups). A group with pathogen-free mice was regarded as a control group (CG group). The eradicate rates of H. pylori were 100%, 93%, 89% in TG, MFA and HF groups. The serum levels of IFN-gamma and gastrin were higher in a MG group than those from all other groups (P < 0.05). The serum levels of IFN-gamma and gastrin were reduced significantly in LF, MF and HF groups (P < 0.05) while little changes were observed in LFA, MFA and HFA groups. In contrast, the serum levels of IL-4 were lower and higher in MG and CG groups compared with other groups (P<0.05). The serum levels of IL-4 were increased significantly in LF, MF and HF groups (P < 0.05) while little changes were found in LFA, MFA and HFA groups. According to pathological scores, flavonoid glycosides therapy showed better protection for gastric injuries than the combination of flavonoid glycoside and amoxicillin (P < 0.05). The results suggested that flavonoid glycoside has repairing functions for gastric injuries. The results suggest that the plant can treat gastritis and protect against gastric injuries. The flavonoid glycosides from Polygonum capitatum should be developed as a potential drug for the therapy of gastritis caused by H. pylori.	[Zhang, Shu; Mo, Fei; Luo, Zhaoxun] Guiyang Med Coll, Guiyang 550004, Peoples R China; [Huang, Jian; Sun, Chaoqin] Guiyang Med Coll, Affiliated Hosp, Guiyang 550004, Peoples R China; [Zhang, Ran] Liaocheng Peoples Hosp, Liaocheng 252000, Shandong, Peoples R China	Guizhou Medical University; Guizhou Medical University	Mo, F (corresponding author), Guiyang Med Coll, Guiyang 550004, Peoples R China.	mofeigy@163.com; zhaoxun1@163.com			Science and Technology Department of Guizhou province [LG (2012)012, LG(2012)054]; Medical College of Guiyang [LG (2012)012, LG(2012)054]; Specialized Program Construction Project in University [21, [2010]15]; Science and Technology Program of Guizhou [[2014]2027]; Ph.D. Programs Foundation of Affiliated hospital of Guiyang Medical College [2014]; College students' innovative entrepreneurial training program of Guizhou [201410660014]	Science and Technology Department of Guizhou province; Medical College of Guiyang; Specialized Program Construction Project in University; Science and Technology Program of Guizhou; Ph.D. Programs Foundation of Affiliated hospital of Guiyang Medical College; College students' innovative entrepreneurial training program of Guizhou	The project was supported by the joint fund of Science and Technology Department of Guizhou province and Medical College of Guiyang (No. LG (2012)012 and LG(2012)054), Specialized Program Construction Project in University (No. 21 (No.[2010]15), the Science and Technology Program of Guizhou (No. [2014]2027), The Ph.D. Programs Foundation of Affiliated hospital of Guiyang Medical College (No. 2014) and College students' innovative entrepreneurial training program of Guizhou (No. 201410660014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi YJ, 2014, J IMMUNOL, V192, P704, DOI 10.4049/jimmunol.1301687; Cao Q, 2010, J AM SOC NEPHROL, V21, P933, DOI 10.1681/ASN.2009060592; Chen MC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/158520; Chen MY, 2013, WORLD J GASTROENTERO, V19, P4242, DOI 10.3748/wjg.v19.i26.4242; Chen S, 1996, Zhonghua Nei Ke Za Zhi, V35, P799; Cover Timothy L, 2012, Methods Mol Biol, V921, P11; Datta BK, 2004, PHARMAZIE, V59, P222; Feng ZX, 2013, J INT MED RES, V41, P239, DOI 10.1177/0300060513475384; Gong EJ, 2014, J KOREAN MED SCI, V29, P704, DOI 10.3346/jkms.2014.29.5.704; Gresser U, 2001, EUR J MED RES, V6, P139; Guo Q, 2013, INT J HEMATOL, V97, P735, DOI 10.1007/s12185-013-1348-2; HAKANSON R, 1992, SCAND J GASTROENTERO, V27, P65, DOI 10.3109/00365529209011169; He CY, 2014, MOLECULES, V19, P10291, DOI 10.3390/molecules190710291; Holden JA, 2014, INFECT IMMUN, V82, P4190, DOI 10.1128/IAI.02325-14; Hoo WS, 2006, CLIN EXP IMMUNOL, V145, P123, DOI 10.1111/j.1365-2249.2006.03107.x; Irani Soussan, 2013, J Dent Res Dent Clin Dent Prospects, V7, P230, DOI 10.5681/joddd.2013.037; Kao JY, 2006, REGUL PEPTIDES, V134, P23, DOI 10.1016/j.regpep.2005.11.002; KARTTUNEN R, 1995, GUT, V36, P341, DOI 10.1136/gut.36.3.341; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Kim J, 2004, NAT HIST, V113, P16; Kline EK, 1948, AM J PUBLIC HEALTH N, V38, P1700, DOI 10.2105/AJPH.38.12.1700-a; Kodaman N, 2014, P NATL ACAD SCI USA, V111, P1455, DOI 10.1073/pnas.1318093111; Kountouras J, 2014, EUR J NEUROL, V21, pE100, DOI 10.1111/ene.12563; Liao SG, 2013, PHYTOCHEM ANALYSIS, V24, P556, DOI 10.1002/pca.2432; Liao SG, 2011, J ETHNOPHARMACOL, V134, P1006, DOI 10.1016/j.jep.2011.01.050; Lim HC, 2014, HELICOBACTER, V19, P455, DOI 10.1111/hel.12147; Lin HJ, 2004, WORLD J GASTROENTERO, V10, P2493, DOI 10.3748/wjg.v10.i17.2493; Liu P, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/642128; LUCKE C, 1976, ACTA ENDOCRINOL-COP, V82, P460, DOI 10.1530/acta.0.0820460; Mendes LST, 2014, GUT, V63, P1526, DOI 10.1136/gutjnl-2014-307389; Mihaljevic S, 2000, HEPATO-GASTROENTEROL, V47, P1482; Mohammadi Marjan, 2012, Methods Mol Biol, V921, P239; Ni B, 2014, J IMMUNOL, V193, P4537, DOI 10.4049/jimmunol.1400124; Nisha KJ, 2016, J INVESTIG CLIN DENT, V7, P37, DOI 10.1111/jicd.12122; Nishizawa T, 2015, J CLIN GASTROENTEROL, V49, P468, DOI 10.1097/MCG.0000000000000165; Ono S, 2009, ANN ONCOL, V20, P1748, DOI 10.1093/annonc/mdp389; Orsini B, 2003, INFECT IMMUN, V71, P6664, DOI 10.1128/IAI.71.11.6664-6667.2003; Park CS, 2014, AM J GASTROENTEROL, V109, P1595, DOI 10.1038/ajg.2014.222; Patel SK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/483136; Peng YC, 2014, J CHIN MED ASSOC, V77, P567, DOI 10.1016/j.jcma.2014.07.006; Picoli SU, 2014, REV INST MED TROP SP, V56, P197, DOI 10.1590/S0036-46652014000300003; Qureshi NN, 2014, MICROB DRUG RESIST, V20, P509, DOI 10.1089/mdr.2014.0019; RATTO GB, 1991, EUR SURG RES, V23, P327, DOI 10.1159/000129172; Rieder G, 2005, GASTROENTEROLOGY, V128, P1229, DOI 10.1053/j.gastro.2005.02.064; Roberts LTD, 2006, SOUTH MED J, V99, P1134, DOI 10.1097/01.smj.0000215746.17667.b1; Salmon-Ehr V, 2000, LAB INVEST, V80, P1337, DOI 10.1038/labinvest.3780141; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Shiota S, 2014, J GASTROEN HEPATOL, V29, P67, DOI 10.1111/jgh.12359; Siavoshi F, 2005, HELICOBACTER, V10, P318, DOI 10.1111/j.1523-5378.2005.00319.x; Siddique I, 2014, GUT PATHOG, V6, DOI 10.1186/s13099-014-0041-1; Slesak G, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-24; Sordal O, 2013, HELICOBACTER, V18, P397, DOI 10.1111/hel.12066; Taiwo BJ, 2014, AFR J TRADIT COMPLEM, V11, P97, DOI 10.4314/ajtcam.v11i3.14; Tsukita S, 1999, J BIOCHEM, V125, P194, DOI 10.1093/oxfordjournals.jbchem.a022259; Tu IF, 2014, HELICOBACTER, V19, P356, DOI 10.1111/hel.12140; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Vivas JR, 2008, INT J IMMUNOPATH PH, V21, P515, DOI 10.1177/039463200802100305; Wagner B, 2010, VET RES, V41, DOI 10.1051/vetres/2010019; Wang YC, 2014, J IMMUNOL, V193, P4149, DOI 10.4049/jimmunol.1400594; Xu LW, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/568106; Yamamoto S, 2001, HELICOBACTER, V6, P136, DOI 10.1046/j.1523-5378.2001.00020.x; Yang Yun-Hui, 2012, Lab Anim Res, V28, P55, DOI 10.5625/lar.2012.28.1.55; Yilmaz O, 2007, WORLD J GASTROENTERO, V13, P671, DOI 10.3748/wjg.v13.i5.671; Yoon KH, 2014, J KOREAN MED SCI, V29, P1240, DOI 10.3346/jkms.2014.29.9.1240; Yue JY, 2014, PAK J MED SCI, V30, P804; Zavros Y, 2000, DIGEST DIS SCI, V45, P2058, DOI 10.1023/A:1005659104779	66	17	18	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126584	10.1371/journal.pone.0126584	http://dx.doi.org/10.1371/journal.pone.0126584			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993258	Green Published, Green Submitted, gold			2022-12-26	WOS:000354917300047
J	Faraone, N; Hillier, NK; Cutler, GC				Faraone, Nicoletta; Hillier, N. Kirk; Cutler, G. Christopher			Plant Essential Oils Synergize and Antagonize Toxicity of Different Conventional Insecticides against Myzus persicae (Hemiptera: Aphididae)	PLOS ONE			English	Article							AEDES-AEGYPTI; BOTANICAL INSECTICIDES; MAJOR CONSTITUENTS; SPODOPTERA-LITURA; AGRICULTURE; PYRETHRUM; PRODUCTS; BLENDS; REPELLENTS; RESISTANCE	Plant-derived products can play an important role in pest management programs. Essential oils from Lavandula angustifolia (lavender) and Thymus vulgaris (thyme) and their main constituents, linalool and thymol, respectively, were evaluated for insecticidal activity and synergistic action in combination with insecticides against green peach aphid, Myzus persicae (Sulzer) (Hemiptera: Aphididae). The essential oils and their main constituents exerted similar insecticidal activity when aphids were exposed by direct sprays, but were non-toxic by exposure to treated leaf discs. In synergism experiments, the toxicity of imidacloprid was synergized 16- to 20-fold by L. angustifolia and T. vulgaris essential oils, but far less synergism occurred with linalool and thymol, indicating that secondary constituents of the oils were probably responsible for the observed synergism. In contrast to results with imidacloprid, the insecticidal activity of spirotetramat was antagonized by L. angustifolia and T. vulgaris essential oils, and linalool and thymol. Our results demonstrate the potential of plant essential oils as synergists of insecticides, but show that antagonistic action against certain insecticides may occur.	[Faraone, Nicoletta; Cutler, G. Christopher] Dalhousie Univ, Fac Agr, Dept Environm Sci, Truro, NS B2N 5E3, Canada; [Hillier, N. Kirk] Acadia Univ, Dept Biol, Wolfville, NS B4P 2R6, Canada	Dalhousie University; Acadia University	Cutler, GC (corresponding author), Dalhousie Univ, Fac Agr, Dept Environm Sci, Truro, NS B2N 5E3, Canada.	chris.cutler@dal.ca	Hillier, Neil/AAM-7270-2020	Cutler, Chris/0000-0002-4666-9987	Atlantic Canada Opportunities Agency, Atlantic Innovation Fund [197853]	Atlantic Canada Opportunities Agency, Atlantic Innovation Fund	This research was supported by an Atlantic Canada Opportunities Agency, Atlantic Innovation Fund to NKH (No. 197853).	Abbassy MA, 2009, ENTOMOL EXP APPL, V131, P225, DOI 10.1111/j.1570-7458.2009.00854.x; Adams RP, 2007, IDENTIFICATION ESSEN, DOI [10.1002/cbdv.201100039, DOI 10.1002/CBDV.201100039]; Athanassiou CG, 2013, J ECON ENTOMOL, V106, P1902, DOI 10.1603/EC12474; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Bass C, 2014, INSECT BIOCHEM MOLEC, V51, P41, DOI 10.1016/j.ibmb.2014.05.003; BBERNARD C, 1993, J TOXICOL ENV HEALTH, V38, P199, DOI 10.1080/15287399309531712; Berenbaum M., 1985, Recent Advances in Phytochemistry, V19, P139; BLACKMAN R.L., 1984, ORIENT INSECTS; Bozin B, 2006, J AGR FOOD CHEM, V54, P1822, DOI 10.1021/jf051922u; Bruck E, 2009, CROP PROT, V28, P838, DOI 10.1016/j.cropro.2009.06.015; Chandler D, 2011, PHILOS T R SOC B, V366, P1987, DOI 10.1098/rstb.2010.0390; Cloyd RA, 2009, J ECON ENTOMOL, V102, P1567, DOI 10.1603/029.102.0422; Enan EE, 2005, INSECT BIOCHEM MOLEC, V35, P309, DOI 10.1016/j.ibmb.2004.12.007; Ghadamyari M, 2012, J PLANT PROT, V26, P29; Gonzalez-Coloma A, 2011, BIOCHEM SYST ECOL, V39, P1, DOI 10.1016/j.bse.2010.08.010; Halbert SE, 2009, ANN APPL BIOL, V154, P303, DOI 10.1111/j.1744-7348.2008.00300.x; Hori M, 1999, APPL ENTOMOL ZOOL, V34, P113, DOI 10.1303/aez.34.113; Hori M, 1998, J CHEM ECOL, V24, P1425, DOI 10.1023/A:1020947414051; Hummelbrunner LA, 2001, J AGR FOOD CHEM, V49, P715, DOI 10.1021/jf000749t; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Isman MB, 2008, PEST MANAG SCI, V64, P8, DOI 10.1002/ps.1470; Isman MB, 2012, PHARM BIOL, V50, P621; Isman MB, 2011, PHYTOCHEM REV, V10, P197, DOI 10.1007/s11101-010-9170-4; Ramirez GIJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048698; Jensen HR, 2006, INSECT MOL BIOL, V15, P329, DOI 10.1111/j.1365-2583.2006.00648.x; Jiang ZL, 2009, J AGR FOOD CHEM, V57, P4833, DOI 10.1021/jf900274r; Joffe T, 2012, PEST MANAG SCI, V68, P178, DOI 10.1002/ps.2241; Koul O, 2013, IND CROP PROD, V49, P428, DOI 10.1016/j.indcrop.2013.05.032; Liu SQ, 2014, J ECON ENTOMOL, V107, P797, DOI 10.1603/EC13440; Lopez MD, 2010, IND CROP PROD, V31, P284, DOI 10.1016/j.indcrop.2009.11.005; Danh LT, 2013, FOOD BIOPROCESS TECH, V6, P3481, DOI 10.1007/s11947-012-1026-z; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; METCALF RL, 1967, ANNU REV ENTOMOL, V12, P229, DOI 10.1146/annurev.en.12.010167.001305; Miresmailli S, 2006, PEST MANAG SCI, V62, P366, DOI 10.1002/ps.1157; Nauen R, 1996, B ENTOMOL RES, V86, P165, DOI 10.1017/S0007485300052408; Nguyen SN, 2007, J ECON ENTOMOL, V100, P534, DOI 10.1603/0022-0493(2007)100[534:TSANEO]2.0.CO;2; Nikolic M, 2014, IND CROP PROD, V61, P225, DOI 10.1016/j.indcrop.2014.07.011; Omolo MO, 2005, PHYTOMEDICINE, V12, P241, DOI 10.1016/j.phymed.2003.10.004; Pavela R., 2006, Journal of Essential Oil-Bearing Plants, V9, P99; Petrakis EA, 2014, IND CROP PROD, V62, P272, DOI 10.1016/j.indcrop.2014.08.041; PMRA, 2008, 1568427 PMRA HLTH CA; Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007; Priestley CM, 2003, BRIT J PHARMACOL, V140, P1363, DOI 10.1038/sj.bjp.0705542; Regnault-Roger C, 2012, ANNU REV ENTOMOL, V57, P405, DOI 10.1146/annurev-ento-120710-100554; SAS, 2008, SAS VERS 9 2; Scott J.G., 1990, PESTICIDE RESISTANCE, P39, DOI DOI 10.1007/978-1-4684-6429-0_3; Shaalan EAS, 2005, J VECTOR ECOL, V30, P284; SUN YP, 1960, J AGR FOOD CHEM, V8, P261, DOI 10.1021/jf60110a003; Tomlin C.D.S., 2004, E PESTICIDE MANUAL, Vthirteenth; Tong F, 2013, J MED ENTOMOL, V50, P826, DOI 10.1603/ME13002; Waliwitiya R, 2012, J MED ENTOMOL, V49, P614, DOI 10.1603/ME10272; Wheeler MW, 2006, ENVIRON TOXICOL CHEM, V25, P1441, DOI 10.1897/05-320R.1; Yu DY, 2011, AFR J BIOTECHNOL, V10, P3424	53	58	63	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127774	10.1371/journal.pone.0127774	http://dx.doi.org/10.1371/journal.pone.0127774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010088	gold, Green Published, Green Submitted			2022-12-26	WOS:000355183900143
J	Panicker, IS; Browning, GF; Markham, PF				Panicker, Indu S.; Browning, Glenn F.; Markham, Philip F.			The Effect of an Alternate Start Codon on Heterologous Expression of a PhoA Fusion Protein in Mycoplasma gallisepticum	PLOS ONE			English	Article							ESCHERICHIA-COLI; TRANSLATIONAL EFFICIENCY; BACILLUS-SUBTILIS; INITIATION CODON; MESSENGER-RNA; GENE-EXPRESSION; GENOME SEQUENCE; PROKARYOTES; EUKARYOTES; PNEUMONIAE	While the genomes of many Mycoplasma species have been sequenced, there are no collated data on translational start codon usage, and the effects of alternate start codons on gene expression have not been studied. Analysis of the annotated genomes found that ATG was the most prevalent translational start codon among Mycoplasma spp. However in Mycoplasma gallisepticum a GTG start codon is commonly used in the vlhA multigene family, which encodes a highly abundant, phase variable lipoprotein adhesin. Therefore, the effect of this alternate start codon on expression of a reporter PhoA lipoprotein was examined in M. gallisepticum. Mutation of the start codon from ATG to GTG resulted in a 2.5 fold reduction in the level of transcription of the phoA reporter, but the level of PhoA activity in the transformants containing phoA with a GTG start codon was only 63% of that of the transformants with a phoA with an ATG start codon, suggesting that GTG was a more efficient translational initiation codon. The effect of swapping the translational start codon in phoA reporter gene expression was less in M. gallisepticum than has been seen previously in Escherichia coli or Bacillus subtilis, suggesting the process of translational initiation in mycoplasmas may have some significant differences from those used in other bacteria. This is the first study of translational start codon usage in mycoplasmas and the impact of the use of an alternate start codon on expression in these bacteria.	[Panicker, Indu S.; Browning, Glenn F.; Markham, Philip F.] Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Melbourne, Vic, Australia	University of Melbourne	Browning, GF (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Melbourne, Vic, Australia.	glenfb@unimelb.edu.au	Somasundara Panicker, Indu/K-6010-2015; Browning, Glenn Francis/P-4459-2014	Somasundara Panicker, Indu/0000-0003-4395-5096; Browning, Glenn Francis/0000-0002-0903-2469	International Postgraduate Research Scholarship from the Commonwealth of Australia	International Postgraduate Research Scholarship from the Commonwealth of Australia	ISP was in receipt of an International Postgraduate Research Scholarship from the Commonwealth of Australia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armengaud J, 2009, CURR OPIN MICROBIOL, V12, P292, DOI 10.1016/j.mib.2009.03.005; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Dandekar T, 2000, NUCLEIC ACIDS RES, V28, P3278, DOI 10.1093/nar/28.17.3278; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Dybvig K, 1996, ANNU REV MICROBIOL, V50, P25, DOI 10.1146/annurev.micro.50.1.25; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; GUILLEREZ J, 1991, NUCLEIC ACIDS RES, V19, P6743, DOI 10.1093/nar/19.24.6743; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; INAMINE JM, 1990, J BACTERIOL, V172, P504, DOI 10.1128/JB.172.1.504-506.1990; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Li WC, 2007, ANTON LEEUW INT J G, V92, P417, DOI 10.1007/s10482-007-9170-6; LOOMAN AC, 1986, FEBS LETT, V197, P315, DOI 10.1016/0014-5793(86)80349-0; Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38; Mazin PV, 2014, NUCLEIC ACIDS RES, V42, P13254, DOI 10.1093/nar/gku976; MUTO A, 2002, MOL BIOL PATHOGENICI, P323; Panicker IS, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-138; REDDY P, 1985, P NATL ACAD SCI USA, V82, P5656, DOI 10.1073/pnas.82.17.5656; Rocha EPC, 1999, NUCLEIC ACIDS RES, V27, P3567, DOI 10.1093/nar/27.17.3567; Sharp JS, 2003, J BACTERIOL, V185, P5372, DOI 10.1128/JB.185.18.5372-5379.2003; Stenstrom CM, 2001, GENE, V263, P273, DOI 10.1016/S0378-1119(00)00550-3; Sussman JK, 1996, MOL MICROBIOL, V21, P347, DOI 10.1046/j.1365-2958.1996.6371354.x; VELLANOWETH RL, 1992, MOL MICROBIOL, V6, P1105, DOI 10.1111/j.1365-2958.1992.tb01548.x; Villegas A, 2008, MICROBIOL-SGM, V154, P2559, DOI 10.1099/mic.0.2008/021360-0; YAMAO F, 1985, P NATL ACAD SCI USA, V82, P2306, DOI 10.1073/pnas.82.8.2306; Yeh CM, 1997, J APPL MICROBIOL, V83, P758, DOI 10.1046/j.1365-2672.1997.00306.x; Zalucki YM, 2009, TRENDS MICROBIOL, V17, P146, DOI 10.1016/j.tim.2009.01.005	31	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127911	10.1371/journal.pone.0127911	http://dx.doi.org/10.1371/journal.pone.0127911			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010086	Green Published, gold			2022-12-26	WOS:000355183900163
J	Upadhyay, SK; Sharma, S; Singh, H; Dixit, S; Kumar, J; Verma, PC; Chandrashekar, K				Upadhyay, Santosh Kumar; Sharma, Shailesh; Singh, Harpal; Dixit, Sameer; Kumar, Jitesh; Verma, Praveen C.; Chandrashekar, K.			Whitefly Genome Expression Reveals Host-Symbiont Interaction in Amino Acid Biosynthesis	PLOS ONE			English	Article							BEMISIA-TABACI HEMIPTERA; GENE-EXPRESSION; TRANSCRIPTOME ANALYSIS; GLUTAMINE-METABOLISM; ACYRTHOSIPHON-PISUM; PEA APHID; SEQUENCE; ALEYRODIDAE; DIFFERENTIATION; DIVERGENCE	Background Whitefly (Bemisia tabaci) complex is a serious insect pest of several crop plants worldwide. It comprises several morphologically indistinguishable species, however very little is known about their genetic divergence and biosynthetic pathways. In the present study, we performed transcriptome sequencing of Asia 1 species of B. tabaci complex and analyzed the interaction of host-symbiont genes in amino acid biosynthetic pathways. Methodology/Principal Findings We obtained about 83 million reads using Illumina sequencing that assembled into 72716 unitigs. A total of 21129 unitigs were annotated at stringent parameters. Annotated unitigs were mapped to 52847 gene ontology (GO) terms and 131 Kyoto encyclopedia of genes and genomes (KEGG) pathways. Expression analysis of the genes involved in amino acid biosynthesis pathways revealed the complementation between whitefly and its symbiont partner Candidatus Portiera aleyrodidarum. Most of the non-essential amino acids and intermediates of essential amino acid pathways were supplied by the host insect to its symbiont. The symbiont expressed the pathways for the essential amino acids arginine, threonine and tryptophan and the immediate precursors of valine, leucine, isoleucine and phenyl-alanine. High level expression of the amino acid transporters in the whitefly suggested the molecular mechanisms for the exchange of amino acids between the host and the symbiont. Conclusions/Significance Our study provides a comprehensive transcriptome data for Asia 1 species of B. tabaci complex that focusses light on integration of host and symbiont genes in amino acid biosynthesis pathways.	[Upadhyay, Santosh Kumar] Panjab Univ, Dept Bot, Chandigarh 160014, India; [Upadhyay, Santosh Kumar; Sharma, Shailesh; Kumar, Jitesh] Govt India, Natl Agri Food Biotechnol Inst, Dept Biotechnol, Mohali 160071, Punjab, India; [Singh, Harpal; Dixit, Sameer; Verma, Praveen C.; Chandrashekar, K.] CSIR, CSIR Natl Bot Res Inst, Lucknow 226001, Uttar Pradesh, India; [Chandrashekar, K.] Indian Agr Res Inst, Reg Stn, Pune 411007, Maharashtra, India; [Dixit, Sameer; Verma, Praveen C.] Acad Sci & Innovat Res AcSIR, New Delhi, India	Panjab University; Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Academy of Scientific & Innovative Research (AcSIR)	Upadhyay, SK (corresponding author), Panjab Univ, Dept Bot, Chandigarh 160014, India.	santoshpandit16@gmail.com	Chadrashekar, K/AAX-4996-2021; Kumar, Jitesh/ABB-5150-2021; Verma, Praveen C/F-9709-2010; Upadhyay, Santosh/ABD-2302-2020	Kumar, Jitesh/0000-0003-1606-3420; Verma, Praveen C/0000-0002-3732-0564; Upadhyay, Santosh/0000-0001-6991-0502	DST-INSPIRE Grant	DST-INSPIRE Grant	This work is supported by DST-INSPIRE Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MZ, 2010, J ECON ENTOMOL, V103, P1848, DOI 10.1603/EC10033; Baumann L, 2004, CURR MICROBIOL, V48, P77, DOI 10.1007/s00284-003-4132-3; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; Buchanan B.B., 2000, BIOCH MOL BIOL PLANT; Buchner, 1965, ENDOSYMBIOSIS ANIMAL, P909; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Crowder DW, 2010, J ANIM ECOL, V79, P563, DOI 10.1111/j.1365-2656.2010.01666.x; Dalton R, 2006, NATURE, V443, P898, DOI 10.1038/443898a; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Drews M, 2000, J BIOTECHNOL, V78, P23, DOI 10.1016/S0168-1656(99)00231-X; Gottlieb Y, 2008, FASEB J, V22, P2591, DOI 10.1096/fj.07-101162; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; Hirayama C, 2002, BBA-GEN SUBJECTS, V1571, P131, DOI 10.1016/S0304-4165(02)00207-6; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jander G, 2010, MOL PLANT, V3, P54, DOI 10.1093/mp/ssp104; Klowden M. J., 2002, PHYSL SYSTEMS INSECT; Li ZX, 2005, EUR J ENTOMOL, V102, P293, DOI 10.14411/eje.2005.041; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Liu SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045161; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakabachi A, 2005, P NATL ACAD SCI USA, V102, P5477, DOI 10.1073/pnas.0409034102; PERRING TM, 1993, SCIENCE, V259, P74, DOI 10.1126/science.8418497; Price DRG, 2014, P NATL ACAD SCI USA, V111, P320, DOI 10.1073/pnas.1306068111; Price DRG, 2011, MOL BIOL EVOL, V28, P3113, DOI 10.1093/molbev/msr140; Salem H, 2013, ENVIRON MICROBIOL, V15, P1956, DOI 10.1111/1462-2920.12001; SANDSTROM J, 1994, J INSECT PHYSIOL, V40, P947, DOI 10.1016/0022-1910(94)90133-3; Sandstrom J, 1999, PHYSIOL ENTOMOL, V26, P202; Santos-Garcia D, 2012, J BACTERIOL, V194, P6654, DOI 10.1128/JB.01793-12; Scaraffia PY, 2010, J INSECT PHYSIOL, V56, P1040, DOI 10.1016/j.jinsphys.2010.02.016; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Singh ST, 2012, INFECT GENET EVOL, V12, P411, DOI 10.1016/j.meegid.2012.01.015; Slansky F. Jr, 1985, P87; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Thakur N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087235; Upadhyay SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083692; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; WANG XH, 2012, J INEQUAL APPL, DOI DOI 10.1186/; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wilson ACC, 2010, INSECT MOL BIOL, V19, P249, DOI 10.1111/j.1365-2583.2009.00942.x; Wolf JBW, 2010, MOL ECOL, V19, P162, DOI 10.1111/j.1365-294X.2009.04471.x; Xie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035181	45	32	33	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126751	10.1371/journal.pone.0126751	http://dx.doi.org/10.1371/journal.pone.0126751			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000976	Green Submitted, gold, Green Published			2022-12-26	WOS:000354931700025
J	LeBlanc, ME; Wang, WW; Caberoy, NB; Chen, XP; Guo, FY; Alvarado, G; Shen, C; Wang, F; Wang, H; Chen, R; Liu, ZJ; Webster, K; Li, W				LeBlanc, Michelle E.; Wang, Weiwen; Caberoy, Nora B.; Chen, Xiuping; Guo, Feiye; Alvarado, Gabriela; Shen, Chen; Wang, Feng; Wang, Hui; Chen, Rui; Liu, Zhao-Jun; Webster, Keith; Li, Wei			Hepatoma-Derived Growth Factor-Related Protein-3 Is a Novel Angiogenic Factor	PLOS ONE			English	Article							HDGF-RELATED PROTEIN-3; ORF PHAGE DISPLAY; BINDING PROTEINS; EFFICIENT IDENTIFICATION; PROGNOSTIC-FACTOR; STROMAL TUMORS; CELL-MIGRATION; DRUG-DELIVERY; BLOOD-VESSELS; EXPRESSION	Hepatoma-derived growth factor-related protein-3 (Hdgfrp3 or HRP-3) was recently reported as a neurotrophic factor and is upregulated in hepatocellular carcinoma to promote cancer cell survival. Here we identified HRP-3 as a new endothelial ligand and characterized its in vitro and in vivo functional roles and molecular signaling. We combined open reading frame phage display with multi-round in vivo binding selection to enrich retinal endothelial ligands, which were systematically identified by next generation DNA sequencing. One of the identified endothelial ligands was HRP-3. HRP-3 expression in the retina and brain was characterized by Western blot and immunohistochemistry. Cell proliferation assay showed that HRP-3 stimulated the growth of human umbilical vein endothelial cells (HUVECs). HRP-3 induced tube formation of HUVECs in culture. Wound healing assay indicated that HRP-3 promoted endothelial cell migration. HRP-3 was further confirmed for its in vitro angiogenic activity by spheroid sprouting assay. HRP-3 extrinsically activated the extracellular-signal-regulated kinase 1/2 (ERK1/2) pathway in endothelial cells. The angiogenic activity of HRP-3 was independently verified by mouse cornea pocket assay. Furthermore, in vivo Matrigel plug assay corroborated HRP-3 activity to promote new blood vessel formation. These results demonstrated that HRP-3 is a novel angiogenic factor.	[LeBlanc, Michelle E.; Wang, Weiwen; Chen, Xiuping; Guo, Feiye; Alvarado, Gabriela; Shen, Chen; Li, Wei] Univ Miami, Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA; [Liu, Zhao-Jun; Webster, Keith; Li, Wei] Univ Miami, Sch Med, Vasc Biol Inst, Miami, FL USA; [Chen, Xiuping] Fudan Univ, Dept Ophthalmol, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Caberoy, Nora B.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Wang, Feng; Wang, Hui; Chen, Rui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Bascom Palmer Eye Institute; University of Miami; University of Miami; Fudan University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Baylor College of Medicine	Li, W (corresponding author), Univ Miami, Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA.	w.li@med.miami.edu	Wang, Feng/G-4847-2015; GUO, FEIYE/O-2729-2018; GUO, FEIYE/AAH-2350-2019	Webster, Keith A/0000-0002-6431-3642	NIH [R01GM094449, R21HD075372]; BrightFocus Foundation [M2012026]; Special Scholar Award from Research to Prevent Blindness (RPB) [K99EY020865/R00EY020865]; American Heart Association (AHA) Predoctoral Fellowship [14PRE18310014, P30-EY014801]; institutional grant from RPB; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD075372] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K99EY020865, P30EY014801, R00EY020865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094449] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BrightFocus Foundation(BrightFocus Foundation); Special Scholar Award from Research to Prevent Blindness (RPB); American Heart Association (AHA) Predoctoral Fellowship(American Heart Association); institutional grant from RPB; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH R01GM094449 (WL), R21HD075372 (WL), BrightFocus Foundation M2012026 (WL), Special Scholar Award from Research to Prevent Blindness (RPB) (WL), K99EY020865/R00EY020865 (NBC), American Heart Association (AHA) Predoctoral Fellowship 14PRE18310014 (MEL), P30-EY014801 and an institutional grant from RPB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzied MM, 2010, J NEUROSCI RES, V88, P3610, DOI 10.1002/jnr.22507; Abouzied MM, 2005, J BIOL CHEM, V280, P10945, DOI 10.1074/jbc.M414652200; Abouzied MM, 2004, BIOCHEM J, V378, P169, DOI 10.1042/BJ20030916; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Caberoy NB, 2010, EMBO J, V29, P3898, DOI 10.1038/emboj.2010.265; Caberoy NB, 2010, J MOL RECOGNIT, V23, P74, DOI 10.1002/jmr.983; Caberoy NB, 2010, EXP CELL RES, V316, P245, DOI 10.1016/j.yexcr.2009.10.008; Caberoy NB, 2009, BIOCHEM BIOPH RES CO, V386, P197, DOI 10.1016/j.bbrc.2009.06.010; Cao QZ, 2011, AMINO ACIDS, V41, P1103, DOI 10.1007/s00726-010-0548-9; Chang KC, 2007, INT J CANCER, V121, P1059, DOI 10.1002/ijc.22803; Coxon A, 2002, ARTHRITIS RHEUM, V46, P2604, DOI 10.1002/art.10546; El-Tahir HM, 2009, J BIOL CHEM, V284, P11637, DOI 10.1074/jbc.M901101200; Everett AD, 2000, J CLIN INVEST, V105, P567, DOI 10.1172/JCI7497; Everett AD, 2004, AM J PHYSIOL-LUNG C, V286, pL1194, DOI 10.1152/ajplung.00427.2003; Everett AD, 2001, J BIOL CHEM, V276, P37564, DOI 10.1074/jbc.M105109200; Hu TH, 2009, DIS COLON RECTUM, V52, P319, DOI 10.1007/DCR.0b013e31819d1666; Izumoto Y, 1997, BIOCHEM BIOPH RES CO, V238, P26, DOI 10.1006/bbrc.1997.7233; Joussen A. M., 2007, RETINAL VASCULAR DIS; Kishima Y, 2002, J BIOL CHEM, V277, P10315, DOI 10.1074/jbc.M111122200; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Lee TY, 2007, CANCER RES, V67, P10958, DOI 10.1158/0008-5472.CAN-07-2233; Li W, 2002, BBA-PROTEINS PROTEOM, V1599, P72, DOI 10.1016/S1570-9639(02)00402-8; Li W, 2012, METHODS, V58, P2, DOI 10.1016/j.ymeth.2012.07.013; Li W, 2012, J CELL PHYSIOL, V227, P1291, DOI 10.1002/jcp.22815; Li W, 2010, APPL MICROBIOL BIOT, V85, P909, DOI 10.1007/s00253-009-2277-0; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; McMahon GA, 2001, J BIOL CHEM, V276, P33964, DOI 10.1074/jbc.M105980200; NAKAMURA H, 1994, J BIOL CHEM, V269, P25143; NAKAMURA H, 1989, CLIN CHIM ACTA, V183, P273, DOI 10.1016/0009-8981(89)90361-6; Okuda Y, 2003, CANCER SCI, V94, P1034, DOI 10.1111/j.1349-7006.2003.tb01397.x; Oliver JA, 1998, J CLIN INVEST, V102, P1208, DOI 10.1172/JCI785; Stewart MW, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0510-4; Su YC, 2006, FASEB J, V20, P1443, DOI 10.1096/fj.05-5354com; Thakar K, 2010, BIOL CHEM, V391, P1401, DOI 10.1515/BC.2010.147; Uyama H, 2006, CLIN CANCER RES, V12, P6043, DOI 10.1158/1078-0432.CCR-06-1064; Wang CH, 2011, BIOCHEM J, V433, P127, DOI 10.1042/BJ20100589; Xiao QY, 2013, GUT, V62, P440, DOI 10.1136/gutjnl-2011-300781; Yamamoto S, 2006, CLIN CANCER RES, V12, P117, DOI 10.1158/1078-0432.CCR-05-1347; Yoshida K, 2003, J GASTROEN HEPATOL, V18, P1293, DOI 10.1046/j.1440-1746.2003.03191.x; Yuan XY, 2009, MOL VIS, V15, P1988; Yun HS, 2014, BIOCHEM BIOPH RES CO, V449, P471, DOI 10.1016/j.bbrc.2014.05.039; Yun HS, 2013, BIOCHEM BIOPH RES CO, V439, P333, DOI 10.1016/j.bbrc.2013.08.086; Zhou ZW, 2004, J BIOL CHEM, V279, P27320, DOI 10.1074/jbc.M308650200	45	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127904	10.1371/journal.pone.0127904	http://dx.doi.org/10.1371/journal.pone.0127904			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996149	Green Submitted, gold, Green Published			2022-12-26	WOS:000356444000095
J	Wang, SJ; Zhao, JX; Chen, QB				Wang, Shaojun; Zhao, Jixia; Chen, Qibo			Controlling Factors of Soil CO2 Efflux in Pinus yunnanensis across Different Stand Ages	PLOS ONE			English	Article							TEMPERATURE SENSITIVITY; ECOSYSTEM RESPIRATION; TEMPORAL VARIATION; FUTURE CLIMATE; FOREST; CHINA; DECOMPOSITION; DEPENDENCE; MOISTURE; DROUGHT	The characteristics of soil respiration (Rs) across different stand ages have not been well investigated. In this study, we identified temporal variation of Rs and its driving factors under three nature forest stands (e.g. 15-yr-old, 30-yr-old, and 45-yr-old) of Pinus yunnanensis in the Plateau of Mid-Yunnan, China. No consistent tendency was found on the change of Rs with the stand ages. Rs was ranked in the order of 30-yr-old > 45-yr-old > 15-yr-old. Rs in 15-yr-old stand was the most sensitive to soil temperature (Ts) among the three sites. However, Ts only explained 30-40% of the seasonal dynamics of Rs at the site. Soil water content (Sw) was the major controlling factor of temporal variation at the three sites. Sw explained 88-93% of seasonal variations of Rs in the 30-yr-old stand, and 63.7-72.7% in the 15-yr-old and 79.1-79.6% in the 45-yr-old stands. In addition, we found that pH, available nitrogen (AN), C/N and total phosphorus (TP) contributed significantly to the seasonal variation of Rs. Sw was significantly related with pH, total nitrogen (TN), AN and TP, suggesting that Sw can affect Rs through improving soil acid-base property and soil texture, and increasing availability of soil nutrient. The results indicated that besides soil water, soil properties (e.g. pH, AN, C/N and TP) were also the important in controlling the temporal variations of Rs across different stand ages in the nature forestry.	[Wang, Shaojun; Zhao, Jixia; Chen, Qibo] Southwest Forestry Univ, Dept Environm Sci & Engn, Kunming, Bailongshi, Peoples R China	Southwest Forestry University - China	Chen, QB (corresponding author), Southwest Forestry Univ, Dept Environm Sci & Engn, Kunming, Bailongshi, Peoples R China.	chengqb2009@163.com			Special Fund for Forestry Scientific Research in the Public Interest [201204101-10]; National Science Foundation of China [41461052]; Fund Project to start science research in Southwest Forestry University [111206]; CFERN & GENE Award Funds on Ecological Paper	Special Fund for Forestry Scientific Research in the Public Interest; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund Project to start science research in Southwest Forestry University; CFERN & GENE Award Funds on Ecological Paper	This research was supported by Special Fund for Forestry Scientific Research in the Public Interest (201204101-10), National Science Foundation of China (No. 41461052), Fund Project to start science research in Southwest Forestry University (111206) and CFERN & GENE Award Funds on Ecological Paper.	A'Bear AD, 2014, SOIL BIOL BIOCHEM, V70, P151, DOI 10.1016/j.soilbio.2013.12.017; Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Bauters TWJ, 1998, SOIL SCI SOC AM J, V62, P1185, DOI 10.2136/sssaj1998.03615995006200050005x; Borken W, 2002, GLOBAL CHANGE BIOL, V8, P1205, DOI 10.1046/j.1365-2486.2002.00547.x; Chen Q, 2010, GLOBAL BIOGEOCHEM CY, P24; Cheng XQ, 2014, BIOL FERT SOILS, V50, P357, DOI 10.1007/s00374-013-0852-0; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2002, AGR FOREST METEOROL, V113, P39, DOI 10.1016/S0168-1923(02)00101-6; Davidson EA, 2004, GLOBAL CHANGE BIOL, V10, P718, DOI 10.1111/j.1365-2486.2004.00762.x; De Remy de Courcelles V.E.M., 2014, THESIS; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Eibisch N, 2015, GEODERMA, V245, P31, DOI 10.1016/j.geoderma.2015.01.009; EWEL KC, 1987, CAN J FOREST RES, V17, P325, DOI 10.1139/x87-054; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; Feng Wen-Ting, 2008, Zhiwu Shengtai Xuebao, V32, P31; Flanagan LB, 2013, AGR FOREST METEOROL, V173, P40, DOI 10.1016/j.agrformet.2013.01.002; Friend AD, 2014, P NATL ACAD SCI USA, V111, P3280, DOI 10.1073/pnas.1222477110; Gaumont-Guay D, 2006, AGR FOREST METEOROL, V140, P220, DOI 10.1016/j.agrformet.2006.08.003; Goebel MO, 2011, GLOBAL CHANGE BIOL, V17, P2640, DOI 10.1111/j.1365-2486.2011.02414.x; Irvine J, 2002, GLOBAL CHANGE BIOL, V8, P1183, DOI 10.1046/j.1365-2486.2002.00544.x; Jassal RS, 2008, GLOBAL CHANGE BIOL, V14, P1305, DOI 10.1111/j.1365-2486.2008.01573.x; Keith H, 1997, PLANT SOIL, V190, P127, DOI 10.1023/A:1004279300622; Klopatek JM, 2002, TREE PHYSIOL, V22, P197, DOI 10.1093/treephys/22.2-3.197; Liu HS, 2006, APPL SOIL ECOL, V32, P284, DOI 10.1016/j.apsoil.2005.08.001; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Lu RK, 2004, ANALYSIS METHOD OF S; Lu S, 2014, ECOL RES, V29, P789, DOI 10.1007/s11284-014-1158-x; Luo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042354; Luo Y., 2006, SOIL RESP ENV, P328, DOI DOI 10.1016/B978-0-12-088782-8.X5000-1; Luo YQ, 2007, SOIL RESPIRATION AND; Muhr J, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000998; Neelin JD, 2006, P NATL ACAD SCI USA, V103, P6110, DOI 10.1073/pnas.0601798103; Nouvellon Y, 2012, BIOGEOCHEMISTRY, V111, P515, DOI 10.1007/s10533-011-9685-9; Qi YC, 2010, SCI CHINA EARTH SCI, V53, P683, DOI 10.1007/s11430-010-0039-6; Qiu J, 2010, NATURE, V465, P142, DOI 10.1038/465142a; Raich JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100275; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Reichstein M, 2002, GLOBAL CHANGE BIOL, V8, P999, DOI 10.1046/j.1365-2486.2002.00530.x; Reichstein M, 2002, FUNCT ECOL, V16, P27, DOI 10.1046/j.0269-8463.2001.00597.x; Saiz G, 2006, GLOBAL CHANGE BIOL, V12, P1007, DOI 10.1111/j.1365-2486.2006.01145.x; Tucker C, 2014, SOIL BIOL BIOCHEM, V78, P90, DOI 10.1016/j.soilbio.2014.06.018; Wallenstein M., 2010, SOIL ENZYMOLOGY, P245, DOI DOI 10.1007/978-3-642-14225-313; Wang B, 2011, SCAND J FOREST RES, V26, P40, DOI 10.1080/02827581.2010.538082; Wang D, 2014, SCAND J FOREST RES, V29, P51, DOI 10.1080/02827581.2013.856936; Wei SC, 2014, SOIL TILL RES, V144, P119, DOI 10.1016/j.still.2014.07.012; Wen XF, 2006, AGR FOREST METEOROL, V137, P166, DOI 10.1016/j.agrformet.2006.02.005; Wiseman PE, 2004, FOREST ECOL MANAG, V192, P297, DOI 10.1016/j.foreco.2004.01.017; Yu L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117490; Yuste JC, 2003, TREE PHYSIOL, V23, P1263, DOI 10.1093/treephys/23.18.1263; Zha TS, 2007, ANN BOT-LONDON, V99, P345, DOI 10.1093/aob/mcl266	51	6	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127274	10.1371/journal.pone.0127274	http://dx.doi.org/10.1371/journal.pone.0127274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996943	Green Submitted, Green Published, gold			2022-12-26	WOS:000356444000053
J	Chen, MZ; McReynolds, N; Campbell, EC; Mazilu, M; Barbosa, J; Dholakia, K; Powis, SJ				Chen, Mingzhou; McReynolds, Naomi; Campbell, Elaine C.; Mazilu, Michael; Barbosa, Joao; Dholakia, Kishan; Powis, Simon J.			The Use of Wavelength Modulated Raman Spectroscopy in Label-Free Identification of T Lymphocyte Subsets, Natural Killer Cells and Dendritic Cells	PLOS ONE			English	Article							FLUORESCENCE SUPPRESSION; PERIPHERAL-BLOOD; SINGLE CELLS; DIFFERENTIATION; POPULATIONS; EXPRESSION; CD4	Determining the identity of cells of the immune system usually involves destructive fixation and chemical staining, or labeling with fluorescently labeled antibodies recognising specific cell surface markers. Completely label-free identification would be a significant advantage in conditions where untouched cells are a priority. We demonstrate here the use of Wavelength Modulated Raman Spectroscopy, to achieve label-free identification of purified, unfixed and untouched populations of major immune cell subsets isolated from healthy human donors. Using this technique we have been able to distinguish between CD4(+) T lymphocytes, CD8(+) T lymphocytes and CD56(+) Natural Killer cells at specificities of up to 96%. Additionally, we have been able to distinguish between CD303(+) plasmacytoid and CD1c(+) myeloid dendritic cell subsets, the key initiator and regulatory cells of many immune responses. This demonstrates the ability to identify unperturbed cells of the immune system, and opens novel opportunities to analyse immunological systems and to develop fully labelfree diagnostic technologies.	[Chen, Mingzhou; McReynolds, Naomi; Mazilu, Michael; Dholakia, Kishan] Univ St Andrews, Sch Phys & Astron, SUPA, St Andrews KY16 9SS, Fife, Scotland; [Campbell, Elaine C.; Powis, Simon J.] Univ St Andrews, Sch Med, St Andrews KY16 9TF, Fife, Scotland; [Barbosa, Joao] Inst Biomed Engn, P-4150180 Oporto, Portugal	University of St Andrews; University of St Andrews; Universidade do Porto	Dholakia, K (corresponding author), Univ St Andrews, Sch Phys & Astron, SUPA, St Andrews KY16 9SS, Fife, Scotland.	kd1@st-andrews.ac.uk; sjp10@st-andrews.ac.uk	Chen, Mingzhou/F-3409-2011; Mazilu, Michael/B-1852-2009	Chen, Mingzhou/0000-0002-6190-5167; Mazilu, Michael/0000-0002-4758-3528; Dholakia, Kishan/0000-0001-6534-9009; Powis, Simon/0000-0003-4218-2984	Cancer Research United Kingdom; European Union FAMOS project (FP7 ICT) [317744]; Engineering and Physical Sciences Research Council; Medical Research Council; Department of Health England Imaging Programme; EPSRC [EP/J01771X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J01771X/1, 1387037] Funding Source: researchfish	Cancer Research United Kingdom(Cancer Research UK); European Union FAMOS project (FP7 ICT); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health England Imaging Programme; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by a Cancer Research United Kingdom, Engineering and Physical Sciences Research Council, Medical Research Council and Department of Health England Imaging Programme (MC, MM KD), and by A European Union FAMOS project (FP7 ICT, 317744) to KD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashok PC, 2014, BIOMEDICAL VIBRATION, P8939; Canetta E, 2014, ACTA BIOMATER, V10, P2043, DOI 10.1016/j.actbio.2013.12.057; Chan JW, 2013, J BIOPHOTONICS, V6, P36, DOI 10.1002/jbio.201200143; De Luca AC, 2010, ANAL CHEM, V82, P738, DOI 10.1021/ac9026737; Dochow S, 2013, ANAL METHODS; Eastaff-Leung N, 2010, J CLIN IMMUNOL, V30, P80, DOI 10.1007/s10875-009-9345-1; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; Vargas-Rojas MI, 2011, RESP MED, V105, P1648, DOI 10.1016/j.rmed.2011.05.017; Jess PRT, 2007, INT J CANCER, V121, P2723, DOI 10.1002/ijc.23046; Kelso A, 1999, INT IMMUNOL, V11, P617, DOI 10.1093/intimm/11.4.617; LEVIN KH, 1978, APPL PHYS LETT, V33, P817, DOI 10.1063/1.90539; Lodoen MB, 2005, NAT REV MICROBIOL, V3, P59, DOI 10.1038/nrmicro1066; Mazilu M, 2010, OPT EXPRESS, V18, P11382, DOI 10.1364/OE.18.011382; Mouchacca P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067239; Onai N, 2013, IMMUNITY, V38, P943, DOI 10.1016/j.immuni.2013.04.006; Peng D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068446; Praveen BB, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.077006; Pully VV, 2011, J RAMAN SPECTROSC, V42, P167, DOI 10.1002/jrs.2683; Ramoji A, 2012, ANAL CHEM, V84, P5335, DOI 10.1021/ac3007363; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Romagnani S, 2006, CLIN EXP ALLERGY, V36, P1357, DOI 10.1111/j.1365-2222.2006.02606.x; Smith ZJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3443794; Swain RJ, 2007, BIOCHEM SOC T, V35, P544, DOI 10.1042/BST0350544; Uzunbajakava N, 2003, BIOPOLYMERS, V72, P1, DOI 10.1002/bip.10246; Wong P, 2003, ANNU REV IMMUNOL, V21, P29, DOI 10.1146/annurev.immunol.21.120601.141114; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zoladek AB, 2010, ANALYST, V135, P3205, DOI 10.1039/c0an00508h	28	34	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125158	10.1371/journal.pone.0125158	http://dx.doi.org/10.1371/journal.pone.0125158			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992777	Green Published, gold			2022-12-26	WOS:000354921400025
J	Fawley, JA; Hofmann, ME; Largent-Milnes, TM; Andresen, MC				Fawley, Jessica A.; Hofmann, Mackenzie E.; Largent-Milnes, Tally M.; Andresen, Michael C.			Temperature Differentially Facilitates Spontaneous but Not Evoked Glutamate Release from Cranial Visceral Primary Afferents	PLOS ONE			English	Article							SYNAPTIC-TRANSMISSION; VANILLOID RECEPTOR; MYELINATED NERVE; CURRENTS; NUCLEUS; NEUROTRANSMISSION; INHIBITION; ACTIVATION; MECHANISMS; CONDUCTION	Temperature is fundamentally important to all biological functions including synaptic glutamate release. Vagal afferents from the solitary tract (ST) synapse on second order neurons in the nucleus of the solitary tract, and glutamate release at this first central synapse controls autonomic reflex function. Expression of the temperature-sensitive Transient Receptor Potential Vanilloid Type 1 receptor separates ST afferents into C-fibers (TRPV1+) and A-fibers (TRPV1-). Action potential-evoked glutamate release is similar between C- and A-fiber afferents, but TRPV1 expression facilitates a second form of synaptic glutamate release in C-fibers by promoting substantially more spontaneous glutamate release. The influence of temperature on different forms of glutamate release is not well understood. Here we tested how temperature impacts the generation of evoked and spontaneous release of glutamate and its relation to TRPV1 expression. In horizontal brainstem slices of rats, activation of ST primary afferents generated synchronous evoked glutamate release (ST-eEPSCs) at constant latency whose amplitude reflects the probability of evoked glutamate release. The frequency of spontaneous EPSCs in these same neurons measured the probability of spontaneous glutamate release. We measured both forms of glutamate from each neuron during ramp changes in bath temperature of 4-5 degrees C. Spontaneous glutamate release from TRPV1+ closely tracked with these thermal changes indicating changes in the probability of spontaneous glutamate release. In the same neurons, temperature changed axon conduction registered as latency shifts but ST-eEPSC amplitudes were constant and independent of TRPV1 expression. These data indicate that TRPV1-operated glutamate release is independent of action potential-evoked glutamate release in the same neurons. Together, these support the hypothesis that evoked and spontaneous glutamate release originate from two pools of vesicles that are independently modulated and are distinct processes.	[Fawley, Jessica A.; Hofmann, Mackenzie E.; Largent-Milnes, Tally M.; Andresen, Michael C.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA	Oregon Health & Science University	Fawley, JA (corresponding author), Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA.	fawley.jessica@gmail.com		Largent-Milnes, Tally/0000-0001-7599-102X	National Institutes of Health [R01-HL-105703, F32-DE-022499, F32 HL112419]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105703, F32HL112419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F32DE022499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from the National Institutes of Health, R01-HL-105703 (MCA) F32-DE-022499 (TML-M) and F32 HL112419 (MEH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung and Blood Institute or the NIH.	Aicher SA, 1999, NEUROSCIENCE, V91, P119, DOI 10.1016/S0306-4522(98)00530-2; Andresen MC, 2008, AM J PHYSIOL-HEART C, V295, pH2032, DOI 10.1152/ajpheart.00568.2008; Andresen MC, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00191; Andresen MC, 2012, AM J PHYSIOL-REG I, V303, pR1207, DOI 10.1152/ajpregu.00398.2012; Bailey TW, 2006, J NEUROSCI, V26, P6131, DOI 10.1523/JNEUROSCI.5176-05.2006; Blair NT, 2003, J NEUROSCI, V23, P10338; Bucurenciu I, 2008, NEURON, V57, P536, DOI 10.1016/j.neuron.2007.12.026; Crawford DC, 2015, TRAFFIC; DeCoursey TE, 1998, J GEN PHYSIOL, V112, P503, DOI 10.1085/jgp.112.4.503; DEROBERTIS E, 1957, J BIOPHYS BIOCHEM CY, V3, P611, DOI 10.1083/jcb.3.4.611; DEROBERTIS EDP, 1955, J BIOPHYS BIOCHEM CY, V1, P47, DOI 10.1083/jcb.1.1.47; Diamond JS, 2000, J NEUROPHYSIOL, V83, P2835, DOI 10.1152/jn.2000.83.5.2835; DOUGLAS WW, 1955, J PHYSIOL-LONDON, V130, P53, DOI 10.1113/jphysiol.1955.sp005392; Doyle MW, 2001, J NEUROPHYSIOL, V85, P2213, DOI 10.1152/jn.2001.85.5.2213; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Fawley JA, 2014, J NEUROSCI, V34, P8324, DOI 10.1523/JNEUROSCI.0315-14.2014; Fawley JA, 2011, J NEUROPHYSIOL, V106, P1833, DOI 10.1152/jn.00476.2011; Ferrer-Montiel A, 2004, EUR J BIOCHEM, V271, P1820, DOI 10.1111/j.1432-1033.2004.04083.x; FRANZ DN, 1968, J PHYSIOL-LONDON, V199, P319, DOI 10.1113/jphysiol.1968.sp008656; GASSER HS, 1950, J GEN PHYSIOL, V33, P651, DOI 10.1085/jgp.33.6.651; Hille B., 2001, IONIC CHANNELS OF EX; Hofmann ME, 2014, J NEUROPHYSIOL, V112, P2697, DOI 10.1152/jn.00316.2014; Jin YH, 2004, J NEUROSCI, V24, P4709, DOI 10.1523/JNEUROSCI.0753-04.2004; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; KATZ B, 1971, SCIENCE, V173, P123, DOI 10.1126/science.173.3992.123; Kavalali ET, 2015, NAT REV NEUROSCI, V16, P5, DOI 10.1038/nrn3875; Kavalali ET, 2011, PHYSIOLOGY, V26, P45, DOI 10.1152/physiol.00040.2010; Klyachko VA, 2006, J NEUROSCI, V26, P6945, DOI 10.1523/JNEUROSCI.1382-06.2006; Largent-Milnes TM, 2014, J NEUROPHYSIOL, V111, P2222, DOI 10.1152/jn.00912.2013; Leitz J, 2014, ELIFE, V3, DOI 10.7554/eLife.03658; MENDELOWITZ D, 1995, J NEUROPHYSIOL, V73, P872, DOI 10.1152/jn.1995.73.2.872; Peters JH, 2008, J NEUROSCI, V28, P11731, DOI 10.1523/JNEUROSCI.3419-08.2008; Peters JH, 2010, NEURON, V65, P657, DOI 10.1016/j.neuron.2010.02.017; Sabatini BL, 1999, ANNU REV PHYSIOL, V61, P521, DOI 10.1146/annurev.physiol.61.1.521; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; SCHWARZ JR, 1986, PFLUG ARCH EUR J PHY, V406, P397, DOI 10.1007/BF00590943; Shoudai K, 2010, J NEUROSCI, V30, P14470, DOI 10.1523/JNEUROSCI.2557-10.2010; Smith AJ, 2000, J PHYSIOL-LONDON, V529, P681, DOI 10.1111/j.1469-7793.2000.00681.x; Smith SM, 2012, CELL CALCIUM, V52, P226, DOI 10.1016/j.ceca.2012.06.001; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; STRICHARTZ GR, 1973, J GEN PHYSIOL, V62, P37, DOI 10.1085/jgp.62.1.37; Tominaga M, 2005, PFLUG ARCH EUR J PHY, V451, P143, DOI 10.1007/s00424-005-1457-8	42	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127764	10.1371/journal.pone.0127764	http://dx.doi.org/10.1371/journal.pone.0127764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992717	gold, Green Published, Green Submitted			2022-12-26	WOS:000354921400134
J	Lammer, AB; Schwab, S; Schramm, A				Laemmer, Alexandra B.; Schwab, Stefan; Schramm, Axel			Ultrasound in Dual Nerve Impairment after Proximal Radial Nerve Lesion	PLOS ONE			English	Article							POSTERIOR INTEROSSEOUS NERVE; MEDIAN NERVE; DIAGNOSTIC UTILITY; ULNAR NEUROPATHY; ULTRASONOGRAPHY; SONOGRAPHY; ENTRAPMENT; US	Introduction Sonography in classical nerve entrapment syndromes is an established and validated method. In contrast, few publications highlight lesions of the radial nerve, particularly of the posterior interosseus nerve (PIN). Method Five patients with a radial nerve lesion were investigated by electromyography, nerve conduction velocity and ultrasound. Further normative values of 26 healthy subjects were evaluated. Results Four patients presented a clinical and electrophysiological proximal axonal radial nerve lesion and one patient showed a typical posterior interosseous nerve syndrome (PINS). The patient with PINS presented an enlargement of the PIN anterior to the supinator muscle. However four patients with proximal lesions showed an unexpected significant enlargement of the PIN within the supinator muscle. Conclusion High-resolution sonography is a feasible method to demonstrate the radial nerve including its distal branches. At least in axonal radial nerve lesions, sonography might reveal abnormalities far distant from a primary proximal lesion site clearly distinct from the appearance in classical PINS.	[Laemmer, Alexandra B.; Schwab, Stefan; Schramm, Axel] Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany	University of Erlangen Nuremberg	Lammer, AB (corresponding author), Univ Erlangen Nurnberg, Dept Neurol, Erlangen, Germany.	Alexandra.laemmer@uk-erlangen.de						Bendszus M, 2004, EXP NEUROL, V188, P171, DOI 10.1016/j.expneurol.2004.03.025; Bianchi S, 2008, JOINT BONE SPINE, V75, P643, DOI 10.1016/j.jbspin.2008.07.002; Bodner G, 2002, J ULTRAS MED, V21, P1159, DOI 10.7863/jum.2002.21.10.1159; Chien AJ, 2003, AM J ROENTGENOL, V181, P219, DOI 10.2214/ajr.181.1.1810219; Duncan RE, 1999, PLAST RECONSTR SURG, V103, P1095, DOI 10.1097/00006534-199903000-00079; Jou I-Ming, 2009, J Med Case Rep, V3, P7258, DOI 10.4076/1752-1947-3-7258; Joy V, 2009, ARCH NEUROL-CHICAGO, V66, P902, DOI 10.1001/archneurol.2009.109; Kinni V, 2009, J ULTRAS MED, V28, P807, DOI 10.7863/jum.2009.28.6.807; Klauser AS, 2009, RADIOLOGY, V250, P171, DOI 10.1148/radiol.2501080397; Kutlay M, 2009, NEUROSURG REV, V32, P225, DOI 10.1007/s10143-008-0162-4; Liotta G, 2010, MUSCLE NERVE, V41, P287, DOI 10.1002/mus.21580; Liotta GA, 2011, MUSCLE NERVE, V43, P767, DOI 10.1002/mus.22011; Martinoli C, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781553; Martinoli C, 2000, RADIOGRAPHICS, V20, pS199, DOI 10.1148/radiographics.20.suppl_1.g00oc08s199; Mondelli M, 2008, ARTHRIT RHEUM-ARTHR, V59, P357, DOI 10.1002/art.23317; Toros T, 2009, J BONE JOINT SURG BR, V91B, P762, DOI 10.1302/0301-620X.91B6.22284; Visser LH, 2009, MUSCLE NERVE, V39, P392, DOI 10.1002/mus.21246; Volpe A, 2009, RHEUMATOLOGY, V48, P1098, DOI 10.1093/rheumatology/kep167; Wiesler ER, 2006, J HAND SURG-AM, V31A, P1088, DOI 10.1016/j.jhsa.2006.06.007; Yamazaki H, 2007, J HAND SURG-BRIT EUR, V32E, P341, DOI 10.1016/j.jhsb.2006.09.014	20	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127456	10.1371/journal.pone.0127456	http://dx.doi.org/10.1371/journal.pone.0127456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992766	Green Submitted, Green Published, gold			2022-12-26	WOS:000354921400120
J	Niemi, M; Blauer, A; Iso-Touru, T; Harjula, J; Edmark, VN; Rannamae, E; Lougas, L; Sajantila, A; Liden, K; Taavitsainen, JP				Niemi, Marianna; Blauer, Auli; Iso-Touru, Terhi; Harjula, Janne; Edmark, Veronica Nystrom; Rannamaee, Eve; Lougas, Lembi; Sajantila, Antti; Liden, Kerstin; Taavitsainen, Jussi-Pekka			Temporal Fluctuation in North East Baltic Sea Region Cattle Population Revealed by Mitochondrial and Y-Chromosomal DNA Analyses	PLOS ONE			English	Article							EUROPEAN CATTLE; GENETIC-EVIDENCE; DOMESTIC CATTLE; MEDIEVAL CATTLE; NEAR-EAST; ANCIENT; DIVERSITY; SUGGESTS; ORIGINS; AUROCHS	Background Ancient DNA analysis offers a way to detect changes in populations over time. To date, most studies of ancient cattle have focused on their domestication in prehistory, while only a limited number of studies have analysed later periods. Conversely, the genetic structure of modern cattle populations is well known given the undertaking of several molecular and population genetic studies. Results Bones and teeth from ancient cattle populations from the North-East Baltic Sea region dated to the Prehistoric (Late Bronze and Iron Age, 5 samples), Medieval (14), and Post-Medieval (26) periods were investigated by sequencing 667 base pairs (bp) from the mitochondrial DNA (mtDNA) and 155 bp of intron 19 in the Y-chromosomal UTY gene. Comparison of maternal (mtDNA haplotypes) genetic diversity in ancient cattle (45 samples) with modern cattle populations in Europe and Asia (2094 samples) revealed 30 ancient mtDNA haplotypes, 24 of which were shared with modern breeds, while 6 were unique to the ancient samples. Of seven Y-chromosomal sequences determined from ancient samples, six were Y2 and one Y1 haplotype. Combined data including Swedish samples from the same periods (64 samples) was compared with the occurrence of Y-chromosomal haplotypes in modern cattle (1614 samples). Conclusions The diversity of haplogroups was highest in the Prehistoric samples, where many haplotypes were unique. The Medieval and Post-Medieval samples also show a high diversity with new haplotypes. Some of these haplotypes have become frequent in modern breeds in the Nordic Countries and North-Western Russia while other haplotypes have remained in only a few local breeds or seem to have been lost. A temporal shift in Y-chromosomal haplotypes from Y2 to Y1 was detected that corresponds with the appearance of new mtDNA haplotypes in the Medieval and Post-Medieval period. This suggests a replacement of the Prehistoric mtDNA and Y- chromosomal haplotypes by new types of cattle.	[Niemi, Marianna; Blauer, Auli; Iso-Touru, Terhi; Harjula, Janne] MTT Agrifood Res Finland, Biotechnol & Food Res, Jokioinen, Finland; [Niemi, Marianna; Sajantila, Antti] Univ Helsinki, Dept Forens Med, SF-00300 Helsinki, Finland; [Blauer, Auli; Harjula, Janne; Taavitsainen, Jussi-Pekka] Univ Turku, Dept Archaeol, Turku, Finland; [Edmark, Veronica Nystrom] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Rannamaee, Eve] Univ Tartu, Inst Hist & Archaeol, EE-50090 Tartu, Estonia; [Lougas, Lembi] Tallinn Univ, Hist Inst, EE-10120 Tallinn, Estonia; [Liden, Kerstin] Stockholm Univ, Archaeol Res Lab, S-10691 Stockholm, Sweden	Natural Resources Institute Finland (Luke); University of Helsinki; University of Turku; Stockholm University; University of Tartu; Tallinn University; Stockholm University	Niemi, M (corresponding author), MTT Agrifood Res Finland, Biotechnol & Food Res, Jokioinen, Finland.	marianna.niemi@helsinki.fi	Sajantila, Antti/AAY-9084-2021; Lõugas, Lembi/N-2409-2019; Lõugas, Lembi/G-6063-2016	Lõugas, Lembi/0000-0003-2011-2141; Lõugas, Lembi/0000-0003-2011-2141; Iso-Touru, Terhi/0000-0001-8258-9047; Rannamae, Eve/0000-0003-1186-5512; Sajantila, Antti/0000-0003-4117-5248; Blauer, Auli/0000-0003-0693-3373	Academy of Finland [128451]; National Population Genetics Doctoral Programme; Estonian Science Foundation [8156]; Ministry for Education and Culture	Academy of Finland(Academy of Finland); National Population Genetics Doctoral Programme; Estonian Science Foundation; Ministry for Education and Culture	This research was funded by Academy of Finland (the project decision number 128451), http://www.aka.fi/en-GB/A/. Work of MN was also funded by National Population Genetics Doctoral Programme, funded by the Ministry for Education and Culture and the Academy of Finland, http://www.oulu.fi/biology/PopGenSchool/. Cattle bone samples from Estonia were part of the grant project no 8156 of Estonian Science Foundation, http://www.etag.ee/rahastamine/etfgrandid/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; [Anonymous], 2003, CAMBRIDGE HIST SCAND; Bailey JF, 1996, P ROY SOC B-BIOL SCI, V263, P1467, DOI 10.1098/rspb.1996.0214; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Blauer A, 2013, J ARCHAEOL SCI, V40, P1646, DOI 10.1016/j.jas.2012.10.033; Bollongino R, 2006, BIOL LETTERS, V2, P155, DOI 10.1098/rsbl.2005.0404; Bollongino R, 2012, MOL BIOL EVOL, V29, P2101, DOI 10.1093/molbev/mss092; Bollongino R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003418; Bonfiglio S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038601; Bonfiglio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015760; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Cymbron T, 2005, P ROY SOC B-BIOL SCI, V272, P1837, DOI 10.1098/rspb.2005.3138; Cymbron T, 1999, P ROY SOC B-BIOL SCI, V266, P597, DOI 10.1098/rspb.1999.0678; DECKER JE, 2014, PLOS GENET, V10, P7980, DOI DOI 10.1371/JOURNAL.PONE.0005541; Depaulis F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005541; Edgren T, 1998, FINLANDS HIST, VI; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Edwards CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015922; Edwards CJ, 2004, J ARCHAEOL SCI, V31, P695, DOI 10.1016/j.jas.2003.11.001; Edwards CJ, 2000, ANIM GENET, V31, P127, DOI 10.1046/j.1365-2052.2000.00602.x; Ginja C, 2010, ANIM GENET, V41, P128, DOI 10.1111/j.1365-2052.2009.01976.x; Gotherstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2345, DOI 10.1098/rspb.2005.3243; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Howard M, 1963, MAN CATTLE, P91; Kala T, 2012, EESTI AJALUGU; Kantanen J, 2009, HEREDITY, V103, P404, DOI 10.1038/hdy.2009.68; Li R, 2013, ANIM GENET, V44, P446, DOI 10.1111/age.12022; Li R, 2013, MOL BIOL REP, V40, P6633, DOI 10.1007/s11033-013-2777-y; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; Lougas L, 2007, ARCHAEOFAUNA, V16, P21; MacHugh DE, 1999, PHILOS T ROY SOC B, V354, P99, DOI 10.1098/rstb.1999.0363; Mona S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-83; Muroma S, 1994, PANE LEIPAAN PUOLET, V19, P25; Niemi M, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-2; Noe-Nygaard N, 2005, J ARCHAEOL SCI, V32, P855, DOI 10.1016/j.jas.2005.01.004; Nystrom V, 2010, P ROY SOC B-BIOL SCI, V277, P2331, DOI 10.1098/rspb.2010.0301; Perez-Pardal L, 2010, ANIM GENET, V41, P232, DOI 10.1111/j.1365-2052.2009.01988.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schlumbaum A, 2006, ANIM GENET, V37, P373, DOI 10.1111/j.1365-2052.2006.01435.x; SOININEN A, 1974, HIST TUTKIMUKSIA, V96; Soininen A. M., 1981, HIST TUTKIMUKSIA, VLVIII; Stock F, 2009, ANIM GENET, V40, P694, DOI 10.1111/j.1365-2052.2009.01905.x; Svensson EM, 2014, SCHWEIZ ARCH TIERH, V156, P17, DOI 10.1024/0036-7281/a000542; Svensson E, 2008, BIOL LETTERS, V4, P752, DOI 10.1098/rsbl.2008.0342; Telldahl Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020748; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tornblom L, 1998, FINLANDS HIST, V1; Tourunen A, 2008, ANN U TURKUENSIS B; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2	54	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0123821	10.1371/journal.pone.0123821	http://dx.doi.org/10.1371/journal.pone.0123821			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992976	gold, Green Published, Green Submitted			2022-12-26	WOS:000354921400012
J	Chen, CM; Lin, YS; Wu, YR; Chen, P; Tsai, FJ; Yang, CL; Tsao, YT; Chang, W; Hsieh, IS; Chern, YJ; Soong, BW				Chen, Chiung-Mei; Lin, Yow-Sien; Wu, Yih-Ru; Chen, Pei; Tsai, Fuu-Jen; Yang, Chueh-Lien; Tsao, Ya-Tzu; Chang, Wen; Hsieh, I-Shan; Chern, Yijuang; Soong, Bing-Wen			High Protein Diet and Huntington's Disease	PLOS ONE			English	Article							PLASMA CITRULLINE; MOUSE MODEL; WEIGHT-LOSS; DEFICIENCY; INCLUSIONS; PATHOLOGY; AGE	Huntington's disease (HD) is a neurodegenerative disorder caused by the huntingtin (HTT) gene with expanded CAG repeats. In addition to the apparent brain abnormalities, impairments also occur in peripheral tissues. We previously reported that mutant Huntingtin (mHTT) exists in the liver and causes urea cycle deficiency. A low protein diet (17%) restores urea cycle activity and ameliorates symptoms in HD model mice. It remains unknown whether the dietary protein content should be monitored closely in HD patients because the normal protein consumption is lower in humans (similar to 15% of total calories) than in mice (similar to 22%). We assessed whether dietary protein content affects the urea cycle in HD patients. Thirty HD patients were hospitalized and received a standard protein diet (13.7% protein) for 5 days, followed by a high protein diet (HPD, 26.3% protein) for another 5 days. Urea cycle deficiency was monitored by the blood levels of citrulline and ammonia. HD progression was determined by the Unified Huntington's Disease Rating Scale (UHDRS). The HPD increased blood citrulline concentration from 15.19 mu mol/l to 16.30 mu mol/l (p = 0.0378) in HD patients but did not change blood ammonia concentration. A 2-year pilot study of 14 HD patients found no significant correlation between blood citrulline concentration and HD progression. Our results indicated a short period of the HPD did not markedly compromise urea cycle function. Blood citrulline concentration is not a reliable biomarker of HD progression.	[Chen, Chiung-Mei; Wu, Yih-Ru] Chang Gung Univ, Dept Neurol, Chang Gung Mem Hosp, Linkou Med Ctr, Taoyuan, Taiwan; [Chen, Chiung-Mei; Wu, Yih-Ru] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lin, Yow-Sien; Chen, Pei; Chern, Yijuang] Acad Sinica, Inst Biomed Sci, Div Neurosci, Taipei, Taiwan; [Tsai, Fuu-Jen] China Med Univ Hosp, Dept Pediat Med Res & Med Genet, Taichung, Taiwan; [Yang, Chueh-Lien; Chang, Wen] Taipei Vet Gen Hosp, Dept Nutr & Dietet, Taipei, Taiwan; [Tsao, Ya-Tzu; Hsieh, I-Shan] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Med Ctr, Dept Nutr, Taoyuan, Taiwan; [Tsao, Ya-Tzu; Hsieh, I-Shan] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Soong, Bing-Wen] Yang Ming Univ, Sch Med, Dept Neurol, Taipei, Taiwan; [Soong, Bing-Wen] Taipei Vet Gen Hosp, Neurol Inst, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Academia Sinica - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Chern, YJ (corresponding author), Acad Sinica, Inst Biomed Sci, Div Neurosci, Taipei, Taiwan.	bmychern@ibms.sinica.edu.tw; bwsoong@ym.edu.tw	chern, yijuang/S-7013-2018; Chen, Chiung-Mei/AAL-6260-2020; Lin, Yow-Sien/D-1895-2011; Tsai, Fuu-Jen/J-4140-2015	chern, yijuang/0000-0002-5842-5429; 	Academia Sinica [AS-97-TP-B02, AS-103-TP-B10]; Institute of Biomedical Sciences/Academia Sinica (Clinical Research Center grant) [CRC98-P03B]	Academia Sinica(Academia Sinica - Taiwan); Institute of Biomedical Sciences/Academia Sinica (Clinical Research Center grant)	This study was supported by grants from the Academia Sinica (AS-97-TP-B02 and AS-103-TP-B10 to Y Chern) and the Institute of Biomedical Sciences/Academia Sinica (Clinical Research Center grants, CRC98-P03B to Y Chern, CM Chen, and BW Soong).	Aziz NA, 2008, NEUROLOGY, V71, P1506, DOI 10.1212/01.wnl.0000334276.09729.0e; Bachmann C, 2005, ACTA GASTRO-ENT BELG, V68, P466; BELL L, 1982, J CAN DIET ASSOC, V43, P342; BURUMA OJS, 1987, J NEUROL SCI, V80, P299, DOI 10.1016/0022-510X(87)90164-X; Celik IH, 2013, J CLIN LAB ANAL, V27, P328, DOI 10.1002/jcla.21607; Chen Chiung-Mei, 2011, Chang Gung Med J, V34, P135; Chiang MC, 2007, HUM MOL GENET, V16, P483, DOI 10.1093/hmg/ddl481; Ciammola A, 2006, CELL DEATH DIFFER, V13, P2068, DOI 10.1038/sj.cdd.4401967; Cordoba J, 2004, J HEPATOL, V41, P38, DOI 10.1016/j.jhep.2004.03.023; Crenn P, 2003, GASTROENTEROLOGY, V124, P1210, DOI 10.1016/S0016-5085(03)00170-7; Endo F, 2004, J NUTR, V134, p1605S, DOI 10.1093/jn/134.6.1605S; GOLLIN SM, 1985, LIFE SCI, V36, P619, DOI 10.1016/0024-3205(85)90165-1; Goossens L, 2011, CLIN CHIM ACTA, V412, P661, DOI 10.1016/j.cca.2010.11.021; Gordon N, 2003, EUR J PAEDIATR NEURO, V7, P115, DOI 10.1016/S1090-3798(03)00040-0; Ju TC, 2012, CELL MOL LIFE SCI, V69, P4107, DOI 10.1007/s00018-012-1025-2; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Lanpher BC, 1993, GENEREVIEWS; Leonard J V, 2002, Semin Neonatol, V7, P27, DOI 10.1053/siny.2001.0085; Lin YS, 2011, J CLIN INVEST, V121, P1519, DOI 10.1172/JCI43220; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marder K, 2013, JAMA NEUROL, V70, P1382, DOI 10.1001/jamaneurol.2013.3487; Mehta N, 2012, SPEC CARE DENT, V32, P155, DOI 10.1111/j.1754-4505.2012.00263.x; Mihm MJ, 2007, NEUROBIOL DIS, V25, P297, DOI 10.1016/j.nbd.2006.09.016; Mochel F, 2011, J CLIN INVEST, V121, P493, DOI 10.1172/JCI45691; Mochel F, 2010, EUR J HUM GENET, V18, P1057, DOI 10.1038/ejhg.2010.72; Ong JP, 2003, AM J MED, V114, P188, DOI 10.1016/S0002-9343(02)01477-8; Pattison JS, 2008, CIRCULATION, V117, P2743, DOI 10.1161/CIRCULATIONAHA.107.750232; Ruskin DN, 2011, PHYSIOL BEHAV, V103, P501, DOI 10.1016/j.physbeh.2011.04.001; SANBERG PR, 1981, MED J AUSTRALIA, V1, P407, DOI 10.5694/j.1326-5377.1981.tb135681.x; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; Smith W, 2005, CRIT CARE CLIN, V21, pS9, DOI 10.1016/j.ccc.2005.05.007; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Trejo A, 2004, NUTRITION, V20, P192, DOI 10.1016/j.nut.2003.10.007; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Wu JY, 2004, J CLIN INVEST, V113, P434, DOI 10.1172/JCI200419574; Wycherley TP, 2012, AM J CLIN NUTR, V96, P1281, DOI 10.3945/ajcn.112.044321	37	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127654	10.1371/journal.pone.0127654	http://dx.doi.org/10.1371/journal.pone.0127654			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992839	Green Submitted, Green Published, gold			2022-12-26	WOS:000354918600072
J	Wang, PY; Xu, CQ; Wang, CC; Wu, YX; Wang, D; Chen, SS; Zhao, YY; Wang, XJ; Li, SS; Yang, Q; Zeng, QT; Tu, X; Liao, YH; Wang, QK; Cheng, X				Wang, Pengyun; Xu, Chengqi; Wang, Chuchu; Wu, Yanxia; Wang, Dan; Chen, Shanshan; Zhao, Yuanyuan; Wang, Xiaojing; Li, Sisi; Yang, Qin; Zeng, Qiutang; Tu, Xin; Liao, Yuhua; Wang, Qing K.; Cheng, Xiang			Association of SNP Rs9943582 in APLNR with Left Ventricle Systolic Dysfunction in Patients with Coronary Artery Disease in a Chinese Han GeneID Population	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; CARDIAC CONTRACTILITY; ANGIOTENSIN-II; APJ RECEPTOR; IN-VIVO; APELIN; SYSTEM; LIGAND; RISK; RAT	Heart failure affects 1-2% of the adult population worldwide and coronary artery disease (CAD) is the underlying etiology of heart failure in 70% of the patients. The pathway of apelin and its apelin receptor (APJ) was implicated in the pathogenesis of heart failure in animal models, but a similar role in humans is unknown. We studied a functional variant, rs9943582 (-154G/A), at the 5'-untranslated region, that was associated with decreased expression of the APJ receptor gene (APLNR) in a population consisting of 1,751 CAD cases and 1,022 controls. Variant rs9943582 was not associated with CAD, but among CAD patients, it showed significant association with left ventricular systolic dysfunction (431 CAD patients with left ventricular systolic dysfunction (LV ejection fraction or LVEF< 40%) versus 1,046 CAD patients without LV systolic dysfunction (LVEF>50%) (P-adj = 6.71x10(-5), OR = 1.43, 95% CI, 1.20-1.70). Moreover, rs9943582 also showed significant association with quantitative echocardiographic parameters, including left ventricular end-diastolic diameter (effect size: increased 1.67 +/- 0.43 mm per risk allele A, P = 1.15x10(-4)), left atrial size (effect size: increased 2.12 +/- 0.61 mm per risk allele A, P = 9.56x10(-4)) and LVEF (effect size: decreased 2.59 +/- 0.32 percent per risk allele A, P = 7.50x10(-15)). Our findings demonstrate that allele A of rs9943582 was significantly associated with left ventricular systolic dysfunction, left ventricular end-diastolic diameter, the left atrial diameter and LVEF in the CAD population, which suggests an important role of the apelin/APJ system in the pathology of heart failure associated with ischemic heart disease.	[Wang, Pengyun; Zeng, Qiutang; Liao, Yuhua; Cheng, Xiang] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Cardiol,Lab Cardiovasc Immunol, Wuhan 430074, Peoples R China; [Xu, Chengqi; Wang, Chuchu; Wang, Dan; Chen, Shanshan; Zhao, Yuanyuan; Wang, Xiaojing; Li, Sisi; Yang, Qin; Tu, Xin; Wang, Qing K.] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Ctr Human Genome Res, Key Lab Mol Biophys,Minist Educ, Wuhan 430074, Peoples R China; [Xu, Chengqi; Wang, Chuchu; Wang, Dan; Chen, Shanshan; Zhao, Yuanyuan; Wang, Xiaojing; Li, Sisi; Yang, Qin; Tu, Xin; Wang, Qing K.] Huazhong Univ Sci & Technol, Cardio X Inst, Wuhan 430074, Peoples R China; [Wu, Yanxia] First Hosp Wuhan City, Wuhan, Peoples R China; [Wang, Qing K.] Case Western Reserve Univ, Cleveland Clin, Ctr Cardiovasc Genet, Lerner Res Inst,Dept Mol Cardiol, Cleveland, OH 44106 USA; [Wang, Qing K.] Case Western Reserve Univ, Dept Genet & Genome Sci, Dept Mol Med, Cleveland, OH 44106 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University	Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Ctr Human Genome Res, Key Lab Mol Biophys,Minist Educ, Wuhan 430074, Peoples R China.	qkwang@mail.hust.edu.cn; nathancx@mail.hust.edu.cn	饭, 蔡/AAI-5850-2020; Zhao, Yuanyuan/AAY-6670-2021; Wu, yanxia/HGA-0318-2022; Chen, Shanshan/ACO-4807-2022	Zhao, Yuanyuan/0000-0003-0217-3290; Chen, Shanshan/0000-0001-9723-2403; Xu, Chengqi/0000-0002-4269-6830; Wang, Qing/0000-0002-5639-8519; Wang, Pengyun/0000-0001-8410-8390	Chinese National Basic Research Programs (973 Programs) [2013CB531101]; National Natural Science Foundation of China [31430047, 91339118, 81222002]; Hubei Province's Outstanding Medical Academic Leader Program; National Institutes of Health/National Heart, Lung, and Blood Institute [R01 HL121358, R01 HL126729]; National Natural Science Foundation of Hubei [2014CFB216]; Specialized Research Fund for the Doctoral Program of Higher Education from the Ministry of Education; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121358, R01HL126729] Funding Source: NIH RePORTER	Chinese National Basic Research Programs (973 Programs)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Province's Outstanding Medical Academic Leader Program; National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Natural Science Foundation of Hubei; Specialized Research Fund for the Doctoral Program of Higher Education from the Ministry of Education; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by Chinese National Basic Research Programs (973 Programs 2013CB531101), grants from the National Natural Science Foundation of China (31430047, 91339118, 81222002), the Hubei Province's Outstanding Medical Academic Leader Program, the National Institutes of Health/National Heart, Lung, and Blood Institute grants R01 HL121358and R01 HL126729, National Natural Science Foundation of Hubei (2014CFB216) and Specialized Research Fund for the Doctoral Program of Higher Education from the Ministry of Education.	Ashley EA, 2005, CARDIOVASC RES, V65, P73, DOI 10.1016/j.cardiores.2004.08.018; Baicu CF, 2005, CIRCULATION, V111, P2306, DOI 10.1161/01.CIR.0000164273.57823.26; Barnes G, 2010, HEART, V96, P1011, DOI 10.1136/hrt.2009.191122; Bui AL, 2010, NAT REV CARDIOL, V8, P30, DOI DOI 10.1038/NRCARDI0.2010.165; Cheng S, 2011, CIRCULATION, V124, pE516, DOI 10.1161/CIRCULATIONAHA.111.070235; Cheng XA, 2011, DIABETES, V60, P680, DOI 10.2337/db10-0185; Chun HJ, 2008, J CLIN INVEST, V118, P3343, DOI 10.1172/JCI34871; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Fox KF, 2001, EUR HEART J, V22, P228, DOI 10.1053/euhj.2000.2289; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; Gheorghiade M, 1998, CIRCULATION, V97, P282, DOI 10.1161/01.CIR.97.3.282; Gurzu B, 2006, J RENIN-ANGIO-ALDO S, V7, P212, DOI 10.3317/jraas.2006.040; Hata J, 2007, HUM MOL GENET, V16, P630, DOI 10.1093/hmg/ddm005; Hinohara K, 2009, J HUM GENET, V54, P554, DOI 10.1038/jhg.2009.78; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Iwanaga Y, 2006, J MOL CELL CARDIOL, V41, P798, DOI 10.1016/j.yjmcc.2006.07.004; Japp AG, 2010, CIRCULATION, V121, P1818, DOI 10.1161/CIRCULATIONAHA.109.911339; Jiang H, 2009, HEART, V95, P1727, DOI 10.1136/hrt.2008.150177; Kane GC, 2011, JAMA-J AM MED ASSOC, V306, P856, DOI 10.1001/jama.2011.1201; Lee DK, 2000, J NEUROCHEM, V74, P34, DOI 10.1046/j.1471-4159.2000.0740034.x; Lee DS, 2006, NEW ENGL J MED, V355, P138, DOI 10.1056/NEJMoa052948; Liew CC, 2004, NAT REV GENET, V5, P811, DOI 10.1038/nrg1470; Morita H, 2005, J CLIN INVEST, V115, P518, DOI 10.1172/JCI200524351; O'Carroll AM, 2006, J MOL ENDOCRINOL, V36, P221, DOI 10.1677/jme.1.01927; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Pitkin SL, 2010, BRIT J PHARMACOL, V160, P1785, DOI 10.1111/j.1476-5381.2010.00821.x; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Scimia MC, 2012, NATURE, V488, P394, DOI 10.1038/nature11263; Sheikh AY, 2008, AM J PHYSIOL-HEART C, V294, pH88, DOI 10.1152/ajpheart.00935.2007; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Tu X, 2013, AM J HUM GENET, V93, P652, DOI 10.1016/j.ajhg.2013.08.009; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Xu CQ, 2010, STROKE, V41, P1587, DOI 10.1161/STROKEAHA.110.583096; Zeng XJ, 2009, PEPTIDES, V30, P1144, DOI 10.1016/j.peptides.2009.02.010	35	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0125926	10.1371/journal.pone.0125926	http://dx.doi.org/10.1371/journal.pone.0125926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993436	Green Published, gold			2022-12-26	WOS:000354918600021
J	Pont, LMEB; Kleijn, A; Kloezeman, JJ; van den Bossche, W; Kaufmann, JK; de Vrij, J; Leenstra, S; Dirven, CMF; Lamfers, MLM				Pont, Lotte M. E. Berghauser; Kleijn, Anne; Kloezeman, Jenneke J.; van den Bossche, Wouter; Kaufmann, Johanna K.; de Vrij, Jeroen; Leenstra, Sieger; Dirven, Clemens M. F.; Lamfers, Martine L. M.			The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; CONDITIONALLY REPLICATIVE ADENOVIRUS; TUMOR STEM-CELLS; DRUG-COMBINATION; EXPRESSION; THERAPY; RECEPTOR; COXSACKIEVIRUS; DELTA-24-RGD; MODULATION	Background A phase I/II trial for glioblastoma with the oncolytic adenovirus Delta24-RGD was recently completed. Delta24-RGD conditionally replicates in cells with a disrupted retinoblastomapathway and enters cells via av beta 3/5 integrins. Glioblastomas are differentially sensitive to Delta24-RGD. HDAC inhibitors (HDACi) affect integrins and share common cell death pathways with Delta24-RGD. We studied the combination treatment effects of HDACi and Delta24-RGD in patient-derived glioblastoma stem-like cells (GSC), and we determined the most effective HDACi. Methods SAHA, Valproic Acid, Scriptaid, MS275 and LBH589 were combined with Delta24-RGD in fourteen distinct GSCs. Synergy was determined by Chou Talalay method. Viral infection and replication were assessed using luciferase and GFP encoding vectors and hexon-titration assays. Coxsackie adenovirus receptor and av beta 3 integrin levels were determined by flow cytometry. Oncolysis and mechanisms of cell death were studied by viability, caspase-3/7, LDH and LC3B/p62, phospho-p70S6K. Toxicity was studied on normal human astrocytes. MGMT promotor methylation status, TCGA classification, Rb-pathway and integrin gene expression levels were assessed as markers of responsiveness. Results Scriptaid and LBH589 acted synergistically with Delta24-RGD in approximately 50% of the GSCs. Both drugs moderately increased ava3 integrin levels and viral infection in responding but not in non-responding GSCs. LBH589 moderately increased late viral gene expression, however, virus titration revealed diminished viral progeny production by both HDACi, Scriptaid augmented caspase-3/7 activity, LC3B conversion, p62 and phosphop70S6K consumption, as well as LDH levels. LBH589 increased LDH and phosphop70S6K consumption. Responsiveness correlated with expression of various Rb-pathway genes and integrins. Combination treatments induced limited toxicity to human astrocytes. Conclusion LBH589 and Scriptaid combined with Delta24-RGD revealed synergistic anti-tumor activity in a subset of GSCs. Both HDACi moderately augmented viral infection and late gene expression, but slightly reduced progeny production. The drugs differentially activated multiple cell death pathways. The limited toxicity on astrocytes supports further evaluation of the proposed combination therapies.	[Pont, Lotte M. E. Berghauser; Kleijn, Anne; Kloezeman, Jenneke J.; van den Bossche, Wouter; Leenstra, Sieger; Dirven, Clemens M. F.; Lamfers, Martine L. M.] Erasmus MC, Brain Tumor Ctr, Dept Neurosurg, Rotterdam, Netherlands; [Kaufmann, Johanna K.] Brigham & Womens Hosp, Dept Neurosurg, Harvey Cushing Neurooncol Labs, Boston, MA 02115 USA; [Kaufmann, Johanna K.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [de Vrij, Jeroen] Univ Utrecht, Med Ctr, Dept Neurosurg, Utrecht, Netherlands; [Leenstra, Sieger] Elisabeth Hosp, Dept Neurosurg, Tilburg, Netherlands	Erasmus University Rotterdam; Erasmus MC; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Utrecht University; Elisabeth-TweeSteden Ziekenhuis (ETZ)	Lamfers, MLM (corresponding author), Erasmus MC, Brain Tumor Ctr, Dept Neurosurg, Rotterdam, Netherlands.	m.lamfers@erasmusmc.nl	Lamfers, Martine/C-6246-2016	van den Bossche, Wouter/0000-0002-2740-8490; de Vrij, Jeroen/0000-0001-6843-2684; Lamfers, Martine/0000-0001-7745-9029				Abou El Hassan MAI, 2004, J VIROL, V78, P12243, DOI 10.1128/JVI.78.22.12243-12251.2004; Alonso MM, 2008, MOL THER, V16, P487, DOI 10.1038/sj.mt.6300400; Balvers RK, 2014, VIRUSES-BASEL, V6, P3080, DOI 10.3390/v6083080; Balvers RK, 2013, NEURO-ONCOLOGY, V15, P1684, DOI 10.1093/neuonc/not116; Berghauser Pont Lotte M E, 2014, Genes Cancer, V5, P445; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cripe TP, 2001, CANCER RES, V61, P2953; de Jonge J, 2013, J GENE MED, V15, P134, DOI 10.1002/jgm.2703; Gammoh N, 2012, P NATL ACAD SCI USA, V109, P6561, DOI 10.1073/pnas.1204429109; Goldsmith ME, 2007, MOL CANCER THER, V6, P496, DOI 10.1158/1535-7163.MCT-06-0431; Grant S, 2012, ADV CANCER RES, V116, P199, DOI 10.1016/B978-0-12-394387-3.00006-9; Hoti N, 2006, MOL THER, V14, P768, DOI 10.1016/j.ymthe.2006.07.009; Jiang H, 2007, J NATL CANCER I, V99, P1410, DOI 10.1093/jnci/djm102; Jiang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097407; Kepp O, 2009, APOPTOSIS, V14, P364, DOI 10.1007/s10495-008-0303-9; Kim DR, 2012, INT J MOL MED, V29, P218, DOI 10.3892/ijmm.2011.831; Kleijn A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097495; Lamfers MLM, 2002, CANCER RES, V62, P5736; Lang FF, 2014, NEURO-ONCOLOGY, V16, DOI 10.1093/neuonc/nou208.61; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Ma JF, 2012, INT J MOL MED, V30, P1403, DOI 10.3892/ijmm.2012.1133; MacTavish H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014462; Monneret C, 2007, ANTI-CANCER DRUG, V18, P363, DOI 10.1097/CAD.0b013e328012a5db; Newbold A, 2014, ONCOGENE, V33, P5415, DOI 10.1038/onc.2013.482; Otsuki A, 2008, MOL THER, V16, P1546, DOI 10.1038/mt.2008.155; Pasqualini R, 1997, NAT BIOTECHNOL, V15, P542, DOI 10.1038/nbt0697-542; Pont LMEB, 2015, CANCER LETT, V356, P525, DOI 10.1016/j.canlet.2014.09.049; Sachs MD, 2004, CANCER GENE THER, V11, P477, DOI 10.1038/sj.cgt.7700726; Sasaki Y, 2008, MOL CANCER THER, V7, P779, DOI 10.1158/1535-7163.MCT-07-0395; Simboeck E, 2010, J BIOL CHEM, V285, P41062, DOI 10.1074/jbc.M110.184481; Singh N, 2007, INDIAN J CLIN BIOCHE, V22, P6, DOI 10.1007/BF02913307; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Suzuki K, 2001, CLIN CANCER RES, V7, P120; Tong AW, 2012, CURR PHARM BIOTECHNO, V13, P1750; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wedel S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-375; Woan KV, 2012, IMMUNOL CELL BIOL, V90, P55, DOI 10.1038/icb.2011.96; Wu W, 2013, J LIPID RES, V54, P936, DOI 10.1194/jlr.M031450	39	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127058	10.1371/journal.pone.0127058	http://dx.doi.org/10.1371/journal.pone.0127058			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993039	Green Submitted, Green Published, gold			2022-12-26	WOS:000354917300080
J	Scherer, R; Faller, J; Friedrich, EVC; Opisso, E; Costa, U; Kubler, A; Muller-Putz, GR				Scherer, Reinhold; Faller, Josef; Friedrich, Elisabeth V. C.; Opisso, Eloy; Costa, Ursula; Kuebler, Andrea; Mueller-Putz, Gernot R.			Individually Adapted Imagery Improves Brain-Computer Interface Performance in End-Users with Disability	PLOS ONE			English	Article							SINGLE-TRIAL EEG; MOTOR IMAGERY; SPATIAL FILTERS; CLASSIFICATION; COMMUNICATION; TECHNOLOGY; PATTERNS; SYSTEM	Brain-computer interfaces (BCIs) translate oscillatory electroencephalogram (EEG) patterns into action. Different mental activities modulate spontaneous EEG rhythms in various ways. Non-stationarity and inherent variability of EEG signals, however, make reliable recognition of modulated EEG patterns challenging. Able-bodied individuals who use a BCI for the first time achieve - on average - binary classification performance of about 75%. Performance in users with central nervous system (CNS) tissue damage is typically lower. User training generally enhances reliability of EEG pattern generation and thus also robustness of pattern recognition. In this study, we investigated the impact of mental tasks on binary classification performance in BCI users with central nervous system (CNS) tissue damage such as persons with stroke or spinal cord injury (SCI). Motor imagery (MI), that is the kinesthetic imagination of movement (e.g. squeezing a rubber ball with the right hand), is the "gold standard" and mainly used to modulate EEG patterns. Based on our recent results in able-bodied users, we hypothesized that pair- wise combination of "brain- teaser" (e.g. mental subtraction and mental word association) and "dynamic imagery" (e. g. hand and feet MI) tasks significantly increases classification performance of induced EEG patterns in the selected end-user group. Within- day (How stable is the classification within a day?) and between- day (How well does a model trained on day one perform on unseen data of day two?) analysis of variability of mental task pair classification in nine individuals confirmed the hypothesis. We found that the use of the classical MI task pair hand vs. feed leads to significantly lower classification accuracy - in average up to 15% less - in most users with stroke or SCI. User-specific selection of task pairs was again essential to enhance performance. We expect that the gained evidence will significantly contribute to make imagery-based BCI technology become accessible to a larger population of users including individuals with special needs due to CNS damage.	[Scherer, Reinhold; Faller, Josef; Friedrich, Elisabeth V. C.; Mueller-Putz, Gernot R.] Graz Univ Technol, Inst Knowledge Discovery, A-8010 Graz, Austria; [Scherer, Reinhold; Faller, Josef; Friedrich, Elisabeth V. C.; Mueller-Putz, Gernot R.] BioTechMed Graz, Graz, Austria; [Scherer, Reinhold] Clin Judendorf Strassengel, A-8111 Gratwein Strassengel, Austria; [Friedrich, Elisabeth V. C.] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; [Opisso, Eloy; Costa, Ursula] UAB, Inst Guttmann, Inst Univ Neurorehabil Adscrit, Badalona 08916, Spain; [Kuebler, Andrea] Univ Wurzburg, Inst Psychol, D-97070 Wurzburg, Germany	Graz University of Technology; University of California System; University of California San Diego; Autonomous University of Barcelona; University of Wurzburg	Scherer, R (corresponding author), Graz Univ Technol, Inst Knowledge Discovery, A-8010 Graz, Austria.	reinhold.scherer@tugraz.at	Friedrich, Elisabeth V. C./AAV-3839-2021; Coish, Elizabeth/AAU-1245-2020; Faller, Josef/ABG-2374-2020	Faller, Josef/0000-0001-7814-9292; Muller-Putz, Gernot/0000-0002-0087-3720; Opisso, Eloy/0000-0002-6868-6737; Scherer, Reinhold/0000-0003-3407-9709; Kubler, Andrea/0000-0003-4876-0415	FP7 EU Research Project BrainAble [247447]; FP7 EU Research Project ABC [287774]; FP7 EU Research Project BackHome [288566]	FP7 EU Research Project BrainAble; FP7 EU Research Project ABC; FP7 EU Research Project BackHome	This work was supported by the FP7 EU Research Projects BrainAble (No. 247447; http://www.brainable.org/), ABC (No. 287774; http://www.abc-project.eu/) and BackHome (No. 288566; http://www.backhome-fp7.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimardani M, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00052; Alimardani M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02396; Allison BZ, 2010, HUM-COMPUT INT-SPRIN, P35, DOI 10.1007/978-1-84996-272-8_3; Ang Kai Keng, 2014, Front Neuroeng, V7, P30, DOI 10.3389/fneng.2014.00030; Bashashati A, 2007, J NEURAL ENG, V4, pR32, DOI 10.1088/1741-2560/4/2/R03; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Cincotti F, 2012, IEEE ENG MED BIO, P4112, DOI 10.1109/EMBC.2012.6346871; Cincotti F, 2008, BRAIN RES BULL, V75, P796, DOI 10.1016/j.brainresbull.2008.01.007; Curran E, 2004, IEEE T NEUR SYS REH, V12, P48, DOI 10.1109/TNSRE.2003.821372; Curran EA, 2003, BRAIN COGNITION, V51, P326, DOI 10.1016/S0278-2626(03)00036-8; Duda R.O., 2000, PATTERN CLASSIFICATI; Faller J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101168; Faller J, 2012, IEEE T NEUR SYS REH, V20, P313, DOI 10.1109/TNSRE.2012.2189584; Fatourechi M, 2007, CLIN NEUROPHYSIOL, V118, P480, DOI 10.1016/j.clinph.2006.10.019; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Friedrich E, 2011, P 5 INT BRAIN COMP I, P156; Friedrich EVC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076214; Friedrich EVC, 2013, CLIN NEUROPHYSIOL, V124, P916, DOI 10.1016/j.clinph.2012.11.010; Friedrich EVC, 2012, INT J PSYCHOPHYSIOL, V84, P86, DOI 10.1016/j.ijpsycho.2012.01.014; Halder S, 2011, NEUROIMAGE, V55, P1779, DOI 10.1016/j.neuroimage.2011.01.021; Horki P, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01009; Kubler A, 2005, NEUROLOGY, V64, P1775, DOI 10.1212/01.WNL.0000158616.43002.6D; Kubler A, 2004, J PSYCHOPHYSIOL, V18, P121, DOI 10.1027/0269-8803.18.23.121; Kubler A, 2001, PSYCHOL BULL, V127, P358, DOI 10.1037//0033-2909.127.3.358; LaFleur K, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046003; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Lotte F, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00568; Lotte F, 2010, PRESENCE-VIRTUAL AUG, V19, P54, DOI 10.1162/pres.19.1.54; Mason SG, 2007, ANN BIOMED ENG, V35, P137, DOI 10.1007/s10439-006-9170-0; McFarland DJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036007; Millan JDR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00161; Millan JD, 2003, IEEE T NEUR SYS REH, V11, P159, DOI 10.1109/TNSRE.2003.814435; Muller-Putz GR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00034; Muller-Gerking J, 1999, CLIN NEUROPHYSIOL, V110, P787, DOI 10.1016/S1388-2457(98)00038-8; Muller-Putz GR, 2005, NEUROSCI LETT, V382, P169, DOI 10.1016/j.neulet.2005.03.021; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Neuper C, 2003, CLIN NEUROPHYSIOL, V114, P399, DOI 10.1016/S1388-2457(02)00387-5; Obermaier B, 2001, IEEE T NEUR SYS REH, V9, P283, DOI 10.1109/7333.948456; Pfurtscheller G, 2006, IEEE T NEUR SYS REH, V14, P205, DOI 10.1109/TNSRE.2006.875528; Pfurtscheller G, 2001, P IEEE, V89, P1123, DOI 10.1109/5.939829; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 2009, COMPUTATIONAL INTELL, DOI 10.1155/2009/104180; Pichiorri F, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025020; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Samek W, 2013, IEEE T BIO-MED ENG, V60, P2289, DOI 10.1109/TBME.2013.2253608; Scherer R, 2008, P 4 INT BRAIN COMP I, P186; Scherer R.A., 2008, THESIS; Scherer R, 2015, ANN PHYS REHABIL MED, V58, P14, DOI 10.1016/j.rehab.2014.11.005; Scherer R, 2013, SOFT COMPUT, V17, P317, DOI 10.1007/s00500-012-0895-4; Scherer R, 2011, LECT NOTES COMPUT SC, V6691, P362, DOI 10.1007/978-3-642-21501-8_45; Scherer R, 2009, INT REV NEUROBIOL, V86, P119, DOI [10.1016/S0074-7742(09)86009-I, 10.1016/S0074-7742(09)86009-1]; Shenoy P, 2006, J NEURAL ENG, V3, pR13, DOI 10.1088/1741-2560/3/1/R02; Toppi J, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035010; Vidaurre C, 2013, CLIN NEUROPHYSIOL, V124, P1824, DOI 10.1016/j.clinph.2013.03.009; Vidaurre C, 2011, IEEE T BIO-MED ENG, V58, P587, DOI 10.1109/TBME.2010.2093133; Vidaurre C, 2010, BRAIN TOPOGR, V23, P194, DOI 10.1007/s10548-009-0121-6; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	58	34	35	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0123727	10.1371/journal.pone.0123727	http://dx.doi.org/10.1371/journal.pone.0123727			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992718	Green Published, Green Submitted, gold			2022-12-26	WOS:000354917300007
J	Darrow, MC; Sergeeva, OA; Isas, JM; Galaz-Montoya, JG; King, JA; Langen, R; Schmid, MF; Chiu, W				Darrow, Michele C.; Sergeeva, Oksana A.; Isas, Jose M.; Galaz-Montoya, Jesus G.; King, Jonathan A.; Langen, Ralf; Schmid, Michael F.; Chiu, Wah			Structural Mechanisms of Mutant Huntingtin Aggregation Suppression by the Synthetic Chaperonin-like CCT5 Complex Explained by Cryoelectron Tomography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; ELECTRON-MICROSCOPY; IN-VIVO; POLYGLUTAMINE AGGREGATION; MOLECULAR CHAPERONES; PROTEIN; DISEASE; OLIGOMERS; IMAGE; VISUALIZATION	Huntington disease, a neurodegenerative disorder characterized by functional deficits and loss of striatal neurons, is linked to an expanded and unstable CAG trinucleotide repeat in the huntingtin gene (HTT). This DNA sequence translates to a polyglutamine repeat in the protein product, leading to mutant huntingtin (mHTT) protein aggregation. The aggregation of mHTT is inhibited in vitro and in vivo by the TCP-1 ring complex (TRiC) chaperonin. Recently, a novel complex comprised of a single type of TRiC subunit has been reported to inhibit mHTT aggregation. Specifically, the purified CCT5 homo-oligomer complex, when compared with TRiC, has a similar structure, ATP use, and substrate refolding activity, and, importantly, it also inhibits mHTT aggregation. Using an aggregation suppression assay and cryoelectron tomography coupled with a novel computational classification method, we uncover the interactions between the synthetic CCT5 complex (similar to 1 MDa) and aggregates of mutant huntingtin exon 1 containing 46 glutamines (mHTTQ46-Ex1). We find that, in a similar fashion to TRiC, synthetic CCT5 complex caps mHTT fibrils at their tips and encapsulates mHTT oligomers, providing a structural description of the inhibition of mHTTQ46-Ex1 by CCT5 complex and a shared mechanism of mHTT inhibition between TRiC chaperonin and the CCT5 complex: cap and contain.	[Darrow, Michele C.; Galaz-Montoya, Jesus G.; Schmid, Michael F.; Chiu, Wah] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Natl Ctr Macromol Imaging, Houston, TX 77030 USA; [Sergeeva, Oksana A.; King, Jonathan A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Isas, Jose M.; Langen, Ralf] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA	Baylor College of Medicine; Massachusetts Institute of Technology (MIT); University of Southern California	Chiu, W (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	wah@bcm.edu	Galaz-Montoya, Jesus G./Q-7245-2019; Regan, Clinton/E-6250-2012; Galaz-Montoya, Jesus G/A-8091-2017	Galaz-Montoya, Jesus G./0000-0002-0113-9325; Schmid, Michael/0000-0003-1077-5750; Sergeeva, Oksana/0000-0002-4830-0518; Darrow, Michele/0000-0001-6259-1684	National Institutes of Health [PN2EY016525, P41GM103832, R01NS084345, R01GM080139]; National Institutes of Health training grant NIBIB through the Keck Center of the Gulf Coast Consortia [T32EB009270]; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103832, R01GM080139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health training grant NIBIB through the Keck Center of the Gulf Coast Consortia; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research has been supported, in whole or in part, by National Institutes of Health Grants PN2EY016525, P41GM103832, R01NS084345, and R01GM080139.; Supported by National Institutes of Health training grant NIBIB T32EB009270 through the Keck Center of the Gulf Coast Consortia.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Arrasate M, 2012, EXP NEUROL, V238, P1, DOI 10.1016/j.expneurol.2011.12.013; Barbaro BA, 2015, HUM MOL GENET, V24, P913, DOI 10.1093/hmg/ddu504; Bates GP, 2005, NAT REV GENET, V6, P766, DOI 10.1038/nrg1686; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Bhardwaj V, 2014, BIOCHEMISTRY-US, V53, P3621, DOI 10.1021/bi500383h; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Caron NS, 2014, HUM MOL GENET, V23, P2324, DOI 10.1093/hmg/ddt625; Clabough Erin B. D., 2013, Yale Journal of Biology and Medicine, V86, P217; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Fodale V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112262; FRYDMAN J, 1992, EMBO J, V11, P4767, DOI 10.1002/j.1460-2075.1992.tb05582.x; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Galaz-Montoya JG, 2015, J STRUCT BIOL, V190, P279, DOI 10.1016/j.jsb.2015.04.016; Gipson TA, 2013, RNA BIOL, V10, P1647, DOI 10.4161/rna.26706; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gronenborn AM, 1999, PROTEIN SCI, V8, P426; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; Hatters DM, 2012, CURR TOP MED CHEM, V12, P2611; Hendrick JP, 1995, FASEB J, V9, P1559, DOI 10.1096/fasebj.9.15.8529835; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; LEPAULT J, 1983, J MICROSC-OXFORD, V129, P89, DOI 10.1111/j.1365-2818.1983.tb04163.x; Margulis BA, 2013, FEBS LETT, V587, P1997, DOI 10.1016/j.febslet.2013.05.022; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Myers Richard H, 2004, NeuroRx, V1, P255, DOI 10.1007/BF03206609; Pruggnaller S, 2008, J STRUCT BIOL, V164, P161, DOI 10.1016/j.jsb.2008.05.003; Russmann F, 2012, P NATL ACAD SCI USA, V109, P21208, DOI 10.1073/pnas.1218836109; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Schmid MF, 2008, J STRUCT BIOL, V161, P243, DOI 10.1016/j.jsb.2007.09.018; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sergeeva OA, 2014, J BIOL CHEM, V289, P27470, DOI 10.1074/jbc.M114.576033; Sergeeva OA, 2013, J BIOL CHEM, V288, P17734, DOI 10.1074/jbc.M112.443929; Shahmoradian SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00710; Sontag EM, 2013, P NATL ACAD SCI USA, V110, P3077, DOI 10.1073/pnas.1222663110; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; van der Putten H, 2013, NEUROTHERAPEUTICS, V10, P416, DOI 10.1007/s13311-013-0186-5; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	47	23	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17451	17461		10.1074/jbc.M115.655373	http://dx.doi.org/10.1074/jbc.M115.655373			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25995452	hybrid, Green Published			2022-12-26	WOS:000357730900037
J	Favaretto, A; Poggiali, D; Lazzarotto, A; Rolma, G; Causin, F; Gallo, P				Favaretto, Alice; Poggiali, Davide; Lazzarotto, Andrea; Rolma, Giuseppe; Causin, Francesco; Gallo, Paolo			The Parallel Analysis of Phase Sensitive Inversion Recovery (PSIR) and Double Inversion Recovery (DIR) Images Significantly Improves the Detection of Cortical Lesions in Multiple Sclerosis (MS) since Clinical Onset	PLOS ONE			English	Article							INTRACORTICAL LESIONS; COGNITIVE IMPAIRMENT; MRI; DEMYELINATION; ATROPHY	Background Double inversion recovery (DIR) detects only a minority (<20%) of cortical lesions (CL) in multiple sclerosis (MS). Phase-sensitive inversion recovery (PSIR) was suggested to be substantially superior to DIR in the detection of cortical lesions (CL). These two sequences might be complementary. Objectives To analyze CL frequency and type in MS patients having different disease duration and disability, including patients at clinical onset, and to discern more correctly the artifacts, by combining DIR and PSIR images. Patients and Methods 40 patients were enrolled in the study: 10 clinically isolated syndrome/early relapsing remitting MS (CIS/eRRMS), 24 relapsing remitting MS (RRMS), 6 secondary progressive MS (SPMS). DIR and PSIR images were jointly used to classify lesions as purely intracortical (IC), leukocortical (LC) and juxtacortical (JC). Results PSIR disclosed CL in 100% of the patients and was capable of identifying more than four times lesions (455.5%, p<0.00001), especially IC (mean numbers: 36.5 in CIS/eRRMS, 45.0 in RRMS and 52.3 in SPMS) and LC (mean numbers: 10.9 in CIS/eRRMS, 20.1 in RRMS and 25.3 in SPMS), compared to DIR (p<0.00001). CL number was significantly higher in SPMS compared to RRMS (p<0.0001). Artifacts were more accurately identified by comparing the two sequences. Conclusions Our study confirms the higher ability of PSIR in disclosing and classifying CL. The presence of CL in all CIS patients further points out the relevance of cortical pathology in MS. Whether the parallel analysis of DIR and PSIR images may be useful for diagnostic purposes, especially when a diagnosis of MS is suspected but not confirmed by routine MRI, needs to be evaluated in larger patient series. The analysis of the cortex by DIR and PSIR may also allow a better stratification of the patients for prognostic and counseling purposes, as well as for their inclusion in clinical studies.	[Favaretto, Alice; Poggiali, Davide; Lazzarotto, Andrea; Gallo, Paolo] Multiple Sclerosis Ctr Veneto Reg CeSMuV, Dept Neurosci SNPSRR, Padua, Italy; [Rolma, Giuseppe; Causin, Francesco] Univ Hosp Padova, Neuroradiol Unit, Padua, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova	Gallo, P (corresponding author), Multiple Sclerosis Ctr Veneto Reg CeSMuV, Dept Neurosci SNPSRR, Padua, Italy.	paolo.gallo@unipd.it	Causin, Francesco/AAR-4624-2021; Poggiali, Davide/AAR-2478-2020	Causin, Francesco/0000-0001-6491-7027; Poggiali, Davide/0000-0002-2894-0825	 [GR-2010-2313255]		This research was supported by grants from the Italian Minister of Public Health, Project GR-2010-2313255.	Bo L, 2003, J NEUROPATH EXP NEUR, V62, P723, DOI 10.1093/jnen/62.7.723; Calabrese M, 2010, NEUROLOGY, V75, P1234, DOI 10.1212/WNL.0b013e3181f5d4da; Calabrese M, 2009, MULT SCLER J, V15, P933, DOI 10.1177/1352458509106510; Calabrese M, 2007, ARCH NEUROL-CHICAGO, V64, P1416, DOI 10.1001/archneur.64.10.1416; Calabrese M, 2012, BRAIN, V135, P2952, DOI 10.1093/brain/aws246; Calabrese M, 2009, ARCH NEUROL-CHICAGO, V66, P1144, DOI 10.1001/archneurol.2009.174; Chard DT, 2002, BRAIN, V125, P327, DOI 10.1093/brain/awf025; Ciccarelli O, 2012, NEUROLOGY, V78, P296, DOI 10.1212/WNL.0b013e318245296f; de Graaf WL, 2013, EUR RADIOL, V23, P528, DOI 10.1007/s00330-012-2619-7; Filippi M, 2010, NEUROLOGY, V75, P1988, DOI 10.1212/WNL.0b013e3181ff96f6; Geurts JJG, 2011, NEUROLOGY, V76, P418, DOI 10.1212/WNL.0b013e31820a0cc4; Geurts JJG, 2005, AM J NEURORADIOL, V26, P572; Geurts JJG, 2005, RADIOLOGY, V236, P254, DOI 10.1148/radiol.2361040450; Howell OW, 2011, BRAIN, V134, P2755, DOI 10.1093/brain/awr182; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038; Miller DH, 2012, LANCET NEUROL, V11, P157, DOI 10.1016/S1474-4422(11)70274-5; Nelson F, 2008, MULT SCLER J, V14, P1214, DOI 10.1177/1352458508094644; Nelson F, 2007, AM J NEURORADIOL, V28, P1645, DOI 10.3174/ajnr.A0645; Nelson F, 2011, MULT SCLER J, V17, P1122, DOI 10.1177/1352458511405561; Nielsen AS, 2013, NEUROLOGY, V81, P641, DOI 10.1212/WNL.0b013e3182a08ce8; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Popescu BFG, 2011, NEUROLOGY, V76, P1705, DOI 10.1212/WNL.0b013e31821a44f1; Popescu Bogdan F Gh, 2013, Continuum (Minneap Minn), V19, P901, DOI 10.1212/01.CON.0000433291.23091.65; Roosendaal SD, 2009, MULT SCLER, V15, P708, DOI 10.1177/1352458509102907; Seewann A, 2012, NEUROLOGY, V78, P302, DOI 10.1212/WNL.0b013e31824528a0; Sethi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078879; Sethi V, 2012, J NEUROL NEUROSUR PS, V83, P877, DOI 10.1136/jnnp-2012-303023; Simon B, 2010, EUR RADIOL, V20, P1675, DOI 10.1007/s00330-009-1705-y	29	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127805	10.1371/journal.pone.0127805	http://dx.doi.org/10.1371/journal.pone.0127805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010425	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900147
J	Nathan, D; Huynh, DQ; Rubenson, J; Rosenberg, M				Nathan, David; Huynh, Du Q.; Rubenson, Jonas; Rosenberg, Michael			Estimating Physical Activity Energy Expenditure with the Kinect Sensor in an Exergaming Environment	PLOS ONE			English	Article							GAUSSIAN-PROCESSES; MECHANICAL WORK; CHILDREN; WALKING; SYSTEM; ADOLESCENTS; EFFICIENCY; ACCURACY; REGRESSION; VALIDITY	Active video games that require physical exertion during game play have been shown to confer health benefits. Typically, energy expended during game play is measured using devices attached to players, such as accelerometers, or portable gas analyzers. Since 2010, active video gaming technology incorporates marker-less motion capture devices to simulate human movement into game play. Using the Kinect Sensor and Microsoft SDK this research aimed to estimate the mechanical work performed by the human body and estimate subsequent metabolic energy using predictive algorithmic models. Nineteen University students participated in a repeated measures experiment performing four fundamental movements (arm swings, standing jumps, body-weight squats, and jumping jacks). Metabolic energy was captured using a Cortex Metamax 3B automated gas analysis system with mechanical movement captured by the combined motion data from two Kinect cameras. Estimations of the body segment properties, such as segment mass, length, centre of mass position, and radius of gyration, were calculated from the Zatsiorsky-Seluyanov's equations of de Leva, with adjustment made for posture cost. GPML toolbox implementation of the Gaussian Process Regression, a locally weighted k-Nearest Neighbour Regression, and a linear regression technique were evaluated for their performance on predicting the metabolic cost from new feature vectors. The experimental results show that Gaussian Process Regression outperformed the other two techniques by a small margin. This study demonstrated that physical activity energy expenditure during exercise, using the Kinect camera as a motion capture system, can be estimated from segmental mechanical work. Estimates for high-energy activities, such as standing jumps and jumping jacks, can be made accurately, but for low-energy activities, such as squatting, the posture of static poses should be considered as a contributing factor. When translated into the active video gaming environment, the results could be incorporated into game play to more accurately control the energy expenditure requirements.	[Nathan, David; Rubenson, Jonas; Rosenberg, Michael] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA 6009, Australia; [Nathan, David; Huynh, Du Q.] Univ Western Australia, Sch Comp Sci & Software Engn, Perth, WA 6009, Australia; [Rubenson, Jonas] Penn State Univ, Dept Kinesiol, Biomech Lab, University Pk, PA 16802 USA	University of Western Australia; University of Western Australia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Rosenberg, M (corresponding author), Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA 6009, Australia.	michael.rosenberg@uwa.edu.au	Rosenberg, Michael/H-5748-2014	Huynh, Du/0000-0003-3080-9655; Rubenson, Jonas/0000-0003-2854-1776; Nathan, David/0000-0003-1105-295X	Western Australian Health Promotion Foundation [19985 MR]	Western Australian Health Promotion Foundation	Funding for the hardware was provided by the Western Australian Health Promotion Foundation (www.healthway.wa.gov.au) (Research Translation Grant #19985 MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN NS, 1992, AM STAT, V46, P175, DOI 10.2307/2685209; Ascher H, 1983, NATO ASI SERIES SERI; Bishop C. M., 2006, J ELECT IMAG, V16, P140; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOUTEN CV, 1994, MED SCI SPORT EXER, V26, P1516; Brehm MA, 2004, GAIT POSTURE, V20, P67, DOI 10.1016/S0966-6362(03)00097-3; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; BROCKWAY JM, 1987, HUM NUTR-CLIN NUTR, V41C, P463; Daley AJ, 2009, PEDIATRICS, V124, P763, DOI 10.1542/peds.2008-2357; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Detrembleur C, 2003, GAIT POSTURE, V18, P47, DOI 10.1016/S0966-6362(02)00193-5; Graves L, 2008, BRIT J SPORT MED, V42, P592, DOI 10.1136/bmj.39415.632951.80; Graves LEF, 2008, EUR J APPL PHYSIOL, V104, P617, DOI 10.1007/s00421-008-0813-8; Graves LEF, 2010, J PHYS ACT HEALTH, V7, P393, DOI 10.1123/jpah.7.3.393; Haddock Bryan L, 2012, Open Sports Sci J, V5, P1, DOI 10.2174/1875399X01205010001; Leatherdale ST, 2010, AM J HEALTH BEHAV, V34, P31; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Macfarlane DJ, 2012, EUR J APPL PHYSIOL, V112, P2539, DOI 10.1007/s00421-011-2230-7; McArdle W. D., 2010, EXERCISE PHYSIOLOGY; Mellecker RR, 2008, ARCH PEDIAT ADOL MED, V162, P886, DOI 10.1001/archpedi.162.9.886; Mills A, 2013, J PEDIATR-US, V163, P806, DOI 10.1016/j.jpeds.2013.03.076; PIMENTAL NA, 1979, ERGONOMICS, V22, P963, DOI 10.1080/00140137908924670; Prieur F, 2003, MED SCI SPORT EXER, V35, P879, DOI 10.1249/01.MSS.0000065003.82941.B0; Prince S.J.D., 2012, COMPUTER VISION MODE, P2; Rasmussen C., 2006, ADAPT COMPUT MACH LE; Rasmussen CE, 2010, J MACH LEARN RES, V11, P3011; Rasmussen CE, 2004, LECT NOTES ARTIF INT, V3176, P63, DOI 10.1007/978-3-540-28650-9_4; Ryschon TW, 1997, J APPL PHYSIOL, V83, P867, DOI 10.1152/jappl.1997.83.3.867; Sasaki K, 2009, J EXP BIOL, V212, P738, DOI 10.1242/jeb.023267; Scharstein D, 2003, PROC CVPR IEEE, P195; SCHENAU GJV, 1990, J BIOMECH, V23, P865, DOI 10.1016/0021-9290(90)90352-4; Schepens B, 2004, J EXP BIOL, V207, P587, DOI 10.1242/jeb.00793; Shotton J, 2011, PROC CVPR IEEE, P1297, DOI 10.1109/CVPR.2011.5995316; Spear BA, 2007, PEDIATRICS, V120, pS254, DOI 10.1542/peds.2007-2329F; Van de Walle P, 2012, GAIT POSTURE, V35, P231, DOI 10.1016/j.gaitpost.2011.09.012; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Vaughan-Nichols SJ, 2009, COMPUTER, V42, P13, DOI 10.1109/MC.2009.260; Vogler AJ, 2010, J SPORT SCI, V28, P733, DOI 10.1080/02640410903582776; WILLEMS PA, 1995, J EXP BIOL, V198, P379; Williams CKI, 1996, ADV NEUR IN, V8, P514; WILLIAMS KR, 1985, MED SCI SPORT EXER, V17, P317; Windolf M, 2008, J BIOMECH, V41, P2776, DOI 10.1016/j.jbiomech.2008.06.024; Zatsiorsky VM., 2002, KINETICS HUMAN MOTIO; Zhang ZY, 2012, IEEE MULTIMEDIA, V19, P4, DOI 10.1109/MMUL.2012.24	44	13	13	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127113	10.1371/journal.pone.0127113	http://dx.doi.org/10.1371/journal.pone.0127113			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000460	gold, Green Submitted, Green Published			2022-12-26	WOS:000354931700042
J	Rehfeld, IS; Guedes, MIMC; Fraiha, ALS; Costa, AG; Matos, ACD; Fluza, ATL; Lobato, ZIP				Rehfeld, Izabelle Silva; Maldonado Coelho Guedes, Maria Isabel; Soares Fraiha, Ana Luiza; Costa, Aristoteles Gomes; Diniz Matos, Ana Carolina; Lino Fluza, Aparecida Tatiane; Portela Lobato, Zelia Ines			Vaccinia virus Transmission through Experimentally Contaminated Milk Using a Murine Model	PLOS ONE			English	Article							BOVINE VACCINIA; HORIZONTAL TRANSMISSION; INFECTION; OUTBREAK; STRAINS; DISEASE; COWPOX	Bovine vaccinia (BV) is a zoonosis caused by Vaccinia virus (VACV), which affects dairy cattle and humans. Previous studies have detected the presence of viable virus particles in bovine milk samples naturally and experimentally contaminated with VACV. However, it is not known whether milk contaminated with VACV could be a route of viral transmission. However, anti-Orthopoxvirus antibodies were detected in humans from BV endemic areas, whom had no contact with affected cows, which suggest that other VACV transmission routes are possible, such as consumption of contaminated milk and dairy products. Therefore, it is important to study the possibility of VACV transmission by contaminated milk. This study aimed to examine VACV transmission, pathogenesis and shedding in mice orally inoculated with experimentally contaminated milk. Thirty mice were orally inoculated with milk containing 10(7) PFU/ml of VACV, and ten mice were orally inoculated with uncontaminated milk. Clinical examinations were performed for 30 consecutive days, and fecal samples and oral swabs (OSs) were collected every other day. Mice were euthanized on predetermined days, and tissue and blood samples were collected. Nested-PCR, plaque reduction neutralization test (PRNT), viral isolation, histopathology, and immunohistochemistry (IHC) methods were performed on the collected samples. No clinical changes were observed in the animals. Viral DNA was detected in feces, blood, OSs and tissues, at least in one of the times tested. The lungs displayed moderate to severe interstitial lymphohistiocytic infiltrates, and only the heart, tonsils, tongue, and stomach did not show immunostaining at the IHC analysis. Neutralizing antibodies were detected at the 20th and 30th days post infection in 50% of infected mice. The results revealed that VACV contaminated milk could be a route of viral transmission in mice experimentally infected, showing systemic distribution and shedding through feces and oral mucosa, albeit without exhibiting any clinical signs.	[Rehfeld, Izabelle Silva; Maldonado Coelho Guedes, Maria Isabel; Soares Fraiha, Ana Luiza; Costa, Aristoteles Gomes; Diniz Matos, Ana Carolina; Portela Lobato, Zelia Ines] Univ Fed Minas Gerais, Escola Vet, Dept Med Vet Prevent, LPVA, Belo Horizonte, MG, Brazil; [Lino Fluza, Aparecida Tatiane] Univ Fed Minas Gerais, Escola Vet, Dept Clin & Cirurgia Vet, Lab Patol Vet, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Lobato, ZIP (corresponding author), Univ Fed Minas Gerais, Escola Vet, Dept Med Vet Prevent, LPVA, Belo Horizonte, MG, Brazil.	ziplobato@gmail.com		Lobato, Zelia/0000-0002-9399-3691; DINIZ MATOS, ANA CAROLINA/0000-0003-3175-2590	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Brazil [APQ-01337-11]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Brazil-Grant number: APQ-01337-11, ZIPL. Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - scholarships for all authors: ISR, MIMCG, ALSF, AGC, ACDM, ATLF, ZIPL. Pro-Reitoria de Pesquisa of UFMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao JS, 2009, FOODBORNE PATHOG DIS, V6, P1141, DOI 10.1089/fpd.2009.0324; Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428; Abrahao JS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-140; Abrahao JS, 2009, ARCH VIROL, V155, P1200; CAMPOS MAD, 1993, REV MICROBIOL, V24, P104; Cargnelutti JF, 2012, MICROB PATHOGENESIS, V52, P192, DOI 10.1016/j.micpath.2011.12.005; Chantrey J, 1999, EPIDEMIOL INFECT, V122, P455, DOI 10.1017/S0950268899002423; Costa GB, 2013, VIRUS REV RES, V18, P84; D'Anunciacao L, 2012, VECTOR-BORNE ZOONOT, V12, P61, DOI 10.1089/vbz.2011.0671; da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223; DAMON IK, 2007, FIELDS VIROLOGY, P2948; GLEDHILL AW, 1962, NATURE, V196, P298, DOI 10.1038/196298a0; Goff A, 2007, VIRUS RES, V128, P88, DOI 10.1016/j.virusres.2007.04.014; Guedes MIMC, 2013, TRANSBOUND EMERG DIS, V60, P552, DOI 10.1111/j.1865-1682.2012.01372.x; Gurav YK, 2011, PREV VET MED, V100, P242, DOI 10.1016/j.prevetmed.2011.03.008; JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1; LOPES ODS, 1965, AM J TROP MED HYG, V14, P156; de Oliveira TML, 2010, FOODBORNE PATHOG DIS, V7, P1491, DOI 10.1089/fpd.2010.0597; Maiboroda A.D., 1982, ACTA VIROL, V2, P106; Oliveira TM, 2014, THESIS U FEDERAL MIN; Rehfeld IS, 2014, VIRUS REV RES, V19, P13; Rehfeld IS, 2013, RES VET SCI, V95, P752, DOI 10.1016/j.rvsc.2013.05.005; Rivetti AV, 2013, VET MICROBIOL, V162, P103, DOI 10.1016/j.vetmic.2012.09.005; Singh RK, 2012, INDIAN J VIROL, V23, P1, DOI 10.1007/s13337-012-0068-1; Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043; Ferreira JMS, 2008, J GEN VIROL, V89, P2986, DOI 10.1099/vir.0.2008/003947-0; Smith JL, 2003, J FOOD PROTECT, V66, P1292, DOI 10.4315/0362-028X-66.7.1292; THORMAR H, 1987, ANTIMICROB AGENTS CH, V31, P27, DOI 10.1128/AAC.31.1.27; Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486; Wahl-Jensen V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024832; WALLACE GD, 1985, LAB ANIM SCI, V35, P41; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373	32	11	11	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127350	10.1371/journal.pone.0127350	http://dx.doi.org/10.1371/journal.pone.0127350			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000966	Green Submitted, Green Published, gold			2022-12-26	WOS:000354931700053
J	Sato, T; Sato, F; Kamezaki, A; Sakaguchi, K; Tanigome, R; Kawakami, K; Sehara-Fujisawa, A				Sato, Tomomi; Sato, Fuminori; Kamezaki, Aosa; Sakaguchi, Kazuya; Tanigome, Ryoma; Kawakami, Koichi; Sehara-Fujisawa, Atsuko			Neuregulin 1 Type II-ErbB Signaling Promotes Cell Divisions Generating Neurons from Neural Progenitor Cells in the Developing Zebrafish Brain	PLOS ONE			English	Article							NERVOUS-SYSTEM; RADIAL GLIA; SYNAPTIC PLASTICITY; CEREBRAL-CORTEX; TECTUM; DIFFERENTIATION; SCHIZOPHRENIA; NEUROGENESIS; EXPRESSION; NEOCORTEX	Post-mitotic neurons are generated from neural progenitor cells (NPCs) at the expense of their proliferation. Molecular and cellular mechanisms that regulate neuron production temporally and spatially should impact on the size and shape of the brain. While transcription factors such as neurogenin1 (neurog1) and neurod govern progression of neurogenesis as cell-intrinsic mechanisms, recent studies show regulatory roles of several cell-extrinsic or intercellular signaling molecules including Notch, FGF and Wnt in production of neurons/neural progenitor cells from neural stem cells/radial glial cells (NSCs/RGCs) in the ventricular zone (VZ). However, it remains elusive how production of post-mitotic neurons from neural progenitor cells is regulated in the sub-ventricular zone (SVZ). Here we show that newborn neurons accumulate in the basal-to-apical direction in the optic tectum (OT) of zebrafish embryos. While neural progenitor cells are amplified by mitoses in the apical ventricular zone, neurons are exclusively produced through mitoses of neural progenitor cells in the sub-basal zone, later in the sub-ventricular zone, and accumulate apically onto older neurons. This neurogenesis depends on Neuregulin 1 type II (NRG1-II)-ErbB signaling. Treatment with an ErbB inhibitor, AG1478 impairs mitoses in the sub-ventricular zone of the optic tectum. Removal of AG1478 resumes sub-ventricular mitoses without precedent mitoses in the apical ventricular zone prior to basal-to-apical accumulation of neurons, suggesting critical roles of ErbB signaling in mitoses for post-mitotic neuron production. Knockdown of NRG1-II impairs both mitoses in the sub-basal/sub-ventricular zone and the ventricular zone. Injection of soluble human NRG1 into the developing brain ameliorates neurogenesis of NRG1-II-knockdown embryos, suggesting a conserved role of NRG1 as a cell-extrinsic signal. From these results, we propose that NRG1-ErbB signaling stimulates cell divisions generating neurons from neural progenitor cells in the developing vertebrate brain.	[Sato, Tomomi; Sato, Fuminori; Kamezaki, Aosa; Sakaguchi, Kazuya; Tanigome, Ryoma; Sehara-Fujisawa, Atsuko] Kyoto Univ, Inst Frontier Med Sci, Dept Growth Regulat, Sakyo Ku, Kyoto, Japan; [Kamezaki, Aosa] Kyoto Univ, Grad Sch Biostudies, Lab Mol Cell Biol & Dev, Sakyo Ku, Kyoto, Japan; [Kawakami, Koichi] Natl Inst Genet, Div Mol & Dev Biol, Mishima, Shizuoka 411, Japan	Kyoto University; Kyoto University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Sato, T (corresponding author), Saitama Med Univ, Fac Med, Dept Obstet & Gynecol, Dept Anat, Moroyama, Saitama, Japan.	tosato@saitama-med.ac.jp; asehara@frontier.kyoto-u.ac.jp	Kawakami, Koichi/AAF-1380-2019		Hayashi Memorial Foundation; Kyoto University; JSPS [23500389]; MEXT [22122007]; Cooperative Research Program of Institute for Frontier Medical Sciences, Kyoto University; MEXT, Japan; Grants-in-Aid for Scientific Research [26650077, 22122007] Funding Source: KAKEN	Hayashi Memorial Foundation; Kyoto University; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cooperative Research Program of Institute for Frontier Medical Sciences, Kyoto University; MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Hayashi Memorial Foundation for Female Natural Scientists (TS), Kyoto University Start-Up Grant-In-Aid for Young Scientists (TS), JSPS KAKENHI 23500389 (TS), MEXT KAKENHI 22122007 (ASF), and Cooperative Research Program of Institute for Frontier Medical Sciences, Kyoto University (KK). A part of this work was also supported by Platform for Dynamic Approaches to Living System from the MEXT, Japan (ASF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; Aizawa H, 2007, DEV CELL, V12, P87, DOI 10.1016/j.devcel.2006.10.004; Alexandre P, 2010, NAT NEUROSCI, V13, P673, DOI 10.1038/nn.2547; Anton ES, 1997, DEVELOPMENT, V124, P3501; Asakawa K, 2009, METHODS, V49, P275, DOI 10.1016/j.ymeth.2009.01.004; Blader P, 2003, MECH DEVELOP, V120, P211, DOI 10.1016/S0925-4773(02)00413-6; Brinkmann BG, 2008, NEURON, V59, P581, DOI 10.1016/j.neuron.2008.06.028; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Chen YJJ, 2008, J NEUROSCI, V28, P6872, DOI 10.1523/JNEUROSCI.1815-08.2008; Coolen M, 2012, DEV CELL, V22, P1052, DOI 10.1016/j.devcel.2012.03.003; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; Dave RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014680; Del Bene F, 2010, SCIENCE, V330, P669, DOI 10.1126/science.1192949; Dong ZQ, 2012, NEURON, V74, P65, DOI 10.1016/j.neuron.2012.01.031; Feijoo CG, 2011, EUR J NEUROSCI, V33, P589, DOI 10.1111/j.1460-9568.2010.07560.x; Franco SJ, 2013, NEURON, V77, P19, DOI 10.1016/j.neuron.2012.12.022; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Honjo Y, 2008, DEVELOPMENT, V135, P2615, DOI 10.1242/dev.022178; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Korzh V, 1998, DEV DYNAM, V213, P92, DOI 10.1002/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T; Liu Y, 2005, DEV BIOL, V283, P437, DOI 10.1016/j.ydbio.2005.04.038; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Meyer D, 1997, DEVELOPMENT, V124, P3575; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Nevin LM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-126; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Sato T, 2006, GENESIS, V44, P136, DOI 10.1002/gene.20196; Sato T, 2007, J NEUROSCI, V27, P5271, DOI 10.1523/JNEUROSCI.0883-07.2007; Satou C, 2013, DEVELOPMENT, V140, P3927, DOI 10.1242/dev.099531; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Shamir A, 2012, J NEUROSCI, V32, P2988, DOI 10.1523/JNEUROSCI.1899-11.2012; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wood JD, 2009, HUM MOL GENET, V18, P391, DOI 10.1093/hmg/ddn361; Wullimann M.F., 1996, NEUROAN ZEBRAFISH BR, P160; WURTZ RH, 1980, ANNU REV NEUROSCI, V3, P189, DOI 10.1146/annurev.ne.03.030180.001201; Yin DM, 2013, NEURON, V78, P644, DOI 10.1016/j.neuron.2013.03.028	47	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127360	10.1371/journal.pone.0127360	http://dx.doi.org/10.1371/journal.pone.0127360			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001123	Green Published, gold, Green Submitted			2022-12-26	WOS:000354931700055
J	Al-Maleki, AR; Mariappan, V; Vellasamy, KM; Tay, ST; Vadivelu, J				Al-Maleki, Anis Rageh; Mariappan, Vanitha; Vellasamy, Kumutha Malar; Tay, Sun Tee; Vadivelu, Jamuna			Altered Proteome of Burkholderia pseudomallei Colony Variants Induced by Exposure to Human Lung Epithelial Cells	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ENTERICA SEROVAR TYPHIMURIUM; BETAINE ALDEHYDE DEHYDROGENASE; III SECRETION SYSTEM; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; REFERENCE MAP; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MYCOBACTERIUM-TUBERCULOSIS	Burkholderia pseudomallei primary diagnostic cultures demonstrate colony morphology variation associated with expression of virulence and adaptation proteins. This study aims to examine the ability of B. pseudomallei colony variants (wild type [WT] and small colony variant [SCV]) to survive and replicate intracellularly in A549 cells and to identify the alterations in the protein expression of these variants, post-exposure to the A549 cells. Intracellular survival and cytotoxicity assays were performed followed by proteomics analysis using two-dimensional gel electrophoresis. B. pseudomallei SCV survive longer than the WT. During post-exposure, among 259 and 260 protein spots of SCV and WT, respectively, 19 were differentially expressed. Among SCV post-exposure up-regulated proteins, glyceraldehyde 3-phosphate dehydrogenase, fructose-bisphosphate aldolase (CbbA) and betaine aldehyde dehydrogenase were associated with adhesion and virulence. Among the down-regulated proteins, enolase (Eno) is implicated in adhesion and virulence. Additionally, post-exposure expression profiles of both variants were compared with pre-exposure. In WT pre-vs post-exposure, 36 proteins were differentially expressed. Of the up-regulated proteins, translocator protein, Eno, nucleoside diphosphate kinase (Ndk), ferritin Dps-family DNA binding protein and peptidyl-prolyl cis-trans isomerase B were implicated in invasion and virulence. In SCV pre-vs post-exposure, 27 proteins were differentially expressed. Among the up-regulated proteins, flagellin, Eno, CbbA, Ndk and phenylacetate-coenzyme A ligase have similarly been implicated in adhesion, invasion. Protein profiles differences post-exposure provide insights into association between morphotypic and phenotypic characteristics of colony variants, strengthening the role of B. pseudomallei morphotypes in pathogenesis of melioidosis.	[Al-Maleki, Anis Rageh; Mariappan, Vanitha; Vellasamy, Kumutha Malar; Tay, Sun Tee; Vadivelu, Jamuna] Univ Malaya, Fac Med, Dept Med Microbiol, TIDREC, Kuala Lumpur, Malaysia	Universiti Malaya	Vadivelu, J (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, TIDREC, Kuala Lumpur, Malaysia.	jamuna@um.edu.my	Mariappan, Vanitha/ABD-4066-2020; Vellasamy, Kumutha Malar/A-6592-2017; Al-Maleki, Anis/GSM-9407-2022; Al-Maleki, Anis Rageh Mohammed/S-1134-2016; Al-Maleki, Anis Rageh Mohammed/AAZ-7933-2021; VADIVELU, JAMUNARANI S/B-8696-2010; Mariappan, Vanitha/I-4769-2013; Tay, Sun Tee/N-2295-2019; Vellasamy, Kumutha Malar/CAF-0007-2022	Mariappan, Vanitha/0000-0002-2351-1597; Vellasamy, Kumutha Malar/0000-0001-7661-3928; Al-Maleki, Anis Rageh Mohammed/0000-0002-9927-8859; Al-Maleki, Anis Rageh Mohammed/0000-0002-9927-8859; VADIVELU, JAMUNARANI S/0000-0001-7322-3676; Mariappan, Vanitha/0000-0002-2351-1597; Tay, Sun Tee/0000-0002-3120-6998; Vellasamy, Kumutha Malar/0000-0001-7661-3928	Ministry of Higher Education (MOHE), Malaysia under High Impact Research (HIR)-MOHE project [E000013-20001]; University of Malaya (IPPP) [PV066/2011A]; Ministry of Science, Innovation and Technology (MOSTI), Malaysia under the Science Fund [55-02-03-1002]	Ministry of Higher Education (MOHE), Malaysia under High Impact Research (HIR)-MOHE project; University of Malaya (IPPP)(Universiti Malaya); Ministry of Science, Innovation and Technology (MOSTI), Malaysia under the Science Fund	The authors acknowledge the financial support provided by Ministry of Higher Education (MOHE), Malaysia under High Impact Research (HIR)-MOHE project (E000013-20001), University of Malaya (IPPP grant [PV066/2011A]) and Ministry of Science, Innovation and Technology (MOSTI), Malaysia under the Science Fund (55-02-03-1002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams GL, 2012, CHEM BIOL, V19, P844, DOI 10.1016/j.chembiol.2012.05.020; Agarwal S, 2008, BBA-PROTEINS PROTEOM, V1784, P986, DOI 10.1016/j.bbapap.2008.03.017; Al-Maleki AR, 2014, J PROTEOMICS, V106, P205, DOI 10.1016/j.jprot.2014.04.005; ALTUVIA S, 1994, MOL MICROBIOL, V13, P265, DOI 10.1111/j.1365-2958.1994.tb00421.x; Alvarez RA, 2003, MOL MICROBIOL, V48, P1417, DOI 10.1046/j.1365-2958.2003.03518.x; Amornrit W., 2012, ASIAN BIOMED, V6, DOI [10.1093/jscr/2012.6.3, DOI 10.1093/JSCR/2012.6.3]; Atkins T, 2002, J MED MICROBIOL, V51, P539, DOI 10.1099/0022-1317-51-7-539; ATTRIDGE SR, 1983, J INFECT DIS, V147, P864, DOI 10.1093/infdis/147.5.864; BADDOUR LM, 1990, J CLIN MICROBIOL, V28, P676, DOI 10.1128/JCM.28.4.676-679.1990; BALWIT JM, 1994, J INFECT DIS, V170, P1033, DOI 10.1093/infdis/170.4.1033; Barnich N, 2003, MOL MICROBIOL, V48, P781, DOI 10.1046/j.1365-2958.2003.03468.x; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Berlutti F, 2008, INT J IMMUNOPATH PH, V21, P51, DOI 10.1177/039463200802100107; Bouchart F, 2007, MICROBIOL-SGM, V153, P760, DOI 10.1099/mic.0.2006/000372-0; BRETT PJ, 1994, INFECT IMMUN, V62, P1914, DOI 10.1128/IAI.62.5.1914-1919.1994; BRIDGER WA, 1987, BIOCHEM SOC SYMP, P103; Bringans S, 2008, PROTEOMICS, V8, P1081, DOI 10.1002/pmic.200700948; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; BRYAN LE, 1981, ANTIMICROB AGENTS CH, V19, P958, DOI 10.1128/AAC.19.6.958; Bukholm G, 1997, SCAND J GASTROENTERO, V32, P445, DOI 10.3109/00365529709025079; Burtnick MN, 2014, INFECT IMMUN, V82, P3214, DOI 10.1128/IAI.01739-14; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; Calhoun LN, 2011, INT J ANTIMICROB AG, V37, P261, DOI 10.1016/j.ijantimicag.2010.11.034; Cano DA, 2003, INFECT IMMUN, V71, P3690, DOI 10.1128/IAI.71.7.3690-3698.2003; Carroll JA, 1999, INFECT IMMUN, V67, P3181, DOI 10.1128/IAI.67.7.3181-3187.1999; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Ceci P, 2003, J BIOL CHEM, V278, P20319, DOI 10.1074/jbc.M302114200; Chantratita N, 2007, J BACTERIOL, V189, P807, DOI 10.1128/JB.01258-06; Chantratita N, 2012, J PROTEOMICS, V75, P1031, DOI 10.1016/j.jprot.2011.10.015; CHAOWAGUL W, 1993, J INFECT DIS, V168, P1181, DOI 10.1093/infdis/168.5.1181; Chaves CAL, 2014, J TISSUE ENG, V5, DOI 10.1177/2041731414540911; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Chodavarapu S, 2008, MOL MICROBIOL, V67, P1331, DOI 10.1111/j.1365-2958.2008.06127.x; Choi SH, 2000, APPL ENVIRON MICROB, V66, P3911, DOI 10.1128/AEM.66.9.3911-3916.2000; Chua KL, 2003, INFECT IMMUN, V71, P1622, DOI 10.1128/IAI.71.4.1622-1629.2003; Chuaygud Tippamas, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS140, DOI 10.1016/S0035-9203(08)70031-2; Chung JW, 2007, MICROBIOL-SGM, V153, P206, DOI 10.1099/mic.0.2006/000455-0; Chutoam P, 2013, MICROBIOL IMMUNOL, V57, P605, DOI 10.1111/1348-0421.12077; Claeyssen E, 2007, PHYTOCHEMISTRY, V68, P709, DOI 10.1016/j.phytochem.2006.12.001; Claret L, 2007, J BIOL CHEM, V282, P33275, DOI 10.1074/jbc.M702800200; Cleveland DW, 2000, NAT MED, V6, P1320, DOI 10.1038/82122; Das P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015466; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; DeShazer D, 1998, MOL MICROBIOL, V30, P1081, DOI 10.1046/j.1365-2958.1998.01139.x; DeShazer D, 1997, J BACTERIOL, V179, P2116, DOI 10.1128/jb.179.7.2116-2125.1997; Deziel E, 2001, J BACTERIOL, V183, P1195, DOI 10.1128/JB.183.4.1195-1204.2001; DRAKE D, 1988, J GEN MICROBIOL, V134, P43; Duan QD, 2013, MICROB PATHOGENESIS, V55, P32, DOI 10.1016/j.micpath.2012.09.010; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Dutta K., 2010, CHARACTERIZATION MUL; Eckweiler D., 2014, GENOME ANNOUNC, V2, P1232, DOI DOI 10.1128/GEN0MEA.01232-13; Eksi R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003314; Erskine PT, 2006, J MOL BIOL, V363, P125, DOI 10.1016/j.jmb.2006.07.069; Essex-Lopresti AE, 2005, INFECT IMMUN, V73, P1260, DOI 10.1128/IAI.73.2.1260-1264.2005; Frangoulidis D, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS40, DOI 10.1016/S0035-9203(08)70011-7; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Goodyear A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037324; Gupta S, 2003, J BIOL CHEM, V278, P5235, DOI 10.1074/jbc.M208825200; Haikarainen T, 2010, CELL MOL LIFE SCI, V67, P341, DOI 10.1007/s00018-009-0168-2; Halsey TA, 2004, INFECT IMMUN, V72, P1155, DOI 10.1128/IAI.72.2.1155-1158.2004; Hamad MA, 2011, ANTIMICROB AGENTS CH, V55, P3313, DOI 10.1128/AAC.00953-10; Haussler S, 2003, EUR J CLIN MICROBIOL, V22, P249, DOI 10.1007/s10096-003-0901-y; Haussler S, 1999, MED MICROBIOL IMMUN, V188, P91, DOI 10.1007/s004300050110; Heim S, 2003, ENVIRON MICROBIOL, V5, P1257, DOI 10.1111/j.1462-2920.2003.00465.x; HENSLEY K, 1995, BBA-MOL BASIS DIS, V1270, P203, DOI 10.1016/0925-4439(95)00043-4; Herbert BR, 1998, ELECTROPHORESIS, V19, P845, DOI 10.1002/elps.1150190540; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson IM, 2003, MICROB PATHOGENESIS, V34, P73, DOI 10.1016/S0882-4010(02)00208-5; Jubair M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092883; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; KANIGA K, 1995, J BACTERIOL, V177, P7078, DOI 10.1128/jb.177.24.7078-7085.1995; Kespichayawattana W, 2004, MICROB PATHOGENESIS, V36, P287, DOI 10.1016/j.micpath.2004.01.001; Kinoshita H, 2008, J APPL MICROBIOL, V104, P1667, DOI 10.1111/j.1365-2672.2007.03679.x; Koh KS, 2007, J BACTERIOL, V189, P119, DOI 10.1128/JB.00930-06; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Law RJ, 2008, J BACTERIOL, V190, P7209, DOI 10.1128/JB.00481-08; Lee, 2007, J MICROBIOL BIOTECHN, V17, P1504; Lee JJ, 2014, VET MICROBIOL, V168, P131, DOI 10.1016/j.vetmic.2013.10.007; Lee Y, 2006, BIOCHEM BIOPH RES CO, V339, P1246, DOI 10.1016/j.bbrc.2005.11.135; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; Liochev SI, 2003, FREE RADICAL BIO MED, V34, P1383, DOI 10.1016/S0891-5849(03)00153-9; Loose M, 2014, NAT CELL BIOL, V16, P38, DOI 10.1038/ncb2885; Lottenberg Richard, 1994, Trends in Microbiology, V2, P20, DOI 10.1016/0966-842X(94)90340-9; Lucero NE, 2006, CLIN MICROBIOL INFEC, V12, P593, DOI 10.1111/j.1469-0691.2006.01386.x; Manni ML, 2011, AM J PATHOL, V178, P2752, DOI 10.1016/j.ajpath.2011.02.007; Mariappan V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077418; Mariappan V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026518; Martin DW, 2000, INFECT IMMUN, V68, P24, DOI 10.1128/IAI.68.1.24-29.2000; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; McCollister BD, 2007, IMMUNOBIOLOGY, V212, P759, DOI 10.1016/j.imbio.2007.09.019; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Minarik P, 2002, GEN PHYSIOL BIOPHYS, V21, P257; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Onyango LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077614; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200; Park Mi-rim, 2003, J Vet Sci, V4, P143; Pavelka MS, 1999, J BACTERIOL, V181, P4780, DOI 10.1128/JB.181.16.4780-4789.1999; Pelitire SM, 2003, FUNCTIONAL ANALYSIS; Picking WL, 2005, INFECT IMMUN, V73, P1432, DOI 10.1128/IAI.73.3.1432-1440.2005; Poon HF, 2005, FREE RADICAL BIO MED, V39, P453, DOI 10.1016/j.freeradbiomed.2005.03.030; Pranting M, 2011, MOL MICROBIOL, V79, P305, DOI 10.1111/j.1365-2958.2010.07458.x; Price EP, 2013, MBIO, V4, DOI 10.1128/mBio.00388-13; PROCTOR RA, 1995, CLIN INFECT DIS, V20, P95, DOI 10.1093/clinids/20.1.95; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; PROCTOR RA, 1994, INFECT AGENT DIS, V3, P302; Pumirat P, 2009, BBA-PROTEINS PROTEOM, V1794, P898, DOI 10.1016/j.bbapap.2009.01.011; Qian F, 2007, PLOS BIOL, V5, P1110, DOI 10.1371/journal.pbio.0050132; Ramiah K, 2008, RES MICROBIOL, V159, P470, DOI 10.1016/j.resmic.2008.06.002; Ramli NSK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044104; Ramnath M, 2003, APPL ENVIRON MICROB, V69, P3368, DOI 10.1128/AEM.69.6.3368-3376.2003; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; Roggenkamp A, 1998, J CLIN MICROBIOL, V36, P2530, DOI 10.1128/JCM.36.9.2530-2534.1998; Rosen R, 2004, PROTEOMICS, V4, P1061, DOI 10.1002/pmic.200300640; Roset MS, 2013, INFECT IMMUN, V81, P521, DOI 10.1128/IAI.01125-12; ROTHSCHILD HA, 1954, J BIOL CHEM, V209, P511; Schuldt L, 2009, J MOL BIOL, V389, P863, DOI 10.1016/j.jmb.2009.04.046; Sha J, 2009, J BACTERIOL, V191, P3095, DOI 10.1128/JB.00005-09; Sheng HQ, 2008, APPL ENVIRON MICROB, V74, P5015, DOI 10.1128/AEM.00743-08; SHIH KJL, 2007, J CANC MOL, V3, P4; Sifri CD, 2006, INFECT IMMUN, V74, P1091, DOI 10.1128/IAI.74.2.1091-1096.2006; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Stevanin TM, 2007, GENE, V398, P62, DOI 10.1016/j.gene.2007.03.021; Stevanin TM, 2002, INFECT IMMUN, V70, P4399, DOI 10.1128/IAI.70.8.4399-4405.2002; Stevens MP, 2004, INT J MED MICROBIOL, V293, P549, DOI 10.1078/1438-4221-00292; Stevens MP, 2002, MOL MICROBIOL, V46, P649, DOI 10.1046/j.1365-2958.2002.03190.x; Subramaniam R, 1997, J NEUROCHEM, V69, P1161; Sultana R, 2004, NEUROCHEM RES, V29, P2215, DOI 10.1007/s11064-004-7028-0; Sun J, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008769, 10.1371/journal.pone.0011351]; Suppiah J, 2010, FEMS MICROBIOL LETT, V306, P9, DOI 10.1111/j.1574-6968.2010.01923.x; Tandhavanant S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-303; Tasteyre A, 2001, INFECT IMMUN, V69, P7937, DOI 10.1128/IAI.69.12.7937-7940.2001; Thongboonkerd V, 2002, J BIOL CHEM, V277, P16599, DOI 10.1074/jbc.M200746200; Tunio SA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-280; Tunio SA, 2010, MOL MICROBIOL, V76, P605, DOI 10.1111/j.1365-2958.2010.07098.x; Ueyama T, 2007, FREE RADICAL BIO MED, V42, P180, DOI 10.1016/j.freeradbiomed.2006.08.024; Van Nostrad JD, 2008, MICROBIOL-SGM, V154, P3813, DOI 10.1099/mic.0.2008/017178-0; VANDERWAUVEN C, 1984, J BACTERIOL, V160, P928, DOI 10.1128/JB.160.3.928-934.1984; Velasco-Garcia R, 2000, BIOCHEM J, V352, P675, DOI 10.1042/0264-6021:3520675; Vellasamy KM, 2011, ELECTROPHORESIS, V32, P310, DOI 10.1002/elps.201000355; von Eiff C, 2006, INJURY, V37, P26, DOI 10.1016/j.injury.2006.04.006; Warawa J, 2005, FEMS MICROBIOL LETT, V242, P101, DOI 10.1016/j.femsle.2004.10.045; WEBER RD, 1989, INFECT IMMUN, V57, P785, DOI 10.1128/IAI.57.3.785-790.1989; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Wonprompitak P, 2009, ASIAN PAC J ALLERGY, V27, P59; Yeom J, 2009, J BACTERIOL, V191, P1472, DOI 10.1128/JB.01473-08; Zhang AD, 2009, VACCINE, V27, P1348, DOI 10.1016/j.vaccine.2008.12.047	150	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127398	10.1371/journal.pone.0127398	http://dx.doi.org/10.1371/journal.pone.0127398			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996927	Green Submitted, Green Published, gold			2022-12-26	WOS:000356444000062
J	Flores, R; Zhong, GM				Flores, Rhonda; Zhong, Guangming			The Chlamydia pneumoniae Inclusion Membrane Protein Cpn1027 Interacts with Host Cell Wnt Signaling Pathway Regulator Cytoplasmic Activation/Proliferation-Associated Protein 2 (Caprin2)	PLOS ONE			English	Article							OBLIGATE INTRACELLULAR PARASITES; NF-KAPPA-B; INC PROTEINS; INFECTED CELLS; TRACHOMATIS; ACTIVATION; GENOME; INHIBITION; APOPTOSIS; IDENTIFICATION	We previously identified hypothetical protein Cpn1027 as a novel inclusion membrane protein that is unique to Chlamydia pneumoniae. In the current study, using a yeast-two hybrid screen assay, we identified host cell cytoplasmic activation/proliferation-associated protein 2 (Caprin2) as an interacting partner of Cpn1027. The interaction was confirmed and mapped to the C-termini of both Cpn1027 and Caprin2 using co-immunoprecipitation and GST pull-down assays. A RFP-Caprin2 fusion protein was recruited to the chlamydial inclusion and so was the endogenous GSK3 beta, a critical component of the beta-catenin destruction complex in the Wnt signaling pathway. Cpn1027 also co-precipitated GSK3 beta. Caprin2 is a key regulator of the Wnt signaling pathway by promoting the recruitment of the beta-catenin destruction complex to the cytoplasmic membrane in the presence of Wnt signaling while GSK3 beta is required for priming beta-catenin for degradation in the absence of Wnt signaling. The Cpn1027 interactions with Caprin2 and GSK3 beta may allow Chlamydia pneumoniae to actively sequester the beta-catenin destruction complex so that beta-catenin is maintained even in the absence of extracellular Wnt activation signals. The maintained beta-catenin can trans-activate Wnt target genes including Bcl-2, which may contribute to the chlamydial antiapoptotic activity. We found that the Chlamydia pneumoniae-infected cells were more resistant to apoptosis induction and the anti-apoptotic activity was dependent on beta-catenin. Thus, the current study suggests that the chlamydial inclusion protein Cpn1027 may be able to manipulate host Wnt signaling pathway for enhancing the chlamydial anti-apoptotic activity.	[Flores, Rhonda; Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Zhong, GM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	zhongg@uthscsa.edu			US National Institutes of Health (NIH) grant [R01AI064537, R01AI047997]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064537, R01AI047997] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research is supported by US National Institutes of Health (NIH) grants R01AI064537 and R01AI047997. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asner SA, 2014, CLIN INFECT DIS, V58, P1198, DOI 10.1093/cid/ciu034; Bannantine JP, 2000, CELL MICROBIOL, V2, P35; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Campbell LA, 2004, NAT REV MICROBIOL, V2, P23, DOI 10.1038/nrmicro796; Cao F, 2007, INFECT IMMUN, V75, P753, DOI 10.1128/IAI.01386-06; Chen CQ, 2006, INFECT IMMUN, V74, P4826, DOI 10.1128/IAI.00081-06; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Cortes C, 2007, INFECT IMMUN, V75, P5586, DOI 10.1128/IAI.01020-07; Dehoux P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-109; Ding Y, 2008, J CELL BIOL, V182, P865, DOI 10.1083/jcb.200803147; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Flores R, 2007, MICROBIOL-SGM, V153, P777, DOI 10.1099/mic.0.2006/002956-0; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Hackstadt T, 1999, CELL MICROBIOL, V1, P119, DOI 10.1046/j.1462-5822.1999.00012.x; Hackstadt T, 1998, CURR OPIN MICROBIOL, V1, P82, DOI 10.1016/S1369-5274(98)80146-X; Hu H, 1999, J CLIN INVEST, V103, P747, DOI 10.1172/JCI4582; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Izumi K M, 2001, Methods Mol Biol, V174, P249; Izumi KM, 1997, P NATL ACAD SCI USA, V94, P12592, DOI 10.1073/pnas.94.23.12592; Li ZY, 2008, INFECT IMMUN, V76, P2746, DOI 10.1128/IAI.00010-08; Luo JH, 2007, MICROB PATHOGENESIS, V42, P111, DOI 10.1016/j.micpath.2006.11.006; Luo JH, 2007, INFECT IMMUN, V75, P497, DOI 10.1128/IAI.00935-06; Luo JH, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-38; Miao H, 2014, J BIOL CHEM; Moore ER, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00157; Moorhead AM, 2010, INFECT IMMUN, V78, P1990, DOI 10.1128/IAI.01340-09; Prozialeck WC, 2002, INFECT IMMUN, V70, P2605, DOI 10.1128/IAI.70.5.2605-2613.2002; Rockey DD, 2002, MICROBES INFECT, V4, P333, DOI 10.1016/S1286-4579(02)01546-0; Rodgers AK, 2011, FERTIL STERIL, V96, P715, DOI 10.1016/j.fertnstert.2011.06.021; Sharma J, 2006, INFECT IMMUN, V74, P1490, DOI 10.1128/IAI.74.3.1490-1499.2006; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; Subtil A, 2001, MOL MICROBIOL, V39, P792, DOI 10.1046/j.1365-2958.2001.02272.x; Toh H, 2003, DNA RES, V10, P9, DOI 10.1093/dnares/10.1.9; Wang J, 2010, J IMMUNOL, V185, P1670, DOI 10.4049/jimmunol.1001240; Wolf K, 2009, CELL MICROBIOL, V11, P769, DOI 10.1111/j.1462-5822.2009.01290.x; Xiao YM, 2005, J IMMUNOL, V174, P1701, DOI 10.4049/jimmunol.174.3.1701; Xiao YM, 2004, INFECT IMMUN, V72, P5470, DOI 10.1128/IAI.72.9.5470-5474.2004; Zhong GM, 1997, P NATL ACAD SCI USA, V94, P13856, DOI 10.1073/pnas.94.25.13856; Zhong YM, 2006, J INFECTION, V53, P408, DOI 10.1016/j.jinf.2005.12.028	43	12	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127909	10.1371/journal.pone.0127909	http://dx.doi.org/10.1371/journal.pone.0127909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996495	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000097
J	Bu, CF; Wu, SF; Han, FP; Yang, YS; Meng, J				Bu, Chongfeng; Wu, Shufang; Han, Fengpeng; Yang, Yongsheng; Meng, Jie			The Combined Effects of Moss-Dominated Biocrusts and Vegetation on Erosion and Soil Moisture and Implications for Disturbance on the Loess Plateau, China	PLOS ONE			English	Article							BIOLOGICAL SOIL; SEMIARID ECOSYSTEMS; MICROBIOTIC CRUSTS; VASCULAR PLANTS; SANDY SOIL; DESERT; INFILTRATION; RUNOFF; GERMINATION; GRASSLAND	Biological soil crusts (BSCs, or biocrusts) have important positive ecological functions such as erosion control and soil fertility improvement, and they may also have negative effects on soil moisture in some cases. Simultaneous discussions of the two-sided impacts of BSCs are key to the rational use of this resource. This study focused on the contribution of BSCs while combining with specific types of vegetation to erosion reduction and their effects on soil moisture, and it addressed the feasibility of removal or raking disturbance. Twelve plots measuring 4 m x 2 m and six treatments (two plots for each) were established on a 15 degrees slope in a small watershed in the Loess Plateau using BSCs, bare land (as a control, BL), Stipa bungeana Trin. (STBU), Caragana korshinskii Kom. (CAKO), STBU planted with BSCs (STBU+BSCs) and CAKO planted with BSCs (CAKO+BSCs). The runoff, soil loss and soil moisture to a depth of 3 m were measured throughout the rainy season (from June to September) of 2010. The results showed that BSCs significantly reduced runoff by 37.3% and soil loss by 81.0% and increased infiltration by 12.4% in comparison with BL. However, when combined with STBU or CAKO, BSCs only made negligible contributions to erosion control (a runoff reduction of 7.4% and 5.7% and a soil loss reduction of 0.7% and 0.3%). Generally, the soil moisture of the vegetation plots was lower in the upper layer than that of the BL plots, although when accompanied with a higher amount of infiltration, this soil moisture consumption phenomenon was much clearer when combining vegetation with BSCs. Because of the trivial contributions from BSCs to erosion control and the remaining exacerbated consumption of soil water, moderate disturbance by BSCs should be considered in plots with adequate vegetation cover to improve soil moisture levels without a significant erosion increase, which was implied to be necessary and feasible.	[Bu, Chongfeng; Han, Fengpeng; Meng, Jie] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China; [Bu, Chongfeng; Han, Fengpeng; Yang, Yongsheng] Chinese Acad Sci & Minist Water Resources, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China; [Wu, Shufang] Northwest A&F Univ, Coll Water Resources & Architectural Engn, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Northwest A&F University - China	Wu, SF (corresponding author), Northwest A&F Univ, Coll Water Resources & Architectural Engn, Yangling, Shaanxi, Peoples R China.	buchongfeng@163.com; wsfjs@163.com	Lang, Ming/HIK-0758-2022		National Natural Science Foundation of China [41071192, 40701096]; Foundation of State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau [K318009902-1405]; Chinese Universities Scientific Fund [2014YQ006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau; Chinese Universities Scientific Fund	The National Natural Science Foundation of China (grant nos. 41071192 & 40701096), the Foundation of State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau (K318009902-1405), and the Chinese Universities Scientific Fund (grant no. 2014YQ006) provided funding for this research.	Belnap J, 2005, ECOLOGY, V86, P298, DOI 10.1890/03-0567; Belnap J, 2003, FRONT ECOL ENVIRON, V1, P181, DOI 10.2307/3868062; Belnap J, 2006, HYDROL PROCESS, V20, P3159, DOI 10.1002/hyp.6325; Bowker MA, 2009, SOIL BIOL BIOCHEM, V42, P1; Bowker MA, 2008, SOIL BIOL BIOCHEM, V40, P2309, DOI 10.1016/j.soilbio.2008.05.008; Briggs AL, 2012, J ARID ENVIRON, V77, P84, DOI 10.1016/j.jaridenv.2011.10.002; Bu C, 2015, PLANT BIOSYST, V149, P364, DOI 10.1080/11263504.2013.819820; [卜崇峰 Bu Chongfeng], 2014, [自然资源学报, Journal of Natural Resources], V29, P490; Bu CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090049; Bu CF, 2013, CLEAN-SOIL AIR WATER, V41, P899, DOI 10.1002/clen.201100675; Carmi G, 2008, CATENA, V74, P37, DOI 10.1016/j.catena.2008.02.002; Chamizo S, 2013, J HYDROL, V489, P74, DOI 10.1016/j.jhydrol.2013.02.051; Chamizo S, 2012, J HYDROL, V452, P130, DOI 10.1016/j.jhydrol.2012.05.045; Chamizo S, 2012, ECOSYSTEMS, V15, P148, DOI 10.1007/s10021-011-9499-6; Cheng Xiang-rong, 2007, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V27, P321; Coppola A, 2011, SOIL TILL RES, V117, P34, DOI 10.1016/j.still.2011.08.003; Dojani S, 2011, APPL SOIL ECOL, V48, P263, DOI 10.1016/j.apsoil.2011.04.013; Eldridge D.J., 2003, BIOL SOIL CRUSTS STR, V150, P315; Evans RD, 2001, ECOL STU AN, V150, P263; Godinez-Alvarez H, 2012, PLANT BIOLOGY, V14, P157, DOI 10.1111/j.1438-8677.2011.00495.x; Hernandez RR, 2011, PLANT ECOL, V212, P1709, DOI 10.1007/s11258-011-9943-x; Kidron GJ, 1999, SOIL SCI, V164, P18, DOI 10.1097/00010694-199901000-00004; Li XR, 2010, HYDROL PROCESS, V24, P3621, DOI 10.1002/hyp.7791; Li XR, 2005, PLANT SOIL, V277, P375, DOI 10.1007/s11104-005-8162-4; Lichner L, 2012, J HYDROL HYDROMECH, V60, P309, DOI 10.2478/v10098-012-0027-y; Liu HJ, 2009, RANGELAND ECOL MANAG, V62, P321, DOI 10.2111/08-179.1; [马全林 MA QuanLin], 2007, [生态学报, Acta Ecologica Sinica], V27, P5057, DOI 10.1016/S1872-2032(08)60014-1; Mazor G, 1996, FEMS MICROBIOL ECOL, V21, P121, DOI 10.1111/j.1574-6941.1996.tb00339.x; Meng J, 2010, J NAT RESOUR, V11, P54; Miralles I, 2012, SOIL BIOL BIOCHEM, V53, P124, DOI 10.1016/j.soilbio.2012.05.016; O'Bryan KE, 2009, OECOLOGIA, V159, P827, DOI 10.1007/s00442-008-1260-2; Rodriguez-Caballero E, 2012, GEOMORPHOLOGY, V145, P81, DOI 10.1016/j.geomorph.2011.12.042; VERRECCHIA E, 1995, J ARID ENVIRON, V29, P427, DOI 10.1016/S0140-1963(95)80015-8; [王翠萍 WANG Cui-ping], 2009, [干旱地区农业研究, Agricultural Research in the Arid Areas], V27, P54; Xiao B, 2010, J ARID ENVIRON, V74, P121, DOI 10.1016/j.jaridenv.2009.06.013; Xiao B, 2011, APPL SOIL ECOL, V48, P11, DOI 10.1016/j.apsoil.2011.02.006; Yuan WP, 2014, REMOTE SENS LETT, V5, P221, DOI 10.1080/2150704X.2014.894655; [张侃侃 ZHANG Kankan], 2011, [干旱区研究, Arid Zone Research], V28, P808; Zhang XZ, 2002, SOIL WATER CONSERVAT, V3, P11; Zhang YM, 2006, GEODERMA, V132, P441, DOI 10.1016/j.geoderma.2005.06.008; [张永萱 ZHANG Yong-xuan], 2009, [水土保持通报, Bulletin of Soil and Water Conservation], V29, P6; Zhao HL, 2010, CATENA, V82, P70, DOI 10.1016/j.catena.2010.05.002; Zhao Yunge, 2006, Yingyong Shengtai Xuebao, V17, P1429	43	28	31	6	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127394	10.1371/journal.pone.0127394	http://dx.doi.org/10.1371/journal.pone.0127394			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993431	Green Submitted, gold, Green Published			2022-12-26	WOS:000354921400112
J	Colgan, MS; Martin, RE; Baldeck, CA; Asner, GP				Colgan, Matthew S.; Martin, Roberta E.; Baldeck, Claire A.; Asner, Gregory P.			Tree Foliar Chemistry in an African Savanna and Its Relation to Life History Strategies and Environmental Filters	PLOS ONE			English	Article							COLOPHOSPERMUM-MOPANE; LEAF; BORON; HERBIVORES; NITROGEN; PHOTOSYNTHESIS; NUTRITION; TANNINS; FITNESS; LEAVES	Understanding the relative importance of environment and life history strategies in determining leaf chemical traits remains a key objective of plant ecology. We assessed 20 foliar chemical properties among 12 African savanna woody plant species and their relation to environmental variables (hillslope position, precipitation, geology) and two functional traits (thorn type and seed dispersal mechanism). We found that combinations of six leaf chemical traits (lignin, hemi-cellulose, zinc, boron, magnesium, and manganese) predicted the species with 91% accuracy. Hillslope position, precipitation, and geology accounted for only 12% of the total variance in these six chemical traits. However, thorn type and seed dispersal mechanism accounted for 46% of variance in these chemical traits. The physically defended species had the highest concentrations of hemi-cellulose and boron. Species without physical defense had the highest lignin content if dispersed by vertebrates, but threefold lower lignin content if dispersed by wind. One of the most abundant woody species in southern Africa, Colophospermum mopane, was found to have the highest foliar concentrations of zinc, phosphorus, and d13C, suggesting that zinc chelation may be used by this species to bind metallic toxins and increase uptake of soil phosphorus. Across all studied species, taxonomy and physical traits accounted for the majority of variability in leaf chemistry.	[Colgan, Matthew S.; Martin, Roberta E.; Baldeck, Claire A.; Asner, Gregory P.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA	Carnegie Institution for Science	Asner, GP (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA.	gpa@carnegiescience.edu	Asner, Gregory/G-9268-2013; Martin, Roberta/A-5073-2015	Asner, Gregory/0000-0001-7893-6421; Martin, Roberta/0000-0003-3509-8530	Andrew Mellon Foundation; Grantham Foundation for the Protection of the Environment; endowment of the Carnegie Institution for Science	Andrew Mellon Foundation; Grantham Foundation for the Protection of the Environment; endowment of the Carnegie Institution for Science	This study was supported by the Andrew Mellon Foundation, Grantham Foundation for the Protection of the Environment, and the endowment of the Carnegie Institution for Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2007, NAT PROTOC, V2, P875, DOI 10.1038/nprot.2007.102; Asner GP, 2011, NEW PHYTOL, V189, P999, DOI 10.1111/j.1469-8137.2010.03549.x; Bellingham PJ, 2000, OIKOS, V89, P409, DOI 10.1034/j.1600-0706.2000.890224.x; BELSKY AJ, 1989, J APPL ECOL, V26, P1005, DOI 10.2307/2403708; Bolanos L, 2004, PLANT PHYSIOL BIOCH, V42, P907, DOI 10.1016/j.plaphy.2004.11.002; BOLANOS L, 1994, PLANT PHYSIOL, V104, P85, DOI 10.1104/pp.104.1.85; Bonilla I, 1997, PLANT PHYSIOL, V115, P1329, DOI 10.1104/pp.115.4.1329; Breiman L., 1984, CLASSIFICATION REGRE; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Brown PH, 2002, PLANT BIOLOGY, V4, P205, DOI 10.1055/s-2002-25740; CHAPIN FS, 1991, BIOSCIENCE, V41, P29, DOI 10.2307/1311538; COLEY PD, 1993, ECOLOGY, V74, P619, DOI 10.2307/1939322; COOPER SM, 1985, OECOLOGIA, V67, P142, DOI 10.1007/BF00378466; Coulthurst SJ, 2002, TRENDS BIOCHEM SCI, V27, P217, DOI 10.1016/S0968-0004(02)02096-0; Cramer MD, 2010, J ECOL, V98, P156, DOI 10.1111/j.1365-2745.2009.01594.x; de Boer WF, 2000, AFR J ECOL, V38, P188, DOI 10.1046/j.1365-2028.2000.00243.x; Eamus D, 1999, PHOTOSYNTHETICA, V36, P575, DOI 10.1023/A:1007048222329; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Ferwerda JG, 2005, PLANT SOIL, V273, P203, DOI 10.1007/s11104-004-7538-1; Fyllas NM, 2009, BIOGEOSCIENCES, V6, P2677, DOI 10.5194/bg-6-2677-2009; Goheen JR, 2010, J ANIM ECOL, V79, P372, DOI 10.1111/j.1365-2656.2009.01644.x; Grant C. C., 2000, African Journal of Range and Forage Science, V17, P81, DOI 10.2989/10220110009485743; Hopcraft JGC, 2010, TRENDS ECOL EVOL, V25, P119, DOI 10.1016/j.tree.2009.08.001; Hrabar H, 2009, J TROP ECOL, V25, P301, DOI 10.1017/S0266467409005872; HUSTON M, 1987, AM NAT, V130, P168, DOI 10.1086/284704; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jordaan A, 2000, S AFR J BOT, V66, P128, DOI 10.1016/S0254-6299(15)31075-9; KENKEL NC, 1986, ECOLOGY, V67, P919, DOI 10.2307/1939814; Lichtenthaler H.K., 2001, CURR PROTOC FOOD ANA, V1, pF4.3.1, DOI [10.1002/0471142913.faf0403s01, DOI 10.1002/0471142913.FAF0403S01]; LOEHLE C, 1988, CAN J FOREST RES, V18, P209, DOI 10.1139/x88-032; McDowell R, 1988, IMPORTANCE CROP RESI, P3; MCNAUGHTON SJ, 1990, NATURE, V345, P613, DOI 10.1038/345613a0; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; MINCHIN PR, 1987, VEGETATIO, V71, P145; Moore BD, 2004, ECOL MONOGR, V74, P553, DOI 10.1890/03-4038; Muola A, 2010, ECOLOGY, V91, P2650, DOI 10.1890/09-0589.1; Niinemets U, 1999, NEW PHYTOL, V144, P35, DOI 10.1046/j.1469-8137.1999.00466.x; Ode PJ, 2006, ANNU REV ENTOMOL, V51, P163, DOI 10.1146/annurev.ento.51.110104.151110; Oliveira PS, 2002, CERRADOS BRAZIL ECOL; Owen-Smith N., 1982, ECOL STUD, P359; Poorter L, 2010, NEW PHYTOL, V185, P481, DOI 10.1111/j.1469-8137.2009.03092.x; R Core Team, 2012, R LANG ENV STAT COMP; Reich PB, 1998, FUNCT ECOL, V12, P395, DOI 10.1046/j.1365-2435.1998.00209.x; Scholes R.J., 1993, AFRICAN SAVANNA SYNT; Skidmore AK, 2010, REMOTE SENS ENVIRON, V114, P64, DOI 10.1016/j.rse.2009.08.010; TAYLOR DR, 1990, OIKOS, V58, P239, DOI 10.2307/3545432; Toth GB, 2001, J CHEM ECOL, V27, P1899, DOI 10.1023/A:1010421128190; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Venter F.J., 2003, KRUGER EXPERIENCE EC, P83, DOI DOI 10.2989/10220110409485835; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; Warington K, 1923, ANN BOT-LONDON, V37, P629, DOI 10.1093/oxfordjournals.aob.a089871; Watt J., 1962, MED POISONOUS PLANTS, P205; Wessels D. C. J., 2007, African Journal of Range & Forage Science, V24, P141, DOI 10.2989/AJRFS.2007.24.3.4.297; ZUCKER WV, 1983, AM NAT, V121, P335, DOI 10.1086/284065	56	5	5	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0124078	10.1371/journal.pone.0124078	http://dx.doi.org/10.1371/journal.pone.0124078			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993539	Green Published, gold, Green Submitted			2022-12-26	WOS:000354921400014
J	Souza, LA; Ferreira, RL; Senna, AR				Souza, Leila A.; Ferreira, Rodrigo L.; Senna, Andre R.			Amphibious Shelter-Builder Oniscidea Species from the New World with Description of a New Subfamily, a New Genus and a New Species from Brazilian Cave (Isopoda, Synocheta, Styloniscidae)	PLOS ONE			English	Article							TERRESTRIAL ISOPODA; CRUSTACEA; LEDIFICATION; ADAPTATION; PHYLOGENY; LOGETTES; MUE	The new subfamily luiuniscinae, Styloniscidae, is erected for the new genus luiuniscus and the new species I. iuiuensis, which is described from cave of the State of Bahia, Northeastern Brazil. A special ecological character is shown here for the first time for a New World Oniscidea: the construction of mud shelters. An introduction addressing the systematics of Synocheta with emphasis on Styloniscidae Vandel, 1952 is provided, as well as general comments about the dependence of water in some Oniscidea and ecological traits of amphibious Synocheta. The problems referring to nomenclature, taxonomy and the interrelationships in Styloniscidae are discussed.	[Souza, Leila A.] Univ Etadual Ceara, Inst Super Ciencias Biomed, Lab Carcinicultura LACAR, Fortaleza, CE, Brazil; [Ferreira, Rodrigo L.] Univ Fed Lavras, Dept Biol, Setor Zool, Lab Ecol Subterranea, Lavras, MG, Brazil; [Senna, Andre R.] Univ Fed Bahia, Inst Biol, Lab Invertebrados Marinhos Crustacea Cnidaria & F, Salvador, BA, Brazil	Universidade Federal de Lavras; Universidade Federal da Bahia	Souza, LA (corresponding author), Univ Etadual Ceara, Inst Super Ciencias Biomed, Lab Carcinicultura LACAR, Campus Itaperi, Fortaleza, CE, Brazil.	leila.souza@uece.br	Ferreira, RL/L-8419-2014; Senna, André/AAT-9628-2021	Ferreira, RL/0000-0003-3288-4405; R. Senna, Andre/0000-0003-0976-849X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [477712/2006-1, 301061/2011-4]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/110.773/2012]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Funding was provided by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), process no 477712/2006-1, and to R. L. F. (CNPq grant nr. 301061/2011-4), and by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) to A. R. S., by grant, process nr. E-26/110.773/2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou S, 2013, PARNASSIANA ARCH, V1, P3; BARNARD K. H., 1958, MEM INST SCI MADAGASCAR SER A BIOL, V12, P67; BORUTSKII E V, 1969, Zoologicheskii Zhurnal, V48, P499; Bowman T.E., 1982, P1; Campos IS, 2014, ZOOL J LINN SOC-LOND, V172, P360, DOI 10.1111/zoj12172; Crawley C., 1910, Entomologist's Record London, V22; DALENS H, 1977, Bulletin de la Societe d'Histoire Naturelle de Toulouse, V113, P181; DALENS H, 1967, CR ACAD SCI D NAT, V265, P701; Dana, 1852, AM J SCI ARTS, V2, P297; DUFFY J. E., 2010, ENCY ANIM BEHAV, V1, P421; Golovatch Sergei I., 2009, Soil Organisms, V81, P565; Holdich D.M., 1984, Symposia of the Zoological Society of London, P1; Hornung Elisabeth, 2011, Terrestrial Arthropod Reviews, V4, P95, DOI 10.1163/187498311X576262; Jugovic J, 2010, J NAT HIST, V44, P2509, DOI 10.1080/00222933.2010.502258; Karaman IM, 2003, ORG DIVERS EVOL S8, V3, P1; KENSLEY B F, 1971, Annals of the South African Museum, V57, P131; RIOJA E, 1952, ANALES I BIOL U MEXI, V23, P227; SCHMALFUSS H, 1989, MONITORE ZOOLOGICO ITALIANO, N S, MONOGRAFIA 4, 1989, P3; Schmalfuss H., 1984, Symposia of the Zoological Society of London, P49; Schmalfuss H, 2003, STUTTGARTER BEITRA A, V654; Schmalfuss H, 1998, STUTTGARTER BEITRA A, V582; Schmalfuss H, 2004, STUTTGARTER BEITRA A, V662; Schmalfuss Helmut, 2005, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V677, P1; Schmidt Christian, 2002, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Zoologische Reihe, V78, P275; Schmidt Christian, 2008, Arthropod Systematics & Phylogeny, V66, P191; Schmolzer K, 1965, BESTIMMUNGSBUCHER BO; SCHULTZ GA, 1994, J CRUSTACEAN BIOL, V14, P763, DOI 10.2307/1548870; Souza-Kury LA, 1997, THESIS U SAO PAULO; STEEL CGH, 1993, CAN J ZOOL, V71, P4, DOI 10.1139/z93-002; Strouhal H., 1961, Annalen des Naturhistorischen Museums in Wien, V64, P185; TABACARU I, 1999, TRAVAUX I SPEOLOGIE, V37, P115; Tabacaru Ionel, 1993, Travaux de l'Institut de Speologie "Emile Racovitza", V32, P43; TAITI S, 1983, REV SUISSE ZOOL, V90, P199; Taiti S, 2012, TROP ZOOL, V25, P183, DOI 10.1080/03946975.2012.751240; Trajano E, 2010, BIOLOGY OF SUBTERRANEAN FISHES, P1, DOI 10.1201/EBK1578086702-f; VANDEL A., 1964, ANN SPELEOL, V19, P729; VANDEL A., 1965, ANN SPELEOL, V20, P489; VANDEL A, 1958, CR HEBD ACAD SCI, V247, P1538; VANDEL A, 1952, CR HEBD ACAD SCI, V235, P997; VANDEL A., 1966, ANN SPELEOLA, V21, P643; Vandel A., 1946, BULL SOC ZOOL FRANCE, V71, P53; Vandel A., 1965, Annales de Speleologie, V20, P347; Vandel A, 1975, MEMOIRES MUSEUM NA A, V88, P197; Vandel A, 1952, MEMOIRES MUSEUM NATL, V6, P1; VANDEL ALBERT, 1960, FAUNE DE FRANCE, V64, P1; Verhoeff K. W., 1951, Further Zoological Results of the Swedish Antarctic Expedition, V4, P1; Verhoeff K. W.Von G. H., 1939, Archiv fuer Naturgeschichte Leipzig, V8, P301	47	25	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0115021	10.1371/journal.pone.0115021	http://dx.doi.org/10.1371/journal.pone.0115021			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992909	Green Submitted, Green Published, gold			2022-12-26	WOS:000354921400004
J	Wang, LL; Koppolu, S; Chappell, C; Moncla, BJ; Hillier, SL; Mahal, LK				Wang, Linlin; Koppolu, Sujeethraj; Chappell, Catherine; Moncla, Bernard J.; Hillier, Sharon L.; Mahal, Lara K.			Studying the Effects of Reproductive Hormones and Bacterial Vaginosis on the Glycome of Lavage Samples from the Cervicovaginal Cavity	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LECTIN MICROARRAY APPROACH; ESCHERICHIA-COLI; RAPID ANALYSIS; VAGINAL FLUID; HIV-INFECTION; BINDING; OLIGOSACCHARIDES; AGGLUTININ; AFFINITY	The cervicovaginal fluid (CVF) coating the vaginal epithelium is an important immunological mediator, providing a barrier to infection. Glycosylation of CVF proteins, such as mucins, IgG and S-IgA, plays a critical role in their immunological functions. Although multiple factors, such as hormones and microflora, may influence glycosylation of the CVF, few studies have examined their impact on this important immunological fluid. Herein we analyzed the glycosylation of cervicovaginal lavage (CVL) samples collected from 165 women under different hormonal conditions including: (1) no contraceptive, post-menopausal, (2) no contraceptive, days 1-14 of the menstrual cycle, (3) no contraceptive, days 15-28 of the menstrual cycle, (4) combined-oral contraceptive pills for at least 6 months, (5) depomedroxyprogesterone acetate (Depo-Provera) injections for at least 6 months, (6) levonorgestrel IUD for at least 1 month. Glycomic profiling was obtained using our lectin microarray system, a rapid method to analyze carbohydrate composition. Although some small effects were observed due to hormone levels, the major influence on the glycome was the presence of an altered bacterial cohort due to bacterial vaginosis (BV). Compared to normal women, samples from women with BV contained lower levels of sialic acid and high-mannose glycans in their CVL. The change in high mannose levels was unexpected and may be related to the increased risk of HIV-infection observed in women with BV, as high mannose receptors are a viral entry pathway. Changes in the glycome were also observed with hormonal contraceptive use, in a contraceptive-dependent manner. Overall, microflora had a greater impact on the glycome than hormonal levels, and both of these effects should be more closely examined in future studies given the importance of glycans in the innate immune system.	[Wang, Linlin; Koppolu, Sujeethraj; Mahal, Lara K.] NYU, Inst Biomed Chem, Dept Chem, New York, NY 10003 USA; [Chappell, Catherine; Moncla, Bernard J.; Hillier, Sharon L.] Univ Pittsburgh, Med Ctr, Dept Obstet Gynecol & Reprod Sci, Magee Womens Hosp, Pittsburgh, PA 15213 USA; [Moncla, Bernard J.; Hillier, Sharon L.] Magee Womens Res Inst, Pittsburgh, PA 15213 USA	New York University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Mahal, LK (corresponding author), NYU, Inst Biomed Chem, Dept Chem, New York, NY 10003 USA.	lkmahal@nyu.edu	Mahal, Lara/GRY-7287-2022; Wang, Linlin/U-9905-2019	Wang, Linlin/0000-0002-2970-1738; Mahal, Lara/0000-0003-4791-8524	National Institutes of Health [U191AI082639]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health, Grant # U191AI082639. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal P, 2014, P NATL ACAD SCI USA, V111, P4338, DOI 10.1073/pnas.1321524111; Alexandre KB, 2010, VIROLOGY, V402, P187, DOI 10.1016/j.virol.2010.03.021; Andersch-Bjorkman Y, 2007, MOL CELL PROTEOMICS, V6, P708, DOI 10.1074/mcp.M600439-MCP200; Bai XM, 2001, GLYCOBIOLOGY, V11, P621, DOI 10.1093/glycob/11.8.621; Bard E, 2003, CLIN CHEM LAB MED, V41, P127, DOI 10.1515/CCLM.2003.021; BHATTACHARYYA L, 1988, BIOCHEMISTRY-US, V27, P1034, DOI 10.1021/bi00403a028; Bird-Lieberman EL, 2012, NAT MED, V18, P315, DOI 10.1038/nm.2616; BrinkmanVanderLinden ECM, 1996, GLYCOBIOLOGY, V6, P407, DOI 10.1093/glycob/6.4.407; BRISELDEN AM, 1992, J CLIN MICROBIOL, V30, P663, DOI 10.1128/JCM.30.3.663-666.1992; Carlstedt I, 1989, Symp Soc Exp Biol, V43, P289; Chappell CA, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.041; CONOVER W. J, 1980, PRACTICAL NONPARAMET; Dam TK, 1998, J BIOL CHEM, V273, P5528, DOI 10.1074/jbc.273.10.5528; DEBRAY H, 1986, CARBOHYD RES, V151, P359, DOI 10.1016/S0008-6215(00)90355-0; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Emau P, 2007, J MED PRIMATOL, V36, P244, DOI 10.1111/j.1600-0684.2007.00242.x; Fanibunda SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028014; FISCHER E, 1995, GLYCOCONJUGATE J, V12, P707, DOI 10.1007/BF00731268; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Govender Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096497; Groot F, 2005, J VIROL, V79, P3009, DOI 10.1128/JVI.79.5.3009-3015.2005; Harman AN, 2013, REV MED VIROL, V23, P319, DOI 10.1002/rmv.1753; HILLIER S, 1999, SEXUALLY TRANSMITTED, P563; Hladik Florian, 2009, Curr HIV/AIDS Rep, V6, P20, DOI 10.1007/s11904-009-0004-1; Hogg RV, 1987, ENGINEERING STATISTI; Hsu KL, 2006, NAT PROTOC, V1, P543, DOI 10.1038/nprot.2006.76; Hsu KL, 2011, METHODS MOL BIOL, V671, P117, DOI 10.1007/978-1-59745-551-0_6; Inoue K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077118; Jadhav SK, 2013, AIDS RES HUM RETROV, V29, P156, DOI [10.1089/aid.2012.0101, 10.1089/AID.2012.0101]; KAKU H, 1992, CARBOHYD RES, V229, P337, DOI 10.1016/S0008-6215(00)90579-2; Kaneda Y, 2002, J BIOL CHEM, V277, P16928, DOI 10.1074/jbc.M112382200; Kilcoyne M, 2014, CARBOHYD RES, V389, P123, DOI 10.1016/j.carres.2014.02.005; Kuno A, 2005, NAT METHODS, V2, P851, DOI 10.1038/NMETH803; Lewis AL, 2012, CELL MICROBIOL, V14, P1174, DOI 10.1111/j.1462-5822.2012.01807.x; Lewis WG, 2012, J BIOL CHEM, V287, P2079, DOI 10.1074/jbc.M111.278135; LILLIEFO.HW, 1969, J AM STAT ASSOC, V64, P387, DOI 10.2307/2283748; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Meuleman P, 2011, ANTIMICROB AGENTS CH, V55, P5159, DOI 10.1128/AAC.00633-11; Mitchell C, 2011, J CLIN MICROBIOL, V49, P735, DOI 10.1128/JCM.00991-10; Myer L, 2005, LANCET INFECT DIS, V5, P786, DOI 10.1016/S1473-3099(05)70298-X; Nakamura-Tsuruta S, 2008, FEBS J, V275, P1227, DOI 10.1111/j.1742-4658.2008.06282.x; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Olmsted SS, 2003, SEX TRANSM DIS, V30, P257, DOI 10.1097/00007435-200303000-00016; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; Pilobello KT, 2007, P NATL ACAD SCI USA, V104, P11534, DOI 10.1073/pnas.0704954104; Pilobello Kanoelani T, 2013, Curr Protoc Chem Biol, V5, P1, DOI 10.1002/9780470559277.ch120035; Pilobello KT, 2005, CHEMBIOCHEM, V6, P985, DOI 10.1002/cbic.200400403; Porter A, 2010, GLYCOBIOLOGY, V20, P369, DOI 10.1093/glycob/cwp187; Rajan N, 1999, INFECT IMMUN, V67, P5027, DOI 10.1128/IAI.67.10.5027-5032.1999; Royce RA, 1999, J ACQ IMMUN DEF SYND, V20, P382, DOI 10.1097/00042560-199904010-00009; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schaeffer AJ, 2001, INT J ANTIMICROB AG, V17, P245, DOI 10.1016/S0924-8579(01)00302-8; Schoor RA, 2001, UROLOGY, V57, P556, DOI 10.1016/S0090-4295(00)01013-X; Sewankambo N, 1997, LANCET, V350, P546, DOI 10.1016/S0140-6736(97)01063-5; Shafer WM, 2002, CURR PHARM DESIGN, V8, P695, DOI 10.2174/1381612023395376; Sigurdsson HH, 2013, INT J PHARMACEUT, V453, P56, DOI 10.1016/j.ijpharm.2013.05.040; Singh T, 2007, MOL IMMUNOL, V44, P451, DOI 10.1016/j.molimm.2006.02.017; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Wang LL, 2014, GLYCOBIOLOGY, V24, P507, DOI 10.1093/glycob/cwu019; WOLD AE, 1990, INFECT IMMUN, V58, P3073, DOI 10.1128/IAI.58.9.3073-3077.1990; Wu AM, 2003, LIFE SCI, V72, P2285, DOI 10.1016/S0024-3205(03)00116-4; YAMASHITA K, 1992, BIOCHEMISTRY-US, V31, P11647, DOI 10.1021/bi00161a052; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yeoman CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056111; Zegels G, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-17; Zou GZ, 2011, J AM CHEM SOC, V133, P18975, DOI 10.1021/ja208390n	66	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127021	10.1371/journal.pone.0127021	http://dx.doi.org/10.1371/journal.pone.0127021			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993513	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000354921400090
J	Liu, XL; Wang, YF; Ming, YN; Song, YY; Zhang, JY; Chen, XY; Zeng, MD; Mao, YM				Liu, Xiaolin; Wang, Yongfeng; Ming, Yanan; Song, Yanyan; Zhang, Jingyi; Chen, Xiaoyu; Zeng, Minde; Mao, Yimin			S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis	PLOS ONE			English	Article							DIABETES-MELLITUS; RISK-FACTORS; ASSOCIATION; EXPRESSION; PREVALENCE; VALIDATION; FIBROSIS; JAPANESE; NASH; RAT	Non-alcoholic fatty liver (NAFL) has the potential to progress to non-alcoholic steatohepatitis (NASH) or to promote type 2 diabetes mellitus (T2DM). However, NASH and T2DM do not always develop coordinately. Additionally, there are no definite noninvasive methods for NASH diagnosis currently. We established rat models of NAFL, NASH, and NAFL + T2DM to recapitulate different phenotypes associated with non-alcoholic fatty liver disease (NAFLD) and its progression. Histologic features of rat livers were scored according to criteria established by the Nonalcoholic Steatohepatitis Clinical Research Network. Microarray was performed to assess gene expression changes in rat livers. We find that gene expression of s100a9 was higher in NAFL group compared with control, and was increased in NASH groups and decreased in NAFL + T2DM group compared with NAFL. In contrast, srebf1, tbx21, and gimap4 only showed limited discriminating abilities in different groups. There is a significant positive correlation between serum levels of S100A9 and NAFLD Activity Score (NAS), the severity of hepatic steatosis, and lobular inflammation (r = 0.80, 0.64 and 0.86, P < 0.001). These findings suggest that S100A9 may be extremely useful in the diagnosis of NASH (AUROC: 0.947, CI: 0.845-1.049). Additionally, serum S100A9 levels displayed a strong correlation with ALT, AST and TBil (r = 0.81, 0.89 and 0.91, P < 0.001) but a weak correlation with FBG, HOMA-IR, TG, and TC (r = -0.41, -0.40, 0.47 and 0.49, P < 0.05). Conclusions: The results we provide here suggest that S100A9 may be useful as a biomarker for the hepatic and metabolic progression of NAFLD and the non-invasive diagnosis of NASH.	[Liu, Xiaolin; Wang, Yongfeng; Ming, Yanan; Zhang, Jingyi; Chen, Xiaoyu; Zeng, Minde; Mao, Yimin] Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Sch Med, Renji Hosp,Div Gastroenterol & Hepatol, Shanghai 200030, Peoples R China; [Song, Yanyan] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Biostat, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Mao, YM (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Sch Med, Renji Hosp,Div Gastroenterol & Hepatol, Shanghai 200030, Peoples R China.	maoym11968@163.com	wang, yan/GSE-6489-2022; Wang, Yanbo/HFZ-8018-2022		Major Project of National Twelfth Five Plan [2012ZX09303-001, 2013ZX10002004]	Major Project of National Twelfth Five Plan	This work was supported by the Major Project of National Twelfth Five Plan (2012ZX09303-001, 2013ZX10002004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Zaigham, 2013, Trop Gastroenterol, V34, P153; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Armstrong MJ, 2014, HEPATOLOGY, V59, P1174, DOI 10.1002/hep.26717; Averill MM, 2011, CIRCULATION, V123, P1216, DOI 10.1161/CIRCULATIONAHA.110.985523; Bouma G, 2004, DIABETES, V53, P1979, DOI 10.2337/diabetes.53.8.1979; Braunersreuther V, 2012, WORLD J GASTROENTERO, V18, P727, DOI 10.3748/wjg.v18.i8.727; Byrne CD, 2009, CLIN SCI, V116, P539, DOI 10.1042/CS20080253; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chen S, 2011, HUM IMMUNOL, V72, P69, DOI 10.1016/j.humimm.2010.10.019; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cusi K, 2014, J HEPATOL, V60, P167, DOI 10.1016/j.jhep.2013.07.042; Davila S, 2010, GENES IMMUN, V11, P232, DOI 10.1038/gene.2010.1; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Feldstein AE, 2009, HEPATOLOGY, V50, P1072, DOI 10.1002/hep.23050; Filen JJ, 2009, MOL CELL PROTEOMICS, V8, P32, DOI 10.1074/mcp.M800139-MCP200; Hou LG, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-126; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kowdley KV, 2012, HEPATOLOGY, V55, P77, DOI 10.1002/hep.24706; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; Lemoine M, 2009, LIVER INT, V29, P1431, DOI 10.1111/j.1478-3231.2009.02022.x; Liu CJ, 2012, J GASTROEN HEPATOL, V27, P1555, DOI 10.1111/j.1440-1746.2012.07222.x; Liu JX, 2008, DIABETES RES CLIN PR, V82, P42, DOI 10.1016/j.diabres.2008.06.017; Machado MV, 2013, J HEPATOL, V58, P1007, DOI 10.1016/j.jhep.2012.11.021; Agra R, 2014, INFLAMMATION, V37, P1504, DOI 10.1007/s10753-014-9876-3; Nishioji K, 2015, J GASTROENTEROL, V50, P95, DOI 10.1007/s00535-014-0948-9; Paradies G, 2014, WORLD J GASTROENTERO, V20, P14205, DOI 10.3748/wjg.v20.i39.14205; Qiang GF, 2012, EUR J PHARMACOL, V685, P156, DOI 10.1016/j.ejphar.2012.04.028; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Sekimoto R, 2012, BIOCHEM BIOPH RES CO, V419, P782, DOI 10.1016/j.bbrc.2012.02.102; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Sumida Y, 2014, WORLD J GASTROENTERO, V20, P475, DOI 10.3748/wjg.v20.i2.475; Sumida Y, 2010, WORLD J HEPATOL, V2, P374, DOI 10.4254/wjh.v2.i10.374; Taccioli C, 2009, GASTROENTEROLOGY, V136, P953, DOI 10.1053/j.gastro.2008.11.039; Tanwar S, 2013, HEPATOLOGY, V57, P103, DOI 10.1002/hep.26030; Tziomalos K, 2012, CURR VASC PHARMACOL, V10, P162, DOI 10.2174/157016112799305012; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Xu ZJ, 2010, DIGEST DIS SCI, V55, P931, DOI 10.1007/s10620-009-0815-3	37	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127352	10.1371/journal.pone.0127352	http://dx.doi.org/10.1371/journal.pone.0127352			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993652	Green Published, Green Submitted, gold			2022-12-26	WOS:000354918600059
J	Ai, DN; Yang, J; Fan, JF; Cong, WJ; Wang, YT				Ai, Danni; Yang, Jian; Fan, Jingfan; Cong, Weijian; Wang, Yongtian			Adaptive Tensor-Based Principal Component Analysis for Low-Dose CT Image Denoising	PLOS ONE			English	Article							ALGORITHMS; FUSION	Computed tomography (CT) has a revolutionized diagnostic radiology but involves large radiation doses that directly impact image quality. In this paper, we propose adaptive tensor- based principal component analysis (AT-PCA) algorithm for low-dose CT image denoising. Pixels in the image are presented by their nearby neighbors, and are modeled as a patch. Adaptive searching windows are calculated to find similar patches as training groups for further processing. Tensor-based PCA is used to obtain transformation matrices, and coefficients are sequentially shrunk by the linear minimum mean square error. Reconstructed patches are obtained, and a denoised image is finally achieved by aggregating all of these patches. The experimental results of the standard test image show that the best results are obtained with two denoising rounds according to six quantitative measures. For the experiment on the clinical images, the proposed AT-PCA method can suppress the noise, enhance the edge, and improve the image quality more effectively than NLM and KSVD denoising methods.	[Ai, Danni; Yang, Jian; Fan, Jingfan; Cong, Weijian; Wang, Yongtian] Beijing Inst Technol, Sch Opt & Elect, Beijing Engn Res Ctr Mixed Real & Adv Display, Beijing 100081, Peoples R China	Beijing Institute of Technology	Yang, J (corresponding author), Beijing Inst Technol, Sch Opt & Elect, Beijing Engn Res Ctr Mixed Real & Adv Display, Beijing 100081, Peoples R China.	jyang@bit.edu.cn	Fan, Jingfan/AAT-3761-2020	Fan, Jingfan/0000-0003-4857-6490	National Basic Research Program of China [2013CB328806]; Key Projects in the National Science & Technology Pillar Program [2013BAI01B01]; National Hi-Tech Research and Development Program [2013AA013703]; China Postdoctoral Science Foundation [2014M560050]	National Basic Research Program of China(National Basic Research Program of China); Key Projects in the National Science & Technology Pillar Program; National Hi-Tech Research and Development Program(National High Technology Research and Development Program of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Basic Research Program of China (2013CB328806), the Key Projects in the National Science & Technology Pillar Program (2013BAI01B01), the National Hi-Tech Research and Development Program (2013AA013703) and the China Postdoctoral Science Foundation (2014M560050).	Abdi H., 2007, ENCY MEASUREMENT STA, DOI 10.4135/9781412952644; Aharon M, 2006, IEEE T SIGNAL PROCES, V54, P4311, DOI 10.1109/TSP.2006.881199; [Anonymous], 2010, EUR J SCI RES; Ardekani BA, 2005, J NEUROSCI METH, V142, P67, DOI 10.1016/j.jneumeth.2004.07.014; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Borsdorf A, 2008, IEEE T MED IMAGING, V27, P1685, DOI 10.1109/TMI.2008.923983; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Buades A, 2005, MULTISCALE MODEL SIM, V4, P490, DOI 10.1137/040616024; Chen Y, 2014, IEEE T MED IMAGING, V33, P2271, DOI 10.1109/TMI.2014.2336860; Chen Y, 2013, PHYS MED BIOL, V58, P5803, DOI 10.1088/0031-9155/58/16/5803; Chen Y, 2011, EUR J RADIOL, V80, pE42, DOI 10.1016/j.ejrad.2010.07.003; Chen YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091104; Dabov K., 2009, WORKSH SIGN PROC AD; De Lathauwer L, 2004, LINEAR ALGEBRA APPL, V391, P31, DOI 10.1016/j.laa.2004.01.016; Elbakri LA, 2003, P SOC PHOTO-OPT INS, V5032, P1839, DOI 10.1117/12.480302; Hao XH, 1999, IEEE T MED IMAGING, V18, P787, DOI 10.1109/42.802756; Kalender WA, 2000, COMPUTED TOMOGRAPHY; Li ZB, 2014, MED PHYS, V41, DOI 10.1118/1.4851635; Muresan DD, 2003, IEEE IMAGE PROC, P101; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; Tomasi C, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P839, DOI 10.1109/ICCV.1998.710815; Wang J, 2008, IEEE T BIO-MED ENG, V55, P1022, DOI 10.1109/TBME.2007.909531; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wang Z, 2009, IEEE SIGNAL PROC MAG, V26, P98, DOI 10.1109/MSP.2008.930649; Wilson TA, 1997, IEEE T GEOSCI REMOTE, V35, P1007, DOI 10.1109/36.602543; Zhang L, 2010, PATTERN RECOGN, V43, P1531, DOI 10.1016/j.patcog.2009.09.023; Zhang ZL, 2001, SIGNAL PROCESS, V81, P1325, DOI 10.1016/S0165-1684(00)00273-5	27	4	6	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126914	10.1371/journal.pone.0126914	http://dx.doi.org/10.1371/journal.pone.0126914			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993566	Green Published, gold, Green Submitted			2022-12-26	WOS:000354917300066
J	Jorde, R; Schirmer, H; Wilsgaard, T; Mathiesen, EB; Njolstad, I; Lochen, ML; Joakimsen, RM; Grimnes, G				Jorde, Rolf; Schirmer, Henrik; Wilsgaard, Tom; Mathiesen, Ellisiv Bogeberg; Njolstad, Inger; Lochen, Maja-Lisa; Joakimsen, Ragnar Martin; Grimnes, Guri			The DBP Phenotype Gc-1f/Gc-1f Is Associated with Reduced Risk of Cancer. The Tromso Study	PLOS ONE			English	Article							D-BINDING-PROTEIN; MACROPHAGE-ACTIVATING FACTOR; HUMAN-CHROMOSOME 4Q11-Q13; MIDDLE-AGED MEN; VITAMIN-D; GC-GLOBULIN; 25-HYDROXYVITAMIN D; PRECURSOR ACTIVITY; FOLLOW-UP; SERUM	Background and Objective In addition to its role as a transport protein, the vitamin D binding protein (DBP) may also affect lipid metabolism, inflammation and carcinogenesis. There are three common variants of the DBP, Gc1s (1s), Gc1f (1f), Gc2 (2) that result in six common phenotypes (1s/1s, 1s/1f, 1s/2, 1f/1f, 1f/2, and 2/2). These phenotypes can be identified by genotyping for the two single nucleotide polymorphisms rs7041 and rs4588 in the GC gene. The DBP variants have different binding coefficients for the vitamin D metabolites, and accordingly there may be important relations between DBP phenotypes and health. Methods DNA was prepared from subjects who participated in the fourth survey of the Tromso Study in 1994-1995 and who were registered with the endpoints myocardial infarction (MI), type 2 diabetes (T2DM), cancer or death as well as a randomly selected control group. The endpoint registers were complete up to 2010-2013. Genotyping was performed for rs7041 and rs4588 and serum 25-hydroxyvitamin D (25(OH) D) was measured. Results Genotyping for rs7041 and rs4588 was performed successfully in 11 704 subjects. Among these, 1660 were registered with incident MI, 958 with T2DM, 2410 with cancer and 4318 had died. Subjects with the DBP phenotype 1f/1f had 23 -26% reduced risk of incident cancer compared to the 1s/1s and 2/2 phenotypes (P < 0.02, Cox regression with gender as covariate). Differences in serum 25(OH) D levels could not explain the apparent cancer protective effect of the DBP variant 1f. In addition to cancer and 25(OH) D, there were significant associations between DBP phenotype and body height, hip circumference and serum calcium. Conclusion There are important biological differences between the common DBP phenotypes. If the relation between the DBP variant 1f and cancer is confirmed in other studies, determination of DBP phenotype may have clinical importance.	[Jorde, Rolf; Joakimsen, Ragnar Martin; Grimnes, Guri] UiT Arctic Univ Norway, Dept Clin Med, Tromso Endocrine Res Grp, Tromso, Norway; [Jorde, Rolf; Joakimsen, Ragnar Martin; Grimnes, Guri] Univ Hosp North Norway, Div Internal Med, Tromso, Norway; [Jorde, Rolf] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand; [Schirmer, Henrik] UiT Arctic Univ Norway, Dept Clin Med, Tromso, Norway; [Wilsgaard, Tom; Njolstad, Inger; Lochen, Maja-Lisa] UiT Arctic Univ Norway, Dept Community Med, Epidemiol Chron Dis Res Grp, Tromso, Norway; [Mathiesen, Ellisiv Bogeberg] UiT Arctic Univ Norway, Dept Clin Med, Brain & Circulat Res Grp, Tromso, Norway; [Mathiesen, Ellisiv Bogeberg] Univ Hosp North Norway, Dept Neurol & Neurophysiol, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Auckland; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Jorde, R (corresponding author), UiT Arctic Univ Norway, Dept Clin Med, Tromso Endocrine Res Grp, Tromso, Norway.	rolf.jorde@unn.no	Njolstad, Inger/X-3784-2019	Schirmer, Henrik/0000-0002-9348-3149; Joakimsen, Ragnar Martin/0000-0002-2125-8081; Lochen, Maja-Lisa/0000-0002-8532-6573	North Norway Regional Health Authority; Norwegian Diabetes Association; UiT The Arctic University of Norway; Research council of Norway	North Norway Regional Health Authority; Norwegian Diabetes Association; UiT The Arctic University of Norway; Research council of Norway(Research Council of Norway)	The present study was supported by grants from The North Norway Regional Health Authority (http://www.helse-nord.no), the Norwegian Diabetes Association (http://www.diabetes.no), UiT The Arctic University of Norway (http://www.uit.no) and The Research council of Norway (http://www.forskningsradet.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.,	Abbas S, 2008, CANCER EPIDEM BIOMAR, V17, P1339, DOI 10.1158/1055-9965.EPI-08-0162; Abboud M, 2014, J STEROID BIOCHEM, V144, P232, DOI 10.1016/j.jsbmb.2013.10.020; Afzal S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6330; ARNAUD J, 1993, HUM GENET, V92, P183; BIKLE DD, 1986, J CLIN ENDOCR METAB, V63, P954, DOI 10.1210/jcem-63-4-954; Bolland MJ, 2014, LANCET DIABETES ENDO, V2, P307, DOI 10.1016/S2213-8587(13)70212-2; Chun RF, 2012, CELL BIOCHEM FUNCT, V30, P445, DOI 10.1002/cbf.2835; COOKE NE, 1986, HUM GENET, V73, P225, DOI 10.1007/BF00401232; Fang Y, 2009, CALCIFIED TISSUE INT, V85, P85, DOI 10.1007/s00223-009-9251-9; Gregory KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013428; Grimnes G, 2010, EUR J ENDOCRINOL, V163, P339, DOI 10.1530/EJE-10-0150; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049; Johnsen MS, 2014, SCAND J CLIN LAB INV, V74, P177, DOI 10.3109/00365513.2013.869701; Jorde R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037295; Jousilahti P, 2000, AM J EPIDEMIOL, V151, P1112, DOI 10.1093/oxfordjournals.aje.a010155; Kulathinal S, 2007, PROJECT EPIDEMIOLOGI, V4, P15, DOI DOI 10.1186/1742-5573-4-15; Lauridsen AL, 2005, CALCIFIED TISSUE INT, V77, P15, DOI 10.1007/s00223-004-0227-5; Lettre G, 2009, CURR OPIN PEDIATR, V21, P515, DOI 10.1097/MOP.0b013e32832c6dce; Malik S, 2013, CRIT REV CL LAB SCI, V50, P1, DOI 10.3109/10408363.2012.750262; McVoy LA, 2005, J IMMUNOL, V175, P4754, DOI 10.4049/jimmunol.175.7.4754; Meier U, 2006, CLIN CHEM, V52, P1247, DOI 10.1373/clinchem.2005.065680; Moukayed M, 2013, NUTRIENTS, V5, P3993, DOI 10.3390/nu5103993; Nagasawa H, 2005, ANTICANCER RES, V25, P3689; Nagasawa H, 2004, ANTICANCER RES, V24, P3361; Negri AL, 2006, NEPHROLOGY, V11, P510, DOI 10.1111/j.1440-1797.2006.00704.x; Njolstad I, 1996, CIRCULATION, V94, P2877; Powe CE, 2011, J BONE MINER RES, V26, P1609, DOI 10.1002/jbmr.387; Schneider GB, 2003, CRIT REV EUKAR GENE, V13, P277; Shui Irene, 2014, Adv Exp Med Biol, V810, P33; Song YH, 1999, GENOME RES, V9, P581; Speeckaert MM, 2014, ADV CLIN CHEM, V63, P1, DOI 10.1016/B978-0-12-800094-6.00001-7; THELLE DS, 1976, ACTA MED SCAND, V200, P107; Thyer L, 2013, NUTRIENTS, V5, P2577, DOI 10.3390/nu5072577; VANBAELEN H, 1978, J BIOL CHEM, V253, P6344; WILLIAMS MH, 1988, BIOCHEM BIOPH RES CO, V153, P1019, DOI 10.1016/S0006-291X(88)81330-5; Wilson RT, 2015, TRANSL RES, V165, P667, DOI 10.1016/j.trsl.2014.08.003; Yamamoto N, 2008, TRANSL ONCOL, V1, P65, DOI 10.1593/tlo.08106; Zhou LQ, 2012, INT J CLIN EXP MED, V5, P72	40	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126359	10.1371/journal.pone.0126359	http://dx.doi.org/10.1371/journal.pone.0126359			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993554	Green Published, gold, Green Submitted			2022-12-26	WOS:000354917300037
J	Qin, YF; Chen, M; Wang, HY; Zheng, XQ				Qin, Yufang; Chen, Ming; Wang, Haiyun; Zheng, Xiaoqi			A Network Flow-Based Method to Predict Anticancer Drug Sensitivity	PLOS ONE			English	Article							MEK INHIBITION; CHEMOSENSITIVITY; ENCYCLOPEDIA; SURVIVAL	Predicting anticancer drug sensitivity can enhance the ability to individualize patient treatment, thus making development of cancer therapies more effective and safe. In this paper, we present a new network flow-based method, which utilizes the topological structure of pathways, for predicting anticancer drug sensitivities. Mutations and copy number alterations of cancer-related genes are assumed to change the pathway activity, and pathway activity difference before and after drug treatment is used as a measure of drug response. In our model, Contributions from different genetic alterations are considered as free parameters, which are optimized by the drug response data from the Cancer Genome Project (CGP). 10-fold cross validation on CGP data set showed that our model achieved comparable prediction results with existing elastic net model using much less input features.	[Qin, Yufang; Chen, Ming] Shanghai Ocean Univ, Coll Informat Technol, Shanghai, Peoples R China; [Wang, Haiyun] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China; [Zheng, Xiaoqi] Shanghai Normal Univ, Dept Math, Shanghai, Peoples R China	Shanghai Ocean University; Tongji University; Shanghai Normal University	Zheng, XQ (corresponding author), Shanghai Normal Univ, Dept Math, Shanghai, Peoples R China.	xqzheng@shnu.edu.cn			National Natural Science Foundation of China [31100953]; Program of Shanghai Normal University [DZL121]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Normal University	This work was supported by the National Natural Science Foundation of China (No. 31100953; XQZ) and the Program of Shanghai Normal University (DZL121; XQZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Cohen AL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.47; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Frieboes HB, 2009, CANCER RES, V69, P4484, DOI 10.1158/0008-5472.CAN-08-3740; Garassino MC, 2011, ANN ONCOL, V22, P235, DOI 10.1093/annonc/mdq680; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Holleman A, 2004, NEW ENGL J MED, V351, P533, DOI 10.1056/NEJMoa033513; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Nakayama N, 2008, BRIT J CANCER, V99, P2020, DOI 10.1038/sj.bjc.6604783; Panka DJ, 2006, CLIN CANCER RES, V12, p2371S, DOI 10.1158/1078-0432.CCR-05-2539; Reuter CWM, 2000, BLOOD, V96, P1655, DOI 10.1182/blood.V96.5.1655.h8001655_1655_1669; Riddick G, 2011, BIOINFORMATICS, V27, P220, DOI 10.1093/bioinformatics/btq628; Ruszczynski A., 2011, NONLINEAR OPTIMIZATI; Shen LL, 2007, CANCER RES, V67, P11335, DOI 10.1158/0008-5472.CAN-07-1502; Solimini NL, 2007, CELL, V130, P986, DOI 10.1016/j.cell.2007.09.007; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tang H, 2013, CLIN CANCER RES, V19, P1577, DOI 10.1158/1078-0432.CCR-12-2321; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Yang QF, 2006, EMBO REP, V7, P622, DOI 10.1038/sj.embor.7400687; Zhao XM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002323	27	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127380	10.1371/journal.pone.0127380	http://dx.doi.org/10.1371/journal.pone.0127380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992881	Green Published, Green Submitted, gold			2022-12-26	WOS:000354917300119
J	He, EH; Pan, F; Li, GC; Li, JJ				He, Enhui; Pan, Fei; Li, Guangchao; Li, Jingjing			Fractionated Ionizing Radiation Promotes Epithelial-Mesenchymal Transition in Human Esophageal Cancer Cells through PTEN Deficiency-Mediated Akt Activation	PLOS ONE			English	Article							SIGNALING PATHWAY; LUNG-CANCER; CARCINOMA; RADIORESISTANCE; SNAIL; EMT; ACQUISITION; PHENOTYPE	In some esophageal cancer patients, radiotherapy may not prevent distant metastasis thus resulting in poor survival. The underlying mechanism of metastasis in these patients is not well established. In this study, we have demonstrated that ionizing radiation may induce epithelial-mesenchymal transition (EMT) accompanied with increased cell migration and invasion, through downregulation of phosphatase and tensin homolog (PTEN), and activation of Akt/GSK-3 beta/Snail signaling. We developed a radioresistant (RR) esophageal squamous cancer cell line, KYSE-150/RR, by fractionated ionizing radiation (IR) treatment, and confirmed its radioresistance using a clonogenic survival assay. We found that the KYSE-150/RR cell line displayed typical morphological and molecular characteristics of EMT. In comparison to the parental cells, KYSE-150/RR cells showed an increase in post-IR colony survival, migration, and invasiveness. Furthermore, a decrease in PTEN in KYSE-150/RR cells was observed. We postulated that over-expression of PTEN may induce mesenchymal-epithelial transition in KYSE-150/RR cells and restore IR-induced increase of cell migration. Mechanistically, fractionated IR inhibits expression of PTEN, which leads to activation of Akt/GSK-3 beta signaling and is associated with the elevated levels of Snail protein, a transcription factor involved in EMT. Correspondingly, treatment with LY294002, a phosphatidylinositol-3-kinase inhibitor, mimicked PTEN overexpression effect in KYSE-150/RR cells, further suggesting a role for the Akt/GSK-3 beta/Snail signaling in effects mediated through PTEN. Together, these results strongly suggest that fractionated IR-mediated EMT in KYSE-150/RR cells is through PTEN-dependent pathways, highlighting a direct proinvasive effect of radiation treatment on tumor cells.	[He, Enhui; Pan, Fei] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [He, Enhui; Li, Jingjing] Chinese Peoples Liberat Army Gen Hosp, Beijing 100853, Peoples R China; [He, Enhui; Li, Jingjing] Chinese PLA Med Sch, Beijing, Peoples R China; [Li, Guangchao] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510641, Guangdong, Peoples R China; [He, Enhui; Li, Jingjing] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China	Nankai University; Chinese People's Liberation Army General Hospital; South China University of Technology; Capital Medical University	Li, JJ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Beijing 100853, Peoples R China.	cc111100@163.com	Pan, Fei/AAF-4042-2021		China Postdoctoral Science Foundation [2013M542451]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The research was supported by the General Financial Grant from China Postdoctoral Science Foundation (to JL, Grant No. 2013M542451) (http://jj.chinapostdoctor.org.cn/V1/Program1/Info_Show.aspx?InfoID=270124f8-9c55-4916-ab8d-1ee53c952329). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao LL, 2013, CANCER LETT, V337, P226, DOI 10.1016/j.canlet.2013.05.007; Bu F, 2014, ONCOTARGET; Coleman C N, 1996, Oncology (Williston Park), V10, P399; Dong Q, 2013, 2013 SIXTH INTERNATIONAL CONFERENCE ON ADVANCED COMPUTATIONAL INTELLIGENCE (ICACI), P150, DOI 10.1109/ICACI.2013.6748492; Fan F, 2012, CANCER MED-US, V1, P5, DOI 10.1002/cam4.4; Hassan H, 2013, FEBS J, V280, P2216, DOI 10.1111/febs.12111; Jing Z, 2009, RADIOTHER ONCOL, V93, P468, DOI 10.1016/j.radonc.2009.08.008; Jung IL, 2010, INT J MOL MED, V25, P517, DOI 10.3892/ijmm_00000372; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Kim June-Bum, 2014, Korean J Pediatr, V57, P1, DOI 10.3345/kjp.2014.57.1.1; Kong Dejuan, 2011, Cancers (Basel), V3, P716, DOI 10.3390/cancers30100716; Lin YS, 2013, J EPIDEMIOL, V23, P233, DOI 10.2188/jea.JE20120162; Liu W, 2014, LAB INVEST, V94, P362, DOI 10.1038/labinvest.2013.153; Lordick F, 2013, LANGENBECK ARCH SURG, V398, P177, DOI 10.1007/s00423-012-1001-1; Maity A, 1997, INT J RADIAT ONCOL, V37, P639, DOI 10.1016/S0360-3016(96)00598-6; Maseki S, 2012, BRIT J CANCER, V106, P1196, DOI 10.1038/bjc.2012.24; Nagarajan D, 2012, FREE RADICAL BIO MED, V52, P983, DOI 10.1016/j.freeradbiomed.2011.11.024; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Qu C, 2012, CELL CYCLE, V11; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Su HF, 2014, CELL BIOL INT, V38, P318, DOI 10.1002/cbin.10202; Theys J, 2011, RADIOTHER ONCOL, V99, P392, DOI 10.1016/j.radonc.2011.05.044; Tseng YH, 2011, J ORAL PATHOL MED, V40, P160, DOI 10.1111/j.1600-0714.2010.00978.x; Wang GY, 2012, BIOCHEM BIOPH RES CO, V425, P309, DOI 10.1016/j.bbrc.2012.07.087; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; Yan S, 2013, INT J ONCOL, V42, P1801, DOI 10.3892/ijo.2013.1852; Yasser M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097777; Zhang CZ, 2011, INT J RADIAT ONCOL, V80, P240, DOI 10.1016/j.ijrobp.2010.12.049; Zhang X, 2011, BIOCHEM BIOPH RES CO, V412, P188, DOI 10.1016/j.bbrc.2011.07.074; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	31	36	40	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126149	10.1371/journal.pone.0126149	http://dx.doi.org/10.1371/journal.pone.0126149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000878	gold, Green Published, Green Submitted			2022-12-26	WOS:000354931700010
J	Marcinska, M; Pospiech, E; Abidi, S; Andersen, JD; van den Berge, M; Carracedo, A; Eduardoff, M; Marczakiewicz-Lustig, A; Morling, N; Sijen, T; Skowron, M; Sochtig, J; Syndercombe-Court, D; Weiler, N; Schneider, PM; Ballard, D; Borsting, C; Parson, W; Phillips, C; Branicki, W				Marcinska, Magdalena; Pospiech, Ewelina; Abidi, Sarah; Andersen, Jeppe Dyrberg; van den Berge, Margreet; Carracedo, Angel; Eduardoff, Mayra; Marczakiewicz-Lustig, Anna; Morling, Niels; Sijen, Titia; Skowron, Malgorzata; Soechtig, Jens; Syndercombe-Court, Denise; Weiler, Natalie; Schneider, Peter M.; Ballard, David; Borsting, Claus; Parson, Walther; Phillips, Chris; Branicki, Wojciech		EUROFORGEN-NOE Consortium	Evaluation of DNA Variants Associated with Androgenetic Alopecia and Their Potential to Predict Male Pattern Baldness	PLOS ONE			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; GENE-GENE INTERACTIONS; EYE COLOR; RECEPTOR GENE; SUSCEPTIBILITY VARIANTS; CANDIDATE GENE; HAIR LOSS; HUMAN AGE; RISK; GENOME	Androgenetic alopecia, known in men as male pattern baldness (MPB), is a very conspicuous condition that is particularly frequent among European men and thus contributes markedly to variation in physical appearance traits amongst Europeans. Recent studies have revealed multiple genes and polymorphisms to be associated with susceptibility to MPB. In this study, 50 candidate SNPs for androgenetic alopecia were analyzed in order to verify their potential to predict MPB. Significant associations were confirmed for 29 SNPs from chromosomes X, 1, 5, 7, 18 and 20. A simple 5-SNP prediction model and an extended 20-SNP model were developed based on a discovery panel of 305 males from various European populations fitting one of two distinct phenotype categories. The first category consisted of men below 50 years of age with significant baldness and the second; men aged 50 years or older lacking baldness. The simple model comprised the five best predictors: rs5919324 near AR, rs1998076 in the 20p11 region, rs929626 in EBF1, rs12565727 in TARDBP and rs756853 in HDAC9. The extended prediction model added 15 SNPs from five genomic regions that improved overall prevalence-adjusted predictive accuracy measured by area under the receiver characteristic operating curve (AUC). Both models were evaluated for predictive accuracy using a test set of 300 males reflecting the general European population. Applying a 65% probability threshold, high prediction sensitivity of 87.1% but low specificity of 42.4% was obtained in men aged <50 years. In men aged >= 50, prediction sensitivity was slightly lower at 67.7% while specificity reached 90%. Overall, the AUC=0.761 calculated for men at or above 50 years of age indicates these SNPs offer considerable potential for the application of genetic tests to predict MPB patterns, adding a highly informative predictive system to the emerging field of forensic analysis of externally visible characteristics.	[Marcinska, Magdalena; Branicki, Wojciech] Inst Forens Res, Sect Forens Genet, Krakow, Poland; [Pospiech, Ewelina; Branicki, Wojciech] Jagiellonian Univ, Dept Genet & Evolut, Krakow, Poland; [Abidi, Sarah; Syndercombe-Court, Denise; Ballard, David] Kings Coll London, Fac Life Sci, London WC2R 2LS, England; [Andersen, Jeppe Dyrberg; Morling, Niels; Borsting, Claus] Univ Copenhagen, Sect Forens Genet, Dept Forens Med, Fac Hlth & Med Sci, DK-1168 Copenhagen, Denmark; [van den Berge, Margreet; Sijen, Titia; Weiler, Natalie] Netherlands Forens Inst, Dept Human Biol Traces, The Hague, Netherlands; [Carracedo, Angel; Soechtig, Jens; Phillips, Chris] Univ Santiago de Compostela, Inst Forens Med, Fac Med, Forens Genet Unit, Santiago De Compostela, Spain; [Carracedo, Angel] Inst Hlth Carlos III, Genom Med Grp, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain; [Eduardoff, Mayra; Parson, Walther] Med Univ Innsbruck, Inst Legal Med, A-6020 Innsbruck, Austria; [Marczakiewicz-Lustig, Anna] Jagiellonian Univ, Dept Analyt Biochem, Coll Med, Krakow, Poland; [Skowron, Malgorzata] Jagiellonian Univ, Dept Dermatol, Coll Med, Krakow, Poland; [Schneider, Peter M.] Univ Cologne, Fac Med, Inst Legal Med, D-50931 Cologne, Germany; [Parson, Walther] Penn State Univ, Forens Sci Program, University Pk, PA 16802 USA	Jagiellonian University; University of London; King's College London; University of Copenhagen; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Medical University of Innsbruck; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Cologne; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Branicki, W (corresponding author), Inst Forens Res, Sect Forens Genet, Krakow, Poland.	wojciech.branicki@uj.edu.pl	Gomes, Iva/A-5510-2017; Phillips, Christopher/E-4005-2012; Carracedo, Angel/D-4257-2012; Ballard, David J/B-8392-2014; Álvarez, María Sonia Fondevila/D-4385-2014; Parson, Walther/AAD-6845-2020	Phillips, Christopher/0000-0002-9601-0128; Carracedo, Angel/0000-0003-1085-8986; Ballard, David J/0000-0002-2755-1326; Borsting, Claus/0000-0003-0421-7429; Morling, Niels/0000-0002-9463-5087; Pospiech, Ewelina/0000-0001-8867-0727; Branicki, Wojciech/0000-0002-7412-5733; Dyrberg Andersen, Jeppe/0000-0002-4395-5232; Schneider, Peter M./0000-0003-0744-2349; Parson, Walther/0000-0002-5692-2392	European Union [285487]	European Union(European Commission)	The work leading to these results was financially supported from a grant from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 285487 (EUROFORGEN-NoE), www.euroforgen.eu.	Bocklandt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014821; Branicki W, 2011, HUM GENET, V129, P443, DOI 10.1007/s00439-010-0939-8; Brockschmidt FF, 2011, BRIT J DERMATOL, V165, P1293, DOI 10.1111/j.1365-2133.2011.10708.x; Brockschmidt FF, 2010, BRIT J DERMATOL, V162, P899, DOI 10.1111/j.1365-2133.2010.09649.x; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Claes P, 2014, FORENSIC SCI INT-GEN, V13, P208, DOI 10.1016/j.fsigen.2014.08.008; Cobb JE, 2010, EXP DERMATOL, V19, P1026, DOI 10.1111/j.1600-0625.2010.01132.x; Ellis JA, 1998, J INVEST DERMATOL, V110, P849, DOI 10.1046/j.1523-1747.1998.00224.x; Ellis JA, 2001, J INVEST DERMATOL, V116, P452, DOI 10.1046/j.1523-1747.2001.01261.x; Griffin MJ, 2013, J BIOL CHEM, V288, P35925, DOI 10.1074/jbc.M113.491936; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; HAMILTON JB, 1951, ANN NY ACAD SCI, V53, P708, DOI 10.1111/j.1749-6632.1951.tb31971.x; Hamilton JB, 1942, AM J ANAT, V71, P451, DOI 10.1002/aja.1000710306; Hart KL, 2013, CROAT MED J, V54, P248, DOI 10.3325/cmj.2013.54.248; Hayes VM, 2005, CANCER EPIDEM BIOMAR, V14, P993, DOI 10.1158/1055-9965.EPI-04-0778; Heilmann S, 2013, J INVEST DERMATOL, V133, P1489, DOI 10.1038/jid.2013.43; Hillmer AM, 2005, AM J HUM GENET, V77, P140, DOI 10.1086/431425; Hillmer AM, 2008, NAT GENET, V40, P1279, DOI 10.1038/ng.228; Hillmer AM, 2009, HUM GENET, V126, P255, DOI 10.1007/s00439-009-0668-z; Jakulin A, 2003, LECT NOTES ARTIF INT, V2838, P229; Karnik P, 2013, J DERMATOL SCI, V72, P183, DOI 10.1016/j.jdermsci.2013.06.017; Kayser M, 2009, FORENSIC SCI INT-GEN, V3, P154, DOI 10.1016/j.fsigen.2009.01.012; Kirin M, 2013, HUM MOL GENET, V22, P3174, DOI 10.1093/hmg/ddt169; Klimentidis YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113072; KUSTER W, 1984, J AM ACAD DERMATOL, V11, P921, DOI 10.1016/S0190-9622(84)80498-3; Lee WS, 2012, ANN DERMATOL, V24, P243, DOI 10.5021/ad.2012.24.3.243; Levy-Nissenbaum E, 2005, EUR J DERMATOL, V15, P339; Li R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002746; Liang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071771; Liu F, 2014, HUM GENET, V133, P587, DOI 10.1007/s00439-013-1394-0; Liu F, 2009, CURR BIOL, V19, pR192, DOI 10.1016/j.cub.2009.01.027; Maronas O, 2014, FORENSIC SCI INT-GEN, V13, P34, DOI 10.1016/j.fsigen.2014.06.017; McLean WHI, 2008, NAT GENET, V40, P1270, DOI 10.1038/ng1108-1270; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Mirmirani P, 2015, MATURITAS, V80, P58, DOI 10.1016/j.maturitas.2014.10.008; NORWOOD OT, 1975, SOUTHERN MED J, V68, P1359, DOI 10.1097/00007611-197511000-00009; Nyholt DR, 2003, J INVEST DERMATOL, V121, P1561, DOI 10.1111/j.1523-1747.2003.12615.x; Phillips C, 2012, METHODS MOL BIOL, V830, P109, DOI 10.1007/978-1-61779-461-2_8; Pneuman A, 2012, LEGAL MED-TOKYO, V14, P78, DOI 10.1016/j.legalmed.2011.12.005; Pospiech E, 2014, FORENSIC SCI INT-GEN, V11, P64, DOI 10.1016/j.fsigen.2014.01.012; Pospiech E, 2012, J FORENSIC SCI, V57, P880, DOI 10.1111/j.1556-4029.2012.02077.x; Pospiech E, 2011, J HUM GENET, V56, P447, DOI 10.1038/jhg.2011.38; Prodi DA, 2008, J INVEST DERMATOL, V128, P2268, DOI 10.1038/jid.2008.60; Rebbeck TR, 2004, NAT REV GENET, V5, P589, DOI 10.1038/nrg1403; Redler S, 2012, BRIT J DERMATOL, V166, P1314, DOI 10.1111/j.1365-2133.2012.10877.x; Rexbye H, 2005, J GERONTOL A-BIOL, V60, P1077, DOI 10.1093/gerona/60.8.1077; Rhodes T, 1998, DERMATOL SURG, V24, P1330, DOI 10.1111/j.1524-4725.1998.tb00009.x; Richards JB, 2008, NAT GENET, V40, P1282, DOI 10.1038/ng.255; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Ruiz Y, 2013, FORENSIC SCI INT-GEN, V7, P28, DOI 10.1016/j.fsigen.2012.05.009; Schmidt B, 2012, EXP DERMATOL, V21, P827, DOI 10.1111/exd.12001; Walsh S, 2011, FORENSIC SCI INT-GEN, V5, P170, DOI 10.1016/j.fsigen.2010.02.004; Weidner CI, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r24; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Zbiec-Piekarska R, 2015, FORENSIC SCI INT-GEN, V14, P161, DOI 10.1016/j.fsigen.2014.10.002; Zhuo FL, 2012, CLIN EXP DERMATOL, V37, P104, DOI 10.1111/j.1365-2230.2011.04186.x; Zubakov D, 2010, CURR BIOL, V20, pR970, DOI 10.1016/j.cub.2010.10.022	59	41	45	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127852	10.1371/journal.pone.0127852	http://dx.doi.org/10.1371/journal.pone.0127852			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001114	Green Published, gold, Green Submitted			2022-12-26	WOS:000354931700090
J	Nagatake, T; Fukuyama, S; Sato, S; Okura, H; Tachibana, M; Taniuchi, I; Ito, K; Shimojou, M; Matsumoto, N; Suzuki, H; Kunisawa, J; Kiyono, H				Nagatake, Takahiro; Fukuyama, Satoshi; Sato, Shintaro; Okura, Hideaki; Tachibana, Masashi; Taniuchi, Ichiro; Ito, Kosei; Shimojou, Michiko; Matsumoto, Naomi; Suzuki, Hidehiko; Kunisawa, Jun; Kiyono, Hiroshi			Central Role of Core Binding Factor beta 2 in Mucosa-Associated Lymphoid Tissue Organogenesis in Mouse	PLOS ONE			English	Article							FETAL LIVER HEMATOPOIESIS; ORGAN DEVELOPMENT; CBF-BETA; CD45(+)CD4(+)CD3(-) CELLS; MYELOID-LEUKEMIA; RETINOIC ACID; RUNX PROTEINS; CUTTING EDGE; ROR-GAMMA; GENE	Mucosa-associated lymphoid tissue (MALT) is a group of secondary and organized lymphoid tissue that develops at different mucosal surfaces. Peyer's patches (PPs), nasopharynx-associated lymphoid tissue (NALT), and tear duct-associated lymphoid tissue (TALT) are representative MALT in the small intestine, nasal cavity, and lacrimal sac, respectively. A recent study has shown that transcriptional regulators of core binding factor (Cbf)beta 2 and promotor-1-transcribed Runt-related transcription factor 1 (P1-Runx1) are required for the differentiation of CD3(-)CD4(+) CD45(+) lymphoid tissue inducer (LTi) cells, which initiate and trigger the developmental program of PPs, but the involvement of this pathway in NALT and TALT development remains to be elucidated. Here we report that Cbf beta 2 plays an essential role in NALT and TALT development by regulating LTi cell trafficking to the NALT and TALT anlagens. Cbf beta 2 was expressed in LTi cells in all three types of MALT examined. Indeed, similar to the previous finding for PPs, we found that Cbf beta 2(-/-) mice lacked NALT and TALT lymphoid structures. However, in contrast to PPs, NALT and TALT developed normally in the absence of P1-Runx1 or other Runx family members such as Runx2 and Runx3. LTi cells for NALT and TALT differentiated normally but did not accumulate in the respective lymphoid tissue anlagens in Cbf beta 2(-/-) mice. These findings demonstrate that Cbf beta 2 is a central regulator of the MALT developmental program, but the dependency of Runx proteins on the lymphoid tissue development would differ among PPs, NALT, and TALT.	[Nagatake, Takahiro; Fukuyama, Satoshi; Sato, Shintaro; Okura, Hideaki; Kunisawa, Jun; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol,Minato Ku, Tokyo 1088639, Japan; [Nagatake, Takahiro; Shimojou, Michiko; Matsumoto, Naomi; Suzuki, Hidehiko; Kunisawa, Jun] Natl Inst Biomed Innovat Hlth & Nutr, Lab Vaccine Mat, Ibaraki, Osaka 5670085, Japan; [Fukuyama, Satoshi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol,Minato Ku, Tokyo 1088639, Japan; [Tachibana, Masashi; Taniuchi, Ichiro] RIKEN Ctr Integrat Med Sci IMS RCAI, Lab Transcript Regulat, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Ito, Kosei] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Bone Biol, Nagasaki 8528588, Japan; [Kunisawa, Jun; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccines, Tokyo 1088639, Japan; [Kunisawa, Jun] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan; [Kunisawa, Jun] Kobe Univ, Sch Med, Dept Microbiol & Immunol, Kobe, Hyogo 650, Japan; [Kiyono, Hiroshi] Univ Tokyo, Grad Sch Med, Tokyo 1088639, Japan; [Kiyono, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba, Japan	University of Tokyo; University of Tokyo; RIKEN; Nagasaki University; University of Tokyo; Osaka University; Kobe University; University of Tokyo; University of Tokyo	Kiyono, H (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kiyono@ims.u-tokyo.ac.jp	Kiyono, Hiroshi/AAC-6735-2022; Taniuchi, Ichiro/N-6399-2015; Nagatake, Takahiro/AAL-1995-2020	Taniuchi, Ichiro/0000-0002-9853-9068; Nagatake, Takahiro/0000-0003-3022-9626; Sato, Shintaro/0000-0001-5156-3354; Tachibana, Masashi/0000-0002-0376-508X	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency; Ministry of Health, Labor and Welfare of Japan [H24-010];  [23229004];  [25893306]; Grants-in-Aid for Scientific Research [26293109] Funding Source: KAKEN	Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by The Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency to HK, A Grant-in-Aid for Scientific Research on Priority Areas, Scientific Research (S) to HK Grant Number 23229004, The Ministry of Health, Labor and Welfare of Japan to HK Grant Number H24-010, Grant-in-Aid for Research Activity Start-up to TN Grant Number 25893306. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bee T, 2010, BLOOD, V115, P3042, DOI 10.1182/blood-2009-08-238626; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Cupedo T, 2002, IMMUNOL REV, V189, P41, DOI 10.1034/j.1600-065X.2002.18905.x; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Finke D, 2002, IMMUNITY, V17, P363, DOI 10.1016/S1074-7613(02)00395-3; Fukuyama S, 2002, IMMUNITY, V17, P31, DOI 10.1016/S1074-7613(02)00339-4; Fukuyama S, 2006, J IMMUNOL, V177, P4276, DOI 10.4049/jimmunol.177.7.4276; HAJRA A, 1995, GENOMICS, V26, P571, DOI 10.1016/0888-7543(95)80177-N; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; Harmsen A, 2002, J IMMUNOL, V168, P986, DOI 10.4049/jimmunol.168.3.986; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Honda K, 2001, J EXP MED, V193, P621, DOI 10.1084/jem.193.5.621; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; Ito K, 2011, GASTROENTEROLOGY, V140, P1536, DOI 10.1053/j.gastro.2011.01.043; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; LIU PP, 1995, BLOOD, V85, P2289, DOI 10.1182/blood.V85.9.2289.bloodjournal8592289; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; Mukai K, 2012, BLOOD, V120, P76, DOI 10.1182/blood-2011-12-399113; Nagatake T, 2009, J EXP MED, V206, P2351, DOI 10.1084/jem.20091436; OGAWA E, 1993, VIROLOGY, V194, P314, DOI 10.1006/viro.1993.1262; Okada K, 2011, ADV OTO-RHINO-LARYNG, V72, P31, DOI 10.1159/000324591; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Okura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108294; Otto F, 2003, J CELL BIOCHEM, V89, P9, DOI 10.1002/jcb.10491; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pozner A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213x-7-84; Puig-Kroger A, 2000, J BIOL CHEM, V275, P28507, DOI 10.1074/jbc.M004323200; Sasaki K, 1996, P NATL ACAD SCI USA, V93, P12359, DOI 10.1073/pnas.93.22.12359; Shikina T, 2004, J IMMUNOL, V172, P6259, DOI 10.4049/jimmunol.172.10.6259; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Tachibana M, 2011, J IMMUNOL, V186, P1450, DOI 10.4049/jimmunol.1000162; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; WANG SW, 1993, MOL CELL BIOL, V13, P3324, DOI 10.1128/MCB.13.6.3324; Weih F, 2003, IMMUNOL REV, V195, P91, DOI 10.1034/j.1600-065X.2003.00064.x; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; Yan JL, 2004, NAT STRUCT MOL BIOL, V11, P901, DOI 10.1038/nsmb819; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 2002, IMMUNITY, V17, P823, DOI 10.1016/S1074-7613(02)00479-X; Yoshida H, 2001, J IMMUNOL, V167, P2511, DOI 10.4049/jimmunol.167.5.2511	51	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127460	10.1371/journal.pone.0127460	http://dx.doi.org/10.1371/journal.pone.0127460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001080	Green Published, Green Submitted, gold			2022-12-26	WOS:000354931700061
J	Rodriguez, O; del Rio, JA; Jaramillo, OA; Martinez, M				Rodriguez, Osvaldo; del Rio, Jesus A.; Jaramillo, Oscar A.; Martinez, Manuel			Wind Power Error Estimation in Resource Assessments	PLOS ONE			English	Article							ENERGY POTENTIAL ASSESSMENT; PROBABILITY-DISTRIBUTIONS; UNCERTAINTIES; SUITABILITY; TURBINES	Estimating the power output is one of the elements that determine the techno-economic feasibility of a renewable project. At present, there is a need to develop reliable methods that achieve this goal, thereby contributing to wind power penetration. In this study, we propose a method for wind power error estimation based on the wind speed measurement error, probability density function, and wind turbine power curves. This method uses the actual wind speed data without prior statistical treatment based on 28 wind turbine power curves, which were fitted by Lagrange's method, to calculate the estimate wind power output and the corresponding error propagation. We found that wind speed percentage errors of 10% were propagated into the power output estimates, thereby yielding an error of 5%. The proposed error propagation complements the traditional power resource assessments. The wind power estimation error also allows us to estimate intervals for the power production leveled cost or the investment time return. The implementation of this method increases the reliability of techno-economic resource assessment studies.	[Rodriguez, Osvaldo] Univ Nacl Autonoma Mexico, Ingn, Temixco, Morelos, Mexico; [Rodriguez, Osvaldo; del Rio, Jesus A.] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City 04510, DF, Mexico; [del Rio, Jesus A.; Jaramillo, Oscar A.; Martinez, Manuel] Univ Nacl Autonoma Mexico, Inst Energias Renovables, Temixco, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Rodriguez, O (corresponding author), Univ Nacl Autonoma Mexico, Ingn, Temixco, Morelos, Mexico.	osroh@ier.unam.mx	Rodriguez, Osvaldo/ABC-8952-2020; del Rio Portilla, Jesus Antonio/C-2125-2009; Rodriguez, Osvaldo/M-4989-2015; Jaramillo, Oscar/H-2120-2019; Fernández, Manuel Martínez/G-8921-2018	Rodriguez, Osvaldo/0000-0002-6567-4669; del Rio Portilla, Jesus Antonio/0000-0001-6180-0608; Rodriguez, Osvaldo/0000-0002-6567-4669; Fernández, Manuel Martínez/0000-0002-8548-3472; Jaramillo, Oscar/0000-0002-5894-3023				BAIRD DC, 1988, EXPT INTRO MEASUREME; Bakhvalov N. S., 1977, NUMERICAL METHODS AN; Bevington P. R., 2002, DATA REDUCTION ERROR; Carta JA, 2009, RENEW SUST ENERG REV, V13, P933, DOI 10.1016/j.rser.2008.05.005; Celik AN, 2004, ENERG CONVERS MANAGE, V45, P1735, DOI 10.1016/j.enconman.2003.09.027; Chadee J. C., 2001, Wind Engineering, V25, P319, DOI 10.1260/030952401760217139; Chang TP, 2011, APPL ENERG, V88, P1848, DOI 10.1016/j.apenergy.2010.11.010; IEC. IEC, 2005, POW PERF MEAS EL PRO; Jaramillo OA, 2004, RENEW ENERG, V29, P1613, DOI 10.1016/j.renene.2004.02.001; Jimenez I, 2008, COSTOS PARAMETROS RE; Jung S, 2013, APPL ENERG, V102, P1492, DOI 10.1016/j.apenergy.2012.09.011; Kahaner D., 1989, NUMERICAL METHODS SO; Kwon SD, 2010, APPL ENERG, V87, P856, DOI 10.1016/j.apenergy.2009.08.038; Lackner MA, 2008, J SOL ENERG-T ASME, V130, DOI 10.1115/1.2931499; Manwell J. F., 2010, WIND ENERGY EXPLAINE; Morgan EC, 2011, ENERG CONVERS MANAGE, V52, P15, DOI 10.1016/j.enconman.2010.06.015; Probst O, 2010, ENERGIES, V3, P1087, DOI 10.3390/en3061087; RETScreen, 2012, SOFTW TOOL HELPS DET; Rodriguez-Hernandez O, 2013, RENEW ENERG, V50, P244, DOI 10.1016/j.renene.2012.06.004; Rodriguez-Hernandez O, 2014, IMPORTANCE MEAN TIME; Singh S, 2006, J ENERG ENG, V132, P8, DOI 10.1061/(ASCE)0733-9402(2006)132:1(8); Trivellato F, 2012, J WIND ENG IND AEROD, V107, P263, DOI 10.1016/j.jweia.2012.04.026; Walker SL, 2011, ENERG BUILDINGS, V43, P1852, DOI 10.1016/j.enbuild.2011.03.032; Wen J, 2009, RENEW SUST ENERG REV, V13, P2485; Whale J, 2013, RENEW ENERG, V55, P55, DOI 10.1016/j.renene.2012.11.032	25	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0124830	10.1371/journal.pone.0124830	http://dx.doi.org/10.1371/journal.pone.0124830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000444	Green Submitted, Green Published, gold			2022-12-26	WOS:000354931700007
J	Zhang, L; Wang, K; Zhu, CY; Yu, FQ; Chen, XG				Zhang, Long; Wang, Kai; Zhu, Chunyan; Yu, Fengqiong; Chen, Xingui			Trait Anxiety Has Effect on Decision Making under Ambiguity but Not Decision Making under Risk	PLOS ONE			English	Article							IOWA GAMBLING TASK; ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; SEX-DIFFERENCES; WORKING-MEMORY; BASOLATERAL AMYGDALA; PERSONALITY-TRAITS; PERFORMANCE; DISORDER; IMPAIRMENTS	Previous studies have reported that trait anxiety (TA) affects decision making. However, results remain largely inconsistent across studies. The aim of the current study was to further address the interaction between TA and decision making. 304 subjects without depression from a sample consisting of 642 participants were grouped into high TA (HTA), medium TA (MTA) and low TA (LTA) groups based on their TA scores from State Trait Anxiety Inventory. All subjects were assessed with the Iowa Gambling Task (IGT) that measures decision making under ambiguity and the Game of Dice Task (GDT) that measures decision making under risk. While the HTA and LTA groups performed worse on the IGT compared to the MTA group, performances on the GDT between the three groups did not differ. Furthermore, the LTA and HTA groups showed different individual deck level preferences in the IGT: the former showed a preference for deck B indicating that these subjects focused more on the magnitude of rewards, and the latter showed a preference for deck A indicating significant decision making impairment. Our findings suggest that trait anxiety has effect on decision making under ambiguity but not decision making under risk and different levels of trait anxiety related differently to individual deck level preferences in the IGT.	[Zhang, Long; Wang, Kai; Chen, Xingui] Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Peoples R China; [Zhang, Long; Wang, Kai; Zhu, Chunyan; Yu, Fengqiong; Chen, Xingui] Anhui Med Univ, Neuropsychol Lab, Hefei, Peoples R China	Anhui Medical University; Anhui Medical University	Wang, K (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Peoples R China.	wangkai1964@126.com			Natural Science Foundation of China [91232717, 31000503, 31100812]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Natural Science Foundation of China (91232717, 31000503, 31100812). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adida M, 2011, BIOL PSYCHIAT, V70, P357, DOI 10.1016/j.biopsych.2011.01.018; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A., 2008, IOWA GAMBLING TASK P; Bechara Antoine, 2003, J Gambl Stud, V19, P23, DOI 10.1023/A:1021223113233; Beck AT, 1996, PSYCHOL ASSESS; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Blanco NJ, 2013, COGNITION, V129, P563, DOI 10.1016/j.cognition.2013.08.018; Bodell LP, 2014, J PSYCHIATR RES, V56, P150, DOI 10.1016/j.jpsychires.2014.05.015; Boller JK, 2014, EXP NEUROL, V254, P70, DOI 10.1016/j.expneurol.2014.01.005; Brand M, 2005, NEUROPSYCHOLOGY, V19, P267, DOI 10.1037/0894-4105.19.3.267; Brand M, 2007, NEUROPSYCHOLOGY, V21, P742, DOI 10.1037/0894-4105.21.6.742; Brand M, 2007, NEUROPSYCHOLOGIA, V45, P1305, DOI 10.1016/j.neuropsychologia.2006.09.021; Brand M, 2006, NEURAL NETWORKS, V19, P1266, DOI 10.1016/j.neunet.2006.03.001; Brand M, 2008, COGN PROCESS, V9, P159, DOI 10.1007/s10339-008-0204-4; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Buelow MT, 2014, APPL NEUROPSYCH-CHIL, V3, P38, DOI 10.1080/21622965.2012.691065; Buelow MT, 2013, PERS INDIV DIFFER, V54, P593, DOI 10.1016/j.paid.2012.11.019; Calvo MG, 2003, EUR PSYCHOL, V8, P252, DOI 10.1027//1016-9040.8.4.252; Cavedini P, 2012, COGN NEUROPSYCHIATRY, V17, P177, DOI 10.1080/13546805.2011.614152; Cella M, 2010, J AFFECT DISORDERS, V124, P207, DOI 10.1016/j.jad.2009.11.013; Chase HW, 2010, COGN AFFECT BEHAV NE, V10, P406, DOI 10.3758/CABN.10.3.406; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Costa PT, 2001, J PERS SOC PSYCHOL, V81, P322, DOI [10.1037/0022-3514.81.2.322, 10.1037//0022-3514.81.2.322]; Damasio AR, 2004, W JAMES MODERN NEMBI, P3; De Visser L, 2011, NEUROSCIENCE, V184, P97, DOI 10.1016/j.neuroscience.2011.02.025; de Visser L, 2010, NEUROPSYCHOLOGIA, V48, P1598, DOI 10.1016/j.neuropsychologia.2010.01.027; de Visser L, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00109, 10.3389/fnins.2011.00102]; Delazer M, 2007, NEUROPSYCHOLOGIA, V45, P1632, DOI 10.1016/j.neuropsychologia.2007.01.006; Donges US, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041745; Dymond S, 2010, J CLIN EXP NEUROPSYC, V32, P239, DOI 10.1080/13803390902971115; Eshel N, 2010, BIOL PSYCHIAT, V68, P118, DOI 10.1016/j.biopsych.2010.01.027; Etkin A, 2004, NEURON, V44, P1043, DOI 10.1016/j.neuron.2004.12.006; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Fales CL, 2008, COGN AFFECT BEHAV NE, V8, P239, DOI 10.3758/CABN.8.3.239; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; Fridberg DJ, 2013, DRUG ALCOHOL DEPEN, V133, P654, DOI 10.1016/j.drugalcdep.2013.08.014; Han G, 2012, J ADOLESCENCE, V35, P11, DOI 10.1016/j.adolescence.2011.06.009; Heaton R.K., 1993, WISCONSIN CARD SORTI; Jollant F, 2010, NEUROIMAGE, V51, P1275, DOI 10.1016/j.neuroimage.2010.03.027; Kindt M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086462; Klanker M, 2013, BEHAV BRAIN RES, V245, P7, DOI 10.1016/j.bbr.2013.01.043; Koot S, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00127; Krug MK, 2010, COGN AFFECT BEHAV NE, V10, P357, DOI 10.3758/CABN.10.3.357; Kuhn S, 2011, J AFFECT DISORDERS, V134, P315, DOI 10.1016/j.jad.2011.06.003; Labudda K, 2008, EXP BRAIN RES, V187, P641, DOI 10.1007/s00221-008-1332-x; Labudda K, 2009, NEUROPSYCHOLOGIA, V47, P50, DOI 10.1016/j.neuropsychologia.2008.08.014; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; Matthies S, 2012, J BEHAV THER EXP PSY, V43, P938, DOI 10.1016/j.jbtep.2012.02.002; Miu AC, 2008, BIOL PSYCHOL, V77, P353, DOI 10.1016/j.biopsycho.2007.11.010; Overman WH, 2004, BRAIN COGNITION, V55, P134, DOI 10.1016/s0278-2626(03)00279-3; Overman W, 2006, BEHAV NEUROSCI, V120, P817, DOI 10.1037/0735-7044.120.4.817; Overman WH, 2011, BEHAV BRAIN RES, V218, P64, DOI 10.1016/j.bbr.2010.11.015; Pais-Vieira M, 2007, NEUROSCIENCE, V145, P225, DOI 10.1016/j.neuroscience.2006.11.058; Perkins AM, 2007, EMOTION, V7, P252, DOI 10.1037/1528-3542.7.2.252; Qi SQ, 2014, BIOL PSYCHOL, V103, P92, DOI 10.1016/j.biopsycho.2014.08.010; Reitan RM, 1992, TRAIL MAKING TEST MA; Rivalan M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00022; Schmitt DP, 2008, J PERS SOC PSYCHOL, V94, P168, DOI 10.1037/0022-3514.94.1.168; Simpson JR, 2001, P NATL ACAD SCI USA, V98, P688, DOI 10.1073/pnas.98.2.688; Spielberger CD, 1983, MANUAL FOR THE STATE; Starcke K, 2010, PSYCHIAT RES, V175, P114, DOI 10.1016/j.psychres.2008.10.022; Starcke Katrin, 2009, Cogn Neuropsychiatry, V14, P199, DOI 10.1080/13546800902996831; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Svaldi J, 2010, APPETITE, V54, P84, DOI 10.1016/j.appet.2009.09.010; Telzer EH, 2008, BIOL PSYCHOL, V79, P216, DOI 10.1016/j.biopsycho.2008.05.004; Thagard P., 2006, HOT THOUGHT MECHANIS; Tsuchida A, 2010, J NEUROSCI, V30, P16868, DOI 10.1523/JNEUROSCI.1958-10.2010; van den Bos R, 2013, BEHAV BRAIN RES, V238, P95, DOI 10.1016/j.bbr.2012.10.002; van den Bos R, 2009, PSYCHONEUROENDOCRINO, V34, P1449, DOI 10.1016/j.psyneuen.2009.04.016; Visu-Petra L, 2013, INT J PSYCHOL, V48, P649, DOI 10.1080/00207594.2012.656132; Wang X, 1999, J CHINESE MENT HEALT, V13, P205; [王振 WANG Zhen], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P476; Weisman O, 2013, PSYCHONEUROENDOCRINO, V38, P694, DOI 10.1016/j.psyneuen.2012.08.011; Werner NS, 2009, INT J PSYCHOPHYSIOL, V74, P259, DOI 10.1016/j.ijpsycho.2009.09.010; Windmann S, 2006, J COGNITIVE NEUROSCI, V18, P1198, DOI 10.1162/jocn.2006.18.7.1198; Xu PF, 2013, J NEUROSCI, V33, P18641, DOI 10.1523/JNEUROSCI.1253-13.2013; Zeeb FD, 2011, J NEUROSCI, V31, P2197, DOI 10.1523/JNEUROSCI.5597-10.2011; Zimmermann-Viehoff F, 2008, AM J HYPERTENS, V21, P1292, DOI 10.1038/ajh.2008.300	79	19	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127189	10.1371/journal.pone.0127189	http://dx.doi.org/10.1371/journal.pone.0127189			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7GR	26000629	gold, Green Published, Green Submitted			2022-12-26	WOS:000354931700043
J	Zollner, S; Sokolnikov, ME; Eidemuller, M				Zoellner, Sascha; Sokolnikov, Mikhail E.; Eidemueller, Markus			Beyond Two-Stage Models for Lung Carcinogenesis in the Mayak Workers: Implications for Plutonium Risk	PLOS ONE			English	Article							BIOLOGICALLY-BASED MODEL; GENOMIC INSTABILITY; MULTISTAGE CARCINOGENESIS; COLON-CANCER; 2-MUTATION MODEL; INITIATED CELLS; HAZARD FUNCTION; TUMOR RISK; RADON; RADIATION	Mechanistic multi-stage models are used to analyze lung-cancer mortality after Plutonium exposure in the Mayak-workers cohort, with follow-up until 2008. Besides the established two-stage model with clonal expansion, models with three mutation stages as well as a model with two distinct pathways to cancer are studied. The results suggest that three-stage models offer an improved description of the data. The best-fitting models point to a mechanism where radiation increases the rate of clonal expansion. This is interpreted in terms of changes in cell-cycle control mediated by bystander signaling or repopulation following cell killing. No statistical evidence for a two-pathway model is found. To elucidate the implications of the different models for radiation risk, several exposure scenarios are studied. Models with a radiation effect at an early stage show a delayed response and a pronounced drop-off with older ages at exposure. Moreover, the dose-response relationship is strongly nonlinear for all three-stage models, revealing a marked increase above a critical dose.	[Zoellner, Sascha; Eidemueller, Markus] Helmholtz Zentrum Munchen, Inst Radiat Protect, Neuherberg, Germany; [Sokolnikov, Mikhail E.] Southern Urals Biophys Inst, Ozyorsk, Russia	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Southern Urals Biophysics Institute	Zollner, S (corresponding author), Helmholtz Zentrum Munchen, Inst Radiat Protect, Neuherberg, Germany.	sascha.zoellner@helmholtz-muenchen.de		Sokolnikov, Mikhail/0000-0001-9492-4316	European Commission [269553]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission under FP7 project no. 269553 (EpiRadBio, http://cordis.europa.eu/fp7/home_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrazzak AB, 2011, RADIAT RES, V176, P346, DOI 10.1667/RR2509.1; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 1999, HLTH EFF EXP RAD BEI; Anspaugh LR, 2002, RADIAT ENVIRON BIOPH, V41, P19, DOI 10.1007/s00411-002-0148-5; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Balashazy I, 2009, J RADIOL PROT, V29, P147, DOI 10.1088/0952-4746/29/2/003; Bijwaard H, 2006, RADIAT RES, V165, P741, DOI 10.1667/RR3548.1; Brenner DJ, 2001, RADIAT RES, V155, P402, DOI 10.1667/0033-7587(2001)155[0402:TBEIRO]2.0.CO;2; Brugmans Marco J. P., 2002, Journal of Radiological Protection, V22, pA75, DOI 10.1088/0952-4746/22/3A/314; Brugmans MJP, 2004, RADIAT ENVIRON BIOPH, V43, P153, DOI 10.1007/s00411-004-0247-6; Chao DL, 2008, P NATL ACAD SCI USA, V105, P15034, DOI 10.1073/pnas.0802211105; Curtis SB, 2004, ADV SPACE RES, V34, P1404, DOI 10.1016/j.asr.2004.03.011; Eidemuller M, 2015, MUTAT RES-FUND MOL M, V775, P1, DOI 10.1016/j.mrfmmm.2015.03.002; Eidemuller M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041431; Gilbert ES, 2013, RADIAT RES, V179, P332, DOI 10.1667/RR3054.1; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harley NH, 1996, ENVIRON INT, V22, P977, DOI [10.1016/S0160-4120(96)00210-3, DOI 10.1016/S0160-4120(96)00210-3]; Hazelton WD, 2001, RADIAT RES, V156, P78, DOI 10.1667/0033-7587(2001)156[0078:AOAHCO]2.0.CO;2; Hazelton WD, 2005, CANCER EPIDEM BIOMAR, V14, P1171, DOI 10.1158/1055-9965.EPI-04-0756; Heidenreich WE, 2008, RADIAT RES, V170, P613, DOI 10.1667/RR0957.1; Heidenreich WF, 2012, RADIAT ENVIRON BIOPH, V51, P263, DOI 10.1007/s00411-012-0423-z; Heidenreich WF, 2004, RADIAT ENVIRON BIOPH, V43, P247, DOI 10.1007/s00411-004-0266-3; Heidenreich WF, 1996, RADIAT ENVIRON BIOPH, V35, P127, DOI 10.1007/s004110050020; Heidenreich WF, 2000, RADIAT ENVIRON BIOPH, V39, P253, DOI 10.1007/s004110000075; Heidenreich WF, 2001, RADIAT RES, V155, P870, DOI 10.1667/0033-7587(2001)155[0870:RICICI]2.0.CO;2; Heidenreich WF, 1997, RISK ANAL, V17, P391, DOI 10.1111/j.1539-6924.1997.tb00878.x; Jacob P, 2007, RADIAT ENVIRON BIOPH, V46, P383, DOI 10.1007/s00411-007-0117-0; Jacob P, 2010, MUTAT RES-FUND MOL M, V687, P34, DOI 10.1016/j.mrfmmm.2010.01.005; Jacob V, 2005, RADIAT ENVIRON BIOPH, V44, P119, DOI 10.1007/s00411-005-0012-5; JAMES F, 1975, COMPUT PHYS COMMUN, V10, P343, DOI 10.1016/0010-4655(75)90039-9; Kaiser JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111024; Khokhryakov VV, 2013, HEALTH PHYS, V104, P366, DOI 10.1097/HP.0b013e31827dbf60; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kopp-Schneider A, 2006, RADIAT RES, V166, P422, DOI 10.1667/RR3526.1; Koshurnikova NA, 1999, RADIAT RES, V152, P352, DOI 10.2307/3580220; Kundrat P, 2014, SUBMITTED TO RADIAT; Leenhouts HP, 1999, RADIAT ENVIRON BIOPH, V38, P57, DOI 10.1007/s004110050138; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Little MP, 2008, J THEOR BIOL, V254, P229, DOI 10.1016/j.jtbi.2008.05.027; Little MP, 2007, CARCINOGENESIS, V28, P479, DOI 10.1093/carcin/bgl173; Little MP, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-19; Little MP, 2003, MATH BIOSCI, V183, P111, DOI 10.1016/S0025-5564(03)00040-3; Little MP, 1995, BIOMETRICS, V51, P1278, DOI 10.2307/2533259; Little MP, 2002, INT J RADIAT BIOL, V78, P49, DOI 10.1080/09553000110085797; Luebeck EG, 2013, CANCER RES, V73, P1086, DOI 10.1158/0008-5472.CAN-12-2198; Luebeck EG, 1999, RADIAT RES, V152, P339, DOI 10.2307/3580219; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; Madas BG, 2014, RADIAT PROT DOSIM, V159, P237, DOI 10.1093/rpd/ncu125; McCullagh P., 1991, GEN LINEAR MODELS; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; Meza R, 2008, CANCER CAUSE CONTROL, V19, P317, DOI 10.1007/s10552-007-9094-5; MOOLGAVKAR SH, 1988, RISK ANAL, V8, P383, DOI 10.1111/j.1539-6924.1988.tb00502.x; MOOLGAVKAR SH, 1979, MATH BIOSCI, V47, P55, DOI 10.1016/0025-5564(79)90005-1; Moolgavkar Suresh, 1999, V131, P179; NORDLING CO, 1953, BRIT J CANCER, V7, P68, DOI 10.1038/bjc.1953.8; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Schollnberger H, 2006, CARCINOGENESIS, V27, P1432, DOI 10.1093/carcin/bgi345; Shuryak I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028559; Tan WY, 2008, HDB CANC MODELS APPL, V9; Trosko JE, 2005, RADIAT ENVIRON BIOPH, V44, P3, DOI 10.1007/s00411-005-0269-8; van Dillen T, 2011, RADIAT RES, V175, P119, DOI 10.1667/RR2102.1; Vasilenko EK, 2007, HEALTH PHYS, V93, P190, DOI 10.1097/01.HP.0000266071.43137.0e; Weinberg R. A., 2013, BIOL CANC; Zhou HN, 2001, P NATL ACAD SCI USA, V98, P14410, DOI 10.1073/pnas.251524798	65	7	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126238	10.1371/journal.pone.0126238	http://dx.doi.org/10.1371/journal.pone.0126238			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000637	Green Published, Green Submitted, gold			2022-12-26	WOS:000354931700015
J	Danis-Wlodarczyk, K; Olszak, T; Arabski, M; Wasik, S; Majkowska-Skrobek, G; Augustyniak, D; Gula, G; Briers, Y; Jang, HB; Vandenheuvel, D; Duda, KA; Lavigne, R; Drulis-Kawa, Z				Danis-Wlodarczyk, Katarzyna; Olszak, Tomasz; Arabski, Michal; Wasik, Slawomir; Majkowska-Skrobek, Grazyna; Augustyniak, Daria; Gula, Grzegorz; Briers, Yves; Jang, Ho Bin; Vandenheuvel, Dieter; Duda, Katarzyna Anna; Lavigne, Rob; Drulis-Kawa, Zuzanna			Characterization of the Newly Isolated Lytic Bacteriophages KTN6 and KT28 and Their Efficacy against Pseudomonas aeruginosa Biofilm	PLOS ONE			English	Article							PROTEIN HOMOLOGY DETECTION; CHRONIC COLONIZATION; SEQUENCE SIMILARITY; HOST DEFENSES; PHAGE; PATHOGENESIS; PYOCYANIN; VIRULENCE; CLASSIFICATION; MECHANISMS	We here describe two novel lytic phages, KT28 and KTN6, infecting Pseudomonas aeruginosa, isolated from a sewage sample from an irrigated field near Wroclaw, in Poland. Both viruses show characteristic features of Pbunalikevirus genus within the Myoviridae family with respect to shape and size of head/tail, as well as LPS host receptor recognition. Genome analysis confirmed the similarity to other PB1-related phages, ranging between 48 and 96%. Pseudomonas phage KT28 has a genome size of 66,381 bp and KTN6 of 65,994 bp. The latent period, burst size, stability and host range was determined for both viruses under standard laboratory conditions. Biofilm eradication efficacy was tested on peg-lid plate assay and PET membrane surface. Significant reduction of colony forming units was observed (70-90%) in 24 h to 72 h old Pseudomonas aeruginosa PAO1 biofilm cultures for both phages. Furthermore, a pyocyanin and pyoverdin reduction tests reveal that tested phages lowers the amount of both secreted dyes in 48-72 h old biofilms. Diffusion and goniometry experiments revealed the increase of diffusion rate through the biofilm matrix after phage application. These characteristics indicate these phages could be used to prevent Pseudomonas aeruginosa infections and biofilm formation. It was also shown, that PB1-related phage treatment of biofilm caused the emergence of stable phage-resistant mutants growing as small colony variants.	[Danis-Wlodarczyk, Katarzyna; Olszak, Tomasz; Majkowska-Skrobek, Grazyna; Augustyniak, Daria; Gula, Grzegorz; Drulis-Kawa, Zuzanna] Univ Wroclaw, Inst Genet & Microbiol, Dept Pathogen Biol & Immunol, PL-50138 Wroclaw, Poland; [Danis-Wlodarczyk, Katarzyna; Briers, Yves; Jang, Ho Bin; Vandenheuvel, Dieter; Lavigne, Rob] Katholieke Univ Leuven, Div Gene Technol, Leuven, Belgium; [Arabski, Michal] Jan Kochanowski Univ Humanities & Sci, Inst Biol, Dept Microbiol, Kielce, Poland; [Wasik, Slawomir] Jan Kochanowski Univ Humanities & Sci, Inst Phys, Dept Mol Phys, Kielce, Poland; [Duda, Katarzyna Anna] Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Struct Biochem, Borstel, Germany	University of Wroclaw; KU Leuven; Jan Kochanowski University; Jan Kochanowski University; Forschungszentrum Borstel	Drulis-Kawa, Z (corresponding author), Univ Wroclaw, Inst Genet & Microbiol, Dept Pathogen Biol & Immunol, PL-50138 Wroclaw, Poland.	zuzanna.drulis-kawa@microb.uni.wroc.pl	Augustyniak, Daria/AAP-4523-2021; Arabski, Michał/S-9907-2019; Duda, Katarzyna/M-5274-2018; Guła, Grzegorz/AAJ-2509-2021; Majkowska-Skrobek, Grazyna/ABD-2320-2020	Arabski, Michał/0000-0002-9712-9286; Duda, Katarzyna/0000-0001-7701-3262; Guła, Grzegorz/0000-0003-1320-884X; Majkowska-Skrobek, Grazyna/0000-0002-7901-619X; Drulis-Kawa, Zuzanna/0000-0002-4733-4660; Wasik, Slawomir/0000-0003-0107-4493; Lavigne, Rob/0000-0001-7377-1314; Olszak, Tomasz/0000-0001-8631-8084; Augustyniak, Daria/0000-0002-0547-3937; Vandenheuvel, Dieter/0000-0002-4398-1916	Polish National Science Centre research [2012/04/M/NZ6/00335]; European Union as part of the European Social Fund	Polish National Science Centre research; European Union as part of the European Social Fund	This study was supported by Polish National Science Centre research grant no. 2012/04/M/NZ6/00335. Katarzyna Danis-Wlodarczyk was co-financed by the European Union as part of the European Social Fund.	Adams MH, 1959, BACTERIOPHAGES, P27; Allen L, 2005, J IMMUNOL, V174, P3643, DOI 10.4049/jimmunol.174.6.3643; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arabski M, 2009, CARBOHYD POLYM, V78, P481, DOI 10.1016/j.carbpol.2009.05.004; Arabski M, 2009, J MICROBIOL METH, V77, P178, DOI 10.1016/j.mimet.2009.01.020; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Brussow H, 2012, MBIO, V3, DOI 10.1128/mBio.00061-12; Carter Chandi D, 2012, Bacteriophage, V2, P178; Ceyssens PJ, 2008, J BACTERIOL, V190, P1429, DOI 10.1128/JB.01441-07; Ceyssens PJ, 2009, ENVIRON MICROBIOL, V11, P2874, DOI 10.1111/j.1462-2920.2009.02030.x; Dacheux D, 2000, INFECT IMMUN, V68, P2916, DOI 10.1128/IAI.68.5.2916-2924.2000; Dagan T, 2011, TRENDS MICROBIOL, V19, P483, DOI 10.1016/j.tim.2011.07.001; Das T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046718; De Soyza A, 2013, MICROBIOLOGYOPEN, V2, P1010, DOI 10.1002/mbo3.141; del Olmo A, 2003, J INORG BIOCHEM, V97, P384, DOI 10.1016/S0162-0134(03)00316-7; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Dorscht J, 2009, J BACTERIOL, V191, P7206, DOI 10.1128/JB.01041-09; Dworecki K, 2003, PHYSICA A, V326, P360, DOI 10.1016/S0378-4371(03)00266-8; Dzieranowska D., 2008, ZAKAZENIA SZPITALNE, V2nd; Essoh C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060575; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Garbe J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-301; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Harrison JJ, 2008, ANTIMICROB AGENTS CH, V52, P2870, DOI 10.1128/AAC.00203-08; HASSETT DJ, 1992, INFECT IMMUN, V60, P328, DOI 10.1128/IAI.60.2.328-336.1992; Jang HB, 2013, J VIROL, V87, P12866, DOI 10.1128/JVI.02656-13; JARRELL K, 1977, J VIROL, V23, P461, DOI 10.1128/JVI.23.3.461-466.1977; Kobayashi H, 2009, J INFECT CHEMOTHER, V15, P125, DOI 10.1007/s10156-008-0691-3; Kropinski Andrew M., 2009, V501, P157, DOI 10.1007/978-1-60327-164-6_16; Kutter Elizabeth, 2009, V501, P141, DOI 10.1007/978-1-60327-164-6_14; Lavigne R, 2004, BIOINFORMATICS, V20, P629, DOI 10.1093/bioinformatics/btg456; Lavigne R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-224; Lawrence JG, 2002, J BACTERIOL, V184, P4891, DOI 10.1128/JB.184.17.4891-4905.2002; Leplae R, 2010, NUCLEIC ACIDS RES, V38, pD57, DOI 10.1093/nar/gkp938; Lima-Mendez G, 2008, MOL BIOL EVOL, V25, P762, DOI 10.1093/molbev/msn023; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Maura D, 2011, APPL MICROBIOL BIOT, V90, P851, DOI 10.1007/s00253-011-3227-1; Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944; Meyer JM, 1996, INFECT IMMUN, V64, P518, DOI 10.1128/IAI.64.2.518-523.1996; Murray TS, 2007, CURR OPIN PEDIATR, V19, P83, DOI 10.1097/MOP.0b013e3280123a5d; Naville M, 2011, RNA BIOL, V8, P11, DOI 10.4161/rna.8.1.13346; Pajunen M, 2000, J BACTERIOL, V182, P5114, DOI 10.1128/JB.182.18.5114-5120.2000; Pirnay JP, 2002, ENVIRON MICROBIOL, V4, P898, DOI 10.1046/j.1462-2920.2002.00321.x; Resch G, 2004, J BACTERIOL, V186, P5523, DOI 10.1128/JB.186.16.5523-5528.2004; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SLOPEK S, 1983, ARCH IMMUNOL THER EX, V31, P267; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Trautmann M, 2005, AM J INFECT CONTROL, V33, pS41, DOI 10.1016/j.ajic.2005.03.006; Wasik S, 2013, EUR BIOPHYS J BIOPHY, V42, P549, DOI 10.1007/s00249-013-0904-2; Wei Q, 2013, INT J MOL SCI, V14, P20983, DOI 10.3390/ijms141020983; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Wright A, 2009, CLIN OTOLARYNGOL, V34, P349, DOI 10.1111/j.1749-4486.2009.01973.x	59	53	55	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127603	10.1371/journal.pone.0127603	http://dx.doi.org/10.1371/journal.pone.0127603			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996839	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000080
J	Keller, U; Scholch, S; Albisser, U; Rudhe, C; Curt, A; Riener, R; Klamroth-Marganska, V				Keller, Urs; Schoelch, Sabine; Albisser, Urs; Rudhe, Claudia; Curt, Armin; Riener, Robert; Klamroth-Marganska, Verena			Robot-Assisted Arm Assessments in Spinal Cord Injured Patients: A Consideration of Concept Study	PLOS ONE			English	Article							MODIFIED ASHWORTH SCALE; UPPER-LIMB; UPPER-EXTREMITY; STROKE; RELIABILITY; REHABILITATION; MULTICENTER; SPASTICITY; PATTERNS; VALIDITY	Robotic assistance is increasingly used in neurological rehabilitation for enhanced training. Furthermore, therapy robots have the potential for accurate assessment of motor function in order to diagnose the patient status, to measure therapy progress or to feedback the movement performance to the patient and therapist in real time. We investigated whether a set of robot-based assessments that encompasses kinematic, kinetic and timing metrics is applicable, safe, reliable and comparable to clinical metrics for measurement of arm motor function. Twenty-four healthy subjects and five patients after spinal cord injury underwent robot-based assessments using the exoskeleton robot ARMin. Five different tasks were performed with aid of a visual display. Ten kinematic, kinetic and timing assessment parameters were extracted on joint- and end-effector level (active and passive range of motion, cubic reaching volume, movement time, distance-path ratio, precision, smoothness, reaction time, joint torques and joint stiffness). For cubic volume, joint torques and the range of motion for most joints, good inter- and intra-rater reliability were found whereas precision, movement time, distance-path ratio and smoothness showed weak to moderate reliability. A comparison with clinical scores revealed good correlations between robot-based joint torques and the Manual Muscle Test. Reaction time and distance-path ratio showed good correlation with the "Graded and Redefined Assessment of Strength, Sensibility and Prehension" (GRASSP) and the Van Lieshout Test (VLT) for movements towards a predefined position in the center of the frontal plane. In conclusion, the therapy robot ARMin provides a comprehensive set of assessments that are applicable and safe. The first results with spinal cord injured patients and healthy subjects suggest that the measurements are widely reliable and comparable to clinical scales for arm motor function. The methods applied and results can serve as a basis for the future development of end-effector and exoskeleton-based robotic assessments.	[Keller, Urs; Schoelch, Sabine; Riener, Robert; Klamroth-Marganska, Verena] ETH, Dept Hlth Sci & Technol, Sensory Motor Syst Lab, Zurich, Switzerland; [Keller, Urs; Schoelch, Sabine; Albisser, Urs; Rudhe, Claudia; Curt, Armin; Riener, Robert; Klamroth-Marganska, Verena] Univ Zurich, Balgrist Univ Hosp, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Keller, U (corresponding author), ETH, Dept Hlth Sci & Technol, Sensory Motor Syst Lab, Zurich, Switzerland.	urs.keller@hest.ethz.ch	Riener, Robert/B-9868-2016	Keller, Urs/0000-0001-6615-6452	Swiss National Science Foundation (SNF) in the framework of the National Centre of Competence in Research (NCCR) transfer project RANA (Robot-Assisted Neurorehabilitation of the Arm) [51NF40-111381]	Swiss National Science Foundation (SNF) in the framework of the National Centre of Competence in Research (NCCR) transfer project RANA (Robot-Assisted Neurorehabilitation of the Arm)(Swiss National Science Foundation (SNSF))	This study was funded by the Swiss National Science Foundation (SNF) in the framework of the National Centre of Competence in Research (NCCR, 51NF40-111381) transfer project RANA (Robot-Assisted Neurorehabilitation of the Arm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2012, IEEE T BIO-MED ENG, V59, P2126, DOI 10.1109/TBME.2011.2179545; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Bolliger M, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-23; Bosecker C, 2010, NEUROREHAB NEURAL RE, V24, P62, DOI 10.1177/1545968309343214; Calota A, 2008, CLIN NEUROPHYSIOL, V119, P2329, DOI 10.1016/j.clinph.2008.07.215; Celik O, 2010, IEEE T NEUR SYS REH, V18, P433, DOI 10.1109/TNSRE.2010.2047600; CHAPMAN LJ, 1987, BRAIN COGNITION, V6, P175, DOI 10.1016/0278-2626(87)90118-7; Cheung VCK, 2012, P NATL ACAD SCI USA, V109, P14652, DOI 10.1073/pnas.1212056109; Clarkson H.M., 2000, MUSCULOSKELETAL ASSE, V2nd ed.; Coderre AM, 2010, NEUROREHAB NEURAL RE, V24, P528, DOI 10.1177/1545968309356091; Colombo R, 2008, NEUROREHABIL NEURAL, P50; Cuthbert Scott C, 2007, Chiropr Osteopat, V15, P4, DOI 10.1186/1746-1340-15-4; Daly JJ, 2005, J REHABIL RES DEV, V42, P723, DOI 10.1682/JRRD.2005.02.0048; Del Din S, 2011, IEEE ENG MED BIO, P5839, DOI 10.1109/IEMBS.2011.6091444; Dipietro L, 2007, J NEUROPHYSIOL, V98, P757, DOI 10.1152/jn.01295.2006; Dobkin BH, 2009, NEUROREHAB NEURAL RE, V23, P197, DOI 10.1177/1545968309331863; Dovat L, 2008, 2008 VIRTUAL REHABILITATION, P28, DOI 10.1109/ICVR.2008.4625116; Ellis MD, 2005, MUSCLE NERVE, V32, P170, DOI 10.1002/mus.20343; Ellis MD, 2009, NEUROREHAB NEURAL RE, V23, P862, DOI 10.1177/1545968309332927; Fluet M, 2011, P IEEE INT C REH ROB, P1, DOI DOI 10.1109/IC0RR.2011.5975348; Gilliaux M, 2014, J REHABIL MED, V46, P117, DOI 10.2340/16501977-1245; Gregson JM, 1999, ARCH PHYS MED REHAB, V80, P1013, DOI 10.1016/S0003-9993(99)90053-9; Guidali M, 2011, MED BIOL ENG COMPUT, V49, P1213, DOI 10.1007/s11517-011-0809-0; Haugh AB, 2006, DISABIL REHABIL, V28, P899, DOI 10.1080/09638280500404305; Hepp W.R., 2014, ORTHOPADISCHES DIAGN; Hislop HJ, 2007, MANUELLE MUSKELTESTS; Hogan N, 2009, J MOTOR BEHAV, V41, P529, DOI 10.3200/35-09-004-RC; Itzkovich M, 2007, DISABIL REHABIL, V29, P1926, DOI 10.1080/09638280601046302; Kalsi-Ryan S, 2012, J NEUROTRAUM, V29, P905, DOI 10.1089/neu.2010.1504; Keller U, 2013, IEEE INT CONF ROBOT, P3908, DOI 10.1109/ICRA.2013.6631127; Kennedy P, 2006, SPINAL CORD, V44, P95, DOI 10.1038/sj.sc.3101787; Klamroth-Marganska V, 2014, LANCET NEUROL, V13, P159, DOI 10.1016/S1474-4422(13)70305-3; Kloosterman MGM, 2009, SPINAL CORD, V47, P196, DOI 10.1038/sc.2008.113; Klopcar N, 2007, J BIOMECH, V40, P86, DOI 10.1016/j.jbiomech.2005.11.010; Koenig A, 2012, P IEEE RAS-EMBS INT, P1862; Krabben T, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-44; Krebs H I, 2002, Top Stroke Rehabil, V8, P54; Kumar RTS, 2006, AGE AGEING, V35, P371, DOI 10.1093/ageing/afj084; Kurillo G, 2013, TECHNOL HEALTH CARE, V21, P641, DOI 10.3233/THC-130764; Lambercy O, 2010, P 4 INT CONV REH ENG, P33; Lambercy O, 2012, NEUROREHABILITATION, P443, DOI 10.1007/978-1-4471-2277-7_24; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Loureiro RCV, 2007, INT C REHAB ROBOT, P757, DOI 10.1109/ICORR.2007.4428510; Lunenburger L, 2005, INT C REHAB ROBOT, P345; Mackin E, 2002, REHABILITATION HAND, V1, P240; Mayo NE, 2002, ARCH PHYS MED REHAB, V83, P1035, DOI 10.1053/apmr.2002.33984; MILNER TE, 1992, NEUROSCIENCE, V49, P487, DOI 10.1016/0306-4522(92)90113-G; Nef T, 2007, MED BIOL ENG COMPUT, V45, P887, DOI 10.1007/s11517-007-0226-6; Pandyan AD, 2001, CLIN BIOMECH, V16, P859, DOI 10.1016/S0268-0033(01)00084-5; Perell K, 1996, PARAPLEGIA, V34, P46, DOI 10.1038/sc.1996.8; Post MWM, 2006, SPINAL CORD, V44, P763, DOI 10.1038/sj.sc.3101937; Reinkensmeyer DJ, 1999, ANN BIOMED ENG, V27, P805, DOI 10.1114/1.233; Rohrer B, 2002, J NEUROSCI, V22, P8297; Schaechter JD, 2004, PROG NEUROBIOL, V73, P61, DOI 10.1016/j.pneurobio.2004.04.001; Soucie JM, 2011, HAEMOPHILIA, V17, P500, DOI 10.1111/j.1365-2516.2010.02399.x; Squeri V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011189; Stienen AHA, 2009, IEEE T ROBOT, V25, P628, DOI 10.1109/TRO.2009.2019147; TREDINNICK TJ, 1988, PHYS THER, V68, P656, DOI 10.1093/ptj/68.5.656; Wood DE, 2005, DISABIL REHABIL, V27, P19, DOI 10.1080/09638280400014683; World Health Organization, 2002, COMMON LANGUAGE FUNC; Zariffa J, 2012, IEEE T NEUR SYS REH, V20, P341, DOI 10.1109/TNSRE.2011.2181537; Zimmerli L, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-6	62	30	31	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0126948	10.1371/journal.pone.0126948	http://dx.doi.org/10.1371/journal.pone.0126948			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK7VW	25996374	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000356444000036
J	Merget, B; Sotriffer, CA				Merget, Benjamin; Sotriffer, Christoph A.			Slow-Onset Inhibition of Mycobacterium tuberculosis InhA: Revealing Molecular Determinants of Residence Time by MD Simulations	PLOS ONE			English	Article							ENOYL-ACP REDUCTASE; DYNAMICS SIMULATION; ACCURATE DOCKING; COMPLEX; MECHANISM; BINDING; GLIDE; MODEL	An important kinetic parameter for drug efficacy is the residence time of a compound at a drug target, which is related to the dissociation rate constant k(off). For the essential antimyco-bacterial target InhA, this parameter is most likely governed by the ordering of the flexible substrate binding loop (SBL). Whereas the diphenyl ether inhibitors 6PP and triclosan (TCL) do not show loop ordering and thus, no slow-binding inhibition and high k(off) values, the slightly modified PT70 leads to an ordered loop and a residence time of 24 minutes. To assess the structural differences of the complexes from a dynamic point of view, molecular dynamics (MD) simulations with a total sampling time of 3.0 mu s were performed for three ligand-bound and two ligand-free (perturbed) InhA systems. The individual simulations show comparable conformational features with respect to both the binding pocket and the SBL, allowing to define five recurring conformational families. Based on their different occurrence frequencies in the simulated systems, the conformational preferences could be linked to structural differences of the respective ligands to reveal important determinants of residence time. The most abundant conformation besides the stable EI* state is characterized by a shift of IIe202 and Val203 toward the hydrophobic pocket of InhA. The analyses revealed potential directions for avoiding this conformational change and, thus, hindering rapid dissociation: (1) an anchor group in 2'-position of the B-ring for scaffold stabilization, (2) proper occupation of the hydrophobic pocket, and (3) the introduction of a barricade sub-stituent in 5'-position of the diphenyl ether B-ring.	[Merget, Benjamin; Sotriffer, Christoph A.] Univ Wurzburg, Inst Pharm & Food Chem, D-97074 Wurzburg, Germany	University of Wurzburg	Sotriffer, CA (corresponding author), Univ Wurzburg, Inst Pharm & Food Chem, Hubland, D-97074 Wurzburg, Germany.	sotriffer@uni-wuerzburg.de			German Research Foundation (DFG) [SFB 630, TP C7]; University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This publication was funded by the German Research Foundation (DFG, www.dfg.de): SFB 630, TP C7 to CAS and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; [Anonymous], PYMOL MOL GRAPH SYST; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bohm HJ, 1996, ANGEW CHEM INT EDIT, V35, P2589; Boyne ME, 2007, ANTIMICROB AGENTS CH, V51, P3562, DOI 10.1128/AAC.00383-07; Burant, 2008, GAUSSIAN 03 REVISION; Case D.A., 2022, AMBER 2020; Chang A, 2013, BIOCHEMISTRY-US, V52, P4217, DOI 10.1021/bi400413c; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; da Costa ALP, 2012, J MOL MODEL, V18, P1779, DOI 10.1007/s00894-011-1200-7; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Draper P, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P261; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Li HJ, 2014, ACS CHEM BIOL, V9, P986, DOI 10.1021/cb400896g; Lindert S, 2012, PROTEIN SCI, V21, P1734, DOI 10.1002/pro.2155; Lu H, 2010, CURR OPIN CHEM BIOL, V14, P467, DOI 10.1016/j.cbpa.2010.06.176; Lu H, 2009, ACS CHEM BIOL, V4, P221, DOI 10.1021/cb800306y; Luckner SR, 2010, J BIOL CHEM, V285, P14330, DOI 10.1074/jbc.M109.090373; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Neudert G, 2011, BIOINFORMATICS, V27, P1021, DOI 10.1093/bioinformatics/btr055; Pan P, 2014, CHEMMEDCHEM, V9, P776, DOI 10.1002/cmdc.201300429; Pan P, 2012, CURR TOP MED CHEM, V12, P672, DOI 10.2174/156802612799984535; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; R Core Team, 2021, R LANGUAGE ENV STAT; Rozwarski DA, 1999, J BIOL CHEM, V274, P15582, DOI 10.1074/jbc.274.22.15582; Sarkar D, 2008, USE R, P1; Schiebel J, 2012, STRUCTURE, V20, P802, DOI 10.1016/j.str.2012.03.013; Schroeder EK, 2005, BIOPHYS J, V89, P876, DOI 10.1529/biophysj.104.053512; Srinivasan J, 1999, THEOR CHEM ACC, V101, P426, DOI 10.1007/s002140050460; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Stone JE, 2007, J COMPUT CHEM, V28, P2618, DOI 10.1002/jcc.20829; Sullivan TJ, 2006, ACS CHEM BIOL, V1, P43, DOI 10.1021/cb0500042; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Xu H, 2008, BIOCHEMISTRY-US, V47, P4228, DOI 10.1021/bi800023a	45	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127009	10.1371/journal.pone.0127009	http://dx.doi.org/10.1371/journal.pone.0127009			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996598	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000038
J	Balogova, M; Gvozdik, L				Balogova, Monika; Gvozdik, Lumir			Can Newts Cope with the Heat? Disparate Thermoregulatory Strategies of Two Sympatric Species in Water	PLOS ONE			English	Article							PREFERRED BODY TEMPERATURES; COST-BENEFIT MODEL; THERMAL BIOLOGY; PREFERENCES; LIZARDS	Many ectotherms effectively reduce their exposure to low or high environmental temperatures using behavioral thermoregulation. In terrestrial ectotherms, thermoregulatory strategies range from accurate thermoregulation to thermoconformity according to the costs and limits of thermoregulation, while in aquatic taxa the quantification of behavioral thermoregulation have received limited attention. We examined thermoregulation in two sympatric newt species, Ichthyosaura alpestris and Lissotriton vulgaris, exposed to elevated water temperatures under semi-natural conditions. According to a recent theory, we predicted that species for which elevated water temperatures pose a lower thermal quality habitat, would thermoregulate more effectively than species in thermally benign conditions. In the laboratory thermal gradient, Lissotriton vulgaris maintained higher body temperatures than Ichthyosaura alpestris. Semi-natural thermal conditions provided better thermal quality of habitat for Lissotriton vulgaris than for Ichthyosaura alpestris. Thermoregulatory indices indicated that Ichthyosaura alpestris actively thermoregulated its body temperature, whereas Lissotriton vulgaris remained passive to the thermal heterogeneity of aquatic environment. In the face of elevated water temperatures, sympatric newt species employed disparate thermoregulatory strategies according to the species-specific quality of the thermal habitat. Both strategies reduced newt exposure to suboptimal water temperatures with the same accuracy but with or without the costs of thermoregulation. The quantification of behavioral thermoregulation proves to be an important conceptual and methodological tool for thermal ecology studies not only in terrestrial but also in aquatic ectotherms.	[Balogova, Monika] Safarik Univ, Fac Sci, Inst Biol & Ecol, Kosice, Slovakia; [Gvozdik, Lumir] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic	University of Pavol Jozef Safarik Kosice; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences	Gvozdik, L (corresponding author), Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic.	gvozdik@brno.cas.cz	Gvoždík, Lumír/G-1178-2014	Gvoždík, Lumír/0000-0002-6495-2233	Czech Science Foundation [15-07140S]; European Operational Programme 'KVARK-The quality of education and development of skills of PhD students and postdocs' [26110230084];  [RVO: 68081766]	Czech Science Foundation(Grant Agency of the Czech Republic); European Operational Programme 'KVARK-The quality of education and development of skills of PhD students and postdocs'; 	Funding provided by: LG: Czech Science Foundation (15-07140S) and institutional support (RVO: 68081766); MB: European Operational Programme 'KVARK-The quality of education and development of skills of PhD students and postdocs' (26110230084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; Blouin-Demers G, 2005, ECOLOGY, V86, P560, DOI 10.1890/04-1403; Blouin-Demers G, 2001, ECOLOGY, V82, P3025; Canty A, 2014, BOOT BOOTSTRAP R S P; Dvorak J, 2010, EVOL ECOL, V24, P1115, DOI 10.1007/s10682-010-9355-8; Fasola Mauro, 1992, Amphibia-Reptilia, V13, P227, DOI 10.1163/156853892X00436; Fay MP, 2010, J STAT SOFTW, V36, P1; GRIFFITHS RA, 1987, HOLARCTIC ECOL, V10, P1; Gvozdik L, 2002, CAN J ZOOL, V80, P479, DOI 10.1139/SZ02-015; Gvozdik L, 2005, CAN J ZOOL, V83, P1038, DOI 10.1139/Z05-096; Gvozdik L, 2003, J THERM BIOL, V28, P545, DOI 10.1016/j.jtherbio.2003.08.002; Gvozdik L, 2015, EVOL BIOL, V42, P137, DOI 10.1007/s11692-015-9305-z; Hadamova M, 2011, PHYSIOL BIOCHEM ZOOL, V84, P166, DOI 10.1086/658202; HERTZ PE, 1993, AM NAT, V142, P796, DOI 10.1086/285573; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; Hutchison Victor H., 1992, P206; Johnson JA, 1998, ENVIRON BIOL FISH, V53, P447, DOI 10.1023/A:1007425215669; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Kurdikova V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023842; Lancaster J, 2013, AQUATIC ENTOMOLOGY, P1, DOI 10.1093/acprof:oso/9780199573219.001.0001; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1553, DOI 10.1139/z97-782; Marek V, 2012, J ETHOL, V30, P35, DOI 10.1007/s10164-011-0287-8; Martin TL, 2008, AM NAT, V171, pE102, DOI 10.1086/527502; Azocar DLM, 2013, OECOLOGIA, V171, P773, DOI 10.1007/s00442-012-2447-0; Pinheiro J, 2020, R PACKAGE VERSION 31; R Core Team, 2021, R LANGUAGE ENV STAT; Rocek Z, 2003, HDB AMPHIBIEN REPTIL, P607; Samajova P, 2009, J THERM BIOL, V34, P401, DOI 10.1016/j.jtherbio.2009.09.001; Schmidtler J.F., 2004, HDB REPTILIEN AMPHIB, V4, P847; Shine R, 1996, PHYSIOL ZOOL, V69, P252, DOI 10.1086/physzool.69.2.30164182; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Smolinsky R, 2014, J THERM BIOL, V39, P12, DOI 10.1016/j.jtherbio.2013.11.004; Smolinsky R, 2013, BIOL J LINN SOC, V108, P109, DOI 10.1111/j.1095-8312.2012.02004.x; Smolinsky R, 2012, OECOLOGIA, V170, P47, DOI 10.1007/s00442-012-2283-2; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Valdecantos S, 2013, J THERM BIOL, V38, P126, DOI 10.1016/j.jtherbio.2012.12.002; Van Buskirk J, 2005, ECOLOGY, V86, P1936, DOI 10.1890/04-1237; Vickers M, 2011, AM NAT, V177, P452, DOI 10.1086/658150; Williams Stephen E, 2008, PLoS Biol, V6, P2621, DOI 10.1371/journal.pbio.0060325; Zuur A, 2009, MIXED EFFECTS MODELS	41	27	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0128155	10.1371/journal.pone.0128155	http://dx.doi.org/10.1371/journal.pone.0128155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993482	Green Published, Green Submitted, gold			2022-12-26	WOS:000354921400143
J	Garcia-Salgado, G; Rebollo, S; Perez-Camacho, L; Martinez-Hesterkamp, S; Navarro, A; Fernandez-Pereira, JM				Garcia-Salgado, Gonzalo; Rebollo, Salvador; Perez-Camacho, Lorenzo; Martinez-Hesterkamp, Sara; Navarro, Alberto; Fernandez-Pereira, Jose-Manuel			Evaluation of Trail-Cameras for Analyzing the Diet of Nesting Raptors Using the Northern Goshawk as a Model	PLOS ONE			English	Article							ACCIPITER-GENTILIS; BREEDING-SEASON; PREY SELECTION; ASSESSING BIAS; VIDEO CAMERA; SYSTEM; NESTLINGS; REMAINS; PELLET; BUTEO	Diet studies present numerous methodological challenges. We evaluated the usefulness of commercially available trail-cameras for analyzing the diet of Northern Goshawks (Accipiter gentilis) as a model for nesting raptors during the period 2007-2011. We compared diet estimates obtained by direct camera monitoring of 80 nests with four indirect analyses of prey remains collected from the nests and surroundings (pellets, bones, feather-and-hair remains, and feather-hair-and-bone remains combined). In addition, we evaluated the performance of the trail-cameras and whether camera monitoring affected Goshawk behavior. The sensitivity of each diet-analysis method depended on prey size and taxonomic group, with no method providing unbiased estimates for all prey sizes and types. The cameras registered the greatest number of prey items and were probably the least biased method for estimating diet composition. Nevertheless this direct method yielded the largest proportion of prey unidentified to species level, and it underestimated small prey. Our trail-camera system was able to operate without maintenance for longer periods than what has been reported in previous studies with other types of cameras. Initially Goshawks showed distrust toward the cameras but they usually became habituated to its presence within 1-2 days. The habituation period was shorter for breeding pairs that had previous experience with cameras. Using trail-cameras to monitor prey provisioning to nests is an effective tool for studying the diet of nesting raptors. However, the technique is limited by technical failures and difficulties in identifying certain prey types. Our study also shows that cameras can alter adult Goshawk behavior, an aspect that must be controlled to minimize potential negative impacts.	[Garcia-Salgado, Gonzalo; Rebollo, Salvador; Perez-Camacho, Lorenzo; Martinez-Hesterkamp, Sara] Univ Alcala, Dept Life Sci, Ecol & Forest Restorat Grp, Madrid, Spain; [Navarro, Alberto] Independent Field Biol, Asturias, Spain; [Fernandez-Pereira, Jose-Manuel] Independent Field Biol, Pontevedra, Spain	Universidad de Alcala	Garcia-Salgado, G (corresponding author), Univ Alcala, Dept Life Sci, Ecol & Forest Restorat Grp, Sci Bldg, Madrid, Spain.	gonzalo.garcias@uah.es	Rebollo, Salvador/L-6451-2014; Pérez-Camacho, Lorenzo/L-6093-2014; GARCIA-SALGADO, GONZALO/F-7122-2019	Rebollo, Salvador/0000-0001-8797-1122; GARCIA-SALGADO, GONZALO/0000-0002-4729-5710; Navarro, Alberto/0000-0002-9396-0339	Spanish Ministerio de Educacion y Ciencia CICYT projects [CGL2007-60533/BOS, CGL2010-18312/BOS]; FPU fellowship [AP2006-00891]; Spanish Ministerio de Economia y Competitividad PEICTI project [CGL2014-53308-P]; Comunidad de Madrid REMEDINAL network projects [S-0505/AMB/0335, S-2009/AMB/1783, S2013/MAE-2719]; University of Alcala project [CCG2014/BIO-002]; FPI fellowship [BES-2008-006630]	Spanish Ministerio de Educacion y Ciencia CICYT projects; FPU fellowship(Spanish Government); Spanish Ministerio de Economia y Competitividad PEICTI project; Comunidad de Madrid REMEDINAL network projects(Comunidad de Madrid); University of Alcala project; FPI fellowship(Spanish Government)	This research was supported by funds from the Spanish Ministerio de Educacion y Ciencia CICYT projects CGL2007-60533/BOS and CGL2010-18312/BOS; FPU fellowship AP2006-00891 (GGS) and FPI fellowship BES-2008-006630 (SMH), and from the Spanish Ministerio de Economia y Competitividad PEICTI project CGL2014-53308-P. Additional support was provided through the Comunidad de Madrid REMEDINAL network projects S-0505/AMB/0335, S-2009/AMB/1783 and S2013/MAE-2719, and University of Alcala project CCG2014/BIO-002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakaloudis DE, 2012, J ARID ENVIRON, V77, P59, DOI 10.1016/j.jaridenv.2011.10.004; Booms TL, 2003, J FIELD ORNITHOL, V74, P416, DOI 10.1648/0273-8570-74.4.416; Carballeira A., 1983, BIOCLIMATOLOGIA GALI; Cox WA, 2012, 250 USGS NO PRAIR WI; Cummings J.H., 1976, Raptor Research, V10, P55; Cutler TL, 1999, WILDLIFE SOC B, V27, P571; Delaney DK, 1998, J RAPTOR RES, V32, P290; DUKE GE, 1975, COMP BIOCHEM PHYS A, V50, P649, DOI 10.1016/0300-9629(75)90121-8; Estes WA, 2003, CONDOR, V105, P107, DOI 10.1650/0010-5422(2003)105[107:FBOCHA]2.0.CO;2; Gronnesby S, 2000, ORNIS FENNICA, V77, P117; Huang KY, 2006, ZOOL STUD, V45, P234; Kenward R.E., 2006, THE GOSHAWK; Lewis SB, 2004, WILDLIFE SOC B, V32, P373, DOI 10.2193/0091-7648(2004)32[373:ACOMFA]2.0.CO;2; Lewis SB, 2004, NORTHWEST SCI, V78, P70; Lopez-Lopez P, 2010, ITAL J ZOOL, V77, P289, DOI 10.1080/11250000902950637; MANOSA S, 1994, J RAPTOR RES, V28, P84; Marches L, 2002, J RAPTOR RES, V36, P11; Margalida A, 2006, J FIELD ORNITHOL, V77, P7, DOI 10.1111/j.1557-9263.2006.00007.x; Margalida A, 2005, J FIELD ORNITHOL, V76, P40, DOI 10.1648/0273-8570-76.1.40; Marti Carl D., 2007, P129; MERSMANN TJ, 1992, J WILDLIFE MANAGE, V56, P73, DOI 10.2307/3808792; ORO D, 1995, J RAPTOR RES, V29, P207; Perez-Camacho L, 2015, OECOLOGIA, V177, P379, DOI 10.1007/s00442-014-3146-9; Purger JJ, 1998, ORNIS FENNICA, V75, P185; Real J, 1996, J WILDLIFE MANAGE, V60, P632, DOI 10.2307/3802082; Rebollo Salvador, 2011, P159; Redpath SM, 2001, CONDOR, V103, P184, DOI 10.1650/0010-5422(2001)103[0184:ARDCPP]2.0.CO;2; Reif V, 2006, EUR J WILDLIFE RES, V52, P251, DOI 10.1007/s10344-006-0039-1; Resano-Mayor J, 2014, IBIS, V156, P176, DOI 10.1111/ibi.12095; REYNOLDS R. T., 1992, RM217 USDA FOR SERV; RICE CG, 1995, WILDLIFE SOC B, V23, P110; Rogers AS, 2005, J RAPTOR RES, V39, P303; Rosenfield Robert N., 2007, P351; Ruddock M, 2009, PEREGRINE FALCON POP, P567; Rutz C, 2003, J ZOOL, V259, P209, DOI 10.1017/S0952836902003175; Sanchez R, 2008, ORNIS FENNICA, V85, P82; Seguin JF, 1998, J RAPTOR RES, V32, P314; Selas V, 2007, ORNIS FENNICA, V84, P97; SIMMONS R E, 1991, Journal of Raptor Research, V25, P63; Slagsvold T, 2007, J AVIAN BIOL, V38, P650, DOI 10.1111/j.2007.0908-8857.04022.x; Smithers BL, 2005, J RAPTOR RES, V39, P264; Swann DE, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P27, DOI 10.1007/978-4-431-99495-4_3; Tornberg R, 1997, ORNIS FENNICA, V74, P15; Tornberg R, 2007, ORNIS FENNICA, V84, P21; YALDEN DW, 1985, BIRD STUDY, V32, P50, DOI 10.1080/00063658509476855	45	21	23	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127585	10.1371/journal.pone.0127585	http://dx.doi.org/10.1371/journal.pone.0127585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992956	Green Published, gold, Green Submitted			2022-12-26	WOS:000354921400125
J	Fang, P; Hou, YJ; Nan, YH				Fang, Pan; Hou, Yongjun; Nan, Yanghai			Synchronization of Two Homodromy Rotors Installed on a Double Vibro-Body in a Coupling Vibration System	PLOS ONE			English	Article							SELF-SYNCHRONIZATION; EXCITERS; DRIVEN; MOTORS	A new mechanism is proposed to implement synchronization of the two unbalanced rotors in a vibration system, which consists of a double vibro-body, two induction motors and spring foundations. The coupling relationship between the vibro-bodies is ascertained with the Laplace transformation method for the dynamics equation of the system obtained with the Lagrange's equation. An analytical approach, the average method of modified small parameters, is employed to study the synchronization characteristics between the two unbalanced rotors, which is converted into that of existence and the stability of zero solutions for the non-dimensional differential equations of the angular velocity disturbance parameters. By assuming the disturbance parameters that infinitely approach to zero, the synchronization condition for the two rotors is obtained. It indicated that the absolute value of the residual torque between the two motors should be equal to or less than the maximum of their coupling torques. Meanwhile, the stability criterion of synchronization is derived with the Routh-Hurwitz method, and the region of the stable phase difference is confirmed. At last, computer simulations are preformed to verify the correctness of the approximate solution of the theoretical computation for the stable phase difference between the two unbalanced rotors, and the results of theoretical computation is in accordance with that of computer simulations. To sum up, only the parameters of the vibration system satisfy the synchronization condition and the stability criterion of the synchronization, the two unbalanced rotors can implement the synchronization operation.	[Fang, Pan; Hou, Yongjun] Southwest Petr Univ, Sch Mech Engn, Chengdu, Peoples R China; [Nan, Yanghai] Univ Libre Bruxelles, Dept Mech Engn & Robot, Brussels, Belgium	Southwest Petroleum University; Universite Libre de Bruxelles	Hou, YJ (corresponding author), Southwest Petr Univ, Sch Mech Engn, Chengdu, Peoples R China.	yongjunhou@126.com	Nan, Yanghai/I-3444-2016	Nan, Yanghai/0000-0001-6646-9475	National Natural Science Foundation of China [51074132]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by National Natural Science Foundation of China (Grant No. 51074132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Balthazar JM, 2005, APPL MATH COMPUT, V164, P615, DOI 10.1016/j.amc.2004.06.010; Balthazar JM, 2004, J VIB CONTROL, V10, P1739, DOI 10.1177/1077546304041754; Blekhman I. I., 1988, SYNCHRONIZATION IN S, P26; Blekhman II, 1997, SYST CONTROL LETT, V31, P299, DOI 10.1016/S0167-6911(97)00047-9; Blekhman II, 2000, 2ND INTERNATIONAL CO; Djanan AAN, 2014, EUR PHYS J-SPEC TOP, V223, P813, DOI 10.1140/epjst/e2014-02142-x; Fang P, 2014, J VIBROENG, V16, P2188; Huygens C., 1673, HOROLOGIUM OSCILATOR; Jovanovic V, 2012, J SOUND VIB, V331, P2887, DOI 10.1016/j.jsv.2012.01.035; Koluda P, 2014, EUR PHYS J-SPEC TOP, V223, P613, DOI 10.1140/epjst/e2014-02129-7; Koluda P, 2014, INT J STRUCT STAB DY, V14, DOI 10.1142/S0219455414400288; Koluda P, 2014, COMMUN NONLINEAR SCI, V19, P977, DOI 10.1016/j.cnsns.2013.08.008; Pikovsky Arkady, 2001, J SYNCHRONIZATION AN; Rayleigh J., 1945, THEORY OF SOUND, P10; Senator M, 2006, J SOUND VIB, V291, P566, DOI 10.1016/j.jsv.2005.06.018; Sperling L, 2000, 2ND INTERNATIONAL CO; van der Pol B., 1920, RADIO REV, V1, P701; Wen B. C., 2009, SYNCHRONIZATION AND; Yuan WJ, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022818; Yuan WJ, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016116; Zhang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093838; Zhang XL, 2012, ACTA MECH SINICA-PRC, V28, P1424, DOI 10.1007/s10409-012-0151-2; Zhang XL, 2014, J SOUND VIB, V333, P2898, DOI 10.1016/j.jsv.2014.01.022; Zhang XL, 2014, INT J NONLIN MECH, V60, P1, DOI 10.1016/j.ijnonlinmec.2013.12.002; Zhao C, 2010, CHINESE PHYS B, V19; Zhao CY, 2010, SCI CHINA TECHNOL SC, V53, P405, DOI 10.1007/s11431-009-0376-x; Zhao CY, 2009, SHOCK VIB, V16, P517, DOI [10.1155/2009/826929, 10.3233/SAV-2009-0485]; Zhao CY, 2009, SHOCK VIB, V16, P505, DOI [10.3233/SAV-2009-0484, 10.1155/2009/259149]	29	8	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0126069	10.1371/journal.pone.0126069	http://dx.doi.org/10.1371/journal.pone.0126069			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993472	Green Published, Green Submitted, gold			2022-12-26	WOS:000354918600025
J	Sun, YL; Kong, XP; Li, CL; Liu, YX; Ding, ZJ				Sun, Yanling; Kong, Xiangpei; Li, Cuiling; Liu, Yongxiu; Ding, Zhaojun			Potassium Retention under Salt Stress Is Associated with Natural Variation in Salinity Tolerance among Arabidopsis Accessions	PLOS ONE			English	Article							VACUOLAR NA+/H+ ANTIPORTER; MOLECULAR-MECHANISMS; DISTINCT MECHANISMS; K+/NA+ HOMEOSTASIS; FREEZING TOLERANCE; ALLELIC VARIATION; GENETIC-VARIATION; PROTEIN-KINASE; K+ NUTRITION; THALIANA	Plants are exposed to various environmental stresses during their life cycle such as salt, drought and cold. Natural variation mediated plant growth adaptation has been employed as an effective approach in response to the diverse environmental cues such as salt stress. However, the molecular mechanism underlying this process is not well understood. In the present study, a collection of 82 Arabidopsis thaliana accessions (ecotypes) was screened with a view to identify variation for salinity tolerance. Seven accessions showed a higher level of tolerance than Col-0. The young seedlings of the tolerant accessions demonstrated a higher K+ content and a lower Na+/K+ ratio when exposed to salinity stress, but its Na+ content was the same as that of Col-0. The K+ transporter genes AtHAK5, AtCHX17 and AtKUP1 were up-regulated significantly in almost all the tolerant accessions, even in the absence of salinity stress. There was little genetic variation or positive transcriptional variation between the selections and Col-0 with respect to Na+-related transporter genes, as AtSOS genes, AtNHX1 and AtHKT1;1. In addition, under salinity stress, these selections accumulated higher compatible solutes and lower reactive oxygen species than did Col-0. Taken together, our results showed that natural variation in salinity tolerance of Arabidopsis seems to have been achieved by the strong capacity of K+ retention.	[Sun, Yanling; Kong, Xiangpei; Li, Cuiling; Ding, Zhaojun] Shandong Univ, Coll Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan 250100, Shandong, Peoples R China; [Liu, Yongxiu] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing 100093, Peoples R China	Shandong University; Chinese Academy of Sciences; Institute of Botany, CAS	Ding, ZJ (corresponding author), Shandong Univ, Coll Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, 27 Shanda South Rd, Jinan 250100, Shandong, Peoples R China.	dingzhaojun@sdu.edu.cn			National Natural Science Foundation of China [31270327, 31222005]; "1000-talents Plan" from China for young researchers [11200095551303]; Research Foundation for Excellent Young Scientist in Shandong Province [BS2013SW005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "1000-talents Plan" from China for young researchers; Research Foundation for Excellent Young Scientist in Shandong Province	This work was supported by the National Natural Science Foundation of China (No. 31270327 and No. 31222005), the "1000-talents Plan" from China for young researchers (11200095551303) and the Research Foundation for Excellent Young Scientist in Shandong Province (No. BS2013SW005). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aleman F, 2011, PLANT CELL PHYSIOL, V52, P1603, DOI 10.1093/pcp/pcr096; Ali Z, 2012, PLANT PHYSIOL, V158, P1463, DOI 10.1104/pp.111.193110; Alonso-Blanco C, 2005, PLANT PHYSIOL, V139, P1304, DOI 10.1104/pp.105.068510; Alonso-Blanco C, 1999, P NATL ACAD SCI USA, V96, P4710, DOI 10.1073/pnas.96.8.4710; Amtmann A, 2008, PHYSIOL PLANTARUM, V133, P682, DOI 10.1111/j.1399-3054.2008.01075.x; Anschutz U, 2014, J PLANT PHYSIOL, V171, P670, DOI 10.1016/j.jplph.2014.01.009; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; BAILEY RW, 1958, BIOCHEM J, V68, P669, DOI 10.1042/bj0680669; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Berthomieu P, 2003, EMBO J, V22, P2004, DOI 10.1093/emboj/cdg207; Borsani O, 2001, PLANT CELL, V13, P873, DOI 10.1105/tpc.13.4.873; BOWLER C, 1994, CRIT REV PLANT SCI, V13, P199, DOI 10.1080/713608062; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cakmak I, 2005, J PLANT NUTR SOIL SC, V168, P521, DOI 10.1002/jpln.200420485; Cellier F, 2004, PLANT J, V39, P834, DOI 10.1111/j.1365-313X.2004.02177.x; Chan ZL, 2013, PLANT PHYSIOL BIOCH, V73, P189, DOI 10.1016/j.plaphy.2013.09.013; Chen Z, 2005, PLANT CELL ENVIRON, V28, P1230, DOI 10.1111/j.1365-3040.2005.01364.x; Chen ZH, 2007, PLANT PHYSIOL, V145, P1714, DOI 10.1104/pp.107.110262; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Cuin TA, 2008, J EXP BOT, V59, P2697, DOI 10.1093/jxb/ern128; Cuin TA, 2007, PLANT CELL ENVIRON, V30, P875, DOI 10.1111/j.1365-3040.2007.01674.x; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Demidchik V, 2010, J CELL SCI, V123, P1468, DOI 10.1242/jcs.064352; Feki K, 2014, PLANT CELL REP, V33, P277, DOI 10.1007/s00299-013-1528-9; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Fu HH, 1998, PLANT CELL, V10, P63, DOI 10.1105/tpc.10.1.63; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Fukuda A, 2004, PLANT CELL PHYSIOL, V45, P146, DOI 10.1093/pcp/pch014; Funck D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-70; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Gierth M, 2005, PLANT PHYSIOL, V137, P1105, DOI 10.1104/pp.104.057216; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gollner K, 2008, NEW PHYTOL, V177, P725, DOI 10.1111/j.1469-8137.2007.02339.x; Grabov A, 2007, ANN BOT-LONDON, V99, P1035, DOI 10.1093/aob/mcm066; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; Guo Y, 2001, PLANT CELL, V13, P1383, DOI 10.1105/tpc.13.6.1383; Gupta B, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/701596; Hannah MA, 2006, PLANT PHYSIOL, V142, P98, DOI 10.1104/pp.106.081141; Harada H, 2006, J EXP BOT, V57, P953, DOI 10.1093/jxb/erj081; Hauser F, 2010, PLANT CELL ENVIRON, V33, P552, DOI 10.1111/j.1365-3040.2009.02056.x; Hu YC, 2005, FUNCT PLANT BIOL, V32, P973, DOI 10.1071/FP05080; Ishitani M, 2000, PLANT CELL, V12, P1667, DOI 10.1105/tpc.12.9.1667; Jha D, 2010, PLANT CELL ENVIRON, V33, P793, DOI 10.1111/j.1365-3040.2009.02105.x; Ji HT, 2013, MOL PLANT, V6, P275, DOI 10.1093/mp/sst017; Jiang YQ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-25; Katori T, 2010, J EXP BOT, V61, P1125, DOI 10.1093/jxb/erp376; Khedr AHA, 2003, J EXP BOT, V54, P2553, DOI 10.1093/jxb/erg277; Kim EJ, 1998, PLANT CELL, V10, P51, DOI 10.1105/tpc.10.1.51; KOWALSKI SP, 1994, MOL GEN GENET, V245, P548, DOI 10.1007/BF00282217; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Liu JP, 1998, SCIENCE, V280, P1943, DOI 10.1126/science.280.5371.1943; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; Maathuis FJM, 2006, J EXP BOT, V57, P1137, DOI 10.1093/jxb/erj001; MAATHUIS FJM, 1994, P NATL ACAD SCI USA, V91, P9272, DOI 10.1073/pnas.91.20.9272; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Miller G, 2009, J BIOL CHEM, V284, P26482, DOI 10.1074/jbc.M109.009340; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Munns R, 2012, NAT BIOTECHNOL, V30, P360, DOI 10.1038/nbt.2120; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Quesada V, 2002, PLANT PHYSIOL, V130, P951, DOI 10.1104/pp.006536; Quintero FJ, 2011, P NATL ACAD SCI USA, V108, P2611, DOI 10.1073/pnas.1018921108; Rahnama A, 2010, FUNCT PLANT BIOL, V37, P255, DOI 10.1071/FP09148; Rao MV, 1999, PLANT J, V17, P603, DOI 10.1046/j.1365-313X.1999.00400.x; Rus A, 2004, PLANT PHYSIOL, V136, P2500, DOI 10.1104/pp.104.042234; Rus A, 2001, P NATL ACAD SCI USA, V98, P14150, DOI 10.1073/pnas.241501798; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Shabala S, 2000, J EXP BOT, V51, P1243, DOI 10.1093/jexbot/51.348.1243; Shabala S, 2008, PHYSIOL PLANTARUM, V133, P651, DOI 10.1111/j.1399-3054.2007.01008.x; Shabala S, 2006, PLANT PHYSIOL, V141, P1653, DOI 10.1104/pp.106.082388; Shabala S, 2014, PHYSIOL PLANTARUM, V151, P257, DOI 10.1111/ppl.12165; Shen B, 1997, PLANT PHYSIOL, V115, P527, DOI 10.1104/pp.115.2.527; Shen B, 1999, PLANT PHYSIOL, V121, P45, DOI 10.1104/pp.121.1.45; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2003, NAT BIOTECHNOL, V21, P81, DOI 10.1038/nbt766; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Shindo C, 2007, ANN BOT-LONDON, V99, P1043, DOI 10.1093/aob/mcl281; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; STOREY R, 1995, AUST J PLANT PHYSIOL, V22, P101, DOI 10.1071/PP9950101; Sunarpi, 2005, PLANT J, V44, P928, DOI 10.1111/j.1365-313X.2005.02595.x; Swarup K, 1999, PLANT J, V20, P67, DOI 10.1046/j.1365-313X.1999.00577.x; Symonds VV, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002069; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; Tanaka Y, 1999, PLANT SCI, V148, P131, DOI 10.1016/S0168-9452(99)00133-8; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Uozumi N, 2000, PLANT PHYSIOL, V122, P1249, DOI 10.1104/pp.122.4.1249; Van Poecke RMP, 2007, PLANT CELL, V19, P4046, DOI 10.1105/tpc.107.053827; Very AA, 2003, ANNU REV PLANT BIOL, V54, P575, DOI 10.1146/annurev.arplant.54.031902.134831; Volkov V, 2006, PLANT J, V48, P342, DOI 10.1111/j.1365-313X.2006.02876.x; WANG Y, 2013, PLOS ONE, V2013; Wang Y, 2013, ANNU REV PLANT BIOL, V64, P451, DOI 10.1146/annurev-arplant-050312-120153; Wang Y, 2010, MOL PLANT, V3, P280, DOI 10.1093/mp/ssq006; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Yamaguchi T, 2003, P NATL ACAD SCI USA, V100, P12510, DOI 10.1073/pnas.2034966100; Yang Q, 2009, MOL PLANT, V2, P22, DOI 10.1093/mp/ssn058; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zhang HX, 2001, P NATL ACAD SCI USA, V98, P12832, DOI 10.1073/pnas.231476498; Zhang JL, 2013, PHOTOSYNTH RES, V115, P1, DOI 10.1007/s11120-013-9813-6; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 1998, PLANT CELL, V10, P1181, DOI 10.1105/tpc.10.7.1181; Zhu JK, 2001, CURR OPIN PLANT BIOL, V4, P401, DOI 10.1016/S1369-5266(00)00192-8; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	115	58	60	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0124032	10.1371/journal.pone.0124032	http://dx.doi.org/10.1371/journal.pone.0124032			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993093	gold, Green Published, Green Submitted			2022-12-26	WOS:000354918600006
J	Crava, CM; Jakubowska, AK; Escriche, B; Herrero, S; Bel, Y				Crava, Cristina M.; Jakubowska, Agata K.; Escriche, Baltasar; Herrero, Salvador; Bel, Yolanda			Dissimilar Regulation of Antimicrobial Proteins in the Midgut of Spodoptera exigua Larvae Challenged with Bacillus thuringiensis Toxins or Baculovirus	PLOS ONE			English	Article							VEGETATIVE INSECTICIDAL PROTEIN; DIAPAUSE-SPECIFIC PEPTIDE; GENE-EXPRESSION; ANTIBACTERIAL PROTEINS; BEET ARMYWORM; CHORISTONEURA-FUMIFERANA; IMMUNE-RESPONSE; CRY1AB PROTOXIN; INNATE IMMUNITY; X-TOX	Antimicrobial peptides (AMPs) and lysozymes are the main effectors of the insect immune system, and they are involved in both local and systemic responses. Among local responses, midgut immune reaction plays an important role in fighting pathogens that reach the insect body through the oral route, as do many microorganisms used in pest control. Under this point of view, understanding how insects defend themselves locally during the first phases of infections caused by food-borne pathogens is important to further improve microbial control strategies. In the present study, we analyzed the transcriptional response of AMPs and lysozymes in the midgut of Spodoptera exigua (Lepidoptera: Noctuidae), a polyphagous pest that is commonly controlled by products based on Bacillus thuringiensis (Bt) or baculovirus. First, we comprehensively characterized the transcripts encoding AMPs and lysozymes expressed in S. exigua larval midgut, identifying 35 transcripts that represent the S. exigua arsenal against microbial infection. Secondly, we analyzed their expression in the midgut after ingestion of sub-lethal doses of two different pore-forming B. thuringiensis toxins, Cry1Ca and Vip3Aa, and the S. exigua nucleopolyhedrovirus (SeMNPV). We observed that both Bt toxins triggered a similar, wide and in some cases high transcriptional activation of genes encoding AMPs and lysozymes, which was not reflected in the activation of the classical systemic immune-marker phenoloxidase in hemolymph. Baculovirus ingestion resulted in the opposed reaction: Almost all transcripts coding for AMPs and lysozymes were down-regulated or not induced 96 hours post infection. Our results shed light on midgut response to different virulence factors or pathogens used nowadays as microbial control agents and point out the importance of the midgut immune response contribution to the larval immunity.	[Crava, Cristina M.; Jakubowska, Agata K.; Escriche, Baltasar; Herrero, Salvador; Bel, Yolanda] Univ Valencia, Dept Genet, Valencia, Spain; [Crava, Cristina M.; Jakubowska, Agata K.; Escriche, Baltasar; Herrero, Salvador; Bel, Yolanda] Univ Valencia, Estruct Recerca Interdisciplinar Biotecnol & Biom, Valencia, Spain	University of Valencia; University of Valencia	Bel, Y (corresponding author), Univ Valencia, Dept Genet, Valencia, Spain.	yolanda.bel@uv.es	Crava, Maria Cristina/AAE-9153-2020; Escriche, Baltasar/N-5136-2014; Bel, Yolanda/I-2700-2015; Herrero, Salva/ABE-5123-2020; Herrero, Salvador/J-5767-2013	Crava, Maria Cristina/0000-0003-3774-4567; Escriche, Baltasar/0000-0003-4889-793X; Bel, Yolanda/0000-0002-6367-9220; Herrero, Salva/0000-0001-5690-2108; Herrero, Salvador/0000-0001-5690-2108	Spanish Ministerio de Ciencia e Inovacion [AGL2009-13340-C02-01, AGL2011-30352-C02-02, AGL2012-39946-C02-01]; Generalitat Valenciana [GVPrometeo2011-044, ISIC/2013/004]; European FEDER funds	Spanish Ministerio de Ciencia e Inovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); European FEDER funds(European Commission)	This research was funded by the Spanish Ministerio de Ciencia e Inovacion (projects AGL2009-13340-C02-01, AGL2011-30352-C02-02 and AGL2012-39946-C02-01), by the Generalitat Valenciana (GVPrometeo2011-044 and ISIC/2013/004) and by the European FEDER funds.	Bang K, 2012, MOL BIOL REP, V39, P5151, DOI 10.1007/s11033-011-1311-3; Barthel A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0897; Behrens S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-445; Bel Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081927; Chapelle M, 2009, MOL IMMUNOL, V47, P261, DOI 10.1016/j.molimm.2009.09.028; d'Alencon E, 2013, INSECT BIOCHEM MOLEC, V43, P54, DOI 10.1016/j.ibmb.2012.10.012; Davis MM, 2012, J INNATE IMMUN, V4, P273, DOI 10.1159/000332947; Dimarcq JL, 1998, BIOPOLYMERS, V47, P465, DOI 10.1002/(SICI)1097-0282(1998)47:6<465::AID-BIP5>3.0.CO;2-#; Duvic B, 2012, J INSECT PHYSIOL, V58, P881, DOI 10.1016/j.jinsphys.2012.04.001; Easton DM, 2009, TRENDS BIOTECHNOL, V27, P582, DOI 10.1016/j.tibtech.2009.07.004; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Eleftherianos I, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00046; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Ericsson JD, 2009, J INVERTEBR PATHOL, V100, P61, DOI 10.1016/j.jip.2008.10.007; Estruch JJ, 1996, P NATL ACAD SCI USA, V93, P5389, DOI 10.1073/pnas.93.11.5389; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Freitak D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-56; Furukawa S, 1999, BIOCHEM J, V340, P265, DOI 10.1042/0264-6021:3400265; Gandhe AS, 2007, INSECT BIOCHEM MOLEC, V37, P655, DOI 10.1016/j.ibmb.2007.03.013; Girard PA, 2008, DEV COMP IMMUNOL, V32, P575, DOI 10.1016/j.dci.2007.09.004; Grizanova EV, 2014, J INVERTEBR PATHOL, V119, P40, DOI 10.1016/j.jip.2014.04.003; Hashimoto K, 2008, COMP BIOCHEM PHYS B, V150, P229, DOI 10.1016/j.cbpb.2008.03.006; Hernandez-Martinez P, 2008, J INVERTEBR PATHOL, V97, P245, DOI 10.1016/j.jip.2007.11.001; Hernandez-Martinez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012795; Hernandez-Martinez P, 2010, ENVIRON MICROBIOL, V12, P2730, DOI 10.1111/j.1462-2920.2010.02241.x; Herrero S, 2004, BIOCHEM J, V384, P507, DOI 10.1042/BJ20041094; Herrero S, 2002, APPL ENVIRON MICROB, V68, P4090, DOI 10.1128/AEM.68.8.4090-4094.2002; HULTMARK D, 1983, EMBO J, V2, P571, DOI 10.1002/j.1460-2075.1983.tb01465.x; Hwang J, 2011, J INVERTEBR PATHOL, V108, P194, DOI 10.1016/j.jip.2011.09.003; Jakubowska AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003379; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Kaneko Y, 2008, BIOSCI BIOTECH BIOCH, V72, P2353, DOI 10.1271/bbb.80263; Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006; Kouno T, 2007, BIOCHEMISTRY-US, V46, P13733, DOI 10.1021/bi701319t; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Lee MK, 2003, APPL ENVIRON MICROB, V69, P4648, DOI 10.1128/AEM.69.8.4648-4657.2003; Lei YY, 2014, GENE, V533, P180, DOI 10.1016/j.gene.2013.09.091; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Mason CJ, 2014, ENVIRON ENTOMOL, V43, P595, DOI 10.1603/EN14031; Mason KL, 2011, MBIO, V2, DOI 10.1128/mBio.00065-11; Meunier L, 2006, INSECT MOL BIOL, V15, P475, DOI 10.1111/j.1365-2583.2006.00659.x; Moreno-Garcia M, 2014, INFECT GENET EVOL, V24, P25, DOI 10.1016/j.meegid.2014.02.010; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Nielsen-LeRoux C, 2012, CURR OPIN MICROBIOL, V15, P220, DOI 10.1016/j.mib.2012.04.006; Oizumi Y, 2005, BBA-PROTEINS PROTEOM, V1752, P83, DOI 10.1016/j.bbapap.2005.07.013; Oppert B, 2010, COMP BIOCHEM PHYS D, V5, P280, DOI 10.1016/j.cbd.2010.08.001; Pascual L, 2012, INSECT BIOCHEM MOLEC, V42, P557, DOI 10.1016/j.ibmb.2012.04.003; Passarelli AL, 2011, VIROLOGY, V411, P383, DOI 10.1016/j.virol.2011.01.009; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rayaprolu S, 2010, DEV COMP IMMUNOL, V34, P638, DOI 10.1016/j.dci.2010.01.008; Rodriguez-Cabrera L, 2008, TOXICON, V51, P681, DOI 10.1016/j.toxicon.2007.12.002; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Scocchi M, 2011, CELL MOL LIFE SCI, V68, P2317, DOI 10.1007/s00018-011-0721-7; Seufi AM, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-47; Singh G, 2010, APPL ENVIRON MICROB, V76, P7202, DOI 10.1128/AEM.01552-10; Sparks ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061190; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Tamez-Guerra P, 2008, J INVERTEBR PATHOL, V98, P218, DOI 10.1016/j.jip.2008.02.008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka H, 2005, J INSECT PHYSIOL, V51, P701, DOI 10.1016/j.jinsphys.2005.03.018; Tanaka H, 2003, PEPTIDES, V24, P1327, DOI 10.1016/j.peptides.2003.07.021; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Vachon V, 2012, J INVERTEBR PATHOL, V111, P1, DOI 10.1016/j.jip.2012.05.001; Valadez-Lira JA, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.8001; van Munster M, 2007, INSECT MOL BIOL, V16, P25, DOI 10.1111/j.1365-2583.2006.00692.x; van Oers MM, 2007, CURR DRUG TARGETS, V8, P1051, DOI 10.2174/138945007782151333; Vilcinskas A, 2013, J INSECT PHYSIOL, V59, P123, DOI 10.1016/j.jinsphys.2012.08.018; Volkoff AN, 2003, GENE, V319, P43, DOI 10.1016/S0378-1119(03)00789-3; Wan H, 2012, J ASIA-PAC ENTOMOL, V15, P369, DOI 10.1016/j.aspen.2012.02.009; Wang Q, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-9; Wen HX, 2009, MOL BIOL REP, V36, P711, DOI 10.1007/s11033-008-9233-4; Wu S, 2010, DEV COMP IMMUNOL, V34, P1191, DOI 10.1016/j.dci.2010.06.013; Yao JX, 2014, TOXINS, V6, P1274, DOI 10.3390/toxins6041274; Yi HY, 2014, APPL MICROBIOL BIOT, V98, P5807, DOI 10.1007/s00253-014-5792-6	76	32	32	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0125991	10.1371/journal.pone.0125991	http://dx.doi.org/10.1371/journal.pone.0125991			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993013	Green Published, Green Submitted, gold			2022-12-26	WOS:000354917300032
J	Ranucci, M; Carboni, G; Cotza, M; Bianchi, P; Di Dedda, U; Aloisio, T				Ranucci, Marco; Carboni, Giovanni; Cotza, Mauro; Bianchi, Paolo; Di Dedda, Umberto; Aloisio, Tommaso		Surgical Clinical Outcome Res SCOR	Hemodilution on Cardiopulmonary Bypass as a Determinant of Early Postoperative Hyperlactatemia	PLOS ONE			English	Article							BLOOD LACTATE LEVELS; ACUTE-RENAL-FAILURE; LACTIC-ACIDOSIS; OXYGEN DELIVERY; LOW HEMATOCRIT; RISK-FACTOR; ADULT; INJURY	Objective The nadir hematocrit (HCT) on cardiopulmonary bypass (CPB) is a recognized independent risk factor for major morbidity and mortality in cardiac surgery. The main interpretation is that low levels of HCT on CPB result in a poor oxygen delivery and dysoxia of end organs. Hyperlactatemia (HL) is a marker of dysoxic metabolism, and is associated with bad outcomes in cardiac surgery. This study explores the relationship between nadir HCT on CPB and early postoperative HL. Design Retrospective study on 3,851 consecutive patients. Measurements and Main Results Nadir HCT on CPB and other potential confounders were explored for association with blood lactate levels at the arrival in the Intensive Care Unit (ICU), and with the presence of moderate (2.1 - 6.0 mMol/L) or severe (>6.0 mMol/L) HL. Nadir HCT on CPB demonstrated a significant negative association with blood lactate levels at the arrival in the ICU. After adjustment for the other confounders, the nadir HCT on CPB remained independently associated with moderate (odds ratio 0.96, 95% confidence interval 0.94-0.99) and severe HL (odds ratio 0.91, 95% confidence interval 0.86-0.97). Moderate and severe HL were significantly associated with increased morbidity and mortality. Conclusions Hemodilution on CPB is an independent determinant of HL. This association, more evident for severe HL, strengthens the hypothesis that a poor oxygen delivery on CPB with consequent organ ischemia is the mechanism leading to hemodilution-associated bad outcomes.	[Ranucci, Marco; Carboni, Giovanni; Cotza, Mauro; Bianchi, Paolo; Di Dedda, Umberto; Aloisio, Tommaso] IRCCS Policlin San Donato, Dept Cardiothorac Vasc Anesthesia & Intens Care, Milan, Italy	IRCCS Policlinico San Donato	Ranucci, M (corresponding author), IRCCS Policlin San Donato, Dept Cardiothorac Vasc Anesthesia & Intens Care, Milan, Italy.	cardioanestesia@virgilio.it	Bianchi, Paolo/AFQ-5221-2022; Ranucci, Marco/K-1040-2016; Aloisio, Tommaso/AAB-3093-2021; Cotza, Mauro/AAB-2235-2021	Ranucci, Marco/0000-0002-4915-3572; Cotza, Mauro/0000-0002-8869-8911; Aloisio, Tommaso/0000-0002-6724-2122	IRCCS Policlinico San Donato - Research Line: Anesthesia, ICU, and extracorporeal technologies	IRCCS Policlinico San Donato - Research Line: Anesthesia, ICU, and extracorporeal technologies	This work was funded by internal research funds of the IRCCS Policlinico San Donato - Research Line: Anesthesia, ICU, and extracorporeal technologies.	Abraham BP, 2010, J THORAC CARDIOV SUR, V139, P170, DOI 10.1016/j.jtcvs.2009.04.060; Bennett MJ, 2013, INTERACT CARDIOV TH, V16, P760, DOI 10.1093/icvts/ivt057; Berend K, 2014, NEW ENGL J MED, V371, P1434, DOI 10.1056/NEJMra1003327; Boldt J, 1999, J CARDIOTHOR VASC AN, V13, P220, DOI 10.1016/S1053-0770(99)90093-9; de Somer F, 2011, CRIT CARE, V15, DOI 10.1186/cc10349; Demers P, 2000, ANN THORAC SURG, V70, P2082, DOI 10.1016/S0003-4975(00)02160-3; Fang WC, 1997, CIRCULATION, V96, P194; Habib RH, 2003, J THORAC CARDIOV SUR, V125, P1438, DOI 10.1016/S0022-5223(02)73291-1; Hajjar LA, 2013, J THORAC CARDIOV SUR, V146, P455, DOI 10.1016/j.jtcvs.2013.02.003; Karkouti K, 2005, ANN THORAC SURG, V80, P1381, DOI 10.1016/j.athoracsur.2005.03.137; Karkouti K, 2005, J THORAC CARDIOV SUR, V129, P391, DOI 10.1016/j.jtcvs.2004.06.028; Maillet JM, 2003, CHEST, V123, P1361, DOI 10.1378/chest.123.5.1361; Ranucci M, 2005, ANN THORAC SURG, V80, P2213, DOI 10.1016/j.athoracsur.2005.05.069; Ranucci Marco, 1994, Perfusion, V9, P319, DOI 10.1177/026765919400900503; Ranucci M, 2006, ANN THORAC SURG, V81, P2189, DOI 10.1016/j.athoracsur.2006.01.025; Ranucci M, 2010, CRIT CARE, V14, DOI 10.1186/cc9217; Ranucci M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013551; Raper RF, 1997, CRIT CARE MED, V25, P46, DOI 10.1097/00003246-199701000-00011; Swaminathan M, 2003, ANN THORAC SURG, V76, P784, DOI 10.1016/S0003-4975(03)00558-7; Takala J, 1996, New Horiz, V4, P483	20	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126939	10.1371/journal.pone.0126939	http://dx.doi.org/10.1371/journal.pone.0126939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992896	Green Submitted, Green Published, gold			2022-12-26	WOS:000354917300069
J	Russkamp, NF; Ruemmler, R; Roewe, J; Moore, BB; Ward, PA; Bosmann, M				Russkamp, Norman F.; Ruemmler, Robert; Roewe, Julian; Moore, Bethany B.; Ward, Peter A.; Bosmann, Markus			Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin	FASEB JOURNAL			English	Article						ARDS; polymorphonuclear neutrophils; C5aR1; maraviroc; cytokines	RESPIRATORY-DISTRESS-SYNDROME; ALVEOLAR MACROPHAGES; IN-VIVO; NEUTROPHIL RECRUITMENT; EPITHELIAL-CELLS; BINDING-PROTEIN; C5A RECEPTOR; P-SELECTIN; TNF-ALPHA; INFLAMMATION	Excessive activation of the complement system is detrimental in acute inflammatory disorders. In this study, we analyzed the role of complement-derived anaphylatoxins in the pathogenesis of experimental acute lung injury/acute respiratory distress syndrome (ALI/ARDS) in C57BL/6J mice. Intratracheal administration of recombinant mouse complement component (C5a) caused alveolar inflammation with abundant recruitment of Ly6-G(+)CD11b(+) leukocytes to the alveolar spaces and severe alveolar-capillary barrier dysfunction (C5a-ALI; EC50[C5a] = 20 ng/g body weight). Equimolar concentrations of C3a or desarginated C5a (C5a(desArg)) did not induce alveolar inflammation. The severity of C5a-ALI was aggravated in C5-deficient mice. Depletion of Ly6-G(+) cells and use of C5aR1(-/-) bone marrow chimeras suggested an essential role of C5aR1(+) hematopoietic cells in C5a-ALI. Blockade of PI3K/Akt and MEK1/2 kinase pathways completely abrogated lung injury. The mechanistic description is that C5a altered the alveolar cytokine milieu and caused significant release of CC-chemokines. Mice with genetic deficiency of CC-chemokine receptor (CCR) type 5, the common receptor of chemokine (C-Cmotif) ligand (CCL) 3, CCL4, and CCL5, displayed reduced lung damage. Moreover, treatment with a CCR5 antagonist, maraviroc, was protective against C5a-ALI. In summary, our results suggest that the detrimental effects of C5a in this model are partly mediated through CCR5 activation downstream of C5aR1, which may be evaluated for potential therapeutic exploitation in ALI/ARDS.	[Russkamp, Norman F.; Ruemmler, Robert; Roewe, Julian; Bosmann, Markus] Univ Med Ctr Mainz, CTH, D-55131 Mainz, Germany; [Moore, Bethany B.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Moore, Bethany B.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Ward, Peter A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	Johannes Gutenberg University of Mainz; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Bosmann, M (corresponding author), Univ Med Ctr Mainz, CTH, Bldg 708,Room 2-032,Langenbeckstr 1, D-55131 Mainz, Germany.	markus.bosmann@unimedizin-mainz.de		Moore, Bethany/0000-0003-3051-745X; Bosmann, Markus/0000-0003-2773-1033	Deutsche Forschungsgemeinschaft Grant [BO3482/3-1]; Federal Ministry of Education and Research Grant - Mainz Research Funding Program (MAIFOR) of University Medical Center Mainz [BMBF-01EO1003]; Marie Curie Career Integration Grant of European Union [334486]; Boehringer Ingelheim Fonds; U.S. National Institutes of Health, National Institute of General Medical Sciences [GM-29507, GM-61656]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI117229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061656, R01GM029507, R37GM029507] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); Federal Ministry of Education and Research Grant - Mainz Research Funding Program (MAIFOR) of University Medical Center Mainz; Marie Curie Career Integration Grant of European Union; Boehringer Ingelheim Fonds(Boehringer Ingelheim); U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Amanda Welton for technical assistance with HR-MRI acquisition and Lisa Kubacki for secretarial assistance. This work was supported by Deutsche Forschungsgemeinschaft Grant BO3482/3-1, Federal Ministry of Education and Research Grant BMBF-01EO1003, funding from the Mainz Research Funding Program (MAIFOR) of the University Medical Center Mainz, and a Marie Curie Career Integration Grant of the European Union (Project 334486) (all to M.B.); the Boehringer Ingelheim Fonds (to N.F.R. and R.R.); and U.S. National Institutes of Health, National Institute of General Medical Sciences Grants GM-29507 and GM-61656 (to P.A.W.). The authors are responsible for the contents of this publication and declare no conflicts of interest. Parts of the data of this paper were used by N.F.R. and R.R. for their M.D. theses (Doctor of Medicine degree).	Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Bless NM, 2000, J IMMUNOL, V164, P2650, DOI 10.4049/jimmunol.164.5.2650; Bosmann M, 2014, EXPERT OPIN THER TAR, V18, P703, DOI 10.1517/14728222.2014.902938; Bosmann M, 2013, FASEB J, V27, P5010, DOI 10.1096/fj.13-236380; Bosmann M, 2013, EUR J IMMUNOL, V43, P1907, DOI 10.1002/eji.201243075; Bosmann M, 2012, J IMMUNOL, V188, P5086, DOI 10.4049/jimmunol.1102914; Bosmann M, 2012, FASEB J, V26, P2137, DOI 10.1096/fj.11-201640; Bosmann M, 2012, FASEB J, V26, P1640, DOI 10.1096/fj.11-199216; Bosmann M, 2011, FASEB J, V25, P4222, DOI 10.1096/fj.11-191205; Bosmann M, 2012, ADV EXP MED BIOL, V946, P147, DOI 10.1007/978-1-4614-0106-3_9; Bosmann M, 2011, SHOCK, V36, P396, DOI 10.1097/SHK.0b013e3182295f5f; Czermak BJ, 1999, J IMMUNOL, V162, P2321; Doerschuk CM, 1996, J IMMUNOL, V157, P4609; Finsterbusch M, 2014, J EXP MED, V211, P1306, DOI 10.1084/jem.20132413; Flierl MA, 2008, SHOCK, V29, P25, DOI 10.1097/shk.0b013e3180556a0b; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; Grailer JJ, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00387; Grommes J, 2014, J INNATE IMMUN, V6, P111, DOI 10.1159/000353229; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Heller T, 1999, J IMMUNOL, V163, P985; HENSON PM, 1979, AM J PATHOL, V97, P93; Hubbard LLN, 2008, EXP LUNG RES, V34, P263, DOI 10.1080/01902140802022518; Huber-Lang M, 2002, AM J PATHOL, V161, P1849, DOI 10.1016/S0002-9440(10)64461-6; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Huttenrach F, 2005, J BIOL CHEM, V280, P37503, DOI 10.1074/jbc.M500535200; Kambas K, 2008, J IMMUNOL, V180, P7368, DOI 10.4049/jimmunol.180.11.7368; Karsten CM, 2015, J IMMUNOL, V194, P1841, DOI 10.4049/jimmunol.1401401; LARSEN GL, 1980, AM J PATHOL, V100, P179; Li R, 2013, FASEB J, V27, P855, DOI 10.1096/fj.12-220509; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Mueller-Ortiz SL, 2009, J IMMUNOL, V182, P6533, DOI 10.4049/jimmunol.0804207; Mulligan MS, 1997, J IMMUNOL, V158, P1857; Mulligan MS, 1996, J CLIN INVEST, V98, P503, DOI 10.1172/JCI118818; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; Price LC, 2012, AM J PHYSIOL-LUNG C, V302, pL803, DOI 10.1152/ajplung.00355.2011; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Riedemann NC, 2002, J IMMUNOL, V168, P1919, DOI 10.4049/jimmunol.168.4.1919; Rittirsch D, 2008, J IMMUNOL, V180, P7664, DOI 10.4049/jimmunol.180.11.7664; ROBBINS RA, 1987, AM REV RESPIR DIS, V135, P651; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Skattum L, 2011, MOL IMMUNOL, V48, P1643, DOI 10.1016/j.molimm.2011.05.001; STEVENS JH, 1986, J CLIN INVEST, V77, P1812, DOI 10.1172/JCI112506; STIMLER NP, 1980, AM J PATHOL, V100, P327; STRUNK RC, 1988, J CLIN INVEST, V81, P1419, DOI 10.1172/JCI113472; TARLING JD, 1987, J LEUKOCYTE BIOL, V42, P443, DOI 10.1002/jlb.42.5.443; TILL GO, 1982, J CLIN INVEST, V69, P1126, DOI 10.1172/JCI110548; Trujillo G, 2013, J IMMUNOL, V191, P848, DOI 10.4049/jimmunol.1202941; WEBSTER RO, 1982, J CLIN INVEST, V70, P1177, DOI 10.1172/JCI110716; WETSEL RA, 1995, IMMUNOL LETT, V44, P183, DOI 10.1016/0165-2478(94)00212-A	52	31	33	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3762	3772		10.1096/fj.15-271635	http://dx.doi.org/10.1096/fj.15-271635			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	25999468	Green Published, Green Submitted			2022-12-26	WOS:000359915600014
J	Risse, E; Nicoll, AJ; Taylor, WA; Wright, D; Badoni, M; Yang, XF; Farrow, MA; Collinge, J				Risse, Emmanuel; Nicoll, Andrew J.; Taylor, William A.; Wright, Daniel; Badoni, Mayank; Yang, Xiaofan; Farrow, Mark A.; Collinge, John			Identification of a Compound That Disrupts Binding of Amyloid-beta to the Prion Protein Using a Novel Fluorescence-based Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; A-BETA; IN-VIVO; NEURODEGENERATIVE DISEASES; MONOCLONAL-ANTIBODIES; SYNAPTIC PLASTICITY; MEMORY IMPAIRMENT; OLIGOMERS; SCRAPIE; PRP	The prion protein (PrP) has been implicated both in prion diseases such as Creutzfeldt-Jakob disease, where its monomeric cellular isoform (PrPC) is recruited into pathogenic self-propagating polymers of misfolded protein, and in Alzheimer disease, where PrPC may act as a receptor for synaptotoxic oligomeric forms of amyloid-beta (A beta). There has been considerable interest in identification of compounds that bind to PrPC, stabilizing its native fold and thereby acting as pharmacological chaperones to block prion propagation and pathogenesis. However, compounds binding PrPC could also inhibit the binding of toxic A beta species and may have a role in treating Alzheimer disease, a highly prevalent dementia for which there are currently no disease-modifying treatments. However, the absence of a unitary, readily measurable, physiological function of PrP makes screening for ligands challenging, and the highly heterogeneous nature of A beta oligomer preparations makes conventional competition binding assays difficult to interpret. We have therefore developed a high-throughput screen that utilizes site-specifically fluorescently labeled protein to identify compounds that bind to PrP and inhibit both A beta binding and prion propagation. Following a screen of 1,200 approved drugs, we identified Chicago Sky Blue 6B as the first small molecule PrP ligand capable of inhibiting A beta binding, demonstrating the feasibility of development of drugs to block this interaction. The interaction of Chicago Sky Blue 6B was characterized by isothermal titration calorimetry, and its ability to inhibit A beta binding and reduce prion levels was established in cell-based assays.	[Farrow, Mark A.] Univ Coll London UCL Inst Neurol, Med Res Council MRC Prion Unit, London WC1N 3BG, England; Univ Coll London UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Farrow, MA (corresponding author), Univ Coll London UCL Inst Neurol, Med Res Council MRC Prion Unit, London WC1N 3BG, England.	m.farrow@prion.ucl.ac.uk; j.collinge@prion.ucl.ac.uk			Medical Research Council; Department of Health (England); MRC [MC_EX_MR/L023180/1, MC_U123192748] Funding Source: UKRI; Medical Research Council [MC_U123192748, MC_EX_MR/L023180/1, 1272604] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health (England); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council and Department of Health (England). J. C. is a director and shareholder of D-Gen Limited, an academic spin-out company in the field of prion diagnosis, decontamination, and therapeutics.	Antonyuk SV, 2009, P NATL ACAD SCI USA, V106, P2554, DOI 10.1073/pnas.0809170106; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Berry DB, 2013, P NATL ACAD SCI USA, V110, pE4160, DOI 10.1073/pnas.1317164110; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Griffiths HH, 2011, J BIOL CHEM, V286, P33489, DOI 10.1074/jbc.M111.278556; Hosszu LLP, 1999, NAT STRUCT BIOL, V6, P740, DOI 10.1038/11507; Hu NW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4374; Jackson GS, 1999, BBA-PROTEIN STRUCT M, V1431, P1, DOI 10.1016/S0167-4838(99)00038-2; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Khalill-Shirazi A, 2007, BBA-PROTEINS PROTEOM, V1774, P1438, DOI 10.1016/j.bbapap.2007.08.028; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Klohn PC, 2012, SCIENCE, V335, P52, DOI 10.1126/science.1215579; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Klyubin I, 2014, J NEUROSCI, V34, P6140, DOI 10.1523/JNEUROSCI.3526-13.2014; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Lauren J, 2014, J ALZHEIMERS DIS, V38, P227, DOI 10.3233/JAD-130950; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Nicoll AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3416; Nicoll AJ, 2010, P NATL ACAD SCI USA, V107, P17610, DOI 10.1073/pnas.1009062107; Nicoll Andrew J., 2009, Infectious Disorders - Drug Targets, V9, P48; Normand A, 2014, BIOCHEM PHARMACOL, V91, P293, DOI 10.1016/j.bcp.2014.07.033; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; ROSETH S, 1995, J NEUROCHEM, V65, P96; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Sandberg MK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5347; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Wagner J, 2013, ACTA NEUROPATHOL, V125, P795, DOI 10.1007/s00401-013-1114-9; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	49	30	30	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					17020	17028		10.1074/jbc.M115.637124	http://dx.doi.org/10.1074/jbc.M115.637124			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25995455	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000357572800044
J	Bumrungthai, S; Ekalaksananan, T; Evans, MF; Chopjitt, P; Tangsiriwatthana, T; Patarapadungkit, N; Kleebkaow, P; Luanratanakorn, S; Kongyingyoes, B; Worawichawong, S; Pientong, C				Bumrungthai, Sureewan; Ekalaksananan, Tipaya; Evans, Mark Francis; Chopjitt, Peechanika; Tangsiriwatthana, Thumwadee; Patarapadungkit, Natcha; Kleebkaow, Pilaiwan; Luanratanakorn, Sanguanchoke; Kongyingyoes, Bunkerd; Worawichawong, Suchin; Pientong, Chamsai			Up-Regulation of miR-21 Is Associated with Cervicitis and Human Papillomavirus Infection in Cervical Tissues	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; TUMOR-GROWTH; MICRORNA EXPRESSION; COLORECTAL-CANCER; INTERLEUKIN-6; CARCINOMA; PDCD4; PROMOTE; CELLS; INVASION	MicroRNA-21 (miR-21) is recognized as an oncomir and shows up-regulation in many types of human malignancy. The aim of this study was to investigate the association of miR-21 expression associated with HPV infection in normal and abnormal cervical tissues. Cervical tissue samples with different cytological or histopathological grades were investigated for HPV by PCR and for miR-21 and programmed cell death, protein 4 (PDCD4) expression using quantitative real-time PCR (qRT-PCR). Laser capture microdissection (LCM) of stromal and epithelial tissues and in situ hybridization (ISH) using locked nucleic acid (LNA) probes were performed on a subset of fixed specimens. Cell line experiments were conducted on fibroblasts stimulated in culture media from HeLa cells, which were then assessed for miR-21, PDCD4, IL-6 and alpha-SMA expression by qRT-PCR. Twenty normal cervical cell, 12 cervicitis, 14 cervical intraepithelial neoplastic I (CIN I), 22 CIN II-III and 43 cervical squamous cell carcinoma (SCC) specimens were investigated. miR-21 levels were significantly lower in normal than in abnormal tissues. The expression of miR-21 in HPV negative normal cytology was significantly lower than in HPV positive samples in abnormal tissue and SCC. The miR-21 expression was significantly higher in HPV negative cervicitis than HPV negative normal cells. LCM and ISH data showed that miR-21 is primarily expressed in the tumor-associated stromal cell microenvironment. Fibroblasts treated with HeLa cell culture media showed up-regulated expression of miR-21, which correlated with increased expression of alpha-SMA and IL-6 and with down-regulation of PDCD4. These results demonstrate that miR-21 is associated with HPV infection and involved in cervical lesions as well as cervicitis and its up-regulation in tumor-stroma might be involved in the inflammation process and cervical cancer progression.	[Bumrungthai, Sureewan; Ekalaksananan, Tipaya; Chopjitt, Peechanika; Pientong, Chamsai] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand; [Evans, Mark Francis] Univ Vermont, Coll Med, Dept Pathol & Lab Med, Burlington, VT USA; [Tangsiriwatthana, Thumwadee] Khon Kaen Hosp, Dept Obstet & Gynecol, Khon Kaen, Thailand; [Patarapadungkit, Natcha] Khon Kaen Univ, Fac Med, Dept Pathol, Khon Kaen, Thailand; [Kleebkaow, Pilaiwan; Luanratanakorn, Sanguanchoke] Khon Kaen Univ, Fac Med, Dept Obstet & Gynecol, Khon Kaen, Thailand; [Kongyingyoes, Bunkerd] Khon Kaen Univ, Fac Med, Dept Pharmacol, Khon Kaen, Thailand; [Worawichawong, Suchin] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pathol, Bangkok 10400, Thailand; [Bumrungthai, Sureewan; Ekalaksananan, Tipaya; Chopjitt, Peechanika; Tangsiriwatthana, Thumwadee; Patarapadungkit, Natcha; Kleebkaow, Pilaiwan; Pientong, Chamsai] Khon Kaen Univ, HPV & EBV & Carcinogenesis Res Grp, Khon Kaen, Thailand	Khon Kaen University; University of Vermont; Khon Kaen University; Khon Kaen University; Khon Kaen University; Mahidol University; Khon Kaen University	Pientong, C (corresponding author), Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand.	chapie@kku.ac.th	Evans, Mark/GYU-3450-2022; Chopjitt, Peechanika/ABD-4917-2020	Chopjitt, Peechanika/0000-0001-5010-4682	Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program [PHD/0212/2550]; Faculty of Medicine, Khon Kaen University [I54225, I57210]; Khon Kaen University, Thailand [551601, 564101, 573001]; Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA	Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); Faculty of Medicine, Khon Kaen University; Khon Kaen University, Thailand; Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA	Financial support was from the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (Grant No. PHD/0212/2550) to student S. B. and advisor C.P. The research was supported by Faculty of Medicine, Khon Kaen University (Grant No. I54225 and I57210); Khon Kaen University, Thailand (Grant No. 551601, 564101 and 573001) and Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab SI, 2012, INT IMMUNOPHARMACOL, V12, P594, DOI 10.1016/j.intimp.2012.01.014; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bauknecht T, 1999, VIROLOGY, V258, P344, DOI 10.1006/viro.1999.9722; Bon MAM, 2000, CLIN CHEM, V46, P1000; Castrilli G, 1997, BRIT J CANCER, V75, P855, DOI 10.1038/bjc.1997.152; Chan JK, 2014, GYNECOL ONCOL, V132, P739, DOI 10.1016/j.ygyno.2014.01.034; Deftereos G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028423; Folini M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-12; Hopman AHN, 1998, J HISTOCHEM CYTOCHEM, V46, P771, DOI 10.1177/002215549804600611; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Hwang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010630; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; IGLESIAS M, 1995, AM J PATHOL, V146, P944; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Jimenez-Wences H, 2014, ONCOL REP, V31, P2467, DOI 10.3892/or.2014.3142; Kenngott RAM, 2011, J HISTOCHEM CYTOCHEM, V59, P312, DOI 10.1369/0022155410397995; Kinoshita H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060914; Kyo S, 2000, GYNECOL ONCOL, V78, P383, DOI 10.1006/gyno.2000.5904; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Lehoux M, 2009, PUBLIC HEALTH GENOM, V12, P268, DOI 10.1159/000214918; Liu XQ, 2011, CARCINOGENESIS, V32, P1798, DOI 10.1093/carcin/bgr213; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Rao QX, 2012, MED ONCOL, V29, P1242, DOI 10.1007/s12032-011-9830-2; Reis PP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-238; Ren CX, 2013, EUR J CANCER, V49, P3889, DOI 10.1016/j.ejca.2013.07.140; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057652; Tang T, 2013, GYNECOL ONCOL, V129, P199, DOI 10.1016/j.ygyno.2012.12.043; TARTOUR E, 1994, CANCER RES, V54, P6243; Tjiong MY, 1999, GYNECOL ONCOL, V73, P285, DOI 10.1006/gyno.1999.5358; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996; Wang X, 2009, RNA, V15, P637, DOI 10.1261/rna.1442309; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Wei LH, 2003, ONCOGENE, V22, P1517, DOI 10.1038/sj.onc.1206226; Wei LH, 2001, GYNECOL ONCOL, V82, P49, DOI 10.1006/gyno.2001.6235; Yang HS, 2001, ONCOGENE, V20, P669, DOI 10.1038/sj.onc.1204137; Yao Q, 2011, INT J CANCER, V128, P1783, DOI 10.1002/ijc.25506; Yao Q, 2009, BIOCHEM BIOPH RES CO, V388, P539, DOI 10.1016/j.bbrc.2009.08.044; Yeung CLA, 2011, ONCOGENE, V30, P2401, DOI 10.1038/onc.2010.613; Yue C, 2011, GYNECOL ONCOL, V122, P33, DOI 10.1016/j.ygyno.2011.03.032	44	43	44	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127109	10.1371/journal.pone.0127109	http://dx.doi.org/10.1371/journal.pone.0127109			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010154	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900064
J	Saksono, B; Dewi, BE; Nainggolan, L; Suda, Y				Saksono, Budi; Dewi, Beti Ernawati; Nainggolan, Leonardo; Suda, Yasuo			A Highly Sensitive Diagnostic System for Detecting Dengue Viruses Using the Interaction between a Sulfated Sugar Chain and a Virion	PLOS ONE			English	Article							ENVELOPE PROTEIN; ANTIVIRAL ACTIVITY; SEROTYPE; INFANTS; CHIPS	We propose a novel method of detecting trace amounts of dengue virus (DENVs) from serum. Our method is based on the interaction between a sulfated sugar chain and a DENV surface glycoprotein. After capturing DENV with the sulfated sugar chain-immobilized gold nanoparticles (SGNPs), the resulting complex is precipitated and viral RNA content is measured using the reverse-transcription quantitative polymerase chain reaction SYBR Green I (RT-qPCR-Syb) method. Sugar chains that bind to DENVs were identified using the array-type sugar chain immobilized chip (Sugar Chip) and surface plasmon resonance (SPR) imaging. Heparin and low-molecular-weight dextran sulfate were identified as binding partners, and immobilized on gold nanoparticles to prepare 3 types of SGNPs. The capacity of these SGNPs to capture and concentrate trace amounts of DENVs was evaluated in vitro. The SGNP with greatest sensitivity was tested using clinical samples in Indonesia in 2013-2014. As a result, the novel method was able to detect low concentrations of DENVs using only 6 mu L of serum, with similar sensitivity to that of a Qiagen RNA extraction kit using 140 mu L of serum. In addition, this method allows for multiplex-like identification of serotypes of DENVs. This feature is important for good healthcare management of DENV infection in order to safely diagnose the dangerous, highly contagious disease quickly, with high sensitivity.	[Saksono, Budi; Suda, Yasuo] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan; [Saksono, Budi] Biotechnol Res Ctr, Indonesian Inst Sci, Cibinong 16911, Indonesia; [Dewi, Beti Ernawati] Univ Indonesia, Fac Med, Dept Microbiol, Jakarta 10320, Indonesia; [Nainggolan, Leonardo] RSUPN Cipto Mangukusumo, Fac Med, Dept Internal Med, Jakarta, Indonesia	Kagoshima University; Indonesian Institute of Sciences; University of Indonesia	Saksono, B (corresponding author), Kagoshima Univ, Grad Sch Sci & Engn, 1-21-40 Kohrimoto, Kagoshima 8900065, Japan.	saksonobudi@yahoo.com; ysuda@eng.kagoshima-u.ac.jp		Saksono, Budi/0000-0001-8934-0914	Japan Science and Technology Agency [V07-05, AS2416907P]; Japan Ministry of Health, Labour and Welfare [H21-Nano-Ippan-002]; Japan Society for the Promotion of Science [SG2504]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Japan Science and Technology Agency (V07-05 and AS2416907P to YS), the Japan Ministry of Health, Labour and Welfare (H21-Nano-Ippan-002 to YS), and the Japan Society for the Promotion of Science (SG2504 to YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006; Chutinimitkul S, 2005, J VIROL METHODS, V129, P8, DOI 10.1016/j.jviromet.2005.05.006; Hernandez SID, 2013, J CLIN VIROL, V58, P258, DOI 10.1016/j.jcv.2013.06.016; Goncalvez AP, 2004, J VIROL, V78, P12919, DOI 10.1128/JVI.78.23.12919-12928.2004; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Hidari KIPJ, 2008, BIOCHEM BIOPH RES CO, V376, P91, DOI 10.1016/j.bbrc.2008.08.100; Hilgard P, 2000, HEPATOLOGY, V32, P1069, DOI 10.1053/jhep.2000.18713; Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762; Hung SL, 1999, VIROLOGY, V257, P156, DOI 10.1006/viro.1999.9633; Jain A, 2010, FEMS IMMUNOL MED MIC, V59, P119, DOI 10.1111/j.1574-695X.2010.00670.x; Kato D, 2010, ANTIVIR RES, V88, P236, DOI 10.1016/j.antiviral.2010.09.002; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lee E, 2006, ANTIVIR RES, V69, P31, DOI 10.1016/j.antiviral.2005.08.006; Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010; Limjindaporn T, 2009, BIOCHEM BIOPH RES CO, V379, P196, DOI 10.1016/j.bbrc.2008.12.070; Lin HE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001447; Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Nakamura-Tsuruta S, 2008, J BIOCHEM, V143, P833, DOI 10.1093/jb/mvn038; Pal T, 2014, J CLIN VIROL, V61, P365, DOI 10.1016/j.jcv.2014.09.003; Patramool S, 2013, J VIROL METHODS, V193, P55, DOI 10.1016/j.jviromet.2013.04.016; Prado I, 2005, J VIROL METHODS, V125, P75, DOI 10.1016/j.jviromet.2005.01.001; Qiu H, 2007, CARBOHYD RES, V342, P2230, DOI 10.1016/j.carres.2007.06.021; Soda Y, 2006, POLYM PREPRINTS, V47, P156; Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06; Suda Y, 2006, BIOCONJUGATE CHEM, V17, P1125, DOI 10.1021/bc0600620; Talarico LB, 2005, ANTIVIR RES, V66, P103, DOI 10.1016/j.antiviral.2005.02.001; Thais MC, 2010, J VIROL METHODS, V163, P1, DOI [10.1016/j.jviromet.2009.10.001, DOI 10.1016/J.JVIROMET.2009.10.001]; Tricou V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001309; VinodKumar CS, 2013, J INFECT PUBLIC HEAL, V6, P302, DOI 10.1016/j.jiph.2013.01.004; Wakao M, 2008, BIOORG MED CHEM LETT, V18, P2499, DOI 10.1016/j.bmcl.2008.01.069; World Health Organization, 2009, DENGUE GUIDELINES DI; Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597	38	4	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0123981	10.1371/journal.pone.0123981	http://dx.doi.org/10.1371/journal.pone.0123981			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010246	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900005
J	Todorovic, M; Newman, JRB; Shan, JG; Bentley, S; Wood, SA; Silburn, PA; Mellick, GD				Todorovic, Michael; Newman, Jeremy R. B.; Shan, Jianguo; Bentley, Steven; Wood, Stephen A.; Silburn, Peter A.; Mellick, George D.			Comprehensive Assessment of Genetic Sequence Variants in the Antioxidant 'Master Regulator' Nrf2 in Idiopathic Parkinson's Disease	PLOS ONE			English	Article							OXIDATIVE STRESS; ASSOCIATION; RISK; NEUROTOXICITY; POLYMORPHISMS; TRANSCRIPTION; ACTIVATION; EXPRESSION; ALZHEIMERS; INCREASE	Parkinson's disease (PD) is a complex neurodegenerative disorder influenced by a combination of genetic and environmental factors. The molecular mechanisms that underlie PD are unknown; however, oxidative stress and impairment of antioxidant defence mechanisms have been implicated as major contributors to disease pathogenesis. Previously, we have reported a PD patient-derived cellular model generated from biopsies of the olfactory mucosa, termed hONS cells, in which the NRF2-mediated antioxidant response pathway genes were among the most differentially-expressed. To date, few studies have examined the role of the NRF2 encoding gene, NFE2L2, and PD. In this study, we comprehensibly assessed whether rare and common NFE2L2 genetic variations modify susceptibility to PD using a large Australian case-control sample (PD = 1338, controls = 1379). We employed a haplotype-tagging approach that identified an association with the tagging SNP rs2364725 and PD (OR = 0.849 (0.760-0.948), P = 0.004). Further genetic screening in hONS cell lines produced no obvious pathogenic variants in the coding regions of NFE2L2. Finally, we investigated the relationship between xenobiotic exposures and NRF2 function, through gene-environment interactions, between NFE2L2 SNPs and smoking or pesticide exposure. Our results demonstrated a significant interaction between rs2706110 and pesticide exposure (OR = 0.597 (0.393-0.900), P = 0.014). In addition, we were able to identify some age-at-onset modifying SNPs and replicate an 'early-onset' haplotype that contains a previously identified 'functional promoter' SNP (rs6721961). Our results suggest a role of NFE2L2 genetic variants in modifying PD susceptibility and onset. Our findings also support the utility of testing gene-environment interactions in genetic studies of PD.	[Todorovic, Michael; Newman, Jeremy R. B.; Shan, Jianguo; Bentley, Steven; Wood, Stephen A.; Mellick, George D.] Griffith Univ, Eskitis Inst Drug Discovery, Nathan, Qld 4111, Australia; [Silburn, Peter A.; Mellick, George D.] Univ Queensland, UQCCR, Asia Pacific Ctr Neuromodulat, Herston, Qld, Australia	Griffith University; University of Queensland	Mellick, GD (corresponding author), Griffith Univ, Eskitis Inst Drug Discovery, Nathan, Qld 4111, Australia.	G.Mellick@griffith.edu.au	Mellick, George D./A-7650-2010; Wood, Stephen A/E-8357-2011; Newman, Jeremy/L-9938-2013	Mellick, George D./0000-0002-7211-4651; Wood, Stephen A/0000-0002-2576-7457; Todorovic, Michael/0000-0003-0806-5610; Bentley, Steven/0000-0002-1888-8488; Newman, Jeremy/0000-0001-8486-2801	National Health and Medical Council of Australia [APP1010225]; Parkinson's Queensland PhD Project Grant; Geriatric Medical Foundation of Queensland	National Health and Medical Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Parkinson's Queensland PhD Project Grant; Geriatric Medical Foundation of Queensland	Support for this study came from the National Health and Medical Council of Australia (Project Grant APP1010225), Parkinson's Queensland PhD Project Grant (No Grant Number), and Geriatric Medical Foundation of Queensland (no Grant Number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam ZI, 1997, J NEUROCHEM, V69, P1326; Alfieri A, 2011, J PHYSIOL-LONDON, V589, P4125, DOI 10.1113/jphysiol.2011.210294; Chen YC, 2013, PARKINSONISM RELAT D, V19, P247, DOI 10.1016/j.parkreldis.2012.10.018; Chien WL, 2011, J NEUROCHEM, V117, P643, DOI 10.1111/j.1471-4159.2011.07229.x; Cook AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021907; Czlonkowska A, 1996, NEURODEGENERATION, V5, P137, DOI 10.1006/neur.1996.0020; Gartner CE, 2005, PARKINSONISM RELAT D, V11, P287, DOI 10.1016/j.parkreldis.2005.04.002; Hampel R, 2010, ENVIRON HEALTH PERSP, V118, P1755, DOI 10.1289/ehp.1001995; Innamorato NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011838; Kaidery NA, 2013, ANTIOXID REDOX SIGN, V18, P139, DOI 10.1089/ars.2011.4491; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lou HY, 2014, NEUROPHARMACOLOGY, V79, P380, DOI 10.1016/j.neuropharm.2013.11.026; Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com; Matigian N, 2010, DIS MODEL MECH, V3, P785, DOI 10.1242/dmm.005447; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Mellick GD, 2006, J NEURAL TRANSM-SUPP, P159; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Payami H, 2010, GENET EPIDEMIOL, V34, P92, DOI 10.1002/gepi.20439; Settivari R, 2013, NEUROTOXICOLOGY, V38, P51, DOI 10.1016/j.neuro.2013.05.014; Song Juhyun, 2014, Exp Neurobiol, V23, P93, DOI 10.5607/en.2014.23.1.93; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; Sutherland GT, 2009, MOVEMENT DISORD, V24, P833, DOI 10.1002/mds.22214; Sykiotis GP, 2011, CURR OPIN CLIN NUTR, V14, P41, DOI 10.1097/MCO.0b013e32834136f2; von Otter M, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-36; Xiao HB, 2011, TOXICOLOGY, V290, P286, DOI 10.1016/j.tox.2011.10.007	25	20	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128030	10.1371/journal.pone.0128030	http://dx.doi.org/10.1371/journal.pone.0128030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010367	Green Published, Green Submitted, gold			2022-12-26	WOS:000355183900186
J	Beutin, L; Delannoy, S; Fach, P				Beutin, Lothar; Delannoy, Sabine; Fach, Patrick			Sequence Variations in the Flagellar Antigen Genes fliC(H25) and fliC(H28) of Escherichia coli and Their Use in Identification and Characterization of Enterohemorrhagic E. coli (EHEC) O145:H25 and O145:H28	PLOS ONE			English	Article							H-ANTIGEN; MOLECULAR CHARACTERIZATION; SEROTYPES O26H11; O157 STRAINS; FLIC ALLELES; O111; DIVERSITY; O103H2; RESTRICTION; REVEALS	Enterohemorrhagic E. coli (EHEC) serogroup O145 is regarded as one of the major EHEC serogroups involved in severe infections in humans. EHEC O145 encompasses motile and non-motile strains of serotypes O145:H25 and O145:H28. Sequencing the fliC-genes associated with the flagellar antigens H25 and H28 revealed the genetic diversity of the fliC(H25) and fliC(H28) gene sequences in E. coli. Based on allele discrimination of these fliC-genes real-time PCR tests were designed for identification of EHEC O145:H25 and O145:H28. The fliC(H25) genes present in O145:H25 were found to be very similar to those present in E. coli serogroups O2, O100, O165, O172 and O177 pointing to their common evolution but were different from fliC(H25) genes of a multiple number of other E. coli serotypes. In a similar way, EHEC O145:H28 harbor a characteristic fliC(H28) allele which, apart from EHEC O145: H28, was only found in enteropathogenic (EPEC) O28:H28 strains that shared some common traits with EHEC O145:H28. The real time PCR-assays targeting these fliC(H25[O145]) and fliC(H28[O145]) alleles allow better characterization of EHEC O145:H25 and EHEC O145: H28. Evaluation of these PCR assays in spiked ready-to eat salad samples resulted in specific detection of both types of EHEC O145 strains even when low spiking levels of 1-10 cfu/g were used. Furthermore these PCR assays allowed identification of non-motile E. coli strains which are serologically not typable for their H-antigens. The combined use of O-antigen genotyping (O145wzy) and detection of the respective fliC(H25[O145]) and fliC(H28[O145]) allele types contributes to improve identification and molecular serotyping of E. coli O145 isolates.	[Beutin, Lothar] BfR Fed Inst Risk Assessment, Natl Reference Lab Escherichia Coli, D-12277 Berlin, Germany; [Delannoy, Sabine; Fach, Patrick] Univ Paris Est, Anses French Agcy Food Environm & Occupat Hlth &, Food Safety Lab, IdentyPath Platform, FR-94700 Maisons Alfort, France	Federal Institute for Risk Assessment; Ecole Nationale Veterinaire d'Alfort (ENVA)	Fach, P (corresponding author), Univ Paris Est, Anses French Agcy Food Environm & Occupat Hlth &, Food Safety Lab, IdentyPath Platform, 14 Rue Pierre & Marie Curie, FR-94700 Maisons Alfort, France.	patrick.fach@anses.fr	Delannoy, Sabine/J-1045-2019	Delannoy, Sabine/0000-0002-9208-5659	French Joint Ministerial Program of R&D against CBRNE Risks [C17609-2]	French Joint Ministerial Program of R&D against CBRNE Risks	The study was supported with funding from the French Joint Ministerial Program of R&D against CBRNE Risks (grant C17609-2).	Anklam KS, 2012, J FOOD PROTECT, V75, P643, DOI 10.4315/0362-028X.JFP-11-392; BETTELHEIM KA, 1978, J HYG-CAMBRIDGE, V80, P83, DOI 10.1017/S0022172400053420; Beutin L, 2004, J CLIN MICROBIOL, V42, P1099, DOI 10.1128/JCM.42.3.1099-1108.2004; Beutin L, 2009, J APPL MICROBIOL, V106, P1122, DOI 10.1111/j.1365-2672.2008.04076.x; Beutin L, 2007, J CLIN MICROBIOL, V45, P333, DOI 10.1128/JCM.01627-06; Beutin L, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0001-2013; Bibbal D, 2014, APPL ENVIRON MICROB, V80, P1177, DOI 10.1128/AEM.03161-13; Bugarel M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-142; Bugarel M, 2010, INT J FOOD MICROBIOL, V142, P318, DOI 10.1016/j.ijfoodmicro.2010.07.010; Bugarel M, 2010, APPL ENVIRON MICROB, V76, P203, DOI 10.1128/AEM.01921-09; Cooper KK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-17; Cooper KK, 2014, GENOME ANNOUNC, V2; Delannoy S, 2013, J CLIN MICROBIOL, V51, P1083, DOI 10.1128/JCM.02864-12; Delannoy S, 2012, J CLIN MICROBIOL, V50, P4035, DOI 10.1128/JCM.02097-12; European Food Safety Authority, 2007, EFSA J, V579, P1; Fields PI, 1997, J CLIN MICROBIOL, V35, P1066, DOI 10.1128/JCM.35.5.1066-1070.1997; Fratamico PM, 2014, J FOOD PROTECT, V77, P180, DOI 10.4315/0362-028X.JFP-13-248; Fratamico PM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00152; Fratamico PM, 2011, FOODBORNE PATHOG DIS, V8, P601, DOI 10.1089/fpd.2010.0773; Hofer E, 2012, FOODBORNE PATHOG DIS, V9, P792, DOI 10.1089/fpd.2012.1156; Iguchi A, 2012, J CLIN MICROBIOL, V50, P2894, DOI 10.1128/JCM.00789-12; ISO (International Organization for Standardization), 2012, 131362012 ISO; Kappeli U, 2011, EPIDEMIOL INFECT, V139, P1097, DOI 10.1017/S0950268810002190; Kappeli U, 2011, EMERG INFECT DIS, V17, P180, DOI 10.3201/eid1702.100909; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011; Kozub-Witkowski E, 2008, J APPL MICROBIOL, V104, P403, DOI 10.1111/j.1365-2672.2007.03545.x; Krause G, 2005, VET MICROBIOL, V106, P87, DOI 10.1016/j.vetmic.2004.11.012; Lin A, 2011, FOOD MICROBIOL, V28, P478, DOI 10.1016/j.fm.2010.10.007; Lindsey RL, 2014, GENOME ANNOUNC, V2; Machado J, 2000, RES MICROBIOL, V151, P535, DOI 10.1016/S0923-2508(00)00223-0; Madic J, 2010, J APPL MICROBIOL, V109, P1696, DOI 10.1111/j.1365-2672.2010.04798.x; Madic J, 2011, APPL ENVIRON MICROB, V77, P2035, DOI 10.1128/AEM.02089-10; Morabito S, 1999, J MED MICROBIOL, V48, P891, DOI 10.1099/00222615-48-10-891; ORSKOV F, 1984, METHOD MICROBIOL, V14, P43, DOI 10.1016/S0580-9517(08)70447-1; Oshima K, 2008, DNA RES, V15, P375, DOI 10.1093/dnares/dsn026; Perelle S, 2003, J APPL MICROBIOL, V94, P587, DOI 10.1046/j.1365-2672.2003.01872.x; Reid SD, 1999, J BACTERIOL, V181, P153, DOI 10.1128/JB.181.1.153-160.1999; Sambrook J., 2001, MOL CLONING LAB MANU; Scheutz F, 2004, APMIS, V112, P569, DOI 10.1111/j.1600-0463.2004.apm1120903.x; Scheutz F, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0019-2013; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Sekse C, 2013, APPL ENVIRON MICROB, V79, P7502, DOI 10.1128/AEM.01825-13; Sonntag AK, 2004, J CLIN MICROBIOL, V42, P954, DOI 10.1128/JCM.42.3.954-962.2004; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; Tzschoppe M, 2012, INT J FOOD MICROBIOL, V152, P19, DOI 10.1016/j.ijfoodmicro.2011.10.009; US Department of Agriculture, 2011, MLG5B01 USDAFSIS; Wang L, 2000, J CLIN MICROBIOL, V38, P1786, DOI 10.1128/JCM.38.5.1786-1790.2000; Wang L, 2003, J BACTERIOL, V185, P2936, DOI 10.1128/JB.185.9.2936-2943.2003; Zhang WL, 2000, J CLIN MICROBIOL, V38, P2989, DOI 10.1128/JCM.38.8.2989-2993.2000	50	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126749	10.1371/journal.pone.0126749	http://dx.doi.org/10.1371/journal.pone.0126749			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000885	gold, Green Submitted, Green Published			2022-12-26	WOS:000354931700024
J	Charkiewicz, K; Blachnio-Zabielska, A; Zbucka-Kretowska, M; Wolczynski, S; Laudanski, P				Charkiewicz, Karol; Blachnio-Zabielska, Agnieszka; Zbucka-Kretowska, Monika; Wolczynski, Slawomir; Laudanski, Piotr			Maternal Plasma and Amniotic Fluid Sphingolipids Profiling in Fetal Down Syndrome	PLOS ONE			English	Article							DISEASE	Introduction Sphingolipids can be potentially involved in the formation of the central and peripheral nervous systems, which are particularly connected with the pathogenesis of Down syndrome. The aim of the study was to determine the concentration of selected sphingolipids in the plasma and amniotic fluid of pregnant patients with fetal Down syndrome. Material and Methods Out of 190 amniocentesis we had 10 patients with confirmed Down syndrome. For the purpose of our control we chose 14 women without confirmed chromosomal aberration. To assess the concentration of 11 sphingolipids in the blood plasma and amniotic fluid we used an ultra-high performance liquid chromatography coupled with triple quadrupole mass spectrometry (UHPLC/MS/MS). Results We showed a significant increase in the concentration of 2 ceramides, C22-Cer and C24:1-Cer, in the plasma of women with fetal Down syndrome. Furthermore we showed a decrease in the concentration of 7 ceramides-C16-Cer, C18-Cer, C18:1-Cer, C20-Cer, C22-Cer, C24: 1-Cer, and C24-Cer-in the amniotic fluid of women with fetal Down syndrome. We created ROC curves for all significant sphingolipids in maternal plasma, which set the threshold values and allowed for predicting the likelihood of Down syndrome in the fetus with specific sensitivity and specificity. We demonstrated a significantly higher risk of Down syndrome when the plasma concentration of C22-Cer > 12.66 ng/100ul (sens. 0.9, sp. 0.79, P value = 0.0007) and C24: 1-Cer > 33,19 ng/100ul (sens. 0.6, sp. 0.86, P value = 0.0194). Conclusion On the basis of our findings, it seems that the sphingolipids may play a role in the pathogenesis of Down syndrome. Defining their potential as biochemical markers of Down syndrome requires further investigation on a larger group of patients.	[Charkiewicz, Karol; Laudanski, Piotr] Med Univ Bialystok, Dept Perinatol & Obstet, Marii Sklodowskiej Curie 24a, PL-15276 Bialystok, Poland; [Blachnio-Zabielska, Agnieszka] Med Univ Bialystok, Dept Physiol, PL-15222 Bialystok, Poland; [Zbucka-Kretowska, Monika; Wolczynski, Slawomir] Med Univ Bialystok, Dept Reprod & Gynecol Endocrinol, PL-15273 Bialystok, Poland	Medical University of Bialystok; Medical University of Bialystok; Medical University of Bialystok	Laudanski, P (corresponding author), Med Univ Bialystok, Dept Perinatol & Obstet, Marii Sklodowskiej Curie 24a, PL-15276 Bialystok, Poland.	plauda@umb.edu.pl	Wołczyński, Sławomir/T-6326-2018; Blachnio-Zabielsk, Agnieszka U/A-4879-2018	Wołczyński, Sławomir/0000-0002-7806-1394; Blachnio-Zabielsk, Agnieszka U/0000-0002-8055-0576; Laudanski, Piotr/0000-0001-8955-8198	Ministry of Higher Education [143-33600L]	Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR))	The project was funded by the Ministry of Higher Education, grant number 143-33600L.	Bahado-Singh RO, 2013, AM J OBSTET GYNECOL, V208, p58e1, DOI DOI 10.1016/J.AJ0G.2012.11.003; Baranowski M, 2014, EUR J APPL PHYSL; Benn PA, 2001, PRENATAL DIAG, V21, P46, DOI 10.1002/1097-0223(200101)21:1<46::AID-PD984>3.3.CO;2-3; Blachnio-Zabielska AU, 2012, RAPID COMMUN MASS SP, V26, P1134, DOI 10.1002/rcm.6216; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Costa V, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-40; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; GBIF, 2014, RESOURCES TOOLS AND; Ghosh S, 2009, AM J MED GENET A, V149A, P1415, DOI 10.1002/ajmg.a.32932; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; He XX, 2002, ANAL BIOCHEM, V306, P115, DOI 10.1006/abio.2002.5686; Knapp M, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0294-0; Kuzmicki M, 2008, HORM METAB RES, V40, P556, DOI 10.1055/s-2008-1073166; Laudanski P, 2006, EUR J OBSTET GYN R B, V124, P23, DOI 10.1016/j.ejogrb.2005.05.006; Laudanski P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/835837; Laudanski P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/185758; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Murphy EJ, 2000, BRAIN RES, V867, P9, DOI 10.1016/S0006-8993(00)02205-8; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Shapiro SS, 2012, APPROXIMATE ANAL VAR; Sherman SL, 2007, MENT RETARD DEV D R, V13, P221, DOI 10.1002/mrdd.20157; Sparks AB, 2012, PRENATAL DIAG, V32, P3, DOI 10.1002/pd.2922; Weiner CP, 2013, AM J OBSTET GYNECOL, V208, P339, DOI 10.1016/j.ajog.2012.12.028; WILCOXON F, 1947, BIOMETRICS, V3, P119, DOI 10.2307/3001946; WISNIEWSKI KE, 1989, CLIN NEUROPATHOL, V8, P55; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	28	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127732	10.1371/journal.pone.0127732	http://dx.doi.org/10.1371/journal.pone.0127732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000716	Green Published, Green Submitted, gold			2022-12-26	WOS:000354931700078
J	Cheng, J; Wang, LX; Zhang, H; Xia, YY				Cheng, Jun; Wang, Lixia; Zhang, Hui; Xia, Yinyin			Diagnostic Value of Symptom Screening for Pulmonary Tuberculosis in China	PLOS ONE			English	Article							PREVALENCE; HIV; THERAPY	Objective To evaluate the diagnostic value of symptom screening for tuberculosis (TB) case finding defined in National Tuberculosis Control Program in China (China NTP) among elderly people( >= 65 years) and younger people(< 65 years). Methods We made a secondary analysis in a population-based TB prevalence survey in China in 2010. Questionnaire including information for cough and haemoptysis was completed by face to face interview, and then chest radiography was conducted in all eligible participants. Sputum smear and culture were followed for all TB suspects. We calculated the odds ratios (OR), sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and the area under the receiver operating characteristic curve (AUC) of using different symptoms for screening to detect bacteriologically positive TB in subpopulations stratified by age 65, to evaluate the performance of symptom screening for TB. Findings Of 315 newly diagnosed bacteriologically positive TB, 131 patients (41.59%) were elderly, and 48.57% of TB patients were asymptomatic. Nearly 50% patients did not present cough of any duration, and less than half present cough more than 2 weeks, a defined suspected symptom in China NTP. Cough of any duration was reported more in patients aged under 65 than those in elderly, especially for the acute cough (9.78% vs 6.87%). Those symptoms defined by China NTP were reported by less than half participants in two subpopulations. Acute cough (< 2 weeks) was an independent predictor of TB in people aged under 65 (adjusted OR: 3.3, 95% CI: 2.0-5.5), but not in those aged 65 and above (adjusted OR: 1.4, 95% CI: 0.7-2.9). The specificity for each symptom was significantly higher in participants aged under 65 (P<0.01), and sensitivities of most symptoms were significantly higher among elderly (P<0.05 or P<0.01). When compared with cough for 2 weeks and more, using cough of any duration for symptom screening increased the sensitivity from 42.9% to 51.% for all participants, and the AUC increased from 0.70 to 0.74 for participants aged under 65 without significant difference. Conclusions There is a high percent of asymptomatic TB patients, and those symptoms adopted in China NTP for screening is poorly predictive for TB. The presence of TB symptoms, the sensitivities and specificities of symptoms for TB were distinct between two subpopulations cut by age 65, implying different case finding strategies should be established for them. The current case finding strategy should be improved, and further studies should be done to evaluate the performance and cost-effectiveness of different symptom screening strategy.	[Cheng, Jun; Wang, Lixia; Zhang, Hui; Xia, Yinyin] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Xia, YY (corresponding author), Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China.	xiayinyin@chinatb.org						Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Corbett EL, 2010, B WORLD HEALTH ORGAN, V88, P13, DOI 10.2471/BLT.08.055467; Day JH, 2006, INT J TUBERC LUNG D, V10, P523; den Boon S, 2006, INT J TUBERC LUNG D, V10, P876; Department of disease control Chinese Ministry of Health, 2008, GUID IMPL NAT TUB CO; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Hoffmann CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062211; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Murhekar MV, 2004, B WORLD HEALTH ORGAN, V82, P836; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Nishikiori N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-97; Salim MAH, 2004, INT J TUBERC LUNG D, V8, P952; Shah S, 2009, JAIDS-J ACQ IMM DEF, V50, P537, DOI 10.1097/QAI.0b013e318196761c; Soemantri S, 2007, INT J TUBERC LUNG D, V11, P398; Technical Guidance Group of the Fifth National TB Epidemiological Survey, 2012, CHINESE J ANTITUBERC, V34, P485; van't Hoog AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038691; Wang LX, 2014, LANCET, V383, P2057, DOI 10.1016/S0140-6736(13)62639-2; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2004, INT POL COLL TB HIV; World Health Organization, 2013, SYST SCREEN TUB PRIN	20	20	25	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127725	10.1371/journal.pone.0127725	http://dx.doi.org/10.1371/journal.pone.0127725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001190	Green Published, gold, Green Submitted			2022-12-26	WOS:000354931700076
J	Mavedzenge, SN; Davey, C; Chirenje, T; Mushati, P; Mtetwa, S; Dirawo, J; Mudenge, B; Phillips, A; Cowan, FM				Mavedzenge, Sue Napierala; Davey, Calum; Chirenje, Tarisai; Mushati, Phyllis; Mtetwa, Sibongile; Dirawo, Jeffrey; Mudenge, Boniface; Phillips, Andrew; Cowan, Frances M.			Finger Prick Dried Blood Spots for HIV Viral Load Measurement in Field Conditions in Zimbabwe	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; ASSAY; SPECIMENS; PLASMA; RNA	Background In the context of a community-randomized trial of antiretrovirals for HIV prevention and treatment among sex workers in Zimbabwe (the SAPPH-IRe trial), we will measure the proportion of women with HIV viral load (VL) above 1000 copies/mL ("VL>1000") as our primary endpoint. We sought to characterize VL assay performance by comparing results from finger prick dried blood spots (DBS) collected in the field with plasma samples, to determine whether finger prick DBS is an acceptable sample for VL quantification in the setting. Methods We collected whole blood from a finger prick onto filter paper and plasma samples using venipuncture from women in two communities. VL quantification was run on samples in parallel using NucliSENS EasyQ HIV-1 v2.0. Our trial outcome is the proportion of women with VL>1000, consistent with WHO guidelines relating to regimen switching. We therefore focused on this cut-off level for assessing sensitivity and specificity. Results were log transformed and the mean difference and standard deviation calculated, and correlation between VL quantification across sample types was evaluated. Results A total of 149 HIV-positive women provided DBS and plasma samples; 56 (63%) reported being on antiretroviral therapy. VL ranged from undetectable-6.08 log(10) using DBS and undetectable-6.40 log(10) using plasma. The mean difference in VL (plasma-DBS) was 0.077 log(10) (95% CI = 0.025-0.18 log(10); standard deviation = 0.63 log(10),). 78 (52%) DBS and 87 (58%) plasma samples had a VL>1000. Based on plasma 'gold-standard', DBS sensitivity for detection of VL>1000 was 87.4%, and specificity was 96.8%. Conclusion There was generally good agreement between DBS and plasma VL for detection of VL>1000. Overall, finger prick DBS appeared to be an acceptable sample for classifying VL as above or below 1000 copies/mL using the NucliSENS assay.	[Mavedzenge, Sue Napierala] RTI Int, Womens Global Hlth Imperat, San Francisco, CA 94104 USA; [Davey, Calum] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Chirenje, Tarisai; Mushati, Phyllis; Mtetwa, Sibongile; Dirawo, Jeffrey; Cowan, Frances M.] Ctr Sexual Hlth & HIV AIDS Res Zimbabwe, Harare, Zimbabwe; [Mudenge, Boniface] Flowcytometry Lab, Harare, Zimbabwe; [Phillips, Andrew; Cowan, Frances M.] UCL, London, England	Research Triangle Institute; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Mavedzenge, SN (corresponding author), RTI Int, Womens Global Hlth Imperat, San Francisco, CA 94104 USA.	smavedzenge@rti.org	Phillips, Andrew N/B-4427-2008	Phillips, Andrew N/0000-0003-2384-4807; Rutsito, Sibongile/0000-0002-9155-840X; Cowan, Frances/0000-0003-3087-4422; Napierala, Sue/0000-0003-1146-8154	United Nations Population Fund (UNFPA) Zimbabwe; United Kingdom Department for International Development (DFID); Government of Sweden; Irish Aid	United Nations Population Fund (UNFPA) Zimbabwe; United Kingdom Department for International Development (DFID); Government of Sweden; Irish Aid(CGIAR)	This research was funded by United Nations Population Fund (UNFPA) Zimbabwe with pooled funding from the United Kingdom Department for International Development (DFID), the Government of Sweden, and Irish Aid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti M, 2010, J CLIN VIROL, V47, P4, DOI 10.1016/j.jcv.2009.11.006; Cowan FM, 2014, ESTIMATION HIV CARE; Cowan FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077080; Fajardo E, 2014, J CLIN MICROBIOL, V52, P1343, DOI 10.1128/JCM.03519-13; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Ikomey G M, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P181, DOI 10.1177/1545109709333111; Johannessen A, 2010, BIOANALYSIS, V2, P1893, DOI 10.4155/BIO.10.120; Johannessen A, 2009, CLIN INFECT DIS, V49, P976, DOI 10.1086/605502; Kane CT, 2008, J VIROL METHODS, V148, P291, DOI 10.1016/j.jviromet.2007.11.011; Lofgren SM, 2009, AIDS, V23, P2459, DOI 10.1097/QAD.0b013e328331f702; Mbida AD, 2009, JAIDS-J ACQ IMM DEF, V52, P9, DOI 10.1097/QAI.0b013e3181aeccbc; Pannus P, 2013, JAIDS-J ACQ IMM DEF, V64, P134, DOI 10.1097/QAI.0b013e3182a61e63; Rottinghaus EK, 2012, CLIN INFECT DIS, V54, P1187, DOI 10.1093/cid/cis015; Rutstein SE, 2014, J CLIN VIROL, V60, P392, DOI 10.1016/j.jcv.2014.05.005; Smit PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086461; Sollis KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085869; World Health Organization, 2014, TECHN OP CONS IMPL H	17	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126878	10.1371/journal.pone.0126878	http://dx.doi.org/10.1371/journal.pone.0126878			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001044	gold, Green Published			2022-12-26	WOS:000354931700033
J	Smith, C; Forster, JE; Levin, MJ; Davies, J; Pappas, J; Kinzie, K; Barr, E; Paul, S; McFarland, EJ; Weinberg, A				Smith, Christiana; Forster, Jeri E.; Levin, Myron J.; Davies, Jill; Pappas, Jennifer; Kinzie, Kay; Barr, Emily; Paul, Suzanne; McFarland, Elizabeth J.; Weinberg, Adriana			Serious Adverse Events Are Uncommon with Combination Neonatal Antiretroviral Prophylaxis: A Retrospective Case Review	PLOS ONE			English	Article							HIV; INFANTS; PHARMACOKINETICS; TRANSMISSION; PREVENTION; STAVUDINE; SAFETY; WOMEN	Six weeks of zidovudine (ZDV) is recommended for postnatal prophylaxis of HIV-exposed infants, but combination antiretrovirals are indicated if HIV transmission risk is increased. We investigated the frequency and severity of adverse events (AE) in infants receiving multiple drug prophylaxis compared to ZDV alone. In this retrospective review of 148 HIV-exposed uninfected infants born between 1997-2009, we determined clinical and laboratory AE that occurred between days of life 8-42. Thirty-six infants received combination prophylaxis; among those, a three-drug regimen containing ZDV, lamivudine, and nevirapine was most common (53%). Rates of laboratory AE grade >= 1 were as follows for the combination prophylaxis and ZDV alone groups, respectively: neutropenia 55% and 39%; anemia 50% and 39%; thrombocytopenia 0 and 3%; elevated aspartate aminotransferase 3% and 3%; elevated alanine aminotransferase 0 and 1%; hyperbilirubinemia 19% and 42%. Anemia occurred more frequently in infants who received three-drug prophylaxis compared to infants who received ZDV alone (63% vs. 39%, p = 0.04); all anemia AE were grade 1 or 2 in the three-drug prophylaxis group. Overall, 75% of infants on combination prophylaxis and 66% of infants on ZDV alone developed grade >= 1 AE (p = 0.32), and 17% of infants in either group developed grade >= 3 AE. Stavudine was substituted for ZDV in 23 infants due to anemia or neutropenia. After this antiretroviral change, 50% of evaluable infants demonstrated improvement in AE grade, and 25% had no change. In conclusion, low grade anemia, neutropenia, and hyperbilirubinemia occurred frequently regardless of the prophylactic regimen, but serious AE were uncommon. Although most AE were typical of ZDV toxicity, the combination of ZDV with lamivudine and nevirapine resulted in an increased frequency of low-grade anemia. Further studies are needed to identify prophylactic regimens with less toxicity for infants born to HIV-infected mothers.	[Smith, Christiana; Levin, Myron J.; Barr, Emily; Paul, Suzanne; McFarland, Elizabeth J.; Weinberg, Adriana] Univ Colorado, Sch Med, Dept Pediat Infect Dis, Aurora, CO 80045 USA; [Smith, Christiana; Levin, Myron J.; Pappas, Jennifer; Kinzie, Kay; Barr, Emily; Paul, Suzanne; McFarland, Elizabeth J.; Weinberg, Adriana] Childrens Hosp Colorado, Aurora, CO USA; [Forster, Jeri E.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Levin, Myron J.; Weinberg, Adriana] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Davies, Jill] Univ Colorado, Sch Med, Dept Obstet & Gynecol, Aurora, CO USA; [Davies, Jill] Denver Hlth Med Ctr, Dept Obstet & Gynecol, Denver, CO USA; [Weinberg, Adriana] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Smith, C (corresponding author), Univ Colorado, Sch Med, Dept Pediat Infect Dis, Aurora, CO 80045 USA.	Christiana.Smith@childrenscolorado.org	Smith, Christiana/AAK-7917-2020	Barr, Emily/0000-0002-8164-7345	Pfizer [2580628]; Abbott [2580614]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER	Pfizer(Pfizer); Abbott(Abbott Laboratories); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was partially supported by contributions from Pfizer (project number 2580628) and Abbott (project number 2580614). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunupuradah T, 2013, INT J INFECT DIS, V17, pE806, DOI 10.1016/j.ijid.2013.04.006; Chadwick EG, 2009, PEDIATR INFECT DIS J, V28, P215, DOI 10.1097/INF.0b013e31818cc053; Chiappini E, 2013, AIDS, V27, P991, DOI 10.1097/QAD.0b013e32835cffb1; Forbes JC, 2012, AIDS, V26, P757, DOI 10.1097/QAD.0b013e328350995c; Haile-Selassie HT, 2011, HIV MED, V12, P422, DOI 10.1111/j.1468-1293.2010.00902.x; Mandelbrot L, 2003, AIDS, V17, P272, DOI 10.1097/00002030-200301240-00023; Mandelbrot L, 2001, JAMA-J AM MED ASSOC, V285, P2083, DOI 10.1001/jama.285.16.2083; McKeegan K, 2011, AIDS PATIENT CARE ST, V25, P1, DOI 10.1089/apc.2010.0255; Mirochnick M, 2008, JAIDS-J ACQ IMM DEF, V47, P334, DOI 10.1097/QAI.0b013e31815f3c23; Mirochnick M, 2011, PEDIATR INFECT DIS J, V30, P769, DOI 10.1097/INF.0b013e3182242950; Montaner JSG, 2003, JAIDS-J ACQ IMM DEF, V34, pS85, DOI 10.1097/00126334-200309011-00013; Naver L, 2006, JAIDS-J ACQ IMM DEF, V42, P484, DOI 10.1097/01.qai.0000224571.30119.3d; Nielsen-Saines K, 2012, NEW ENGL J MED, V366, P2368, DOI 10.1056/NEJMoa1108275; Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, 2014, REC US ANT DRUGS PRE; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Reiser Diana J, 2004, Crit Care Nurs Clin North Am, V16, P257, DOI 10.1016/j.ccell.2004.02.010; Rongkavilit C, 2001, ANTIMICROB AGENTS CH, V45, P3585, DOI 10.1128/AAC.45.12.3585-3590.2001; Shetty AK, 2003, JAIDS-J ACQ IMM DEF, V34, P482, DOI 10.1097/00126334-200312150-00006; Singh A, 2014, INT J STD A IN PRESS; Smith Dawn K., 2005, Morbidity and Mortality Weekly Report, V54, P1; US Food and Drug Administration, 2011, KAL LOP RIT OR SOL L; Wade NA, 2004, J INFECT DIS, V190, P2167, DOI 10.1086/425903; Weinberg Adriana, 2011, Infect Dis Obstet Gynecol, V2011, P867674, DOI 10.1155/2011/867674; Weinberg Adriana, 2009, Infect Dis Obstet Gynecol, V2009, P621780, DOI 10.1155/2009/621780; Weinberg A, 2009, J CLIN VIROL, V45, P39, DOI 10.1016/j.jcv.2009.02.009	25	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127062	10.1371/journal.pone.0127062	http://dx.doi.org/10.1371/journal.pone.0127062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000984	gold, Green Published, Green Submitted			2022-12-26	WOS:000354931700039
J	Jerominek, M; Classen-Bockhoff, R				Jerominek, Markus; Classen-Bockhoff, Regine			Electrical Signals in Prayer Plants (Marantaceae)? Insights into the Trigger Mechanism of the Explosive Style Movement	PLOS ONE			English	Article							ACTION-POTENTIALS; MIMOSA; CELLS	The explosive pollination mechanism of the prayer plants (Marantaceae) is unique among plants. After a tactile stimulus by a pollinator, the style curls up rapidly and mediates pollen exchange. It is still under discussion whether this explosive movement is released electrophysiologically, i.e. by a change in the membrane potential (as in Venus flytrap), or purely mechanically. In the present study, electrophysiological experiments are conducted to clarify the mechanism. Artificial release experiments (chemical and electrical) and electrophysiological measurements were conducted with two phylogenetically distant species, Goeppertia bachemiana (E. Morren) Borchs. & S. Suarez and Donax canniformis (G. Forst.) K. Schum. Electric responses recorded after style release by extracellular measurements are characterised as variation potentials due to their long repolarization phase and lack of self-perpetuation. In both species, chemical and electric stimulations do not release the style movement. It is concluded that the style movement in Marantaceae is released mechanically by relieving the tissue pressure. Accordingly, the variation potential is an effect of the movement and not its cause. The study exemplarily shows that fast movements in plants are not necessarily initiated by electric changes of the membrane as known from the Venus flytrap.	[Jerominek, Markus; Classen-Bockhoff, Regine] Johannes Gutenberg Univ Mainz, Inst Spezielle Bot & Bot Garten, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Jerominek, M (corresponding author), Johannes Gutenberg Univ Mainz, Inst Spezielle Bot & Bot Garten, D-55122 Mainz, Germany.	mail@spinningspecies.com						BUNNING ERWIN, 1934, PLANTA, V22, P251; Burdon-Sanderson JI., 1873, P R SOC LOND, V21, P495, DOI DOI 10.1098/RSPL.1872.0092; CLAssEN-BocicHoFF R., 2008, STAPFIA, V88, P557; Davies E, 2004, NEW PHYTOL, V161, P607, DOI 10.1111/j.1469-8137.2003.01018.x; Dean J. A., 1999, LANGES HDB CHEM; DELPINO F, 1869, NUOVO GIORN BOT ITAL, V1, P293; Eckenhoff R G, 2001, Mol Interv, V1, P258; Eckenhoff RG, 2008, ANESTH ANALG, V107, P859, DOI 10.1213/ane.0b013e31817ee7ee; Felle HH, 2007, PLANTA, V226, P203, DOI 10.1007/s00425-006-0458-y; Fleurat-Lessard P, 1990, PULVINUS MOTOR ORGAN, P101; FLEURATLESSARD P, 1982, ANN BOT-LONDON, V50, P83, DOI 10.1093/oxfordjournals.aob.a086348; Fromm J, 2007, PLANT CELL ENVIRON, V30, P249, DOI 10.1111/j.1365-3040.2006.01614.x; HODICK D, 1988, PLANTA, V174, P8, DOI 10.1007/BF00394867; IIJIMA T, 1981, PLANT CELL PHYSIOL, V22, P1595, DOI 10.1093/oxfordjournals.pcp.a076312; Kennedy H., 1978, SYSTEMATICS POLLINAT; KUNZE H, 1984, FLORA, V175, P301; Ley AC, 2012, BOT J LINN SOC, V168, P300, DOI 10.1111/j.1095-8339.2011.01202.x; Lindley J., 1819, BOT REGISTER, V5, P385, DOI DOI 10.1098/RSTA.2016.0183; Lindley J, 1826, BOT REG, V12, P1020; MAYER WE, 1985, PLANTA, V163, P381, DOI 10.1007/BF00395147; METZNER H, 1982, PFLANZENPHYSIOLOGISC; Petersen O.G., 1890, FLORA BRASILIENSIS, V3, P81, DOI DOI 10.5962/BHL.TITLE.454; Pischtschan E, 2008, PLANT BIOLOGY, V10, P441, DOI 10.1111/j.1438-8677.2008.00051.x; Pischtschan E, 2010, PLANT SYST EVOL, V286, P91, DOI 10.1007/s00606-010-0282-5; Schumann K., 1902, PFLANZENREICH, V4, P1; SIBAOKA T, 1962, SCIENCE, V137, P226, DOI 10.1126/science.137.3525.226; SINYUKHI.AM, 1967, NATURE, V215, P1278, DOI 10.1038/2151278a0; STAHLBERG R, 1994, PLANT CELL ENVIRON, V17, P1143, DOI 10.1111/j.1365-3040.1994.tb02012.x; STUHLMAN O, 1950, SCIENCE, V111, P491, DOI 10.1126/science.111.2888.491; SUKSATHAN P, 2008, FLORA THAILAND, V9, P123; Talbot MJ, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-36; Umrath K, 1928, PLANTA, V5, P274, DOI 10.1007/BF01981103; Volkov AG, 2007, PLANT SIGNAL BEHAV, V2, P139, DOI 10.4161/psb.2.3.4217; WILDON DC, 1992, NATURE, V360, P62, DOI 10.1038/360062a0	34	1	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0126411	10.1371/journal.pone.0126411	http://dx.doi.org/10.1371/journal.pone.0126411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25997015	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000023
J	Koprowski, P; Grajkowski, W; Balcerzak, M; Filipiuk, I; Fabczak, H; Kubalski, A				Koprowski, Piotr; Grajkowski, Wojciech; Balcerzak, Marcin; Filipiuk, Iwona; Fabczak, Hanna; Kubalski, Andrzej			Cytoplasmic Domain of MscS Interacts with Cell Division Protein FtsZ: A Possible Non-Channel Function of the Mechanosensitive Channel in Escherichia Coli	PLOS ONE			English	Article							MEMBRANE-PROTEINS; SPATIAL SCALE; WALL; SHAPE; RING; IDENTIFICATION; LOCALIZATION; ORGANIZATION; ACTIVATION; INHIBITORS	Bacterial mechano-sensitive (MS) channels reside in the inner membrane and are considered to act as emergency valves whose role is to lower cell turgor when bacteria enter hypo-osmotic environments. However, there is emerging evidence that members of the Mechano-sensitive channel Small (MscS) family play additional roles in bacterial and plant cell physiology. MscS has a large cytoplasmic C-terminal region that changes its shape upon activation and inactivation of the channel. Our pull-down and co-sedimentation assays show that this domain interacts with FtsZ, a bacterial tubulin-like protein. We identify point mutations in the MscS C-terminal domain that reduce binding to FtsZ and show that bacteria expressing these mutants are compromised in growth on sublethal concentrations of beta-lactam antibiotics. Our results suggest that interaction between MscS and FtsZ could occur upon inactivation and/or opening of the channel and could be important for the bacterial cell response against sustained stress upon stationary phase and in the presence of beta-lactam antibiotics.	[Koprowski, Piotr; Grajkowski, Wojciech; Balcerzak, Marcin; Filipiuk, Iwona; Fabczak, Hanna; Kubalski, Andrzej] Polish Acad Sci, Nencki Inst Expt Biol, Dept Cell Biol, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Koprowski, P (corresponding author), Polish Acad Sci, Nencki Inst Expt Biol, Dept Cell Biol, Pasteur 3, Warsaw, Poland.	p.koprowski@nencki.gov.pl	Fabczak, Hanna/R-4095-2016; Koprowski, Piotr R/R-4088-2016	Fabczak, Hanna/0000-0001-6661-4599; Koprowski, Piotr R/0000-0002-7571-2446	Polish Ministry of Science [2P04C0167, NN301338033]; Polish Network for Mechanisms of Cell Mobility; Human Frontier Science Program Long Term Fellowship; Foundation of Polish Science START Fellowship	Polish Ministry of Science(Ministry of Science and Higher Education, Poland); Polish Network for Mechanisms of Cell Mobility; Human Frontier Science Program Long Term Fellowship(Human Frontier Science Program); Foundation of Polish Science START Fellowship	Supported by grants from the Polish Ministry of Science (2P04C0167 and NN301338033), the Polish Network for Mechanisms of Cell Mobility and the Human Frontier Science Program Long Term Fellowship to PK and the Foundation of Polish Science START Fellowship to MB. Flow cytometry was performed in the Nencki Institute Laboratory of Cytometry.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Akitake B, 2005, J GEN PHYSIOL, V125, P143, DOI 10.1085/jgp.200409198; Akitake B, 2007, NAT STRUCT MOL BIOL, V14, P1141, DOI 10.1038/nsmb1341; Anishkin A, 2009, J BIOL CHEM, V284, P19153, DOI 10.1074/jbc.R109.009357; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Bhaskara RM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00040; BI E, 1993, J BACTERIOL, V175, P1118, DOI 10.1128/JB.175.4.1118-1125.1993; Bialecka-Fornal M, 2015, J BACTERIOL, V197, P231, DOI 10.1128/JB.02175-14; Boer M, 2011, BIOCHEMISTRY-US, V50, P4087, DOI 10.1021/bi1019435; Booth IR, 2012, J BACTERIOL, V194, P4802, DOI 10.1128/JB.00576-12; Buddelmeijer N, 2002, CURR OPIN MICROBIOL, V5, P553, DOI 10.1016/S1369-5274(02)00374-0; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Cabeen MT, 2009, EMBO J, V28, P1208, DOI 10.1038/emboj.2009.61; Camberg JL, 2011, J BACTERIOL, V193, P1911, DOI 10.1128/JB.01317-10; Chiang CS, 2004, BIOPHYS J, V86, P2846, DOI 10.1016/S0006-3495(04)74337-4; Cox CD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3137; de Pedro MA, 2002, MICROBIOL-SGM, V148, P79, DOI 10.1099/00221287-148-1-79; DELPORTILLO FG, 1989, J BACTERIOL, V171, P4217; Edwards MD, 2012, CHANNELS, V6, P272, DOI 10.4161/chan.20998; Gan L, 2008, P NATL ACAD SCI USA, V105, P18953, DOI 10.1073/pnas.0808035105; Grajkowski W, 2005, BIOPHYS J, V88, P3050, DOI 10.1529/biophysj.104.053546; Haeusser DP, 2009, J BACTERIOL, V191, P1986, DOI 10.1128/JB.01606-07; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; Haswell ES, 2006, CURR BIOL, V16, P1, DOI 10.1016/j.cub.2005.11.044; Hernandez-Rocamora VM, 2012, J BIOL CHEM, V287, P30097, DOI 10.1074/jbc.M112.388959; Huang KC, 2008, P NATL ACAD SCI USA, V105, P19282, DOI 10.1073/pnas.0805309105; Kamaraju K, 2011, J GEN PHYSIOL, V138, P49, DOI 10.1085/jgp.201110606; KITANO K, 1979, ANTIMICROB AGENTS CH, V16, P838, DOI 10.1128/AAC.16.6.838; Koch AL, 1996, J MICROBIOL METH, V27, P49, DOI 10.1016/0167-7012(96)00928-1; Kodama Y, 2012, BIOTECHNIQUES, V53, P285, DOI [10.2144/0000113943, 10.2144/000113943]; Koprowski P, 2003, J BIOL CHEM, V278, P11237, DOI 10.1074/jbc.M212073200; Koprowski P, 1998, J MEMBRANE BIOL, V164, P253, DOI 10.1007/s002329900410; Koprowski P, 2011, J BIOL CHEM, V286, P877, DOI 10.1074/jbc.M110.176131; Kung C, 2010, ANNU REV MICROBIOL, V64, P313, DOI 10.1146/annurev.micro.112408.134106; LEDERBERG J, 1956, P NATL ACAD SCI USA, V42, P574, DOI 10.1073/pnas.42.9.574; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Li SY, 2009, J PHYS CHEM B, V113, P14431, DOI 10.1021/jp9053567; Machiyama H, 2009, BIOPHYS J, V97, P1048, DOI 10.1016/j.bpj.2009.05.021; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Nomura T, 2006, BIOPHYS J, V91, P2874, DOI 10.1529/biophysj.106.084541; Osanai T, 2005, J BIOL CHEM, V280, P34684, DOI 10.1074/jbc.M507489200; Osawa M, 2005, MICROBIOL-SGM, V151, P4033, DOI 10.1099/mic.0.28219-0; Pink D, 2000, J BACTERIOL, V182, P5925, DOI 10.1128/JB.182.20.5925-5930.2000; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Romantsov T, 2010, J BACTERIOL, V192, P912, DOI 10.1128/JB.00967-09; Rowe I, 2014, J GEN PHYSIOL, V143, P543, DOI 10.1085/jgp.201311114; Schumann U, 2004, FEBS LETT, V572, P233, DOI 10.1016/j.febslet.2004.07.045; Schumann U, 2010, P NATL ACAD SCI USA, V107, P12664, DOI 10.1073/pnas.1001405107; SCHWARZ U, 1969, J MOL BIOL, V41, P419, DOI 10.1016/0022-2836(69)90285-X; SCHWARZ U, 1981, FEMS MICROBIOL LETT, V10, P107, DOI 10.1111/j.1574-6968.1981.tb06217.x; Shiomi D, 2007, J BACTERIOL, V189, P236, DOI 10.1128/JB.00666-06; Snider Jamie, 2010, J Vis Exp, DOI 10.3791/1698; Soejima T, 2009, FEMS MICROBIOL LETT, V294, P74, DOI 10.1111/j.1574-6968.2009.01549.x; Sotomayor M, 2004, BIOPHYS J, V87, P3050, DOI 10.1529/biophysj.104.046045; STAUGAARD P, 1976, J BACTERIOL, V127, P1376, DOI 10.1128/JB.127.3.1376-1381.1976; Stokes NR, 2003, P NATL ACAD SCI USA, V100, P15959, DOI 10.1073/pnas.2536607100; Sugimoto S, 2010, J BIOL CHEM, V285, P6648, DOI 10.1074/jbc.M109.080739; Uehara T, 2009, J BACTERIOL, V191, P5094, DOI 10.1128/JB.00505-09; Varma A, 2007, J BACTERIOL, V189, P5692, DOI 10.1128/JB.00455-07; Varma A, 2009, J BACTERIOL, V191, P3526, DOI 10.1128/JB.01812-08; Veley KM, 2014, PLANT CELL, V26, P3115, DOI 10.1105/tpc.114.128082; Veley KM, 2012, CURR BIOL, V22, P408, DOI 10.1016/j.cub.2012.01.027; WACHI M, 1989, J BACTERIOL, V171, P3123, DOI 10.1128/jb.171.6.3123-3127.1989; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; Wilson M, 2012, PLANT SIGNAL BEHAV, V7, P467; Wilson ME, 2011, PLANT CELL, V23, P2939, DOI 10.1105/tpc.111.088112	73	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127029	10.1371/journal.pone.0127029	http://dx.doi.org/10.1371/journal.pone.0127029			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996836	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000040
J	Merli, M; Lucidi, C; Di Gregorio, V; Falcone, M; Giannelli, V; Lattanzi, B; Giusto, M; Ceccarelli, G; Farcomeni, A; Riggio, O; Venditti, M				Merli, Manuela; Lucidi, Cristina; Di Gregorio, Vincenza; Falcone, Marco; Giannelli, Valerio; Lattanzi, Barbara; Giusto, Michela; Ceccarelli, Giancarlo; Farcomeni, Alessio; Riggio, Oliviero; Venditti, Mario			The Spread of Multi Drug Resistant Infections Is Leading to an Increase in the Empirical Antibiotic Treatment Failure in Cirrhosis: A Prospective Survey	PLOS ONE			English	Article							HEALTH-CARE; ANTIMICROBIAL-RESISTANCE; BACTERIAL-INFECTIONS; DISEASES-SOCIETY; RISK-FACTORS; COMMUNITY; EPIDEMIOLOGY; OUTCOMES; AMERICA	Background The spread of multi-resistant infections represents a continuously growing problem in cirrhosis, particularly in patients in contact with the healthcare environment. Aim Our prospective study aimed to analyze epidemiology, prevalence and risk factors of multiresistant infections, as well as the rate of failure of empirical antibiotic therapy in cirrhotic patients. Methods All consecutive cirrhotic patients hospitalized between 2008 and 2013 with a microbiologically-documented infection (MDI) were enrolled. Infections were classified as Community-Acquired (CA), Hospital-Acquired (HA) and Healthcare-Associated (HCA). Bacteria were classified as Multidrug-Resistant (MDR) if resistant to at least three antimicrobial classes, Extensively-Drug-Resistant (XDR) if only sensitive to one/two classes and Pandrug-Resistant (PDR) if resistant to all classes. Results One-hundred-twenty-four infections (15% CA, 52% HA, 33% HCA) were observed in 111 patients. Urinary tract infections, pneumonia and spontaneous bacterial peritonitis were the more frequent. Forty-seven percent of infections were caused by Gram-negative bacteria. Fifty-one percent of the isolates were multi-resistant to antibiotic therapy (76% MDR, 21% XDR, 3% PDR): the use of antibiotic prophylaxis (OR = 8.4; 95% CI = 1.03-76; P = 0,05) and current/recent contact with the healthcare-system (OR = 3.7; 95% CI = 1.05-13; P = 0.04) were selected as independent predictors. The failure of the empirical antibiotic therapy was progressively more frequent according to the degree of resistance. The therapy was inappropriate in the majority of HA and HCA infections. Conclusions Multi-resistant infections are increasing in hospitalized cirrhotic patients. A better knowledge of the epidemiological characteristics is important to improve the efficacy of empirical antibiotic therapy. The use of preventive measures aimed at reducing the spread of multi-resistant bacteria is also essential.	[Merli, Manuela; Lucidi, Cristina; Di Gregorio, Vincenza; Giannelli, Valerio; Lattanzi, Barbara; Giusto, Michela; Riggio, Oliviero] Univ Roma La Sapienza, Dept Clin Med, Gastroenterol, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Falcone, Marco; Ceccarelli, Giancarlo; Venditti, Mario] Univ Roma La Sapienza, Dept Infect Dis, I-00185 Rome, Italy; [Farcomeni, Alessio] Univ Roma La Sapienza, Stat Sect, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	Merli, M (corresponding author), Univ Roma La Sapienza, Dept Clin Med, Gastroenterol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	manuela.merli@uniroma1.it	Ceccarelli, Giancarlo/ABD-8347-2020; Riggio, Oliviero/ABG-6697-2020; Farcomeni, Alessio/K-8719-2016; Falcone, Marco/K-7614-2016; Ceccarelli, Giancarlo/K-6454-2016; Merli, Manuela/D-2311-2010	Ceccarelli, Giancarlo/0000-0001-5921-3180; Riggio, Oliviero/0000-0003-0241-3223; Farcomeni, Alessio/0000-0002-7104-5826; Falcone, Marco/0000-0003-3813-8796; Ceccarelli, Giancarlo/0000-0001-5921-3180; Merli, Manuela/0000-0003-3173-9767; VENDITTI, Mario/0000-0003-2639-0281; Lattanzi, Barbara/0000-0003-2685-6504				Ariza X, 2012, J HEPATOL, V56, P825, DOI 10.1016/j.jhep.2011.11.010; Bajaj JS, 2012, HEPATOLOGY, V56, P2328, DOI 10.1002/hep.25947; Bartoletti M, 2014, J HEPATOL, V61, P51, DOI 10.1016/j.jhep.2014.03.021; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Di Gregorio V, 2014, J HEP, V60, pS215; Fernandez J, 2002, HEPATOLOGY, V35, P140, DOI 10.1053/jhep.2002.30082; Fernandez J, 2012, HEPATOLOGY, V55, P1551, DOI 10.1002/hep.25532; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Gines P, 2010, J HEPATOL, V53, P397, DOI 10.1016/j.jhep.2010.05.004; Harbarth S, 2001, Lancet Infect Dis, V1, P251, DOI 10.1016/S1473-3099(01)00120-7; Harrison PF, 1998, IOM, P8; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Merli M, 2012, J HEPATOL, V56, P756, DOI 10.1016/j.jhep.2011.12.004; Merli M, 2010, CLIN GASTROENTEROL H, V8, P979, DOI 10.1016/j.cgh.2010.06.024; Shlaes DM, 1997, INFECT CONT HOSP EP, V18, P275; Venditti M, 2009, ANN INTERN MED, V150, P19, DOI 10.7326/0003-4819-150-1-200901060-00005; Zinn CS, 2004, MICROB DRUG RESIST, V10, P160, DOI 10.1089/1076629041310055	17	60	63	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127448	10.1371/journal.pone.0127448	http://dx.doi.org/10.1371/journal.pone.0127448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996499	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000067
J	Stelkens, RB; Schmid, C; Seehausen, O				Stelkens, Rike Bahati; Schmid, Corinne; Seehausen, Ole			Hybrid Breakdown in Cichlid Fish	PLOS ONE			English	Article							POSTZYGOTIC ISOLATION; LOCAL ADAPTATION; HYBRIDIZATION; EVOLUTION; INVIABILITY; PATTERNS; GENETICS; FITNESS; INCOMPATIBILITIES; DIVERGENCE	Studies from a wide diversity of taxa have shown a negative relationship between genetic compatibility and the divergence time of hybridizing genomes. Theory predicts the main breakdown of fitness to happen after the F1 hybrid generation, when heterosis subsides and recessive allelic (Dobzhansky-Muller) incompatibilities are increasingly unmasked. We measured the fitness of F2 hybrids of African haplochromine cichlid fish bred from species pairs spanning several thousand to several million years divergence time. F2 hybrids consistently showed the lowest viability compared to F1 hybrids and non-hybrid crosses (crosses within the grandparental species), in agreement with hybrid breakdown. Especially the short-and long-term survival (2 weeks to 6 months) of F2 hybrids was significantly reduced. Overall, F2 hybrids showed a fitness reduction of 21% compared to F1 hybrids, and a reduction of 43% compared to the grandparental, non-hybrid crosses. We further observed a decrease of F2 hybrid viability with the genetic distance between grandparental lineages, suggesting an important role for negative epistatic interactions in cichlid fish postzygotic isolation. The estimated time window for successful production of F2 hybrids resulting from our data is consistent with the estimated divergence time between the multiple ancestral lineages that presumably hybridized in three major adaptive radiations of African cichlids.	[Stelkens, Rike Bahati] Max Planck Inst Evolutionary Biol, Plon, Germany; [Schmid, Corinne; Seehausen, Ole] Univ Bern, Inst Ecol & Evolut, Dept Aquat Ecol & Macroevolut, Bern, Switzerland; [Schmid, Corinne; Seehausen, Ole] Swiss Fed Inst Aquat Sci & Technol EAWAG, CEEB, Dept Fish Ecol & Evolut, Kastanienbaum, Switzerland	Max Planck Society; University of Bern; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Seehausen, O (corresponding author), Univ Bern, Inst Ecol & Evolut, Dept Aquat Ecol & Macroevolut, Bern, Switzerland.	ole.seehausen@eawag.ch	Seehausen, Ole/C-8272-2011	Seehausen, Ole/0000-0001-6598-1434	Swiss National Science Foundation [31003A118293]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	OS received funding from the Swiss National Science Foundation (project 31003A118293). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Bolnick DI, 2005, EVOLUTION, V59, P1754, DOI 10.1111/j.0014-3820.2005.tb01824.x; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Burke JM, 2001, ANNU REV GENET, V35, P31, DOI 10.1146/annurev.genet.35.102401.085719; Cattani MV, 2012, GENETICS, V191, P549, DOI 10.1534/genetics.112.139683; Coyne J.A., 2004, SPECIATION; COYNE JA, 1989, EVOLUTION, V43, P362, DOI [10.2307/2409213, 10.1111/j.1558-5646.1989.tb04233.x]; Dobzhansky T, 1936, GENETICS, V21, P113; Edmands S, 1999, EVOLUTION, V53, P1757, DOI 10.1111/j.1558-5646.1999.tb04560.x; Foltz DW, 1997, EVOLUTION, V51, P283, DOI 10.1111/j.1558-5646.1997.tb02410.x; Fraser DJ, 2008, EVOL APPL, V1, P501, DOI 10.1111/j.1752-4571.2008.00037.x; Garrity DM, 2002, DEVELOPMENT, V129, P4635; Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050; Genner MJ, 2012, MOL BIOL EVOL, V29, P195, DOI 10.1093/molbev/msr183; Joyce DA, 2005, NATURE, V435, P90, DOI 10.1038/nature03489; Joyce DA, 2011, CURR BIOL, V21, pR108, DOI 10.1016/j.cub.2010.11.029; Leinonen PH, 2011, EVOLUTION, V65, P90, DOI 10.1111/j.1558-5646.2010.01119.x; Lijtmaer DA, 2003, EVOLUTION, V57, P1411, DOI 10.1111/j.0014-3820.2003.tb00348.x; Lopez-Fernandez H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001294; Matute DR, 2010, SCIENCE, V329, P1518, DOI 10.1126/science.1193440; Mendelson TC, 2003, EVOLUTION, V57, P317; MOLL RH, 1965, GENETICS, V52, P139; Moyle LC, 2010, SCIENCE, V329, P1521, DOI 10.1126/science.1193063; Muller HJ, 1942, BIOL S, V6, P71; Nolte AW, 2010, TRENDS GENET, V26, P54, DOI 10.1016/j.tig.2009.12.001; ORR HA, 1995, GENETICS, V139, P1805; Orr HA, 2001, EVOLUTION, V55, P1085; Orr HA, 1997, ANNU REV ECOL SYST, V28, P195, DOI 10.1146/annurev.ecolsys.28.1.195; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Presgraves DC, 2002, EVOLUTION, V56, P1168, DOI 10.1111/j.0014-3820.2002.tb01430.x; Price TD, 2002, EVOLUTION, V56, P2083; Pritchard VL, 2013, J EVOLUTION BIOL, V26, P416, DOI 10.1111/jeb.12060; Pritchard VL, 2013, EVOLUTION, V67, P774, DOI 10.1111/j.1558-5646.2012.01814.x; Russell ST, 2003, ANN ZOOL FENN, V40, P321; Seehausen O, 2003, P ROY SOC B-BIOL SCI, V270, P2637, DOI 10.1098/rspb.2003.2001; Seehausen O, 2013, J EVOLUTION BIOL, V26, P279, DOI 10.1111/jeb.12026; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Stelkens RB, 2009, BMC EVOLUTIONARY BIO, V9, DOI [10.1186/471-2148-9-283, DOI 10.1186/471-2148-9-283]; Stelkens RB, 2010, EVOLUTION, V64, P617, DOI 10.1111/j.1558-5646.2009.00849.x; Sturmbauer C, 2001, MOL BIOL EVOL, V18, P144, DOI 10.1093/oxfordjournals.molbev.a003788; TEMPLETON AR, 1986, ZOO BIOL, V5, P115, DOI 10.1002/zoo.1430050206; Turelli M, 2000, GENETICS, V154, P1663; Turner LM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004162; Wang RJ, 2013, EVOLUTION, V67, P2905, DOI 10.1111/evo.12173	44	42	42	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127207	10.1371/journal.pone.0127207	http://dx.doi.org/10.1371/journal.pone.0127207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996870	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000050
J	Sun, L; Hu, CY; Qian, Y; Zheng, CG; Liang, QH; Lv, ZP; Huang, ZZ; Qi, KY; Huang, J; Zhou, Q; Yang, Z				Sun, Liang; Hu, Caiyou; Qian, Yu; Zheng, Chenguang; Liang, Qinghua; Lv, Zeping; Huang, Zezhi; Qi, Keyan; Huang, Jin; Zhou, Qin; Yang, Ze			Age-Based Differences in the Genetic Determinants of Glycemic Control: A Case of FOXO3 Variations	PLOS ONE			English	Article							DIABETES-MELLITUS; SIGNALING PATHWAY; ASSOCIATION; LONGEVITY; CHINESE; TRANSCRIPTION; VARIANTS; EXERCISE; DISEASE; RISK	Background Glucose homeostasis is a trait of healthy ageing and is crucial to the elderly, but less consideration has been given to the age composition in most studies involving genetics and hyperglycemia. Methods Seven variants in FOXO3 were genotyped in three cohorts (n = 2037; LLI, MI_S and MI_N; mean age: 92.5 +/- 3.6, 45.9 +/- 8.2 and 46.8 +/- 10.3, respectively) to compare the contribution of FOXO3 to fasting hyperglycemia (FH) between long-lived individuals (LLI, aged over 90 years) and middle-aged subjects (aged from 35-65 years). Results A different genetic predisposition of FOXO3 alleles to FH was observed between LLI and both of two middle-aged cohorts. In the LLI cohort, the longevity beneficial alleles of three variants with the haplotype "AGGC" in block 1 were significantly protective to FH, fasting glucose, hemoglobin A(1C) and HOMA-IR. Notably, combining multifactor dimensionality reduction and logistic regression, we identified a significant 3-factor interaction model (rs2802288, rs2802292 and moderate physical activity) associated with lower FH risk. However, not all of the findings were replicated in the two middle-aged cohorts. Conclusion Our data provides a novel insight into the inconsistent genetic determinants between middle-aged and LLI subjects. FOXO3 might act as a shared genetic predisposition to hyperglycemia and lifespan.	[Sun, Liang; Yang, Ze] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China; [Hu, Caiyou; Liang, Qinghua; Lv, Zeping; Zhou, Qin] Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China; [Qian, Yu] Jiangbin Hosp, Dept Neurol, Nanning, Guangxi, Peoples R China; [Zheng, Chenguang] Chongqing Univ, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing 630044, Peoples R China; [Huang, Zezhi] Guangxi Maternal & Child Hlth Hosp, Dept Cardiothorac Surg, Nanning, Guangxi, Peoples R China; [Qi, Keyan] Peoples Govt Yongfu Cty, Off Longev Cultural, Yongfu, Guangxi, Peoples R China; [Huang, Jin] Beijing Obstet & Gynecol Hosp, Lab Genet & Metab, Beijing, Peoples R China; Beijing Shunyi Airport Hosp, Dept Obstet, Beijing, Peoples R China	Beijing Hospital; Chongqing University; Capital Medical University	Yang, Z (corresponding author), Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China.	yang_ze@sina.com			Beijing Nova program [Z121107002512058]; Natural Science Foundation of China [81061120527, 81370445, 81472408]; National Department Public Benefit Research Foundation by Ministry of Health P. R. China [201302008]; 12th 5 Year National Program from the Ministry of Scientific Technology [2012BAI10B01]	Beijing Nova program(Beijing Municipal Science & Technology Commission); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department Public Benefit Research Foundation by Ministry of Health P. R. China; 12th 5 Year National Program from the Ministry of Scientific Technology	This study was supported by the Beijing Nova program (Z121107002512058), Natural Science Foundation of China (81061120527, 81370445, 81472408), funding from National Department Public Benefit Research Foundation by Ministry of Health P. R. China (201302008) and 12th 5 Year National Program from the Ministry of Scientific Technology (2012BAI10B01).	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Anselmi CV, 2009, REJUV RES, V12, P95, DOI 10.1089/rej.2008.0827; Banasik K, 2011, J CLIN ENDOCR METAB, V96, pE119, DOI 10.1210/jc.2010-0881; BARBAGALLO CM, 1995, GERONTOLOGY, V41, P260; Donlon TA, 2012, J GERONTOL A-BIOL, V67, P1132, DOI 10.1093/gerona/gls067; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Graff M, 2013, HUM MOL GENET, V22, P3597, DOI 10.1093/hmg/ddt205; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Li HX, 2013, DIABETES, V62, P291, DOI 10.2337/db12-0454; Li Y, 2009, HUM MOL GENET, V18, P4897, DOI 10.1093/hmg/ddp459; Lin CH, 2014, AGE, V36, DOI 10.1007/s11357-014-9705-5; Lissner L, 1996, AM J EPIDEMIOL, V143, P54; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Muggeo M, 2000, DIABETES CARE, V23, P45, DOI 10.2337/diacare.23.1.45; Nair AK, 2012, GENE, V491, P182, DOI 10.1016/j.gene.2011.09.032; National Center for Chronic Disease Prevention and Health Promotion C, 1999, HEALTHY AGING, V12; Onuma H, 2006, MOL ENDOCRINOL, V20, P2831, DOI 10.1210/me.2006-0085; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Ponugoti B, 2012, EXP DIABETES RES, DOI 10.1155/2012/939751; Rodriguez BL, 1996, DIABETES CARE, V19, P587, DOI 10.2337/diacare.19.6.587; Sanchez AMJ, 2015, J PHYSIOL-LONDON, V593, P363, DOI 10.1113/jphysiol.2014.285999; SCHMIDT MI, 1981, DIABETES CARE, V4, P579, DOI 10.2337/diacare.4.6.579; Sheehan John P, 2004, Diabetes Technol Ther, V6, P525, DOI 10.1089/1520915041705910; Soerensen M, 2013, AGE, V35, P487, DOI 10.1007/s11357-011-9373-7; Sun L, 2006, DIABETIC MED, V23, P1085, DOI 10.1111/j.1464-5491.2006.01949.x; Sun L, 2014, EXP GERONTOL, V55, P129, DOI 10.1016/j.exger.2014.04.003; Sun L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072537; Tissenbaum HA, 1998, GENETICS, V148, P703; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853	31	1	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126696	10.1371/journal.pone.0126696	http://dx.doi.org/10.1371/journal.pone.0126696			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993007	Green Published, Green Submitted, gold			2022-12-26	WOS:000354921400071
J	Pham, AT; Harris, DK; Buck, J; Hoskins, A; Serrano, J; Abdel-Haleem, H; Cregan, P; Song, QJ; Boerma, HR; Li, ZL				Pham, Anh-Tung; Harris, Donna K.; Buck, James; Hoskins, Aaron; Serrano, Jonathan; Abdel-Haleem, Hussein; Cregan, Perry; Song, Qijian; Boerma, H. Roger; Li, Zenglu			Fine Mapping and Characterization of Candidate Genes that Control Resistance to Cercospora sojina K. Hara in Two Soybean Germplasm Accessions	PLOS ONE			English	Article							FROGEYE LEAF-SPOT; SSR MARKERS; REGION; REGISTRATION; IDENTIFICATION; INHERITANCE; QUINONE; RACE-5; LOCUS; YIELD	Frogeye leaf spot (FLS), caused by the fungus Cercospora sojina K. Hara, may cause a significant yield loss to soybean growers in regions with a warm and humid climate. Two soybean accessions, PI 594891 and PI 594774, were identified to carry a high level of resistance similar to that conditioned by the Rcs3 gene in 'Davis'. Previously, we reported that the resistance to FLS in these two plant introductions (PIs) was controlled by a novel gene (s) on chromosome 13 that is different from Rcs3. To fine-map the novel FLS resistance gene(s) in these two PIs, F-2:3 seeds from the crosses between PI 594891 and PI 594774, and the FLS susceptible genotype 'Blackhawk' were genotyped with SNP markers that were designed based on the SoySNP50k iSelect BeadChip data to identify recombinant events and locate candidate genes. Analysis of lines possessing key recombination events helped narrow down the FLS-resistance genomic region in PI 594891 from 3.3 Mb to a 72.6 kb region with five annotated genes. The resistance gene in PI 594774 was fine-mapped into a 540 kb region that encompasses the 72.6 kb region found in PI 594891. Sequencing five candidate genes in PI 594891 identified three genes that have several mutations in the promoter, intron, 5', and 3' UTR regions. qPCR analysis showed a difference in expression levels of these genes in both lines compared to Blackhawk in the presence of C. sojina. Based on phenotype, genotype and haplotype analysis results, these two soybean accessions might carry different resistance alleles of the same gene or two different gene(s). The identified SNPs were used to develop Kompetitive Allele Specific PCR (KASP) assays to detect the resistance alleles on chromosome 13 from the two PIs for marker-assisted selection.	[Pham, Anh-Tung; Harris, Donna K.; Hoskins, Aaron; Serrano, Jonathan; Abdel-Haleem, Hussein; Boerma, H. Roger; Li, Zenglu] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA; [Pham, Anh-Tung; Harris, Donna K.; Hoskins, Aaron; Serrano, Jonathan; Abdel-Haleem, Hussein; Boerma, H. Roger; Li, Zenglu] Univ Georgia, Dept Crop & Soil Sci, Athens, GA 30602 USA; [Buck, James] Univ Georgia, Dept Plant Pathol, Griffin, GA USA; [Cregan, Perry; Song, Qijian] ARS, USDA, Soybean Genom & Improvement Lab, Beltsville, MD USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA)	Li, ZL (corresponding author), Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA.	zli@uga.edu			ARS [ARS-0425341] Funding Source: Federal RePORTER	ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)		AKEM CN, 1994, CROP PROT, V13, P607, DOI 10.1016/0261-2194(94)90006-X; Ashfield T, 1998, THEOR APPL GENET, V96, P1013, DOI 10.1007/s001220050833; ATHOW K, 1952, PHYTOPATHOLOGY, V42, P660; BOERMA HR, 1992, CROP SCI, V32, P497, DOI 10.2135/cropsci1992.0011183X003200020048x; BOERMA HR, 1994, CROP SCI, V34, P1411, DOI 10.2135/cropsci1994.0011183X003400050059x; BURTON JW, 1987, CROP SCI, V27, P1093; Carmona MA, 2009, PLANT DIS, V93, P966, DOI 10.1094/PDIS-93-9-0966B; Carter TE, 2003, CROP SCI, V43, P1125, DOI 10.2135/cropsci2003.1125; Cook DE, 2012, SCIENCE, V338, P1206, DOI 10.1126/science.1228746; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Diwan N, 1997, THEOR APPL GENET, V95, P723, DOI 10.1007/s001220050618; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Gordon SG, 2006, CROP SCI, V46, P168, DOI 10.2135/cropsci2004.04-0024; Gore MA, 2002, GENOME, V45, P592, DOI 10.1139/G02-009; Grau CR, 2004, SOYBEANS IMPROVEMENT, V3, P763, DOI DOI 10.1111/J.1471-8286.2007.01758.X; Hill CB, 2012, EUPHYTICA, V186, P635, DOI 10.1007/s10681-012-0695-z; Hoskin A, 2011, GENETIC MAPPING SOYB; Keim P., 1988, Soybean Genetics Newsletter, V15, P150; Kim KS, 2010, THEOR APPL GENET, V121, P599, DOI 10.1007/s00122-010-1333-6; Koenning SR, 2010, PLANT HLTH PROGR, DOI 10.1094/PHP-2010-1122-01-RS; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LAVIOLETTE FA, 1970, CROP SCI, V10, P418, DOI 10.2135/cropsci1970.0011183X001000040031x; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma ShuMei, 1997, Acta Phytopathologica Sinica, V27, P180; Melchers L. E., 1925, PLANT DIS REP S, V40, P186; Mian MAR, 2008, CROP SCI, V48, P14, DOI 10.2135/cropsci2007.08.0432; Mian MAR, 1998, PLANT DIS, V82, P1017, DOI 10.1094/PDIS.1998.82.9.1017; Milne I, 2010, BIOINFORMATICS, V26, P3133, DOI 10.1093/bioinformatics/btq580; Missaoui AM, 2007, CROP SCI, V47, P1263, DOI 10.2135/cropsci2006.07.0472; Narusaka Y, 2004, MOL PLANT MICROBE IN, V17, P749, DOI 10.1094/MPMI.2004.17.7.749; Palma K, 2007, GENE DEV, V21, P1484, DOI 10.1101/gad.1559607; PHILLIPS DV, 1981, PHYTOPATHOLOGY, V71, P334, DOI 10.1094/Phyto-71-334; PHILLIPS DV, 1982, PHYTOPATHOLOGY, V72, P764, DOI 10.1094/Phyto-72-764; Ploper LD, 2001, PLANT DIS, V85, P8012; PROBST A. H., 1965, CROP SCI, V5, P332, DOI 10.2135/cropsci1965.0011183X000500040013x; Rosso ML, 2008, CROP SCI, V48, P2215, DOI 10.2135/cropsci2008.01.0035; Simonetti E, 2012, LETT APPL MICROBIOL, V55, P170, DOI 10.1111/j.1472-765X.2012.03266.x; Sinclair J. B., 1989, COMPENDIUM SOYBEAN D; Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985; Song QJ, 2010, CROP SCI, V50, P1950, DOI 10.2135/cropsci2009.10.0607; Sun JT, 2014, THEOR APPL GENET, V127, P913, DOI 10.1007/s00122-014-2266-2; Tian ZD, 2006, PLANT CELL REP, V25, P1094, DOI 10.1007/s00299-006-0169-7; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Wan XY, 2008, GENETICS, V179, P2239, DOI 10.1534/genetics.108.089862; Wang HH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-428; Weihmann T, 2012, PLANT CELL PHYSIOL, V53, P1617, DOI 10.1093/pcp/pcs103; Yamashita Y, 2013, BREEDING SCI, V63, P417, DOI 10.1270/jsbbs.63.417; Yorinori JT., 1992, PEST MANAGEMENT SOYB, P185; Yorinori JT, 1987, WORLD SOYBEAN PRODUC, VIV, P1275; Zhang GR, 2012, PLANT DIS, V96, P767, DOI 10.1094/PDIS-10-11-0915-PDN; Zhang GR, 2012, CROP PROT, V40, P63, DOI 10.1016/j.cropro.2012.04.025; Zou JJ, 1999, CHINESE SCI BULL, V44, P452	55	21	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0126753	10.1371/journal.pone.0126753	http://dx.doi.org/10.1371/journal.pone.0126753			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993056	Green Published, Green Submitted, gold			2022-12-26	WOS:000354918600043
J	Trzepizur, W; Gaceb, A; Arnaud, C; Ribuot, C; Levy, P; Martinez, MC; Gagnadoux, F; Andriantsitohaina, R				Trzepizur, Wojciech; Gaceb, Abderahim; Arnaud, Claire; Ribuot, Christophe; Levy, Patrick; Martinez, M. Carmen; Gagnadoux, Frederic; Andriantsitohaina, Ramaroson			Vascular and Hepatic Impact of Short-Term Intermittent Hypoxia in a Mouse Model of Metabolic Syndrome	PLOS ONE			English	Article							FATTY LIVER-DISEASE; MITOCHONDRIAL COMPLEX-III; NITRIC-OXIDE; ENDOTHELIAL DYSFUNCTION; INDUCIBLE FACTOR-1-ALPHA; INDEPENDENT ASSOCIATION; INSULIN-RESISTANCE; OBESITY; APNEA; GLUCOSE	Background Experimental models of intermittent hypoxia (IH) have been developed during the last decade to investigate the consequences of obstructive sleep apnea. IH is usually associated with detrimental metabolic and vascular outcomes. However, paradoxical protective effects have also been described depending of IH patterns and durations applied in studies. We evaluated the impact of short-term IH on vascular and metabolic function in a diet-induced model of metabolic syndrome (MS). Methods Mice were fed either a standard diet or a high fat diet (HFD) for 8 weeks. During the final 14 days of each diet, animals were exposed to either IH (1 min cycle, FiO(2) 5% for 30s, FiO(2) 21% for 30s; 8 h/day) or intermittent air (FiO(2) 21%). Ex-vivo vascular reactivity in response to acetylcholine was assessed in aorta rings by myography. Glucose, insulin and leptin levels were assessed, as well as serum lipid profile, hepatic mitochondrial activity and tissue nitric oxide (NO) release. Results Mice fed with HFD developed moderate markers of dysmetabolism mimicking MS, including increased epididymal fat, dyslipidemia, hepatic steatosis and endothelial dysfunction. HFD decreased mitochondrial complex I, II and IV activities and increased lactate dehydrogenase (LDH) activity in liver. IH applied to HFD mice induced a major increase in insulin and leptin levels and prevented endothelial dysfunction by restoring NO production. IH also restored mitochondrial complex I and IV activities, moderated the increase in LDH activity and liver triglyceride accumulation in HFD mice. Conclusion In a mouse model of MS, short-term IH increases insulin and leptin levels, restores endothelial function and mitochondrial activity and limits liver lipid accumulation.	[Trzepizur, Wojciech; Gaceb, Abderahim; Martinez, M. Carmen; Gagnadoux, Frederic; Andriantsitohaina, Ramaroson] Univ Angers, INSERM, Sopam, U1063, F-49045 Angers, France; [Trzepizur, Wojciech; Gagnadoux, Frederic] Angers Univ Hosp, Dept Resp Dis, Angers, France; [Arnaud, Claire; Ribuot, Christophe; Levy, Patrick] Joseph Fourier Univ, INSERM, Lab HP2, U1042, Grenoble, France; [Levy, Patrick] A Michallon Univ Hosp, Labs Sommeil & EFCR, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes	Trzepizur, W (corresponding author), Univ Angers, INSERM, Sopam, U1063, F-49045 Angers, France.	wotrzepizur@chu-angers.fr	Arnaud, Claire/D-4698-2014; Christophe, Ribuot/M-7105-2014; LEVY, Patrick/AAX-2802-2020; ANDRIANTSITOHAINA, Ramaroson/H-5286-2018	Arnaud, Claire/0000-0003-0964-9423; Christophe, Ribuot/0000-0003-4425-6203; LEVY, Patrick/0000-0003-3174-7935; Martinez, M Carmen/0000-0003-3897-7397; andriantsitohaina, ramaroson/0000-0002-4770-3585				Agouni A, 2008, AM J PATHOL, V173, P1210, DOI 10.2353/ajpath.2008.080228; Allende-Vigo MZ, 2010, ENDOCR PRACT, V16, P692, DOI 10.4158/EP09340.RA; Almendros I, 2014, AM J PHYSIOL-LUNG C, V307, pL129, DOI 10.1152/ajplung.00089.2014; Arnaud C, 2011, AM J RESP CRIT CARE, V184, P724, DOI 10.1164/rccm.201012-2033OC; Badran M, 2014, SLEEP MED, V15, P596, DOI 10.1016/j.sleep.2014.01.013; Berlanga A, 2014, CLIN EXP GASTROENTER, V7, P221, DOI 10.2147/CEG.S62831; Bertuglia S, 2008, AM J PHYSIOL-HEART C, V294, pH1914, DOI 10.1152/ajpheart.01371.2007; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Delarue J, 2007, CURR OPIN CLIN NUTR, V10, P142, DOI 10.1097/MCO.0b013e328042ba90; Dematteis M, 2008, AM J RESP CRIT CARE, V177, P227, DOI 10.1164/rccm.200702-238OC; Dematteis M, 2009, ILAR J, V50, P262, DOI 10.1093/ilar.50.3.262; Drager LF, 2011, OBESITY, V19, P2167, DOI 10.1038/oby.2011.240; Drager LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012065; Duennwald T, 2013, DIABETES CARE, V36, P2183, DOI 10.2337/dc12-2113; Epstein LJ, 2001, RESPIRATION, V68, P28, DOI 10.1159/000050459; Grattagliano I, 2012, CLIN BIOCHEM, V45, P610, DOI 10.1016/j.clinbiochem.2012.03.024; Guzy RD, 2007, ANTIOXID REDOX SIGN, V9, P1317, DOI 10.1089/ars.2007.1708; HOCHACHKA PW, 1983, RESP PHYSIOL, V52, P303, DOI 10.1016/0034-5687(83)90087-7; Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095; Iiyori N, 2007, AM J RESP CRIT CARE, V175, P851, DOI 10.1164/rccm.200610-1527OC; Jackman KA, 2014, STROKE, V45, P1460, DOI 10.1161/STROKEAHA.114.004816; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kanagy NL, 2001, HYPERTENSION, V37, P511, DOI 10.1161/01.HYP.37.2.511; Ketonen J, 2010, HEART VESSELS, V25, P254, DOI 10.1007/s00380-009-1182-x; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kuboki K, 2000, CIRCULATION, V101, P676, DOI 10.1161/01.CIR.101.6.676; Lyamina NP, 2011, J HYPERTENS, V29, P2265, DOI 10.1097/HJH.0b013e32834b5846; Malagat MLT DG, 1999, MITOCHONDRIAL DISEAS; Manrique C, 2014, ANN NY ACAD SCI, V1311, P138, DOI 10.1111/nyas.12395; Manukhina EB, 2011, EXP BIOL MED, V236, P867, DOI 10.1258/ebm.2011.011023; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Martin S, 2004, CIRCULATION, V109, P1653, DOI 10.1161/01.CIR.0000124065.31211.6E; Milano G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076659; Mingorance C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034268; Minville C, 2014, CHEST, V145, P525, DOI 10.1378/chest.13-0938; Montagnani M, 2002, MOL ENDOCRINOL, V16, P1931, DOI 10.1210/me.2002-0074; Montagnani M, 2002, J BIOL CHEM, V277, P1794, DOI 10.1074/jbc.M103728200; Muniyappa R, 2007, ENDOCR REV, V28, P463, DOI 10.1210/er.2007-0006; Olea E, 2014, J APPL PHYSIOL, V117, P706, DOI 10.1152/japplphysiol.00454.2014; Perlemuter G, 2007, NAT CLIN PRACT ENDOC, V3, P458, DOI 10.1038/ncpendmet0505; Phillips SA, 2004, AM J PHYSIOL-HEART C, V286, pH388, DOI 10.1152/ajpheart.00683.2003; Priou P, 2012, DIABETES CARE, V35, P1902, DOI 10.2337/dc11-2538; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Reinke C, 2011, J APPL PHYSIOL, V111, P881, DOI 10.1152/japplphysiol.00492.2011; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Savransky V, 2007, AM J PHYSIOL-GASTR L, V293, pG871, DOI 10.1152/ajpgi.00145.2007; Thakur ML, 2012, ATHEROSCLEROSIS, V223, P507, DOI 10.1016/j.atherosclerosis.2012.06.005; TILKIAN AG, 1976, ANN INTERN MED, V85, P714, DOI 10.7326/0003-4819-85-6-714; Trzepizur W, 2013, CHEST, V143, P1584, DOI 10.1378/chest.12-1652; Vial G, 2011, J HEPATOL, V54, P348, DOI 10.1016/j.jhep.2010.06.044; Villanova N, 2005, HEPATOLOGY, V42, P473, DOI 10.1002/hep.20781; Wang BS, 2013, SLEEP MED, V14, P165, DOI 10.1016/j.sleep.2012.10.020; Wang N, 2013, EXP PHYSIOL, V98, P1376, DOI 10.1113/expphysiol.2013.072454; Wang Z, 2013, UPSALA J MED SCI, V118, P65, DOI 10.3109/03009734.2013.766914; Wang ZH, 2012, EXP PHYSIOL, V97, P1105, DOI 10.1113/expphysiol.2012.065102; Xu HY, 2006, BIOCHEM BIOPH RES CO, V349, P439, DOI 10.1016/j.bbrc.2006.08.071; Yang RH, 2011, AM J PHYSIOL-HEART C, V300, pH1467, DOI 10.1152/ajpheart.00604.2009; Yokoe T, 2008, J PHYSIOL-LONDON, V586, P899, DOI 10.1113/jphysiol.2007.143586	59	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0124637	10.1371/journal.pone.0124637	http://dx.doi.org/10.1371/journal.pone.0124637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993257	gold, Green Published, Green Submitted			2022-12-26	WOS:000354917300009
J	Ting, PY; Johnson, CW; Fang, C; Cao, XQ; Graeber, TG; Mattos, C; Colicelli, J				Ting, Pamela Y.; Johnson, Christian W.; Fang, Cong; Cao, Xiaoqing; Graeber, Thomas G.; Mattos, Carla; Colicelli, John			Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding	FASEB JOURNAL			English	Article						GTPase; signal transduction; RIN1; RAF1	NUCLEOTIDE EXCHANGE FACTOR; K-RAS; GTPASE ACTIVITY; BCR-ABL; RIN1; PROTEIN; ACTIVATION; PROMOTES; KINASES; SWITCH	RAS proteins are signal transduction gatekeepers that mediate cell growth, survival, and differentiation through interactions with multiple effector proteins. The RAS effector RAS- and RAB-interacting protein 1 (RIN1) activates its own downstream effectors, the small GTPase RAB5 and the tyrosine kinase Abelson tyrosine-protein kinase (ABL), to modulate endocytosis and cytoskeleton remodeling. To identify ABL substrates downstream of RAS-to-RIN1 signaling, we examined human HEK293T cells over-expressing components of this pathway. Proteomic analysis revealed several novel phosphotyrosine peptides, including Harvey rat sarcoma oncogene (HRAS)-pTyr(137). Here we report that ABL phosphorylates tyrosine 137 of H-, K-, and NRAS. Increased RIN1 levels enhanced HRAS-Tyr(137) phosphorylation by nearly 5-fold, suggesting that RAS-stimulated RIN1 can drive ABL-mediated RAS modification in a feedback circuit. Tyr(137) is well conserved among RAS orthologs and is part of a transprotein H-bond network. Crystal structures of HRAS(Y137F) and HRAS(Y137E) revealed conformation changes radiating from the mutated residue. Although consistent with Tyr(137) participation in allosteric control of HRAS function, the mutations did not alter intrinsic GTP hydrolysis rates in vitro. HRAS-Tyr(137) phosphorylation enhanced HRAS signaling capacity in cells, however, as reflected by a 4-fold increase in the association of phosphorylated HRAS(G12V) with its effector protein RAF proto-oncogene serine/threonine protein kinase 1 (RAF1). These data suggest that RAS phosphorylation at Tyr(137) allosterically alters protein conformation and effector binding, providing a mechanism for effector-initiated modulation of RAS signaling.	[Ting, Pamela Y.; Cao, Xiaoqing; Colicelli, John] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Mol Biol Inst,Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Johnson, Christian W.; Mattos, Carla] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Fang, Cong; Graeber, Thomas G.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Crump Inst Mol Imaging, Metabol & Prote Ctr,Calif Nanosyst Inst, Los Angeles, CA 90095 USA; [Fang, Cong; Graeber, Thomas G.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Northeastern University; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Colicelli, J (corresponding author), Univ Calif Los Angeles, Box 951737,350C BSRB, Los Angeles, CA 90095 USA.	colicelli@mednet.ucla.edu		Johnson, Christian/0000-0002-6521-3803; Graeber, Thomas/0000-0001-8574-9181	U.S. National Institutes of Health (NIH) National Cancer Institute (NCI) Grant [CA136699]; Ruth L. Kirschstein National Research Service Award Grant [GM007185]; Whitcome Training Fellowship; U.S. National Science Foundation Grant [MCB-1244203]; NIH NCI Grant [CA168585]; American Cancer Society Research Scholar Award [RSG-12-257-01-TBE]; U.S. National Center for Advancing Translational Sciences Grant [UL1TR000124]; University of California, Los Angeles (UCLA) Jonsson Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [R01CA136699, P01CA168585] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1244203] Funding Source: National Science Foundation	U.S. National Institutes of Health (NIH) National Cancer Institute (NCI) Grant; Ruth L. Kirschstein National Research Service Award Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitcome Training Fellowship; U.S. National Science Foundation Grant(National Science Foundation (NSF)); NIH NCI Grant; American Cancer Society Research Scholar Award(American Cancer Society); U.S. National Center for Advancing Translational Sciences Grant; University of California, Los Angeles (UCLA) Jonsson Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank Drs. James Wohlschlegel and Ajay Vashisht for helpful discussions and insight into RAS binding partners, Dr. Greg Buhrman for initial guidance in performing the hydrolysis rates experiments, and Dr. Paul Swartz for help with data collection for the RAS<SUP>Y137E</SUP> mutant. The authors also thank the following colleagues for generously sharing key reagents: Dr. Shawn Li (pDEST15 RASA1-C SH2), Dr. John Kuriyan (pProExHT-HRAS), and Dr. Frank McCormick [pGEX-KG-RafRBD(1-149)]. This work was supported by the U.S. National Institutes of Health (NIH) National Cancer Institute (NCI) Grant CA136699 (to J.C.); the Ruth L. Kirschstein National Research Service Award Grant GM007185 (to P.T.); the Whitcome Training Fellowship (to P.T.); the U.S. National Science Foundation Grant MCB-1244203 (to C.M.); NIH NCI Grant CA168585 (to T.G.G.); American Cancer Society Research Scholar Award RSG-12-257-01-TBE (to T.G.G.); U.S. National Center for Advancing Translational Sciences Grant UL1TR000124 (to T.G.G.), and University of California, Los Angeles (UCLA) Jonsson Comprehensive Cancer Center for support of the Molecular Screening Shared Resource. The coordinates and structure factors for the X-ray crystal structures have been deposited in the PDB with the following codes: HRAS<SUP>Y137E</SUP>-GppNHp, PDB code 4XVQ; and HRAS<SUP>Y137F</SUP>-GppNHp, PDB code 4XVR.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afar DEH, 1997, IMMUNITY, V6, P773, DOI 10.1016/S1074-7613(00)80452-5; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Balaji Kavitha, 2013, Commun Integr Biol, V6, pe25421, DOI 10.4161/cib.25421; Balaji K, 2012, J CELL SCI, V125, P5887, DOI 10.1242/jcs.113688; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Buhrman G, 2003, STRUCTURE, V11, P747, DOI 10.1016/S0969-2126(03)00128-X; Buhrman G, 2011, J MOL BIOL, V413, P773, DOI 10.1016/j.jmb.2011.09.011; Buhrman G, 2011, J BIOL CHEM, V286, P3323, DOI 10.1074/jbc.M110.193854; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; Bunda S, 2014, P NATL ACAD SCI USA, V111, pE3785, DOI 10.1073/pnas.1406559111; BUSS JE, 1986, MOL CELL BIOL, V6, P116, DOI 10.1128/MCB.6.1.116; Cao XQ, 2008, J BIOL CHEM, V283, P31401, DOI 10.1074/jbc.M804002200; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Dhaka A, 2003, J NEUROSCI, V23, P748; Dzudzor B, 2010, MOL CELL NEUROSCI, V43, P108, DOI 10.1016/j.mcn.2009.09.012; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang P, 2012, TUMOR BIOL, V33, P1511, DOI 10.1007/s13277-012-0402-7; Fetics SK, 2015, STRUCTURE, V23, P505, DOI 10.1016/j.str.2014.12.017; GIBBS JB, 1984, P NATL ACAD SCI-BIOL, V81, P5704, DOI 10.1073/pnas.81.18.5704; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; HAN LM, 1995, MOL CELL BIOL, V15, P1318; Han LM, 1997, P NATL ACAD SCI USA, V94, P4954, DOI 10.1073/pnas.94.10.4954; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hu HL, 2008, MOL CELL BIOL, V28, P1573, DOI 10.1128/MCB.01087-07; Hu HL, 2005, CURR BIOL, V15, P815, DOI 10.1016/j.cub.2005.03.049; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; Ito Y, 1997, BIOCHEMISTRY-US, V36, P9109, DOI 10.1021/bi970296u; Jeong WJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002242; Johnson CW, 2013, ENZYMES, V33, P41, DOI 10.1016/B978-0-12-416749-0.00003-8; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Kearney BN, 2014, J MOL BIOL, V426, P611, DOI 10.1016/j.jmb.2013.10.036; Li L, 2008, NUCLEIC ACIDS RES, V36, P3263, DOI 10.1093/nar/gkn161; Lock P, 1999, J BIOL CHEM, V274, P22775, DOI 10.1074/jbc.274.32.22775; NEAL SE, 1988, J BIOL CHEM, V263, P19718; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prakash A, 2006, MOL CELL PROTEOMICS, V5, P423, DOI 10.1074/mcp.M500133-MCP200; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Shan GY, 2012, TUMOR BIOL, V33, P847, DOI 10.1007/s13277-011-0311-1; Sung PJ, 2013, P NATL ACAD SCI USA, V110, P20593, DOI 10.1073/pnas.1306431110; Thai M, 2011, LEUKEMIA, V25, P290, DOI 10.1038/leu.2010.268; Tomshine JC, 2009, J BIOL CHEM, V284, P26331, DOI 10.1074/jbc.M109.033514; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; Wang Q, 2012, ACTA HISTOCHEM, V114, P463, DOI 10.1016/j.acthis.2011.08.008; Wang Y, 2002, MOL CELL BIOL, V22, P916, DOI 10.1128/MCB.22.3.916-926.2001; Wang Y, 2001, METHOD ENZYMOL, V332, P139; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Williams JG, 2003, P NATL ACAD SCI USA, V100, P6376, DOI 10.1073/pnas.1037299100; WITTINGHOFER A, 1995, FEBS LETT, V369, P52, DOI 10.1016/0014-5793(95)00667-X; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Xu LZ, 2010, CURR BIOL, V20, P1372, DOI 10.1016/j.cub.2010.06.051; Yu HF, 2012, TUMOR BIOL, V33, P1557, DOI 10.1007/s13277-012-0409-0; Zimman A, 2010, J PROTEOME RES, V9, P2812, DOI 10.1021/pr901194x	61	25	26	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3750	3761		10.1096/fj.15-271510	http://dx.doi.org/10.1096/fj.15-271510			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	25999467	Green Published			2022-12-26	WOS:000359915600013
J	Aro, E; Salo, AM; Khatri, R; Finnila, M; Miinalainen, I; Sormunen, R; Pakkanen, O; Holster, T; Soininen, R; Prein, C; Clausen-Schaumann, H; Aszodi, A; Tuukkanen, J; Kivirikko, KI; Schipani, E; Myllyharju, J				Aro, Ellinoora; Salo, Antti M.; Khatri, Richa; Finnila, Mikko; Miinalainen, Ilkka; Sormunen, Raija; Pakkanen, Outi; Holster, Tiina; Soininen, Raija; Prein, Carina; Clausen-Schaumann, Hauke; Aszodi, Attila; Tuukkanen, Juha; Kivirikko, Kari I.; Schipani, Ernestina; Myllyharju, Johanna			Severe Extracellular Matrix Abnormalities and Chondrodysplasia in Mice Lacking Collagen Prolyl 4-Hydroxylase Isoenzyme II in Combination with a Reduced Amount of Isoenzyme I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-PLATE CHONDROCYTES; ATOMIC-FORCE MICROSCOPY; ALPHA-SUBUNIT ISOFORM; TRANSGENIC MICE; KEY ENZYMES; CARTILAGE; EXPRESSION; CLONING; HYPOXIA; BONE	Collagen prolyl 4-hydroxylases (C-P4H-I, C-P4H-II, and C-P4H-III) catalyze formation of 4-hydroxyproline residues required to form triple-helical collagen molecules. Vertebrate C-P4Hs are alpha(2)beta(2) tetramers differing in their catalytic alpha subunits. C-P4H-I is the major isoenzyme in most cells, and inactivation of its catalytic subunit (P4ha1(-/-)) leads to embryonic lethality in mouse, whereas P4ha1(+/-) mice have no abnormalities. To study the role of C-P4H-II, which predominates in chondrocytes, we generated P4ha2(-/-) mice. Surprisingly, they had no apparent phenotypic abnormalities. To assess possible functional complementarity, we established P4ha1(+/-); P4ha2(-/-) mice. They were smaller than their littermates, had moderate chondrodysplasia, and developed kyphosis. A transient inner cell death phenotype was detected in their developing growth plates. The columnar arrangement of proliferative chondrocytes was impaired, the amount of 4-hydroxyproline and the T-m of collagen II were reduced, and the extracellular matrix was softer in the growth plates of newborn P4ha1(+/-); P4ha2(-/-) mice. No signs of uncompensated ER stress were detected in the mutant growth plate chondrocytes. Some of these defects were also found in P4ha2(-/-) mice, although in a much milder form. Our data show that C-P4H-I can to a large extent compensate for the lack of C-P4H-II in proper endochondral bone development, but their combined partial and complete inactivation, respectively, leads to biomechanically impaired extracellular matrix, moderate chondrodysplasia, and kyphosis. Our mouse data suggest that inactivating mutations in human P4HA2 are not likely to lead to skeletal disorders, and a simultaneous decrease in P4HA1 function would most probably be required to generate such a disease phenotype.	[Aro, Ellinoora; Salo, Antti M.; Pakkanen, Outi; Holster, Tiina; Soininen, Raija; Kivirikko, Kari I.; Myllyharju, Johanna] Univ Oulu, Oulu Ctr Cell Matrix Res, FIN-90014 Oulu, Finland; [Aro, Ellinoora; Salo, Antti M.; Miinalainen, Ilkka; Sormunen, Raija; Pakkanen, Outi; Holster, Tiina; Soininen, Raija; Kivirikko, Kari I.; Myllyharju, Johanna] Univ Oulu, Bioctr Oulu, FIN-90014 Oulu, Finland; [Aro, Ellinoora; Salo, Antti M.; Pakkanen, Outi; Holster, Tiina; Soininen, Raija; Kivirikko, Kari I.; Myllyharju, Johanna] Univ Oulu, Fac Biochem & Mol Med, FIN-90014 Oulu, Finland; [Finnila, Mikko; Tuukkanen, Juha] Univ Oulu, Dept Anat & Cell Biol, FIN-90014 Oulu, Finland; [Sormunen, Raija] Univ Oulu, Dept Pathol, FIN-90014 Oulu, Finland; [Khatri, Richa; Schipani, Ernestina] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Prein, Carina; Clausen-Schaumann, Hauke] Munich Univ Appl Sci, Dept Appl Sci & Mechatron, D-80335 Munich, Germany; [Prein, Carina; Clausen-Schaumann, Hauke; Aszodi, Attila] Munich Univ Appl Sci, Ctr Appl Tissue Engn & Regenerat Med, D-80335 Munich, Germany; [Clausen-Schaumann, Hauke] Univ Munich, Ctr NanoSci, D-80539 Munich, Germany; [Aszodi, Attila] Univ Munich, Ctr Clin, Dept Surg, Lab Expt Surg & Regenerat Med, D-80336 Munich, Germany	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; Indiana University System; Indiana University Bloomington; University of Munich; University of Munich; University of Munich; University of Munich	Myllyharju, J (corresponding author), Univ Oulu, Bioctr Oulu, Oulu Ctr Cell Matrix Res, Aapistie 7,POB 5000, FIN-90014 Oulu, Finland.	johanna.myllyharju@oulu.fi	Finnila, Mikko/X-6492-2019; Clausen-Schaumann, Hauke/W-1830-2017; Tuukkanen, Juha/R-3728-2018	Clausen-Schaumann, Hauke/0000-0002-9413-0310; Tuukkanen, Juha/0000-0002-1723-6461; Miinalainen, Ilkka/0000-0002-3922-3442; Finnila, Mikko/0000-0002-3348-5759	University of Oulu; Biocenter Finland; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065403] Funding Source: NIH RePORTER	University of Oulu; Biocenter Finland; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Minna Siurua, Liisa Aijala, and Anu Myllymaki and the personnel of the Biocenter Oulu Transgenic and EM Core Facilities cofunded by the University of Oulu and Biocenter Finland, and the University of Oulu Laboratory Animal Centre for excellent technical assistance.	Allen JL, 2012, MOL BIOL CELL, V23, P3731, DOI 10.1091/mbc.E12-03-0172; Annunen P, 1997, J BIOL CHEM, V272, P17342, DOI 10.1074/jbc.272.28.17342; Annunen P, 1998, J BIOL CHEM, V273, P5989, DOI 10.1074/jbc.273.11.5989; Aro E, 2012, J BIOL CHEM, V287, P37134, DOI 10.1074/jbc.M112.352872; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Barbieri O, 2003, AM J PHYSIOL-CELL PH, V285, pC1504, DOI 10.1152/ajpcell.00579.2002; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Bengtsson T, 2005, J CELL SCI, V118, P929, DOI 10.1242/jcs.01678; Bentovim L, 2012, DEVELOPMENT, V139, P4473, DOI 10.1242/dev.083881; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006; Dreier R, 2008, MATRIX BIOL, V27, P319, DOI 10.1016/j.matbio.2008.01.006; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Heino J, 2014, ADV EXP MED BIOL, V819, P143, DOI 10.1007/978-94-017-9153-3_10; HELAAKOSKI T, 1989, P NATL ACAD SCI USA, V86, P4392, DOI 10.1073/pnas.86.12.4392; HELAAKOSKI T, 1995, P NATL ACAD SCI USA, V92, P4427, DOI 10.1073/pnas.92.10.4427; Holster T, 2007, J BIOL CHEM, V282, P2512, DOI 10.1074/jbc.M606608200; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kukkola L, 2003, J BIOL CHEM, V278, P47685, DOI 10.1074/jbc.M306806200; Lamberg A, 1996, J BIOL CHEM, V271, P11988, DOI 10.1074/jbc.271.20.11988; Laws N, 2004, J APPL PHYSIOL, V97, P1970, DOI 10.1152/japplphysiol.01357.2003; Leighton MP, 2007, HUM MOL GENET, V16, P1728, DOI 10.1093/hmg/ddm121; LI SW, 1995, GENE DEV, V9, P2821, DOI 10.1101/gad.9.22.2821; Loparic M, 2010, BIOPHYS J, V98, P2731, DOI 10.1016/j.bpj.2010.02.013; Maes C, 2012, J BONE MINER RES, V27, P596, DOI 10.1002/jbmr.1487; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Nissi R, 2001, J HISTOCHEM CYTOCHEM, V49, P1143, DOI 10.1177/002215540104900908; Nokelainen M, 2001, EUR J BIOCHEM, V268, P5300, DOI 10.1046/j.0014-2956.2001.02464.x; Rajpar MH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000691; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Schipani E, 2001, GENE DEV, V15, P2865; Van den Diepstraten C, 2003, CIRCULATION, V108, P508, DOI 10.1161/01.CIR.0000080883.53863.5C; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Yang CL, 1997, EXP CELL RES, V235, P370, DOI 10.1006/excr.1997.3692	39	30	31	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16964	16978		10.1074/jbc.M115.662635	http://dx.doi.org/10.1074/jbc.M115.662635			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	26001784	hybrid, Green Published			2022-12-26	WOS:000357572800040
J	Bednarczyk-Cwynar, B; Partyka, D; Zaprutko, L				Bednarczyk-Cwynar, Barbara; Partyka, Danuta; Zaprutko, Lucjusz			Simple Amides of Oleanolic Acid as Effective Penetration Enhancers	PLOS ONE			English	Article							STRUCTURE ELUCIDATION; DERIVATIVES; MEMBRANES; SKIN; TRITERPENOIDS; MECHANISMS; TRANSPORT; DELIVERY	Transdermal transport is now becoming one of the most convenient and safe pathways for drug delivery. In some cases it is necessary to use skin penetration enhancers in order to allow for the transdermal transport of drugs that are otherwise insufficiently skin-permeable. A series of oleanolic acid amides as potential transdermal penetration enhancers was formed by multistep synthesis and the synthesis of all newly prepared compounds is presented. The synthetized amides of oleanolic acid were tested for their in vitro penetration promoter activity. The above activity was evaluated by means of using the Furst Method. The relationships between the chemical structure of the studied compounds and penetration activity are presented.	[Bednarczyk-Cwynar, Barbara; Zaprutko, Lucjusz] Poznan Univ Med Sci, Fac Pharm, Dept Organ Chem, PL-60780 Poznan, Poland; [Partyka, Danuta] Poznan Univ Med Sci, Fac Pharm, Dept Technol Drug Forms, PL-60780 Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences	Bednarczyk-Cwynar, B (corresponding author), Poznan Univ Med Sci, Fac Pharm, Dept Organ Chem, Grunwaldzka Str 6, PL-60780 Poznan, Poland.	bcwynar@ump.edu.pl	Partyka, Danuta/P-5766-2015; 张, 张鑫月/AAP-1001-2020	Zaprutko, Lucjusz/0000-0003-1121-6272				Asbill Charles S., 2000, Pharmaceutical Science and Technology Today, V3, P36, DOI 10.1016/S1461-5347(99)00225-4; Barry BW, 2001, EUR J PHARM SCI, V14, P101, DOI 10.1016/S0928-0987(01)00167-1; Bednarczyk-Cwynar B, 2013, J MOL STRUCT, V1053, P115, DOI 10.1016/j.molstruc.2013.09.006; Chen Y, 2011, CHINA J CHIN MAT MED, V36, P4; Demir YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077289; FURST W, 1980, PHARMAZIE, V35, P106; Godwin DA, 1997, INT J PHARM, V155, P241, DOI 10.1016/S0378-5173(97)00163-4; Hadgraft J, 1996, INT J PHARM, V141, P17, DOI 10.1016/0378-5173(96)04609-1; Han SK, 1997, LIPIDS, V32, P769, DOI 10.1007/s11745-997-0098-9; Harrison JE, 1996, J CONTROL RELEASE, V41, P283, DOI 10.1016/0168-3659(96)01348-X; Honeywell-Nguyen P Loan, 2005, Drug Discov Today Technol, V2, P67, DOI 10.1016/j.ddtec.2005.05.003; Ibrahim SA, 2010, INT J PHARMACEUT, V383, P89, DOI 10.1016/j.ijpharm.2009.09.014; Jaworska M, 2013, ACTA BIOCHIM POL, V60, P779; Karande P, 2009, BBA-BIOMEMBRANES, V1788, P2362, DOI 10.1016/j.bbamem.2009.08.015; Kim N, 2001, J CONTROL RELEASE, V73, P183, DOI 10.1016/S0168-3659(01)00350-9; Marepally S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082581; Ogura M, 2008, ADV DRUG DELIVER REV, V60, P1218, DOI 10.1016/j.addr.2008.03.006; Pino CJ, 2014, DRUG DELIV TRANSL RE, V4, P131, DOI 10.1007/s13346-013-0186-3; Pino CJ, 2012, P NATL ACAD SCI USA, V109, P21283, DOI 10.1073/pnas.1200942109; Pungitore CR, 2005, J STORED PROD RES, V41, P433, DOI 10.1016/j.jspr.2004.07.001; RICHTER H, 1978, PHARMAZIE, V33, P523; Sinico C, 2005, J CONTROL RELEASE, V103, P123, DOI 10.1016/j.jconrel.2004.11.020; Vogel A. I., 1989, VOGELS TXB PRACTICAL, P395; Williams AC, 2004, ADV DRUG DELIVER REV, V56, P603, DOI 10.1016/j.addr.2003.10.025; WRZECIONO U, 1984, PHARMAZIE, V39, P683; WRZECIONO U, 1985, PHARMAZIE, V40, P542; Yan G, 2005, J CONTROL RELEASE, V110, P141, DOI 10.1016/j.jconrel.2005.09.006; YASUE M, 1974, YAKUGAKU ZASSHI, V94, P1468, DOI 10.1248/yakushi1947.94.11_1468; Zaprutko L, 2004, BIOORG MED CHEM LETT, V14, P4723, DOI 10.1016/j.bmcl.2004.06.087; ZAPRUTKO L, 1995, POL J CHEM, V69, P1003	30	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0122857	10.1371/journal.pone.0122857	http://dx.doi.org/10.1371/journal.pone.0122857			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010090	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900003
J	Kurushima, Y; Ikebe, K; Matsuda, K; Enoki, K; Ogata, S; Yamashita, M; Murakami, S; Maeda, Y				Kurushima, Yuko; Ikebe, Kazunori; Matsuda, Ken-ichi; Enoki, Kaori; Ogata, Soshiro; Yamashita, Motozo; Murakami, Shinya; Maeda, Yoshinobu		Osaka Twin Res Grp	Examination of the Relationship between Oral Health and Arterial Sclerosis without Genetic Confounding through the Study of Older Japanese Twins	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; TOOTH LOSS; MASTICATORY PERFORMANCE; CAROTID ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; ASYMPTOMATIC SUBJECTS; PERIODONTAL-DISEASE; WALL THICKNESS; HEART-DISEASE; RISK	Objective Although researchers have recently demonstrated a relationship between oral health and arterial sclerosis, the genetic contribution to this relationship has been ignored even though genetic factors are expected to have some effect on various diseases. The aim of this study was to evaluate oral health as a significant risk factor related to arterial sclerosis after eliminating genetic confounding through study of older Japanese twins. Subjects and Methods Medical and dental surveys were conducted individually for 106 Japanese twin pairs over the age of 50 years. Maximal carotid intima-media thickness (IMT-Cmax) was measured as a surrogate marker of arterial sclerosis. IMT-Cmax > 1.0 mm was diagnosed as arterial sclerosis. All of the twins were examined for the number of remaining teeth, masticatory performance, and periodontal status. We evaluated each measurement related with IMT-Cmax and arterial sclerosis using generalized estimating equations analysis adjusted for potential risk factors. For non-smoking monozygotic twins, a regression analysis using a "between within" model was conducted to evaluate the relationship between IMT-Cmax and the number of teeth as the environmental factor controlling genetic and familial confounding. Results We examined 91 monozygotic and 15 dizygotic twin pairs (males: 42, females: 64) with a mean (+/- standard deviation) age of 67.4 +/- 10.0 years. Out of all of the oral health-related measurements collected, only the number of teeth was significantly related to arterial sclerosis (odds ratio: 0.72, 95% confidence interval: 0.52-0.99 per five teeth). Regression analysis showed a significant association between the IMT-Cmax and the number of teeth as an environmental factor (p = 0.037). Conclusions Analysis of monozygotic twins older than 50 years of age showed that having fewer teeth could be a significant environmental factor related to arterial sclerosis, even after controlling for genetic and familial confounding.	[Kurushima, Yuko; Ikebe, Kazunori; Matsuda, Ken-ichi; Enoki, Kaori; Maeda, Yoshinobu] Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Suita, Osaka, Japan; [Ogata, Soshiro; Osaka Twin Res Grp] Osaka Univ, Grad Sch Med, Ctr Twin Res, Suita, Osaka, Japan; [Yamashita, Motozo; Murakami, Shinya] Osaka Univ, Dept Periodontol, Grad Sch Dent, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Ikebe, K (corresponding author), Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Suita, Osaka, Japan.	ikebe@dent.osaka-u.ac.jp	Gao, Jing/M-8264-2018	Murakami, Shinya/0000-0002-5230-452X	Japan Society of Science Promotion	Japan Society of Science Promotion	This study was funded by the Japan Society of Science Promotion (http://www.jsps.go.jp/english/e-grants/index.html). The funder had a role in data collection and analysis, as well as in preparing the manuscript.	Abnet CC, 2005, INT J EPIDEMIOL, V34, P467, DOI 10.1093/ije/dyh375; Beck JD, 2001, ARTERIOSCL THROM VAS, V21, P1816, DOI 10.1161/hq1101.097803; Bots ML, 2003, STROKE, V34, P2985, DOI 10.1161/01.STR.0000102044.27905.B5; Carlin JB, 2005, INT J EPIDEMIOL, V34, P1089, DOI 10.1093/ije/dyi153; Chambless LE, 2000, AM J EPIDEMIOL, V151, P478; Christensen K, 2001, J EPIDEMIOL COMMUN H, V55, P583, DOI 10.1136/jech.55.8.583; Enoki K, 2013, J ORAL REHABIL, V40, P252, DOI 10.1111/joor.12031; Fox CS, 2003, STROKE, V34, P397, DOI 10.1161/01.STR.0000048214.56981.6F; Hayakawa K, 2013, TWIN RES HUM GENET, V16, P217, DOI 10.1017/thg.2012.141; HOWARD G, 1993, STROKE, V24, P1297, DOI 10.1161/01.STR.24.9.1297; Ikebe K, 2007, INT J PROSTHODONT, V20, P161; Ikebe K, 2006, INT J PROSTHODONT, V19, P475; Joshipura KJ, 2003, STROKE, V34, P47, DOI 10.1161/01.STR.0000052974.79428.0C; Kato K, 2006, ARCH GEN PSYCHIAT, V63, P1267, DOI 10.1001/archpsyc.63.11.1267; Krenke BE, 2002, J FORENSIC SCI, V47, P773; Loos BG, 2000, J PERIODONTOL, V71, P1528, DOI 10.1902/jop.2000.71.10.1528; Lopez-Jornet P, 2012, J PERIODONTOL, V83, P690, DOI 10.1902/jop.2011.110412; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Medda E, 2014, NUTR METAB CARDIOVAS, V24, P511, DOI 10.1016/j.numecd.2013.10.031; Pinho MM, 2013, J PERIODONTAL RES, V48, P452, DOI 10.1111/jre.12026; Mucci LA, 2005, J DENT RES, V84, P800, DOI 10.1177/154405910508400904; Nokubi T, 2013, GERODONTOLOGY, V30, P76, DOI 10.1111/j.1741-2358.2012.00647.x; Nowjack-Raymer RE, 2003, J DENT RES, V82, P123, DOI 10.1177/154405910308200209; Padilha DMP, 2008, J GERONTOL A-BIOL, V63, P739, DOI 10.1093/gerona/63.7.739; Sacco RL, 2009, STROKE, V40, P2307, DOI 10.1161/STROKEAHA.109.554121; Shah PK, 2010, J AM COLL CARDIOL, V56, P98, DOI 10.1016/j.jacc.2009.09.081; Song C, 2014, J INTERN MED, V275, P631, DOI 10.1111/joim.12177; Sun Y, 2002, ATHEROSCLEROSIS, V164, P89, DOI 10.1016/S0021-9150(02)00017-5; Tonetti MS, 2013, J CLIN PERIODONTOL, V40, pS24, DOI 10.1111/jcpe.12089; Wakai K, 2010, COMMUNITY DENT ORAL, V38, P43, DOI 10.1111/j.1600-0528.2009.00512.x; Watt RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030797; Yang MJ, 2006, HUM REPROD, V21, P2175, DOI 10.1093/humrep/del133	32	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127642	10.1371/journal.pone.0127642	http://dx.doi.org/10.1371/journal.pone.0127642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009883	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900122
J	Abdallah, HM; Wintermans, BB; Reuland, EA; Koek, A; al Naiemi, N; Ammar, M; Mohamed, AA; Vandenbroucke-Grauls, CMJE				Abdallah, H. M.; Wintermans, B. B.; Reuland, E. A.; Koek, A.; al Naiemi, N.; Ammar, M.; Mohamed, A. A.; Vandenbroucke-Grauls, C. M. J. E.			Extended-Spectrum beta-Lactamase- and Carbapenemase-Producing Enterobacteriaceae Isolated from Egyptian Patients with Suspected Blood Stream Infection	PLOS ONE			English	Article							REAL-TIME PCR; ESCHERICHIA-COLI; CTX-M; KLEBSIELLA-PNEUMONIAE; VIRULENCE FACTORS; RESISTANCE; IDENTIFICATION; ENTERITIDIS; PREVALENCE; EMERGENCE	Objectives The aim of the study was to investigate the prevalence of extended-spectrum beta-lactamase and carbapenemase production among Enterobacteriaceae isolated from Egyptian patients with suspected blood stream infection. Methods Ninety-four Enterobacteriaceae blood culture isolates from Egyptian patients with suspected blood stream infection were collected, one isolate per patient. Identification of bacterial isolates was performed with MALDI-TOF (MS-based Vitek MS system, bioMerieux). Screening for ESBLs and carbapenemases production was done with the Vitek 2 system (bioMerieux). ESBL production was confirmed using the combined disk diffusion method for cefotaxime, ceftazidime, and cefepime, all with and without clavulanic acid (Rosco). Realtime PCR and sequencing were used to characterize the resistance genes. The phylogenetic groups of E. coli were identified by a PCR-based method. Results Of the 94 Enterobacteriaceae isolates 46 (48.93%) showed an ESBL phenotype. One Enterobacter spp isolate was ESBL-producer and meropenem-resistant. The genetic analysis showed that CTX-M was present in 89.13% (41/46) of the ESBL-producing Enterobacteriaceae, whereas TEM and SHV were detected in 56.52% (26/46) and 21.74% (10/46) respectively (47.83%) of the ESBL-producing isolates were multidrug resistant (MDR). Eleven out of 30 ESBL-producing E-coli isolates were assigned to phylogroup B2, followed by groups B1 (8 isolates), A (6 isolates) and D (5 isolates). Conclusions The high ESBL-E rates (48.93%) found in this study together with the identification of one carbapenem-resistant Enterobacter spp isolate is worrisome. Our results indicate that systems for monitoring and detection of ESBL-producing bacteria in Egyptian hospitals have to be established. Also strict hospital infection control policies with the restriction of the consumption of extended-spectrum cephalosporins are necessary.	[Abdallah, H. M.; Wintermans, B. B.; Reuland, E. A.; Koek, A.; al Naiemi, N.; Vandenbroucke-Grauls, C. M. J. E.] Vrije Univ Amsterdam Med Ctr, Med Microbiol & Infect Control, Amsterdam, Netherlands; [Abdallah, H. M.; Ammar, M.; Mohamed, A. A.] Zagazig Univ, Fac Vet Med, Dept Bacteriol Mycol & Immunol, Zagazig, Egypt; [al Naiemi, N.] Lab Med Microbiol & Publ Hlth, Hengelo, Netherlands; [al Naiemi, N.] Ziekenhuisgrp Twente, Microbiol & Infect Control, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Egyptian Knowledge Bank (EKB); Zagazig University	Abdallah, HM (corresponding author), Vrije Univ Amsterdam Med Ctr, Med Microbiol & Infect Control, Amsterdam, Netherlands.	bactine_ho@yahoo.com	Vandenbroucke-Grauls, Christina/AAO-7953-2020	Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; abdallah, Hossam/0000-0003-0384-7322	Egyptian high education ministry; VU medical center, the Netherlands	Egyptian high education ministry(Ministry of Higher Education & Scientific Research (MHESR)); VU medical center, the Netherlands	The research is funded by the joint supervision mission between Egyptian high education ministry and VU medical center, the Netherlands.	Abdelaziz MO, 2013, J GLOB ANTIMICROB RE, V1, P213, DOI 10.1016/j.jgar.2013.06.003; Ahmed Shaaban H, 2009, BMC Res Notes, V2, P76, DOI 10.1186/1756-0500-2-76; Al Naiemi N, 2012, NVMM GUIDELINE LAB D; Biehl LM, 2016, CRIT REV MICROBIOL, V42, P1, DOI 10.3109/1040841X.2013.875515; Bouchillon SK, 2004, INT J ANTIMICROB AG, V24, P119, DOI 10.1016/j.ijantimicag.2004.01.010; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Branger C, 2005, EMERG INFECT DIS, V11, P54, DOI 10.3201/eid1101.040257; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Carlet J, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-1; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; De Medici D, 2003, APPL ENVIRON MICROB, V69, P3456, DOI 10.1128/AEM.69.6.3456-3461.2003; Epstein S., 2015, SMALL ANIMAL CRITICA, P537, DOI [10.1016/B978-1-4557-0306-7.00103-3, DOI 10.1016/B978-1-4557-0306-7.00103-3]; EUCAST, 2014, EUR COMM ANT SUSC TE; Fam N, 2011, MICROB DRUG RESIST, V17, P67, DOI 10.1089/mdr.2010.0063; Lee JH, 2012, MED RES REV, V32, P216, DOI 10.1002/med.20210; Lee S, 2010, ANN CLIN LAB SCI, V40, P361; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Livermore DM, 2006, TRENDS MICROBIOL, V14, P413, DOI 10.1016/j.tim.2006.07.008; Morosini MI, 2006, ANTIMICROB AGENTS CH, V50, P2695, DOI 10.1128/AAC.00155-06; Mulvey MR, 2003, J CLIN MICROBIOL, V41, P460, DOI 10.1128/JCM.41.1.460-462.2003; Naas T, 2007, ANTIMICROB AGENTS CH, V51, P223, DOI 10.1128/AAC.00611-06; Nagoba BS, 2007, MICROBIOLOGY DENT ST, P342; Newire EA, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-16; Olesen I, 2004, MICROB DRUG RESIST, V10, P334, DOI 10.1089/mdr.2004.10.334; Pasteran F, 2009, J CLIN MICROBIOL, V47, P1631, DOI 10.1128/JCM.00130-09; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pitout JDD, 2005, ANTIMICROB AGENTS CH, V49, P4667, DOI 10.1128/AAC.49.11.4667-4670.2005; Poirel L, 2011, J ANTIMICROB CHEMOTH, V66, P2781, DOI 10.1093/jac/dkr384; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Reuland EA, 2013, CLIN MICROBIOL INFEC, V19, P542, DOI 10.1111/j.1469-0691.2012.03947.x; Robertson SM, 2011, INFECT DIS-SER, P425, DOI 10.1007/978-1-61779-213-7_13; Rubin JE, 2014, VET MICROBIOL, V170, P10, DOI 10.1016/j.vetmic.2014.01.017; Saied T, 2011, AM J INFECT CONTROL, V39, pE61, DOI 10.1016/j.ajic.2011.04.009; Shahcheraghi F, 2013, MICROB DRUG RESIST, V19, P30, DOI 10.1089/mdr.2012.0078; Sonnevend A, 2013, J MED MICROBIOL, V62, P1044, DOI 10.1099/jmm.0.059014-0; Tham J, 2010, SCAND J INFECT DIS, V42, P275, DOI 10.3109/00365540903493715; Tsakris A, 2009, J CLIN MICROBIOL, V47, P362, DOI 10.1128/JCM.01922-08; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Wang LJ, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-9; Weill FX, 2004, J CLIN MICROBIOL, V42, P2432, DOI 10.1128/JCM.42.6.2432-2437.2004; Wilke MS, 2005, CURR OPIN MICROBIOL, V8, P525, DOI 10.1016/j.mib.2005.08.016; Wu TL, 2001, J ANTIMICROB CHEMOTH, V47, P755, DOI 10.1093/jac/47.6.755	42	28	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0128120	10.1371/journal.pone.0128120	http://dx.doi.org/10.1371/journal.pone.0128120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001049	gold, Green Published, Green Submitted			2022-12-26	WOS:000354931700103
J	Brembilla-Perrot, B; Sellal, JM; Olivier, A; Manenti, V; Villemin, T; Beurrier, D; De Chillou, C; Lamiral, Z; Girerd, N				Brembilla-Perrot, Beatrice; Sellal, Jean Marc; Olivier, Arnaud; Manenti, Vladimir; Villemin, Thibault; Beurrier, Daniel; De Chillou, Christian; Lamiral, Zohra; Girerd, Nicolas			Risk and Outcome after Ablation of Isthmus-Dependent Atrial Flutter in Elderly Patients	PLOS ONE			English	Article							TERM-FOLLOW-UP; CATHETER ABLATION; RADIOFREQUENCY ABLATION; CAVOTRICUSPID ISTHMUS; FIBRILLATION; PREDICTORS; UNDERTREATMENT; PREVALENCE; GUIDELINES; MANAGEMENT	Purpose of the research To study the influence of age on the clinical presentation and long-term outcome of patients referred for atrial flutter (AFL) ablation. Age-related differences have been reported regarding the prognosis of arrhythmias. Methods A total of 1187 patients with a mean age 65+/-12 years consecutively referred for AFL ablation were retrospectively analyzed in the study. Results 445 (37.5%) patients were aged >= 70 (range 70 to 93) among which 345 were aged 70 to 79 years (29.1%) and 100 were aged >= 80 (8.4%). In multivariable analysis, AFL-related rhythmic cardiomyopathy and presentation with 1/1 AFL were less frequent (respectively adjusted OR = 0.44, 0.27-0.74, p = 0.002 and adjusted OR = 0.29, 0.16-0.52, p<0.0001). AFL ablation-related major complications were more frequent in patients >= 70 although remained lower than 10% (7.4% in >= 70 vs. 4.2% in < 70, adjusted OR = 1.74, 1.04-2.89, p = 0.03). After 2.1+/-2.7 years, AFL recurrence was less frequent in patients >= 70 (adjusted OR = 0.54, 0.37-0.80, p = 0.002) whereas atrial fibrillation (AF) occurrence was as frequent in the 70-79 and >= 80 age subsets. As expected, cardiac mortality was higher in older patients. Patients aged >= 80 also had a low probability of AFL recurrence (5.0%) and AF onset (19.0%). Conclusions Older patients represent 37.5% of patients referred for AFL ablation and displayed a < 10% risk of ablation-related complications. Importantly, AFL recurrences were less frequent in patients >= 70 while AF occurrence was as frequent as in patients < 70. Similar observations were made in patients >= 80 years. AFL ablation appears to be safe and efficient and should not be ruled out in elderly patients.	[Brembilla-Perrot, Beatrice; Sellal, Jean Marc; Olivier, Arnaud; Manenti, Vladimir; Villemin, Thibault; Beurrier, Daniel; De Chillou, Christian] Nancy Univ Hosp, Dept Cardiol, Vandoeuvre Les Nancy, France; [Lamiral, Zohra; Girerd, Nicolas] Univ Lorraine, Ctr Invest Clin 1433, Inst Lorrain Coeur & Vaisseaux, INSERM,CHU Nancy, Nancy, France	CHU de Nancy; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine	Brembilla-Perrot, B (corresponding author), Nancy Univ Hosp, Dept Cardiol, Vandoeuvre Les Nancy, France.	b.brembilla-perrot@chu-nancy.fr	GIRERD, Nicolas/D-5493-2011; de+CHILLOU, Christian/AAV-3626-2021; SELLAL, Jean-Marc/AAX-7975-2020	Girerd, Nicolas/0000-0002-3278-2057				Bandini A, 2011, J CARDIOVASC MED, V12, P110, DOI 10.2459/JCM.0b013e3283403301; Bertaglia E, 2004, PACE, V27, P1507, DOI 10.1111/j.1540-8159.2004.00668.x; Bertaglia E, 2004, HEART, V90, P59, DOI 10.1136/heart.90.1.59; Bohnen M, 2011, HEART RHYTHM, V8, P1661, DOI 10.1016/j.hrthm.2011.05.017; Brembilla-Perrot B, 2015, INT J CARDIOL, V179, P292, DOI 10.1016/j.ijcard.2014.11.071; Brembilla-Perrot B, 2014, J CARDIOVASC ELECTR, V25, P813, DOI 10.1111/jce.12413; Brembilla-Perrot B, 2013, INT J CARDIOL, V168, P3287, DOI 10.1016/j.ijcard.2013.04.047; Brembilla-Perrot B, 2012, PACE, V35, P1061, DOI 10.1111/j.1540-8159.2012.03464.x; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; COSIO FG, 1993, AM J CARDIOL, V71, P705, DOI 10.1016/0002-9149(93)91014-9; Da Costa A, 2003, PACE, V26, P1729, DOI 10.1046/j.1460-9592.2003.t01-1-00259.x; De Sisti A, 1998, G Ital Cardiol, V28, P1253; Della Bella P, 1999, Cardiologia, V44, P439; Ellis K, 2007, J CARDIOVASC ELECTR, V18, P799, DOI 10.1111/j.1540-8167.2007.00885.x; Fairhead JF, 2006, BMJ-BRIT MED J, V333, P525, DOI 10.1136/bmj.38895.646898.55; FURBERG CD, 1994, AM J CARDIOL, V74, P236, DOI 10.1016/0002-9149(94)90363-8; Granada J, 2000, J AM COLL CARDIOL, V36, P2242, DOI 10.1016/S0735-1097(00)00982-7; Hsieh MH, 2002, J INTERV CARD ELECTR, V7, P225, DOI 10.1023/A:1021392105994; Kennedy R, 2013, EXPERT REV CARDIOVAS, V11, P697, DOI [10.1586/ERC.13.2, 10.1586/erc.13.2]; Laish-Farkash A, 2013, J CARDIOVASC ELECTR, V24, P739, DOI 10.1111/jce.12164; Liu Y, 2011, INT J CARDIOL, V152, P266, DOI 10.1016/j.ijcard.2011.07.104; McLaughlin TJ, 1996, ARCH INTERN MED, V156, P799, DOI 10.1001/archinte.156.7.799; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Nabar A, 1999, CIRCULATION, V99, P1441, DOI 10.1161/01.CIR.99.11.1441; Naccarelli GV, 2012, AM J CARDIOL, V109, P1524, DOI 10.1016/j.amjcard.2012.01.371; Paydak H, 1998, CIRCULATION, V98, P315, DOI 10.1161/01.CIR.98.4.315; Pokushalov E, 2013, HEART RHYTHM, V10, P1280, DOI 10.1016/j.hrthm.2013.04.016; Reithmann C, 2003, EUR HEART J, V24, P1264, DOI 10.1016/S0195-668X(03)00233-1; Schmieder S, 2003, EUR HEART J, V24, P956, DOI 10.1016/S0195-668X(02)00846-1; Shah DC, 1999, PACE, V22, P344, DOI 10.1111/j.1540-8159.1999.tb00449.x; Tulner LR, 2010, DRUG AGING, V27, P831, DOI 10.2165/11539330-000000000-00000; Wazni O, 2003, CIRCULATION, V108, P2479, DOI 10.1161/01.CIR.0000101684.88679.AB; Wellens HJJ, 2002, CIRCULATION, V106, P649, DOI 10.1161/01.CIR.0000027683.00417.9A; Wijetunga M, 2004, PACE, V27, P1428, DOI 10.1111/j.1540-8159.2004.00649.x; Zado ES, 2000, J AM COLL CARDIOL, V35, P458, DOI 10.1016/S0735-1097(99)00544-6	35	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127672	10.1371/journal.pone.0127672	http://dx.doi.org/10.1371/journal.pone.0127672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000772	Green Submitted, Green Published, gold			2022-12-26	WOS:000354931700072
J	Butler, AA; Heroux, ME; Gandevia, SC				Butler, Annie A.; Heroux, Martin E.; Gandevia, Simon C.			How Weight Affects the Perceived Spacing between the Thumb and Fingers during Grasping	PLOS ONE			English	Article							MOTOR COMMANDS; POSITION SENSE; BODY REPRESENTATION; ILLUSORY MOVEMENTS; LIFTING OBJECTS; SIZE; MUSCLE; HAND; PERCEPTION; SKIN	We know much about mechanisms determining the perceived size and weight of lifted objects, but little about how these properties of size and weight affect the body representation (e.g. grasp aperture of the hand). Without vision, subjects (n = 16) estimated spacing between fingers and thumb (perceived grasp aperture) while lifting canisters of the same width (6.6cm) but varied weights (300, 600, 900, and 1200 g). Lifts were performed by movement of either the wrist, elbow or shoulder to examine whether lifting with different muscle groups affects the judgement of grasp aperture. Results for perceived grasp aperture were compared with changes in perceived weight of objects of different sizes (5.2, 6.6, and 10 cm) but the same weight (600 g). When canisters of the same width but different weights were lifted, perceived grasp aperture decreased 4.8% [2.2 - 7.4] (mean [95% CI]; P < 0.001) from the lightest to the heaviest canister, no matter how they were lifted. For objects of the same weight but different widths, perceived weight decreased 42.3% [38.2 - 46.4] from narrowest to widest (P< 0.001), as expected from the size-weight illusion. Thus, despite a highly distorted perception of the weight of objects based on their size, we conclude that proprioceptive afferents maintain a reasonably stable perception of the aperture of the grasping hand over a wide range of object weights. Given the small magnitude of this 'weight-grasp aperture' illusion, we propose the brain has access to a relatively stable 'perceptual ruler' to aid the manipulation of different objects.	[Gandevia, Simon C.] Neurosci Res Australia, Sydney, NSW, Australia; Univ New S Wales, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney	Gandevia, SC (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	s.gandevia@neura.edu.au	Heroux, Martin/AAD-7694-2021; Gandevia, Simon/D-5009-2011	Heroux, Martin/0000-0002-3354-7104; Gandevia, Simon/0000-0002-1345-3821	National Health and Medical Research Council [1055084]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council (Grant number 1055084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo D, 2009, EXP BRAIN RES, V192, P87, DOI 10.1007/s00221-008-1560-0; AGLIOTI S, 1995, CURR BIOL, V5, P679, DOI 10.1016/S0960-9822(95)00133-3; Bays PM, 2007, J PHYSIOL-LONDON, V578, P387, DOI 10.1113/jphysiol.2006.120121; BERGMAN L, 1970, PSYCHOL FORSCH, V33, P310, DOI 10.1007/BF00424557; Berryman LJ, 2006, J NEUROPHYSIOL, V96, P27, DOI 10.1152/jn.01190.2005; Birznieks I, 2001, J NEUROSCI, V21, P8222, DOI 10.1523/JNEUROSCI.21-20-08222.2001; Buckingham G, 2014, EXP BRAIN RES, V232, P1623, DOI 10.1007/s00221-014-3926-9; Buckingham G, 2009, J NEUROPHYSIOL, V102, P3111, DOI 10.1152/jn.00515.2009; BURKE D, 1988, J PHYSIOL-LONDON, V402, P347, DOI 10.1113/jphysiol.1988.sp017208; Case LK, 2012, EXP BRAIN RES, V217, P79, DOI 10.1007/s00221-011-2974-7; Charpentier A., 1891, ARCHIVE PHYSIOLOGIE, V3, P122; Cole JD, 1995, BODY SELF, P245; Collins DF, 1996, J PHYSIOL-LONDON, V496, P857, DOI 10.1113/jphysiol.1996.sp021733; Collins DF, 2005, J NEUROPHYSIOL, V94, P1699, DOI 10.1152/jn.00191.2005; Craje C, 2011, EXP BRAIN RES, V212, P119, DOI 10.1007/s00221-011-2704-1; CRASKE B, 1977, SCIENCE, V196, P71, DOI 10.1126/science.841342; de Vignemont F, 2010, NEUROPSYCHOLOGIA, V48, P669, DOI 10.1016/j.neuropsychologia.2009.09.022; Dimitriou M, 2008, J NEUROSCI, V28, P12632, DOI 10.1523/JNEUROSCI.3357-08.2008; EDIN BB, 1992, J PHYSIOL-LONDON, V450, P547, DOI 10.1113/jphysiol.1992.sp019142; EDIN BB, 1991, J NEUROPHYSIOL, V65, P657, DOI 10.1152/jn.1991.65.3.657; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ellis RR, 1999, PERCEPT PSYCHOPHYS, V61, P1564, DOI 10.3758/BF03213118; ELLIS RR, 1993, PERCEPT PSYCHOPHYS, V53, P315, DOI 10.3758/BF03205186; Ernst MO, 2009, CURR BIOL, V19, pR23, DOI 10.1016/j.cub.2008.10.039; Farne A, 2000, NEUROREPORT, V11, P1645, DOI 10.1097/00001756-200006050-00010; Flanagan JR, 2008, CURR BIOL, V18, P1742, DOI 10.1016/j.cub.2008.09.042; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; FLANAGAN JR, 1995, PERCEPT PSYCHOPHYS, V57, P282, DOI 10.3758/BF03213054; Flanagan JR, 2002, ENCY HUMAN BRAIN, V2, P399, DOI DOI 10.1016/B0-12-227210-2/00157-6; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Gandevia SC, 1999, J PHYSIOL-LONDON, V514, P609, DOI 10.1111/j.1469-7793.1999.609ae.x; Gandevia SC, 2006, J PHYSIOL-LONDON, V571, P703, DOI 10.1113/jphysiol.2005.103093; GANDEVIA SC, 1987, TRENDS NEUROSCI, V10, P81, DOI 10.1016/0166-2236(87)90030-0; GANDEVIA SC, 1985, BRAIN, V108, P965, DOI 10.1093/brain/108.4.965; GANDEVIA SC, 1977, BRAIN, V100, P345, DOI 10.1093/brain/100.2.345; Gandevia SC, 2014, PROCEEDINGS FROM PHY, pC48; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GOODWIN AW, 1992, EXP BRAIN RES, V88, P447, DOI 10.1007/BF02259120; Hamilton AFD, 2004, EXP BRAIN RES, V157, P417, DOI 10.1007/s00221-004-1856-7; Head H, 1911, BRAIN, P34; Heroux ME, 2013, J PHYSIOL-LONDON, V591, P5661, DOI 10.1113/jphysiol.2013.261461; Hirsiger S, 2012, EXP BRAIN RES, V223, P137, DOI 10.1007/s00221-012-3247-9; Ho HN, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2899574; JEANNEROD M, 1994, NEUROPSYCHOLOGIA, V32, P369, DOI 10.1016/0028-3932(94)90084-1; JEANNEROD M, 1986, BEHAV BRAIN RES, V19, P99, DOI 10.1016/0166-4328(86)90008-2; Jeannerod M, 2009, EXP BRAIN RES, V192, P527, DOI 10.1007/s00221-008-1533-3; Jenmalm P, 1997, J NEUROSCI, V17, P4486; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; JONES LA, 1986, PSYCHOL BULL, V100, P29, DOI 10.1037/0033-2909.100.1.29; Linkenauger SA, 2014, PSYCHOL SCI, V25, P2086, DOI 10.1177/0956797614548875; Longo MR, 2010, P NATL ACAD SCI USA, V107, P11727, DOI 10.1073/pnas.1003483107; Longo MR, 2010, NEUROPSYCHOLOGIA, V48, P655, DOI 10.1016/j.neuropsychologia.2009.08.022; Luu BL, 2011, J PHYSIOL-LONDON, V589, P3135, DOI 10.1113/jphysiol.2011.208447; Macefield VG, 1996, EXP BRAIN RES, V108, P155; MCCLOSKEY DI, 1974, NEUROPSYCHOLOGIA, V12, P513, DOI 10.1016/0028-3932(74)90081-5; MILNER AD, 1993, PROG BRAIN RES, V95, P317, DOI 10.1016/S0079-6123(08)60379-9; Proske U, 2014, EXP BRAIN RES, V232, P3397, DOI 10.1007/s00221-014-4088-5; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; ROTHWELL JC, 1982, BRAIN, V105, P515, DOI 10.1093/brain/105.3.515; Santello M, 2002, J NEUROSCI, V22, P1426, DOI 10.1523/JNEUROSCI.22-04-01426.2002; Santello M, 1997, SOMATOSENS MOT RES, V14, P203; Santello M, 1998, J NEUROPHYSIOL, V79, P1307, DOI 10.1152/jn.1998.79.3.1307; Shibata D, 2014, FRONT HUM NEUROSCI, V8, DOI [10.3389/fnhum.2014.01050, 10.3389/fnhum.2014.00564]; Shibata D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066140; Smith JL, 2009, J APPL PHYSIOL, V106, P950, DOI 10.1152/japplphysiol.91365.2008; Usnadze D, 1931, PSYCHOL FORSCH, V14, P366, DOI 10.1007/BF00403879; VALLBO AB, 1974, ACTA PHYSIOL SCAND, V90, P319, DOI 10.1111/j.1748-1716.1974.tb05594.x; Walsh LD, 2014, SPRINGER TRAC ADV RO, V95, P123, DOI 10.1007/978-3-319-03017-3_6; Walsh LD, 2013, J PHYSIOL-LONDON, V591, P6103, DOI 10.1113/jphysiol.2013.259127; Walsh LD, 2011, J PHYSIOL-LONDON, V589, P3009, DOI 10.1113/jphysiol.2011.204941; Walsh LD, 2011, J PHYSIOL-LONDON, V589, P547, DOI 10.1113/jphysiol.2010.198689; Walsh LD, 2010, J PHYSIOL-LONDON, V588, P1269, DOI 10.1113/jphysiol.2009.183038; Walsh LD, 2009, EXP BRAIN RES, V195, P603, DOI 10.1007/s00221-009-1832-3; Whitham EM, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00160; Whitwell RL, 2008, EXP BRAIN RES, V188, P603, DOI 10.1007/s00221-008-1395-8; Williams LE, 2010, SCHIZOPHR RES, V121, P101, DOI 10.1016/j.schres.2009.10.021; Wilson LR, 1997, J PHYSIOL-LONDON, V504, P221, DOI 10.1111/j.1469-7793.1997.221bf.x	79	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127983	10.1371/journal.pone.0127983	http://dx.doi.org/10.1371/journal.pone.0127983			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996760	gold, Green Published, Green Submitted			2022-12-26	WOS:000356444000099
J	Gu, JM; Yang, JS; Chang, Q; Liu, ZH; Ghayur, T; Gu, JJ				Gu, Jinming; Yang, Jinsong; Chang, Qing; Liu, Zhihong; Ghayur, Tariq; Gu, Jijie			Identification of Anti-EGFR and Anti-ErbB3 Dual Variable Domains Immunoglobulin (DVD-Ig) Proteins with Unique Activities	PLOS ONE			English	Article							RECEPTOR; CANCER; HEREGULIN; ERBB3; EXPRESSION; CELLS	Epidermal growth factor receptor (EGFR) and receptor tyrosine-protein kinase 3 (ErbB3) are two well-established targets in cancer therapy. There is significant crosstalk among these two receptors and others. To block signaling from both EGFR and ErbB3, we generated anti-EGFR and anti-ErbB3 DVD-Ig proteins. Two DVD-Ig proteins maintained the functions of the combination of the two parental antibodies. The DVD-Ig proteins inhibit cell signaling and proliferation in A431 and FaDu cells while half DVD-Ig proteins lost proliferation inhibition function. Interestingly, in the presence of beta-Heregulin (HRG), the DVD-Ig proteins show synergies with respect to inhibiting cell proliferation. The DVD-Ig proteins downregulate EGFR protein expression in the presence of HRG, which may be due to receptor internalization. Furthermore, the DVD-Ig proteins remarkably disrupt beta-Heregulin binding to FaDu cells.	[Gu, Jinming; Yang, Jinsong; Chang, Qing; Ghayur, Tariq; Gu, Jijie] AbbVie Biores Ctr, R&D, Worcester, MA 01605 USA; [Liu, Zhihong] AbbVie Inc, R&D, Canc Res, N Chicago, IL 60064 USA	AbbVie; AbbVie	Gu, JM (corresponding author), AbbVie Biores Ctr, R&D, Worcester, MA 01605 USA.	jinming.gu@yahoo.com; jijie.gu@abbvie.com			AbbVie Inc.	AbbVie Inc.(AbbVie)	All authors were employees of AbbVie Inc. (formerly Abbott Laboratories) when this study was performed and authors may own AbbVie stock. AbbVie Inc. sponsored the study, contributed to the study design, participated in the collection, analysis and interpretation of the data, and in the writing, reviewing, and approval of this publication.	Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; DiGiammarino E, METHOD MOL BIOL, V899, P145, DOI [10.1007/978-1-61779-921-1_9, DOI 10.1007/978-1-61779-921-1_9]; Erjala K, 2006, CLIN CANCER RES, V12, P4103, DOI 10.1158/1078-0432.CCR-05-2404; Esteva FJ, PATHOLOGY ONCOLOGY R, V7, P171; Fukuda K, 2012, INT J ONCOL, V40, P975, DOI 10.3892/ijo.2011.1279; Gu JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097292; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jakob CG, MABS, V5; Lynch TJ, 2010, J CLIN ONCOL, V28, P911, DOI 10.1200/JCO.2009.21.9618; Lyne JC, CANC J SCI AM, V3, P21; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Schoeberl B, 2010, CANCER RES, V70, P2485, DOI 10.1158/0008-5472.CAN-09-3145; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Tsai MS, ONCOGENE, V22, P761; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wu CB, 2009, MABS, V1, P339, DOI 10.4161/mabs.1.4.8755	18	16	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0124135	10.1371/journal.pone.0124135	http://dx.doi.org/10.1371/journal.pone.0124135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25997020	Green Submitted, Green Published, gold			2022-12-26	WOS:000356444000003
J	Karimian, H; Fadaeinasab, M; Moghadamtousi, SZ; Hajrezaei, M; Razavi, M; Safi, SZ; Abdulla, MA; Ali, HM; Noordin, MI				Karimian, Hamed; Fadaeinasab, Mehran; Moghadamtousi, Soheil Zorofchian; Hajrezaei, Maryam; Razavi, Mahboubeh; Safi, Sher Zaman; Abdulla, Mahmood Ameen; Ali, Hapipah Mohd; Noordin, Mohamad Ibrahim			Chemopreventive Activity of Ferulago angulate against Breast Tumor in Rats and the Apoptotic Effect of Polycerasoidin in MCF7 Cells: A Bioassay-Guided Approach	PLOS ONE			English	Article							ANNONA MURICATA LEAVES; NUCLEAR ANTIGEN; CYCLE ARREST; IN-VITRO; CANCER; SURVIVAL; FAMILY; BCL-2; GROWTH	Ferulago angulataleaf hexane extract (FALHE) was found to be a potent inducer of MCF7 cell apoptosis. The aims of the present study were to investigate the in vivo chemopreventive effect of FALHE in rats, to identify the contributing anticancer compound in FALHE and to determine its potential mechanism of action against MCF7 cells. Thirty rats harboring LA7-induced breast tumors were divided into five groups: tumor control, low-dose FALHE, high-dose FALHE, treatment control (tamoxifen) and normal control. Breast tissues were then subjected to histopathological and immunohistochemical analyses. A bioassay-guided investigation on FALHE was performed to identify the cytotoxic compound and its mechanism of action through flow cytometry, real-time qPCR and western blotting analyses. An in vivo study showed that FALHE suppressed the expression of the tumor markers PCNA and Ki67. The tumor size was reduced from 2031 +/- 281 mm(3) to 432 +/- 201 mm(3) after FALHE treatment. FALHE administration induced apoptosis in breast tumor cells, and this was confirmed by high expression levels of Bax, p53 and caspase 3. Cell cycle arrest was suggested by the expression of p21 and p27. The in vitro experimental results resulted in the isolation of polycerasoidin as a bioactive ingredient of FALHE with an IC50 value of 3.16 +/- 0.31 mu g/ml against MCF7 cells. Polycerasoidin induced mitochondrial-dependent apoptosis in breast cancer cells via caspase activation and changes in the mRNA and protein expression of Bax and Bcl-2. In addition, flow cytometric analysis demonstrated that the treated MCF7 cells were arrested at the G(1) phase, and this was associated with the up-regulation of p21 and p27 at both the mRNA and protein levels. The results of the present study reinforce further investigations scrutinizing the promising potential of the F. angulata chemical constituents as breast cancer chemopreventive agents.	[Karimian, Hamed; Moghadamtousi, Soheil Zorofchian; Razavi, Mahboubeh; Noordin, Mohamad Ibrahim] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Fadaeinasab, Mehran; Ali, Hapipah Mohd] Univ Malaya, Fac Med, Dept Chem, Kuala Lumpur, Malaysia; [Safi, Sher Zaman] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Hajrezaei, Maryam; Abdulla, Mahmood Ameen] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Karimian, H (corresponding author), Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia.	hamedkarimian61@gmail.com; ibrahimn@um.edu.my	Safi, Sher Zaman/G-9599-2014; Noordin, Mohamed/AAK-4152-2021; Fadaeinasab, Mehran/A-8810-2016	Fadaeinasab, Mehran/0000-0002-2501-894X	University of Malaya; high impact research research grant (UM-MOHE) [UM.C/625/1/HIR/MOHE/SC/09]; Institute of Research Management and Monitoring research grant [PG053/2012B]	University of Malaya(Universiti Malaya); high impact research research grant (UM-MOHE); Institute of Research Management and Monitoring research grant	Financial support from the University of Malaya, the high impact research research grant (UM-MOHE UM.C/625/1/HIR/MOHE/SC/09), and the Institute of Research Management and Monitoring research grant (PG053/2012B) is greatly appreciated.	Abbasalipourkabir R, 2010, AFR J BIOTECHNOL, V9, P4491; Amirghofran Z, 2006, NEOPLASMA, V53, P428; Andrade FD, 2014, J NUTR BIOCHEM, V25, P613, DOI 10.1016/j.jnutbio.2014.02.002; Bardi DA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/918460; Bielitzki J., 2011, GUIDE CARE USE LAB A; Breckenridge DG, 2004, CURR OPIN CELL BIOL, V16, P647, DOI 10.1016/j.ceb.2004.09.009; Cheang MC, 2009, J NATL CANC I; Cocola C, 2008, CYTOTECHNOLOGY, V58, P25, DOI 10.1007/s10616-008-9173-9; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Esposito L, 2013, CURR PHARM DESIGN, V19, P5327, DOI 10.2174/13816128113199990377; Evergetis E, 2014, IND CROP PROD, V54, P70, DOI 10.1016/j.indcrop.2014.01.009; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Frenzel A, 2009, APOPTOSIS, V14, P584, DOI 10.1007/s10495-008-0300-z; GONZALEZ MC, 1995, J NAT PRODUCTS, V58, P1278, DOI 10.1021/np50122a022; Hajrezaie M, 2014, SCI WORLD J, DOI 10.1155/2014/540463; Hajrezaie M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091246; Karimian H, 2014, DRUG DES DEV THER, V8, P1481, DOI 10.2147/DDDT.S68818; Karimian H, 2014, MOLECULES, V19, P9478, DOI 10.3390/molecules19079478; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lakshmi A, 2014, BIOCHIMIE, V99, P96, DOI 10.1016/j.biochi.2013.11.017; Liew SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087286; Lin H, 2008, APOPTOSIS, V13, P247, DOI 10.1007/s10495-007-0170-9; Liu DP, 2010, ONCOGENE, V29, P949, DOI 10.1038/onc.2009.376; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; MAYER A, 1993, CANCER, V71, P2454, DOI 10.1002/1097-0142(19930415)71:8<2454::AID-CNCR2820710805>3.0.CO;2-2; Mirzaaghaei S, 2014, ARCH IRAN MED, V17, P278, DOI 014174/AIM.0011; Moghadamtousi SZ, 2014, J ETHNOPHARMACOL, V156, P277, DOI 10.1016/j.jep.2014.08.011; Moghadamtousi SZ, 2014, DRUG DES DEV THER, V8, P2099, DOI 10.2147/DDDT.S70096; Moghadamtousi SZ, 2014, SCI WORLD J, DOI 10.1155/2014/768323; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ocker M, 2012, EUR SURG RES, V48, P111, DOI 10.1159/000336875; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Paydar M, 2014, DRUG DES DEV THER, V8, P719, DOI 10.2147/DDDT.S58178; Peto J, 2001, NATURE, V411, P390, DOI 10.1038/35077256; Pietenpol JA, 2002, TOXICOLOGY, V181, P475, DOI 10.1016/S0300-483X(02)00460-2; Randhawa MA, 2011, AM J CHINESE MED, V39, P1075, DOI 10.1142/S0192415X1100941X; Rani M. L., 2014, Indian Journal of Veterinary Pathology, V38, P43; Shahneh F. Z., 2013, Journal of Medicinal Plants Research, V7, P677; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Sodeifian G, 2011, J SUPERCRIT FLUID, V57, P38, DOI 10.1016/j.supflu.2011.02.002; Taran M, 2010, JUNDISHAPUR J MICROB, V3, P10; Teegarden D, 2012, NUTR RES REV, V25, P68, DOI 10.1017/S0954422411000199; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0	47	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127434	10.1371/journal.pone.0127434	http://dx.doi.org/10.1371/journal.pone.0127434			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996383	gold, Green Published, Green Submitted			2022-12-26	WOS:000356444000066
J	Xu, SX; Wang, ZW; Gao, YQ; Zhang, SM; Wu, K				Xu, Shuxia; Wang, Zhiwei; Gao, Yuqian; Zhang, Shimin; Wu, Kun			Adsorption of Rare Earths(III) Using an Efficient Sodium Alginate Hydrogel Cross-Linked with Poly-gamma-Glutamate	PLOS ONE			English	Article							PHYSICOCHEMICAL PROPERTIES; AQUEOUS-SOLUTIONS; REMOVAL; EQUILIBRIUM; KINETICS; BEADS; WATER; BIOSORPTION; CHROMIUM; ACID	With the exploitation of rare earth ore, more and more REEs came into groundwater. This was a waste of resources and could be harmful to the organisms. This study aimed to find an efficient adsorption material to mitigate the above issue. Through doping sodium alginate (SA) with poly-gamma-glutamate (PGA), an immobilized gel particle material was produced. The composite exhibited excellent capacity for adsorbing rare earth elements (REEs). The amount of La3+ adsorbed on the SA-PGA gel particles reached approximately 163.93 mg/g compared to the 81.97 mg/g adsorbed on SA alone. The factors that potentially affected the adsorption efficiency of the SA-PGA composite, including the initial concentration of REEs, the adsorbent dosage, and the pH of the solution, were investigated. 15 types of REEs in single and mixed aqueous solutions were used to explore the selective adsorption of REEs on gel particles. Scanning electron microscopy (SEM) and Fourier transform infrared (FTIR) spectroscopy analyses of the SA and SA-PGA gel beads suggested that the carboxyl groups in the composite might play a key role in the adsorption process and the morphology of SA-PGA changed from the compact structure of SA to a porous structure after doping PGA. The kinetics and thermodynamics of the adsorption of REEs were well fit with the pseudo-second-order equation and the Langmuir adsorption isotherm model, respectively. It appears that SA-PGA is useful for recycling REEs from wastewater.	[Xu, Shuxia; Wang, Zhiwei; Gao, Yuqian; Zhang, Shimin; Wu, Kun] Henan Agr Univ, Coll Life Sci, Zhengzhou 450002, Peoples R China	Henan Agricultural University	Wu, K (corresponding author), Henan Agr Univ, Coll Life Sci, Zhengzhou 450002, Peoples R China.	wukun63@126.com			Henan Provincial Natural Science Foundation of China [2011180025]; Programs for Science and Technology Development [1224050012]	Henan Provincial Natural Science Foundation of China; Programs for Science and Technology Development	This work was financially supported by Henan Provincial Natural Science Foundation of China (No. 2011180025) and Programs for Science and Technology Development (No. 1224050012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashiuchi M, 2002, APPL MICROBIOL BIOT, V59, P9, DOI 10.1007/s00253-002-0984-x; Bao WW, 2013, CHEM RES CHINESE U, V29, P126, DOI 10.1007/s40242-013-2139-2; BREMMER W., 1994, RARE EARTHS SPECIALT, V3, P20; Brioschi L, 2013, PLANT SOIL, V366, P143, DOI 10.1007/s11104-012-1407-0; Chen H, 2011, J HAZARD MATER, V192, P246, DOI 10.1016/j.jhazmat.2011.05.014; Chen H, 2011, J HAZARD MATER, V186, P1320, DOI 10.1016/j.jhazmat.2010.12.006; Chen ZH, 2011, J RARE EARTH, V29, P1, DOI 10.1016/S1002-0721(10)60401-2; Demirbas E, 2004, WATER SA, V30, P533; Diban N, 2008, J FOOD ENG, V84, P82, DOI 10.1016/j.jfoodeng.2007.04.024; Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385; Gordon B., 2002, RARE EARTH ELEMENTS; Ho YS, 1998, PROCESS SAF ENVIRON, V76, P313, DOI 10.1205/095758298529678; Kilic M, 2009, BIORESOURCE TECHNOL, V100, P2130, DOI 10.1016/j.biortech.2008.11.002; Kwiatkowska-Marks S, 2011, PRZEM CHEM, V90, P1924; Lagergren S., 1898, HANDLINGER, DOI [10.4236/ss.2014.52008, DOI 10.4236/SS.2014.52008]; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Mark SS, 2006, BIOTECHNOL PROGR, V22, P523, DOI 10.1021/bp060040s; Moriwaki H, 2013, APPL MICROBIOL BIOT, V97, P3721, DOI 10.1007/s00253-012-4200-3; Ngomsik AF, 2009, J HAZARD MATER, V166, P1043, DOI 10.1016/j.jhazmat.2008.11.109; Sari A, 2008, J HAZARD MATER, V160, P349, DOI 10.1016/j.jhazmat.2008.03.005; Shu T, 2013, BIORESOURCE TECHNOL, V136, P182, DOI 10.1016/j.biortech.2013.02.087; Shukla A, 2002, J HAZARD MATER, V95, P137, DOI 10.1016/S0304-3894(02)00089-4; Studies CfSal, 2010, RAR EARTH EL WRENCH; Taniguchi M, 2005, J BIOSCI BIOENG, V99, P130, DOI 10.1263/jbb.99.130; Wang FC, 2013, IND ENG CHEM RES, V52, P3453, DOI 10.1021/ie302753q; Windhues T, 2003, CARBOHYD POLYM, V52, P47, DOI 10.1016/S0144-8617(02)00265-5; Yu K, 2013, COLLOID SURFACE A, V425, P31, DOI 10.1016/j.colsurfa.2012.12.043; Zhang L, 2011, J CHEM ENG DATA, V56, P2280, DOI 10.1021/je101270j	28	25	27	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0124826	10.1371/journal.pone.0124826	http://dx.doi.org/10.1371/journal.pone.0124826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996388	Green Submitted, Green Published, gold			2022-12-26	WOS:000356444000006
J	Huang, CY				Huang, Cheng-Yang			Inhibition of a Putative Dihydropyrimidinase from Pseudomonas aeruginosa PAO1 by Flavonoids and Substrates of Cyclic Amidohydrolases	PLOS ONE			English	Article							CARBOXYLATED LYSINE; GLUTAMINYL CYCLASE; CRYSTAL-STRUCTURES; BINDING; PROTEIN; DIHYDROOROTASE; METAL; HYDROLYSIS; PURIFICATION; ALLANTOINASE	Dihydropyrimidinase is a member of the cyclic amidohydrolase family, which also includes allantoinase, dihydroorotase, hydantoinase, and imidase. These metalloenzymes possess very similar active sites and may use a similar mechanism for catalysis. However, whether the substrates and inhibitors of other cyclic amidohydrolases can inhibit dihydropyrimidinase remains unclear. This study investigated the inhibition of dihydropyrimidinase by flavonoids and substrates of other cyclic amidohydrolases. Allantoin, dihydroorotate, 5hydantoin acetic acid, acetohydroxamate, orotic acid, and 3-amino-1,2,4-triazole could slightly inhibit dihydropyrimidinase, and the IC50 values of these compounds were within the millimolar range. The inhibition of dihydropyrimidinase by flavonoids, such as myricetin, quercetin, kaempferol, galangin, dihydromyricetin, and myricitrin, was also investigated. Some of these compounds are known as inhibitors of allantoinase and dihydroorotase. Although the inhibitory effects of these flavonoids on dihydropyrimidinase were substrate-dependent, dihydromyricetin significantly inhibited dihydropyrimidinase with IC50 values of 48 and 40 mu M for the substrates dihydrouracil and 5-propyl-hydantoin, respectively. The results from the Lineweaver-Burk plot indicated that dihydromyricetin was a competitive inhibitor. Results from fluorescence quenching analysis indicated that dihydromyricetin could form a stable complex with dihydropyrimidinase with the K-d value of 22.6 mu M. A structural study using PatchDock showed that dihydromyricetin was docked in the active site pocket of dihydropyrimidinase, which was consistent with the findings from kinetic and fluorescence studies. This study was the first to demonstrate that naturally occurring product dihydromyricetin inhibited dihydropyrimidinase, even more than the substrate analogs (>3 orders of magnitude). These flavonols, particularly myricetin, may serve as drug leads and dirty drugs (for multiple targets) for designing compounds that target several cyclic amidohydrolases.	[Huang, Cheng-Yang] Chung Shan Med Univ, Sch Biomed Sci, Taichung 40201, Taiwan; [Huang, Cheng-Yang] Chung Shan Med Univ Hosp, Dept Med Res, Taichung 40201, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Huang, CY (corresponding author), Chung Shan Med Univ, Sch Biomed Sci, 110,Sec 1,Chien Kuo N Rd, Taichung 40201, Taiwan.	cyhuang@csmu.edu.tw			Ministry of Science and Technology, Taiwan [MOST 103-2320-B-040-018-MY2]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by a grant from the Ministry of Science and Technology, Taiwan (MOST 103-2320-B-040-018-MY2 to C.Y. Huang). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenbuchner J, 2001, CURR OPIN BIOTECH, V12, P559, DOI 10.1016/S0958-1669(01)00263-4; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Burda S, 2001, J AGR FOOD CHEM, V49, P2774, DOI 10.1021/jf001413m; Bush K, 2010, CURR OPIN MICROBIOL, V13, P558, DOI 10.1016/j.mib.2010.09.006; Chen CC, 2011, PROTEIN J, V30, P59, DOI 10.1007/s10930-010-9302-0; Chen CC, 2006, NUCLEIC ACIDS RES, V34, pW152, DOI 10.1093/nar/gkl187; Cushnie TPT, 2005, INT J ANTIMICROB AG, V26, P343, DOI 10.1016/j.ijantimicag.2005.09.002; Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; Gojkovic Z, 2003, NUCLEIC ACIDS RES, V31, P1683, DOI 10.1093/nar/gkg258; Grande-Garcia A, 2014, STRUCTURE, V22, P185, DOI 10.1016/j.str.2013.10.016; Hermoso JA, 2014, STRUCTURE, V22, P179, DOI 10.1016/j.str.2014.01.005; Ho YY, 2013, AMINO ACIDS, V44, P1181, DOI 10.1007/s00726-012-1451-3; HOLLAND DR, 1995, PROTEIN SCI, V4, P1955, DOI 10.1002/pro.5560041001; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; Hsieh HC, 2011, BIOCHEM BIOPH RES CO, V404, P546, DOI 10.1016/j.bbrc.2010.12.023; Hsieh YC, 2013, J BIOL CHEM, V288, P30645, DOI 10.1074/jbc.M113.496778; Hsu CC, 2010, EXPERT OPIN DRUG MET, V6, P591, DOI 10.1517/17425251003601987; Huang CY, 2009, J BIOL INORG CHEM, V14, P111, DOI 10.1007/s00775-008-0428-x; Huang CY, 2003, BIOCHEM BIOPH RES CO, V312, P467, DOI 10.1016/j.bbrc.2003.10.151; Huang CY, 2002, BIOCHEM BIOPH RES CO, V297, P1027, DOI 10.1016/S0006-291X(02)02330-6; Huang KF, 2014, ACTA CRYSTALLOGR D, V70, P789, DOI 10.1107/S1399004713033488; Huang KF, 2005, PROTEIN EXPRES PURIF, V43, P65, DOI 10.1016/j.pep.2005.02.020; Huang YH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/573936; Huang YH, 2013, BIOCHEM BIOPH RES CO, V442, P147, DOI 10.1016/j.bbrc.2013.11.069; Huang YH, 2013, GENES CELLS, V18, P1007, DOI 10.1111/gtc.12095; Huang YH, 2012, GENES CELLS, V17, P837, DOI 10.1111/gtc.12001; Huang YH, 2012, GENES CELLS, V17, P146, DOI 10.1111/j.1365-2443.2011.01577.x; Keum YS, 2012, BIOCHEM PHARMACOL, V84, P1351, DOI 10.1016/j.bcp.2012.08.012; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Kumar V, 2011, PROTEIN PEPTIDE LETT, V18, P663, DOI 10.2174/092986611795446049; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lin HB, 2012, SCI TECHNOL NUCL INS, V2012, DOI 10.1155/2012/501532; Lohkamp B, 2006, J BIOL CHEM, V281, P13762, DOI 10.1074/jbc.M513266200; Martinez-Rodriguez S, 2010, J STRUCT BIOL, V169, P200, DOI 10.1016/j.jsb.2009.10.013; Patrick G.L., 2013, INTRO MED CHEM, V5th; Peng WF, 2014, BIOCHIMIE, V101, P113, DOI 10.1016/j.biochi.2014.01.001; Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957; Schnackerz KD, 2008, BBA-PROTEINS PROTEOM, V1784, P431, DOI 10.1016/j.bbapap.2008.01.005; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schoemaker HE, 2003, SCIENCE, V299, P1694, DOI 10.1126/science.1079237; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Shadrick WR, 2013, J BIOMOL SCREEN, V18, P761, DOI 10.1177/1087057113482586; Teillet F, 2008, MED RES REV, V28, P715, DOI 10.1002/med.20122; WALLACH DP, 1957, J BIOL CHEM, V226, P277; Wolfe KL, 2008, J AGR FOOD CHEM, V56, P8404, DOI 10.1021/jf8013074; Xu H, 2001, NUCLEIC ACIDS RES, V29, P5058, DOI 10.1093/nar/29.24.5058; Yang YL, 1998, J BIOL CHEM, V273, P7814, DOI 10.1074/jbc.273.14.7814; YANG YS, 1993, J BIOL CHEM, V268, P10870; Zhao WH, 2010, CRIT REV MICROBIOL, V36, P245, DOI 10.3109/1040841X.2010.481763	51	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127634	10.1371/journal.pone.0127634	http://dx.doi.org/10.1371/journal.pone.0127634			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993634	Green Published, Green Submitted, gold			2022-12-26	WOS:000354918600070
J	Khan, M; Malik, R; Munir, A; Khan, WA				Khan, Masood; Malik, Rabia; Munir, Asif; Khan, Waqar Azeem			Flow and Heat Transfer to Sisko Nanofluid over a Nonlinear Stretching Sheet	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; BUONGIORNOS MODEL; SURFACE; SUCTION	The two-dimensional boundary layer flow and heat transfer to Sisko nanofluid over a non-linearly stretching sheet is scrutinized in the concerned study. Our nanofluid model incorporates the influences of the thermophoresis and Brownian motion. The convective boundary conditions are taken into account. Implementation of suitable transformations agreeing with the boundary conditions result in reduction of the governing equations of motion, energy and concentration into non-linear ordinary differential equations. These coupled non-linear ordinary differential equations are solved analytically by using the homotopy analysis method (HAM) and numerically by the shooting technique. The effects of the thermophoresis and Brownian motion parameters on the temperature and concentration fields are analyzed and graphically presented. The secured results make it clear that the temperature distribution is an increasing function of the thermophoresis and Brownian motion parameters and concentration distribution increases with the thermophoresis parameter but decreases with the Brownian motion parameter. To see the validity of the present work, we made a comparison with the numerical results as well as previously published work with an outstanding compatibility.	[Khan, Masood; Malik, Rabia; Munir, Asif; Khan, Waqar Azeem] Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan	Quaid I Azam University	Malik, R (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan.	rabiamalik.qau@gmail.com	KHAN, Masood/AAA-7384-2020; khan, Masood/F-7143-2015; Khan, Dr. Waqar Azeem/AAZ-9625-2021	KHAN, Masood/0000-0003-4404-1456; 				Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Choi S.U.S., 1995, ENHANCING THERMAL CO, V231, P99; GORLA RSR, 1994, APPL SCI RES, V52, P247, DOI 10.1007/BF00853952; Hady F.M., 2014, APPL MATH INF SCI LE, V2, P43, DOI DOI 10.12785/AMISL/020203; Hady FM, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-229; Hayat T, 2013, COMPUT FLUIDS, V86, P103, DOI 10.1016/j.compfluid.2013.07.003; Hayat T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083153; Khan WA, 2011, INT J THERM SCI, V50, P2154, DOI 10.1016/j.ijthermalsci.2011.05.022; Khan WA, 2010, INT J HEAT MASS TRAN, V53, P2477, DOI 10.1016/j.ijheatmasstransfer.2010.01.032; Khan WA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105107; Kwak K, 2005, KOREA-AUST RHEOL J, V17, P35; Malik R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107989; Malvandi A, 2014, INT J THERM SCI, V84, P196, DOI 10.1016/j.ijthermalsci.2014.05.013; Masuda H., 1993, NETSU BUSSEI, V4, P227, DOI [10.2963/jjtp.7.227, DOI 10.2963/JJTP.7.227]; Munir A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100056; Rahman MM, 2014, INT J HEAT MASS TRAN, V77, P1133, DOI 10.1016/j.ijheatmasstransfer.2014.06.013; Rohni AM, 2013, INT COMMUN HEAT MASS, V43, P75, DOI 10.1016/j.icheatmasstransfer.2013.02.001; Rosca NC, 2014, COMPUT FLUIDS, V95, P49, DOI 10.1016/j.compfluid.2014.02.011; Sanjayanand E, 2006, INT J THERM SCI, V45, P819, DOI 10.1016/j.ijthermalsci.2005.11.002; SISKO AW, 1958, IND ENG CHEM, V50, P1789, DOI 10.1021/ie50588a042; Wang C. Y., 1989, J APPL MATH MECH ZAM, V69, P418; Zaimi K, 2014, INT J HEAT MASS TRAN, V68, P509, DOI 10.1016/j.ijheatmasstransfer.2013.09.047	22	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0125683	10.1371/journal.pone.0125683	http://dx.doi.org/10.1371/journal.pone.0125683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993658	Green Published, Green Submitted, gold			2022-12-26	WOS:000354917300022
J	Tuz, K; Mezic, KG; Xu, TH; Barquera, B; Juarez, O				Tuz, Karina; Mezic, Katherine G.; Xu, Tianhao; Barquera, Blanca; Juarez, Oscar			The Kinetic Reaction Mechanism of the Vibrio cholerae Sodium-dependent NADH Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-TRANSLOCATING NADH; PUMPING NADHQUINONE OXIDOREDUCTASE; QUINONE OXIDOREDUCTASE; BINDING-SITE; UBIQUINONE OXIDOREDUCTASE; SUBUNIT-B; NADHUBIQUINONE OXIDOREDUCTASE; CONFORMATIONAL-CHANGES; CHARGE TRANSLOCATION; PROSTHETIC GROUPS	The sodium-dependent NADH dehydrogenase (Na+-NQR) is the main ion transporter in Vibrio cholerae. Its activity is linked to the operation of the respiratory chain and is essential for the development of the pathogenic phenotype. Previous studies have described different aspects of the enzyme, including the electron transfer pathways, sodium pumping structures, cofactor and subunit composition, among others. However, the mechanism of the enzyme remains to be completely elucidated. In this work, we have studied the kinetic mechanism of Na+-NQR with the use of steady state kinetics and stopped flow analysis. Na+-NQR follows a hexa-uni ping-pong mechanism, in which NADH acts as the first substrate, reacts with the enzyme, and the oxidized NAD leaves the catalytic site. In this conformation, the enzyme is able to capture two sodium ions and transport them to the external side of the membrane. In the last step, ubiquinone is bound and reduced, and ubiquinol is released. Our data also demonstrate that the catalytic cycle involves two redox states, the three-and five-electron reduced forms. A model that gathers all available information is proposed to explain the kinetic mechanism of Na+-NQR. This model provides a background to understand the current structural and functional information.	[Tuz, Karina; Xu, Tianhao; Juarez, Oscar] IIT, Dept Biol Sci, Chicago, IL 60616 USA; [Mezic, Katherine G.; Barquera, Blanca] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA	Illinois Institute of Technology; Rensselaer Polytechnic Institute	Juarez, O (corresponding author), Life Sci Bldg,3101 S Dearborn St, Chicago, IL 60616 USA.	ojuarez@iit.edu		Xu, Tianhao/0000-0003-2935-6353; Juarez, Oscar/0000-0002-2915-8413; Tuz, Karina/0000-0002-1669-4612	Illinois Institute of Technology startup funds; National Science Foundation [MCB-1052234]	Illinois Institute of Technology startup funds; National Science Foundation(National Science Foundation (NSF))	This work was supported by Illinois Institute of Technology startup funds (to O. J.) and National Science Foundation Grant MCB-1052234 (to B. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2003, J AM CHEM SOC, V125, P265, DOI 10.1021/ja0207201; Barquera B, 2006, J BIOL CHEM, V281, P36482, DOI 10.1074/jbc.M605765200; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6291, DOI 10.1021/bi900524m; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6299, DOI 10.1021/bi900525v; Bogachev AV, 2009, J BIOL CHEM, V284, P5533, DOI 10.1074/jbc.M808984200; BUHLER R, 1991, J MEMBRANE BIOL, V121, P141, DOI 10.1007/BF01870529; Casutt MS, 2011, J BIOL CHEM, V286, P40075, DOI 10.1074/jbc.M111.224980; Casutt MS, 2010, J BIOL CHEM, V285, P27088, DOI 10.1074/jbc.M109.071126; Clarke RJ, 1998, BIOPHYS J, V75, P1340, DOI 10.1016/S0006-3495(98)74052-4; Duffy EB, 2006, J BACTERIOL, V188, P8343, DOI 10.1128/JB.01383-06; Fadeeva MS, 2008, BIOCHEMISTRY-MOSCOW+, V73, P123, DOI 10.1134/S0006297908020028; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Hayashi M, 2001, BBA-BIOENERGETICS, V1505, P37, DOI 10.1016/S0005-2728(00)00275-9; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; Juarez O, 2012, BBA-BIOENERGETICS, V1817, P1823, DOI 10.1016/j.bbabio.2012.03.017; Juarez O, 2012, J BIOL CHEM, V287, P25678, DOI 10.1074/jbc.M112.366088; Juarez O, 2011, J BIOL CHEM, V286, P26383, DOI 10.1074/jbc.M111.257873; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; KUBOTA T, 1992, J BIOCHEM-TOKYO, V111, P91, DOI 10.1093/oxfordjournals.jbchem.a123725; Marvig RL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-155; MCMINN CL, 1977, BIOCHEM J, V161, P569, DOI 10.1042/bj1610569; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Nakayama Y, 1999, BIOL PHARM BULL, V22, P1064; Nedielkov R, 2013, J BIOL CHEM, V288, P30597, DOI 10.1074/jbc.M112.435750; Neehaubl Y, 2013, BIOCHEMISTRY-US, V52, P3085, DOI 10.1021/bi4000386; Neehaul Y, 2012, BIOCHEMISTRY-US, V51, P4072, DOI 10.1021/bi300343u; NGO TT, 1978, J NEUROCHEM, V31, P69, DOI 10.1111/j.1471-4159.1978.tb12434.x; PfenningerLi XD, 1996, BIOCHEMISTRY-US, V35, P6233, DOI 10.1021/bi953032l; PRATAP PR, 1991, BIOCHIM BIOPHYS ACTA, V1069, P288, DOI 10.1016/0005-2736(91)90137-W; PRATAP PR, 1993, BIOCHIM BIOPHYS ACTA, V1151, P89, DOI 10.1016/0005-2736(93)90075-B; Reyes-Prieto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096696; Segel IH, 1993, ENZYME KINETICS, P506; Shea ME, 2015, BIOCHEMISTRY-US, V54, P490, DOI 10.1021/bi501266e; Shea ME, 2013, J BIOL CHEM, V288, P31241, DOI 10.1074/jbc.M113.510776; SKULACHEV VP, 1989, J BIOENERG BIOMEMBR, V21, P635, DOI 10.1007/BF00762683; Steuber J, 2014, NATURE, V516, P62, DOI 10.1038/nature14003; Steuber J, 2014, BIOL CHEM, V395, P1389, DOI 10.1515/hsz-2014-0204; Strickland M, 2014, J BIOL CHEM, V289, P23723, DOI 10.1074/jbc.M114.574640; STURMER W, 1991, J MEMBRANE BIOL, V121, P163, DOI 10.1007/BF01870530; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; Turk K, 2004, J BIOL CHEM, V279, P21349, DOI 10.1074/jbc.M311692200; Verkhovsky MI, 2010, BBA-BIOENERGETICS, V1797, P738, DOI 10.1016/j.bbabio.2009.12.020; YAGI T, 1991, J BIOENERG BIOMEMBR, V23, P211, DOI 10.1007/BF00762218; Zhou WD, 1999, BIOCHEMISTRY-US, V38, P16246, DOI 10.1021/bi991664s	51	18	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20009	20021		10.1074/jbc.M115.658773	http://dx.doi.org/10.1074/jbc.M115.658773			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26004776	Green Published, hybrid			2022-12-26	WOS:000359608900001
J	Dalpiaz, PLM; Lamas, AZ; Caliman, IF; Ribeiro, RF; Abreu, GR; Moyses, MR; Andrade, TU; Gouvea, SA; Alves, MF; Carmona, AK; Bissoli, NS				Dalpiaz, P. L. M.; Lamas, A. Z.; Caliman, I. F.; Ribeiro, R. F., Jr.; Abreu, G. R.; Moyses, M. R.; Andrade, T. U.; Gouvea, S. A.; Alves, M. F.; Carmona, A. K.; Bissoli, N. S.			Sex Hormones Promote Opposite Effects on ACE and ACE2 Activity, Hypertrophy and Cardiac Contractility in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; II-INDUCED HYPERTENSION; GENDER-DIFFERENCES; BLOOD-PRESSURE; HEART-FAILURE; CONVERTING ENZYME-2; TYPE-2 RECEPTOR; EXPRESSION; PHOSPHOLAMBAN; MODULATION	Background There is growing interest in sex differences and RAS components. However, whether gender influences cardiac angiotensin I-converting enzyme (ACE) and angiotensin-converting enzyme 2 (ACE2) activity is still unknown. In the present work, we determined the relationship between ACE and ACE2 activity, left ventricular function and gender in spontaneously hypertensive rats (SHRs). Methodology / Principal Findings Twelve-week-old female (F) and male (M) SHRs were divided into 2 experimental groups (n = 7 in each group): sham (S) and gonadectomized (G). Fifty days after gonadectomy, we measured positive and negative first derivatives (dP/dt maximum left ventricle (LV) and dP/dt minimum LV, respectively), hypertrophy (morphometric analysis) and ACE and ACE2 catalytic activity (fluorimetrically). Expression of calcium handling proteins was measured by western blot. Male rats exhibited higher cardiac ACE and ACE2 activity as well as hypertrophy compared to female rats. Orchiectomy decreased the activity of these enzymes and hypertrophy, while ovariectomy increased hypertrophy and ACE2, but did not change ACE activity. For cardiac function, the male sham group had a lower +dP/dt than the female sham group. After gonadectomy, the +dP/dt increased in males and reduced in females. The male sham group had a lower -dP/dt than the female group. After gonadectomy, the -dP/dt increased in the male and decreased in the female groups when compared to the sham group. No difference was observed among the groups in SERCA2a protein expression. Gonadectomy increased protein expression of PLB (phospholamban) and the PLB to SERCA2a ratio in female rats, but did not change in male rats. Conclusion Ovariectomy leads to increased cardiac hypertrophy, ACE2 activity, PLB expression and PLB to SERCA2a ratio, and worsening of hemodynamic variables, whereas in males the removal of testosterone has the opposite effects on RAS components.	[Dalpiaz, P. L. M.; Lamas, A. Z.; Caliman, I. F.; Ribeiro, R. F., Jr.; Abreu, G. R.; Moyses, M. R.; Bissoli, N. S.] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil; [Andrade, T. U.] Univ Vila Velha, Dept Pharm, Vila Velha, ES, Brazil; [Gouvea, S. A.] Univ Fed Espirito Santo, Nucleus Biotechnol, Vitoria, ES, Brazil; [Alves, M. F.; Carmona, A. K.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biophys, Sao Paulo, Brazil	Universidade Federal do Espirito Santo; Centro Universitario Vila Velha; Universidade Federal do Espirito Santo; Universidade Federal de Sao Paulo (UNIFESP)	Dalpiaz, PLM (corresponding author), Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil.	polyvitoria@yahoo.com.br	Ribeiro, Rogerio/F-7116-2012; Bissoli, Nazare/ABA-2679-2021; Carmona, Adriana K/D-2240-2012; Andrade, Tadeu U/M-4616-2016; dalpiaz, Polyana/AFK-3054-2022	Ribeiro, Rogerio/0000-0002-9725-3869; Carmona, Adriana K/0000-0003-3311-5456; Andrade, Tadeu U/0000-0001-6387-7895; Caliman, Izabela/0000-0002-6357-1375	FAPES Casadinho/Procad [54688175/2011]	FAPES Casadinho/Procad	FAPES Casadinho/Procad, 54688175/2011; http://www.fapes.es.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MF, 2005, BRAZ J MED BIOL RES, V38, P861, DOI 10.1590/S0100-879X2005000600007; BACHMANN J, 1993, J HYPERTENS, V11, pS226; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Bhatia K, 2013, AM J HYPERTENS, V26, P591, DOI 10.1093/ajh/hps088; Brosnihan KB, 1997, AM J PHYSIOL-REG I, V273, pR1908, DOI 10.1152/ajpregu.1997.273.6.R1908; Bubb KJ, 2012, BRIT J PHARMACOL, V167, P298, DOI 10.1111/j.1476-5381.2012.02036.x; Burchill L, 2008, EXP PHYSIOL, V93, P622, DOI 10.1113/expphysiol.2007.040386; Burrell LM, 2005, EUR HEART J, V26, P369, DOI 10.1093/eurheartj/ehi114; Burrell LM, 2004, TRENDS ENDOCRIN MET, V15, P166, DOI 10.1016/j.tem.2004.03.001; Campbell DJ, 2004, HYPERTENSION, V43, P854, DOI 10.1161/01.HYP.0000119190.06968.f1; Campbell DJ, 2003, HYPERTENSION, V41, P383, DOI 10.1161/01.HYP.0000054215.71691.16; Chappell MC, 2003, HYPERTENSION, V42, P781, DOI 10.1161/01.HYP.0000085210.66399.A3; Chen J, 2003, AM J PHYS HEAR CIRC, V27709, P2657; CHEN YF, 1992, HYPERTENSION, V19, P456, DOI 10.1161/01.HYP.19.5.456; Chu SH, 2005, LIFE SCI, V76, P2735, DOI 10.1016/j.lfs.2004.12.013; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Crowley SD, 2012, EXP CELL RES, V318, P1049, DOI 10.1016/j.yexcr.2012.02.023; Dalpiaz PLM, 2013, BRAZ J MED BIOL RES, V46, P171, DOI 10.1590/1414-431X20122472; Dias DPM, 2010, BRAZ J MED BIOL RES, V43, P969, DOI 10.1590/S0100-879X2010001000008; Dong B, 2012, J AM COLL CARDIOL, V59, P739, DOI 10.1016/j.jacc.2011.09.071; Duarte DR, 2009, CLINICS, V64, P691, DOI 10.1590/S1807-59322009000700014; ELLISON KE, 1989, J CLIN INVEST, V83, P1941, DOI 10.1172/JCI114102; Fabris B, 2011, J HYPERTENS, V29, P273, DOI 10.1097/HJH.0b013e328340d0d3; Falcon BL, 2004, PHYSIOL GENOMICS, V19, P255, DOI 10.1152/physiolgenomics.00170.2004; Ferreira AJ, 2010, HYPERTENSION, V55, P207, DOI 10.1161/HYPERTENSIONAHA.109.140145; Ferreira C, 2010, CLINICS, V65, P723, DOI 10.1590/S1807-59322010000700012; Gallagher PE, 2006, AM J PHYSIOL-CELL PH, V290, pC420, DOI 10.1152/ajpcell.00409.2004; Hayasaki-Kajiwara Y, 1999, J MOL CELL CARDIOL, V31, P1559, DOI 10.1006/jmcc.1999.0993; Hilliard LM, 2013, CURR HYPERTENS REP, V15, P71, DOI 10.1007/s11906-012-0319-y; Hudson M, 2007, EUR J HEART FAIL, V9, P602, DOI 10.1016/j.ejheart.2007.02.001; Kadambi VJ, 1996, J CLIN INVEST, V97, P533, DOI 10.1172/JCI118446; Kassiri Z, 2009, CIRC-HEART FAIL, V2, P446, DOI 10.1161/CIRCHEARTFAILURE.108.840124; Khalil RA, 2005, HYPERTENSION, V46, P249, DOI 10.1161/01.HYP.0000172945.06681.a4; Komukai K, 2010, FUND CLIN PHARMACOL, V24, P687, DOI 10.1111/j.1472-8206.2010.00854.x; Koss KL, 1997, BASIC RES CARDIOL, V92, P17, DOI 10.1007/BF00794064; Li L, 2008, PHARMACOL RES, V58, P196, DOI 10.1016/j.phrs.2008.06.009; Lim YK, 2002, ATHEROSCLEROSIS, V160, P311, DOI 10.1016/S0021-9150(01)00576-7; Lindsey SH, 2009, ENDOCRINOLOGY, V150, P3753, DOI 10.1210/en.2008-1664; Maric-Bilkan C, 2012, GENDER MED, V9, P287, DOI 10.1016/j.genm.2012.06.005; Os I, 2008, HYPERTENSION, V51, P1103, DOI 10.1161/HYPERTENSIONAHA.107.105296; Pelzer T, 2005, CARDIOVASC RES, V67, P604, DOI 10.1016/j.cardiores.2005.04.035; Pendergrass KD, 2008, AM J PHYSIOL-HEART C, V295, pH10, DOI 10.1152/ajpheart.01277.2007; Piro M, 2010, J AM COLL CARDIOL, V55, P1057, DOI 10.1016/j.jacc.2009.09.065; R Jr RF, 2010, LIPIDS HLTH DIS, V9, P1, DOI 10.1186/1476-511X-9-1; Reckelhoff JF, 1998, HYPERTENSION, V31, P435, DOI 10.1161/01.HYP.31.1.435; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; Reckelhoff JF, 1999, HYPERTENSION, V34, P920, DOI 10.1161/01.HYP.34.4.920; Reckelhoff JF, 2000, HYPERTENSION, V35, P480, DOI 10.1161/01.HYP.35.1.480; Remme WJ, 2003, CARDIOVASC DRUG THER, V17, P349, DOI 10.1023/A:1027351808326; Riviere G, 2005, HYPERTENSION, V46, P1169, DOI 10.1161/01.HYP.0000185148.27901.fe; Sarkissian SD, 2008, HYPERTENSION, V51, P712, DOI 10.1161/HYPERTENSIONAHA.107.100693; Sarkissian SD, 2013, J AM SOC HYPERTENS, V7, P118, DOI 10.1016/j.jash.2013.01.002; Shenoy V, 2009, PEPTIDES, V30, P2309, DOI 10.1016/j.peptides.2009.09.005; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Sullivan JC, 2008, AM J PHYSIOL-REG I, V294, pR1220, DOI 10.1152/ajpregu.00864.2007; Sullivan JC, 2010, HYPERTENSION, V56, P658, DOI 10.1161/HYPERTENSIONAHA.110.153668; Tatchum-Talom R, 2011, J CARDIOVASC PHARM, V57, P357, DOI 10.1097/FJC.0b013e31820b7dc9; VALLOTTON MB, 1987, TRENDS PHARMACOL SCI, V8, P69, DOI 10.1016/0165-6147(87)90013-7; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Wang X, 2003, J APPL PHYSIOL, V94, P752, DOI 10.1152/japplphysiol.00248.2002; Xue BJ, 2005, AM J PHYSIOL-HEART C, V288, pH2177, DOI 10.1152/ajpheart.00969.2004; Yanes LL, 2009, AM J PHYSIOL-HEART C, V297, pH1583, DOI 10.1152/ajpheart.00901.2009; YIN FCP, 1982, AM J PHYSIOL, V243, pH941, DOI 10.1152/ajpheart.1982.243.6.H941; Zhao YX, 2010, HUM GENE THER, V21, P1545, DOI 10.1089/hum.2009.160; Zimmerman MA, 2013, PHYSIOLOGY, V28, P234, DOI 10.1152/physiol.00013.2013	65	78	79	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127515	10.1371/journal.pone.0127515	http://dx.doi.org/10.1371/journal.pone.0127515			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010093	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900103
J	Jian, WJ; Zhong, L; Wen, J; Tang, Y; Qiu, B; Wu, ZQ; Yan, JH; Zhou, XH; Zhao, T				Jian, Wenjing; Zhong, Lin; Wen, Jing; Tang, Yao; Qiu, Bo; Wu, Ziqing; Yan, Jinhai; Zhou, Xinhua; Zhao, Tong			SEPTIN2 and STATHMIN Regulate CD99-Mediated Cellular Differentiation in Hodgkin's Lymphoma	PLOS ONE			English	Article							REED-STERNBERG CELLS; HIGH EXPRESSION; GENE FAMILY; PHOSPHOPROTEIN; CD99; ORGANIZATION; LYMPHOCYTES; ACTIVATION; GENERATION; INHIBITION	Hodgkin's lymphoma (HL) is a lymphoid neoplasm characterized by Hodgkin's and Reed-Sternberg (H/RS) cells, which is regulated by CD99. We previously reported that CD99 downregulation led to the transformation of murine B lymphoma cells (A20) into cells with an H/RS phenotype, while CD99upregulation induced differentiation of classical Hodgkin's lymphoma (cHL) cells (L428) into terminal B-cells. However, the molecular mechanism remains unclear. In this study, using fluorescence two-dimensional differential in-gel electrophoresis and matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS), we have analyzed the alteration of protein expression following CD99 upregulation in L428 cells as well as downregulation of mouse CD99 antigen-like 2 (mCD99L2) in A20 cells. Bioinformatics analysis showed that SEPTIN2 and STATHMIN, which are cytoskeleton proteins, were significantly differentially expressed, and chosen for further validation and functional analysis. Differential expression of SEPTIN2 was found in both models and was inversely correlated with CD99 expression. STATHMIN was identified in the A20 cell line model and its expression was positively correlated with that of CD99. Importantly, silencing of SEPTIN2 with siRNA substantially altered the cellular cytoskeleton in L428 cells. The downregulation of STATHMIN by siRNA promoted the differentiation of H/RS cells toward terminal B-cells. These results suggest that SEPTIN2-mediated cytoskeletal rearrangement and STATHMIN-mediated differentiation may contribute to changes in cell morphology and differentiation of H/RS cells with CD99 upregulation in HL.	[Jian, Wenjing; Wen, Jing; Tang, Yao; Qiu, Bo; Wu, Ziqing; Yan, Jinhai; Zhou, Xinhua] Southern Med Univ, Sch Basic Med Sci, Dept Mol & Tumor Pathol, Lab Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Zhong, Lin; Zhao, Tong] Southern Med Univ, Affiliated Hosp 3, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Zhou, XH (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Mol & Tumor Pathol, Lab Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	balbc@smu.edu.cn; zhaotongketizu@126.com	wen, jing/HDM-2205-2022		National Natural Science Foundation of China [81071941, 81302051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from National Natural Science Foundation of China (Grant numbers: 81071941, 81302051).	Alli E, 2002, CANCER RES, V62, P6864; Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Buettner M, 2005, HEMATOL ONCOL, V23, P127, DOI 10.1002/hon.764; Calame K, 2008, CURR OPIN IMMUNOL, V20, P259, DOI 10.1016/j.coi.2008.04.010; Charbaut E, 2001, J BIOL CHEM, V276, P16146, DOI 10.1074/jbc.M010637200; DOYE V, 1992, DIFFERENTIATION, V50, P89, DOI 10.1111/j.1432-0436.1992.tb00489.x; DWORZAK MN, 1994, BLOOD, V83, P415, DOI 10.1182/blood.V83.2.415.bloodjournal832415; Farrell K, 2011, HISTOPATHOLOGY, V58, P15, DOI 10.1111/j.1365-2559.2010.03705.x; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Gavet O, 1998, J CELL SCI, V111, P3333; GRATIOTDEANS J, 1992, J CLIN INVEST, V90, P1576, DOI 10.1172/JCI116026; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Hertel CB, 2002, ONCOGENE, V21, P4908, DOI 10.1038/sj.onc.1205629; Holmfeldt P, 2001, MOL BIOL CELL, V12, P73, DOI 10.1091/mbc.12.1.73; Huang XP, 2012, INT J CANCER, V131, pE382, DOI 10.1002/ijc.26503; Iancu C, 2001, J CELL SCI, V114, P909; Iancu-Rubin C, 2005, CELL CYCLE, V4, P1774, DOI 10.4161/cc.4.12.2171; Iancu-Rubin C, 2011, BLOOD, V117, P4580, DOI 10.1182/blood-2010-09-305540; Isobe K, 2001, LEUKEMIA LYMPHOMA, V42, P499, DOI 10.3109/10428190109064607; Jeha S, 1996, CANCER RES, V56, P1445; KIM KJ, 1979, J IMMUNOL, V122, P549; Kim SH, 1998, BLOOD, V92, P4287, DOI 10.1182/blood.V92.11.4287.423k41_4287_4295; Kotoula V, 2002, LEUKEMIA LYMPHOMA, V43, P393, DOI 10.1080/10428190290006215; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Kuppers R, 2002, ADV CANCER RES, V84, P277, DOI 10.1016/S0065-230X(02)84009-X; Lee IS, 2003, INT J HEMATOL, V77, P330, DOI 10.1007/BF02982639; Lin O, 2009, APPL IMMUNOHISTO M M, V17, P409, DOI 10.1097/PAI.0b013e3181972b6d; Liu F, 2013, ONCOL REP, V30, P783, DOI 10.3892/or.2013.2522; Liu F, 2013, ONCOL REP, V29, P1405, DOI 10.3892/or.2013.2244; Liu M, 2010, MOL BIOL REP, V37, P3601, DOI 10.1007/s11033-010-0009-2; Ma L, 2007, BRIT J HAEMATOL, V139, P217, DOI 10.1111/j.1365-2141.2007.06782.x; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Maus M, 2013, J LEUKOCYTE BIOL, V93, P537, DOI 10.1189/jlb.0312169; Melamed I, 1999, CELL IMMUNOL, V194, P136, DOI 10.1006/cimm.1999.1506; MELAMED I, 1991, J IMMUNOL, V147, P1139; Montes-Moreno S, 2008, BLOOD, V111, P351, DOI 10.1182/blood-2007-06-094151; NYLANDER K, 1995, HISTOCHEM J, V27, P155; Passineau MJ, 2005, LEUKEMIA LYMPHOMA, V46, P1627, DOI 10.1080/10428190500221454x; Piekny AJ, 2010, SEMIN CELL DEV BIOL, V21, P881, DOI 10.1016/j.semcdb.2010.08.002; Re D, 2001, CANCER RES, V61, P2080; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; Rui LX, 2010, CANCER CELL, V18, P590, DOI 10.1016/j.ccr.2010.11.013; Schneider M, 2014, BLOOD, V123, P3672, DOI 10.1182/blood-2014-02-553263; SOBEL A, 1989, J BIOL CHEM, V264, P3765; Suh YH, 2003, GENE, V307, P63, DOI 10.1016/S0378-1119(03)00401-3; Thavarajah Rooban, 2012, J Oral Maxillofac Pathol, V16, P73, DOI 10.4103/0973-029X.92977; Treanor B, 2010, CURR OPIN IMMUNOL, V22, P299, DOI 10.1016/j.coi.2010.03.009; van den Berg A, 1999, AM J PATHOL, V154, P1685, DOI 10.1016/S0002-9440(10)65424-7; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407	49	6	6	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127568	10.1371/journal.pone.0127568	http://dx.doi.org/10.1371/journal.pone.0127568			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000982	gold, Green Submitted, Green Published			2022-12-26	WOS:000354931700067
J	Lehmann, H; Saez-Pons, J; Syrdal, DS; Dautenhahn, K				Lehmann, Hagen; Saez-Pons, Joan; Syrdal, Dag Sverre; Dautenhahn, Kerstin			In Good Company? Perception of Movement Synchrony of a Non-Anthropomorphic Robot	PLOS ONE			English	Article							UNCANNY VALLEY; ATTENTION; PERSONALITY; BEHAVIOR; INFANTS; ANIMACY; AGENTS; HEAD	Recent technological developments like cheap sensors and the decreasing costs of computational power have brought the possibility of robotic home companions within reach. In order to be accepted it is vital for these robots to be able to participate meaningfully in social interactions with their users and to make them feel comfortable during these interactions. In this study we investigated how people respond to a situation where a companion robot is watching its user. Specifically, we tested the effect of robotic behaviours that are synchronised with the actions of a human. We evaluated the effects of these behaviours on the robot's likeability and perceived intelligence using an online video survey. The robot used was Care-O-bot3, a non-anthropomorphic robot with a limited range of expressive motions. We found that even minimal, positively synchronised movements during an object-oriented task were interpreted by participants as engagement and created a positive disposition towards the robot. However, even negatively synchronised movements of the robot led to more positive perceptions of the robot, as compared to a robot that does not move at all. The results emphasise a) the powerful role that robot movements in general can have on participants' perception of the robot, and b) that synchronisation of body movements can be a powerful means to enhance the positive attitude towards a non-anthropomorphic robot.	[Lehmann, Hagen; Saez-Pons, Joan; Syrdal, Dag Sverre; Dautenhahn, Kerstin] Univ Hertfordshire, Sch Comp Sci, Hatfield AL10 9AB, Herts, England	University of Hertfordshire	Lehmann, H (corresponding author), Univ Hertfordshire, Sch Comp Sci, Coll Lane, Hatfield AL10 9AB, Herts, England.	hagen.lehmann@iit.it	Lehmann, Hagen/D-8782-2018; Pons, Joan S./AAL-7011-2020	Dautenhahn, Kerstin/0000-0002-9263-3897; Lehmann, Hagen/0000-0001-9676-2269; Syrdal, Dag Sverre/0000-0002-1339-4382	European Commission [287624]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was funded by the European Commission under the 7th Framework Programme for Research, ACCOMPANY Project - Grant Agreement No: 287624 (KD), http://accompanyproject.eu/.	Abell F, 2000, COGNITIVE DEV, V15, P1, DOI 10.1016/S0885-2014(00)00014-9; Amano S, 2004, INFANT BEHAV DEV, V27, P64, DOI 10.1016/j.infbeh.2003.06.005; Andrist S, 2014, ACMIEEE INT CONF HUM, P25, DOI 10.1145/2559636.2559666; ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Bainbridge WA, 2008, 2008 17TH IEEE INTERNATIONAL SYMPOSIUM ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, VOLS 1 AND 2, P701, DOI 10.1109/ROMAN.2008.4600749; Bartneck C, 2009, INT J SOC ROBOT, V1, P71, DOI 10.1007/s12369-008-0001-3; Broz F., 2013, EYE GAZE INTELLIGENT, P41; Csibra G, 2007, ACTA PSYCHOL, V124, P60, DOI 10.1016/j.actpsy.2006.09.007; Damiano L., 2014, INT J SOC ROBOT, P1; Dautenhahn K, 1997, CYBERNET SYST, V28, P417, DOI 10.1080/019697297126074; Dautenhahn K, 2005, 2005 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P1488; Dautenhahn K., 2013, ENCY HUMAN COMPUTER, V2nd; Dautenhahn K, 2007, PHILOS T R SOC B, V362, P679, DOI 10.1098/rstb.2006.2004; Evers M, 2000, LECT NOTES COMPUT SC, V1948, P526; Fischer K, 2013, PROCEEDINGS OF THE 2013 INTERNATIONAL CONFERENCE ON COLLABORATION TECHNOLOGIES AND SYSTEMS (CTS), P210; GERGELY G, 1995, COGNITION, V56, P165, DOI 10.1016/0010-0277(95)00661-H; HADAR U, 1985, J NONVERBAL BEHAV, V9, P214, DOI 10.1007/BF00986881; Hall J, 2014, ROBOT AUTON SYST, V62, P392, DOI 10.1016/j.robot.2013.09.012; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Koay K.L., 2011, MIXED REALITY HUMAN, P133, DOI DOI 10.1007/978-94-007-0582-1_8; Koay K.L., 2014, INT J SOCIA IN PRESS; Kopp S., 2003, KI, V17, P11; Kuo I. H., 2009, RO-MAN 2009 - The 18th IEEE International Symposium on Robot and Human Interactive Communication, P214, DOI 10.1109/ROMAN.2009.5326292; Lee KM, 2006, INT J HUM-COMPUT ST, V64, P962, DOI 10.1016/j.ijhcs.2006.05.002; Lehmann H, 2013, LECT NOTES ARTIF INT, V8239, P402, DOI 10.1007/978-3-319-02675-6_40; Lester J.C., 1997, CHI, P359, DOI DOI 10.1145/258549.258797; Lohse M, 2008, 2008 17TH IEEE INTERNATIONAL SYMPOSIUM ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, VOLS 1 AND 2, P488, DOI 10.1109/ROMAN.2008.4600714; Ma LL, 2013, DEV PSYCHOL, V49, P1330, DOI 10.1037/a0029620; MacDorman KF, 2006, INTERACT STUD, V7, P297, DOI 10.1075/is.7.3.03mac; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; Moore C., 1995, JOINT ATTENTION ITS; Moore RK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00864; Mori M., 1970, ENERGY, V7, P33, DOI DOI 10.1109/MRA.2012.2192811; Moshkina L, 2011, INT J SOC ROBOT, V3, P207, DOI 10.1007/s12369-011-0090-2; Noma M, 2006, IEEE-RAS INT C HUMAN, P163, DOI 10.1109/ICHR.2006.321379; Nunnally J., 1967, PSYCHOMETRIC THEORY, V226, P6; Pantelis P. C., 2011, J VISION, V11, P1990; Reiser Ulrich, 2013, Your Virtual Butler. The Making-of: LNCS 7407, P97, DOI 10.1007/978-3-642-37346-6_9; Rotondo J. L., 2002, MIRROR NEURONS EVOLU, V42, P151; Saez-Pons J., 2014, P 4 INT C DEV LEARN; Salem M, 2012, INT J SOC ROBOT, V4, P201, DOI 10.1007/s12369-011-0124-9; Schermerhorn P., 2008, 2008 3rd ACM/IEEE International Conference on Human-Robot Interaction (HRI 2008), P263; Scholl BJ, 2000, TRENDS COGN SCI, V4, P299, DOI 10.1016/S1364-6613(00)01506-0; Scopelliti M., 2005, Universal Access in the Information Society, V4, P146, DOI 10.1007/s10209-005-0118-1; Scopelliti M, 2004, DESIGNING A MORE INCLUSIVE WORLD, P257; Skantze G., 2013, P 14 ANN M SPEC INT, P375; Slaughter V, 2003, J GENET PSYCHOL, V164, P54, DOI 10.1080/00221320309597503; Syrdal D.S., 2014, COGNITIVE C IN PRESS; Syrdal DS, 2010, 2010 IEEE RO-MAN, P632, DOI 10.1109/ROMAN.2010.5598693; Tomasello M, 2007, J HUM EVOL, V52, P314, DOI 10.1016/j.jhevol.2006.10.001; Tremoulet PD, 2000, PERCEPTION, V29, P943, DOI 10.1068/p3101; United Nations, 2002, WORLD POPULATION AGE; Walters ML, 2008, AUTON ROBOT, V24, P159, DOI 10.1007/s10514-007-9058-3; Walters ML, 2011, ADV ROBOTICS, V25, P2233, DOI 10.1163/016918611X603800; Woods S. N., 2006, ROMAN 2006 THE15TH I, P51, DOI DOI 10.1109/ROMAN.2006.314394; Woods S.N., 2006, P AMC 06 9 INT WORKS; Yamaoka F, 2007, CONNECT SCI, V19, P143, DOI 10.1080/09540090701371519; Yoshikawa Y, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P4564, DOI 10.1109/IROS.2006.282160	58	16	16	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127747	10.1371/journal.pone.0127747	http://dx.doi.org/10.1371/journal.pone.0127747			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7GR	26001025	gold, Green Published, Green Submitted			2022-12-26	WOS:000354931700081
J	Nishiyama, Y; Okamoto, Y; Kunisato, Y; Okada, G; Yoshimura, S; Kanai, Y; Yamamura, T; Yoshino, A; Jinnin, R; Takagaki, K; Onoda, K; Yamawaki, S				Nishiyama, Yoshiko; Okamoto, Yasumasa; Kunisato, Yoshihiko; Okada, Go; Yoshimura, Shinpei; Kanai, Yoshihiro; Yamamura, Takanao; Yoshino, Atsuo; Jinnin, Ran; Takagaki, Koki; Onoda, Keiichi; Yamawaki, Shigeto			fMRI Study of Social Anxiety during Social Ostracism with and without Emotional Support	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; BRIEF VERSION; SELF-ESTEEM; FEAR; DISORDER; ACTIVATION; REACTIVITY; MIND; INFORMATION	Social anxiety is characterized by an excessive fear of being embarrassed in social interactions or social performance situations. Emotional support can help to decrease or diminish social distress. Such support may play an important role at different points of social interaction. However, it is unclear how the beneficial effects of social support are represented in the brains of socially anxious individuals. To explore this, we used the same paradigm previously used to examine the effects of emotional support on social pain caused by exclusion. Undergraduates (n = 46) showing a wide range of social anxiety scores underwent functional magnetic resonance imaging (fMRI) while participating in a Cyberball game. Participants were initially included and later excluded from the game. In the latter half of the session in which participants were excluded, they were provided with supportive messages. In line with our previous work, we found that social exclusion led to increased anterior cingulate cortex (ACC) activity, whereas emotional support led to increased left dorsolateral prefrontal cortex (DLPFC) activity. Despite validation of the paradigm, social anxiety was not associated with increased ACC activity during social exclusion, or during perceived emotional support. Instead, fear of negative evaluation as assessed by the Brief Fear of Negative Evaluation (BFNE) scale showed positive associations with left DLPFC activation while receiving emotional support, compared to while being socially excluded. The more socially anxious an individual was, the greater was the left DLPFC activity increased during receipt of messages. This suggests that highly socially anxious people still have the ability to perceive social support, but that they are nevertheless susceptible to negative evaluation by others.	[Nishiyama, Yoshiko; Okamoto, Yasumasa; Okada, Go; Yamamura, Takanao; Yoshino, Atsuo; Jinnin, Ran; Takagaki, Koki; Yamawaki, Shigeto] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Psychiat & Neurosci, Hiroshima, Japan; [Kunisato, Yoshihiko] Senshu Univ, Sch Human Sci, Dept Psychol, Kawasaki, Kanagawa, Japan; [Yoshimura, Shinpei] Otemon Gakuin Univ, Fac Psychol, Dept Psychol, Osaka, Japan; [Kanai, Yoshihiro] Tohoku Gakuin Univ, Fac Liberal Arts, Dept Human Sci, Sendai, Miyagi 980, Japan; [Onoda, Keiichi] Shimane Univ, Dept Neurol, Izumo, Shimane, Japan	Hiroshima University; Tohoku Gakuin University; Shimane University	Yamawaki, S (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Psychiat & Neurosci, Hiroshima, Japan.	yamawaki@hiroshima-u.ac.jp	Onoda, Keiichi/N-2944-2019; Kanai, Yoshihiro/P-4034-2019; Yoshimura, Shinpei/AAG-5540-2019	Onoda, Keiichi/0000-0002-3882-3446; Yoshimura, Shinpei/0000-0001-9957-7982; Yoshimura, Shimpei/0000-0001-6756-4829	Japanese Ministry of Education, Science, and Culture [20730446]; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [24-2]; Labour and Welfare; JSPS KAKENHI [26461748]; Grants-in-Aid for Scientific Research [25780413, 25780428] Funding Source: KAKEN	Japanese Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP(National Center for Neurology & Psychiatry - Japan); Labour and Welfare; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Science, and Culture (20730446), http://www.jsps.go.jp/english/e-grants/grants01.html (YK); Intramural Research Grant (24-2) for Neurological and Psychiatric Disorders of NCNP, http://www.ncnp.go.jp/ (OY); Labour and Welfare; Scientific Research (C) (JSPS KAKENHI Grant Number 26461748), http://www.jsps.go.jp/english/e-grants/grants01.html (OY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden LE, 2004, CLIN PSYCHOL REV, V24, P857, DOI 10.1016/j.cpr.2004.07.006; Amir N, 2005, BIOL PSYCHIAT, V57, P975, DOI 10.1016/j.biopsych.2005.01.044; Bastian B, 2010, J EXP SOC PSYCHOL, V46, P107, DOI 10.1016/j.jesp.2009.06.022; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Choi J, 2009, BIOL PSYCHIAT, V65, P227, DOI 10.1016/j.biopsych.2008.06.022; Chou KL, 2011, J CLIN PSYCHIAT, V72, P1468, DOI 10.4088/JCP.10m06019gry; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Coles ME, 2001, BEHAV RES THER, V39, P651, DOI 10.1016/S0005-7967(00)00035-8; Collins KA, 2005, J ANXIETY DISORD, V19, P345, DOI 10.1016/j.janxdis.2004.02.003; Davila J, 2002, BEHAV THER, V33, P427, DOI 10.1016/S0005-7894(02)80037-5; Edwards SL, 2003, COGNITIVE THER RES, V27, P603, DOI 10.1023/A:1026395526858; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Goldin PR, 2009, BIOL PSYCHIAT, V66, P1091, DOI 10.1016/j.biopsych.2009.07.014; Goldin PR, 2009, ARCH GEN PSYCHIAT, V66, P170, DOI 10.1001/archgenpsychiatry.2008.525; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; Hofmann Stefan G., 2007, Cognitive Behaviour Therapy, V36, P193, DOI 10.1080/16506070701421313; Hofmann SG, 2012, COGNITION EMOTION, V26, P282, DOI 10.1080/02699931.2011.579414; Iffland B, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00956; Koric L, 2012, HUM BRAIN MAPP, V33, P1973, DOI 10.1002/hbm.21340; La Greca AM, 1998, J ABNORM CHILD PSYCH, V26, P83, DOI 10.1023/A:1022684520514; Lang PJ, 2009, ANXIETY STRESS COPIN, V22, P5, DOI 10.1080/10615800802478247; Leary M.R., 1997, SOCIAL ANXIETY; LEARY MR, 1983, PERS SOC PSYCHOL B, V9, P371, DOI 10.1177/0146167283093007; Levinson CA, 2013, BEHAV THER, V44, P470, DOI 10.1016/j.beth.2013.04.007; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Liebowitz M R, 1987, Mod Probl Pharmacopsychiatry, V22, P141; Masten CL, 2009, SOC COGN AFFECT NEUR, V4, P143, DOI 10.1093/scan/nsp007; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; Meltzer H, 2013, SOC PSYCH PSYCH EPID, V48, P5, DOI 10.1007/s00127-012-0515-8; Merikangas KR, 2002, BIOL PSYCHIAT, V51, P81, DOI 10.1016/S0006-3223(01)01309-9; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moriya J, 2011, ACTA PSYCHOL, V138, P162, DOI 10.1016/j.actpsy.2011.05.019; Oaten M, 2008, J SOC CLIN PSYCHOL, V27, P471, DOI 10.1521/jscp.2008.27.5.471; Onoda K, 2010, SOC COGN AFFECT NEUR, V5, P385, DOI 10.1093/scan/nsq002; Onoda K, 2009, SOC NEUROSCI-UK, V4, P443, DOI 10.1080/17470910902955884; PREMACK D, 1978, SCIENCE, V202, P532, DOI 10.1126/science.705342; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Rodebaugh TL, 2004, PSYCHOL ASSESSMENT, V16, P169, DOI 10.1037/1040-3590.16.2.169; Ruscio AM, 2010, J ABNORM PSYCHOL, V119, P662, DOI 10.1037/a0019341; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Stein DJ, 2010, DEPRESS ANXIETY, V27, P390, DOI 10.1002/da.20639; Stein DJ, 2004, J CLIN PSYCHIAT, V65, P27; Stein MB, 2002, J NERV MENT DIS, V190, P219, DOI 10.1097/00005053-200204000-00002; Stein MB, 2008, LANCET, V371, P1115, DOI 10.1016/S0140-6736(08)60488-2; WATSON D, 1969, J CONSULT CLIN PSYCH, V33, P448, DOI 10.1037/h0027806; Weeks JW, 2008, J ANXIETY DISORD, V22, P386, DOI 10.1016/j.janxdis.2007.04.009; Williams KD, 2000, J PERS SOC PSYCHOL, V79, P748, DOI 10.1037/0022-3514.79.5.748; Zadro L, 2004, J EXP SOC PSYCHOL, V40, P560, DOI 10.1016/j.jesp.2003.11.006; Zadro L, 2006, J EXP SOC PSYCHOL, V42, P692, DOI 10.1016/j.jesp.2005.10.007	51	13	14	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127426	10.1371/journal.pone.0127426	http://dx.doi.org/10.1371/journal.pone.0127426			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000902	Green Published, gold, Green Submitted			2022-12-26	WOS:000354931700059
J	Nielsen, J; Farup, J; Rahbek, SK; de Paoli, FV; Vissing, K				Nielsen, Joachim; Farup, Jean; Rahbek, Stine Klejs; de Paoli, Frank Vincenzo; Vissing, Kristian			Enhanced Glycogen Storage of a Subcellular Hot Spot in Human Skeletal Muscle during Early Recovery from Eccentric Contractions	PLOS ONE			English	Article							EXERCISE; LOCALIZATION; DAMAGE; METABOLISM; SIZE; GRANULE; PROTEIN; NUMBER; GLUT4; TIME	Unaccustomed eccentric exercise is accompanied by muscle damage and impaired glucose uptake and glycogen synthesis during subsequent recovery. Recently, it was shown that the role and regulation of glycogen in skeletal muscle are dependent on its subcellular localization, and that glycogen synthesis, as described by the product of glycogen particle size and number, is dependent on the time course of recovery after exercise and carbohydrate availability. In the present study, we investigated the subcellular distribution of glycogen in fibers with high (type I) and low (type II) mitochondrial content during post-exercise recovery from eccentric contractions. Analysis was completed on five male subjects performing an exercise bout consisting of 15 x 10 maximal eccentric contractions. Carbohydrate-rich drinks were subsequently ingested throughout a 48 h recovery period and muscle biopsies for analysis included time points 3, 24 and 48 h post exercise from the exercising leg, whereas biopsies corresponding to prior to and at 48 h after the exercise bout were collected from the non-exercising, control leg. Quantitative imaging by transmission electron microscopy revealed an early (post 3 and 24 h) enhanced storage of intramyofibrillar glycogen (defined as glycogen particles located within the myofibrils) of type I fibers, which was associated with an increase in the number of particles. In contrast, late in recovery (post 48 h), intermyofibrillar, intramyofibrillar and subsarcolemmal glycogen in both type I and II fibers were lower in the exercise leg compared with the control leg, and this was associated with a smaller size of the glycogen particles. We conclude that in the carbohydrate-supplemented state, the effect of eccentric contractions on glycogen metabolism depends on the subcellular localization, muscle fiber's oxidative capacity, and the time course of recovery. The early enhanced storage of intramyofibrillar glycogen after the eccentric contractions may entail important implications for muscle function and fatigue resistance.	[Nielsen, Joachim] Univ Southern Denmark, SDU Muscle Res Cluster SMRC, Dept Sports Sci & Clin Biomech, Odense M, Denmark; [Nielsen, Joachim] Odense Univ Hosp, SDU Muscle Res Cluster SMRC, Dept Pathol, DK-5000 Odense, Denmark; [Farup, Jean; Rahbek, Stine Klejs; Vissing, Kristian] Aarhus Univ, Dept Publ Hlth, Sect Sport Sci, Aarhus, Denmark; [de Paoli, Frank Vincenzo] Aarhus Univ, Dept Biomed, Aarhus, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Aarhus University; Aarhus University	Nielsen, J (corresponding author), Univ Southern Denmark, SDU Muscle Res Cluster SMRC, Dept Sports Sci & Clin Biomech, Odense M, Denmark.	jnielsen@health.sdu.dk	Vissing, Kristian/GOP-0449-2022; Nielsen, Joachim/G-8675-2016	Nielsen, Joachim/0000-0003-1730-3094; Vissing, Kristian/0000-0001-5810-5241; Farup, Jean/0000-0002-7579-6512; de Paoli, Frank Vincenzo/0000-0002-2174-2295	Arla Foods Ingredients Group	Arla Foods Ingredients Group	The authors received funding from a commercial source 'Arla Foods Ingredients Group'. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Asp S, 1998, J PHYSIOL-LONDON, V509, P305, DOI 10.1111/j.1469-7793.1998.305bo.x; ASP S, 1995, J PHYSIOL-LONDON, V482, P705, DOI 10.1113/jphysiol.1995.sp020553; Asp S, 1996, J PHYSIOL-LONDON, V494, P891, DOI 10.1113/jphysiol.1996.sp021541; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brockett CL, 2002, J APPL PHYSIOL, V92, P1104, DOI 10.1152/japplphysiol.00479.2001; Clarkson PM, 2002, AM J PHYS MED REHAB, V81, pS52, DOI [10.1097/00002060-200211001-00007, 10.1097/01.PHM.0000029772.45258.43]; COSTILL DL, 1990, J APPL PHYSIOL, V69, P46, DOI 10.1152/jappl.1990.69.1.46; DOYLE JA, 1993, J APPL PHYSIOL, V74, P1848, DOI 10.1152/jappl.1993.74.4.1848; Duchateau J, 2011, BRAIN RES, V1409, P42, DOI 10.1016/j.brainres.2011.06.011; Farup J, 2014, AMINO ACIDS, V46, P2503, DOI 10.1007/s00726-014-1810-3; FRIDEN J, 1985, CELL TISSUE RES, V242, P229; FRIDEN J, 1989, ACTA PHYSIOL SCAND, V135, P381, DOI 10.1111/j.1748-1716.1989.tb08591.x; FRIDEN J, 1983, INT J SPORTS MED, V4, P170, DOI 10.1055/s-2008-1026030; Graham TE, 2010, ACTA PHYSIOL, V199, P489, DOI 10.1111/j.1748-1716.2010.02131.x; Hansen BF, 2000, AM J PHYSIOL-ENDOC M, V278, pE398, DOI 10.1152/ajpendo.2000.278.3.E398; Howard CV, 2005, UNBIASED STEREOLOGY; JONES DA, 1986, J PHYSIOL-LONDON, V375, P435, DOI 10.1113/jphysiol.1986.sp016126; KIRWAN JP, 1992, J APPL PHYSIOL, V72, P2197, DOI 10.1152/jappl.1992.72.6.2197; Klip A, 2014, AM J PHYSIOL-CELL PH, V306, pC879, DOI 10.1152/ajpcell.00069.2014; Marchand I, 2007, J PHYSIOL-LONDON, V580, P617, DOI 10.1113/jphysiol.2006.122457; Marchand I, 2002, J APPL PHYSIOL, V93, P1598, DOI 10.1152/japplphysiol.00585.2001; MCCULLY K, 1992, MED SCI SPORT EXER, V24, P537; Nielsen J, 2009, J PHYSIOL-LONDON, V587, P3679, DOI 10.1113/jphysiol.2009.174862; Nielsen J, 2014, J PHYSIOL-LONDON, V592, P2003, DOI 10.1113/jphysiol.2014.271528; Nielsen J, 2013, APPL PHYSIOL NUTR ME, V38, P91, DOI 10.1139/apnm-2012-0184; Nielsen J, 2012, EUR J APPL PHYSIOL, V112, P3559, DOI 10.1007/s00421-012-2341-9; Nielsen J, 2011, J PHYSIOL-LONDON, V589, P2871, DOI 10.1113/jphysiol.2010.204487; Nielsen J, 2010, AM J PHYSIOL-ENDOC M, V299, pE1053, DOI 10.1152/ajpendo.00324.2010; Oberholzer F, 1976, Schweiz Z Sportmed, V24, P71; Ortenblad N, 2011, J PHYSIOL-LONDON, V589, P711, DOI 10.1113/jphysiol.2010.195982; PLOUG T, 1987, AM J PHYSIOL, V253, pE12, DOI 10.1152/ajpendo.1987.253.1.E12; Prats C, 2009, J BIOL CHEM, V284, P15692, DOI 10.1074/jbc.M900845200; Proske U, 2001, J PHYSIOL-LONDON, V537, P333, DOI 10.1111/j.1469-7793.2001.00333.x; Quintero OA, 2009, CURR BIOL, V19, P2008, DOI 10.1016/j.cub.2009.10.026; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; RODENBURG JB, 1995, ACTA PHYSIOL SCAND, V153, P97, DOI 10.1111/j.1748-1716.1995.tb09840.x; SCHMALBRUCH H, 1974, EXP NEUROL, V44, P313, DOI 10.1016/0014-4886(74)90069-7; SJOSTROM M, 1982, MUSCLE NERVE, V5, P538, DOI 10.1002/mus.880050708; SJOSTROM M, 1982, HISTOCHEMISTRY, V76, P425, DOI 10.1007/BF00489899; Skurat AV, 1997, EUR J BIOCHEM, V245, P147, DOI 10.1111/j.1432-1033.1997.t01-1-00147.x; Tee JC, 2007, SPORTS MED, V37, P827, DOI 10.2165/00007256-200737100-00001; WEIBEL ER, 1980, STEREOLOGICAL METHOD, V2; WIDRICK JJ, 1992, J APPL PHYSIOL, V72, P1999, DOI 10.1152/jappl.1992.72.5.1999; Wilson RJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1815, DOI 10.1152/ajpendo.00598.2006	45	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127808	10.1371/journal.pone.0127808	http://dx.doi.org/10.1371/journal.pone.0127808			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996774	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000089
J	Frost, SR; Gilbert, CC; Pugh, KD; Guthrie, EH; Delson, E				Frost, Stephen R.; Gilbert, Christopher C.; Pugh, Kelsey D.; Guthrie, Emily H.; Delson, Eric			The Hand of Cercopithecoides williamsi (Mammalia, Primates): Earliest Evidence for Thumb Reduction among Colobine Monkeys	PLOS ONE			English	Article							OLD-WORLD MONKEYS; DIVERGENCE DATES; FOSSIL; KENYA; PHYLOGENY	Thumb reduction is among the most important features distinguishing the African and Asian colobines from each other and from other Old World monkeys. In this study we demonstrate that the partial skeleton KNM-ER 4420 from Koobi Fora, Kenya, dated to 1.9 Ma and assigned to the Plio-Pleistocene colobine species Cercopithecoides williamsi, shows marked reduction of its first metacarpal relative to the medial metacarpals. Thus, KNM-ER 4420 is the first documented occurrence of cercopithecid pollical reduction in the fossil record. In the size of its first metacarpal relative to the medial metacarpals, C. williamsi is similar to extant African colobines, but different from cercopithecines, extant Asian colobines and the Late Miocene colobines Microcolobus and Mesopithecus. This feature clearly links the genus Cercopithecoides with the extant African colobine clade and makes it the first definitive African colobine in the fossil record. The postcranial adaptations to terrestriality in Cercopithecoides are most likely secondary, while ancestral colobinans (and colobines) were arboreal. Finally, the absence of any evidence for pollical reduction in Mesopithecus implies either independent thumb reduction in African and Asian colobines or multiple colobine dispersal events out of Africa. Based on the available evidence, we consider the first scenario more likely.	[Frost, Stephen R.; Guthrie, Emily H.] 1218 Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Gilbert, Christopher C.] CUNY Hunter Coll, Dept Anthropol, New York, NY 10065 USA; [Gilbert, Christopher C.; Pugh, Kelsey D.; Delson, Eric] New York Consortium Evolutionary Primatol, New York, NY 10024 USA; [Gilbert, Christopher C.; Pugh, Kelsey D.; Delson, Eric] NYU, Grad Ctr, PhD Program Anthropol, New York, NY 10016 USA; [Guthrie, Emily H.] Univ Washington, Human Subjects Div, Seattle, WA 98185 USA; [Delson, Eric] Amer Museum Nat Hist, Dept Vertebrate Paleontol, New York, NY 10024 USA; [Delson, Eric] CUNY Herbert H Lehman Coll, Dept Anthropol, Bronx, NY 10468 USA	University of Oregon; City University of New York (CUNY) System; Hunter College (CUNY); New York University; University of Washington; University of Washington Seattle; American Museum of Natural History (AMNH); City University of New York (CUNY) System; Lehman College (CUNY)	Frost, SR (corresponding author), 1218 Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA.	sfrost@uoregon.edu		Delson, Eric/0000-0002-4062-7567; Gilbert, Christopher/0000-0001-8768-3171	Wenner-Gren Foundation; Professional Staff Congress-City University of New York Faculty Research Award Program; Hunter College; City University of New York Faculty Research Award Program; University of Oregon; National Science Foundation; L.S.B. Leakey Foundation; Geological Society of America and Paleontological Society	Wenner-Gren Foundation; Professional Staff Congress-City University of New York Faculty Research Award Program; Hunter College; City University of New York Faculty Research Award Program; University of Oregon; National Science Foundation(National Science Foundation (NSF)); L.S.B. Leakey Foundation; Geological Society of America and Paleontological Society	Wenner-Gren Foundation, the Professional Staff Congress-City University of New York Faculty Research Award Program, and Hunter College to CG; the City University of New York Faculty Research Award Program to ED; University of Oregon to SF; and National Science Foundation, L.S.B. Leakey Foundation, Geological Society of America and Paleontological Society to EG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENEFIT BR, 1986, AM J PHYS ANTHROPOL, V69, P441, DOI 10.1002/ajpa.1330690404; BIRCHETTE MG, 1981, AM J PHYS ANTHROPOL, V54, P201; DELSON E, 1975, CONTRIB PRIMATOL, V5, P167; DELSON E, 1977, J HUM EVOL, V6, P433, DOI 10.1016/S0047-2484(77)80057-2; Delson E., 1973, THESIS COLUMBIA U; Delson E, 2000, ENCY HUMAN EVOLUTION, V2nd, P186; Delson Eric, 1994, P11; Finstermeier K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069504; Fleagle JG, 2013, PRIMATE ADAPTATION AND EVOLUTION, 3RD EDITION, P1; Freedman L., 1957, Annals of the Transvaal Museum, V23, P121; Frost SR, 2003, AM J PHYS ANTHROPOL, V122, P191, DOI 10.1002/ajpa.10279; Frost SR, 2002, J HUM EVOL, V43, P687, DOI 10.1006/jhev.2002.0603; Frost Stephen R., 2001, American Museum Novitates, V3350, P1, DOI 10.1206/0003-0082(2001)350<0001:NEPCMP>2.0.CO;2; Gilbert WH, 2008, MID AWASH SER, V1, P115; Harris J.M., 1988, CONTRIBUTIONS SCI, V399, P1; Harrison T, 2011, VERTEBR PALEOBIOL PA, P83, DOI 10.1007/978-90-481-9962-4_6; Jablonski N.G., 2008, KOOBI FORA RES PROJE, V6, P31; Jablonski NG, 2002, CAM S BIO EVOL ANTHR, V33, P255; Jablonski Nina G., 2010, P393; Jouffroy F.K., 1992, Human Evolution, V6, P269, DOI 10.1007/BF02437254; LEAKEY MG, 1982, AM J PHYS ANTHROPOL, V58, P153, DOI 10.1002/ajpa.1330580207; Leakey MG, 1987, CAHIERS PALEONTOLOGI, P150; Leakey R.E.F., 1969, FOSSIL VERTEBR AFR, V1, P53; MAIER W, 1970, Palaeontologia Africana, V13, P69; McKee JK, 2011, J HUM EVOL, V60, P83, DOI 10.1016/j.jhevol.2010.08.002; Miller ER, 2009, J HUM EVOL, V57, P195, DOI 10.1016/j.jhevol.2009.06.006; Nakatsukasa M, 2010, AM J PHYS ANTHROPOL, V143, P365, DOI 10.1002/ajpa.21327; Orme D., 2018, R PACKAGE VERSION, V5, P1; Patel BA, 2010, J HUM EVOL, V58, P320, DOI 10.1016/j.jhevol.2010.01.001; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; R Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Rae TC, 2008, J HUM EVOL, V54, P279, DOI 10.1016/j.jhevol.2007.07.010; Rossie JB, 2013, P NATL ACAD SCI USA, V110, P5818, DOI 10.1073/pnas.1213691110; Steiper ME, 2012, P NATL ACAD SCI USA, V109, P6006, DOI 10.1073/pnas.1119506109; STRASSER E, 1987, J HUM EVOL, V16, P81, DOI 10.1016/0047-2484(87)90061-3; Szalay F.S., 1979, EVOLUTIONARY HIST PR; Tague RG, 2002, AM J PHYS ANTHROPOL, V117, P195, DOI 10.1002/ajpa.10028; Ting N, 2008, J HUM EVOL, V55, P312, DOI 10.1016/j.jhevol.2008.02.011; Verheyen W.N., 1962, ANNAL KONINKLIJIK MU, V105, P1; Xing J, 2005, MOL PHYLOGENET EVOL, V37, P872, DOI 10.1016/j.ympev.2005.04.015; Zapfe H., 1991, MESOPITHECUS PENTELI	42	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125030	10.1371/journal.pone.0125030	http://dx.doi.org/10.1371/journal.pone.0125030			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993410	Green Published, gold			2022-12-26	WOS:000354921400023
J	Seidman, G; Unnikrishnan, S; Kenny, E; Myslinski, S; Cairns-Smith, S; Mulligan, B; Engmann, C				Seidman, Gabriel; Unnikrishnan, Shalini; Kenny, Emma; Myslinski, Scott; Cairns-Smith, Sarah; Mulligan, Brian; Engmann, Cyril			Barriers and Enablers of Kangaroo Mother Care Practice: A Systematic Review	PLOS ONE			English	Article							SKIN-TO-SKIN; RANDOMIZED CONTROLLED-TRIAL; BIRTH-WEIGHT INFANTS; PRETERM INFANTS; SWEDISH MOTHERS; CONTACT; DETERMINANTS; PERCEPTIONS; EXPERIENCES; MORTALITY	Kangaroo mother care (KMC) is an evidence-based approach to reducing mortality and morbidity in preterm infants. Although KMC is a key intervention package in newborn health initiatives, there is limited systematic information available on the barriers to KMC practice that mothers and other stakeholders face while practicing KMC. This systematic review sought to identify the most frequently reported barriers to KMC practice for mothers, fathers, and health practitioners, as well as the most frequently reported enablers to practice for mothers. We searched nine electronic databases and relevant reference lists for publications reporting barriers or enablers to KMC practice. We identified 1,264 unique publications, of which 103 were included based on pre-specified criteria. Publications were scanned for all barriers / enablers. Each publication was also categorized based on its approach to identification of barriers / enablers, and more weight was assigned to publications which had systematically sought to understand factors influencing KMC practice. Four of the top five ranked barriers to KMC practice for mothers were resource-related: "Issues with the facility environment / resources," "negative impressions of staff attitudes or interactions with staff," "lack of help with KMC practice or other obligations," and "low awareness of KMC / infant health."Considering only publications from low-and middle-income countries, "pain / fatigue" was ranked higher than when considering all publications. Top enablers to practice were included "mother-infant attachment" and "support from family, friends, and other mentors." Our findings suggest that mother can understand and enjoy KMC, and it has benefits for mothers, infants, and families. However, continuous KMC may be physically and emotionally difficult, and often requires support from family members, health practitioners, or other mothers. These findings can serve as a starting point for researchers and program implementers looking to improve KMC programs.	[Seidman, Gabriel] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Unnikrishnan, Shalini; Myslinski, Scott; Cairns-Smith, Sarah] Boston Consulting Grp Inc, Boston, MA USA; [Kenny, Emma] Boston Consulting Grp Inc, New York, NY USA; [Mulligan, Brian; Engmann, Cyril] Bill & Melinda Gates Fdn, Seattle, WA USA	Harvard University; Harvard T.H. Chan School of Public Health; Boston Consulting Group (BCG); Boston Consulting Group (BCG); Bill & Melinda Gates Foundation	Seidman, G (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	Gabriel.seidman@gmail.com			Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The Bill & Melinda Gates Foundation provided funding for this review. Two authors (BM, CE) were employees of the foundation at the time of writing. They were not involved in collection or analysis of data, but did provide input into revisions / edits of the manuscript.	Abul-Fadl AMAM, 2012, BREASTFEED MED, V7, P173, DOI 10.1089/bfm.2011.0028; Bazzano A, 2012, GLOB HEALTH PROMOT, V19, P42, DOI 10.1177/1757975912453185; Beach MC, 2005, MED CARE, V43, P356, DOI 10.1097/01.mlr.0000156861.58905.96; Bergh A-M, 2013, Ghana Med J, V47, P57; Bergh AM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-75; Bigelow A, 2012, JOGNN-J OBST GYN NEO, V41, P369, DOI 10.1111/j.1552-6909.2012.01350.x; Blencowe H., 2005, Malawi Medical Journal, V17, P39; Blencowe H, 2009, J TROP PEDIATRICS, V55, P244, DOI 10.1093/tropej/fmn116; Blomqvist YT, 2013, SCAND J CARING SCI, V27, P345, DOI 10.1111/j.1471-6712.2012.01040.x; Blomqvist YT, 2012, J ADV NURS, V68, P1988, DOI 10.1111/j.1365-2648.2011.05886.x; Blomqvist YT, 2011, J CLIN NURS, V20, P1472, DOI 10.1111/j.1365-2702.2010.03369.x; Boo NY, 2007, J PAEDIATR CHILD H, V43, P831, DOI 10.1111/j.1440-1754.2007.01198.x; Bramson L, 2010, JOURNAL OF HUMAN LAC; Brimdyr K, 2012, J PERINAT EDUC, V21, P149, DOI 10.1891/1058-1243.21.3.149; Broughton E, 2013, COST SAVINGS IMPLEME; Cattaneo A, 1998, ACTA PAEDIATR, V87, P976, DOI 10.1080/080352598750031653; Central Intelligence Agency, 2013, WORLD FACTB 2013 201; Charpak N, 1997, PEDIATRICS, V100, P682, DOI 10.1542/peds.100.4.682; Charpak N, 2006, ACTA PAEDIATR, V95, P529, DOI 10.1080/08035250600599735; Conde-Agudelo A, 2014, KANGAROO MOTHER CARE; Department of Reproductive Health and ResearchW, 2003, KANG MOTH CAR PRACT; El-Nagger NSM, 2013, LIFE SCI J, V10, P703; Engmann C, 2013, LANCET, V382, pE26, DOI 10.1016/S0140-6736(13)62293-X; Feldman R, 2003, J FAM PSYCHOL, V17, P94, DOI 10.1037/0893-3200.17.1.94; Fleuren M, 2004, INT J QUAL HEALTH C, V16, P107, DOI 10.1093/intqhc/mzh030; Gathwala G, 2008, INDIAN J PEDIATR, V75, P43, DOI 10.1007/s12098-008-0005-x; Gregson S., 2011, BR J MIDWIFERY, V19, P568, DOI [10.12968/bjom.2011.19.9.568, DOI 10.12968/BJOM.2011.19.9.568, DOI 10.12968/BJ0M.2011.19.9.568]; Heinemann AB, 2013, ACTA PAEDIATR, V102, P695, DOI 10.1111/apa.12267; Kambarami RA, 2002, TROP DOCT, V32, P131, DOI 10.1177/004947550203200303; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Kymre IG, 2013, INT J QUALITATIVE ST, V8; Kymre IG, 2013, SCAND J CARING SCI, V27, P669, DOI 10.1111/j.1471-6712.2012.01076.x; Lawn JE, 2010, INT J EPIDEMIOL, V39, P144, DOI 10.1093/ije/dyq031; Lee HC, 2012, BREASTFEED MED, V7, P79, DOI 10.1089/bfm.2011.0004; Lemmen Desiree, 2013, Open Nurs J, V7, P41, DOI 10.2174/1874434601307010041; Leonard A, HLTH SA GESONDHEID, V13, P16; Lessing-Pernak J, 2011, GINEKOLOGIA POLOZNIC, V22, P37; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lima G, 2000, ANN TROP PAEDIATR, V20, P22, DOI 10.1080/02724930092020; Lincetto O, 2000, J TROP PEDIATRICS, V46, P293, DOI 10.1093/tropej/46.5.293; Lipato T, 2012, EVALUATION KANGAROO; March of Dimes PMNCH Save the Children WHO, 2012, BORN TOO SOON GLOB A, DOI [10.1186/1742-4755-10-S1-S1, DOI 10.1186/1742-4755-10-S1-S1]; MCHIP, 2012, MCHIP USAID HOST 1 L; McMaster P, 2000, TROP DOCT, V30, P136, DOI 10.1177/004947550003000307; Muddu GK, 2013, INDIAN J PEDIAT; Nguah SB, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-99; Nyqvist K H, 1994, J Hum Lact, V10, P237, DOI 10.1177/089033449401000418; Nyqvist KH, 2008, J HUM LACT, V24, P252, DOI 10.1177/0890334408319156; Parmar VR, 2009, INDIAN J PEDIATR, V76, P25, DOI 10.1007/s12098-009-0024-2; Quasem Iftekhar, 2003, J Perinatol, V23, P646, DOI 10.1038/sj.jp.7210999; Rojas MA, 2003, J DEV BEHAV PEDIATR, V24, P163, DOI 10.1097/00004703-200306000-00006; Roller CG, 2005, JOGNN-J OBST GYN NEO, V34, P210, DOI 10.1177/0884217504273675; Save the Children, 2013, COMMUNICATION    AUG; Sivapriya S, 2007, PERINATOLOGY, V9, P219; Sloan NL, 2008, PEDIATRICS, V121, pE1047, DOI 10.1542/peds.2007-0076; Solomons N, 2012, S AFR J CLIN NUTR, V25, P33; Swider SM, 2002, PUBLIC HEALTH NURS, V19, P11, DOI 10.1046/j.1525-1446.2002.19003.x; Tessier R, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.2.e17; van der Meijden MJ, 2003, J AM MED INFORM ASSN, V10, P235, DOI 10.1197/jamia.M1094; Vesel L, 2013, TROP MED INT HEALTH, V18, P952, DOI 10.1111/tmi.12134; Victor L, 1994, Crit Care Nurs Clin North Am, V6, P891; Waiswa P, 2010, TROP MED INT HEALTH, V15, P1140, DOI 10.1111/j.1365-3156.2010.02603.x; Worku B, 2005, J TROP PEDIATRICS, V51, P93, DOI 10.1093/tropej/fmh085; World Health Organization, 2014, KANG MOTH CAR RED MO; Yoshida S, 2014, DEFINING NEWBO UNPUB	65	116	119	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125643	10.1371/journal.pone.0125643	http://dx.doi.org/10.1371/journal.pone.0125643			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7CV	25993306	Green Submitted, Green Published, gold			2022-12-26	WOS:000354921400039
J	Brummett, AE; Schnicker, NJ; Crider, A; Todd, JD; Dey, M				Brummett, Adam E.; Schnicker, Nicholas J.; Crider, Alexander; Todd, Jonathan D.; Dey, Mishtu			Biochemical, Kinetic, and Spectroscopic Characterization of Ruegeria pomeroyi DddW-A Mononuclear Iron-Dependent DMSP Lyase	PLOS ONE			English	Article							DIMETHYL SULFIDE; DIMETHYLSULFONIOPROPIONATE LYASE; MARINE-BACTERIA; DESULFOVIBRIO ACRYLICUS; GAS DIMETHYLSULFIDE; SULFUR CYCLE; ACTIVE-SITE; ALGAL BLOOM; FOOD-WEB; BINDING	The osmolyte dimethylsulfoniopropionate (DMSP) is a key nutrient in marine environments and its catabolism by bacteria through enzymes known as DMSP lyases generates dimethylsulfide (DMS), a gas of importance in climate regulation, the sulfur cycle, and signaling to higher organisms. Despite the environmental significance of DMSP lyases, little is known about how they function at the mechanistic level. In this study we biochemically characterize DddW, a DMSP lyase from the model roseobacter Ruegeria pomeroyi DSS-3. DddW is a 16.9 kDa enzyme that contains a C-terminal cupin domain and liberates acrylate, a proton, and DMS from the DMSP substrate. Our studies show that as-purified DddWis a metalloenzyme, like the DddQ and DddP DMSP lyases, but contains an iron cofactor. The metal cofactor is essential for DddW DMSP lyase activity since addition of the metal chelator EDTA abolishes its enzymatic activity, as do substitution mutations of key metal-binding residues in the cupin motif (His81, His83, Glu87, and His121). Measurements of metal binding affinity and catalytic activity indicate that Fe(II) is most likely the preferred catalytic metal ion with a nanomolar binding affinity. Stoichiometry studies suggest DddW requires one Fe (II) per monomer. Electronic absorption and electron paramagnetic resonance (EPR) studies show an interaction between NO and Fe(II)-DddW, with NO binding to the EPR silent Fe (II) site giving rise to an EPR active species (g = 4.29, 3.95, 2.00). The change in the rhombicity of the EPR signal is observed in the presence of DMSP, indicating that substrate binds to the iron site without displacing bound NO. This work provides insight into the mechanism of DMSP cleavage catalyzed by DddW.	[Brummett, Adam E.; Schnicker, Nicholas J.; Crider, Alexander; Dey, Mishtu] Univ Iowa, Dept Chem, Iowa City, IA 52242 USA; [Todd, Jonathan D.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of Iowa; University of East Anglia	Dey, M (corresponding author), Univ Iowa, Dept Chem, Iowa City, IA 52242 USA.	mishtu-dey@uiowa.edu	Todd, Jonathan/B-8967-2009	Todd, Jonathan/0000-0003-0777-9312; Schnicker, Nicholas/0000-0002-5189-4943	University of Iowa College of Liberal Arts and Sciences; Natural Environment Research Council [NE/J01138X/1, NE/M004449/1, 875790] Funding Source: researchfish; NERC [NE/J01138X/1, NE/M004449/1] Funding Source: UKRI	University of Iowa College of Liberal Arts and Sciences; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by University of Iowa College of Liberal Arts and Sciences (MD).	Acolombri U, 2014, BIOCHEMISTRY-US, V53, P5473, DOI 10.1021/bi500853s; Biers EJ, 2009, APPL ENVIRON MICROB, V75, P2221, DOI 10.1128/AEM.02118-08; Chai SC, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-32; Chai SC, 2009, ANAL BIOCHEM, V395, P263, DOI 10.1016/j.ab.2009.07.054; Chavez FA, 2011, MODELING METAL BINDI; CHEN VJ, 1989, J BIOL CHEM, V264, P21677; Curson ARJ, 2008, ENVIRON MICROBIOL, V10, P757, DOI 10.1111/j.1462-2920.2007.01499.x; Curson ARJ, 2011, NAT REV MICROBIOL, V9, P849, DOI 10.1038/nrmicro2653; Curson ARJ, 2011, ISME J, V5, P1191, DOI 10.1038/ismej.2010.203; Curson ARJ, 2010, ISME J, V4, P144, DOI 10.1038/ismej.2009.93; Cuss CW, 2014, ANAL BIOANAL CHEM, V406, P867, DOI 10.1007/s00216-013-7529-2; DESOUZA MP, 1995, APPL ENVIRON MICROB, V61, P21, DOI 10.1128/AEM.61.1.21-26.1995; Dogbo D. O., 2012, African Crop Science Journal, V20, P85; Dudev T, 2007, ACCOUNTS CHEM RES, V40, P85, DOI 10.1021/ar068181i; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Fu XT, 2007, ENZYME MICROB TECH, V41, P828, DOI 10.1016/j.enzmictec.2007.07.003; Gonzalez JM, 1997, APPL ENVIRON MICROB, V63, P4237; Gonzalez JM, 2000, APPL ENVIRON MICROB, V66, P4237, DOI 10.1128/AEM.66.10.4237-4246.2000; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; Hajnal I, 2013, FEBS J, V280, P5815, DOI 10.1111/febs.12501; HALEY EE, 1968, J BIOL CHEM, V243, P5748; Hehemann JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103128; KELLER MD, 1989, ACS SYM SER, V393, P167; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kettle AJ, 1999, GLOBAL BIOGEOCHEM CY, V13, P399, DOI 10.1029/1999GB900004; Khuri S, 2001, MOL BIOL EVOL, V18, P593, DOI 10.1093/oxfordjournals.molbev.a003840; KIENE RP, 1990, NATURE, V345, P702, DOI 10.1038/345702a0; KIENE RP, 1988, NATURE, V332, P148, DOI 10.1038/332148a0; Kirkwood M, 2010, MICROBIOL-SGM, V156, P1900, DOI 10.1099/mic.0.038927-0; Kiss AL, 2004, FEBS LETT, V571, P17, DOI 10.1016/j.febslet.2004.06.054; Leitgeb S, 2009, BIOCHEM J, V418, P403, DOI 10.1042/BJ20081161; Li CY, 2014, P NATL ACAD SCI USA, V111, P1026, DOI 10.1073/pnas.1312354111; LOVELOCK JE, 1972, NATURE, V237, P452, DOI 10.1038/237452a0; Lyons TJ., 2007, BIOL INORGANIC CHEM, P57; MacDonald LC, 2014, J BIOL CHEM, V289, P312, DOI 10.1074/jbc.M113.489195; Machczynski MC, 2004, PROTEIN SCI, V13, P2388, DOI 10.1110/ps.04759104; Malin G, 2006, SCIENCE, V314, P607, DOI 10.1126/science.1133279; Moran MA, 2012, ANNU REV MAR SCI, V4, P523, DOI 10.1146/annurev-marine-120710-100827; ORVILLE AM, 1993, J BIOL CHEM, V268, P8596; Otte ML, 2004, J EXP BOT, V55, P1919, DOI 10.1093/jxb/erh178; Raina JB, 2013, NATURE, V502, P677, DOI 10.1038/nature12677; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; Raina JB, 2009, APPL ENVIRON MICROB, V75, P3492, DOI 10.1128/AEM.02567-08; Reisch CR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00172; Reisch CR, 2008, J BACTERIOL, V190, P8018, DOI 10.1128/JB.00770-08; Roy K.-M., 2000, ULLMANNS ENCY IND CH; Seymour JR, 2010, SCIENCE, V329, P342, DOI 10.1126/science.1188418; Simo R, 2001, TRENDS ECOL EVOL, V16, P287, DOI 10.1016/S0169-5347(01)02152-8; Stefels J, 2007, BIOGEOCHEMISTRY, V83, P245, DOI 10.1007/s10533-007-9091-5; Steinke M, 1998, MAR ECOL PROG SER, V175, P215, DOI 10.3354/meps175215; Tang J, 2009, J MOL BIOL, V389, P90, DOI 10.1016/j.jmb.2009.03.074; Tangerman A, 2007, J CLIN PERIODONTOL, V34, P748, DOI 10.1111/j.1600-051X.2007.01116.x; Tangerman A, 2009, J CHROMATOGR B, V877, P3366, DOI 10.1016/j.jchromb.2009.05.026; Todd JD, 2009, ENVIRON MICROBIOL, V11, P1376, DOI 10.1111/j.1462-2920.2009.01864.x; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; Todd JD, 2012, ISME J, V6, P223, DOI 10.1038/ismej.2011.79; Todd JD, 2011, ENVIRON MICROBIOL, V13, P427, DOI 10.1111/j.1462-2920.2010.02348.x; Todd JD, 2010, ENVIRON MICROBIOL, V12, P327, DOI 10.1111/j.1462-2920.2009.02071.x; Urvoas A, 2004, EUR J BIOCHEM, V271, P993, DOI 10.1111/j.1432-1033.2004.04001.x; vanderMaarel MJEC, 1996, ARCH MICROBIOL, V166, P109, DOI 10.1007/s002030050363; vanderMaarel MJEC, 1996, FEMS MICROBIOL LETT, V143, P241, DOI 10.1016/0378-1097(96)00320-5; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002; Zubkov MV, 2001, ENVIRON MICROBIOL, V3, P304, DOI 10.1046/j.1462-2920.2001.00196.x	63	32	33	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127288	10.1371/journal.pone.0127288	http://dx.doi.org/10.1371/journal.pone.0127288			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993446	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000354918600057
J	Figueroa-Vega, N; Moreno-Frias, C; Malacara, JM				Figueroa-Vega, Nicte; Moreno-Frias, Carmen; Manuel Malacara, Juan			Alterations in Adhesion Molecules, Pro-Inflammatory Cytokines and Cell-Derived Microparticles Contribute to Intima-Media Thickness and Symptoms in Postmenopausal Women	PLOS ONE			English	Article							EARLY MENOPAUSAL WOMEN; ENDOTHELIAL FUNCTION; VASCULAR INFLAMMATION; WALL THICKNESS; SEX-HORMONES; RISK-FACTORS; HOT FLASHES; LOW-GRADE; ESTROGEN; PERIMENOPAUSAL	Menopause, the cessation of menses, occurs with estrogens decline, low-grade inflammation, and impaired endothelial function, contributing to atherosclerotic risk. Intima-media thickness (IMT) is an early subclinical biomarker of atherosclerosis. Inflammation may have a role on symptoms: hot flashes, anxiety, and depressive mood, which also are related to endothelial dysfunction, increased IMT and cardiovascular risk. In this study we compared several inflammatory markers in early vs. late postmenopausal women and studied the association of IMT and symptoms with these markers in the full sample. In a cross-sectional design including 60 women (53.1 +/- 4.4 years old) at early and late postmenopause, we evaluated the expression of CD62L, ICAM-1, PSGL-1, CD11b, CD11c, and IL-8R on PBMC by flow cytometry. Serum soluble ICAM-1, sVCAM-1, sCD62E, sCD62P, CXCL8, IL-1 beta, IL-6, and TNF-alpha levels were quantified by ELISA. Plasma levels of microparticles (MPs) were determined by FACS. Finally, carotid intima-media thickness (IMT) was measured by ultrasound. We observed that ICAM-1 expression by lymphocytes and serum sVCAM-1 levels were augmented at late postmenopause. Late postmenopause women with severe hot flashes had increased expression of CD62L and IL-8R on neutrophils. By multivariate analysis, the carotid IMT was strongly associated with membrane-bound TNF-alpha, CD11b expression, Annexin V+ CD3(+) MPs, LPS-induced NO production, HDL-cholesterol and age. Depressive mood was associated negatively with PSGL-1 and positively with LPS-induced NO. Finally, Log(AMH) levels were associated with carotid IMT, IL-8R expression and time since menopause. IMT and depressive mood were the main clinical features related to vascular inflammation. Aging, hormonal changes and obesity were also related to endothelial dysfunction. These findings provide further evidence for a link between estrogen deficiency and low-grade inflammation in endothelial impairment in mature women.	[Figueroa-Vega, Nicte; Moreno-Frias, Carmen; Manuel Malacara, Juan] Univ Guanajuato, Dept Med Sci, Leon, Gto, Mexico	Universidad de Guanajuato	Malacara, JM (corresponding author), Univ Guanajuato, Dept Med Sci, Leon Campus, Leon, Gto, Mexico.	jmmalacara@hotmail.com		Moreno Frias, Carmen/0000-0002-7316-6816; Malacara, Juan Manuel/0000-0001-9150-9088	Consejo Nacional de Ciencia y Tecnologia (CONACYT Ciencia Basica, Mexico) [CA4O030112]	Consejo Nacional de Ciencia y Tecnologia (CONACYT Ciencia Basica, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the grant CA4O030112 from the Consejo Nacional de Ciencia y Tecnologia (CONACYT Ciencia Basica 2010, Mexico, to NF-V). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Taha M, 2009, J IMMUNOL, V183, P1393, DOI 10.4049/jimmunol.0803157; Aguilar-Zavala H, 2012, MENOPAUSE, V19, P1140, DOI 10.1097/gme.0b013e3182503bde; ASA D, 1995, J BIOL CHEM, V270, P11662, DOI 10.1074/jbc.270.19.11662; Badeau RM, 2013, EUR J CLIN INVEST, V43, P317, DOI 10.1111/eci.12044; Barnes MJ, 2002, EXP BIOL MED, V227, P817, DOI 10.1177/153537020222700915; Barreiro O, 2010, CARDIOVASC RES, V86, P174, DOI 10.1093/cvr/cvq001; Bechlioulis A, 2012, J CLIN ENDOCR METAB, V97, pE760, DOI 10.1210/jc.2011-3151; Bechlioulis A, 2012, MATURITAS, V71, P389, DOI 10.1016/j.maturitas.2012.01.001; Bechlioulis A, 2010, J CLIN ENDOCR METAB, V95, P1199, DOI 10.1210/jc.2009-2262; Begic I, 2012, MED GLAS, V9, P32; Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; Broer SL, 2014, HUM REPROD UPDATE, V20, P688, DOI 10.1093/humupd/dmu020; Burger HG, 1999, J STEROID BIOCHEM, V69, P31, DOI 10.1016/S0960-0760(98)00145-9; Cagnacci A, 2012, CLIMACTERIC, V15, P157, DOI 10.3109/13697137.2011.617852; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Csongradi E, 2011, THROMB HAEMOSTASIS, V106, P683, DOI 10.1160/TH11-01-0030; El Khoudary SR, 2013, ATHEROSCLEROSIS, V231, P54, DOI 10.1016/j.atherosclerosis.2013.08.039; El Khoudary SR, 2013, MENOPAUSE, V20, P8, DOI 10.1097/gme.0b013e3182611787; El Khoudary SR, 2012, ATHEROSCLEROSIS, V225, P180, DOI 10.1016/j.atherosclerosis.2012.07.025; Gomita K, 2012, J ATHEROSCLER THROMB, V19, P227, DOI 10.5551/jat.9399; Gonzalez-Amaro R, 2011, ACTA PHARMACOL SIN, V32, P1431, DOI 10.1038/aps.2011.154; Goto J, 1997, HUM REPROD, V12, P2729, DOI 10.1093/humrep/12.12.2729; Harris KF, 2003, PSYCHOSOM MED, V65, P402, DOI 10.1097/01.PSY.0000035720.08842.9F; Huerta R, 1995, PSYCHONEUROENDOCRINO, V20, P851, DOI 10.1016/0306-4530(95)00030-5; Huerta R, 1997, ENDOCRINE, V7, P281, DOI 10.1007/BF02801320; Jakimiuk AJ, 2007, GYNECOL ENDOCRINOL, V23, P584, DOI 10.1080/09513590701553605; Jayachandran M, 2009, CLIMACTERIC, V12, P177, DOI 10.1080/13697130802488607; Jayachandran M, 2011, J CARDIOVASC TRANSL, V4, P811, DOI 10.1007/s12265-011-9296-9; Kang LS, 2011, AM J PHYSIOL-HEART C, V300, pH2105, DOI 10.1152/ajpheart.00349.2010; Kim OY, 2012, AGE, V34, P415, DOI 10.1007/s11357-011-9244-2; Leonard Brian E., 2010, Current Immunology Reviews, V6, P205; Licht RW, 2005, ACTA PSYCHIAT SCAND, V111, P144, DOI 10.1111/j.1600-0447.2004.00440.x; Malacara JM, 2002, MATURITAS, V43, P11, DOI 10.1016/S0378-5122(02)00077-4; Meadows JL, 2011, MATURITAS, V69, P120, DOI 10.1016/j.maturitas.2011.03.012; Moreau KL, 2012, J CLIN ENDOCR METAB, V97, P4692, DOI 10.1210/jc.2012-2244; Moreno-Frias C, 2014, MENOPAUSE, V21, P1017, DOI [10.1097/gme.0000000000000206, 10.1097/GME.0000000000000206]; Novella S, 2012, ARTERIOSCL THROM VAS, V32, P2035, DOI 10.1161/ATVBAHA.112.250308; Ohira T, 2012, PSYCHOSOM MED, V74, P517, DOI 10.1097/PSY.0b013e31824f6267; Roelke LH, 2013, ARQ BRAS CARDIOL, V101, P211, DOI 10.5935/abc.20130151; Saveanu RV, 2012, PSYCHIAT CLIN N AM, V35, P51, DOI 10.1016/j.psc.2011.12.001; Schoppen S, 2010, NUTR HOSP, V25, P256, DOI 10.3305/nh.2010.25.2.4460; Seals DR, 2011, CLIN SCI, V120, P357, DOI 10.1042/CS20100476; Soules MR, 2001, J WOMEN HEALTH GEN-B, V10, P843, DOI 10.1089/152460901753285732; Sowers M, 2007, J CLIN ENDOCR METAB, V92, P895, DOI 10.1210/jc.2006-1393; Szmuilowicz ED, 2011, MENOPAUSE, V18, P603, DOI 10.1097/gme.0b013e3182014849; Thurston RC, 2012, MENOPAUSE, V19, P406, DOI 10.1097/gme.0b013e3182337166; Vara D, 2014, CURR MOL MED, V14, P1103, DOI 10.2174/1566524014666140603114010; Woollard KJ, 2013, CLIN SCI, V125, P221, DOI 10.1042/CS20120576; Wu DY, 2008, J LEUKOCYTE BIOL, V84, P900, DOI 10.1189/jlb.0108023; Yamamoto Kazuhiko, 2007, Journal of Physiological Anthropology, V26, P149, DOI 10.2114/jpa2.26.149; Yasui T, 2006, J CLIN ENDOCR METAB, V91, P4805, DOI 10.1210/jc.2006-1100	51	34	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0120990	10.1371/journal.pone.0120990	http://dx.doi.org/10.1371/journal.pone.0120990			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993480	gold, Green Published, Green Submitted			2022-12-26	WOS:000354918600001
J	Xing, Y; Ji, QH; Lin, Y; Fu, M; Gao, JX; Zhang, P; Hu, XB; Feng, L; Liu, YF; Han, H; Li, W				Xing, Ying; Ji, Qiuhe; Lin, Ying; Fu, Meng; Gao, Jixin; Zhang, Ping; Hu, Xingbin; Feng, Lei; Liu, Yufeng; Han, Hua; Li, Wei			Positive Selection of Natural Poly-Reactive B Cells in the Periphery Occurs Independent of Heavy Chain Allelic Inclusion	PLOS ONE			English	Article							LYMPHOCYTE DEVELOPMENT; NEGATIVE SELECTION; ESCAPE TOLERANCE; TRANSGENIC MICE; MARGINAL ZONE; BONE-MARROW; EXPRESSION; ANTIBODY; DIFFERENTIATION; AUTOANTIBODIES	Natural autoreactive B cells are important mediators of autoimmune diseases. Receptor editing is known to play an important role in both central and peripheral B cell tolerance. However, the role of allelic inclusion in the development of natural autoreactive B cells is not clear. Previously, we generated mu chain (TgVH(3)B4I) and mu/kappa. chains (TgV(H/L)3B4) transgenic mice using transgene derived from the 3B4 hybridoma, which produce poly-reactive natural autoantibodies. In this study, we demonstrate that a considerable population of B cells edited their B cells receptors (BCRs) via light chain or heavy chain allelic inclusion during their development in TgV(H)3B4I mice. Additionally, allelic inclusion occurred more frequently in the periphery and promoted the differentiation of B cells into marginal zone or B-1a cells in TgV(H)3B4I mice. B cells from TgV(H/L)3B4 mice expressing the intact transgenic 3B4 BCR without receptor editing secreted poly-reactive 3B4 antibody. Interestingly, however, B cell that underwent allelic inclusion in TgV(H)3B4I mice also produced poly-reactive autoantibodies in vivo and in vitro. Our findings suggest that receptor editing plays a minor role in the positive selection of B cells expressing natural poly-reactive BCRs, which can be positively selected through heavy chain allelic inclusion to retain their poly-reactivity in the periphery.	[Xing, Ying; Fu, Meng; Gao, Jixin; Liu, Yufeng; Li, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China; [Xing, Ying; Ji, Qiuhe] Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol & Metab Dis, Xian 710032, Peoples R China; [Xing, Ying; Hu, Xingbin; Feng, Lei; Han, Hua] Fourth Mil Med Univ, Dept Med Genet & Dev Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Lin, Ying; Zhang, Ping] Fourth Mil Med Univ, Xijing Hosp, Dept Otolaryngol Head & Neck Surg, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Han, H (corresponding author), Fourth Mil Med Univ, Dept Med Genet & Dev Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China.	huahan@fmmu.edu.cn; liwei1@fmmu.edu.cn	fu, meng/GZG-3120-2022; Hu, XB/U-8501-2019	fu, meng/0000-0002-8867-0951	National Natural Science Foundation of China [30901336, 31070793, 81070663, 81273320, 81271750]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China: 30901336 (YX), 31070793 (WL), 81070663 (QJ), 81273320 (WL), 81271750 (YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; Arakawa H, 1996, INT IMMUNOL, V8, P1319, DOI 10.1093/intimm/8.8.1319; CARSETTI R, 1995, J EXP MED, V181, P2129, DOI 10.1084/jem.181.6.2129; CHEN C, 1995, NATURE, V373, P252, DOI 10.1038/373252a0; Chu YP, 2004, AUTOIMMUNITY, V37, P27, DOI 10.1080/08916930310001619481; Edry E, 2004, J IMMUNOL, V173, P4265, DOI 10.4049/jimmunol.173.7.4265; ERA T, 1991, EMBO J, V10, P337, DOI 10.1002/j.1460-2075.1991.tb07954.x; Fu M, 2007, APOPTOSIS, V12, P355, DOI 10.1007/s10495-006-0581-z; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; Gerdes T, 2004, NAT IMMUNOL, V5, P1282, DOI 10.1038/ni1133; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Heltemes-Harris L, 2005, INT IMMUNOL, V17, P1447, DOI 10.1093/intimm/dxh323; IMAI H, 1994, J IMMUNOL, V153, P2290; Jankovic M, 2004, ANNU REV IMMUNOL, V22, P485, DOI 10.1146/annurev.immunol.22.012703.104707; Lacroix-Desmazes S, 1998, J IMMUNOL METHODS, V216, P117, DOI 10.1016/S0022-1759(98)00074-X; Lam KP, 1999, J EXP MED, V190, P471, DOI 10.1084/jem.190.4.471; Lamoureux JL, 2007, J EXP MED, V204, P2853, DOI 10.1084/jem.20071268; Levine MH, 2000, P NATL ACAD SCI USA, V97, P2743, DOI 10.1073/pnas.050552997; Li H, 2001, IMMUNITY, V15, P947, DOI 10.1016/S1074-7613(01)00251-5; Li W, 2007, CELL MICROBIOL, V9, P306, DOI 10.1111/j.1462-5822.2006.00786.x; Li YJ, 2002, J EXP MED, V196, P1543, DOI 10.1084/jem.20021560; Li YJ, 2002, J EXP MED, V195, P181, DOI 10.1084/jem.20011453; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Liu S, 2005, J IMMUNOL, V175, P5067, DOI 10.4049/jimmunol.175.8.5067; MEYER KB, 1990, NUCLEIC ACIDS RES, V18, P5609, DOI 10.1093/nar/18.19.5609; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71; Pelanda R, 2006, CURR OPIN IMMUNOL, V18, P184, DOI 10.1016/j.coi.2006.01.005; Pillai S, 2004, IMMUNOL REV, V197, P206, DOI 10.1111/j.0105-2896.2003.097.x; RADIC MZ, 1993, J EXP MED, V177, P1165, DOI 10.1084/jem.177.4.1165; ROEHM NW, 1984, J EXP MED, V160, P679, DOI 10.1084/jem.160.3.679; Sekiguchi DR, 2003, J EXP MED, V197, P27, DOI 10.1084/jem.20020737; Sirac C, 2006, P NATL ACAD SCI USA, V103, P7747, DOI 10.1073/pnas.0509121103; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Verkoczy LK, 2004, CURR OPIN IMMUNOL, V16, P808, DOI 10.1016/j.coi.2004.09.017; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Watanabe N, 1999, J EXP MED, V190, P461, DOI 10.1084/jem.190.4.461; WORTIS HH, 1995, P NATL ACAD SCI USA, V92, P3348, DOI 10.1073/pnas.92.8.3348; Yachimovich-Cohen N, 2003, EUR J IMMUNOL, V33, P2469, DOI 10.1002/eji.200324025; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Yurasov S, 2006, J EXP MED, V203, P2255, DOI 10.1084/jem.20061446	46	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0125747	10.1371/journal.pone.0125747	http://dx.doi.org/10.1371/journal.pone.0125747			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993514	Green Published, gold, Green Submitted			2022-12-26	WOS:000354918600018
J	Appel, M; Scholz, CJ; Muller, T; Dittrich, M; Konig, C; Bockstaller, M; Oguz, T; Khalili, A; Antwi-Adjei, E; Schauer, T; Margulies, C; Tanimoto, H; Yarali, A				Appel, Mirjam; Scholz, Claus-Juergen; Mueller, Tobias; Dittrich, Marcus; Koenig, Christian; Bockstaller, Marie; Oguz, Tuba; Khalili, Afshin; Antwi-Adjei, Emmanuel; Schauer, Tamas; Margulies, Carla; Tanimoto, Hiromu; Yarali, Ayse			Genome-Wide Association Analyses Point to Candidate Genes for Electric Shock Avoidance in Drosophila melanogaster	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; DISRUPTION PROJECT; NATURAL VARIATION; COMPLEX TRAITS; NETWORKS; BEHAVIOR; FLIES; TEMPERATURE; GENETICS; PAINFUL	Electric shock is a common stimulus for nociception-research and the most widely used reinforcement in aversive associative learning experiments. Yet, nothing is known about the mechanisms it recruits at the periphery. To help fill this gap, we undertook a genome-wide association analysis using 38 inbred Drosophila melanogaster strains, which avoided shock to varying extents. We identified 514 genes whose expression levels and/or sequences covaried with shock avoidance scores. We independently scrutinized 14 of these genes using mutants, validating the effect of 7 of them on shock avoidance. This emphasizes the value of our candidate gene list as a guide for follow-up research. In addition, by integrating our association results with external protein-protein interaction data we obtained a shock avoidance- associated network of 38 genes. Both this network and the original candidate list contained a substantial number of genes that affect mechanosensory bristles, which are hairlike organs distributed across the fly's body. These results may point to a potential role for mechanosensory bristles in shock sensation. Thus, we not only provide a first list of candidate genes for shock avoidance, but also point to an interesting new hypothesis on nociceptive mechanisms.	[Appel, Mirjam; Koenig, Christian; Khalili, Afshin; Antwi-Adjei, Emmanuel; Yarali, Ayse] Leibniz Inst Neurobiol, Res Grp Mol Syst Biol Learning, Magdeburg, Germany; [Appel, Mirjam; Bockstaller, Marie; Oguz, Tuba; Tanimoto, Hiromu; Yarali, Ayse] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Scholz, Claus-Juergen] Univ Wurzburg, IZKF, Lab Microarray Applicat, D-97070 Wurzburg, Germany; [Mueller, Tobias; Dittrich, Marcus] Univ Wurzburg, Dept Bioinformat, Bioctr, D-97070 Wurzburg, Germany; [Dittrich, Marcus] Univ Wurzburg, Inst Human Genet, D-97070 Wurzburg, Germany; [Schauer, Tamas; Margulies, Carla] Univ Munich, Butenandt Inst, Dept Physiol Chem, Munich, Germany; [Schauer, Tamas; Margulies, Carla] Univ Munich, LMU Biomed Ctr, Fac Med, Munich, Germany; [Tanimoto, Hiromu] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan; [Yarali, Ayse] Ctr Behav Brain Sci, Magdeburg, Germany	Leibniz Institut fur Neurobiologie (LIN); Max Planck Society; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Munich; University of Munich; Tohoku University	Yarali, A (corresponding author), Leibniz Inst Neurobiol, Res Grp Mol Syst Biol Learning, Magdeburg, Germany.	ayse.yarali@lin-magdeburg.de	Oguz, Tuba/ABS-8261-2022; Scholz, Claus Jürgen/H-3202-2019; /AHD-6000-2022; Tanimoto, Hiromu/J-6810-2016; Müller, Tobias/A-8952-2008	Oguz, Tuba/0000-0002-7852-0394; Scholz, Claus Jürgen/0000-0002-6406-7859; /0000-0002-7852-0394; Konig, Christian/0000-0001-6033-8255	Deutche Forschungsgemeinschaft [YA272/2-1]; Max Planck Institute for Neurobiology; Leibniz Institute for Neurobiology; Studienstiftung des deutschen Volkes	Deutche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Institute for Neurobiology; Leibniz Institute for Neurobiology; Studienstiftung des deutschen Volkes	This study was funded by a research grant from the Deutche Forschungsgemeinschaft to AY (YA272/2-1) (http://www.dfg.de/) and institutional support from the Max Planck Institute for Neurobiology (http://www.neuro.mpg.de/) and the Leibniz Institute for Neurobiology (http://www.linmagdeburg.de/index.jsp). MA received a PhD stipend from Studienstiftung des deutschen Volkes (http://www. studienstiftung.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anholt RRH, 2004, NAT REV GENET, V5, P838, DOI 10.1038/nrg1472; Appel M, 2009, ANIM BEHAV, V78, P1373, DOI 10.1016/j.anbehav.2009.09.008; Arya GH, 2010, GENETICS, V186, P1475, DOI 10.1534/genetics.110.123166; Aso Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002768; Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Beisser D, 2010, BIOINFORMATICS, V26, P1129, DOI 10.1093/bioinformatics/btq089; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CAREW TJ, 1981, SCIENCE, V211, P501, DOI 10.1126/science.7455692; Ciapponi L, 2004, CURR BIOL, V14, P1360, DOI 10.1016/j.cub.2004.07.019; Dittrich MT, 2008, BIOINFORMATICS, V24, pI223, DOI 10.1093/bioinformatics/btn161; Edwards AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r76; Galili DS, 2014, CURR BIOL, V24, P1712, DOI 10.1016/j.cub.2014.06.062; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gerber B, 2014, LEARN MEMORY, V21, P232, DOI 10.1101/lm.032995.113; Greenspan RJ, 2004, HUM MOL GENET, V13, pR267, DOI 10.1093/hmg/ddh248; Guo A, 1996, LEARN MEMORY, V3, P49, DOI 10.1101/lm.3.1.49; Harbison ST, 2009, NAT GENET, V41, P371, DOI 10.1038/ng.330; Hong ST, 2008, NATURE, V454, P771, DOI 10.1038/nature07090; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; JANAL MN, 1991, PERCEPT PSYCHOPHYS, V50, P108, DOI 10.3758/BF03212212; Leviten MW, 1996, DEV BIOL, V176, P264, DOI 10.1006/dbio.1996.0133; Mackay TEC, 2006, ANNU REV GENOM HUM G, V7, P339, DOI 10.1146/annurev.genom.7.080505.115758; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; Morozova TV, 2009, GENETICS, V183, P733, DOI 10.1534/genetics.109.107490; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Neely GG, 2010, CELL, V143, P628, DOI 10.1016/j.cell.2010.09.047; Pavlov I.P., 1927, CONDITIONED REFLEXES; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Yu WJ, 2006, J CELL SCI, V119, P4793, DOI 10.1242/jcs.03174	37	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126986	10.1371/journal.pone.0126986	http://dx.doi.org/10.1371/journal.pone.0126986			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992709	Green Published, Green Submitted, gold			2022-12-26	WOS:000354917300072
J	Wen, ZY; Ma, H; Zhao, Y; Fan, ZM; Zhang, ZQ; Choi, SI; Choe, YH; Liu, JY				Wen, Zhaoying; Ma, Heng; Zhao, Ying; Fan, Zhanming; Zhang, Zhaoqi; Choi, Sang Il; Choe, Yeon Hyeon; Liu, Jiayi			Left Ventricular Diastolic Dysfunction Assessment with Dual-Source CT	PLOS ONE			English	Article							LEFT ATRIAL FUNCTION; SPECKLE TRACKING ECHOCARDIOGRAPHY; PRESERVED EJECTION FRACTION; COMPUTED-TOMOGRAPHY; HEART-FAILURE; 2-DIMENSIONAL ECHOCARDIOGRAPHY; MYOCARDIAL-INFARCTION; FILLING PRESSURE; PUMP FUNCTION; VOLUME	Purpose To assess the impact of left ventricular (LV) diastolic dysfunction on left atrial (LA) phasic volume and function using dual-source CT (DSCT) and to find a viable alternative prognostic parameter of CT for LV diastolic dysfunction through quantitative evaluation of LA phasic volume and function in patients with LV diastolic dysfunction. Materials and Methods Seventy-seven patients were examined using DSCT and Doppler echocardiography on the same day. Reservoir, conduit, and contractile function of LA were evaluated by measuring LA volume (LAV) during different cardiac phases and all parameters were normalized to body surface area (BSA). Patients were divided into four groups (normal, impaired relaxation, pseudonormal, and restrictive LV diastolic filling) according to echocardiographic findings. The LA phasic volume and function in different stages of LV diastolic function was compared using one-way ANOVA analysis. The correlations between indexed volume of LA (LAVi) and diastolic function in different stages of LV were evaluated using Spearman correlation analysis. Results LA ejection fraction (LAEF), LA contraction, reservoir, and conduit function in patients in impaired relaxation group were not different from those in the normal group, but they were lower in patients in the pseudonormal and restrictive LV diastolic dysfunction groups (P < 0.05). For LA conduit function, there were no significant differences between the patients in the pseudonormal group and restrictive filling group (P = 0.195). There was a strong correlation between the indexed maximal left atrial volume (LAVmax, r = 0.85, P < 0.001), minimal left atrial volume (LAVmin, r = 0.91, P < 0.001), left atrial volume at the onset of P wave (LAVp, r = 0.84, P < 0.001), and different stages of LV diastolic function. The LAVi increased as the severity of LV diastolic dysfunction increased. Conclusions LA remodeling takes place in patients with LV diastolic dysfunction. At the same time, LA phasic volume and function parameters evaluated by DSCT indicated the severity of the LV diastolic dysfunction. Quantitative analysis of LA phasic volume and function parameters using DSCT could be a viable alternative prognostic parameter of LV diastolic function.	[Wen, Zhaoying; Fan, Zhanming; Zhang, Zhaoqi; Liu, Jiayi] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Radiol, Beijing Anzhen Hosp, Beijing, Peoples R China; [Ma, Heng] Yuhuangding Hosp, Dept Radiol, Yantai, Shandong, Peoples R China; [Zhao, Ying] Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Echocardiol, Beijing Anzhen Hosp, Beijing, Peoples R China; [Choi, Sang Il] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Seoul, South Korea; [Choe, Yeon Hyeon] Sungkyunkwan Univ, Sch Med, Dept Radiol, Seoul, South Korea; [Choe, Yeon Hyeon] Sungkyunkwan Univ, Sch Med, Cardiovasc & Stroke Imaging Ctr, Heart Vasc Stroke Inst,Samsung Med Ctr, Seoul, South Korea	Capital Medical University; Capital Medical University; Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center	Liu, JY (corresponding author), Capital Med Univ, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Radiol, Beijing Anzhen Hosp, Beijing, Peoples R China.	ljy76519@163.com	Choe, Yeon Hyeon/F-1422-2010	Choe, Yeon Hyeon/0000-0002-9983-048X	Beijing National Science Foundation [7142047]; National Natural Science Foundation Of China [81401375, 81401385, 81200166]; Shandong Province Natural Science Foundation [ZR2014HQ011]; Yantai City Science and Technology Development Plan [2012090]	Beijing National Science Foundation; National Natural Science Foundation Of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Yantai City Science and Technology Development Plan	The study was supported by the following fundings: grant numbers: 7142047, the URLs: http://www.bjnsf.org/nsf_tzgg/201401/t20140116_9626.html, Beijing National Science Foundation, ZYW; grant numbers: 81401375, the URLs:http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list, National Natural Science Foundation Of China, ZYW; grant numbers: 81401385, the URLs: http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list, National Natural Science Foundation Of China, HM; grant numbers: ZR2014HQ011, the URLs: http://www.sdnsf.gov.cn/portal/, Shandong Province Natural Science Foundation, HM; grant numbers: 2012090, Yantai City Science and Technology Development Plan, HM; grant numbers: 81200166, the URLs: http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list, National Natural Science Foundation Of China, YZ; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835; Chinali M, 2005, AM J HYPERTENS, V18, P899, DOI 10.1016/j.amjhyper.2005.01.005; Christiaens L, 2009, INT J CARDIOL, V131, P217, DOI 10.1016/j.ijcard.2007.10.020; Demirkol S, 2012, ECHOCARDIOGR-J CARD, V29, P1064, DOI 10.1111/j.1540-8175.2012.01751.x; Garcia MJ, 1998, J AM COLL CARDIOL, V32, P865, DOI 10.1016/S0735-1097(98)00345-3; GREENBERG B, 1979, AM HEART J, V98, P742, DOI 10.1016/0002-8703(79)90473-3; Hillis GS, 2004, J AM COLL CARDIOL, V43, P360, DOI 10.1016/j.jacc.2003.07.044; Khan UA, 2013, ECHOCARDIOGR-J CARD, V30, P309, DOI 10.1111/echo.12043; KIRCHER B, 1991, AM HEART J, V121, P864, DOI 10.1016/0002-8703(91)90200-2; KONO T, 1992, CIRCULATION, V86, P1317, DOI 10.1161/01.CIR.86.4.1317; Kostopoulou AG, 2014, AM J HEMATOL, V89, P13, DOI 10.1002/ajh.23581; Kuhl JT, 2011, JACC-CARDIOVASC IMAG, V4, P1080, DOI 10.1016/j.jcmg.2011.08.008; La Meir M, 2013, J THORAC CARDIOV SUR, V146, P72, DOI 10.1016/j.jtcvs.2012.05.068; Leschka S, 2007, INVEST RADIOL, V42, P543, DOI 10.1097/RLI.0b013e31803b93cf; Mahabadi AA, 2010, J CARDIOVASC COMPUT, V4, P49, DOI 10.1016/j.jcct.2009.10.013; MATSUZAKI M, 1991, AM J CARDIOL, V67, P1121, DOI 10.1016/0002-9149(91)90876-M; Murata M, 2008, AM J CARDIOL, V102, P1097, DOI 10.1016/j.amjcard.2008.05.067; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Otani K, 2010, J AM SOC ECHOCARDIOG, V23, P961, DOI 10.1016/j.echo.2010.06.023; Rodevand O, 1999, INT J CARDIAC IMAG, V15, P397, DOI 10.1023/A:1006276513186; Santos ABS, 2014, EUR J HEART FAIL, V16, P1096, DOI 10.1002/ejhf.147; Savino G, 2007, J THORAC IMAG, V22, P86, DOI 10.1097/RTI.0b013e3180317433; Spencer KT, 2001, HEART, V85, P272, DOI 10.1136/heart.85.3.272; Stojanovska J, 2014, ACAD RADIOL, V21, P1162, DOI 10.1016/j.acra.2014.02.018; Stolzmann P, 2008, INVEST RADIOL, V43, P284, DOI 10.1097/RLI.0b013e3181626853; To ACY, 2011, JACC-CARDIOVASC IMAG, V4, P788, DOI 10.1016/j.jcmg.2011.02.018; Tsang TSM, 2002, AM J CARDIOL, V90, P1284, DOI 10.1016/S0002-9149(02)02864-3; Tsang TSM, 2001, MAYO CLIN PROC, V76, P467, DOI 10.4065/76.5.467; Tsang TSM, 2003, J AM COLL CARDIOL, V42, P1199, DOI 10.1016/S0735-1097(03)00943-4; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; Welles CC, 2012, J AM COLL CARDIOL, V59, P673, DOI 10.1016/j.jacc.2011.11.012; Wen ZY, 2010, INT J CARDIOVAS IMAG, V26, P83, DOI 10.1007/s10554-009-9569-4; Wolf F, 2010, EUR J RADIOL, V75, pE141, DOI 10.1016/j.ejrad.2010.03.020	33	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127289	10.1371/journal.pone.0127289	http://dx.doi.org/10.1371/journal.pone.0127289			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993545	Green Submitted, gold, Green Published			2022-12-26	WOS:000354917300111
J	Li, KKW; Qi, Y; Xia, T; Yao, Y; Zhou, LF; Lau, KM; Ng, HK				Li, Kay Ka-Wai; Qi, Yan; Xia, Tian; Yao, Yu; Zhou, Liangfu; Lau, Kin-Mang; Ng, Ho-Keung			CRMP1 Inhibits Proliferation of Medulloblastoma and Is Regulated by HMGA1	PLOS ONE			English	Article							RESPONSE MEDIATOR PROTEIN-1; ADJUVANT CHEMOTHERAPY; INVASION; EXPRESSION; METASTASIS; CHILDREN; THERAPY; PATHWAY; FAMILY; TUMORS	Many facets of the tumor biology of medulloblastoma (MB) have not been fully elucidated. Collapsin response mediator protein 1 (CRMP1) is a member of cytoplasmic family of proteins that regulate the development of central nervous system. Recent studies demonstrated that CRMP1 could function as an invasion suppressor. We reported previously that high mobility group AT-hook 1 (HMGA1) contributed to development of MB and regulated its growth and migration/invasion. Transcriptional profiling and quantitative RT-PCR revealed increased expression of CRMP1 in HMGA1-depleted cells, suggesting that CRMP1 may be a downstream target of HMGA1 in MB. In this study, we showed HMGA1 can bind CRMP1 promoter by chromatin immunoprecipitation (ChIP) assay. Luciferase assay demonstrated a marked enhancement of CRMP1 transcription activity in HMGA1-depleted cells. Furthermore, quantitative RT-PCR revealed a negative correlation between HMGA1 and CRMP1 in 32 MB samples. To investigate the biological roles of CRMP1 in MB pathogenesis, we established MB clones stably expressing CRMP1. Functional analysis revealed that expression of CRMP1 significantly inhibited proliferation, migration, invasion and formation of filopodia and intense stress fiber of MB cells. Our data suggest that HMGA1 regulates CRMP1 expression and CRMP1 is implicated in MB pathogenesis.	[Li, Kay Ka-Wai; Qi, Yan; Xia, Tian; Lau, Kin-Mang; Ng, Ho-Keung] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China; [Li, Kay Ka-Wai; Ng, Ho-Keung] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Yao, Yu; Zhou, Liangfu] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong, Shenzhen; Fudan University	Lau, KM (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, 30-32 Ngan Shing St, Shatin, Hong Kong, Peoples R China.	kmlau@cuhk.edu.hk; hkng@cuhk.edu.hk	Ng, Ho Keung/I-3952-2015	Lau, Kin-Mang/0000-0001-5888-1937	Hong Kong Research Grants Council [CUHK 469211]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This study was supported by Hong Kong Research Grants Council (ref. no. CUHK 469211).	Buel GR, 2010, J CELL BIOCHEM, V111, P20, DOI 10.1002/jcb.22659; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Charrier E, 2006, GENES CELLS, V11, P1337, DOI 10.1111/j.1365-2443.2006.01024.x; Chen JJW, 2001, CANCER RES, V61, P5223; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; FRIEDMANN M, 1993, NUCLEIC ACIDS RES, V21, P4259, DOI 10.1093/nar/21.18.4259; Gao M, 2008, BIOCHEM BIOPH RES CO, V376, P283, DOI 10.1016/j.bbrc.2008.08.144; Giangaspero F, 2007, WHO CLASSIFICATION T, P132; Hamajima N, 1996, GENE, V180, P157, DOI 10.1016/S0378-1119(96)00445-3; HE XM, 1991, LAB INVEST, V64, P833; Jayasena CS, 2011, GENE EXPR PATTERNS, V11, P395, DOI 10.1016/j.gep.2011.05.002; JOHNSON KR, 1989, MOL CELL BIOL, V9, P2114, DOI 10.1128/MCB.9.5.2114; Keles GE, 1995, ONCOL RES, V7, P493; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Lau KM, 2012, ACTA NEUROPATHOL, V123, P553, DOI 10.1007/s00401-011-0934-8; Li CX, 2004, J NEUROSCI, V24, P6161, DOI 10.1523/JNEUROSCI.1476-04.2004; Luo J, 2012, NEUROCHEM RES, V37, P1381, DOI 10.1007/s11064-012-0712-6; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Morita A, 2006, J NEUROSCI, V26, P2971, DOI 10.1523/JNEUROSCI.5453-05.2006; Mukherjee J, 2009, CANCER RES, V69, P8545, DOI 10.1158/0008-5472.CAN-09-1778; Mulhern RK, 2005, J CLIN ONCOL, V23, P5511, DOI 10.1200/JCO.2005.00.703; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; O'Connor Kathleen, 2013, Small GTPases, V4, P141, DOI 10.4161/sgtp.25131; Packer RJ, 2006, J CLIN ONCOL, V24, P4202, DOI 10.1200/JCO.2006.06.4980; Packer RJ, 2013, NEURO-ONCOLOGY, V15, P97, DOI 10.1093/neuonc/nos267; Quach TT, 2004, MOL CELL NEUROSCI, V25, P433, DOI 10.1016/j.mcn.2003.11.006; Quinn CC, 1999, J NEUROBIOL, V41, P158, DOI 10.1002/(SICI)1097-4695(199910)41:1<158::AID-NEU19>3.0.CO;2-0; Raverot G, 2010, J CLIN ENDOCR METAB, V95, P1708, DOI 10.1210/jc.2009-1191; Ribi K, 2005, NEUROPEDIATRICS, V36, P357, DOI 10.1055/s-2005-872880; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; Shah SN, 2012, HISTOL HISTOPATHOL, V27, P567, DOI 10.14670/HH-27.567; Shih JY, 2001, JNCI-J NATL CANCER I, V93, P1392, DOI 10.1093/jnci/93.18.1392; Shih JY, 2003, CLIN EXP METASTAS, V20, P69, DOI 10.1023/A:1022598604565; Tan F, 2014, ONCOL LETT, V7, P1333, DOI 10.3892/ol.2014.1909; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Veyrac A, 2005, EUR J NEUROSCI, V21, P2635, DOI 10.1111/j.1460-9568.2005.04112.x; Wierinckx A, 2007, ENDOCR-RELAT CANCER, V14, P887, DOI 10.1677/ERC-07-0062; Yamashita N, 2012, MOL NEUROBIOL, V45, P234, DOI 10.1007/s12035-012-8242-4; Yamashita N, 2006, J NEUROSCI, V26, P13357, DOI 10.1523/JNEUROSCI.4276-06.2006	42	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127910	10.1371/journal.pone.0127910	http://dx.doi.org/10.1371/journal.pone.0127910			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009886	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900162
J	Wagner, A; Schabussova, I; Ruttkowski, B; Peschke, R; Kundi, JKM; Kundi, M; Joachim, A; Wiedermann, U				Wagner, Angelika; Schabussova, Irma; Ruttkowski, Berbel; Peschke, Roman; Kur, Jozef; Kundi, Michael; Joachim, Anja; Wiedermann, Ursula			Prime-Boost Vaccination with Toxoplasma Lysate Antigen, but Not with a Mixture of Recombinant Protein Antigens, Leads to Reduction of Brain Cyst Formation in BALB/c Mice	PLOS ONE			English	Article							ALLERGIC IMMUNE-RESPONSES; MAJOR SURFACE PROTEIN; GONDII INFECTION; PUBLIC-HEALTH; HOST-CELLS; IMMUNIZATION; PARASITE; STRATEGIES; RESISTANCE; INTESTINE	Introduction Infection with the ubiquitous parasite Toxoplasma gondii is a threat for immunocompromised patients and pregnant women and effective immune-prophylaxis is still lacking. Methods Here we tested a mixture of recombinant T. gondii antigens expressed in different developmental stages, i.e., SAG1, MAG1 and GRA7 (SMG), and a lysate derived from T. gondii tachyzoites (TLA) for prophylactic vaccination against cyst formation. Both vaccine formulations were applied systemically followed by an oral TLA-booster in BALB/c mice. Results Systemic priming with SMG and oral TLA-booster did not show significant induction of protective immune responses. In contrast, systemic priming and oral booster with TLA induced higher levels of Toxoplasma-specific IgG, IgG1 and IgG2a in sera as well as high levels of Toxoplasma-specific IgG1 in small intestines. Furthermore, high levels of Toxoplasma-specific Th1-, Th17-and Th2-associated cytokines were only detected in restimulated splenocytes of TLA-vaccinated mice. Importantly, in mice orally infected with T. gondii oocysts, only TLA-vaccination and booster reduced brain cysts. Furthermore, sera from these mice reduced tachyzoites invasion of Vero cells in vitro, indicating that antibodies may play a critical role for protection against Toxoplasma infection. Additionally, supernatants from splenocyte cultures of TLA-vaccinated mice containing high levels of IFN-gamma lead to substantial production of nitric oxide (NO) after incubation with macrophages in vitro. Since NO is involved in the control of parasite growth, the high levels of IFN-gamma induced by vaccination with TLA may contribute to the protection against T. gondii. Conclusion In conclusion, our data indicate that prime-boost approach with TLA, but not with the mixture of recombinant antigens SMG, induces effective humoral and cellular Toxoplasma-specific responses and leads to significant reduction of cerebral cysts, thereby presenting a viable strategy for further vaccine development against T. gondii infection.	[Wagner, Angelika; Schabussova, Irma; Wiedermann, Ursula] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria; [Ruttkowski, Berbel; Peschke, Roman; Joachim, Anja] Univ Vet Med, Inst Parasitol, Dept Pathobiol, Vienna, Austria; [Kur, Jozef] Gdansk Univ Technol, Fac Chem, Dept Microbiol, Gdansk, Poland; [Kundi, Michael] Med Univ Vienna, Inst Environm Hlth, Vienna, Austria; [Wiedermann, Ursula] Univ Gothenburg, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden	Medical University of Vienna; University of Veterinary Medicine Vienna; Fahrenheit Universities; Gdansk University of Technology; Medical University of Vienna; University of Gothenburg	Wiedermann, U (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Specif Prophylaxis & Trop Med, Vienna, Austria.	ursula.wiedermann@meduniwien.ac.at		Wagner, Angelika/0000-0002-5447-9534; Schabussova, Irma/0000-0002-2109-2640; Wiedermann, Ursula/0000-0002-1302-3223; Joachim, Anja/0000-0003-3082-6885	Austrian Science Fund [SFB F46]	Austrian Science Fund(Austrian Science Fund (FWF))	The work was supported by Austrian Science Fund, SFB F46, https://www.fwf.ac.at/.	Allen A, 2013, SCIENCE, V341, P454, DOI 10.1126/science.341.6145.454; Bhopale GM, 2003, MICROBES INFECT, V5, P457, DOI 10.1016/S1286-4579(03)00048-0; Cenci-Goga BT, 2011, FOODBORNE PATHOG DIS, V8, P751, DOI 10.1089/fpd.2010.0795; Che FY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000745; Chen K, 2010, IMMUNITY, V33, P479, DOI 10.1016/j.immuni.2010.09.013; Debierre-Grockiego F, 2010, TRENDS PARASITOL, V26, P404, DOI 10.1016/j.pt.2010.04.006; Djurkovic-Djakovic O, 2012, EXP PARASITOL, V131, P372, DOI 10.1016/j.exppara.2012.05.006; Dubey JP, 2012, PARASITOLOGY, V139, P1375, DOI 10.1017/S0031182012000765; Dubey JP, 2012, PARASITOLOGY, V139, P1, DOI 10.1017/S0031182011001673; Dziadek B, 2011, VACCINE, V29, P821, DOI 10.1016/j.vaccine.2010.11.002; Fiorino F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00128; Gatkowska J, 2006, EXP PARASITOL, V114, P220, DOI 10.1016/j.exppara.2006.03.011; Higgs R, 2012, MUCOSAL IMMUNOL, V5, P485, DOI 10.1038/mi.2012.54; Hill D, 2002, CLIN MICROBIOL INFEC, V8, P634, DOI 10.1046/j.1469-0691.2002.00485.x; Holec L, 2007, CLIN VACCINE IMMUNOL, V14, P220, DOI 10.1128/CVI.00419-06; Homan WL, 2000, INT J PARASITOL, V30, P69, DOI 10.1016/S0020-7519(99)00170-8; Innes EA, 2006, PARASITOLOGY, V133, pS145, DOI 10.1017/S0031182006001855; Innes EA, 2009, PARASITOLOGY, V136, P1887, DOI 10.1017/S0031182009991636; Jones JL, 2012, CLIN INFECT DIS, V55, P845, DOI 10.1093/cid/cis508; Jongert E, 2009, MEM I OSWALDO CRUZ, V104, P252, DOI 10.1590/S0074-02762009000200019; Kelly MN, 2005, INFECT IMMUN, V73, P617, DOI 10.1128/IAI.73.1.617-621.2005; Kur J, 2009, EXPERT REV VACCINES, V8, P791, DOI [10.1586/erv.09.27, 10.1586/ERV.09.27]; Luo QL, 2011, MICROBES INFECT, V13, P1199, DOI 10.1016/j.micinf.2011.08.013; MACK DG, 1992, J CLIN INVEST, V90, P2585, DOI 10.1172/JCI116153; Min J, 2012, VACCINE, V30, P5631, DOI 10.1016/j.vaccine.2012.06.081; MINEO JR, 1993, J IMMUNOL, V150, P3951; MINEO JR, 1994, EXP PARASITOL, V79, P11, DOI 10.1006/expr.1994.1054; Parmley S, 2002, J INFECT DIS, V185, pS90, DOI 10.1086/338464; Passos ST, 2010, J IMMUNOL, V184, P1776, DOI 10.4049/jimmunol.0901843; Petersen E, 1998, VACCINE, V16, P1283, DOI 10.1016/S0264-410X(98)00039-5; Pifer R, 2011, TRENDS PARASITOL, V27, P388, DOI 10.1016/j.pt.2011.03.009; Sanchez J, 2008, CELL MOL LIFE SCI, V65, P1347, DOI 10.1007/s00018-008-7496-5; Sayles PC, 2000, INFECT IMMUN, V68, P1026, DOI 10.1128/IAI.68.3.1026-1033.2000; Sturge CR, 2014, INFECT IMMUN, V82, P3090, DOI 10.1128/IAI.01722-14; Stutz A, 2012, IMMUNOBIOLOGY, V217, P28, DOI 10.1016/j.imbio.2011.08.008; Suzuki Y, 2000, J IMMUNOL, V164, P5375, DOI 10.4049/jimmunol.164.10.5375; Suzuki Y, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002018; Torrey EF, 2013, TRENDS PARASITOL, V29, P380, DOI 10.1016/j.pt.2013.06.001; Wagner A, 2009, INT J PARASITOL, V39, P465, DOI 10.1016/j.ijpara.2008.09.003; Winkler B, 2002, CLIN EXP ALLERGY, V32, P30, DOI 10.1046/j.0022-0477.2001.01214.x; Yarovinsky F, 2014, NAT REV IMMUNOL, V14, P109, DOI 10.1038/nri3598; Zhang NZ, 2013, EXPERT REV VACCINES, V12, P1287, DOI 10.1586/14760584.2013.844652; Zhang Y, 1999, INFECT IMMUN, V67, P4383, DOI 10.1128/IAI.67.9.4383-4392.1999	43	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126334	10.1371/journal.pone.0126334	http://dx.doi.org/10.1371/journal.pone.0126334			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010355	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900026
J	Bhardwaj, A; Ganesan, N; Tachibana, K; Rajapakshe, K; Albarracin, CT; Gunaratne, PH; Coarfa, C; Bedrosian, I				Bhardwaj, Anjana; Ganesan, Nivetha; Tachibana, Kazunoshin; Rajapakshe, Kimal; Albarracin, Constance T.; Gunaratne, Preethi H.; Coarfa, Cristian; Bedrosian, Isabelle			Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling	PLOS ONE			English	Article							RIBOSOMAL-PROTEIN; DECREASED EXPRESSION; KAPPA-B; PHOSPHORYLATION; GROWTH; MATRIX-METALLOPROTEINASE-9; OVEREXPRESSION; TRANSLATION; PROGRESSION; APOPTOSIS	Introduction Annexin A1 (ANXA1) is an anti-inflammatory protein reported to play a role in cell proliferation and apoptosis, and to be deregulated in breast cancer. The exact role of annexin A1 in the biology of breast cancer remains unclear. We hypothesized that the annexin A1 plays an oncogenic role in basal subtype of breast cancer by modulating key growth pathway(s). Methods By mining the Cancer Genome Atlas (TCGA)-Breast Cancer dataset and manipulating annexin A1 levels in breast cancer cell lines, we studied the role of annexin A1 in breast cancer and underlying signaling pathways. Results Our in-silico analysis of TCGA-breast cancer dataset demonstrated that annexin A1 mRNA expression is higher in basal subtype compared to luminal and HER2 subtypes. Within the basal subtype, patients show significantly poorer overall survival associated with higher expression of annexin A1. In both TCGA patient samples and cell lines, annexin A1 levels were significantly higher in basal-like breast cancer than luminal and Her2/neu-positive breast cancer. Stable annexin A1 knockdown in TNBC cell lines suppressed the mTOR-S6 pathway likely through activation of AMPK but had no impact on the MAPK, c-Met, and EGFR pathways. In a cell migration assay, annexin A1-depleted TNBC cells showed delayed migration as compared to wild-type cells, which could be responsible for poor patient prognosis in basal like breast cancers that are known to express higher annexin A1. Conclusions Our data suggest that annexin A1 is prognostic only in patients with basal like breast cancer. This appears to be in part due to the role of annexin A1 in activating mTORpS6 pathway.	[Bhardwaj, Anjana; Ganesan, Nivetha; Tachibana, Kazunoshin; Bedrosian, Isabelle] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Rajapakshe, Kimal; Coarfa, Cristian] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Albarracin, Constance T.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Gunaratne, Preethi H.] Univ Houston, Dept Biol & Biochem, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Houston System; University of Houston	Bhardwaj, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA.	abhardwaj@mdanderson.org; ibedrosian@mdanderson.org	Rajapakshe, Kimal/P-1592-2015	Bhardwaj, Anjana/0000-0003-4234-0241	NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn SH, 1997, CLIN EXP METASTAS, V15, P151, DOI 10.1023/A:1018452810915; Alexander A, 2011, FEBS LETT, V585, P952, DOI 10.1016/j.febslet.2011.03.010; Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Ang EZF, 2009, MOL CANCER RES, V7, P266, DOI 10.1158/1541-7786.MCR-08-0147; Bai XF, 2004, WORLD J GASTROENTERO, V10, P1466; BASTIAN BC, 1993, J INVEST DERMATOL, V101, P359, DOI 10.1111/1523-1747.ep12365541; Berven LA, 2004, EXP CELL RES, V296, P183, DOI 10.1016/j.yexer.2003.12.032; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Bhardwaj A, 2008, MOL CELL BIOL, V28, P2138, DOI 10.1128/MCB.01170-07; Bist P, 2011, ONCOGENE, V30, P3174, DOI 10.1038/onc.2011.28; Cao Y, 2008, APPL IMMUNOHISTO M M, V16, P530, DOI 10.1097/PAI.0b013e31817432c3; Chaisuparat R, 2013, PATHOL ONCOL RES, V19, P189, DOI 10.1007/s12253-012-9568-y; CIRINO G, 1989, P NATL ACAD SCI USA, V86, P3428, DOI 10.1073/pnas.86.9.3428; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Dhingra R, 2013, CIRC-HEART FAIL, V6, P335, DOI 10.1161/CIRCHEARTFAILURE.112.000061; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; FUTTER CE, 1993, J CELL BIOL, V120, P77, DOI 10.1083/jcb.120.1.77; Guo CM, 2013, FUTURE ONCOL, V9, P1773, DOI [10.2217/FON.13.114, 10.2217/fon.13.114]; Hummerich L, 2006, ONCOGENE, V25, P111, DOI 10.1038/sj.onc.1209016; Iwenofu OH, 2008, MODERN PATHOL, V21, P231, DOI 10.1038/modpathol.3800995; Kang H, 2012, BIOCHEM BIOPH RES CO, V423, P188, DOI 10.1016/j.bbrc.2012.05.114; Kang JS, 2002, CLIN CANCER RES, V8, P117; Kaufman M, 1996, BIOCHEM J, V316, P35, DOI 10.1042/bj3160035; Khandoga A, 2006, J LEUKOCYTE BIOL, V79, P1295, DOI 10.1189/jlb.0805468; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Lin CY, 2008, J SURG ONCOL, V97, P544, DOI 10.1002/jso.20992; Liu L, 2008, ONCOGENE, V27, P4998, DOI 10.1038/onc.2008.137; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Liu LH, 2011, J CELL BIOL, V194, P815, DOI 10.1083/jcb.201102090; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; Murooka TT, 2008, BLOOD, V111, P4892, DOI 10.1182/blood-2007-11-125039; Pencil SD, 1998, CLIN EXP METASTAS, V16, P113, DOI 10.1023/A:1021917017109; Peterson RT, 1998, CURR BIOL, V8, pR248, DOI 10.1016/S0960-9822(98)70152-6; Rescher U, 2000, J CELL SCI, V113, P3931; Rhee NJ, 2000, EUR J BIOCHEM, V267, P3220, DOI 10.1046/j.1432-1327.2000.01345.x; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Shen DJ, 2006, HUM PATHOL, V37, P1583, DOI 10.1016/j.humpath.2006.06.001; Sun CK, 2014, ONCOTARGET, V5, P3375, DOI 10.18632/oncotarget.1952; Therneau T.M., 2000, MODELING SURVIVAL DA; Vaillant C, 2003, MOL CELL NEUROSCI, V24, P395, DOI 10.1016/S1044-7431(03)00196-9; Vilella-Bach M, 1999, J BIOL CHEM, V274, P4266, DOI 10.1074/jbc.274.7.4266; Wang KL, 2006, CLIN CANCER RES, V12, P4598, DOI 10.1158/1078-0432.CCR-06-0483; Wang LD, 2008, J INT MED RES, V36, P665, DOI 10.1177/147323000803600407; Wang LP, 2010, NEOPLASMA, V57, P253, DOI 10.4149/neo_2010_03_253; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yom CK, 2011, J BREAST CANCER, V14, P262, DOI 10.4048/jbc.2011.14.4.262; Zhang JS, 2013, NAT CELL BIOL, V15, P1486, DOI 10.1038/ncb2874; Zhou HY, 2006, ENDOCRINOLOGY, V147, P2557, DOI 10.1210/en.2005-1404	52	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127678	10.1371/journal.pone.0127678	http://dx.doi.org/10.1371/journal.pone.0127678			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000884	Green Submitted, Green Published, gold			2022-12-26	WOS:000354931700073
J	Herrero, J; Weindorf, DC; Castaneda, C				Herrero, Juan; Weindorf, David C.; Castaneda, Carmen			Two Fixed Ratio Dilutions for Soil Salinity Monitoring in Hypersaline Wetlands	PLOS ONE			English	Article							INFRARED REFLECTANCE SPECTROSCOPY; TOTAL DISSOLVED SALTS; SAN-JOAQUIN VALLEY; ELECTRICAL-CONDUCTIVITY; SPATIAL VARIABILITY; SATURATED PASTE; ELECTROMAGNETIC INDUCTION; SONGNEN PLAIN; SODIC SOIL; WATER	Highly soluble salts are undesirable in agriculture because they reduce yields or the quality of most cash crops and can leak to surface or sub-surface waters. In some cases salinity can be associated with unique history, rarity, or special habitats protected by environmental laws. Yet in considering the measurement of soil salinity for long-term monitoring purposes, adequate methods are required. Both saturated paste extracts, intended for agriculture, and direct surface and/or porewater salinity measurement, used in inundated wetlands, are unsuited for hypersaline wetlands that often are only occasionally inundated. For these cases, we propose the use of 1:5 soil/water(weight/weight) extracts as the standard for expressing the electrical conductivity(EC) of such soils and for further salt determinations. We also propose checking for ion-pairing with a 1:10 or more diluted extract in hypersaline soils. As an illustration, we apply the two-dilutions approach to a set of 359 soil samples from saline wetlands ranging in ECe from 2.3 dS m(-1) to 183.0 dS m(-1). This easy procedure will be useful in survey campaigns and in the monitoring of soil salt content.	[Herrero, Juan; Castaneda, Carmen] CSIC, Estn Expt Aula Dei, Zaragoza 50059, Spain; [Weindorf, David C.] Texas Tech Univ, Dept Plant & Soil Sci, Lubbock, TX 79409 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Aula Dei (EEAD); Texas Tech University System; Texas Tech University	Herrero, J (corresponding author), CSIC, Estn Expt Aula Dei, Ave Montanana 1005, Zaragoza 50059, Spain.	jhi@eead.csic.es	Herrero, Juan/A-6738-2010; Castañeda, Carmen/E-7588-2012; Weindorf, David/AAP-5579-2021	Herrero, Juan/0000-0002-4132-4920; Castañeda, Carmen/0000-0002-7467-4812; Weindorf, David/0000-0002-3814-825X	Spanish Ministry of Economy and Competitiveness [AGL2012-40100]; Texas Tech University; BL Allen Endowment for Pedology	Spanish Ministry of Economy and Competitiveness(Spanish Government); Texas Tech University; BL Allen Endowment for Pedology	This article is a result of the research project AGL2012-40100 funded by the Spanish Ministry of Economy and Competitiveness. The authors thank Texas Tech University and the BL Allen Endowment for Pedology for the facilities and support provided in the framework of the Letter of Intent between CSIC and TTU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS F, 1971, SOIL SCI SOC AM PRO, V35, P420, DOI 10.2136/sssaj1971.03615995003500030028x; Al-Busaidi A., 2006, J JPN SOC SOIL PHYS, V104, P27; Alvarez-Rogel J, 1997, ARID SOIL RES REHAB, V11, P315, DOI 10.1080/15324989709381485; Amakor XN, 2013, SOIL SCI SOC AM J, V77, P792, DOI 10.2136/sssaj2012.0235; AMUNDSON RG, 1985, SOIL SCI, V140, P213, DOI 10.1097/00010694-198509000-00009; Artieda O, 2006, SOIL SCI SOC AM J, V70, P1932, DOI 10.2136/sssaj2006.0043N; Barrett G, 2006, J ARID ENVIRON, V67, P77, DOI 10.1016/j.jaridenv.2006.01.016; Bastida JAH, 2004, ARID LAND RES MANAG, V18, P265, DOI 10.1080/15324980490451348; Bennett SJ, 2009, AGR ECOSYST ENVIRON, V129, P349, DOI 10.1016/j.agee.2008.10.013; Bilgili AV, 2010, J ARID ENVIRON, V74, P229, DOI 10.1016/j.jaridenv.2009.08.011; Bilgili AV, 2013, FRESEN ENVIRON BULL, V22, P1339; Cantero JJ, 1998, PLANT ECOL, V137, P79, DOI 10.1023/A:1008071813231; Casby-Horton S, 2015, ADV AGRON, V130, P231, DOI 10.1016/bs.agron.2014.10.002; Castaneda C, 2013, GEOL ACTA, V11, P371, DOI 10.1344/105.000002055; Castaneda C, 2008, CATENA, V72, P205, DOI 10.1016/j.catena.2007.05.007; Castroviejo S, 1975, VAS SAL C PHYT LILL, VIV, P115; Cemek B, 2007, ENVIRON MONIT ASSESS, V124, P223, DOI 10.1007/s10661-006-9220-y; Ceuppens J, 1999, GEODERMA, V92, P125, DOI 10.1016/S0016-7061(99)00034-8; Ceuppens J, 1997, SOIL SCI SOC AM J, V61, P1122, DOI 10.2136/sssaj1997.03615995006100040019x; CHANG C, 1983, CAN J SOIL SCI, V63, P79, DOI 10.4141/cjss83-008; Chi CM, 2010, ARID LAND RES MANAG, V24, P1, DOI 10.1080/15324980903439362; Cooper CA, 2008, COMMUN SOIL SCI PLAN, V39, P329, DOI 10.1080/00103620701826464; Daniells IG, 2001, AUST J EXP AGR, V41, P211, DOI 10.1071/EA00084; DARAB K, 1980, GEODERMA, V23, P95, DOI 10.1016/0016-7061(80)90013-0; de Souza ER, 2013, REV BRAS ENG AGR AMB, V17, P510, DOI 10.1590/S1415-43662013000500007; Dehaan RL, 2002, REMOTE SENS ENVIRON, V80, P406, DOI 10.1016/S0034-4257(01)00321-2; Demir Y, 2009, ENVIRON MONIT ASSESS, V158, P279, DOI 10.1007/s10661-008-0582-1; Diaz FJ, 2013, AGR WATER MANAGE, V118, P59, DOI 10.1016/j.agwat.2012.11.017; DIAZ L, 1992, SOIL SCI, V154, P151, DOI 10.1097/00010694-199208000-00009; Dominguez-Beisiegel M, 2013, SOIL SCI SOC AM J, V77, P653, DOI 10.2136/sssaj2012.0014; Dunn BW, 2002, AUST J EXP AGR, V42, P607, DOI 10.1071/EA01172; Elgharably A, 2011, SOIL SCI PLANT NUTR, V57, P396, DOI 10.1080/00380768.2011.582588; Fowler D., 2013, THESIS LOUISIANA STA; Garcia E, 2012, EUR J SOIL SCI, V63, P650, DOI 10.1111/j.1365-2389.2012.01472.x; George R.J., 2000, EXPLORATORY GEOPHYSI, V31, P249, DOI 10.1071/eg00249.; Goff A, 2014, SOIL SCI SOC AM J, V78, P1686, DOI 10.2136/sssaj2014.02.0078; Guler M, 2014, AGR WATER MANAGE, V135, P1, DOI 10.1016/j.agwat.2013.12.011; Guo Y, 2013, SOIL USE MANAGE, V29, P445, DOI 10.1111/sum.12059; Gutierrez-Canovas C, 2009, HYDROBIOLOGIA, V619, P119, DOI 10.1007/s10750-008-9604-9; Hao XY, 2003, AGR ECOSYST ENVIRON, V94, P89, DOI 10.1016/S0167-8809(02)00008-7; Harper RJ, 2012, AGR ECOSYST ENVIRON, V163, P3, DOI 10.1016/j.agee.2012.03.013; He YB, 2013, CAN J SOIL SCI, V93, P585, DOI [10.4141/CJSS2012-080, 10.4141/cjss2012-080]; He YB, 2012, GEODERMA, V185, P12, DOI 10.1016/j.geoderma.2012.03.022; Herrero J, 2005, GEODERMA, V125, P287, DOI 10.1016/j.geoderma.2004.09.004; Herrero J, 2009, SOIL SCI SOC AM J, V73, P1757, DOI 10.2136/sssaj2008.0224; Herrero J., 2008, MEMORIAS REAL SOC ES, VIV; Herrero J., 1991, SUELO PLANTA, V602, P585; Herrero J., 2009, MEDIO AMBIENTE MEDIO, V2, P346; Herrero J, 2014, PADDY WATER ENVIRON, V12, P263, DOI 10.1007/s10333-013-0371-5; Herrero J, 2013, CATENA, V109, P58, DOI 10.1016/j.catena.2013.05.011; HOGG TJ, 1984, CAN J SOIL SCI, V64, P699, DOI 10.4141/cjss84-069; Huang JY, 2014, SOIL RES, V52, P327, DOI 10.1071/SR13314; JACOBER F, 1971, SOIL SCI, V112, P263, DOI 10.1097/00010694-197110000-00008; JUNIPER S, 1993, MYCORRHIZA, V4, P45, DOI 10.1007/BF00204058; Karlen DL, 2013, SOIL TILL RES, V130, P24, DOI 10.1016/j.still.2013.02.003; Khorsandi F, 2007, COMMUN SOIL SCI PLAN, V38, P1105, DOI 10.1080/00103620701278120; Khorsandi F, 2011, COMMUN SOIL SCI PLAN, V42, P315, DOI 10.1080/00103624.2011.538885; Klimanov AV, 2014, EURASIAN SOIL SCI+, V47, P266, DOI 10.1134/S1064229314040036; Konig P, 2012, J ARID ENVIRON, V85, P122, DOI 10.1016/j.jaridenv.2012.06.007; KOK B, 1986, RECLAM REVEG RES, V5, P501; Kortekaas KH, 2004, SUS WORLD, V9, P199; Le Brusq J. Y., 1982, Cahiers ORSTOM Pedologie, V19, P293; Lesch SM, 1998, SOIL SCI SOC AM J, V62, P232, DOI 10.2136/sssaj1998.03615995006200010030x; Li KL, 2011, PEDOSPHERE, V21, P793, DOI 10.1016/S1002-0160(11)60183-5; Maas E. V., 1999, Agricultural drainage., P55; McFadden LD, 1998, GEOMORPHOLOGY, V24, P101, DOI 10.1016/S0169-555X(97)00095-0; MEYER SE, 1992, J VEG SCI, V3, P429, DOI 10.2307/3235799; Mondal MK, 2001, AGR WATER MANAGE, V47, P9, DOI 10.1016/S0378-3774(00)00098-6; Moral FJ, 2010, SOIL TILL RES, V106, P335, DOI 10.1016/j.still.2009.12.002; Morari F, 2008, AGR ECOSYST ENVIRON, V124, P85, DOI 10.1016/j.agee.2007.08.001; Mousavifard SM, 2013, ARCH AGRON SOIL SCI, V59, P1573, DOI 10.1080/03650340.2012.740556; Nasiev BN, 2014, EURASIAN SOIL SCI+, V47, P613, DOI 10.1134/S1064229314060076; Nikiforova EM, 2014, EURASIAN SOIL SCI+, V47, P203, DOI 10.1134/S1064229314030041; Paliwal KV, 1978, CURRENT AGR, V2, P43; Peck AJ, 2003, J HYDROL, V272, P191, DOI 10.1016/S0022-1694(02)00264-0; Perez Garcia V., 1975, Anales de Edafologia y Agrobiologia, V34, P595; Piernik A, 2005, PHYTOCOENOLOGIA, V35, P19, DOI 10.1127/0340-269X/2005/0035-0019; Playan E, 2008, AGR WATER MANAGE, V95, P645, DOI 10.1016/j.agwat.2008.01.012; Quintero JM, 2014, SPAN J AGRIC RES, V12, P809, DOI 10.5424/sjar/2014123-5273; Rhoades J., 1999, SOIL USE MANAGE, V57th, DOI DOI 10.1111/sum.12554; RICHARD M, 1965, ANN AGRON, V16, P625; Rogers ME, 2002, AUST J EXP AGR, V42, P265, DOI 10.1071/EA00128; Semiz GD, 2013, J FOOD AGRIC ENVIRON, V11, P748; Shi Z, 2005, ENVIRON GEOL, V48, P967, DOI [10.1007/s00254-005-0035-x, 10.1007/s00254-005-1285-3]; Shirokova Y., 2000, Irrigation and Drainage Systems, V14, P199, DOI 10.1023/A:1026560204665; Sidike A, 2014, INT J APPL EARTH OBS, V26, P156, DOI 10.1016/j.jag.2013.06.002; Sigua GC, 2008, J SOIL SEDIMENT, V8, P193, DOI 10.1007/s11368-008-0003-7; SIMON M, 1994, EUR J SOIL SCI, V45, P153, DOI 10.1111/j.1365-2389.1994.tb00496.x; Soil Survey Staff, 2014, 51 USDANRCS; Sonmez S, 2008, GEODERMA, V144, P361, DOI 10.1016/j.geoderma.2007.12.005; SONNEVELD C, 1971, PLANT SOIL, V35, P505, DOI 10.1007/BF01372683; STIVEN GA, 1966, J SOIL SCI, V17, P255, DOI 10.1111/j.1365-2389.1966.tb01471.x; SUMNER ME, 1998, SODIC SOILS DISTRIBU, P3; Swanhart S, 2014, SOIL SCI, V179, P417, DOI 10.1097/SS.0000000000000088; SYLLA M, 1995, AGR ECOSYST ENVIRON, V54, P1, DOI 10.1016/0167-8809(95)00594-I; TANJI KK, 1969, SOIL SCI SOC AM PRO, V33, P887, DOI 10.2136/sssaj1969.03615995003300060026x; Toth T, 2010, GRASSL SCI, V56, P13, DOI 10.1111/j.1744-697X.2009.00167.x; U.S. Salinity Laboratory Staff, 1969, AGR HDB, V60; Ulery AL, 1998, AGRON J, V90, P556, DOI 10.2134/agronj1998.00021962009000040019x; USDA NRCS, 2014, SOIL SURV STAFF KEYS; Visconti F, 2010, EUR J SOIL SCI, V61, P980, DOI 10.1111/j.1365-2389.2010.01284.x; Visconti F, 2010, GEODERMA, V154, P387, DOI 10.1016/j.geoderma.2009.11.012; Watson EB, 2009, PLANT ECOL, V205, P113, DOI 10.1007/s11258-009-9602-7; Weindorf DC, 2013, SOIL SCI SOC AM J, V77, P2071, DOI 10.2136/sssaj2013.05.0170; WILLIAMS BG, 1982, AUST J SOIL RES, V20, P107, DOI 10.1071/SR9820107; Williams WD, 2002, ENVIRON CONSERV, V29, P154, DOI 10.1017/S0376892902000103; Williams WD, 1999, AQUAT CONSERV, V9, P517, DOI 10.1002/(SICI)1099-0755(199911/12)9:6<517::AID-AQC383>3.0.CO;2-C; Wu JH, 2014, ENVIRON EARTH SCI, V71, P3465, DOI 10.1007/s12665-013-2736-x; Xu Y, 2014, J COASTAL RES, V30, P411, DOI 10.2112/JCOASTRES-D-13-00078.1; Yang F, 2011, INT J ENV RES PUB HE, V8, P374, DOI 10.3390/ijerph8020374; Zalba Pablo, 2013, Cienc. suelo, V31, P265	112	14	16	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126493	10.1371/journal.pone.0126493	http://dx.doi.org/10.1371/journal.pone.0126493			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001130	Green Published, gold, Green Submitted			2022-12-26	WOS:000354931700020
J	Ngamskulrungroj, P; Sanmee, S; Pusathit, P; Piewngam, P; Elliott, B; Riley, TV; Kiratisin, P				Ngamskulrungroj, Popchai; Sanmee, Sittinee; Pusathit, Papanin; Piewngam, Pipat; Elliott, Briony; Riley, Thomas V.; Kiratisin, Pattarachai			Molecular Epidemiology of Clostridium difficile Infection in a Large Teaching Hospital in Thailand	PLOS ONE			English	Article							IN-VITRO SUSCEPTIBILITY; BINARY TOXIN; STRAINS; PREVENTION	Clostridium difficile infection (CDI) is a leading cause of healthcare-associated morbidity and mortality worldwide. In Thailand, CDI exhibits low recurrence and mortality and its molecular epidemiology is unknown. CDI surveillance was conducted in a tertiary facility (Siriraj Hospital, Bangkok). A total of 53 toxigenic C. difficile strains from Thai patients were analyzed by multi-locus sequence typing (MLST), PCR ribotyping, and pulse-field gel electrophoresis (PFGE). The mean age of the cohort was 64 years and 62.3% were female; 37.7% of patients were exposed to > two antibiotics prior to a diagnosis of CDI, with beta-lactams the most commonly used drug (56.3%). Metronidazole was used most commonly (77.5%; success rate 83.9%), and non-responders were treated with vancomycin (success rate 100%). None of the isolates carried binary toxin genes. Most isolates (98.2-100%) were susceptible to metronidazole, vancomycin, tigecycline and daptomycin. There were 11 sequence types (STs), 13 ribotypes (RTs) and four PFGE types. Six previously identified STs (ST12, ST13, ST14, ST33, ST41 and ST45) and five novel STs unique to Thailand (ST66, ST67, ST68, ST69 and ST70) were identified. PCR RTs UK 017 (ST45) (45.3%) and UK 014/020 (ST33) (24.5%) were the most common. High concordance was observed between the MLST and ribotyping results (p<0.001). C. difficile isolates from Thai patients were highly susceptible to standard antimicrobial agents. In conclusion, the five STs indicate the high genetic diversity and unique polymorphisms in Thailand. Moreover, the emergence of antimicrobial resistance to vancomycin warranted continuous surveillance to prevent further spread of the toxigenic C. difficile isolates.	[Ngamskulrungroj, Popchai; Sanmee, Sittinee; Piewngam, Pipat; Kiratisin, Pattarachai] Mahidol Univ, Fac Med, Dept Microbiol, Siriraj Hosp, Bangkok 10700, Thailand; [Pusathit, Papanin; Elliott, Briony; Riley, Thomas V.] Univ Western Australia, Sch Pathol & Lab Med, Crawley, Australia; [Riley, Thomas V.] Queen Elizabeth II Med Ctr, PathWest Lab Med WA, Nedlands, WA, Australia	Mahidol University; University of Western Australia; University of Western Australia	Kiratisin, P (corresponding author), Mahidol Univ, Fac Med, Dept Microbiol, Siriraj Hosp, Bangkok 10700, Thailand.	pattarachai.kir@mahidol.ac.th	Ngamskulrungroj, Popchai/ABE-7699-2021; Piewngam, Pipat/AAN-4264-2021; Ngamskulrungroj, Popchai/N-8545-2019; Piewngam, Pipat/AAX-8553-2020; Elliott, Briony/J-3274-2013	Ngamskulrungroj, Popchai/0000-0001-5162-5498; Piewngam, Pipat/0000-0002-9083-0483; Putsathit, Papanin/0000-0001-9789-4239; Elliott, Briony/0000-0001-6268-3642	Faculty of Medicine Siriraj Hospital, Mahidol University (Bangkok, Thailand) [R015333009]; 'Chalermphrakiat' grant, Faculty of Medicine Siriraj Hospital	Faculty of Medicine Siriraj Hospital, Mahidol University (Bangkok, Thailand); 'Chalermphrakiat' grant, Faculty of Medicine Siriraj Hospital	This work was supported by a research grant (to PK) from the Faculty of Medicine Siriraj Hospital, Mahidol University (Bangkok, Thailand) (grant no. R015333009). PN and PK were also supported by a 'Chalermphrakiat' grant, Faculty of Medicine Siriraj Hospital, during this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourgault AM, 2006, ANTIMICROB AGENTS CH, V50, P3473, DOI 10.1128/AAC.00479-06; Bouza E, 2006, MED CLIN N AM, V90, P1141, DOI 10.1016/j.mcna.2006.07.011; Cecil JA, 2012, CURR INFECT DIS REP, V14, P612, DOI 10.1007/s11908-012-0298-9; Chia JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075471; Drekonja DM, 2011, ANN INTERN MED, V155, P839, DOI 10.7326/0003-4819-155-12-201112200-00007; Erikstrup LT, 2012, CLIN MICROBIOL INFEC, V18, pE266, DOI 10.1111/j.1469-0691.2012.03907.x; EUCAST (European Committee on Antimicrobial Susceptibility Testing), 2013, BREAKP TABL INT MICS; Fawley WN, 2005, J CLIN MICROBIOL, V43, P2685, DOI 10.1128/JCM.43.6.2685-2696.2005; Geric B, 2003, J CLIN MICROBIOL, V41, P5227, DOI 10.1128/JCM.41.11.5227-5232.2003; Gouliouris T, 2011, CLIN MED, V11, P75, DOI 10.7861/clinmedicine.11-1-75; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Gulke I, 2001, INFECT IMMUN, V69, P6004, DOI 10.1128/IAI.69.10.6004-6011.2001; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Higa JT, 2013, J INTENSIVE CARE MED; KATO N, 1991, J CLIN MICROBIOL, V29, P33, DOI 10.1128/JCM.29.1.33-37.1991; Kuijper EJ, 2009, METHODS MOL BIOL, V551, P159, DOI 10.1007/978-1-60327-999-4_13; Lemee L, 2011, CLOSTRIDIUM DIFFICIL; Lemee L, 2010, METHODS MOL BIOL, V646, P77, DOI 10.1007/978-1-60327-365-7_6; Liao CH, 2012, ANTIMICROB AGENTS CH, V56, P3943, DOI 10.1128/AAC.00191-12; Noren T, 2010, CLIN MICROBIOL INFEC, V16, P1104, DOI 10.1111/j.1469-0691.2009.03048.x; Pant C, 2013, CURR MED RES OPIN; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Persson S, 2008, CLIN MICROBIOL INFEC, V14, P1057, DOI 10.1111/j.1469-0691.2008.02092.x; POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988; Pupaibool Jakrapan, 2008, Journal of the Medical Association of Thailand, V91, P37; Rodriguez-Palacios A, 2011, J FOOD PROTECT, V74, P1618, DOI 10.4315/0362-028X.JFP-11-141; Rupnik M, 2003, ANAEROBE, V9, P289, DOI 10.1016/j.anaerobe.2003.09.002; Rupnik M, 2003, J CLIN MICROBIOL, V41, P1118, DOI 10.1128/JCM.41.3.1118-1125.2003; Stewart DB, 2013, J GASTROINTEST SURG, V17, P118, DOI 10.1007/s11605-012-2056-6; Stubbs S, 2000, FEMS MICROBIOL LETT, V186, P307, DOI 10.1016/S0378-1097(00)00162-2; Stubbs SLJ, 1999, J CLIN MICROBIOL, V37, P461, DOI 10.1128/JCM.37.2.461-463.1999; Thipmontree Wilawan, 2011, J Med Assoc Thai, V94 Suppl 1, pS207; Wise R, 1998, J ANTIMICROB CHEMOTH, V42, P721, DOI 10.1093/jac/42.6.721; WONGWANICH S, 1990, Southeast Asian Journal of Tropical Medicine and Public Health, V21, P367; Yan Q, 2013, EPIDEMIOL INFECT, V141, P195, DOI 10.1017/S0950268812000453	35	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127026	10.1371/journal.pone.0127026	http://dx.doi.org/10.1371/journal.pone.0127026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000789	Green Submitted, Green Published, gold			2022-12-26	WOS:000354931700037
J	Wikstrom, N; Kainulainen, K; Razafimandimbison, SG; Smedmark, JEE; Bremer, B				Wikstrom, Niklas; Kainulainen, Kent; Razafimandimbison, Sylvain G.; Smedmark, Jenny E. E.; Bremer, Birgitta			A Revised Time Tree of the Asterids: Establishing a Temporal Framework For Evolutionary Studies of the Coffee Family (Rubiaceae)	PLOS ONE			English	Article							RELAXED MOLECULAR CLOCKS; DIVERGENCE TIMES; FOSSIL RECORD; HISTORICAL BIOGEOGRAPHY; FRUIT CHARACTERISTICS; SYSTEMATIC POSITION; ALLIANCE RUBIACEAE; SEQUENCE ALIGNMENT; BAYESIAN MODELS; ABSOLUTE RATES	Divergence time analyses in the coffee family (Rubiaceae) have all relied on the same Gentianales crown group age estimate, reported by an earlier analysis of the asterids, for defining the upper age bound of the root node in their analyses. However, not only did the asterid analysis suffer from several analytical shortcomings, but the estimate itself has been used in highly inconsistent ways in these Rubiaceae analyses. Based on the original data, we here reanalyze the divergence times of the asterids using relaxed-clock models and 14 fossil-based minimum age constraints. We also expand the data set to include an additional 67 taxa from Rubiaceae sampled across all three subfamilies recognized in the family. Three analyses are conducted: a separate analysis of the asterids, which completely mirrors the original asterid analysis in terms of taxon sample and data; a separate analysis of the Gentianales, where the result from the first analysis is used for defining a secondary root calibration point; and a combined analysis where all taxa are analyzed simultaneously. Results are presented in the form of a time-calibrated phylogeny, and age estimates for asterid groups, Gentianales, and major groups of Rubiaceae are compared and discussed in relation to previously published estimates. Our updated age estimates for major groups of Rubiaceae provide a significant step forward towards the long term goal of establishing a robust temporal framework for the divergence of this biologically diverse and fascinating group of plants.	[Wikstrom, Niklas; Kainulainen, Kent; Razafimandimbison, Sylvain G.; Bremer, Birgitta] Stockholm Univ, Royal Swedish Acad Sci, Bergius Fdn, SE-10691 Stockholm, Sweden; [Wikstrom, Niklas; Kainulainen, Kent; Razafimandimbison, Sylvain G.; Bremer, Birgitta] Stockholm Univ, Dept Ecol Environm & Plant Sci, SE-10691 Stockholm, Sweden; [Smedmark, Jenny E. E.] Univ Bergen, Univ Museum Bergen, Nat Hist Collect, NO-5020 Bergen, Norway	Royal Swedish Academy of Sciences; Stockholm University; Stockholm University; University of Bergen	Wikstrom, N (corresponding author), Stockholm Univ, Royal Swedish Acad Sci, Bergius Fdn, SE-10691 Stockholm, Sweden.	niklas.wikstrom@bergianska.se	Kainulainen, Kent/D-2581-2017; Razafimandimbison, Sylvain G./AAD-3437-2021	Kainulainen, Kent/0000-0003-4271-1778; 	Swedish Research Council [A0529602]; Knut and Alice Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Research Council (A0529602) and the Knut and Alice Wallenberg Foundation to BB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CL, 2001, AUST SYST BOT, V14, P231, DOI 10.1071/SB00021; Andersson L, 2005, TAXON, V54, P17, DOI 10.2307/25065299; Antonelli A, 2009, P NATL ACAD SCI USA, V106, P9749, DOI 10.1073/pnas.0811421106; Aris-Brosou S, 2002, SYST BIOL, V51, P703, DOI 10.1080/10635150290102375; Aris-Brosou S, 2003, MOL BIOL EVOL, V20, P1947, DOI 10.1093/molbev/msg226; Barrabe L, 2014, MOL PHYLOGENET EVOL, V71, P15, DOI 10.1016/j.ympev.2013.10.020; Barreda VD, 2012, ANN BOT-LONDON, V109, P127, DOI 10.1093/aob/mcr240; Bell CD, 2005, EVOLUTION, V59, P1245, DOI 10.1111/j.0014-3820.2005.tb01775.x; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Bremer B, 1999, SYST BIOL, V48, P413, DOI 10.1080/106351599260085; BREMER B, 1992, BIOL J LINN SOC, V47, P79, DOI 10.1111/j.1095-8312.1992.tb00657.x; Bremer B, 2002, MOL PHYLOGENET EVOL, V24, P274, DOI 10.1016/S1055-7903(02)00240-3; Bremer B, 2009, INT J PLANT SCI, V170, P766, DOI 10.1086/599077; Bremer B, 2009, ANN MO BOT GARD, V96, P4, DOI 10.3417/2006197; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Burleigh JG, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-61; Chandler MEJ, 1962, FLORA PIPE CLAY SERI; Clarke JT, 2011, NEW PHYTOL, V192, P266, DOI 10.1111/j.1469-8137.2011.03794.x; Collinson Margaret E., 2012, Abhandlungen der Senckenberg Gesellschaft fur Naturforschung, V570, P1; Collinson ME, 2010, B GEOSCI, V85, P155, DOI 10.3140/bull.geosci.1155; Crepet WL, 2004, AM J BOT, V91, P1666, DOI 10.3732/ajb.91.10.1666; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Davis AP, 2009, ANN MO BOT GARD, V96, P68, DOI 10.3417/2006205; DILCHER DL, 1970, AM J BOT, V57, P153, DOI 10.2307/2440507; Donoghue PCJ, 2007, TRENDS ECOL EVOL, V22, P424, DOI 10.1016/j.tree.2007.05.005; Dorofeev P.I., 1963, TRETICHNYE FLORY ZAP; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; ERIKSSON O, 1991, AM NAT, V138, P751, DOI 10.1086/285247; FRIIS EM, 1985, BIOL SKR DAN VID SEL, V24, P1; Friis EM, 2006, PALAEOGEOGR PALAEOCL, V232, P251, DOI 10.1016/j.palaeo.2005.07.006; FRIIS EM, 1982, ANN BOT-LONDON, V50, P569, DOI 10.1093/oxfordjournals.aob.a086399; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gandolfo MA, 1998, AM J BOT, V85, P376, DOI 10.2307/2446331; Gillespie J.H., 1992, CAUSES MOL EVOLUTION; Govaerts R, 2014, WORLD CHECKLIST RUBI; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1, DOI 10.1016/B978-0-444-59425-9.00001-9; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Graham A, 2009, ANN MO BOT GARD, V96, P90, DOI 10.3417/2006165; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Ho SYW, 2009, BIOL LETTERS, V5, P421, DOI 10.1098/rsbl.2008.0729; Hooker JJ, 2009, GEOL SOC AM SPEC PAP, V452, P179, DOI 10.1130/2009.2452(12); Hooker J, 2007, J GEOL SOC LONDON, V164, P685, DOI 10.1144/0016-76492006-098; Huang WP, 2013, BOT J LINN SOC, V171, P395, DOI 10.1111/j.1095-8339.2012.01321.x; Huelsenbeck JP, 2000, GENETICS, V154, P1879; HUGHES NF, 1990, REV PALAEOBOT PALYNO, V65, P145, DOI 10.1016/0034-6667(90)90065-Q; Huysmans S, 2003, REV PALAEOBOT PALYNO, V127, P219, DOI 10.1016/S0034-6667(03)00121-0; Jansen S, 2002, IAWA J, V23, P1, DOI 10.1163/22941932-90000288; Jansen S, 2003, ANN BOT-LONDON, V91, P657, DOI 10.1093/aob/mcg071; JOHNSON LA, 1994, SYST BOT, V19, P143, DOI 10.2307/2419718; Kainulainen K, 2014, TAXON, V63, P819, DOI 10.12705/634.2; Kainulainen K, 2013, BOT J LINN SOC, V173, P387, DOI 10.1111/boj.12038; Kainulainen K, 2010, AM J BOT, V97, P1961, DOI 10.3732/ajb.1000090; Keller JA, 1996, AM J BOT, V83, P528, DOI 10.2307/2446221; King C, 2006, GEOLOGY ENGLAND WALE, P395; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Leopold E. B., 1969, GEOL SURV PROF PAPER, V260, P1133; Lepage T, 2007, MOL BIOL EVOL, V24, P2669, DOI 10.1093/molbev/msm193; Li WLS, 2012, MOL BIOL EVOL, V29, P751, DOI 10.1093/molbev/msr232; Linder M, 2011, SYST BIOL, V60, P329, DOI 10.1093/sysbio/syr009; Magallon SA, 2005, EVOLUTION, V59, P1653, DOI 10.1554/04-565.1; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; MAI D H, 1987, Feddes Repertorium, V98, P105; Mai D. H., 1985, ABH STAAT MUS MINER, V33, P1; Mai D.H., 2000, RANDGEBIETEALTENBURG, V13, P1; Mai D. H., 1978, ABH STAATL MUS MINER, V28, P1; Mai Dieter Hans, 1997, Palaeontographica Abteilung B Palaeophytologie, V244, P1; MANCHESTER SR, 1995, INT J PLANT SCI, V156, P709, DOI 10.1086/297293; Manchester SR, 2009, J SYST EVOL, V47, P1, DOI 10.1111/j.1759-6831.2009.00001.x; Manns U, 2012, INT J PLANT SCI, V173, P261, DOI 10.1086/663971; Martinez-Millan M, 2010, BOT REV, V76, P83, DOI 10.1007/s12229-010-9040-1; Martinez-Millan M, 2009, AM J BOT, V96, P933, DOI 10.3732/ajb.0800347; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Mouly A, 2014, TAXON, V63, P801, DOI 10.12705/634.4; Nepokroeff M, 2003, SYST BIOL, V52, P820, DOI 10.1080/10635150390251072; Nie ZL, 2013, ANN BOT-LONDON, V111, P873, DOI 10.1093/aob/mct053; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; NYLANDER J.A.A., 2004, MRAIC PL PROGRAM DIS; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Ogg JG, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P85, DOI 10.1016/B978-0-444-59425-9.00005-6; OLMSTEAD RG, 1992, ANN MO BOT GARD, V79, P249, DOI 10.2307/2399768; Olmstead RG, 2000, MOL PHYLOGENET EVOL, V16, P96, DOI 10.1006/mpev.1999.0769; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Rambaut A, 2009, TRACERV 1 5; Razafimandimbison SG, 2005, MOL PHYLOGENET EVOL, V34, P334, DOI 10.1016/j.ympev.2004.10.005; Razafimandimbison SG, 2014, AM J BOT, V101, P1102, DOI 10.3732/ajb.1400076; Razafimandimbison SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040851; Razafimandimbison SG, 2011, TAXON, V60, P941, DOI 10.1002/tax.604001; Refulio-Rodriguez NF, 2014, AM J BOT, V101, P287, DOI 10.3732/ajb.1300394; Reid E. M., 1926, CATALOGUE CAINZOIC P, V1; RoBBRECHT E., 1988, OPERA BOT BELG, V1, P13, DOI DOI 10.2307/4110534; Robbrecht Elmar, 2006, Systematics and Geography of Plants, V76, P85; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Rydin C, 2008, MOL PHYLOGENET EVOL, V48, P74, DOI 10.1016/j.ympev.2008.04.006; Rydin C, 2009, TAXON, V58, P793, DOI 10.1002/tax.583009; Rydin C, 2009, PLANT SYST EVOL, V278, P101, DOI 10.1007/s00606-008-0138-4; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Sazima M, 1999, ANN BOT-LONDON, V83, P705, DOI 10.1006/anbo.1999.0876; Schonenberger J, 2005, INT J PLANT SCI, V166, P265, DOI 10.1086/427198; Shi XG, 2012, REV PALAEOBOT PALYNO, V179, P13, DOI 10.1016/j.revpalbo.2012.04.001; Smedmark JEE, 2014, MOL PHYLOGENET EVOL, V70, P182, DOI 10.1016/j.ympev.2013.09.007; Smedmark JEE, 2010, J BIOGEOGR, V37, P2260, DOI 10.1111/j.1365-2699.2010.02366.x; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Solds DE, 2008, ANN NY ACAD SCI, V1133, P3, DOI 10.1196/annals.1438.005; Soltis DE, 2007, INT J PLANT SCI, V168, P137, DOI 10.1086/509788; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Soltis PS, 2002, P NATL ACAD SCI USA, V99, P4430, DOI 10.1073/pnas.032087199; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Staden R, 2000, Methods Mol Biol, V132, P115; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tank DC, 2010, SYST BOT, V35, P425, DOI 10.1600/036364410791638306; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Wen HZ, 2012, J SYST EVOL, V50, P467, DOI 10.1111/j.1759-6831.2012.00196.x; Wertheim JO, 2010, SYST BIOL, V59, P1, DOI 10.1093/sysbio/syp072; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wikstrom N, 2003, SYST ASSOC SPEC VOL, P142; Wikstrom N, 2010, J BIOGEOGR, V37, P1094, DOI 10.1111/j.1365-2699.2009.02258.x; Wilf P, 2005, AM NAT, V165, P634, DOI 10.1086/430055; Winkworth RC, 2008, TAXON, V57, P53, DOI 10.2307/25065948; Yoder AD, 2000, MOL BIOL EVOL, V17, P1081, DOI 10.1093/oxfordjournals.molbev.a026389	133	52	53	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0126690	10.1371/journal.pone.0126690	http://dx.doi.org/10.1371/journal.pone.0126690			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996595	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000028
J	Loosley, AJ; O'Brien, XM; Reichner, JS; Tang, JX				Loosley, Alex J.; O'Brien, Xian M.; Reichner, Jonathan S.; Tang, Jay X.			Describing Directional Cell Migration with a Characteristic Directionality Time	PLOS ONE			English	Article							NEUTROPHIL CHEMOTAXIS; MOVEMENT; MODELS	Many cell types can bias their direction of locomotion by coupling to external cues. Characteristics such as how fast a cell migrates and the directedness of its migration path can be quantified to provide metrics that determine which biochemical and biomechanical factors affect directional cell migration, and by how much. To be useful, these metrics must be reproducible from one experimental setting to another. However, most are not reproducible because their numerical values depend on technical parameters like sampling interval and measurement error. To address the need for a reproducible metric, we analytically derive a metric called directionality time, the minimum observation time required to identify motion as directionally biased. We show that the corresponding fit function is applicable to a variety of ergodic, directionally biased motions. A motion is ergodic when the underlying dynamical properties such as speed or directional bias do not change over time. Measuring the directionality of nonergodic motion is less straightforward but we also show how this class of motion can be analyzed. Simulations are used to show the robustness of directionality time measurements and its decoupling from measurement errors. As a practical example, we demonstrate the measurement of directionality time, step-by-step, on noisy, nonergodic trajectories of chemotactic neutrophils. Because of its inherent generality, directionality time ought to be useful for characterizing a broad range of motions including intracellular transport, cell motility, and animal migration.	[Loosley, Alex J.; Tang, Jay X.] Brown Univ, Dept Phys, Providence, RI 02912 USA; [O'Brien, Xian M.; Reichner, Jonathan S.] Brown Univ, Rhode Isl Hosp, Dept Surg, Div Surg Res, Providence, RI 02912 USA; [O'Brien, Xian M.; Reichner, Jonathan S.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Tang, JX (corresponding author), Brown Univ, Dept Phys, Providence, RI 02912 USA.	Jay_Tang@brown.edu		Reichner, Jonathan/0000-0002-7349-6321	National Science Foundation grant [PHYS-1058375]; National Institutes of Health [GM-066194, AI-079582]; Natural Sciences and Engineering Research Council of Canada Post Graduate Fellowship; Rhode Island Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM066194, R01GM066194] Funding Source: NIH RePORTER	National Science Foundation grant(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada Post Graduate Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Rhode Island Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by National Science Foundation grant PHYS-1058375 (to JXT), National Institutes of Health grants GM-066194 and AI-079582 (to JSR), allocations to the Department of Surgery by Rhode Island Hospital, and by a Natural Sciences and Engineering Research Council of Canada Post Graduate Fellowship (to AJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, 2D PBRW SIMULATIONS; Batschelet E, 1981, CIRCULAR STAT BIOL; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Cooper CR, 2000, PROSTATE CANCER P D, V3, P6, DOI 10.1038/sj.pcan.4500387; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Evans M., 1993, STAT DISTRIBUTIONS; George SP, 2013, J CELL SCI, V126, P312, DOI 10.1242/jcs.116244; GOLDSTEIN S, 1951, Q J MECH APPL MATH, V4, P129, DOI 10.1093/qjmam/4.2.129; Gorelik R, 2014, NAT PROTOC, V9, P1931, DOI 10.1038/nprot.2014.131; Guevorkian K, 2006, P NATL ACAD SCI USA, V103, P13051, DOI 10.1073/pnas.0601839103; Jannat RA, 2011, BIOPHYS J, V101, P575, DOI 10.1016/j.bpj.2011.05.040; Jannat RA, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194117; Kim BJ, 2012, ANN BIOMED ENG, V40, P1316, DOI 10.1007/s10439-011-0489-9; LEVITAN DR, 1995, TRENDS ECOL EVOL, V10, P228, DOI 10.1016/S0169-5347(00)89071-0; Lin CL, 1998, EUR J IMMUNOL, V28, P4114, DOI 10.1002/(SICI)1521-4141(199812)28:12<4114::AID-IMMU4114>3.0.CO;2-C; Lin F, 2004, BIOCHEM BIOPH RES CO, V319, P576, DOI 10.1016/j.bbrc.2004.05.029; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lombardi ML, 2007, J CELL SCI, V120, P1624, DOI 10.1242/jcs.002527; Luo WW, 2013, J CELL BIOL, V202, P1057, DOI 10.1083/jcb.201210123; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MARSH LM, 1988, J THEOR BIOL, V133, P113, DOI 10.1016/S0022-5193(88)80028-6; MCCARTHY JB, 1983, J CELL BIOL, V97, P772, DOI 10.1083/jcb.97.3.772; O'Brien XM, 2014, J LEUKOCYTE BIOL, V95, P993, DOI 10.1189/jlb.0913478; Oakes PW, 2009, BLOOD, V114, P1387, DOI 10.1182/blood-2008-11-191445; OTHMER HG, 1988, J MATH BIOL, V26, P263, DOI 10.1007/BF00277392; Reinhart-King CA, 2008, BIOPHYS J, V95, P6044, DOI 10.1529/biophysj.107.127662; Richardson L.F., 1961, GEN SYSTEMS YB, V6, P139; Stroka KM, 2009, CELL MOTIL CYTOSKEL, V66, P328, DOI 10.1002/cm.20363; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F	32	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127425	10.1371/journal.pone.0127425	http://dx.doi.org/10.1371/journal.pone.0127425			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992908	gold, Green Submitted, Green Published			2022-12-26	WOS:000354921400117
J	Acuna-Espinoza, A; Aragon-Vargas, LF				Acuna-Espinoza, Alejandro; Aragon-Vargas, Luis Fernando			Rapid Changes of Body Weight after a Headstand: A Metrological Analysis	PLOS ONE			English	Article								Despite recent rules from amateur wrestling sport-governing bodies intended to discourage extreme weight loss measures, wrestling culture still includes varied methods to make weight, including holding a headstand position immediately before stepping on the scale. The procedure, according to the notion, will reduce reported mass anywhere between 250 and 500g (weight between 2.45 and 4.89 N). The aim of this study was to compare any possible differences between the headstand procedure (HS) and a normal (CON) weight measure, using a metrological approach defined by the European Association of National Metrology Institutes. Seventeen adult men were weighed on a force plate before and after doing a headstand or standing normally for 30s. The order of treatment application was assigned randomly. Post-test weight was significantly larger than pre-test (mean +/- s.d.) (640.7 +/- 62.8 N and 640.3 +/- 62.7 N, respectively, p<0.0001) under both treatments. No treatment vs. time of test interaction was found. No significant difference was found between CON and HS weight (640.6 +/- 62.8 N and 640.9 +/- 62.9 N, respectively, p=0.3815). The metrological tests suggest that the statistical differences found are related to the force plate measuring errors in every pre-established time interval. The 45g (0.44 N) difference found between pretest and post-test lies within the uncertainty range identified for the equipment (+/- 110 g or 1.08 N). In conclusion, a 30-second headstand has no significant effect on registered body weight. The small variations obtained were due to equipment-associated measuring errors. This experiment offers systematic empirical evidence to aid in the elimination of this unjustified practice among the wrestling community.	[Acuna-Espinoza, Alejandro; Aragon-Vargas, Luis Fernando] Univ Costa Rica, Human Movement Sci Res Ctr, San Jose, Costa Rica	Universidad Costa Rica	Aragon-Vargas, LF (corresponding author), Univ Costa Rica, Human Movement Sci Res Ctr, San Jose, Costa Rica.	luis.aragon@ucr.ac.cr	Aragón-Vargas, Luis Fernando/G-3538-2016	Aragón-Vargas, Luis Fernando/0000-0002-8030-974X				[Anonymous], 2009, EFSA J; Federation Internationale des Luttes Associees, 2008, FED REP NIG TRAIN MA, P6; Horswill CA, 2009, SPORTS MED SCI COMBA, P21; International Competition Network Antitrust Enforcement in Regulated Sectors Working Group, 2004, R11114 OIML, P11; Joint Committee for Guides in Metrology, 2008, 1002008 JCGMWG 1, V1st, P5; Joint Committee for Guides in Metrology, 2008, 2002012 JCGM, V3rd, P21; National Collegiate Athletic Association, 2011, WR69 NAT COLL ATHL A; Resnick R., 2002, FISICA; Robertson G, 2004, RES METHODS BIOMECHA, V2nd, P232; Winter DA, 1990, BIOMECHANICS MOTOR C, V2nd, P29	10	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0124764	10.1371/journal.pone.0124764	http://dx.doi.org/10.1371/journal.pone.0124764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993631	Green Published, gold, Green Submitted			2022-12-26	WOS:000354918600010
J	Diaz-Gustavo, N; Martinez-Salvador, M; Garcia-Hernandez, JL; Norzagaray-Campos, M; Luna-Gonzalez, A; Gonzalez-Ocampo, HA				Diaz-Gustavo, Norma; Martinez-Salvador, Martin; Garcia-Hernandez, Jose Luis; Norzagaray-Campos, Mariano; Luna-Gonzalez, Antonio; Gonzalez-Ocampo, Hector Abelardo			Carbon Sequestration of Caesalpinia platyloba S. Watt (Leguminosae) (Lott 1985) in the Tropical Deciduous Forest	PLOS ONE			English	Article							TECTONA-GRANDIS PLANTATIONS; COSTA-RICA; ABOVEGROUND BIOMASS; SITE INDEX; DRY FOREST; BIODIVERSITY CONSERVATION; ENVIRONMENTAL SERVICES; ECOSYSTEM SERVICES; BIOSPHERE RESERVE; GROWTH	Caesalpinia platyloba was evaluated as an alternative for the retention of atmospheric carbon and as a feasible and viable economic activity in terms of income for tropical deciduous forest (TDF) peasants in the carbon markets. A total of 110 trees of C. platyloba from plantations and a TDF in the Northwest of Mexico were sampled. Growth (increase in height, diameter, and volume curves) was adjusted to assess their growth. Growth of individuals (height, diameter at breast height [DBH], age, and tree crown cover) was recorded. The Schumacher model (H = beta(0)e(beta 1.E-1)), by means of the guided curve method, was used to adjust growth models. Information analysis was made through the non-linear procedure with the multivariate secant or false position (DUD) method using the SAS software. Growth and increase models revealed acceptable adjustments (pseudo R-2>0.8). C. platyloba reaches >8m of height with 12cm in diameter and 550cm(3) of volume, presenting the highest increase at 11 years considered as basal age. Highest significant density of wood was in good quality sites (0.80g.cm(-3)), with a carbon content (average of 99.15tC.ha(-1)) at the highest density of 2500 trees.ha(-1) (without thinning). Average incomes of US$483.33tC.ha(-1) are expected. The profitability values (NPW= US$81,646.65, IRR = 472%, and B/C = 0.82) for C. platyloba make its cultivation a viable and profitable activity, considering a management scheme of the income derived from wood selling and from carbon credits.	[Martinez-Salvador, Martin] SAGARPA, Inst Nacl Invest Forest INIFAP, Mexico City, DF, Mexico; [Garcia-Hernandez, Jose Luis] Carretera Delicias Ros, Delicias 33000, Chihuahua, Mexico; [Diaz-Gustavo, Norma; Norzagaray-Campos, Mariano; Luna-Gonzalez, Antonio; Gonzalez-Ocampo, Hector Abelardo] Inst Politecn Nacl, CIIDIR, SINALOA, Guasave 81000, Sinaloa, Mexico	Instituto Politecnico Nacional - Mexico	Gonzalez-Ocampo, HA (corresponding author), Inst Politecn Nacl, CIIDIR, SINALOA, Juan de Dios Batiz Paredes 250, Guasave 81000, Sinaloa, Mexico.	hgocampo@yahoo.com	González-Ocampo, Héctor/A-4713-2012; GARCIA-HERNANDEZ, JOSE L./AAH-8215-2021; MARTÍNEZ-SALVADOR, MARTÍN/AAR-9544-2020	González-Ocampo, Héctor/0000-0003-2179-1166; MARTÍNEZ-SALVADOR, MARTÍN/0000-0002-2679-5070; Norzagaray campos, Mariano/0000-0002-6911-7392	SIP [20100303]; Instituto Politecnico Nacional (IPN) project [SIP-20110313, 20120079]; FOMIX CONACYT-CAMPECHE project [144280]	SIP; Instituto Politecnico Nacional (IPN) project; FOMIX CONACYT-CAMPECHE project	This research was supported by SIP 20100303 EVALUACION DE TRES ESPECIES FORESTALES PARA EL INTERCAMBIO DE BONOS DE CARBONO EN EL VALLE DE GUASAVE: data collection and analysis, HAGO. We thank the Instituto Politecnico Nacional (IPN) (SIP-20110313 and 20120079) and FOMIX CONACYT-CAMPECHE (144280) projects for financial supports for the data collection and analysis.	Ardo Jonas, 2008, Carbon Balance Manag, V3, P7, DOI 10.1186/1750-0680-3-7; Arroyo-Quiroz I, 2007, BIODIVERS CONSERV, V16, P931, DOI 10.1007/s10531-006-9033-x; Bastian O, 2013, ECOL INDIC, V24, P12, DOI 10.1016/j.ecolind.2012.05.016; Blanco-Garcia A, 2008, NEW FOREST, V36, P299, DOI 10.1007/s11056-008-9101-z; Bohn JL, 2014, AGROFOREST SYST, V88, P269, DOI 10.1007/s10457-014-9674-9; BROWN S, 1992, INTERCIENCIA, V17, P8; Burquez A, 2010, J ARID ENVIRON, V74, P1240, DOI 10.1016/j.jaridenv.2010.04.004; Chacon P, 2007, TIERRA TROPICAL, V3, P1; Chaturvedi RK, 2011, FOREST ECOL MANAG, V262, P1576, DOI 10.1016/j.foreco.2011.07.006; Chave J, 2003, ENVIRON RESOUR ECON, V26, P527, DOI 10.1023/B:EARE.0000007348.42742.49; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Clutter J., 1992, TIMBER MANAGEMENT QU; de Leon GC, 2013, BOSQUE, V34, P311, DOI 10.4067/S0717-92002013000300007; Daniel TW., 1979, PRINCIPLES SILVICULT; Datta M., 2007, Journal of Forestry Research (Harbin), V18, P261, DOI 10.1007/s11676-007-0053-5; Davalos Sotelo R, 2008, AGROECOSISTEMAS CAFE, P330; Douglass LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023843; Engel S, 2008, ECOL ECON, V65, P663, DOI 10.1016/j.ecolecon.2008.03.011; Escalante T, 2007, NATURWISSENSCHAFTEN, V94, P561, DOI 10.1007/s00114-007-0228-0; Felger R. S., 2001, TREES SONORA MEXICO; Felger RS, 2002, PLANT PRESS ARIZONA, V26, P3; Foroughbakhch R, 2006, FOREST ECOL MANAG, V235, P194, DOI 10.1016/j.foreco.2006.08.012; Forster R, 2002, COMUNIDADES FORESTAL; Gang H, 2012, SOIL BIOL BIOCHEM, V47, P123, DOI [10.1016/j.soilbio.2011.12.025, DOI 10.1016/J.SOILBIO.2011.12.025]; Gelfand I, 2009, SOIL BIOL BIOCHEM, V41, P1561, DOI 10.1016/j.soilbio.2009.04.018; Salcido RPG, 2009, BIODIVERS CONSERV, V18, P1421, DOI 10.1007/s10531-008-9538-6; Gittinger J.P., 1982, EC ANAL AGR PROJECTS; Gonzalez GJC, 2006, LIVESTOCK RES RURAL, V18; Grunzweig JM, 2003, GLOBAL CHANGE BIOL, V9, P791, DOI 10.1046/j.1365-2486.2003.00612.x; Hu YL, 2008, J ARID ENVIRON, V72, P2193, DOI 10.1016/j.jaridenv.2008.07.007; Huante P, 1998, OIKOS, V82, P449, DOI 10.2307/3546366; Iftekhar M. S., 2008, Wetlands Ecology and Management, V16, P119, DOI 10.1007/s11273-007-9060-8; Jaramillo VJ, 2003, ECOSYSTEMS, V6, P609, DOI 10.1007/s10021-002-0195-4; Jeddi K, 2009, J ARID ENVIRON, V73, P1005, DOI 10.1016/j.jaridenv.2009.05.005; Jeddi K, 2012, FLORA, V207, P693, DOI 10.1016/j.flora.2012.07.002; Jerez-Rico M, 2011, AGROCIENCIA-MEXICO, V45, P135; Kraenzel M, 2003, FOREST ECOL MANAG, V173, P213, DOI 10.1016/S0378-1127(02)00002-6; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lin DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048244; Liu XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082208; Liu Yang, 2013, Biomed Res Int, V2013, P839683, DOI 10.1155/2013/839683; Maass JM, 2005, ECOL SOC, V10; Mansourian S, 2005, RESTORING QUALITY EX, P185; Mares-Arreola O, 2004, REV FITOTEC MEX, V27, P77; Megginson WL, 2008, CAPITAL BUDGETING PR; Mendez-Larios I, 2006, BIODIVERS CONSERV, V15, P1627, DOI 10.1007/s10531-004-5013-1; Meunpong P., 2010, Kasetsart Journal, Natural Sciences, V44, P1044; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Nanang DM, 1999, FOREST ECOL MANAG, V118, P211, DOI 10.1016/S0378-1127(98)00501-5; Navar-Chaidez J, 2009, MEXICO TROPICAL SUBT, V10, P45; Newton I, 2007, NEARCTIC NEOTROPICAL, P729; Noronha, 1987, PROJETOS AGROPECUARI; Nosetto MD, 2006, J ARID ENVIRON, V67, P142, DOI 10.1016/j.jaridenv.2005.12.008; Orihuela-Belmonte DE, 2013, AGR ECOSYST ENVIRON, V171, P72, DOI 10.1016/j.agee.2013.03.012; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Perez D, 2005, FOREST ECOL MANAG, V210, P425, DOI 10.1016/j.foreco.2005.02.037; Perez-Quezada JF, 2011, J ARID ENVIRON, V75, P29, DOI 10.1016/j.jaridenv.2010.08.003; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Piotto D, 2004, FOREST ECOL MANAG, V190, P359, DOI 10.1016/j.foreco.2003.11.005; Piotto D, 2003, FOREST ECOL MANAG, V177, P427, DOI 10.1016/S0378-1127(02)00445-0; Pritchett W.L., 1991, SUELOS FORESTALES PR; Rendon-Carmona H, 2009, FOREST ECOL MANAG, V257, P567, DOI 10.1016/j.foreco.2008.09.031; RENNOLLS K, 1995, FOREST ECOL MANAG, V71, P217, DOI 10.1016/0378-1127(94)06102-O; Rincon E, 2000, B SOC BOT MEX, V66, P5; Rodriguez-Laguna R, 2006, CIENCIA UANL, VIX, P179; Sandra R-G, 2008, INTERCIENCIA, V33, P200; Sax DF, 2002, SPECIES INVASIONS EX; Sax DF, 2008, P NATL ACAD SCI; Scheller RM, 2011, ECOSYSTEMS, V14, P987, DOI 10.1007/s10021-011-9462-6; Schumacher F. X., 1939, Journal of Forestry, V37, P819; STAGE ALBERT R., 1963, FOREST SCI, V9, P167; Stegen JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P617, DOI 10.1111/j.1466-8238.2009.00471.x; Tellez Mejia E., 2008, Revista Fitotecnia Mexicana, V31, P173; TORELLI N, 1994, HOLZ ROH WERKST, V52, P337, DOI 10.1007/BF02621429; Torres Danny A., 2012, Journal of Forestry Research (Harbin), V23, P405, DOI 10.1007/s11676-012-0277-x; Torres-Rojo J. M., 2001, Agrociencia, V35, P87; Vallejos O, 2007, INTERAMERICAN J ENV, V3, P16; Van Deusen PC, 2010, CAN J FOREST RES, V40, P2243, DOI 10.1139/X10-142; Vanclay JK, 2010, FOREST ECOL MANAG, V259, P1050, DOI 10.1016/j.foreco.2009.12.026; Wang FM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0077449, 10.1371/journal.pone.0079738]; WBG, 2013, 2014 ANN REP; Williamson GB, 2010, BIOTROPICA, V42, P590, DOI 10.1111/j.1744-7429.2009.00618.x; Witt GB, 2011, AGR ECOSYST ENVIRON, V141, P108, DOI 10.1016/j.agee.2011.02.020; Yerena-Yamallel JI, 2011, REV CHAPINGO SER CIE, V17, P283, DOI 10.5154/r.rchscfa.2010.02.004; Zepeda BB, 1984, REV CIENCIA FORESTAL, V51, P1	86	3	4	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0125478	10.1371/journal.pone.0125478	http://dx.doi.org/10.1371/journal.pone.0125478			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992905	Green Submitted, Green Published, gold			2022-12-26	WOS:000354918600015
J	Falconer, RE; Battaia, G; Schmidt, S; Baveye, P; Chenu, C; Otten, W				Falconer, Ruth E.; Battaia, Guillaume; Schmidt, Sonja; Baveye, Philippe; Chenu, Claire; Otten, Wilfred			Microscale Heterogeneity Explains Experimental Variability and Non-Linearity in Soil Organic Matter Mineralisation	PLOS ONE			English	Article							FUNGAL PLANT PATHOGEN; INVASION; CARBON; ARCHITECTURE; THRESHOLDS; FRACTIONS; SIZE	Soil respiration represents the second largest CO2 flux from terrestrial ecosystems to the atmosphere, and a small rise could significantly contribute to further increase in atmospheric CO2. Unfortunately, the extent of this effect cannot be quantified reliably, and the outcomes of experiments designed to study soil respiration remain notoriously unpredictable. In this context, the mathematical simulations described in this article suggest that assumptions of linearity and presumed irrelevance of micro-scale heterogeneity, commonly made in quantitative models of microbial growth in subsurface environments and used in carbon stock models, do not appear warranted. Results indicate that microbial growth is non-linear and, at given average nutrient concentrations, strongly dependent on the microscale distribution of both nutrients and microbes. These observations have far-reaching consequences, in terms of both experiments and theory. They indicate that traditional, macroscopic soil measurements are inadequate to predict microbial responses, in particular to rising temperature conditions, and that an explicit account is required of microscale heterogeneity. Furthermore, models should evolve beyond traditional, but overly simplistic, assumptions of linearity of microbial responses to bulk nutrient concentrations. The development of a new generation of models along these lines, and in particular incorporating upscaled information about microscale processes, will undoubtedly be challenging, but appears to be key to understanding the extent to which soil carbon mineralization could further accelerate climate change.	[Falconer, Ruth E.; Schmidt, Sonja; Otten, Wilfred] Abertay Univ, SIMBIOS Sch Sci Engn & Technol, Dundee, Scotland; [Battaia, Guillaume; Baveye, Philippe; Chenu, Claire] Univ Paris Saclay, AgroParisTech, Bioemco, Thiverval Grignon, France; [Baveye, Philippe] Rensselaer Polytech Inst, Dept Civil & Environm Engn, Lab Soil & Water Engn, Troy, NY USA	University of Abertay Dundee; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paris Saclay; Rensselaer Polytechnic Institute	Falconer, RE (corresponding author), Abertay Univ, SIMBIOS Sch Sci Engn & Technol, Dundee, Scotland.	r.falconer@abertay.ac.uk	Otten, Wilfried/H-7168-2019	Otten, Wilfried/0000-0002-3847-9825; Baveye, Philippe/0000-0002-8432-6141; Falconer, Ruth E./0000-0003-2189-0818	French ANR [ANR-09-SYSCOMM MEPSOM]; Scottish Alliance for Geosciences, Environment and Society (SAGES)	French ANR(French National Research Agency (ANR)); Scottish Alliance for Geosciences, Environment and Society (SAGES)	This work received financial assistance from the French ANR (project ANR-09-SYSCOMM MEPSOM) and the Scottish Alliance for Geosciences, Environment and Society (SAGES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; [Anonymous], 1997, INTRO SOIL MICROBIOL; Bailey DJ, 2000, NEW PHYTOL, V146, P535, DOI 10.1046/j.1469-8137.2000.00660.x; Barrios E, 1996, SOIL BIOL BIOCHEM, V28, P185, DOI 10.1016/0038-0717(95)00110-7; Cazelles K, 2013, ECOL MODEL, V248, P165, DOI 10.1016/j.ecolmodel.2012.08.008; Cheryl H., 2010, OPER RES INT J, V10, P247, DOI [DOI 10.1007/S12351-009-0059-1, 10.1007/s12351-009-0059-1]; Dungait JAJ, 2012, GLOBAL CHANGE BIOL, V18, P1781, DOI 10.1111/j.1365-2486.2012.02665.x; Falconer RE, 2005, P ROY SOC B-BIOL SCI, V272, P1727, DOI 10.1098/rspb.2005.3150; Falconer RE, 2012, SOIL SCI, V177, P111, DOI 10.1097/SS.0b013e318241133a; Houston AN, 2013, COMPUT GEOSCI-UK, V54, P239, DOI 10.1016/j.cageo.2012.11.016; Juarez S, 2013, EUR J SOIL BIOL, V58, P81, DOI 10.1016/j.ejsobi.2013.06.005; Otten W, 1999, SOIL BIOL BIOCHEM, V31, P1803, DOI 10.1016/S0038-0717(99)00099-1; Otten W, 2004, NEW PHYTOL, V163, P125, DOI 10.1111/j.1469-8137.2004.01086.x; Salvo L, 2010, SOIL TILL RES, V109, P116, DOI 10.1016/j.still.2010.05.008; Six J., 2002, ENCY SOIL SCI, P936, DOI DOI 10.1081/E-ESS-120001812; Wachinger G, 2000, SOIL BIOL BIOCHEM, V32, P1121, DOI 10.1016/S0038-0717(00)00024-9	16	43	43	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0123774	10.1371/journal.pone.0123774	http://dx.doi.org/10.1371/journal.pone.0123774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992875	Green Published, Green Submitted, gold			2022-12-26	WOS:000354918600005
J	Srirangan, S; Sauer, ML; Howard, B; Dvora, M; Dums, J; Backman, P; Sederoff, H				Srirangan, Soundarya; Sauer, Marie-Laure; Howard, Brian; Dvora, Mia; Dums, Jacob; Backman, Patrick; Sederoff, Heike			Interaction of Temperature and Photoperiod Increases Growth and Oil Content in the Marine Microalgae Dunaliella viridis	PLOS ONE			English	Article							POSTTRANSLATIONAL REDOX-MODIFICATION; ADP-GLUCOSE PYROPHOSPHORYLASE; FATTY-ACID-COMPOSITION; LIGHT-INDUCED GENES; CHLAMYDOMONAS-REINHARDTII; NITROGEN DEPRIVATION; STARCH METABOLISM; PHOTOSYSTEM-II; GREEN-ALGAE; HEAT-SHOCK	Eukaryotic marine microalgae like Dunaliella spp. have great potential as a feedstock for liquid transportation fuels because they grow fast and can accumulate high levels of triacylgycerides with little need for fresh water or land. Their growth rates vary between species and are dependent on environmental conditions. The cell cycle, starch and triacylglycerol accumulation are controlled by the diurnal light: dark cycle. Storage compounds like starch and triacylglycerol accumulate in the light when CO2 fixation rates exceed the need of assimilated carbon and energy for cell maintenance and division during the dark phase. To delineate environmental effects, we analyzed cell division rates, metabolism and transcriptional regulation in Dunaliella viridis in response to changes in light duration and growth temperatures. Its rate of cell division was increased under continuous light conditions, while a shift in temperature from 25 degrees C to 35 degrees C did not significantly affect the cell division rate, but increased the triacylglycerol content per cell several-fold under continuous light. The amount of saturated fatty acids in triacylglycerol fraction was more responsive to an increase in temperature than to a change in the light regime. Detailed fatty acid profiles showed that Dunaliella viridis incorporated lauric acid (C12:0) into triacylglycerol after 24 hours under continuous light. Transcriptome analysis identified potential regulators involved in the light and temperature-induced lipid accumulation in Dunaliella viridis.	[Srirangan, Soundarya; Sauer, Marie-Laure; Howard, Brian; Dvora, Mia; Dums, Jacob; Backman, Patrick; Sederoff, Heike] N Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Sederoff, H (corresponding author), N Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA.	hwsedero@ncsu.edu	Sederoff, Heike/AAE-1505-2021	Sederoff, Heike/0000-0002-0960-9678; Dums, Jacob/0000-0002-6314-4779	NSF Emerging Frontiers in Research and Innovation (EFRI) [0937721, 1332341]; Directorate For Engineering [1332341] Funding Source: National Science Foundation	NSF Emerging Frontiers in Research and Innovation (EFRI)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Funding for this project and the presented research was provided by NSF Emerging Frontiers in Research and Innovation (EFRI) grant #0937721 and #1332341.	Andre C, 2012, P NATL ACAD SCI USA, V109, P10107, DOI 10.1073/pnas.1204604109; [Anonymous], 1998, [No title captured]; [Anonymous], 1990, 13 INT SEAW S; [Anonymous], 1993, THESIS U GOTTINGEN G; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Barbarino E, 2005, J APPL PHYCOL, V17, P447, DOI 10.1007/s10811-005-1641-4; Ben-Amotz A, 1992, DUNALIELLA PHYSL BIO; BenAmotz A., 2009, ALGA DUNALIELLA BIOD; Benning C, 2005, J BIOL CHEM, V280, P2397, DOI 10.1074/jbc.R400032200; Bisova K, 2014, J EXP BOT, V65, P2585, DOI 10.1093/jxb/ert466; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOROWITZKA LJ, 1990, B MAR SCI, V47, P244; Boyle NR, 2012, J BIOL CHEM, V287, P15811, DOI 10.1074/jbc.M111.334052; Busi MV, 2014, STARCH-STARKE, V66, P28, DOI 10.1002/star.201200211; Chen JE, 2012, J BIOTECHNOL, V162, P28, DOI 10.1016/j.jbiotec.2012.05.009; Chen JP, 2006, PLANT CELL ENVIRON, V29, P1437, DOI 10.1111/j.1365-3040.2006.01527.x; Chen M, 2011, BIORESOURCE TECHNOL, V102, P1649, DOI 10.1016/j.biortech.2010.09.062; Chisti Y, 2008, TRENDS BIOTECHNOL, V26, P126, DOI 10.1016/j.tibtech.2007.12.002; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Davis R, 2011, APPL ENERG, V88, P3524, DOI 10.1016/j.apenergy.2011.04.018; Dubots E, 2010, J BIOL CHEM, V285, P6003, DOI 10.1074/jbc.M109.071928; Eriksson MJ, 1996, J BACTERIOL, V178, P4839, DOI 10.1128/jb.178.16.4839-4846.1996; Falcone Deane L., 2004, BMC Plant Biology, V4, P17, DOI 10.1186/1471-2229-4-17; GIROUD C, 1988, PLANT CELL PHYSIOL, V29, P587; Glaring MA, 2012, PLANT PHYSIOL BIOCH, V58, P89, DOI 10.1016/j.plaphy.2012.06.017; Gong YM, 2011, J BASIC MICROB, V51, P666, DOI 10.1002/jobm.201000520; Gordillo FJL, 1998, J APPL PHYCOL, V10, P135, DOI 10.1023/A:1008067022973; Guarnieri MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025851; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; HARRISON MA, 1992, BIOCHIM BIOPHYS ACTA, V1100, P83, DOI 10.1016/0167-4838(92)90539-P; Havaux M, 1996, PLANT CELL ENVIRON, V19, P1359, DOI 10.1111/j.1365-3040.1996.tb00014.x; Heckathorn SA, 1998, PLANT PHYSIOL, V116, P439, DOI 10.1104/pp.116.1.439; Hendriks JHM, 2003, PLANT PHYSIOL, V133, P838, DOI 10.1104/pp.103.024513; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Im CS, 2002, PLANT J, V30, P301, DOI 10.1046/j.1365-313X.2001.01287.x; Jin ES, 2003, BIOTECHNOL BIOENG, V81, P115, DOI 10.1002/bit.10459; Johnson MTJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050226; KATOH S, 1967, ARCH BIOCHEM BIOPHYS, V121, P211, DOI 10.1016/0003-9861(67)90026-4; Kuhn ML, 2009, J BIOL CHEM, V284, P34092, DOI 10.1074/jbc.M109.037614; Lamers PP, 2012, J BIOTECHNOL, V162, P21, DOI 10.1016/j.jbiotec.2012.04.018; Laurens LML, 2012, ANAL BIOANAL CHEM, V403, P167, DOI 10.1007/s00216-012-5814-0; LERS A, 1991, J BIOL CHEM, V266, P13698; LEVY H, 1993, J BIOL CHEM, V268, P20892; Li XB, 2012, PLANT CELL, V24, P4670, DOI 10.1105/tpc.112.105106; MAMEDOV M, 1993, BIOCHIM BIOPHYS ACTA, V1142, P1, DOI 10.1016/0005-2728(93)90077-S; Matasci N, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-17; Michalska J, 2009, P NATL ACAD SCI USA, V106, P9908, DOI 10.1073/pnas.0903559106; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Msanne J, 2012, PHYTOCHEMISTRY, V75, P50, DOI 10.1016/j.phytochem.2011.12.007; Muhlhaus T, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M110.006650, DOI 10.1074/MCP.M110.006650]; Muradyan EA, 2004, RUSS J PLANT PHYSL+, V51, P53, DOI 10.1023/B:RUPP.0000011303.11957.48; NEALE PJ, 1986, J PHYCOL, V22, P531, DOI 10.1111/j.1529-8817.1986.tb02497.x; Neidhardt J, 1998, PHOTOSYNTH RES, V56, P175, DOI 10.1023/A:1006024827225; Nguyen HM, 2011, PROTEOMICS, V11, P4266, DOI 10.1002/pmic.201100114; Nguyen HM, 2013, PLANT PHYSIOL, V163, P914, DOI 10.1104/pp.113.223941; Niittyla T, 2004, SCIENCE, V303, P87, DOI 10.1126/science.1091811; Ohlrogge JB, 1997, ANNU REV PLANT PHYS, V48, P109, DOI 10.1146/annurev.arplant.48.1.109; Oren Aharon, 2005, Saline Syst, V1, P2, DOI 10.1186/1746-1448-1-2; Ral JP, 2006, PLANT PHYSIOL, V142, P305, DOI 10.1104/pp.106.081885; RIENS B, 1994, PLANTA, V192, P497, DOI 10.1007/BF00203587; Rismani-Yazdi H, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-74; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; ROUGHAN PG, 1982, ANNU REV PLANT PHYS, V33, P97, DOI 10.1146/annurev.pp.33.060182.000525; Samburova V, 2013, J AM OIL CHEM SOC, V90, P53, DOI 10.1007/s11746-012-2138-3; SHINTANI DK, 1995, PLANT J, V7, P577, DOI 10.1046/j.1365-313X.1995.7040577.x; SMITH BM, 1990, PLANT PHYSIOL, V93, P1433, DOI 10.1104/pp.93.4.1433; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Sorokina O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-36; SPALDING MH, 1982, FEBS LETT, V145, P41, DOI 10.1016/0014-5793(82)81202-7; STAPEL D, 1993, J PHOTOCH PHOTOBIO B, V21, P211, DOI 10.1016/1011-1344(93)80185-C; SUKENIK A, 1988, BIOCHIM BIOPHYS ACTA, V932, P206, DOI 10.1016/0005-2728(88)90157-0; SUKENIK A, 1990, J PHYCOL, V26, P463, DOI 10.1111/j.0022-3646.1990.00463.x; SUSS KH, 1986, PLANT PHYSIOL, V81, P192, DOI 10.1104/pp.81.1.192; Tafreshi AH, 2009, J APPL MICROBIOL, V107, P14, DOI 10.1111/j.1365-2672.2009.04153.x; Takagi M, 2006, J BIOSCI BIOENG, V101, P223, DOI 10.1263/jbb.101.223; Tanaka A, 1997, PLANT CELL PHYSIOL, V38, P17, DOI 10.1093/oxfordjournals.pcp.a029080; Tanaka Y, 2000, PLANT PHYSIOL, V124, P441, DOI 10.1104/pp.124.1.441; Tiessen A, 2002, PLANT CELL, V14, P2191, DOI 10.1105/tpc.003640; Vitova M, 2011, PLANTA, V234, P599, DOI 10.1007/s00425-011-1427-7; Vitova M, 2011, PLANTA, V233, P75, DOI 10.1007/s00425-010-1282-y; Wang TY, 2007, APPL MICROBIOL BIOT, V76, P651, DOI 10.1007/s00253-007-1040-7; WEBB MR, 1995, PLANT PHYSIOL, V107, P885, DOI 10.1104/pp.107.3.885; Wei-Cheng Wang, 2013, Environmental Progress & Sustainable Energy, V32, P916, DOI 10.1002/ep.11855; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; YAMASHITA T, 1968, PLANT PHYSIOL, V43, P2037, DOI 10.1104/pp.43.12.2037; Ye ZW, 2008, BIOTECHNOL ADV, V26, P352, DOI 10.1016/j.biotechadv.2008.03.004; Yoon K, 2012, PLANT CELL, V24, P3708, DOI 10.1105/tpc.112.100701; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795	90	26	27	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127562	10.1371/journal.pone.0127562	http://dx.doi.org/10.1371/journal.pone.0127562			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992838	Green Published, Green Submitted, gold			2022-12-26	WOS:000354918600067
J	Vincent, J; Martre, P; Gouriou, B; Ravel, C; Dai, Z; Petit, JM; Pailloux, M				Vincent, Jonathan; Martre, Pierre; Gouriou, Benjamin; Ravel, Catherine; Dai, Zhanwu; Petit, Jean-Marc; Pailloux, Marie			RulNet: A Web-Oriented Platform for Regulatory Network Inference, Application to Wheat -Omics Data	PLOS ONE			English	Article							GENE-EXPRESSION DATA; SULFUR FERTILIZATION; PROTEIN-COMPOSITION; ASSOCIATION RULES; WINTER-WHEAT; AMINO-ACIDS; QUALITY; GRAIN; ACCUMULATION; INTEGRATION	With the increasing amount of -omics data available, a particular effort has to be made to provide suitable analysis tools. A major challenge is that of unraveling the molecular regulatory networks from massive and heterogeneous datasets. Here we describe RulNet, a web-oriented platform dedicated to the inference and analysis of regulatory networks from qualitative and quantitative -omics data by means of rule discovery. Queries for rule discovery can be written in an extended form of the RQL query language, which has a syntax similar to SQL. RulNet also offers users interactive features that progressively adjust and refine the inferred networks. In this paper, we present a functional characterization of RulNet and compare inferred networks with correlation-based approaches. The performance of RulNet has been evaluated using the three benchmark datasets used for the transcriptional network inference challenge DREAM5. Overall, RulNet performed as well as the best methods that participated in this challenge and it was shown to behave more consistently when compared across the three datasets. Finally, we assessed the suitability of RulNet to analyze experimental -omics data and to infer regulatory networks involved in the response to nitrogen and sulfur supply in wheat (Triticum aestivum L.) grains. The results highlight putative actors governing the response to nitrogen and sulfur supply in wheat grains. We evaluate the main characteristics and features of RulNet as an all-in-one solution for RN inference, visualization and editing. Using simple yet powerful RulNet queries allowed RNs involved in the adaptation of wheat grain to N and S supply to be discovered. We demonstrate the effectiveness and suitability of RulNet as a platform for the analysis of RNs involving different types of -omics data. The results are promising since they are consistent with what was previously established by the scientific community.	[Vincent, Jonathan; Gouriou, Benjamin; Pailloux, Marie] Univ Blaise Pascal, CNRS LIMOS UMR6158, Lab Informat Modelisat & Optimisat Syst, F-63173 Aubiere, France; [Vincent, Jonathan; Martre, Pierre; Ravel, Catherine; Dai, Zhanwu] INRA, Genet Divers & Ecophysiol Cereals UMR1095, F-63039 Clermont Ferrand, France; [Vincent, Jonathan; Martre, Pierre; Ravel, Catherine; Dai, Zhanwu] Univ Blaise Pascal, Genet Divers & Ecophysiol Cereals UMR1095, F-63177 Clermont Ferrand, France; [Petit, Jean-Marc] Inst Natl Sci Appl, CNRS LIRIS UMR5205, Lab Informat Images & Syst Informat, F-69621 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); INRAE; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Institut National des Sciences Appliquees de Lyon - INSA Lyon	Martre, P (corresponding author), INRA, UMR Lab Ecophysiol Plantes Stress Environm UMR759, Pl Viala, F-34060 Montpellier, France.	pierre.martre@supagro.inra.fr; pailloux@isima.fr	Martre, Pierre/G-5399-2013; Martre, Pierre/AAB-5118-2019; Vincent, Jonathan/HHY-9994-2022; Dai, Zhanwu/V-6274-2019; Dai, Zhanwu/F-7355-2019	Martre, Pierre/0000-0002-7419-6558; Martre, Pierre/0000-0002-7419-6558; Dai, Zhanwu/0000-0002-7625-8337; Dai, Zhanwu/0000-0002-7625-8337; Petit, Jean Marc/0000-0002-0015-745X	French Ministry for Higher Education and Research; French Government; France AgriMer; French Fund	French Ministry for Higher Education and Research; French Government; France AgriMer; French Fund	This work was supported in the context of a Ph.D. grant from the French Ministry for Higher Education and Research to JV and received funding from the French Government managed by the Research National Agency (ANR) in the framework of the Investments for the Future (ANR-10-BTBR-03), France AgriMer and the French Fund to support Plant Breeding (FSOV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agier M, 2007, FUND INFORM, V78, P543; Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Armstrong W. W., 1974, INFORM PROCESSING, P580, DOI DOI 10.1007/978-3-642-21498-152; BACKUS JW, 1960, COMMUN ACM, V3, P299, DOI 10.1145/367236.367262; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BEERI C, 1984, J ACM, V31, P30, DOI 10.1145/2422.322414; Belcastro V, 2011, NUCLEIC ACIDS RES, V39, P8677, DOI 10.1093/nar/gkr593; Besseau S, 2012, J EXP BOT, V63, P2667, DOI 10.1093/jxb/err450; Bohannon P., 2007, ICDE, P746, DOI DOI 10.1109/ICDE.2007.367920; Brin S., 1997, SIGMOD Record, V26, P255, DOI [10.1145/253262.253327, 10.1145/253262.253325]; CASTLE SL, 1987, AUST J PLANT PHYSIOL, V14, P503, DOI 10.1071/PP9870503; Chardin B., 2013, PROCEEDINGS OF THE 1, P35; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270; Daniel C, 2001, AUST J PLANT PHYSIOL, V28, P1197; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Durzinsky M, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-113; EITER T, 1995, SIAM J COMPUT, V24, P1278, DOI 10.1137/S0097539793250299; Fan WF, 2008, ACM T DATABASE SYST, V33, DOI 10.1145/1366102.1366103; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Ganter B, 1997, FORMAL CONCEPT ANALY; Geng LQ, 2006, ACM COMPUT SURV, V38, DOI 10.1145/1132960.1132963; Georgii E, 2005, BIOINFORMATICS, V21, P123, DOI 10.1093/bioinformatics/bti1121; Gibon Y, 2009, PLANT CELL ENVIRON, V32, P859, DOI 10.1111/j.1365-3040.2009.01965.x; Gottlob G., 1990, Acta Cybernetica, V9, P385; Granvogl M, 2007, J AGR FOOD CHEM, V55, P4271, DOI 10.1021/jf070262l; GUPTA RB, 1989, THEOR APPL GENET, V77, P57, DOI 10.1007/BF00292316; Gupta RB, 1996, J EXP BOT, V47, P1377, DOI 10.1093/jxb/47.9.1377; Haibe-Kains B, 2012, NUCLEIC ACIDS RES, V40, pD866, DOI 10.1093/nar/gkr1050; Heyndrickx KS, 2012, PLANT PHYSIOL, V159, P884, DOI 10.1104/pp.112.196725; Kauffman S, 2003, P NATL ACAD SCI USA, V100, P14796, DOI 10.1073/pnas.2036429100; Kotera M, 2012, NUCLEIC ACIDS RES, V40, pW162, DOI 10.1093/nar/gks459; Kuffner R, 2000, BIOINFORMATICS, V16, P825, DOI 10.1093/bioinformatics/16.9.825; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Liang JH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-113; Lopes S, 2002, J EXP THEOR ARTIF IN, V14, P93, DOI 10.1080/09528130210164143; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Martinez R, 2008, BIOINFORMATICS, V24, P2643, DOI 10.1093/bioinformatics/btn490; Martre P, 2003, PLANT PHYSIOL, V133, P1959, DOI 10.1104/pp.103.030585; MILLER JH, 1968, NATURE, V220, P1287, DOI 10.1038/2201287a0; Mordelet F, 2008, BIOINFORMATICS, V24, pI76, DOI 10.1093/bioinformatics/btn273; Murakami K, ARXIV 2011 E PRINTS; Muttucumaru N, 2006, J AGR FOOD CHEM, V54, P8951, DOI 10.1021/jf0623081; Pan Y, 2013, PLANT PHYSIOL, V161, P1476, DOI 10.1104/pp.112.212654; Piatetsky-Shapiro G., 1991, Knowledge discovery in databases, P229; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Reinbold J, 2008, J AGR FOOD CHEM, V56, P6844, DOI 10.1021/jf800880n; Rustenholz C, 2011, PLANT PHYSIOL, V157, P1596, DOI 10.1104/pp.111.183921; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shewry PR, 2001, PLANT GROWTH REGUL, V34, P105, DOI 10.1023/A:1013382803849; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Tan PN, 2004, INFORM SYST, V29, P293, DOI 10.1016/S0306-4379(03)00072-3; Tea I, 2005, J CEREAL SCI, V41, P305, DOI 10.1016/j.jcs.2004.10.003; Triboi E, 2000, EUR J AGRON, V13, P47, DOI 10.1016/S1161-0301(00)00059-9; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weber EA, 2008, J PLANT NUTR SOIL SC, V171, P643, DOI 10.1002/jpln.200700229; WRIGLEY CW, 1984, J CEREAL SCI, V2, P15, DOI 10.1016/S0733-5210(84)80003-X; Yoon HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000306; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zorb C, 2009, J AGR FOOD CHEM, V57, P3877, DOI 10.1021/jf8038988	63	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127127	10.1371/journal.pone.0127127	http://dx.doi.org/10.1371/journal.pone.0127127			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993562	Green Published, gold			2022-12-26	WOS:000354918600050
J	Farley, JH; Davis, TLO; Bravington, MV; Andamari, R; Davies, CR				Farley, Jessica H.; Davis, Tim L. O.; Bravington, Mark V.; Andamari, Retno; Davies, Campbell R.			Spawning Dynamics and Size Related Trends in Reproductive Parameters of Southern Bluefin Tuna, Thunnus maccoyii	PLOS ONE			English	Article							BATCH FECUNDITY; FREQUENCY; BEHAVIOR; FISH	Knowledge of spawning behaviour and fecundity of fish is important for estimating the reproductive potential of a stock and for constructing appropriate statistical models for assessing sustainable catch levels. Estimates of length-based reproductive parameters are particularly important for determining potential annual fecundity as a function of fish size, but they are often difficult to estimate reliably. Here we provide new information on the reproductive dynamics of southern bluefin tuna (SBT) Thunnus maccoyii through the analysis of fish size and ovary histology collected on the spawning ground in 1993-1995 and 1999-2002. These are used to refine previous parameter estimates of spawning dynamics and investigate size related trends in these parameters. Our results suggest that the small SBT tend to arrive on the spawning ground slightly later and depart earlier in the spawning season relative to large fish. All females were mature and the majority were classed as spawning capable (actively spawning or non-spawning) with a very small proportion classed as regressing. The fraction of females spawning per day decreased with fish size, but once females start a spawning episode, they spawned daily irrespective of size. Mean batch fecundity was estimated directly at 6.5 million oocytes. Analysis of ovary histology and ovary weight data indicated that relative batch fecundity, and the duration of spawning and non-spawning episodes, increased with fish size. These reproductive parameter estimates could be used with estimates of residency time on the spawning ground as a function of fish size (if known) and demographic data for the spawning population to provide a time series of relative annual fecundity for SBT.	[Farley, Jessica H.; Davis, Tim L. O.; Davies, Campbell R.] Oceans & Atmosphere Flagship, Hobart, Tas, Australia; [Bravington, Mark V.] Digital Prod Flagship, Hobart, Tas, Australia; [Andamari, Retno] Inst Mariculture Res & Dev, Gondol, Bali, Indonesia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Farley, JH (corresponding author), Oceans & Atmosphere Flagship, Hobart, Tas, Australia.	Jessica.Farley@csiro.au	Davies, Campbell R/N-8086-2013; Farley, Jessica/E-4957-2014	Davies, Campbell R/0000-0002-2028-1060; Farley, Jessica/0000-0002-5047-746X	CSIRO Oceans and Atmosphere Flagship; Australian Fisheries Research and Development Corporation [1999/106]	CSIRO Oceans and Atmosphere Flagship; Australian Fisheries Research and Development Corporation	This work was supported by funding from CSIRO Oceans and Atmosphere Flagship, and the Australian Fisheries Research and Development Corporation (Project # 1999/106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076445; Basson M., 2012, 2003002 FRDC, P347; Bestley S, 2008, J ANIM ECOL, V77, P1223, DOI 10.1111/j.1365-2656.2008.01437.x; Bestley S, 2010, ECOLOGY, V91, P2373, DOI 10.1890/08-2019.1; Bromley PJ, 2000, J FISH BIOL, V56, P264, DOI 10.1111/j.1095-8649.2000.tb02105.x; Brown-Peterson NJ, 2011, MAR COAST FISH, V3, P52, DOI 10.1080/19425120.2011.555724; CCSBT, 2012, REPORT 17 M SCI COMM; Davis TLO, 1995, INDONESIAN FISH RES, V1, P68; Evans K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034550; Farley J, 2012, CCSBT EXT SCI COMM 1; Farley JH, 2007, FISH RES, V83, P151, DOI 10.1016/j.fishres.2006.09.006; Farley JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060577; Farley JH, 1998, FISH B-NOAA, V96, P223; Fitzhugh GR, 2012, FISH B-NOAA, V110, P413; FITZHUGH GR, 1995, FISH B-NOAA, V93, P568; Goldberg S. R., 1986, P ICCAT C INT SKIPJ, P248; Gunn J, 2001, TUNA PHYSL ECOLOGY E, P167, DOI DOI 10.1016/S1546-5098(01)19006-0; Hillary RM, 2011, CCSBT EXT SCI COMM 1; Hunter J.R., 1985, NOAA Technical Report NMFS, V36, P79; Hunter J.R., 1985, NOAA Technical Report NMFS, V36, P67; Hunter J.R., 1980, California Cooperative Oceanic Fisheries Investigations Reports, V21, P139; HUNTER JR, 1979, FISH B-NOAA, V77, P641; HUNTER JR, 1986, FISH B-NOAA, V84, P895; Itoh T, 2002, 7 M CCSBT SCI COMM S; Kolody D, 2001, CCSBT SCI M 28 31 AU; LECREN ED, 1951, J ANIM ECOL, V20, P201, DOI 10.2307/1540; Lowerre-Barbieri SK, 2011, MAR COAST FISH, V3, P71, DOI 10.1080/19425120.2011.556932; Marshall C. T., 2003, J NW ATL FISH SCI, V33, P161, DOI [DOI 10.2960/J.V33.A8, 10.2960/J.V33.A8]; MCPHERSON GR, 1991, AUST J MAR FRESH RES, V42, P465, DOI 10.1071/MF9910465; McPherson GR, 1988, 889 FRB QLD DEP PRIM; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P33, DOI 10.2960/J.v33.a3; NIKAIDO H, 1991, B NATL RES I FAR SEA, V28, P47; Patterson TA, 2008, FISH OCEANOGR, V17, P352, DOI 10.1111/j.1365-2419.2008.00483.x; Pavlov Dimitri A., 2009, P48, DOI 10.1002/9781444312133.ch2; Sancho G, 2000, MAR ECOL PROG SER, V206, P193, DOI 10.3354/meps206193; SCHAEFER K M, 1987, Inter-American Tropical Tuna Commission Bulletin, V19, P169; Schaefer KM, 1996, FISH B-NOAA, V94, P98; Schaefer KM, 1998, B INTERAMERICAN TROP, V21, P201; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; Schirripa Michael J., 2011, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V66, P898; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; Van Winkle W, 1995, EARLY LIFE HIST RECR, P103; Vandeperre F, 2007, ESTUAR COAST SHELF S, V71, P391, DOI 10.1016/j.ecss.2006.07.020	43	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0125744	10.1371/journal.pone.0125744	http://dx.doi.org/10.1371/journal.pone.0125744			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993276	gold, Green Published, Green Submitted			2022-12-26	WOS:000354917300025
J	Drozak, J; Piecuch, M; Poleszak, O; Kozlowski, P; Chrobok, L; Baelde, HJ; de Heer, E				Drozak, Jakub; Piecuch, Maria; Poleszak, Olga; Kozlowski, Piotr; Chrobok, Lukasz; Baelde, Hans J.; de Heer, Emile			UPF0586 Protein C9orf41 Homolog Is Anserine-producing Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYLOGENETIC ANALYSIS; CARNOSINE; HUMANS; METHYLATION; EXPRESSION; MUSCLE; GENE; LOCALIZATION; PREDICTION; DATABASE	Anserine (beta-alanyl-N(P-i)-methyl-L-histidine), a methylated derivative of carnosine (beta-alanyl-L-histidine), is an abundant constituent of vertebrate skeletal muscles. Although it has been suggested to serve as a proton buffer and radical scavenger, its physiological function remains mysterious. The formation of anserine is catalyzed by carnosine N-methyltransferase, recently identified in chicken as histamine N-methyltransferaselike (HNMT-like) protein. Although the HNMT-like gene is absent in mammalian genomes, the activity of carnosine N-methyltransferase was reported in most mammalian species. In the present investigation, we purified carnosineN-methyltransferase from rat muscles about 2600-fold. Three polypeptides of similar to 45, 50, and 70 kDa coeluting with the enzyme activity were identified in the preparation. Mass spectrometry analysis of these polypeptides resulted in the identification of UPF0586 protein C9orf41 homolog as the only meaningful candidate. Rat UPF0586 and its yeast, chicken, and human orthologs were expressed in COS-7 cells and purified to homogeneity. Although all recombinant proteins catalyzed the formation of anserine, as confirmed by chromatographic and mass spectrometry analysis, rat UPF0586 was more active on carnosine than other orthologs. Confocal microscopy of HeLa cells expressing recombinant UPF5086 proteins revealed their presence in both cytosol and nucleus. Carnosine and Gly-His were the best substrates for all UPF0586 orthologs studied, although the enzymes also methylated other L-histidine-containing di- and tripeptides. Finally, cotransfection of COS-7 cells with rat or human UPF0586 and carnosine synthase transformed the cells into efficient anserine producers. We conclude that UPF0586 is mammalian carnosine N-methyl-transferase and hypothesize that it may also serve as a peptide or protein methyltransferase in eukaryotes.	[Drozak, Jakub; Piecuch, Maria; Poleszak, Olga; Chrobok, Lukasz] Univ Warsaw, Fac Biol, Inst Biochem, Dept Metab Regulat, PL-02096 Warsaw, Poland; [Kozlowski, Piotr] Univ Warsaw, Fac Biol, Inst Biochem, Dept Mol Biol, PL-02096 Warsaw, Poland; [Baelde, Hans J.; de Heer, Emile] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands	University of Warsaw; University of Warsaw; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Drozak, J (corresponding author), Univ Warsaw, Fac Biol, Inst Biochem, Dept Metab Regulat, Miecznikowa 1, PL-02096 Warsaw, Poland.	jdrozak@biol.uw.edu.pl		baelde, Hans/0000-0002-1214-500X; Drozak, Jakub/0000-0002-3601-3845; Krupska, Olga/0000-0003-3218-7108	Opus-6 Grant from the Polish National Science Center [DEC-2013/11/B/NZ1/00078]; European Union European Regional Development Fund within the Operational Program "Innovative Economy"	Opus-6 Grant from the Polish National Science Center; European Union European Regional Development Fund within the Operational Program "Innovative Economy"	This work was supported by Opus-6 Grant DEC-2013/11/B/NZ1/00078 from the Polish National Science Center. It was carried out with the use of the CePT infrastructure financed by the European Union European Regional Development Fund within the Operational Program "Innovative Economy" for 2007-2013. The authors declare that they have no conflicts of interest with the contents of this article.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bae ON, 2013, STROKE, V44, P205, DOI 10.1161/STROKEAHA.112.673954; Baglietto MG, 2014, EUR J MED GENET, V57, P44, DOI 10.1016/j.ejmg.2013.12.001; Banko MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074885; Boldyrev A. A, 2007, CARNOSINE OXIDATIVE, P37; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; Boudry-Labis E, 2013, EUR J MED GENET, V56, P163, DOI 10.1016/j.ejmg.2012.12.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; CHRISTMAN AA, 1976, INT J BIOCHEM, V7, P519, DOI 10.1016/0020-711X(76)90055-0; Clarke S, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P63; CRUSH KG, 1970, COMP BIOCHEM PHYSIOL, V34, P3, DOI 10.1016/0010-406X(70)90049-6; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Drozak J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064805; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; HARMS WS, 1954, BIOCHIM BIOPHYS ACTA, V15, P480, DOI 10.1016/0006-3002(54)90005-0; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Kubomura D, 2010, NUTR NEUROSCI, V13, P183, DOI 10.1179/147683010X12611460764363; Li DL, 2009, NUCLEIC ACIDS RES, V37, P7059, DOI 10.1093/nar/gkp773; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MADSHUS IH, 1988, BIOCHEM J, V250, P1, DOI 10.1042/bj2500001; MANNION AF, 1992, EUR J APPL PHYSIOL O, V64, P47, DOI 10.1007/BF00376439; Martins MLL, 2002, J BIOCHEM MOL BIOL, V35, P220; MCMANUS IR, 1962, J BIOL CHEM, V237, P1207; Miller BG, 2005, BIOCHEMISTRY-US, V44, P10776, DOI 10.1021/bi0506268; Mora L, 2007, J AGR FOOD CHEM, V55, P4664, DOI 10.1021/jf0703809; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Peters V, 2012, AMINO ACIDS, V42, P2411, DOI 10.1007/s00726-011-1046-4; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smyk A, 2006, FEBS J, V273, P4728, DOI 10.1111/j.1742-4658.2006.05477.x; STOCK A, 1987, FEBS LETT, V220, P8, DOI 10.1016/0014-5793(87)80866-9; Szwergold BS, 2005, BIOCHEM BIOPH RES CO, V336, P36, DOI 10.1016/j.bbrc.2005.08.033; Thapar N, 2001, PLANT PHYSIOL, V125, P1023, DOI 10.1104/pp.125.2.1023; Tomonaga S, 2007, NUTR NEUROSCI, V10, P181, DOI 10.1080/10284150701587338; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Veiga-da-Cunha M, 2014, J BIOL CHEM, V289, P19726, DOI 10.1074/jbc.M114.576579; Webb KJ, 2010, J BIOL CHEM, V285, P37598, DOI 10.1074/jbc.M110.170787; Webb KJ, 2010, BIOCHEMISTRY-US, V49, P5225, DOI 10.1021/bi100428x; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wirth VJ, 1998, J ATHL TRAINING, V33, P211; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018	48	23	27	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17190	17205		10.1074/jbc.M115.640037	http://dx.doi.org/10.1074/jbc.M115.640037			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26001783	hybrid, Green Published			2022-12-26	WOS:000357730900016
J	Sakai, T; Jung, HS; Sato, O; Yamada, MD; You, DJ; Ikebe, R; Ikebe, M				Sakai, Tsuyoshi; Jung, Hyun Suk; Sato, Osamu; Yamada, Masafumi D.; You, Dong-Ju; Ikebe, Reiko; Ikebe, Mitsuo			Structure and Regulation of the Movement of Human Myosin VIIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; POLYMERASE-CHAIN-REACTION; USHER-SYNDROME PROTEINS; GLOBULAR TAIL DOMAIN; MOTOR-ACTIVITY; CELLS; CARGO; EXPRESSION; BINDING; HEAD	Human myosin VIIA (HM7A) is responsible for human Usher syndrome type 1B, which causes hearing and visual loss in humans. Here we studied the regulation of HM7A. The actin-activated ATPase activity of full-length HM7A (HM7AFull) was lower than that of tail-truncated HM7A(HM7A Delta Tail). Deletion of the C-terminal 40 amino acids and mutation of the basic residues in this region (R2176A or K2179A) abolished the inhibition. Electron microscopy revealed that HM7AFull is a monomer in which the tail domain bends back toward the head-neck domain to form a compact structure. This compact structure is extended at high ionic strength or in the presence of Ca2+. Although myosin VIIA has five isoleucine-glutamine (IQ) motifs, the neck length seems to be shorter than the expected length of five bound calmodulins. Supporting this observation, the IQ domain bound only three calmodulins in Ca2+, and the first IQ motif failed to bind calmodulin in EGTA. These results suggest that the unique IQ domain of HM7A is important for the tail-neck interaction and, therefore, regulation. Cellular studies revealed that dimer formation of HM7A is critical for its translocation to filopodial tips and that the tail domain (HM7ATail) markedly reduced the filopodial tip localization of the HM7A Delta Tail dimer, suggesting that the tail-inhibition mechanism is operating in vivo. The translocation of the HM7AFull dimer was significantly less than that of the HM7A Delta Tail dimer, and R2176A/R2179A mutation rescued the filopodial tip translocation. These results suggest that HM7A can transport its cargo molecules, such as USH1 proteins, upon release of the tail-dependent inhibition.	[Sakai, Tsuyoshi; Sato, Osamu; Yamada, Masafumi D.; Ikebe, Reiko; Ikebe, Mitsuo] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01605 USA; [Sakai, Tsuyoshi; Sato, Osamu; Ikebe, Reiko; Ikebe, Mitsuo] Univ Texas Hlth Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75708 USA; [Jung, Hyun Suk; You, Dong-Ju] Korea Basic Sci Inst, Div Electron Microscop Res, Taejon 305333, South Korea; [Jung, Hyun Suk] Kangwon Natl Univ, Dept Biochem, Coll Nat Sci, Chuncheon Si 200701, Gangwon Do, South Korea	University of Massachusetts System; University of Massachusetts Worcester; University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); Korea Basic Science Institute (KBSI); Kangwon National University	Ikebe, M (corresponding author), Univ Texas Hlth Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75708 USA.	Mitsuo.Ikebe@uthct.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [DC610063]; Korea Basic Science Institute [T34415]; Global Frontier Research Grant [NRF-M1AXA002-2011-0031424]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Basic Science Institute; Global Frontier Research Grant	This work was supported, in whole or in part, by National Institutes of Health found that Drosophila myosin VIIA is a high duty ratio motor grant DC610063 (to M. I.). This work was also supported by Korea Basic Science Institute Grant T34415 (to M. I. and H. S. J) and Global Frontier Research Grant NRF-M1AXA002-2011-0031424 (to H. S. J.).	Adato A, 2005, HUM MOL GENET, V14, P347, DOI 10.1093/hmg/ddi031; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bird JE, 2014, P NATL ACAD SCI USA, V111, P12390, DOI 10.1073/pnas.1409459111; Blumenschein TMA, 2000, BIOCHEMISTRY-US, V39, P3603, DOI 10.1021/bi9924718; Burgess SA, 2004, J STRUCT BIOL, V147, P247, DOI 10.1016/j.jsb.2004.04.004; Chen ZY, 1996, GENOMICS, V36, P440, DOI 10.1006/geno.1996.0489; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; CHIEN YH, 1984, MOL CELL BIOL, V4, P507, DOI 10.1128/MCB.4.3.507; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Coudrier E, 2007, PIGM CELL RES, V20, P153, DOI 10.1111/j.1600-0749.2007.00376.x; Futter CE, 2004, MOL BIOL CELL, V15, P2264, DOI 10.1091/mbc.E03-10-0772; Gourinath S, 2003, STRUCTURE, V11, P1621, DOI 10.1016/j.str.2003.10.013; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; Guzik-Lendrum S, 2013, J BIOL CHEM, V288, P9532, DOI 10.1074/jbc.M112.441238; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Inoue A, 2003, J BIOL CHEM, V278, P5478, DOI 10.1074/jbc.M210489200; Jones I, 1996, CURR OPIN BIOTECH, V7, P512, DOI 10.1016/S0958-1669(96)80054-1; Jung HS, 2008, MOL BIOL CELL, V19, P3234, DOI 10.1091/mbc.E08-02-0206; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Liu XR, 1999, J NEUROSCI, V19, P6267; Maruta S, 1998, EUR J BIOCHEM, V256, P229, DOI 10.1046/j.1432-1327.1998.2560229.x; Mukherjea M, 2009, MOL CELL, V35, P305, DOI 10.1016/j.molcel.2009.07.010; O'Reilly D R, 1997, Methods Mol Biol, V62, P235; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phichith D, 2009, P NATL ACAD SCI USA, V106, P17320, DOI 10.1073/pnas.0909748106; Reiners J, 2006, EXP EYE RES, V83, P97, DOI 10.1016/j.exer.2005.11.010; REYNARD AM, 1961, J BIOL CHEM, V236, P2277; Richardson GP, 2011, ANNU REV PHYSIOL, V73, P311, DOI 10.1146/annurev-physiol-012110-142228; Sakai T, 2011, P NATL ACAD SCI USA, V108, P7028, DOI 10.1073/pnas.1009188108; Sellers JR, 2007, J MUSCLE RES CELL M, V28, P363, DOI 10.1007/s10974-008-9134-0; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; SUMMERS MD, 1972, J VIROL, V9, P710, DOI 10.1128/JVI.9.4.710-713.1972; TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Udovichenko IP, 2002, J CELL SCI, V115, P445; Umeki N, 2011, NAT STRUCT MOL BIOL, V18, P783, DOI 10.1038/nsmb.2065; Umeki N, 2009, P NATL ACAD SCI USA, V106, P8483, DOI 10.1073/pnas.0812930106; Watanabe S, 2006, J BIOL CHEM, V281, P7151, DOI 10.1074/jbc.M511592200; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Wu L, 2011, SCIENCE, V331, P757, DOI 10.1126/science.1198848; Yang Y, 2006, P NATL ACAD SCI USA, V103, P5746, DOI 10.1073/pnas.0509935103; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106; Yu C, 2009, CELL, V138, P537, DOI 10.1016/j.cell.2009.05.030; Zhu T, 1996, BIOCHEMISTRY-US, V35, P513, DOI 10.1021/bi952053c	56	28	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17587	17598		10.1074/jbc.M114.599365	http://dx.doi.org/10.1074/jbc.M114.599365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	26001786	hybrid, Green Published			2022-12-26	WOS:000357730900049
J	Caseys, C; Stritt, C; Glauser, G; Blanchard, T; Lexer, C				Caseys, Celine; Stritt, Christoph; Glauser, Gaetan; Blanchard, Thierry; Lexer, Christian			Effects of Hybridization and Evolutionary Constraints on Secondary Metabolites: The Genetic Architecture of Phenylpropanoids in European Populus Species	PLOS ONE			English	Article							REPRODUCTIVE ISOLATION; PLANT DEFENSE; HYBRID ZONES; FLAVONOID BIOSYNTHESIS; HERBIVORE RESISTANCE; COMMUNITY; SELECTION; PATTERNS; GENOMICS; METABOLOMICS	The mechanisms responsible for the origin, maintenance and evolution of plant secondary metabolite diversity remain largely unknown. Decades of phenotypic studies suggest hybridization as a key player in generating chemical diversity in plants. Knowledge of the genetic architecture and selective constraints of phytochemical traits is key to understanding the effects of hybridization on plant chemical diversity and ecological interactions. Using the European Populus species P. alba (White poplar) and P. tremula (European aspen) and their hybrids as a model, we examined levels of inter- and intraspecific variation, heritabilities, phenotypic correlations, and the genetic architecture of 38 compounds of the phenylpropanoid pathway measured by liquid chromatography and mass spectrometry (UHPLC-MS). We detected 41 quantitative trait loci (QTL) for chlorogenic acids, salicinoids and flavonoids by genetic mapping in natural hybrid crosses. We show that these three branches of the phenylpropanoid pathway exhibit different geographic patterns of variation, heritabilities, and genetic architectures, and that they are affected differently by hybridization and evolutionary constraints. Flavonoid abundances present high species specificity, clear geographic structure, and strong genetic determination, contrary to salicinoids and chlorogenic acids. Salicinoids, which represent important defence compounds in Salicaceae, exhibited pronounced genetic correlations on the QTL map. Our results suggest that interspecific phytochemical differentiation is concentrated in downstream sections of the phenylpropanoid pathway. In particular, our data point to glycosyltransferase enzymes as likely targets of rapid evolution and interspecific differentiation in the 'model forest tree' Populus.	[Caseys, Celine; Stritt, Christoph; Blanchard, Thierry; Lexer, Christian] Univ Fribourg, Dept Biol, Unit Ecol & Evolut, CH-1700 Fribourg, Switzerland; [Caseys, Celine] Univ British Columbia, Dept Bot, Vancouver, BC V5Z 1M9, Canada; [Caseys, Celine] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Glauser, Gaetan] Univ Neuchatel, Fac Sci, Neuchatel Platform Analyt Chem, CH-2000 Neuchatel, Switzerland; [Lexer, Christian] Univ Vienna, Dept Bot & Biodivers Res, Vienna, Austria	University of Fribourg; University of British Columbia; University of British Columbia; University of Neuchatel; University of Vienna	Caseys, C (corresponding author), Univ Fribourg, Dept Biol, Unit Ecol & Evolut, CH-1700 Fribourg, Switzerland.	celine.caseys@gmail.com	Caseys, Celine/E-9837-2015; Glauser, Gaetan/K-7574-2017	Caseys, Celine/0000-0003-4187-9018; Glauser, Gaetan/0000-0002-0983-8614; Lexer, Christian/0000-0002-7221-7482	Swiss National Science Foundation (SNF) [31003A_127059, P2FRP3_151662]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	Swiss National Science Foundation (SNF) grant 31003A_127059 to CL and postdoctoral fellowship P2FRP3_151662 to CC. http://www.snf.ch The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2012, SCIENCE, V338, P113, DOI 10.1126/science.1225977; Aksamit-Stachurska A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-25; Anderson JT, 2011, FUNCT ECOL, V25, P312, DOI 10.1111/j.1365-2435.2010.01785.x; Arnold M. L, 2007, EVOLUTION GENETIC EX; Babst BA, 2014, J EXP BOT, V65, P4191, DOI 10.1093/jxb/eru192; Babst BA, 2010, J CHEM ECOL, V36, P286, DOI 10.1007/s10886-010-9757-7; Bangert RK, 2006, MOL ECOL, V15, P1379, DOI 10.1111/j.1365-294X.2005.02749.x; Barbehenn R, 2010, OECOLOGIA, V164, P993, DOI 10.1007/s00442-010-1733-y; Beavis WD, 1998, MOL DISSECTION COMPL, P145, DOI DOI 10.1093/MP/SSR111; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Bernhardsson C, 2013, ECOL LETT, V16, P791, DOI 10.1111/ele.12114; Boeckler GA, 2011, PHYTOCHEMISTRY, V72, P1497, DOI 10.1016/j.phytochem.2011.01.038; Brachi B, 2015, P NATL ACAD SCI USA, V112, P4032, DOI 10.1073/pnas.1421416112; Camacho D, 2005, METABOLOMICS, V1, P53, DOI 10.1007/s11306-005-1107-3; Cardinali A., 2006, PHYTOCHEM ADV RES, V661, P23; Caseys C, 2012, PLANT ECOL DIVERS, V5, P457, DOI 10.1080/17550874.2012.748850; Chae L, 2014, SCIENCE, V344, P510, DOI 10.1126/science.1252076; Chen F, 2009, CRIT REV PLANT SCI, V28, P375, DOI 10.1080/07352680903241279; Cheng DD, 2011, PHYTOCHEM REV, V10, P107, DOI 10.1007/s11101-010-9194-9; Chu SS, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-76; Clotault J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038724; De Carvalho D, 2010, MOL ECOL, V19, P1638, DOI 10.1111/j.1365-294X.2010.04595.x; DeWoody J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079925; Dickmann DI, 2009, PSYCHOL MED, P1; Eckenwalder J.E., 1996, BIOL POPULUS ITS IMP, P542; Feder JL, 2012, TRENDS GENET, V28, P342, DOI 10.1016/j.tig.2012.03.009; Fussi B, 2010, TREE GENET GENOMES, V6, P439, DOI 10.1007/s11295-009-0262-5; Futuyma DJ, 2009, P NATL ACAD SCI USA, V106, P18054, DOI 10.1073/pnas.0904106106; Gachon CMM, 2005, TRENDS PLANT SCI, V10, P542, DOI 10.1016/j.tplants.2005.09.007; Gompert Z, 2009, MOL ECOL, V18, P1207, DOI 10.1111/j.1365-294X.2009.04098.x; Jaakola L, 2010, PLANT CELL ENVIRON, V33, P1239, DOI 10.1111/j.1365-3040.2010.02154.x; Johnson MTJ, 2011, NEW PHYTOL, V191, P589, DOI 10.1111/j.1469-8137.2011.03816.x; Karrenberg S, 2007, AM NAT, V169, P725, DOI 10.1086/516758; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Keefover-Ring K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107189; Lexer C, 2004, FOREST ECOL MANAG, V197, P49, DOI 10.1016/j.foreco.2004.05.004; Lexer C, 2010, GENETICS, V186, P699, DOI 10.1534/genetics.110.118828; Lexer C, 2009, TAXON, V58, P349, DOI 10.1002/tax.582003; Lindtke D, 2013, HEREDITY, V111, P474, DOI 10.1038/hdy.2013.69; Lindtke D, 2014, MOL ECOL, V23, P4316, DOI 10.1111/mec.12759; Lindtke D, 2012, MOL ECOL, V21, P5042, DOI 10.1111/j.1365-294X.2012.05744.x; Lynch M., 1998, GENETICS ANAL QUANTI; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Morreel K, 2006, PLANT J, V47, P224, DOI 10.1111/j.1365-313X.2006.02786.x; Nolte AW, 2010, TRENDS GENET, V26, P54, DOI 10.1016/j.tig.2009.12.001; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Orians CM, 2010, OECOLOGIA, V163, P283, DOI 10.1007/s00442-009-1521-8; Philippe RN, 2007, CAN J BOT, V85, P1111, DOI 10.1139/B07-109; Pichersky E, 2011, ANNU REV PLANT BIOL, V62, P549, DOI 10.1146/annurev-arplant-042110-103814; Ramsay H, 2009, MOL BIOL EVOL, V26, P1045, DOI 10.1093/molbev/msp021; Rausher MD, 2013, EVOLUTION, V67, P34, DOI 10.1111/j.1558-5646.2012.01771.x; Rausher MD, 1999, MOL BIOL EVOL, V16, P266, DOI 10.1093/oxfordjournals.molbev.a026108; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Rieseberg LH, 2002, P NATL ACAD SCI USA, V99, P12242, DOI 10.1073/pnas.192360899; Rieseberg LH, 2002, AM NAT, V159, pS36, DOI 10.1086/338371; RIESEBERG LH, 1993, CRIT REV PLANT SCI, V12, P213, DOI 10.1080/713608045; Ritland K, 1996, EVOLUTION, V50, P1074, DOI 10.1111/j.1558-5646.1996.tb02348.x; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Rockman MV, 2012, EVOLUTION, V66, P1, DOI 10.1111/j.1558-5646.2011.01486.x; Schweitzer JA, 2008, ECOSYSTEMS, V11, P1005, DOI 10.1007/s10021-008-9173-9; Sellis D, 2015, EVOLUTION, V69, P75, DOI 10.1111/evo.12548; Steuer R, 2006, BRIEF BIOINFORM, V7, P151, DOI 10.1093/bib/bbl009; Stolting KN, 2015, NEW PHYTOL, V207, P723, DOI 10.1111/nph.13392; Stolting KN, 2013, MOL ECOL, V22, P842, DOI 10.1111/mec.12011; Treutter D, 2006, ENVIRON CHEM LETT, V4, P147, DOI 10.1007/s10311-006-0068-8; Tsai C.J., 2006, INT J APPL SCI ENG, V4, P221; van Loo M, 2008, NEW PHYTOL, V177, P506, DOI 10.1111/j.1469-8137.2007.02266.x; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; Vogt T, 2000, TRENDS PLANT SCI, V5, P380, DOI 10.1016/S1360-1385(00)01720-9; Weng JK, 2012, SCIENCE, V336, P1667, DOI 10.1126/science.1217411; Whitham TG, 1999, ECOLOGY, V80, P416; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Widmer A, 2009, HEREDITY, V102, P31, DOI 10.1038/hdy.2008.69; Yonekura-Sakakibara K, 2011, PLANT J, V66, P182, DOI 10.1111/j.1365-313X.2011.04493.x; Yu O, 2008, PLANT J, V54, P750, DOI 10.1111/j.1365-313X.2008.03436.x; Zust T, 2012, SCIENCE, V338, P116, DOI 10.1126/science.1226397	76	22	23	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128200	10.1371/journal.pone.0128200	http://dx.doi.org/10.1371/journal.pone.0128200			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010156	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900204
J	Hoang, V; Bi, JJ; Mohankumar, SM; Vyas, AK				Hoang, Vanessa; Bi, Jiangjiang; Mohankumar, Sheba M.; Vyas, Arpita K.			Liraglutide Improves Hypertension and Metabolic Perturbation in a Rat Model of Polycystic Ovarian Syndrome	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; GLUCAGON-LIKE PEPTIDE-1; HORMONE-SECRETION; ANDROGEN EXCESS; BLOOD-PRESSURE; WOMEN; RISK; GLUCOSE; OBESITY; HYPERGLYCEMIA	Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, with a prevalence of 5-8%. Type 2 diabetes and cardiovascular disease (CVD) are its long-term complications. Targeted therapies addressing both these complications together are lacking. Glucagon like peptide-1 (GLP-1) agonists that are used to treat type 2 diabetes mellitus have beneficial effects on the cardiovascular system. Hence we hypothesized that a GLP-1 agonist would improve both cardiovascular and metabolic outcomes in PCOS. To test this hypothesis, we used an established rat model of PCOS. Prepubertal female Sprague Dawley rats were sham-implanted or implanted s.c. with dihydrotestosterone (DHT) pellets (90 day release; 83 mu g/day). At 12 wks of age, sham implanted rats received saline injections and the DHT treated animals were administered either saline or liraglutide (0.2mg/kg s.c twice daily) for 4 weeks. Subgroups of rats were implanted with telemeters between 12-13 weeks of age to monitor blood pressure. DHT implanted rats had irregular estrus cycles and were significantly heavier than the control females at 12 weeks (mean +/- SEM 251.9 +/- 3.4 vs 216.8 +/- 3.4 respectively; p<0.05) and 4 weeks of treatment with liraglutide in DHT treated rats significantly decreased body weight (mean +/- SEM 294.75 +/- 3.2 in DHT+ saline vs 276.25 +/- 2.7 in DHT+ liraglutide group respectively; p<0.01). Liraglutide treatment in the DHT implanted rats significantly improved glucose excursion during oral glucose tolerance test (area under the curve: DHT+ saline 28674 +/- 310 vs 24990 +/- 420 in DHT+ liraglutide p<0.01). DHT rats were hypertensive and liraglutide treatment significantly improved mean arterial pressure. These results suggest that GLP-1 treatment could improve DHT-induced metabolic and blood pressure deficits associated with PCOS.	[Hoang, Vanessa; Bi, Jiangjiang; Vyas, Arpita K.] Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA; [Mohankumar, Sheba M.] Univ Georgia, Dept Vet Biosci & Diagnost Imaging, Athens, GA 30602 USA; [Bi, Jiangjiang] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Anesthesiol, Wuhan 430074, Hubei, Peoples R China	Michigan State University; University System of Georgia; University of Georgia; Huazhong University of Science & Technology	Vyas, AK (corresponding author), Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA.	Arpita.Vyas@hc.msu.edu	MohanKumar, Sheba/AAH-8075-2020	MohanKumar, Sheba/0000-0002-3365-7864	National Institutes of Health from the Office of Research on Women's Health [K12HD065879]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD065879] Funding Source: NIH RePORTER	National Institutes of Health from the Office of Research on Women's Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by National Institutes of Health grant K12HD065879 (BIRCWH) from the Office of Research on Women's Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrup A, 2009, LANCET, V374, P1606, DOI 10.1016/S0140-6736(09)61375-1; Aydin K, 2014, CLIN ENDOCRINOL, V81, P588, DOI 10.1111/cen.12468; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; Beckman JA, 2002, CIRC RES, V90, P107, DOI 10.1161/hh0102.102359; Bentley-Lewis R, 2011, ENDOCRIN METAB CLIN, V40, P433, DOI 10.1016/j.ecl.2011.01.009; Birdsall MA, 1997, ANN INTERN MED, V126, P32, DOI 10.7326/0003-4819-126-1-199701010-00005; Bloomgarden AT, 2004, DIABETES CARE, V27, P2554, DOI 10.2337/diacare.27.10.2554; Carmina E, 2009, CLIMACTERIC, V12, P22, DOI 10.1080/13697130903003842; Carreau AM, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-014-0564-3; CONWAY GS, 1992, CLIN ENDOCRINOL, V37, P119, DOI 10.1111/j.1365-2265.1992.tb02295.x; Coviello AD, 2006, J CLIN ENDOCR METAB, V91, P492, DOI 10.1210/jc.2005-1666; Cummings BP, 2010, DIABETES, V59, P2653, DOI 10.2337/db09-1564; Daan NM, FERTILITY STERILITY; DAHLGREN E, 1992, ACTA OBSTET GYN SCAN, V71, P599, DOI 10.3109/00016349209006227; De Leo V, 2009, DRUG TODAY, V45, P763, DOI 1396674/dot.2009.45.10.1429463; DiVasta-AD, 2013, CONT OB GYN; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Flint A, 2001, INT J OBESITY, V25, P781, DOI 10.1038/sj.ijo.0801627; Holte J, 1996, HUM REPROD, V11, P23; Jensterle M, ENDOCRINE RES, V20, P1; Keller J, 2011, ENDOCRINOLOGY, V152, P4927, DOI 10.1210/en.2011-1424; King AJ, 2007, HYPERTENSION, V50, P547, DOI 10.1161/HYPERTENSIONAHA.107.090696; Kotsis V, 2010, HYPERTENS RES, V33, P386, DOI 10.1038/hr.2010.9; Lass N, 2011, J CLIN ENDOCR METAB, V96, P3533, DOI 10.1210/jc.2011-1609; Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165; Lovshin JA, 2014, CAN J DIABETES, V38, P364, DOI 10.1016/j.jcjd.2014.05.001; Manneras L, 2007, ENDOCRINOLOGY, V148, P3781, DOI 10.1210/en.2007-0168; Meyer C, 2005, J CLIN ENDOCR METAB, V90, P4630, DOI 10.1210/jc.2004-1487; Morigi M, 1998, J CLIN INVEST, V101, P1905, DOI 10.1172/JCI656; Ndefo UA, P T, V38, P336; Okerson T, 2012, CARDIOVASC THER, V30, pe146, DOI 10.1111/j.1755-5922.2010.00256.x; Randeva HS, 2012, ENDOCR REV, V33, P812, DOI 10.1210/er.2012-1003; Rasmussen CB, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00140; Salley KES, 2007, J CLIN ENDOCR METAB, V92, P4546, DOI 10.1210/jc.2007-1549; Sara L, 2012, ACTA PHYSIOL HUNG, V99, P279, DOI 10.1556/APhysiol.99.2012.3.5; Sara L, GYNECOL ENDOCRINOL; Sara L, 2012, FERTIL STERIL, V97, P462, DOI 10.1016/j.fertnstert.2011.11.015; Secher A, 2014, J CLIN INVEST, V124, P4473, DOI 10.1172/JCI75276; Sever MJ, 2014, EUR J ENDOCRINOL, V170, P451, DOI 10.1530/EJE-13-0797; Sirivelu MP, 2009, HUM REPROD, V24, P718, DOI 10.1093/humrep/den434; Svendsen PF, 2009, METABOLISM, V58, P586, DOI 10.1016/j.metabol.2008.11.009; TESFAMARIAM B, 1992, AM J PHYSIOL, V263, pH321, DOI 10.1152/ajpheart.1992.263.2.H321; Verdich C, 2001, J CLIN ENDOCR METAB, V86, P4382, DOI 10.1210/jc.86.9.4382; Vilsboll T, 2009, DRUG TODAY, V45, P101, DOI 10.1358/dot.2009.45.2.1336104; Vrbikova J, 2008, EUR J ENDOCRINOL, V159, P121, DOI 10.1530/EJE-08-0097; Vrbikova J, 2009, OBESITY FACTS, V2, P26, DOI 10.1159/000194971; Vyas AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017178; Wang B, DIABETES OBESITY MET, V15, P737; Wild S, 2000, CLIN ENDOCRINOL, V52, P595, DOI 10.1046/j.1365-2265.2000.01000.x; Yanes LL, 2011, GENDER MED, V8, P103, DOI 10.1016/j.genm.2010.11.013	51	22	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126119	10.1371/journal.pone.0126119	http://dx.doi.org/10.1371/journal.pone.0126119			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010091	gold, Green Published, Green Submitted			2022-12-26	WOS:000355183900023
J	Lu, LL; Zhou, J; Shi, J; Peng, XJ; Qi, XX; Wang, Y; Li, FY; Zhou, FY; Liu, L; Liu, ZQ				Lu, Linlin; Zhou, Juan; Shi, Jian; Peng, Xiao-juan; Qi, Xiao-xiao; Wang, Ying; Li, Fang-yuan; Zhou, Fu-Yuan; Liu, Liang; Liu, Zhong-Qiu			Drug-Metabolizing Activity, Protein and Gene Expression of UDP-Glucuronosyltransferases Are Significantly Altered in Hepatocellular Carcinoma Patients	PLOS ONE			English	Article							HUMAN-LIVER; 7-ETHYL-10-HYDROXYCAMPTOTHECIN SN-38; IRINOTECAN CPT-11; GLUCURONIDATION; POLYMORPHISMS; CANCER; ENZYMES; UGT1A1; MICROSOMES; ISOFORMS	UDP-glucuronosyltransferases (UGTs), the most important enzymes in body detoxification and homeostasis maintaining, govern the glucuronidation reaction of various endogenous and environmental carcinogens. The metabolic function of UGTs can be severely influenced by hepatocellular carcinoma (HCC), the fifth prevalent and third malignant cancer worldwide. Particularly in China, HBV-positive HCC account for approximately 80% of HCC patients. But rare papers addressed the alteration on the metabolism of UGTs specific substrates, translational and transcriptional activity of UGTs in HBV-positive HCC patients. In present study, we choose the main UGT isoforms, UGT1As, UGT1A1, UGT1A9, UGT1A4 and UGT2B7, to determine the alterations of metabolic activity, protein and gene expression of UGTs in HBV-positive HCC. The corresponding specific substrates such as genistein, SN-38, tamoxifen, propofol and zidovudine were utilized respectively in UGTs metabolic activity determination. Furthermore, the plausible mechanism responsible for UGTs alterations was addressed by analyzing the protein and gene expressions in tumor and the adjacent normal tissues in HBV-positive HCC. The results revealed that in the tumor human liver microsomes (HLMs), either V-max (maximum reaction rate, R-max for UGT1A1) or the clearance rates (V-max/K-m, Clint) of UGT1A, UGT1A1, UGT1A4, UGT1A9 and UGT2B7 were significant lower than those of in the adjacent normal HLMs. Subsequently, the relative protein and gene expressions of these isoforms were notably decreased in most of tumor tissues comparing with the adjacent normal tissues. More interestingly, in tumor tissues, the metabolic activity reduction ratio of each UGT isoform was closely related to its protein reduction ratio, indicating that decreasing protein level would contribute to the reduced metabolic function of UGTs in HBV-positive HCC. In summary, our study firstly determined the alteration of UGT function in HBV-positive HCC patients, which would provide an important insight for toxicity or efficacy determination of chemotherapeutic drugs, and even bring a new strategy for clinical regimen in the health cares for the relative patients.	[Lu, Linlin; Shi, Jian; Qi, Xiao-xiao; Wang, Ying; Li, Fang-yuan; Liu, Zhong-Qiu] Guangzhou Univ Chinese Med, Int Inst Translat Chinese Med, Guangzhou 510006, Guangdong, Peoples R China; [Zhou, Juan; Shi, Jian; Peng, Xiao-juan; Wang, Ying; Liu, Zhong-Qiu] Southern Med Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Guangzhou 510515, Guangdong, Peoples R China; [Zhou, Fu-Yuan] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou 510515, Guangdong, Peoples R China; [Liu, Liang] Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Macau 999078, Peoples R China	Guangzhou University of Chinese Medicine; Southern Medical University - China; Southern Medical University - China; Macau University of Science & Technology	Liu, ZQ (corresponding author), Guangzhou Univ Chinese Med, Int Inst Translat Chinese Med, Guangzhou 510006, Guangdong, Peoples R China.	liuzq@gzucm.edu.cn	Liu, Zhongqiu/AHC-9661-2022; Liu, Zhongqiu/ABB-8204-2021; lu, Linlin/K-6600-2016	Liu, Zhongqiu/0000-0001-6986-9677; lu, Linlin/0000-0002-9943-2422	Project of National Natural Science Foundation of China [81120108025, 81473410]; Central Platform Project from Department of Education of Guangdong Province [GDJX20141L]	Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central Platform Project from Department of Education of Guangdong Province	This work was mainly supported by Project of National Natural Science Foundation of China (81120108025 and 81473410) and the Central Platform Project from Department of Education of Guangdong Province (GDJX20141L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Y, 1998, ANN ONCOL, V9, P845, DOI 10.1023/A:1008438109725; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Barve A, 2013, NATURE, V500, P203, DOI 10.1038/nature12301; Bellemare J, 2011, J PATHOL, V223, P425, DOI 10.1002/path.2805; Chung CJ, 2013, TOXICOL LETT, V216, P16, DOI 10.1016/j.toxlet.2012.11.002; DEBINSKI HS, 1995, GASTROENTEROLOGY, V108, P1464, DOI 10.1016/0016-5085(95)90695-9; Ehmer U, 2004, HEPATOLOGY, V39, P970, DOI 10.1002/hep.20131; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; ELMOUELHI M, 1987, CANCER RES, V47, P460; Fang JL, 2002, CANCER RES, V62, P1978; Fujiwara R, 2007, DRUG METAB DISPOS, V35, P747, DOI 10.1124/dmd.106.014191; Fujiwara R, 2010, P NATL ACAD SCI USA, V107, P5024, DOI 10.1073/pnas.0913290107; Gagne JF, 2002, MOL PHARMACOL, V62, P608, DOI 10.1124/mol.62.3.608; Gagnon JF, 2006, CLIN CANCER RES, V12, P1850, DOI 10.1158/1078-0432.CCR-05-2130; Galijatovic A, 2000, PHARMACEUT RES, V17, P21, DOI 10.1023/A:1007506222436; Guillemette C, 2014, CLIN PHARMACOL THER, V96, P324, DOI 10.1038/clpt.2014.126; Hardwick RN, 2013, DRUG METAB DISPOS, V41, P554, DOI 10.1124/dmd.112.048439; Hu DG, 2014, MOL PHARMACOL, V85, P887, DOI 10.1124/mol.114.091603; Innocenti F, 2001, DRUG METAB DISPOS, V29, P686; Iyer L, 1998, J CLIN INVEST, V101, P847, DOI 10.1172/JCI915; Jinno H, 2003, DRUG METAB DISPOS, V31, P108, DOI 10.1124/dmd.31.1.108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Radominska-Pandya A, 1999, DRUG METAB REV, V31, P817, DOI 10.1081/DMR-100101944; de Lope CR, 2012, J HEPATOL, V56, pS75, DOI 10.1016/S0168-8278(12)60009-9; Rossi L, 2010, WORLD J GASTRO ONCOL, V2, P348, DOI 10.4251/wjgo.v2.i9.348; Stingl JC, 2014, PHARMACOL THERAPEUT, V141, P92, DOI 10.1016/j.pharmthera.2013.09.002; Strassburg CP, 1997, CANCER RES, V57, P2979; Strassburg CP, 2002, GUT, V50, P851, DOI 10.1136/gut.50.6.851; Tang L, 2009, MOL PHARM, V6, P1644, DOI [10.1021/mp9000298, DOI 10.1021/MP9000298]; Tang L, 2009, MOL PHARMACEUT, V6, P1466, DOI 10.1021/mp8002557; Wang T, 2013, NUCLEIC ACIDS RES, V41, P4743, DOI 10.1093/nar/gkt178; Xu Feng, 2005, Sheng Li Ke Xue Jin Zhan, V36, P295; Ye L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096664; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554; Zhu LL, 2012, CHEM RES TOXICOL, V25, P2663, DOI 10.1021/tx300310k	35	28	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127524	10.1371/journal.pone.0127524	http://dx.doi.org/10.1371/journal.pone.0127524			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010150	gold, Green Published, Green Submitted			2022-12-26	WOS:000355183900104
J	Hegge, AM; Myhre, K; Welde, B; Holmberg, HC; Sandbakk, O				Hegge, Ann Magdalen; Myhre, Kenneth; Welde, Boye; Holmberg, Hans-Christer; Sandbakk, Oyvind			Are Gender Differences in Upper-Body Power Generated by Elite Cross-Country Skiers Augmented by Increasing the Intensity of Exercise?	PLOS ONE			English	Article							ANAEROBIC PERFORMANCE; STRENGTH; WOMEN; LEGS; MASS; MEN	In the current study, we evaluated the impact of exercise intensity on gender differences in upper-body poling among cross-country skiers, as well as the associated differences in aerobic capacity, maximal strength, body composition, technique and extent of training. Eight male and eight female elite skiers, gender-matched for level of performance by FIS points, carried out a 4-min submaximal, and a 3-min and 30-sec maximal all-out test of isolated upper-body double poling on a Concept2 ski ergometer. Maximal upper-body power and strength (1RM) were determined with a pull-down exercise. In addition, body composition was assessed with a DXA scan and training during the previous six months quantified from diaries. Relative to the corresponding female values (defined as 100%), the power output produced by the men was 88%, 95% and 108% higher during the submaximal, 3-min and 30-sec tests, respectively, and peak power in the pull-down strength exercise was 118% higher (all P<0.001). During the ergometer tests the work performed per cycle by the men was 97%, 102% and 91% greater, respectively, and the men elevated their cycle rate to a greater extent at higher intensities (both P<0.01). Furthermore, men had a 61% higher VO(2)peak, 58% higher 1RM, relatively larger upper-body mass (61% vs 56%) and reported considerably more upper-body strength and endurance training (all P<0.05). In conclusion, gender differences in upper-body power among cross-country skiers augmented as the intensity of exercise increased. The gender differences observed here are greater than those reported previously for both lower-and whole-body sports and coincided with greater peak aerobic capacity and maximal upper-body strength, relatively more muscle mass in the upper-body, and more extensive training of upper-body strength and endurance among the male skiers.	[Hegge, Ann Magdalen; Sandbakk, Oyvind] Norwegian Univ Sci & Technol, Dept Neurosci, Ctr Elite Sports Res, N-7034 Trondheim, Norway; [Myhre, Kenneth; Welde, Boye] North Troendelag Univ Coll, Dept Sports & Phys Educ, Levanger, Norway; [Holmberg, Hans-Christer] Mid Sweden Univ, Swedish Winter Sports Res Ctr, Ostersund, Sweden	Norwegian University of Science & Technology (NTNU); Mid-Sweden University	Hegge, AM (corresponding author), Norwegian Univ Sci & Technol, Dept Neurosci, Ctr Elite Sports Res, N-7034 Trondheim, Norway.	ann.hegge@ntnu.no	Welde, Boye/AAN-3785-2020	Welde, Boye/0000-0003-3805-1615				Andersson E, 2010, EUR J APPL PHYSIOL, V110, P585, DOI 10.1007/s00421-010-1535-2; BAROR O, 1987, SPORTS MED, V4, P381, DOI 10.2165/00007256-198704060-00001; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Coast JR, 2004, CAN J APPL PHYSIOL, V29, P139, DOI 10.1139/h04-010; Drinkwater B L, 1984, Exerc Sport Sci Rev, V12, P21; Fukuda DH, 2014, PHYSIOL MEAS, V35, P31, DOI 10.1088/0967-3334/35/1/31; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; HEYWARD VH, 1986, RES Q EXERCISE SPORT, V57, P154, DOI 10.1080/02701367.1986.10762192; Holmberg HC, 2006, MED SCI SPORT EXER, V38, P1853, DOI 10.1249/01.mss.0000230121.83641.d1; INGJER F, 1991, Scandinavian Journal of Medicine and Science in Sports, V1, P25; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Lepers R, 2010, J SPORT SCI, V28, P1555, DOI 10.1080/02640414.2010.517545; Lindinger SJ, 2011, EUR J APPL PHYSIOL, V111, P1103, DOI 10.1007/s00421-010-1736-8; Lindinger SJ, 2009, MED SCI SPORT EXER, V41, P210, DOI 10.1249/MSS.0b013e318184f436; Linnamo V, 6 INT C SCI SKIING20, P84; Maud P J, 1986, Br J Sports Med, V20, P51; MEDBO JI, 1988, J APPL PHYSIOL, V64, P50, DOI 10.1152/jappl.1988.64.1.50; MILLER AEJ, 1993, EUR J APPL PHYSIOL O, V66, P254, DOI 10.1007/BF00235103; NINDL BC, 1995, MED SCI SPORT EXER, V27, P235; Pellegrini B, 2013, HUM MOVEMENT SCI, V32, P1415, DOI 10.1016/j.humov.2013.07.010; Sandbakk O, 2014, SCAND J MED SCI SPOR, V24, P28, DOI 10.1111/j.1600-0838.2012.01482.x; Sandbakk O, 2012, EUR J APPL PHYSIOL, V112, P1087, DOI 10.1007/s00421-011-2063-4; Sandbakk O, 2010, EUR J APPL PHYSIOL, V109, P473, DOI 10.1007/s00421-010-1372-3; Schumacher YO, 2001, J SPORT MED PHYS FIT, V41, P139; Seiler KS, 2006, SCAND J MED SCI SPOR, V16, P49, DOI 10.1111/j.1600-0838.2004.00418.x; Seiler S, 2007, MED SCI SPORT EXER, V39, P534, DOI 10.1249/01.mss.0000247005.17342.2b; SPARLING PB, 1980, RES Q EXERCISE SPORT, V51, P542, DOI 10.1080/02701367.1980.10608077; Stefani RT, 2006, J SPORT SCI, V24, P1329, DOI 10.1080/02640410500520559; Sylta O, 2014, INT J SPORT PHYSIOL, V9, P100, DOI 10.1123/IJSPP.2013-0298; Sylta O, 2014, INT J SPORT PHYSIOL, V9, P85, DOI [10.1123/ijspp.2013-0203, 10.1123/IJSPP.2013-0203]; TANAKA H, 1993, INT J SPORTS MED, V14, P334, DOI 10.1055/s-2007-1021188; Tonnessen E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101796; van den Tillaar R, 2004, EUR J APPL PHYSIOL, V91, P413, DOI 10.1007/s00421-003-1019-8; Weber CL, 2006, MED SCI SPORT EXER, V38, P129, DOI 10.1249/01.mss.0000179902.31527.2c	34	34	35	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127509	10.1371/journal.pone.0127509	http://dx.doi.org/10.1371/journal.pone.0127509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7GR	26000713	Green Published, gold			2022-12-26	WOS:000354931700064
J	Stein, AB; Goonewardena, SN; Jones, TA; Prusick, PJ; Bazzi, AA; Belyavskaya, JM; McCoskey, MM; Dandar, RA				Stein, Adam B.; Goonewardena, Sascha N.; Jones, Thomas A.; Prusick, Parker J.; Bazzi, Ahmad A.; Belyavskaya, Jane M.; McCoskey, Makayla M.; Dandar, Rachel A.			The PTIP-Associated Histone Methyltransferase Complex Prevents Stress-Induced Maladaptive Cardiac Remodeling	PLOS ONE			English	Article							GENE-EXPRESSION; CELL-DEATH; HEART; METHYLATION; MECHANISMS; LYSINE-4; H3; PATHWAYS; ADULT	Pressure overload induces stress-induced signaling pathways and a coordinated transcriptional response that begets concentric cardiac hypertrophy. Although concentric hypertrophy initially attenuates wall stress and maintains cardiac function, continued stress can result in maladaptive cardiac remodeling. Cardiac remodeling is orchestrated by transcription factors that act within the context of an epigenetic landscape. Since the epigenetic landscape serves as a molecular link between environmental factors (stress) and cellular phenotype (disease), defining the role of the epigenome in the development and progression of cardiac remodeling could lead to new therapeutic approaches. In this study, we hypothesized that the epigenetic landscape is important in the development of cardiac hypertrophy and the progression to maladaptive remodeling. To demonstrate the importance of the epigenome in HF, we targeted the PTIP-associated histone methyltransferase complex in adult cardiac myocytes. This complex imparts histone H3 lysine 4 (H3K4) methylation marks at actively expressed genes. We subjected PTIP null (PTIP-) mice to 2 weeks of transverse aortic constriction, a stress that induces concentric hypertrophy in control mice (PTIP+). PTIP-mice have a maladaptive response to 2wk of transverse aortic constriction (TAC)-induced pressure overload characterized by cardiac dilatation, decreased LV function, cardiac fibrosis, and increased cell death. PTIP deletion resulted in altered stress-induced gene expression profiles including blunted expression of ADRA1A, ADRA1B, JUN, ATP2A2, ATP1A2, SCN4B, and CACNA1G. These results suggest that H3K4 methylation patterns and the complexes that regulate them, specifically the PTIP-associated HMT, are necessary for the adaptive response to TAC.	[Stein, Adam B.; Goonewardena, Sascha N.; Jones, Thomas A.; Bazzi, Ahmad A.; Belyavskaya, Jane M.; McCoskey, Makayla M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Prusick, Parker J.] Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA; [Dandar, Rachel A.] Kalamazoo Coll, Dept Biol, Kalamazoo, MI 49006 USA	University of Michigan System; University of Michigan; Central Michigan University; Kalamazoo College	Stein, AB (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	adamstei@med.umich.edu			University of Michigan Frankel Cardiovascular Center; University of Michigan McKay Grant; Frankel Cardiovascular Center Summer Undergraduate Fellowship Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL123621, T35HL007690] Funding Source: NIH RePORTER	University of Michigan Frankel Cardiovascular Center; University of Michigan McKay Grant(University of Michigan System); Frankel Cardiovascular Center Summer Undergraduate Fellowship Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the University of Michigan Frankel Cardiovascular Center, the University of Michigan McKay Grant, and the Frankel Cardiovascular Center Summer Undergraduate Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI M, 1993, CIRC RES, V72, P463, DOI 10.1161/01.RES.72.2.463; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Daniel JA, 2010, SCIENCE, V329, P917, DOI 10.1126/science.1187942; David Allis C., 2007, EPIGENETICS-US; Feinberg Andrew P, 2013, Trans Am Clin Climatol Assoc, V124, P84; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gong ZH, 2009, J BIOL CHEM, V284, P7284, DOI 10.1074/jbc.M809158200; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jowsey PA, 2004, J BIOL CHEM, V279, P55562, DOI 10.1074/jbc.M411021200; Kaneda R, 2009, GENES CELLS, V14, P69, DOI 10.1111/j.1365-2443.2008.01252.x; Kang PM, 2003, TRENDS MOL MED, V9, P177, DOI 10.1016/S1471-4914(03)00025-X; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Konstantinidis K, 2012, ARTERIOSCL THROM VAS, V32, P1552, DOI 10.1161/ATVBAHA.111.224915; Liu Y, 2014, BIOCHEM BIOPH RES CO, V444, P634, DOI 10.1016/j.bbrc.2014.01.143; Medeiros-Domingo A, 2007, CIRCULATION, V116, P134, DOI 10.1161/CIRCULATIONAHA.106.659086; Munoz IM, 2007, NUCLEIC ACIDS RES, V35, P5312, DOI 10.1093/nar/gkm493; Nakayama H, 2009, J CLIN INVEST, V119, P3787, DOI 10.1172/JCI39724; Nguyen AT, 2011, GENE DEV, V25, P263, DOI 10.1101/gad.2018511; O'Connell TD, 2006, J CLIN INVEST, V116, P1005, DOI 10.1172/JCI22811; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Papait R, 2013, P NATL ACAD SCI USA, V110, P20164, DOI 10.1073/pnas.1315155110; Papolos A, 2013, CARDIOL REV, V21, P151, DOI 10.1097/CRD.0b013e3182749cdb; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Ritchie ME, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-261; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Siebel AL, 2010, BIOCHEM PHARMACOL, V80, P1853, DOI 10.1016/j.bcp.2010.06.005; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Stein AB, 2011, J CLIN INVEST, V121, P2641, DOI 10.1172/JCI44641; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Windak R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073294; Wu JX, 2009, J BIOL CHEM, V284, P18078, DOI 10.1074/jbc.M109.002527; Zhang QJ, 2011, J CLIN INVEST, V121, P2447, DOI 10.1172/JCI46277	43	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127839	10.1371/journal.pone.0127839	http://dx.doi.org/10.1371/journal.pone.0127839			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001054	Green Submitted, Green Published, gold			2022-12-26	WOS:000354931700089
J	Deng, LL; Que, F; Wei, HW; Xu, GW; Dong, XW; Zhang, H				Deng, Lingli; Que, Fei; Wei, Hewen; Xu, Guangwei; Dong, Xiaowei; Zhang, Hui			Solubilization of Tea Seed Oil in a Food-Grade Water-Dilutable Microemulsion	PLOS ONE			English	Article							SUBZERO TEMPERATURE BEHAVIOR; CAMELLIA-OLEIFERA ABEL.; NONIONIC MICROEMULSIONS; VEGETABLE-OIL; STRUCTURAL TRANSITIONS; ORAL BIOAVAILABILITY; PHASE-BEHAVIOR; MICROSTRUCTURE; SURFACTANTS; FORMULATION	Food-grade microemulsions containing oleic acid, ethanol, Tween 20, and water were formulated as a carrier system for tea seed oil (Camellia oleifera Abel.). The effect of ethanol on the phase behavior of the microemulsion system was clearly reflected in pseudo-ternary diagrams. The solubilization capacity and solubilization efficiency of tea seed oil dispersions were measured along the dilution line at a 70/30 surfactant/oil mass ratio with Tween 20 as the surfactant and oleic acid and ethanol (1: 3, w/w) as the oil phase. The dispersed phase of the microemulsion (1.5% weight ratio of tea seed oil to the total amount of oil, surfactant, and tea seed oil) could be fully diluted with water without phase separation. Differential scanning calorimetry and viscosity measurements indicated that both the carrier and solubilized systems underwent a similar microstructure transition upon dilution. The dispersion phases gradually inverted from the water-in-oil phase (< 35% water) to the bicontinuous phase (40-45% water) and finally to the oil-in-water phase (> 45% water) along the dilution line.	[Deng, Lingli; Zhang, Hui] Zhejiang Univ, Zhejiang R&D Ctr Food Technol & Equipment, Coll Biosyst Engn & Food Sci, Fuli Inst Food Sci,Zhejiang Key Lab Agro Food Pro, Hangzhou 310058, Zhejiang, Peoples R China; [Que, Fei] Zhejiang Econ & Trade Polytech, Dept Appl Engn, Hangzhou 310018, Zhejiang, Peoples R China; [Wei, Hewen; Xu, Guangwei; Dong, Xiaowei] Jinhua Supervising & Testing Inst Qual & Technol, Jinhua 321000, Peoples R China	Zhejiang University	Zhang, H (corresponding author), Zhejiang Univ, Zhejiang R&D Ctr Food Technol & Equipment, Coll Biosyst Engn & Food Sci, Fuli Inst Food Sci,Zhejiang Key Lab Agro Food Pro, Hangzhou 310058, Zhejiang, Peoples R China.	hubert0513@zju.edu.cn	张, 辉/ABF-4186-2020; , 张辉/ABE-8532-2020; lingli, deng/M-4549-2019	lingli, deng/0000-0003-3105-9104	National Natural Science Foundation of China [31471622]; Zhejiang Province Natural Science Foundation of China [LY14C200010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China (Grant No. 31471622) and Zhejiang Province Natural Science Foundation of China (Grant No. LY14C200010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar I, 2003, J AGR FOOD CHEM, V51, P4775, DOI 10.1021/jf026222t; Djekic L, 2013, TENSIDE SURFACT DET, V50, P409, DOI 10.3139/113.110272; Djekic L, 2011, J MOL LIQ, V160, P81, DOI 10.1016/j.molliq.2011.02.010; Do LD, 2009, J SURFACTANTS DETERG, V12, P91, DOI 10.1007/s11743-008-1096-0; Fanun M, 2001, COLLOID SURFACE A, V180, P173, DOI 10.1016/S0927-7757(00)00744-5; Flanagan J, 2006, CRIT REV FOOD SCI, V46, P221, DOI 10.1080/10408690590956710; Garti N, 2003, J DISPER SCI TECHNOL, V24, P397, DOI 10.1081/DIS-120021797; Garti N, 2005, SOFT MATTER, V1, P206, DOI 10.1039/b506233k; Garti N, 2001, J AGR FOOD CHEM, V49, P2552, DOI 10.1021/jf001390b; Garti N, 1996, J COLLOID INTERF SCI, V178, P60, DOI 10.1006/jcis.1996.0093; Gradzielski M, 1998, LANGMUIR, V14, P6037, DOI 10.1021/la980074c; Jeirani Z, 2013, IND CROP PROD, V43, P6, DOI 10.1016/j.indcrop.2012.07.002; Kogan A, 2007, J COLLOID INTERF SCI, V315, P637, DOI 10.1016/j.jcis.2007.06.087; Lee CP, 2007, FOOD CHEM TOXICOL, V45, P888, DOI 10.1016/j.fct.2006.11.007; Lee CP, 2006, J AGR FOOD CHEM, V54, P779, DOI 10.1021/jf052325a; Maswal M, 2014, FOOD HYDROCOLLOID, V37, P182, DOI 10.1016/j.foodhyd.2013.10.035; McClements DJ, 2012, SOFT MATTER, V8, P1719, DOI 10.1039/c2sm06903b; PARRIS N, 1994, J AGR FOOD CHEM, V42, P1295, DOI 10.1021/jf00042a008; Podlogar F, 2004, INT J PHARMACEUT, V276, P115, DOI 10.1016/j.ijpharm.2004.02.018; Sahari MA, 2004, J AM OIL CHEM SOC, V81, P585, DOI 10.1007/s11746-006-0945-0; SAIDI Z, 1990, PHYS REV A, V42, P872, DOI 10.1103/PhysRevA.42.872; SENATRA D, 1991, PROG COLL POL SCI S, V84, P122; Spernath A, 2002, J AGR FOOD CHEM, V50, P6917, DOI 10.1021/jf025762n; Spernath A, 2006, ADV COLLOID INTERFAC, V128, P47, DOI 10.1016/j.cis.2006.11.016; Spernath A, 2006, J COLLOID INTERF SCI, V299, P900, DOI 10.1016/j.jcis.2006.02.024; Stavarache C, 2005, ULTRASON SONOCHEM, V12, P367, DOI 10.1016/j.ultsonch.2004.04.001; Stehle R, 2014, J COLLOID INTERF SCI, V413, P127, DOI 10.1016/j.jcis.2013.09.027; Wang AL, 2014, J CHEM ENG DATA, V59, P666, DOI 10.1021/je400595k; Yaghmur A, 2003, LANGMUIR, V19, P1063, DOI 10.1021/la026404h; Yaghmur A, 2002, J THERM ANAL CALORIM, V69, P163, DOI 10.1023/A:1019997909346; Yi CX, 2012, INT J NANOMED, V7, P5067, DOI 10.2147/IJN.S34612; You XH, 2014, INT J PHARMACEUT, V471, P276, DOI 10.1016/j.ijpharm.2014.05.031; Zhang Bing, 1995, Acta Nutrimenta Sinica, V17, P199; Zhang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076245; Zhang H, 2013, FOOD CHEM, V141, P3050, DOI 10.1016/j.foodchem.2013.05.141; Zhang H, 2009, INT J FOOD MICROBIOL, V135, P211, DOI 10.1016/j.ijfoodmicro.2009.08.015	36	16	16	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127291	10.1371/journal.pone.0127291	http://dx.doi.org/10.1371/journal.pone.0127291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996147	Green Published, Green Submitted, gold			2022-12-26	WOS:000356444000055
J	Liu, JJ; Hao, HJ; Xia, L; Ti, DD; Huang, H; Dong, L; Tong, C; Hou, Q; Zhao, YL; Liu, HL; Fu, XB; Han, WD				Liu, Jiejie; Hao, Haojie; Xia, Lei; Ti, Dongdong; Huang, Hong; Dong, Liang; Tong, Chuan; Hou, Qian; Zhao, Yali; Liu, Huiling; Fu, Xiaobing; Han, Weidong			Hypoxia Pretreatment of Bone Marrow Mesenchymal Stem Cells Facilitates Angiogenesis by Improving the Function of Endothelial Cells in Diabetic Rats with Lower Ischemia	PLOS ONE			English	Article							STROMAL CELLS; IN-VIVO; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; OXIDATIVE STRESS; OXYGEN; TRANSPLANTATION; ARTERIOGENESIS; PROLIFERATION; MECHANISMS	Endothelial dysfunction induced by unordered metabolism results in vascular reconstruction challenges in diabetic lower limb ischemia (DLLI). Mesenchymal stem cells (MSCs) are multipotent secretory cells that are suitable for clinical DLLI treatment, but their use has been hampered by poor survival after injection. Hypoxia can significantly enhance the capacity of MSCs to secrete angiogenic factors. We investigated transient hypoxia pretreatment of MSCs to facilitate revascularization in DLLI. Rat bone marrow MSCs (BM-MSCs) were cultured at different oxygen concentrations for varying time periods. The results indicated that transient pretreatment (5% O-2, 48 h) not only increased the expression of VEGF-1 alpha, ANG, HIF-1 alpha and MMP-9 in BM-MSCs as assessed by real-time RT-PCR, but also increased the expression of Bcl-2 as determined by western blotting. The transplantation of pretreated BM-MSCs into rats with DLLI demonstrated accelerated vascular reconstruction when assayed by angiography and immunohistochemistry. CM-Dil-labeled tracer experiments indicated that the survival of BM-MSCs was significantly improved, with approximately 5% of the injected cells remaining alive at 14 days. The expression levels of VEGF-1 alpha, MMP-9 and VEGF-R were significantly increased, and the expression of pAKT was up-regulated in ischemic muscle. Double immunofluorescence studies confirmed that the pretreated BM-MSCs promoted the proliferation and inhibited the apoptosis of endothelial cells. In vitro, pretreated BM-MSCs increased the migratory and tube forming capacity of endothelial cells (ECs). Hypoxia pretreatment of BM-MSCs significantly improved angiogenesis in response to tissue ischemia by ameliorating endothelial cell dysfunction and is a promising therapeutic treatment for DLLI.	[Liu, Jiejie; Hao, Haojie; Ti, Dongdong; Huang, Hong; Dong, Liang; Tong, Chuan; Hou, Qian; Liu, Huiling; Fu, Xiaobing; Han, Weidong] Chinese Peoples Liberat Army Gen Hosp, Coll Life Sci, Inst Basic Med Sci, Beijing 100853, Peoples R China; [Zhao, Yali] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Cent Lab, Sanya, Peoples R China; [Xia, Lei] Chinese Peoples Liberat Army Gen Hosp, Dept Med Adm, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Fu, XB (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Coll Life Sci, Inst Basic Med Sci, Beijing 100853, Peoples R China.	fuxiaobing@vip.sina.com; hanwdrsw@sina.com	Hao, Haojie/D-6982-2013	Huang, Hong/0000-0003-3883-2833	National Basic Science and Development Program [2012CB518103, 2012CB518105]; 863 Projects of Ministry of Science and Technology of China [2013AA020105, 2012AA020502]; National Natural Science Foundation of China [81121004, 81230041]; key sciences and technology project in hainan province [ZDZX2013003]	National Basic Science and Development Program; 863 Projects of Ministry of Science and Technology of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key sciences and technology project in hainan province	This research was supported in part by the National Basic Science and Development Program (2012CB518103, 2012CB518105), the 863 Projects of Ministry of Science and Technology of China (2013AA020105 and 2012AA020502), National Natural Science Foundation of China (81121004, and 81230041), key sciences and technology project in hainan province (ZDZX2013003).	Annabi B, 2003, STEM CELLS, V21, P337, DOI 10.1634/stemcells.21-3-337; Bucci E, 2009, BIOPHYS CHEM, V142, P1, DOI 10.1016/j.bpc.2008.12.009; Burt RK, 2008, JAMA-J AM MED ASSOC, V299, P925, DOI 10.1001/jama.299.8.925; Cao YW, 2006, UROL RES, V34, P271, DOI 10.1007/s00240-006-0055-3; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chacko SM, 2010, AM J PHYSIOL-CELL PH, V299, pC1562, DOI 10.1152/ajpcell.00221.2010; Chang EI, 2007, CIRCULATION, V116, P2818, DOI 10.1161/CIRCULATIONAHA.107.715847; Cousin Beatrice, 2006, Journal de la Societe de Biologie, V200, P51, DOI 10.1051/jbio:2006007; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571; Hung SC, 2007, STEM CELLS, V25, P2363, DOI 10.1634/stemcells.2006-0686; Kajiya M, 2007, AM J PHYSIOL-HEART C, V292, pH2737, DOI 10.1152/ajpheart.00548.2006; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; KOHNER EM, 1995, DIABETES, V44, P603, DOI 10.2337/diabetes.44.6.603; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Leroux L, 2010, MOL THER, V18, P1545, DOI 10.1038/mt.2010.108; Li HY, 2000, DIABETES CARE, V23, P589, DOI 10.2337/diacare.23.5.589; Lozito TP, 2011, J CELL PHYSIOL, V226, P385, DOI 10.1002/jcp.22344; Mathew SA, 2013, CELL BIOL INT, V37, P1197, DOI 10.1002/cbin.10154; Meshkani R, 2009, CLIN BIOCHEM, V42, P1331, DOI 10.1016/j.clinbiochem.2009.05.018; Nekanti U, 2010, INT J BIOL SCI, V6, P499; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Panchision DM, 2009, J CELL PHYSIOL, V220, P562, DOI 10.1002/jcp.21812; PECORARO RE, 1990, DIABETES CARE, V13, P513, DOI 10.2337/diacare.13.5.513; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reiser J, 2005, EXPERT OPIN BIOL TH, V5, P1571, DOI 10.1517/14712598.5.12.1571; Ren HY, 2006, BIOCHEM BIOPH RES CO, V347, P12, DOI 10.1016/j.bbrc.2006.05.169; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Shen GX, 2010, CAN J PHYSIOL PHARM, V88, P241, DOI 10.1139/Y10-018; Steinberger J, 2003, CIRCULATION, V107, P1448, DOI 10.1161/01.CIR.0000060923.07573.F2; Tang YL, 2004, REGUL PEPTIDES, V117, P3, DOI 10.1016/j.regpep.2003.09.005; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Zhang HK, 2008, ANN VASC SURG, V22, P238, DOI 10.1016/j.avsg.2007.07.037	35	61	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0126715	10.1371/journal.pone.0126715	http://dx.doi.org/10.1371/journal.pone.0126715			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996677	Green Published, Green Submitted, gold			2022-12-26	WOS:000356444000029
J	Bhatt, DP; Puig, KL; Gorr, MW; Wold, LE; Combs, CK				Bhatt, Dhaval P.; Puig, Kendra L.; Gorr, Matthew W.; Wold, Loren E.; Combs, Colin K.			A Pilot Study to Assess Effects of Long-Term Inhalation of Airborne Particulate Matter on Early Alzheimer-Like Changes in the Mouse Brain	PLOS ONE			English	Article							AIR-POLLUTION EXPOSURE; INFLAMMATION; DISEASE; CHILDREN; EPIGENETICS; ACTIVATION; EXPRESSION; HEALTH; ALTERS	Exposure to air pollutants, including particulate matter, results in activation of the brain inflammatory response and Alzheimer disease (AD)-like pathology in dogs and humans. However, the length of time required for inhalation of ambient particulate matter to influence brain inflammation and AD pathology is less clear. Here, we studied the effect of 3 and 9 months of air particulate matter (<2.5 mu m diameter, PM2.5) exposure on brain inflammatory phenotype and pathological hallmarks of AD in C57BL/6 mice. Using western blot, ELISA, and cytokine array analysis we quantified brain APP, beta-site APP cleaving enzyme (BACE), oligomeric protein, total A beta 1-40 and A beta 1-42 levels, inducible nitric oxide synthase (iNOS), nitrotyrosine-modified proteins, HNE-Michael adducts, vascular cell adhesion molecule 1 (VCAM-1), glial markers (GFAP, Iba-1), pre- and post-synaptic markers (synaptophysin and PSD-95), cyclooxygenase (COX-1, COX-2) levels, and the cytokine profile in PM2.5 exposed and filtered air control mice. Only 9 month PM2.5 exposure increased BACE protein levels, APP processing, and A beta 1-40 levels. This correlated with a concomitant increase in COX-1 and COX-2 protein levels and a modest alteration in the cytokine profile. These data support the hypothesis that prolonged exposure to airborne particulate matter has the potential to alter brain inflammatory phenotype and promote development of early AD-like pathology.	[Bhatt, Dhaval P.; Puig, Kendra L.; Combs, Colin K.] UND Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58202 USA; [Bhatt, Dhaval P.] Duke Univ, Duke Mol Physiol Inst, Durham, NC USA; [Gorr, Matthew W.; Wold, Loren E.] Ohio State Univ, Coll Med, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Gorr, Matthew W.; Wold, Loren E.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Gorr, Matthew W.; Wold, Loren E.] Ohio State Univ, Coll Nursing, Columbus, OH 43210 USA	Duke University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Combs, CK (corresponding author), UND Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58202 USA.	colin.combs@med.und.edu	Wold, Loren E/E-4320-2011; Bhatt, Dhaval Paresh/AAZ-9303-2020	Bhatt, Dhaval Paresh/0000-0002-2037-9332; Gorr, Matthew/0000-0001-7561-6481	NIH [5R01AG042819, R21AG042727, 5R01ES019923]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG042819, R21AG042727] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This publication was supported by NIH 5R01AG042819 and NIH R21AG042727 to CKC and 5R01ES019923 to LEW. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2010, J APPL PHYSIOL, V109, P243, DOI 10.1152/japplphysiol.00068.2010; Association A.s., 2010, ALZHEIMERS DEMENT, P158, DOI [10.1016/j.jalz.2010.01.009, DOI 10.1016/J.JALZ.2010.01.009]; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Block ML, 2012, NEUROTOXICOLOGY, V33, P972, DOI 10.1016/j.neuro.2012.08.014; Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calderon-Garciduenas L, 2008, INHAL TOXICOL, V20, P499, DOI 10.1080/08958370701864797 ; Calderon-Garciduenas L, 2004, TOXICOL PATHOL, V32, P650, DOI 10.1080/01926230490520232; Calderon-Garciduenas L, 2003, TOXICOL PATHOL, V31, P524, DOI 10.1080/01926230390226645; Calderon-Garciduenas L, 2002, TOXICOL PATHOL, V30, P373, DOI 10.1080/01926230252929954; Calderon-Garciduenas L, 2008, BRAIN COGNITION, V68, P117, DOI 10.1016/j.bandc.2008.04.008; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Calderon-Garciduenas L, 2009, TOXICOL PATHOL, V37, P644, DOI 10.1177/0192623309340277; Campbell A, 2005, NEUROTOXICOLOGY, V26, P133, DOI 10.1016/j.neuro.2004.08.003; Carmona JJ, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-94; Chen Bingheng, 2008, Environmental Health and Preventive Medicine, V13, P94, DOI 10.1007/s12199-007-0018-5; Chen L, 2008, J NEUROIMMUNE PHARM, V3, P286, DOI 10.1007/s11481-008-9131-5; Coppieters N, 2011, CURR PHARM DESIGN, V17, P3398, DOI 10.2174/138161211798072544; Cruchaga C, 2013, NEURON, V78, P256, DOI 10.1016/j.neuron.2013.02.026; Fuso A, 2005, MOL CELL NEUROSCI, V28, P195, DOI 10.1016/j.mcn.2004.09.007; Ho L, 2001, ARCH NEUROL-CHICAGO, V58, P487, DOI 10.1001/archneur.58.3.487; McGeer PL, 2007, NEUROBIOL AGING, V28, P639, DOI 10.1016/j.neurobiolaging.2006.03.013; McGeer PL, 2013, ACTA NEUROPATHOL, V126, P479, DOI 10.1007/s00401-013-1177-7; Pritchard C, 2013, PUBLIC HEALTH, V127, P357, DOI 10.1016/j.puhe.2012.12.018; Rao JS, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.55; Sun QH, 2008, ARTERIOSCL THROM VAS, V28, P1760, DOI 10.1161/ATVBAHA.108.166967; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Thomson EM, 2007, ENVIRON RES, V105, P224, DOI 10.1016/j.envres.2007.06.005; Wold LE, 2012, CIRC-HEART FAIL, V5, P452, DOI 10.1161/CIRCHEARTFAILURE.112.966580; Ying ZK, 2009, AM J PHYSIOL-HEART C, V296, pH1540, DOI 10.1152/ajpheart.01270.2008	30	88	93	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127102	10.1371/journal.pone.0127102	http://dx.doi.org/10.1371/journal.pone.0127102			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992783	gold, Green Submitted, Green Published			2022-12-26	WOS:000354921400097
J	Spilling, K; Ylostalo, P; Simis, S; Seppala, J				Spilling, Kristian; Ylostalo, Pasi; Simis, Stefan; Seppala, Jukka			Interaction Effects of Light, Temperature and Nutrient Limitations (N, P and Si) on Growth, Stoichiometry and Photosynthetic Parameters of the Cold-Water Diatom Chaetoceros wighamii	PLOS ONE			English	Article							CARBON-TO-CHLOROPHYLL; SPRING BLOOM; PHYTOPLANKTON STOICHIOMETRY; MARINE-PHYTOPLANKTON; CHEMICAL-COMPOSITION; A-RATIO; MODEL; PHOTORESPIRATION; PHOSPHORUS; METABOLISM	Light (20-450 mu mol photons m(-2) s(-1)), temperature (3-11 degrees C) and inorganic nutrient composition (nutrient replete and N, P and Si limitation) were manipulated to study their combined influence on growth, stoichiometry (C:N:P:Chl a) and primary production of the cold water diatom Chaetoceros wighamii. During exponential growth, the maximum growth rate (similar to 0.8 d(-1)) was observed at high temperture and light; at 3 degrees C the growth rate was similar to 30% lower under similar light conditions. The interaction effect of light and temperature were clearly visible from growth and cellular stoichiometry. The average C:N:P molar ratio was 80:13:1 during exponential growth, but the range, due to different light acclimation, was widest at the lowest temperature, reaching very low C:P (similar to 50) and N:P ratios (similar to 8) at low light and temperature. The C:Chl a ratio had also a wider range at the lowest temperature during exponential growth, ranging 16-48 (weight ratio) at 3 degrees C compared with 17-33 at 11 degrees C. During exponential growth, there was no clear trend in the Chl a normalized, initial slope (alpha*) of the photosynthesis-irradiance (PE) curve, but the maximum photosynthetic production (P-m) was highest for cultures acclimated to the highest light and temperature. During the stationary growth phase, the stoichiometric relationship depended on the limiting nutrient, but with generally increasing C:N:P ratio. The average photosynthetic quotient (PQ) during exponential growth was 1.26 but decreased to <1 under nutrient and light limitation, probably due to photorespiration. The results clearly demonstrate that there are interaction effects between light, temperature and nutrient limitation, and the data suggests greater variability of key parameters at low temperature. Understanding these dynamics will be important for improving models of aquatic primary production and biogeochemical cycles in a warming climate.	[Spilling, Kristian; Ylostalo, Pasi; Simis, Stefan; Seppala, Jukka] Finnish Environm Inst, Ctr Marine Res, Helsinki, Finland; [Spilling, Kristian] Univ Helsinki, Tvarminne Zool Stn, Hango, Finland; [Simis, Stefan] Plymouth Marine Lab, Plymouth, Devon, England	Finnish Environment Institute; University of Helsinki; Plymouth Marine Laboratory	Spilling, K (corresponding author), Finnish Environm Inst, Ctr Marine Res, POB 140, Helsinki, Finland.	kristian.spilling@environment.fi	Seppälä, Jukka/L-5035-2014; Spilling, Kristian/L-7932-2014	Seppälä, Jukka/0000-0002-1210-9893; Spilling, Kristian/0000-0002-8390-8270; Simis, Stefan/0000-0002-6296-9146; Ylostalo, Pasi/0000-0003-4702-2840	Academy of Finland [124320, 259164]; Walter and Andree de Nottbeck Foundation	Academy of Finland(Academy of Finland); Walter and Andree de Nottbeck Foundation	Funding was provided by Academy of Finland (decision no 124320 and 259164); http://www.aka.fi/en-GB/A/; KS, JS, Walter and Andree de Nottbeck Foundation; http://www.nottbeck.org/en/index.htm; KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird ME, 2013, LIMNOL OCEANOGR, V58, P1215, DOI 10.4319/lo.2013.58.4.1215; Bonachela JA, 2013, BIOGEOSCIENCES, V10, P4341, DOI 10.5194/bg-10-4341-2013; Buchanan C, 2005, ESTUARIES, V28, P138, DOI 10.1007/BF02732760; CHAN AT, 1980, J PHYCOL, V16, P428, DOI 10.1111/j.1529-8817.1980.tb03056.x; Dickman EM, 2006, OECOLOGIA, V149, P676, DOI 10.1007/s00442-006-0473-5; DROOP MR, 1968, J MAR BIOL ASSOC UK, V48, P689, DOI 10.1017/S0025315400019238; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; Faure V, 2006, CR BIOL, V329, P813, DOI 10.1016/j.crvi.2006.07.006; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Geider RJ, 1998, LIMNOL OCEANOGR, V43, P679, DOI 10.4319/lo.1998.43.4.0679; GEIDER RJ, 1987, NEW PHYTOL, V106, P1, DOI 10.1111/j.1469-8137.1987.tb04788.x; Geider RJ, 2002, PHYTOPLANKTON PRODUC, P44, DOI [10.1063/1.39754, DOI 10.1002/9780470995204.CH3]; GOLDMAN JC, 1979, NATURE, V279, P210, DOI 10.1038/279210a0; Grasshoff K., 1999, METHODS SEAWATER ANA, V3rd; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; Hillebrand H, 2013, LIMNOL OCEANOGR, V58, P2076, DOI 10.4319/lo.2013.58.6.2076; Iriarte A, 1999, CAH BIOL MAR, V40, P29; JESPERSEN AM, 1987, ARCH HYDROBIOL, V109, P445; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Klausmeier CA, 2004, NATURE, V429, P171, DOI 10.1038/nature02454; Kozaki A, 1996, NATURE, V384, P557, DOI 10.1038/384557a0; KRAUSSE GL, 1983, FRESHWATER BIOL, V13, P73, DOI 10.1111/j.1365-2427.1983.tb00658.x; LAWS EA, 1991, DEEP-SEA RES, V38, P143, DOI 10.1016/0198-0149(91)90059-O; Martiny AC, 2013, NAT GEOSCI, V6, P279, DOI [10.1038/NGEO1757, 10.1038/ngeo1757]; Nicklisch A, 2008, J PLANKTON RES, V30, P75, DOI 10.1093/plankt/fbm099; Pahlow M, 2013, MAR ECOL PROG SER, V473, P1, DOI 10.3354/meps10181; PLATT T, 1980, J MAR RES, V38, P687; Rachmilevitch S, 2004, P NATL ACAD SCI USA, V101, P11506, DOI 10.1073/pnas.0404388101; Raven J.A, 2013, AQUATIC PHOTOSYNTHES; RHEE GY, 1978, LIMNOL OCEANOGR, V23, P10, DOI 10.4319/lo.1978.23.1.0010; RHEE GY, 1973, J PHYCOL, V9, P495, DOI 10.1111/j.1529-8817.1973.tb04126.x; Sakshaug E, 1997, J PLANKTON RES, V19, P1637, DOI 10.1093/plankt/19.11.1637; Sathyendranath S, 2009, MAR ECOL PROG SER, V383, P73, DOI 10.3354/meps07998; SCHINDLER DW, 1972, J FISH RES BOARD CAN, V29, P1627, DOI 10.1139/f72-250; SOLORZANO L, 1980, LIMNOL OCEANOGR, V25, P754, DOI 10.4319/lo.1980.25.4.0754; Spilling K, 2014, BIOGEOSCIENCES, V11, P7275, DOI 10.5194/bg-11-7275-2014; Spilling K, 2007, THESIS U HELSINKI; Spilling K, 2008, J MARINE SYST, V73, P323, DOI 10.1016/j.jmarsys.2006.10.012; Steemann-Nielsen E, 1952, J CONS CONS PERM INT, V18, P117, DOI DOI 10.1093/ICESJMS/18.2.117; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Taylor AH, 1997, MAR ECOL PROG SER, V152, P51, DOI 10.3354/meps152051; TILZER MM, 1986, POLAR BIOL, V5, P105, DOI 10.1007/BF00443382; Toseland A, 2013, NAT CLIM CHANGE, V3, P979, DOI 10.1038/NCLIMATE1989; Wang XJ, 2009, BIOGEOSCIENCES, V6, P391, DOI 10.5194/bg-6-391-2009; WILLIAMS PJB, 1979, OCEANOL ACTA, V2, P411; YODER JA, 1979, J PHYCOL, V15, P362	47	47	49	3	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126308	10.1371/journal.pone.0126308	http://dx.doi.org/10.1371/journal.pone.0126308			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993327	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000354921400061
J	Jacobson, KB; Moll, AP; Friedland, GH; Shenoi, SV				Jacobson, Karen B.; Moll, Anthony P.; Friedland, Gerald H.; Shenoi, Sheela V.			Successful Tuberculosis Treatment Outcomes among HIV/TB Coinfected Patients Down-Referred from a District Hospital to Primary Health Clinics in Rural South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; TREATMENT PROGRAM; CAPE-TOWN; CARE; THERAPY; INTEGRATION; DECENTRALIZATION; SERVICES; DELIVERY; LESSONS	Background HIV and tuberculosis (TB) coinfection remains a major public health threat in sub-Saharan Africa. Integration and decentralization of HIV and TB treatment services are being implemented, but data on outcomes of this strategy are lacking in rural, resource-limited settings. We evaluated TB treatment outcomes in TB/HIV coinfected patients in an integrated and decentralized system in rural KwaZulu-Natal, South Africa. Methods We retrospectively studied a cohort of HIV/TB coinfected patients initiating treatment for drug-susceptible TB at a district hospital HIV clinic from January 2012-June 2013. Patients were eligible for down-referral to primary health clinics(PHCs) for TB treatment completion if they met specific clinical criteria. Records were reviewed for patients' demographic, baseline clinical and laboratory information, past HIV and TB history, and TB treatment outcomes. Results Of 657(88.7%) patients, 322(49.0%) were female, 558(84.9%) were new TB cases, and 572(87.1%) had pulmonary TB. After TB treatment initiation, 280(42.6%) were down-referred from the district level HIV clinic to PHCs for treatment completion; 377(57.4%) remained at the district hospital. Retained patients possessed characteristics indicative of more severe disease. In total, 540(82.2%) patients experienced treatment success, 69 (10.5%) died, and 46(7.0%) defaulted. Down-referred patients experienced higher treatment success, and lower mortality, but were more likely to default, primarily at the time of transfer to PHC. Conclusion Decentralization of TB treatment to the primary care level is feasible in rural South Africa. Treatment outcomes are favorable when patients are carefully chosen for down-referral. Higher mortality in retained patients reflects increased baseline disease severity while higher default among down-referred patients reflects failed linkage of care. Better linkage mechanisms are needed including improved identification of potential defaulters, increased patient education, active communication between hospitals and PHCs, and tracing of patients lost to follow up. Decentralized and integrated care is successful for carefully selected TB/HIV coinfected patients and should be expanded.	[Jacobson, Karen B.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Moll, Anthony P.] Church Scotland Hosp, Tugela Ferry, Kwazulu Natal, South Africa; [Friedland, Gerald H.; Shenoi, Sheela V.] Yale Univ, Sch Med, Dept Med, Sect Infect Dis,AIDS Program, New Haven, CT 06510 USA	Icahn School of Medicine at Mount Sinai; Yale University	Shenoi, SV (corresponding author), Yale Univ, Sch Med, Dept Med, Sect Infect Dis,AIDS Program, New Haven, CT 06510 USA.	Sheela.Shenoi@yale.edu	Shenoi, Sheela/GRY-6103-2022; Shenoi, Sheela/Z-2641-2019	Jacobson, Karen/0000-0003-3050-4595; Shenoi, Sheela/0000-0001-7654-4344	Doris Duke Foundation Clinical Research Fellowship [2012088]; National Institute of Allergy and Infectious Diseases [5K23AI089260-03]; Gilead Foundation [157201]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI089260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294] Funding Source: NIH RePORTER	Doris Duke Foundation Clinical Research Fellowship; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Gilead Foundation(Gilead Sciences); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Doris Duke Foundation Clinical Research Fellowship, http://www.ddcf.org/Programs/Medical-Research/Goals-and-Strategies/Build-the-ClinicalResearch-Career-Ladder/Clinical-ResearchMentorships/, #2012088 provided funding to KJ. National Institute of Allergy and Infectious Diseases, http://www.niaid.nih.gov/Pages/default.aspx, #5K23AI089260-03 provided funding to SS. Gilead Foundation, http://www.gilead.com/responsibility/gilead-foundation, #157201 provided funding to GF and SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2013, LANCET, V382, P5; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Boyer S, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000366078.45451.46; Brennan AT, 2011, AIDS, V25, P2027, DOI 10.1097/QAD.0b013e32834b6480; Bronner LE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-621; Chan AK, 2010, TROP MED INT HEALTH, V15, P90, DOI 10.1111/j.1365-3156.2010.02503.x; Chimbindi N, 2013, SAMJ S AFR MED J, V103, P237, DOI [10.7196/SAMJ.6423, 10.7196/samj.6423]; Churchyard G, 2014, 21 C RETR OPP INF BO; Coetzee D, 2004, TROP MED INT HEALTH, V9, pA11, DOI 10.1111/j.1365-3156.2004.01259.x; Cohen R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-23; Decroo T, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-6; DELIMA YV, 2013, PLOS ONE, V0008; Friedland G, 2007, J INFECT DIS, V196, pS114, DOI 10.1086/518664; Harris JB, 2008, INT J TUBERC LUNG D, V12, P773; Kaplan R, 2014, SAMJ S AFR MED J, V104, P204, DOI [10.7196/samj.7696, 10.7196/SAMJ.7696]; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Loveday M, 2008, INT J TUBERC LUNG D, V12, P1042; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Nglazi MD, 2012, SAMJ S AFR MED J, V102, P936, DOI [10.7196/SAMJ.6024, 10.7196/samj.6024]; Nunn AJ, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a257; O'Connor C, 2011, JAIDS-J ACQ IMM DEF, V58, P429, DOI 10.1097/QAI.0b013e318230d507; Republic of South Africa Department of Health, 2009, NAT TUB MAN GUID; Republic of South Africa Department of Health, 2008, UMZ DISTR HLTH PROF; Rudolf F, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24303; Rudolf F, 2013, SCAND J INFECT DIS, V45, P825, DOI 10.3109/00365548.2013.826876; Saly Saint, 2006, Kekkaku, V81, P467; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Tweya H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075761; Uyei J, 2014, HEALTH POLICY PLANN, V29, P42, DOI 10.1093/heapol/czs131; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wilkinson D, 1996, AM J PUBLIC HEALTH, V86, P1094, DOI 10.2105/AJPH.86.8_Pt_1.1094	31	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127024	10.1371/journal.pone.0127024	http://dx.doi.org/10.1371/journal.pone.0127024			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993636	gold, Green Submitted, Green Published			2022-12-26	WOS:000354918600047
J	Yukiura, H; Kano, K; Kise, R; Inoue, A; Aoki, J				Yukiura, Hiroshi; Kano, Kuniyuki; Kise, Ryoji; Inoue, Asuka; Aoki, Junken			Autotaxin Overexpression Causes Embryonic Lethality and Vascular Defects	PLOS ONE			English	Article							LPA-PRODUCING ENZYME; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPASE-D; ENDOTHELIAL NOTCH; MOUSE; GENE; IDENTIFICATION; ANGIOGENESIS; EXPRESSION; RECEPTORS	Autotaxin (ATX) is a secretory protein, which converts lysophospholipids to lysophosphatidic acid (LPA), and is essential for embryonic vascular formation. ATX is abundantly detected in various biological fluids and its level is elevated in some pathophysiological conditions. However, the roles of elevated ATX levels remain to be elucidated. In this study, we generated conditional transgenic (Tg) mice overexpressing ATX and examined the effects of excess LPA signalling. We found that ATX overexpression in the embryonic period caused severe vascular defects and was lethal around E9.5. ATX was conditionally overexpressed in the neonatal period using the Cre/loxP system, which resulted in a marked increase in the plasma LPA level. This resulted in retinal vascular defects including abnormal vascular plexus and increased vascular regression. Our findings indicate that the ATX level must be carefully regulated to ensure coordinated vascular formation	[Yukiura, Hiroshi; Kano, Kuniyuki; Kise, Ryoji; Inoue, Asuka; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi, Japan; [Inoue, Asuka] Japan Sci & Technol Agcy, PREST, Kawaguchi, Saitama, Japan; [Aoki, Junken] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Tohoku University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Aoki, J (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, 6-3 Aoba, Sendai, Miyagi, Japan.	jaoki@m.tohoku.ac.jp		Aoki, Junken/0000-0001-9435-1896; Kano, Kuniyuki/0000-0002-4539-5750	CREST (Japan Science and technology Corporation), Science, Sports, and Culture of Japan	CREST (Japan Science and technology Corporation), Science, Sports, and Culture of Japan	This research was supported by grants from CREST (Japan Science and technology Corporation to JA), Science, Sports, and Culture of Japan to JA.	Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH547, DOI 10.1152/ajpheart.00616.2005; Escalante-Alcalde D, 2003, DEVELOPMENT, V130, P4623, DOI 10.1242/dev.00635; Ferry G, 2007, FEBS LETT, V581, P3572, DOI 10.1016/j.febslet.2007.06.064; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Guarani V, 2011, NATURE, V473, P234, DOI 10.1038/nature09917; Im E, 2010, MOL CELL BIOL, V30, P2401, DOI 10.1128/MCB.01275-09; Inoue A, 2011, EMBO J, V30, P4248, DOI 10.1038/emboj.2011.296; Kanegae Y, 1996, GENE, V181, P207, DOI 10.1016/S0378-1119(96)00516-1; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Koike S, 2011, DEV DYNAM, V240, P413, DOI 10.1002/dvdy.22543; Kondo M, 2014, CLIN CHIM ACTA, V433, P128, DOI 10.1016/j.cca.2014.03.006; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Masuda A, 2008, BRIT J HAEMATOL, V143, P60, DOI 10.1111/j.1365-2141.2008.07325.x; Masuda A, 2011, CLIN CHIM ACTA, V412, P1944, DOI 10.1016/j.cca.2011.06.039; Moolenaar WH, 2013, BBA-MOL CELL BIOL L, V1831, P13, DOI 10.1016/j.bbalip.2012.09.013; Nakai Y, 2011, CLIN BIOCHEM, V44, P576, DOI 10.1016/j.clinbiochem.2011.03.128; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Nakao A, 2014, J INVEST DERMATOL, V134, P1745, DOI 10.1038/jid.2014.24; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Smyth SS, 2008, BBA-MOL CELL BIOL L, V1781, P563, DOI 10.1016/j.bbalip.2008.05.008; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Tammela T, 2011, NAT CELL BIOL, V13, P1202, DOI 10.1038/ncb2331; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Tokumura A, 2002, BIOL REPROD, V67, P1386, DOI 10.1095/biolreprod.102.004051; Tokumura A, 2007, LIFE SCI, V80, P1641, DOI 10.1016/j.lfs.2006.12.041; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Watanabe N, 2007, J CLIN GASTROENTEROL, V41, P616, DOI 10.1097/01.mcg.0000225642.90898.0e; Yang SY, 2002, CLIN EXP METASTAS, V19, P603, DOI 10.1023/A:1020950420196; Yukiura H, 2011, J BIOL CHEM, V286, P43972, DOI 10.1074/jbc.M111.301093	35	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0126734	10.1371/journal.pone.0126734	http://dx.doi.org/10.1371/journal.pone.0126734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992708	gold, Green Submitted, Green Published			2022-12-26	WOS:000354918600042
J	Fromberger, P; Meyer, S; Kempf, C; Jordan, K; Muller, JL				Fromberger, Peter; Meyer, Sabrina; Kempf, Christina; Jordan, Kirsten; Mueller, Juergen L.			Virtual Viewing Time: The Relationship between Presence and Sexual Interest in Androphilic and Gynephilic Men	PLOS ONE			English	Article							PROLONGED RESPONSE LATENCIES; ATTRACTIVE TARGETS; EYE-MOVEMENTS; REALITY; ENVIRONMENTS; EXPERIENCE; ANXIETY; PREFERENCES; COMPONENTS; STIMULI	Virtual Reality (VR) has successfully been used in the research of human behavior for more than twenty years. The main advantage of VR is its capability to induce a high sense of presence. This results in emotions and behavior which are very close to those shown in real situations. In the context of sex research, only a few studies have used high-immersive VR so far. The ones that did can be found mostly in the field of forensic psychology. Nevertheless, the relationship between presence and sexual interest still remains unclear. The present study is the first to examine the advantages of high-immersive VR in comparison to a conventional standard desktop system regarding their capability to measure sexual interest. 25 gynephilic and 20 androphilic healthy men underwent three experimental conditions, which differed in their ability to induce a sense of presence. In each condition, participants were asked to rate ten male and ten female virtual human characters regarding their sexual attractiveness. Without their knowledge, the subjects' viewing time was assessed throughout the rating. Subjects were then asked to rate the sense of presence they had experienced as well as their perceived realism of the characters. Results suggested that stereoscopic viewing can significantly enhance the subjective sexual attractiveness of sexually relevant characters. Furthermore, in all three conditions participants looked significantly longer at sexually relevant virtual characters than at sexually non-relevant ones. The high immersion condition provided the best discriminant validity. From a statistical point of view, however, the sense of presence had no significant influence on the discriminant validity of the viewing time task. The study showed that high-immersive virtual environments enhance realism ratings as well as ratings of sexual attractiveness of three-dimensional human stimuli in comparison to standard desktop systems. Results also show that viewing time seems to be influenced neither by sexual attractiveness nor by realism of stimuli. This indicates how important task specific mechanisms of the viewing time effect are.	[Fromberger, Peter; Meyer, Sabrina; Kempf, Christina; Jordan, Kirsten; Mueller, Juergen L.] Univ Gottingen, Fac Med, Ludwig Meyer Inst Forens Psychiat & Psychotherapy, D-37073 Gottingen, Lower Saxony, Germany	University of Gottingen	Fromberger, P (corresponding author), Univ Gottingen, Fac Med, Ludwig Meyer Inst Forens Psychiat & Psychotherapy, D-37073 Gottingen, Lower Saxony, Germany.	peter.fromberger@medizin.uni-goettingen.de	Jordan, Kirsten/M-5540-2019; Fromberger, Peter/X-9765-2019	Jordan, Kirsten/0000-0001-8083-5857; 	research program of the Faculty of Medicine, Georg-August-University Gottingen	research program of the Faculty of Medicine, Georg-August-University Gottingen	The work was supported by the research program of the Faculty of Medicine, Georg-August-University Gottingen (http://www.med.uni-goettingen.de/de/content/forschung/181.html). PF received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel GG, 1998, SEX ABUSE-J RES TR, V10, P81, DOI DOI 10.1177/107906329801000202; Alsina-Jurnet I, 2011, COMPUT HUM BEHAV, V27, P504, DOI 10.1016/j.chb.2010.09.018; Association A P, 2000, DSM 4 TR DIAGN STAT; Bailenson JN, 2005, PRESENCE-VIRTUAL AUG, V14, P379, DOI 10.1162/105474605774785235; Banos RM, 2004, CYBERPSYCHOL BEHAV, V7, P734, DOI 10.1089/cpb.2004.7.734; Banos RM, 2008, CYBERPSYCHOL BEHAV, V11, P1, DOI 10.1089/cpb.2007.9936; Banos RM, 2006, LECT NOTES COMPUT SC, V3962, P7; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Barr DJ, 2013, FRONT PSYCHOL, P4; Bates D, IME4 LINEAR MIXED EF; Bohil CJ, 2011, NAT REV NEUROSCI, V12, P752, DOI 10.1038/nrn3122; Bouchard S, 2013, CYBERPSYCH BEH SOC N, V16, P61, DOI 10.1089/cyber.2012.1571; Juan MC, 2009, PRESENCE-TELEOP VIRT, V18, P232, DOI 10.1162/pres.18.3.232; Cobb SVG, 1999, PRESENCE-TELEOP VIRT, V8, P169, DOI 10.1162/105474699566152; Dombert B, 2013, SEX ABUSE-J RES TR, V25, P557, DOI 10.1177/1079063212469062; Dores AR, 2013, NEUROREHABILITATION, V33, P505, DOI 10.3233/NRE-130987; Eichenberg C, 2012, VIRTUAL REALITY IN PSYCHOLOGICAL, MEDICAL AND PEDAGOGICAL APPLICATIONS, P35, DOI 10.5772/50094; Everaerd W, 1989, J PSYCHOL HUMAN SEXU, V1, P3, DOI DOI 10.1300/J056V01N02_02; Felnhofer A, 2014, CYBERPSYCH BEH SOC N, V17, P310, DOI 10.1089/cyber.2013.0472; Freeman J, 1999, PRESENCE-TELEOP VIRT, V8, P1, DOI 10.1162/105474699566017; FRIJDA NH, 1988, AM PSYCHOL, V43, P349, DOI 10.1037/0003-066X.43.5.349; Fromberger P, 2014, NERVENARZT, V85, P298, DOI 10.1007/s00115-013-3904-7; Fromberger P, 2013, J ABNORM PSYCHOL, V122, P587, DOI 10.1037/a0030659; Fromberger P, 2012, J SEX MED, V9, P1868, DOI 10.1111/j.1743-6109.2012.02754.x; Fromberger P, 2012, ARCH SEX BEHAV, V41, P919, DOI 10.1007/s10508-011-9816-3; Garau M., 2003, P SIGCHI C HUM FACT, P529, DOI [DOI 10.1145/642611.642703, 10.1145/642611.642703]; Georgescu AL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00807; Glasgow D. V., 2009, COGNITIVE APPROACHES, P59, DOI [DOI 10.1002/9780470747551.CH3, 10.1002/9780470747551.ch3]; Glasgow D. V., 2003, BRIT J LEARN DISABIL, V31, P96, DOI DOI 10.1046/J.1468-3156.2003.00180.X; Gorini A, 2010, ANN GEN PSYCHIATR, V9, DOI 10.1186/1744-859X-9-30; Harris GT, 1996, BEHAV RES THER, V34, P389, DOI 10.1016/0005-7967(95)00070-4; Harris GT., 1992, PSYCHOL ASSESSMENT, V4, P502, DOI [10.1037/1040-3590.4.4.502, DOI 10.1037/1040-3590.4.4.502]; Hendrix C., 1995, Proceedings. Virtual Reality Annual International Symposium '95 (Cat. No.95CH35761), P74, DOI 10.1109/VRAIS.1995.512482; Hendrix C, 1996, PRESENCE-TELEOP VIRT, V5, P274, DOI 10.1162/pres.1996.5.3.274; Ijsselsteijn W, 2001, PRESENCE-TELEOP VIRT, V10, P298, DOI 10.1162/105474601300343621; IJsselsteijn WA, 2000, PROC SPIE, V3959, P520, DOI 10.1117/12.387188; Imhoff R, 2012, ARCH SEX BEHAV, V41, P1389, DOI 10.1007/s10508-011-9879-1; Imhoff R, 2010, ARCH SEX BEHAV, V39, P1275, DOI 10.1007/s10508-009-9595-2; International Society for Presence Research, 2000, CONC PRES EXPL STAT; Israel E, 2009, ARCH SEX BEHAV, V38, P551, DOI 10.1007/s10508-007-9246-4; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Kim K, 2014, COMPUT METH PROG BIO, V113, P882, DOI 10.1016/j.cmpb.2013.12.024; Kim YY, 2005, PSYCHOPHYSIOLOGY, V42, P616, DOI 10.1111/j.1469-8986.2005.00349.x; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Laws D. R., 2009, COGNITIVE APPROACHES, P7, DOI DOI 10.1002/9780470747551.CH1; Lenth R. V., 2015, LEAST SQUARES MEANS; Mehlitz M, 1998, ST HEAL T, V52, P1051; Morina N, 2014, PEERJ, V2, DOI 10.7717/peerj.337; Regenbrecht H, 2002, PRESENCE-TELEOP VIRT, V11, P425, DOI 10.1162/105474602760204318; Renaud P, 2005, ANN REV CYBERTHERAPY, V3, P85; Renaud P, 2002, CYBERPSYCHOL BEHAV, V5, P1, DOI 10.1089/109493102753685836; Renaud P., 2010, J VIRTUAL REALITY BR, V7, P1860; Renaud P, 2012, J EYE TRACKING VISUA; Renaud P, 2009, J VIRTUAL REALITY BR, V6; Renaud P, 2014, CYBERPSYCH BEH SOC N, V17, P241, DOI 10.1089/cyber.2013.0165; Renaud P, 2014, VIRTUAL REAL-LONDON, V18, P37, DOI 10.1007/s10055-013-0235-8; Renaud P, 2010, NONLIN DYNAM PSYCHOL, V14, P463; Riener R., 2012, VIRTUAL REALITY MED; Riva G, 2005, CYBERPSYCHOL BEHAV, V8, P220, DOI 10.1089/cpb.2005.8.220; Riva G, 2012, BEING THERE UNDERSTA; Riva G, 2007, CYBERPSYCHOL BEHAV, V10, P45, DOI 10.1089/cpb.2006.9993; Rosenzweig S, 1942, PSYCHOSOM MED, V4, P150, DOI 10.1097/00006842-194204000-00004; Rullo JE, 2010, ARCH SEX BEHAV, V39, P874, DOI 10.1007/s10508-009-9497-3; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Schubert T, 2001, PRESENCE-VIRTUAL AUG, V10, P266, DOI 10.1162/105474601300343603; Schubert T., 1999, VISUAL REPRESENTATIO, P269, DOI DOI 10.1007/978-1-4471-0563-3_30; Schubert TW, 2009, COMMUN THEOR, V19, P161, DOI 10.1111/j.1468-2885.2009.01340.x; Schuemie MJ, 2001, CYBERPSYCHOL BEHAV, V4, P183, DOI 10.1089/109493101300117884; Schultheis MT, 2001, REHABIL PSYCHOL, V46, P296, DOI 10.1037/0090-5550.46.3.296; Singmann H., 2015, AFEX ANAL FACTORIAL; STEUER J, 1992, J COMMUN, V42, P73, DOI 10.1111/j.1460-2466.1992.tb00812.x; Sutherland I.E., 1965, PROC IFIP C, P506, DOI DOI 10.1109/MC.2005.274; Takatalo J, 2008, COMPUT HUM BEHAV, V24, P1, DOI 10.1016/j.chb.2006.11.003; Team RC, 2014, R LANG ENV STAT COMP; Thornton D., 2009, COGNITIVE APPROACHES; Trottier D, 2014, J SEX RES, V51, P946, DOI 10.1080/00224499.2013.832133; VANSELST M, 1994, Q J EXP PSYCHOL-A, V47, P631, DOI 10.1080/14640749408401131; Villani D, 2012, INTERACT COMPUT, V24, P265, DOI 10.1016/j.intcom.2012.04.008; Welch RB, 1996, PRESENCE-TELEOP VIRT, V5, P263, DOI 10.1162/pres.1996.5.3.263; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; ZAMANSKY HS, 1956, J PERS, V24, P436, DOI 10.1111/j.1467-6494.1956.tb01280.x	82	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127156	10.1371/journal.pone.0127156	http://dx.doi.org/10.1371/journal.pone.0127156			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7BG	25992790	Green Published, gold, Green Submitted			2022-12-26	WOS:000354917300096
J	Watanabe, A; Kumagai, M; Mishima, T; Ito, J; Otoki, Y; Harada, T; Kato, T; Yoshida, M; Suzuki, M; Yoshida, I; Fujita, K; Watai, M; Nakagawa, K; Miyazawa, T				Watanabe, Akio; Kumagai, Momochika; Mishima, Takashi; Ito, Junya; Otoki, Yurika; Harada, Teppei; Kato, Tsuyoshi; Yoshida, Mikihiko; Suzuki, Misora; Yoshida, Izumi; Fujita, Kazuhiro; Watai, Masatoshi; Nakagawa, Kiyotaka; Miyazawa, Teruo			Toddaculin, Isolated from of Toddalia asiatica (L.) Lam., Inhibited Osteoclastogenesis in RAW 264 Cells and Enhanced Osteoblastogenesis in MC3T3-E1 Cells	PLOS ONE			English	Article							PARATHYROID-HORMONE; DIFFERENTIATION; EXPRESSION; OSTEOPOROSIS; BISPHOSPHONATES; COUMARIN	Osteoporosis with bone loss is widely recognized as a major health problem. Bone homeostasis is maintained by balancing bone formation and bone resorption. The imbalance caused by increased bone resorption over bone formation can lead to various bone-related diseases such as osteoporosis and rheumatoid arthritis. Osteoclasts are the principal cells responsible for bone resorption and the main targets of anti-resorptive therapies. However, excessive inhibition of osteoclast differentiation may lead to inhibition of osteoblast differentiation. Therefore, it is important to screen for new compounds capable of inhibiting bone resorption and enhancing bone formation. Toddalia asiatica (L.) Lam. has been utilized traditionally for medicinal purposes such as the treatment of rheumatism. Currently, the extract is considered to be a good source of pharmacological agents for the treatment of bone-related diseases, but the active compounds have yet to be identified. We investigated whether toddaculin, derived from Toddalia asiatica (L.) Lam., affects both processes by inhibiting bone resorption and enhancing bone formation. Towards this end, we used pre-osteoclastic RAW 264 cells and pre-osteoblastic MC3T3-E1 cells. We found that toddaculin not only inhibited the differentiation of osteoclasts via activation of the NF-kappa B, ERK 1/2, and p38 MAPK signaling pathways, but it also induced differentiation and mineralization of osteoblasts by regulating differentiation factors. Thus, toddaculin might be beneficial for the prevention and treatment of osteoporosis.	[Watanabe, Akio; Kumagai, Momochika; Mishima, Takashi; Harada, Teppei; Yoshida, Izumi; Fujita, Kazuhiro; Watai, Masatoshi] Japan Food Res Labs, Saito Lab, Food Funct Res Team, Ibaraki, Osaka, Japan; [Watanabe, Akio; Ito, Junya; Otoki, Yurika; Nakagawa, Kiyotaka; Miyazawa, Teruo] Tohoku Univ, Grad Sch Agr Sci, Food & Biodynam Chem Lab, Sendai, Miyagi 980, Japan; [Kato, Tsuyoshi] Japan Food Res Labs, Tama Lab, Sect Appl Testing, Tama, Tokyo, Japan; [Yoshida, Mikihiko] Japan Food Res Labs, Saito Lab, Sect Nutraceut Anal, Ibaraki, Osaka, Japan; [Suzuki, Misora] Japan Food Res Labs, Tama Lab, Sect Biol Safety Res, Tama, Tokyo, Japan	Tohoku University	Watanabe, A (corresponding author), Japan Food Res Labs, Saito Lab, Food Funct Res Team, Ibaraki, Osaka, Japan.	watanabea@jfrl.or.jp						Aaseth J, 2012, J TRACE ELEM MED BIO, V26, P149, DOI 10.1016/j.jtemb.2012.03.017; AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E; Beck GR, 1998, J CELL BIOCHEM, V68, P269, DOI 10.1002/(SICI)1097-4644(19980201)68:2<269::AID-JCB13>3.0.CO;2-A; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Duraipandiyan V, 2006, BMC COMPLEM ALTERN M, V4, P311; Feng X, 2005, IUBMB LIFE, V57, P389, DOI 10.1080/15216540500137669; Gallacher SJ, 2010, CALCIFIED TISSUE INT, V87, P469, DOI 10.1007/s00223-010-9420-x; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kitahara K, 2003, ENDOCRINOLOGY, V144, P2132, DOI 10.1210/en.2002-220996; Kono SJ, 2007, BONE, V40, P68, DOI 10.1016/j.bone.2006.07.024; Leboime A, 2010, JOINT BONE SPINE, V77, pS107, DOI 10.1016/S1297-319X(10)70004-X; Matsuguchi T, 2009, J BONE MINER RES, V24, P398, DOI 10.1359/JBMR.081107; Motyckova G, 2001, P NATL ACAD SCI USA, V98, P5798, DOI 10.1073/pnas.091479298; Nakamura T, 2009, J NAT MED-TOKYO, V63, P15, DOI 10.1007/s11418-008-0268-6; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Putnam SE, 2007, PHYTOTHER RES, V21, P99, DOI 10.1002/ptr.2030; Quinn JMW, 1998, ENDOCRINOLOGY, V139, P4424, DOI 10.1210/endo.139.10.6331; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; REDDY SV, 1995, J BONE MINER RES, V10, P601; Reinholz GG, 2000, CANCER RES, V60, P6001; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vazquez R, 2012, PHYTOMEDICINE, V19, P737, DOI 10.1016/j.phymed.2012.03.008; Watanabe A, 2014, BIOCHEM BIOPH RES CO, V453, P787, DOI 10.1016/j.bbrc.2014.10.027; Yang K, 2013, J ETHNOPHARMACOL, V146, P355, DOI 10.1016/j.jep.2013.01.004	29	14	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127158	10.1371/journal.pone.0127158	http://dx.doi.org/10.1371/journal.pone.0127158			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993011	Green Published, Green Submitted, gold			2022-12-26	WOS:000354917300098
J	Chan, D; Barratt, J; Roberts, T; Lee, R; Shea, M; Marriott, D; Harkness, J; Malik, R; Jones, M; Aghazadeh, M; Ellis, J; Stark, D				Chan, Douglas; Barratt, Joel; Roberts, Tamalee; Lee, Rogan; Shea, Michael; Marriott, Deborah; Harkness, John; Malik, Richard; Jones, Malcolm; Aghazadeh, Mahdis; Ellis, John; Stark, Damien			The Prevalence of Angiostrongylus cantonensis/mackerrasae Complex in Molluscs from the Sydney Region	PLOS ONE			English	Article							EOSINOPHILIC MENINGITIS; RATTUS-FUSCIPES; CANTONENSIS; MENINGOENCEPHALITIS; INFECTION; AUSTRALIA; INGESTION; SAMPLES	Angiostrongylus cantonensis and Angiostrongylus mackerrasae are metastrongyloid nematodes that infect various rat species. Terrestrial and aquatic molluscs are intermediate hosts of these worms while humans and dogs are accidental hosts. Angiostrongylus cantonensis is the major cause of angiostrongyliasis, a disease characterised by eosinophilic meningitis. Although both A. cantonensis and A. mackerrasae are found in Australia, A. cantonensis appears to account for most infections in humans and animals. Due to the occurrence of several severe clinical cases in Sydney and Brisbane, the need for epidemiological studies on angiostrongyliasis in this region has become apparent. In the present study, a conventional PCR and a TaqMan assay were compared for their ability to amplify Angiostrongylus DNA from DNA extracted from molluscs. The TaqMan assay was more sensitive, capable of detecting the DNA equivalent to one hundredth of a nematode larva. Therefore, the TaqMan assay was used to screen molluscs (n = 500) of 14 species collected from the Sydney region. Angiostrongylus DNA was detected in 2 of the 14 mollusc species; Cornu aspersum [14/312 (4.5%)], and Bradybaenia similaris [1/10 (10%)], which are non-native terrestrial snails commonly found in urban habitats. The prevalence of Angiostrongylus spp. was 3.0% +/- 0.8% (CI 95%). Additionally, experimentally infected Austropeplea lessoni snails shed A. cantonensis larvae in their mucus, implicating mucus as a source of infection. This is the first Australian study to survey molluscs using real-time PCR and confirms that the garden snail, C. aspersum, is a common intermediate host for Angiostrongylus spp. in Sydney.	[Chan, Douglas; Roberts, Tamalee; Marriott, Deborah; Harkness, John; Stark, Damien] St Vincents Hosp, SydPath, Dept Microbiol, Darlinghurst, NSW 2010, Australia; [Chan, Douglas; Barratt, Joel] Univ Technol, i3 Inst, Ultimo, NSW, Australia; [Barratt, Joel; Ellis, John] Univ Technol, Sch Med & Mol Sci, Ultimo, NSW, Australia; [Lee, Rogan] Westmead Hosp, ICPMR, Ctr Infect Dis & Microbiol Lab Serv, Westmead, NSW 2145, Australia; [Shea, Michael] Australian Museum, Malacol Dept, Sydney, NSW 2000, Australia; [Malik, Richard] Univ Sydney, Ctr Vet Educ, Camperdown, NSW, Australia; [Jones, Malcolm; Aghazadeh, Mahdis] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia	St Vincents Hospital Sydney; University of Technology Sydney; University of Technology Sydney; University of Sydney; Australian Museum; University of Sydney; University of Queensland	Chan, D (corresponding author), St Vincents Hosp, SydPath, Dept Microbiol, Victoria St, Darlinghurst, NSW 2010, Australia.	douglas.chan@svha.org.au	Aghazadeh, Mahdis/I-1556-2019; Jones, Malcolm K/A-1097-2009; Roberts, Tamalee/GOE-6303-2022; Malik, Richard/I-2009-2019; Ellis, John T/L-6988-2016	Aghazadeh, Mahdis/0000-0002-7687-5351; Jones, Malcolm K/0000-0002-0035-6141; Ellis, John T/0000-0001-7328-4831; Barratt, Joel/0000-0001-8711-2408; Roberts, Tamalee/0000-0001-8599-737X	SydPath Research Grant	SydPath Research Grant	Supported by SydPath Research Grant.	ALICATA J. E., 1965, Adv. Parasit., V3, P223, DOI 10.1016/S0065-308X(08)60366-8; Alto W, 2001, Pac Health Dialog, V8, P176; BHAIBULAYA M, 1968, PARASITOLOGY, V58, P789, DOI 10.1017/S0031182000069572; Blair NF, 2013, MED J AUSTRALIA, V198, P440, DOI 10.5694/mja12.11085; Cowie Robert H, 2013, Hawaii J Med Public Health, V72, P70; Cowie Robert H, 2013, Hawaii J Med Public Health, V72, P6; Eamsobhana Praphathip, 2013, Hawaii J Med Public Health, V72, P15; GUTTERIDGE BH, 1972, PATHOLOGY, V4, P63, DOI 10.1016/S0031-3025(16)39339-4; Hadziavdic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087624; Jarvi SI, 2012, MOL BIOCHEM PARASIT, V185, P174, DOI 10.1016/j.molbiopara.2012.08.002; Kim JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094969; Lai CH, 2007, AM J TROP MED HYG, V76, P399, DOI 10.4269/ajtmh.2007.76.399; Morton NJ, 2013, CLIN INFECT DIS, V57, P1158, DOI 10.1093/cid/cit444; Qvarnstrom Y, 2007, APPL ENVIRON MICROB, V73, P1415, DOI 10.1128/AEM.01968-06; Qvarnstrom Y, 2010, APPL ENVIRON MICROB, V76, P5287, DOI 10.1128/AEM.00546-10; Sawanyawisuth K, 2009, AM J TROP MED HYG, V81, P698, DOI 10.4269/ajtmh.2009.09-0309; Schnyder M, 2011, VET PARASITOL, V179, P152, DOI 10.1016/j.vetpar.2011.01.054; Senanayake SN, 2003, MED J AUSTRALIA, V179, P430, DOI 10.5694/j.1326-5377.2003.tb05623.x; Simoes RO, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-100; Stokes VL, 2007, AUST J ZOOL, V55, P177, DOI 10.1071/ZO06061; Teem John L, 2013, Hawaii J Med Public Health, V72, P11; Thiengo Silvana Carvalho, 2013, Hawaii J Med Public Health, V72, P18; Thyssen A, 2013, PEDIATR INFECT DIS J, V32, P194, DOI 10.1097/INF.0b013e31827c9726; Wang QP, 2012, EUR J CLIN MICROBIOL, V31, P389, DOI 10.1007/s10096-011-1328-5; Wang QP, 2008, LANCET INFECT DIS, V8, P621, DOI 10.1016/S1473-3099(08)70229-9; Wilkins Patricia P, 2013, Hawaii J Med Public Health, V72, P55; Yeung Norine W, 2013, Hawaii J Med Public Health, V72, P83; YONG W K, 1981, Southeast Asian Journal of Tropical Medicine and Public Health, V12, P608	28	19	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0128128	10.1371/journal.pone.0128128	http://dx.doi.org/10.1371/journal.pone.0128128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000568	Green Submitted, Green Published, gold			2022-12-26	WOS:000354931700105
J	Kaspric, N; Picard, B; Reichstadt, M; Tournayre, J; Bonnet, M				Kaspric, Nicolas; Picard, Brigitte; Reichstadt, Matthieu; Tournayre, Jeremy; Bonnet, Muriel			ProteINSIDE to Easily Investigate Proteomics Data from Ruminants: Application to Mine Proteome of Adipose and Muscle Tissues in Bovine Foetuses	PLOS ONE			English	Article							SIGNAL PEPTIDE PREDICTION; SKELETAL-MUSCLE; GENE-EXPRESSION; INTERACTION NETWORK; PLASMA PROTEOME; SECRETOME; ONTOLOGY; TOOL; WEB; ADIPOGENESIS	Genomics experiments are widely acknowledged to produce a huge amount of data to be analysed. The challenge is to extract meaningful biological context for proteins or genes which is currently difficult because of the lack of an integrative workflow that hinders the efficiency and the robustness of data mining performed by biologists working on ruminants. Thus, we designed ProteINSIDE, a free web service (www. proteinside. org) that (I) provides an overview of the biological information stored in public databases or provided by annotations according to the Gene Ontology, (II) predicts proteins that are secreted to search for proteins that mediate signalisation between cells or tissues, and (III) analyses protein-protein interactions to identify proteins contributing to a process or to visualize functional pathways. Using lists of proteins or genes as a unique input, ProteINSIDE is an original all-inone tool that merges data from these searches to present a fast overview and integrative analysis of genomic and proteomic data from Bovine, Ovine, Caprine, Human, Rat, and Murine species. ProteINSIDE was bench tested with 1000 proteins identifiers from each species by comparison with DAVID, BioMyn, AgBase, PrediSi, and Phobius. Compared to DAVID or BioMyn, identifications and annotations provided by ProteINSIDE were similar from monogastric proteins but more numerous and relevant for ruminants proteins. ProteINSIDE, thanks to SignalP, listed less proteins potentially secreted with a signal peptide than PrediSi and Phobius, in agreement with the low false positive rate of SignalP. In addition ProteINSIDE is the only resource that predicts proteins secreted by cellular processes that do not involve a signal peptide. Lastly, we reported the usefulness of ProteINSIDE to bring new biological hypotheses of research from proteomics data: the biological meaning of the uptake of adiponectin by the foetal muscle and a role for autophagy during ontogenesis of adipose and muscle tissues.	[Kaspric, Nicolas; Picard, Brigitte; Reichstadt, Matthieu; Tournayre, Jeremy; Bonnet, Muriel] INRA, Herbivores UMR1213, F-63122 St Genes Champanelle, France; [Kaspric, Nicolas; Picard, Brigitte; Reichstadt, Matthieu; Tournayre, Jeremy; Bonnet, Muriel] Clermont Univ, VetAgro Sup, Herbivores UMR1213, Clermont Ferrand, France	INRAE; VetAgro Sup; VetAgro Sup	Bonnet, M (corresponding author), INRA, Herbivores UMR1213, F-63122 St Genes Champanelle, France.	muriel.bonnet@clermont.inra.fr	Bonnet, Muriel/M-6265-2017	Bonnet, Muriel/0000-0001-7193-3543	regional council of Auvergne in France; APIS-GENE	regional council of Auvergne in France(Region Auvergne-Rhone-Alpes); APIS-GENE	This study was supported by the regional council of Auvergne in France and APIS-GENE. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. APIS-GENE gave the authors its agreement to publish.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Aranda B, 2011, NAT METHODS, V8, P528, DOI 10.1038/nmeth.1637; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baerga R, 2009, AUTOPHAGY, V5, P1118, DOI 10.4161/auto.5.8.9991; Bag S, 2014, J THEOR BIOL; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Bionaz M, 2012, GENE REGUL SYST BIO, V6, P109, DOI 10.4137/GRSB.S9852; Bonnet M, 2013, ANIMAL, V7, P1344, DOI 10.1017/S1751731113000475; Bonnet M, 2010, ANIMAL, V4, P1093, DOI 10.1017/S1751731110000601; Caccia D, 2013, BBA-PROTEINS PROTEOM, V1834, P2442, DOI 10.1016/j.bbapap.2013.01.039; Calloni R, 2013, STEM CELLS DEV, V22, P1455, DOI 10.1089/scd.2012.0637; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chaze T, 2009, ANIMAL, V3, P980, DOI 10.1017/S1751731109004315; Chaze T, 2008, PROTEOMICS, V8, P4236, DOI 10.1002/pmic.200701101; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chiellini C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-26; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Frank K, 2008, BIOINFORMATICS, V24, P2172, DOI 10.1093/bioinformatics/btn422; Guillemin N, 2011, J PROTEOMICS, V75, P352, DOI 10.1016/j.jprot.2011.07.026; Hartwig S, 2014, BBA-PROTEINS PROTEOM, V1844, P1011, DOI 10.1016/j.bbapap.2013.08.004; He H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064356; Heid H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090386; Henning AK, 2014, VET J, V199, P175, DOI 10.1016/j.tvjl.2013.10.029; Hernandez-Toro J, 2007, BIOINFORMATICS, V23, P2495, DOI 10.1093/bioinformatics/btm373; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hudson NJ, 2013, GENE EXPR PATTERNS, V13, P109, DOI 10.1016/j.gep.2013.02.001; Hwang S, 2008, J THEOR BIOL, V252, P722, DOI 10.1016/j.jtbi.2008.02.011; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Krause MP, 2008, AM J PHYSIOL-CELL PH, V295, pC203, DOI 10.1152/ajpcell.00030.2008; KWIATKOWSKI DJ, 1986, NATURE, V323, P455, DOI 10.1038/323455a0; Le Bihan MC, 2012, J PROTEOMICS, V77, P344, DOI 10.1016/j.jprot.2012.09.008; Lecourt S, 2010, EXP CELL RES, V316, P2513, DOI 10.1016/j.yexcr.2010.04.020; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Martha VS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S7; Martinez-Lopez N, 2013, EMBO REP, V14, P795, DOI 10.1038/embor.2013.111; McCarthy FM, 2011, NUCLEIC ACIDS RES, V39, pD497, DOI 10.1093/nar/gkq1115; McMillan EM, 2014, BIOCHEM J, V462, P267, DOI 10.1042/BJ20140312; NAVAL J, 1992, J BIOCHEM, V111, P649, DOI 10.1093/oxfordjournals.jbchem.a123813; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Picard B, 2011, COMPREHENSIVE BIOTECHNOLOGY, VOL 4: AGRICULTURAL AND RELATED BIOTECHNOLOGIES, 2ND EDITION, P395; Ramirez F, 2012, BIOINFORMATICS, V28, P269, DOI 10.1093/bioinformatics/btr631; Raschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062008; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roelofsen H, 2009, MOL CELL PROTEOMICS, V8, P316, DOI 10.1074/mcp.M800254-MCP200; Romacho T, 2014, ACTA PHYSIOL, V210, P733, DOI 10.1111/apha.12246; Romao JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083211; Sadkowski T, 2014, MEAT SCI, V97, P32, DOI 10.1016/j.meatsci.2013.12.017; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Scheideler M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-340; Shahzad K, 2012, CURR GENOMICS, V13, P379, DOI 10.2174/138920212801619269; Skop V., 2014, DIFFERENTIATION; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Taga H, 2012, J CELL PHYSIOL, V227, P1688, DOI 10.1002/jcp.22893; Tarcea VG, 2009, NUCLEIC ACIDS RES, V37, pD642, DOI 10.1093/nar/gkn722; Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230; Welle S, 2009, PHYSIOL GENOMICS, V38, P342, DOI 10.1152/physiolgenomics.00054.2009; Welle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001385; Woelders H, 2011, ANIMAL, V5, P1036, DOI 10.1017/S1751731111000036; Yang BC, 2006, BIOCHEM BIOPH RES CO, V341, P209, DOI 10.1016/j.bbrc.2005.12.172; Yoon JH, 2011, J PROTEOME RES, V10, P5315, DOI 10.1021/pr200573b; Zhang Q, 2014, BIOTECHNOL LETT, V36, P1225, DOI 10.1007/s10529-014-1489-2; Zhong J, 2010, J PROTEOME RES, V9, P5228, DOI 10.1021/pr100521c	76	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0128086	10.1371/journal.pone.0128086	http://dx.doi.org/10.1371/journal.pone.0128086			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000831	Green Published, gold, Green Submitted			2022-12-26	WOS:000354931700101
J	Urbisz, AZ; Chajec, L; Swiatek, P				Urbisz, Anna Z.; Chajec, Lukasz; Swiatek, Piotr			The Ovary of Tubifex tubifex (Clitellata, Naididae, Tubificinae) Is Composed of One, Huge Germ-Line Cyst that Is Enriched with Cytoskeletal Components	PLOS ONE			English	Article							STABLE INTERCELLULAR BRIDGES; CELL CLUSTER FORMATION; CAENORHABDITIS-ELEGANS; REPRODUCTIVE-SYSTEM; ACTIN CYTOSKELETON; CYTOPLASMIC CORE; OOGENESIS; ANNELIDA; ORGANIZATION; FEMALE	Recent studies on the ovary organization and oogenesis in Tubificinae have revealed that their ovaries are small polarized structures that are composed of germ cells in subsequent stages of oogenesis that are associated with somatic cells. In syncytial cysts, as a rule, each germ cell is connected to the central cytoplasmic mass, the cytophore, via only one stable intercellular bridge (ring canal). In this paper we present detailed data about the composition of germ-line cysts in Tubifex tubifex with special emphasis on the occurrence and distribution of the cytoskeletal elements. Using fixed material and live cell imaging techniques, we found that the entire ovary of T. tubifex is composed of only one, huge multicellular germ-line cyst, which may contain up to 2,600 cells. Its architecture is broadly similar to the cysts that are found in other clitellate annelids, i.e. a common, anuclear cytoplasmic mass in the center of the cyst and germ cells that are connected to it via intercellular bridges. The cytophore in the T. tubifex cyst extends along the long axis of the ovary in the form of elongated and branched cytoplasmic strands. Rhodamine-coupled phalloidin staining revealed that the prominent strands of actin filaments occur inside the cytophore. Similar to the cytophore, F-actin strands are branched and they are especially well developed in the middle and outermost parts of the ovary. Microfilaments are also present in the ring canals that connect the germ cells with the cytophore in the narrow end of the ovary. Using Tubulin-Tracker, we found that the microtubules form a prominent network of loosely and evenly distributed tubules inside the cytophore as well as in every germ cell. The well-developed cytoskeletal elements in T. tubifex ovary seem to ensure the integrity of such a huge germline cyst of complex (germ cells - ring canals - cytophore) organization. A comparison between the cysts that are described here and other well-known female germ-line cysts is also made.	[Urbisz, Anna Z.; Chajec, Lukasz; Swiatek, Piotr] Univ Silesia, Dept Anim Histol & Embryol, PL-40007 Katowice, Poland	University of Silesia in Katowice	Urbisz, AZ (corresponding author), Univ Silesia, Dept Anim Histol & Embryol, Bankowa 9, PL-40007 Katowice, Poland.	anna.urbisz@us.edu.pl	Urbisz, Anna/ABF-8414-2020; Swiatek, Piotr/AAE-6559-2020	Swiatek, Piotr/0000-0001-9410-4510; Chajec, Lukasz/0000-0001-6455-9063; Urbisz, Anna/0000-0002-0300-4280				Aisenstadt TB, 1967, CITOLOGIYA, V9, P397; Amini R, 2014, J CELL BIOL, V206, P129, DOI 10.1083/jcb.201310117; Anan'ina TV, 2014, PROTOPLASMA, V251, P913, DOI 10.1007/s00709-013-0593-9; ANDERSON E, 1968, J MORPHOL, V126, P163, DOI 10.1002/jmor.1051260203; Ben Ahmed R, 2013, MICRON, V44, P275, DOI 10.1016/j.micron.2012.07.005; Ben Ahmed R, 2010, ZOOL ANZ, V249, P201, DOI 10.1016/j.jcz.2010.08.004; Bielecki A, 2014, CLADISTICS, V30, P540, DOI 10.1111/cla.12058; BILINSKI SM, 1993, INT J INSECT MORPHOL, V22, P255, DOI 10.1016/0020-7322(93)90014-R; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Brubacher JL, 2011, DEV BIOL, V357, P96, DOI 10.1016/j.ydbio.2011.06.026; Brubacher JL, 2009, J MORPHOL, V270, P413, DOI 10.1002/jmor.10687; Buning J, 1998, INT J INSECT MORPHOL, V27, P3, DOI 10.1016/S0020-7322(97)00028-7; BUNING J, 1985, J MORPHOL, V186, P209, DOI 10.1002/jmor.1051860206; Buning J., 1994, INSECT OVARY ULTRAST, Vfirst; de Cuevas M, 1997, ANNU REV GENET, V31, P405, DOI 10.1146/annurev.genet.31.1.405; Eikenes AH, 2013, DEV BIOL, V377, P9, DOI 10.1016/j.ydbio.2013.02.021; Fernandez Juan, 1992, P323; FOOR W E, 1968, Bulletin of the Tulane University Medical Faculty, V27, P23; Ganguly S, 2012, P NATL ACAD SCI USA, V109, P15109, DOI 10.1073/pnas.1203575109; GIBERT MA, 1984, BIOL CELL, V50, P77, DOI 10.1111/j.1768-322X.1984.tb00254.x; Greenbaum MP, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005850; Gu X, 1992, P INT C ENT 19 BEIJ, P81; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Haglund Kaisa, 2011, Communicative & Integrative Biology, V4, P1, DOI 10.4161/cib.4.1.13550; Hall DH, 1999, DEV BIOL, V212, P101, DOI 10.1006/dbio.1999.9356; HIRSH D, 1976, DEV BIOL, V49, P200, DOI 10.1016/0012-1606(76)90267-0; Jaglarz MK, 2014, ZOOLOGY, V117, P207, DOI 10.1016/j.zool.2013.12.002; Kloc M, 2004, DEV BIOL, V266, P43, DOI 10.1016/j.ydbio.2003.10.002; Li MG, 1999, J CELL BIOL, V146, P1061, DOI 10.1083/jcb.146.5.1061; Liana M, 2012, INT J ACAROL, V38, P648, DOI 10.1080/01647954.2012.734333; Maddox AS, 2005, DEVELOPMENT, V132, P2837, DOI 10.1242/dev.01828; Matova N, 2001, DEV BIOL, V231, P291, DOI 10.1006/dbio.2000.0120; Mazurkiewicz M, 2001, FOLIA BIOL-KRAKOW, V49, P205; Ong SK, 2010, DEV BIOL, V337, P84, DOI 10.1016/j.ydbio.2009.10.018; PASCHMA MARIAN, 1962, ZOOL POLON, V12, P145; Pekala J., 2002, ZOOL POLONIAE, V47, P59; Pepling ME, 1999, TRENDS CELL BIOL, V9, P257, DOI 10.1016/S0962-8924(99)01594-9; Poprawa I, 2014, PROTOP IN PRESS 1130; Poprawa I, 2014, PROTOP IN PRESS 1108; Pyka-Fosciak G, 2008, INT J DEV BIOL, V52, P259, DOI 10.1387/ijdb.072338gp; Robinson DN, 1997, ANNU REV CELL DEV BI, V13, P147, DOI 10.1146/annurev.cellbio.13.1.147; Robinson DN, 1996, TRENDS CELL BIOL, V6, P474, DOI 10.1016/0962-8924(96)84945-2; ROBINSON DN, 1994, DEVELOPMENT, V120, P2015; RYABOVA LV, 1994, MOL REPROD DEV, V37, P99, DOI 10.1002/mrd.1080370114; Serbus LR, 2005, DEVELOPMENT, V132, P3743, DOI 10.1242/dev.01956; Siekierska E, 2003, TISSUE CELL, V35, P252, DOI 10.1016/S0040-8166(03)00038-7; Spalek-Wolczynska A, 2008, J MORPHOL, V269, P18, DOI 10.1002/jmor.10568; Swiatek P, 2005, J MORPHOL, V266, P309, DOI 10.1002/jmor.10379; Swiatek P, 2002, FOLIA BIOL-KRAKOW, V50, P153; Swiatek P, 2008, ZOOMORPHOLOGY, V127, P213, DOI 10.1007/s00435-008-0065-5; Swiatek P, 2014, POSTEPY BIOL KOMORKI, V41, P507; Swiatek P, 2012, ZOOL ANZ, V251, P71, DOI 10.1016/j.jcz.2011.08.001; Swiatek P, 2010, INVERTEBR REPROD DEV, V54, P53, DOI 10.1080/07924259.2010.9652317; Swiatek P, 2009, CELL TISSUE RES, V337, P137, DOI 10.1007/s00441-009-0788-8; Szklarzewicz T, 1997, TISSUE CELL, V29, P31, DOI 10.1016/S0040-8166(97)80069-9; Szklarzewicz T, 2007, ARTHROPOD STRUCT DEV, V36, P199, DOI 10.1016/j.asd.2006.09.001; Telfer W. H., 1975, Advances Insect Physiol, V11, P223, DOI 10.1016/S0065-2806(08)60164-2; Tworzydlo W, 2014, ZOOLOGY, V117, P200, DOI 10.1016/j.zool.2014.01.002; Tworzydlo W, 2010, FOLIA BIOL-KRAKOW, V58, P67, DOI 10.3409/fb58_1-2.67-72; Urbisz AZ, 2014, J MORPHOL, V275, P479, DOI 10.1002/jmor.20229; Urbisz AZ, 2013, ZOOLOGY, V116, P118, DOI 10.1016/j.zool.2012.10.003; Urbisz AZ, 2010, ZOOMORPHOLOGY, V129, P235, DOI 10.1007/s00435-010-0116-6; Wang Y, 2008, MECH DEVELOP, V125, P142, DOI 10.1016/j.mod.2007.09.008; Wolke U, 2007, DEVELOPMENT, V134, P2227, DOI 10.1242/dev.004952	64	13	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126173	10.1371/journal.pone.0126173	http://dx.doi.org/10.1371/journal.pone.0126173			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001069	Green Published, Green Submitted, gold			2022-12-26	WOS:000354931700012
J	Coughlan, KA; Balon, TW; Valentine, RJ; Petrocelli, R; Schultz, V; Brandon, A; Cooney, GJ; Kraegen, EW; Ruderman, NB; Saha, AK				Coughlan, Kimberly A.; Balon, Thomas W.; Valentine, Rudy J.; Petrocelli, Robert; Schultz, Vera; Brandon, Amanda; Cooney, Gregory J.; Kraegen, Edward W.; Ruderman, Neil B.; Saha, Asish K.			Nutrient Excess and AMPK Downregulation in Incubated Skeletal Muscle and Muscle of Glucose Infused Rats	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; INSULIN-RESISTANCE; MALONYL-COA; LIPID-METABOLISM; PHOSPHATASE 2A; AMINO-ACID; SIRT1; PHOSPHORYLATION; GLYCOGEN; INHIBITION	We have previously shown that incubation for 1h with excess glucose or leucine causes insulin resistance in rat extensor digitorum longus (EDL) muscle by inhibiting AMP-activated protein kinase (AMPK). To examine the events that precede and follow these changes, studies were performed in rat EDL incubated with elevated levels of glucose or leucine for 30min-2h. Incubation in high glucose (25mM) or leucine (100 mu M) significantly diminished AMPK activity by 50% within 30min, with further decreases occurring at 1 and 2h. The initial decrease in activity at 30min coincided with a significant increase in muscle glycogen. The subsequent decreases at 1h were accompanied by phosphorylation of alpha AMPK at Ser(485/491), and at 2h by decreased SIRT1 expression and increased PP2A activity, all of which have previously been shown to diminish AMPK activity. Glucose infusion in vivo, which caused several fold increases in plasma glucose and insulin, produced similar changes but with different timing. Thus, the initial decrease in AMPK activity observed at 3h was associated with changes in Ser(485/491) phosphorylation and SIRT1 expression and increased PP2A activity was a later event. These findings suggest that both ex vivo and in vivo, multiple factors contribute to fuel-induced decreases in AMPK activity in skeletal muscle and the insulin resistance that accompanies it.	[Coughlan, Kimberly A.; Balon, Thomas W.; Valentine, Rudy J.; Petrocelli, Robert; Schultz, Vera; Ruderman, Neil B.; Saha, Asish K.] Boston Univ, Med Ctr, Dept Med, Sect Endocrinol & Diabet, Boston, MA 02215 USA; [Brandon, Amanda; Cooney, Gregory J.; Kraegen, Edward W.] Univ NSW, Garvan Inst Med Res, Diabet & Obes Program, Sydney, NSW, Australia; [Brandon, Amanda; Cooney, Gregory J.; Kraegen, Edward W.] Univ NSW, Sch Med Sci, Sydney, NSW, Australia	Boston University; Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney	Saha, AK (corresponding author), Boston Univ, Med Ctr, Dept Med, Sect Endocrinol & Diabet, Boston, MA 02215 USA.	aksaha@bu.edu		/0000-0003-1359-7830; Coughlan, Kimberly/0000-0002-4667-6909	USPHS [RO1DK19514, RO1DK67509]; NIH [5T32GM008541, 5T32HL007224]; National Health and Medical Research Council (NHMRC) of Australia [535921]; NHMRC Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007969, T32HL007224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019514, R01DK067509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008541] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by USPHS grants RO1DK19514, RO1DK67509 (to NBR and AKS), NIH training grants 5T32GM008541 (to KAC) and 5T32HL007224 (to RJV), National Health and Medical Research Council (NHMRC) of Australia Program Grant 535921 and the NHMRC Fellowship scheme (to EWK and GJC). Funding agency websites: http://www.nih.gov/ and http://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berggreen C, 2009, AM J PHYSIOL-ENDOC M, V296, pE635, DOI 10.1152/ajpendo.90596.2008; Brandon AE, 2011, ARCH BIOCHEM BIOPHYS, V509, P133, DOI 10.1016/j.abb.2011.03.008; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Coughlan KA, 2014, AM DIAB ASS 74 SCI S; Dagon Y, 2012, CELL METAB, V16, P104, DOI 10.1016/j.cmet.2012.05.010; Derave W, 2000, DIABETES, V49, P1281, DOI 10.2337/diabetes.49.8.1281; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; HAGER SR, 1991, AM J PHYSIOL, V260, pE353, DOI 10.1152/ajpendo.1991.260.3.E353; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Hoy AJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1358, DOI 10.1152/ajpendo.00133.2007; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Ido Y, 2002, DIABETES, V51, P159, DOI 10.2337/diabetes.51.1.159; Itani SI, 2003, DIABETES, V52, P1635, DOI 10.2337/diabetes.52.7.1635; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Koh HJ, 2008, CURR OPIN CLIN NUTR, V11, P227, DOI 10.1097/MCO.0b013e3282fb7b76; Kowluru A, 2012, BIOCHEM PHARMACOL, V84, P591, DOI 10.1016/j.bcp.2012.05.003; Kraegen EW, 2006, AM J PHYSIOL-ENDOC M, V290, pE471, DOI 10.1152/ajpendo.00316.2005; Kurowski TG, 1999, DIABETES, V48, P658, DOI 10.2337/diabetes.48.3.658; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Laybutt DR, 1997, AM J PHYSIOL-ENDOC M, V273, pE1, DOI 10.1152/ajpendo.1997.273.1.E1; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Long YC, 2008, AM J PHYSIOL-ENDOC M, V295, pE545, DOI 10.1152/ajpendo.90259.2008; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Park H, 2002, J BIOL CHEM, V277, P32571, DOI 10.1074/jbc.M201692200; Ruderman NB, 2003, ENDOCRINOLOGY, V144, P5166, DOI 10.1210/en.2003-0849; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Saha AK, 2010, DIABETES, V59, P2426, DOI 10.2337/db09-1870; Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Suzuki T, 2013, MOL CELL, V50, P407, DOI 10.1016/j.molcel.2013.03.022; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tsuchiya Y, 2012, BIOSCIENCE REP, V32, P197, DOI 10.1042/BSR20110076; Valentine RJ, 2014, ARCH BIOCHEM BIOPHYS, V562, P62, DOI 10.1016/j.abb.2014.08.013; Wang MY, 2005, AM J PHYSIOL-ENDOC M, V288, pE216, DOI 10.1152/ajpendo.00004.2004; Wojtaszewski JFP, 2002, DIABETES, V51, P284, DOI 10.2337/diabetes.51.2.284; Wojtaszewski JFP, 2003, AM J PHYSIOL-ENDOC M, V284, pE813, DOI 10.1152/ajpendo.00436.2002; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200	41	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127388	10.1371/journal.pone.0127388	http://dx.doi.org/10.1371/journal.pone.0127388			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996822	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000060
J	Hughes, J; Berger, T				Hughes, Jennifer; Berger, Trish			Development of Apical Blebbing in the Boar Epididymis	PLOS ONE			English	Article							REDUCED ENDOGENOUS ESTROGEN; SERTOLI-CELL PROLIFERATION; APOCRINE SECRETION; EPITHELIAL-CELLS; RAT EPIDIDYMIS; POSTNATAL-DEVELOPMENT; COAGULATING GLAND; PLASMA-MEMBRANE; V-ATPASE; PROTEINS	Microvesicles are of increasing interest in biology as part of normal function of numerous systems; from the immune system (T cell activation) to implantation of the embryo (invasion of the trophoblasts) and sperm maturation (protein transfer in the epididymis). Yet, the mechanisms involved in the appearance of apical blebbing from healthy cells as part of their normal function remain understudied. Microvesicles are produced via one of two pathways: exocytosis or apical blebbing also termed ectocytosis. This work quantifies the histological appearance of apical blebbing in the porcine epididymis during development and examines the role of endogenous estrogens in regulating this blebbing. Apical blebbing appears at puberty and increases in a linear manner into sexual maturity suggesting that this blebbing is a mature phenotype. Endogenous estrogen levels were reduced with an aromatase inhibitor but such a reduction did not affect apical blebbing in treated animals compared with their vehicle-treated littermates. Epididymal production of apical blebs is a secretion mechanism of functionally mature principal cells regulated by factors other than estradiol.	[Hughes, Jennifer; Berger, Trish] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Hughes, J (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.	jrhughes@ucdavis.edu	; , Trish/M-7848-2015	Hughes, Jennifer/0000-0002-7197-2195; , Trish/0000-0002-7780-2293	National Research Initiative Competitive Grant from USDA National Institute of Food and Agriculture [2008-35203-19082]; multistate research project [W2171]; W.K. Kellogg Endowment; Humphries Fellowship; Austin Eugene Lyons Memorial Fellowship	National Research Initiative Competitive Grant from USDA National Institute of Food and Agriculture; multistate research project; W.K. Kellogg Endowment; Humphries Fellowship; Austin Eugene Lyons Memorial Fellowship	This research was supported in part by the National Research Initiative Competitive Grant 2008-35203-19082 from the USDA National Institute of Food and Agriculture to TB, W2171 multistate research project to TB, a W.K. Kellogg Endowment to TB, Humphries Fellowship to JRH, Austin Eugene Lyons Memorial Fellowship to JRH and the infrastructure support of the Department of Animal Science, College of Agricultural and Environmental Sciences, and The California Agricultural Experiment Station of the University of California-Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLRICH RD, 1982, J ANIM SCI, V55, P1139, DOI 10.2527/jas1982.5551139x; Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; At-Taras EE, 2006, BIOL REPROD, V74, P58, DOI 10.1095/biolreprod.105.043760; Aumuller G, 1999, ANN ANAT, V181, P437, DOI 10.1016/S0940-9602(99)80020-X; BEDFORD JM, 1967, J EXP ZOOL, V166, P271, DOI 10.1002/jez.1401660210; Berger T, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.117770; Berger T, 2013, MOL CELL ENDOCRINOL, V366, P53, DOI 10.1016/j.mce.2012.11.011; Berger T, 2012, REPRODUCTION, V143, P523, DOI 10.1530/REP-11-0464; Burnett LA, 2012, J CLIN ENDOCR METAB, V97, P4613, DOI 10.1210/jc.2012-2098; Caballero JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065364; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Da Silva N, 2007, AM J PHYSIOL-CELL PH, V293, pC199, DOI 10.1152/ajpcell.00596.2006; Eickhoff R, 2006, CELLS TISSUES ORGANS, V182, P22, DOI 10.1159/000091715; Fan XP, 1998, ENDOCRINOLOGY, V139, P2128, DOI 10.1210/en.139.4.2128; FASS, 2010, GUID CAR US AGR AN R, V3rd; Girouard J, 2009, BIOL REPROD, V80, P965, DOI 10.1095/biolreprod.108.073551; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hermo L, 2002, MOL REPROD DEV, V63, P394, DOI 10.1002/mrd.90023; HOLTERHUS PM, 1993, ANAT REC, V235, P223, DOI 10.1002/ar.1092350206; JENKINS AD, 1983, J ANDROL, V4, P272; Katleba KD, 2015, J ENDOCRINOLOGY; Marengo SR, 2008, ANIM REPROD SCI, V105, P52, DOI 10.1016/j.anireprosci.2007.11.018; MOORE HDM, 1979, ANAT REC, V193, P293, DOI 10.1002/ar.1091930209; Morelli A, 2003, MOL BIOL CELL, V14, P2655, DOI 10.1091/mbc.02-04-0061; NAGY F, 1975, FERTIL STERIL, V26, P460; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Oh JS, 2009, MOL CELLS, V28, P441, DOI 10.1007/s10059-009-0140-x; Paunescu TG, 2014, MOL HUM REPROD, V20, P929, DOI 10.1093/molehr/gau052; Pearl CA, 2007, REPRODUCTION, V134, P593, DOI 10.1530/REP-06-0239; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Saez F, 2003, J ANDROL, V24, P149; Schwarz A, 2013, CELL TISSUE RES, V353, P549, DOI 10.1007/s00441-013-1633-7; STEINHOFF M, 1994, EUR J CELL BIOL, V65, P49; Sullivan R, 2007, ASIAN J ANDROL, V9, P483, DOI 10.1111/j.1745-7262.2007.00281.x; SUN EL, 1982, ANAT REC, V203, P273, DOI 10.1002/ar.1092030209; Syntin P, 1996, BIOL REPROD, V55, P956, DOI 10.1095/biolreprod55.5.956; Syntin P, 1999, BIOL REPROD, V61, P1622, DOI 10.1095/biolreprod61.6.1622; Thimon V, 2008, HUM REPROD, V23, P1698, DOI 10.1093/humrep/den181; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Verhoef PA, 2003, J IMMUNOL, V170, P5728, DOI 10.4049/jimmunol.170.11.5728	41	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0126848	10.1371/journal.pone.0126848	http://dx.doi.org/10.1371/journal.pone.0126848			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996942	Green Published, Green Submitted, gold			2022-12-26	WOS:000356444000033
J	Valeri, M; Zurli, V; Ayala, I; Colanzi, A; Lapazio, L; Corda, D; Soriani, M; Pizza, M; Paccani, SR				Valeri, Maria; Zurli, Vanessa; Ayala, Inmaculada; Colanzi, Antonino; Lapazio, Lucia; Corda, Daniela; Soriani, Marco; Pizza, Mariagrazia; Paccani, Silvia Rossi			The Neisseria meningitidis ADP-Ribosyltransferase NarE Enters Human Epithelial Cells and Disrupts Epithelial Monolayer Integrity	PLOS ONE			English	Article							HEAT-LABILE ENTEROTOXIN; NUCLEOTIDE-SEQUENCE; PSEUDOMONAS-AERUGINOSA; VACCINE DEVELOPMENT; ESCHERICHIA-COLI; SENSOR ARRAYS; TOXIN; ACTIN; RIBOSYLATION; GENE	Many pathogenic bacteria utilize ADP-ribosylating toxins to modify and impair essential functions of eukaryotic cells. It has been previously reported that Neisseria meningitidis possesses an ADP-ribosyltransferase enzyme, NarE, retaining the capacity to hydrolyse NAD and to transfer ADP-ribose moiety to arginine residues in target acceptor proteins. Here we show that upon internalization into human epithelial cells, NarE gains access to the cytoplasm and, through its ADP-ribosylating activity, targets host cell proteins. Notably, we observed that these events trigger the disruption of the epithelial monolayer integrity and the activation of the apoptotic pathway. Overall, our findings provide, for the first time, evidence for a biological activity of NarE on host cells, suggesting its possible involvement in Neisseria pathogenesis.	[Valeri, Maria; Zurli, Vanessa; Lapazio, Lucia; Soriani, Marco; Pizza, Mariagrazia; Paccani, Silvia Rossi] GSK Co, Vaccines & Diagnost Srl, Siena, Italy; [Ayala, Inmaculada; Colanzi, Antonino; Corda, Daniela] CNR, Inst Prot Biochem, Naples, Italy	GlaxoSmithKline; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Paccani, SR (corresponding author), GSK Co, Vaccines & Diagnost Srl, Via Fiorentina 1, Siena, Italy.	silvia.x.rossi-paccani@gsk.com	Ayala, Inmaculada/U-4565-2018; Colanzi, Antonino/D-6821-2012; Corda, Daniela/K-6385-2016; Zurli, Vanessa/Z-5927-2019	Ayala, Inmaculada/0000-0002-3329-1428; Colanzi, Antonino/0000-0002-5643-0216; Corda, Daniela/0000-0002-3614-751X; Zurli, Vanessa/0000-0001-8069-9242; SORIANI, Marco/0000-0002-9752-5844	Novartis Vaccines and Diagnostics S.r.l.-a GSK company; Italian Association for Cancer Research (AIRC, Milan, Italy) [IG10341, IG14675]; PON project [01/00117]	Novartis Vaccines and Diagnostics S.r.l.-a GSK company; Italian Association for Cancer Research (AIRC, Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); PON project(Ministry of Education, Universities and Research (MIUR))	This work was supported by internal funding by Novartis Vaccines and Diagnostics S.r.l.-a GSK company-and grants from the Italian Association for Cancer Research (AIRC, Milan, Italy; IG10341 and IG14675) and the PON project no. 01/00117. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Novartis Vaccines and Diagnostics S.r.l.-a GSK company-provided support in the form of salaries for authors MV, VZ, LL, MGP, MS, SRP but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKTORIES K, 1989, TRENDS PHARMACOL SCI, V10, P415, DOI 10.1016/0165-6147(89)90191-0; AKTORIES K, 1986, EUR J BIOCHEM, V161, P155, DOI 10.1111/j.1432-1033.1986.tb10136.x; Aktories K, 2012, TOXICON, V60, P572, DOI 10.1016/j.toxicon.2012.04.338; Althaus F R, 1987, Mol Biol Biochem Biophys, V37, P1; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Barbieri JT, 2002, ANNU REV CELL DEV BI, V18, P315, DOI 10.1146/annurev.cellbio.18.012502.134748; Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; Coureuil M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012393; FrithzLindsten E, 1997, MOL MICROBIOL, V25, P1125, DOI 10.1046/j.1365-2958.1997.5411905.x; GRAY GL, 1984, P NATL ACAD SCI-BIOL, V81, P2645, DOI 10.1073/pnas.81.9.2645; Gunther F, 2012, 18 INT PATH NEISS C; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Heine K, 2008, INFECT IMMUN, V76, P4600, DOI 10.1128/IAI.00651-08; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Horstman AL, 2002, J BIOL CHEM, V277, P32538, DOI 10.1074/jbc.M203740200; Koehler C, 2011, J BIOL CHEM, V286, P14842, DOI 10.1074/jbc.M110.193623; Lesnick ML, 2001, MOL MICROBIOL, V39, P1464, DOI 10.1046/j.1365-2958.2001.02360.x; LOCHT C, 1986, SCIENCE, V232, P1258, DOI 10.1126/science.3704651; Masignani V, 2004, INT J MED MICROBIOL, V293, P471, DOI 10.1078/1438-4221-00296; Masignani V, 2003, MOL MICROBIOL, V50, P1055, DOI 10.1046/j.1365-2958.2003.03770.x; MEKALANOS JJ, 1983, NATURE, V306, P551, DOI 10.1038/306551a0; PAPPENHEIMER AM, 1977, ANNU REV BIOCHEM, V46, P69, DOI 10.1146/annurev.bi.46.070177.000441; Picchianti M, 2013, FASEB J, V27, P4723, DOI 10.1096/fj.13-229955; PIZZA M, 1989, SCIENCE, V246, P497, DOI 10.1126/science.2683073; Rappuoli R, 1997, NAT MED, V3, P374, DOI 10.1038/nm0497-374; SCHERING B, 1988, EUR J BIOCHEM, V171, P225, DOI 10.1111/j.1432-1033.1988.tb13780.x; Schwan C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000626; Sutherland TC, 2010, INFECT IMMUN, V78, P3832, DOI 10.1128/IAI.01377-09; UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.biochem.54.1.73; Wilde C, 2001, J BIOL CHEM, V276, P9537, DOI 10.1074/jbc.M011035200; YAMAMOTO T, 1984, J BIOL CHEM, V259, P5037; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v	33	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127614	10.1371/journal.pone.0127614	http://dx.doi.org/10.1371/journal.pone.0127614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996923	Green Submitted, gold, Green Published			2022-12-26	WOS:000356444000081
J	Aslam, M; Tahir, M; Hussain, Z; Al-Zahrani, B				Aslam, Muhammad; Tahir, Muhammad; Hussain, Zawar; Al-Zahrani, Bander			A 3-Component Mixture of Rayleigh Distributions: Properties and Estimation in Bayesian Framework	PLOS ONE			English	Article							ELICITATION; WEIBULL	To study lifetimes of certain engineering processes, a lifetime model which can accommodate the nature of such processes is desired. The mixture models of underlying lifetime distributions are intuitively more appropriate and appealing to model the heterogeneous nature of process as compared to simple models. This paper is about studying a 3-component mixture of the Rayleigh distributionsin Bayesian perspective. The censored sampling environment is considered due to its popularity in reliability theory and survival analysis. The expressions for the Bayes estimators and their posterior risks are derived under different scenarios. In case the case that no or little prior information is available, elicitation of hyperparameters is given. To examine, numerically, the performance of the Bayes estimators using non-informative and informative priors under different loss functions, we have simulated their statistical properties for different sample sizes and test termination times. In addition, to highlight the practical significance, an illustrative example based on a real-life engineering data is also given.	[Aslam, Muhammad] Riphah Int Univ, Dept Basic Sci A, Islamabad 44000, Pakistan; [Tahir, Muhammad; Hussain, Zawar] Quaid I Azam Univ, Dept Stat, Islamabad 44000, Pakistan; [Al-Zahrani, Bander] King Abdulaziz Univ, Dept Stat, Jeddah 80203, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Tahir, M (corresponding author), Govt Coll Univ, Dept Stat, Faisalabad 38000, Pakistan.	tahirqaustat@yahoo.com	Tahir, Muhammad/R-1218-2019; Aslam, Muhammad/GRS-8220-2022; Hussain, Zawar/I-1616-2012	Aslam, Muhammad/0000-0002-6071-5468; 	Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah [163-130-1435]; DSR	Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah; DSR	This project was funded by the Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, under Grant no. 163-130-1435. The authors, therefore, acknowledge with thanks DSR technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SA, 2012, JORDAN J MECH IND EN, V6, P135; Al-Awadhi SA, 1998, COMMUN STAT-THEOR M, V27, P1123, DOI 10.1080/03610929808832149; Aslam M., 2003, J STAT THEORY APPL, V2, P70; Bayes T., 1764, PHILOS T ROY SOC LON, V53, P370, DOI [10.1098/rstl.1763.0053, DOI 10.1098/RSTL.1763.0053]; Berger J.O., 1995, STAT DECISION THEORY, V2nd ed; BERNARDO JM, 1979, J R STAT SOC B, V41, P113; BURCKHARDT CB, 1978, IEEE T SON ULTRASON, V25, P1, DOI 10.1109/T-SU.1978.30978; CHIVERS R C, 1977, Ultrasound in Medicine and Biology, V3, P1, DOI 10.1016/0301-5629(77)90115-6; DAVIS DJ, 1952, J AM STAT ASSOC, V47, P113, DOI 10.2307/2280740; de Laplace PS., 1820, THEORIE ANAL PROBABI; DeGroot M.H., 2005, OPTIMAL STAT DECISIO; GAVASAKAR U, 1988, MANAGE SCI, V34, P784, DOI 10.1287/mnsc.34.6.784; GEISSER S, 1984, AM STAT, V38, P244, DOI 10.2307/2683393; Gijbels I, 2010, WIRES COMPUT STAT, V2, P178, DOI 10.1002/wics.80; Hahn ED, 2006, J ROY STAT SOC A STA, V169, P37, DOI 10.1111/j.1467-985X.2005.00381.x; HARRIS CM, 1983, COMMUN STAT-THEOR M, V12, P987, DOI 10.1080/03610928308828511; Hebert JL, 2004, COMMUN STAT-THEOR M, V33, P29, DOI 10.1081/STA-120026575; JEFFREYS H, 1946, PROC R SOC LON SER-A, V186, P453, DOI 10.1098/rspa.1946.0056; Jeffreys H., 1961, THEORY PROBABILITY; Jones P. N., 1990, J APPL STAT, V17, P271, DOI DOI 10.1080/757582839; KADANE JB, 1980, J AM STAT ASSOC, V75, P845, DOI 10.2307/2287171; Kalbfleisch R.L, 2011, STAT ANAL FAILURE TI; Kanji K. G., 1985, J APPL STAT, V12, P49, DOI DOI 10.1080/02664768500000006; Kazmi SM., 2012, INT J APPL SCI TECHN, V2, P197; Legendre A.M., 1806, NOUVELLES METHODES D; Li L. A., 1982, TECHNICAL REPORT; LI LA, 1988, ANN STAT, V16, P1623, DOI 10.1214/aos/1176351057; Li LA, 1983, THESIS STATE U NEW Y; MCCULLAGH P, 1994, BIOMETRIKA, V81, P721; MENDENHALL W, 1958, BIOMETRIKA, V45, P504, DOI 10.2307/2333197; Norstrom JG, 1996, IEEE T RELIAB, V45, P400, DOI 10.1109/24.536992; Rattanapitikon W, 2010, OCEAN ENG, V37, P1554, DOI 10.1016/j.oceaneng.2010.09.013; Romeu L. J., 2004, STRATEGIC ARMS REDUC, V11, P1; Saleem M, 2008, J APPL STAT SCI, V16, P493; Saleem M., 2010, J APPL STAT, V37, P25, DOI DOI 10.1080/02664760902914557; Siddiqui M.M, 1962, J RES NBS SECTION RA, V66D, P167, DOI [10.6028/jres.066d.020, DOI 10.6028/JRES.066D.020]; Sinha S. K., 1998, BAYESIAN ESTIMATION; Sultan KS, 2007, COMPUT STAT DATA AN, V51, P5377, DOI 10.1016/j.csda.2006.09.016; van Vledder G.Ph., 2013, COASTAL DYN, V2013, P1799	39	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126183	10.1371/journal.pone.0126183	http://dx.doi.org/10.1371/journal.pone.0126183			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993475	gold, Green Submitted, Green Published			2022-12-26	WOS:000354921400057
J	Khonsari, AS; Kollmann, M				Khonsari, Armin S.; Kollmann, Markus			Perception and Regulatory Principles of Microbial Growth Control	PLOS ONE			English	Article							FLUX BALANCE ANALYSIS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; ENVIRONMENTAL-CHANGES; ADAPTIVE PREDICTION; OVERFLOW METABOLISM; GLUCOSE; MICROORGANISMS; OPTIMALITY; REPRESSION	Fast growth represents an effective strategy for microbial organisms to survive in competitive environments. To accomplish this task, cells must adapt their metabolism to changing nutrient conditions in a way that maximizes their growth rate. However, the regulation of the growth related metabolic pathways can be fundamentally different among microbes. We therefore asked whether growth control by perception of the cell's intracellular metabolic state can give rise to higher growth than by direct perception of extracellular nutrient availability. To answer this question, we created a simplified dynamical computer model of a cellular metabolic network whose regulation was inferred by an optimization approach. We used this model for a competing species experiment, where a species with extracellular nutrient perception competes against one with intracellular nutrient perception by evaluating their respective average growth rate. We found that the intracellular perception is advantageous under situations where the up and down regulation of pathways cannot follow the fast changing nutrient availability in the environment. In this case, optimal regulation ignores any other nutrients except the most preferential ones, in agreement with the phenomenon of catabolite repression in prokaryotes. The corresponding metabolic pathways remain activated, despite environmental fluctuations. Therefore, the cell can take up preferential nutrients as soon as they are available without any prior regulation. As a result species that rely on intracellular perception gain a relevant fitness advantage in fluctuating nutrient environments, which enables survival by outgrowing competitors.	[Khonsari, Armin S.; Kollmann, Markus] Univ Dusseldorf, Math Modellierung Biol Syst, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Khonsari, AS (corresponding author), Univ Dusseldorf, Math Modellierung Biol Syst, Dusseldorf, Germany.	armin.khonsari@uni-duesseldorf.de			Deutsche Forschungsgemeinschaft excellence program CEPLAS [EXC 1028]	Deutsche Forschungsgemeinschaft excellence program CEPLAS	The authors acknowledge funding by the Deutsche Forschungsgemeinschaft excellence program CEPLAS (EXC 1028) (URL: http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adadi R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002575; Alon U., 2006, INTRO SYSTEMS BIOL D; Beg QK, 2007, P NATL ACAD SCI USA, V104, P12663, DOI 10.1073/pnas.0609845104; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; HOLLYWOOD N, 1976, MICROBIOS, V17, P23; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Kotte O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.10; Lee JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000086; Lincoln TA, 2009, SCIENCE, V323, P1229, DOI 10.1126/science.1167856; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Miermont A, 2013, P NATL ACAD SCI USA, V110, P5725, DOI 10.1073/pnas.1215367110; Mitchell A, 2011, P NATL ACAD SCI USA, V108, P7271, DOI 10.1073/pnas.1019754108; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Molenaar D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.82; Moriya H, 2004, P NATL ACAD SCI USA, V101, P1572, DOI 10.1073/pnas.0305901101; Nagrath D, 2007, ANN BIOMED ENG, V35, P863, DOI 10.1007/s10439-007-9283-0; New AM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001764; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882; Scott M, 2011, CURR OPIN BIOTECH, V22, P559, DOI 10.1016/j.copbio.2011.04.014; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; Vazquez A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-7; Vemuri GN, 2007, P NATL ACAD SCI USA, V104, P2402, DOI 10.1073/pnas.0607469104; Vemuri GN, 2006, APPL ENVIRON MICROB, V72, P3653, DOI 10.1128/AEM.72.5.3653-3661.2006; Westergaard SL, 2007, BIOTECHNOL BIOENG, V96, P134, DOI 10.1002/bit.21135; You CH, 2013, NATURE, V500, P301, DOI 10.1038/nature12446; Youk H, 2009, NATURE, V462, P875, DOI 10.1038/nature08653; Young J, 2004, CHEM ENG SCI, V59, P5041, DOI 10.1016/j.ces.2004.09.037; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	35	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126244	10.1371/journal.pone.0126244	http://dx.doi.org/10.1371/journal.pone.0126244			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992898	Green Published, Green Submitted, gold			2022-12-26	WOS:000354921400059
J	Ning, LL; Pan, DB; Zhang, Y; Wang, SP; Liu, HX; Yao, XJ				Ning, Lulu; Pan, Dabo; Zhang, Yan; Wang, Shaopeng; Liu, Huanxiang; Yao, Xiaojun			Effects of the Pathogenic Mutation A117V and the Protective Mutation H111S on the Folding and Aggregation of PrP106-126: Insights from Replica Exchange Molecular Dynamics Simulations	PLOS ONE			English	Article							HUMAN PRION PROTEIN; STRAUSSLER-SCHEINKER SYNDROME; CONFORMATIONAL POLYMORPHISM; PEPTIDE; STATES; RESIDUES; DISEASE; PRP; NEUROTOXICITY; RESISTANT	The fragment 106-126 of prion protein exhibits similar properties to full-length prion. Experiments have shown that the A117V mutation enhances the aggregation of PrP106-126, while the H111S mutation abolishes the assembly. However, the mechanism of the change in the aggregation behavior of PrP106-126 upon the two mutations is not fully understood. In this study, replica exchange molecular dynamics simulations were performed to investigate the conformational ensemble of the WT PrP106-126 and its two mutants A117V and H111S. The obtained results indicate that the three species are all intrinsically disordered but they have distinct morphological differences. The A117V mutant has a higher propensity to form beta-hairpin structures than the WT, while the H111S mutant has a higher population of helical structures. Furthermore, the A117V mutation increases the hydrophobic solvent accessible surface areas of PrP106-126 and the H111S mutation reduces the exposure of hydrophobic residues. It can be concluded that the difference in populations of beta-hairpin structures and the change of hydrophobic solvent accessible areas may induce the different aggregation behaviors of the A117V and the H111S mutated PrP106-126. Understanding why the two mutations have contrary effects on the aggregation of PrP106-126 is very meaningful for further elucidation of the mechanism underlying aggregation and design of inhibitor against aggregation process.	[Ning, Lulu; Pan, Dabo; Wang, Shaopeng; Yao, Xiaojun] Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China; [Ning, Lulu; Pan, Dabo; Wang, Shaopeng; Yao, Xiaojun] Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China; [Zhang, Yan; Liu, Huanxiang] Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China; [Yao, Xiaojun] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Taipa, Macau, Peoples R China; [Pan, Dabo] Qiandongnan Natl Polytech, Sch Pharmaceut Technol, Kaili, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University; Macau University of Science & Technology	Liu, HX (corresponding author), Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China.	hxliu@lzu.edu.cn; xjyao@lzu.edu.cn		Liu, Huanxiang/0000-0002-9284-3667	National Natural Science Foundation of China [21103075, 21375054]; Natural Science Foundation of Gansu Province, China [1208RJYA034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Gansu Province, China	This work was supported by the National Natural Science Foundation of China (Grant Nos: 21103075 and 21375054) and the Natural Science Foundation of Gansu Province, China (Grant No: 1208RJYA034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altis A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2945165; Babin V., 2008, AMBER; Ball KA, 2013, BIOPHYS J, V104, P2714, DOI 10.1016/j.bpj.2013.04.056; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; BROWN DR, 1994, NEUROREPORT, V5, P2057, DOI 10.1097/00001756-199410270-00017; Brown DR, 2000, BIOCHEM J, V346, P785, DOI 10.1042/0264-6021:3460785; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Coskuner O, 2013, ACS CHEM NEUROSCI, V4, P310, DOI 10.1021/cn300149j; Daidone I, 2011, BIOPHYS J, V100, P3000, DOI 10.1016/j.bpj.2011.04.053; DEGIOIA L, 1994, J BIOL CHEM, V269, P7859; Di Natale G, 2005, ORG BIOMOL CHEM, V3, P490, DOI 10.1039/b407928k; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; FORLONI G, 1994, EUR J NEUROSCI, V6, P1415, DOI 10.1111/j.1460-9568.1994.tb01003.x; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Frishman D, 2004, PROTEIN-STRUCT FUNCT, V23, P566; Gill AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087354; Grabenauer M, 2010, J AM CHEM SOC, V132, P532, DOI 10.1021/ja905595k; Guo JJ, 2012, BBA-GEN SUBJECTS, V1820, P116, DOI 10.1016/j.bbagen.2011.11.013; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Kuwata K, 2003, P NATL ACAD SCI USA, V100, P14790, DOI 10.1073/pnas.2433563100; Levy Y, 2001, PROTEINS, V45, P382, DOI 10.1002/prot.1157; Li SS, 2014, J CHEM THEORY COMPUT, V10, P2255, DOI 10.1021/ct5002279; Lu Y, 2011, J PHYS CHEM B, V115, P1282, DOI 10.1021/jp110269a; Viet MH, 2013, ACS CHEM NEUROSCI, V4, P1446, DOI 10.1021/cn400110d; Matthes D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019129; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Miller C, 2013, J PHYS CHEM B, V117, P16066, DOI 10.1021/jp409755y; Muramoto T, 1997, NAT MED, V3, P750, DOI 10.1038/nm0797-750; Muramoto T, 1996, P NATL ACAD SCI USA, V93, P15457, DOI 10.1073/pnas.93.26.15457; Nandi PK, 1998, ARCH VIROL, V143, P1251, DOI 10.1007/s007050050373; Nguyen PH, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4866902; Nguyen PH, 2014, J PHYS CHEM B, V118, P501, DOI 10.1021/jp4115404; Nguyen PH, 2011, PHYS CHEM CHEM PHYS, V13, P9778, DOI 10.1039/c1cp20323a; Ning LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087266; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Patriksson A, 2008, PHYS CHEM CHEM PHYS, V10, P2073, DOI 10.1039/b716554d; Petty SA, 2005, BIOCHEMISTRY-US, V44, P4720, DOI 10.1021/bi047445a; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qiao Q, 2013, J AM CHEM SOC, V135, P16092, DOI 10.1021/ja403147m; Reddy AS, 2010, BIOPHYS J, V99, P2208, DOI 10.1016/j.bpj.2010.07.014; Rosenman DJ, 2013, J MOL BIOL, V425, P3338, DOI 10.1016/j.jmb.2013.06.021; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salmona M, 1999, BIOCHEM J, V342, P207, DOI 10.1042/0264-6021:3420207; SELVAGGINI C, 1993, BIOCHEM BIOPH RES CO, V194, P1380, DOI 10.1006/bbrc.1993.1977; Sgourakis NG, 2011, J MOL BIOL, V405, P570, DOI 10.1016/j.jmb.2010.10.015; Singh S, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4798460; Smith MD, 2014, PHYS CHEM CHEM PHYS, V16, P13069, DOI 10.1039/c4cp01090f; STAHL N, 1991, FASEB J, V5, P2799, DOI 10.1096/fasebj.5.13.1916104; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Tranchant C, 1997, J NEUROL NEUROSUR PS, V63, P240, DOI 10.1136/jnnp.63.2.240; van der Kamp MW, 2010, J MOL BIOL, V404, P732, DOI 10.1016/j.jmb.2010.09.060; Villa A, 2006, J PHYS CHEM B, V110, P1423, DOI 10.1021/jp052722o; Walsh P, 2010, J AM CHEM SOC, V132, P7684, DOI 10.1021/ja100431q; Walsh P, 2009, STRUCTURE, V17, P417, DOI 10.1016/j.str.2008.12.018; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang XS, 2013, J BIOL INORG CHEM, V18, P767, DOI 10.1007/s00775-013-1030-4; Wei GH, 2010, PHYS CHEM CHEM PHYS, V12, P3622, DOI 10.1039/c000755m; Weissmann C, 2005, CELL, V122, P165, DOI 10.1016/j.cell.2005.07.001; Xu L, 2013, ACS CHEM NEUROSCI, V4, P1458, DOI 10.1021/cn4001445; Xu L, 2013, J COMPUT CHEM, V34, P2524, DOI 10.1002/jcc.23416; Xu L, 2013, J PHYS CHEM B, V117, P6206, DOI 10.1021/jp403288b	73	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125899	10.1371/journal.pone.0125899	http://dx.doi.org/10.1371/journal.pone.0125899			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993001	gold, Green Submitted, Green Published			2022-12-26	WOS:000354921400049
J	Pathman, T; Ghetti, S				Pathman, Thanujeni; Ghetti, Simona			Eye Movements Provide an Index of Veridical Memory for Temporal Order	PLOS ONE			English	Article							VISUAL-SPATIAL INFORMATION; RELATIONAL MEMORY; SCENE PERCEPTION; DEPENDENT MEMORY; WORKING-MEMORY; NATURAL SCENES; SERIAL MEMORY; TIME; RETRIEVAL; TRACKING	The present research examined whether eye movements during retrieval capture the relation between an event and its temporal attributes. In two experiments (N=76), we found converging evidence that eye movements reflected the veridicality of memory for temporal order seconds before overt memory judgments, suggesting that these movements captured indirect access to temporal information. These eye movements did not entirely depend on the amount of contextual cueing available (Experiment 1) and reflected the unique ordinal position of an event in a sequence (Experiment 2). Based on our results, we conclude that eye movements reflected the absolute temporal order of past events.	[Pathman, Thanujeni] Univ N Carolina, Dept Psychol, Greensboro, NC 27412 USA; [Ghetti, Simona] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	University of North Carolina; University of North Carolina Greensboro; University of California System; University of California Davis	Pathman, T (corresponding author), Univ N Carolina, Dept Psychol, Greensboro, NC 27412 USA.	t_pathma@uncg.edu		Pathman, Thanujeni/0000-0003-0017-7319	A James S. McDonnell Foundation; UNCG College of Arts and Sciences	A James S. McDonnell Foundation; UNCG College of Arts and Sciences	A James S. McDonnell Foundation scholar award to S. G. supported the work. UNCG College of Arts and Sciences provided support in the form of the publication fee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck MR, 2007, MEM COGNITION, V35, P610, DOI 10.3758/BF03193299; Brodeur MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010773; Carlson-Radvansky LA, 1999, PERCEPT PSYCHOPHYS, V61, P919, DOI 10.3758/BF03206906; Ezzyat Y, 2014, NEURON, V81, P1179, DOI 10.1016/j.neuron.2014.01.042; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Foulsham T, 2013, J EXP PSYCHOL GEN, V142, P41, DOI 10.1037/a0028227; Friedman WJ, 2004, SOC COGNITION, V22, P591, DOI 10.1521/soco.22.5.591.50766; FRIEDMAN WJ, 1993, PSYCHOL BULL, V113, P44, DOI 10.1037/0033-2909.113.1.44; Godijn R, 2012, MEM COGNITION, V40, P52, DOI 10.3758/s13421-011-0132-x; Hannula DE, 2007, J COGNITIVE NEUROSCI, V19, P1690, DOI 10.1162/jocn.2007.19.10.1690; Hannula DE, 2012, PSYCHOL SCI, V23, P278, DOI 10.1177/0956797611429799; Hannula DE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00166; Hannula DE, 2009, NEURON, V63, P592, DOI 10.1016/j.neuron.2009.08.025; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Hayhoe MM, 1998, VISION RES, V38, P125, DOI 10.1016/S0042-6989(97)00116-8; Henderson JM, 2003, PERCEPT PSYCHOPHYS, V65, P58, DOI 10.3758/BF03194783; Hollingworth A, 2001, PSYCHON B REV, V8, P761, DOI 10.3758/BF03196215; Holm L, 2007, MEM COGNITION, V35, P1664, DOI 10.3758/BF03193500; Holm L, 2008, J VISION, V8, DOI 10.1167/8.4.14; Hooge LTC, 1996, PERCEPT PSYCHOPHYS, V58, P969, DOI 10.3758/BF03206825; Hoover MA, 2008, COGNITION, V108, P533, DOI 10.1016/j.cognition.2008.02.011; Hsieh LT, 2014, NEURON, V81, P1165, DOI 10.1016/j.neuron.2014.01.015; Irwin DE, 2002, PERCEPT PSYCHOPHYS, V64, P882, DOI 10.3758/BF03196793; Johansson R, 2014, PSYCHOL SCI, V25, P236, DOI 10.1177/0956797613498260; Koski J, 2013, MEMORY, V21, P396, DOI 10.1080/09658211.2012.735241; Kukona A, 2014, COGNITION, V133, P25, DOI 10.1016/j.cognition.2014.05.011; Kumaran D, 2009, NEURON, V63, P561, DOI 10.1016/j.neuron.2009.08.027; Laeng B, 2014, COGNITION, V131, P263, DOI 10.1016/j.cognition.2014.01.003; Liversedge S., 2011, OXFORD HDB EYE MOVEM; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; Marshuetz C, 2005, PSYCHOL BULL, V131, P323, DOI 10.1037/0033-2909.131.3.323; NAVEHBENJAMIN M, 1990, J EXP PSYCHOL LEARN, V16, P117, DOI 10.1037/0278-7393.16.1.117; Olsen RK, 2014, J VISION, V14, DOI 10.1167/14.1.8; Pathman T, 2014, CHILD DEV, V85, P792, DOI 10.1111/cdev.12152; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Richmond J, 2009, DEVELOPMENTAL SCI, V12, P549, DOI 10.1111/j.1467-7687.2009.00795.x; Richmond JL, 2014, DEV PSYCHOBIOL, V56, P1341, DOI 10.1002/dev.21213; Ryan JD, 2000, PSYCHOL SCI, V11, P454, DOI 10.1111/1467-9280.00288; Ryan JD, 2004, J EXP PSYCHOL HUMAN, V30, P988, DOI 10.1037/0096-1523.30.5.988; Ryan JD, 2004, NEUROPSYCHOLOGIA, V42, P497, DOI 10.1016/j.neuropsychologia.2003.08.011; Ryan JD, 2007, MEMORY, V15, P508, DOI 10.1080/09658210701391022; Ryan JD, 2009, VIS COGN, V17, P254, DOI 10.1080/13506280802336362; Saint-Aubin J, 2007, EXP PSYCHOL, V54, P264, DOI 10.1027/1618-3169.54.4.264; Schwedes C, 2012, MEM COGNITION, V40, P642, DOI 10.3758/s13421-011-0173-1; Smith CN, 2006, J NEUROSCI, V26, P11304, DOI 10.1523/JNEUROSCI.3071-06.2006; Solway A, 2012, MEM COGNITION, V40, P177, DOI 10.3758/s13421-011-0142-8; Theeuwes J, 2009, ACTA PSYCHOL, V132, P106, DOI 10.1016/j.actpsy.2009.01.005; Tobii Technology, 2010, WHIT PAP TIM GUID TO; TOGLIA MP, 1976, J EXP PSYCHOL-HUM L, V2, P431; Tremblay S, 2006, PSYCHON B REV, V13, P452, DOI 10.3758/BF03193869; Tubridy S, 2011, CEREB CORTEX, V21, P272, DOI 10.1093/cercor/bhq092; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Tulving E., 1972, ORG MEMORY, P382, DOI DOI 10.1007/978-1-4419-0463-8_37; Van der Stigchel S, 2006, NEUROSCI BIOBEHAV R, V30, P666, DOI 10.1016/j.neubiorev.2005.12.001; Zelinsky GJ, 2005, PERCEPT PSYCHOPHYS, V67, P676, DOI 10.3758/BF03193524; ZIMMERMAN J, 1968, J GEN PSYCHOL, V79, P301, DOI 10.1080/00221309.1968.9710477	56	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125648	10.1371/journal.pone.0125648	http://dx.doi.org/10.1371/journal.pone.0125648			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7CV	25993437	Green Submitted, gold, Green Published			2022-12-26	WOS:000354921400040
J	Ramis, R; Gomez-Barroso, D; Tamayo, I; Garcia-Perez, J; Morales, A; Romaguera, EP; Lopez-Abente, G				Ramis, Rebeca; Gomez-Barroso, Diana; Tamayo, Ibon; Garcia-Perez, Javier; Morales, Antonio; Pardo Romaguera, Elena; Lopez-Abente, Gonzalo			Spatial Analysis of Childhood Cancer: A Case/Control Study	PLOS ONE			English	Article							NERVOUS-SYSTEM TUMORS; ACUTE-LEUKEMIA; INFECTIOUS ETIOLOGY; CLUSTER DETECTION; EPIDEMIOLOGY; RISK; HETEROGENEITY; PATTERN; FRANCE	Background Childhood cancer was the leading cause of death among children aged 1-14 years for 2012 in Spain. Leukemia has the highest incidence, followed by tumors of the central nervous system (CNS) and lymphomas (Hodgkin lymphoma, HL, and Non-Hodgkin's lymphoma, NHL). Spatial distribution of childhood cancer cases has been under concern with the aim of identifying potential risk factors. Objective The two objectives are to study overall spatial clustering and cluster detection of cases of the three main childhood cancer causes, looking to increase etiological knowledge. Methods We ran a case-control study. The cases were children aged 0 to 14 diagnosed with leukemia, lymphomas (HL and NHL) or CNS neoplasm in five Spanish regions for the period 1996-2011. As a control group, we used a sample from the Birth Registry matching every case by year of birth, autonomous region of residence and sex with six controls. We geo-coded and validated the address of the cases and controls. For our two objectives we used two different methodologies. For the first, for overall spatial clustering detection, we used the differences of K functions from the spatial point patterns perspective proposed by Diggle and Chetwynd and the second, for cluster detection, we used the spatial scan statistic proposed by Kulldorff with a level for statistical significance of 0.05. Results We had 1062 cases of leukemia, 714 cases of CNS, 92 of HL and 246 of NHL. Accordingly we had 6 times the number of controls, 6372 controls for leukemia, 4284 controls for CNS, 552 controls for HL and 1476 controls for NHL. We found variations in the estimated empirical D(s) for the different regions and cancers, including some overall spatial clustering for specific regions and distances. We did not find statistically significant clusters. Conclusions The variations in the estimated empirical D(s) for the different regions and cancers could be partially explained by the differences in the spatial distribution of the population; however, according to the literature, we cannot discard environmental hazards or infections agents in the etiology of these cancers.	[Ramis, Rebeca; Garcia-Perez, Javier; Lopez-Abente, Gonzalo] ISCIII, Natl Ctr Epidemiol, Environm Epidemiol & Canc Unit, Madrid, Spain; [Ramis, Rebeca; Gomez-Barroso, Diana; Tamayo, Ibon; Garcia-Perez, Javier; Lopez-Abente, Gonzalo] CIBERESP, Consortium Biomed Res Epidemiol & Publ Hlth, Madrid, Spain; [Tamayo, Ibon] BIODonostia Res Inst, Publ Hlth Div Gipuzkoa, Dept Hlth Reg Govt Basque Country, Donostia San Sebastian, Spain; [Morales, Antonio] ISCIII, IIER, Rare Dis Res Inst, Madrid, Spain; [Morales, Antonio] CIBERER, Consortium Biomed Res Rare Dis, Madrid, Spain; [Pardo Romaguera, Elena] Univ Valencia, RETI SEHOP, Valencia, Spain	Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Basque Government; Instituto de Salud Carlos III; Instituto de Investigacion de Enfermedades Raras (IIER); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Valencia	Ramis, R (corresponding author), ISCIII, Natl Ctr Epidemiol, Environm Epidemiol & Canc Unit, Madrid, Spain.	rramis@isciii.es	García-Pérez, Javier/F-4566-2016; Tamayo-Uria, Ibon/H-5283-2019; Lopez-Abente, Gonzalo/E-5221-2010; Ramis, Rebeca/E-1743-2015; Gomez-Barroso, Diana/Q-5417-2018	García-Pérez, Javier/0000-0003-0300-1810; Tamayo-Uria, Ibon/0000-0002-8183-7106; Lopez-Abente, Gonzalo/0000-0003-2423-8075; Ramis, Rebeca/0000-0001-6154-9142; Gomez-Barroso, Diana/0000-0001-7388-1767	Spain's Health Research Fund (Fondo de Investigacion Sanitaria) [FIS 12/01416]	Spain's Health Research Fund (Fondo de Investigacion Sanitaria)(Instituto de Salud Carlos III)	This study was funded by Spain's Health Research Fund (Fondo de Investigacion Sanitaria - FIS 12/01416) http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-planificacion-2/accion-estrategica-salud.shtml.	Alexander F, 1998, RADIAT ENVIRON BIOPH, V37, P71, DOI 10.1007/s004110050096; ALEXANDER FE, 1993, EUR J CANCER, V29A, P1424, DOI 10.1016/0959-8049(93)90016-9; Alexander FE, 1998, BRIT J CANCER, V77, P818, DOI 10.1038/bjc.1998.133; Alexander FE, 1999, EUR J CANCER, V35, P439, DOI 10.1016/S0959-8049(98)00385-2; Badaloni C, 2013, OCCUP ENVIRON MED, V70, P876, DOI 10.1136/oemed-2013-101604; Demoury C, 2012, EUR J CANCER PREV, V21, P367, DOI 10.1097/CEJ.0b013e32834e31d8; DIGGLE PJ, 1991, BIOMETRICS, V47, P1155, DOI 10.2307/2532668; Dixon PM, 2002, ENCY ENV, DOI [10.1002/9780470057339.var046.pub2/full, DOI 10.1002/9780470057339.VAR046.PUB2/FULL]; Faure C, 2009, EUR J CANCER PREV, V18, P267, DOI 10.1097/CEJ.0b013e32832bf43a; Grimes DA, 2005, LANCET, V365, P1429, DOI 10.1016/S0140-6736(05)66379-9; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lopez-Abente G, 2003, OCCUP ENVIRON MED, V60, P504, DOI 10.1136/oem.60.7.504; Luquero FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019005; McKinney PA, 2005, BIOELECTROMAGNETICS, pS60, DOI 10.1002/bem.20149; McNally RJQ, 2014, AM J EPIDEMIOL, V179, P492, DOI 10.1093/aje/kwt308; McNally RJQ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-13; McNally RJQ, 2009, INT J CANCER, V124, P932, DOI 10.1002/ijc.23965; McNally RJQ, 2004, BRIT J HAEMATOL, V127, P243, DOI 10.1111/j.1365-2141.2004.05166.x; McNally RJQ, 2002, BRIT J CANCER, V86, P1070, DOI [10.1038/sj.bjc.6600228, 10.1038/sj/bjc/6600228]; Pedersen C, 2014, CANCER CAUSE CONTROL, V25, P171, DOI 10.1007/s10552-013-0319-5; Peris-Bonet R, 2010, ANN ONCOL, V21, piii103, DOI 10.1093/annonc/mdq092; Peris-Bonet R, 2013, CANC INFANTIL ESPANA; Quantum GIS Development Team, 2014, QUANTUM GIS GEOGRAPH; Ramis R, 2014, GEOSPATIAL HEALTH, V8, P517, DOI 10.4081/gh.2014.41; ROBISON LL, 1995, ENVIRON HEALTH PERSP, V103, P111, DOI 10.2307/3432358; Ross J A, 2000, Curr Oncol Rep, V2, P234, DOI 10.1007/s11912-000-0073-1; Rothman KJ, 2012, MODERN EPIDEMIOLOGY; ROWLINGSON BS, 1993, COMPUT GEOSCI, V19, P627, DOI 10.1016/0098-3004(93)90099-Q; Schottenfeld D, 2006, CANC EPIDEMIOLOGY PR; Selvin S, 2004, INT J HYG ENVIR HEAL, V207, P555, DOI 10.1078/1438-4639-00327; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Stiller CA, 2006, EUR J CANCER, V42, P1952, DOI 10.1016/j.ejca.2006.05.017; Torabi M, 2011, SPAT SPATIO-TEMPORAL, V2, P321, DOI 10.1016/j.sste.2011.10.003; Vinson F, 2011, OCCUP ENVIRON MED, V68, P694, DOI 10.1136/oemed-2011-100082; Waller L, 2010, CH CRC HANDB MOD STA, P403	35	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127273	10.1371/journal.pone.0127273	http://dx.doi.org/10.1371/journal.pone.0127273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992892	Green Published, gold			2022-12-26	WOS:000354921400104
J	Venn-Watson, S; Colegrove, KM; Litz, J; Kinsel, M; Terio, K; Saliki, J; Fire, S; Carmichael, R; Chevis, C; Hatchett, W; Pitchford, J; Tumlin, M; Field, C; Smith, S; Ewing, R; Fauquier, D; Lovewell, G; Whitehead, H; Rotstein, D; Mcfee, W; Fougeres, E; Rowles, T				Venn-Watson, Stephanie; Colegrove, Kathleen M.; Litz, Jenny; Kinsel, Michael; Terio, Karen; Saliki, Jeremiah; Fire, Spencer; Carmichael, Ruth; Chevis, Connie; Hatchett, Wendy; Pitchford, Jonathan; Tumlin, Mandy; Field, Cara; Smith, Suzanne; Ewing, Ruth; Fauquier, Deborah; Lovewell, Gretchen; Whitehead, Heidi; Rotstein, David; Mcfee, Wayne; Fougeres, Erin; Rowles, Teri			Adrenal Gland and Lung Lesions in Gulf of Mexico Common Bottlenose Dolphins (Tursiops truncatus) Found Dead following the Deepwater Horizon Oil Spill	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MINK MUSTELA-VISON; MORBILLIVIRUS INFECTION; AROMATIC-HYDROCARBONS; CANARY-ISLANDS; CHRONIC STRESS; CRUDE-OIL; ATLANTIC; BRUCELLA; EXPOSURE	A northern Gulf of Mexico (GoM) cetacean unusual mortality event (UME) involving primarily bottlenose dolphins (Tursiops truncatus) in Louisiana, Mississippi, and Alabama began in February 2010 and continued into 2014. Overlapping in time and space with this UME was the Deepwater Horizon (DWH) oil spill, which was proposed as a contributing cause of adrenal disease, lung disease, and poor health in live dolphins examined during 2011 in Barataria Bay, Louisiana. To assess potential contributing factors and causes of deaths for stranded UME dolphins from June 2010 through December 2012, lung and adrenal gland tissues were histologically evaluated from 46 fresh dead non-perinatal carcasses that stranded in Louisiana (including 22 from Barataria Bay), Mississippi, and Alabama. UME dolphins were tested for evidence of biotoxicosis, morbillivirus infection, and brucellosis. Results were compared to up to 106 fresh dead stranded dolphins from outside the UME area or prior to the DWH spill. UME dolphins were more likely to have primary bacterial pneumonia (22% compared to 2% in non-UME dolphins, P = .003) and thin adrenal cortices (33% compared to 7% in non-UME dolphins, P = .003). In 70% of UME dolphins with primary bacterial pneumonia, the condition either caused or contributed significantly to death. Brucellosis and morbillivirus infections were detected in 7% and 11% of UME dolphins, respectively, and biotoxin levels were low or below the detection limit, indicating that these were not primary causes of the current UME. The rare, life-threatening, and chronic adrenal gland and lung diseases identified in stranded UME dolphins are consistent with exposure to petroleum compounds as seen in other mammals. Exposure of dolphins to elevated petroleum compounds present in coastal GoM waters during and after the DWH oil spill is proposed as a cause of adrenal and lung disease and as a contributor to increased dolphin deaths.	[Venn-Watson, Stephanie] Natl Marine Mammal Fdn, San Diego, CA 92106 USA; [Colegrove, Kathleen M.; Kinsel, Michael; Terio, Karen] Univ Illinois, Zool Pathol Program, Maywood, IL USA; [Litz, Jenny; Ewing, Ruth] Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Miami, FL USA; [Saliki, Jeremiah] Univ Georgia, Coll Vet Med, Athens Vet Diagnost Lab, Athens, GA 30602 USA; [Fire, Spencer] NOAA, Natl Ocean Serv, Marine Biotoxins Program, Charleston, SC USA; [Fire, Spencer] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA; [Carmichael, Ruth] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Carmichael, Ruth] Univ S Alabama, Dauphin Isl, AL USA; [Chevis, Connie; Hatchett, Wendy; Pitchford, Jonathan] Inst Marine Mammal Studies, Gulfport, MS USA; [Tumlin, Mandy] Louisiana Dept Wildlife & Fisheries, Baton Rouge, LA USA; [Field, Cara; Smith, Suzanne] Audubon Aquarium Amer, New Orleans, LA USA; [Fauquier, Deborah; Rowles, Teri] Natl Marine Fisheries Serv, Off Protected Resources, Silver Spring, MD USA; [Lovewell, Gretchen] Mote Marine Lab, Sarasota, FL 34236 USA; [Whitehead, Heidi] Texas Marine Mammal Stranding Network, Galveston, TX USA; [Rotstein, David] Marine Mammal Pathol Serv, Olney, MD USA; [Mcfee, Wayne] Natl Ctr Coastal Ocean Sci, Natl Ocean Serv, Charleston, SC USA; [Fougeres, Erin] Natl Marine Fisheries Serv, Southeast Reg Off, St Petersburg, FL USA	University of Illinois System; University of Illinois Urbana-Champaign; National Oceanic Atmospheric Admin (NOAA) - USA; University System of Georgia; University of Georgia; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; Florida Institute of Technology; Dauphin Island Sea Lab; University of South Alabama; National Oceanic Atmospheric Admin (NOAA) - USA; Mote Marine Laboratory & Aquarium; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Centers for Coastal Ocean Science (NOOCS); National Oceanic Atmospheric Admin (NOAA) - USA	Venn-Watson, S (corresponding author), Natl Marine Mammal Fdn, San Diego, CA 92106 USA.	stephanie.venn-watson@nmmf.org	Rotstein, David/K-6691-2019; Terio, Karen/AAC-5376-2019; Fire, Spencer/P-6040-2014	Fire, Spencer/0000-0002-1657-790X; Carmichael, Ruth/0000-0002-6033-3777; McFee, Wayne/0000-0002-5781-2961; rotstein, david/0000-0001-7438-2281; Saliki, Jeremiah/0000-0003-0050-4324	Deepwater Horizon National Resource Damage Assessment; Federal and State Trustees; BP; Contingency Fund of the Working Group for Marine Mammal Unusual Mortality Events (WGMMUME); National Fish and Wildlife Foundation; NOAA's Marine Mammal Health and Stranding Response Network	Deepwater Horizon National Resource Damage Assessment; Federal and State Trustees; BP; Contingency Fund of the Working Group for Marine Mammal Unusual Mortality Events (WGMMUME); National Fish and Wildlife Foundation; NOAA's Marine Mammal Health and Stranding Response Network	This study was funded by the Deepwater Horizon National Resource Damage Assessment being conducted cooperatively among the National Oceanic and Atmospheric Administration (NOAA) (www.noaa.gov), other Federal and State Trustees, and BP; the Contingency Fund of the Working Group for Marine Mammal Unusual Mortality Events (WGMMUME)(http://www.nmfs.noaa.gov/pr/health/mmume/history.htm); National Fish and Wildlife Foundation (www.nfwf.org); and NOAA's Marine Mammal Health and Stranding Response Network (http://www.nmfs.noaa.gov/pr/health/). NOAA and the WGMMUME aided in reviewing the study design and manuscript. BP funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agamy E, 2012, TOXICOL PATHOL, V40, P1128, DOI 10.1177/0192623312448936; Allan SE, 2012, ENVIRON SCI TECHNOL, V46, P2033, DOI 10.1021/es202942q; Antonio FJ, 2011, AQUAT TOXICOL, V105, P177, DOI 10.1016/j.aquatox.2011.05.022; Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7; Azeez Oyebisi M, 2012, Toxicol Int, V19, P306, DOI 10.4103/0971-6580.103678; BOND B, 1969, BRIT J CANCER, V23, P188, DOI 10.1038/bjc.1969.27; Bornstein SR, 1999, J CLIN ENDOCR METAB, V84, P1729; Bytnerowicz A, 2010, ATMOS ENVIRON, V44, P678, DOI 10.1016/j.atmosenv.2009.11.014; Carmichael RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041155; Cassle S, 1999, P 40 C INT ASS AQ AN, P129; Clark LS, 2006, J COMP PATHOL, V135, P208, DOI 10.1016/j.jcpa.2006.07.005; Clark LS, 2005, ANAT HISTOL EMBRYOL, V34, P132, DOI 10.1111/j.1439-0264.2004.00600.x; Coppock RW, 1996, VET HUM TOXICOL, V38, P36; Cullen J.M., 2007, PATHOLOGIC BASIS VET, P393; Dagleish MP, 2007, VET REC, V160, P876, DOI 10.1136/vr.160.25.876; Davison NJ, 2009, VET REC, V165, P86, DOI 10.1136/vetrec.165.3.86; Demling Robert H, 2008, Eplasty, V8, pe27; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Duignan PJ, 1996, MAR MAMMAL SCI, V12, P499; EADE NR, 1974, PEDIATRICS, V54, P351; EDWARDS WC, 1989, VET CLIN N AM-FOOD A, V5, P363, DOI 10.1016/S0749-0720(15)30981-6; Engelbrecht Y, 2000, J ANIM SCI, V78, P371; Fauquier DA, 2009, DIS AQUAT ORGAN, V88, P85, DOI 10.3354/dao02095; Ficht TA, 1996, INT J SYST BACTERIOL, V46, P329, DOI 10.1099/00207713-46-1-329; Fire SE, 2008, MAR MAMMAL SCI, V24, P831, DOI 10.1111/j.1748-7692.2008.00221.x; Fire SE, 2011, HARMFUL ALGAE, V10, P330, DOI 10.1016/j.hal.2010.12.001; GORSLINE J, 1982, ENVIRON RES, V28, P139, DOI 10.1016/0013-9351(82)90162-1; Green R.F., 1972, P247; GREINER JW, 1976, BIOCHEM PHARMACOL, V25, P951, DOI 10.1016/0006-2952(76)90321-X; Gulland FMD, 2006, MAR MAMMAL SCI, V15, P810; Hahner S, 2010, EUR J ENDOCRINOL, V162, P597, DOI 10.1530/EJE-09-0884; Hernandez-Mora G, 2013, REV SCI TECH OIE, V32, P89; HILLS AG, 1954, J CLIN INVEST, V33, P1466, DOI 10.1172/JCI103025; Hoffman RJ, 1991, MARINE MAMMAL STRAND, P7; Houser DS, 2011, J ZOO WILDLIFE MED, V42, P565, DOI 10.1638/2010-0121.1; HUGGINS C, 1961, J EXP MED, V114, P741, DOI 10.1084/jem.114.5.741; Irving L, 1941, J CELL COMPAR PHYSL, V17, P145, DOI 10.1002/jcp.1030170203; Jaber JR, 2004, VET PATHOL, V41, P147, DOI 10.1354/vp.41-2-147; Kokaly RF, 2013, REMOTE SENS ENVIRON, V129, P210, DOI 10.1016/j.rse.2012.10.028; KRAFFT A, 1995, J WILDLIFE DIS, V31, P410, DOI 10.7589/0090-3558-31.3.410; KUIKEN T, 1993, MAR POLLUT BULL, V26, P440, DOI 10.1016/0025-326X(93)90532-O; Lair S, 1997, J WILDLIFE DIS, V33, P430, DOI 10.7589/0090-3558-33.3.430; LALONDE C, 1994, J APPL PHYSIOL, V77, P15, DOI 10.1152/jappl.1994.77.1.15; Lattin CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102106; Leger JAS, 2009, VET PATHOL, V46, P299, DOI 10.1354/vp.08-VP-0209-S-FL; LEVIN W, 1967, CANCER RES, V27, P1931; Lin QX, 2012, ENVIRON SCI TECHNOL, V46, P3737, DOI 10.1021/es203552p; Lipscomb TP, 1996, J VET DIAGN INVEST, V8, P283, DOI 10.1177/104063879600800302; LIPSCOMB TP, 1993, VET PATHOL, V30, P1, DOI 10.1177/030098589303000101; Litz JA, 2014, DIS AQUAT ORGAN, V112, P161, DOI 10.3354/dao02807; Maucher JM, 2007, ENVIRON SCI TECHNOL, V41, P563, DOI 10.1021/es0612605; McNutt MK, 2012, P NATL ACAD SCI USA, V109, P20222, DOI 10.1073/pnas.1214389109; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; Miller WG, 1999, J ZOO WILDLIFE MED, V30, P100; Mohr FC, 2008, ARCH ENVIRON CON TOX, V54, P337, DOI 10.1007/s00244-007-9021-5; Mohr FC, 2010, J WILDLIFE DIS, V46, P103, DOI 10.7589/0090-3558-46.1.103; National Oceanic and Atmospheric Administration, T V PER AN C; National Oceanic and Atmospheric Administration, CED MAN VILL SPILL; Nichols JW, 2011, ENVIRON TOXICOL CHEM, V30, P39, DOI 10.1002/etc.376; Oelkers W, 1996, NEW ENGL J MED, V335, P1206, DOI 10.1056/NEJM199610173351607; Pancheco M, 2002, ECOTOX ENVIRON SAFE, V53, P331; RIBELIN WE, 1984, FUND APPL TOXICOL, V4, P105, DOI 10.1016/0272-0590(84)90224-0; RIDEOUT BA, 1985, ZOO BIOL, V4, P129, DOI 10.1002/zoo.1430040206; RIDGWAY SH, 1969, SCIENCE, V166, P1651, DOI 10.1126/science.166.3913.1651; Ridgway SH, 1972, MAMMALS SEA BIOL MED, P260; Rosol TJ, 2001, TOXICOL PATHOL, V29, P41, DOI 10.1080/019262301301418847; ROWE LD, 1973, J AM VET MED ASSOC, V162, P61; Sasano H, 2010, ENDOCRINE PATHOLOGY: DIFFERENTIAL DIAGNOSIS AND MOLECULAR ADVANCES, P261, DOI 10.1007/978-1-4419-1069-1_11; Schulman FY, 1997, VET PATHOL, V34, P288, DOI 10.1177/030098589703400404; Schwacke LH, 2014, ENVIRON SCI TECHNOL, V48, P93, DOI 10.1021/es403610f; Sierra E, 2014, J CLIN MICROBIOL, V52, P2390, DOI 10.1128/JCM.02906-13; Silliman BR, 2012, PNAS, V109, P1123; Teles M, 2003, ECOTOX ENVIRON SAFE, V55, P98, DOI 10.1016/S0147-6513(02)00134-3; Terio KA, 2004, J WILDLIFE DIS, V40, P259, DOI 10.7589/0090-3558-40.2.259; Turnbull BS, 1999, VET PATHOL, V36, P28, DOI 10.1354/vp.36-1-28; Turner RE, 2008, ENVIRON SCI TECHNOL, V42, P2323, DOI 10.1021/es071617k; Twiner MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042974; Venn-Watson S, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0117248; Venn-Watson S, 2013, INHAL TOXICOL, V25, P481, DOI 10.3109/08958378.2013.804611; Zwemer RL, 1936, AM J PATHOL, V12, P107	80	58	60	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126538	10.1371/journal.pone.0126538	http://dx.doi.org/10.1371/journal.pone.0126538			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992681	gold, Green Published, Green Submitted			2022-12-26	WOS:000354921400067
J	Li, ZG; Park, BK; Liu, WG; Zhang, JH; Reed, MP; Rupp, JD; Hoff, CN; Hu, JW				Li, Zhigang; Park, Byoung-Keon; Liu, Weiguo; Zhang, Jinhuan; Reed, Matthew P.; Rupp, Jonathan D.; Hoff, Carrie N.; Hu, Jingwen			A Statistical Skull Geometry Model for Children 0-3 Years Old	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; REAL-WORLD TRAUMA; HEAD CIRCUMFERENCE; CRANIAL BONE; BRAIN; INJURY; IMPACT; INFANTS; SHAPE	Head injury is the leading cause of fatality and long-term disability for children. Pediatric heads change rapidly in both size and shape during growth, especially for children under 3 years old (YO). To accurately assess the head injury risks for children, it is necessary to understand the geometry of the pediatric head and how morphologic features influence injury causation within the 0-3 YO population. In this study, head CT scans from fifty-six 0-3 YO children were used to develop a statistical model of pediatric skull geometry. Geometric features important for injury prediction, including skull size and shape, skull thickness and suture width, along with their variations among the sample population, were quantified through a series of image and statistical analyses. The size and shape of the pediatric skull change significantly with age and head circumference. The skull thickness and suture width vary with age, head circumference and location, which will have important effects on skull stiffness and injury prediction. The statistical geometry model developed in this study can provide a geometrical basis for future development of child anthropomorphic test devices and pediatric head finite element models.	[Li, Zhigang] Beijing Jiaotong Univ, Sch Mech Elect & Control Engn, Beijing, Peoples R China; [Li, Zhigang; Park, Byoung-Keon; Reed, Matthew P.; Rupp, Jonathan D.; Hu, Jingwen] Univ Michigan, Transportat Res Inst, Ann Arbor, MI 48109 USA; [Li, Zhigang; Zhang, Jinhuan] Tsinghua Univ, State Key Lab Automot Safety & Energy, Beijing 100084, Peoples R China; [Liu, Weiguo] Zhejiang Key Lab Automobile Safety Technol, Hangzhou, Zhejiang, Peoples R China; [Reed, Matthew P.] Univ Michigan, Ctr Ergon Ind & Operat Engn, Ann Arbor, MI 48109 USA; [Rupp, Jonathan D.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Rupp, Jonathan D.] Univ Michigan, Sch Med, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Hoff, Carrie N.] Univ Michigan, Sch Med, Dept Radiol, Ann Arbor, MI 48109 USA; [Hu, Jingwen] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA	Beijing Jiaotong University; University of Michigan System; University of Michigan; Tsinghua University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hu, JW (corresponding author), Univ Michigan, Transportat Res Inst, Ann Arbor, MI 48109 USA.	jwhu@umich.edu	Li, Zhigang/Q-2558-2015		National Institute of Justice [2012-DN-BX-K045]; Foundation of Zhejiang Key Laboratory of Automobile Safety Technology from China; China Postdoctoral Science Foundation [2014T70071]	National Institute of Justice(US National Institute of Justice); Foundation of Zhejiang Key Laboratory of Automobile Safety Technology from China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by the National Institute of Justice (2012-DN-BX-K045): MR JR JH; Foundation of Zhejiang Key Laboratory of Automobile Safety Technology from China: ZL WL; China Postdoctoral Science Foundation (2014T70071): ZL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atabaki SM, 2007, PEDIATR REV, V28, P215, DOI 10.1542/pir.28-6-215; BURDI AR, 1969, J BIOMECH, V2, P267, DOI 10.1016/0021-9290(69)90083-9; CDC, 2002, 2000 CDC GROWTH CHAR; Coats B, 2007, STAPP CAR CRASH JO, V51, P1; Danelson KA, 2008, STAPP CAR C, V52, P59; Desantis Klinich Kathleen, 2002, Stapp Car Crash J, V46, P165; HUBBARD RP, 1971, J BIOMECH, V4, P251, DOI 10.1016/0021-9290(71)90031-5; IRWIN A, 1997, BIOMECHANICAL BASES; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Lapeer RJ, 2001, J BIOMECH, V34, P1125, DOI 10.1016/S0021-9290(01)00070-7; Li ZG, 2013, ANN BIOMED ENG, V41, P215, DOI 10.1007/s10439-012-0682-5; Li ZG, 2011, ANN BIOMED ENG, V39, P2984, DOI 10.1007/s10439-011-0409-z; LIVSHITS G, 1986, ANN HUM BIOL, V13, P387, DOI 10.1080/03014468600008561; Loyd Andre M, 2010, Stapp Car Crash J, V54, P167; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; MCPHERSON GK, 1980, J BIOMECH, V13, P17, DOI 10.1016/0021-9290(80)90004-4; Mertz HJ, 1997, SAE T, P3563; Netter FH, 2019, ATLAS HUMAN ANATOMY, VSeventh; Neubauer S, 2009, J ANAT, V215, P240, DOI 10.1111/j.1469-7580.2009.01106.x; Reed MP., 2003, P ASME 2008 INT DE A, P561; Ridgway EB, 2004, PEDIATR CLIN N AM, V51, P359, DOI 10.1016/j.pcl.2003.12.001; ROCHE AF, 1987, PEDIATRICS, V79, P706; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; Roth S, 2008, COMPUT METH PROG BIO, V90, P262, DOI 10.1016/j.cmpb.2008.01.007; Roth S, 2007, INT J LEGAL MED, V121, P223, DOI 10.1007/s00414-006-0129-3; Roth S, 2010, COMPUT METH PROG BIO, V99, P25, DOI 10.1016/j.cmpb.2009.10.004; Roth S, 2009, COMPUT METH PROG BIO, V93, P32, DOI 10.1016/j.cmpb.2008.08.001; Snyder RG, NA ADV CONSUMER RES, V05, P499, DOI [10.1099/mic.0.000073, DOI 10.1099/MIC.0.000073]; Viano D, 1997, ACCIDENT ANAL PREV, V29, P811, DOI 10.1016/S0001-4575(97)00050-X; Yamada S, 2012, DEV ANATOMY HUMAN EM; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	31	24	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127322	10.1371/journal.pone.0127322	http://dx.doi.org/10.1371/journal.pone.0127322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992998	Green Submitted, Green Published, gold			2022-12-26	WOS:000354917300115
J	Liang, SL; Ren, ZW; Han, XX; Yang, JL; Shan, LL; Li, L; Wang, BY; Zhang, QY; Mu, TY; Chen, KX; Xiong, SB; Wang, GW				Liang, Shoulei; Ren, Zhiwu; Han, Xiuxin; Yang, Jilong; Shan, Luling; Li, Lin; Wang, Binying; Zhang, Qianyi; Mu, Tianyang; Chen, Kexin; Xiong, Shunbin; Wang, Guowen			PLA2G16 Expression in Human Osteosarcoma Is Associated with Pulmonary Metastasis and Poor Prognosis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; LYSOPHOSPHATIDIC ACID; OBESITY; SURVIVAL; CANCER; ACTIVATION; H-REV107; LEUKEMIA; PATHWAY; CELLS	Background Osteosarcoma is the most frequent type of malignant bone tumor in children and adolescents and is associated with a high propensity for lung metastasis. Recent experiments have indicated that PLA2G16 contributes to osteosarcoma progression and metastasis in both mouse and human osteosarcoma cell lines. The aim of this study was to compare the expression of PLA2G16 in non-metastatic and metastatic osteosarcomas to determine whether PLA2G16 expression can serve as a biomarker of osteosarcoma prognosis and metastasis. Methods Quantitative real-time PCR was used to examine PLA2G16 mRNA in primary osteosarcoma patients (18 patients without metastases and 17 patients with metastases), and immunohistochemistry (IHC) staining of PLA2G16 was performed on tissue microarrays from 119 osteosarcoma patients. Tumor metastatic behavior and survival of the patients were followed up for a minimum of 36 months and a maximum of 171 months. The prognostic value of PLA2G16 expression was evaluated by the Kaplan-Meier method and a log-rank test. Multivariate Cox regression analysis was used to identify significant independent prognostic factors. Results Osteosarcoma patients with metastasis showed a higher expression of PLA2G16 at both the mRNA and protein levels (both at P values< 0.05) than did patients without metastasis. Osteosarcoma patients with positive IHC staining of PLA2G16 expression at primary sites had shorter overall survival and metastasis-free survival (both at P values <0.02). Moreover, multivariate Cox analysis identified PLA2G16 expression as an independent prognostic factor to predict poor overall survival and metastasis-free survival (both P values < 0.03). Conclusions This study indicated that PLA2G16 expression is a significant prognostic factor in primary osteosarcoma patients for predicting the development of metastases and poor survival.	[Liang, Shoulei; Ren, Zhiwu; Han, Xiuxin; Yang, Jilong; Shan, Luling; Wang, Guowen] Tianjin Med Univ, Dept Bone & Soft Tissue Tumors, Key Lab Canc Prevent & Therapy, Canc Inst & Hosp,Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Li, Lin; Zhang, Qianyi; Mu, Tianyang] Dalian Med Univ, Inst Canc Stem Cell, Ctr Canc, Dalian, Peoples R China; [Wang, Binying] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Peoples R China; [Chen, Kexin] Tianjin Med Univ, Canc Inst & Hosp, Dept Epidemiol & Biostat, Tianjin, Peoples R China; [Xiong, Shunbin] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	Tianjin Medical University; Dalian Medical University; Wenzhou Medical University; Tianjin Medical University; University of Texas System; UTMD Anderson Cancer Center	Xiong, SB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.	sxiong@mdanderson.org; wangguowendr@163.com	Yang, Jilong/AAF-7236-2019; Xiong, Shunbin/AAR-5823-2021	Yang, Jilong/0000-0001-5162-3740; Chen, Kexin/0000-0003-4248-7681	Program for National Clinical Research Center of Cancer	Program for National Clinical Research Center of Cancer	This work was supported by the Program for National Clinical Research Center of Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaf S, 2013, PEDIATR BLOOD CANCER, V60, P2042, DOI 10.1002/pbc.24580; Cao Y, 2002, J CELL PHYSIOL, V190, P279, DOI 10.1002/jcp.10068; Chan RJ, 2009, LEUKEMIA RES, V33, P355, DOI 10.1016/j.leukres.2008.08.022; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; Du J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015940; Duncan RE, 2008, J BIOL CHEM, V283, P25428, DOI 10.1074/jbc.M804146200; Ferguson WS, 2001, CANCER INVEST, V19, P292, DOI 10.1081/CNV-100102557; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; HAJNAL A, 1994, ONCOGENE, V9, P479; Husmann K, 1998, ONCOGENE, V17, P1305, DOI 10.1038/sj.onc.1202060; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Kaidar-Person O, 2011, OBES SURG, V21, P1792, DOI 10.1007/s11695-011-0490-2; Kim MS, 2007, CLIN ORTHOP RELAT R, P229, DOI 10.1097/BLO.0b013e3180413dbf; Lichtman MA, 2010, ONCOLOGIST, V15, P1083, DOI 10.1634/theoncologist.2010-0206; Louie SM, 2013, BBA-MOL CELL BIOL L, V1831, P1499, DOI 10.1016/j.bbalip.2013.02.008; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Nazarenko I, 2006, AM J PATHOL, V169, P1427, DOI 10.2353/ajpath.2006.051341; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Parekh N, 2012, ANNU REV NUTR, V32, P311, DOI 10.1146/annurev-nutr-071811-150713; Ritter J, 2010, ANN ONCOL, V21, P320, DOI 10.1093/annonc/mdq276; Rodriguez NI, 2008, J PEDIAT HEMATOL ONC, V30, P507, DOI 10.1097/MPH.0b013e31816e238c; Shida D, 2003, CANCER RES, V63, P1706; Siegrist S, 2001, ONCOGENE, V20, P5155, DOI 10.1038/sj.onc.1204658; Ta H, 2009, CANCER METAST REV, V28, P247, DOI 10.1007/s10555-009-9186-7; Tawadros T, 2012, BRIT J CANCER, V107, P1737, DOI 10.1038/bjc.2012.457; Xiong SB, 2014, P NATL ACAD SCI USA, V111, P11145, DOI 10.1073/pnas.1404139111; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037	27	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127236	10.1371/journal.pone.0127236	http://dx.doi.org/10.1371/journal.pone.0127236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993412	Green Submitted, Green Published, gold			2022-12-26	WOS:000354917300103
J	Pilla, KB; Leman, JK; Otting, G; Huber, T				Pilla, Kala Bharath; Leman, Julia Koehler; Otting, Gottfried; Huber, Thomas			Capturing Conformational States in Proteins Using Sparse Paramagnetic NMR Data	PLOS ONE			English	Article							VIRUS NS2B-NS3 PROTEASE; WEST-NILE-VIRUS; PSEUDOCONTACT SHIFTS; STRUCTURE PREDICTION; NS3 PROTEASE; BINDING MODE; DENGUE; COFACTOR; ROSETTA; FOLD	Capturing conformational changes in proteins or protein-protein complexes is a challenge for both experimentalists and computational biologists. Solution nuclear magnetic resonance (NMR) is unique in that it permits structural studies of proteins under greatly varying conditions, and thus allows us to monitor induced structural changes. Paramagnetic effects are increasingly used to study protein structures as they give ready access to rich structural information of orientation and long-range distance restraints from the NMR signals of backbone amides, and reliable methods have become available to tag proteins with paramagnetic metal ions site-specifically and at multiple sites. In this study, we show how sparse pseudocontact shift (PCS) data can be used to computationally model conformational states in a protein system, by first identifying core structural elements that are not affected by the environmental change, and then computationally completing the remaining structure based on experimental restraints from PCS. The approach is demonstrated on a 27 kDa two-domain NS2B-NS3 protease system of the dengue virus serotype 2, for which distinct closed and open conformational states have been observed in crystal structures. By changing the input PCS data, the observed conformational states in the dengue virus protease are reproduced without modifying the computational procedure. This data driven Rosetta protocol enables identification of conformational states of a protein system, which are otherwise difficult to obtain either experimentally or computationally.	[Pilla, Kala Bharath; Otting, Gottfried; Huber, Thomas] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia; [Leman, Julia Koehler] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA	Australian National University; Johns Hopkins University	Huber, T (corresponding author), Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia.	t.huber@anu.edu.au	Huber, Thomas/A-5278-2008; Otting, Gottfried/H-8413-2014	Huber, Thomas/0000-0002-3680-8699; Otting, Gottfried/0000-0002-0563-0146; Pilla, Kala Bharath/0000-0002-8327-1687	Australian Research Council [DP120100561, DP150100383]	Australian Research Council(Australian Research Council)	This study was supported by the Australian Research Council (DP120100561, DP150100383), which the authors gratefully acknowledge. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207; Allegrozzi M, 2000, J AM CHEM SOC, V122, P4154, DOI 10.1021/ja993691b; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; Bertini I, 2002, PROG NUCL MAG RES SP, V40, P249, DOI 10.1016/S0079-6565(02)00002-X; BLOEMBERGEN N, 1948, PHYS REV, V73, P679, DOI 10.1103/PhysRev.73.679; Bowers PM, 2000, J BIOMOL NMR, V18, P311, DOI 10.1023/A:1026744431105; Chandramouli S, 2010, J VIROL, V84, P3059, DOI 10.1128/JVI.02044-09; Chen WN, 2014, FEBS LETT, V588, P2206, DOI 10.1016/j.febslet.2014.05.018; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; de la Cruz L, 2014, FEBS J, V281, P1517, DOI 10.1111/febs.12729; de la Cruz L, 2011, J AM CHEM SOC, V133, P19205, DOI 10.1021/ja208435s; Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073; Fleishman SJ, 2012, CELL, V149, P262, DOI 10.1016/j.cell.2012.03.016; GEORGE A, 1994, ACTA CRYSTALLOGR D, V50, P361, DOI 10.1107/S0907444994001216; Graham B, 2011, BIOCONJUGATE CHEM, V22, P2118, DOI 10.1021/bc200353c; Junaid M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036872; Keizers PM, 2011, PROG NUCL MAG RES SP, V58, P88, DOI 10.1016/j.pnmrs.2010.08.001; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723; Kitahara R, 2005, J MOL BIOL, V347, P277, DOI 10.1016/j.jmb.2005.01.052; Koehler J, 2011, PROG NUCL MAG RES SP, V59, P360, DOI 10.1016/j.pnmrs.2011.05.001; Kondo MY, 2011, BIOCHEM BIOPH RES CO, V407, P640, DOI 10.1016/j.bbrc.2011.03.054; Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200; Li JP, 2013, J AM CHEM SOC, V135, P8294, DOI 10.1021/ja4021149; Liu W-M, 2013, COORD CHEM REV; Mao BC, 2014, J AM CHEM SOC, V136, P1893, DOI 10.1021/ja409845w; Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026; Rodriguez-Castaneda F, 2006, MAGN RESON CHEM, V44, pS10, DOI 10.1002/mrc.1811; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmitz C, 2012, J MOL BIOL, V416, P668, DOI 10.1016/j.jmb.2011.12.056; Shishmarev D, 2014, NUCLEIC ACIDS RES, V42, P2750, DOI 10.1093/nar/gkt1238; Su XC, 2010, J BIOMOL NMR, V46, P101, DOI 10.1007/s10858-009-9331-1; van Ingen H, 2014, J MAGN RESON, V241, P103, DOI 10.1016/j.jmr.2013.10.021; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Yagi H, 2013, STRUCTURE, V21, P883, DOI 10.1016/j.str.2013.04.001; Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963	39	22	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127053	10.1371/journal.pone.0127053	http://dx.doi.org/10.1371/journal.pone.0127053			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992808	Green Published, Green Submitted, gold			2022-12-26	WOS:000354917300078
J	Waithe, D; Rennert, P; Brostow, G; Piper, MDW				Waithe, Dominic; Rennert, Peter; Brostow, Gabriel; Piper, Matthew D. W.			QuantiFly: Robust Trainable Software for Automated Drosophila Egg Counting	PLOS ONE			English	Article							DIETARY RESTRICTION; IMAGE	We report the development and testing of software called QuantiFly: an automated tool to quantify Drosophila egg laying. Many laboratories count Drosophila eggs as a marker of fitness. The existing method requires laboratory researchers to count eggs manually while looking down a microscope. This technique is both time-consuming and tedious, especially when experiments require daily counts of hundreds of vials. The basis of the QuantiFly software is an algorithm which applies and improves upon an existing advanced pattern recognition and machine-learning routine. The accuracy of the baseline algorithm is additionally increased in this study through correction of bias observed in the algorithm output. The QuantiFly software, which includes the refined algorithm, has been designed to be immediately accessible to scientists through an intuitive and responsive user-friendly graphical interface. The software is also open-source, self-contained, has no dependencies and is easily installed (https://github.com/dwaithe/quantifly). Compared to manual egg counts made from digital images, QuantiFly achieved average accuracies of 94% and 85% for eggs laid on transparent (defined) and opaque (yeast-based) fly media. Thus, the software is capable of detecting experimental differences in most experimental situations. Significantly, the advanced feature recognition capabilities of the software proved to be robust to food surface artefacts like bubbles and crevices. The user experience involves image acquisition, algorithm training by labelling a subset of eggs in images of some of the vials, followed by a batch analysis mode in which new images are automatically assessed for egg numbers. Initial training typically requires approximately 10 minutes, while subsequent image evaluation by the software is performed in just a few seconds. Given the average time per vial for manual counting is approximately 40 seconds, our software introduces a timesaving advantage for experiments starting with as few as 20 vials. We also describe an optional acrylic box to be used as a digital camera mount and to provide controlled lighting during image acquisition which will guarantee the conditions used in this study.	[Waithe, Dominic; Rennert, Peter; Brostow, Gabriel] UCL, Dept Comp Sci, London WC1E 6BT, England; [Waithe, Dominic] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Wolfson Imaging Ctr, Oxford OX3 9DS, England; [Piper, Matthew D. W.] UCL, Inst Hlth Ageing, London WC1E 6BT, England; [Piper, Matthew D. W.] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England	University of London; University College London; University of Oxford; University of London; University College London; University of London; University College London	Brostow, G (corresponding author), UCL, Dept Comp Sci, Gower St, London WC1E 6BT, England.	g.brostow@cs.ucl.ac.uk; m.piper@ucl.ac.uk	Brostow, Gabriel/S-1464-2019; Piper, Matthew/C-1714-2008	Brostow, Gabriel/0000-0001-8472-3828; Piper, Matthew/0000-0003-3245-7219; Waithe, Dominic/0000-0003-2685-4226	Biotechnology and Biological Sciences Research Council [BBI011544/1]; Royal Society [UF100158, RG110303]; UCL Crucible; BBSRC; EPSRC; ESRC; MRC [G0700729]; Engineering and Physical Sciences Research Council [EP/K023578/1]; BBSRC [BB/I011544/1] Funding Source: UKRI; EPSRC [EP/K015664/1, EP/K015664/2, EP/K023578/1] Funding Source: UKRI; MRC [MR/K01577X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I011544/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/K015664/2, EP/K015664/1] Funding Source: researchfish; Medical Research Council [MR/K01577X/1, G0700729] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); UCL Crucible; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Work was funded by the Biotechnology and Biological Sciences Research Council http://www.bbsrc.ac.uk/home/home.aspx (BBI011544/1, M.D.W.P) and the Royal Society https://royalsociety.org/ (UF100158 & RG110303, M.D.W.P), the UCL Crucible, http://crucible.cege.ucl.ac.uk/homepage/, a multi research-council initiative by the BBSRC, EPSRC, ESRC and MRC (#G0700729,G.B., M.D.W.P), and the Engineering and Physical Sciences Research Council, https://www.epsrc.ac.uk (EP/K023578/1, G.B.).	Arteta C, 2012, LECT NOTES COMPUT SC, V7510, P348, DOI 10.1007/978-3-642-33415-3_43; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Criminisi A, 2011, DECISION FORESTS CLA; DAUGMAN JG, 1985, J OPT SOC AM A, V2, P1160, DOI 10.1364/JOSAA.2.001160; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Eliceiri KW, 2012, NAT METHODS, V9, P697, DOI [10.1038/nmeth.2084, 10.1038/NMETH.2084]; Fiaschi L, 2012, INT C PATT RECOG, P2685; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI [10.1007/b94608, DOI 10.1007/B94608]; Huh S, 2011, IEEE T MED IMAGING, V30, P586, DOI 10.1109/TMI.2010.2089384; JULESZ B, 1981, NATURE, V290, P91, DOI 10.1038/290091a0; Kanade T., 2011, 2011 IEEE WORKSH APP, P374; Kothe U, 1999, 6 REUSABLE SOFTWARE; Lempitsky V., 2010, NIPS, P1324; Oeilly M, 2011, CIRCLE BASED METHOD; Piper MDW, 2014, NAT METHODS, V11, P971, DOI 10.1038/nmeth0914-971c; Piper MDW, 2011, CELL METAB, V14, P154, DOI 10.1016/j.cmet.2011.06.013; ROSSUM G, 1995, PYTHON TUTORIAL; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SIMONCELLI EP, 1992, IEEE T INFORM THEORY, V38, P587, DOI 10.1109/18.119725; Varma M, 2005, INT J COMPUT VISION, V62, P61, DOI 10.1007/s11263-005-4635-4	23	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127659	10.1371/journal.pone.0127659	http://dx.doi.org/10.1371/journal.pone.0127659			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992957	Green Published, gold, Green Submitted			2022-12-26	WOS:000354917300132
J	Matsunaga, A; Harita, Y; Shibagaki, Y; Shimizu, N; Shibuya, K; Ono, H; Kato, H; Sekine, T; Sakamoto, N; Igarashi, T; Hattori, S				Matsunaga, Atsuko; Harita, Yutaka; Shibagaki, Yoshio; Shimizu, Nobutaka; Shibuya, Kazuhiko; Ono, Hiroshi; Kato, Hitoshi; Sekine, Takashi; Sakamoto, Naoko; Igarashi, Takashi; Hattori, Seisuke			Identification of 4-Trimethylaminobutyraldehyde Dehydrogenase (TMABA-DH) as a Candidate Serum Autoantibody Target for Kawasaki Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ENDOTHELIAL-CELLS; ANTIENDOTHELIAL CELL; CORONARY-ARTERY; ACUTE PHASE; T-CELLS; ANTIBODIES; NEUTROPHILS; SUSCEPTIBILITY; AUTOIMMUNITY	Kawasaki disease (KD), an acute vasculitis that preferentially affects coronary arteries, is still the leading cause of acquired heart disease in children. Although the involvement of immune system malfunction in the onset of KD is suggested, its etiology still remains to be clarified. We investigated autoantibodies in KD patients, which are frequently found in sera from patients with autoimmune diseases, vasculitides and arteritides. We performed two-dimensional western blotting and LC-MS/MS to analyze the antigens of autoantibodies, detected two protein spots with 4 out of 24 sera from KD patients but not with 6 control sera, and identified the antigens as 4-trimethylaminobutyraldehyde dehydrogenase (TMABA-DH). A slot blot analysis with TMABA-DH as an antigen also revealed higher reactivities of patients' sera than control sera (positive rates: 18/43 vs 3/41). Using an enzyme-linked immunosorbent assay (ELISA), we found that the reactivity of anti-TMABA-DH antibodies in sera from KD patients was significantly higher than that in sera from age-matched controls. The optimal cut-off value of 0.043 had a sensitivity of 83.7% and a specificity of 80.0% in detecting KD patients (positive rates: 37/43 for KD patients, 9/41 for controls). Immunohistochemistry performed on thin sections of rat heart revealed that TMABA-DH colocalized with myosin light chains in cardiac myocytes. Patient sera with high reactivity gave similar immunostaining pattern. These results suggest that the detection of anti-TMABA-DH autoantibody could be a potential strategy for a diagnosis of KD.	[Matsunaga, Atsuko; Harita, Yutaka; Hattori, Seisuke] Univ Tokyo, Inst Med Sci, Div Cellular Prote, Minato Ku, Tokyo, Japan; [Matsunaga, Atsuko; Shibagaki, Yoshio; Hattori, Seisuke] Kitasato Univ, Sch Pharmaceut Sci, Div Biochem, Minato Ku, Tokyo 108, Japan; [Harita, Yutaka; Shimizu, Nobutaka; Sekine, Takashi; Igarashi, Takashi] Univ Tokyo, Dept Pediat, Grad Sch Med, Bunkyo Ku, Tokyo, Japan; [Shibuya, Kazuhiko] Tokyo Metropolitan Childrens Med Ctr, Fuchu, Tokyo, Japan; [Ono, Hiroshi; Kato, Hitoshi; Sakamoto, Naoko; Igarashi, Takashi] Natl Ctr Child Hlth & Dev, Setagaya Ku, Tokyo, Japan; [Sekine, Takashi] Toho Univ, Sch Med, Dept Pediat, Ohashi Hosp,Meguro Ku, Tokyo, Japan	University of Tokyo; Kitasato University; University of Tokyo; Tokyo Metropolitan Children's Medical Center; National Center for Child Health & Development - Japan; Toho University	Hattori, S (corresponding author), Univ Tokyo, Inst Med Sci, Div Cellular Prote, Minato Ku, Tokyo, Japan.	hattoris@pharm.kitasato-u.ac.jp		Matsunaga, Atsuko/0000-0002-4019-1249	Ministry of Health, Labour and Welfare, Japan	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This research was funded by the Ministry of Health, Labour and Welfare, Japan to SH (2009 to 2011, Health and Labour Sciences Research Grants to The Study Group for Treatment Guideline on Refractory Kawasaki Disease, SH is a member of The Study Group). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE J, 1992, P NATL ACAD SCI USA, V89, P4066, DOI 10.1073/pnas.89.9.4066; Abe J, 2008, J ALLERGY CLIN IMMUN, V122, P1008, DOI 10.1016/j.jaci.2008.09.011; Benseler SM, 2005, PEDIATRICS, V116, pE760, DOI 10.1542/peds.2005-0559; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; CHARLES LA, 1991, J LEUKOCYTE BIOL, V50, P539, DOI 10.1002/jlb.50.6.539; Cunningham MW, 1999, J IMMUNOL, V163, P1060; DAJANI AS, 1993, CIRCULATION, V87, P1776, DOI 10.1161/01.CIR.87.5.1776; DeLaurenzi V, 1996, NAT GENET, V12, P52; FALK RJ, 1988, NEW ENGL J MED, V318, P1651, DOI 10.1056/NEJM198806233182504; Falk RJ, 1997, J AM SOC NEPHROL, V8, P314; Fujieda M, 1997, CLIN EXP IMMUNOL, V107, P120, DOI 10.1046/j.1365-2249.1997.d01-894.x; Fujieda M, 2012, MICROBIOL IMMUNOL, V56, P56, DOI 10.1111/j.1348-0421.2011.00393.x; Geraghty MT, 1998, HUM MOL GENET, V7, P1411, DOI 10.1093/hmg/7.9.1411; Gibson KM, 1998, NEUROPEDIATRICS, V29, P14, DOI 10.1055/s-2007-973527; HULSE JD, 1980, J BIOL CHEM, V255, P1146; Inada T, 2008, PHARMACOGENET GENOM, V18, P317, DOI 10.1097/FPC.0b013e3282f70492; JENNETTE JC, 1990, BLOOD, V75, P2263; Karasawa R, 2010, CLIN EXP IMMUNOL, V161, P459, DOI 10.1111/j.1365-2249.2010.04218.x; Katsumata Y, 2013, MOD RHEUMATOL, V23, P71, DOI 10.1007/s10165-012-0624-y; Katsumata Y, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005330; KAWASAKI T, 1967, JAP J ALLERG, V16, P178, DOI DOI 10.4070/KCJ.2018.0214; Kentsis A, 2013, EMBO MOL MED, V5, P210, DOI 10.1002/emmm.201201494; Lee KH, 2003, ARTHRITIS RHEUM, V48, P2025, DOI 10.1002/art.11074; Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227; LEUNG DYM, 1986, J CLIN INVEST, V77, P1428, DOI 10.1172/JCI112454; Leung DYM, 2002, J PEDIATR-US, V140, P742, DOI 10.1067/mpd.2002.123664; LEUNG DYM, 1986, J EXP MED, V164, P1958, DOI 10.1084/jem.164.6.1958; Lin SW, 1996, GENOMICS, V34, P376, DOI 10.1006/geno.1996.0300; LINDQVIST KJ, 1971, CLIN EXP IMMUNOL, V9, P753; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; MATSUURA H, 1987, BRIT HEART J, V58, P385; Nussinovitch U, 2009, ARCH IMMUNOL THER EX, V57, P95, DOI 10.1007/s00005-009-0013-1; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Radford DJ, 2000, ARTHRITIS RHEUM, V43, P1337, DOI 10.1002/1529-0131(200006)43:6<1337::AID-ANR16>3.0.CO;2-M; Regent A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3388; Rizzo WB, 1999, AM J HUM GENET, V65, P1547, DOI 10.1086/302681; Rowley AH, 2000, J INFECT DIS, V182, P1183, DOI 10.1086/315832; Rowley AH, 1997, J IMMUNOL, V159, P5946; Rowley AH, 2001, J IMMUNOL, V166, P1334, DOI 10.4049/jimmunol.166.2.1334; SIMA D, 1994, ARTHRITIS RHEUM, V37, P441, DOI 10.1002/art.1780370323; Talha SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084050; TAN EM, 1972, ARTHRITIS RHEUM, V15, P23, DOI 10.1002/art.1780150104; Uchida T, 2013, J PROTEOMICS, V91, P259, DOI 10.1016/j.jprot.2013.07.021; Vasiliou V, 2000, PHARMACOLOGY, V61, P192, DOI 10.1159/000028400; Yeter D, 2012, AUTOIMMUN REV, V11, P903, DOI 10.1016/j.autrev.2012.03.006; Yoneyama K, 2014, ANTICANCER RES, V34, P5021; Yoshioka T, 1999, IMMUNOLOGY, V96, P465, DOI 10.1046/j.1365-2567.1999.00695.x	48	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128189	10.1371/journal.pone.0128189	http://dx.doi.org/10.1371/journal.pone.0128189			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010099	gold, Green Published, Green Submitted			2022-12-26	WOS:000355183900203
J	Yan, H; Liu, RQ; Liu, ZN; Wang, X; Luo, WB; Sheng, LX				Yan, Hong; Liu, Ruiquan; Liu, Zinan; Wang, Xue; Luo, Wenbo; Sheng, Lianxi			Growth and Physiological Responses to Water Depths in Carex schmidtii Meinsh.	PLOS ONE			English	Article							SUBMERGED WETLAND PLANTS; INDUCED SHOOT ELONGATION; RESOURCE-ALLOCATION; UNDERWATER PHOTOSYNTHESIS; FLOODING TOLERANCE; MEIONECTES-BROWNII; BIOMASS ALLOCATION; NATURAL VARIATION; SEDIMENT TYPE; STRESS	A greenhouse experiment was performed to investigate growth and physiological responses to water depth in completely submerged condition of a wetland plant Carex schmidtii Meinsh., one of the dominant species in the Longwan Crater Lake wetlands (China). Growth and physiological responses of C. schmidtii were investigated by growing under control (non-submerged) and three submerged conditions (5 cm, 15 cm and 25 cm water level). Total biomass was highest in control, intermediate in 5 cm treatment and lowest in the other two submerged treatments. Water depth prominently affected the first-order lateral root to main root mass ratio. Alcohol dehydrogenase (ADH) activity decreased but malondialdehyde (MDA) content increased as water depth increased. The starch contents showed no differences among the various treatments at the end of the experiment. However, soluble sugar contents were highest in control, intermediate in 5 cm and 15 cm treatments and lowest in 25 cm treatment. Our data suggest that submergence depth affected some aspects of growth and physiology of C. schmidtii, which can reduce anoxia damage not only through maintaining the non-elongation strategy in shoot part but also by adjusting biomass allocation to different root orders rather than adjusting root-shoot biomass allocation.	[Yan, Hong; Liu, Ruiquan; Liu, Zinan; Wang, Xue; Luo, Wenbo; Sheng, Lianxi] NE Normal Univ, Sch Environm, Key Lab Wetland Ecol & Vegetat Restorat Natl Envi, Changchun, Peoples R China; [Yan, Hong] Jilin Prov Acad Forestry Sci, Changchun, Peoples R China; [Luo, Wenbo] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	Northeast Normal University - China; University of Montana System; University of Montana	Luo, WB (corresponding author), NE Normal Univ, Sch Environm, Key Lab Wetland Ecol & Vegetat Restorat Natl Envi, Changchun, Peoples R China.	luowb330@nenu.edu.cn; shenglx@nenu.edu.cn			National Natural Science Foundation of China [31000184]; Environmental Public Welfare Sector Special Research Project [2011467032]; Natural Science Foundation Project [20130101111 JC]; China National special funds of science and technology for control and remediation of water pollution [2012ZX07201-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Environmental Public Welfare Sector Special Research Project; Natural Science Foundation Project(National Natural Science Foundation of China (NSFC)); China National special funds of science and technology for control and remediation of water pollution	This study was supported by the National Natural Science Foundation of China (31000184), Environmental Public Welfare Sector Special Research Project (2011467032), Natural Science Foundation Project (20130101111 JC) and China National special funds of science and technology for control and remediation of water pollution (2012ZX07201-001).	Albrecht BG, 1997, NEW PHYTOL, V136, P137; Alcoverro T, 1999, MAR ECOL PROG SER, V187, P121, DOI 10.3354/meps187121; Armstrong W, 2000, PLANT ROOTS HIDDEN H, P729; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Bailey-Serres J, 2010, CURR OPIN PLANT BIOL, V13, P489, DOI 10.1016/j.pbi.2010.08.002; Barrat-Segretain MH, 2007, AQUAT BOT, V87, P255, DOI 10.1016/j.aquabot.2007.06.009; Blom CWPM, 1996, TRENDS ECOL EVOL, V11, P290, DOI 10.1016/0169-5347(96)10034-3; Budelsky RA, 2000, J APPL ECOL, V37, P971, DOI 10.1046/j.1365-2664.2000.00540.x; CAKMAK I, 1991, PHYSIOL PLANTARUM, V83, P463, DOI 10.1111/j.1399-3054.1991.tb00121.x; Casanova MT, 2000, PLANT ECOL, V147, P237, DOI 10.1023/A:1009875226637; Chen X, 2011, NEW PHYTOL, V190, P409, DOI 10.1111/j.1469-8137.2010.03639.x; Chen X, 2010, PLANT PHYSIOL, V154, P969, DOI 10.1104/pp.110.162792; Colmer TD, 2009, FUNCT PLANT BIOL, V36, P665, DOI 10.1071/FP09144; Colmer TD, 2008, NEW PHYTOL, V177, P918, DOI 10.1111/j.1469-8137.2007.02318.x; Crawford RMM, 1996, J EXP BOT, V47, P145, DOI 10.1093/jxb/47.2.145; Das KK, 2005, PLANT SCI, V168, P131, DOI 10.1016/j.plantsci.2004.07.023; Edwards AL, 2003, CAN J BOT, V81, P964, DOI 10.1139/B03-091; Fraser LH, 2005, WETLANDS, V25, P520, DOI 10.1672/0277-5212(2005)025[0520:ACAOSS]2.0.CO;2; Fukao T, 2009, ANN BOT-LONDON, V103, P143, DOI 10.1093/aob/mcn172; Hernandez JA, 2002, PHYSIOL PLANTARUM, V115, P251, DOI 10.1034/j.1399-3054.2002.1150211.x; Jackson MB, 2008, ANN BOT-LONDON, V101, P229, DOI 10.1093/aob/mcm237; Li YZ, 2007, AQUAT BOT, V86, P295, DOI 10.1016/j.aquabot.2006.11.001; Luo WB, 2008, WETLANDS, V28, P866, DOI 10.1672/07-225.1; Luo WB, 2009, HYDROBIOLOGIA, V624, P151, DOI 10.1007/s10750-008-9689-1; McConnaughay KDM, 1999, ECOLOGY, V80, P2581, DOI 10.1890/0012-9658(1999)080[2581:BAIPOO]2.0.CO;2; Munne-Bosch S, 2002, PLANTA, V214, P608, DOI 10.1007/s004250100646; Nabben RHM, 1999, NEW PHYTOL, V144, P313, DOI 10.1046/j.1469-8137.1999.00519.x; Pierik R, 2009, ANN BOT-LONDON, V103, P353, DOI 10.1093/aob/mcn143; Rich SM, 2013, PLANT CELL ENVIRON, V36, P213, DOI 10.1111/j.1365-3040.2012.02568.x; Rich SM, 2012, ANN BOT-LONDON, V110, P405, DOI 10.1093/aob/mcs051; Ridge I., 1987, Plant life in aquatic and amphibious habitats., P53; Sauter M, 2000, NATURWISSENSCHAFTEN, V87, P289, DOI 10.1007/s001140050725; Setter TL, 1996, J EXP BOT, V47, P1551, DOI 10.1093/jxb/47.10.1551; Sofo A, 2004, PHYSIOL PLANTARUM, V121, P58, DOI 10.1111/j.0031-9317.2004.00294.x; Visser EJW, 2000, NEW PHYTOL, V148, P93, DOI 10.1046/j.1469-8137.2000.00742.x; Voesenek LACJ, 2006, NEW PHYTOL, V170, P213, DOI 10.1111/j.1469-8137.2006.01692.x; Voesenek LACJ, 2004, ECOLOGY, V85, P16, DOI 10.1890/02-740; Wang QL, 2014, FLORA, V209, P279, DOI 10.1016/j.flora.2014.03.006; WEBB T, 1983, J EXP BOT, V34, P579, DOI 10.1093/jxb/34.5.579; WIGNARAJAH K, 1976, NEW PHYTOL, V77, P585, DOI 10.1111/j.1469-8137.1976.tb04650.x; Xie YH, 2005, FRESHWATER BIOL, V50, P391, DOI 10.1111/j.1365-2427.2004.01327.x; Xie Y, 2007, ANN BOT-LONDON, V100, P1517, DOI 10.1093/aob/mcm236; Yoshida S, 1971, INT RICE RES I; Zedler JB, 2010, FRONT ECOL ENVIRON, V8, P540, DOI 10.1890/090109	44	13	19	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128176	10.1371/journal.pone.0128176	http://dx.doi.org/10.1371/journal.pone.0128176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009895	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900202
J	Kurakawa, T; Ogata, K; Matsuda, K; Tsuji, H; Kubota, H; Takada, T; Kado, Y; Asahara, T; Takahashi, T; Nomoto, K				Kurakawa, Takashi; Ogata, Kiyohito; Matsuda, Kazunori; Tsuji, Hirokazu; Kubota, Hiroyuki; Takada, Toshihiko; Kado, Yukiko; Asahara, Takashi; Takahashi, Takuya; Nomoto, Koji			Diversity of Intestinal Clostridium coccoides Group in the Japanese Population, as Demonstrated by Reverse Transcription-Quantitative PCR	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BUTYRATE-PRODUCING BACTERIA; POLYMERASE-CHAIN-REACTION; HUMAN FECAL MICROBIOTA; IN-SITU HYBRIDIZATION; REAL-TIME PCR; GUT MICROBIOTA; COMMENSAL BACTERIA; GEN. NOV.	We used sensitive rRNA-targeted reverse transcription-quantitative PCR (RT-qPCR) to quantify the Clostridium coccoides group, which is a major anaerobic population in the human intestine. For this purpose, the C. coccoides group was classified into 3 subgroups and 19 species for expediency in accordance with the existing database, and specific primers were newly developed to evaluate them. Population levels of the C. coccoides group in human feces determined by RT-qPCR were equivalent to those determined by fluorescence in situ hybridization. RT-qPCR analysis of fecal samples from 96 volunteers (32 young children, 32 adults and 32 elderly) by using the 22 new primer sets together with the C. coccoides group-specific primer setm revealed that (i) total counts obtained as the sum of the 3 subgroups and 19 species were equivalent to the results obtained by using the C. coccoides group-specific primer set; (ii) total C. coccoides-group counts in the elderly were significantly lower than those in young children and adults; (iii) genus Blautia was the most common subgroup in the human intestinal C. coccoides-group populations at all age populations tested; (iv) the prevalences of Fusicatenibacter saccharivorans and genus Dorea were significantly higher in adults than in young children and the elderly; and (v) the prevalences of C. scindens and C. hylemonae, both of which produce secondary bile acid in the human intestine, were significantly higher in the elderly than in young children and adults. Hierarchical clustering and principal component analysis showed clear separation of the bacterial components between adult and elderly populations. Taken together, these data suggest that aging plays an important role in the diversity of C. coccoides-group populations in human intestinal microbiota; changes in this diversity likely influence the health of the host.	[Kurakawa, Takashi; Ogata, Kiyohito; Matsuda, Kazunori; Tsuji, Hirokazu; Kubota, Hiroyuki; Takada, Toshihiko; Kado, Yukiko; Asahara, Takashi; Takahashi, Takuya; Nomoto, Koji] Yakult Cent Inst Microbiol Res, Kunitachi, Tokyo 1868650, Japan; [Matsuda, Kazunori] ESV, Yakult Honsha European Res Ctr Microbiol, B-9052 Ghent, Belgium	Yakult Honsha Company, Limited; Yakult Honsha Company, Limited	Kurakawa, T (corresponding author), Yakult Cent Inst Microbiol Res, 5-11 Izumi, Kunitachi, Tokyo 1868650, Japan.	takashi-kurakawa@yakult.co.jp	Matsuda, Kazunori/N-5743-2018	Matsuda, Kazunori/0000-0002-5242-6332; Takada, Toshihiko/0000-0002-9914-8253; Hirokazu, Tsuji/0000-0003-2856-6447				Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Batta AK, 1998, CANCER RES, V58, P1684; Bezirtzoglou E, 1997, ANAEROBE, V3, P173, DOI 10.1006/anae.1997.0102; Bleve G, 2003, APPL ENVIRON MICROB, V69, P4116, DOI 10.1128/AEM.69.7.4116-4122.2003; Braune A, 2001, APPL ENVIRON MICROB, V67, P5558, DOI 10.1128/AEM.67.12.5558-5567.2001; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Filocamo A, 2012, PHYTOMEDICINE, V19, P707, DOI 10.1016/j.phymed.2012.02.018; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; HAVSTEEN B, 1983, BIOCHEM PHARMACOL, V32, P1141, DOI 10.1016/0006-2952(83)90262-9; Hayashi H, 2006, FEMS MICROBIOL LETT, V257, P202, DOI 10.1111/j.1574-6968.2006.00171.x; Hayashi H, 2003, MICROBIOL IMMUNOL, V47, P557, DOI 10.1111/j.1348-0421.2003.tb03418.x; Hayashi H, 2002, MICROBIOL IMMUNOL, V46, P535, DOI 10.1111/j.1348-0421.2002.tb02731.x; Hold GL, 2002, FEMS MICROBIOL ECOL, V39, P33, DOI 10.1111/j.1574-6941.2002.tb00904.x; Jansen GJ, 1999, J MICROBIOL METH, V37, P215, DOI 10.1016/S0167-7012(99)00049-4; Kakiyama G, 2013, J HEPATOL, V58, P949, DOI 10.1016/j.jhep.2013.01.003; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Kitahara M, 2000, INT J SYST EVOL MICR, V50, P971, DOI 10.1099/00207713-50-3-971; Kubota H, 2010, APPL ENVIRON MICROB, V76, P5440, DOI 10.1128/AEM.03132-09; Kurakawa T, 2013, J MICROBIOL METH, V92, P213, DOI 10.1016/j.mimet.2012.12.008; Kurakawa T, 2012, MICROBIOL IMMUNOL, V56, P10, DOI 10.1111/j.1348-0421.2011.00405.x; Liu CX, 2008, INT J SYST EVOL MICR, V58, P1896, DOI 10.1099/ijs.0.65208-0; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Makivuokko H, 2010, BRIT J NUTR, V103, P227, DOI 10.1017/S0007114509991553; Marcille F, 2002, APPL ENVIRON MICROB, V68, P3424, DOI 10.1128/AEM.68.7.3424-3431.2002; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Matsuda K, 2012, APPL ENVIRON MICROB, V78, P5111, DOI 10.1128/AEM.07990-11; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; McKillip JL, 1998, APPL ENVIRON MICROB, V64, P4264; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Murri M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-46; Nam YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022109; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; REDDY BS, 1977, CANCER RES, V37, P3238; Ringel-Kulka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064315; Simmering R, 2002, FEMS MICROBIOL ECOL, V40, P243, DOI 10.1111/j.1574-6941.2002.tb00957.x; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Takada T, 2004, J MICROBIOL METH, V58, P413, DOI 10.1016/j.mimet.2004.05.006; Takada T, 2013, INT J SYST EVOL MICR, V63, P3691, DOI 10.1099/ijs.0.045823-0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tiihonen K, 2008, BRIT J NUTR, V100, P130, DOI 10.1017/S000711450888871X; Tsuji H, 2012, BENEF MICROBES, V3, P113, DOI 10.3920/BM2011.0038; Tyakht AV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3469; van Tongeren SP, 2005, APPL ENVIRON MICROB, V71, P6438, DOI 10.1128/AEM.71.10.6438-6442.2005; Yaron S, 2002, J APPL MICROBIOL, V92, P633, DOI 10.1046/j.1365-2672.2002.01563.x; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P4225, DOI 10.1128/AEM.68.9.4225-4232.2002; Zwielehner J, 2009, EXP GERONTOL, V44, P440, DOI 10.1016/j.exger.2009.04.002	52	41	41	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126226	10.1371/journal.pone.0126226	http://dx.doi.org/10.1371/journal.pone.0126226			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000453	Green Published, Green Submitted, gold			2022-12-26	WOS:000354931700014
J	Mellemkjaer, L; Papadopoulos, FC; Pukkala, E; Ekbom, A; Gissler, M; Christensen, J; Olsen, JH				Mellemkjaer, Lene; Papadopoulos, Fotios C.; Pukkala, Eero; Ekbom, Anders; Gissler, Mika; Christensen, Jane; Olsen, Jorgen H.			Cancer Incidence among Patients with Anorexia Nervosa from Sweden, Denmark and Finland	PLOS ONE			English	Article							BREAST-CANCER; CALORIC RESTRICTION; EATING-DISORDERS; BULIMIA-NERVOSA; RISK; WOMEN; EPIDEMIOLOGY; PATTERNS	A diet with restricted energy content reduces the occurrence of cancer in animal experiments. It is not known if the underlying mechanism also exists in human beings. To determine whether cancer incidence is reduced among patients with anorexia nervosa who tend to have a low intake of energy, we carried out a retrospective cohort study of 22 654 women and 1678 men diagnosed with anorexia nervosa at ages 10-50 years during 1968-2010 according to National Hospital Registers in Sweden, Denmark and Finland. The comparison group consisted of randomly selected persons from population registers who were similar to the anorexia nervosa patients in respect to sex, year of birth and place of residence. Patients and population comparisons were followed for cancer by linkage to Cancer Registries. Incidence rate ratios (IRR) were estimated using Poisson models. In total, 366 cases of cancer (excluding non-melanoma skin cancer) were seen among women with anorexia nervosa, and the IRR for all cancer sites was 0.97 (95% CI = 0.87-1.08) adjusted for age, parity and age at first child. There were 76 breast cancers corresponding to an adjusted IRR of 0.61 (95% CI = 0.49-0.77). Significantly increased IRRs were observed for esophageal, lung, and liver cancer. Among men with anorexia nervosa, there were 23 cases of cancer (age-adjusted IRR = 1.08; 95% CI = 0.71-1.66). There seems to be no general reduction in cancer occurrence among patients with anorexia nervosa, giving little support to the energy restriction hypothesis.	[Mellemkjaer, Lene] Danish Canc Soc, Res Ctr, Virus Lifestyle & Genes, Copenhagen, Denmark; [Papadopoulos, Fotios C.] Uppsala Univ, Univ Uppsala Hosp, Dept Neurosci, Psychiat, Uppsala, Sweden; [Pukkala, Eero] Finnish Canc Registry, Inst Stat & Epidemiol Canc Res, FIN-00170 Helsinki, Finland; [Pukkala, Eero] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland; [Ekbom, Anders] Karolinska Univ Hosp, Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden; [Gissler, Mika] Natl Inst Hlth & Welf, Helsinki, Finland; [Christensen, Jane] Danish Canc Soc, Res Ctr, Stat Bioinformat & Registry, Copenhagen, Denmark; [Olsen, Jorgen H.] Danish Canc Soc, Res Ctr, Res Management, Copenhagen, Denmark	Danish Cancer Society; Uppsala University; Uppsala University Hospital; Finnish Cancer Registry; Tampere University; Karolinska Institutet; Karolinska University Hospital; Finland National Institute for Health & Welfare; Danish Cancer Society; Danish Cancer Society	Mellemkjaer, L (corresponding author), Danish Canc Soc, Res Ctr, Virus Lifestyle & Genes, Copenhagen, Denmark.	lene@cancer.dk	Papadopoulos, Fotios/H-1319-2019	Papadopoulos, Fotios/0000-0002-8692-3652; Gissler, Mika/0000-0001-8254-7525; Mellemkjaer, Lene/0000-0001-9222-6215	Danish Council for Independent Research [11-108395]; Swedish Society of Medicine [SLS-253101, SLS-230421]; Stockholm County Council [20100328, 20130084]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Swedish Society of Medicine; Stockholm County Council(Stockholm County Council)	This work was supported by the Danish Council for Independent Research (grant number 11-108395) (LM), the Swedish Society of Medicine (grant numbers SLS-253101, SLS-230421) (FCP), and the Stockholm County Council (grant numbers 20100328, 20130084) (AE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzengruber Doris, 2006, Eat Behav, V7, P291, DOI 10.1016/j.eatbeh.2006.06.005; Becker AE, 1999, NEW ENGL J MED, V340, P1092, DOI 10.1056/NEJM199904083401407; Elias SG, 2004, J NATL CANCER I, V96, P539, DOI 10.1093/jnci/djh087; Elias SG, 2005, CANCER EPIDEM BIOMAR, V14, P1981, DOI 10.1158/1055-9965.EPI-04-0839; Foo JP, 2012, METABOLISM, V61, P899, DOI 10.1016/j.metabol.2012.01.003; Franco M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1515; Harris RH, 2013, INT J EAT DISORDER, V46, P369, DOI 10.1002/eat.22073; Karamanis G, 2014, INT J CANCER, V134, P1751, DOI 10.1002/ijc.28495; Keinan-Boker L, 2009, JNCI-J NATL CANCER I, V101, P1489, DOI 10.1093/jnci/djp327; Keskimaki I, 1991, INT J HLTH SCI, V2, P15, DOI DOI 10.1177/1403494812456637; Longo VD, 2010, TRENDS PHARMACOL SCI, V31, P89, DOI 10.1016/j.tips.2009.11.004; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mehler PS, 2011, INT J EAT DISORDER, V44, P95, DOI 10.1002/eat.20825; Mellemkjaer L, 2001, CANCER CAUSE CONTROL, V12, P173, DOI 10.1023/A:1008974414116; Michels KB, 2004, JAMA-J AM MED ASSOC, V291, P1226, DOI 10.1001/jama.291.10.1226; Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Nandrino JL, 2006, J PSYCHOSOM RES, V61, P537, DOI 10.1016/j.jpsychores.2006.02.008; Papadopoulos FC, 2009, EUR J CANCER PREV, V18, P207, DOI 10.1097/CEJ.0b013e32831bc558; Pinheiro AP, 2010, INT J EAT DISORDER, V43, P123, DOI 10.1002/eat.20671; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Riman T, 2004, ACTA OBSTET GYN SCAN, V83, P783, DOI 10.1111/j.0001-6349.2004.00550.x; Robsahm TE, 2002, BRIT J CANCER, V86, P362, DOI 10.1038/sj.bjc.6600084; Root TL, 2010, PSYCHOL MED, V40, P105, DOI 10.1017/S0033291709005662; Spechler SJ, 2013, JAMA-J AM MED ASSOC, V310, P627, DOI 10.1001/jama.2013.226450; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Terra X, 2013, INT J EAT DISORDER, V46, P855, DOI 10.1002/eat.22166; Tretli S, 1996, CANCER CAUSE CONTROL, V7, P507, DOI 10.1007/BF00051882; Vestergaard P, 2002, INT J EAT DISORDER, V32, P301, DOI 10.1002/eat.10101; Willcox DC, 2009, J AM COLL NUTR, V28, p500S, DOI 10.1080/07315724.2009.10718117; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P, P211; Zhang YW, 2013, WORLD J GASTROENTERO, V19, P5598, DOI 10.3748/wjg.v19.i34.5598	33	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0128018	10.1371/journal.pone.0128018	http://dx.doi.org/10.1371/journal.pone.0128018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7GR	26000630	Green Published, gold, Green Submitted			2022-12-26	WOS:000354931700099
J	Zhou, YH; Lin, FS; Cui, ZL; Zhang, XR; Hu, CM; Shen, T; Chen, CY; Zhang, X; Guo, XK				Zhou, Yuhua; Lin, Feishen; Cui, Zelin; Zhang, Xiangrong; Hu, Chunmei; Shen, Tian; Chen, Chunyan; Zhang, Xia; Guo, Xiaokui			Correlation between Either Cupriavidus or Porphyromonas and Primary Pulmonary Tuberculosis Found by Analysing the Microbiota in Patients' Bronchoalveolar Lavage Fluid	PLOS ONE			English	Article							INFECTION; SPUTUM; PNEUMONIA	Pulmonary tuberculosis (TB) has gained attention in recent decades because of its rising incidence trend; simultaneously, increasing numbers of studies have identified the relationship between microbiota and chronic infectious diseases. In our work, we enrolled 32 patients with primary TB characterised by unilateral TB lesion formation diagnosed by chest radiographic exam. Bronchoalveolar lavage fluid was taken from both lungs. Twenty-four healthy people were chosen as controls. Pyrosequencing was performed on the V3 hypervariable region of 16S rDNA in all bacterial samples and used as a culture-independent method to describe the phylogenetic composition of the microbiota. Through pyrosequencing, 271,764 amplicons were detected in samples and analysed using tools in the Ribosomal Database Project (RDP) and bioinformatics. These analyses revealed significant differences in the microbiota in the lower respiratory tract (LRT) of TB patients compared with healthy controls; in contrast, the microbiota of intra/extra-TB lesions were similar. These results showed that the dominant bacterial genus in the LRT of TB patients was Cupriavidus and not Streptococcus, which resulted in a significant change in the microbiota in TB patients. The abundance of Mycobacteria and Porphyromonas significantly increased inside TB lesions when compared with non-lesion-containing contralateral lungs. From these data, it can be concluded that Cupriavidus plays an important role in TB's secondary infection and that in addition to Mycobacteria, Porphyromonas may also be a co-factor in lesion formation. The mechanisms underlying this connection warrant further research.	[Zhou, Yuhua; Cui, Zelin; Chen, Chunyan; Guo, Xiaokui] Shanghai Jiao Tong Univ, Dept Med Microbiol & Parasitol, Sch Med, Inst Med Sci, Shanghai 200030, Peoples R China; [Lin, Feishen; Zhang, Xiangrong; Hu, Chunmei; Zhang, Xia] Nanjing Chest Hosp, Dept TB, Nanjing, Jiangsu, Peoples R China; [Zhou, Yuhua] Shanghai Jiao Tong Univ, Sch Med, Dept Emergency Med, Rui Jin Hosp, Shanghai 200030, Peoples R China; [Shen, Tian] Shanghai Jiao Tong Univ, Sch Med, Dept Prevent Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, X (corresponding author), Nanjing Chest Hosp, Dept TB, Nanjing, Jiangsu, Peoples R China.	zhangxia365@sina.com; microbiology@sjtu.edu.cn	Zhou, Yuhua/AAT-8209-2021	Cui, Zelin/0000-0002-2700-5800; Guo, Xiao-Kui/0000-0002-1595-9965	National Natural Science Foundation of China [81271793, 81261160321]; Research Fund for the Doctoral Program of Higher Education of China [20120073110071]; National Support Program of Science and Technology [2012EP001004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Support Program of Science and Technology	This work was supported by grants from the National Natural Science Foundation of China (81271793, and 81261160321), the Research Fund for the Doctoral Program of Higher Education of China (20120073110071), and the National Support Program of Science and Technology (2012EP001004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armougom F, 2009, EUR J CLIN MICROBIOL, V28, P1151, DOI 10.1007/s10096-009-0749-x; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Chen CY, 2013, ACTA BIOCH BIOPH SIN, V45, P1039, DOI 10.1093/abbs/gmt116; Christensen JB, 2010, J CLIN MICROBIOL, V48, P2623, DOI 10.1128/JCM.00507-10; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cui ZL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-276; Goldberg AE, 2008, J TRAUMA, V65, P871, DOI 10.1097/TA.0b013e31818481e0; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Houben ENG, 2009, MOL MICROBIOL, V72, P41, DOI 10.1111/j.1365-2958.2009.06612.x; Jeannin L, 1997, Rev Prat, V47, P97; Kalka-Moll WM, 2009, J CLIN MICROBIOL, V47, P3026, DOI 10.1128/JCM.00846-09; Kanazawa M, 1996, INTERNAL MED, V35, P946, DOI 10.2169/internalmedicine.35.946; Krimsky WS, 2010, J THORAC CARDIOV SUR, V139, P781, DOI 10.1016/j.jtcvs.2009.03.051; Langevin S, 2011, J CLIN MICROBIOL, V49, P744, DOI 10.1128/JCM.01947-10; Lee J H, 2000, Respirology, V5, P411, DOI 10.1046/j.1440-1843.2000.00285.x; Mimoz O, 2007, INTENS CARE MED, V33, P1495, DOI 10.1007/s00134-007-0689-9; Nelson DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014116; Price LB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006462; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; Cruz RDS, 2008, REV ASSOC MED BRAS, V54, P406; Sato K, 1995, Kekkaku, V70, P585; Tattevin P, 1999, CHEST, V115, P1248, DOI 10.1378/chest.115.5.1248; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Xue Q, 2011, EUR J CLIN MICROBIOL, V30, P1039, DOI 10.1007/s10096-011-1205-2; Yam Wing-Cheong, 2013, Methods Mol Biol, V943, P171, DOI 10.1007/978-1-60327-353-4_12; Young D, 2008, NAT REV MICROBIOL, V6, P520, DOI 10.1038/nrmicro1919; Zhou YH, 2010, ACTA BIOCH BIOPH SIN, V42, P754, DOI 10.1093/abbs/gmq081	28	32	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0124194	10.1371/journal.pone.0124194	http://dx.doi.org/10.1371/journal.pone.0124194			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000957	Green Submitted, Green Published, gold			2022-12-26	WOS:000354931700004
J	Abraham, P; Sundaram, A; Asha, R; Reshmy, V; George, S; Kumar, KS				Abraham, Parvin; Sundaram, Anand; Asha, R.; Reshmy, V; George, Sanil; Kumar, K. Santhosh			Structure-Activity Relationship and Mode of Action of a Frog Secreted Antibacterial Peptide B1CTcu5 Using Synthetically and Modularly Modified or Deleted (SMMD) Peptides	PLOS ONE			English	Article							AMPHIBIAN ANTIMICROBIAL PEPTIDES; RANA-ESCULENTA; RESISTANCE	All life forms are equipped with rapidly acting, evolutionally conserved components of an innate immune defense system that consists of a group of unique and diverse molecules known as host defense peptides (HDPs). A Systematic and Modular Modification and Deletion (SMMD) approach was followed to analyse the structural requirement of B1CTcu5, a brevinin antibacterial peptide amide identified from the skin secretion of frog Clinotarsus curtipes, India, to show antibacterial activity and to explore the active core region. Seventeen SMMD-B1CTcu5 analogs were designed and synthesised by C and N-terminal amino acid substitution or deletion. Enhancement in cationicity by N-terminal Lys/Arg substitution or hydrophobicity by Trp substitution produced no drastic change in bactericidal nature against selected bacterial strains except S. aureus. But the sequential removal of N-terminal amino acids had a negative effect on bactericidal potency. Analog B1CTcu5-LIAG obtained by the removal of four N-terminal amino acids displayed bactericidal effect comparable to, or in excess of, the parent peptide with reduced hemolytic character. Its higher activity was well correlated with the improved inner membrane permeabilisation capacity. This region may act as the active core of B1CTcu5. Presence of C-terminal disulphide bond was not a necessary condition to display antibacterial activity but helped to promote hemolytic nature. Removal of the C-terminal rana box region drastically reduced antibacterial and hemolytic activity of the peptide, showing that this region is important for membrane targeting. The bactericidal potency of the D-peptide (DB1CTcu5) helped to rule out the stereospecific interaction with the bacterial membrane. Our data suggests that both the C and N-terminal regions are necessary for bactericidal activity, even though the active core region is located near the N-terminal of B1CTcu5. A judicious modification at the N-terminal region may produce a short SMMD analog with enhanced bactericidal activity and low toxicity against eukaryotic cells.	[Abraham, Parvin; Sundaram, Anand; Asha, R.; Reshmy, V; George, Sanil; Kumar, K. Santhosh] Rajiv Gandhi Ctr Biotechnol, Biol Chem Lab, Thiruvananthapuram, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Kumar, KS (corresponding author), Rajiv Gandhi Ctr Biotechnol, Biol Chem Lab, Thiruvananthapuram, Kerala, India.	kskumar@rgcb.res.in		Abraham, Parvin/0000-0001-5091-9419	Department of Biotechnology, Government of India [BT/PR8835/NDB/52/61/2007]; Rajiv Gandhi Centre for Biotechnology, Kerala, India; CSIR, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Rajiv Gandhi Centre for Biotechnology, Kerala, India; CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	The authors thank the Department of Biotechnology, Government of India for funding the project (Grant No. BT/PR8835/NDB/52/61/2007), the core funding of the Rajiv Gandhi Centre for Biotechnology, Kerala, India, and CSIR, India for awarding a fellowship to Parvin Abraham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham P, 2014, BIOCHIMIE, V97, P144, DOI 10.1016/j.biochi.2013.10.005; Andra J, 2007, J BIOL CHEM, V282, P14719, DOI 10.1074/jbc.M608920200; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Conlon JM, 2007, METHODS, V42, P349, DOI 10.1016/j.ymeth.2007.01.004; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Ganz T, 2003, INTEGR COMP BIOL, V43, P300, DOI 10.1093/icb/43.2.300; Hagiwara Y, 2009, J AM CHEM SOC, V131, P16697, DOI 10.1021/ja903451b; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Haney EF, 2009, BBA-BIOMEMBRANES, V1788, P1639, DOI 10.1016/j.bbamem.2009.01.002; Khandelia H, 2008, BBA-BIOMEMBRANES, V1778, P1528, DOI 10.1016/j.bbamem.2008.02.009; Kim HJ, 2004, J PEPT RES, V64, P151, DOI 10.1111/j.1399-3011.2004.00183.x; Kwon MY, 1998, BBA-PROTEIN STRUCT M, V1387, P239, DOI 10.1016/S0167-4838(98)00123-X; Mangoni ML, 2003, PEPTIDES, V24, P1771, DOI 10.1016/j.peptides.2003.07.029; Mant CT, 2009, BIOPOLYMERS, V92, P573, DOI 10.1002/bip.21316; McGahee W, 2000, SEMIN RESP INFECT; Nascimento ACC, 2003, PROTEIN PEPTIDE LETT, V10, P227, DOI 10.2174/0929866033478933; Nielsen SL, 2007, PROTEIN SCI, V16, P1969, DOI 10.1110/ps.072966007; Nijnik A, 2009, EMERGING HLTH THREAT, P2, DOI 10.3134/ehtj.09.009; Nuding S, 2006, J MICROBIOL METH, V65, P335, DOI 10.1016/j.mimet.2005.08.004; Peschel A, 2001, PEPTIDES, V22, P1651, DOI 10.1016/S0196-9781(01)00500-9; Pukala TL, 2006, NAT PROD REP, V23, P368, DOI 10.1039/b512118n; Vignal E, 1998, EUR J BIOCHEM, V253, P221, DOI 10.1046/j.1432-1327.1998.2530221.x; Wang H, 2009, BIOCHIMIE, V91, P540, DOI 10.1016/j.biochi.2009.01.007; Worthington RJ, 2012, ORG BIOMOL CHEM, V10, P7457, DOI 10.1039/c2ob25835h; Wu MH, 1999, J BIOL CHEM, V274, P29, DOI 10.1074/jbc.274.1.29; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	29	26	26	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0124210	10.1371/journal.pone.0124210	http://dx.doi.org/10.1371/journal.pone.0124210			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25997127	gold, Green Published, Green Submitted			2022-12-26	WOS:000356444000004
J	Chen, X; Wang, X; He, H; Liu, ZL; Hu, JF; Li, W				Chen, Xi; Wang, Xu; He, Hua; Liu, Ziling; Hu, Ji-Fan; Li, Wei			Combination of Circulating Tumor Cells with Serum Carcinoembryonic Antigen Enhances Clinical Prediction of Non-Small Cell Lung Cancer	PLOS ONE			English	Article							PERIPHERAL-BLOOD; PROGNOSTIC-SIGNIFICANCE; COLORECTAL-CANCER; MESSENGER-RNA; BONE-MARROW; MARKERS CEA; SCC-AG; CARCINOMA; DIAGNOSIS; NSE	Circulating tumor cells (CTCs) have emerged as a potential biomarker in the diagnosis, prognosis, treatment, and surveillance of lung cancer. However, CTC detection is not only costly, but its sensitivity is also low, thus limiting its usage and the collection of robust data regarding the significance of CTCs in lung cancer. We aimed to seek clinical variables that enhance the prediction of CTCs in patients with non-small cell lung cancer (NSCLC). Clinical samples and pathological data were collected from 169 NSCLC patients. CTCs were detected by CellSearch and tumor markers were detected using the Luminex xMAP assay. Univariate analyses revealed that histology, tumor stage, tumor size, invasiveness, tumor grade and carcinoembryonic antigen (CEA) were associated with the presence of CTCs. However, the level of CTCs was not associated with the degree of nodal involvement (N) or tumor prognostic markers Ki-67, CA125, CA199, Cyfra21-1, and SCCA. Using logistic regression analysis, we found that the combination of CTCs with tumor marker CEA has a better disease prediction. Advanced stage NSCLC patients with elevated CEA had higher numbers of CTCs. These data suggest a useful prediction model by combining CTCs with serum CEA in NSCLC patients.	[Chen, Xi; Wang, Xu; He, Hua; Liu, Ziling; Hu, Ji-Fan; Li, Wei] Jilin Univ, Affiliated Hosp 1, Canc & Stem Cell Ctr, Changchun 130061, Jilin, Peoples R China; [Hu, Ji-Fan] Stanford Univ, Sch Med, Palo Alto Vet Inst Res, Palo Alto, CA 94304 USA	Jilin University; Stanford University	Hu, JF (corresponding author), Jilin Univ, Affiliated Hosp 1, Canc & Stem Cell Ctr, Changchun 130061, Jilin, Peoples R China.	jifan@stanford.edu; jdyylw@163.com	Hu, Jifan/Q-3003-2019		California Institute of Regenerative Medicine (CIRM) [RT201942]; National Natural Science Foundation of China (CN) [81071920, 81372835, 81272294, 31430021]; Jilin Provincial Science and Technology Department [11ZDGG003, 20120720]; National Health and Family Planning Commission of the People's Republic of China (CN) [2001133]	California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); National Natural Science Foundation of China (CN)(National Natural Science Foundation of China (NSFC)); Jilin Provincial Science and Technology Department; National Health and Family Planning Commission of the People's Republic of China (CN)	This work was funded by the California Institute of Regenerative Medicine (CIRM)(RT201942), National Natural Science Foundation of China (CN) (#81071920, #81372835, #81272294, #31430021), Jilin Provincial Science and Technology Department (11ZDGG003, #20120720), and National Health and Family Planning Commission of the People's Republic of China (CN) (#2001133).	Alix-Panabieres C, 2008, CLIN CANCER RES, V14, P5013, DOI 10.1158/1078-0432.CCR-07-5125; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Barlesi F, 2004, RESP MED, V98, P357, DOI 10.1016/j.rmed.2003.11.003; Cedres S, 2011, CLIN LUNG CANCER, V12, P172, DOI 10.1016/j.cllc.2011.03.019; Dabrowska Marla, 2004, Pol Arch Med Wewn, V111, P659; DECOS JS, 1994, CHEST, V105, P773, DOI 10.1378/chest.105.3.773; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Han B, 2009, NUCL MED COMMUN, V30, P831, DOI 10.1097/MNM.0b013e32832dcfc4; Hofman V, 2011, INT J CANCER, V129, P1651, DOI 10.1002/ijc.25819; Huang JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078070; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Juan O, 2014, CLIN TRANSL ONCOL, V16, P637, DOI 10.1007/s12094-013-1128-8; Kalogeraki A, 2010, IN VIVO, V24, P667; Kosacka M, 2009, POL ARCH MED WEWN, V119, P33, DOI 10.20452/pamw.598; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Lu J, 2010, INT J CANCER, V126, P669, DOI 10.1002/ijc.24814; MINO N, 1988, CANCER, V62, P730, DOI 10.1002/1097-0142(19880815)62:4<730::AID-CNCR2820620415>3.0.CO;2-W; Molina R, 2003, TUMOR BIOL, V24, P209, DOI 10.1159/000074432; Molnar B, 2008, DIS MARKERS, V24, P141, DOI 10.1155/2008/941509; MORO D, 1995, LUNG CANCER, V13, P169, DOI 10.1016/0169-5002(95)00485-8; NIKLINSKI J, 1992, NEOPLASMA, V39, P279; Ou SHI, 2007, CANCER-AM CANCER SOC, V110, P1532, DOI 10.1002/cncr.22938; PALERMO F, 1990, International Journal of Biological Markers, V5, P118; Rao CG, 2005, INT J ONCOL, V27, P49; Schneider Joachim, 2002, Int J Clin Oncol, V7, P145, DOI 10.1007/s101470200021; Soomro I N, 1998, J Pak Med Assoc, V48, P66; Sun ZF, 2006, J THORAC CARDIOV SUR, V131, P1014, DOI 10.1016/j.jtcvs.2005.12.057; Tanaka F, 2009, CLIN CANCER RES, V15, P6980, DOI 10.1158/1078-0432.CCR-09-1095; Thunnissen FBJM, 2006, HISTOPATHOLOGY, V48, P779, DOI 10.1111/j.1365-2559.2006.02386.x; Wang B, 2014, ASIAN PAC J CANCER P, V15, P9611, DOI 10.7314/APJCP.2014.15.22.9611; Weckermann D, 1999, J CLIN ONCOL, V17, P3438, DOI 10.1200/JCO.1999.17.11.3438; Weihrauch MR, 2002, J CLIN ONCOL, V20, P4338, DOI 10.1200/JCO.2002.02.152; Yamashita J, 2002, J THORAC CARDIOV SUR, V124, P299, DOI 10.1067/mtc.2002.124370; Yap TA, 2014, CLIN CANCER RES, V20, P2553, DOI 10.1158/1078-0432.CCR-13-2664; Yoon SO, 2011, LUNG CANCER, V71, P209, DOI 10.1016/j.lungcan.2010.04.017; Yu DF, 2013, INT J MOL SCI, V14, P11145, DOI 10.3390/ijms140611145; Yu Z, 2014, ASIAN PAC J CANCER P, V15, P9367, DOI 10.7314/APJCP.2014.15.21.9367	38	30	38	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0126276	10.1371/journal.pone.0126276	http://dx.doi.org/10.1371/journal.pone.0126276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996878	Green Submitted, Green Published, gold			2022-12-26	WOS:000356444000020
J	Jiang, WY; Gong, GL; Wu, F; Kong, LT; Chen, KY; Cui, WH; Ren, L; Fan, GG; Sun, WG; Ma, H; Xu, K; Tang, YQ; Wang, F				Jiang, Wenyan; Gong, Gaolang; Wu, Feng; Kong, Lingtao; Chen, Kaiyuan; Cui, Wenhui; Ren, Ling; Fan, Guoguang; Sun, Wenge; Ma, Huan; Xu, Ke; Tang, Yanqing; Wang, Fei			The Papez Circuit in First-Episode, Treatment-Naive Adults with Major Depressive Disorder: Combined Atlas-Based Tract-Specific Quantification Analysis and Voxel-Based Analysis	PLOS ONE			English	Article							WHITE-MATTER MICROSTRUCTURE; ANTERIOR CINGULATE; WHOLE-BRAIN; DIFFUSION; ABNORMALITIES; CONNECTIVITY; ANATOMY; HISTORY; SYSTEM	Previous findings suggest that the Papez Circuit may have a role in major depressive disorders. We used atlas-based tract-specific quantification analysis and voxel-based analysis to examine the integrity of white matter tracts involved in mood regulation (including tracts in the Papez Circuit). Diffusion tensor imaging acquired from 35 first-episode, treatment-naive adults with major depressive disorders and 34 healthy adult controls were compared. Our statistical approach compared structural integrity of 11 major white matter tracts between the major depressive disorder and adult controls, as well as illness duration influence in patients. Fractional anisotropy was decreased in the hippocampal cingulum and in the anterior thalamic radiation according to both analytical approaches, all of which were important tracts included in the Papez Circuit. Our results support the role of the Papez Circuit in major depressive disorders with the minimal probability of false positive due to similar findings in both analyses that have complementary advantages. Dysfunction of the Papez Circuit may be a potential marker for studying the pathogenesis of major depressive disorders.	[Jiang, Wenyan; Wu, Feng; Kong, Lingtao; Chen, Kaiyuan; Cui, Wenhui; Ma, Huan; Tang, Yanqing; Wang, Fei] China Med Univ, Affiliated Hosp 1, Dept Psychiat, Shenyang 110001, Liaoning, Peoples R China; [Ren, Ling; Fan, Guoguang; Sun, Wenge; Xu, Ke; Wang, Fei] China Med Univ, Affiliated Hosp 1, Dept Radiol, Shenyang 110001, Liaoning, Peoples R China; [Wang, Fei] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Jiang, Wenyan] Liaoning Canc Hosp & Inst, Dept Radiol, Shenyang 110042, Liaoning, Peoples R China; [Gong, Gaolang] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	China Medical University; China Medical University; Yale University; Beijing Normal University	Xu, K (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Radiol, Shenyang 110001, Liaoning, Peoples R China.	kexu@vip.sina.com; yanqingtang@163.com	Fan, Guoguang/AAF-1892-2019		National Natural Science Foundation of China [81071099, 81271499]; Liaoning Science and Technology Foundation [2008225010-14]; National Institute of Health [K01MH086621]; Liaoning Education Foundation; National Alliance for Research on Schizophrenia and Depression; Klingenstein Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Science and Technology Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Liaoning Education Foundation; National Alliance for Research on Schizophrenia and Depression(NARSAD); Klingenstein Foundation(Klingenstein Philanthropies)	This study was supported by the National Natural Science Foundation of China (81071099 and 81271499, Yanqing Tang), the Liaoning Science and Technology Foundation (2008225010-14, Yanqing Tang), National Institute of Health (K01MH086621, Fei Wang), the Liaoning Education Foundation (Pandeng Schoolar, Fei Wang), the National Alliance for Research on Schizophrenia and Depression (Fei Wang) and the Klingenstein Foundation (Fei Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2010, PSYCHIAT RES-NEUROIM, V181, P64, DOI 10.1016/j.pscychresns.2009.07.007; Alexopoulos GS, 2008, AM J PSYCHIAT, V165, P238, DOI 10.1176/appi.ajp.2007.07050744; Ardekani S, 2007, MAGN RESON IMAGING, V25, P154, DOI 10.1016/j.mri.2006.09.045; Bae JN, 2006, BIOL PSYCHIAT, V60, P1356, DOI 10.1016/j.biopsych.2006.03.052; Chakravarty A, 2012, ANN INDIAN ACAD NEUR, V15, P71, DOI 10.4103/0972-2327.94986; Chapman CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057768; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Colloby SJ, 2011, J AFFECT DISORDERS, V135, P216, DOI 10.1016/j.jad.2011.07.025; Cullen KR, 2010, J AM ACAD CHILD PSY, V49, P173, DOI 10.1016/j.jaac.2009.11.005; Cunningham MG, 2002, J COMP NEUROL, V453, P116, DOI 10.1002/cne.10376; Dalby RB, 2010, PSYCHIAT RES-NEUROIM, V184, P38, DOI 10.1016/j.pscychresns.2010.06.008; Eggers AE, 2007, MED HYPOTHESES, V69, P852, DOI 10.1016/j.mehy.2007.01.074; First M.B., 2014, STRUCTURED CLIN INTE; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Horn DI, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00033; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Huang H, 2012, NEUROBIOL AGING, V33, P2029, DOI 10.1016/j.neurobiolaging.2011.06.027; Jankowski MM, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00045; Janssen J, 2004, BIOL PSYCHIAT, V56, P825, DOI 10.1016/j.biopsych.2004.09.011; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kiehl KA, 2001, BIOL PSYCHIAT, V50, P677, DOI 10.1016/S0006-3223(01)01222-7; Kieseppa T, 2010, J AFFECT DISORDERS, V120, P240, DOI 10.1016/j.jad.2009.04.023; Kinoshita M, 2014, CLIN NEUROL NEUROSUR, V117, P45, DOI 10.1016/j.clineuro.2013.12.002; Kong LT, 2013, J PSYCHIATR RES, V47, P733, DOI 10.1016/j.jpsychires.2013.02.003; Korgaonkar MS, 2011, HUM BRAIN MAPP, V32, P2161, DOI 10.1002/hbm.21178; Kumari V, 2003, BIOL PSYCHIAT, V54, P777, DOI 10.1016/S0006-3223(02)01785-7; Lai CH, 2010, EUR NEUROPSYCHOPHARM, V20, P676, DOI 10.1016/j.euroneuro.2010.06.002; Liu Y, 2012, MULT SCLER J, V18, P1013, DOI 10.1177/1352458511431731; Lyden H, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.21; Mahon K, 2012, BIPOLAR DISORD, V14, P80, DOI 10.1111/j.1399-5618.2012.00984.x; Milne AMB, 2012, J PSYCHIATR NEUROSCI, V37, P28, DOI 10.1503/jpn.110004; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; MUFSON EJ, 1984, J COMP NEUROL, V225, P31, DOI 10.1002/cne.902250105; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P981; Nishio Y, 2011, J NEUROL NEUROSUR PS, V82, P1195, DOI 10.1136/jnnp.2010.236463; Papez JW, 1937, ARCH NEURO PSYCHIATR, V38, P725, DOI 10.1001/archneurpsyc.1937.02260220069003; Park JY, 2010, CORTEX, V46, P161, DOI 10.1016/j.cortex.2008.06.008; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Schmahmann JD, 2007, J HIST NEUROSCI, V16, P362, DOI 10.1080/09647040600620468; Shah A, 2012, J CLIN NEUROSCI, V19, P289, DOI 10.1016/j.jocn.2011.04.039; Snook L, 2007, NEUROIMAGE, V34, P243, DOI 10.1016/j.neuroimage.2006.07.021; Steffens DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022697; Tang YQ, 2007, PSYCHIAT RES-NEUROIM, V156, P83, DOI 10.1016/j.pscychresns.2007.03.005; Van Hecke W, 2011, NEUROIMAGE, V55, P566, DOI 10.1016/j.neuroimage.2010.12.005; Werner NS, 2009, J AFFECT DISORDERS, V119, P124, DOI 10.1016/j.jad.2009.03.003; Wu F, 2011, PSYCHIAT RES-NEUROIM, V191, P80, DOI 10.1016/j.pscychresns.2010.09.002; Xu K, 2013, J PSYCHIATR NEUROSCI, V38, P43, DOI 10.1503/jpn.110132; Yuan YG, 2007, NEUROREPORT, V18, P1845, DOI 10.1097/WNR.0b013e3282f1939f; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhu XL, 2011, BRAIN RES, V1369, P223, DOI 10.1016/j.brainres.2010.10.104	51	16	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0126673	10.1371/journal.pone.0126673	http://dx.doi.org/10.1371/journal.pone.0126673			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996480	gold, Green Published, Green Submitted			2022-12-26	WOS:000356444000027
J	Radaelli, E; Hermans, E; Omodho, L; Francis, A; Borght, SV; Marine, JC; van den Oord, J; Amant, F				Radaelli, Enrico; Hermans, Els; Omodho, Lorna; Francis, Annick; Borght, Sara Vander; Marine, Jean-Christophe; van den Oord, Joost; Amant, Frederic			Spontaneous Post-Transplant Disorders in NOD.Cg- Prkdc(scid) Il2rg(tm1Sug)/JicTac (NOG) Mice Engrafted with Patient-Derived Metastatic Melanomas	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; B-CELL LYMPHOMA; TUMOR XENOGRAFTS; IMMUNODEFICIENT MICE; HUMANIZED MOUSE; T-CELLS; MODELS; GENERATION; EXPRESSION; ANTIBODIES	Patient-derived tumor xenograft (PDTX) approach is nowadays considered a reliable preclinical model to study in vivo cancer biology and therapeutic response. NOD scid and Il2rg-deficient mice represent the "gold standard" host for the generation of PDTXs. Compared to other immunocompromised murine lines, these mice offers several advantages including higher engraftment rate, longer lifespan and improved morphological and molecular preservation of patient-derived neoplasms. Here we describe a spectrum of previously uncharacterized post-transplant disorders affecting 14/116 (12%) NOD.Cg-Prkdc(scid) Il2rg(tm1Sug)/JicTac (NOG) mice subcutaneously engrafted with patient-derived metastatic melanomas. Affected mice exhibited extensive scaling/crusting dermatitis (13/14) associated with emaciation (13/14) and poor/unsuccessful tumor engraftment (14/14). In this context, the following pathological conditions have been recognized and characterized in details: (i) immunoinflammatory disorders with features of graft versus host disease (14/14); (ii) reactive lymphoid infiltrates effacing xenografted tumors (8/14); (iii) post-transplant B cell lymphomas associated with Epstein-Barr virus reactivation (2/14). We demonstrate that all these entities are driven by co-transplanted human immune cells populating patient-derived tumor samples. Since the exploding interest in the utilization of NOD scid and Il2rg-deficient mice for the establishment of PDTX platforms, it is of uppermost importance to raise the awareness of the limitations associated with this model. The disorders here described adversely impact tumor engraftment rate and animal lifespan, potentially representing a major confounding factor in the context of efficacy and personalized therapy studies. The occurrence of these conditions in the NOG model reflects the ability of this mouse line to promote efficient engraftment of human immune cells. Co-transplanted human lymphoid cells have indeed the potential to colonize the recipient mouse initiating the post-transplant conditions here reported. On the other hand, the evidence of an immune response of human origin against the xenotransplanted melanoma opens intriguing perspectives for the establishment of suitable preclinical models of anti-melanoma immunotherapy.	[Radaelli, Enrico; Omodho, Lorna; Francis, Annick] KU Leuven Ctr Human Genet, Ctr Biol Dis VIB11, Leuven, Belgium; [Radaelli, Enrico; Francis, Annick] InfraMouse, KU Leuven VIB, Leuven, Belgium; [Hermans, Els; Amant, Frederic] Katholieke Univ Leuven, UZ Leuven, Dept Oncol, Gynaecol Oncol, Leuven, Belgium; [Borght, Sara Vander] Univ Hosp Leuven, Dept Pathol, Lab Morphol & Mol Pathol, Leuven, Belgium; [Marine, Jean-Christophe] KU Leuven Ctr Human Genet, Ctr Biol Dis VIB11, Lab Mol Canc Biol, Leuven, Belgium; [van den Oord, Joost] Katholieke Univ Leuven, Dept Imaging & Pathol, Translat Cell & Tissue Res, Leuven, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven	Hermans, E (corresponding author), Katholieke Univ Leuven, UZ Leuven, Dept Oncol, Gynaecol Oncol, Leuven, Belgium.	Els.Hermans@uzleuven.be	Amant, Frédéric/W-7436-2019; Marine, Jean Christophe/J-2237-2015; Marine, Jean-Christophe/K-3292-2016	Amant, Frédéric/0000-0002-5452-4905; Marine, Jean-Christophe/0000-0003-2433-9837	Ministry of Health, Belgium Cancer Plan (FOD Volksgezondheid, Veiligheid van de voedselketen en Leefmilieu); Ministries of Health, National Kanker Plan (FOD Volksgezondheid, Veiligheid van de voedselketen en Leefmilieu);  [KPC_29_005];  [3M130168]	Ministry of Health, Belgium Cancer Plan (FOD Volksgezondheid, Veiligheid van de voedselketen en Leefmilieu); Ministries of Health, National Kanker Plan (FOD Volksgezondheid, Veiligheid van de voedselketen en Leefmilieu); ; 	This work was supported by the Ministries of Health, Belgium Cancer Plan, National Kanker Plan (grant from the FOD Volksgezondheid, Veiligheid van de voedselketen en Leefmilieu); KPC_29_005; http://www.kanker.be/ FA: GOA; 3M130168; www.kuleuven.be/onderzoek/kernprojecten/goa.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantar-Orozco EM, 2013, HUM GENE THER METHOD, V24, P310, DOI 10.1089/hgtb.2013.022; Ali N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044219; Bankert RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024420; Baron PW, 2001, LIVER TRANSPLANT, V7, P62, DOI 10.1053/jlts.2001.20781; BENIERS AJMC, 1992, AM J PATHOL, V140, P483; BILZER T, 1991, ANTICANCER RES, V11, P547; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; BRASOVEANU LI, 1995, INT J CANCER, V61, P548, DOI 10.1002/ijc.2910610420; Brehm MA, 2014, J IMMUNOL METHODS, V410, P3, DOI 10.1016/j.jim.2014.02.011; Carreno BM, 2009, CLIN CANCER RES, V15, P3277, DOI 10.1158/1078-0432.CCR-08-2502; Cassard L, 2008, INT J CANCER, V123, P2832, DOI 10.1002/ijc.23870; Cohen-Solal JFG, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/657406; Dangaj D, 2013, CANCER RES, V73, P4820, DOI 10.1158/0008-5472.CAN-12-3457; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Elsasser-Beile U, 2006, PROSTATE, V66, P1359, DOI 10.1002/pros.20367; Foote JB, 2014, VET IMMUNOL IMMUNOP, V157, P131, DOI 10.1016/j.vetimm.2013.11.007; Foreman O, 2011, VET PATHOL, V48, P495, DOI 10.1177/0300985810378282; Fujii E, 2014, EXP ANIM TOKYO, V63, P289, DOI 10.1538/expanim.63.289; GOLD DV, 1983, J NATL CANCER I, V71, P117; Hatano R, 2013, BRIT J HAEMATOL, V162, P263, DOI 10.1111/bjh.12378; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jin KT, 2010, CLIN TRANSL ONCOL, V12, P473, DOI 10.1007/s12094-010-0540-6; Katano I, 2011, EXP ANIM TOKYO, V60, P181, DOI 10.1538/expanim.60.181; Koo GC, 2009, EXPERT REV VACCINES, V8, P113, DOI 10.1586/14760584.8.1.113; Landis MD, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3355; Lee-Chang C, 2014, BLOOD, V124, P1450, DOI 10.1182/blood-2014-03-563940; Lones MA, 1997, ARCH PATHOL LAB MED, V121, P701; Malaney P, 2014, CANCER LETT, V344, P1, DOI 10.1016/j.canlet.2013.10.010; MASCARO JM, 1987, AM J DERMATOPATH, V9, P497, DOI 10.1097/00000372-198712000-00005; Montes-Moreno S, 2010, HAEMATOL-HEMATOL J, V95, P1342, DOI 10.3324/haematol.2009.016113; Perry AM, 2013, BLOOD, V121, P1377, DOI 10.1182/blood-2012-06-438549; Petersdorf EW, 2013, BLOOD, V122, P1863, DOI 10.1182/blood-2013-05-355982; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Quintana E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004599; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Rajesh D, 2010, HUM IMMUNOL, V71, P551, DOI 10.1016/j.humimm.2010.02.019; Schreiber TH, 2010, SEMIN IMMUNOL, V22, P105, DOI 10.1016/j.smim.2010.02.001; Scott CL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00295; Shulman HM, 2006, BIOL BLOOD MARROW TR, V12, P31, DOI 10.1016/j.bbmt.2005.10.023; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Simpson-Abelson MR, 2008, J IMMUNOL, V180, P7009, DOI 10.4049/jimmunol.180.10.7009; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; The Jackson Laboratory, 2013, IMM JAX MIC MOD; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; von Bonin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060680; Wetterauer C, 2015, PROSTATE, V75, P585, DOI 10.1002/pros.22939; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081; Zhou QJ, 2014, CANCER LETT, V344, P13, DOI 10.1016/j.canlet.2013.10.015	51	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0124974	10.1371/journal.pone.0124974	http://dx.doi.org/10.1371/journal.pone.0124974			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996609	Green Published, Green Submitted, gold			2022-12-26	WOS:000356444000008
J	Wu, K; Fang, ZY; Guo, R; Pan, B; Shi, W; Yuan, SF; Guan, HL; Gong, M; Shen, B; Shen, QR				Wu, Kai; Fang, Zhiying; Guo, Rong; Pan, Bin; Shi, Wen; Yuan, Saifei; Guan, Huilin; Gong, Ming; Shen, Biao; Shen, Qirong			Pectin Enhances Bio-Control Efficacy by Inducing Colonization and Secretion of Secondary Metabolites by Bacillus amyloliquefaciens SQY 162 in the Rhizosphere of Tobacco	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; BIOFILM FORMATION; BACTERIAL WILT; RALSTONIA-SOLANACEARUM; SURFACTIN PRODUCTION; PLANT-PATHOGENS; SUBTILIS; BIOCONTROL; TOMATO; DISEASE	Bacillus amyloliquefaciens is a plant-beneficial Gram-positive bacterium involved in suppressing soil-borne pathogens through the secretion of secondary metabolites and high rhizosphere competence. Biofilm formation is regarded as a prerequisite for high rhizosphere competence. In this work, we show that plant extracts affect the chemotaxis and biofilm formation of B. amyloliquefaciens SQY 162 (SQY 162). All carbohydrates tested induced the chemotaxis and biofilm formation of the SQY 162 strain; however, the bacterial growth rate was not influenced by the addition of carbohydrates. A strong chemotactic response and biofilm formation of SQY 162 were both induced by pectin through stimulation of surfactin synthesis and transcriptional expression of biofilm formation related matrix genes. These results suggested that pectin might serve as an environmental factor in the stimulation of the biofilm formation of SQY 162. Furthermore, in pot experiments the surfactin production and the population of SQY 162 in the rhizosphere significantly increased with the addition of sucrose or pectin, whereas the abundance of the bacterial pathogen Ralstonia decreased. With increased production of secondary metabolites in the rhizosphere of tobacco by SQY 162 and improved colonization density of SQY 162 in the pectin treatment, the disease incidences of bacterial wilt were efficiently suppressed. The present study revealed that certain plant extracts might serve as energy sources or environmental cues for SQY 162 to enhance the population density on tobacco root and bio-control efficacy of tobacco bacterial wilt.	[Wu, Kai; Fang, Zhiying; Guo, Rong; Pan, Bin; Shi, Wen; Yuan, Saifei; Shen, Biao; Shen, Qirong] Nanjing Agr Univ, Coll Resources & Environm Sci, Natl Engn Res Ctr Organ Based Fertilizers, Nanjing 210095, Jiangsu, Peoples R China; [Wu, Kai; Guan, Huilin] Yunnan Normal Univ, Coll Energy & Environm Sci, Engn Res Ctr Sustainable Dev & Utilizat Biomass E, Key Lab,Minist Educ, Kunming 650500, Peoples R China; [Gong, Ming] Yunnan Normal Univ, Sch Life Sci, Kunming 650500, Peoples R China	Nanjing Agricultural University; Yunnan Normal University; Yunnan Normal University	Shen, B (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Natl Engn Res Ctr Organ Based Fertilizers, Nanjing 210095, Jiangsu, Peoples R China.	ghl0871@aliyun.com; shenbiao@njau.edu.cn	Shen, Qirong/AAB-6531-2020		Programs of Study and Application of Key Technologies for Soil Bioremediation in Guizhou Province [110201002019]; projects of the 111 project [B12009]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Chinese Ministry of Agriculture [201103004]; National Natural Science Foundation of China [41361075]; Applied and Basic Research Foundation of Yunnan province [2013FA015]; Science Research Program of Provincial Education Department of Yunnan province [ZD2013008]	Programs of Study and Application of Key Technologies for Soil Bioremediation in Guizhou Province; projects of the 111 project; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied and Basic Research Foundation of Yunnan province; Science Research Program of Provincial Education Department of Yunnan province	This research was financially supported by Programs of Study and Application of Key Technologies for Soil Bioremediation in Guizhou Province (110201002019), the projects of the 111 project (B12009), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the Chinese Ministry of Agriculture (201103004), the National Natural Science Foundation of China (41361075), the Applied and Basic Research Foundation of Yunnan province (2013FA015), and the Science Research Program of Provincial Education Department of Yunnan province (ZD2013008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badri DV, 2009, PLANT PHYSIOL, V151, P2006, DOI 10.1104/pp.109.147462; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bais HP, 2004, PLANT PHYSIOL, V134, P307, DOI 10.1104/pp.103.028712; Bartholdson SJ, 2008, MICROBIOL-SGM, V154, P2513, DOI 10.1099/mic.0.2008/019216-0; Beauregard PB, 2013, P NATL ACAD SCI USA, V110, pE1621, DOI 10.1073/pnas.1218984110; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Cawoy H, 2014, MOL PLANT MICROBE IN, V27, P87, DOI 10.1094/MPMI-09-13-0262-R; Chai YR, 2012, MBIO, V3, DOI 10.1128/mBio.00184-12; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Chen Y, 2013, ENVIRON MICROBIOL, V15, P848, DOI 10.1111/j.1462-2920.2012.02860.x; Chen Y, 2012, MOL MICROBIOL, V85, P418, DOI 10.1111/j.1365-2958.2012.08109.x; Chowdhury SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068818; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Ding CY, 2013, PLANT SOIL, V366, P453, DOI 10.1007/s11104-012-1425-y; Elphinstone JG, 1996, B OEPP EPPO B, V26, P663, DOI DOI 10.1111/J.1365-2338.1996.TB01511.X; Fan B, 2011, J BIOTECHNOL, V151, P303, DOI 10.1016/j.jbiotec.2010.12.022; Hamon MA, 2001, MOL MICROBIOL, V42, P1199, DOI 10.1046/j.1365-2958.2001.02709.x; Handelsman J, 1996, PLANT CELL, V8, P1855, DOI 10.1105/tpc.8.10.1855; Hao WY, 2010, PLANT SOIL, V336, P485, DOI 10.1007/s11104-010-0505-0; HENDRICK CA, 1984, APPL ENVIRON MICROB, V48, P94, DOI 10.1128/AEM.48.1.94-101.1984; Jiang M, 2000, MOL MICROBIOL, V38, P535, DOI 10.1046/j.1365-2958.2000.02148.x; Kamilova F, 2005, ENVIRON MICROBIOL, V7, P1809, DOI 10.1111/j.1462-2920.2005.00889.x; Kinsella K, 2009, SOIL BIOL BIOCHEM, V41, P374, DOI 10.1016/j.soilbio.2008.11.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez D, 2009, P NATL ACAD SCI USA, V106, P280, DOI 10.1073/pnas.0810940106; Nakaho K, 2009, J PHYTOPATHOL, V157, P228, DOI 10.1111/j.1439-0434.2008.01467.x; Nihorimbere V, 2012, FEMS MICROBIOL ECOL, V79, P176, DOI 10.1111/j.1574-6941.2011.01208.x; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Ongena M, 2007, ENVIRON MICROBIOL, V9, P1084, DOI 10.1111/j.1462-2920.2006.01202.x; Pertot I, 2013, FEMS MICROBIOL ECOL, V86, P505, DOI 10.1111/1574-6941.12177; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Rudrappa T, 2008, PLANT PHYSIOL, V148, P1547, DOI 10.1104/pp.108.127613; Tan SY, 2013, PEST MANAG SCI, V69, P1245, DOI 10.1002/ps.3491; Tan SY, 2013, APPL SOIL ECOL, V64, P15, DOI 10.1016/j.apsoil.2012.10.011; Tans-Kersten J, 1998, APPL ENVIRON MICROB, V64, P4918; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010; Weng J, 2013, APPL MICROBIOL BIOT, V97, P8823, DOI 10.1007/s00253-012-4572-4; Wu K, 2014, BIOL FERT SOILS, V50, P961, DOI 10.1007/s00374-014-0916-9; Xu ZH, 2014, APPL ENVIRON MICROB, V80, P2941, DOI 10.1128/AEM.03943-13; Xu ZH, 2013, APPL ENVIRON MICROB, V79, P808, DOI 10.1128/AEM.02645-12; Yao J, 2006, J BACTERIOL, V188, P3697, DOI 10.1128/JB.188.10.3697-3708.2006; Yuan SF, 2014, APPL SOIL ECOL, V75, P86, DOI 10.1016/j.apsoil.2013.11.004; Zhao QY, 2011, APPL SOIL ECOL, V47, P67, DOI 10.1016/j.apsoil.2010.09.010; Zhu Z, 2013, WORLD J MICROB BIOT, V29, P2105, DOI 10.1007/s11274-013-1375-4; Zhu Z, 2013, J ENVIRON MANAGE, V127, P96, DOI 10.1016/j.jenvman.2013.04.017	47	14	19	9	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127418	10.1371/journal.pone.0127418	http://dx.doi.org/10.1371/journal.pone.0127418			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996156	gold, Green Published, Green Submitted			2022-12-26	WOS:000356444000065
J	Bawono, P; van der Velde, A; Abeln, S; Heringa, J				Bawono, Punto; van der Velde, Arjan; Abeln, Sanne; Heringa, Jaap			Quantifying the Displacement of Mismatches in Multiple Sequence Alignment Benchmarks	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; ACCURACY	Multiple Sequence Alignment (MSA) methods are typically benchmarked on sets of reference alignments. The quality of the alignment can then be represented by the sum-of-pairs (SP) or column (CS) scores, which measure the agreement between a reference and corresponding query alignment. Both the SP and CS scores treat mismatches between a query and reference alignment as equally bad, and do not take the separation into account between two amino acids in the query alignment, that should have been matched according to the reference alignment. This is significant since the magnitude of alignment shifts is often of relevance in biological analyses, including homology modeling and MSA refinement/manual alignment editing. In this study we develop a new alignment benchmark scoring scheme, SPdist, that takes the degree of discordance of mismatches into account by measuring the sequence distance between mismatched residue pairs in the query alignment. Using this new score along with the standard SP score, we investigate the discriminatory behavior of the new score by assessing how well six different MSA methods perform with respect to BAliBASE reference alignments. The SP score and the SPdist score yield very similar outcomes when the reference and query alignments are close. However, for more divergent reference alignments the SPdist score is able to distinguish between methods that keep alignments approximately close to the reference and those exhibiting larger shifts. We observed that by using SPdist together with SP scoring we were able to better delineate the alignment quality difference between alternative MSA methods. With a case study we exemplify why it is important, from a biological perspective, to consider the separation of mismatches. The SPdist scoring scheme has been implemented in the VerAlign web server (http://www.ibi.vu.nl/programs/veralignwww/). The code for calculating SPdist score is also available upon request.	[Bawono, Punto; van der Velde, Arjan; Abeln, Sanne; Heringa, Jaap] Vrije Univ Amsterdam, Ctr Integrat Bioinformat IBIVU, Amsterdam, Netherlands; [Heringa, Jaap] Vrije Univ Amsterdam, AIMMS, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Bawono, P (corresponding author), Vrije Univ Amsterdam, Ctr Integrat Bioinformat IBIVU, Amsterdam, Netherlands.	p.bawono@vu.nl; j.heringa@vu.nl		van der Velde, Arjan/0000-0003-1086-0859; Abeln, Sanne/0000-0002-2779-7174	Netherlands Bioinformatics Centre (NBIC); Netherlands Organisation for Scientific Research (NWO)	Netherlands Bioinformatics Centre (NBIC); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Punto Bawono has been supported by the Netherlands Bioinformatics Centre (NBIC), Biorange project BR1.3 (www.nbic.nl). Sanne Abeln has been supported by the Netherlands Organisation for Scientific Research (NWO) (www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen Claus A F, 2003, Methods Biochem Anal, V44, P341; Arkin IT, 1998, BBA-PROTEIN STRUCT M, V1429, P113, DOI 10.1016/S0167-4838(98)00225-8; Armougom F, 2006, BIOINFORMATICS, V22, pE35, DOI 10.1093/bioinformatics/btl218; BACON DJ, 1986, J MOL BIOL, V191, P153, DOI 10.1016/0022-2836(86)90252-4; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Blackburne BP, 2012, BIOINFORMATICS, V28, P495, DOI 10.1093/bioinformatics/btr701; Cline M, 2002, BIOINFORMATICS, V18, P306, DOI 10.1093/bioinformatics/18.2.306; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2006, CURR OPIN STRUC BIOL, V16, P368, DOI 10.1016/j.sbi.2006.04.004; Golubchik T, 2007, MOL BIOL EVOL, V24, P2433, DOI 10.1093/molbev/msm176; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Higgins DG, 2000, METH MOL B, V143, P1; Higgs PG, 2009, BIOINFORMATICS AND M, P119; HOGEWEG P, 1984, J MOL EVOL, V20, P175, DOI 10.1007/BF02257378; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lackner P, 2000, PROTEIN ENG, V13, P745, DOI 10.1093/protein/13.11.745; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ma JZ, 2012, BIOINFORMATICS, V28, pI59, DOI 10.1093/bioinformatics/bts213; Moult J, 2001, PROTEINS, P2; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Notredame C, 2007, PLOS COMPUT BIOL, V3, P1405, DOI 10.1371/journal.pcbi.0030123; Phillips A, 2000, MOL PHYLOGENET EVOL, V16, P317, DOI 10.1006/mpev.2000.0785; Raghava GPS, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-47; SANKOFF D, 1973, NATURE-NEW BIOL, V245, P232, DOI 10.1038/newbio245232a0; SCHOLTZ JM, 1992, ANNU REV BIOPH BIOM, V21, P95, DOI 10.1146/annurev.bb.21.060192.000523; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Thompson JD, 2005, PROTEINS, V61, P127, DOI 10.1002/prot.20527; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; Valencia A, 2002, CURR OPIN STRUC BIOL, V12, P368, DOI 10.1016/S0959-440X(02)00333-0; Van Walle I, 2005, BIOINFORMATICS, V21, P1267, DOI 10.1093/bioinformatics/bth493; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zhang Y, 2008, CURR OPIN STRUC BIOL, V18, P342, DOI 10.1016/j.sbi.2008.02.004	36	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127431	10.1371/journal.pone.0127431	http://dx.doi.org/10.1371/journal.pone.0127431			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993129	Green Submitted, gold, Green Published			2022-12-26	WOS:000354918600063
J	Madgwick, A; Fort, P; Hanson, PS; Thibault, P; Gaudreau, MC; Lutfalla, G; Moroy, T; Abou Elela, S; Chaudhry, B; Elliott, DJ; Morris, CM; Venables, JP				Madgwick, Alicia; Fort, Philippe; Hanson, Peter S.; Thibault, Philippe; Gaudreau, Marie-Claude; Lutfalla, Georges; Moeroey, Tarik; Abou Elela, Sherif; Chaudhry, Bill; Elliott, David J.; Morris, Christopher M.; Venables, Julian P.			Neural Differentiation Modulates the Vertebrate Brain Specific Splicing Program	PLOS ONE			English	Article							ZEBRAFISH; CANCER; EXPRESSION; DYNAMICS; REVEALS; NEURONS; TISSUES; HUMANS; FAMILY; RBFOX2	Alternative splicing patterns are known to vary between tissues but these patterns have been found to be predominantly peculiar to one species or another, implying only a limited function in fundamental neural biology. Here we used high-throughput RT-PCR to monitor the expression pattern of all the annotated simple alternative splicing events (ASEs) in the Reference Sequence Database, in different mouse tissues and identified 93 brain-specific events that shift from one isoform to another (switch-like) between brain and other tissues. Consistent with an important function, regulation of a core set of 9 conserved switch-like ASEs is highly conserved, as they have the same pattern of tissue-specific splicing in all vertebrates tested: human, mouse and zebrafish. Several of these ASEs are embedded within genes that encode proteins associated with the neuronal microtubule network, and show a dramatic and concerted shift within a short time window of human neural stem cell differentiation. Similarly these exons are dynamically regulated in zebrafish development. These data demonstrate that although alternative splicing patterns often vary between species, there is nonetheless a core set of vertebrate brain-specific ASEs that are conserved between species and associated with neural differentiation.	[Madgwick, Alicia; Chaudhry, Bill; Elliott, David J.; Venables, Julian P.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Fort, Philippe] Univ Montpellier, CNRS, CRBM, UMR5237, F-34059 Montpellier, France; [Hanson, Peter S.; Morris, Christopher M.] Newcastle Univ, Med Toxicol Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Thibault, Philippe; Abou Elela, Sherif] Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, Quebec City, PQ, Canada; [Gaudreau, Marie-Claude; Moeroey, Tarik] Univ Montreal, Inst Rech Clin Montreal, Quebec City, PQ, Canada; [Gaudreau, Marie-Claude; Moeroey, Tarik] Univ Montreal, Dept Microbiol Infectiol & Immunol, Quebec City, PQ, Canada; [Lutfalla, Georges] Univ Montreal, CNRS, UMR 5235, Dynam Interact Membranaires Norm & Pathol, Quebec City, PQ, Canada	Newcastle University - UK; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Newcastle University - UK; University of Sherbrooke; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; Universite de Montreal	Venables, JP (corresponding author), Newcastle Univ, Inst Med Genet, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.	julian.venables2@ncl.ac.uk	Fort, Philippe/M-9498-2015; Lutfalla, Georges/AAW-9386-2021	Fort, Philippe/0000-0001-5997-8722; LUTFALLA, Georges/0000-0002-6591-7894; Elliott, David/0000-0002-6930-0699; Madgwick, Alicia/0000-0003-1225-8132; Gaudreau, Marie-Claude/0000-0003-2833-7951; Morris, Christopher/0000-0002-3749-0993; Abou Elela, Sherif/0000-0002-0630-3294	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7) under REA [PCIG13-GA-2013-618114]; Wellcome trust [WT080368MA, WT089225/Z/09/Z]; CIHR [MOP- 86516]; Canadian Institutes of Health Research (CIHR); MRC [G1100540, MR/L016451/1, G0900652, G0502157, G0400074] Funding Source: UKRI; Medical Research Council [G0502157, MR/L016451/1, G1100540, G0400074, G0900652] Funding Source: researchfish; Alzheimer&quot;s Society [181] Funding Source: researchfish	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7) under REA; Wellcome trust(Wellcome TrustEuropean Commission); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Alzheimer&quot;s Society	The research leading to these results was primarily funded by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement awarded to JPV no [PCIG13-GA-2013-618114]. DJE was funded by Wellcome trust grants WT080368MA and WT089225/Z/09/Z. TM was supported by CIHR grant (MOP- 86516). M-C G was supported by a fellowship from the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Alibaud L, 2011, MOL MICROBIOL, V80, P919, DOI 10.1111/j.1365-2958.2011.07618.x; Barbosa-Morais NL, 2006, GENOME RES, V16, P66, DOI 10.1101/gr.3936206; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; Das D, 2007, NUCLEIC ACIDS RES, V35, P4845, DOI 10.1093/nar/gkm485; Dillman AA, 2013, NAT NEUROSCI, V16, P499, DOI 10.1038/nn.3332; Ehrmann I, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003474; Ellis JD, 2012, MOL CELL, V46, P884, DOI 10.1016/j.molcel.2012.05.037; Han H, 2013, NATURE, V498, P241, DOI 10.1038/nature12270; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Hoogenraad CC, 2002, NAT GENET, V32, P116, DOI 10.1038/ng954; Jelen N, 2007, PLOS GENET, V3, P1838, DOI 10.1371/journal.pgen.0030173; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klinck R, 2008, CANCER RES, V68, P657, DOI 10.1158/0008-5472.CAN-07-2580; Kurzawa-Akanbi M, 2012, J NEUROCHEM, V123, P298, DOI 10.1111/j.1471-4159.2012.07879.x; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lauriat TL, 2006, BRAIN RES, V1121, P1, DOI 10.1016/j.brainres.2006.08.099; Matsushita M, 2009, TRAFFIC, V10, P1647, DOI 10.1111/j.1600-0854.2009.00975.x; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Nisar R, 2015, ARCH TOXICO IN PRESS; Pandey P, 2014, ONCOTARGET; Pillai RN, 2012, CURR ONCOL REP, V14, P105, DOI 10.1007/s11912-012-0213-4; Pollmann M, 2006, EXP CELL RES, V312, P3241, DOI 10.1016/j.yexcr.2006.06.035; Poulain FE, 2010, MOL CELL NEUROSCI, V43, P15, DOI 10.1016/j.mcn.2009.07.012; STAMM S, 1994, NUCLEIC ACIDS RES, V22, P1515, DOI 10.1093/nar/22.9.1515; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Suzuki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016880; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; Uehara R, 2013, J CELL BIOL, V202, P623, DOI 10.1083/jcb.201302123; Venables JP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3480; Venables JP, 2013, MOL CELL BIOL, V33, P396, DOI 10.1128/MCB.01174-12; Venables JP, 2012, MOL BIOL EVOL, V29, P260, DOI 10.1093/molbev/msr193; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yap K, 2012, GENE DEV, V26, P1209, DOI 10.1101/gad.188037.112; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108	40	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0125998	10.1371/journal.pone.0125998	http://dx.doi.org/10.1371/journal.pone.0125998			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993117	Green Published, Green Submitted, gold			2022-12-26	WOS:000354918600024
J	Gogia, S; Lo, CY; Neelamegham, S				Gogia, Shobhit; Lo, Chi Y.; Neelamegham, Sriram			Detection of Plasma Protease Activity Using Microsphere-Cytometry Assays with E-coli Derived Substrates: VWF Proteolysis by ADAMTS13	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; THROMBOTIC THROMBOCYTOPENIC PURPURA; SHEAR-STRESS; HYPERBILIRUBINEMIA; SPECIFICITY; FRETS-VWF73; PROTEOME; DISEASE; BOND	Protease levels in human blood are often prognostic indicators of inflammatory, thrombotic or oncogenic disorders. The measurement of such enzyme activities in substrate-based assays is complicated due to the low prevalence of these enzymes and steric hindrance of the substrates by the more abundant blood proteins. To address these limitations, we developed a molecular construct that is suitable for microsphere-cytometer based assays in the milieu of human blood plasma. In this proof of principle study, we demonstrate the utility of this substrate to measure metalloprotease ADAMTS13 activity. The substrate, expressed in E. coli as a fusion protein, contains the partial A2-domain of von Willebrand factor (VWF amino acids 1594-1670) that is mutated to include a single primary amine at the N-terminus and free cysteines at the C-terminus. N-terminus fluorescence conjugation was possible using NHS (N-hydroxysuccinimide) chemistry. Maleimide-PEG(Polyethylene glycol)(n)-biotin coupling at the C-terminus allowed biotinylation with variable PEG spacer lengths. Once bound to streptavidin-bearing microspheres, the substrate fluorescence signal decreased in proportion with ADAMTS13 concentration. Whereas recombinant ADAMTS13 activity could be quantified using substrates with all PEG repeat-lengths, only the construct with the longer 77 PEG-unit could quantify proteolysis in blood plasma. Using this longer substrate, plasma ADAMTS13 down to 5% of normal levels could be detected within 30 min. Such measurements could also be readily performed under conditions resembling hyperbilirubinemia. Enzyme catalytic activity was tuned by varying buffer calcium, with lower divalent ion concentrations enhancing cleavage. Overall, the study highlights the substrate design features important for the creation of efficient proteolysis assays in the setting of human plasma. In particular, it emphasizes the need to introduce PEG spacers in plasma-based experiments, a design attribute commonly ignored in immobilized peptide-substrate assays.	[Neelamegham, Sriram] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA; SUNY Buffalo, NY State Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Neelamegham, S (corresponding author), SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.	neel@buffalo.edu		Neelamegham, Sriram/0000-0002-1371-8500	National Institutes of Health (NIH) [HL77258]; T32 NIH Ruth L. Kirschstein Postdoctoral Research Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM099607] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 NIH Ruth L. Kirschstein Postdoctoral Research Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant HL77258. C. Y. L. is supported by a T32 NIH Ruth L. Kirschstein Postdoctoral Research Training Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Anderson PJ, 2006, J BIOL CHEM, V281, P850, DOI 10.1074/jbc.M504540200; Crawley JTB, 2011, BLOOD, V118, P3212, DOI 10.1182/blood-2011-02-306597; Dayananda KM, 2011, ANAL BIOCHEM, V410, P206, DOI 10.1016/j.ab.2010.12.005; Dayananda KM, 2010, BLOOD, V116, P3990, DOI 10.1182/blood-2010-02-269266; Dervenoulas J, 2000, ANN HEMATOL, V79, P66, DOI 10.1007/s002770050012; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Edwards BS, 2012, CYTOM PART A, V81A, P419, DOI 10.1002/cyto.a.22039; Evers TH, 2006, BIOCHEMISTRY-US, V45, P13183, DOI 10.1021/bi061288t; Gosalia DN, 2005, PROTEOMICS, V5, P1292, DOI 10.1002/pmic.200401011; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; JAFFE EA, 1973, BLOOD, V42, P499, DOI 10.1182/blood.V42.4.499.499; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Kokame K, 2004, BLOOD, V103, P607, DOI 10.1182/blood-2003-08-2861; Meyer SC, 2007, J THROMB HAEMOST, V5, P866, DOI 10.1111/j.1538-7836.2007.02438.x; Mocchegiani E, 2011, CURR OPIN PULM MED, V17, pS11, DOI 10.1097/01.mcp.0000410743.98087.12; Paliouras M, 2007, CANCER LETT, V249, P61, DOI 10.1016/j.canlet.2006.12.018; Peyvandi F, 2010, J THROMB HAEMOST, V8, P631, DOI 10.1111/j.1538-7836.2010.03761.x; Piyasena ME, 2014, LAB CHIP, V14, P1044, DOI 10.1039/c3lc51152a; Rashidian M, 2013, BIOCONJUGATE CHEM, V24, P1277, DOI 10.1021/bc400102w; Ratto TV, 2004, BIOPHYS J, V86, P2430, DOI 10.1016/S0006-3495(04)74299-X; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Saunders MJ, 2006, CYTOM PART A, V69A, P342, DOI 10.1002/cyto.a.20268; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schiff DE, 2004, J PEDIAT HEMATOL ONC, V26, P535, DOI 10.1097/01.mph.0000135284.85292.2c; Scully M, 2008, BRIT J HAEMATOL, V142, P819, DOI 10.1111/j.1365-2141.2008.07276.x; Shim K, 2008, BLOOD, V111, P651, DOI 10.1182/blood-2007-05-093021; Singh I, 2009, BIOPHYS J, V96, P2313, DOI 10.1016/j.bpj.2008.12.3900; Tirumalai RS, 2003, MOL CELL PROTEOMICS, V2, P1096, DOI 10.1074/mcp.M300031-MCP200; Tsai HM, 2010, INT J HEMATOL, V91, P1, DOI 10.1007/s12185-009-0476-1; TSAI HM, 1994, BLOOD, V83, P2171; Zhou MY, 2011, BLOOD, V117, P4623, DOI 10.1182/blood-2010-11-321596	32	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126556	10.1371/journal.pone.0126556	http://dx.doi.org/10.1371/journal.pone.0126556			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992814	gold, Green Submitted, Green Published			2022-12-26	WOS:000354917300045
J	Deng, C; Chen, HD; Yang, N; Feng, Y; Hsueh, AJW				Deng, Cheng; Chen, Haidi; Yang, Na; Feng, Yi; Hsueh, Aaron J. W.			Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN RECEPTOR; G-PROTEIN; CARDIOVASCULAR-RESPONSES; KNOCKOUT MICE; FOOD-INTAKE; LIGAND; APELIN-13; RATS; PEPTIDE; BRAIN	Apela ( APJ early endogenous ligand, also known as elabela or toddler) is a recently discovered peptide hormone. Based on genetic studies in zebrafish, apela was found to be important for endoderm differentiation and heart development during embryogenesis. Although common phenotypes of apela and APJ-null zebrafish during embryonic development suggested that apela interacts with the APJ receptor, kinetics of apela binding to APJ and intracellular signaling pathways for apela remain unknown. The role of apela in adults is also uncertain. Using a chimeric apela ligand, we showed direct binding of apela to APJ with high affinity (K-d = 0.51 nM) and the ability of apelin, the known peptide ligand for APJ, to compete for apela binding. Apela, similar to apelin, acts through the inhibitory G protein pathway by inhibiting forskolin-stimulated cAMP production and by inducing ERK1/2 phosphorylation. In adult rats, apela is expressed exclusively in the kidney, unlike the wide tissue distribution of apelin. In vivo studies demonstrated the ability of apela to regulate fluid homeostasis by increasing diuresis and water intake. Dose-response studies further indicated that apela induces 2- and 5-fold higher maximal responses than apelin in ERK1/2 phosphorylation and diuresis/water intake, respectively. After designing an apela antagonist, we further demonstrated the role of endogenous ligand(s) in regulating APJ-mediated fluid homeostasis. Our results identified apela as a potent peptide hormone capable of regulating fluid homeostasis in adult kidney through coupling to the APJ-mediated G(i) signaling pathway.	[Deng, Cheng; Chen, Haidi; Yang, Na] Nanjing Normal Univ, Jiangsu Key Lab Biodivers & Biotechnol, Coll Life Sci, Nanjing 210023, Jiangsu, Peoples R China; [Deng, Cheng; Feng, Yi; Hsueh, Aaron J. W.] Stanford Univ, Program Reprod & Stem Cell Biol, Dept Ob Gyn, Sch Med, Stanford, CA 94305 USA	Nanjing Normal University; Stanford University	Hsueh, AJW (corresponding author), Stanford Univ, Program Reprod & Stem Cell Biol, Dept Ob Gyn, Sch Med, Stanford, CA 94305 USA.	aaron.hsueh@stanford.edu		deng, cheng/0000-0002-5296-8879	National Natural Science Foundation of China [31401207]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); One Hundred Person Project of Nanjing Normal University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); One Hundred Person Project of Nanjing Normal University	This work was supported by the National Natural Science Foundation of China (31401207), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and the One Hundred Person Project of Nanjing Normal University. The authors declare that they have no conflicts of interest with the contents of this article.	Bai B, 2008, ACTA BIOCH BIOPH SIN, V40, P311, DOI 10.1111/j.1745-7270.2008.00403.x; Ben-Shlomo I, 2005, MOL ENDOCRINOL, V19, P1097, DOI 10.1210/me.2004-0451; Ben-Shlomo Izhar, 2003, Sci STKE, V2003, pRE9, DOI 10.1126/stke.2003.187.re9; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Cheng Zhijie, 2010, Curr Chem Genomics, V4, P84, DOI 10.2174/1875397301004010084; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; Habata Y, 1999, BBA-MOL CELL RES, V1452, P25, DOI 10.1016/S0167-4889(99)00114-7; Hekmat AS, 2011, REGUL PEPTIDES, V172, P62, DOI 10.1016/j.regpep.2011.08.010; Horiuchi Y, 2003, J NEUROIMMUNOL, V144, P46, DOI 10.1016/j.jneuroim.2003.08.029; Hus-Citharel A, 2008, KIDNEY INT, V74, P486, DOI 10.1038/ki.2008.199; Jung BP, 1997, BIOCHEM BIOPH RES CO, V230, P69, DOI 10.1006/bbrc.1996.5828; Katugampola SD, 2001, BRIT J PHARMACOL, V132, P1255, DOI 10.1038/sj.bjp.0703939; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Lee DK, 2000, J NEUROCHEM, V74, P34, DOI 10.1046/j.1471-4159.2000.0740034.x; Lee DK, 2005, ENDOCRINOLOGY, V146, P231, DOI 10.1210/en.2004-0359; Masri B, 2002, BIOCHEM BIOPH RES CO, V290, P539, DOI 10.1006/bbrc.2001.6230; Masri B, 2006, J BIOL CHEM, V281, P18317, DOI 10.1074/jbc.M600606200; McKinley MJ, 2001, JPN J PHYSIOL, V51, P281, DOI 10.2170/jjphysiol.51.281; Metpally RPR, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-106; Mitra A, 2006, PHYSIOL BEHAV, V89, P221, DOI 10.1016/j.physbeh.2006.06.006; Najafipour H, 2012, REGUL PEPTIDES, V178, P43, DOI 10.1016/j.regpep.2012.06.006; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Reaux A, 2001, J NEUROCHEM, V77, P1085, DOI 10.1046/j.1471-4159.2001.00320.x; Reichman-Fried M, 2014, BIOESSAYS, V36, P741, DOI 10.1002/bies.201400048; Roberts EM, 2010, J NEUROENDOCRINOL, V22, P301, DOI 10.1111/j.1365-2826.2010.01968.x; Roberts EM, 2009, J ENDOCRINOL, V202, P453, DOI 10.1677/JOE-09-0134; Rowland NE, 2003, AM J PHYSIOL-REG I, V284, pR1586, DOI 10.1152/ajpregu.00730.2002; STEIN JH, 1972, J CLIN INVEST, V51, P1709, DOI 10.1172/JCI106972; Sunter D, 2003, NEUROSCI LETT, V353, P1, DOI 10.1016/S0304-3940(03)00351-3; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Taheri S, 2002, BIOCHEM BIOPH RES CO, V291, P1208, DOI 10.1006/bbrc.2002.6575; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Wang GY, 2004, ENDOCRINOLOGY, V145, P1342, DOI 10.1210/en.2003-1116; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8	35	73	77	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18261	18268		10.1074/jbc.M115.648238	http://dx.doi.org/10.1074/jbc.M115.648238			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	25995451	Green Published, hybrid			2022-12-26	WOS:000358512100001
J	Jegouzo, SAF; Feinberg, H; Dungarwalla, T; Drickamer, K; Weis, WI; Taylor, ME				Jegouzo, Sabine A. F.; Feinberg, Hadar; Dungarwalla, Tabassum; Drickamer, Kurt; Weis, William I.; Taylor, Maureen E.			A Novel Mechanism for Binding of Galactose-terminated Glycans by the C-type Carbohydrate Recognition Domain in Blood Dendritic Cell Antigen 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL-BASIS; LIGAND-BINDING; LECTIN; RECEPTORS; BDCA-2; EXPRESSION; PROTEIN	Blood dendritic cell antigen 2 (BDCA-2; also designated CLEC4C or CD303) is uniquely expressed on plasmacytoid dendritic cells. Stimulation of BDCA-2 with antibodies leads to an anti-inflammatory response in these cells, but the natural ligands for the receptor are not known. The C-type carbohydrate recognition domain in the extracellular portion of BDCA-2 contains a signature motif typical of C-type animal lectins that bind mannose, glucose, or GlcNAc, yet it has been reported that BDCA-2 binds selectively to galactose-terminated, biantennary N-linked glycans. A combination of glycan array analysis and binding competition studies with monosaccharides and natural and synthetic oligosaccharides have been used to define the binding epitope for BDCA-2 as the trisaccharide Gal beta 1-3/4GlcNAc beta 1-2Man. X-ray crystallography and mutagenesis studies show that mannose is ligated to the conserved Ca2+ in the primary binding site that is characteristic of C-type carbohydrate recognition domains, and the GlcNAc and galactose residues make additional interactions in a wide, shallow groove adjacent to the primary binding site. As predicted from these studies, BDCA-2 binds to IgG, which bears galactose-terminated glycans that are not commonly found attached to other serum glycoproteins. Thus, BDCA-2 has the potential to serve as a previously unrecognized immunoglobulin Fc receptor.	[Feinberg, Hadar; Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Feinberg, Hadar; Weis, William I.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Jegouzo, Sabine A. F.; Dungarwalla, Tabassum; Drickamer, Kurt; Taylor, Maureen E.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England	Stanford University; Stanford University; Imperial College London	Taylor, ME (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Sir Ernst Chain Bldg, London SW7 2AZ, England.	maureen.taylor@imperial.ac.uk	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Taylor, Maureen/0000-0001-8300-4987; Jegouzo, Sabine/0000-0001-7768-0102	 [NIGMS GM62116];  [GM98791]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116, P41GM103393, R24GM098791] Funding Source: NIH RePORTER	; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Nicola Stambach for providing the initial cDNA clone of BDCA-2, Paul Hitchen for performing mass spectrometry, and the Consortium for Functional Glycomics (funded by Grants NIGMS GM62116 and GM98791) for production of the mammalian glycan microarray by the Glycan Array Synthesis Core of the Scripps Research Institute, La Jolla, CA) and for analysis of samples on the array by David Smith and Jamie Heimburg-Molinaro in the Protein-Glycan Interaction Core of Emory University School of Medicine (Atlanta, GA).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Cao W., 2007, PLOS BIOL, V5, pe248; Chan VSF, 2012, AUTOIMMUN REV, V11, P890, DOI 10.1016/j.autrev.2012.03.004; Cormack B., 2001, CURR PROTOC NEUROSCI, V4, P11, DOI DOI 10.1002/0471142727.MB0805S37; DRICKAMER K, 1992, NATURE, V360, P183, DOI 10.1038/360183a0; Dzionek A, 2000, J IMMUNOL, V165, P6037, DOI 10.4049/jimmunol.165.11.6037; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Feinberg H, 2000, J BIOL CHEM, V275, P21539, DOI 10.1074/jbc.M002366200; Feinberg H, 2000, J BIOL CHEM, V275, P35176, DOI 10.1074/jbc.M005557200; Feinberg H, 2007, J BIOL CHEM, V282, P17250, DOI 10.1074/jbc.M701624200; Feinberg H, 2013, J BIOL CHEM, V288, P28457, DOI 10.1074/jbc.M113.497149; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Jahn PS, 2010, CELL IMMUNOL, V265, P15, DOI 10.1016/j.cellimm.2010.06.005; Jegouzo SAF, 2014, GLYCOBIOLOGY, V24, P1291, DOI 10.1093/glycob/cwu072; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kolatkar AR, 1996, J BIOL CHEM, V271, P6679, DOI 10.1074/jbc.271.12.6679; Lee RT, 2011, GLYCOBIOLOGY, V21, P512, DOI 10.1093/glycob/cwq193; LEE RT, 1991, J BIOL CHEM, V266, P4810; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mizuno H, 1997, NAT STRUCT BIOL, V4, P438, DOI 10.1038/nsb0697-438; Nagae M, 2014, PROTEINS, V82, P1512, DOI 10.1002/prot.24504; Nagae M, 2013, J BIOL CHEM, V288, P33598, DOI 10.1074/jbc.M113.513572; Ng KKS, 2002, J BIOL CHEM, V277, P16088, DOI 10.1074/jbc.M200493200; Plato A, 2013, INT REV IMMUNOL, V32, P134, DOI 10.3109/08830185.2013.777065; Raghavan M, 1996, ANNU REV CELL DEV BI, V12, P181, DOI 10.1146/annurev.cellbio.12.1.181; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Riboldi E, 2011, J BIOL CHEM, V286, P35329, DOI 10.1074/jbc.C111.290494; Rock J, 2007, EUR J IMMUNOL, V37, P3564, DOI 10.1002/eji.200737711; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Schraml BU, 2015, CURR OPIN IMMUNOL, V32, P13, DOI 10.1016/j.coi.2014.11.001; Suzuki N, 2004, P NATL ACAD SCI USA, V101, P9023, DOI 10.1073/pnas.0402822101; Varki A., 2001, CURR PROT MOL BIOL, V17, P2021; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Zou Y, 2012, J CARBOHYD CHEM, V31, P436, DOI 10.1080/07328303.2012.666689	40	24	24	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16759	16771		10.1074/jbc.M115.660613	http://dx.doi.org/10.1074/jbc.M115.660613			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25995448	Green Published, hybrid			2022-12-26	WOS:000357572800023
J	Cai, CF; Cheng, FY; Wu, J; Zhong, Y; Liu, GX				Cai, Changfu; Cheng, Fang-Yun; Wu, Jing; Zhong, Yuan; Liu, Gaixiu			The First High-Density Genetic Map Construction in Tree Peony (Paeonia Sect. Moutan) using Genotyping by Specific-Locus Amplified Fragment Sequencing	PLOS ONE			English	Article							SATURATED LINKAGE MAP; SEGREGATION DISTORTION; SNP DISCOVERY; QTL ANALYSIS; MARKERS; CULTIVARS; IDENTIFICATION	Genetic linkage maps, permitting the elucidation of genome structure, are one of most powerful genomic tools to accelerate marker-assisted breeding. However, due to a lack of sufficient user-friendly molecular markers, no genetic linkage map has been developed for tree peonies (Paeonia Sect. Moutan), a group of important horticultural plants worldwide. Specific-locus amplified fragment sequencing (SLAF-seq) is a recent molecular marker development technology that enable the large-scale discovery and genotyping of sequence-based marker in genome-wide. In this study, we performed SLAF sequencing of an F1 population, derived from the cross P. ostti 'FenDanBai' x P. x suffruticosa 'HongQiao', to identify sufficient high-quality markers for the construction of high-density genetic linkage map in tree peonies. After SLAF sequencing, a total of 78 Gb sequencing data and 285,403,225 pairend reads were generated. We detected 309,198 high-quality SLAFs from these data, of which 85,124 (27.5%) were polymorphic. Subsequently, 3518 of the polymorphic markers, which were successfully encoded in to Mendelian segregation types, and were in conformity with the criteria of high-quality markers, were defined as effective markers and used for genetic linkage mapping. Finally, we constructed an integrated genetic map, which comprised 1189 markers on the five linkage groups, and spanned 920.699 centiMorgans (cM) with an average inter-marker distance of 0.774 cM. There were 1115 'SNP-only' markers, 18 'InDelonly' markers, and 56 'SNP&InDel' markers on the map. Among these markers, 450 (37.85%) showed significant segregation distortion (P < 0.05). In conclusion, this investigation reported the first large-scale marker development and high-density linkage map construction for tree peony. The results of this study will serve as a solid foundation not only for marker-assisted breeding, but also for genome sequence assembly for tree peony.	[Cai, Changfu; Cheng, Fang-Yun; Wu, Jing; Zhong, Yuan] Beijing Forestry Univ, Landscape Architecture Coll, Natl Flower Engn Res Ctr, Beijing, Peoples R China; [Liu, Gaixiu] Natl Peony Garden, Luoyang, Henan, Peoples R China	Beijing Forestry University	Cheng, FY (corresponding author), Beijing Forestry Univ, Landscape Architecture Coll, Natl Flower Engn Res Ctr, Beijing, Peoples R China.	chengfy8@263.net			Natural Science Foundation of China [31471898]; National High Technology Research and Development Program of China (863 Program) [2011AA100207]; National Science and Technology Support Program of China [2012BAD01B07]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Science and Technology Support Program of China	This work was supported by the Natural Science Foundation of China (No. 31471898; http://www.nsfc.gov.cn; FYC), the National High Technology Research and Development Program of China (863 Program, 2011AA100207; http://www.863.gov.cn; FYC), and the National Science and Technology Support Program of China (2012BAD01B07; http://www.most.gov.cn; FYC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Celton JM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-155; Chan EKF, 2010, GENETICS, V185, P991, DOI 10.1534/genetics.109.108522; Chen SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065122; Cheng F. Y., 2007, INT J PLANT BREEDING, V1, P89, DOI [10.3923/ijpbg.2007.89.94, DOI 10.3923/IJPBG.2007.89.94, DOI 10.3923/ijpbg.2007.89.94]; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; FAURE S, 1993, THEOR APPL GENET, V87, P517, DOI 10.1007/BF00215098; Gai SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055297; Gaur R, 2012, DNA RES, V19, P357, DOI 10.1093/dnares/dss018; Gonen S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-166; Guo DL, 2009, J HORTIC SCI BIOTECH, V84, P131, DOI 10.1080/14620316.2009.11512493; Han XY, 2008, BIOCHEM GENET, V46, P162, DOI 10.1007/s10528-007-9140-8; He D, 2014, PLANT BREEDING, V133, P138, DOI 10.1111/pbr.12100; Hong DY, 2005, ACTA PHYTOTAXON SIN, V43, P169, DOI 10.1360/aps040065; Iehisa JCM, 2014, DNA RES, V21, P555, DOI 10.1093/dnares/dsu020; Kakioka R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-32; Kang BY, 2011, GENOME, V54, P128, DOI 10.1139/G10-099; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Li J.J., 2011, TREE PEONY OF CHINA; Li SS, 2015, FOOD CHEM, V173, P133, DOI 10.1016/j.foodchem.2014.10.017; Liu DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098855; Liu J, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-34; Luo MC, 2009, P NATL ACAD SCI USA, V106, P15780, DOI 10.1073/pnas.0908195106; Ma H, 2004, GENETICS, V166, P419, DOI 10.1534/genetics.166.1.419; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Ooijen JV, 2006, JOINMAP 4 SOFTWARE C, P1; Oyant LHS, 2008, TREE GENET GENOMES, V4, P11, DOI 10.1007/s11295-007-0084-2; Paillard S, 2003, THEOR APPL GENET, V107, P1235, DOI 10.1007/s00122-003-1361-6; Perfectti F, 1996, THEOR APPL GENET, V93, P440, DOI 10.1007/BF00223188; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Pindo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-12; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Qi ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104871; Rogers A., 1995, PEONIES; Song WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052097; Sun L., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1111/MPP.12078; Sun LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059562; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Suo ZL, 2005, HORTSCIENCE, V40, P329, DOI 10.21273/HORTSCI.40.2.329; Talukder ZI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098628; Taylor DR, 2003, GENETICA, V117, P27, DOI 10.1023/A:1022308414864; Wang LY., 1998, CHINESE TREE PEONY; Wang N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-148; Wang WX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-523; Ward JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-2; Wei QZ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1158; Wister J.C., 1962, THE PEONIES; Wu J, 2014, MOL BREEDING, V34, P1853, DOI 10.1007/s11032-014-0144-x; Xia C, 2014, EUPHYTICA, DOI [10.1007/s10681-014-1202-05, DOI 10.1007/S10681-014-1202-05]; Xu SZ, 2008, GENETICS, V180, P2201, DOI 10.1534/genetics.108.090688; Yagi M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-734; Yu C, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00796; Yu HP, 2013, SCI HORTIC-AMSTERDAM, V164, P58, DOI 10.1016/j.scienta.2013.06.043; Yuan JH, 2014, MOL ECOL, V23, P82, DOI 10.1111/mec.12567; Yuan JH, 2011, CONSERV GENET, V12, P1539, DOI 10.1007/s10592-011-0251-8; Yuan JH, 2010, INT J PLANT SCI, V171, P409, DOI 10.1086/651228; Zhang C, 2014, PLANT CELL REP, V33, P111, DOI 10.1007/s00299-013-1516-0; Zhang D.Q., 2007, FOREST STUD CHINA, V9, P1, DOI [10.1007/s11632-007-0001-7, DOI 10.1007/S11632-007-0001-7]; Zhang F, 2011, MOL BREEDING, V27, P11, DOI 10.1007/s11032-010-9409-1; Zhang F, 2010, SCI HORTIC-AMSTERDAM, V125, P422, DOI 10.1016/j.scienta.2010.03.028; Zhang JJ, 2012, PLANT CELL REP, V31, P299, DOI 10.1007/s00299-011-1164-1; Zhang LY, 2010, THEOR APPL GENET, V121, P1071, DOI 10.1007/s00122-010-1372-z; Zhang YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-141; [周海梅 ZHOU Haimei], 2009, [中国油脂, China Oils and Fats], V34, P72; Zhou H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079996	67	40	47	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128584	10.1371/journal.pone.0128584	http://dx.doi.org/10.1371/journal.pone.0128584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010095	Green Submitted, gold, Green Published			2022-12-26	WOS:000355183900243
J	Du, T; Hu, D; Cai, D				Du, Tao; Hu, Dan; Cai, David			Outflow Boundary Conditions for Blood Flow in Arterial Trees	PLOS ONE			English	Article							PARAMETER-ESTIMATION; COMPUTER-SIMULATION; MATHEMATICAL-MODEL; WAVE-PROPAGATION; VISCOUS DRAG; SHOCK-WAVES; PRESSURE; HEMODYNAMICS; CIRCULATION; VELOCITY	In the modeling of the pulse wave in the systemic arterial tree, it is necessary to truncate small arterial crowns representing the networks of small arteries and arterioles. Appropriate boundary conditions at the truncation points are required to represent wave reflection effects of the truncated arterial crowns. In this work, we provide a systematic method to extract parameters of the three-element Windkessel model from the impedance of a truncated arterial tree or from experimental measurements of the blood pressure and flow rate at the inlet of the truncated arterial crown. In addition, we propose an improved three-element Windkessel model with a complex capacitance to accurately capture the fundamental-frequency time lag of the reflection wave with respect to the incident wave. Through our numerical simulations of blood flow in a single artery and in a large arterial tree, together with the analysis of the modeling error of the pulse wave in large arteries, we show that both a small truncation radius and the complex capacitance in the improved Windkessel model play an important role in reducing the modeling error, defined as the difference in dynamics induced by the structured tree model and the Windkessel models.	[Du, Tao; Hu, Dan; Cai, David] Shanghai Jiao Tong Univ, Inst Nat Sci, Dept Math, Shanghai 200030, Peoples R China; [Du, Tao; Hu, Dan; Cai, David] Shanghai Jiao Tong Univ, MOE LSC, Shanghai 200030, Peoples R China; [Cai, David] NYU, Courant Inst Math Sci, New York, NY USA; [Cai, David] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Cai, David] New York Univ Abu Dhabi, NYUAD Inst, Abu Dhabi, U Arab Emirates	Shanghai Jiao Tong University; Shanghai Jiao Tong University; New York University; New York University	Hu, D (corresponding author), Shanghai Jiao Tong Univ, Inst Nat Sci, Dept Math, Shanghai 200030, Peoples R China.	hudan80@sjtu.edu.cn			Natural Science Foundation of China [11004131, 91230202, 11471213, 11071161]; National Science Foundation [DMS-1009575]; NYU Abu Dhabi Institute [G1301]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF)); NYU Abu Dhabi Institute	The work of DH is supported by Natural Science Foundation of China (grant nos. 11004131, 91230202, and 11471213). The work of DC is supported by Natural Science Foundation of China grant no. 11071161, National Science Foundation grant no. DMS-1009575, and the NYU Abu Dhabi Institute under grant no. G1301. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alastruey J, 2008, COMMUN COMPUT PHYS, V4, P317; Alastruey J, 2008, INT J NUMER METH FL, V56, P1061, DOI 10.1002/fld.1606; ANLIKER M, 1971, Z ANGEW MATH PHYS, V22, P217, DOI 10.1007/BF01591407; Azer K, 2006, THESIS NYU; Azer Karim, 2007, Cardiovasc Eng, V7, P51, DOI 10.1007/s10558-007-9031-y; BARNARD ACL, 1966, BIOPHYS J, V6, P717, DOI 10.1016/S0006-3495(66)86690-0; Batchelor G.K., 2000, INTRO FLUID DYNAMICS, DOI DOI 10.1017/CBO9780511800955; Blacher J, 1999, HYPERTENSION, V33, P1111, DOI 10.1161/01.HYP.33.5.1111; Caro C.G., 2011, MECH CIRCULATION, V2nd; Clipp R, 2012, MATH BIOSCI ENG, V9, P61, DOI 10.3934/mbe.2012.9.61; Clipp RB, 2009, IEEE T BIO-MED ENG, V56, P862, DOI 10.1109/TBME.2008.2010133; Conrad L.I., 1995, W MED TRADITION 800, V1; Cousins W, 2014, INT J NUMER METH BIO, V30, P1294, DOI 10.1002/cnm.2658; Cousins W, 2013, SIAM J APPL MATH, V73, P1203, DOI 10.1137/120895470; Fogliardi R, 1996, AM J PHYSIOL-HEART C, V271, pH2661, DOI 10.1152/ajpheart.1996.271.6.H2661; FORBES LK, 1981, J AUST MATH SOC B, V22, P257, DOI 10.1017/S0334270000002617; Frank O., 1899, 1 ABHANDLUNG BIOL, P483, DOI DOI 10.1097/SIH.0B013E31818B27A8; HALE JF, 1955, J PHYSIOL-LONDON, V128, P629, DOI 10.1113/jphysiol.1955.sp005330; Hast J, 2003, SELF MIXING INTERFER; HUGHES T J R, 1973, Mathematical Biosciences, V18, P161, DOI 10.1016/0025-5564(73)90027-8; Huo YL, 2007, AM J PHYSIOL-HEART C, V292, pH2623, DOI 10.1152/ajpheart.00987.2006; Huo YL, 2006, AM J PHYSIOL-HEART C, V291, pH1074, DOI 10.1152/ajpheart.00200.2006; JOHNSON GA, 1992, J BIOMECH, V25, P91, DOI 10.1016/0021-9290(92)90248-Y; Khir AW, 2001, J BIOMECH, V34, P1145, DOI 10.1016/S0021-9290(01)00076-8; Lambermont B, 1997, ARCH PHYSIOL BIOCHEM, V105, P625, DOI 10.1076/apab.105.7.625.11383; LASKEY WK, 1990, J APPL PHYSIOL, V69, P112, DOI 10.1152/jappl.1990.69.1.112; Liang YL, 1998, CLIN SCI, V95, P669, DOI 10.1042/cs0950669; Mynard JP, 2008, COMMUN NUMER METH EN, V24, P367, DOI 10.1002/cnm.1117; OKA S, 1987, BIORHEOLOGY, V24, P737; OLSEN JH, 1967, J FLUID MECH, V29, P513, DOI 10.1017/S0022112067001004; Olufsen MS, 2002, AM J PHYSIOL-REG I, V282, pR611, DOI 10.1152/ajpregu.00285.2001; Olufsen MS, 2000, ANN BIOMED ENG, V28, P1281, DOI 10.1114/1.1326031; Olufsen MS, 1999, AM J PHYSIOL-HEART C, V276, pH257, DOI 10.1152/ajpheart.1999.276.1.H257; Olufsen MS, 1998, THESIS ROSKILDE U; Parker KH, 2009, MED BIOL ENG COMPUT, V47, P175, DOI 10.1007/s11517-009-0439-y; Podesser BK, 1998, ACTA ANAT, V163, P63; Porkert M, 1983, ACTA MED SINENSIS ZU; Reymond P, 2009, AM J PHYSIOL-HEART C, V297, pH208, DOI 10.1152/ajpheart.00037.2009; SCHAAF BW, 1972, J BIOMECH, V5, P345, DOI 10.1016/0021-9290(72)90064-4; SHIM YT, 1994, ANN BIOMED ENG, V22, P66, DOI 10.1007/BF02368223; Steinman DA, 2005, ANN BIOMED ENG, V33, P1704, DOI 10.1007/s10439-005-8772-2; STERGIOPULOS N, 1995, AM J PHYSIOL-HEART C, V268, pH1540, DOI 10.1152/ajpheart.1995.268.4.H1540; Stergiopulos N, 1999, AM J PHYSIOL-HEART C, V276, pH424, DOI 10.1152/ajpheart.1999.276.2.H424; STERGIOPULOS N, 1992, J BIOMECH, V25, P1477, DOI 10.1016/0021-9290(92)90060-E; STETTLER JC, 1981, ANN BIOMED ENG, V9, P145, DOI 10.1007/BF02363533; STREETER VL, 1963, CIRC RES, V13, P3, DOI 10.1161/01.RES.13.1.3; Sun J.L., 2006, THESIS MIT; Taylor CA, 2004, ANNU REV FLUID MECH, V36, P197, DOI 10.1146/annurev.fluid.36.050802.121944; TOOROP GP, 1987, AM J PHYSIOL, V252, pH1275, DOI 10.1152/ajpheart.1987.252.6.H1275; van de Vosse FN, 2011, ANNU REV FLUID MECH, V43, P467, DOI 10.1146/annurev-fluid-122109-160730; vanderGeest RJ, 1995, COMPUT CARDIOL, P29, DOI 10.1109/CIC.1995.482563; Wang JJ, 2004, J BIOMECH, V37, P457, DOI 10.1016/j.jbiomech.2003.09.007; WESTERHOF N, 1971, J APPL PHYSIOL, V31, P776, DOI 10.1152/jappl.1971.31.5.776; Westerhof N, 2010, SNAPSHOTS OF HEMODYNAMICS: AN AID FOR CLINICAL RESEARCH AND GRADUATE EDUCATION, SECOND EDITION, P1, DOI 10.1007/978-1-4419-6363-5; WOMERSLEY JR, 1957, PHYS MED BIOL, V2, P178, DOI 10.1088/0031-9155/2/2/305; WOMERSLEY JR, 1955, J PHYSIOL-LONDON, V127, P553, DOI 10.1113/jphysiol.1955.sp005276	56	19	20	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0128597	10.1371/journal.pone.0128597	http://dx.doi.org/10.1371/journal.pone.0128597			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000782	Green Published, Green Submitted, gold			2022-12-26	WOS:000354931700107
J	Haring, R; Schurmann, C; Homuth, G; Steil, L; Volker, U; Volzke, H; Keevil, BG; Nauck, M; Wallaschofski, H				Haring, Robin; Schurmann, Claudia; Homuth, Georg; Steil, Leif; Voelker, Uwe; Voelzke, Henry; Keevil, Brian G.; Nauck, Matthias; Wallaschofski, Henri			Associations between Serum Sex Hormone Concentrations and Whole Blood Gene Expression Profiles in the General Population	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; ESTROGEN-RECEPTOR-BETA; TESTOSTERONE; ESTRADIOL; ERYTHROPOIESIS; METAANALYSIS; DISEASE; HEALTH; MEN	Background Despite observational evidence from epidemiological and clinical studies associating sex hormones with various cardiometabolic risk factors or diseases, pathophysiological explanations are sparse to date. To reveal putative functional insights, we analyzed associations between sex hormone levels and whole blood gene expression profiles. Methods We used data of 991 individuals from the population-based Study of Health in Pomerania (SHIP-TREND) with whole blood gene expression levels determined by array-based transcriptional profiling and serum concentrations of total testosterone (TT), sex hormone-binding globulin (SHBG), free testosterone (free T), dehydroepiandrosterone sulfate (DHEAS), androstenedione (AD), estradiol (E2), and estrone (E1) measured by liquid chromatography- tandem mass spectrometry (LC-MS/MS) and immunoassay. Associations between sex hormone concentrations and gene expression profiles were analyzed using sex-specific regression models adjusted for age, body mass index, and technical covariables. Results In men, positive correlations were detected between AD and DDIT4mRNA levels, as well as between SHBG and the mRNA levels of RPIA, RIOK3, GYPB, BPGM, and RAB2B. No additional significant associations were observed. Conclusions Besides the associations between AD and DDIT4 expression and SHBG and the transcript levels of RPIA, RIOK3, GYPB, BPGM, and RAB2B, the present study did not indicate any association between sex hormone concentrations and whole blood gene expression profiles in men and women from the general population.	[Haring, Robin; Nauck, Matthias; Wallaschofski, Henri] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Haring, Robin; Voelker, Uwe; Voelzke, Henry; Nauck, Matthias; Wallaschofski, Henri] DZHK German Ctr Cardiovasc Res, Greifswald, Germany; [Schurmann, Claudia; Homuth, Georg; Steil, Leif; Voelker, Uwe] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Keevil, Brian G.] Univ S Manchester Hosp, Dept Clin Chem, Manchester M20 8LR, Lancs, England	Greifswald Medical School; German Centre for Cardiovascular Research; Greifswald Medical School; Greifswald Medical School; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Haring, R (corresponding author), European Univ Appl Sci, Fac Appl Publ Hlth, Rostock, Germany.	robin.haring@uni-greifswald.de	keevil, brian/AAP-6147-2020; Schurmann, Claudia/L-1204-2016; Steil, Leif/F-1246-2010; Wilkening, Robin/J-5535-2018	Schurmann, Claudia/0000-0003-4158-9192; Steil, Leif/0000-0002-0733-8421; Wilkening, Robin/0000-0002-8332-5016; Volker, Uwe/0000-0002-5689-3448	Federal Ministry of Education and Research; Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania [(03IS2061A]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; DZHK (German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research) [03ZIK012]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; DZHK (German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF))	This work is part of the research project Greifswald Approach to Individualized Medicine (GANI_MED). The GANI_MED consortium is funded by the Federal Ministry of Education and Research and the Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania (03IS2061A). Data collection was supported by the Community Medicine Research network (CMR) of the University of Greifswald, Germany, and is funded by the Federal Ministry of Education and Research, the Ministry of Cultural Affairs, as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. The CMR encompasses several research projects that share data from the population-based Study of Health in Pomerania (SHIP; http://www.community-medicine.de). This study was also supported by the DZHK (German Centre for Cardiovascular Research) and by the BMBF (German Ministry of Education and Research, grant no. 03ZIK012). RH is the guarantor of this work, had full access to all the data, and takes full responsibility for the integrity of data and the accuracy of data analysis. Furthermore, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo AB, 2011, J CLIN ENDOCR METAB, V96, P3007, DOI 10.1210/jc.2011-1137; BLOBEL GA, 1995, MOL CELL BIOL, V15, P3147; Bord S, 2001, J CLIN ENDOCR METAB, V86, P2309, DOI 10.1210/jc.86.5.2309; Brand JS, 2011, INT J EPIDEMIOL, V40, P189, DOI 10.1093/ije/dyq158; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; Coviello AD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002805; EVENS RP, 1974, J CLIN PHARMACOL, V14, P94, DOI 10.1002/j.1552-4604.1974.tb02298.x; Haring R, 2012, J CLIN ENDOCR METAB, V97, P408, DOI 10.1210/jc.2011-2134; Herring MJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000271; Khetawat G, 2000, BLOOD, V95, P2289, DOI 10.1182/blood.V95.7.2289.007k03_2289_2296; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Liu M, 2013, MOL ENDOCRINOL, V27, P657, DOI 10.1210/me.2012-1397; Murphy AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005539; Ohlsson C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002313; Owen LJ, 2014, ANN CLIN BIOCHEM, V51, P360, DOI 10.1177/0004563213501478; Rochira V, 2009, J STEROID BIOCHEM, V113, P189, DOI 10.1016/j.jsbmb.2008.12.007; Schurmann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050938; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Vitale C, 2009, NAT REV CARDIOL, V6, P532, DOI 10.1038/nrcardio.2009.105; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Waaseth M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-29; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Zhai GJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002025	23	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127466	10.1371/journal.pone.0127466	http://dx.doi.org/10.1371/journal.pone.0127466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001193	Green Submitted, Green Published, gold			2022-12-26	WOS:000354931700062
J	Maruthur, NM; Joy, SM; Dolan, JG; Shihab, HM; Singh, S				Maruthur, Nisa M.; Joy, Susan M.; Dolan, James G.; Shihab, Hasan M.; Singh, Sonal			Use of the Analytic Hierarchy Process for Medication Decision-Making in Type 2 Diabetes	PLOS ONE			English	Article							ELICIT PATIENT PREFERENCES; HEALTH-CARE; SAFETY; MANAGEMENT; EFFICACY; SUPPORT; RISK	Aim To investigate the feasibility and utility of the Analytic Hierarchy Process (AHP) for medication decision-making in type 2 diabetes. Methods We conducted an AHP with nine diabetes experts using structured interviews to rank add-on therapies (to metformin) for type 2 diabetes. During the AHP, participants compared treatment alternatives relative to eight outcomes (hemoglobin A1c-lowering and seven potential harms) and the relative importance of the different outcomes. The AHP model and instrument were pre-tested and pilot-tested prior to use. Results were discussed and an evaluation of the AHP was conducted during a group session. We conducted the quantitative analysis using Expert Choice software with the ideal mode to determine the priority of treatment alternatives. Results Participants judged exenatide to be the best add-on therapy followed by sitagliptin, sulfonylureas, and then pioglitazone. Maximizing benefit was judged 21% more important than minimizing harm. Minimizing severe hypoglycemia was judged to be the most important harm to avoid. Exenatide was the best overall alternative if the importance of minimizing harms was prioritized completely over maximizing benefits. Participants reported that the AHP improved transparency, consistency, and an understanding of others' perspectives and agreed that the results reflected the views of the group. Conclusions The AHP is feasible and useful to make decisions about diabetes medications. Future studies which incorporate stakeholder preferences should evaluate other decision contexts, objectives, and treatments.	[Maruthur, Nisa M.; Shihab, Hasan M.; Singh, Sonal] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Maruthur, Nisa M.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Maruthur, Nisa M.] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Joy, Susan M.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; [Dolan, James G.] Univ Rochester, Dept Publ Hlth Sci, Rochester, NY USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Rochester	Singh, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	sssingh31@jhu.edu	Singh, Sonal/A-4614-2008	Singh, Sonal/0000-0003-0912-941X	Food and Drug Administration, Department of Health and Human Services [HHSF2232010000072C]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL093488] Funding Source: NIH RePORTER	Food and Drug Administration, Department of Health and Human Services; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The analysis upon which this publication is based were performed under contract number HHSF2232010000072C, entitled, "Partnership in Applied Comparative Effectiveness Science," sponsored by the Food and Drug Administration, Department of Health and Human Services.	Abdul-Ghani MA, 2012, CURR DIABETES REP, V12, P230, DOI 10.1007/s11892-012-0275-6; American Diabetes Association, 2013, DIABETES CARE S1, V36, pS4, DOI DOI 10.2337/DC13-S004; [Anonymous], 1999, NEW DRUG APPL ACTOS; Bennett WL, 2011, ANN INTERN MED, V154, P602, DOI 10.7326/0003-4819-154-9-201105030-00336; Danner M, 2011, INT J TECHNOL ASSESS, V27, P369, DOI 10.1017/S0266462311000523; Dolan JG, 2012, MED DECIS MAKING, V32, P840, DOI 10.1177/0272989X12445284; Dolan JG, 2010, PATIENT, V3, P229, DOI 10.2165/11539470-000000000-00000; DOLAN JG, 1989, MED DECIS MAKING, V9, P40, DOI 10.1177/0272989X8900900108; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Forman EH, 2001, OPER RES, V49, P469, DOI 10.1287/opre.49.4.469.11231; Guo JJ, 2010, VALUE HEALTH, V13, P657, DOI 10.1111/j.1524-4733.2010.00725.x; Huang IB, 2011, SCI TOTAL ENVIRON, V409, P3578, DOI 10.1016/j.scitotenv.2011.06.022; Hummel MJM, 2012, PATIENT, V5, P225, DOI 10.2165/11635240-000000000-00000; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Ishizaka A, 2011, EXPERT SYST APPL, V38, P14336, DOI 10.1016/j.eswa.2011.04.143; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Liberatore MJ, 2008, EUR J OPER RES, V189, P194, DOI 10.1016/j.ejor.2007.05.001; Maruthur Nisa M, 2013, F1000Res, V2, P160, DOI 10.12688/f1000research.2-160.v1; Neumann A, 2012, DIABETOLOGIA, V55, P1953, DOI 10.1007/s00125-012-2538-9; Saaty T. L., 2006, FUNDAMENTALS DECISIO; SAATY TL, 1994, INTERFACES, V24, P19, DOI 10.1287/inte.24.6.19; Saaty TL., 1980, ANAL HIERARCHY PROCE; US Food and Drug Administration, 2013, STRUCT APPR BEN RISK	23	27	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126625	10.1371/journal.pone.0126625	http://dx.doi.org/10.1371/journal.pone.0126625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000636	gold, Green Published, Green Submitted			2022-12-26	WOS:000354931700022
J	Wilunda, C; Putoto, G; Dalla Riva, D; Manenti, F; Atzori, A; Calia, F; Assefa, T; Turri, B; Emmanuel, O; Straneo, M; Kisika, F; Tarmbulini, G				Wilunda, Calistus; Putoto, Giovanni; Dalla Riva, Donata; Manenti, Fabio; Atzori, Andrea; Calia, Federico; Assefa, Tigist; Turri, Bruno; Emmanuel, Onapa; Straneo, Manuela; Kisika, Firma; Tarmbulini, Giorgio			Assessing Coverage, Equity and Quality Gaps in Maternal and Neonatal Care in Sub-Saharan Africa: An Integrated Approach	PLOS ONE			English	Article							EMERGENCY OBSTETRIC CARE; NEWBORN HEALTH; CHILD HEALTH; INTERVENTIONS; AVAILABILITY; MORTALITY	Background Gaps in coverage, equity and quality of health services hinder the achievement of the Millennium Development Goals 4 and 5 in most countries of sub-Saharan Africa as well as in other high-burden countries, yet few studies attempt to assess all these dimensions as part of the situation analysis. We present the base-line data of a project aimed at simultaneously addressing coverage, equity and quality issues in maternal and neonatal health care in five districts belonging to three African countries. Methods Data were collected in cross-sectional studies with three types of tools. Coverage was assessed in three hospitals and 19 health centres (HCs) utilising emergency obstetric and newborn care needs assessment tools developed by the Averting Maternal Death and Disability program. Emergency obstetrics care (EmOC) indicators were calculated. Equity was assessed in three hospitals and 13 HCs by means of proxy wealth indices and women delivering in health facilities were compared with those in the general population to identify inequities. Quality was assessed in three hospitals using the World Health Organization's maternal and neonatal quality of hospital care assessment tool which evaluates the whole range of aspects of obstetric and neonatal care and produces an average score for each main area of care. Results All the three hospitals qualified as comprehensive EmOC facilities but none of the HCs qualified for basic EmOC. None of the districts met the minimum requisites for EmOC indicators. In two out of three hospitals, there were major quality gaps which were generally greater in neonatal care, management of emergency and complicated cases and monitoring. Higher access to care was coupled by low quality and good quality by very low access. Stark inequities in utilisation of institutional delivery care were present in all districts and across all health facilities, especially at hospital level. Conclusion Our findings confirm the existence of serious issues regarding coverage, equity and quality of health care for mothers and newborns in all study districts. Gaps in one dimension hinder the potential gains in health outcomes deriving from good performances in other dimensions, thus confirm the need for a three-dimensional profiling of health care provision as a basis for data-driven planning.	[Wilunda, Calistus; Putoto, Giovanni; Dalla Riva, Donata; Manenti, Fabio; Atzori, Andrea] Doctors Africa CUAMM, Projects Dept, Padua, Italy; [Wilunda, Calistus] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Kyoto, Japan; [Calia, Federico] Doctors Africa CUAMM, Wolisso, Ethiopia; [Assefa, Tigist] WolissoHospital, Wolisso, Ethiopia; [Turri, Bruno] Doctors Africa CUAMM, Aber, Uganda; [Emmanuel, Onapa] Aber Hosp, Aber, Uganda; [Straneo, Manuela] Doctors Africa CUAMM, Iringa, Tanzania; [Kisika, Firma] Minist Hlth & Social Welf, Iringa, Tanzania; [Tarmbulini, Giorgio] European Sch Maternal Newborn Child & Adolescent, Trieste, Italy; [Tarmbulini, Giorgio] Ctr Salute Bambino, Trieste, Italy	Kyoto University	Wilunda, C (corresponding author), Doctors Africa CUAMM, Projects Dept, Padua, Italy.	calistuswilunda@yahoo.co.uk	Putoto, Giovanni/ABG-2069-2020	Wilunda, Calistus/0000-0002-6606-6534	Italian Banks Foundation; Cordaid	Italian Banks Foundation; Cordaid(CGIAR)	The project "mothers and children first" is funded by Italian Banks Foundation. The assessments were funded by Cordaid (https://www.cordaid.org/en/). The funding sources played no role in the study design, data collection and analysis, and preparation of the manuscript.	Averting Maternal Deaths and Disability, 2009, AMDD NEEDS ASSESSMEN; Bailey P, 2006, INT J GYNECOL OBSTET, V93, P285, DOI 10.1016/j.ijgo.2006.01.028; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Central Statistical Agency [Ethiopia], 2012, ICF INTERNATIONAL ET; Commission on Social Determinants of Health, 2008, CLOSING THE GAP IN A; Countdown to 2015, MATERNAL NEWBORN AND; Dettrick Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083070; Dickson KE, 2014, LANCET, V384, P438, DOI 10.1016/S0140-6736(14)60582-1; Doctors with Africa CUAMM, 2008, STRENGTHENING AFRICA; Freedman LP, 2007, LANCET, V370, P1383, DOI 10.1016/S0140-6736(07)61581-5; Holmer H, 2015, BJOG-INT J OBSTET GY, V122, P183, DOI 10.1111/1471-0528.13230; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Lawn Joy, 2006, OPPORTUNITIES FOR AF; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Ministry of Health and Social Welfare United Republic of Tanzania, 2008, THE NATIONAL ROAD MA; Ministry of Health Federal Democratic Republic of Ethiopia, 2006, NATIONAL REPRODUCTIV, DOI [10.1016/j.fertnstert.2014.09.002, DOI 10.1016/J.FERTNSTERT.2014.09.002]; Ministry of Health Republic of Uganda, 2007, ROADMAP FOR ACCELERA; Mphatswe W, 2012, B WORLD HEALTH ORGAN, V90, P176, DOI 10.2471/BLT.11.092759; Partnership for Maternal Newborn & Child Health, 2014, WHO A POLICY GUIDE F; Paxton A, 2006, INT J GYNECOL OBSTET, V93, P300, DOI 10.1016/j.ijgo.2006.01.030; Pitchforth E, 2007, HEALTH POLICY PLANN, V22, P311, DOI 10.1093/heapol/czm022; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; StataCorp, 2009, STATA SURVEY DATA RE; Tamburlini G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078282; Tamburlini G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028763; United Nations, 2010, GLOBAL STRATEGY FOR; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; WHO, 2009, MONITORING EMERGENCY; WHO Regional Office for Europe, 2009, MAKING PREGNANCY SAF; Wilunda C, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-27; World Health Organisation, 2007, STRENGTHENING HEALTH, DOI [10.1186/s12916-015-0309-4, DOI 10.1186/S12916-015-0309-4]	35	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127827	10.1371/journal.pone.0127827	http://dx.doi.org/10.1371/journal.pone.0127827			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000964	Green Submitted, Green Published, gold			2022-12-26	WOS:000354931700088
J	Xiao, J; Zhao, J; Liu, MJ; Liu, P; Dai, L; Zhao, ZH				Xiao, Jing; Zhao, Jin; Liu, Mengjun; Liu, Ping; Dai, Li; Zhao, Zhihui			Genome-Wide Characterization of Simple Sequence Repeat (SSR) Loci in Chinese Jujube and Jujube SSR Primer Transferability	PLOS ONE			English	Article							GENETIC-LINKAGE MAP; CHLOROPLAST GENOME; DIVERSITY; MARKERS; MICROSATELLITES; L.; APPLE; CONSTRUCTION; POLYMORPHISM; SORGHUM	Chinese jujube (Ziziphus jujuba), an economically important species in the Rhamnaceae family, is a popular fruit tree in Asia. Here, we surveyed and characterized simple sequence repeats (SSRs) in the jujube genome. A total of 436,676 SSR loci were identified, with an average distance of 0.93 Kb between the loci. A large proportion of the SSRs included mononucleotide, dinucleotide and trinucleotide repeat motifs, which accounted for 64.87%, 24.40%, and 8.74% of all repeats, respectively. Among the mononucleotide repeats, A/T was the most common, whereas AT/TA was the most common dinucleotide repeat. A total of 30,565 primer pairs were successfully designed and screened using a series of criteria. Moreover, 725 of 1,000 randomly selected primer pairs were effective among 6 cultivars, and 511 of these primer pairs were polymorphic. Sequencing the amplicons of two SSRs across three jujube cultivars revealed variations in the repeats. The transferability of jujube SSR primers proved that 35/64 SSRs could be transferred across family boundary. Using jujube SSR primers, clustering analysis results from 15 species were highly consistent with the Angiosperm Phylogeny Group (APGIII) System. The genome-wide characterization of SSRs in Chinese jujube is very valuable for whole-genome characterization and marker-assisted selection in jujube breeding. In addition, the transferability of jujube SSR primers could provide a solid foundation for their further utilization.	[Xiao, Jing; Liu, Mengjun; Liu, Ping; Dai, Li; Zhao, Zhihui] Agr Univ Hebei, Res Ctr Chinese Jujube, Baoding 071000, Peoples R China; [Zhao, Jin] Agr Univ Hebei, Coll Life Sci, Baoding 071000, Peoples R China	Hebei Agricultural University; Hebei Agricultural University	Zhao, J (corresponding author), Agr Univ Hebei, Coll Life Sci, Baoding 071000, Peoples R China.	zhaojinbd@126.com; lmj1234567@aliyun.com			National Science and Technology Support Plan of China [2013BAD14B03]; Provincial Key Technology R&D Program of Hebei, China [11230606D-6]	National Science and Technology Support Plan of China; Provincial Key Technology R&D Program of Hebei, China	This study was supported by grants from National Science and Technology Support Plan of China (No. 2013BAD14B03), Provincial Key Technology R&D Program of Hebei, China (No. 11230606D-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraket G, 2011, PLANT MOL BIOL REP, V29, P171, DOI 10.1007/s11105-010-0217-x; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Cai B, 2009, J NANJING AGR U, V32, P501; Campoy JA, 2011, PLANT MOL BIOL REP, V29, P404, DOI 10.1007/s11105-010-0242-9; Chen CX, 2006, THEOR APPL GENET, V112, P1248, DOI 10.1007/s00122-006-0226-1; Cheng XM, 2009, THEOR APPL GENET, V118, P1121, DOI 10.1007/s00122-009-0967-8; Cristofani-Yaly M, 2011, PLANT MOL BIOL REP, V29, P418, DOI 10.1007/s11105-010-0241-x; Ekue MRM, 2009, PLANT MOL BIOL REP, V27, P570, DOI 10.1007/s11105-009-0115-2; Fan L, 2013, PLANT MOL BIOL REP, V31, P1271, DOI 10.1007/s11105-013-0586-z; Fan SH, 2003, PROG BIOCHEM BIOPHYS, V30, P221; Feng SP, 2009, MOL BREEDING, V23, P85, DOI 10.1007/s11032-008-9216-0; Guang L, 2012, SCI AGR SINICA, V44, P4415; Harr B, 2000, GENETICS, V155, P1213; He NJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3445; He QA, 2011, PLANT MOL BIOL REP, V29, P197, DOI 10.1007/s11105-010-0218-9; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; Lee SB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-61; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Li YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106438; Liu M J, 2009, CHINESE JUJUBE GERMS, P46; Liu MJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6315; Ma QiuYue, 2013, Scientia Silvae Sinicae, V49, P81; Monfort A, 2006, MOL ECOL NOTES, V6, P197, DOI 10.1111/j.1471-8286.2005.01191.x; Olmstead JW, 2008, TREE GENET GENOMES, V4, P897, DOI 10.1007/s11295-008-0161-1; Qu Z.Z., 1993, CHINA FRUITS MONOGRA, V56, P229; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; SCHORDERET DF, 1992, P NATL ACAD SCI USA, V89, P957, DOI 10.1073/pnas.89.3.957; Shang MingZhao, 2011, Scientia Agricultura Sinica, V44, P245; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Silfverberg-Dilworth E, 2006, TREE GENET GENOMES, V2, P202, DOI 10.1007/s11295-006-0045-1; Swapna M, 2011, PLANT MOL BIOL REP, V29, P505, DOI 10.1007/s11105-010-0254-5; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Vezzulli S, 2008, THEOR APPL GENET, V117, P499, DOI 10.1007/s00122-008-0794-3; Wang SQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099842; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Wu YQ, 2007, GENOME, V50, P84, DOI 10.1139/G06-133; Xu X, 2000, NAT GENET, V24, P396, DOI 10.1038/74238; Yamamoto T, 2001, THEOR APPL GENET, V102, P865, DOI 10.1007/s001220000524; Zaki NM, 2012, INT J MOL SCI, V13, P4069, DOI 10.3390/ijms13044069; Zhang CM, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0809-y; Zhang Q, 2012, PLANT MOL BIOL REP, V30, P539, DOI 10.1007/s11105-011-0366-6; Zhang QX, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2290; [赵锦 ZHAO Jin], 2009, [植物遗传资源学报, Journal of Plant Genetic Resources], V10, P111	47	39	48	7	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127812	10.1371/journal.pone.0127812	http://dx.doi.org/10.1371/journal.pone.0127812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000739	Green Submitted, Green Published, gold			2022-12-26	WOS:000354931700086
J	Gabriel-Costa, D; da Cunha, TF; Bechara, LRG; Fortunato, RS; Bozi, LHM; Coelho, MD; Barreto-Chaves, ML; Brum, PC				Gabriel-Costa, Daniele; da Cunha, Telma Fatima; Grassmann Bechara, Luiz Roberto; Fortunato, Rodrigo Soares; Marchesi Bozi, Luiz Henrique; Coelho, Marcele de Almeida; Barreto-Chaves, Maria Luiza; Brum, Patricia Chakur			Lactate Up-Regulates the Expression of Lactate Oxidation Complex-Related Genes in Left Ventricular Cardiac Tissue of Rats	PLOS ONE			English	Article							MYOCARDIAL VOLUME OVERLOAD; HUMAN ASTROCYTOMA-CELLS; SKELETAL-MUSCLE; SUPEROXIDE-DISMUTASE; LACTIC-ACID; HEART-FAILURE; DEHYDROGENASE; MCT1; PGC-1-ALPHA; METABOLISM	Background Besides its role as a fuel source in intermediary metabolism, lactate has been considered a signaling molecule modulating lactate-sensitive genes involved in the regulation of skeletal muscle metabolism. Even though the flux of lactate is significantly high in the heart, its role on regulation of cardiac genes regulating lactate oxidation has not been clarified yet. We tested the hypothesis that lactate would increase cardiac levels of reactive oxygen species and up-regulate the expression of genes related to lactate oxidation complex. Methods/Principal Findings Isolated hearts from male adult Wistar rats were perfused with control, lactate or acetate (20mM) added Krebs-Henseleit solution during 120 min in modified Langendorff apparatus. Reactive oxygen species (O-2(center dot-)/H2O2) levels, and NADH and NADPH oxidase activities (in enriched microsomal or plasmatic membranes, respectively) were evaluated by fluorimetry while SOD and catalase activities were evaluated by spectrophotometry. mRNA levels of lactate oxidation complex and energetic enzymes MCT1, MCT4, HK, LDH, PDH, CS, PGC1 alpha and COXIV were quantified by real time RT-PCR. Mitochondrial DNA levels were also evaluated. Hemodynamic parameters were acquired during the experiment. The key findings of this work were that lactate elevated cardiac NADH oxidase activity but not NADPH activity. This response was associated with increased cardiac O-2(center dot-)/H2O2 levels and up-regulation of MCT1, MCT4, LDH and PGC1 alpha with no changes in HK, PDH, CS, COXIV mRNA levels and mitochondrial DNA levels. Lactate increased NRF-2 nuclear expression and SOD activity probably as counter-regulatory responses to increased O-2(center dot-)/H2O2. Conclusions Our results provide evidence for lactate-induced up-regulation of lactate oxidation complex associated with increased NADH oxidase activity and cardiac O-2(center dot-)/H2O2 driving to an anti-oxidant response. These results unveil lactate as an important signaling molecule regulating components of the lactate oxidation complex in cardiac muscle.	[Gabriel-Costa, Daniele; da Cunha, Telma Fatima; Grassmann Bechara, Luiz Roberto; Marchesi Bozi, Luiz Henrique; Coelho, Marcele de Almeida; Brum, Patricia Chakur] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Fortunato, Rodrigo Soares] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Rio De Janeiro, Brazil; [Barreto-Chaves, Maria Luiza] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo	Brum, PC (corresponding author), Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil.	pcbrum@usp.br	Fortunato, Rodrigo/AAM-9931-2020; Brum, Patricia C/E-6605-2011; Gabriel-Costa, Daniele/P-2899-2015; Barreto-Chaves, Maria Luiza/Y-9264-2019; Bozi, Luiz/AAT-6126-2020; Bozi, Luiz H M/K-5259-2012; Cunha, Telma F/I-5222-2016; Barreto-Chaves, Maria Luiza/C-4459-2012; Bechara, Luiz R G/K-4095-2012; Fortunato, Rodrigo/F-2020-2014	Brum, Patricia C/0000-0002-4750-6506; Gabriel-Costa, Daniele/0000-0003-2961-9344; Barreto-Chaves, Maria Luiza/0000-0001-5514-7921; Bozi, Luiz H M/0000-0002-5698-1181; Barreto-Chaves, Maria Luiza/0000-0001-5514-7921; Bechara, Luiz/0000-0002-1642-1008; Fortunato, Rodrigo/0000-0003-3497-8173	Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) [503204/2011-0, 302201/2011-4]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil [2010/50048-1]	Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	DGC held a post doctoral grant from Conselho Nacional de Pesquisa e Desenvolvimento (CNPq#503204/2011-0). PCB holds grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (#2010/50048-1) and Conselho Nacional de Pesquisa e Desenvolvimento (CNPq#302201/2011-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; ALP PR, 1976, BIOCHEM J, V154, P689, DOI 10.1042/bj1540689; Aschenbach WG, 2001, AM J PHYSIOL-REG I, V281, pR176, DOI 10.1152/ajpregu.2001.281.1.R176; Barbieri Elena, 2012, J Signal Transduct, V2012, P982794, DOI 10.1155/2012/982794; Bassenge E, 2000, AM J PHYSIOL-HEART C, V279, pH2431, DOI 10.1152/ajpheart.2000.279.5.H2431; Benton CR, 2008, PHYSIOL GENOMICS, V35, P45, DOI 10.1152/physiolgenomics.90217.2008; Bergman BC, 1999, J APPL PHYSIOL, V87, P1684, DOI 10.1152/jappl.1999.87.5.1684; Brooks GA, 1999, P NATL ACAD SCI USA, V96, P1129, DOI 10.1073/pnas.96.3.1129; Brooks GA, 2000, MED SCI SPORT EXER, V32, P790, DOI 10.1097/00005768-200004000-00011; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Chatham JC, 2001, AM J PHYSIOL-ENDOC M, V281, pE794, DOI 10.1152/ajpendo.2001.281.4.E794; de Bari L, 2010, FEBS LETT, V584, P2285, DOI 10.1016/j.febslet.2010.03.038; Dubouchaud H, 2000, AM J PHYSIOL-ENDOC M, V278, pE571, DOI 10.1152/ajpendo.2000.278.4.E571; Elustondo PA, 2013, J BIOL CHEM, V288, P25309, DOI 10.1074/jbc.M113.476648; Evans RK, 2003, J APPL PHYSIOL, V94, P1169, DOI 10.1152/japplphysiol.00778.2002; Favero TG, 1999, EXP PHYSIOL, V84, P989, DOI 10.1017/S0958067099018862; Fletcher WM, 1907, J PHYSIOL-LONDON, V35, P247; Fortunato RS, 2013, THYROID, V23, P111, DOI 10.1089/thy.2012.0142; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Gladden LB, 2001, P NATL ACAD SCI USA, V98, P395, DOI 10.1073/pnas.98.2.395; Hashimoto T, 2007, FASEB J, V21, P2602, DOI 10.1096/fj.07-8174com; Hermansen L, 1981, Ciba Found Symp, V82, P75; HINMAN LM, 1981, J BIOL CHEM, V256, P6583; Johannsson E, 2001, CIRCULATION, V104, P729, DOI 10.1161/hc3201.092286; Montoya JJ, 2011, J CARDIOVASC PHARM, V58, P392, DOI 10.1097/FJC.0b013e318226bcf7; Lemire J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001550; Lemire J, 2014, J NEUROSCI RES, V92, P464, DOI 10.1002/jnr.23338; Lustig Y, 2011, GENE DEV, V25, P1232, DOI 10.1101/gad.2054711; Macedo DV, 2009, ADV PHYSIOL EDUC, V33, P302, DOI 10.1152/advan.00039.2009; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Miller BF, 2005, J APPL PHYSIOL, V98, P856, DOI 10.1152/japplphysiol.00753.2004; MOHAZZAB HK, 1997, CIRCULATION, V96, P614; Oliveira RSF, 2009, J PHYSIOL-LONDON, V587, P3899, DOI 10.1113/jphysiol.2009.173948; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; ROSENBERG JC, 1966, CLIN CHEM, V12, P299; Srivastava S, 2007, CARDIOVASC RES, V74, P445, DOI 10.1016/j.cardiores.2007.02.016; van Deel ED, 2008, FREE RADICAL BIO MED, V44, P1305, DOI 10.1016/j.freeradbiomed.2007.12.007; van Hall G, 2010, ACTA PHYSIOL, V199, P499, DOI 10.1111/j.1748-1716.2010.02122.x; Vassallo PF, 1998, BRAZ J MED BIOL RES, V31, P1353, DOI 10.1590/S0100-879X1998001000019; Westerblad H, 2002, NEWS PHYSIOL SCI, V17, P17; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; Xia RH, 2003, AM J PHYSIOL-CELL PH, V285, pC215, DOI 10.1152/ajpcell.00034.2002; ZAMMIT VA, 1976, BIOCHEM J, V160, P447, DOI 10.1042/bj1600447	43	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127843	10.1371/journal.pone.0127843	http://dx.doi.org/10.1371/journal.pone.0127843			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996919	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000091
J	Morgan, FJ; Daigneault, AJ				Morgan, Fraser J.; Daigneault, Adam J.			Estimating Impacts of Climate Change Policy on Land Use: An Agent-Based Modelling Approach	PLOS ONE			English	Article							SOCIAL NETWORKS; WATER-QUALITY; COVER CHANGE; SIMULATION; DYNAMICS; BEHAVIOR; ONTARIO; SYSTEMS; GIS	Agriculture is important to New Zealand's economy. Like other primary producers, New Zealand strives to increase agricultural output while maintaining environmental integrity. Utilising modelling to explore the economic, environmental and land use impacts of policy is critical to understand the likely effects on the sector. Key deficiencies within existing land use and land cover change models are the lack of heterogeneity in farmers and their behaviour, the role that social networks play in information transfer, and the abstraction of the global and regional economic aspects within local-scale approaches. To resolve these issues we developed the Agent-based Rural Land Use New Zealand model. The model utilises a partial equilibrium economic model and an agent-based decision-making framework to explore how the cumulative effects of individual farmer's decisions affect farm conversion and the resulting land use at a catchment scale. The model is intended to assist in the development of policy to shape agricultural land use intensification in New Zealand. We illustrate the model, by modelling the impact of a greenhouse gas price on farm-level land use, net revenue, and environmental indicators such as nutrient losses and soil erosion for key enterprises in the Hurunui and Waiau catchments of North Canterbury in New Zealand. Key results from the model show that farm net revenue is estimated to increase over time regardless of the greenhouse gas price. Net greenhouse gas emissions are estimated to decline over time, even under a no GHG price baseline, due to an expansion of forestry on low productivity land. Higher GHG prices provide a greater net reduction of emissions. While social and geographic network effects have minimal impact on net revenue and environmental outputs for the catchment, they do have an effect on the spatial arrangement of land use and in particular the clustering of enterprises.	[Morgan, Fraser J.; Daigneault, Adam J.] Landcare Res, Auckland, New Zealand	Landcare Research - New Zealand	Morgan, FJ (corresponding author), Landcare Res, Auckland, New Zealand.	morganf@landcareresearch.co.nz		Daigneault, Adam/0000-0002-8287-8727; Morgan, Fraser/0000-0002-7964-3361	Landcare Research through their Capability Fund [CF1112-83-02, CF1011-83-11]; New Zealand Ministry of Business, Innovation and Employment [C09X1307]	Landcare Research through their Capability Fund; New Zealand Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	FM and AD were supported by Landcare Research through their Capability Fund (CF1112-83-02 and CF1011-83-11). FM was also supported by the New Zealand Ministry of Business, Innovation and Employment under the "Building biodiversity into an ecosystem service-based approach for resource management" project (C09X1307). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal C, 2002, NE297 UFS USDA FOR S; Alam SJ, 2010, JASSS-J ARTIF SOC S, V13, DOI 10.18564/jasss.1667; Anastasiadis S, 2013, LAND USE FARMING INT; Anastasiadis S, 2014, AUST J AGR RESOUR EC, V58, P130, DOI 10.1111/1467-8489.12024; [Anonymous], NZ GREENH GAS INV 19; [Anonymous], SUSTAINABLE LAND MAN; [Anonymous], 1991, ECOL STUD ANAL SYNTH, DOI DOI 10.1007/978-1-4757-4244-2_10; Baker WL, 1989, LANDSCAPE ECOL, V2, P112; Bakker MM, 2009, LAND USE POLICY, V26, P809, DOI 10.1016/j.landusepol.2008.10.010; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bandura Albert, 1977, SOCIAL LEARNING THEO; Banerjee A, 2014, ARXIV E PRINTS, V1406; Bolte JP, 2007, ENVIRON MODELL SOFTW, V22, P570, DOI 10.1016/j.envsoft.2005.12.033; Brandmeyer JE, 2000, ENVIRON MODELL SOFTW, V15, P479, DOI 10.1016/S1364-8152(00)00027-X; Brown DG, 2005, INT J GEOGR INF SCI, V19, P153, DOI 10.1080/13658810410001713399; Brown P, 2013, RE5002013062 MIN ENV; Burton RJF, 2009, STRATEGIC DECISION M; Burton RJF, 2014, J ENVIRON MANAGE, V135, P19, DOI 10.1016/j.jenvman.2013.12.005; CHUVIECO E, 1993, INT J GEOGR INF SYST, V7, P71, DOI 10.1080/02693799308901940; Daigneault A., 2013, MODELLING EC IMPACTS; Daigneault A, 2012, EVALUATION IMPACT DI; Daigneault A, 2012, AUSTR AGR RES EC SOC; Daigneault A, 2014, AUST J AGR RESOUR EC, V58, P281, DOI 10.1111/1467-8489.12051; Environment Canterbury, HUR WAT PROJ WAIT PR; Evans TP, 2005, SEEING THE FOREST AND THE TREES, P187; Evans TP, 2006, INT J GEOGR INF SCI, V20, P1013, DOI 10.1080/13658810600830764; Farmer JD, 2009, NATURE, V460, P685, DOI 10.1038/460685a; Gimblett HR, 2005, INT C MOD SIM MODSIM; Gotts NM, 2009, JASSS-J ARTIF SOC S, V12; Hendy J., 2008, CLEAN DEV MECH LAW, P198; Hersperger AM, 2010, ECOL SOC, V15; Hill Z, 2010, R10 ENV CANT; Irwin EG, 2010, J REGIONAL SCI, V50, P65, DOI 10.1111/j.1467-9787.2009.00655.x; Jager W, 2000, ECOL ECON, V35, P357, DOI 10.1016/S0921-8009(00)00220-2; Kaye-Blake W, 2014, JASSS-J ARTIF SOC S, V17; Kerr S, 2012, FORESTS, V3, P1133, DOI 10.3390/f3041133; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Leggett CG, 2000, J ENVIRON ECON MANAG, V39, P121, DOI 10.1006/jeem.1999.1096; LONGLEY P, 1994, INT J GEOGR INF SYST, V8, P217, DOI 10.1080/02693799408901995; Lynn I.H., 2009, LAND USE CAPABILITY; Maertens A, 2013, AM J AGR ECON, V95, P353, DOI 10.1093/ajae/aas049; Ministry for Primary Industries, 2013, SIT OUTL PRIM IND; Monaghan RM, 2008, J ENVIRON MANAGE, V87, P609, DOI 10.1016/j.jenvman.2006.07.017; Nelson KC, 2014, AGR HUM VALUES, V31, P245, DOI 10.1007/s10460-013-9462-6; Nuthall P., 2014, REPORT SUCCESSION GO; NZIER Infometrics, 2009, EC MOD NZ CLIM CHANG; Parker DC, 2008, COMPUT ENVIRON URBAN, V32, P454, DOI 10.1016/j.compenvurbsys.2008.09.012; Parker DC, 2003, ANN ASSOC AM GEOGR, V93, P314, DOI 10.1111/1467-8306.9302004; Parliamentary Commissioner for the Environment, 2013, WAT QUAL NZ LAND US; Ramirez A, 2013, PROCD SOC BEHV, V79, P101, DOI 10.1016/j.sbspro.2013.05.059; Rindfuss RR, 2004, P NATL ACAD SCI USA, V101, P13976, DOI 10.1073/pnas.0401545101; Schmit C, 2006, AGR ECOSYST ENVIRON, V115, P113, DOI 10.1016/j.agee.2005.12.019; Smajgl A, 2009, WATER POLICY, V11, P191, DOI 10.2166/wp.2009.022; Smajgl A, 2011, ENVIRON MODELL SOFTW, V26, P837, DOI 10.1016/j.envsoft.2011.02.011; Smithers J, 2004, CAN GEOGR-GEOGR CAN, V48, P191, DOI 10.1111/j.0008-3658.2004.00055.x; Smithers J, 2003, LAND USE POLICY, V20, P343, DOI 10.1016/S0264-8377(03)00055-3; Veldkamp A, 2001, AGR ECOSYST ENVIRON, V85, P1, DOI 10.1016/S0167-8809(01)00199-2; WEINBERG M, 1993, AM J AGR ECON, V75, P278, DOI 10.2307/1242912	58	21	21	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127317	10.1371/journal.pone.0127317	http://dx.doi.org/10.1371/journal.pone.0127317			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK7VW	25996591	Green Submitted, gold, Green Published			2022-12-26	WOS:000356444000058
J	Shaikh, H; Boudes, E; Khoja, Z; Shevell, M; Wintermark, P				Shaikh, Henna; Boudes, Elodie; Khoja, Zehra; Shevell, Michael; Wintermark, Pia			Angiogenesis Dysregulation in Term Asphyxiated Newborns Treated with Hypothermia	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FOCAL CEREBRAL-ISCHEMIA; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; DEVELOPING RAT-BRAIN; LARGE GENE LISTS; PERINATAL ASPHYXIA; NEONATAL ENCEPHALOPATHY; ENHANCES NEUROGENESIS; CEREBROSPINAL-FLUID; IGF-I	Background Neonatal encephalopathy following birth asphyxia is a major predictor of long-term neurological impairment. Therapeutic hypothermia is currently the standard of care to prevent brain injury in asphyxiated newborns but is not protective in all cases. More robust and versatile treatment options are needed. Angiogenesis is a demonstrated therapeutic target in adult stroke. However, no systematic study examines the expression of angiogenesis-related markers following birth asphyxia in human newborns. Objective This study aimed to evaluate the expression of angiogenesis-related protein markers in asphyxiated newborns developing and not developing brain injury compared to healthy control newborns. Design/Methods Twelve asphyxiated newborns treated with hypothermia were prospectively enrolled; six developed eventual brain injury and six did not. Four healthy control newborns were also included. We used Rules-Based Medicine multi-analyte profiling and protein array technologies to study the plasma concentration of 49 angiogenesis-related proteins. Mean protein concentrations were compared between each group of newborns. Results Compared to healthy newborns, asphyxiated newborns not developing brain injury showed up-regulation of pro-angiogenic proteins, including fatty acid binding protein-4, glucose-6-phosphate isomerase, neuropilin-1, and receptor tyrosine-protein kinase erbB-3; this up-regulation was not evident in asphyxiated newborns eventually developing brain injury. Also, asphyxiated newborns developing brain injury showed a decreased expression of anti-angiogenic proteins, including insulin-growth factor binding proteins -1, -4, and -6, compared to healthy newborns. Conclusions These findings suggest that angiogenesis pathways are dysregulated following birth asphyxia and are putatively involved in brain injury pathology and recovery.	[Shaikh, Henna; Boudes, Elodie; Khoja, Zehra; Wintermark, Pia] McGill Univ, Dept Pediat, Div Newborn Med, Montreal, PQ H3A 2T5, Canada; [Shevell, Michael] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2T5, Canada	McGill University; McGill University	Wintermark, P (corresponding author), McGill Univ, Dept Pediat, Div Newborn Med, Montreal, PQ H3A 2T5, Canada.	pia.wintermark@bluemail.ch			Fonds de la Recherche en Sante Quebec (FRQS) Clinical Research Scholar Career Award Junior 1; NeuroDevNet Networks of Centres of Excellence (NCE) Cerebral Palsy Demonstration Project; Canadian Institutes of Health Research (CIHR) Operating Grant; New Investigator Research Grant from the SickKids Foundation; CIHR Institute of Human Development, Child and Youth Health (IHDCYH)	Fonds de la Recherche en Sante Quebec (FRQS) Clinical Research Scholar Career Award Junior 1; NeuroDevNet Networks of Centres of Excellence (NCE) Cerebral Palsy Demonstration Project; Canadian Institutes of Health Research (CIHR) Operating Grant(Canadian Institutes of Health Research (CIHR)); New Investigator Research Grant from the SickKids Foundation; CIHR Institute of Human Development, Child and Youth Health (IHDCYH)(Canadian Institutes of Health Research (CIHR))	Pia Wintermark received research grant funding from the Fonds de la Recherche en Sante Quebec (FRQS) Clinical Research Scholar Career Award Junior 1, NeuroDevNet Networks of Centres of Excellence (NCE) Cerebral Palsy Demonstration Project, Canadian Institutes of Health Research (CIHR) Operating Grant, and New Investigator Research Grant from the SickKids Foundation and the CIHR Institute of Human Development, Child and Youth Health (IHDCYH).	Abumiya T, 2005, BRAIN RES, V1049, P95, DOI 10.1016/j.brainres.2005.05.011; Aimes RT, 2003, THROMB HAEMOSTASIS, V89, P561, DOI 10.1055/s-0037-1613388; Aly H, 2009, BRAIN DEV-JPN, V31, P600, DOI 10.1016/j.braindev.2008.09.004; [Anonymous], 2014, Obstet Gynecol, V123, P896, DOI 10.1097/01.AOG.0000445580.65983.d2; Ara J, 2013, J NEUROCHEM, V124, P735, DOI 10.1111/jnc.12110; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Bader M, 2009, ARTERIOSCL THROM VAS, V29, P617, DOI 10.1161/ATVBAHA.109.184549; Barkovich AJ, 1998, AM J NEURORADIOL, V19, P143; Beck H, 2002, J NEUROPATH EXP NEUR, V61, P339, DOI 10.1093/jnen/61.4.339; Bednarek N, 2012, PEDIATR RES, V71, P63, DOI 10.1038/pr.2011.3; Beresewicz M, 2010, INT J DEV NEUROSCI, V28, P91, DOI 10.1016/j.ijdevneu.2009.09.002; Boudes E, 2015, ARCH DIS CHILD FETAL; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Clawson TF, 1999, BIOL SIGNAL RECEPT, V8, P281; Contois LW, 2012, J BIOL CHEM, V287, P1779, DOI 10.1074/jbc.M111.267732; Council on Children With Disabilities and Medical Home Implementation-Project Advisory Committee, 2014, PEDIATRICS, V133, pe1451, DOI DOI 10.1542/PEDS.2014-0724; Cunningham LA, 2005, GLIA, V50, P329, DOI 10.1002/glia.20169; Delafontaine P, 2004, ARTERIOSCL THROM VAS, V24, P435, DOI 10.1161/01.ATV.0000105902.89459.09; Dilenge ME, 2001, J CHILD NEUROL, V16, P781, DOI 10.1177/08830738010160110201; Doverhag C, 2010, NEUROBIOL DIS, V38, P36, DOI 10.1016/j.nbd.2009.12.024; Dragun P, 2008, J PHYSIOL PHARMACOL, V59, P441; Dzietko M, 2013, TRANSL STROKE RES, V4, P189, DOI 10.1007/s12975-012-0221-6; Ergenekon E, 2004, BRAIN DEV-JPN, V26, P283, DOI 10.1016/S0387-7604(03)00166-9; Feng YZ, 2008, PEDIATR RES, V64, P370, DOI 10.1203/PDR.0b013e318180ebe6; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Graham EM, 2004, NEUROBIOL DIS, V17, P89, DOI 10.1016/j.nbd.2004.05.007; Gustafson K, 1999, PEDIATR RES, V45, P318, DOI 10.1203/00006450-199903000-00005; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imam S S, 2009, Pak J Biol Sci, V12, P1498, DOI 10.3923/pjbs.2009.1498.1504; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jin KL, 2004, J CEREBR BLOOD F MET, V24, P399, DOI 10.1097/00004647-200404000-00005; Kimura R, 2005, STROKE, V36, P1259, DOI 10.1161/01.STR.0000165925.20413.14; Korhonen L, 1998, NEUROSCI LETT, V240, P151, DOI 10.1016/S0304-3940(97)00937-3; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Lee WH, 1996, J CEREBR BLOOD F MET, V16, P227, DOI 10.1097/00004647-199603000-00007; Li LH, 2008, BRAIN RES, V1197, P152, DOI 10.1016/j.brainres.2007.12.059; Li LH, 2008, ACTA NEUROPATHOL, V115, P297, DOI 10.1007/s00401-008-0339-5; Li L, 2007, BRAIN RES, V1180, P133, DOI 10.1016/j.brainres.2007.08.059; Liu F, 2013, CELL BIOCHEM BIOPHYS, V66, P389, DOI 10.1007/s12013-012-9478-3; Mu DZ, 2003, NEUROBIOL DIS, V14, P524, DOI 10.1016/j.nbd.2003.08.020; Muramatsu K, 1997, STROKE, V28, P2281, DOI 10.1161/01.STR.28.11.2281; Okazaki K, 2012, CYTOKINE, V60, P812, DOI 10.1016/j.cyto.2012.08.001; Oyagi A, 2011, NEUROSCIENCE, V185, P116, DOI 10.1016/j.neuroscience.2011.04.034; Rho SB, 2008, CARCINOGENESIS, V29, P2106, DOI 10.1093/carcin/bgn206; Rosenkranz K, 2012, CELL TISSUE RES, V348, P429, DOI 10.1007/s00441-012-1401-0; Satar M, 2004, BIOL NEONATE, V85, P15, DOI 10.1159/000074952; Savman K, 2013, TRANSL STROKE RES, V4, P228, DOI 10.1007/s12975-012-0216-3; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Sugiura S, 2005, STROKE, V36, P859, DOI 10.1161/01.STR.0000158905.22871.95; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Sunagawa S, 2009, BRAIN DEV-JPN, V31, P588, DOI 10.1016/j.braindev.2008.09.001; Svedin P, 2007, J NEUROSCI, V27, P1511, DOI 10.1523/JNEUROSCI.4391-06.2007; Tagin MA, 2012, ARCH PEDIAT ADOL MED, V166, P558, DOI 10.1001/archpediatrics.2011.1772; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Vasiljevic B, 2011, PEDIATR INT, V53, P454, DOI 10.1111/j.1442-200X.2010.03290.x; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang Y, 2013, INT J NEUROSCI, V123, P191, DOI 10.3109/00207454.2012.744755; Wei Ling, 2005, Pathophysiology, V12, P47, DOI 10.1016/j.pathophys.2004.11.002; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369	62	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0128028	10.1371/journal.pone.0128028	http://dx.doi.org/10.1371/journal.pone.0128028			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996847	Green Published, Green Submitted, gold			2022-12-26	WOS:000356444000100
J	Kiniwa, Y; Li, J; Wang, MJ; Sun, C; Lee, JE; Wang, RF; Wang, HY				Kiniwa, Yukiko; Li, Jiang; Wang, Mingjun; Sun, Chuang; Lee, Jeffrey E.; Wang, Rong-Fu; Wang, Helen Y.			Identification of DRG-1 As a Melanoma-Associated Antigen Recognized by CD4(+) Th1 Cells	PLOS ONE			English	Article							T-CELLS; METASTATIC MELANOMA; CANCER-IMMUNOTHERAPY; SUPPRESSOR GENE; POOR-PROGNOSIS; ADOPTIVE IMMUNOTHERAPY; TUMOR-METASTASIS; PEPTIDE VACCINE; CD4+T CELLS; IN-VIVO	Immunotherapy has emerged as a promising strategy for the treatment of metastatic melanoma. Clinical studies have demonstrated the feasibility of cancer immunotherapy using tumor antigens recognized by CD8(+) T cells. However, the overall immune responses induced by these antigens are too weak and transient to induce tumor regression in the majority of patients who received immunization. A growing body of evidence suggests that CD4(+) T helper (Th) cells play an important role in antitumor immunity. Therefore, the identification ofMHC class II-restricted tumor antigens capable of stimulating CD4(+) T cells may provide opportunities for developing effective cancer vaccines. To this end, we describe the identification of developmentally regulated GTP-binding protein 1 (DRG-1) as a melanoma-associated antigen recognized by HLA-DR11-restricted CD4(+) Th1 cells. Epitope mapping analysis showed that the DRG1248-268 epitope of DRG-1 was required for T cell recognition. Reverse transcriptionpolymerase chain reaction revealed that DRG-1 was highly expressed in melanoma cell lines but not in normal tissues. DRG-1 knockdown by lentiviral-based shRNA suppressedmelanoma cell proliferation and soft agar colony formation. Taken together, these data suggest that DRG-1 plays an important role inmelanoma cell growth and transformation, indicating that DRG1 may represent a novel target for CD4(+) T cell-mediated immunotherapy inmelanoma.	[Kiniwa, Yukiko; Li, Jiang; Wang, Rong-Fu; Wang, Helen Y.] Baylor Coll Med, Dept Pathol & Immunol, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Wang, Mingjun; Sun, Chuang; Wang, Rong-Fu; Wang, Helen Y.] Houston Methodist Res Inst, Ctr Inflammat & Epigenet, Houston, TX USA; [Lee, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; University of Texas System; UTMD Anderson Cancer Center	Wang, RF (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	rwang3@houstonmethodist.org; ywang4@houstonmethodist.org		WANG, MINGJUN/0000-0002-5848-0444	National Cancer Institute, National Institutes of Health [R01 CA09327, R01CA116408, P50 CA093459]; NATIONAL CANCER INSTITUTE [R01CA116408, P50CA093459] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by grants from National Cancer Institute, National Institutes of Health (R01 CA09327, R01CA116408, and P50 CA093459 to RW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2006, DIS ESOPHAGUS, V19, P454, DOI 10.1111/j.1442-2050.2006.00618.x; Azuma K, 2012, J THORAC ONCOL, V7, P779, DOI 10.1097/JTO.0b013e31824c92b4; Baig Ruqia Mehmood, 2012, Cancers (Basel), V4, P658, DOI 10.3390/cancers4030658; Bandyopadhyay S, 2004, ONCOGENE, V23, P5675, DOI 10.1038/sj.onc.1207734; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Bhatia S, 2009, ONCOLOGY-NY, V23, P488; Campoli M, 2002, VACCINE, V20, pA40, DOI 10.1016/S0264-410X(02)00386-9; Cangul H, 2002, CELL BIOL TOXICOL, V18, P87, DOI 10.1023/A:1015376032736; Chakraborty R, 2013, PHARMACOGN PERS MED, V6, P49, DOI 10.2147/PGPM.S44800; Chua MS, 2007, MODERN PATHOL, V20, P76, DOI 10.1038/modpathol.3800711; Cohen PA, 2000, CRIT REV IMMUNOL, V20, P17; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; GREENBERG PD, 1991, ADV IMMUNOL, V49, P281; Guang RJ, 2000, CANCER RES, V60, P749; Gyobu H, 2004, CANCER RES, V64, P1490, DOI 10.1158/0008-5472.CAN-03-2780; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kochenderfer JN, 2013, NAT REV CLIN ONCOL, V10, P267, DOI 10.1038/nrclinonc.2013.46; Kovacevic Z, 2013, ANTIOXID REDOX SIGN, V18, P874, DOI 10.1089/ars.2011.4273; Maruyama Y, 2006, CANCER RES, V66, P6233, DOI 10.1158/0008-5472.CAN-06-0183; Marzo AL, 2000, J IMMUNOL, V165, P6047, DOI 10.4049/jimmunol.165.11.6047; Matsushita K, 2013, PEDIATR SURG INT, V29, P363, DOI 10.1007/s00383-012-3248-6; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Mumberg D, 1999, P NATL ACAD SCI USA, V96, P8633, DOI 10.1073/pnas.96.15.8633; Nishio S, 2008, CANCER LETT, V264, P36, DOI 10.1016/j.canlet.2008.01.020; Ossendorp F, 1998, J EXP MED, V187, P693, DOI 10.1084/jem.187.5.693; Peng W, 2008, CANCER RES, V68, P7228, DOI 10.1158/0008-5472.CAN-08-1245; Phan GQ, 2013, CANCER CONTROL, V20, P289, DOI 10.1177/107327481302000406; Poole RM, 2014, DRUGS, V74, P1973, DOI 10.1007/s40265-014-0314-5; Qin ZH, 2000, IMMUNITY, V12, P677, DOI 10.1016/S1074-7613(00)80218-6; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Riker A, 1999, SURGERY, V126, P112, DOI 10.1067/msy.1999.98739; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosenberg SA, 1998, NAT MED, V4, P321, DOI 10.1038/nm0398-321; Rosenberg SA, 2004, P NATL ACAD SCI USA, V101, P14639, DOI 10.1073/pnas.0405730101; Rosenberg SA, 2014, CANCER GENE THER, V21, P45, DOI 10.1038/cgt.2014.3; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Toes REM, 1999, J EXP MED, V189, P753, DOI 10.1084/jem.189.5.753; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; Wang HY, 2002, J EXP MED, V195, P1397, DOI 10.1084/jem.20020141; Wang HY, 2004, IMMUNITY, V20, P107, DOI 10.1016/S1074-7613(03)00359-5; Wang RF, 1999, SCIENCE, V284, P1351, DOI 10.1126/science.284.5418.1351; Wang RF, 2001, TRENDS IMMUNOL, V22, P269, DOI 10.1016/S1471-4906(01)01896-8; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099	51	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0124094	10.1371/journal.pone.0124094	http://dx.doi.org/10.1371/journal.pone.0124094			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993655	Green Published, gold, Green Submitted			2022-12-26	WOS:000354921400015
J	Sasayama, K; Ochi, E; Adachi, M				Sasayama, Kensaku; Ochi, Eisuke; Adachi, Minoru			Importance of Both Fatness and Aerobic Fitness on Metabolic Syndrome Risk in Japanese Children	PLOS ONE			English	Article							SHUTTLE-RUN TEST; CARDIOVASCULAR-DISEASE MORTALITY; BODY-MASS INDEX; CARDIORESPIRATORY FITNESS; PHYSICAL-ACTIVITY; ADOLESCENTS; YOUTH; OVERWEIGHT; INSULIN; PREVALENCE	Associations between body mass index (BMI), peak oxygen consumption (VO2peak), and metabolic syndrome (MetS) risk factors have not been adequately studied in Japanese children. Here the relationships between these parameters and the threshold aerobic fitness level necessary for low MetS risk were determined. The participants (299 children; 140 boys and 159 girls, aged 9.1 +/- 0.3 years) were divided into four groups using the medians of predicted VO2peak (pVO2peak) and BMI. MetS risk scores were calculated using z-scores. Receiver Operating Characteristic analysis was used to determine the threshold aerobic fitness level necessary for low MetS risk. The MetS risk score of the High BMI group was significantly higher than that of the Low BMI group for both sexes (p < 0.0001). However, the High BMI/High Fitness group had a significantly lower MetS risk score than the High BMI/Low Fitness group for both sexes. The pVO2peak cut-off values for low MetS risk were 47.9 and 44.9 ml/kg/min for boys and girls, respectively. Our results suggest that improvements in both fatness and aerobic fitness are important for decreasing MetS risk. We also confirmed the pVO2peak of cut-off values necessary for low MetS risk in Japanese children.	[Sasayama, Kensaku; Adachi, Minoru] Hyogo Univ Teachers Educ, Joint Grad Sch Sci Sch Educ, Kato, Hyogo, Japan; [Ochi, Eisuke; Adachi, Minoru] Okayama Univ, Grad Sch Educ, Okayama, Japan	Hyogo University of Teacher Education; Okayama University	Ochi, E (corresponding author), Okayama Univ, Grad Sch Educ, Okayama, Japan.	eisukeochi@cc.okayama-u.ac.jp	Ochi, Eisuke/AFT-4666-2022	Ochi, Eisuke/0000-0002-2497-0250				Adegboye ARA, 2011, BRIT J SPORT MED, V45, P722, DOI 10.1136/bjsm.2009.068346; Boddy LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045755; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Chen W, 1999, AM J EPIDEMIOL, V150, P667; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; Cruz Martha L, 2004, Curr Diab Rep, V4, P53, DOI 10.1007/s11892-004-0012-x; Cruz ML, 2004, J CLIN ENDOCR METAB, V89, P108, DOI 10.1210/jc.2003-031188; Dencker M, 2012, EUR J PEDIATR, V171, P705, DOI 10.1007/s00431-011-1617-0; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Eisenmann JC, 2005, INT J OBESITY, V29, P1077, DOI 10.1038/sj.ijo.0802995; Eisenmann JC, 2007, MED SCI SPORT EXER, V39, P1251, DOI 10.1249/MSS.0b013e318064c8b0; Eisenmann JC, 2007, INT J PEDIATR OBES, V2, P66, DOI 10.1080/17477160601133713; Ekelund U, 2007, DIABETOLOGIA, V50, P1832, DOI 10.1007/s00125-007-0762-5; Gulias-Gonzalez R, 2014, J SCHOOL HEALTH, V84, P625, DOI 10.1111/josh.12192; Hanson RL, 2002, DIABETES, V51, P3120, DOI 10.2337/diabetes.51.10.3120; Hurtig-Wennlof A, 2007, EUR J CARDIOV PREV R, V14, P575, DOI 10.1097/HJR.0b013e32808c67e3; Ishizaka N, 2005, HYPERTENS RES, V28, P27, DOI 10.1291/hypres.28.27; Jago R, 2010, MED SCI SPORT EXER, V42, P1502, DOI 10.1249/MSS.0b013e3181d322c4; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lee CD, 1999, AM J CLIN NUTR, V69, P373; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Matsuzaka A, 2004, PEDIATR EXERC SCI, V16, P113, DOI 10.1123/pes.16.2.113; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Okada T, 2002, PEDIATR INT, V44, P596, DOI 10.1046/j.1442-200X.2002.01634.x; Olds T, 2006, J SPORT SCI, V24, P1025, DOI 10.1080/02640410500432193; RAITAKARI OT, 1995, DIABETOLOGIA, V38, P1042, DOI 10.1007/s001250050389; Rizzo NS, 2007, J PEDIATR-US, V150, P388, DOI 10.1016/j.jpeds.2006.12.039; Ruiz JR, 2007, PEDIATR RES, V61, P350, DOI 10.1203/pdr.0b013e318030d1bd; Suriano K, 2010, J PEDIATR-US, V157, P552, DOI 10.1016/j.jpeds.2010.04.042; Urakami T, 2007, PEDIATR RES, V61, P141, DOI 10.1203/pdr.0b013e31802d8a69; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Yoshinaga M, 2005, OBES RES, V13, P1135, DOI 10.1038/oby.2005.134	33	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127400	10.1371/journal.pone.0127400	http://dx.doi.org/10.1371/journal.pone.0127400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993528	gold, Green Published, Green Submitted			2022-12-26	WOS:000354921400113
J	Tang, AD; Makowiecki, K; Bartlett, C; Rodger, J				Tang, Alexander D.; Makowiecki, Kalina; Bartlett, Carole; Rodger, Jennifer			Low Intensity Repetitive Transcranial Magnetic Stimulation Does Not Induce Cell Survival or Regeneration in a Mouse Optic Nerve Crush Model	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; ALTERNATING-CURRENT STIMULATION; THETA-BURST STIMULATION; NEUROTROPHIC FACTOR; FUNCTIONAL RECOVERY; RAT MODEL; BDNF; RTMS; INJURY; TRANSECTION	Low intensity repetitive Transcranial Magnetic Stimulation (LI-rTMS), a non-invasive form of brain stimulation, has been shown to induce structural and functional brain plasticity, including short distance axonal sprouting. However, the potential for LI-rTMS to promote axonal regeneration following neurotrauma has not been investigated. This study examined the effect of LI-rTMS on retinal ganglion cell (RGC) survival, axon regeneration and levels of BDNF in an optic nerve crush neurotrauma model. Adult C57Bl/6J mice received a unilateral intraorbital optic nerve crush. Mice received 10 minutes of sham (handling control without stimulation) (n=6) or LI-rTMS (n = 8) daily stimulation for 14 days to the operated eye. Immunohistochemistry was used to assess RGC survival (beta-3 Tubulin) and axon regeneration across the injury (GAP43). Additionally, BDNF expression was quantified in a separate cohort by ELISA in the retina and optic nerve of injured (optic nerve crush) (sham n = 5, LIrTMS n = 5) and non-injured mice (sham n = 5, LI-rTMS n = 5) that received daily stimulation as above for 7 days. Following 14 days of LI-rTMS there was no significant difference in mean RGC survival between sham and treated animals (p > 0.05). Also, neither sham nor LIrTMS animals showed GAP43 positive labelling in the optic nerve, indicating that regeneration did not occur. At 1 week, there was no significant difference in BDNF levels in the retina or optic nerves between sham and LI-rTMS in injured or non-injured mice (p > 0.05). Although LI-rTMS has been shown to induce structural and molecular plasticity in the visual system and cerebellum, our results suggest LI-rTMS does not induce neuroprotection or regeneration following a complete optic nerve crush. These results help define the therapeutic capacity and limitations of LI-rTMS in the treatment of neurotrauma.	[Tang, Alexander D.; Makowiecki, Kalina; Bartlett, Carole; Rodger, Jennifer] Univ Western Australia, Sch Anim Biol, Dept Expt & Regenerat Neurosci, Perth, WA 6009, Australia	University of Western Australia	Rodger, J (corresponding author), Univ Western Australia, Sch Anim Biol, Dept Expt & Regenerat Neurosci, Perth, WA 6009, Australia.	jennifer.rodger@uwa.edu.au	Rodger, Jennifer/H-5735-2014; Tang, Alexander D/S-5258-2018	Rodger, Jennifer/0000-0003-3413-4229; Tang, alexander/0000-0002-3832-847X; Makowiecki, Kalina/0000-0003-4550-3819	National Health and Medical Research Council Neurotrauma Research Program [634386, APP1002258]; State Government of Western Australia; Australian Research Council [LP110100201]	National Health and Medical Research Council Neurotrauma Research Program(National Health and Medical Research Council (NHMRC) of Australia); State Government of Western Australia; Australian Research Council(Australian Research Council)	This work was supported by the National Health and Medical Research Council (634386, APP1002258; http://www.nhmrc.gov.au/) Neurotrauma Research Program, State Government of Western Australia (no grant number available, http://www.nrp.org.au/), and the Australian Research Council (LP110100201; http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin-Abidin S, 2008, EXP BRAIN RES, V188, P249, DOI 10.1007/s00221-008-1356-2; Bates KA, 2012, BRAIN RES, V1458, P76, DOI 10.1016/j.brainres.2012.04.006; Bodeutsch N, 1999, J NEUROBIOL, V38, P116, DOI 10.1002/(SICI)1097-4695(199901)38:1<116::AID-NEU9>3.0.CO;2-F; Bortolomasi M, 2007, PSYCHIAT RES, V150, P181, DOI 10.1016/j.psychres.2006.04.010; Chen H, 2001, INVEST OPHTH VIS SCI, V42, P966; de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109; Di Lazzaro V, 2013, BRAIN STIMUL, V6, P469, DOI 10.1016/j.brs.2013.01.004; Dixon KJ, 2006, EXP NEUROL, V202, P44, DOI 10.1016/j.expneurol.2006.05.010; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Funke K, 2011, J PHYSIOL-LONDON, V589, P4423, DOI 10.1113/jphysiol.2011.206573; Gao F, 2010, EUR J NUCL MED MOL I, V37, P954, DOI 10.1007/s00259-009-1342-3; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; Grehl S, 2015, BRAIN STIMUL, V8, P114, DOI 10.1016/j.brs.2014.09.012; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Henrich-Noack P, 2013, BRAIN RES BULL, V95, P7, DOI 10.1016/j.brainresbull.2013.02.008; Henrich-Noack Petra, 2013, Neurosci Lett, V543, P1, DOI 10.1016/j.neulet.2013.03.013; Hoogendam JM, 2010, BRAIN STIMUL, V3, P95, DOI 10.1016/j.brs.2009.10.005; Hou JM, 2014, J NEUROTRAUM, V31, P1088, DOI 10.1089/neu.2013.3096; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Isenmann S, 1998, EUR J NEUROSCI, V10, P2751, DOI 10.1046/j.1460-9568.1998.00325.x; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; Khedr EM, 2010, ACTA NEUROL SCAND, V121, P30, DOI 10.1111/j.1600-0404.2009.01195.x; Kleinjung T, 2005, OTOLARYNG HEAD NECK, V132, P566, DOI 10.1016/j.otohns.2004.09.134; Koda M, 2004, J NEUROTRAUM, V21, P329, DOI 10.1089/089771504322972112; Lenz M, 2014, BRAIN STRUCT FUNCT, P1; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P3766, DOI 10.1167/iovs.14-13895; Macharadze T, 2009, NEUROREPORT, V20, P301, DOI 10.1097/WNR.0b013e32832027e6; Makowiecki K, 2014, J NEUROSCI, V34, P10780, DOI 10.1523/JNEUROSCI.0723-14.2014; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; Morellini N, 2015, CEREBELLUM, V14, P23, DOI 10.1007/s12311-014-0617-9; Morimoto T, 2005, INVEST OPHTH VIS SCI, V46, P2147, DOI 10.1167/iovs.04-1339; Morimoto T, 2002, NEUROREPORT, V13, P227, DOI 10.1097/00001756-200202110-00011; Muller MB, 2000, NEUROPSYCHOPHARMACOL, V23, P205, DOI 10.1016/S0893-133X(00)00099-3; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Panagis L, 2005, EUR J NEUROSCI, V21, P2305, DOI 10.1111/j.1460-9568.2005.04046.x; Coimbra JP, 2009, J COMP NEUROL, V514, P66, DOI 10.1002/cne.21992; Peinemann A, 2004, CLIN NEUROPHYSIOL, V115, P1519, DOI 10.1016/j.clinph.2004.02.005; Prilloff S, 2012, INVEST OPHTH VIS SCI, V53, P1460, DOI 10.1167/iovs.11-8306; Rodger J, 2012, FASEB J, V26, P1593, DOI 10.1096/fj.11-194878; Sergeeva EG, 2012, J NEUROPHYSIOL, V108, P2494, DOI 10.1152/jn.00341.2012; Seung HS, 2014, NEURON, V83, P1262, DOI 10.1016/j.neuron.2014.08.054; Szapacs ME, 2004, J NEUROSCI METH, V140, P81, DOI 10.1016/j.jneumeth.2004.03.026; Templeton JP, 2012, MOL VIS, V18, P2147; Trippe J, 2009, EXP BRAIN RES, V199, P411, DOI 10.1007/s00221-009-1961-8; Vlachos A, 2012, J NEUROSCI, V32, P17514, DOI 10.1523/JNEUROSCI.0409-12.2012; Volz LJ, 2013, BRAIN STIMUL, V6, P598, DOI 10.1016/j.brs.2013.01.008; Weber AJ, 2010, INVEST OPHTH VIS SCI, V51, P327, DOI 10.1167/iovs.09-3740; WEIBEL D, 1995, BRAIN RES, V679, P249, DOI 10.1016/0006-8993(95)00238-L; WEISSMAN JD, 1992, ELECTROEN CLIN NEURO, V85, P215, DOI 10.1016/0168-5597(92)90135-X; Yin YQ, 2003, J NEUROSCI, V23, P2284; Yoon KJ, 2011, EXP BRAIN RES, V214, P549, DOI 10.1007/s00221-011-2853-2; Zanardini R, 2006, J AFFECT DISORDERS, V91, P83, DOI 10.1016/j.jad.2005.12.029	52	17	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126949	10.1371/journal.pone.0126949	http://dx.doi.org/10.1371/journal.pone.0126949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993112	Green Published, Green Submitted, gold			2022-12-26	WOS:000354921400085
J	Abdullahi, N; Saion, E; Shaari, AH; Al-Hada, NM; Keiteb, A				Abdullahi, Nura; Saion, Elias; Shaari, Abdul Halim; Al-Hada, Naif Mohammed; Keiteb, Aysar			Optimisation of the Photonic Efficiency of TiO2 Decorated on MWCNTs for Methylene Blue Photodegradation	PLOS ONE			English	Article							ENHANCED PHOTOCATALYTIC ACTIVITY; CARBON NANOTUBES; THIN-FILMS; DEGRADATION; NANOCOMPOSITES; IRRADIATION	MWCNTs/TiO2 nanocomposite was prepared by oxidising MWCNT in H2SO4/HNO3 then decorating it with TiO2-p25 nanopowder. The composites were characterised using XRD, TEM, FT-IR PL and UV-vis spectroscopy. The TEM images have shown TiO2 nanoparticles immobilised onto the sidewalls of the MWCNTs. The UV-vis spectrum confirms that the nanocomposites can significantly absorb more light in the visible regions compared with the commercial TiO2 (P25). The catalytic activity of these nanocomposites was determined by photooxidation of MB aqueous solution in the presence of visible light. The MWCNTs/TiO2 (1: 3) mass ratio showed maximum degradation efficiency. However, its activity was more favourable in alkaline and a neutral pH than an acidic medium.	[Abdullahi, Nura; Saion, Elias; Shaari, Abdul Halim; Al-Hada, Naif Mohammed; Keiteb, Aysar] Univ Putra Malaysia, Fac Sci, Dept Phys, Serdang 43400, Selangor, Malaysia	Universiti Putra Malaysia	Abdullahi, N (corresponding author), Univ Putra Malaysia, Fac Sci, Dept Phys, Serdang 43400, Selangor, Malaysia.	nuraddeen27@gmail.com	Keiteb, Aysar S./AHE-1042-2022; Al-Hada, Naif Mohammed/D-2435-2010	Al-Hada, Naif Mohammed/0000-0002-7318-8185; shaari, abdul halim/0000-0001-6729-630X	Research Management Center (RMC), Universiti Putra Malaysia	Research Management Center (RMC), Universiti Putra Malaysia	This work was financially supported by the Research Management Center (RMC), Universiti Putra Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi Y, 2012, INT J MOL SCI, V13, P302, DOI 10.3390/ijms13010302; Al-Hada NM, 2014, MAT SCI SEMICON PROC, V26, P460, DOI 10.1016/j.mssp.2014.05.032; Al-Hada NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103134; Anpo M, 2000, PURE APPL CHEM, V72, P1265, DOI 10.1351/pac200072071265; Arabatzis IM, 2003, APPL CATAL B-ENVIRON, V42, P187, DOI 10.1016/S0926-3373(02)00233-3; Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051; Carp O, 2004, PROG SOLID STATE CH, V32, P33, DOI 10.1016/j.progsolidstchem.2004.08.001; Chen M-L, 2006, CARBON SCI, V7, P259; Cirkva V, 2008, J PHOTOCH PHOTOBIO A, V198, P13, DOI 10.1016/j.jphotochem.2008.02.009; Elliott JA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.095501; Fan WG, 2006, J AM CERAM SOC, V89, P2671, DOI 10.1111/j.1551-2916.2006.01112.x; Gao B, 2009, APPL CATAL B-ENVIRON, V89, P503, DOI 10.1016/j.apcatb.2009.01.009; He C, 2002, APPL SURF SCI, V200, P239, DOI 10.1016/S0169-4332(02)00927-3; Hou PX, 2008, CARBON, V46, P2003, DOI 10.1016/j.carbon.2008.09.009; Jiang GH, 2011, POWDER TECHNOL, V207, P465, DOI 10.1016/j.powtec.2010.11.029; Kataoka S, 2002, J PHOTOCH PHOTOBIO A, V148, P323, DOI 10.1016/S1010-6030(02)00059-X; Kusiak-Nejman E, 2011, J PHOTOCH PHOTOBIO A, V226, P68, DOI 10.1016/j.jphotochem.2011.10.018; Lee WJ, 2012, ACS NANO, V6, P935, DOI 10.1021/nn204504h; Liu CC, 2006, DYES PIGMENTS, V68, P191, DOI 10.1016/j.dyepig.2004.12.002; Nag M, 2008, MATER RES BULL, V43, P3270, DOI 10.1016/j.materresbull.2008.02.021; Osterloh FE, 2008, CHEM MATER, V20, P35, DOI 10.1021/cm7024203; Pardeshi SK, 2009, J MOL CATAL A-CHEM, V308, P32, DOI 10.1016/j.molcata.2009.03.023; Sakthivel S, 2003, ANGEW CHEM INT EDIT, V42, P4908, DOI 10.1002/anie.200351577; Shankar MV, 2004, J CHEM TECHNOL BIOT, V79, P1279, DOI 10.1002/jctb.1124; Stobinski L, 2010, J ALLOY COMPD, V501, P77, DOI 10.1016/j.jallcom.2010.04.032; Wang Q, 2007, J NANOPART RES, V9, P1087, DOI 10.1007/S11051-006-9199-X; Wei BQ, 2001, APPL PHYS LETT, V79, P1172, DOI 10.1063/1.1396632; Xia XH, 2007, CARBON, V45, P717, DOI 10.1016/j.carbon.2006.11.028; Xu YJ, 2010, J PHYS CHEM C, V114, P2669, DOI 10.1021/jp909855p; Yu JG, 2003, J PHYS CHEM B, V107, P13871, DOI 10.1021/jp036158y; Yu Y, 2005, APPL CATAL A-GEN, V289, P186, DOI 10.1016/j.apcata.2005.04.057; Zhang FJ, 2009, J CERAM PROCESS RES, V10, P600; Zhao DL, 2013, J COLLOID INTERF SCI, V398, P234, DOI 10.1016/j.jcis.2013.02.017	33	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0125511	10.1371/journal.pone.0125511	http://dx.doi.org/10.1371/journal.pone.0125511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993127	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000354917300019
J	Yan, Q; Liu, HS; Yao, D; Li, X; Chen, H; Dou, Y; Wang, Y; Pei, Y; Xiao, YH				Yan, Qian; Liu, Hou-Sheng; Yao, Dan; Li, Xin; Chen, Han; Dou, Yang; Wang, Yi; Pei, Yan; Xiao, Yue-Hua			The Basic/Helix-Loop-Helix Protein Family in Gossypium: Reference Genes and Their Evolution during Tetraploidization	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FAMILY; GENOME-WIDE ANALYSIS; BHLH; EXPRESSION; FIBER; ARABIDOPSIS; CLASSIFICATION; DOMINANCE; SEQUENCE; REVEALS	Basic/helix-loop-helix (bHLH) proteins comprise one of the largest transcription factor families and play important roles in diverse cellular and molecular processes. Comprehensive analyses of the composition and evolution of the bHLH family in cotton are essential to elucidate their functions and the molecular basis of cotton development. By searching bHLH homologous genes in sequenced diploid cotton genomes (Gossypium raimondii and G. arboreum), a set of cotton bHLH reference genes containing 289 paralogs were identified and named as GobHLH001-289. Based on their phylogenetic relationships, these cotton bHLH proteins were clustered into 27 subfamilies. Compared to those in Arabidopsis and cacao, cotton bHLH proteins generally increased in number, but unevenly in different subfamilies. To further uncover evolutionary changes of bHLH genes during tetraploidization of cotton, all genes of S5a and S5b subfamilies in upland cotton and its diploid progenitors were cloned and compared, and their transcript profiles were determined in upland cotton. A total of 10 genes of S5a and S5b subfamilies (doubled from A-and D-genome progenitors) maintained in tetraploid cottons. The major sequence changes in upland cotton included a 15-bp in-frame deletion in GhbHLH130D and a long terminal repeat retrotransposon inserted in GhbHLH062A, which eliminated GhbHLH062A expression in various tissues. The S5a and S5b bHLH genes of A and D genomes (except GobHLH062) showed similar transcription patterns in various tissues including roots, stems, leaves, petals, ovules, and fibers, while the A-and D-genome genes of GobHLH110 and GobHLH130 displayed clearly different transcript profiles during fiber development. In total, this study represented a genome-wide analysis of cotton bHLH family, and revealed significant changes in sequence and expression of these genes in tetraploid cottons, which paved the way for further functional analyses of bHLH genes in the cotton genus.	[Yan, Qian; Liu, Hou-Sheng; Yao, Dan; Li, Xin; Chen, Han; Dou, Yang; Wang, Yi; Pei, Yan; Xiao, Yue-Hua] Southwest Univ, Biotechnol Res Ctr, Chongqing Key Lab Applicat & Safety Control Genet, Chongqing, Peoples R China	Southwest University - China	Xiao, YH (corresponding author), Southwest Univ, Biotechnol Res Ctr, Chongqing Key Lab Applicat & Safety Control Genet, Chongqing, Peoples R China.	xiaoyuehua@swu.edu.cn			National Natural Science Foundation of China [31130039, 30971713, 31271769]; Genetically Modified Organisms Breeding Major Project of China [2014ZX08005005-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Genetically Modified Organisms Breeding Major Project of China	This work was partially supported by the National Natural Science Foundation of China (31130039 to Y.P., 30971713 and 31271769 to Y.H.X.) and by the Genetically Modified Organisms Breeding Major Project of China (2014ZX08005005-001 to Y.H.X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2004, GENETICS, V168, P2217, DOI 10.1534/genetics.104.033522; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Bai MY, 2012, PLANT CELL, V24, P4917, DOI 10.1105/tpc.112.105163; Bailey PC, 2003, PLANT CELL, V15, P2497, DOI 10.1105/tpc.151140; Bao Y, 2011, P NATL ACAD SCI USA, V108, P21152, DOI 10.1073/pnas.1115926109; Carretero-Paulet L, 2010, PLANT PHYSIOL, V153, P1398, DOI 10.1104/pp.110.153593; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chaudhary B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-378; Chen XD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030056; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Feldman M, 2012, GENETICS, V192, P763, DOI 10.1534/genetics.112.146316; Flagel L, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-16; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Guo WZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-314; Gyoja F, 2014, GENE, V542, P29, DOI 10.1016/j.gene.2014.03.024; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Hovav R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040025; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Jones S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-226; Kazan K, 2013, MOL PLANT, V6, P686, DOI 10.1093/mp/sss128; Leivar P, 2014, PLANT CELL, V26, P56, DOI 10.1105/tpc.113.120857; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Liu A, 2013, MOL GENET GENOMICS, V288, P365, DOI 10.1007/s00438-013-0755-7; Lockhart Jennifer, 2013, Plant Cell, V25, P1483, DOI 10.1105/tpc.113.250510; Madden T., 2008, BLAST HELP; Motamayor JC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r53; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Pires N, 2010, MOL BIOL EVOL, V27, P862, DOI 10.1093/molbev/msp288; Ran JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078997; Sailsbery JK, 2012, MOL BIOL EVOL, V29, P1301, DOI 10.1093/molbev/msr288; Sasaki-Sekimoto Y, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27639; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Song XM, 2014, MOL GENET GENOMICS, V289, P77, DOI 10.1007/s00438-013-0791-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan JF, 2013, PLANT PHYSIOL, V162, P86, DOI 10.1104/pp.112.212142; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Woodhouse MR, 2014, P NATL ACAD SCI USA, V111, P5283, DOI 10.1073/pnas.1402475111; Xiao Yue-Hua, 2002, Acta Genetica Sinica, V29, P62; Xiao YH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086344, 10.1371/journal.pone.0095875]; Xu WJ, 2014, NEW PHYTOL, V202, P132, DOI 10.1111/nph.12620; Yoo MJ, 2013, HEREDITY, V110, P171, DOI 10.1038/hdy.2012.94; Yu J, 2014, NUCLEIC ACIDS RES, V42, pD1229, DOI 10.1093/nar/gkt1064; Yuan DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022758; Zhao HT, 2012, PLANT SIGNAL BEHAV, V7, P1556, DOI 10.4161/psb.22404; Zhao L, 2013, FUNCT INTEGR GENOMIC, V13, P75, DOI 10.1007/s10142-012-0301-4; Zhou RC, 2011, P NATL ACAD SCI USA, V108, P16122, DOI 10.1073/pnas.1109551108; Zhu HY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-40; Zhu YQ, 2003, PLANT PHYSIOL, V133, P580, DOI 10.1104/pp.103.027052	52	13	15	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126558	10.1371/journal.pone.0126558	http://dx.doi.org/10.1371/journal.pone.0126558			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992947	gold, Green Submitted, Green Published			2022-12-26	WOS:000354917300046
J	Lucena, MM; da Silva, FD; da Costa, AD; Guimaraes, GR; Ruas, ACN; Braga, FPB; Braga, MPB; Reis, JGC; da Costa, DCS; Palmeiro, MR; Rolla, VC; Valete-Rosalino, CM				Lucena, Marcia Mendonca; da Silva, Fernanda dos Santos; da Costa, Ananda Dutra; Guimaraes, Gabriela Rodrigues; Nunes Ruas, Ana Cristina; Bom Braga, Frederico Pereira; Bom Braga, Mateus Pereira; Correa Reis, Joao Gustavo; Silva da Costa, Daniel Cesar; Palmeiro, Mariana Reuter; Rolla, Valeria Cavalcanti; Valete-Rosalino, Claudia Maria			Evaluation of Voice Disorders in Patients with Active Laryngeal Tuberculosis	PLOS ONE			English	Article								Introduction Laryngeal tuberculosis (LTB) is the most frequent larynx granulomatous disease. In general there is lung involvement, but in an important proportion of cases you can find LTB without pulmonary disease. The lesions observed in LTB, such as ulceration and fibrosis, can interfere in the process of voice production. The involvement of the mucous lining of the vocal folds can change their flexibility and, consequently, change voice quality, and the main symptom is dysphonia present in almost 90% of cases. Objective To describe the anatomical characteristics and voice quality in LTB patients. Material and Method A descriptive cross-sectional study was conducted with 24 patients. Result The most frequently affected sites were vocal folds in 87.5% patients, vestibular folds in 66.7%, epiglottis in 41.7%, arytenoid in 50%, aryepiglottic folds in 33.3%, and interarytenoid region in 33.3% patients. We found 95.8% cases of dysphonia. The voice acoustic analysis showed 58.3% cases of Jitter alterations, 83.3% of Shimmer and 70.8% of GNE. Conclusion Voice disorders found in active laryngeal tuberculosis are similar to those reported after clinical healing of the disease, suggesting that sequelae and vocal adjustments may install during the active phase of the disease, negatively impacting the process of vocal quality reestablishment.	[Lucena, Marcia Mendonca; da Silva, Fernanda dos Santos; da Costa, Ananda Dutra; Bom Braga, Frederico Pereira; Bom Braga, Mateus Pereira; Correa Reis, Joao Gustavo; Silva da Costa, Daniel Cesar; Palmeiro, Mariana Reuter; Valete-Rosalino, Claudia Maria] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Lab Clin Res & Surveillance Leishmaniasis, Rio De Janeiro, RJ, Brazil; [Lucena, Marcia Mendonca; Nunes Ruas, Ana Cristina] Univ Fed Rio de Janeiro, Dept Speech Pathol, Rio De Janeiro, RJ, Brazil; [Guimaraes, Gabriela Rodrigues] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Rolla, Valeria Cavalcanti] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Lab Clin Res Mycobacteriosis, Rio De Janeiro, RJ, Brazil; [Valete-Rosalino, Claudia Maria] Univ Fed Rio de Janeiro, Dept Otorhinolaryngol & Ophthalmol, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Valete-Rosalino, CM (corresponding author), Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Lab Clin Res & Surveillance Leishmaniasis, Rio De Janeiro, RJ, Brazil.	claudia.valete@ini.fiocruz.br	Rolla, Valeria Cavalcanti/AAI-6078-2021; Valete-Rosalino, Cláudia Maria/AAR-4293-2021	Rolla, Valeria Cavalcanti/0000-0002-0841-1408; 	National Institute of Infectious Diseases (INI) [(PA2010-2013)-FIOCRUZ]; Papes VI/FIOCRUZ/Brazilian National Council for Scientific and Technological Development (CNPq) [407758/2012-7]; Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ), Brazil [E-26/102.183/2013]; FAPERJ	National Institute of Infectious Diseases (INI); Papes VI/FIOCRUZ/Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ), Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was funded by National Institute of Infectious Diseases (INI) (PA2010-2013)-FIOCRUZ, Papes VI/FIOCRUZ/Brazilian National Council for Scientific and Technological Development (CNPq) (407758/2012-7), and Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ) (E-26/102.183/2013), Brazil. CMVR is the recipient of fellowships from FAPERJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behlau M, 2001, REVINTER RIO JANEIRO, V1, P86; Fagundes Raquel de Cássia Ferro, 2011, Rev. soc. bras. fonoaudiol., V16, P99, DOI 10.1590/S1516-80342011000100018; Gandhi S, 2012, INDIAN J OTOLARYNGOL, V64, P244, DOI 10.1007/s12070-011-0333-4; Haddad Leonardo, 2006, Rev. Bras. Otorrinolaringol., V72, P295, DOI 10.1590/S0034-72992006000300002; Hirano M, 1981, CLIN EXAMINATION VOI, V5, P100; Lim JY, 2006, EUR ARCH OTO-RHINO-L, V263, P838, DOI 10.1007/s00405-006-0063-5; Ling L, 2010, INT J INFECT DIS, V14, pE230, DOI 10.1016/j.ijid.2009.05.002; Martinez A, 2010, ACTA OTORRINOLARINGO, V62, P401; Ruas ACN, 2010, J LARYNGOL OTOL, V124, P1153, DOI 10.1017/S0022215110001106; Ozudogru E, 2005, Acta Otorhinolaryngol Ital, V25, P374; Porras Alonso E, 2002, Rev Laryngol Otol Rhinol (Bord), V123, P47; Sens Patricia Maria, 2008, Braz J Otorhinolaryngol, V74, P621; Tarantino AB, 2002, GUANABARA KOOGAN RIO, V5, P324	13	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126876	10.1371/journal.pone.0126876	http://dx.doi.org/10.1371/journal.pone.0126876			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009888	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900042
J	Xu, MM; Yu, WW; Tong, SL; Jia, L; Liang, FC; Pan, XC				Xu, Meimei; Yu, Weiwei; Tong, Shilu; Jia, Lei; Liang, Fengchao; Pan, Xiaochuan			Non-Linear Association between Exposure to Ambient Temperature and Children's Hand-Foot-and-Mouth Disease in Beijing, China	PLOS ONE			English	Article							HEAT-RELATED MORTALITY; CASE-CROSSOVER DESIGN; ENTEROVIRUS 71; VULNERABILITY	Background Hand, foot and mouth disease (HFMD) was listed as a notifiable communicable disease in 2008 and is an emerging public health problem in China, especially for children. However, few data are available on the risk assessment of the potential reasons for HFMD in Beijing. This study examined the association of temperature with the incidence of children's HFMD in Beijing at the daily scale for the first time. Methods A newly developed case-crossover design with a distributed lag nonlinear model (DLNM) was used to assess the delayed and cumulative associations of daily temperature with gender- and age-specific HFMD in Beijing, China, during 2010-2012. Relative humidity, day of the week, public holiday, season and long-term trends were controlled in the model. Results Among the total of 113,475 cases, the ratio between males and females was 1.52:1. HFMD was more prevalent in May-July. The temperature-HFMD relationships were non-linear in most age groups except for children aged 6-15 years, with a peak at 25.0 similar to 27.5 degrees C. The high-temperature risks were greater, appeared earlier and lasted longer than the low-temperature risks. The relative risks for female children and those aged 6-15 years were higher than those among other groups. Conclusion Rising temperatures increased the incidence of children's HFMD, with the largest association at 25.0 similar to 27.5 degrees C. Females and children aged 6-15 years were more vulnerable to changes in temperature with regard to the transmission of HFMD than males and other age groups, respectively. Further studies are warranted to confirm these findings in other populations.	[Xu, Meimei; Liang, Fengchao; Pan, Xiaochuan] Peking Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Beijing 100191, Peoples R China; [Yu, Weiwei] Univ Queensland, Sch Populat Hlth, Epidemiol & Biostat Discipline, Brisbane, Qld 4006, Australia; [Tong, Shilu] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld 4059, Australia; [Jia, Lei] Inst Infect Dis & Endem Dis Control, Beijing Ctr Dis Prevent & Control, Beijing 100013, Peoples R China	Peking University; University of Queensland; Queensland University of Technology (QUT)	Yu, WW (corresponding author), Univ Queensland, Sch Populat Hlth, Epidemiol & Biostat Discipline, Brisbane, Qld 4006, Australia.	w.yu@uq.edu.au; xcpan@bjmu.edu.cn	Ibrahim, Essam Hassan/G-1960-2018; Liang, Fenghua/HHM-3798-2022; Liang, Feng/GZK-4305-2022; Yu, Vivian/B-5837-2015	Ibrahim, Essam Hassan/0000-0003-0130-2257; Yu, Vivian/0000-0003-2452-8304	National Natural Science Foundation of China [81273033]; National Health and Medical Research Council (NHMRC) Research Fellowship [553043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Health and Medical Research Council (NHMRC) Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	Authors would like to acknowledge National Natural Science Foundation of China (#81273033) and National Health and Medical Research Council (NHMRC) Research Fellowship (#553043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAD FX, 1994, APPL ENVIRON MICROB, V60, P3704, DOI 10.1128/AEM.60.10.3704-3710.1994; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; [Anonymous], 2011, GUID CLIN MAN PUBL H; Basu R, 2008, AM J EPIDEMIOL, V168, P632, DOI 10.1093/aje/kwn170; Beijing Statistics Bureau, 2013, STAT COMM BEIJ 2012; Bell ML, 2008, INT J EPIDEMIOL, V37, P796, DOI 10.1093/ije/dyn094; Bendig J W, 1996, Commun Dis Rep CDR Rev, V6, pR81; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; CHANG HH, 2012, PLOS ONE, V7, DOI DOI 10.1371/journal.pone.0033067; Chatproedprai S, 2010, JPN J INFECT DIS, V63, P229; Chen CJ, 2013, INT CONF BIOMETR; Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8; DruytsVoets E, 1997, EPIDEMIOL INFECT, V119, P71, DOI 10.1017/S0950268897007656; Guo YM, 2011, ENVIRON HEALTH PERSP, V119, P1719, DOI 10.1289/ehp.1103598; Ha J, 2011, SCI TOTAL ENVIRON, V409, P3274, DOI 10.1016/j.scitotenv.2011.05.034; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-134; Ji Z, 2012, MICROBES ENVIRON, V27, P288, DOI 10.1264/jsme2.ME11352; Li T, 2013, EPIDEMIOL INFECT, P1; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; Ma E, 2010, JPN J INFECT DIS, V63, P422; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Ooi EE, 2002, EMERG INFECT DIS, V8, P995, DOI 10.3201/eid0809.010397; Roberts S, 2007, ENVIRON RES, V104, P193, DOI 10.1016/j.envres.2007.01.009; Stafoggia M, 2006, EPIDEMIOLOGY, V17, P315, DOI 10.1097/01.ede.0000208477.36665.34; Suminski RR, 2008, INT J BIOMETEOROL, V52, P189, DOI 10.1007/s00484-007-0110-y; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; Zhu Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-300	30	44	51	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126171	10.1371/journal.pone.0126171	http://dx.doi.org/10.1371/journal.pone.0126171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010147	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900024
J	Asghar, MN; Silvander, JSG; Helenius, TO; Lahdeniemi, IAK; Alam, C; Fortelius, LE; Holmsten, RO; Toivola, DM				Asghar, M. Nadeem; Silvander, Jonas S. G.; Helenius, Terhi O.; Lahdeniemi, Iris A. K.; Alam, Catharina; Fortelius, Lina E.; Holmsten, Rickard O.; Toivola, Diana M.			The Amount of Keratins Matters for Stress Protection of the Colonic Epithelium	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; MICE; DISEASE; COLITIS; LIVER; SUSCEPTIBILITY; INFLAMMATION; RESISTANCE; HEALTH; INJURY	Keratins (K) are important for epithelial stress protection as evidenced by keratin mutations predisposing to human liver diseases and possibly inflammatory bowel diseases. A role for K8 in the colon is supported by the ulcerative colitis-phenotype with epithelial hyperproliferation and abnormal ion transport in K8-knockout (K8(-/-)) mice. The heterozygote knockout (K8(+/-)) colon appears normal but displays a partial ion transport-defect. Characterizing the colonic phenotype we show that K8(+/-)colon expresses similar to 50% less keratins compared to K8 wild type (K8(+/+)) but de novo K7 expression is observed in the top-most cells of the K8(+/-) and K8(-/-) crypts. The K8(+/-)colonic crypts are significantly longer due to increased epithelial hyperproliferation, but display no defects in apoptosis or inflammation in contrast to K8(-/-). When exposed to colitis using the dextran sulphate sodium-model, K8(+/-)mice showed higher disease sensitivity and delayed recovery compared to K8(+/+) littermates. Therefore, the K8(+/-)mild colonic phenotype correlates with decreased keratin levels and increased sensitivity to experimental colitis, suggesting that a sufficient amount of keratin is needed for efficient stress protection in the colonic epithelia.	[Toivola, Diana M.] Abo Akad Univ, Fac Sci & Engn, Cell Biol, Biosci, Turku, Finland; Turku Ctr Dis Modeling, Turku, Finland	Abo Akademi University	Toivola, DM (corresponding author), Abo Akad Univ, Fac Sci & Engn, Cell Biol, Biosci, Turku, Finland.	dtoivola@abo.fi	Asghar, Muhammad Nadeem/CAI-9008-2022	Alam, Catharina/0000-0003-3839-145X; Toivola, Diana M./0000-0001-7165-9839	Academy of Finland [140759/126161, 266582]; Sigrid Juselius Foundation; Liv och Halsa foundation; European Union Finnish Diabetes Research Foundation; Abo Akademi University Center of Excellence on Cell Stress and Molecular Aging; Turku Doctoral Programme for Biomedical Sciences; Abo Akademi University Doctoral Network in Molecular Biosciences; Swedish Cultural foundation; Finnish Cultural Foundation; Victoriastiftelsen-foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Liv och Halsa foundation; European Union Finnish Diabetes Research Foundation; Abo Akademi University Center of Excellence on Cell Stress and Molecular Aging; Turku Doctoral Programme for Biomedical Sciences; Abo Akademi University Doctoral Network in Molecular Biosciences; Swedish Cultural foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Victoriastiftelsen-foundation	This work was supported by funding from the Academy of Finland #140759/126161 and 266582 to DMT, http://www.aka.fi/en-GB/A/; Sigrid Juselius Foundation to DMT, http://www.sigridjuselius.fi/foundation/contact-info/; Liv och Halsa foundation to DMT, http://www.livochhalsa.fi/; European Union Framework 7 International Reintegration Grant to DMT, http://ec.europa.eu/research/mariecurieactions/about-mca/actions/cig/index_en.htm; The Finnish Diabetes Research Foundation to DMT, http://www.diabetestutkimus.fi/en; Abo Akademi University Center of Excellence on Cell Stress and Molecular Aging to DMT, http://www.abo.fi/fakultet/en/Content/Document/document/26585; Turku Doctoral Programme for Biomedical Sciences to MNA, http://www.tubs.utu.fi/; Abo Akademi University Doctoral Network in Molecular Biosciences to ISKL and JSGS, http://www.abo.fi/forskning/doctoralnetworkmolecularbiosciences; Swedish Cultural foundation to IAKL, http://www.kulturfonden.fi/en/; Finnish Cultural Foundation to CA, https://www.skr.fi/en; and Victoriastiftelsen-foundation to TOH, http://victoriastiftelsen.fi/start/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam C, 2010, DIABETES, V59, P2237, DOI 10.2337/db10-0147; Ameen NA, 2001, J CELL SCI, V114, P563; Asghar MN, 2014, INFLAMM BOWEL DIS, V20, P1435, DOI 10.1097/MIB.0000000000000118; BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; BARIBAULT H, 1993, GENE DEV, V7, P1191, DOI 10.1101/gad.7.7a.1191; Cadrin M, 2000, J HEPATOL, V33, P199, DOI 10.1016/S0168-8278(00)80360-8; Chuang SS, 1997, AM J CLIN PATHOL, V107, P410; Habtezion A, 2005, J CELL SCI, V118, P1971, DOI 10.1242/jcs.02316; Habtezion A, 2011, P NATL ACAD SCI USA, V108, P1445, DOI 10.1073/pnas.1010833108; Haybaeck J, 2012, LAB INVEST, V92, P857, DOI 10.1038/labinvest.2012.49; Iyer SV, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053532, 10.1371/journal.pone.0059613]; Kielland A, 2009, FREE RADICAL BIO MED, V47, P760, DOI 10.1016/j.freeradbiomed.2009.06.013; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Koch S, 2011, GASTROENTEROLOGY, V141, P259, DOI 10.1053/j.gastro.2011.03.043; Ku NO, 2004, METHOD CELL BIOL, V78, P489; Ku NO, 1999, AM J PHYSIOL-GASTR L, V277, pG1108, DOI 10.1152/ajpgi.1999.277.6.G1108; Majumdar D, 2012, INT J EXP PATHOL, V93, P305, DOI 10.1111/j.1365-2613.2012.00830.x; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Omary MB, 2009, J CLIN INVEST, V119, P1756, DOI 10.1172/JCI39894; Pallari Hanna-Mari, 2006, Sci STKE, V2006, ppe53, DOI 10.1126/stke.3662006pe53; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Pekny M, 2007, EXP CELL RES, V313, P2244, DOI 10.1016/j.yexcr.2007.04.023; Sandilands A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064404; Schweinfest CW, 2006, J BIOL CHEM, V281, P37962, DOI 10.1074/jbc.M607527200; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Tao GZ, 2007, CLIN GASTROENTEROL H, V5, P857, DOI 10.1016/j.cgh.2007.02.017; Tao GZ, 2003, J CELL SCI, V116, P4629, DOI 10.1242/jcs.00782; Ten Hove T, 2002, DIGEST DIS SCI, V47, P2056, DOI 10.1023/A:1019629013945; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Toivola DA, 2004, HEPATOLOGY, V40, P459, DOI 10.1002/hep.20277; Toivola DM, 2015, CURR OPIN CELL BIOL, V32, P73, DOI 10.1016/j.ceb.2014.12.008; Toivola DM, 2005, TRENDS CELL BIOL, V15, P608, DOI 10.1016/j.tcb.2005.09.004; Toivola DM, 2004, J CELL BIOL, V164, P911, DOI 10.1083/jcb.200308103; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Zhong BH, 2004, EXP CELL RES, V299, P404, DOI 10.1016/j.yexcr.2004.05.026; Zupancic T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099398	37	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127436	10.1371/journal.pone.0127436	http://dx.doi.org/10.1371/journal.pone.0127436			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000979	gold, Green Submitted, Green Published			2022-12-26	WOS:000354931700060
J	Azzag, K; Chelin, Y; Rousset, F; Le Goff, E; Martinand-Mari, C; Martinez, AM; Maurin, B; Daujat-Chavanieu, M; Godefroy, N; Averseng, J; Mangeat, P; Baghdiguian, S				Azzag, Karim; Chelin, Yoann; Rousset, Francois; Le Goff, Emilie; Martinand-Mari, Camille; Martinez, Anne-Marie; Maurin, Bernard; Daujat-Chavanieu, Martine; Godefroy, Nelly; Averseng, Julien; Mangeat, Paul; Baghdiguian, Stephen			The Non-Proliferative Nature of Ascidian Folliculogenesis as a Model of Highly Ordered Cellular Topology Distinct from Proliferative Epithelia	PLOS ONE			English	Article							CIONA-INTESTINALIS; MORPHOGENESIS; DROSOPHILA; CELLS; ACTIVATION; MECHANICS; APOPTOSIS; PACKING; DEATH	Previous studies have addressed why and how mono-stratified epithelia adopt a polygonal topology. One major additional, and yet unanswered question is how the frequency of different cell shapes is achieved and whether the same distribution applies between non-proliferative and proliferative epithelia. We compared different proliferative and non-proliferative epithelia from a range of organisms as well as Drosophila melanogaster mutants, deficient for apoptosis or hyperproliferative. We show that the distribution of cell shapes in non-proliferative epithelia (follicular cells of five species of tunicates) is distinctly, and more stringently organized than proliferative ones (cultured epithelial cells and Drosophila melanogaster imaginal discs). The discrepancy is not supported by geometrical constraints (spherical versus flat monolayers), number of cells, or apoptosis events. We have developed a theoretical model of epithelial morphogenesis, based on the physics of divided media, that takes into account biological parameters such as cell-cell contact adhesions and tensions, cell and tissue growth, and which reproduces the effects of proliferation by increasing the topological heterogeneity observed experimentally. We therefore present a model for the morphogenesis of epithelia where, in a proliferative context, an extended distribution of cell shapes (range of 4 to 10 neighbors per cell) contrasts with the narrower range of 5-7 neighbors per cell that characterizes non proliferative epithelia.	[Azzag, Karim; Chelin, Yoann; Rousset, Francois; Le Goff, Emilie; Martinand-Mari, Camille; Martinez, Anne-Marie; Maurin, Bernard; Daujat-Chavanieu, Martine; Godefroy, Nelly; Averseng, Julien; Mangeat, Paul; Baghdiguian, Stephen] Univ Montpellier, F-34095 Montpellier 5, France; [Azzag, Karim; Rousset, Francois; Le Goff, Emilie; Martinand-Mari, Camille; Godefroy, Nelly; Baghdiguian, Stephen] CNRS, Inst Sci Evolut ISE M, Montpellier, France; [Chelin, Yoann; Maurin, Bernard; Averseng, Julien] CNRS, Lab Mecan & Genie Civil LMGC, Montpellier, France; [Martinez, Anne-Marie] CNRS, Inst Genet Humaine IGH, Montpellier, France; [Daujat-Chavanieu, Martine] INSERM, U1040, Montpellier, France; [Daujat-Chavanieu, Martine] CHU Montpellier, Inst Biotherapie, Montpellier, France; [Mangeat, Paul] CNRS, Ctr Rech Biochim Macromol CRBM, Montpellier, France	Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Baghdiguian, S (corresponding author), Univ Montpellier, Pl Eugene Bataillon, F-34095 Montpellier 5, France.	stephen.baghdiguian@univ-montp2.fr	Rousset, Francois/C-7360-2008; Godefroy, Nelly/AAG-2052-2020; Daujat-Chavanieu, Martine/AAU-2908-2020; Rousset, Francois/GRJ-3980-2022; Daujat-Chavanieu, Martine/T-5155-2018; martinez, Anne-marie A.M/R-2751-2017	Rousset, Francois/0000-0003-4670-0371; Daujat-Chavanieu, Martine/0000-0001-5560-1610; Rousset, Francois/0000-0003-4670-0371; Daujat-Chavanieu, Martine/0000-0001-5560-1610; martinez, Anne-marie A.M/0000-0001-8562-7627; Baghdiguian, Stephen/0000-0002-2992-9708				Blair SS, 2003, DEVELOPMENT, V130, P5065, DOI 10.1242/dev.00774; Chambon JP, 2002, DEVELOPMENT, V129, P3105; Chelin Y, 2013, COMPUT METHOD BIOMEC, V16, P2, DOI 10.1080/10255842.2013.815848; Chelin Y, 2013, J BIOMECH, V46, P1075, DOI 10.1016/j.jbiomech.2013.01.015; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; CLONEY RA, 1995, ACTA ZOOL-STOCKHOLM, V76, P89, DOI 10.1111/j.1463-6395.1995.tb00985.x; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Gibson WT, 2011, CELL, V144, P427, DOI 10.1016/j.cell.2010.12.035; Gibson WT, 2009, CURR TOP DEV BIOL, V89, P87, DOI 10.1016/S0070-2153(09)89004-2; Hooke Robert, 1665, MICROGRAPHIA SOME PH; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Martinand-Mari C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004202; Martinez AM, 2009, NAT GENET, V41, P1076, DOI 10.1038/ng.414; Maury B, 2006, DEV BIOL, V289, P152, DOI 10.1016/j.ydbio.2005.10.021; Milan M, 1997, P NATL ACAD SCI USA, V94, P5691, DOI 10.1073/pnas.94.11.5691; Monier B, 2015, NATURE, V518, P245, DOI 10.1038/nature14152; OKADA T, 1993, DEV GROWTH DIFFER, V35, P495; PANKRATZ MJ, 1995, DEVELOPMENT, V121, P1885; Prodon F, 2006, DEV BIOL, V290, P297, DOI 10.1016/j.ydbio.2005.11.025; Ragkousi K, 2014, J CELL BIOL, V207, P181, DOI 10.1083/jcb.201408044; Rousset F, 2014, ECOGRAPHY, V37, P781, DOI 10.1111/ecog.00566; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sugino Y, 1987, J EXP ZOOL, P205; Thompson D., 1945, GROWTH FORM; Toyama Y, 2008, SCIENCE, V321, P1683, DOI 10.1126/science.1157052	26	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126341	10.1371/journal.pone.0126341	http://dx.doi.org/10.1371/journal.pone.0126341			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000769	Green Published, gold, Green Submitted			2022-12-26	WOS:000354931700016
J	Hart, SJ; Veblen, TT; Mietkiewicz, N; Kulakowski, D				Hart, Sarah J.; Veblen, Thomas T.; Mietkiewicz, Nathan; Kulakowski, Dominik			Negative Feedbacks on Bark Beetle Outbreaks: Widespread and Severe Spruce Beetle Infestation Restricts Subsequent Infestation	PLOS ONE			English	Article							POSTFIRE TREE REGENERATION; POTENTIAL FIRE BEHAVIOR; MOUNTAIN PINE; LODGEPOLE PINE; DISTURBANCE INTERACTIONS; SPATIOTEMPORAL PATTERNS; VARIABLE IMPORTANCE; CROWN FIRE; FORESTS; COLEOPTERA	Understanding disturbance interactions and their ecological consequences remains a major challenge for research on the response of forests to a changing climate. When, where, and how one disturbance may alter the severity, extent, or occurrence probability of a subsequent disturbance is encapsulated by the concept of linked disturbances. Here, we evaluated 1) how climate and forest habitat variables, including disturbance history, interact to drive 2000s spruce beetle (Dendroctonus rufipennis) infestation of Engelmann spruce (Picea engelmannii) across the Southern Rocky Mountains; and 2) how previous spruce beetle infestation affects subsequent infestation across the Flat Tops Wilderness in northwestern Colorado, which experienced a severe landscape-scale spruce beetle infestation in the 1940s. We hypothesized that drought and warm temperatures would promote infestation, whereas small diameter and non-host trees, which may reflect past disturbance by spruce beetles, would inhibit infestation. Across the Southern Rocky Mountains, we found that climate and forest structure interacted to drive the 2000s infestation. Within the Flat Tops study area we found that stands infested in the 1940s were composed of higher proportions of small diameter and non-host trees ca. 60 years later. In this area, the 2000s infestation was constrained by a paucity of large diameter host trees (> 23 cm at diameter breast height), not climate. This suggests that there has not been sufficient time for trees to grow large enough to become susceptible to infestation. Concordantly, we found no overlap between areas affected by the 1940s infestation and the current infestation. These results show a severe spruce beetle infestation, which results in the depletion of susceptible hosts, can create a landscape template reducing the potential for future infestations.	[Hart, Sarah J.; Veblen, Thomas T.] Univ Colorado, Dept Geog, Boulder, CO 80309 USA; [Mietkiewicz, Nathan; Kulakowski, Dominik] Clark Univ, Sch Geog, Worcester, MA 01610 USA	University of Colorado System; University of Colorado Boulder; Clark University	Hart, SJ (corresponding author), Univ Colorado, Dept Geog, Boulder, CO 80309 USA.	Sarah.Hart@Colorado.edu	Veblen, Thomas T./U-6461-2018	Hart, Sarah/0000-0001-8371-8568; Mietkiewicz, Nathan/0000-0002-2287-0408	National Science Foundation [1262687, 1262691]; Division Of Behavioral and Cognitive Sci [1262687] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was supported by National Science Foundation (http://www.nsf.gov) awards 1262687 (awarded to TTV) and 1262691 (awarded to DK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bebi P, 2003, ECOLOGY, V84, P362, DOI 10.1890/0012-9658(2003)084[0362:IBFASB]2.0.CO;2; Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6; BENTZ BJ, 1991, CAN ENTOMOL, V123, P1083, DOI 10.4039/Ent1231083-5; Berg EE, 2006, FOREST ECOL MANAG, V227, P219, DOI 10.1016/j.foreco.2006.02.038; Bigler C, 2005, ECOLOGY, V86, P3018, DOI 10.1890/05-0011; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cahill D, 1951, NET IMPACT SPRUCE BE, P1; Chapman TB, 2012, ECOLOGY, V93, P2175, DOI 10.1890/11-1055.1; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; DeRose RJ, 2013, FOREST ECOL MANAG, V308, P198, DOI 10.1016/j.foreco.2013.07.061; Derose RJ, 2009, ECOSCIENCE, V16, P28, DOI 10.2980/16-1-3160; DeRose RJ, 2014, FOREST SCI, V60, P1205, DOI 10.5849/forsci.13-507; Ecoregional Gap Analysis of the Southwestern United States, 2007, SW REG GAP AN PROJ F, P1; Gaylord ML, 2013, NEW PHYTOL, V198, P567, DOI 10.1111/nph.12174; Hansen EM, 2003, CAN ENTOMOL, V135, P697; Hart SJ, 2014, FOREST ECOL MANAG, V318, P44, DOI 10.1016/j.foreco.2013.12.035; Hart SJ, 2014, ECOLOGY, V95, P930, DOI 10.1890/13-0230.1; Harvey BJ, 2014, P NATL ACAD SCI USA, V111, P15120, DOI 10.1073/pnas.1411346111; Harvey BJ, 2014, ECOL APPL, V24, P1608, DOI 10.1890/13-1851.1; Harvey BJ, 2013, ECOLOGY, V94, P2475, DOI 10.1890/13-0188.1; Hebertson EG, 2008, ENVIRON ENTOMOL, V37, P281, DOI 10.1603/0046-225X(2008)37[281:CFAWHS]2.0.CO;2; Hoffman CM, 2015, AGR FOREST METEOROL, V204, P79, DOI 10.1016/j.agrformet.2015.01.018; Hoffman CM, 2013, FOREST SCI, V59, P390, DOI 10.5849/forsci.11-114; Holden ZA, 2009, FOREST ECOL MANAG, V258, P2399, DOI 10.1016/j.foreco.2009.08.017; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Jenkins MJ, 2008, FOREST ECOL MANAG, V254, P16, DOI 10.1016/j.foreco.2007.09.045; Klutsch JG, 2011, WEST J APPL FOR, V26, P101, DOI 10.1093/wjaf/26.3.101; Kulakowski D, 2003, J BIOGEOGR, V30, P1445, DOI 10.1046/j.1365-2699.2003.00912.x; Kulakowski D, 2002, J ECOL, V90, P806, DOI 10.1046/j.1365-2745.2002.00722.x; Kulakowski D, 2007, ECOLOGY, V88, P759, DOI 10.1890/06-0124; Kulakowski D, 2013, J VEG SCI, V24, P168, DOI 10.1111/j.1654-1103.2012.01437.x; Kulakowski D, 2012, J BIOGEOGR, V39, P2052, DOI 10.1111/j.1365-2699.2012.02748.x; Kulakowski D, 2011, FOREST ECOL MANAG, V262, P1686, DOI 10.1016/j.foreco.2011.07.016; Lynch HJ, 2006, ECOSYSTEMS, V9, P1318, DOI 10.1007/s10021-006-0173-3; Meddens AJH, 2012, ECOL APPL, V22, P1876, DOI 10.1890/11-1785.1; Netherer S, 2015, NEW PHYTOL, V205, P1128, DOI 10.1111/nph.13166; O'Sullivan D., 2002, GEOGRAPHIC INFORM AN; Page W, 2007, FOREST SCI, V53, P662; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Preisler HK, 2012, ECOLOGY, V93, P2421, DOI 10.1890/11-1412.1; PRISM Climate Group, 2013, GIDD CLIM DAT CONT U; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Rousseau J., 2012, Journal of the Acadian Entomological Society, V8, P1; SCHMIDTKE J R, 1977, P1; Schoennagel T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030002; Simard M, 2011, ECOL MONOGR, V81, P3, DOI 10.1890/10-1176.1; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Temperli C, 2013, ECOL MONOGR, V83, P383, DOI 10.1890/12-1503.1; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; US EPA, 2013, LEVLE 3 EC CONT US; USFS, 2015, AER SURV HIGHL COL 2; USFS, 2003, USDA FOR SERV REG 2; USFS and its partners, 2013, USFS ITS PARTNERS US; USGS, 2013, LANDFIRE 1 20 EX VEG; USGS, 2011, GAP AN PROGR GAP; USGS, 2008, LANDFIRE NAT MIL OV; VEBLEN TT, 1991, CAN J FOREST RES, V21, P242, DOI 10.1139/x91-030; VEBLEN TT, 1994, J ECOL, V82, P125, DOI 10.2307/2261392; White TCR, 2014, J APPL ENTOMOL	61	40	40	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127975	10.1371/journal.pone.0127975	http://dx.doi.org/10.1371/journal.pone.0127975			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000906	Green Submitted, Green Published, gold			2022-12-26	WOS:000354931700094
J	Fan, SY; Jiang, JD; Qian, J; Lu, YC; Hu, GH; Luo, C; Hou, WD; Wang, Q				Fan, Song-Yuan; Jiang, Jian-Dong; Qian, Jun; Lu, Yi-Cheng; Hu, Guo-Han; Luo, Chun; Hou, Wei-Dong; Wang, Qi			Overexpression of RLIP76 Required for Proliferation in Meningioma Is Associated with Recurrence	PLOS ONE			English	Article							CANCER DOXORUBICIN RESISTANCE; LUNG-CANCER; GLUTATHIONE-CONJUGATE; CELL-PROLIFERATION; EXPRESSION; APOPTOSIS; EFFECTOR; STRESS; GRADE	The GTPase-activating protein RLIP76 is overexpressed in and correlates with the pathological grade of many malignant tumor cells. But the potential correlation between RLIP76 and clinical outcomes in patients with meningioma remains unknown. In this study, we examined the expression of RLIP76 in meningioma and correlated the RLIP76 expression to the patient outcome. RLIP76 expression in tumor tissues was examined with immunohistochemistry, quantitative reverse-transcription polymerase chain reaction(RT-PCR) and Western-blot. Immunohistochemistry showed an increased RLIP76 immunostaining score in anaplastic and atypical meningiomas versus classical meningiomas. Statistical analyses revealed that RLIP76 immunostaining positively correlated with immunostaining for Ki-67, a nuclear protein highly expressed in proliferating cells(r=0.29, p=0.034 by Spearman's correlation coefficient). Clinicopathological evaluation suggested that RLIP76 expression be associated with tumor grade and recurrence(P<0.05). Univariate and Cox analysis indicated that RLIP76 was an independent prognostic factor for tumor recurrence. Furthermore, the human malignant meningioma cell lines IOMM-Lee and CH157-MN stably transfected with short hairpin RNA (siRNA) targeting RLIP76 were then examined by in vitro growth assays, and apoptosis assays. RLIP76 knockdown in IOMM-Lee and CH157-MN cells inhibited cell proliferation and induced apoptosis. Western blot analysis revealed that cells underexpressing RLIP76 exhibited decreased B-cell lymphoma-2(Bcl-2) expression but increased apoptosis effector caspase-3 expression. These findings demonstrate that high RLIP76 expression is associated with a poor outcome of meningioma and may provide a new gene therapy approach for patients with malignant meningiomas.	[Fan, Song-Yuan; Hou, Wei-Dong; Wang, Qi] PLA, Hosp 322, Dept Neurosurg, Shanxi 03700, Peoples R China; [Jiang, Jian-Dong] Xiamen Univ, Chenggong Hosp, PLA, Dept Neurosurg,Hosp 174, Xiamen 361003, Peoples R China; [Qian, Jun; Lu, Yi-Cheng; Hu, Guo-Han; Luo, Chun; Wang, Qi] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai 200003, Peoples R China	Xiamen University; Naval Medical University	Wang, Q (corresponding author), PLA, Hosp 322, Dept Neurosurg, 2 Yunzhong Rd, Shanxi 03700, Peoples R China.	czyylyc@163.com						Awasthi S, 1998, BIOCHEMISTRY-US, V37, P5231, DOI 10.1021/bi972130z; Awasthi S, 2003, INT J ONCOL, V22, P721; Awasthi S, 2003, INT J ONCOL, V22, P713; Awasthi S, 2008, CLIN CANCER RES, V14, P4372, DOI 10.1158/1078-0432.CCR-08-0145; Bie L, 2011, CANCER GENET-NY, V204, P536, DOI 10.1016/j.cancergen.2011.08.019; De la Garza-Ramos R, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.8.FOCUS13305; Ding D, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.9.FOCUS13364; Drake KJ, 2007, INT J ONCOL, V30, P139; Du YM, 2012, J BIOL CHEM, V287, P26302, DOI 10.1074/jbc.M112.342113; Hu YZ, 2003, J BIOL CHEM, V278, P17299, DOI 10.1074/jbc.M300788200; Jiang L, 2012, J SURG ONCOL, V106, P327, DOI 10.1002/jso.22141; Johnson MD, 2002, J NEURO-ONCOL, V56, P133, DOI 10.1023/A:1014588214966; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; Konstantinidou AE, 2007, APOPTOSIS, V12, P695, DOI 10.1007/s10495-006-0001-4; Liu ZY, 2013, ONCOGENE, V32, P1216, DOI 10.1038/onc.2012.155; MAIER H, 1992, J NEUROSURG, V77, P616, DOI 10.3171/jns.1992.77.4.0616; Margutti P, 2008, BLOOD, V111, P4559, DOI 10.1182/blood-2007-05-092825; Pasquier D, 2008, INT J RADIAT ONCOL, V71, P1388, DOI 10.1016/j.ijrobp.2007.12.020; Rosse C, 2003, J BIOL CHEM, V278, P30597, DOI 10.1074/jbc.M302191200; Rousseau A, 2008, CURR OPIN NEUROL, V21, P720, DOI 10.1097/WCO.0b013e328312c3a7; Singhal J, 2011, CANCER PREV RES, V4, P879, DOI 10.1158/1940-6207.CAPR-11-0025; Singhal SS, 2009, CANCER RES, V69, P4244, DOI 10.1158/0008-5472.CAN-08-3521; Singhal SS, 2009, BIOCHEM PHARMACOL, V77, P1074, DOI 10.1016/j.bcp.2008.11.013; Singhal SS, 2009, BIOCHEM PHARMACOL, V77, P761, DOI 10.1016/j.bcp.2008.10.006; Uzum N, 2008, TUMORI J, V94, P389; Vatsyayan R, 2010, BIOCHEM PHARMACOL, V79, P1699, DOI 10.1016/j.bcp.2010.01.016; Vatsyayan R, 2009, INT J ONCOL, V34, P1505, DOI 10.3892/ijo_00000279; Wang Q, 2014, EJSO-EUR J SURG ONC, V40, P1056, DOI 10.1016/j.ejso.2014.02.243; Wang Q, 2013, CARCINOGENESIS, V34, P916, DOI 10.1093/carcin/bgs401; Wang Q, 2013, J NEURO-ONCOL, V112, P73, DOI 10.1007/s11060-013-1045-2; Yadav S, 2004, BIOCHEMISTRY-US, V43, P16243, DOI 10.1021/bi0482811	31	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125661	10.1371/journal.pone.0125661	http://dx.doi.org/10.1371/journal.pone.0125661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993541	Green Published, gold, Green Submitted			2022-12-26	WOS:000354921400041
J	Forse, GJ; Uson, ML; Nasertorabi, F; Kolatkar, A; Lamberto, I; Pasquale, EB; Kuhn, P				Forse, Garry Jason; Uson, Maria Loressa; Nasertorabi, Fariborz; Kolatkar, Anand; Lamberto, Ilaria; Pasquale, Elena Bianca; Kuhn, Peter			Distinctive Structure of the EphA3/Ephrin-A5 Complex Reveals a Dual Mode of Eph Receptor Interaction for Ephrin-A5	PLOS ONE			English	Article							TYROSINE KINASE; CRYSTAL-STRUCTURES; LIGAND-BINDING; MUTATIONS; PEPTIDES; DOMAIN	The Eph receptor tyrosine kinase/ephrin ligand system regulates a wide spectrum of physiological processes, while its dysregulation has been implicated in cancer progression. The human EphA3 receptor is widely upregulated in the tumor microenvironment and is highly expressed in some types of cancer cells. Furthermore, EphA3 is among the most highly mutated genes in lung cancer and it is also frequently mutated in other cancers. We report the structure of the ligand-binding domain of the EphA3 receptor in complex with its preferred ligand, ephrin-A5. The structure of the complex reveals a pronounced tilt of the ephrin-A5 ligand compared to its orientation when bound to the EphA2 and EphB2 receptors and similar to its orientation when bound to EphA4. This tilt brings an additional area of ephrin-A5 into contact with regions of EphA3 outside the ephrin-binding pocket thereby enlarging the size of the interface, which is consistent with the high binding affinity of ephrin-A5 for EphA3. This large variation in the tilt of ephrin-A5 bound to different Eph receptors has not been previously observed for other ephrins.	[Forse, Garry Jason; Uson, Maria Loressa; Nasertorabi, Fariborz; Kolatkar, Anand; Kuhn, Peter] Univ So Calif, Dornsife Coll Letters Arts & Sci, Los Angeles, CA 90089 USA; [Lamberto, Ilaria; Pasquale, Elena Bianca] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Pasquale, Elena Bianca] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of Southern California; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Kuhn, P (corresponding author), Univ So Calif, Dornsife Coll Letters Arts & Sci, 3430 S Vermont Ave,Suite 105 110,MC3301, Los Angeles, CA 90089 USA.	peter.kuhn@usc.edu			NIH/NCI [P01CA138390]; NATIONAL CANCER INSTITUTE [P01CA138390] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by NIH/NCI P01CA138390 to Pasquale EB and Kuhn P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barquilla A, 2015, ANNU REV PHARMACOL, V55, P465, DOI 10.1146/annurev-pharmtox-011112-140226; Bowden TA, 2009, STRUCTURE, V17, P1386, DOI 10.1016/j.str.2009.07.018; Choi Y, 2009, BIOORG MED CHEM LETT, V19, P4467, DOI 10.1016/j.bmcl.2009.05.029; Chrencik JE, 2006, J BIOL CHEM, V281, P28185, DOI 10.1074/jbc.M605766200; Davis TL, 2008, STRUCTURE, V16, P873, DOI 10.1016/j.str.2008.03.008; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farenc C, 2011, FEBS LETT, V585, P3593, DOI 10.1016/j.febslet.2011.10.028; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; Janes PW, 2014, GROWTH FACTORS, V32, P176, DOI 10.3109/08977194.2014.982276; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lackmann M, 1997, J BIOL CHEM, V272, P16521, DOI 10.1074/jbc.272.26.16521; Lackmann M, 1998, J BIOL CHEM, V273, P20228, DOI 10.1074/jbc.273.32.20228; Lahtela J, 2013, CELL CYCLE, V12, P625, DOI 10.4161/cc.23515; Lamberto I, 2012, BIOCHEM J, V445, P47, DOI 10.1042/BJ20120408; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lisabeth EM, 2012, BIOCHEMISTRY-US, V51, P1464, DOI 10.1021/bi2014079; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Noberini R, 2012, SEMIN CELL DEV BIOL, V23, P51, DOI 10.1016/j.semcdb.2011.10.023; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; Qin HN, 2010, J BIOL CHEM, V285, P644, DOI 10.1074/jbc.M109.064824; Seiradake E, 2013, NAT STRUCT MOL BIOL, V20, P958, DOI 10.1038/nsmb.2617; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; Smith FM, 2004, J BIOL CHEM, V279, P9522, DOI 10.1074/jbc.M309326200; Vail ME, 2014, CANCER RES, V74, P4470, DOI 10.1158/0008-5472.CAN-14-0218; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Xu K, 2013, P NATL ACAD SCI USA, V110, P14634, DOI 10.1073/pnas.1311000110; Zhuang GL, 2012, JNCI-J NATL CANCER I, V104, P1182, DOI 10.1093/jnci/djs297	38	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127081	10.1371/journal.pone.0127081	http://dx.doi.org/10.1371/journal.pone.0127081			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993310	Green Published, gold, Green Submitted			2022-12-26	WOS:000354921400094
J	Kanaan, NM; Collier, TJ; Cole-Strauss, A; Grabinski, T; Mattingly, ZR; Winn, ME; Steece-Collier, K; Sortwell, CE; Manfredsson, FP; Lipton, JW				Kanaan, Nicholas M.; Collier, Timothy J.; Cole-Strauss, Allyson; Grabinski, Tessa; Mattingly, Zachary R.; Winn, Mary E.; Steece-Collier, Kathy; Sortwell, Caryl E.; Manfredsson, Fredric P.; Lipton, Jack W.			The Longitudinal Transcriptomic Response of the Substantia Nigra to Intrastriatal 6-Hydroxydopamine Reveals Significant Upregulation of Regeneration-Associated Genes	PLOS ONE			English	Article							REPEAT PROTEIN 1A; SPINAL-CORD; NIGROSTRIATAL SYSTEM; NEUROTROPHIC FACTOR; AXOTOMIZED NEURONS; AXON REGENERATION; INDUCIBLE GENE; GROWTH; EXPRESSION; ACTIVATION	We hypothesized that the study of gene expression at 1, 2, 4, 6 and 16 weeks in the substantia nigra (SN) after intrastriatal 6-OHDA in the Sprague-Dawley rat (rattus norvegicus) would identify cellular responses during the degenerative process that could be axoprotective. Specifically, we hypothesized that genes expressed within the SN that followed a profile of being highly upregulated early after the lesion (during active axonal degeneration) and then progressively declined to baseline over 16 weeks as DA neurons died are indicative of potential protective responses to the striatal 6-OHDA insult. Utilizing a.-means cluster analysis strategy, we demonstrated that one such cluster followed this hypothesized expression pattern over time, and that this cluster contained several interrelated transcripts that are classified as regeneration-associated genes (RAGs) including Atf3, Sprr1a, Ecel1, Gadd45a, Gpnmb, Sox11, Mmp19, Srgap1, Rab15, Lifr, Trib3, Tgfb1, and Sema3c. All exemplar transcripts tested from this cluster (Sprr1a, Ecel1, Gadd45a, Atf3 and Sox11) were validated by qPCR and a smaller subset (Sprr1a, Gadd45a and Sox11) were shown to be exclusively localized to SN DA neurons using a dual label approach with RNAScope in situ hybridization and immunohistochemistry. Upregulation of RAGs is typically associated with the response to axonal injury in the peripheral nerves and was not previously reported as part of the axodegenerative process for DA neurons of the SN. Interestingly, as part of this cluster, other transcripts were identified based on their expression pattern but without a RAG provenance in the literature. These "RAG-like" transcripts need further characterization to determine if they possess similar functions to or interact with known RAG transcripts. Ultimately, it is hoped that some of the newly identified axodegeneration-reactive transcripts could be exploited as axoprotective therapies in PD and other neurodegenerative diseases.	[Kanaan, Nicholas M.; Collier, Timothy J.; Cole-Strauss, Allyson; Grabinski, Tessa; Mattingly, Zachary R.; Steece-Collier, Kathy; Sortwell, Caryl E.; Manfredsson, Fredric P.; Lipton, Jack W.] Michigan State Univ, Coll Human Med, Dept Translat Sci & Mol Med, Grand Rapids, MI 49503 USA; [Kanaan, Nicholas M.; Collier, Timothy J.; Cole-Strauss, Allyson; Steece-Collier, Kathy; Sortwell, Caryl E.; Lipton, Jack W.] Michigan State Univ, Morris K Udall Ctr Excellence Parkinsons Dis Res, Grand Rapids, MI USA; [Kanaan, Nicholas M.; Collier, Timothy J.; Steece-Collier, Kathy; Sortwell, Caryl E.; Lipton, Jack W.] Mercy Hlth St Marys, Hauenstein Neurosci Ctr, Grand Rapids, MI USA; [Winn, Mary E.] Van Andel Res Inst, Bioinformat & Biostat Core, Grand Rapids, MI USA	Michigan State University; Michigan State University College of Human Medicine; Michigan State University; Van Andel Institute	Lipton, JW (corresponding author), Michigan State Univ, Coll Human Med, Dept Translat Sci & Mol Med, Grand Rapids, MI 49503 USA.	jack.lipton@hc.msu.edu	Winn, Mary/AAN-6495-2021; Manfredsson, Fredric/GMI-5876-2022; Lipton, Jack/L-3631-2019; Kanaan, Nicholas M./J-3428-2016	Manfredsson, Fredric/0000-0001-5802-5487; Lipton, Jack/0000-0003-0991-8275; Kanaan, Nicholas M./0000-0002-4362-2593	National Institute of Neurological Disorders and Stroke (US) [P50 NS058830]; Office of the Vice President of Research Graduate Studies, Michigan State University; Saint Mary's Foundation (Doran Foundation), Mercy Health Saint Mary's, Grand Rapids, MI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS058830, R01NS082730] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (US); Office of the Vice President of Research Graduate Studies, Michigan State University; Saint Mary's Foundation (Doran Foundation), Mercy Health Saint Mary's, Grand Rapids, MI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institute of Neurological Disorders and Stroke (US), P50 NS058830 (to TJC, JWL, KSC, CES), the Office of the Vice President of Research Graduate Studies, Michigan State University (to JWL), and Saint Mary's Foundation (Doran Foundation), Mercy Health Saint Mary's, Grand Rapids, MI (to NMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara J, 2004, NEUROCHEM RES, V29, P1153, DOI 10.1023/B:NERE.0000023602.72354.82; Baleriola J, 2014, CELL, V158, P1159, DOI 10.1016/j.cell.2014.07.001; Befort K, 2003, EUR J NEUROSCI, V18, P911, DOI 10.1046/j.1460-9568.2003.02827.x; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Choi HJ, 2011, BRIT J PHARMACOL, V162, P175, DOI 10.1111/j.1476-5381.2010.01041.x; Davis JF, 2008, BEHAV NEUROSCI, V122, P1257, DOI 10.1037/a0013111; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Fernandes KA, 2013, EXP EYE RES, V112, P106, DOI 10.1016/j.exer.2013.04.021; Fudge NJ, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-15; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039586; Gombash SE, 2012, MOL THER, V20, P544, DOI 10.1038/mt.2011.216; Gombash SE, 2014, GENE THER; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Gonthier B, 2007, CEREB CORTEX, V17, P1712, DOI 10.1093/cercor/bhl082; Grabinski T, 2015, PLOS ONE IN PRESS; Henry B, 1998, EXP NEUROL, V151, P334, DOI 10.1006/exnr.1998.6819; Huebner EA, 2009, RESULTS PROBL CELL D, V48, P339, DOI 10.1007/400_2009_19; Jing XT, 2012, EXP NEUROL, V233, P221, DOI 10.1016/j.expneurol.2011.10.005; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Kiryu-Seo S, 2006, ANAT SCI INT, V81, P1, DOI 10.1111/j.1447-073X.2006.00136.x; Koprich JB, 2003, NEUROTOXICOL TERATOL, V25, P509, DOI 10.1016/S0892-0362(03)00091-6; Kordower JH, 2013, BRAIN, V136, P2419, DOI 10.1093/brain/awt192; Leibinger M, 2009, J NEUROSCI, V29, P14334, DOI 10.1523/JNEUROSCI.2770-09.2009; Li SX, 2003, J NEUROSCI, V23, P4219; Lin CR, 2011, J NEUROSCI RES, V89, P689, DOI 10.1002/jnr.22589; Ling ZD, 2004, NEUROSCIENCE, V124, P619, DOI 10.1016/j.neuroscience.2003.12.017; Ma Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057865; Marklund N, 2006, EXP NEUROL, V197, P70, DOI 10.1016/j.expneurol.2005.08.029; MENDEZ JS, 1975, J NEUROSURG, V42, P166, DOI 10.3171/jns.1975.42.2.0166; Moreno-Flores MT, 2003, J NEUROCHEM, V87, P879, DOI 10.1046/j.1471-4159.2003.02051.x; Nie X, 2006, CELL BIOL INT, V30, P295, DOI 10.1016/j.cellbi.2005.12.001; Nie X, 2014, CELL BIOCHEM BIOPHYS, V68, P163, DOI 10.1007/s12013-013-9683-8; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ojeda V, 2003, J NEUROSCI RES, V73, P686, DOI 10.1002/jnr.10705; Ord D, 2005, BIOCHEM BIOPH RES CO, V330, P210, DOI 10.1016/j.bbrc.2005.02.149; Perez SE, 2005, J NEUROSCI, V25, P10220, DOI 10.1523/JNEUROSCI.2773-05.2005; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Reiprich S, 2015, CELL TISSUE RES, V359, P111, DOI 10.1007/s00441-014-1909-6; SCHERER SS, 1993, GLIA, V8, P265, DOI 10.1002/glia.440080407; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Senbabaoglu Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06207; Spieles-Engemann AL, 2010, NEUROBIOL DIS, V39, P105, DOI 10.1016/j.nbd.2010.03.009; Spieles-Engemann AL, 2011, J PARKINSON DIS, V1, P123, DOI 10.3233/JPD-2011-11008; Starkey ML, 2009, J COMP NEUROL, V513, P51, DOI 10.1002/cne.21944; Steup A, 2000, MOL CELL NEUROSCI, V15, P141, DOI 10.1006/mcne.1999.0818; Tanabe K, 2003, J NEUROSCI, V23, P9675; Tanaka H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00573; Unschuld PG, 2006, MOL BIOL REP, V33, P13, DOI 10.1007/s11033-005-3961-5; Vu TQ, 2000, J NEURAL TRANSM, V107, P159, DOI 10.1007/s007020050014; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Zhang YY, 2013, J NEUROSCI, V33, P11655, DOI 10.1523/JNEUROSCI.0288-13.2013	53	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127768	10.1371/journal.pone.0127768	http://dx.doi.org/10.1371/journal.pone.0127768			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992874	Green Published, gold, Green Submitted			2022-12-26	WOS:000354921400135
J	Shimoshige, H; Kobayashi, H; Mizuki, T; Nagaoka, Y; Inoue, A; Maekawa, T				Shimoshige, Hirokazu; Kobayashi, Hideki; Mizuki, Toru; Nagaoka, Yutaka; Inoue, Akira; Maekawa, Toru			Effect of Polyethylene Glycol on the Formation of Magnetic Nanoparticles Synthesized by Magnetospirillum magnetotacticum MS-1	PLOS ONE			English	Article							OXYGEN-CONTROLLED FERMENTER; MAGNETOSOME FORMATION; BACTERIAL MAGNETOSOMES; GRYPHISWALDENSE MSR-1; FE3O4 NANOPARTICLES; DRUG CARRIERS; CELL BIOLOGY; IN-VIVO; GROWTH; PARTICLES	Magnetotactic bacteria (MTB) synthesize intracellular magnetic nanocrystals called magnetosomes, which are composed of either magnetite (Fe3O4) or greigite (Fe3S4) and covered with lipid membranes. The production of magnetosomes is achieved by the biomineralization process with strict control over the formation of magnetosome membrane vesicles, uptake and transport of iron ions, and synthesis of mature crystals. These magnetosomes have high potential for both biotechnological and nanotechnological applications, but it is still extremely difficult to grow MTB and produce a large amount of magnetosomes under the conventional cultural conditions. Here, we investigate as a first attempt the effect of polyethylene glycol (PEG) added to the culture medium on the increase in the yield of magnetosomes formed in Magnetospirillum magnetotacticum MS-1. We find that the yield of the formation of magnetosomes can be increased up to approximately 130 % by adding PEG200 to the culture medium. We also measure the magnetization of the magnetosomes and find that the magnetosomes possess soft ferromagnetic characteristics and the saturation mass magnetization is increased by 7 %.	[Shimoshige, Hirokazu; Mizuki, Toru; Nagaoka, Yutaka; Inoue, Akira; Maekawa, Toru] Toyo Univ, Bionano Elect Res Ctr, Kawagoe, Saitama, Japan; [Kobayashi, Hideki] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Mizuki, Toru; Nagaoka, Yutaka; Inoue, Akira; Maekawa, Toru] Toyo Univ, Grad Sch Interdisciplinary New Sci, Kawagoe, Saitama, Japan	Toyo University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Toyo University	Maekawa, T (corresponding author), Toyo Univ, Bionano Elect Res Ctr, Kawagoe, Saitama, Japan.	maekawa@toyo.jp		Mizuki, Toru/0000-0003-2744-881X; Shimoshige, Hirokazu/0000-0002-0583-6160	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [S1101017]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant for the Program for the Strategic Research Foundation at Private Universities S1101017 organized by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; BLAKEMORE RP, 1979, J BACTERIOL, V140, P720, DOI 10.1128/JB.140.2.720-729.1979; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Grunberg K, 2004, APPL ENVIRON MICROB, V70, P1040, DOI 10.1128/AEM.70.2.1040-1050.2004; Halverson LJ, 2000, APPL ENVIRON MICROB, V66, P2414, DOI 10.1128/AEM.66.6.2414-2421.2000; Heyen U, 2003, APPL MICROBIOL BIOT, V61, P536, DOI 10.1007/s00253-002-1219-x; Hui C, 2008, J PHYS CHEM C, V112, P11336, DOI 10.1021/jp801632p; Jogler C, 2009, ANNU REV MICROBIOL, V63, P501, DOI 10.1146/annurev.micro.62.081307.162908; Li AH, 2010, J SEP SCI, V33, P3437, DOI 10.1002/jssc.201000441; MANN S, 1984, NATURE, V310, P405, DOI 10.1038/310405a0; Matsunaga T, 1996, BIOTECHNOL TECH, V10, P495; MATSUNAGA T, 1987, APPL MICROBIOL BIOT, V26, P328; Moisescu C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00049; NAKAMURA C, 1995, J BIOL CHEM, V270, P28392; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Nomura T, 2012, P NATL ACAD SCI USA, V109, P8770, DOI 10.1073/pnas.1200051109; Pan YX, 2004, CHINESE SCI BULL, V49, P2563, DOI 10.1360/982004-153; Schuler D, 2008, FEMS MICROBIOL REV, V32, P654, DOI 10.1111/j.1574-6976.2008.00116.x; Staniland S, 2008, NAT NANOTECHNOL, V3, P158, DOI 10.1038/nnano.2008.35; Sun JB, 2008, BIOTECHNOL BIOENG, V101, P1313, DOI 10.1002/bit.22011; Sun JB, 2008, APPL MICROBIOL BIOT, V79, P389, DOI 10.1007/s00253-008-1453-y; Sun JB, 2007, CANCER LETT, V258, P109, DOI 10.1016/j.canlet.2007.08.018; Tanaka M, 2010, APPL ENVIRON MICROB, V76, P5526, DOI 10.1128/AEM.00589-10; Veronese FM, 2008, BIODRUGS, V22, P315, DOI 10.2165/00063030-200822050-00004; Wacker R, 2007, BIOCHEM BIOPH RES CO, V357, P391, DOI 10.1016/j.bbrc.2007.03.156; Xiang L, 2007, J GENE MED, V9, P679, DOI 10.1002/jgm.1068; Yang J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00210; Yang TZ, 2005, J PHYS CHEM B, V109, P23233, DOI 10.1021/jp054291f; Yoshino T, 2008, BIOTECHNOL BIOENG, V101, P470, DOI 10.1002/bit.21912; Zhang Y, 2011, APPL ENVIRON MICROB, V77, P5851, DOI 10.1128/AEM.05962-11	31	5	5	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127481	10.1371/journal.pone.0127481	http://dx.doi.org/10.1371/journal.pone.0127481			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993286	Green Submitted, Green Published, gold			2022-12-26	WOS:000354921400123
J	Sommer, U; Paul, C; Moustaka-Gouni, M				Sommer, Ulrich; Paul, Carolin; Moustaka-Gouni, Maria			Warming and Ocean Acidification Effects on Phytoplankton-From Species Shifts to Size Shifts within Species in a Mesocosm Experiment	PLOS ONE			English	Article							CLIMATE-CHANGE; CARBON ACQUISITION; CO2 CONCENTRATION; MARINE; IMPACT; BLOOM; MECHANISMS; SUCCESSION; SYSTEM; WINTER	While the isolated responses of marine phytoplankton to climate warming and to ocean acidification have been studied intensively, studies on the combined effect of both aspects of Global Change are still scarce. Therefore, we performed a mesocosm experiment with a factorial combination of temperature (9 and 15 degrees C) and pCO(2) (means: 439 ppm and 1040 ppm) with a natural autumn plankton community from the western Baltic Sea. Temporal trajectories of total biomass and of the biomass of the most important higher taxa followed similar patterns in all treatments. When averaging over the entire time course, phytoplankton biomass decreased with warming and increased with CO2 under warm conditions. The contribution of the two dominant higher phytoplankton taxa (diatoms and cryptophytes) and of the 4 most important species (3 diatoms, 1 cryptophyte) did not respond to the experimental treatments. Taxonomic composition of phytoplankton showed only responses at the level of subdominant and rare species. Phytoplankton cell sizes increased with CO2 addition and decreased with warming. Both effects were stronger for larger species. Warming effects were stronger than CO2 effects and tended to counteract each other. Phytoplankton communities without calcifying species and exposed to short-term variation of CO2 seem to be rather resistant to ocean acidification.	[Sommer, Ulrich; Paul, Carolin] GEOMAR Helmholtz Ctr Ocean Res Kiel, Marine Ecol, Kiel, Germany; [Moustaka-Gouni, Maria] Aristotle Univ Thessaloniki, Sch Biol, GR-54006 Thessaloniki, Greece	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Aristotle University of Thessaloniki	Sommer, U (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Marine Ecol, Kiel, Germany.	usommer@geomar.de	/AAL-3738-2021	Moustaka-Gouni, Maria/0000-0002-0845-1928	Bundesministerium fur Bildung und Forschung (Federal Ministry of Eductation and Pesearch) through the compound project BIOACID [03F0655A]	Bundesministerium fur Bildung und Forschung (Federal Ministry of Eductation and Pesearch) through the compound project BIOACID	Bundesministerium fur Bildung und Forschung (Federal Ministry of Eductation and Pesearch, www.bmbf.de) through the compound project BIOACID (www.bioacid.de), grant number 03F0655A.	Atkinson D, 2003, P ROY SOC B-BIOL SCI, V270, P2605, DOI 10.1098/rspb.2003.2538; Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Berry L, 2002, FUNCT PLANT BIOL, V29, P289, DOI 10.1071/PP01218; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; BROCK TD, 1981, ECOL MODEL, V14, P1, DOI 10.1016/0304-3800(81)90011-9; Burkhardt S, 2001, LIMNOL OCEANOGR, V46, P1378, DOI 10.4319/lo.2001.46.6.1378; Christaki U, 2014, MICROB ECOL, V67, P13, DOI 10.1007/s00248-013-0290-4; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Eggers SL, 2014, GLOBAL CHANGE BIOL, V20, P713, DOI 10.1111/gcb.12421; Engel A, 2005, LIMNOL OCEANOGR, V50, P493, DOI 10.4319/lo.2005.50.2.0493; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Garzke J., 2014, THESIS U KIEL GERMAN; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hofmann M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034035; Intergovernmental Panel on Climate Change, 2013, CLIM CHANG 2013 PHYS; Joint I, 2011, ISME J, V5, P1, DOI 10.1038/ismej.2010.79; Kim JM, 2006, LIMNOL OCEANOGR, V51, P1629, DOI 10.4319/lo.2006.51.4.1629; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Lewandowska AM, 2014, ECOL LETT, V17, P614, DOI 10.1111/ele.12265; Lindh MV, 2013, ENV MICROBIOL REP, V5, P252, DOI 10.1111/1758-2229.12009; O'Connor MI, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000178; O'Connor MI, 2009, ECOLOGY, V90, P388, DOI 10.1890/08-0034.1; Peter KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071528; Peter KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049632; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Riebesell U., 2000, NATURE, V407, P634, DOI DOI 10.1038/35030078; Rossoll D, 2013, MAR ECOL PROG SER, V486, P37, DOI 10.3354/meps10352; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Rost B, 2003, LIMNOL OCEANOGR, V48, P55, DOI 10.4319/lo.2003.48.1.0055; Rost B, 2008, MAR ECOL PROG SER, V373, P227, DOI 10.3354/meps07776; Sommer U, 2008, GLOBAL CHANGE BIOL, V14, P1199, DOI 10.1111/j.1365-2486.2008.01571.x; Sommer U, 2007, OECOLOGIA, V150, P655, DOI 10.1007/s00442-006-0539-4; Sommer U, 2012, MAR BIOL, V159, P2479, DOI [10.1007/s00227-012-2085-4, 10.1007/s00227-012-1897-6]; Sommer U, 2011, GLOBAL CHANGE BIOL, V17, P154, DOI 10.1111/j.1365-2486.2010.02182.x; Taucher J, 2012, BIOGEOSCIENCES, V9, P3531, DOI 10.5194/bg-9-3531-2012; Thoms S, 2001, J THEOR BIOL, V208, P295, DOI 10.1006/jtbi.2000.2219; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Tortell PD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032583; Utermohl H, 1958, MITTEILUNGEN INT VER, V9, P263; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yoshimura T, 2010, J EXP MAR BIOL ECOL, V395, P191, DOI 10.1016/j.jembe.2010.09.001; Yvon-Durocher G, 2011, GLOBAL CHANGE BIOL, V17, P1681, DOI 10.1111/j.1365-2486.2010.02321.x	47	78	78	9	158	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125239	10.1371/journal.pone.0125239	http://dx.doi.org/10.1371/journal.pone.0125239			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993440	gold, Green Published, Green Accepted			2022-12-26	WOS:000354921400029
J	Esquenazi, D; Alvim, IMP; Pinheiro, RO; de Oliveira, EB; Moreira, LD; Sarno, EN; Nery, JAD				Esquenazi, Danuza; Peixoto Alvim, Iris Maria; Pinheiro, Roberta Olmo; de Oliveira, Eliane Barbosa; Moreira, Lilian de Oliveira; Sarno, Euzenir Nunes; da Costa Nery, Jose Augusto			Correlation between Central Memory T Cell Expression and Proinflammatory Cytokine Production with Clinical Presentation of Multibacillary Leprosy Relapse	PLOS ONE			English	Article							MULTIPLE-DRUG THERAPY; FIXED DURATION; SUBSETS; IL-10; MYCOBACTERIA; TUBERCULOSIS; GENERATION; INFECTION; MIGRATION; PATTERNS	Background Despite the efficacy of multidrug therapy, surviving Mycobacterium leprae causes relapse in some leprosy patients, and these patients present signs and symptoms of disease after healing. This study focused on the cellular immune response in relapsed multibacillary patients but also included non-relapsed multibacillary cured individuals, newly diagnosed and untreated multibacillary patients, paucibacillary patients just before the beginning of treatment, and voluntary healthy individuals for comparative analysis. Methodology/Principal Findings Inhibition of CD86 expression in the blood-derived monocytes and dendritic cells of relapsed multibacillary patients, either ex vivo or after M. leprae antigen stimulation was observed by flow cytometry. In addition, no significant changes in Interferon-gamma (IFN-g) expression were observed in 5-day culture supernatants of relapsed patients in response to M. leprae, neither before nor after treatment, as measured by ELISA. However, these patients demonstrated a significant increase in central memory CD4+ and CD8+ M. lepraespecific T cells, as assessed by multiparametric flow cytometry. The increase in frequency of central memory T cells in relapsed patients strongly correlated with the bacillary index and the number of skin lesions observed in these subjects. Moreover, cytokine multiplex analysis demonstrated significant antigen-specific production of Interlukin-1beta (IL-1b), IL-6, and Tumour Necrosis Factor (TNF) in the relapsed group with extremely low IL-10 production, which resulted in a high TNF/IL-10 ratio. Conclusions/Significance Inhibition of CD86 expression may function to reduce effector T cell responses against the M. leprae antigen. Furthermore, the predominance of central memory T cells in association with the high TNF/IL-10 ratio and no observed IFN-g production may be related to the pathogenesis of relapse in multibacillary leprosy. Therefore, our findings may be a direct result of the clinical presentation, including a number of skin lesions and bacterial load, of relapsed patients. To our knowledge, this is the first study correlating immune response parameters with the clinical presentation of relapsed multibacillary patients.	[Esquenazi, Danuza; Pinheiro, Roberta Olmo; de Oliveira, Eliane Barbosa; Sarno, Euzenir Nunes; da Costa Nery, Jose Augusto] Fiocruz MS, Inst Oswaldo Cruz, Leprosy Lab, BR-21045900 Rio De Janeiro, Brazil; [Peixoto Alvim, Iris Maria; Moreira, Lilian de Oliveira] Fiocruz MS, Inst Oswaldo Cruz, Lab Cellular Microbiol, BR-21045900 Rio De Janeiro, Brazil; [Esquenazi, Danuza] State Univ Rio de Janeiro UERJ, Sch Med Sci, Dept Pathol & Labs, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro	Esquenazi, D (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Leprosy Lab, BR-21045900 Rio De Janeiro, Brazil.	danuza@ioc.fiocruz.br	Pinheiro, R O/A-2525-2013	Pinheiro, R O/0000-0001-8471-4227; Nunes Sarno, Euzenir/0000-0003-0129-2159	FAPERJ [E-26-111799/2012]; FIOCRUZ/PAPES VI [407838/2012-0]	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FIOCRUZ/PAPES VI	This work was supported by the FAPERJ (from portuguese: Fundacaoo Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, grant number E-26-111799/2012) and FIOCRUZ/PAPES VI (from portuguese: Fundaca Oswaldo Cruz/Programa Estrategico de Apoio a Pesquisa em Saude, grant number 407838/2012-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrewala JN, 1998, CLIN EXP IMMUNOL, V111, P56; Ali M K Showkath, 2005, Indian J Lepr, V77, P105; [Anonymous], 2014, Wkly Epidemiol Rec, V89, P389; Balagon MF, 2009, AM J TROP MED HYG, V81, P895, DOI 10.4269/ajtmh.2009.09-0189; Trindade MAB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000921; Bobosha K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002773; Dagur PK, 2010, MOL IMMUNOL, V47, P943, DOI 10.1016/j.molimm.2009.11.009; de Oliveira AL, 2013, IMMUNOLOGY, V140, P47, DOI 10.1111/imm.12108; ESQUENAZI DA, 1990, LEPROSY REV, V61, P251; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebre S, 2000, LEPROSY REV, V71, P325; Girdhar BK, 2000, LEPROSY REV, V71, P144; Hagge DA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003149; Joshi B, 2001, INT J LEPROSY, V69, P195; Kaimal S, 2009, INDIAN J DERMATOL VE, V75, P126, DOI 10.4103/0378-6323.48656; Kumar A, 2003, Acta Leprol, V12, P123; Kumar A, 2013, INDIAN J MED RES, V138, P536; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; Lima MCBS, 2000, SCAND J IMMUNOL, V51, P419, DOI 10.1046/j.1365-3083.2000.00703.x; Makino M, 2006, EUR J IMMUNOL, V36, P1443, DOI 10.1002/eji.200535727; Mitra DK, 1999, INT IMMUNOL, V11, P1801, DOI 10.1093/intimm/11.11.1801; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Nogueira RS, 2014, CLIN EXP IMMUNOL, V177, P679, DOI 10.1111/cei.12364; Pereira AC, 2009, GENES IMMUN, V10, P174, DOI 10.1038/gene.2008.97; Pereira-Carvalho R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081529; Pinheiro RO, 2013, CLIN EXP IMMUNOL, V171, P210, DOI 10.1111/cei.12007; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Rocha AD, 2012, J CLIN MICROBIOL, V50, P1912, DOI 10.1128/JCM.06561-11; Rodrigues LC, 2011, LANCET INFECT DIS, V11, P464, DOI 10.1016/S1473-3099(11)70006-8; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Santos D O, 2001, Nihon Hansenbyo Gakkai Zasshi, V70, P15; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Shen JP, 2006, LEPROSY REV, V77, P219; Shetty VP, 2005, LEPROSY REV, V76, P241; SIELING PA, 1993, J IMMUNOL, V150, P5501; Singh P, 2011, FUTURE MICROBIOL, V6, P57, DOI 10.2217/FMB.10.153; WATERS MFR, 1990, LEPROSY REV, V61, P347	38	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127416	10.1371/journal.pone.0127416	http://dx.doi.org/10.1371/journal.pone.0127416			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992795	Green Published, Green Submitted, gold			2022-12-26	WOS:000354918600061
J	Gonzalez-Cabaleiro, R; Lema, JM; Rodriguez, J				Gonzalez-Cabaleiro, Rebeca; Lema, Juan M.; Rodriguez, Jorge			Metabolic Energy-Based Modelling Explains Product Yielding in Anaerobic Mixed Culture Fermentations	PLOS ONE			English	Article							HYDROGEN-PRODUCTION; ESCHERICHIA-COLI; MICROBIAL-METABOLISM; ORGANIC-ACIDS; BUTYRYL-COA; ELECTRON; PH; GLUCOSE; THERMODYNAMICS; KINETICS	The fermentation of glucose using microbial mixed cultures is of great interest given its potential to convert wastes into valuable products at low cost, however, the difficulties associated with the control of the process still pose important challenges for its industrial implementation. A deeper understanding of the fermentation process involving metabolic and biochemical principles is very necessary to overcome these difficulties. In this work a novel metabolic energy based model is presented that accurately predicts for the first time the experimentally observed changes in product spectrum with pH. The model predicts the observed shift towards formate production at high pH, accompanied with ethanol and acetate production. Acetate (accompanied with a more reduced product) and butyrate are predicted main products at low pH. The production of propionate between pH 6 and 8 is also predicted. These results are mechanistically explained for the first time considering the impact that variable proton motive potential and active transport energy costs have in terms of energy harvest over different products yielding. The model results, in line with numerous reported experiments, validate the mechanistic and bioenergetics hypotheses that fermentative mixed cultures products yielding appears to be controlled by the principle of maximum energy harvest and the necessity of balancing the redox equivalents in absence of external electron acceptors.	[Gonzalez-Cabaleiro, Rebeca; Lema, Juan M.] Univ Santiago de Compostela, Inst Technol, Dept Chem Engn, Santiago De Compostela 15782, Galicia, Spain; [Rodriguez, Jorge] Masdar Inst Sci & Technol, Dept Chem & Environm Engn CEE, Inst Ctr Water & Environm iWater, Abu Dhabi, U Arab Emirates	Universidade de Santiago de Compostela; Khalifa University of Science & Technology	Rodriguez, J (corresponding author), Masdar Inst Sci & Technol, Dept Chem & Environm Engn CEE, Inst Ctr Water & Environm iWater, POB 54224, Abu Dhabi, U Arab Emirates.	jrodriguez@masdar.ac.ae	Cabaleiro, Rebeca Gonzalez/AAA-6733-2020; R., Jorge Rodríguez/N-5916-2019; R., Jorge Rodríguez/A-9879-2008; Lema, Juan M./F-6718-2016	Cabaleiro, Rebeca Gonzalez/0000-0002-4000-5928; R., Jorge Rodríguez/0000-0002-5936-9676; R., Jorge Rodríguez/0000-0002-5936-9676; Lema, Juan M./0000-0001-5616-2584	Xunta de Galicia [Plan I2C 2011/2015]; Masdar Institute of Science and Technology (Abu Dhabi) [11WAMA1]; Spanish Ministry of Education, COMDIGEST Project [CTM2010-17196]; FEDER [GRC 2013-032]	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Masdar Institute of Science and Technology (Abu Dhabi); Spanish Ministry of Education, COMDIGEST Project; FEDER(European Commission)	This work was supported by Xunta de Galicia under a predoctoral grant (Plan I2C 2011/2015) to RG-C; The Masdar Institute of Science and Technology (Abu Dhabi) under the joint MI-MIT joint research programme (11WAMA1); Spanish Ministry of Education, COMDIGEST Project (CTM2010-17196). The authors from University of Santiago de Compostela are part of the Galician Competitive Research Group GRC 2013-032, program co-funded by FEDER.	Aceves-Lara CA, 2008, WATER RES, V42, P2539, DOI 10.1016/j.watres.2008.02.018; Agler MT, 2011, TRENDS BIOTECHNOL, V29, P70, DOI 10.1016/j.tibtech.2010.11.006; Angenent LT, 2008, BIOENERGY, P179; Angenent LT, 2004, TRENDS BIOTECHNOL, V22, P477, DOI 10.1016/j.tibtech.2004.07.001; Bar-Even A, 2012, BBA-BIOENERGETICS, V1817, P1646, DOI 10.1016/j.bbabio.2012.05.002; Bar-Even A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002166; Batstone DJ, 2006, WATER SCI TECHNOL, V54, P1, DOI 10.2166/wst.2006.520; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BENNETT GN, 1995, FEMS MICROBIOL REV, V17, P241, DOI 10.1016/0168-6445(95)00011-Z; BRILL WJ, 1965, FED PROC, V24, P233; BRINK BT, 1985, J BACTERIOL, V162, P383, DOI 10.1128/JB.162.1.383-390.1985; Canelas AB, 2008, BIOTECHNOL BIOENG, V100, P734, DOI 10.1002/bit.21813; Chowdhury NP, 2014, J BIOL CHEM, V289, P5145, DOI 10.1074/jbc.M113.521013; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; DiezGonzalez F, 1997, MICROBIOL-UK, V143, P1175, DOI 10.1099/00221287-143-4-1175; Eggeman T, 2005, APPL BIOCHEM BIOTECH, V121, P605; Elston T, 1998, NATURE, V391, P510, DOI 10.1038/35185; Fang HHP, 2002, BIORESOURCE TECHNOL, V82, P87, DOI 10.1016/S0960-8524(01)00110-9; Flamholz A, 2012, NUCLEIC ACIDS RES, V40, pD770, DOI 10.1093/nar/gkr874; Gadhamshetty V, 2010, INT J HYDROGEN ENERG, V35, P479, DOI 10.1016/j.ijhydene.2009.11.007; Gonzalez-Cabaleiro R, 2013, ENERG ENVIRON SCI, V6, P3780, DOI 10.1039/c3ee42754d; Heijnen JJ, 2010, BIOSEPARATION CELL T, P1; Hoehler TM, 2013, NAT REV MICROBIOL, V11, P83, DOI 10.1038/nrmicro2939; Hoelzle RD, 2014, BIOTECHNOL BIOENG, V111, P2139, DOI 10.1002/bit.25321; Horiuchi JI, 2002, BIORESOURCE TECHNOL, V82, P209, DOI 10.1016/S0960-8524(01)00195-X; Huang HY, 2012, J BACTERIOL, V194, P3689, DOI 10.1128/JB.00385-12; Jackson BE, 2002, NATURE, V415, P454, DOI 10.1038/415454a; Jin Q, 2007, AM J SCI, V307, P643, DOI 10.2475/04.2007.01; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kleerebezem R, 2008, WATER SCI TECHNOL, V57, P493, DOI 10.2166/wst.2008.094; Kleerebezem R, 2006, WATER SCI TECHNOL, V54, P51, DOI 10.2166/wst.2006.525; Kleerebezem R, 2000, BIOTECHNOL BIOENG, V67, P529, DOI 10.1002/(SICI)1097-0290(20000305)67:5<529::AID-BIT4>3.0.CO;2-Q; Kleerebezem R, 2007, CURR OPIN BIOTECH, V18, P207, DOI 10.1016/j.copbio.2007.05.001; Kleerebezem R, 2010, CRIT REV ENV SCI TEC, V40, P1, DOI 10.1080/10643380802000974; Kohn R. A., 2000, Modelling nutrient utilization in farm animals, P11, DOI 10.1079/9780851994499.0011; KONINGS WN, 1995, ARCH MICROBIOL, V164, P235, DOI 10.1007/s002030050260; LaRowe DE, 2012, GEOCHIM COSMOCHIM AC, V90, P96, DOI 10.1016/j.gca.2012.05.011; Lee HS, 2009, BIOTECHNOL BIOENG, V104, P687, DOI 10.1002/bit.22442; Lengeler JW, 1999, BIOL PROKARIOTES; MCCARTY PL, 1991, WATER SCI TECHNOL, V24, P17, DOI 10.2166/wst.1991.0216; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; MOSEY FE, 1983, WATER SCI TECHNOL, V15, P209, DOI 10.2166/wst.1983.0168; Noor E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003483; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; OTTO R, 1980, P NATL ACAD SCI-BIOL, V77, P5502, DOI 10.1073/pnas.77.9.5502; PAPOUTSAKIS ET, 1985, BIOTECHNOL BIOENG, V27, P67, DOI 10.1002/bit.260270109; Penumathsa BKV, 2008, WATER RES, V42, P4379, DOI 10.1016/j.watres.2008.07.030; PIRT SJ, 1965, PROC R SOC SER B-BIO, V163, P224, DOI 10.1098/rspb.1965.0069; Reis MAM, 2003, BIOPROC BIOSYST ENG, V25, P377, DOI 10.1007/s00449-003-0322-4; Rodriguez J, 2006, BIOTECHNOL BIOENG, V93, P592, DOI 10.1002/bit.20765; Rodriguez J, 2009, WATER SCI TECHNOL, V60, P1669, DOI 10.2166/wst.2009.224; Rodriguez J, 2008, TRENDS BIOTECHNOL, V26, P366, DOI 10.1016/j.tibtech.2008.04.003; RUSSELL JB, 1995, MICROBIOL REV, V59, P48, DOI 10.1128/MMBR.59.1.48-62.1995; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; Seedorf H, 2008, P NATL ACAD SCI USA, V105, P2128, DOI 10.1073/pnas.0711093105; Sieuwerts S, 2008, APPL ENVIRON MICROB, V74, P4997, DOI 10.1128/AEM.00113-08; Singhania RR, 2013, BIORESOURCE TECHNOL, V145, P166, DOI 10.1016/j.biortech.2012.12.137; SMITH DP, 1989, BIOTECHNOL BIOENG, V34, P885, DOI 10.1002/bit.260340702; STAMS AJM, 1994, ANTON LEEUW INT J G, V66, P271, DOI 10.1007/BF00871644; Temudo MF, 2008, APPL MICROBIOL BIOT, V80, P1121, DOI 10.1007/s00253-008-1669-x; Temudo MF, 2007, BIOTECHNOL BIOENG, V98, P69, DOI 10.1002/bit.21412; TEMUDO MF, 2008, DIRECTING PRODUCT FO; THAUER RK, 1977, BACTERIOL REV, V41, P809; TIJHUIS L, 1993, BIOTECHNOL BIOENG, V42, P509, DOI 10.1002/bit.260420415; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; Vallino JJ, 2003, BIOL BULL-US, V204, P174, DOI 10.2307/1543554; von Stockar U, 2006, J BIOTECHNOL, V121, P517, DOI 10.1016/j.jbiotec.2005.08.012; White D., 2007, PHYSL BIOCH PROKARYO; Wu L, 2004, EUR J BIOCHEM, V271, P3348, DOI 10.1111/j.0014-2956.2004.04269.x; Yang YT, 2001, METAB ENG, V3, P115, DOI 10.1006/mben.2000.0166; Zhang F, 2013, BIOTECHNOL BIOENG, V110, P1884, DOI 10.1002/bit.24855; ZOETEMEYER RJ, 1982, WATER RES, V16, P303, DOI 10.1016/0043-1354(82)90190-7	74	47	48	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0126739	10.1371/journal.pone.0126739	http://dx.doi.org/10.1371/journal.pone.0126739			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992959	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000354917300050
J	Leyrer, M; Linkenauger, SA; Bulthoff, HH; Mohler, BJ				Leyrer, Markus; Linkenauger, Sally A.; Buelthoff, Heinrich H.; Mohler, Betty J.			The Importance of Postural Cues for Determining Eye Height in Immersive Virtual Reality	PLOS ONE			English	Article							DISTANCE; ACCOMMODATION; PERTURBATION; AFFORDANCES; VISION; SCALE	In human perception, the ability to determine eye height is essential, because eye height is used to scale heights of objects, velocities, affordances and distances, all of which allow for successful environmental interaction. It is well understood that eye height is fundamental to determine many of these percepts. Yet, how eye height itself is provided is still largely unknown. While the information potentially specifying eye height in the real world is naturally coincident in an environment with a regular ground surface, these sources of information can be easily divergent in similar and common virtual reality scenarios. Thus, we conducted virtual reality experiments where we manipulated the virtual eye height in a distance perception task to investigate how eye height might be determined in such a scenario. We found that humans rely more on their postural cues for determining their eye height if there is a conflict between visual and postural information and little opportunity for perceptual-motor calibration is provided. This is demonstrated by the predictable variations in their distance estimates. Our results suggest that the eye height in such circumstances is informed by postural cues when estimating egocentric distances in virtual reality and consequently, does not depend on an internalized value for eye height.	[Leyrer, Markus; Buelthoff, Heinrich H.; Mohler, Betty J.] Max Planck Inst Biol Cybernet, Tbingen, Germany; [Linkenauger, Sally A.] Univ Lancaster, Dept Psychol, Lancaster, England; [Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Max Planck Society; Lancaster University; Korea University	Leyrer, M (corresponding author), Max Planck Inst Biol Cybernet, Tbingen, Germany.	Markus.Leyrer@tuebingen.mpg.de; Betty.Mohler@tuebingen.mpg.de	Bülthoff, Heinrich H/J-6579-2012; Bülthoff, Heinrich/AAC-8818-2019	Bülthoff, Heinrich H/0000-0003-2568-0607; Linkenauger, Sally/0000-0002-6056-0187	EC FP7 project VR-HYPERSPACE [AAT-285681]; Max Planck Society; Brain Korea 21 PLUS Program through the National Research Foundation of Korea - Ministry of Education	EC FP7 project VR-HYPERSPACE; Max Planck Society(Max Planck Society); Brain Korea 21 PLUS Program through the National Research Foundation of Korea - Ministry of Education	This research was supported in part by the EC FP7 project VR-HYPERSPACE (AAT-285681), by the Max Planck Society, and by the Brain Korea 21 PLUS Program through the National Research Foundation of Korea funded by the Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingham GP, 2001, J EXP PSYCHOL HUMAN, V27, P1314, DOI 10.1037//0096-1523.27.6.1314; Campos JL, 2012, EXP BRAIN RES, V218, P551, DOI 10.1007/s00221-012-3048-1; Campos JL, 2010, EUR J NEUROSCI, V31, P1889, DOI 10.1111/j.1460-9568.2010.07212.x; Coats RO, 2014, J EXP PSYCHOL HUMAN, V40, P328, DOI 10.1037/a0033802; D'Cruz M, 2014, 2014 IEEE VIRTUAL REALITY (VR), P167, DOI 10.1109/VR.2014.6802104; Dixon MW, 2000, J EXP PSYCHOL HUMAN, V26, P582, DOI 10.1037/0096-1523.26.2.582; Gibson JJ, 1979, ECOLOGICAL APPROACH; Glennerster A, 2006, CURR BIOL, V16, P428, DOI 10.1016/j.cub.2006.01.019; Hoffman DM, 2008, J VISION, V8, DOI 10.1167/8.3.33; LEE DN, 1980, PHILOS T R SOC B, V290, P169, DOI 10.1098/rstb.1980.0089; Leyrer Markus, 2011, P ACM SIGGRAPH S APP, P67, DOI [DOI 10.1145/2077451.2077464, DOI 10.1145/2077451]; Loomis JM, 2003, VIRTUAL AND ADAPTIVE ENVIRONMENTS: APPLICATIONS, IMPLICATIONS, AND HUMAN PERFORMANCE ISSUES, P21; MARK LS, 1987, J EXP PSYCHOL HUMAN, V13, P361, DOI 10.1037/0096-1523.13.3.361; Mittelstaedt H, 1998, NEUROSCI BIOBEHAV R, V22, P473, DOI 10.1016/S0149-7634(97)00032-8; Mohler BJ, 2007, THESIS U UTAH; Nesti A, 2014, EXP BRAIN RES, V232, P303, DOI 10.1007/s00221-013-3741-8; Ooi TL, 2001, NATURE, V414, P197, DOI 10.1038/35102562; Pan JS, 2014, J EXP PSYCHOL HUMAN, V40, P404, DOI 10.1037/a0033795; Proffitt DR, 2013, ACTION SCIENCE: FOUNDATIONS OF AN EMERGING DISCIPLINE, P171; Pylyshyn Z, 1999, BEHAV BRAIN SCI, V22, P341, DOI 10.1017/S0140525X99002022; Richardson AR, 2007, HUM FACTORS, V49, P507, DOI 10.1518/001872007X200139; Sedgwick H. A., 1986, HDB PERCEPTION HUMAN, V1; Sedgwick HA, 1973, VISIBLE HORIZON POTE, P1301; Sinai MJ, 1998, NATURE, V395, P497, DOI 10.1038/26747; Waller D, 2004, PSYCHON B REV, V11, P157, DOI 10.3758/BF03206476; Waller D, 2008, J EXP PSYCHOL-APPL, V14, P61, DOI 10.1037/1076-898X.14.1.61; WARREN WH, 1987, J EXP PSYCHOL HUMAN, V13, P371, DOI 10.1037/0096-1523.13.3.371; Wraga M, 1999, J EXP PSYCHOL HUMAN, V25, P518, DOI 10.1037/0096-1523.25.2.518; Wraga M, 1999, PERCEPT PSYCHOPHYS, V61, P490, DOI 10.3758/BF03211968; Wu B, 2004, NATURE, V428, P73, DOI 10.1038/nature02350	30	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127000	10.1371/journal.pone.0127000	http://dx.doi.org/10.1371/journal.pone.0127000			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7BG	25993274	Green Submitted, gold, Green Published			2022-12-26	WOS:000354917300076
J	Probst, AJ; Weinmaier, T; DeSantis, TZ; Domingo, JWS; Ashbolt, N				Probst, Alexander J.; Weinmaier, Thomas; DeSantis, Todd Z.; Domingo, Jorge W. Santo; Ashbolt, Nicholas			New Perspectives on Microbial Community Distortion after Whole-Genome Amplification	PLOS ONE			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; ESCHERICHIA-COLI O157-H7; DIVERSITY; METAGENOMICS; ENVIRONMENTS; SEDIMENT; OUTBREAK; BACTERIA; SEQUENCE; AQUIFER	Whole-genome amplification (WGA) has become an important tool to explore the genomic information of microorganisms in an environmental sample with limited biomass, however potential selective biases during the amplification processes are poorly understood. Here, we describe the effects of WGA on 31 different microbial communities from five biotopes that also included low-biomass samples from drinking water and groundwater. Our findings provide evidence that microbiome segregation by biotope was possible despite WGA treatment. Nevertheless, samples from different biotopes revealed different levels of distortion, with genomic GC content significantly correlated with WGA perturbation. Certain phylogenetic clades revealed a homogenous trend across various sample types, for instance Alpha- and Betaproteobacteria showed a decrease in their abundance after WGA treatment. On the other hand, Enterobacteriaceae, an important biomarker group for fecal contamination in groundwater and drinking water, were strongly affected by WGA treatment without a predictable pattern. These novel results describe the impact of WGA on low-biomass samples and may highlight issues to be aware of when designing future metagenomic studies that necessitate preceding WGA treatment.	[Probst, Alexander J.; Weinmaier, Thomas; DeSantis, Todd Z.] Second Genome Inc, Dept Bioinformat, San Francisco, CA USA; [Domingo, Jorge W. Santo; Ashbolt, Nicholas] US EPA, Cincinnati, OH 45268 USA	United States Environmental Protection Agency	Domingo, JWS (corresponding author), US EPA, Cincinnati, OH 45268 USA.	Santodomingo.Jorge@epa.gov; Ashbolt@ualberta.ca	Probst, Alexander J/K-2813-2016; Ashbolt, Nicholas/H-4004-2014; Weinmaier, Thomas/K-5780-2013	Ashbolt, Nicholas/0000-0002-3853-0096; Weinmaier, Thomas/0000-0002-9552-3220; Probst, Alexander/0000-0002-9392-6544	US EPA Carbon Sequestration Program; Alberta Innovates [201300490] Funding Source: researchfish	US EPA Carbon Sequestration Program; Alberta Innovates	US EPA Carbon Sequestration Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulencia CB, 2006, APPL ENVIRON MICROB, V72, P3291, DOI 10.1128/AEM.72.5.3291-3301.2006; Akama T, 2013, PATHOGENS, V2, P591, DOI 10.3390/pathogens2040591; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Beaulieu JJ, 2014, BIOGEOCHEMISTRY, V121, P107, DOI 10.1007/s10533-014-9971-4; Binga EK, 2008, ISME J, V2, P233, DOI 10.1038/ismej.2008.10; Castelle CJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3120; Cooper M, 2011, APPL ENVIRON MICROB, V77, P5438, DOI 10.1128/AEM.00192-11; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Direito SOL, 2014, ENVIRON MICROBIOL, V16, P643, DOI 10.1111/1462-2920.12365; Edberg SC, 2000, J APPL MICROBIOL, V88, p106S, DOI 10.1111/j.1365-2672.2000.tb05338.x; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Flynn TM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-146; GELDREICH EE, 1992, WATER RES, V26, P1127, DOI 10.1016/0043-1354(92)90150-3; Gonzalez JM, 2005, ENVIRON MICROBIOL, V7, P1024, DOI 10.1111/j.1462-2920.2005.00779.x; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; La Duc MT, 2009, APPL ENVIRON MICROB, V75, P6559, DOI 10.1128/AEM.01073-09; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Miezeiewski M, 2015, ISME J, V9, P321, DOI 10.1038/ismej.2014.127; Olsen SJ, 2002, EMERG INFECT DIS, V8, P370, DOI 10.3201/eid0804.000218; Probst A, 2010, APPL ENVIRON MICROB, V76, P2837, DOI 10.1128/AEM.02167-09; Probst AJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6497; Probst AJ, 2014, MICROARRAYS: CURRENT TECHNOLOGY, INNOVATIONS AND APPLICATIONS, P99; Probst AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099801; Probst AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065388; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Revetta RP, 2013, FEMS MICROBIOL ECOL, V86, P404, DOI 10.1111/1574-6941.12170; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Sharon I, 2013, SCIENCE, V342, P1057, DOI 10.1126/science.1247023; Tyson GW, 2005, TRENDS MICROBIOL, V13, P411, DOI 10.1016/j.tim.2005.07.003; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Vaishampayan P, 2013, ISME J, V7, P312, DOI 10.1038/ismej.2012.114; Venkateswaran K, 2001, SYST APPL MICROBIOL, V24, P311, DOI 10.1078/0723-2020-00018; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wrighton KC, 2012, SCIENCE, V337, P1661, DOI 10.1126/science.1224041; Wu LY, 2006, APPL ENVIRON MICROB, V72, P4931, DOI 10.1128/AEM.02738-05; Yilmaz S, 2010, NAT METHODS, V7, P943, DOI 10.1038/nmeth1210-943; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	46	17	17	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0124158	10.1371/journal.pone.0124158	http://dx.doi.org/10.1371/journal.pone.0124158			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010362	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900006
J	Gianinazzi, ME; Rueegg, CS; Zimmerman, K; Kuehni, CE; Michel, G				Gianinazzi, Micol E.; Rueegg, Corina S.; Zimmerman, Karin; Kuehni, Claudia E.; Michel, Gisela		SPOG	Intra-Rater and Inter-Rater Reliability of a Medical Record Abstraction Study on Transition of Care after Childhood Cancer	PLOS ONE			English	Article							AGREEMENT; KAPPA	Background The abstraction of data from medical records is a widespread practice in epidemiological research. However, studies using this means of data collection rarely report reliability. Within the Transition after Childhood Cancer Study (TaCC) which is based on a medical record abstraction, we conducted a second independent abstraction of data with the aim to assess a) intra-rater reliability of one rater at two time points; b) the possible learning effects between these two time points compared to a gold-standard; and c) inter-rater reliability. Method Within the TaCC study we conducted a systematic medical record abstraction in the 9 Swiss clinics with pediatric oncology wards. In a second phase we selected a subsample of medical records in 3 clinics to conduct a second independent abstraction. We then assessed intra-rater reliability at two time points, the learning effect over time (comparing each rater at two time-points with a gold-standard) and the inter-rater reliability of a selected number of variables. We calculated percentage agreement and Cohen's kappa. Findings For the assessment of the intra-rater reliability we included 154 records (80 for rater 1; 74 for rater 2). For the inter-rater reliability we could include 70 records. Intra-rater reliability was substantial to excellent (Cohen's kappa 0-6-0.8) with an observed percentage agreement of 75%-95%. In all variables learning effects were observed. Inter-rater reliability was substantial to excellent (Cohen's kappa 0.70-0.83) with high agreement ranging from 86% to 100%. Conclusions Our study showed that data abstracted from medical records are reliable. Investigating intra-rater and inter-rater reliability can give confidence to draw conclusions from the abstracted data and increase data quality by minimizing systematic errors.	[Gianinazzi, Micol E.; Rueegg, Corina S.; Michel, Gisela] Univ Lucerne, Dept Hlth Sci & Hlth Policy, Luzern, Switzerland; [Zimmerman, Karin] Univ Childrens Hosp, Pediat Hematol Oncol, Bern, Switzerland; [Kuehni, Claudia E.] Univ Bern, Inst Social & Prevent Med, Swiss Childhood Canc Registry, Bern, Switzerland	University of Lucerne; University of Bern; University Hospital of Bern; University of Bern	Michel, G (corresponding author), Univ Lucerne, Dept Hlth Sci & Hlth Policy, Luzern, Switzerland.	gisela.michel@unilu.ch	Rueegg, Corina Silvia/H-7128-2019; Michel, Gisela/G-1081-2018	Rueegg, Corina Silvia/0000-0003-3720-4659; Michel, Gisela/0000-0002-9589-0928; Kuehni, Claudia E./0000-0001-8957-2002; Leibundgut, Kurt/0000-0003-2514-6041	Swiss National Science Foundation [PZ00P3_121682/1, PZ00P3-141722]; Swiss Cancer League [KLS-01605-10-2004, KLS-2215-02-2008, KFS-02631-08-2010, KLS-02783-02-2011]; Cancer League Bern; Stiftung zur Krebsbekampfung; Swiss Paediatric Oncology Group; Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren; Swiss Cancer Research; Kinderkrebshilfe Schweiz; Ernst-Gohner Stiftung; Stiftung Domarena; National Institute of Cancer Epidemiology and Registration	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; Cancer League Bern; Stiftung zur Krebsbekampfung; Swiss Paediatric Oncology Group; Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren; Swiss Cancer Research; Kinderkrebshilfe Schweiz; Ernst-Gohner Stiftung; Stiftung Domarena; National Institute of Cancer Epidemiology and Registration	This work was supported by the Swiss National Science Foundation (Ambizione grant PZ00P3_121682/1 and PZ00P3-141722 to GM); the Swiss Cancer League (grant KLS-01605-10-2004, KLS-2215-02-2008, KFS-02631-08-2010, KLS-02783-02-2011); Cancer League Bern; and Stiftung zur Krebsbekampfung. The work of the Swiss Childhood Cancer Registry is supported by the Swiss Paediatric Oncology Group (www.spog.ch), Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren (www.gdk-cds.ch), Swiss Cancer Research (www.krebsforschung.ch), Kinderkrebshilfe Schweiz (www.kinderkrebshilfe.ch), Ernst-Gohner Stiftung, Stiftung Domarena, and National Institute of Cancer Epidemiology and Registration (www.nicer.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison J J, 2000, Jt Comm J Qual Improv, V26, P115; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Eder C, 2005, APPL NURS RES, V18, P50, DOI 10.1016/j.apnr.2004.04.005; FLEISS JL, 1969, PSYCHOL BULL, V72, P323, DOI 10.1037/h0028106; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Kottner J, 2011, INT J NURS STUD, V48, P661, DOI 10.1016/j.ijnurstu.2011.01.016; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Michel G, 2008, PEDIATR BLOOD CANCER, V50, P46, DOI 10.1002/pbc.21129; Michel G, 2007, SWISS MED WKLY, V137, P502; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Reeves MJ, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-19; To T, 2008, BMC MED RES METHODOL, P8; Viera AJ, 2005, FAM MED, V37, P360; vonKoss Krowchuk H, 1995, J Nurs Meas, V3, P3; Yawn BP, 2005, AM J EPIDEMIOL, V161, P974, DOI 10.1093/aje/kwi122	16	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0124290	10.1371/journal.pone.0124290	http://dx.doi.org/10.1371/journal.pone.0124290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7GR	26001046	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000354931700005
J	Jiao, XD; Teng, YG; Zhan, YH; Wu, J; Lin, XY				Jiao, Xudong; Teng, Yanguo; Zhan, Yanhong; Wu, Jin; Lin, Xueyu			Soil Heavy Metal Pollution and Risk Assessment in Shenyang Industrial District, Northeast China	PLOS ONE			English	Article							SAMPLING UNCERTAINTY ANALYSIS; URBAN SOILS; CONTAMINATION; SEDIMENT; OLD; FIELD; CITY; GIS	To investigate the soil heavymetal pollution characteristics and ecological risk factors, 42 samples and six typical soil profiles were collected from the Shenyang industrial district in northeast China and were analyzed for contents of titanium (Ti), copper (Cu), lead (Pb), zinc (Zn), cobalt (Co), nickel (Ni), chromium (Cr) and arsenic (As). Through statistical analysis, it was found that the mean concentrations were higher than their background values (Ti = 4.77>3.8g/kg, Cu = 33.75>22.6 mg/kg, Pb = 45.95>26 mg/kg, Zn = 81.54>74.2 mg/kg, Co = 12.91>12.7 mg/kg, Ni = 32.26>26.9 mg/kg, Cr = 83.36>61 mg/kg and As = 13.69>11.2 mg/kg) but did not exceed their corresponding pollution limits for the Chinese Environmental Quality Standard for Soils (State Environmental Protection Administration of China, 1995). There were contamination hotspots thatmay be caused by human activities such as smelting plants and sewage irrigation. The Enrichment Factor and Ecological Risk Index were used to identify the anthropogenic contamination and ecological risks of heavy metals. Soil in the study area could be considered lightly or partially polluted by heavy metals. According to clustering analysis, distinct groups of heavymetals were discriminated between natural or anthropogenic sources.	[Jiao, Xudong; Teng, Yanguo; Zhan, Yanhong; Wu, Jin; Lin, Xueyu] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China; [Jiao, Xudong; Teng, Yanguo; Zhan, Yanhong; Wu, Jin; Lin, Xueyu] Minist Educ China, Engn Res Ctr Groundwater Pollut Control & Remedia, Beijing 100875, Peoples R China	Beijing Normal University; Ministry of Education, China	Jiao, XD (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China.	jxd-figo@163.com	WU, JIN/AAE-9081-2019		Natural Science Foundation of China [41473086]; Special Research on Public Service Environment Protection in China [201509031]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Research on Public Service Environment Protection in China	Natural Science Foundation of China (No. 41473086) and the Special Research on Public Service Environment Protection in China (No. 201509031).	Bai JH, 2011, ENVIRON POLLUT, V159, P817, DOI 10.1016/j.envpol.2010.11.004; Camobreco VJ, 1996, SOIL SCI, V161, P740, DOI 10.1097/00010694-199611000-00003; Chen T, 2009, ENVIRON POLLUT, V157, P1003, DOI 10.1016/j.envpol.2008.10.011; Han Ch. M., 2006, ANAL FORM DISTRIBUTI; Hou L, 2011, J LIAONING FORESTRY, V3, P5, DOI [DOI 10.4238/2015.MARCH.30.18, 10.4238/2015.March.30.18]; Kartal S, 2006, J HAZARD MATER, V132, P80, DOI 10.1016/j.jhazmat.2005.11.091; Li FY, 2009, ENVIRON GEOL, V57, P1815, DOI 10.1007/s00254-008-1469-8; Li JL, 2009, J HAZARD MATER, V164, P976, DOI 10.1016/j.jhazmat.2008.08.112; Li XY, 2013, GEODERMA, V192, P50, DOI 10.1016/j.geoderma.2012.08.011; Liu XM, 2006, ENVIRON POLLUT, V141, P257, DOI 10.1016/j.envpol.2005.08.048; Manta DS, 2002, SCI TOTAL ENVIRON, V300, P229, DOI 10.1016/S0048-9697(02)00273-5; Richards BK, 1998, ENVIRON POLLUT, V99, P365, DOI 10.1016/S0269-7491(98)00011-6; Steinmann M, 1997, APPL GEOCHEM, V12, P607, DOI 10.1016/S0883-2927(97)00017-6; Sun L N, 2009, J LIAONING TU NATURA, V28, P842; Sun YB, 2010, J HAZARD MATER, V174, P455, DOI 10.1016/j.jhazmat.2009.09.074; Sutherland RA, 2000, ENVIRON GEOL, V39, P611, DOI 10.1007/s002540050473; Teng YG, 2010, J GEOCHEM EXPLOR, V104, P118, DOI 10.1016/j.gexplo.2010.01.006; Teng YG, 2009, ENVIRON GEOL, V57, P1649, DOI 10.1007/s00254-008-1446-2; Wilcke W, 1998, GEODERMA, V86, P211, DOI 10.1016/S0016-7061(98)00045-7; Xie YF, 2011, CHEMOSPHERE, V82, P468, DOI 10.1016/j.chemosphere.2010.09.053; [徐争启 Xu Zhengqi], 2008, [环境科学与技术, Enuivonmental Science and Technology], V31, P112; Zhang CS, 2006, ENVIRON POLLUT, V142, P501, DOI 10.1016/j.envpol.2005.10.028; Zhang Y., 2001, CHIN J SOIL SCI, V32, P182, DOI [10.19336/j.cnki, DOI 10.19336/J.CNKI]; Zheng N, 2010, SCI TOTAL ENVIRON, V408, P726, DOI 10.1016/j.scitotenv.2009.10.075	24	56	59	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127736	10.1371/journal.pone.0127736	http://dx.doi.org/10.1371/journal.pone.0127736			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25997173	gold, Green Published, Green Submitted			2022-12-26	WOS:000356444000084
J	Kaija, H; Pakanen, L; Kortelainen, ML; Porvari, K				Kaija, Helena; Pakanen, Lasse; Kortelainen, Marja-Leena; Porvari, Katja			Hypothermia and Rewarming Induce Gene Expression and Multiplication of Cells in Healthy Rat Prostate Tissue	PLOS ONE			English	Article							RECEPTOR LIGANDS; CANCER CELLS; EGF RECEPTOR; COLD STRESS; AMPHIREGULIN; P21; THROMBOMODULIN; FIBROBLASTS; ACTIVATION; MECHANISMS	Prostate cancer has been extensively studied, but cellular stress responses in healthy prostate tissue are rarely investigated. Hypothermia is known to cause alterations in mRNA and protein expressions and stability. The aim of this study was to use normal rat prostate as a model in order to find out consequences of cold exposure and rewarming on the expressions of genes which are either members or functionally/structurally related to erythroblastic leukemia viral oncogene B (ErbB) signaling pathway. Relative mRNA expressions of amphiregulin (AMR), cyclin D1 (CyD1), cyclin-dependent kinase inhibitor 1A (p21), transmembrane form of the prostatic acid phosphatase (PAcP), thrombomodulin (TM) and heat shock transcription factor 1 (HSF1) in rat ventral prostate were quantified in mild (2 or 4.5 h at room temperature) and severe (2 or 4.5 h at + 10 degrees C) hypothermia and in rewarming after cold exposure (2 h at + 10 degrees C followed by 2 h at room temperature or 3 h at + 28 degrees C). AMR protein level, apoptotic Bcl-2 associated X protein to B-cell CLL/lymphoma 2(Bax/Bcl-2) mRNA ratio and proliferative index Ki-67 were determined. 4.5-h mild hypothermia, 2-h severe hypothermia and rewarming increased expression of all these genes. Elevated proliferation index Ki-67 could be seen in 2-h severe hypothermia, and the proliferation index had its highest value in longer rewarming with totally recovered normal body temperature. Proapoptotic tendency could be seen in 2-h mild hypothermia while anti-apoptosis was predominant in 4.5-h mild hypothermia and in shorter rewarming with only partly recovered body temperature. Hypothermia and following rewarming promote the proliferation of cells in healthy rat prostate tissue possibly via ErbB signaling pathway.	[Kaija, Helena; Pakanen, Lasse; Kortelainen, Marja-Leena; Porvari, Katja] Univ Oulu, Fac Med, Dept Forens Med, Oulu, Finland; [Kaija, Helena; Pakanen, Lasse; Porvari, Katja] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Kaija, Helena; Pakanen, Lasse; Porvari, Katja] Univ Oulu, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu	Porvari, K (corresponding author), Univ Oulu, Fac Med, Dept Forens Med, Oulu, Finland.	katja.porvari@oulu.fi						Alam HB, 2010, J TRAUMA, V68, P1084, DOI 10.1097/TA.0b013e3181d76bd1; Baust JG, 2004, CRYOBIOLOGY, V48, P190, DOI 10.1016/j.cryobiol.2004.01.005; Bostwick DG, 2004, PROSTATE, V58, P164, DOI 10.1002/pros.10322; Busser B, 2011, BBA-REV CANCER, V1816, P119, DOI 10.1016/j.bbcan.2011.05.003; De Witte JL, 2010, ANESTH ANALG, V110, P829, DOI 10.1213/ANE.0b013e3181cb3ebf; ESMON CT, 1981, P NATL ACAD SCI-BIOL, V78, P2249, DOI 10.1073/pnas.78.4.2249; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Harris RC, 2003, EXP CELL RES, V284, P2, DOI 10.1016/S0014-4827(02)00105-2; Hedelin H, 2007, SCAND J UROL NEPHROL, V41, P430, DOI 10.1080/00365590701365123; Hynson J M, 1992, J Clin Anesth, V4, P194, DOI 10.1016/0952-8180(92)90064-8; Iacopino F, 2006, ANTICANCER RES, V26, P1849; Janicke RU, 2007, CELL CYCLE, V6, P407; Jiang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085179; Kaija H, 2014, STRESS, V17, P504, DOI 10.3109/10253890.2014.953477; Kang KH, 1999, EXP CELL RES, V253, P403, DOI 10.1006/excr.1999.4644; Kasina S, 2009, CELL PROLIFERAT, V42, P799, DOI 10.1111/j.1365-2184.2009.00645.x; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Matijasevic Z, 1998, ONCOL RES, V10, P605; Meng TC, 1998, J BIOL CHEM, V273, P22096, DOI 10.1074/jbc.273.34.22096; Roobol A, 2011, BIOCHEM J, V435, P499, DOI 10.1042/BJ20101303; Roobol A, 2009, FEBS J, V276, P286, DOI 10.1111/j.1742-4658.2008.06781.x; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Sessler DI, 2009, CRIT CARE MED, V37, pS203, DOI 10.1097/CCM.0b013e3181aa5568; SHOYAB M, 1989, SCIENCE, V243, P1074, DOI 10.1126/science.2466334; Sonna LA, 2002, J APPL PHYSIOL, V92, P1725, DOI 10.1152/japplphysiol.01143.2001; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; Swindle CS, 2001, J CELL BIOL, V154, P459, DOI 10.1083/jcb.200103103; Tikhomirov O, 2005, J CELL SCI, V118, P5681, DOI 10.1242/jcs.02676; Torring N, 1998, PROSTATE CANCER P D, V1, P262, DOI 10.1038/sj.pcan.4500250; Tveita AA, 2012, CRYOBIOLOGY, V64, P201, DOI 10.1016/j.cryobiol.2012.01.009; Van de Wouwer M, 2004, CRIT CARE MED, V32, pS254, DOI 10.1097/01.CCM.0000128036.64448.9e; Vihervaara A, 2014, J CELL SCI, V127, P261, DOI 10.1242/jcs.132605	32	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127854	10.1371/journal.pone.0127854	http://dx.doi.org/10.1371/journal.pone.0127854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996932	gold, Green Submitted, Green Published			2022-12-26	WOS:000356444000092
J	Kim, KE; Kim, DM; Flammer, J; Kim, KN				Kim, Ko Eun; Kim, Dong Myung; Flammer, Josef; Kim, Kyoung Nam			Central Retinal Venous Pressure in Eyes of Normal-Tension Glaucoma Patients with Optic Disc Hemorrhage	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; RISK-FACTORS; PERFUSION-PRESSURE; LAMINA-CRIBROSA; VISUAL-FIELD; NERVE HEAD; VEIN; PROGRESSION; PULSATION; NEUROPATHY	Objective To compare central retinal venous pressure (CRVP) among eyes with and without optic disc hemorrhage (ODH) in bilateral normal-tension glaucoma (NTG) patients and NTG eyes without an episode of ODH. Methods In this prospective study, 22 bilateral NTG patients showing a unilateral ODH and 29 bilateral NTG patients without an episode of ODH were included. Eyes were categorized into group A (n = 22, eyes with ODH), group B (n = 22, fellow eyes without ODH), and group C (n = 29, NTG eyes without an episode of ODH). A contact lens ophthalmodynamometer was used to measure CRVP and central retinal arterial pressure (CRAP). Results Intraocular pressure (IOP) measured on the day of contact lens ophthalmodynamometry showed no difference among groups. However, the mean baseline IOP in group A was significantly lower than that in group C (P= .008). The CRVP in group A (29.1 +/- 10.8 mmHg) was significantly lower than that in group C (40.1 +/- 8.8 mmHg, P = .001), but similar to that in group B (30.5 +/- 8.7 mmHg, P = .409). A similar relationship was noted for CRAP. No significant eye-associated variable for ODH was found in group A and B by conditional logistic regression analysis (all P > 0.05). However, multivariate logistic regression analysis in groups A and C revealed that low mean baseline IOP (odds ratio [OR] = 0.69, 95% confidence interval [CI] 0.49-0.98, P = 0.043) and low CRVP (OR = 0.88, 95% CI 0.80-0.95, P = 0.003) were associated with ODH. Conclusions CRVP was lower in NTG eyes with ODH than in eyes without an episode of ODH, but similar to that of fellow eyes without ODH. These imply less likelihood of association between increased central retinal venous resistance and ODH.	[Kim, Ko Eun; Kim, Dong Myung] Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul 110744, South Korea; [Flammer, Josef] Univ Basel, Dept Ophthalmol, Basel, Switzerland; [Kim, Kyoung Nam] Chungnam Natl Univ Hosp, Dept Ophthalmol, Taejon, South Korea	Seoul National University (SNU); Seoul National University Hospital; University of Basel; Chungnam National University; Chungnam National University Hospital	Kim, DM (corresponding author), Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul 110744, South Korea.	dmkim@snu.ac.kr		Kim, Kyoung Nam/0000-0003-3898-3236	Seoul National University Hospital Research Fund [30-2012-0210]	Seoul National University Hospital Research Fund	This work was supported by a grant (Grant Number: 30-2012-0210) from the Seoul National University Hospital Research Fund donated by Gaunet Co., Ltd., Seoul, South Korea. The funding incorporation had no role in study design, data collection and analysis, preparation of the manuscript, or decision to publish.	AIRAKSINEN PJ, 1983, ACTA OPHTHALMOL, V61, P186; Balaratnasingam C, 2007, BRIT J OPHTHALMOL, V91, P441, DOI 10.1136/bjo.2006.105338; BEGG IS, 1970, CAN J OPHTHALMOLOGY, V5, P321; BEGG IS, 1971, BRIT J OPHTHALMOL, V55, P73, DOI 10.1136/bjo.55.2.73; Bonomi L, 2000, OPHTHALMOLOGY, V107, P1287, DOI 10.1016/S0161-6420(00)00138-X; Budenz DL, 2006, OPHTHALMOLOGY, V113, P2137, DOI 10.1016/j.ophtha.2006.06.022; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Chen BH, 2014, J GLAUCOMA; Contact lens dynamometer user manual, 2007, CONT LENS DYN US MAN; Delgado E, 2010, GRAEF ARCH CLIN EXP, V248, P213, DOI 10.1007/s00417-009-1235-y; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; DRANCE SM, 1989, SURV OPHTHALMOL, V33, P331, DOI 10.1016/0039-6257(89)90010-6; Flammer J, 2013, EPMA J, V4, DOI 10.1186/1878-5085-4-14; Ghanem M, 2013, KLIN MONATSBL AUGENH, V230, P358, DOI 10.1055/s-0032-1328361; Grodum K, 2002, J GLAUCOMA, V11, P226, DOI 10.1097/01.IJG.0000013483.08219.F0; Hanley JA, 2000, STAT MED, V19, P715, DOI 10.1002/(SICI)1097-0258(20000315)19:5<715::AID-SIM342>3.0.CO;2-T; Harder B, 2007, BRIT J OPHTHALMOL, V91, P401, DOI 10.1136/bjo.2006.103341; Healey PR, 1998, OPHTHALMOLOGY, V105, P216, DOI 10.1016/S0161-6420(98)92704-X; Jeoung JW, 2008, OPHTHALMOLOGY, V115, P2132, DOI 10.1016/j.ophtha.2008.08.024; Jonas JB, 1994, AM J OPHTHALMOL, V18, P1; Jonas JB, 2015, PROG RETIN EYE RES; Jonas JB, 2007, AM J OPHTHALMOL, V143, P112, DOI 10.1016/j.ajo.2006.09.019; Kim M, 2014, INVEST OPHTH VIS SCI, V55, P2822, DOI 10.1167/iovs.13-13836; Kim SH, 2006, OPHTHALMOLOGY, V113, P598, DOI 10.1016/j.ophtha.2005.12.018; Kim YD, 2010, EYE, V24, P567, DOI 10.1038/eye.2009.163; KITAZAWA Y, 1986, OPHTHALMOLOGY, V93, P853; Lee EJ, 2014, INVEST OPHTH VIS SCI, V55, P2805, DOI 10.1167/iovs.13-12742; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Medeiros FA, 2010, OPHTHALMOLOGY, V117, P2061, DOI 10.1016/j.ophtha.2010.02.015; MEYERSCHWICKERATH R, 1995, GRAEF ARCH CLIN EXP, V233, P783, DOI 10.1007/BF00184090; Miglior S, 2007, AM J OPHTHALMOL, V144, P266, DOI 10.1016/j.ajo.2007.04.040; Morgan WH, 2004, OPHTHALMOLOGY, V111, P1489, DOI 10.1016/j.ophtha.2003.12.053; Morgan William H, 2013, J Glaucoma, V22 Suppl 5, pS15, DOI 10.1097/IJG.0b013e31829349d7; Morgan WH, 2010, GRAEF ARCH CLIN EXP, V248, P401, DOI 10.1007/s00417-009-1288-y; Pillunat KR, 2014, BRIT J OPHTHALMOL, V98, P1374, DOI 10.1136/bjophthalmol-2014-305126; Querfurth HW, 2004, NEUROCRIT CARE, V1, P183, DOI 10.1385/NCC:1:2:183; RIVA CE, 1986, INVEST OPHTH VIS SCI, V27, P1706; Roberts MD, 2009, INVEST OPHTH VIS SCI, V50, P681, DOI 10.1167/iovs.08-1792; Siegner SW, 1996, OPHTHALMOLOGY, V103, P1014, DOI 10.1016/S0161-6420(96)30572-1; Soares AS, 2004, OPHTHALMOLOGY, V111, P1653, DOI 10.1016/j.ophtha.2004.03.023; Sokal RR., 1973, INTRO BIOSTATISTICS, V2; Stodtmeister R, 2013, INVEST OPHTH VIS SCI, V54, P4698, DOI 10.1167/iovs.12-10607; Yang DY, 2014, INVEST OPHTH VIS SCI, V55, P3067, DOI 10.1167/iovs.13-13657; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zheng YF, 2010, INVEST OPHTH VIS SCI, V51, P3399, DOI 10.1167/iovs.09-4867	45	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127920	10.1371/journal.pone.0127920	http://dx.doi.org/10.1371/journal.pone.0127920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996599	Green Published, Green Submitted, gold			2022-12-26	WOS:000356444000098
J	Sachdeva, KS; Raizada, N; Sreenivas, A; van't Hoog, AH; van den Hof, S; Dewan, PK; Thakur, R; Gupta, RS; Kulsange, S; Vadera, B; Babre, A; Gray, C; Parmar, M; Ghedia, M; Ramachandran, R; Alavadi, U; Arinaminpathy, N; Denkinger, C; Boehme, C; Paramasivan, CN				Sachdeva, Kuldeep Singh; Raizada, Neeraj; Sreenivas, Achuthan; van't Hoog, Anna H.; van den Hof, Susan; Dewan, Puneet K.; Thakur, Rahul; Gupta, R. S.; Kulsange, Shubhangi; Vadera, Bhavin; Babre, Ameet; Gray, Christen; Parmar, Malik; Ghedia, Mayank; Ramachandran, Ranjani; Alavadi, Umesh; Arinaminpathy, Nimalan; Denkinger, Claudia; Boehme, Catharina; Paramasivan, C. N.			Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India	PLOS ONE			English	Article								Background Xpert MTB/RIF, the first automated molecular test for tuberculosis, is transforming the diagnostic landscape in high-burden settings. This study assessed the impact of up-front Xpert MTB/RIF testing on detection of pulmonary tuberculosis (PTB) and rifampicin-resistant PTB (DR-TB) cases in India. Methods This demonstration study was implemented in 18 sub-district level TB programme units (TUs) in India in diverse geographic and demographic settings covering a population of 8.8 million. A baseline phase in 14 TUs captured programmatic baseline data, and an intervention phase in 18 TUs had Xpert MTB/RIF offered to all presumptive TB patients. We estimated changes in detection of TB and DR-TB, the former using binomial regression models to adjust for clustering and covariates. Results In the 14 study TUs, which participated in both phases, 10,675 and 70,556 presumptive TB patients were enrolled in the baseline and intervention phase, respectively, and 1,532 (14.4%) and 14,299 (20.3%) bacteriologically confirmed PTB cases were detected. The implementation of Xpert MTB/RIF was associated with increases in both notification rates of bacteriologically confirmed TB cases (adjusted incidence rate ratio [aIRR] 1.39; CI 1.18-1.64), and proportion of bacteriological confirmed TB cases among presumptive TB cases (adjusted risk ratio (aRR) 1.33; CI 1.6-1.52). Compared with the baseline strategy of selective drug-susceptibility testing only for PTB cases at high risk of drug-resistant TB, Xpert MTB/RIF implementation increased rifampicin resistant TB case detection by over fivefold. Among, 2765 rifampicin resistance cases detected, 1055 were retested with conventional drug susceptibility testing (DST). Positive predictive value (PPV) of rifampicin resistance detected by Xpert MTB/RIF was 94.7% (CI 91.3-98.1), in comparison to conventional DST. Conclusion Introduction of Xpert MTB/RIF as initial diagnostic test for TB in public health facilities significantly increased case-notification rates of all bacteriologically confirmed TB by 39% and rifampicin-resistant TB case notification by fivefold.	[Sachdeva, Kuldeep Singh; Gupta, R. S.; Ghedia, Mayank] Govt India, Cent TB Div, New Delhi, India; [Raizada, Neeraj; Thakur, Rahul; Kulsange, Shubhangi; Vadera, Bhavin; Babre, Ameet; Gray, Christen; Alavadi, Umesh; Denkinger, Claudia; Boehme, Catharina; Paramasivan, C. N.] Fdn Innovat New Diagnost, Geneva, Switzerland; [Sreenivas, Achuthan; Dewan, Puneet K.; Parmar, Malik; Ramachandran, Ranjani] WHO, India Country Off, New Delhi, India; [van't Hoog, Anna H.; van den Hof, Susan] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [van't Hoog, Anna H.; van den Hof, Susan] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [van den Hof, Susan] KNCV TB Fdn, The Hague, Netherlands; [Arinaminpathy, Nimalan] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, London, England	Foundation For Innovative New Diagnostics; World Health Organization; University of Amsterdam; Academic Medical Center Amsterdam; KNCV Tuberculosis Foundation; Imperial College London	Raizada, N (corresponding author), Fdn Innovat New Diagnost, Geneva, Switzerland.	drneerajraizada@gmail.com		Arinaminpathy, Nimalan/0000-0001-9502-6876; Raizada, Neeraj/0000-0003-2116-332X; Nair, Sreenivas/0000-0002-2586-6797; Gray, Christen/0000-0002-9723-3032	USAID; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish	USAID(United States Agency for International Development (USAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by USAID. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, M REPORT DATA SCALE; [Anonymous], 2009, GEN MTBDRPLUS MOL GE, P23; Central TB Division Ministry of Health and Family WelfareNew Delhi India, 2009, REV NAT TB CONTR PRO; Central TB Division Ministry of Health and Family WelfareNew Delhi India, 2012, REV NAT TB CONTR PRO; Central TB Division Ministry of Health and Family WelfareNew Delhi India, 2005, REV NAT TB CONTR PRO; Cepheid, 2009, XPERT MTB RIF 2 HOUR; Dorman SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043307; Durovni B, 2013, INT J TUBERC LUNG S2, V17, pS204; National Health Laboratory Service South Africa, 2012, GENEXPERT MTB RIF PR; Raizada N, 2014, PLOS ONE, DOI [10.1371/journal.pone.0089301, DOI 10.1371/JOURNAL.PONE.0089301]; Rath GM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036966, DOI 10.1371/JOURNAL.PONE.0036966]; Steingart R, 2013, CHOCHRANE DATABASE S, V1, DOI [10.1002/14651858.CD009593.pub2, DOI 10.1002/14651858.CD009593.PUB2]; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; WHO, 2011, AUT REAL TIM NUCL AC; World Health Organization, 2011, WHOHTMTB20112; World Health Organization, 2021, 10 THREATS GLOB HLTH; World Health Organization, 2012, GLOB ACT PLAN PREV C, P3	18	59	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0126065	10.1371/journal.pone.0126065	http://dx.doi.org/10.1371/journal.pone.0126065			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996389	gold, Green Published, Green Submitted			2022-12-26	WOS:000356444000016
J	Brunye, TT; Collier, ZA; Cantelon, J; Holmes, A; Wood, MD; Linkov, I; Taylor, HA				Brunye, Tad T.; Collier, Zachary A.; Cantelon, Julie; Holmes, Amanda; Wood, Matthew D.; Linkov, Igor; Taylor, Holly A.			Strategies for Selecting Routes through Real-World Environments: Relative Topography, Initial Route Straightness, and Cardinal Direction	PLOS ONE			English	Article							SELF-REPORT MEASURE; CHOICE; CONSTRAINTS; NAVIGATION; BEHAVIOR; TRAVEL; NORTH	Previous research has demonstrated that route planners use several reliable strategies for selecting between alternate routes. Strategies include selecting straight rather than winding routes leaving an origin, selecting generally south-rather than north-going routes, and selecting routes that avoid traversal of complex topography. The contribution of this paper is characterizing the relative influence and potential interactions of these strategies. We also examine whether individual differences would predict any strategy reliance. Results showed evidence for independent and additive influences of all three strategies, with a strong influence of topography and initial segment straightness, and relatively weak influence of cardinal direction. Additively, routes were also disproportionately selected when they traversed relatively flat regions, had relatively straight initial segments, and went generally south rather than north. Two individual differences, extraversion and sense of direction, predicted the extent of some effects. Under real-world conditions navigators indeed consider a route's initial straightness, cardinal direction, and topography, but these cues differ in relative influence and vary in their application across individuals.	[Brunye, Tad T.; Cantelon, Julie; Holmes, Amanda] US Army Natick Soldier Res, Ctr Dev & Engn, Natick, MA 01760 USA; [Brunye, Tad T.; Cantelon, Julie; Holmes, Amanda] Tufts Univ, Dept Psychol, Medford, MA 02155 USA; [Collier, Zachary A.; Wood, Matthew D.; Linkov, Igor; Taylor, Holly A.] US Army Engineer Res & Dev Ctr, Vicksburg, MS USA	United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); Tufts University; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Brunye, TT (corresponding author), US Army Natick Soldier Res, Ctr Dev & Engn, Natick, MA 01760 USA.	thaddeus.t.brunye.civ@mail.mil	Cantelon, Julie/AAA-3439-2021; Wood, Matthew/HDN-1469-2022; Linkov, Igor/AAH-5981-2019	Linkov, Igor/0000-0002-0823-8107; Brunye, Tad/0000-0002-8788-8764	U.S. Army Natick Soldier Research, Development, and Engineering Center (NSRDEC) [W911QY-13-C-0012]; U.S. Army Basic Research Program within the Geospatial Research and Engineering (GRE) Program of the U.S. Army Engineer Research & Development Center (ERDC)	U.S. Army Natick Soldier Research, Development, and Engineering Center (NSRDEC); U.S. Army Basic Research Program within the Geospatial Research and Engineering (GRE) Program of the U.S. Army Engineer Research & Development Center (ERDC)	This work was funded by the U.S. Army Natick Soldier Research, Development, and Engineering Center (NSRDEC, Grant #W911QY-13-C-0012, PI: Holly A. Taylor), and the U.S. Army Basic Research Program within the Geospatial Research and Engineering (GRE) Program of the U.S. Army Engineer Research & Development Center (ERDC). Permission was granted by the U.S. Army Corps of Engineers, Chief of Engineers, and the U.S. Army Natick Soldier Research, Development, and Engineering Center, to publish this material. The views expressed in this article are solely those of the authors and do not reflect the official policies or positions of the Department of Army, the Department of Defense, or any other department or agency of the U.S. government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailenson JN, 1998, J ENVIRON PSYCHOL, V18, P251, DOI 10.1006/jevp.1998.0095; Bailenson JN, 2000, MEM COGNITION, V28, P306, DOI 10.3758/BF03213808; Bekhor S, 2014, TRANSPORT RES F-TRAF, V22, P39, DOI 10.1016/j.trf.2013.10.009; Brunye TT, 2012, J ENVIRON PSYCHOL, V32, P297, DOI 10.1016/j.jenvp.2012.05.003; Brunye TT, 2012, Q J EXP PSYCHOL, V65, P1880, DOI 10.1080/17470218.2012.663393; Brunye TT, 2010, MEM COGNITION, V38, P700, DOI 10.3758/MC.38.6.700; CHOWN E, 1995, COGNITIVE SCI, V19, P1, DOI 10.1207/s15516709cog1901_1; CHRISTENFELD N, 1995, PSYCHOL SCI, V6, P50, DOI 10.1111/j.1467-9280.1995.tb00304.x; Delling D, 2009, LECT NOTES COMPUT SC, V5515, P117, DOI 10.1007/978-3-642-02094-0_7; Freeman JB, 2010, BEHAV RES METHODS, V42, P226, DOI 10.3758/BRM.42.1.226; Gigerenzer G., 2008, RATIONALITY MORTALS; Golledge RG, 1995, LECT NOTES COMPUT SC, V988, P207; Gray WD, 2006, PSYCHOL REV, V113, P461, DOI 10.1037/0033-295X.113.3.461; Hegarty M, 2002, INTELLIGENCE, V30, P425, DOI 10.1016/S0160-2896(02)00116-2; Heth CD, 1998, J ENVIRON PSYCHOL, V18, P223, DOI 10.1006/jevp.1998.0093; Hochmair HH, 2004, LECT NOTES COMPUT SC, V3343, P79; Hochmair HH, 1995, DEV SPATIAL DATA HAN, P481; Holscher C, 2011, COGNITION, V121, P228, DOI 10.1016/j.cognition.2011.06.005; Hoogendoorn SP, 2004, TRANSPORT RES B-METH, V38, P169, DOI 10.1016/S0191-2615(03)00007-9; Hughes RL, 2002, TRANSPORT RES B-METH, V36, P507, DOI 10.1016/S0191-2615(01)00015-7; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Kaplan S, 2012, TRANSPORT RES F-TRAF, V15, P9, DOI 10.1016/j.trf.2011.11.001; Miller JD, 2004, PERS INDIV DIFFER, V36, P1611, DOI 10.1016/j.paid.2003.06.009; Munzer S, 2011, DIAGNOSTICA, V57, P111, DOI 10.1026/0012-1924/a000040; PIMENTAL NA, 1979, ERGONOMICS, V22, P963, DOI 10.1080/00140137908924670; Pingel TJ, 2010, CARTOGR GEOGR INF SC, V37, P137, DOI 10.1559/152304010791232163; Proffitt DR, 1995, PSYCHON B REV, V2, P409, DOI 10.3758/BF03210980; Roets A, 2008, SOC COGNITION, V26, P333, DOI 10.1521/soco.2008.26.3.333; Roets A, 2011, PERS INDIV DIFFER, V50, P90, DOI 10.1016/j.paid.2010.09.004; Seneviratne P. N., 1985, Transport Planning and Technology, V10, P147, DOI 10.1080/03081068508717309; Smith AM, 2011, NETWORK BASED APPROA; Taylor HA, 2013, PSYCHOL LEARN MOTIV, V58, P77, DOI 10.1016/B978-0-12-407237-4.00003-7; Tobler W, 1993, NONISOTROPIC GEOGRAP; Tower-Richardi SM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00361; Wiener JM, 2004, J ENVIRON PSYCHOL, V24, P475, DOI 10.1016/j.jenvp.2004.09.006; Zanolie K, 2012, BRAIN COGNITION, V78, P50, DOI 10.1016/j.bandc.2011.10.006	36	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0124404	10.1371/journal.pone.0124404	http://dx.doi.org/10.1371/journal.pone.0124404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992685	Green Published, Green Submitted, gold			2022-12-26	WOS:000354921400017
J	Oka, N; Yoshino, K; Yamamoto, K; Takahashi, H; Li, S; Sugimachi, T; Nakano, K; Suda, Y; Kato, T				Oka, Noriyuki; Yoshino, Kayoko; Yamamoto, Kouji; Takahashi, Hideki; Li, Shuguang; Sugimachi, Toshiyuki; Nakano, Kimihiko; Suda, Yoshihiro; Kato, Toshinori			Greater Activity in the Frontal Cortex on Left Curves: A Vector-Based fNIRS Study of Left and Right Curve Driving	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; NEAR-INFRARED SPECTROSCOPY; DIRECT-CURRENT STIMULATION; BLOOD-FLOW; PREMOTOR CORTEX; WORKING-MEMORY; BRAIN ACTIVITY; EYE-MOVEMENT; MOTOR; ACTIVATION	Objectives In the brain, the mechanisms of attention to the left and the right are known to be different. It is possible that brain activity when driving also differs with different horizontal road alignments (left or right curves), but little is known about this. We found driver brain activity to be different when driving on left and right curves, in an experiment using a large-scale driving simulator and functional near-infrared spectroscopy (fNIRS). Research Design and Methods The participants were fifteen healthy adults. We created a course simulating an expressway, comprising straight line driving and gentle left and right curves, and monitored the participants under driving conditions, in which they drove at a constant speed of 100 km/h, and under non-driving conditions, in which they simply watched the screen (visual task). Changes in hemoglobin concentrations were monitored at 48 channels including the prefrontal cortex, the premotor cortex, the primary motor cortex and the parietal cortex. From orthogonal vectors of changes in deoxyhemoglobin and changes in oxyhemoglobin, we calculated changes in cerebral oxygen exchange, reflecting neural activity, and statistically compared the resulting values from the right and left curve sections. Results Under driving conditions, there were no sites where cerebral oxygen exchange increased significantly more during right curves than during left curves (p > 0.05), but cerebral oxygen exchange increased significantly more during left curves (p < 0.05) in the right premotor cortex, the right frontal eye field and the bilateral prefrontal cortex. Under non-driving conditions, increases were significantly greater during left curves (p < 0.05) only in the right frontal eye field. Conclusions Left curve driving was thus found to require more brain activity at multiple sites, suggesting that left curve driving may require more visual attention than right curve driving. The right frontal eye field was activated under both driving and non-driving conditions.	[Oka, Noriyuki; Yoshino, Kayoko; Kato, Toshinori] KatoBrain Co Ltd, Dept Brain Environm Res, Tokyo, Japan; [Yamamoto, Kouji] Cent Nippon Expressway Co Ltd, Dept Environm Engn, Tokyo Branch, Tokyo, Japan; [Takahashi, Hideki] Cent Nippon Expressway Co Ltd, Dept Environm Engn, Nagoya, Aichi, Japan; [Li, Shuguang; Sugimachi, Toshiyuki; Nakano, Kimihiko; Suda, Yoshihiro] Univ Tokyo, Inst Ind Sci, Tokyo, Japan	University of Tokyo	Kato, T (corresponding author), KatoBrain Co Ltd, Dept Brain Environm Res, Tokyo, Japan.	kato@katobrain.com			NEXCO; Grants-in-Aid for Scientific Research [14J08950] Funding Source: KAKEN	NEXCO; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The experiment and research expenses were funded by NEXCO. The funders had role in study design, data collection, and decision to publish. The funders had no role in data analysis and preparation of the manuscript.	Benarroch EE, 2005, BASIC NEUROSCIENCES, P501; Calhoun VD, 2012, NEUROIMAGE, V59, P25, DOI 10.1016/j.neuroimage.2011.06.037; Calhoun VD, 2002, HUM BRAIN MAPP, V16, P158, DOI 10.1002/hbm.10032; Cho SS, 2012, BRAIN STIMUL, V5, P116, DOI 10.1016/j.brs.2012.03.007; Choi E-H., 2010, 811366 DOT HS; Chouinard PA, 2006, NEUROSCIENTIST, V12, P143, DOI 10.1177/1073858405284255; DAMASIO AR, 1980, NEUROPSYCHOLOGIA, V18, P123, DOI 10.1016/0028-3932(80)90058-5; Debaere F, 2004, NEUROIMAGE, V21, P1416, DOI 10.1016/j.neuroimage.2003.12.011; Fisk GD, 2002, ARCH PHYS MED REHAB, V83, P469, DOI 10.1053/apmr.2002.31179; Fukushima K, 2000, J NEUROPHYSIOL, V83, P563, DOI 10.1152/jn.2000.83.1.563; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; Giglia G, 2014, FUNCT NEUROL, V29, P189, DOI 10.11138/FNeur/2014.29.3.189; Goldberg ME, 1991, PRINCIPLES NEURAL SC, P672; Graydon FX, 2004, TRANSPORT RES F-TRAF, V7, P271, DOI 10.1016/j.trf.2004.09.006; HARDYCK C, 1977, PSYCHOL BULL, V84, P385, DOI 10.1037/0033-2909.84.3.385; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; Hong KS, 2015, NEUROSCI LETT, V587, P87, DOI 10.1016/j.neulet.2014.12.029; Hong KS, 2014, BIOMED OPT EXPRESS, V5, P1778, DOI 10.1364/BOE.5.001778; Horikawa E, 2005, BRAIN COGNITION, V58, P166, DOI 10.1016/j.bandc.2004.10.002; Husain M, 1996, J NEUROL, V243, P652, DOI 10.1007/BF00878662; Institute for Traffic Accident Research and Data Analysis, 2007, ACC AR CAUS MIS TRAF, P67; Jancke L, 2008, NEUROREPORT, V19, P1127, DOI 10.1097/WNR.0b013e3283056521; Japan Safe Driving Center, 1988, STUD ACT SIT TRAFF A; Julien C, 2006, CARDIOVASC RES, V70, P12, DOI 10.1016/j.cardiores.2005.11.008; KASHIWAGI A, 1990, BRAIN, V113, P1005, DOI 10.1093/brain/113.4.1005; Kato T, 2014, 20 ANN M HUM BRAIN M; Kato T., 2006, Apparatus for evaluating biological function, Patent No. [WO/ 2003/ 068070, 2003068070, WO/2003/068070]; Kato T., 2007, Biofunction diagnosis device, biofunction diagnosis method, bioprobe, bioprobe wearing tool, bioprobe support tool, and bioprobe wearing assisting tool, Patent No. [WO/2006/009178, 2006009178]; Khan M., 2014, INT J DISTRIB SENS N, V2014, P8, DOI DOI 10.1155/2014/968484; Kinsbourne M, 1977, Adv Neurol, V18, P41; Kirilina E, 2012, NEUROIMAGE, V61, P70, DOI 10.1016/j.neuroimage.2012.02.074; Konen CS, 2004, NEUROIMAGE, V22, P304, DOI 10.1016/j.neuroimage.2003.12.039; Korner-Bitensky N, 2000, AM J PHYS MED REHAB, V79, P253, DOI 10.1097/00002060-200005000-00007; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Liu T, 2012, NEUROSCI LETT, V506, P220, DOI 10.1016/j.neulet.2011.11.009; Mars F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043858; Matusmoto K, 2011, 46 C JPTA MIYAZ JAP; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; Mazer BL, 2001, AM J OCCUP THER, V55, P552, DOI 10.5014/ajot.55.5.552; Naseer N, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00003; Naseer N, 2013, NEUROSCI LETT, V553, P84, DOI 10.1016/j.neulet.2013.08.021; National Highway Traffic Safety Administration, 2008, NAT MOT VEH CRASH CA; National Police Agency, 2013, OCC TRAFF ACC; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Praeg E, 2005, NEUROREPORT, V16, P1715, DOI 10.1097/01.wnr.0000183333.36488.1c; QUIGLEY FL, 1983, AM J OCCUP THER, V37, P474, DOI 10.5014/ajot.37.7.474; Richter W, 1997, NEUROREPORT, V8, P1257, DOI 10.1097/00001756-199703240-00040; Sano M, 2013, NEUROREPORT, V24, P935, DOI 10.1097/WNR.0000000000000008; Schubotz RI, 2003, NEUROIMAGE, V20, pS120, DOI 10.1016/j.neuroimage.2003.09.014; Schweizer TA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00053; Sims B., 1985, BRIT J OCCUPATIONAL, V48, P363; Society of Osaka traffic Scientific Research, 2000, STUD TRAFF SAF NEW T, P159; Sugawara K, 2013, BRAIN TOPOGR, V26, P581, DOI 10.1007/s10548-013-0299-5; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; Thomas LC, 2013, PHYS THER, V93, P1563, DOI 10.2522/ptj.20120477; Tsunashima H., 2009, COMPUT INTEL NEUROSC; Uchiyama Y, 2012, TRANSPORT RES F-TRAF, V15, P25, DOI 10.1016/j.trf.2011.11.002; van't Wout M, 2005, NEUROREPORT, V16, P1849, DOI 10.1097/01.wnr.0000183907.08149.14; Vingerhoets G, 2012, HUM BRAIN MAPP, V33, P763, DOI 10.1002/hbm.21247; Wu YJ, 2014, BRAIN COGNITION, V91, P87, DOI 10.1016/j.bandc.2014.09.002; Yoshino K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00895; Yoshino K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00882; Yoshino K, 2012, NEUROREPORT, V23, P947, DOI 10.1097/WNR.0b013e328359833b	63	31	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127594	10.1371/journal.pone.0127594	http://dx.doi.org/10.1371/journal.pone.0127594			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI7BT	25993263	Green Published, gold, Green Submitted			2022-12-26	WOS:000354918600068
J	Sycz, G; Carrica, MC; Tseng, TS; Bogomolni, RA; Briggs, WR; Goldbaum, FA; Paris, G				Sycz, Gabriela; Carmen Carrica, Mariela; Tseng, Tong-Seung; Bogomolni, Roberto A.; Briggs, Winslow R.; Goldbaum, Fernando A.; Paris, Gaston			LOV Histidine Kinase Modulates the General Stress Response System and Affects the virB Operon Expression in Brucella abortus	PLOS ONE			English	Article							SIGMA-FACTOR MIMICRY; 2-COMPONENT SYSTEM; STRUCTURAL BASIS; CAULOBACTER-CRESCENTUS; SIGNAL-TRANSDUCTION; METHYLOBACTERIUM-EXTORQUENS; SINORHIZOBIUM-MELILOTI; ALPHA-PROTEOBACTERIA; REGULATOR; LIGHT	Brucella is the causative agent of the zoonotic disease brucellosis, and its success as an intracellular pathogen relies on its ability to adapt to the harsh environmental conditions that it encounters inside the host. The Brucella genome encodes a sensor histidine kinase containing a LOV domain upstream from the kinase, LOVHK, which plays an important role in light-regulated Brucella virulence. In this report we study the intracellular signaling pathway initiated by the light sensor LOVHK using an integrated biochemical and genetic approach. From results of bacterial two-hybrid assays and phosphotransfer experiments we demonstrate that LOVHK functionally interacts with two response regulators: PhyR and LovR, constituting a functional two-component signal-transduction system. LOVHK contributes to the activation of the General Stress Response (GSR) system in Brucella via PhyR, while LovR is proposed to be a phosphate-sink for LOVHK, decreasing its phosphorylation state. We also show that in the absence of LOVHK the expression of the virB operon is down-regulated. In conclusion, our results suggest that LOVHK positively regulates the GSR system in vivo, and has an effect on the expression of the virB operon. The proposed regulatory network suggests a similar role for LOVHK in other microorganisms.	[Sycz, Gabriela; Carmen Carrica, Mariela; Goldbaum, Fernando A.; Paris, Gaston] Fdn Inst Leloir IIBBA CONICET, Lab Inmunol & Microbiol Mol, Buenos Aires, DF, Argentina; [Tseng, Tong-Seung; Briggs, Winslow R.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Bogomolni, Roberto A.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Carnegie Institution for Science; University of California System; University of California Santa Cruz	Paris, G (corresponding author), Fdn Inst Leloir IIBBA CONICET, Lab Inmunol & Microbiol Mol, Buenos Aires, DF, Argentina.	gparis@leloir.org.ar	; Paris, Gaston/J-6100-2014	Goldbaum, Fernando/0000-0001-6235-3002; Paris, Gaston/0000-0001-5984-7394	Agencia Nacional de Promocion Cientifica [PICT-2011-2672]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP-2012]; National Science Foundation [0843617]; CONICET	Agencia Nacional de Promocion Cientifica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Science Foundation(National Science Foundation (NSF)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Agencia Nacional de Promocion Cientifica (www.agencia.mincyt.gob.ar) grant PICT-2011-2672 to FAG, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(www.conicet.gov.ar) PIP-2012 to GP and National Science Foundation (www.nsf.gov) 0843617 to WRB. FAG and GP are researchers of CONICET. GS is recipient of a fellowship of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abromaitis S, 2013, J BACTERIOL, V195, P2662, DOI 10.1128/JB.01972-12; Alvarez-Martinez CE, 2007, MOL MICROBIOL, V66, P1240, DOI 10.1111/j.1365-2958.2007.06005.x; Arocena GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035394; Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; Bastiat B, 2010, J BACTERIOL, V192, P2255, DOI 10.1128/JB.01666-09; Campagne S, 2012, P NATL ACAD SCI USA, V109, pE1405, DOI 10.1073/pnas.1117003109; Cao Z, 2008, BIOPHYS J, V94, P897, DOI 10.1529/biophysj.107.108977; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Correa F, 2013, BIOCHEMISTRY-US, V52, P4656, DOI 10.1021/bi400617y; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; Deighan P, 2008, P NATL ACAD SCI USA, V105, P15305, DOI 10.1073/pnas.0805757105; Carrica MD, 2012, MOL MICROBIOL, V85, P39, DOI 10.1111/j.1365-2958.2012.08095.x; Delory M, 2006, J BACTERIOL, V188, P7707, DOI 10.1128/JB.00644-06; Eskra L, 2001, INFECT IMMUN, V69, P7736, DOI 10.1128/IAI.69.12.7736-7742.2001; Ferooz J, 2011, MICROBIOL-SGM, V157, P1263, DOI 10.1099/mic.0.044875-0; Foreman R, 2012, J BACTERIOL, V194, P3038, DOI 10.1128/JB.00182-12; Francez-Charlot A, 2009, P NATL ACAD SCI USA, V106, P3467, DOI 10.1073/pnas.0810291106; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gourion B, 2008, J BACTERIOL, V190, P1027, DOI 10.1128/JB.01483-07; Gourion B, 2009, MOL MICROBIOL, V73, P291, DOI 10.1111/j.1365-2958.2009.06769.x; Gourley CR, 2015, PATHOG DIS, V73, DOI 10.1111/2049-632X.12209; Hallez R, 2007, EMBO J, V26, P1444, DOI 10.1038/sj.emboj.7601577; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Herrou J, 2012, P NATL ACAD SCI USA, V109, pE1415, DOI 10.1073/pnas.1116887109; Herrou J, 2010, MOL MICROBIOL, V78, P290, DOI 10.1111/j.1365-2958.2010.07323.x; Iguchi H, 2013, ARCH MICROBIOL, V195, P717, DOI 10.1007/s00203-013-0922-6; Jans A, 2013, MICROBIOLOGYOPEN, V2, P976, DOI 10.1002/mbo3.137; Kaczmarczyk A, 2011, J BACTERIOL, V193, P6629, DOI 10.1128/JB.06006-11; Karniol B, 2004, J BACTERIOL, V186, P445, DOI 10.1128/JB.186.2.445-453.2004; Kim HS, 2014, MOL MICROBIOL, V94, P913, DOI 10.1111/mmi.12809; Kim HS, 2013, J BIOL CHEM, V288, P13906, DOI 10.1074/jbc.M113.459305; Krauss U, 2009, J BACTERIOL, V191, P7234, DOI 10.1128/JB.00923-09; Kulkarni G, 2013, J BACTERIOL, V195, P2490, DOI 10.1128/JB.00186-13; Lacerda TLS, 2013, CURR OPIN MICROBIOL, V16, P45, DOI 10.1016/j.mib.2012.11.005; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lourenco RF, 2011, MOL MICROBIOL, V80, P1598, DOI 10.1111/j.1365-2958.2011.07668.x; Metzger LC, 2013, MICROBIOL-SGM, V159, P1067, DOI 10.1099/mic.0.066068-0; Ondrusch N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016151; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pazy Y, 2009, J MOL BIOL, V392, P1205, DOI 10.1016/j.jmb.2009.07.064; Price CW, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P301; Purcell EB, 2007, P NATL ACAD SCI USA, V104, P18241, DOI 10.1073/pnas.0705887104; Purcell EB, 2010, BIOCHEMISTRY-US, V49, P6761, DOI 10.1021/bi1006404; Rinaldi J, 2012, J MOL BIOL, V420, P112, DOI 10.1016/j.jmb.2012.04.006; Roop RM, 2009, MED MICROBIOL IMMUN, V198, P221, DOI 10.1007/s00430-009-0123-8; Rouot B, 2003, INFECT IMMUN, V71, P1075, DOI 10.1128/IAI.71.3.1075-1082.2003; Bonomi HR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009435; Sambrook J., 1989, MOLECULAR CLONING A; Sauviac L, 2007, J BACTERIOL, V189, P4204, DOI 10.1128/JB.00175-07; Sauviac L, 2014, J BACTERIOL, V196, P2526, DOI 10.1128/JB.01623-14; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Sieira R, 2000, J BACTERIOL, V182, P4849, DOI 10.1128/JB.182.17.4849-4855.2000; Sieira R, 2004, MOL MICROBIOL, V54, P808, DOI 10.1111/j.1365-2958.2004.04316.x; Sieira R, 2013, FUTURE MICROBIOL, V8, P1193, DOI 10.2217/fmb.13.83; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Staron A, 2010, MOL MICROBIOL, V78, P271, DOI 10.1111/j.1365-2958.2010.07336.x; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Swartz TE, 2007, SCIENCE, V317, P1090, DOI 10.1126/science.1144306; Thomas SA, 2008, MOL MICROBIOL, V69, P453, DOI 10.1111/j.1365-2958.2008.06296.x; Unger T, 2010, J STRUCT BIOL, V172, P34, DOI 10.1016/j.jsb.2010.06.016; Van der Henst C, 2012, J BACTERIOL, V194, P5305, DOI 10.1128/JB.00699-12; von Bargen K, 2012, FEMS MICROBIOL REV, V36, P533, DOI 10.1111/j.1574-6976.2012.00334.x	65	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0124058	10.1371/journal.pone.0124058	http://dx.doi.org/10.1371/journal.pone.0124058			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993430	gold, Green Published, Green Submitted			2022-12-26	WOS:000354918600007
J	Yang, P; Qin, Y; Bian, C; Zhao, YD; Zhang, W				Yang, Ping; Qin, Yu; Bian, Chen; Zhao, Yandong; Zhang, Wen			Intrathecal Delivery of IL-6 Reactivates the Intrinsic Growth Capacity of Pyramidal Cells in the Sensorimotor Cortex after Spinal Cord Injury	PLOS ONE			English	Article							FUNCTIONAL RECOVERY; AXON REGENERATION; NEUROTROPHIC FACTOR; SENSORY NEURONS; NEURITE GROWTH; ADULT CNS; INTERLEUKIN-6; BRAIN; NERVE; EXPRESSION	We have previously demonstrated the growth-promoting effect of intrathecal delivery of recombinant rat IL-6 immediately after corticospinal tract (CST) injury. Our present study aims to further clarify whether intrathecal delivery of IL-6 after CST injury could reactivate the intrinsic growth capacity of pyramidal cells in the sensorimotor cortex which project long axons to the spinal cord. We examined, by ELISA, levels of cyclic adenosine monophosphate (cAMP), adenylyl cyclase (AC, which synthesizes cAMP), phosphodiesterases (PDE, which degrades cAMP), and, by RT-PCR, the expression of regeneration-associated genes in the rat sensorimotor cortex after intrathecal delivery of IL-6 for 7 days, started immediately after CST injury. Furthermore, we injected retrograde neuronal tracer Fluorogold (FG) to the spinal cord to label pyramidal cells in the sensorimotor cortex, layers V and VI, combined with beta III-tubulin immunostaining, then we analyzed by immunohistochemisty and western blot the expression of the co-receptor gp-130 of IL-6 family, and pSTAT3 and mTOR, downstream IL-6/JAK/STAT3 and PI3K/AKT/mTOR signaling pathways respectively. We showed that intrathecal delivery of IL-6 elevated cAMP level and upregulated the expression of regeneration-associated genes including GAP-43, SPRR1A, CAP-23 and JUN-B, and the expression of pSTAT3 and mTOR in pyramidal cells of the sensorimotor cortex. In contrast, AG490, an inhibitor of JAK, partially blocked these effects of IL-6. All these results indicate that intrathecal delivery of IL-6 immediately after spinal cord injury can reactivate the intrinsic growth capacity of pyramidal cells in the sensorimotor cortex and these effects of IL-6 were partially JAK/STAT3-dependent.	[Yang, Ping; Bian, Chen; Zhao, Yandong] Third Mil Med Univ, Chongqing Key Lab Neurobiol, Dept Neurobiol, Chongqing 400038, Peoples R China; [Qin, Yu; Zhang, Wen] Third Mil Med Univ, Cadet Brigade, Chongqing 400038, Peoples R China	Army Medical University; Army Medical University	Yang, P (corresponding author), Third Mil Med Univ, Chongqing Key Lab Neurobiol, Dept Neurobiol, Chongqing 400038, Peoples R China.	cp_yang_1999@yahoo.com			National Natural Science Foundation of China (NSFC) [81171719]; Chongqing Natural Science of Foundation of China (CSTC) [2008 BB5281]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science of Foundation of China (CSTC)	This work was supported by grants from the National Natural Science Foundation of China (NSFC No: 81171719) and from Chongqing Natural Science of Foundation of China (CSTC, 2008 BB5281).	Batchelor PE, 1999, J NEUROSCI, V19, P1708; Beattie EC, 1996, COLD SPRING HARB SYM, V61, P389; Bechmann I, 1997, HISTOCHEM CELL BIOL, V107, P391, DOI 10.1007/s004180050125; BENVENISTE EN, 1995, INT J DEV NEUROSCI, V13, P341, DOI 10.1016/0736-5748(94)00061-7; Boyd JG, 2003, MOL NEUROBIOL, V27, P277, DOI 10.1385/MN:27:3:277; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Canu MH, 2010, BEHAV BRAIN RES, V209, P289, DOI 10.1016/j.bbr.2010.02.006; Cao ZX, 2006, J NEUROSCI, V26, P5565, DOI 10.1523/JNEUROSCI.0815-06.2006; Chan K, 2014, EXP NEUROL; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; German CL, 2011, EXP CELL RES, V317, P1955, DOI 10.1016/j.yexcr.2011.05.009; Giordano V, 1997, J IMMUNOL, V158, P4097; Hakkoum D, 2007, J NEUROCHEM, V100, P747, DOI 10.1111/j.1471-4159.2006.04257.x; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Harrington AW, 2013, NAT REV NEUROSCI, V14, P177, DOI 10.1038/nrn3253; He Y, 2003, NEURON, V39, P57; Heerssen HM, 2004, NAT NEUROSCI, V7, P596, DOI 10.1038/nn1242; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; KIEFER R, 1993, EUR J NEUROSCI, V5, P775, DOI 10.1111/j.1460-9568.1993.tb00929.x; Kim H, 1999, MOL CELL BIOL, V19, P5326; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Kurek JB, 1996, NEUROMUSCULAR DISORD, V6, P105, DOI 10.1016/0960-8966(95)00029-1; Leibinger M, 2013, CELL DEATH DIS; Leibinger M, 2012, NEUROBIOL DIS, V46, P314, DOI 10.1016/j.nbd.2012.01.004; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; MURPHY PG, 1995, J NEUROSCI, V15, P5130; Mutlu Leman K, 2004, Best Pract Res Clin Anaesthesiol, V18, P407, DOI 10.1016/j.bpa.2003.12.003; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; Niederost B, 2002, J NEUROSCI, V22, P10368; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Qiu J, 2005, J NEUROSCI, V25, P1645, DOI 10.1523/JNEUROSCI.3269-04.2005; Schwab JM, 2006, PROG NEUROBIOL, V78, P91, DOI 10.1016/j.pneurobio.2005.12.004; SCHWAB ME, 1990, EXP NEUROL, V109, P2, DOI 10.1016/S0014-4886(05)80003-2; Spooren A, 2011, BRAIN RES REV, V67, P157, DOI 10.1016/j.brainresrev.2011.01.002; Sun F, 2010, CURR OPIN NEUROBIOL, V20, P510, DOI 10.1016/j.conb.2010.03.013; Takahashi-Tezuka M, 1998, MOL CELL BIOL, V18, P4109, DOI 10.1128/MCB.18.7.4109; Yang P, 2012, EXP NEUROL, V236, P19, DOI 10.1016/j.expneurol.2012.03.019; Yang P, 2012, J NEUROL SCI, V312, P1, DOI 10.1016/j.jns.2011.08.037	42	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127772	10.1371/journal.pone.0127772	http://dx.doi.org/10.1371/journal.pone.0127772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25992975	gold, Green Published, Green Submitted			2022-12-26	WOS:000354918600074
J	Nathoo, N; Rogers, JA; Yong, VW; Dunn, JF				Nathoo, Nabeela; Rogers, James A.; Yong, V. Wee; Dunn, Jeff F.			Detecting Deoxyhemoglobin in Spinal Cord Vasculature of the Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis Using Susceptibility MRI and Hyperoxygenation	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; IRON DEPOSITION; HIGH-RESOLUTION; ANIMAL-MODEL; FIELD MRI; ARTERIAL; LESIONS; OXYGEN; BRAIN	Susceptibility-weighted imaging (SWI) detects hypointensities due to iron deposition and deoxyhemoglobin. Previously it was shown that SWI detects hypointensities in the experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis (MS), most of which are due to intravascular deoxyhemoglobin, with a small proportion being due to iron deposition in the central nervous system parenchyma and demyelination. However, animals had to be sacrificed to differentiate these two types of lesions which is impractical for time course studies or for human application. Here, we proposed altering the inspired oxygen concentration during imaging to identify deoxyhemoglobin-based hypointensities in vivo. SWI was performed on lumbar spinal cords of naive control and EAE mice using 30% O-2 then 100% O-2. Some mice were imaged using 30% O-2, 100% O-2 and after perfusion. Most SWI-visible hypointensities seen with 30% O-2 changed in appearance upon administration of 100% O-2, and were not visible after perfusion. That hypointensities changed with hyperoxygenation indicates that they were caused by deoxyhemoglobin. We show that increasing the inspired oxygen concentration identifies deoxyhemoglobin-based hypointensities in vivo. This could be applied in future studies to investigate the contribution of vascular-based hypointensities with SWI in EAE and MS over time.	[Nathoo, Nabeela; Rogers, James A.; Yong, V. Wee; Dunn, Jeff F.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Nathoo, Nabeela; Dunn, Jeff F.] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Rogers, James A.; Yong, V. Wee] Univ Calgary, Dept Clin Neurosci & Oncol, Calgary, AB, Canada; [Dunn, Jeff F.] Univ Calgary, Expt Imaging Ctr, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary	Dunn, JF (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	dunnj@ucalgary.ca	Nathoo, Nabeela/AAC-6098-2022	Yong, V. Wee/0000-0002-2600-3563; Nathoo, Nabeela/0000-0001-6446-1146	Canadian Institutes of Health Research [CRH-120244]; Natural Sciences and Engineering Research Council of Canada [RGPIN/386056-2010]; Canadian Foundation for Innovation, Alberta Innovates-Health Solutions [4933]; Multiple Sclerosis Society of Canada; Alberta endMS Regional Research and Training Centre of the endMS Research and Training Network; Alberta Innovates [201400620, 201300669] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation, Alberta Innovates-Health Solutions; Multiple Sclerosis Society of Canada; Alberta endMS Regional Research and Training Centre of the endMS Research and Training Network; Alberta Innovates	This work was supported by the Canadian Institutes of Health Research (CRH-120244), the Natural Sciences and Engineering Research Council of Canada (RGPIN/386056-2010), the Canadian Foundation for Innovation (Project #4933), Alberta Innovates-Health Solutions, the Multiple Sclerosis Society of Canada and the Alberta endMS Regional Research and Training Centre of the endMS Research and Training Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addicott MA, 2009, HUM BRAIN MAPP, V30, P3102, DOI 10.1002/hbm.20732; Agrawal SM, 2011, J NEUROSCI, V31, P669, DOI 10.1523/JNEUROSCI.3659-10.2011; Ashkanian M, 2009, BRAIN RES, V1304, P90, DOI 10.1016/j.brainres.2009.09.076; Bagnato F, 2011, BRAIN, V134, P3599, DOI 10.1093/brain/awr278; Chavhan GB, 2009, RADIOGRAPHICS, V29, P1433, DOI 10.1148/rg.295095034; Eissa A, 2009, J MAGN RESON IMAGING, V30, P737, DOI 10.1002/jmri.21926; ElSankari S, 2013, J CEREBR BLOOD F MET, V33, P1314, DOI 10.1038/jcbfm.2013.95; Engberink RDO, 2010, MOL IMAGING, V9, P268, DOI 10.2310/7290.2010.00016; Haacke EM, 2009, J MAGN RESON IMAGING, V29, P537, DOI 10.1002/jmri.21676; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Ishizaka K, 2010, J MAGN RESON IMAGING, V31, P32, DOI 10.1002/jmri.21989; Johnston AJ, 2003, BRIT J ANAESTH, V90, P774, DOI 10.1093/bja/aeg104; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; Langkammer C, 2013, RADIOLOGY, V267, P551, DOI 10.1148/radiol.12120707; Lee J, 2012, NEUROIMAGE, V59, P3967, DOI 10.1016/j.neuroimage.2011.10.076; Mori Y, 2014, INT IMMUNOL, V26, P93, DOI 10.1093/intimm/dxt044; Nair JR, 2010, AM J ROENTGENOL, V195, P1007, DOI 10.2214/AJR.10.4218; Nathoo N, 2013, MULT SCLER J, V19, P721, DOI 10.1177/1352458512460602; Rauscher A, 2005, MAGNET RESON MED, V54, P87, DOI 10.1002/mrm.20520; Sati P, 2014, MULT SCLER J, V20, P1464, DOI 10.1177/1352458514525868; Schuh C, 2014, ACTA NEUROPATHOL, V128, P247, DOI 10.1007/s00401-014-1263-5; Steen C, 2013, MULT SCLER J, V19, P1282, DOI 10.1177/1352458513477228; Sun X, 1998, Ann Nucl Med, V12, P89; Vigue B, 2000, INTENS CARE MED, V26, P722, DOI 10.1007/s001340051238; Weaver A, 2005, FASEB J, V19, P1668, DOI 10.1096/fj.04-2030fje; Wiggermann V, 2013, NEUROLOGY, V81, P211, DOI 10.1212/WNL.0b013e31829bfd63; Wuerfel J, 2007, EUR J NEUROSCI, V26, P190, DOI 10.1111/j.1460-9568.2007.05644.x	27	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127033	10.1371/journal.pone.0127033	http://dx.doi.org/10.1371/journal.pone.0127033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992667	Green Published, Green Submitted, gold			2022-12-26	WOS:000354917300077
J	Zhou, HX; Gao, SG; Duan, XX; Liang, S; Scott, DA; Lamont, RJ; Wang, HZ				Zhou, Huaxin; Gao, Shegan; Duan, Xiaoxian; Liang, Shuang; Scott, David A.; Lamont, Richard J.; Wang, Huizhi			Inhibition of serum- and glucocorticoid-inducible kinase 1 enhances TLR-mediated inflammation and promotes endotoxin-driven organ failure	FASEB JOURNAL			English	Article						SGK1; inflammatory cytokines; TAK1; LPS	TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTORS; NF-KAPPA-B; PROTEIN-KINASE; SIGNALING PATHWAYS; CYTOKINE PRODUCTION; PI3K-AKT PATHWAY; IMMUNE-SYSTEM; TAK1; ACTIVATION	Serum- and glucocorticoid-regulated kinase (SGK) 1 is associated with several important pathologic conditions and plays a modulatory role in adaptive immune responses. However, the involvement and functional role of SGK1 in innate immune responses remain entirely unknown. In this study, we establish that SGK1 is a novel and potent negative regulator of TLR-induced inflammation. Pharmacologic inhibition of SGK1 or suppression by small interfering RNA enhances proinflammatory cytokine (TNF, IL-12, and IL-6) production in TLR-engaged monocytes, a result confirmed in Cre-loxP-mediated SGK1-deficient cells. SGK1 inhibition or gene deficiency results in increased phosphorylation of IKK, I kappa B alpha, and NF-kappa B p65 in LPS-stimulated cells. Enhanced NF-kappa B p65 DNA binding also occurs upon SGK1 inhibition. The subsequent enhancement of proinflammatory cytokines is dependent on the phosphorylation of TGF-beta-activated kinase 1 (TAK1), as confirmed by TAK1 gene silencing. In vivo relevance was established in a murine endotoxin model, in which we found that SGK1 inhibition aggravates the severity of multiple organ damage and enhances the inflammatory response by heightening both proinflammatory cytokine levels and neutrophil infiltration. These findings have identified an anti-inflammatory function of SGK1, elucidated the underlying intracellular mechanisms, and establish, for the first time, that SGK1 holds potential as a novel target for intervention in the control of inflammatory diseases.	[Zhou, Huaxin; Duan, Xiaoxian; Liang, Shuang; Scott, David A.; Lamont, Richard J.; Wang, Huizhi] Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, Louisville, KY 40202 USA; [Gao, Shegan] Henan Univ Sci & Technol, Affiliated Hosp 1, Inst Canc, Dept Oncol, Luoyang, Peoples R China; [Scott, David A.; Wang, Huizhi] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA	University of Louisville; Henan University of Science & Technology; University of Louisville	Lamont, RJ (corresponding author), Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, 501 South Preston St,Room 263D, Louisville, KY 40202 USA.	rich.lamont@louisville.edu; hhwang01@louisville.edu	Wang, Huizhi/M-8229-2015; Wang, Huizhi/AAA-3874-2020; Scott, David/GYU-8656-2022	Scott, David A./0000-0003-1007-2756	U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research [DE023633, DE017921, DE011111, DE017680]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017921, R01DE011111, R37DE011111, R21DE023633, R01DE017680] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by Grants DE023633 (to H.W.), DE017921 and DE011111 (to R.J.L.), and DE017680 (to D.A.S.) from the U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research.	Ackermann TF, 2011, CELL PHYSIOL BIOCHEM, V28, P137, DOI 10.1159/000331722; Ajibade AA, 2013, TRENDS IMMUNOL, V34, P307, DOI 10.1016/j.it.2013.03.007; Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Bethin KE, 2000, P NATL ACAD SCI USA, V97, P9317, DOI 10.1073/pnas.97.16.9317; Blunt MD, 2012, CURR OPIN PHARMACOL, V12, P444, DOI 10.1016/j.coph.2012.02.015; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Burgon J, 2014, J IMMUNOL, V192, P1796, DOI 10.4049/jimmunol.1300087; Coll RC, 2010, J INNATE IMMUN, V2, P406, DOI 10.1159/000315469; Courties G, 2010, BLOOD, V116, P3505, DOI 10.1182/blood-2010-02-269605; de Seigneux S, 2008, J BIOL CHEM, V283, P25671, DOI 10.1074/jbc.M803812200; Fan YH, 2010, J BIOL CHEM, V285, P5347, DOI 10.1074/jbc.M109.076976; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Gu MD, 2014, J IMMUNOL, V192, P2846, DOI 10.4049/jimmunol.1302537; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Heikamp EB, 2014, NAT IMMUNOL, V15, P457, DOI 10.1038/ni.2867; Hosoi T, 2005, AUTON NEUROSCI-BASIC, V120, P104, DOI 10.1016/j.autneu.2004.11.012; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Kim SY, 2014, MOL CELL BIOL, V34, P510, DOI 10.1128/MCB.01225-13; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Lang F, 2001, Sci STKE, V2001, pre17, DOI 10.1126/stke.2001.108.re17; Lee J, 2000, J LEUKOCYTE BIOL, V68, P909; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Li Liwu, 2004, Curr Drug Targets Inflamm Allergy, V3, P81, DOI 10.2174/1568010043483863; Lu XQ, 2014, NEPHROLOGY, V19, P307, DOI 10.1111/nep.12225; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Luyendyk JP, 2008, J IMMUNOL, V180, P4218, DOI 10.4049/jimmunol.180.6.4218; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; O'Neill LAJ, 2008, NAT IMMUNOL, V9, P459, DOI 10.1038/ni0508-459; PERLSTEIN RS, 1993, ENDOCRINOLOGY, V132, P946, DOI 10.1210/en.132.3.946; Rehani K, 2008, BBA-MOL CELL RES, V1783, P375, DOI 10.1016/j.bbamcr.2007.12.003; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schabbauer G, 2004, ARTERIOSCL THROM VAS, V24, P1963, DOI 10.1161/01.ATV.0000143096.15099.ce; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Tessier M, 2006, J CELL BIOCHEM, V98, P1391, DOI 10.1002/jcb.20894; Troutman TD, 2012, CELL CYCLE, V11, P3559, DOI 10.4161/cc.21572; Wagner JG, 1999, J LEUKOCYTE BIOL, V66, P10, DOI 10.1002/jlb.66.1.10; Waldegger S, 1999, GASTROENTEROLOGY, V116, P1081, DOI 10.1016/S0016-5085(99)70011-9; Wang HZ, 2013, J IMMUNOL, V191, P1164, DOI 10.4049/jimmunol.1203084; Wang HZ, 2011, J IMMUNOL, V186, P5217, DOI 10.4049/jimmunol.1002513; Wrann CD, 2007, J IMMUNOL, V178, P5940, DOI 10.4049/jimmunol.178.9.5940; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yu YM, 2006, J IMMUNOL, V176, P6194, DOI 10.4049/jimmunol.176.10.6194; Zhang WJ, 2007, P NATL ACAD SCI USA, V104, P4077, DOI 10.1073/pnas.0700305104; Zheng H, 2013, J BIOL CHEM, V288, P819, DOI 10.1074/jbc.M112.412643	54	21	23	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3737	3749		10.1096/fj.15-270462	http://dx.doi.org/10.1096/fj.15-270462			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	25993992	Green Published			2022-12-26	WOS:000359915600012
J	Liu, J; Qu, B; Zhu, YX; Hu, BX				Liu, Jie; Qu, Bo; Zhu, Yaxin; Hu, Bingxue			The Influence of Social Support on Quality of Life of Men Who Have Sex with Men in China: A Preliminary Study	PLOS ONE			English	Article							STRUCTURAL EQUATION MODEL; GAY MEN; HIV; HEALTH; DEPRESSION; WOMEN; STIGMA; EXPERIENCES; CHALLENGES; SYPHILIS	The quality of life (QOL) of men who have sex with men (MSM) has received increasing attention in recent years. Our study surveyed the QOL and explored the influence of social support on QOL in Chinese MSM. A cross-sectional survey was conducted from September 2013 to March 2014 of 438 MSM in Huludao and Zhengzhou City, China. The results of univariate analysis showed that higher QOL scores were associated with receiving psychosocial counseling, higher health education, younger age and marital status of being single or unmarried p < 0.05). The structural equation model fitted well, with chi(2) = 2083.47 (p < 0.05), RMSEA = 0.07, and GFI = 0.88. Among the latent factors, social support, with a factor load of 0.47, had greater impact on QOL than demographic characteristics. Within social support, the item loads for psychosocial counseling and health education were 0.17 and 0.29, respectively. Basic demographic characteristics also influenced social support, with a factor load of -0.65. For demographic characteristics, the greatest item loads were for marital status and age (0.77 and 0.71, respectively). These findings suggest that strengthening social support, especially for older and married individuals, would improve QOL in MSM in China.	[Liu, Jie; Qu, Bo; Zhu, Yaxin; Hu, Bingxue] China Med Univ, Sch Publ Hlth, Dept Hlth Stat, Shenyang 110001, Liaoning, Peoples R China	China Medical University	Qu, B (corresponding author), China Med Univ, Sch Publ Hlth, Dept Hlth Stat, Shenyang 110001, Liaoning, Peoples R China.	qubo6666@163.com			National Natural Science Foundation of China [81273186, 71473269]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant Number 81273186 and 71473269). BQ received the funding.	Asante KO, 2013, AFR HEALTH SCI, V13, P270, DOI 10.4314/ahs.v13i2.11; Baker SR, 2007, QUAL LIFE RES, V16, P297, DOI 10.1007/s11136-006-9108-x; Bastardo YM, 2000, AIDS CARE, V12, P673, DOI 10.1080/095401200750003842; Bouhnik AD, 2006, JAIDS-J ACQ IMM DEF, V42, P597, DOI 10.1097/01.qai.0000221674.76327.d7; Bucciardini R, 2014, HIV CLIN TRIALS, V15, P176, DOI 10.1310/hct1504-176; Cao Z, 2014, SEX TRANSM DIS, V41, P98, DOI 10.1097/OLQ.0000000000000074; Chirawu P, 2010, AIDS CARE, V22, P81, DOI 10.1080/09540120903012577; Chow EPF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089959; Chow EPF, 2013, SEX HEALTH, V10, P533, DOI 10.1071/SH13097; Darbes LA, 2012, AIDS BEHAV, V16, P159, DOI 10.1007/s10461-010-9868-8; Deuba K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058099; Eriksson LE, 2007, INT J STD AIDS, V18, P207, DOI 10.1258/095646207780132442; Feng MC, 2009, AIDS CARE, V21, P482, DOI 10.1080/09540120802290373; Fueki K, 2011, J ORAL REHABIL, V38, P86, DOI 10.1111/j.1365-2842.2010.02134.x; Gallicchio L, 2007, QUAL LIFE RES, V16, P777, DOI 10.1007/s11136-006-9162-4; Gielen AC, 2001, SOC SCI MED, V52, P315, DOI 10.1016/S0277-9536(00)00135-0; Gore-Felton C, 2006, J HEALTH PSYCHOL, V11, P711, DOI 10.1177/1359105306066626; Guo Y, 2011, AIDS BEHAV, V15, P521, DOI 10.1007/s10461-010-9808-7; Herbst JH, 2005, JAIDS-J ACQ IMM DEF, V39, P228; Hoover KW, 2010, SEX TRANSM DIS, V37, P771, DOI 10.1097/OLQ.0b013e3181e50058; Huang ZJ, 2012, AIDS BEHAV, V16, P858, DOI 10.1007/s10461-011-0119-4; Lari MA, 2013, IRAN J PSYCHIATRY BE, V7, P61; Li DL, 2010, AIDS PATIENT CARE ST, V24, P595, DOI 10.1089/apc.2010.0083; Li YZ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-531; Mavandadi S, 2009, JAIDS-J ACQ IMM DEF, V51, P91, DOI 10.1097/QAI.0b013e318199069b; Mazaheri M, 2012, IRAN J PSYCHIATRY, V5, P134; Mlay R, 2008, AIDS CARE, V20, P356, DOI 10.1080/09540120701561304; Mohamed BA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/971203; Munoz M, 2011, PSYCHIAT RES, V186, P402, DOI 10.1016/j.psychres.2010.06.019; Ou FR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038861; Rao D, 2012, INT J STD AIDS, V23, P481, DOI 10.1258/ijsa.2009.009428; Razavi P, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/849406; Safren SA, 2011, AIDS BEHAV, V15, pS30, DOI 10.1007/s10461-011-9898-x; Sandfort TGM, 2003, ARCH SEX BEHAV, V32, P15, DOI 10.1023/A:1021885127560; Semple SJ, 2012, DRUG ALCOHOL DEPEN, V125, P154, DOI 10.1016/j.drugalcdep.2012.04.007; Simoni JM, 2011, AIDS BEHAV, V15, P376, DOI 10.1007/s10461-010-9836-3; So WKW, 2013, EUR J ONCOL NURS, V17, P442, DOI 10.1016/j.ejon.2012.11.001; Srisurapanont M, 2001, AIDS PATIENT CARE ST, V15, P211, DOI 10.1089/10872910151133765; Stephenson R, 2014, AIDS CARE, V26, P191, DOI 10.1080/09540121.2013.808731; Sun W, 2014, INT J INFECT DIS, V28, P147, DOI 10.1016/j.ijid.2014.07.010; Tomarken AJ, 2005, ANNU REV CLIN PSYCHO, V1, P31, DOI 10.1146/annurev.clinpsy.1.102803.144239; Vyavaharkar M, 2011, AIDS EDUC PREV, V23, P78, DOI 10.1521/aeap.2011.23.1.78; Wang FTY, 2009, CULT HEALTH SEX, V11, P285, DOI 10.1080/13691050802572711; Wang Hsiu-Hung, 2003, Kaohsiung Journal of Medical Sciences, V19, P345, DOI 10.1016/S1607-551X(09)70436-X; Wong CF, 2014, PREV SCI, V15, P44, DOI 10.1007/s11121-012-0348-4; Wu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098366; Wu Z, 2010, J ACQ IMMUN DEF SYND, V53, P1, DOI DOI 10.1097/QAI.0B013E3181C7D379; Yadav S, 2010, QUAL LIFE RES, V19, P157, DOI 10.1007/s11136-009-9574-z; Yamamura S, 2005, J PHARM PHARM SCI, V8, P544; Yang C, 2013, J COMMUNITY PSYCHOL, V41, P435, DOI 10.1002/jcop.21548; Zhang L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058440, 10.1371/journal.pone.0066496]; ZHANG W., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0099693	52	5	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127644	10.1371/journal.pone.0127644	http://dx.doi.org/10.1371/journal.pone.0127644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010133	gold, Green Submitted, Green Published			2022-12-26	WOS:000355183900124
J	Ross, E; Ata, R; Thavarajah, T; Medvedev, S; Bowden, P; Marshall, JG; Antonescu, CN				Ross, Eden; Ata, Rehman; Thavarajah, Thanusi; Medvedev, Sergei; Bowden, Peter; Marshall, John G.; Antonescu, Costin N.			AMP-Activated Protein Kinase Regulates the Cell Surface Proteome and Integrin Membrane Traffic	PLOS ONE			English	Article							CANCER-CELLS; LIQUID-CHROMATOGRAPHY; INDUCED GROWTH; GLUCOSE-UPTAKE; ENERGY SENSOR; ENDOCYTOSIS; MIGRATION; RECEPTOR; A-769662; METABOLISM	The cell surface proteome controls numerous cellular functions including cell migration and adhesion, intercellular communication and nutrient uptake. Cell surface proteins are controlled by acute changes in protein abundance at the plasma membrane through regulation of endocytosis and recycling (endomembrane traffic). Many cellular signals regulate endomembrane traffic, including metabolic signaling; however, the extent to which the cell surface proteome is controlled by acute regulation of endomembrane traffic under various conditions remains incompletely understood. AMP-activated protein kinase (AMPK) is a key metabolic sensor that is activated upon reduced cellular energy availability. AMPK activation alters the endomembrane traffic of a few specific proteins, as part of an adaptive response to increase energy intake and reduce energy expenditure. How increased AMPK activity during energy stress may globally regulate the cell surface proteome is not well understood. To study how AMPK may regulate the cell surface proteome, we used cell-impermeable biotinylation to selectively purify cell surface proteins under various conditions. Using ESI-MS/MS, we found that acute (90 min) treatment with the AMPK activator A-769662 elicits broad control of the cell surface abundance of diverse proteins. In particular, A-769662 treatment depleted from the cell surface proteins with functions in cell migration and adhesion. To complement our mass spectrometry results, we used other methods to show that A-769662 treatment results in impaired cell migration. Further, A-769662 treatment reduced the cell surface abundance of beta 1-integrin, a key cell migration protein, and AMPK gene silencing prevented this effect. While the control of the cell surface abundance of various proteins by A-769662 treatment was broad, it was also selective, as this treatment did not change the cell surface abundance of the transferrin receptor. Hence, the cell surface proteome is subject to acute regulation by treatment with A-769662, at least some of which is mediated by the metabolic sensor AMPK.	[Ross, Eden; Ata, Rehman; Thavarajah, Thanusi; Medvedev, Sergei; Bowden, Peter; Marshall, John G.; Antonescu, Costin N.] Ryerson Univ, Dept Biol & Chem, Toronto, ON M5B 2K3, Canada	Toronto Metropolitan University	Antonescu, CN (corresponding author), Ryerson Univ, Dept Biol & Chem, 350 Victoria St, Toronto, ON M5B 2K3, Canada.	cantonescu@ryerson.ca	Marshall, John G/E-8974-2012	Marshall, John G/0000-0002-7124-1448; Antonescu, Costin/0000-0001-9192-6340	Ryerson University	Ryerson University	This work was supported by funding provided by Ryerson University to C.N.A. in the form of start-up funds and a Dean's Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Aguet F, 2013, DEV CELL, V26, P279, DOI 10.1016/j.devcel.2013.06.019; Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Antonescu CN, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016964; Antonescu CN, 2011, MOL BIOL CELL, V22, P2588, DOI 10.1091/mbc.E11-04-0362; Aoh QL, 2013, MOL BIOL CELL, V24, P832, DOI 10.1091/mbc.E12-10-0750; Benziane B, 2009, AM J PHYSIOL-CELL PH, V297, pC1554, DOI 10.1152/ajpcell.00010.2009; Bergeron JJ, 2007, NAT BIOTECHNOL, V25, P61, DOI 10.1038/nbt0107-61; Binz PA, 2008, NAT BIOTECHNOL, V26, P862, DOI 10.1038/nbt0808-862; Bisi S, 2013, CURR OPIN CELL BIOL, V25, P565, DOI 10.1016/j.ceb.2013.04.001; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Bowden P, 2012, J PROTEOME RES, V11, P2032, DOI 10.1021/pr2000013; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chen ZP, 2006, AM J RESP CELL MOL, V35, P127, DOI 10.1165/rcmb.2006-0044OC; Danzer C, 2012, J PROTEOME RES, V11, P1598, DOI 10.1021/pr2007895; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Faca VM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002425; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Ferla R, 2012, ONCOL LETT, V4, P1077, DOI 10.3892/ol.2012.843; Florentinus AK, 2012, J PROTEOMICS, V75, P1303, DOI 10.1016/j.jprot.2011.11.002; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Frasa MAM, 2012, NAT REV MOL CELL BIO, V13, P67, DOI 10.1038/nrm3267; Garcia-Garcia C, 2010, BIOCHEM PHARMACOL, V79, P853, DOI 10.1016/j.bcp.2009.10.022; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Gusarova GA, 2009, MOL CELL BIOL, V29, P3455, DOI 10.1128/MCB.00054-09; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jankowski A, 2008, ANAL BIOCHEM, V380, P235, DOI 10.1016/j.ab.2008.05.047; Jinadasa T, 2014, J BIOL CHEM, V289, P20879, DOI 10.1074/jbc.M114.555284; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kaiser R, 2012, J CELL MOL MED, V16, P2387, DOI 10.1111/j.1582-4934.2012.01553.x; Kanellis J, 2006, IMMUNOL CELL BIOL, V84, P6, DOI 10.1111/j.1440-1711.2005.01388.x; Kim AS, 2011, J MOL CELL CARDIOL, V51, P24, DOI 10.1016/j.yjmcc.2011.03.003; Klip A, 2009, ACTA PHYSIOL, V196, P27, DOI 10.1111/j.1748-1716.2009.01974.x; Kumar SH, 2009, J VIROL, V83, P8565, DOI 10.1128/JVI.00603-09; Lang MJ, 2014, J BIOL CHEM, V289, P16736, DOI 10.1074/jbc.M113.525782; Lee SK, 2013, ANAL BIOANAL CHEM, V405, P5501, DOI 10.1007/s00216-013-6969-z; Liang KW, 2008, EUR J PHARMACOL, V590, P343, DOI 10.1016/j.ejphar.2008.06.034; Liu XM, 2011, AM J PHYSIOL-HEART C, V300, pH84, DOI 10.1152/ajpheart.00749.2010; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Mai A, 2011, J CELL BIOL, V194, P291, DOI 10.1083/jcb.201012126; Moreno D, 2008, FEBS LETT, V582, P2650, DOI 10.1016/j.febslet.2008.06.044; Nakano A, 2010, NAT CELL BIOL, V12, P583, DOI 10.1038/ncb2060; Niehage C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020399; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; PosthumaDeBoer J, 2013, BRIT J CANCER, V109, P2142, DOI 10.1038/bjc.2013.578; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Rugg-Gunn PJ, 2012, DEV CELL, V22, P887, DOI 10.1016/j.devcel.2012.01.005; Samovski D, 2012, J LIPID RES, V53, P709, DOI 10.1194/jlr.M023424; Schiess R, 2009, MOL CELL PROTEOMICS, V8, P624, DOI 10.1074/mcp.M800172-MCP200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Sing A, 2014, CELL, V158, P1293, DOI 10.1016/j.cell.2014.07.036; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329; Treebak JT, 2009, AM J PHYSIOL-CELL PH, V297, pC1041, DOI 10.1152/ajpcell.00051.2009; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Vincent EE, 2015, ONCOGENE, V34, P3627, DOI 10.1038/onc.2014.301; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Xu KP, 2007, INVEST OPHTH VIS SCI, V48, P2242, DOI 10.1167/iovs.06-0560; Yang J, 2005, J BIOL CHEM, V280, P4070, DOI 10.1074/jbc.M410213200; Zhang JH, 2008, J BIOL CHEM, V283, P27452, DOI 10.1074/jbc.M802578200; Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104; Zhu PH, 2011, ANAL BIOCHEM, V409, P189, DOI 10.1016/j.ab.2010.10.027; Zhu YL, 2014, INT J MOL SCI, V15, P11190, DOI 10.3390/ijms150611190	81	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128013	10.1371/journal.pone.0128013	http://dx.doi.org/10.1371/journal.pone.0128013			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010094	gold, Green Published, Green Submitted			2022-12-26	WOS:000355183900183
J	Guarnizo, CE; Paz, A; Munoz-Ortiz, A; Flechas, SV; Mendez-Narvaez, J; Crawford, AJ				Guarnizo, Carlos E.; Paz, Andrea; Munoz-Ortiz, Astrid; Flechas, Sandra V.; Mendez-Narvaez, Javier; Crawford, Andrew J.			DNA Barcoding Survey of Anurans across the Eastern Cordillera of Colombia and the Impact of the Andes on Cryptic Diversity	PLOS ONE			English	Article							GENETIC DIFFERENTIATION; MOLECULAR PHYLOGENETICS; SPECIES RICHNESS; EVOLUTIONARY DIFFERENTIATION; MAXIMUM-LIKELIHOOD; CLIMATE-CHANGE; BODY-SIZE; LAND-USE; CONSERVATION; DIVERSIFICATION	Colombia hosts the second highest amphibian species diversity on Earth, yet its fauna remains poorly studied, especially using molecular genetic techniques. We present the results of the first wide-scale DNA barcoding survey of anurans of Colombia, focusing on a transect across the Eastern Cordillera. We surveyed 10 sites between the Magdalena Valley to the west and the eastern foothills of the Eastern Cordillera, sequencing portions of the mitochondrial 16S ribosomal RNA and cytochrome oxidase subunit 1 (CO1) genes for 235 individuals from 52 nominal species. We applied two barcode algorithms, Automatic Barcode Gap Discovery and Refined Single Linkage Analysis, to estimate the number of clusters or "unconfirmed candidate species" supported by DNA barcode data. Our survey included similar to 7% of the anuran species known from Colombia. While barcoding algorithms differed slightly in the number of clusters identified, between three and ten nominal species may be obscuring candidate species (in some cases, more than one cryptic species per nominal species). Our data suggest that the high elevations of the Eastern Cordillera and the low elevations of the Chicamocha canyon acted as geographic barriers in at least seven nominal species, promoting strong genetic divergences between populations associated with the Eastern Cordillera.	[Guarnizo, Carlos E.] Univ Brasilia, Dept Zool, BR-70910900 Brasilia, DF, Brazil; [Paz, Andrea; Munoz-Ortiz, Astrid; Flechas, Sandra V.; Mendez-Narvaez, Javier; Crawford, Andrew J.] Univ Los Andes, Dept Biol Sci, Bogota 4976, Colombia; [Munoz-Ortiz, Astrid] La Salle Univ, Dept Basic Sci, Bogota, Colombia; [Crawford, Andrew J.] Smithsonian Trop Res Inst, Panama City, Panama	Universidade de Brasilia; Universidad de los Andes (Colombia); Universidad de La Salle; Smithsonian Institution; Smithsonian Tropical Research Institute	Guarnizo, CE (corresponding author), Univ Brasilia, Dept Zool, BR-70910900 Brasilia, DF, Brazil.	carlosguarnizo@gmail.com	Guarnizo, Carlos E/A-6383-2011; Crawford, Andrew J./G-6365-2012; Narvaez, Javier Mendez/AAK-7534-2020; Paz, Andrea/W-1068-2019	Guarnizo, Carlos E/0000-0001-7324-1241; Crawford, Andrew J./0000-0003-3153-6898; Paz, Andrea/0000-0001-6484-1210; Flechas, Sandra/0000-0002-3967-5991; Mendez Narvaez, Javier/0000-0001-6127-3377	Ecopetrol [156-09]	Ecopetrol	Field and laboratory work were financed by grant number 156-09 from Ecopetrol. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AmphibiaWeb, 2013, INF AMPH BIOL CONS; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; BARTON NH, 1995, PHILOS T ROY SOC B, V349, P49, DOI 10.1098/rstb.1995.0090; Beebee TJC, 2005, HEREDITY, V95, P423, DOI 10.1038/sj.hdy.6800736; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Bernal XE, 2005, HERPETOLOGICA, V61, P395, DOI 10.1655/04-87.1; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bush MB, 2002, GLOBAL ECOL BIOGEOGR, V11, P463, DOI 10.1046/j.1466-822X.2002.00305.x; Cadena CD, 2007, MOL PHYLOGENET EVOL, V44, P993, DOI 10.1016/j.ympev.2006.12.012; Cadena CD, 2010, BIOL J LINN SOC, V99, P152, DOI 10.1111/j.1095-8312.2009.01333.x; Chaves JA, 2011, MOL ECOL, V20, P4564, DOI 10.1111/j.1365-294X.2011.05304.x; Che J, 2012, MOL ECOL RESOUR, V12, P247, DOI 10.1111/j.1755-0998.2011.03090.x; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Chevallier P, 2011, REG ENVIRON CHANGE, V11, pS179, DOI 10.1007/s10113-010-0177-6; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Crawford AJ, 2013, MOL ECOL RESOUR, V13, P1005, DOI 10.1111/1755-0998.12054; DeSalle R, 2006, CONSERV BIOL, V20, P1545, DOI 10.1111/j.1523-1739.2006.00543.x; Duellman WE, 1999, PATTERNS OF DISTRIBU; Duforet-Frebourg N, 2014, EVOLUTION, V68, P1110, DOI 10.1111/evo.12342; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ersts P, 2011, GEOGRAPHIC DISTANCE; Feeley KJ, 2010, GLOBAL CHANGE BIOL, V16, P3215, DOI 10.1111/j.1365-2486.2010.02197.x; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fouquet A, 2007, MOL PHYLOGENET EVOL, V43, P567, DOI 10.1016/j.ympev.2006.12.006; Funk WC, 2009, J EVOLUTION BIOL, V22, P1839, DOI 10.1111/j.1420-9101.2009.01795.x; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; Gehara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103958; Glaw Frank, 1998, Herpetological Review, V29, P11; Gonzalez-Voyer A, 2011, J EVOLUTION BIOL, V24, P931, DOI 10.1111/j.1420-9101.2011.02243.x; Guarnizo CE, 2013, J ZOOL SYST EVOL RES, V51, P333, DOI 10.1111/jzs.12027; Guarnizo CE, 2012, HERPETOLOGICA, V68, P523, DOI 10.1655/HERPETOLOGICA-D-10-00038; Guarnizo CE, 2009, MOL PHYLOGENET EVOL, V50, P84, DOI 10.1016/j.ympev.2008.10.005; Gutierrez-Pinto N, 2012, MOL PHYLOGENET EVOL, V64, P156, DOI 10.1016/j.ympev.2012.03.011; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hamilton CA, 2014, MOL PHYLOGENET EVOL, V71, P79, DOI 10.1016/j.ympev.2013.11.007; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hooghiemstra H, 2004, PHILOS T ROY SOC B, V359, P173, DOI 10.1098/rstb.2003.1420; Horton B.K., 2010, GSAT, V20, P4, DOI [10.1130/GSATG76A.1, DOI 10.1130/GSATG76A.1]; Hutter CR, 2013, ECOL LETT, V16, P1135, DOI 10.1111/ele.12148; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Kattan GH, 2004, J BIOGEOGR, V31, P1829, DOI 10.1111/j.1365-2699.2004.01109.x; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kohler J, 2008, TRENDS RATES AMPHIBI, V18; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lou M, 2012, MOL PHYLOGENET EVOL, V65, P765, DOI 10.1016/j.ympev.2012.07.033; Lynch John D., 1997, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V21, P237; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Munoz-Ortiz A, 2015, J BIOGEOGR, V42, P193, DOI 10.1111/jbi.12409; Murphy RW, 2013, MOL ECOL RESOUR, V13, P161, DOI 10.1111/1755-0998.12050; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pabijan M, 2012, J EVOLUTION BIOL, V25, P2310, DOI 10.1111/j.1420-9101.2012.02613.x; Padial JM, 2007, ZOOTAXA, P67, DOI 10.11646/zootaxa.1586.1.7; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Palumbi Stephen R., 1996, P205; Parra JL, 2009, MOL PHYLOGENET EVOL, V53, P425, DOI 10.1016/j.ympev.2009.07.006; Paz A, 2012, J BIOSCIENCES, V37, P887, DOI 10.1007/s12038-012-9255-x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Romdal TS, 2013, GLOBAL ECOL BIOGEOGR, V22, P344, DOI 10.1111/j.1466-8238.2012.00786.x; Sarkinen TE, 2011, TAXON, V60, P139, DOI 10.1002/tax.601012; Santos JC, 2009, PLOS BIOL, V7, P448, DOI 10.1371/journal.pbio.1000056; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Slade RW, 1998, P ROY SOC B-BIOL SCI, V265, P769, DOI 10.1098/rspb.1998.0359; Smith MA, 2005, ECOGRAPHY, V28, P110; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Torres-Carvajal O, 2007, COPEIA, P56, DOI 10.1643/0045-8511(2007)7[56:NASOSS]2.0.CO;2; Valderrama E, 2014, J BIOGEOGR, V41, P1533, DOI 10.1111/jbi.12317; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Vargas-Ramirez M, 2014, S AM J HERPETOL, V9, P131, DOI 10.2994/SAJH-D-13-00013.1; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Vuille M, 2008, EARTH-SCI REV, V89, P79, DOI 10.1016/j.earscirev.2008.04.002; WADE MJ, 1988, EVOLUTION, V42, P995, DOI 10.1111/j.1558-5646.1988.tb02518.x; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Wake DB, 2009, ANNU REV ECOL EVOL S, V40, P333, DOI 10.1146/annurev.ecolsys.39.110707.173552; Wang IJ, 2013, ECOL LETT, V16, P175, DOI 10.1111/ele.12025; Weigt LA, 2005, MOL ECOL, V14, P3857, DOI 10.1111/j.1365-294X.2005.02707.x; Weir JT, 2009, ANN MO BOT GARD, V96, P410, DOI 10.3417/2008011; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wiens JJ, 2003, SYST BIOL, V52, P501, DOI 10.1080/10635150390218222; Wollenberg KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-217; Wright S, 1943, GENETICS, V28, P114	97	41	47	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127312	10.1371/journal.pone.0127312	http://dx.doi.org/10.1371/journal.pone.0127312			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000447	Green Published, gold, Green Submitted			2022-12-26	WOS:000354931700049
J	Wang, S; Hannafon, BN; Lind, SE; Ding, WQ				Wang, Shuai; Hannafon, Bethany N.; Lind, Stuart E.; Ding, Wei-Qun			Zinc Protoporphyrin Suppresses beta-Catenin Protein Expression in Human Cancer Cells: The Potential Involvement of Lysosome-Mediated Degradation	PLOS ONE			English	Article							MEMBRANE PERMEABILIZATION; TUMOR-GROWTH; BREFELDIN-A; PROTEASOME; MECHANISM; APOPTOSIS; ENDOCYTOSIS; INHIBITION; CLIOQUINOL; INDUCTION	Zinc protoporphyrin (ZnPP) has been found to have anticancer activity both in vitro and in vivo. We have recently demonstrated that ZnPP diminishes beta-catenin protein expression in cancer cells. The present study examined the cellular mechanisms that mediate ZnPP's suppression of beta-catenin expression. We demonstrate that ZnPP induces a rapid degradation of the beta-catenin protein in cancer cells, which is accompanied by a significant inhibition of proteasome activity, suggesting that proteasome degradation does not directly account for the suppression. The possibility that ZnPP induces beta-catenin exportation was rejected by the observation that there was no detectable beta-catenin protein in the conditioned medium after ZnPP treatment of cancer cells. Further experimentation demonstrated that ZnPP induces lysosome membrane permeabilization, which was reversed by pretreatment with a protein transportation inhibitor cocktail containing Brefeldin A (BFA) and Monensin. More significantly, pretreatment of cancer cells with BFA and Monensin attenuated the ZnPP-induced suppression of beta-catenin expression in a concentration-and time-dependent manner, indicating that the lysosome protein degradation pathway is likely involved in the ZnPP-induced suppression of beta-catenin expression. Whether there is cross-talk between the ubiquitin-proteasome system and the lysosome pathway that may account for ZnPP-induced beta-catenin protein degradation is currently unknown. These findings provide a novel mechanism of ZnPP's anticancer action and reveal a potential new strategy for targeting the beta-catenin Wnt signaling pathway for cancer therapy.	[Wang, Shuai; Hannafon, Bethany N.; Ding, Wei-Qun] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Lind, Stuart E.] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO USA; [Lind, Stuart E.] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Ding, WQ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA.	weiqun-ding@ouhsc.edu	Hannafon, Bethany N./R-1233-2019	Hannafon, Bethany N./0000-0003-0596-9171	American Cancer Society [CNE-117557]; Susan G. Komen for the Cure Foundation [KG081083]; NIH OK-INBRE program [3P20RR016478-09S2]; Oklahoma Center for the Advancement of Science and Technology [HR14-147]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103447, U54GM104938] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); NIH OK-INBRE program; Oklahoma Center for the Advancement of Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the American Cancer Society (CNE-117557) to WQD, Susan G. Komen for the Cure Foundation (KG081083) to WQD, NIH OK-INBRE program (3P20RR016478-09S2) to WQD and the Oklahoma Center for the Advancement of Science and Technology (HR14-147) to WQD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrova A, 2008, CELL BIOCHEM FUNCT, V26, P392, DOI 10.1002/cbf.1459; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Chi CW, 2010, J BIOL CHEM, V285, P21817, DOI 10.1074/jbc.M110.131714; Ciechanover A, 2013, BIOORGAN MED CHEM, V21, P3400, DOI 10.1016/j.bmc.2013.01.056; Cvek B, 2008, J MED CHEM, V51, P6256, DOI 10.1021/jm8007807; Ding WQ, 2005, CANCER RES, V65, P3389, DOI 10.1158/0008-5472.CAN-04-3577; Erdal H, 2005, P NATL ACAD SCI USA, V102, P192, DOI 10.1073/pnas.0408592102; Fang J, 2012, EUR J PHARM BIOPHARM, V81, P540, DOI 10.1016/j.ejpb.2012.04.016; Hirai K, 2007, INT J CANCER, V120, P500, DOI 10.1002/ijc.22287; Janda E, 2006, ONCOGENE, V25, P7117, DOI 10.1038/sj.onc.1209701; Kim I, 2004, EXP CELL RES, V298, P229, DOI 10.1016/j.yexcr.2004.04.017; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; La P, 2009, J BIOL CHEM, V284, P36302, DOI 10.1074/jbc.M109.031641; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Misinzo G, 2008, J VIROL, V82, P1128, DOI 10.1128/JVI.01229-07; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nowis D, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-197; O'Neil-Andersen NJ, 2002, CLIN DIAGN LAB IMMUN, V9, P243, DOI 10.1128/CDLI.9.2.243-250.2001; ODA K, 1989, BIOCHEM BIOPH RES CO, V163, P220, DOI 10.1016/0006-291X(89)92124-4; Pan J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013298; POHLMANN R, 1984, BIOCHEM J, V217, P649, DOI 10.1042/bj2170649; Polakis P, 2012, EMBO J, V31, P2737, DOI 10.1038/emboj.2012.126; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rattan S, 2000, J PHARMACOL EXP THER, V294, P1009; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Tanaka S, 2003, BRIT J CANCER, V88, P902, DOI 10.1038/sj.bjc.6600830; Wang S, 2013, BIOCHEM PHARMACOL, V85, P1611, DOI 10.1016/j.bcp.2013.03.011; Yang G, 2001, BLOOD, V97, P1306, DOI 10.1182/blood.V97.5.1306; Yu HJ, 2009, BIOCHEM J, V417, P133, DOI 10.1042/BJ20081421; Zhang XX, 2011, J BIOL CHEM, V286, P1429, DOI 10.1074/jbc.M110.146530; Zhang Z, 2012, J BIOL INORG CHEM, V17, P1257, DOI 10.1007/s00775-012-0940-x	34	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127413	10.1371/journal.pone.0127413	http://dx.doi.org/10.1371/journal.pone.0127413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000787	Green Submitted, Green Published, gold			2022-12-26	WOS:000354931700058
J	Mahapatra, T; Biswas, S; Nandi, S; Ghosh, P; Ghosh, M; Mondal, S; Saha, MK				Mahapatra, Tanmay; Biswas, Subrata; Nandi, Srijita; Ghosh, Piyali; Ghosh, Mallika; Mondal, Soumya; Saha, Malay K.			Burden and Correlates of HIV among Men Who Have Sex with Men in West Bengal, India: Analysis of Sentinel Surveillance Data	PLOS ONE			English	Article							KOTHI-IDENTIFIED MEN; RISK BEHAVIORS; ANDHRA-PRADESH; CHENNAI; PREVENTION; INFECTION; MSM; PREVALENCE; WOMEN; MUMBAI	Background Little is known about the socio-behavioral risk factors for HIV acquisition among hard-to-reach men who have sex with men (MSM) population in India, particularly from the densely populated eastern part. Thus to measure the burden and correlates of HIV among MSM in West Bengal state of eastern India, a cross-sectional analysis of the national HIV Sentinel Surveillance (HSS) data was conducted. Methods In 2011, between July and September, involving all sentinel sites of the state, 1237 consenting MSM were anonymously interviewed and tested for HIV following national guidelines. Using a short, structured questionnaire, information was collected on socio-behavioral factors along with sexual practices and was analyzed to determine burden of HIV and the role of its socio-behavioral correlates on HIV acquisition. Results Among participants, mean age was 23.4 years, 44.55% were "Kothis" (usually receptive partner) and 25.1% admitted receiving money for sex with man. HIV sero-positivity was 5.09%. Using logistic regression method, for both bivariate and multivariate (with saturated model) analyses, transport-workers [adjusted odds ratio (AOR)=8.95, 95% confidence interval (95% CI): 1.09-73.71), large business-owners/self-employed (AOR=8.46, 95% CI: 1.25-57.49), small business-owners/cultivators (AOR=7.90, 95% CI: 1.67-37.38), those who visited the sentinel site for official purposes (AOR=7.60, 95% CI: 1.21-47.83) and paying money for having sex with men (AOR=3.03, 95% CI: 1.10-8.33) were strongly associated with higher HIV sero-positivity with than their counterparts. Using the parsimonious model for multivariate analysis, Kothis (AOR=4.64, 95% CI: 1.03-20.89), paying (AOR=2.96, 95% CI: 1.15-7.58) or receiving (AOR=2.06, 95% CI: 1.06-3.99) money for having sex with a man were associated with higher risk of HIV. Conclusions Focused intervention targeting the high risk MSM subgroups including Kothis, transport-workers, business-owners/self-employed and those who exchanged money for having sex with men, seemed to be the need of the hour for preventing the spread of HIV infection within and from this understudied population.	[Mahapatra, Tanmay; Biswas, Subrata; Nandi, Srijita; Ghosh, Piyali; Ghosh, Mallika; Saha, Malay K.] Natl Inst Cholera & Enter Dis, Scheme XM, Kolkata, W Bengal, India; [Mondal, Soumya] West Bengal AIDS Prevent & Control Soc, Monitoring & Evaluat Div, Kolkata, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Saha, MK (corresponding author), Natl Inst Cholera & Enter Dis, Scheme XM, P-33, Kolkata, W Bengal, India.	sahamk@yahoo.com			Regional Institute for HIV Sentinel Surveillance Fund of National AIDS Control Organization (NACO), New Delhi, Government of India [T.11020/113/2008-NACO]	Regional Institute for HIV Sentinel Surveillance Fund of National AIDS Control Organization (NACO), New Delhi, Government of India	This work was supported by the Regional Institute for HIV Sentinel Surveillance Fund [No. T.11020/113/2008-NACO (BSD)] of National AIDS Control Organization (NACO), New Delhi, Government of India (http://naco.gov.in/NACO/National_AIDS_Control_Program/10711/). MKS received the funding. The funder designed the HIV sentinel surveillance and its implementation but had no role in this study design, data compilation and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, STAT FACT SHEETS NAT; [Anonymous], 2012, ANN REP 2011 2012 GO; [Anonymous], 2011, ANN HIV SENT SURV CO; [Anonymous], 2013, ANN REP 2012 2013 GO; Asthana S, 2001, SOC SCI MED, V52, P707, DOI 10.1016/S0277-9536(00)00167-2; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Brahmam GNV, 2008, AIDS, V22, pS45, DOI 10.1097/01.aids.0000343763.54831.15; Census of India, 2011, CENS OF IND; Chakrapani V, 2008, CULT HEALTH SEX, V10, P313, DOI 10.1080/13691050701816714; Chakrapani V, 2011, AIDS CARE, V23, P1687, DOI 10.1080/09540121.2011.582076; Dandona L, 2005, AIDS, V19, P611, DOI 10.1097/01.aids.0000163938.01188.e4; Deb Soumya, 2009, Indian J Community Med, V34, P206, DOI 10.4103/0970-0218.55285; Go VF, 2004, JAIDS-J ACQ IMM DEF, V35, P314, DOI 10.1097/00126334-200403010-00014; Gupta A, 2006, JAIDS-J ACQ IMM DEF, V43, P483; Hernandez AL, 2006, AIDS BEHAV, V10, pS5, DOI 10.1007/s10461-006-9129-z; Jha UM, 2014, HIV AIDS-RES PALLIAT, V6, P159, DOI 10.2147/HIV.S69708; Khan S, 2001, J HOMOSEXUAL, V40, P99, DOI 10.1300/J082v40n03_06; KUMAR B, 1991, INT J STD AIDS, V2, P442, DOI 10.1177/095646249100200611; Kumta S, 2010, JAIDS-J ACQ IMM DEF, V53, P227, DOI 10.1097/QAI.0b013e3181c354d8; National AIDS Control Organisation, 2012, HIV SENT SURV 2012 1; Newman PA, 2008, SEX TRANSM INFECT, V84, P434, DOI 10.1136/sti.2008.031484; Newman PA, 2014, VACCINE, V32, P5854, DOI 10.1016/j.vaccine.2014.08.043; Newmann S, 2000, INT J STD AIDS, V11, P250, DOI 10.1258/0956462001915796; Ramesh S, 2015, GLOB PUBLIC HEALTH, V10, P474, DOI 10.1080/17441692.2014.1003571; Safren SA, 2006, AIDS EDUC PREV, V18, P323, DOI 10.1521/aeap.2006.18.4.323; Setia Maninder Singh, 2006, Indian J Dermatol Venereol Leprol, V72, P425; Thomas B, 2012, AIDS EDUC PREV, V24, P483, DOI 10.1521/aeap.2012.24.6.483; Thomas B, 2012, AIDS CARE, V24, P1401, DOI 10.1080/09540121.2012.672717; Thomas B, 2011, INDIAN J MED RES, V134, P920, DOI 10.4103/0971-5916.92637; Thomas B, 2009, AIDS EDUC PREV, V21, P372, DOI 10.1521/aeap.2009.21.4.372; *UNAIDS, 2010, UN GEN ASS SPEC SESS; Verma RK, 2004, AIDS, V18, P1845, DOI 10.1097/00002030-200409030-00014; Woodford MR, 2012, AIDS BEHAV, V16, P53, DOI 10.1007/s10461-011-9974-2; Yadav D, 2014, AIDS BEHAV, V18, P1330, DOI 10.1007/s10461-014-0699-x	34	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127232	10.1371/journal.pone.0127232	http://dx.doi.org/10.1371/journal.pone.0127232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK7VW	25996926	gold, Green Published, Green Submitted			2022-12-26	WOS:000356444000051
J	Ronquist, F; Nieves-Aldrey, JL; Buffington, ML; Liu, ZW; Liljeblad, J; Nylander, JAA				Ronquist, Fredrik; Nieves-Aldrey, Jose-Luis; Buffington, Matthew L.; Liu, Zhiwei; Liljeblad, Johan; Nylander, Johan A. A.			Phylogeny, Evolution and Classification of Gall Wasps: The Plot Thickens	PLOS ONE			English	Article							AUSTRALIAN THRASORINAE HYMENOPTERA; FIGITIDAE HYMENOPTERA; GALLWASPS HYMENOPTERA; CYNIPOIDEA; CYNIPIDAE; SUBFAMILY; INQUILINE; REVISION; BIOLOGY; MODEL	Gall wasps (Cynipidae) represent the most spectacular radiation of gall-inducing insects. In addition to true gall formers, gall wasps also include phytophagous inquilines, which live inside the galls induced by gall wasps or other insects. Here we present the first comprehensive molecular and total-evidence analyses of higher-level gall wasp relationships. We studied more than 100 taxa representing a rich selection of outgroups and the majority of described cynipid genera outside the diverse oak gall wasps (Cynipini), which were more sparsely sampled. About 5 kb of nucleotide data from one mitochondrial (COI) and four nuclear (28S, LWRh, EF1alpha F1, and EF1alpha F2) markers were analyzed separately and in combination with morphological and life-history data. According to previous morphology-based studies, gall wasps evolved in the Northern Hemisphere and were initially herb gallers. Inquilines originated once from gall inducers that lost the ability to initiate galls. Our results, albeit not conclusive, suggest a different scenario. The first gall wasps were more likely associated with woody host plants, and there must have been multiple origins of gall inducers, inquilines or both. One possibility is that gall inducers arose independently from inquilines in several lineages. Except for these surprising results, our analyses are largely consistent with previous studies. They confirm that gall wasps are conservative in their host-plant preferences, and that herb-galling lineages have radiated repeatedly onto the same set of unrelated host plants. We propose a revised classification of the family into twelve tribes, which are strongly supported as monophyletic across independent datasets. Four are new: Aulacideini, Phanacidini, Diastrophini and Ceroptresini. We present a key to the tribes and discuss their morphological and biological diversity. Until the relationships among the tribes are resolved, the origin and early evolution of gall wasps will remain elusive.	[Ronquist, Fredrik; Nylander, Johan A. A.] Swedish Museum Nat Hist, Dept Bioinformat & Genet, S-10405 Stockholm, Sweden; [Nieves-Aldrey, Jose-Luis] CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolut, E-28006 Madrid, Spain; [Buffington, Matthew L.] USDA, Smithsonian Inst, Systemat Entomol Lab, Washington, DC 20250 USA; [Liu, Zhiwei] Eastern Illinois Univ, Dept Biol Sci, Charleston, IL 61920 USA; [Liljeblad, Johan] Swedish Univ Agr Sci, Swedish Species Informat Ctr, Uppsala, Sweden; [Nylander, Johan A. A.] Linkoping Univ, Bioinformat Infrastruct Life Sci, Linkoping, Sweden	Swedish Museum of Natural History; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of Agriculture (USDA); Eastern Illinois University; Swedish University of Agricultural Sciences; Linkoping University	Ronquist, F (corresponding author), Swedish Museum Nat Hist, Dept Bioinformat & Genet, S-10405 Stockholm, Sweden.	fredrik.ronquist@nrm.se	Ronquist, Fredrik/Q-2013-2015; Liu, Zhiwei/AAI-7700-2020; Liljeblad, Johan/H-4765-2011	Ronquist, Fredrik/0000-0002-3929-251X; Buffington, Matthew/0000-0003-1900-3861; Liljeblad, Johan/0000-0003-0442-8162	Swedish Research Council [20115622]; Spanish Ministry of Science and Innovation [CGL-2009-10111, CGL-2010-15786]; Kalbfleisch Fellowship, American Museum of Natural History; Boyd Scholarship, The Field Museum; National Science Foundation [1K12 Gm00708]; (HymAToL), National Science Foundation [DEB-0337220]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Kalbfleisch Fellowship, American Museum of Natural History; Boyd Scholarship, The Field Museum; National Science Foundation(National Science Foundation (NSF)); (HymAToL), National Science Foundation	This work received support from: 20115622, Swedish Research Council (http://vr.se): FR. CGL-2009-10111 and CGL-2010-15786, Spanish Ministry of Science and Innovation (http://www.idi.mineco.gob.es): JLNA. Kalbfleisch Fellowship, American Museum of Natural History (http://www.amnh.org): ZL. Boyd Scholarship, The Field Museum (http://www.fieldmuseum.org): ZL. Training Grant #1K12 Gm00708, National Science Foundation (http://www.nsf.gov): ZL. DEB-0337220 (HymAToL), National Science Foundation (http://www.nsf.gov): FR MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2011, ANN ENTOMOL SOC AM, V104, P115, DOI 10.1603/AN10149; Abe Y, 2007, ORIENT INSECTS, V41, P169, DOI 10.1080/00305316.2007.10417504; Ashmead W. H., 1903, PSYCHE CAMBRIDGE, V10, P210, DOI [DOI 10.1155/1903/21809, http://dx.doi.org/10.1155/1903/21809]; Askew R.R., 1984, P223; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bergsten J, 2013, SYST BIOL, V62, P660, DOI 10.1093/sysbio/syt029; Blanquart S, 2008, MOL BIOL EVOL, V25, P842, DOI 10.1093/molbev/msn018; Buffington ML, 2008, AUST J ENTOMOL, V47, P203, DOI 10.1111/j.1440-6055.2008.00647.x; Buffington ML, 2007, CLADISTICS, V23, P403, DOI 10.1111/j.1096-0031.2007.00153.x; Buffington ML, 2008, J HYMENOPT RES, V17, P44; Buffington ML, 2012, SYST ENTOMOL, V37, P287, DOI 10.1111/j.1365-3113.2012.00617.x; Buffington ML, 2011, P ENTOMOL SOC WASH, V113, P91, DOI 10.4289/0013-8797.113.2.91; Cockerell MT, 1890, ENTOMOLOGIST, V23, P73; Cockerell T. D. K., 1890, NATURE, V42, P344; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farre PR, 2007, ZOOTAXA, P1; Gauld I. D., 1988, HYMENOPTERA; Hartig T., 1840, Z FIR ENTOMOLOGIE, V2, P176; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hollis WA, 1889, NATURE, V41, P131; Huelsenbeck JP, 2004, MOL BIOL EVOL, V21, P1123, DOI 10.1093/molbev/msh123; Kinsey A. C., 1919, Psyche Boston, V26, DOI 10.1155/1919/96156; Kinsey AC, 1920, B AM MUS NAT HIST, V42, P358; Klopfstein S, 2013, MOL PHYLOGENET EVOL, V67, P266, DOI 10.1016/j.ympev.2013.01.015; La Salle John, 2005, P507; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Liljeblad J, 1998, SYST ENTOMOL, V23, P229, DOI 10.1046/j.1365-3113.1998.00053.x; Liljeblad J, 2002, THESIS U STOCKHOLM S; Liljeblad J, 2011, ZOOTAXA, P35, DOI 10.11646/zootaxa.2806.1.3; Liljeblad J, 2008, ZOOTAXA, P1; Nieves-Aldrey JL, 2009, ZOOTAXA, P1; Malyshev S. I., 1968, GENESIS HYMENOPTERA; Melika G, 2010, ZOOTAXA, P1; Nieves Aldrey Jose Luis, 2003, Boletin de la SEA, V32, P111; Nieves-Aldrey JL, 2014, ZOOTAXA, V3846, P221, DOI 10.11646/zootaxa.3846.2.3; Nieves-Aldrey J. L., 2001, HYMENOPTERA CYNIPIDA, V16; Nieves-Aldrey Jose Luis, 2004, Boletin de la SEA, V34, P85; Nieves-Aldrey JU, 2005, ZOOL SCR, V34, P15, DOI 10.1111/j.1463-6409.2005.00175.x; Nordlander G, 1996, SYST ENTOMOL, V21, P151, DOI 10.1046/j.1365-3113.1996.d01-4.x; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Paretas-Martinez J, 2011, ZOOKEYS, P21, DOI 10.3897/zookeys.108.829; Rokas A, 2002, MOL PHYLOGENET EVOL, V22, P206, DOI 10.1006/mpev.2001.1032; Romanes G., 1889, NATURE, V41, P80; Ronquist F, 1995, SYST ENTOMOL, V20, P309, DOI 10.1111/j.1365-3113.1995.tb00099.x; RONQUIST F, 1994, EVOLUTION, V48, P241, DOI 10.1111/j.1558-5646.1994.tb01310.x; Ronquist F, 2001, EVOLUTION, V55, P2503; Ronquist F, 2001, ZOOL J LINN SOC-LOND, V133, P483, DOI [10.1111/j.1096-3642.2001.tb00636.x, 10.1006/zjls.2001.0302]; Ronquist F, 1999, ZOOL SCR, V28, P139, DOI 10.1046/j.1463-6409.1999.00022.x; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Ros-Farre P, 2000, ZOOL J LINN SOC-LOND, V129, P467, DOI 10.1006/zjls.1999.0204; Roskam JC, 1992, BIOL INSECT INDUCED, P34; SHORTHOUSE JD, 1980, B SOC BOT FR-ACTUAL, V127, P79, DOI 10.1080/01811789.1980.10826439; Stone GN, 2002, ANNU REV ENTOMOL, V47, P633, DOI 10.1146/annurev.ento.47.091201.145247; Stone GN, 2009, EVOLUTION, V63, P854, DOI 10.1111/j.1558-5646.2008.00604.x; Van Noort S, 2007, BIOL J LINN SOC, V90, P153, DOI 10.1111/j.1095-8312.2007.00719.x; Wells BW, 1921, BOT GAZ, V71, P358, DOI 10.1086/332848; Wharton Robert A., 2005, P495; Yoder MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015991	59	128	141	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0123301	10.1371/journal.pone.0123301	http://dx.doi.org/10.1371/journal.pone.0123301			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993346	Green Published, gold, Green Submitted			2022-12-26	WOS:000354921400009
J	Zhu, B; Mizoguchi, T; Kojima, T; Nakano, H				Zhu, Bo; Mizoguchi, Takuro; Kojima, Takaaki; Nakano, Hideo			Ultra-High-Throughput Screening of an In Vitro-Synthesized Horseradish Peroxidase Displayed on Microbeads Using Cell Sorter	PLOS ONE			English	Article							FREE PROTEIN-SYNTHESIS; ESCHERICHIA-COLI; FUNCTIONAL EXPRESSION; DIRECTED EVOLUTION; MANGANESE PEROXIDASE; CODON USAGE; IMPROVEMENT; INHIBITORS; STABILITY; ENZYME	The C1a isoenzyme of horseradish peroxidase (HRP) is an industrially important heme-containing enzyme that utilizes hydrogen peroxide to oxidize a wide variety of inorganic and organic compounds for practical applications, including synthesis of fine chemicals, medical diagnostics, and bioremediation. To develop a ultra-high-throughput screening system for HRP, we successfully produced active HRP in an Escherichia coli cell-free protein synthesis system, by adding disulfide bond isomerase DsbC and optimizing the concentrations of hemin and calcium ions and the temperature. The biosynthesized HRP was fused with a single-chain Cro (scCro) DNA-binding tag at its N-terminal and C-terminal sites. The addition of the scCro-tag at both ends increased the solubility of the protein. Next, HRP and its fusion proteins were successfully synthesized in a water droplet emulsion by using hexadecane as the oil phase and SunSoft No. 818SK as the surfactant. HRP fusion proteins were displayed on microbeads attached with double-stranded DNA (containing the scCro binding sequence) via scCro-DNA interactions. The activities of the immobilized HRP fusion proteins were detected with a tyramide-based fluorogenic assay using flow cytometry. Moreover, a model microbead library containing wild type hrp (WT) and inactive mutant (MUT) genes was screened using fluorescence-activated cell-sorting, thus efficiently enriching the WT gene from the 1: 100 (WT: MUT) library. The technique described here could serve as a novel platform for the ultra-high-throughput discovery of more useful HRP mutants and other heme-containing peroxidases.	[Zhu, Bo; Mizoguchi, Takuro; Kojima, Takaaki; Nakano, Hideo] Nagoya Univ, Grad Sch Bioagr Sci, Mol Biotechnol Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Nakano, H (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Mol Biotechnol Lab, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	hnakano@agr.nagoya-u.ac.jp	Zhu, Bo/AAG-7402-2020; Kojima, Takaaki/H-6802-2017	Zhu, Bo/0000-0002-4001-6045; 	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [23360367, 26119707]; Program for Leading Graduate Schools "Integrative Graduate Education and Research in Green Natural Sciences", MEXT, Japan	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Leading Graduate Schools "Integrative Graduate Education and Research in Green Natural Sciences", MEXT, Japan	This work was supported in part by a Grant-in-Aid for Scientific Research (B) (No. 23360367) (to HN) and a Grant-in-Aid for Scientific Research on Innovative Areas (No. 26119707) (to HN) aimed at Synthetic Biology for the Comprehension of Biological Networks from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (http://www.mext.go.jp/), as well as the Program for Leading Graduate Schools "Integrative Graduate Education and Research in Green Natural Sciences" (http://iger.bio.nagoya-u.ac.jp/), MEXT, Japan.	Agresti JJ, 2010, P NATL ACAD SCI USA, V107, P4004, DOI 10.1073/pnas.0910781107; BARTONEKROXA E, 1994, J BIOTECHNOL, V37, P133, DOI 10.1016/0168-1656(94)90004-3; Bernath K, 2005, J MOL BIOL, V345, P1015, DOI 10.1016/j.jmb.2004.11.017; BOBROW MN, 1989, J IMMUNOL METHODS, V125, P279, DOI 10.1016/0022-1759(89)90104-X; BUDWITNOVOTNY DA, 1986, CANCER RES, V46, P5419; Caschera F, 2014, BIOCHIMIE, V99, P162, DOI 10.1016/j.biochi.2013.11.025; Delvaux M, 2005, BIOSENS BIOELECTRON, V20, P1587, DOI 10.1016/j.bios.2004.07.017; Demmano G, 1996, EUR J BIOCHEM, V238, P785, DOI 10.1111/j.1432-1033.1996.0785w.x; Diamante L, 2013, PROTEIN ENG DES SEL, V26, P713, DOI 10.1093/protein/gzt039; EGOROV AM, 1991, ANN NY ACAD SCI, V646, P35; FUJIYAMA K, 1988, EUR J BIOCHEM, V173, P681, DOI 10.1111/j.1432-1033.1988.tb14052.x; Gan R, 2008, BIOTECHNOL PROGR, V24, P1107, DOI 10.1002/btpr.43; Gan R, 2010, J BIOSCI BIOENG, V109, P411, DOI 10.1016/j.jbiosc.2009.10.009; GAZARYAN IG, 1995, RUSS CHEM B+, V44, P363; Gazaryan IG, 1999, BIOCHEM BIOPH RES CO, V262, P297, DOI 10.1006/bbrc.1999.1155; Guang HM, 2006, ACTA PHARMACOL SIN, V27, P760, DOI 10.1111/j.1745-7254.2006.00336.x; Hopman AHN, 1998, J HISTOCHEM CYTOCHEM, V46, P771, DOI 10.1177/002215549804600611; Howes BD, 2001, J BIOL CHEM, V276, P40704, DOI 10.1074/jbc.M107489200; Jana R, 1998, BIOCHEMISTRY-US, V37, P6446, DOI 10.1021/bi980152v; Kaltenbach M, 2012, LAB CHIP, V12, P4185, DOI 10.1039/c2lc40281e; Kondo A, 2000, J BIOSCI BIOENG, V90, P600, DOI 10.1263/jbb.90.600; Levy I, 2003, BIOTECHNOL BIOENG, V82, P223, DOI 10.1002/bit.10562; Lin ZL, 1999, BIOTECHNOL PROGR, V15, P467, DOI 10.1021/bp990037r; Miyazaki-Imamura C, 2003, PROTEIN ENG, V16, P423, DOI 10.1093/protein/gzg054; MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P197, DOI 10.1111/j.1365-3083.1985.tb01871.x; Morawski B, 2001, BIOTECHNOL BIOENG, V76, P99, DOI 10.1002/bit.1149; Morawski B, 2000, PROTEIN ENG, V13, P377, DOI 10.1093/protein/13.5.377; Newmyer SL, 1996, BIOCHEMISTRY-US, V35, P12788, DOI 10.1021/bi9609331; Nilsson MTI, 2004, BIOCHEMISTRY-US, V43, P12038, DOI 10.1021/bi049122k; Ninomiya R, 2014, J BIOSCI BIOENG, V117, P652, DOI 10.1016/j.jbiosc.2013.11.003; NIRENBERG M, 1961, P NATL ACAD SCI USA, V47, P1588, DOI 10.1073/pnas.47.10.1588; ORTLEPP SA, 1989, J BIOTECHNOL, V11, P353, DOI 10.1016/0168-1656(89)90019-9; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Sabourin M, 2007, YEAST, V24, P39, DOI 10.1002/yea.1431; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SMITH AT, 1990, J BIOL CHEM, V265, P13335; Stapleton JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015275; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Veitch NC, 2004, PHYTOCHEMISTRY, V65, P249, DOI 10.1016/j.phytochem.2003.10.022; WELINDER KG, 1976, FEBS LETT, V72, P19, DOI 10.1016/0014-5793(76)80804-6	40	24	24	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127479	10.1371/journal.pone.0127479	http://dx.doi.org/10.1371/journal.pone.0127479			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993095	Green Published, Green Submitted, gold			2022-12-26	WOS:000354921400122
J	Harter, PN; Jennewein, L; Baumgarten, P; Ilina, E; Burger, MC; Thiepold, AL; Tichy, J; Zornig, M; Senft, C; Steinbach, JP; Mittelbronn, M; Ronellenfitsch, MW				Harter, Patrick N.; Jennewein, Lukas; Baumgarten, Peter; Ilina, Elena; Burger, Michael C.; Thiepold, Anna-Luisa; Tichy, Julia; Zoernig, Martin; Senft, Christian; Steinbach, Joachim P.; Mittelbronn, Michel; Ronellenfitsch, Michael W.			Immunohistochemical Assessment of Phosphorylated mTORC1-Pathway Proteins in Human Brain Tumors	PLOS ONE			English	Article							GIANT-CELL ASTROCYTOMAS; PHASE-II TRIAL; RAPAMYCIN AY-22,989; MAMMALIAN TARGET; MTOR; TEMSIROLIMUS; INHIBITION; THERAPY; PATHWAY; AKT	Background Current pathological diagnostics include the analysis of (epi-) genetic alterations as well as oncogenic pathways. Deregulated mammalian target of rapamycin complex 1 (mTORC1) signaling has been implicated in a variety of cancers including malignant gliomas and is considered a promising target in cancer treatment. Monitoring of mTORC1 activity before and during inhibitor therapy is essential. The aim of our study is to provide a recommendation and report on pitfalls in the use of phospho-specific antibodies against mTORC1-targets phospho-RPS6 (Ser235/236; Ser240/244) and phospho-4EBP1 (Thr37/46) in formalin fixed, paraffin embedded material. Methods and Findings Primary, established cell lines and brain tumor tissue from routine diagnostics were assessed by immunocyto-, immunohistochemistry, immunofluorescent stainings and immunoblotting. For validation of results, immunoblotting experiments were performed. mTORC-pathway activation was pharmacologically inhibited by torin2 and rapamycin. Torin2 treatment led to a strong reduction of signal intensity and frequency of all tested antibodies. In contrast phospho-4EBP1 did not show considerable reduction in staining intensity after rapamycin treatment, while immunocytochemistry with both phospho-RPS6-specific antibodies showed a reduced signal compared to controls. Staining intensity of both phospho-RPS6-specific antibodies did not show considerable decrease in stability in a timeline from 0-230 minutes without tissue fixation, however we observed a strong decrease of staining intensity in phospho-4EBP1 after 30 minutes. Detection of phospho-signals was strongly dependent on tissue size and fixation gradient. mTORC1-signaling was significantlyinduced in glioblastomas although not restricted to cancer cells but also detectable in nonneoplastic cells. Conclusion Here we provide a recommendation for phospho-specific immunohistochemistry for patient-orientated therapy decisions and monitoring treatment response.	[Harter, Patrick N.; Jennewein, Lukas; Baumgarten, Peter; Ilina, Elena; Mittelbronn, Michel] Goethe Univ Frankfurt, Inst Neurol, Edinger Inst, D-60054 Frankfurt, Germany; [Harter, Patrick N.; Burger, Michael C.; Senft, Christian; Steinbach, Joachim P.; Mittelbronn, Michel; Ronellenfitsch, Michael W.] German Canc Consortium DKTK, Heidelberg, Germany; [Harter, Patrick N.; Burger, Michael C.; Senft, Christian; Steinbach, Joachim P.; Mittelbronn, Michel; Ronellenfitsch, Michael W.] German Canc Res Ctr, Heidelberg, Germany; [Baumgarten, Peter; Senft, Christian] Goethe Univ Frankfurt, Dept Neurosurg, D-60054 Frankfurt, Germany; [Burger, Michael C.; Thiepold, Anna-Luisa; Tichy, Julia; Steinbach, Joachim P.; Ronellenfitsch, Michael W.] Goethe Univ Frankfurt, Senckenberg Inst Neurooncol, D-60054 Frankfurt, Germany; [Zoernig, Martin] Inst Tumor Biol & Expt Therapy, Georg Speyer Haus, Frankfurt, Germany	Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Goethe University Frankfurt; Goethe University Frankfurt	Harter, PN (corresponding author), Goethe Univ Frankfurt, Inst Neurol, Edinger Inst, D-60054 Frankfurt, Germany.	patrick.harter@kgu.de; m.ronellenfitsch@gmx.net	Thiepold, Anna-Luisa/AAW-8310-2021; Senft, Christian/F-4252-2010; Baumgarten, Peter/AAS-6061-2020; Ronellenfitsch, Michael/AAW-8201-2020; Baumgarten, Peter/AAE-1140-2021; Jennewein, Lukas/AAV-8077-2020	Senft, Christian/0000-0003-1288-6913; Baumgarten, Peter/0000-0002-2563-2691; Ronellenfitsch, Michael/0000-0002-1402-6290; Baumgarten, Peter/0000-0002-2563-2691; Jennewein, Lukas/0000-0001-6919-9394; Ilina, Elena/0000-0001-8774-8465; Harter, Patrick N./0000-0001-5530-6910; Mittelbronn, Michel/0000-0002-2998-052X	LOEWE Center for Cell and Gene Therapy (State of Hessen); German Federal Ministry of Health (BMG); Ministry of Higher Education, Research; Arts of the state of Hessen (HMWK); Dr. Senckenberg Foundation; Hertie Foundation	LOEWE Center for Cell and Gene Therapy (State of Hessen); German Federal Ministry of Health (BMG); Ministry of Higher Education, Research; Arts of the state of Hessen (HMWK); Dr. Senckenberg Foundation; Hertie Foundation	MZ is supported by the LOEWE Center for Cell and Gene Therapy (State of Hessen). The Georg-Speyer-Haus is funded jointly by the German Federal Ministry of Health (BMG) and the Ministry of Higher Education, Research and the Arts of the state of Hessen (HMWK). The Dr. Senckenberg Institute of Neurooncology is supported by the Dr. Senckenberg Foundation and the Hertie Foundation. JPS is "Hertie Professor of Neurooncology".	Ahmed M, 2014, CARCINOGENESIS, V35, P1564, DOI 10.1093/carcin/bgu051; Ayuso MI, 2010, J BIOL CHEM, V285, P34355, DOI 10.1074/jbc.M110.135103; Baker AF, 2005, CLIN CANCER RES, V11, P4338, DOI 10.1158/1078-0432.CCR-05-0422; Chang SM, 2005, INVEST NEW DRUG, V23, P357, DOI 10.1007/s10637-005-1444-0; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; DEMPSTER WT, 1960, AM J ANAT, V107, P59, DOI 10.1002/aja.1001070105; ENG CP, 1984, J ANTIBIOT, V37, P1231, DOI 10.7164/antibiotics.37.1231; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Franz DN, 2013, LANCET, V381, P125, DOI 10.1016/S0140-6736(12)61134-9; Galanis E, 2005, J CLIN ONCOL, V23, P5294, DOI 10.1200/JCO.2005.23.622; Hess G, 2009, J CLIN ONCOL, V27, P3822, DOI 10.1200/JCO.2008.20.7977; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; KRIEG J, 1988, J BIOL CHEM, V263, P11473; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Lisi L, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-125; Liu QS, 2013, CANCER RES, V73, P2574, DOI 10.1158/0008-5472.CAN-12-1702; Liu QS, 2011, J MED CHEM, V54, P1473, DOI 10.1021/jm101520v; Malik SN, 2002, CLIN CANCER RES, V8, P1168; MARTEL RR, 1977, CAN J PHYSIOL PHARM, V55, P48, DOI 10.1139/y77-007; MARTINPEREZ J, 1983, P NATL ACAD SCI-BIOL, V80, P926, DOI 10.1073/pnas.80.4.926; Orlova KA, 2010, ANN NY ACAD SCI, V1184, P87, DOI 10.1111/j.1749-6632.2009.05117.x; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Qian ZR, 2013, J CLIN ONCOL, V31, P3418, DOI 10.1200/JCO.2012.46.6946; Ronellenfitsch MW, 2009, BRAIN, V132, P1509, DOI 10.1093/brain/awp093; SEHGAL SN, 1975, J ANTIBIOT, V28, P727, DOI 10.7164/antibiotics.28.727; START RD, 1992, J CLIN PATHOL, V45, P1120, DOI 10.1136/jcp.45.12.1120; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; van den Bent MJ, 2009, J CLIN ONCOL, V27, P1268, DOI 10.1200/JCO.2008.17.5984; Wander SA, 2011, J CLIN INVEST, V121, P1231, DOI 10.1172/JCI44145; Xie LK, 2014, J IMMUNOL, V192, P6009, DOI 10.4049/jimmunol.1303492	33	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127123	10.1371/journal.pone.0127123	http://dx.doi.org/10.1371/journal.pone.0127123			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993328	gold, Green Published, Green Submitted			2022-12-26	WOS:000354918600049
J	Khan, M; Xu, YY; Hua, S; Johnson, J; Belevych, A; Janssen, PML; Gyorke, S; Guan, JJ; Angelos, MG				Khan, Mahmood; Xu, Yanyi; Hua, Serena; Johnson, Jed; Belevych, Andriy; Janssen, Paul M. L.; Gyorke, Sandor; Guan, Jianjun; Angelos, Mark G.			Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch	PLOS ONE			English	Article							TISSUE ENGINEERING SCAFFOLDS; MIGRATION; ALIGNMENT; THERAPY; GRAFTS; DESIGN; MODEL	Introduction Dilated cardiomyopathy is a major cause of progressive heart failure. Utilization of stem cell therapy offers a potential means of regenerating viable cardiac tissue. However, a major obstacle to stem cell therapy is the delivery and survival of implanted stem cells in the ischemic heart. To address this issue, we have developed a biomimetic aligned nanofibrous cardiac patch and characterized the alignment and function of human inducible pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) cultured on this cardiac patch. This hiPSC-CMs seeded patch was compared with hiPSC-CMs cultured on standard flat cell culture plates. Methods hiPSC-CMs were cultured on; 1) a highly aligned polylactide-co-glycolide (PLGA) nanofiber scaffold (similar to 50 microns thick) and 2) on a standard flat culture plate. Scanning electron microscopy (SEM) was used to determine alignment of PLGA nanofibers and orientation of the cells on the respective surfaces. Analysis of gap junctions (Connexin-43) was performed by confocal imaging in both the groups. Calcium cycling and patch-clamp technique were performed to measure calcium transients and electrical coupling properties of cardiomyocytes. Results SEM demonstrated >90% alignment of the nanofibers in the patch which is similar to the extracellular matrix of decellularized rat myocardium. Confocal imaging of the cardiomyocytes demonstrated symmetrical alignment in the same direction on the aligned nanofiber patch in sharp contrast to the random appearance of cardiomyocytes cultured on a tissue culture plate. The hiPSC-CMs cultured on aligned nanofiber cardiac patches showed more efficient calcium cycling compared with cells cultured on standard flat surface culture plates. Quantification of mRNA with qRT-PCR confirmed that these cardiomyocytes expressed alpha-actinin, troponin-T and connexin-43 in-vitro. Conclusions Overall, our results demonstrated changes in morphology and function of human induced pluripotent derived cardiomyocytes cultured in an anisotropic environment created by an aligned nanofiber patch. In this environment, these cells better approximate normal cardiac tissue compared with cells cultured on flat surface and can serve as the basis for bioengineering of an implantable cardiac patch.	[Khan, Mahmood; Hua, Serena; Angelos, Mark G.] Ohio State Univ, Dept Emergency Med, Davis Heart Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA; [Xu, Yanyi; Guan, Jianjun] Ohio State Univ, Dept Mat Sci & Engn, Davis Heart Lung Res Inst, Columbus, OH 43210 USA; [Johnson, Jed] Nanofiber Solut, Columbus, OH USA; [Belevych, Andriy; Janssen, Paul M. L.; Gyorke, Sandor] Ohio State Univ, Wexner Med Ctr, Davis Heart Lung Res Inst, Dept Physiol & Cell Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Angelos, MG (corresponding author), Ohio State Univ, Dept Emergency Med, Davis Heart Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA.	mark.angelos@osumc.edu		Xu, Yanyi/0000-0003-0270-2017; Belevych, Andriy/0000-0002-1272-5784; Janssen, Paul/0000-0002-9682-3014	Direct For Mathematical & Physical Scien [1006734] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Agudelo-Garcia PA, 2011, NEOPLASIA, V13, P831, DOI 10.1593/neo.11612; Asiri AM, 2014, INT J NANOMED, V9, DOI 10.2147/IJN.S71587; Bartunek J, 2013, J AM COLL CARDIOL, V61, P2329, DOI 10.1016/j.jacc.2013.02.071; Belevych AE, 2012, CIRC RES, V110, P569, DOI 10.1161/CIRCRESAHA.111.260455; Beltrami AP, 2011, STEM CELLS BIOL REG, P149, DOI 10.1007/978-1-61779-021-8_10; BESSE P, 1971, Archives des Maladies du Coeur et des Vaisseaux, V64, P485; Bian WN, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024109; Brunello L, 2013, P NATL ACAD SCI USA, V110, P10312, DOI 10.1073/pnas.1300052110; Citro L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116281; Courtney T, 2006, BIOMATERIALS, V27, P3631, DOI 10.1016/j.biomaterials.2006.02.024; Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316; Fink C, 2000, FASEB J, V14, P669, DOI 10.1096/fasebj.14.5.669; Forte G, 2011, STEM CELLS, V29, P2051, DOI 10.1002/stem.763; Hashizume R, 2013, J THORAC CARDIOV SUR, V146, P391, DOI 10.1016/j.jtcvs.2012.11.013; Hong KU, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0346-0; Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749; Huang HZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059482, 10.1371/journal.pone.0076982, 10.1371/journal.pone.0071808]; Johnson J, 2007, J APPL POLYM SCI, V104, P2919, DOI 10.1002/app.25965; Johnson J, 2009, TISSUE ENG PART C-ME, V15, P531, DOI [10.1089/ten.tec.2008.0486, 10.1089/ten.TEC.2008.0486]; Kai D, 2011, J BIOMED MATER RES B, V98B, P379, DOI 10.1002/jbm.b.31862; Kharaziha M, 2014, BIOMATERIALS, V35, P7346, DOI 10.1016/j.biomaterials.2014.05.014; McBane JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077538; Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078; Nam J, 2008, J APPL POLYM SCI, V107, P1547, DOI 10.1002/app.27063; Nolan DJ, 2013, DEV CELL, V26, P204, DOI 10.1016/j.devcel.2013.06.017; Parker KK, 2007, PHILOS T R SOC B, V362, P1267, DOI 10.1098/rstb.2007.2114; Parrag IC, 2012, BIOTECHNOL BIOENG, V109, P813, DOI 10.1002/bit.23353; Pok S, 2013, ACTA BIOMATER, V9, P5630, DOI 10.1016/j.actbio.2012.10.032; Qian L, 2012, TISSUE ENG PT A, V18, P1652, DOI [10.1089/ten.tea.2011.0591, 10.1089/ten.TEA.2011.0591]; Rhett JM, 2011, MOL BIOL CELL, V22, P1516, DOI 10.1091/mbc.E10-06-0548; Roger VL, 2013, CIRC RES, V113, P646, DOI 10.1161/CIRCRESAHA.113.300268; Rubin E GF, 2004, PATHOLOGY; Sacconi L, 2012, P NATL ACAD SCI USA, V109, P5815, DOI 10.1073/pnas.1120188109; Shin HJ, 2006, J BIOMAT SCI-POLYM E, V17, P103, DOI 10.1163/156856206774879126; Shin M, 2004, BIOMATERIALS, V25, P3717, DOI 10.1016/j.biomaterials.2003.10.055; Terzic A, 2014, EUR HEART J, V35, P1231, DOI 10.1093/eurheartj/ehu117; Wang PY, 2011, ACTA BIOMATER, V7, P3285, DOI 10.1016/j.actbio.2011.05.021; Zhang DH, 2013, BIOMATERIALS, V34, P5813, DOI 10.1016/j.biomaterials.2013.04.026; Zong XH, 2004, ANN SURG, V240, P910, DOI 10.1097/01.sla.0000143302.48223.7e	39	55	61	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0126338	10.1371/journal.pone.0126338	http://dx.doi.org/10.1371/journal.pone.0126338			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993466	Green Published, Green Submitted, gold			2022-12-26	WOS:000354918600032
J	Artinian, N; Cloninger, C; Holmes, B; Benavides-Serrato, A; Bashir, T; Gera, J				Artinian, Nicholas; Cloninger, Cheri; Holmes, Brent; Benavides-Serrato, Angelica; Bashir, Tariq; Gera, Joseph			Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YES-ASSOCIATED PROTEIN-1; TUMOR-SUPPRESSOR; MOLECULAR PATHOLOGY; COMPLEX; GLIOMAS; ONCOPROTEIN; INHIBITION; RESISTANCE; REGULATOR; CANCER	The mechanistic target of rapamycin (mTOR) and Hippo signaling pathways are two major signaling cascades that coordinately regulate cell growth and proliferation. Dysregulation of these pathways plays a critical role in gliomagenesis. Recent reports have provided evidence of cross-talk between the mTOR and Hippo pathways; however, a complete description of the signaling relationships between these pathways remains to be elucidated. Utilizing a gene-trapping strategy in a mouse glioma model, we report the identification of AMOTL2 as a candidate substrate for mTORC2. AMOTL2 is phosphorylated at serine 760 by mTORC2. Mutation of AMOTL2 mimicking constitutive Ser(760) phosphorylation blocks its ability to bind and repress YAP leading to increased relative expression of known YAP gene targets. Moreover, overexpression of AMOTL2 or a non-phosphorylatable AMOTL2-S760A mutant inhibited YAP-induced transcription, foci formation, growth, and metastatic properties, whereas overexpression of a phosphomimetic AMOTL2-S760E mutant negated these repressive effects of AMOTL2 in glioblastoma (GBM) cells in vitro. Similar effects on xenograft growth were observed in GBM cells expressing these AMOTL2 Ser(760) mutants. YAP was also shown to be required for Rictor-mediated GBM growth and survival. Finally, an analysis of mTORC2/AMOTL2/YAP activities in primary GBM samples supported the clinical relevance of this signaling cascade, and we propose that pharmacological agents cotargeting these regulatory circuits may hold therapeutic potential.	[Artinian, Nicholas; Bashir, Tariq; Gera, Joseph] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Gera, Joseph] Univ Calif Los Angeles, Jonnson Comprehens Canc Ctr, Los Angeles, CA 90048 USA; [Gera, Joseph] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90048 USA; [Artinian, Nicholas; Cloninger, Cheri; Holmes, Brent; Benavides-Serrato, Angelica; Bashir, Tariq; Gera, Joseph] Greater Los Angeles Vet Affairs Healthcare Syst, Dept Res & Dev, Los Angeles, CA 91343 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Gera, J (corresponding author), 16111 Plummer St 151 Bldg 1,Rm C111A, Los Angeles, CA 91343 USA.	jgera@mednet.ucla.edu	Regan, Clinton/E-6250-2012	Holmes, Brent/0000-0002-2768-2991; Gera, Joseph/0000-0002-2908-6894	National Institutes of Health [R01CA168700]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA168700] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA168700. This work was also supported by the Department of Veterans Affairs. The authors declare that they have no conflicts of interest with the contents of this article.	Bashir T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047741; Benavides-Serrato Angelica, 2014, Genes Cancer, V5, P393; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Cloninger C, 2011, MOL CANCER THER, V10, P2244, DOI 10.1158/1535-7163.MCT-11-0478; Cloughesy TF, 2014, ANNU REV PATHOL-MECH, V9, P1, DOI 10.1146/annurev-pathol-011110-130324; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Csibi A, 2012, NAT CELL BIOL, V14, P1244, DOI 10.1038/ncb2634; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Fernandez A, 2012, ONCOGENE, V31, P1923, DOI 10.1038/onc.2011.379; Grzmil M, 2013, BBA-PROTEINS PROTEOM, V1834, P1371, DOI 10.1016/j.bbapap.2013.01.041; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Holmes B, 2012, CELL SIGNAL, V24, P309, DOI 10.1016/j.cellsig.2011.09.015; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; Kamnasaran D, 2007, P NATL ACAD SCI USA, V104, P8053, DOI 10.1073/pnas.0611669104; Kim SG, 2013, MOL CELLS, V35, P463, DOI 10.1007/s10059-013-0138-2; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lau YKI, 2008, CANCER RES, V68, P5733, DOI 10.1158/0008-5472.CAN-08-0190; Liang N, 2014, J EXP MED, V211, P2249, DOI 10.1084/jem.20140341; Liu YC, 2015, TUMOR BIOL, V36, P2223, DOI 10.1007/s13277-015-3297-2; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Masui K, 2012, NEUROPATH APPL NEURO, V38, P271, DOI 10.1111/j.1365-2990.2011.01238.x; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Modena P, 2006, J CLIN ONCOL, V24, P5223, DOI 10.1200/JCO.2006.06.3701; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Orr BA, 2011, J NEUROPATH EXP NEUR, V70, P568, DOI 10.1097/NEN.0b013e31821ff8d8; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Striedinger K, 2008, NEOPLASIA, V10, P1204, DOI 10.1593/neo.08642; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; SUZUMURA A, 1984, BRAIN RES, V324, P379, DOI 10.1016/0006-8993(84)90054-4; Tanaka K, 2011, CANCER DISCOV, V1, P524, DOI 10.1158/2159-8290.CD-11-0124; Tumaneng K, 2012, NAT CELL BIOL, V14, P1322, DOI 10.1038/ncb2615; Urh M, 2009, METHOD ENZYMOL, V463, P417, DOI 10.1016/S0076-6879(09)63026-3; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wu Si-Han, 2014, Cancer Biology Medicine, V11, P255, DOI 10.7497/j.issn.2095-3941.2014.04.004; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	46	65	69	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19387	19401		10.1074/jbc.M115.656587	http://dx.doi.org/10.1074/jbc.M115.656587			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	25998128	Green Published, hybrid			2022-12-26	WOS:000359364600001
J	Chen, JJ; Cai, WY; Liu, XW; Luo, QC; Chen, G; Huang, WF; Li, N; Cai, JC				Chen, Jia-jia; Cai, Wang-yu; Liu, Xue-wen; Luo, Qi-cong; Chen, Gang; Huang, Wei-feng; Li, Na; Cai, Jian-chun			Reverse Correlation between MicroRNA-145 and FSCN1 Affecting Gastric Cancer Migration and Invasion	PLOS ONE			English	Article							EXPRESSION SUPPRESSES; FASCIN1 EXPRESSION; PROLIFERATION; METASTASIS; CARCINOMA; MIR-145; KNOCKDOWN; GROWTH	MicroRNAs (miRs) play important roles in modulating gene expression during the processes of tumorigenesis and tumor development. Previous studies have found that miR-145 is down-regulated in the stomach neoplasm and is related to tumor migration and invasion. However, both the molecular mechanism and function of miR-145 in gastric cancer remain unclear. The present study is the first demonstration of the significant down-regulation of miR-145 expression in infiltrative gastric cancer compared to expanding gastric cancer. Additionally, correlation analyses revealed strong inverse correlations between miR-145 and FSCN1 expression levels in infiltrative gastric cancer. Furthermore, we demonstrated that miR-145 directly targets FSCN1 and suppresses cell migration and invasion in gastric cancer. Knocking down the expression of FSCN1 led to the suppression of migration and invasion in gastric cancer cells, and re-expressing FSCN1 in miR-145-overexpressing cells reversed their migration and invasion defects. Thus, we concluded that miR-145 regulates cell migration and invasion in gastric cancer primarily by directly targeting FSCN1.	[Chen, Jia-jia; Cai, Wang-yu; Liu, Xue-wen; Luo, Qi-cong; Chen, Gang; Huang, Wei-feng; Li, Na; Cai, Jian-chun] Xiamen Univ, Zhongshan Hosp, Dept Gastrointestinal Surg, Xiamen, Fujian, Peoples R China; [Chen, Jia-jia; Cai, Wang-yu; Liu, Xue-wen; Luo, Qi-cong; Chen, Gang; Cai, Jian-chun] Xiamen Univ, Coll Med, Inst Gastrointestinal Oncol, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University	Cai, WY (corresponding author), Xiamen Univ, Zhongshan Hosp, Dept Gastrointestinal Surg, Xiamen, Fujian, Peoples R China.	zaizai005@126.com; jianchunfh2@sina.com	LUO, QI/GQH-7209-2022		National Natural Science Foundation of China [81172283]; Natural Science Foundation of Fujian Province [2012D037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	1. National Natural Science Foundation of China (Grant No. 81172283) JCC (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2. Natural Science Foundation of Fujian Province (Grant No. 2012D037) JCC (http://xmgl.fjkjt.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2014, GUT, V63, P64, DOI 10.1136/gutjnl-2013-305033; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Dynoodt P, 2013, INT J ONCOL, V42, P1443, DOI 10.3892/ijo.2013.1823; Espejo Romero Hernán, 2003, Rev. gastroenterol. Perú, V23, P199; Feng Y, 2014, BRIT J CANCER, V110, P2300, DOI 10.1038/bjc.2014.122; Fu H, 2009, PATHOLOGY, V41, P655, DOI 10.3109/00313020903273100; Fuse M, 2011, INT J ONCOL, V38, P1093, DOI 10.3892/ijo.2011.919; Gao P, 2013, ONCOGENE, V32, P491, DOI 10.1038/onc.2012.61; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanker LC, 2013, ANTICANCER RES, V33, P371; Hashimoto Y, 2011, J PATHOL, V224, P289, DOI 10.1002/path.2894; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamikihara T, 2012, PATHOL INT, V62, P161, DOI 10.1111/j.1440-1827.2011.02774.x; Kano M, 2010, INT J CANCER, V127, P2804, DOI 10.1002/ijc.25284; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Liu X, 2009, CLIN CANCER RES, V15, P1177, DOI 10.1158/1078-0432.CCR-08-1355; Lu RJ, 2014, J CANCER RES CLIN, V140, P387, DOI 10.1007/s00432-013-1577-z; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; MING SC, 1977, CANCER, V39, P2475, DOI 10.1002/1097-0142(197706)39:6<2475::AID-CNCR2820390626>3.0.CO;2-L; Park SH, 2014, INT J ONCOL, V44, P637, DOI 10.3892/ijo.2013.2232; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Takikita M, 2011, ANTICANCER RES, V31, P945; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Zhang BG, 2012, ONCOL REP, V27, P1019, DOI 10.3892/or.2012.1645	26	7	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126890	10.1371/journal.pone.0126890	http://dx.doi.org/10.1371/journal.pone.0126890			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010149	gold, Green Submitted, Green Published			2022-12-26	WOS:000355183900044
J	Doropoulos, C; Ward, S; Roff, G; Gonzalez-Rivero, M; Mumby, PJ				Doropoulos, Christopher; Ward, Selina; Roff, George; Gonzalez-Rivero, Manuel; Mumby, Peter J.			Linking Demographic Processes of Juvenile Corals to Benthic Recovery Trajectories in Two Common Reef Habitats	PLOS ONE			English	Article							LIFE-HISTORY STRATEGIES; POPULATION-DYNAMICS; POSTSETTLEMENT SURVIVAL; POCILLOPORA-DAMICORNIS; SCLERACTINIAN CORALS; HERMATYPIC CORALS; CLIMATE-CHANGE; LONG-TERM; RECRUITMENT; MORTALITY	Tropical reefs are dynamic ecosystems that host diverse coral assemblages with different life-history strategies. Here, we quantified how juvenile (<50 mm) coral demographics influenced benthic coral structure in reef flat and reef slope habitats on the southern Great Barrier Reef, Australia. Permanent plots and settlement tiles were monitored every six months for three years in each habitat. These environments exhibited profound differences: the reef slope was characterised by 95% less macroalgal cover, and twice the amount of available settlement substrata and rates of coral settlement than the reef flat. Consequently, post-settlement coral survival in the reef slope was substantially higher than that of the reef flat, and resulted in a rapid increase in coral cover from 7 to 31% in 2.5 years. In contrast, coral cover on the reef flat remained low (similar to 10%), whereas macroalgal cover increased from 23 to 45%. A positive stock-recruitment relationship was found in brooding corals in both habitats; however, brooding corals were not directly responsible for the observed changes in coral cover. Rather, the rapid increase on the reef slope resulted from high abundances of broadcast spawning Acropora recruits. Incorporating our results into transition matrix models demonstrated that most corals escape mortality once they exceed 50 mm, but for smaller corals mortality in brooders was double those of spawners (i.e. acroporids and massive corals). For corals on the reef flat, sensitivity analysis demonstrated that growth and mortality of larger juveniles (21-50 mm) highly influenced population dynamics; whereas the recruitment, growth and mortality of smaller corals (<20 mm) had the highest influence on reef slope population dynamics. Our results provide insight into the population dynamics and recovery trajectories in disparate reef habitats, and highlight the importance of acroporid recruitment in driving rapid increases in coral cover following large-scale perturbation in reef slope environments.	[Doropoulos, Christopher; Ward, Selina; Roff, George; Mumby, Peter J.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Doropoulos, Christopher; Roff, George; Mumby, Peter J.] Australian Res Council Ctr Excellence Coral Reef, St Lucia, Qld, Australia; [Gonzalez-Rivero, Manuel] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Doropoulos, C (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	c.doropoulos@gmail.com	Roff, George/ABB-4406-2021; Mumby, Peter/F-9914-2010; Roff, George/C-8766-2015; González-Rivero, Manuel/A-3482-2016; Doropoulos, Christopher/B-7249-2016	Roff, George/0000-0002-2823-0575; Mumby, Peter/0000-0002-6297-9053; Roff, George/0000-0002-2823-0575; González-Rivero, Manuel/0000-0003-0252-584X; Doropoulos, Christopher/0000-0001-8038-2771	Winifred Violet Scott Foundation; QLD Smart Future Scholarship; ARC Discovery Grant; ARC Laureate Fellowship	Winifred Violet Scott Foundation; QLD Smart Future Scholarship; ARC Discovery Grant(Australian Research Council); ARC Laureate Fellowship(Australian Research Council)	Financial assistance was provided to CD from the Winifred Violet Scott Foundation and a QLD Smart Future Scholarship; to SW from an ARC Discovery Grant; and to PJM from an ARC Laureate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Agrawal AA, 2007, FRONT ECOL ENVIRON, V5, P145, DOI 10.1890/1540-9295(2007)5[145:FKGIPA]2.0.CO;2; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Babcock R, 1996, J EXP MAR BIOL ECOL, V206, P179, DOI 10.1016/S0022-0981(96)02622-6; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; Baird AH, 2000, J EXP MAR BIOL ECOL, V251, P117, DOI 10.1016/S0022-0981(00)00209-4; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; BAK RPM, 1979, MAR BIOL, V54, P341, DOI 10.1007/BF00395440; Baria MVB, 2012, B MAR SCI, V88, P61, DOI 10.5343/bms.2011.1075; Bates D., 2013, LME4 LINEAR MIXED EF; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Bramanti L, 2015, CORAL REEFS, P1; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Caswell, 2000, MATRIX POPULATION MO; Connell JH, 2004, ECOL MONOGR, V74, P179, DOI 10.1890/02-4043; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Connolly SR, 2010, ECOLOGY, V91, P3572, DOI 10.1890/10-0143.1; Crawley M.J., 2007, R BOOK; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; Diaz-Pulido G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005239; Doropoulos C, 2014, CORAL REEFS, V33, P613, DOI 10.1007/s00338-014-1149-y; Doropoulos C, 2012, ECOLOGY, V93, P2131, DOI 10.1890/12-0495.1; Doropoulos C, 2012, ECOL LETT, V15, P338, DOI 10.1111/j.1461-0248.2012.01743.x; Edmunds P, 2014, MARINE FRESHWATER RE; Edwards AJ, 2001, MAR POLLUT BULL, V42, P7, DOI 10.1016/S0025-326X(00)00200-9; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Gorley RN, 2006, PRIMER V6; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Harriott V.J., 1983, Coral Reefs, V2, P9, DOI 10.1007/BF00304727; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2005, LIMNOL OCEANOGR, V50, P265, DOI 10.4319/lo.2005.50.1.0265; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 1996, ECOLOGY, V77, P2256, DOI 10.2307/2265718; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; HUGHES TP, 1987, AM NAT, V129, P818, DOI 10.1086/284677; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Kerry JT, 2012, CORAL REEFS, V31, P415, DOI 10.1007/s00338-011-0859-7; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; KOJIS BL, 1986, MAR BIOL, V91, P291, DOI 10.1007/BF00428623; Lenihan HS, 2011, ECOLOGY, V92, P1959, DOI 10.1890/11-0108.1; Linares C, 2011, MAR ECOL PROG SER, V438, P97, DOI 10.3354/meps09272; McCauley DJ, 2010, MAR BIOL, V157, P2739, DOI 10.1007/s00227-010-1533-2; Melbourne-Thomas J, 2011, ECOL APPL, V21, P1380, DOI 10.1890/09-1564.1; Ortiz JC, 2009, CORAL REEFS, V28, P999, DOI 10.1007/s00338-009-0546-0; Ortiz JC, 2014, NAT CLIM CHANGE, V4, P1090, DOI 10.1038/NCLIMATE2439; PEARSON RG, 1981, MAR ECOL PROG SER, V4, P105, DOI 10.3354/meps004105; Penin L, 2013, MAR ECOL PROG SER, V473, P149, DOI 10.3354/meps10101; Penin L, 2010, MAR ECOL PROG SER, V408, P55, DOI 10.3354/meps08554; Pinheiro J., 2007, R PACKAGE VERSION, V3, P57; POTTS DC, 1984, LIMNOL OCEANOGR, V29, P504, DOI 10.4319/lo.1984.29.3.0504; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Riegl BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036921; Riegl BM, 2009, ECOL MODEL, V220, P192, DOI 10.1016/j.ecolmodel.2008.09.022; RINKEVICH B, 1979, MAR ECOL PROG SER, V1, P145, DOI 10.3354/meps001145; Roff G, 2014, MAR BIOL, V161, P1385, DOI 10.1007/s00227-014-2426-6; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Roth MS, 2009, MAR ECOL PROG SER, V376, P133, DOI 10.3354/meps07787; Santos IR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046053; SATO M, 1985, CORAL REEFS, V4, P27, DOI 10.1007/BF00302201; Steneck RS, 2014, MAR ECOL PROG SER, V506, P115, DOI 10.3354/meps10764; STIMSON JS, 1978, MAR BIOL, V48, P173, DOI 10.1007/BF00395017; Tanner JE, 2009, ECOLOGY, V90, P506, DOI 10.1890/08-0399.1; TANNER JE, 1995, J EXP MAR BIOL ECOL, V190, P151, DOI 10.1016/0022-0981(95)00027-O; TANNER JE, 1994, ECOLOGY, V75, P2204, DOI 10.2307/1940877; Torda G, 2013, MOL ECOL, V22, P5821, DOI 10.1111/mec.12539; Trapon ML, 2013, CORAL REEFS, V32, P1051, DOI 10.1007/s00338-013-1059-4; Trapon ML, 2013, MAR ECOL PROG SER, V488, P157, DOI 10.3354/meps10389; Trapon ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057788; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; van Oppen MJH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003401; Vermeij MJA, 2005, MAR ECOL PROG SER, V295, P123, DOI 10.3354/meps295123; WALLACE CC, 1985, MAR ECOL PROG SER, V21, P289, DOI 10.3354/meps021289; Webster FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124162; Yearsley JM, 2004, ECOL MODEL, V177, P245, DOI 10.1016/j.ecolmodel.2003.12.053	84	79	79	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128535	10.1371/journal.pone.0128535	http://dx.doi.org/10.1371/journal.pone.0128535			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009892	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900242
J	Nomokonova, T; Losey, RJ; Goriunova, OI; Novikov, AG; Weber, AW				Nomokonova, Tatiana; Losey, Robert J.; Goriunova, Ol'ga I.; Novikov, Alexei G.; Weber, Andrzej W.			A 9,000 Year History of Seal Hunting on Lake Baikal, Siberia: The Zooarchaeology of Sagan-Zaba II	PLOS ONE			English	Article							MIDDLE HOLOCENE; CIS-BAIKAL; BRONZE-AGE; VEGETATION; CLIMATE; POLLEN; REGION; DYNAMICS; RECORDS; RECONSTRUCTION	Sagan-Zaba II, a habitation site on the shore of Siberia's Lake Baikal, contains a record of seal hunting that spans much of the Holocene, making it one of the longest histories of seal use in North Asia. Zooarchaeological analyses of the 16,000 Baikal seal remains from this well-dated site clearly show that sealing began here at least 9000 calendar years ago. The use of these animals at Sagan-Zaba appears to have peaked in the Middle Holocene, when foragers used the site as a spring hunting and processing location for yearling and juvenile seals taken on the lake ice. After 4800 years ago, seal use declined at the site, while the relative importance of ungulate hunting and fishing increased. Pastoralists began occupying Sagan-Zaba at some point during the Late Holocene, and these groups too utilized the lake's seals. Domesticated animals are increasingly common after about 2000 years ago, a pattern seen elsewhere in the region, but spring and some summer hunting of seals was still occurring. This use of seals by prehistoric herders mirrors patterns of seal use among the region's historic and modern groups. Overall, the data presented in the paper demonstrate that Lake Baikal witnessed thousands of years of human use of aquatic resources.	[Nomokonova, Tatiana] Univ British Columbia, Anthropol Program, Community Culture & Global Studies, Kelowna, BC, Canada; [Losey, Robert J.; Weber, Andrzej W.] Univ Alberta, Dept Anthropol, Edmonton, AB, Canada; [Goriunova, Ol'ga I.; Novikov, Alexei G.] Russian Acad Sci, Siberian Branch, Inst Archaeol & Ethnog, Lab Archaeol & Paleoecol, Irkutsk 664003, Russia	University of British Columbia; University of Alberta; Russian Academy of Sciences	Losey, RJ (corresponding author), Univ Alberta, Dept Anthropol, Edmonton, AB, Canada.	robert.losey@ualberta.ca	Goriunova, Olga/L-1252-2017; Weber, Andrzej W/F-9780-2016	Gorunova, Ol'ga/0000-0002-5159-0894; Novikov, Aleksei/0000-0001-8965-8957	Social Sciences and Humanities Research Council of Canada (Major Collaborative Research Initiative) [412-2005-1004, 412-2011-1001]	Social Sciences and Humanities Research Council of Canada (Major Collaborative Research Initiative)	The project is funded by the Social Sciences and Humanities Research Council of Canada (Major Collaborative Research Initiative, grant numbers 412-2005-1004 and 412-2011-1001). AW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov MP, 1990, STRATIGRAFIIA PALEOG, P88; Amano M, 2000, ADV ECOL RES, V31, P449, DOI 10.1016/S0065-2504(00)31024-8; Balikci A, 1970, THE NETSILIK ESKIMO; Bezrukova EV, 2013, QUATERN INT, V290, P35, DOI 10.1016/j.quaint.2012.10.043; Bezrukova EV, 2010, PALAEOGEOGR PALAEOCL, V296, P185, DOI 10.1016/j.palaeo.2010.07.020; Boas F, 1888, 6 SMITHS I; Bogoras W, 1904, CHUKCHEE MEMOIRS A 1, V11; Braje TJ, 2011, HUMAN IMPACTS ON SEALS, SEA LIONS, AND SEA OTTERS: INTEGRATING ARCHAEOLOGY AND ECOLOGY IN THE NORTHEAST PACIFIC, P1, DOI 10.1525/california/9780520267268.001.0001; Buck C.E., 1999, INTERNET ARCHAEOLOGY, V7, DOI [10.11141/IA.7.1, DOI 10.11141/IA.7.1]; Dashibalov BB, 1995, ARKHEOLOGICHESKIE PA; Demske D, 2005, GLOBAL PLANET CHANGE, V46, P255, DOI 10.1016/j.gloplacha.2004.09.020; Devlet Ekaterina, 2001, ARCHAEOLOGY SHAMANIS, P43; Diab MC, 1998, J ARCHAEOL SCI, V25, P1, DOI 10.1006/jasc.1997.0196; Dikov N.N., 1977, ARKHEOLOGICHESKIE PA; [Долганов Вадим Александрович Dolganov V.A.], 2011, [Вестник Новосибирского государственного университета. Серия: История, филология, Vestnik Novosibirskogo gosudarstvennogo universiteta. Seriya: Istoriya, filologiya], V10, P84; [Долганов Вадим Александрович Dolganov V.A.], 2013, [Вестник Новосибирского государственного университета. Серия: История, филология, Vestnik Novosibirskogo gosudarstvennogo universiteta. Seriya: Istoriya, filologiya], V12, P125; Edlund A.-C., 2004, LINGUAGEM CULTURA E, P215; Erlandson JM, 2001, J ARCHAEOL RES, V9, P287, DOI 10.1023/A:1013062712695; Georgi, 1777, OPISANIE VSEKH ROS 3; Goebel T, 1999, EVOL ANTHROPOL, V8, P208; Goriunova O.I, 2002, DREVNIE MOGILNIKI PR; GORIUNOVA OI, 2000, OLKHONSKII RAION MAT; Goriunova OI, 2007, PROBLEMY ARKHEOLOGII, V13, P212; Goriunova OI, 2007, SEVERNAIA EVRAZIIA A, V1, P168; Goriunova OI, 2012, EVRAZIIA KAINOZOE ST, V1, P86; Goriunova OI, 2008, PROBLEMY ARKHEOLGII, V14, P32; Goriunova OI, 2009, IZVESTIIA LAB DREVNI, V7, P73; Grousset R, 2005, EMPIRE STEPPES HIST; Hodgetts L, 2005, Exploitation and Cultural Importance of Sea Mammals, P62; Juel E, 1945, ETHNOS, V10, P143; Katzenberg MA, 2012, J ARCHAEOL SCI, V39, P2612, DOI 10.1016/j.jas.2011.08.010; Katzenberg MA, 2010, PREHISTORIC HUNTER-GATHERERS OF THE BAIKAL REGION, SIBERIA, P175; Katzenberg MA, 2009, J ARCHAEOL SCI, V36, P663, DOI 10.1016/j.jas.2008.10.012; Katzenberg MA, 1999, J ARCHAEOL SCI, V26, P651, DOI 10.1006/jasc.1998.0382; Kharinskii AV, 2001, PREDBAIKALE KON TYS; Kharinsky A. V., 2005, IZVESTIIA LAB DREVNI, V3, P198; Kiryak (Dikova) MA, 2010, BAR INT SERIES, V2099; Klevezal G.A., 1988, REGISTRIRUIUSHCHIE S; Kreinovich EA, 1934, SOV ETNOGR, V5, P78; Kuzmin YV, 2006, BAR INT SERIES, V1540, P167; Lam YM, 2005, EVOL ANTHROPOL, V14, P99, DOI 10.1002/evan.20053; Levin N.P., 1897, IZVESTIIA VOSTOCHNO, V28, P44; Losey RJ, 2014, SERIIA GEOARKHEOLOGI, V7, P3; Losey RJ, 2008, J ARCHAEOL SCI, V35, P577, DOI 10.1016/j.jas.2007.05.005; Losey RJ, 2016, QUATERN INT, V419, P62, DOI 10.1016/j.quaint.2014.08.021; Losey RJ, 2012, J ISL COAST ARCHAEOL, V7, P126, DOI 10.1080/15564894.2011.611854; Lyman R. Lee, 2004, VERTEBRATE TAPHONOMY; Lyman RL, 2008, CAMB MAN ARCHAEOL, P1, DOI 10.1017/CBO9780511813863; Mackay AW, 2013, QUATERN INT, V290, P46, DOI 10.1016/j.quaint.2012.09.031; Mikhailov T. M., 1987, BURIATSKII SHAMANIZM; Monks G, 2005, P 9 ICAZ C DURH 2002; Nelson R.K, 1969, HUNTERS NO ICE; Nomokonova T, 2011, THESIS U ALBERTA; Nomokonova T., 2009, PREHISTORIC FISHING; Nomokonova T., 2013, P 27 ANN INT AB S, P25; Nomokonova T, 2009, SERIIA ISTORIIA FILO, V5, p[116, 8]; Nomokonova T, 2013, J ETHNOBIOL, V33, P259, DOI 10.2993/0278-0771-33.2.259; Nomokonova T, 2013, QUATERN INT, V290, P110, DOI 10.1016/j.quaint.2012.06.007; Nomokonova Tatiana, 2011, Asian Perspectives, V49, P157; Nomokonova TIU, 2013, DREVNIE KULTURY MONG, V4, P329; Nomokonova TIU, 2014, ARCHAEOL ETHNOG ANTH, V3, P21; Nuttall M., 1992, ARCTIC HOMELAND KINS; Ohtsuka K, 1994, B NATL MUSEUM ETHNOL, V19, P543; Okladnikov A.P., 1974, PETROGLIFY BAIKALA P; PASTUKHOV V D, 1969, Zoologicheskii Zhurnal, V48, P722; Pastukhov VD, 1993, NERPA BAIKALA BIOLOG; PELLY DF, 2001, PORTRAIT RELATIONSHI; Petrov E. A., 2009, BAIKALSKAIA NERPA; SCHEFFER VB, 1950, SCIENCE, V112, P309, DOI 10.1126/science.112.2907.309-a; Shichi K, 2009, QUATERN INT, V205, P98, DOI 10.1016/j.quaint.2009.02.005; Stora J, 2002, INT J OSTEOARCHAEOL, V12, P49, DOI 10.1002/oa.612.abs; Stora J., 2000, ARCHAEOZOOLOGIA, V11, P199; Tarasov P, 2007, PALAEOGEOGR PALAEOCL, V252, P440, DOI 10.1016/j.palaeo.2007.05.002; Tarasov PE, 2009, CLIM PAST, V5, P285, DOI 10.5194/cp-5-285-2009; Toporkov NN, 1926, SEVERNAIA AZIIA, V5-6, P63; Walker MJC, 2012, J QUATERNARY SCI, V27, P649, DOI 10.1002/jqs.2565; WEBER A, 1995, J WORLD PREHIST, V9, P99, DOI 10.1007/BF02221004; WEBER A, 1993, J ARCHAEOL SCI, V20, P629, DOI 10.1006/jasc.1993.1038; Weber A.W., 2008, NO HUNTER GATHERERS, V4; Weber AW, 2011, J ANTHROPOL ARCHAEOL, V30, P523, DOI 10.1016/j.jaa.2011.06.006; Weber AW, 2010, J ANTHROPOL ARCHAEOL, V29, P491, DOI 10.1016/j.jaa.2010.08.002; Weber AW, 2002, J ANTHROPOL ARCHAEOL, V21, P230, DOI 10.1006/jaar.2001.0395; Weber AW, 1998, J ARCHAEOL SCI, V25, P215, DOI 10.1006/jasc.1997.0235; Weber AW, 2010, PREHISTORIC HUNTER-GATHERERS OF THE BAIKAL REGION, SIBERIA, P1; Weber AW, QUATERN INT IN PRESS; Weber AW, 2012, NO HUNTER GATHERES R, V6; White D, 2010, PREHISTORIC HUNTER-GATHERERS OF THE BAIKAL REGION, SIBERIA, P1; Zhambalova S.G., 1984, ETNICHESKAIA ISTORII, P97	88	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128314	10.1371/journal.pone.0128314	http://dx.doi.org/10.1371/journal.pone.0128314			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26009890	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900222
J	Wang, Q; Wang, JM; Zhang, YY; Zhang, Y; Xu, SC; Lu, YM				Wang, Qing; Wang, Jingmao; Zhang, Yiying; Zhang, Yue; Xu, Shunchao; Lu, Yingmin			The Application of Fluorescence In Situ Hybridization in Different Ploidy Levels Cross-Breeding of Lily	PLOS ONE			English	Article							ASIATIC LILIES LILIUM; KARYOTYPE ANALYSIS; SEXUAL POLYPLOIDIZATION; BANDING-PATTERNS; F-1 HYBRID; 2N POLLEN; LONGIFLORUM; CHROMOSOMES; RDNA; 5S	21 crossing were conducted between Asiatic Lily with different ploidy levels, the results showed that the interploidy hybridization between diploid and tetraploid lilies was not as successful as intraploidy hybridization. Regardless of male sterility, triploid lilies could be used as female parents in the hybridization which the progenies were aneuploidy. 3xx4x crosses could be cultured more successfully than 3xx2x crosses. 45S rDNA was mapped on the chromosomes of seven Lilium species and their progenies using fluorescence in situ hybridization (FISH). FISH revealed six to sixteen 45S rDNA gene loci, and normally the sites were not in pairs. The asymmetry indexes of LA (Longiflorum hybrids x Asiatic hybrids) hybrids was higher than Asiatic hybrids, the evolution degree was LA hybrids > Asiatic hybrids. 45S rDNA distributed variably on chromosome 1-10 and 12 among Asiatic hybrids. Chromosome 1 had invariable sites of 45S rDNA in all Asiatic hybrids, which could be considered as the characteristic of Asiatic hybrids. LA hybrid 'Freya' had two sites of 45S rDNA on one homologous chromosome 5, and also it could be found in the progenies. The karyotype and fluorescence in situ hybridization with 45S rDNA as probe were applied to identify the different genotypes of 9 hybrids. Typical chromosomes with parental signal sites could be observed in all the genotypes of hybrids, it was confirmed that all the hybrids were true.	[Wang, Qing; Wang, Jingmao; Zhang, Yiying; Zhang, Yue; Xu, Shunchao; Lu, Yingmin] Beijing Forestry Univ, Coll Landscape Architecture, Beijing 100083, Peoples R China	Beijing Forestry University	Lu, YM (corresponding author), Beijing Forestry Univ, Coll Landscape Architecture, Beijing 100083, Peoples R China.	luyingmin@bjfu.edu.cn			'863' research program [2011AA10020804]; China National Natural Science Foundation [31071815, 31272204]; D. Programs Foundation of the Ministry of Education of China [20110014110006]	'863' research program(National High Technology Research and Development Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China)	This work was supported by the '863' research program (Grant No. 2011AA10020804), China National Natural Science Foundation (Grant No. 31071815 and No. 31272204), and the D. Programs Foundation of the Ministry of Education of China (Grant No. 20110014110006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu M, 2007, EUPHYTICA, V155, P143, DOI 10.1007/s10681-006-9317-y; Barba-Gonzalez R, 2005, EUPHYTICA, V143, P67, DOI 10.1007/s10681-005-2657-1; Barba-Gonzalez R, 2004, THEOR APPL GENET, V109, P1125, DOI 10.1007/s00122-004-1739-0; Barba-Gonzalez R, 2006, EUPHYTICA, V151, P243, DOI 10.1007/s10681-006-9148-x; BRANDHAM PE, 1982, GENETICA, V59, P29, DOI 10.1007/BF00130812; Carputo D, 2005, ANN APPL BIOL, V146, P71, DOI 10.1111/j.1744-7348.2005.04070.x; Chung MY, 2006, HORTSCIENCE, V41, P1040; Eeckhautt T, 2006, ACTA HORTIC, P113, DOI 10.17660/ActaHortic.2006.714.13; GILL B S, 1974, Cereal Research Communications, V2, P87; Hasterok R, 2001, THEOR APPL GENET, V103, P486, DOI 10.1007/s001220100653; HOLM PB, 1976, CARLSBERG RES COMMUN, V41, P217; Hwang YJ, 2011, HORTIC ENVIRON BIOTE, V52, P292, DOI 10.1007/s13580-011-0225-2; JOHNSTON SA, 1980, THEOR APPL GENET, V57, P5, DOI 10.1007/BF00276002; Karlov GI, 1999, GENOME, V42, P681, DOI 10.1139/gen-42-4-681; Kohler C, 2010, HEREDITY, V105, P57, DOI 10.1038/hdy.2009.176; KONGSUWAN K, 1977, CHROMOSOMA, V60, P169, DOI 10.1007/BF00288463; Koo DH, 2002, MOL CELLS, V13, P413; KUSPIRA J, 1986, CAN J GENET CYTOL, V28, P867, DOI 10.1139/g86-121; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Lim KB, 2001, THEOR APPL GENET, V103, P219, DOI 10.1007/s001220100638; Lim KB, 2003, THEOR APPL GENET, V106, P568, DOI 10.1007/s00122-002-1070-6; Lim KB, 2000, CHROMOSOME RES, V8, P119, DOI 10.1023/A:1009290418889; Lim KB, 2001, GENOME, V44, P911, DOI 10.1139/gen-44-5-911; Lim KiByung, 2004, Korean Journal of Breeding, V36, P123; Lim KY, 2005, CYTOGENET GENOME RES, V109, P298, DOI 10.1159/000082413; Lyrene PM, 2003, EUPHYTICA, V133, P27, DOI 10.1023/A:1025608408727; MAHESHWARI P, 1948, BOT REV, V14, P1, DOI 10.1007/BF02861693; Marasek A, 2004, ACTA HORTIC, P77, DOI 10.17660/ActaHortic.2004.651.7; Mizuochi H, 2007, EUPHYTICA, V155, P235, DOI 10.1007/s10681-006-9325-y; Noda S., 1956, MEM FAC SCI KYUSHU E, V2, P95; Ramanna MS, 2003, EUPHYTICA, V133, P3, DOI 10.1023/A:1025600824483; Ramsey J, 2002, ANNU REV ECOL SYST, V33, P589, DOI 10.1146/annurev.ecolsys.33.010802.150437; Sato T, 2009, ACTA HORTIC, P243; Schmitzer E., 1991, Quarterly Bulletin of the North American Lily Society, V45, P6; Scott RJ, 1998, DEVELOPMENT, V125, P3329; Sijak-Yakovev S, 2003, PLANT SYST EVOL, V236, P165, DOI [10.1007/s00606-002-0240-y, 10.1007/S00606-002-0240-y]; SMYTH DR, 1989, PLANT SYST EVOL, V163, P53, DOI 10.1007/BF00936153; Snowdon RJ, 2000, ANN BOT-LONDON, V86, P201, DOI 10.1006/anbo.2000.1156; Son JH, 1978, KOR J BOT, V21, P29; Stebbins G. L., 1971, CHROMOSOMAL EVOLUTIO; STEWART RN, 1947, AM J BOT, V34, P9, DOI 10.2307/2437190; Sultana S, 2010, J PLANT BIOL, V53, P433, DOI 10.1007/s12374-010-9133-8; Synge P. M., 1980, LILIES; Taketa S, 1999, THEOR APPL GENET, V98, P1, DOI 10.1007/s001220051033; Van Tuyl JM, 2003, ACTA HORTIC, P13, DOI 10.17660/ActaHortic.2003.612.1; Veilleux R., 1985, Plant Breeding Reviews, V3, P253; VOSA CG, 1976, HEREDITY, V37, P395, DOI 10.1038/hdy.1976.104; WATANABE K, 1992, EUPHYTICA, V60, P21; Wiejacha K, 2001, ACTA HORTIC, P281, DOI 10.17660/ActaHortic.2001.546.34; WOODCOCK H. B. D., 1950, Lilies of the world.; Xie SL, 2010, ACTA HORTIC, V855, P299; Zhou SJ, 2012, EUPHYTICA, V184, P401, DOI 10.1007/s10681-011-0609-5; Zhou SJ, 2011, HORTSCIENCE, V46, P558, DOI 10.21273/HORTSCI.46.4.558; Zhou SJ, 2008, J GENET GENOMICS, V35, P687, DOI 10.1016/S1673-8527(08)60091-0; Zhou SJ, 2007, INTERGENOMIC RECOMBI, P23	55	13	15	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126899	10.1371/journal.pone.0126899	http://dx.doi.org/10.1371/journal.pone.0126899			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010356	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900046
J	Bittencourt, CE; Ha, JP; Maitta, RW				Bittencourt, Cassiana E.; Ha, Jennifer P.; Maitta, Robert W.			Re-Examination of 30-Day Survival and Relapse Rates in Patients with Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome	PLOS ONE			English	Article							FACTOR-CLEAVING PROTEASE; THERAPEUTIC PLASMA-EXCHANGE; SYNDROME TTP-HUS; ADAMTS13; EXPERIENCE; OUTCOMES; TTP/HUS	Background and Objectives Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) are characterized by microangiopathic hemolytic anemia and thrombocytopenia. Interestingly, markedly different survival rates have been reported despite increases in survivability. We studied TTP-HUS 30-day mortality and relapse rates of patients who received TPE at our institution and compared them to published data. Patients and Methods Retrospective study analyzed 30-day mortality and relapse rates attributed to TTP-HUS from 01/01/2008 to 12/31/2012 and compared them to comparable literature reporting mortality and survival. Studies describing other etiologies for TPE and different mortality time interval were excluded. Results Fifty-nine patients were analyzed and all were initially treated with TPE and corticosteroids. Eleven patients were classified as not having TTP-HUS due to testing or clinical reassessment which ruled in other etiologies, and 18/59 patients had ADAMTS13 activity < 10%. Of remaining patients, 36/48 (75%) were diagnosed as idiopathic and 12/48 (25%) as secondary TTP-HUS. Patients received a mean of 12 TPEs (range 1-42); 42/48 (87.5%) patients had ADAMTS13 activity measured; complete response obtained in 39/48 (81.2%) patients (platelet count > 100 x 10(9)/L); partial response in 4/48 (8%); and 5/48 (10.4%) did not have increases in platelet counts (2/5 of these patients died within the study period). Forty percent of patients obtained platelet counts > 150 x 109/L. Overall 30-day mortality for our patient cohort was 6.7% (4/59). Comparison of our mortality rate to combined data of five published studies of 16% (92/571) showed a significant difference, p = 0.04. Our relapse rate was 18.6% (11/59) similar to previous reports. Conclusions Wide differences in mortality may be due to grouping of two distinct pathologic entities under TTP-HUS; and presence of confounding factors in the patient populations under study such as co-morbidities, promptness of TPE initiation, delay in diagnosis and therapeutic practice.	[Bittencourt, Cassiana E.; Ha, Jennifer P.; Maitta, Robert W.] Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH 44106 USA; [Bittencourt, Cassiana E.; Ha, Jennifer P.; Maitta, Robert W.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University	Maitta, RW (corresponding author), Univ Hosp Case Med Ctr, Dept Pathol, Cleveland, OH 44106 USA.	robert.maitta@case.edu	Maitta, Robert/J-9318-2019	Maitta, Robert/0000-0002-5424-5519	Office of Diversity and Inclusion of the University Hospitals Case Medical Center, Cleveland, Ohio	Office of Diversity and Inclusion of the University Hospitals Case Medical Center, Cleveland, Ohio	This study was fully supported by a grant from the Office of Diversity and Inclusion of the University Hospitals Case Medical Center, Cleveland, Ohio, awarded to RWM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMOROSI EL, 1977, ANN INTERN MED, V86, P102, DOI 10.7326/0003-4819-86-1-102; AMOROSI EL, 1966, MEDICINE, V45, P139, DOI 10.1097/00005792-196603000-00003; Clark WF, 2012, SEMIN DIALYSIS, V25, P214, DOI 10.1111/j.1525-139X.2011.01035.x; Colflesh CR, 1996, AM J MED SCI, V311, P167, DOI 10.1097/00000441-199604000-00002; Coppo P, 2004, MEDICINE, V83, P233, DOI 10.1097/01.md.0000133622.03370.07; Dervenoulas J, 2000, ANN HEMATOL, V79, P66, DOI 10.1007/s002770050012; Forzley BR, 2008, BRIT J HAEMATOL, V143, P100, DOI 10.1111/j.1365-2141.2008.07317.x; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Garg AX, 2003, JAMA-J AM MED ASSOC, V290, P1360, DOI 10.1001/jama.290.10.1360; George JN, 2010, BLOOD, V116, P4060, DOI 10.1182/blood-2010-07-271445; George JN, 2000, BLOOD, V96, P1223, DOI 10.1182/blood.V96.4.1223.h8001223_1223_1229; George JN, 2004, SEMIN HEMATOL, V41, P60, DOI 10.1053/j.seminhematol.2003.10.001; Hong H, 2015, TRANSFUSION, V55, P756, DOI 10.1111/trf.12912; Hosler GA, 2003, ARCH PATHOL LAB MED, V127, P834; Hovinga JAK, 2010, BLOOD, V115, P1500, DOI 10.1182/blood-2009-09-243790; Kier YE, 2013, TRANSFUS APHER SCI, V49, P644, DOI 10.1016/j.transci.2013.07.005; Kim JW, 2011, HEMATOLOGY, V16, P73, DOI 10.1179/102453311X12902908411995; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Korkmaz S, 2013, TRANSFUS APHER SCI, V48, P353, DOI 10.1016/j.transci.2013.04.016; Lara PN, 1999, AM J MED, V107, P573, DOI 10.1016/S0002-9343(99)00286-7; Levandovsky M, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-23; Michael M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003595.pub2; REMUZZI G, 1987, KIDNEY INT, V32, P292, DOI 10.1038/ki.1987.206; Remuzzi G, 2002, BLOOD, V100, P778, DOI 10.1182/blood-2001-12-0166; Roberts A W, 1991, J Clin Apher, V6, P150, DOI 10.1002/jca.2920060305; ROCK G, 1992, TRANSFUSION, V32, P710, DOI 10.1046/j.1537-2995.1992.32893032096.x; ROCK GA, 1991, NEW ENGL J MED, V325, P393, DOI 10.1056/NEJM199108083250604; RUGGENENTI P, 1990, HEMATOL ONCOL CLIN N, V4, P219, DOI 10.1016/S0889-8588(18)30514-8; Schiviz A, 2012, BLOOD, V119, P6128, DOI 10.1182/blood-2011-09-380535; Terrell DR, 2011, TRANSFUSION, V51, P2237, DOI 10.1111/j.1537-2995.2011.03125.x; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Vanhoorelbeke K, 2013, J THROMB HAEMOST, V11, P2, DOI 10.1111/jth.12255; Vesely SK, 2003, BLOOD, V102, P60, DOI 10.1182/blood-2003-01-0193	33	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127744	10.1371/journal.pone.0127744	http://dx.doi.org/10.1371/journal.pone.0127744			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000799	Green Published, Green Submitted, gold			2022-12-26	WOS:000354931700079
J	Ci, XX; Kuraoka, M; Wang, HX; Carico, Z; Hopper, K; Shin, J; Deng, XM; Qiu, YR; Unniraman, S; Kelsoe, G; Zhong, XP				Ci, Xinxin; Kuraoka, Masayuki; Wang, Hongxia; Carico, Zachary; Hopper, Kristen; Shin, Jinwook; Deng, Xuming; Qiu, Yirong; Unniraman, Shyam; Kelsoe, Garnett; Zhong, Xiao-Ping			TSC1 Promotes B Cell Maturation but Is Dispensable for Germinal Center Formation	PLOS ONE			English	Article							TUMOR-SUPPRESSOR TSC1; SCLEROSIS COMPLEX 1; MAMMALIAN TARGET; GENE-PRODUCTS; T-CELLS; MTOR; ACTIVATION; EFFECTOR; QUIESCENCE; KINASE	Accumulating evidence indicates that the tuberous sclerosis complex 1 (TSC1), a tumor suppressor that acts by inhibiting mTOR signaling, plays an important role in the immune system. We report here that TSC1 differentially regulates mTOR complex 1 (mTORC1) and mTORC2/Akt signaling in B cells. TSC1 deficiency results in the accumulation of transitional-1 (T1) B cells and progressive losses of B cells as they mature beyond the T1 stage. Moreover, TSC1KO mice exhibit a mild defect in the serum antibody responses or rate of Ig class-switch recombination after immunization with a T-cell-dependent antigen. In contrast to a previous report, we demonstrate that both constitutive Peyer's patch germinal centers (GCs) and immunization-induced splenic GCs are unimpaired in TSC1-deficient (TSC1KO) mice and that the ratio of GC B cells to total B cells is comparable in WT and TSC1KO mice. Together, our data demonstrate that TSC1 plays important roles for B cell development, but it is dispensable for GC formation and serum antibody responses.	[Ci, Xinxin; Wang, Hongxia; Shin, Jinwook; Zhong, Xiao-Ping] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Ci, Xinxin; Deng, Xuming] Jilin Univ, Coll Anim Sci & Vet Med, Inst Zoonosis, Key Lab Zoonosis,Minist Educ, Changchun 130062, Peoples R China; [Kuraoka, Masayuki; Carico, Zachary; Hopper, Kristen; Unniraman, Shyam; Kelsoe, Garnett; Zhong, Xiao-Ping] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Wang, Hongxia; Qiu, Yirong] Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou 510515, Guangdong, Peoples R China	Duke University; Jilin University; Duke University; Southern Medical University - China	Kelsoe, G (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.	ghkelsoe@duke.edu; zhong001@mc.duke.edu	Shin, Jinwook/AAG-6004-2019	Shin, Jinwook/0000-0003-3476-7595; Wang, Hongxia/0000-0001-5082-003X	National Institutes of Health [AI076357, AI079088, AI101206, AI079873]; American Cancer Society [RSG-08-186-01-LIB];  [AI24335];  [AI56363]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056363, R01AI076357, T32AI052077, R01AI024335, R01AI101206, R01AI079088, R21AI079873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by funding from the National Institutes of Health (AI076357, AI079088, AI101206, and AI079873), and the American Cancer Society (RSG-08-186-01-LIB, X.-P.Z.), and by AI24335 and AI56363 (GK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman D, 2004, IMMUNOL REV, V197, P147, DOI 10.1111/j.0105-2896.2004.0108.x; Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Astrinidis A, 2002, ONCOGENE, V21, P8470, DOI 10.1038/sj.onc.1205962; Benhamron S, 2011, EUR J IMMUNOL, V41, P2390, DOI 10.1002/eji.201041336; Calamito M, 2010, BLOOD, V115, P4043, DOI 10.1182/blood-2009-09-241638; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Chen H, 2013, FASEB J, V27, P3979, DOI 10.1096/fj.13-235408; Chen J, 2010, EUR J IMMUNOL, V40, P1890, DOI 10.1002/eji.200939817; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; GEARHART PJ, 1981, NATURE, V291, P29, DOI 10.1038/291029a0; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Han SH, 1997, SCIENCE, V278, P301, DOI 10.1126/science.278.5336.301; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Holl EK, 2011, J IMMUNOL, V186, P5603, DOI 10.4049/jimmunol.1003464; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Krishna S, 2014, INFECT IMMUN, V82, P3045, DOI 10.1128/IAI.01816-14; Kuraoka M, 2009, J IMMUNOL, V183, P3237, DOI 10.4049/jimmunol.0901548; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee K, 2013, BLOOD, V122, P2369, DOI 10.1182/blood-2013-01-477505; Lee K, 2010, IMMUNITY, V32, P743, DOI 10.1016/j.immuni.2010.06.002; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; O'Brien TF, 2012, ARCH IMMUNOL THER EX, V60, P173, DOI 10.1007/s00005-012-0171-4; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Pan HJ, 2013, J IMMUNOL, V191, P699, DOI 10.4049/jimmunol.1201443; Pan HJ, 2012, J IMMUNOL, V188, P3658, DOI 10.4049/jimmunol.1102187; Park Y, 2013, J CLIN INVEST, V123, P5165, DOI 10.1172/JCI69751; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shapiro-Shelef M, 2005, J EXP MED, V202, P1471, DOI 10.1084/jem.20051611; Shin J, 2014, P NATL ACAD SCI USA, V111, pE776, DOI 10.1073/pnas.1315435111; Shin J, 2012, BLOOD, V119, P3306, DOI 10.1182/blood-2011-05-353342; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002; Wu JH, 2014, J CLIN INVEST, V124, P1685, DOI 10.1172/JCI69780; Wu JH, 2014, J IMMUNOL, V192, P2643, DOI 10.4049/jimmunol.1302076; Wu Q, 2011, J IMMUNOL, V187, P1106, DOI 10.4049/jimmunol.1003968; Xie DL, 2012, P NATL ACAD SCI USA, V109, P14152, DOI 10.1073/pnas.1119744109; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030249, 10.1371/journal.pone.0030592]; Zhang SL, 2011, BLOOD, V117, P1228, DOI 10.1182/blood-2010-05-287821; Zhong XP, 2012, CELL CYCLE, V11, P3909, DOI 10.4161/cc.22235; Zhong XP, 2011, IMMUNOL RES, V49, P109, DOI 10.1007/s12026-010-8175-9	55	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127527	10.1371/journal.pone.0127527	http://dx.doi.org/10.1371/journal.pone.0127527			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000908	gold, Green Published, Green Submitted			2022-12-26	WOS:000354931700066
J	Gupte, TM				Gupte, Tejas M.			Mitochondrial Fragmentation Due to Inhibition of Fusion Increases Cyclin B through Mitochondrial Superoxide Radicals	PLOS ONE			English	Article							DYNAMIN-RELATED PROTEIN; CELL-CYCLE; DROSOPHILA-MELANOGASTER; DNA-REPLICATION; SINGLE-SAMPLE; G(2)/M PHASE; FISSION; PROLIFERATION; PROGRESSION; KINASE	During the cell cycle, mitochondria undergo regulated changes in morphology. Two particularly interesting events are first, mitochondrial hyperfusion during the G(1)-S transition and second, fragmentation during entry into mitosis. The mitochondria remain fragmented between late G(2)- and mitotic exit. This mitotic mitochondrial fragmentation constitutes a checkpoint in some cell types, of which little is known. We bypass the 'mitotic mitochondrial fragmentation' checkpoint by inducing fragmented mitochondrial morphology and then measure the effect on cell cycle progression. Using Drosophila larval hemocytes, Drosophila S2R(+) cell and cells in the pouch region of wing imaginal disc of Drosophila larvae we show that inhibiting mitochondrial fusion, thereby increasing fragmentation, causes cellular hyperproliferation and an increase in mitotic index. However, mitochondrial fragmentation due to over-expression of the mitochondrial fission machinery does not cause these changes. Our experiments suggest that the inhibition of mitochondrial fusion increases superoxide radical content and leads to the upregulation of cyclin B that culminates in the observed changes in the cell cycle. We provide evidence for the importance of mitochondrial superoxide in this process. Our results provide an insight into the need for mitofusin-degradation during mitosis and also help in understanding the mechanism by which mitofusins may function as tumor suppressors.	[Gupte, Tejas M.] Natl Ctr Biol Sci NCBS TIFR, Bangalore 560065, Karnataka, India; [Gupte, Tejas M.] Inst Stem Cell Biol & Regenerat Med, InStem, Bangalore 560065, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem	Gupte, TM (corresponding author), Natl Ctr Biol Sci NCBS TIFR, UAS GKVK Campus,Bellary Rd, Bangalore 560065, Karnataka, India.	tejasmgupte@gmail.com		Gupte, Tejas/0000-0001-7422-016X	National Centre for Biological Sciences; Tata Institute of Fundamental Research; Department of Biotechnology, Government of India [BT/PR9504/AGR/36/23/2007]	National Centre for Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by intramural funds from National Centre for Biological Sciences, from Tata Institute of Fundamental Research, and grant number BT/PR9504/AGR/36/23/2007 from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki N, 2006, BIOL PHARM BULL, V29, P1962, DOI 10.1248/bpb.29.1962; Asha H, 2003, GENETICS, V163, P203; BEGG AC, 1985, CYTOMETRY, V6, P620, DOI 10.1002/cyto.990060618; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Cheng X, 2013, NEOPLASMA, V60, P620, DOI 10.4149/neo_2013_080; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Colanzi A, 2007, EMBO J, V26, P2465, DOI 10.1038/sj.emboj.7601686; de la Cruz Aida Flor A., 2008, V420, P373, DOI 10.1007/978-1-59745-583-1_24; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Dolezal T, 2005, PLOS BIOL, V3, P1213, DOI 10.1371/journal.pbio.0030201; Eidukevicius R, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-122; Feinstein TN, 2007, MOL BIOL CELL, V18, P594, DOI 10.1091/mbc.E06-06-0530; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Goyal G, 2007, DEV CELL, V12, P807, DOI 10.1016/j.devcel.2007.02.002; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Honda S, 2005, J CELL SCI, V118, P3153, DOI 10.1242/jcs.02449; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jin ZG, 2008, GENETICS, V180, P2123, DOI 10.1534/genetics.108.093195; Khurana V, 2006, CURR BIOL, V16, P230, DOI 10.1016/j.cub.2005.12.042; Kirby K, 2002, P NATL ACAD SCI USA, V99, P16162, DOI 10.1073/pnas.252342899; Lee SR, 2005, J CELL PHYSIOL, V205, P270, DOI 10.1002/jcp.20395; Legent K, 2006, GENES CELLS, V11, P907, DOI 10.1111/j.1365-2443.2006.00993.x; Li N, 1998, J CELL PHYSIOL, V175, P359, DOI 10.1002/(SICI)1097-4652(199806)175:3<359::AID-JCP14>3.0.CO;2-0; Lim S, 2007, FREE RADICAL BIO MED, V42, P1178, DOI 10.1016/j.freeradbiomed.2007.01.013; Ma L, 2013, INT J ONCOL, V42, P1993, DOI 10.3892/ijo.2013.1903; Manak R, 2007, NAT CELL BIOL, V9, P581, DOI 10.1038/ncb1580; Menon SG, 2007, CANCER RES, V67, P6392, DOI 10.1158/0008-5472.CAN-07-0225; Misko AL, 2012, J NEUROSCI, V32, P4145, DOI 10.1523/JNEUROSCI.6338-11.2012; Muliyil S, 2011, DEVELOPMENT, V138, P3043, DOI 10.1242/dev.060731; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; OBERLEY LW, 1980, MED HYPOTHESES, V6, P249, DOI 10.1016/0306-9877(80)90123-1; OBERLEY LW, 1981, MED HYPOTHESES, V7, P21, DOI 10.1016/0306-9877(81)90018-9; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Park YY, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-25; Persico A, 2010, MOL BIOL CELL, V21, P3708, DOI 10.1091/mbc.E10-03-0243; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Qian W, 2012, J CELL SCI, V125, P5745, DOI 10.1242/jcs.109769; Qu L, 2013, TUMORI, V99, P697, DOI 10.1700/1390.15458; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; RIMMINGTON G, 1994, J CELL SCI, V107, P2729; Rohn JL, 2014, CURR BIOL, V24, P2598, DOI 10.1016/j.cub.2014.09.045; Roy S, 1997, CURR BIOL, V7, P222, DOI 10.1016/S0960-9822(06)00117-5; Sarsour EH, 2008, AGING CELL, V7, P405, DOI 10.1111/j.1474-9726.2008.00384.x; Schulz LL, 2006, FASEB J, V20, P488, DOI 10.1096/fj.05-5020fje; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Sriram V, 2003, J CELL BIOL, V161, P593, DOI 10.1083/jcb.200210166; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Swaminathan A, 2010, MECH DEVELOP, V127, P96, DOI 10.1016/j.mod.2009.10.003; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004492; Wang ZQ, 2014, DEV CELL, V29, P217, DOI 10.1016/j.devcel.2014.03.012; Westrate LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091911; Wu MYW, 2007, EMBO J, V26, P371, DOI 10.1038/sj.emboj.7601487; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341; Zunino R, 2009, J BIOL CHEM, V284, P17783, DOI 10.1074/jbc.M901902200	56	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126829	10.1371/journal.pone.0126829	http://dx.doi.org/10.1371/journal.pone.0126829			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000631	Green Submitted, Green Published, gold			2022-12-26	WOS:000354931700029
J	Kumar, S; Sharma, RK				Kumar, Sujeet; Sharma, Rajendra K.			N-Terminal Region of the Catalytic Domain of Human N-Myristoyltransferase 1 Acts as an Inhibitory Module	PLOS ONE			English	Article							PROTEIN MYRISTOYLATION; FUNCTIONAL ROLES; N-MYRISTOYLTRANSFERASE-1; APOPTOSIS; ACYLATION; COA	N-myristoyltransferase (NMT) plays critical roles in the modulation of various signaling molecules, however, the regulation of this enzyme in diverse cellular states remains poorly understood. We provide experimental evidence to show for the first time that for the isoform 1 of human NMT (hNMT1), the regulatory roles extend into the catalytic core. In our present study, we expressed, purified, and characterized a truncation mutant devoid of 28 N-terminal amino acids from the catalytic module (Delta 28-hNMT1s) and compared its properties to the full-length catalytic domain of hNMT1. The deletion of the N-terminal peptide had no effect on the enzyme stability. Our findings suggest that the N-terminal region in the catalytic module of hNMT1 functions serves as a regulatory control element. The observations of an similar to 3 fold increase in enzymatic efficiency following removal of the N-terminal peptide of hNMT1s indicates that N-terminal amino acids acts as an inhibitory segment and negatively regulate the enzyme activity. Our findings that the N-terminal region confers control over activity, taken together with the earlier observations that the N-terminal of hNMT1 is differentially processed in diverse cellular states, suggests that the proteolytic processing of the peptide segment containing the inhibitory region provides a molecular mechanism for physiological up-regulation of myristoyltransferase activity.	[Kumar, Sujeet; Sharma, Rajendra K.] Univ Saskatchewan, Coll Med, Canc Cluster, Dept Pathol & Lab Med, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan	Sharma, RK (corresponding author), Univ Saskatchewan, Coll Med, Canc Cluster, Dept Pathol & Lab Med, Saskatoon, SK S7N 0W0, Canada.	rajendra.sharma@usask.ca		Kumar, Sujeet/0000-0001-5427-8735	Canadian Breast Cancer Foundation-Prairies/NWT operating grant [412572]	Canadian Breast Cancer Foundation-Prairies/NWT operating grant	This work was supported by the Canadian Breast Cancer Foundation-Prairies/NWT operating grant to RKS (Grant number - 412572). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Bhandarkar SS, 2008, CLIN CANCER RES, V14, P5743, DOI 10.1158/1078-0432.CCR-08-0405; Bhatnagar RS, 1998, NAT STRUCT BIOL, V5, P1091, DOI 10.1038/4202; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Bowyer PW, 2008, CHEMMEDCHEM, V3, P402, DOI 10.1002/cmdc.200700301; Brannigan JA, 2010, J MOL BIOL, V396, P985, DOI 10.1016/j.jmb.2009.12.032; Breuer S, 2006, BIOCHEMISTRY-US, V45, P2339, DOI 10.1021/bi052052c; Bruylants G, 2005, CURR MED CHEM, V12, P2011, DOI 10.2174/0929867054546564; Burnaevskiy N, 2013, NATURE, V496, P106, DOI 10.1038/nature12004; Carballeira NM, 2008, PROG LIPID RES, V47, P50, DOI 10.1016/j.plipres.2007.10.002; Cordeddu V, 2009, NAT GENET, V41, P1022, DOI 10.1038/ng.425; Das U, 2012, CURR CANCER DRUG TAR, V12, P667, DOI 10.2174/156800912801784857; de Jonge H R, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.63.pe1; Ducker CE, 2005, MOL CANCER RES, V3, P463, DOI 10.1158/1541-7786.MCR-05-0037; DURONIO RJ, 1992, P NATL ACAD SCI USA, V89, P4129, DOI 10.1073/pnas.89.9.4129; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Farazi TA, 2001, BIOCHEMISTRY-US, V40, P9177, DOI 10.1021/bi0107997; Giang DG, 1998, J BIOL CHEM, V273, P6595, DOI 10.1074/jbc.273.12.6595; Gilbert IH, 2013, J MED CHEM, V56, P7719, DOI 10.1021/jm400362b; Glover CJ, 1997, J BIOL CHEM, V272, P28680, DOI 10.1074/jbc.272.45.28680; Gluck JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010081; Goldston AM, 2014, TRENDS PARASITOL, V30, P350, DOI 10.1016/j.pt.2014.05.003; Goncalves V, 2012, ANAL BIOCHEM, V421, P342, DOI 10.1016/j.ab.2011.10.013; Heal WP, 2012, NAT PROTOC, V7, P105, DOI 10.1038/nprot.2011.425; Kumar S, 2014, MOL CELL BIOCHEM, V392, P175, DOI 10.1007/s11010-014-2029-z; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Martin DDO, 2011, BIOCHIMIE, V93, P18, DOI 10.1016/j.biochi.2010.10.018; McCabe JB, 1999, MOL BIOL CELL, V10, P3771, DOI 10.1091/mbc.10.11.3771; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Perinpanayagam MA, 2013, FASEB J, V27, P811, DOI 10.1096/fj.12-214924; PESECKIS SM, 1994, J BIOL CHEM, V269, P30888; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 2012, TRENDS MOL MED, V18, P206, DOI 10.1016/j.molmed.2012.01.007; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rose PW, 2015, NUCLEIC ACIDS RES, V43, pD345, DOI 10.1093/nar/gku1214; Selvakumar P, 2007, PROG LIPID RES, V46, P1, DOI 10.1016/j.plipres.2006.05.002; Shrivastav A, 2008, J IMMUNOL, V180, P1019, DOI 10.4049/jimmunol.180.2.1019; Taniguchi H, 1999, BIOPHYS CHEM, V82, P129, DOI 10.1016/S0301-4622(99)00112-X; WILCOX C, 1987, SCIENCE, V238, P1275, DOI 10.1126/science.3685978; Wright Megan H, 2010, J Chem Biol, V3, P19, DOI 10.1007/s12154-009-0032-8; Wu J, 2007, J BIOL CHEM, V282, P22185, DOI 10.1074/jbc.M702696200; Yang SH, 2005, J BIOL CHEM, V280, P18990, DOI 10.1074/jbc.M412917200; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zhao C, 2014, CHEMMEDCHEM, V9, P2425, DOI 10.1002/cmdc.201402174	46	6	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127661	10.1371/journal.pone.0127661	http://dx.doi.org/10.1371/journal.pone.0127661			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000639	Green Published, gold, Green Submitted			2022-12-26	WOS:000354931700071
J	Li, M; Cima, MJ; Milner, DA				Li, Matthew; Cima, Michael J.; Milner, Danny A., Jr.			If It's Not One Thing, It's Another: An Inverse Relationship of Malignancy and Atherosclerotic Disease	PLOS ONE			English	Article							AORTIC ATHEROSCLEROSIS; CHOLESTEROL LEVELS; T-CELLS; INFLAMMATION; CORONARY; STATINS	Atherosclerosis and malignancy are pervasive pathological conditions that account for the bulk of morbidity and mortality in developed countries. Our current understanding of the patholobiology of these fundamental disorders suggests that inflammatory processes may differentially affect them; thus, atherosclerosis can be largely driven by inflammation, where as cancer often flourishes as inflammatory responses are modulated. A corollary of this hypothesis is that cancer (or its treatment may significantly attenuate atherosclerotic disease by diminishing host inflammatory response, suggesting potential therapeutic approaches. To evaluate the relationship between cancer and cardiovascular atherosclerotic disease, we assessed 1,024 autopsy reports from Brigham and Women's Hospital and performed correlative analyses on atherosclerotic severity and cancer prevalence. In gender-and agematched populations, there is a statistically significant inverse correlation between history of malignancy and autopsy-proven atherosclerotic disease. In a second analysis, we evaluated 147,779 patients through analysis of the Harvard Catalyst SHRINE database and demonstrated a reduced non-coronary atherosclerotic disease rate: control (27.40%), leukemia/lymphoma (12.57%), lung (17.63%), colorectal (18.17%), breast (9.79%), uterus/cervix (11.47%), and prostate (18.40%). We herein report that, based on two separate medical records analysis, an inverse correlation between cancer and atherosclerosis. Furthermore, this correlation is not uniformly associated with anti-neoplastic treatment, suggesting that the inverse relationship may be in part attributable to an individual's intrinsic inflammatory propensity, and/or to inflammation-modulatory properties of neoplasms.	[Li, Matthew] Harvard Univ, MIT, Sch Med, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Cima, Michael J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Milner, Danny A., Jr.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital	Li, M (corresponding author), Harvard Univ, MIT, Sch Med, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA.	m_li@mit.edu	Milner, Danny/K-3568-2019	Milner, Jr, Danny Arnold/0000-0002-6685-8208				Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Ammirati E, 2012, J AM HEART ASSOC, V1, P27, DOI 10.1161/JAHA.111.000125; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Buggins AGS, 2001, J IMMUNOL, V167, P6021, DOI 10.4049/jimmunol.167.10.6021; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; ELKELES A, 1959, BRIT J CANCER, V13, P403, DOI 10.1038/bjc.1959.46; ELKELES A, 1956, BRIT J CANCER, V10, P247, DOI 10.1038/bjc.1956.28; Forrester JS, 2000, J AM COLL CARDIOL, V36, P1419, DOI 10.1016/S0735-1097(00)00829-9; Hayward RA, 2006, ANN INTERN MED, V145, P520, DOI 10.7326/0003-4819-145-7-200610030-00010; Henkin Yaakov, 2008, J AM COLL CARDIOL, V52, DOI [10.1016/j.jacc.2008.05.002, DOI 10.1016/J.JACC.2008.05.002]; Howard G, 1998, JAMA-J AM MED ASSOC, V308, P2577; Jaffer FA, 2002, ARTERIOSCL THROM VAS, V22, P849, DOI 10.1161/01.ATV.0000012662.29622.00; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Kim HJ, 1999, J KOREAN MED SCI, V14, P299, DOI 10.3346/jkms.1999.14.3.299; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Mallat Z, 2007, TRENDS CARDIOVAS MED, V17, P113, DOI 10.1016/j.tcm.2007.03.001; Maniscalco Benedict S., 2004, Pathophysiology, V11, P95, DOI 10.1016/j.pathophys.2004.06.001; Marsh MM, 1999, J LIPID RES, V40, P893; Mayo Clinic, HEART DIS TREATM DRU; McFadden D., 1977, 474 YAL U COWL FDN; Nathan L, 1997, ANNU REV PHARMACOL, V37, P477, DOI 10.1146/annurev.pharmtox.37.1.477; NUMANO F, 1980, JPN CIRC J, V44, P55, DOI 10.1253/jcj.44.55; Oka K, 2005, ACTA BIOCHIM POL, V52, P311; PEDERSEN TR, 1994, LANCET, V344, P1383; Poli A, 2010, EUR J INTERN MED, V21, P372, DOI 10.1016/j.ejim.2010.04.013; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; SACKS FM, 1995, AM J CARDIOL, V76, pC78, DOI 10.1016/S0002-9149(99)80475-5; Sekijima T, 2011, CLIMACTERIC, V14, P31, DOI 10.3109/13697137.2010.522278; Slattery ML, 1998, AM J EPIDEMIOL, V148, P4, DOI 10.1093/aje/148.1.4-a; SPAIN DM, 1956, AM J MED SCI, V231, P165, DOI 10.1097/00000441-195623120-00007; Sparrow CP, 2001, ARTERIOSCL THROM VAS, V21, P115, DOI 10.1161/01.ATV.21.1.115; Steinberg D, 2004, J LIPID RES, V45, P1583, DOI 10.1194/jlr.R400003-JLR200; Topfer K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/918471; Ustun C, 2011, BLOOD, V118, P5084, DOI 10.1182/blood-2011-07-365817; Weitz-Schmidt G, 2002, TRENDS PHARMACOL SCI, V23, P482, DOI 10.1016/S0165-6147(02)02077-1; WHO, CARD DIS CVDS; WILENS SL, 1947, AM J PATHOL, V23, P793; Winklestein R, BRIT J CANC, V13, P606; Zindl CL, 2010, SCIENCE, V328, P697, DOI 10.1126/science.1190310; Zyga S, 2011, J REN CARE, V37, P12, DOI 10.1111/j.1755-6686.2011.00201.x	40	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126855	10.1371/journal.pone.0126855	http://dx.doi.org/10.1371/journal.pone.0126855			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000958	Green Published, gold, Green Submitted			2022-12-26	WOS:000354931700032
J	Sonakowska, L; Wlodarczyk, A; Poprawa, I; Binkowski, M; Srobka, J; Kaminska, K; Kszuk-Jendrysik, M; Chajec, L; Zajusz, B; Rost-Roszkowska, MM				Sonakowska, Lidia; Wlodarczyk, Agnieszka; Poprawa, Izabela; Binkowski, Marcin; Srobka, Joanna; Kaminska, Karolina; Kszuk-Jendrysik, Michalina; Chajec, Lukasz; Zajusz, Bartlomiej; Rost-Roszkowska, Magdalena Maria			Structure and Ultrastructure of the Endodermal Region of the Alimentary Tract in the Freshwater Shrimp Neocaridina heteropoda (Crustacea, Malacostraca)	PLOS ONE			English	Article							PALAEMONETES-ARGENTINUS CRUSTACEA; PENAEUS-SEMISULCATUS CRUSTACEA; MIDGUT EPITHELIUM; FINE-STRUCTURE; SPECIAL EMPHASIS; DIGESTIVE CELLS; VENTRAL CECA; MOLT CYCLE; B-CELLS; HEPATOPANCREAS	The freshwater shrimp Neocaridina heteropoda (Crustacea, Malacostraca, Decapoda) originates from Asia and is one of the species that is widely available all over the world because it is the most popular shrimp that is bred in aquaria. The structure and the ultrastructure of the midgut have been described using X-ray microtomography, transmission electron microscopy, light and fluorescence microscopes. The endodermal region of the alimentary system in Neocaridina heteropoda consists of an intestine and a hepatopancreas. No differences were observed in the structure and ultrastructure of males and females of the shrimp that were examined. The intestine is a tube-shaped organ and the hepatopancreas is composed of two large diverticles that are divided into the blind-end tubules. Hepatopancreatic tubules have three distinct zones - proximal, medial and distal. Among the epithelial cells of the intestine, two types of cells were distinguished - D and E-cells, while three types of cells were observed in the epithelium of the hepatopancreas - F, B and E-cells. Our studies showed that the regionalization in the activity of cells occurs along the length of the hepatopancreatic tubules. The role and ultrastructure of all types of epithelial cells are discussed, with the special emphasis on the function of the E-cells, which are the midgut regenerative cells. Additionally, we present the first report on the existence of an intercellular junction that is connected with the E-cells of Crustacea.	[Sonakowska, Lidia; Wlodarczyk, Agnieszka; Poprawa, Izabela; Kaminska, Karolina; Kszuk-Jendrysik, Michalina; Chajec, Lukasz; Zajusz, Bartlomiej; Rost-Roszkowska, Magdalena Maria] Univ Silesia, Dept Anim Histol & Embryol, Katowice, Poland; [Binkowski, Marcin; Srobka, Joanna] Univ Silesia, Dept Biomed Comp Syst, Xray Microtomog Lab, Chorzow, Poland	University of Silesia in Katowice; University of Silesia in Katowice	Rost-Roszkowska, MM (corresponding author), Univ Silesia, Dept Anim Histol & Embryol, Katowice, Poland.	magdalena.rost-roszkowska@us.edu.pl	Rost-Roszkowska, Magdalena/AAM-7005-2020	Poprawa, Izabela/0000-0002-8930-1592; Wlodarczyk, Agnieszka/0000-0002-2374-4892; Rost-Roszkowska, Magdalena/0000-0001-7124-8423; Chajec, Lukasz/0000-0001-6455-9063				ALMOHANNA S, 1987, J MAR BIOL ASSOC UK, V67, P803, DOI 10.1017/S0025315400057040; ALMOHANNA SY, 1989, MAR BIOL, V101, P535, DOI 10.1007/BF00541656; ALMOHANNA SY, 1986, J MAR BIOL ASSOC UK, V66, P403, DOI 10.1017/S0025315400043034; ARNAUD J, 1978, CELL TISSUE RES, V187, P333; CACECI T, 1988, J MAR BIOL ASSOC UK, V68, P323, DOI 10.1017/S002531540005222X; Ceccaldi H.J., 1989, AQUACULTURE, V9, P243, DOI DOI 10.1007/S00248-011-9936-2; Chajec L, 2014, ARTHROPOD STRUCT DEV, V43, P27, DOI 10.1016/j.asd.2013.06.002; COLEMAN CO, 1990, J NAT HIST, V24, P1573, DOI 10.1080/00222939000770901; Correia AD, 2002, J MAR BIOL ASSOC UK, V82, P201, DOI 10.1017/S0025315402005362; Fernandes KM, 2014, PARASITOL INT, V63, P506, DOI 10.1016/j.parint.2014.01.004; Fialho MDCQ, 2009, ANN ENTOMOL SOC AM, V102, P119, DOI 10.1603/008.102.0113; Franceschini-Vicentini IB, 2009, INT J MORPHOL, V27, P121, DOI 10.4067/S0717-95022009000100022; Gibson R., 1979, Oceanography and Marine Biology an Annual Review, V17, P285; Goncalves WG, 2014, CR BIOL, V337, P365, DOI 10.1016/j.crvi.2014.04.002; Hakim RS, 2010, ANNU REV ENTOMOL, V55, P593, DOI 10.1146/annurev-ento-112408-085450; HAMES CAC, 1991, CAN J ZOOL, V69, P1931, DOI 10.1139/z91-267; Herrera-Alvarez L, 2000, J MORPHOL, V244, P177, DOI 10.1002/(SICI)1097-4687(200006)244:3<177::AID-JMOR3>3.0.CO;2-D; ICELY JD, 1980, MAR BIOL, V57, P193, DOI 10.1007/BF00390737; ICELY JD, 1984, PHILOS T ROY SOC B, V306, P49, DOI 10.1098/rstb.1984.0081; Icely JD, 1992, MICROSCOPIC ANATOMY, V10; Johnston DJ, 1998, J CRUSTACEAN BIOL, V18, P271, DOI 10.2307/1549320; Lane N.J., 1980, Advances in Insect Physiology, V15, P35, DOI 10.1016/S0065-2806(08)60141-1; MORITZ K, 1973, CYTOBIOLOGIE, V8, P39; MUSKO IB, 1988, ZOOL ANZ, V220, P152; MYCLES DL, 1979, ZOOMORPHOLOGY, V92, P201; Nassiri Y, 2000, MAR BIOL, V136, P477, DOI 10.1007/s002270050707; Petriella A. M., 1998, PHYSIS, V55, P25; Pillai RS, 1992, MICROSCOPIC ANATOMY, V10; PROSI F, 1983, ZOOMORPHOLOGY, V102, P53, DOI 10.1007/BF00310732; Rost-Roszkowska MM, 2012, ARTHROPOD STRUCT DEV, V41, P271, DOI 10.1016/j.asd.2012.01.001; Rost-Roszkowska MM, 2010, FOLIA BIOL-KRAKOW, V58, P217, DOI 10.3409/fb58_3-4.217-227; Rost-Roszkowska MM, 2010, ZOOL STUD, V49, P10; Sosinka A, 2014, ARTHROPOD STRUCT DEV, V43, P477, DOI 10.1016/j.asd.2014.06.005; Sousa LG, 2007, REV BIOL TROP, V55, P79; Sousa LG, 2005, BIOCELL, V29, P25; Sousa LG, 2001, BIOCELL, V25, P275; Sousa LG, 2000, BIOCELL, V24, P189; Sousa LG, 2006, BIOCELL, V30, P287; Symonova R, 2007, HYDROBIOLOGIA, V585, P213, DOI 10.1007/s10750-007-0639-0; Szewczak P, 2011, ZESZYTY AKWARYSTYCZN, V18, P1, DOI [10.1186/1687-9856-2011-18, DOI 10.1186/1687-9856-2011-18]; Tam Q, 2009, ARTHROPOD STRUCT DEV, V38, P45, DOI 10.1016/j.asd.2008.07.003; Tam Q, 2009, ARTHROPOD STRUCT DEV, V38, P391, DOI 10.1016/j.asd.2009.03.002; Teixeira AD, 2013, ARTHROPOD STRUCT DEV, V42, P237, DOI 10.1016/j.asd.2013.02.004; VANWEEL PB, 1974, COMP BIOCHEM PHYSIOL, V47, P1, DOI 10.1016/0300-9629(74)90044-9; VOGT G, 1989, HISTOCHEMISTRY, V91, P373, DOI 10.1007/BF00493824; WEEKS JM, 1992, OPHELIA, V36, P119, DOI 10.1080/00785326.1992.10430363; Znidarsic N, 2003, ENVIRON TOXICOL PHAR, V13, P161, DOI 10.1016/S1382-6689(02)00158-8	47	26	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0126900	10.1371/journal.pone.0126900	http://dx.doi.org/10.1371/journal.pone.0126900			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996951	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000034
J	Boucas, J; Fritz, C; Schmitt, A; Riabinska, A; Thelen, L; Peifer, M; Leeser, U; Nuernberg, P; Altmueller, J; Gaestel, M; Dieterich, C; Reinhardt, HC				Boucas, Jorge; Fritz, Christian; Schmitt, Anna; Riabinska, Arina; Thelen, Lisa; Peifer, Martin; Leeser, Uschi; Nuernberg, Peter; Altmueller, Janine; Gaestel, Matthias; Dieterich, Christoph; Reinhardt, H. Christian			Label-Free Protein-RNA Interactome Analysis Identifies Khsrp Signaling Downstream of the p38/Mk2 Kinase Complex as a Critical Modulator of Cell Cycle Progression	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; BINDING PROTEINS; CHECKPOINT PATHWAY; GENE-EXPRESSION; PHOSPHORYLATION; KSRP; ATR; STABILIZATION; ASSOCIATION; STRESS	Growing evidence suggests a key role for RNA binding proteins (RBPs) in genome stability programs. Additionally, recent developments in RNA sequencing technologies, as well as mass-spectrometry techniques, have greatly expanded our knowledge on protein-RNA interactions. We here use full transcriptome sequencing and label-free LC/MS/MS to identify global changes in protein-RNA interactions in response to etoposide-induced genotoxic stress. We show that RBPs have distinct binding patterns in response to genotoxic stress and that inactivation of the RBP regulator module, p38/MK2, can affect the entire spectrum of protein-RNA interactions that take place in response to stress. In addition to validating the role of known RBPs like Srsf1, Srsf2, Elavl1 in the genotoxic stress response, we add a new collection of RBPs to the DNA damage response. We identify Khsrp as a highly regulated RBP in response to genotoxic stress and further validate its role as a driver of the G(1)/S transition through the suppression of Cdkn1a(P21) transcripts. Finally, we identify KHSRP as an indicator of overall survival, as well as disease free survival in glioblastoma multiforme.	[Boucas, Jorge; Fritz, Christian; Schmitt, Anna; Riabinska, Arina; Thelen, Lisa; Leeser, Uschi; Reinhardt, H. Christian] Univ Hosp Cologne, Dept Internal Med 1, D-50931 Cologne, Germany; [Boucas, Jorge; Fritz, Christian; Schmitt, Anna; Riabinska, Arina; Thelen, Lisa; Leeser, Uschi; Nuernberg, Peter; Reinhardt, H. Christian] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Peifer, Martin; Nuernberg, Peter] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Peifer, Martin] Univ Cologne, Dept Translat Genom, D-50931 Cologne, Germany; [Nuernberg, Peter; Altmueller, Janine] Univ Cologne, CCG, D-50931 Cologne, Germany; [Gaestel, Matthias] Hannover Med Sch, Inst Biochem, Hannover, Germany; [Dieterich, Christoph] Max Planck Inst Biol Ageing, Computat RNA Biol & Ageing, D-50913 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Hannover Medical School; Max Planck Society	Boucas, J (corresponding author), Univ Hosp Cologne, Dept Internal Med 1, Weyertal 115B, D-50931 Cologne, Germany.	jorge.boucas@age.mpg.de; christian.reinhardt@uk-koeln.de	Dieterich, Christoph/ABF-8459-2021; Gaestel, Matthias/A-6560-2013	Gaestel, Matthias/0000-0002-4944-4652; Peifer, Martin/0000-0002-5243-5503	Volkswagenstiftung (Lichtenberg Program); Deutsche Forschungsgemeinschaft [KFO-286, RE2246/2-1]; Helmholtz-Gemeinschaft (Preclinical Comprehensive Cancer Center); Federal Ministry for Research and Education (BMBF) [01ZX1303A]; Else Kroner-Fresenius Stiftung [EKFS-2014-A06]; Deutsche Krebshilfe [DKH-111112]; Deutsche Jose Carreras Stiftung [DJCLS-R12/26]	Volkswagenstiftung (Lichtenberg Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz-Gemeinschaft (Preclinical Comprehensive Cancer Center); Federal Ministry for Research and Education (BMBF); Else Kroner-Fresenius Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Jose Carreras Stiftung	This work was supported by the Volkswagenstiftung (Lichtenberg Program H.C.R.), the Deutsche Forschungsgemeinschaft (KFO-286, RE2246/2-1 to H.C.R.), the Helmholtz-Gemeinschaft (Preclinical Comprehensive Cancer Center to H.C.R.), Federal Ministry for Research and Education (BMBF, 01ZX1303A to H.C.R.), the Else Kroner-Fresenius Stiftung (EKFS-2014-A06 to H.C.R.), the Deutsche Krebshilfe (DKH-111112 to H.C.R.) and Deutsche Jose Carreras Stiftung (DJCLS-R12/26 to H.C.R.).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Blake JA, 2014, NUCLEIC ACIDS RES, V42, pD810, DOI 10.1093/nar/gkt1225; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Bollig F, 2003, BIOCHEM BIOPH RES CO, V301, P665, DOI 10.1016/S0006-291X(03)00015-9; Boucas Jorge, 2012, Frontiers in Genetics, V3, P159, DOI 10.3389/fgene.2012.00159; Briata P, 2005, MOL CELL, V20, P891, DOI 10.1016/j.molcel.2005.10.021; Briata P, 2013, BBA-GENE REGUL MECH, V1829, P689, DOI 10.1016/j.bbagrm.2012.11.003; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Castello A, 2013, TRENDS GENET, V29, P318, DOI 10.1016/j.tig.2013.01.004; Castello A, 2013, NAT PROTOC, V8, P491, DOI 10.1038/nprot.2013.020; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dassi E, 2014, TRANSLATION, V2, DOI 10.4161/trla.27738; Davezac N, 2000, ONCOGENE, V19, P2179, DOI 10.1038/sj.onc.1203545; Edmond V, 2011, EMBO J, V30, P510, DOI 10.1038/emboj.2010.333; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; Forrest A, 2001, ONCOGENE, V20, P4393, DOI 10.1038/sj.onc.1204574; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hurov KE, 2010, GENE DEV, V24, P1939, DOI 10.1101/gad.1934210; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Lal A, 2006, MOL CELL, V22, P117, DOI 10.1016/j.molcel.2006.03.016; Leva V, 2012, NUCLEIC ACIDS RES, V40, P1106, DOI 10.1093/nar/gkr837; Lin WJ, 2011, MOL CELL BIOL, V31, P3196, DOI 10.1128/MCB.05073-11; Loewe S, 1926, N-S ARCH EX PATH PH, V114, P313; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Maitra S, 2008, RNA, V14, P950, DOI 10.1261/rna.983708; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Merdzhanova G, 2008, CELL DEATH DIFFER, V15, P1815, DOI 10.1038/cdd.2008.135; Montecucco Alessandra, 2013, Frontiers in Genetics, V4, P102, DOI 10.3389/fgene.2013.00102; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Raman M, 2007, EMBO J, V26, P2005, DOI 10.1038/sj.emboj.7601668; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Reinhardt HC, 2011, CELL CYCLE, V10, P23, DOI 10.4161/cc.10.1.14351; Reinhardt HC, 2010, MOL CELL, V40, P34, DOI 10.1016/j.molcel.2010.09.018; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Rousseau S, 2002, EMBO J, V21, P6505, DOI 10.1093/emboj/cdf639; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Schwermann J, 2009, EMBO J, V28, P1392, DOI 10.1038/emboj.2009.100; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; THISSEN D, 1981, PSYCHOL BULL, V90, P179, DOI 10.1037/0033-2909.90.1.179; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Wilusz CJ, 2004, TRENDS GENET, V20, P491, DOI 10.1016/j.tig.2004.07.011; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Zaru R, 2007, NAT IMMUNOL, V8, P1227, DOI 10.1038/ni1517; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667	71	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125745	10.1371/journal.pone.0125745	http://dx.doi.org/10.1371/journal.pone.0125745			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993413	gold, Green Published, Green Submitted			2022-12-26	WOS:000354921400046
J	Kamikawa, YF; Donohoe, ME				Kamikawa, Yasunao F.; Donohoe, Mary E.			Histone Demethylation Maintains Prdm14 and Tsix Expression and Represses Xist in Embryonic Stem Cells	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; DNA DEMETHYLATION; JMJD3; UTX; METHYLATION; CHROMATIN; RNA; IDENTIFICATION; ESTABLISHMENT; INHIBITION	Epigenetic reprogramming is exemplified by the remarkable changes observed in cellular differentiation and X-chromosome inactivation (XCI) in mammalian female cells. Histone 3 lysine 27 trimethylation (H3K27me3) is a modification that suppresses gene expression in multiple contexts including embryonic stem cells (ESCs) and decorates the entire inactive X-chromosome. The conversion of female somatic cells to induced pluripotency is accompanied by X-chromosome reactivation (XCR) and H3K27me3 erasure. Here, we show that the H3K27-specific demethylase Utx regulates the expression of the master regulators for XCI and XCR: Prdm14, Tsix, and Xist. Female ESC transcriptome analysis using a small molecule inhibitor for H3K27 demethylases, GSK-J4, identifies novel targets of H3K27 demethylation. Consistent with a recent report that GSK-J4 can inhibit other histone demethylase, we found that elevated H3K4me3 levels are associated with increased gene expression including Xist. Our data suggest multiple regulatory mechanisms for XCI via histone demethylation.	[Kamikawa, Yasunao F.; Donohoe, Mary E.] Burke Med Res Inst, White Plains, NY 10605 USA; [Kamikawa, Yasunao F.; Donohoe, Mary E.] Weill Cornell Med Coll, Dept Neurosci, Brain Mind Res Inst, New York, NY USA; [Kamikawa, Yasunao F.; Donohoe, Mary E.] Weill Cornell Med Coll, Dept Cell & Dev, New York, NY USA	Cornell University; Cornell University	Donohoe, ME (corresponding author), Burke Med Res Inst, White Plains, NY 10605 USA.	med2008@med.cornell.edu			National Institute of Health [1R01MH 090267]; Burke Foundation; Thomas and Agnes Carvel foundation; Eisenberg Ahsen Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090267] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burke Foundation; Thomas and Agnes Carvel foundation; Eisenberg Ahsen Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Work in the Donohoe lab is supported by the National Institute of Health (1R01MH 090267), the Burke Foundation, the Thomas and Agnes Carvel foundation, and the Eisenberg Ahsen Foundation.	Berletch JB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003489; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Burgold T, 2012, CELL REP, V2, P1244, DOI 10.1016/j.celrep.2012.09.013; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen SZ, 2012, GENE DEV, V26, P1364, DOI 10.1101/gad.186056.111; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Francis NJ, 2009, CELL, V137, P110, DOI 10.1016/j.cell.2009.02.017; Gillich A, 2012, CELL STEM CELL, V10, P425, DOI 10.1016/j.stem.2012.01.020; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Heinemann B, 2014, NATURE, V514, pE1, DOI 10.1038/nature13688; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Kamikawa Y, 2014, MOL REPROD DEV, V81, P141, DOI 10.1002/mrd.22282; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JT, 2011, NAT REV MOL CELL BIO, V12, P815, DOI 10.1038/nrm3231; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; Lee S, 2012, DEV CELL, V22, P25, DOI 10.1016/j.devcel.2011.11.009; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Monfort A, 2013, EMBO REP, V14, P337, DOI 10.1038/embor.2013.29; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Navarro P, 2010, NATURE, V468, P457, DOI 10.1038/nature09496; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Ohno R, 2013, DEVELOPMENT, V140, P2892, DOI 10.1242/dev.093229; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; Outchkourov NS, 2013, CELL REP, V3, P1071, DOI 10.1016/j.celrep.2013.02.030; Payer B, 2013, MOL CELL, V52, P805, DOI 10.1016/j.molcel.2013.10.023; Petruk S, 2012, CELL, V150, P922, DOI 10.1016/j.cell.2012.06.046; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shibata S, 2003, HUM MOL GENET, V12, P125, DOI 10.1093/hmg/ddg010; Shpargel KB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004507; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Welstead GG, 2012, P NATL ACAD SCI USA, V109, P13004, DOI 10.1073/pnas.1210787109; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	56	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125626	10.1371/journal.pone.0125626	http://dx.doi.org/10.1371/journal.pone.0125626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993097	Green Submitted, gold, Green Published			2022-12-26	WOS:000354921400038
J	Wang, X; Sun, LX; Li, JH; Xia, DP; Sun, BH; Zhang, D				Wang, Xi; Sun, Lixing; Li, Jinhua; Xia, Dongpo; Sun, Binghua; Zhang, Dao			Collective Movement in the Tibetan Macaques (Macaca thibetana): Early Joiners Write the Rule of the Game	PLOS ONE			English	Article							CONSENSUS DECISION-MAKING; VOCAL COORDINATION; SELF-ORGANIZATION; CAPUCHIN MONKEYS; MT. HUANGSHAN; DOMINANCE; FISSION; LEADERSHIP; DEPARTURE; BEHAVIOR	Collective behavior has recently attracted a great deal of interest in both natural and social sciences. While the role of leadership has been closely scrutinized, the rules used by joiners in collective decision making have received far less attention. Two main hypotheses have been proposed concerning these rules: mimetism and quorum. Mimetism predicts that individuals are increasingly likely to join collective behavior as the number of participants increases. It can be further divided into selective mimetism, where relationships among the participants affect the process, and anonymous mimetism, where no such effect exists. Quorum predicts that a collective behavior occurs when the number of participants reaches a threshold. To probe into which rule is used in collective decision making, we conducted a study on the joining process in a group of free-ranging Tibetan macaques (Macaca thibetana) in Huangshan, China using a combination of all-occurrence and focal animal sampling methods. Our results show that the earlier individuals joined movements, the more central a role they occupied among the joining network. We also found that when less than three adults participated in the first five minutes of the joining process, no entire group movement occurred subsequently. When the number of these early joiners ranged from three to six, selective mimetism was used. This means higher rank or closer social affiliation of early joiners could be among the factors of deciding whether to participate in movements by group members. When the number of early joiners reached or exceeded seven, which was the simple majority of the group studied, entire group movement always occurred, meaning that the quorum rule was used. Putting together, Macaca thibetana used a combination of selective mimetism and quorum, and early joiners played a key role in deciding which rule should be used.	[Wang, Xi; Li, Jinhua; Sun, Binghua; Zhang, Dao] Anhui Univ, Sch Resources & Environm Engn, Hefei, Anhui, Peoples R China; [Sun, Lixing] Cent Washington Univ, Dept Biol Sci, Ellensburg, WA 98926 USA; [Li, Jinhua] Anhui Normal Univ, Sch Life Sci, Wuhu, Anhui, Peoples R China; [Xia, Dongpo] Anhui Univ, Sch Life Sci, Hefei, Anhui, Peoples R China	Anhui University; Central Washington University; Anhui Normal University; Anhui University	Sun, LX (corresponding author), Cent Washington Univ, Dept Biol Sci, Ellensburg, WA 98926 USA.	Lixing@cwu.edu; jhli@ahu.edu.cn; dpxia@ahu.edu.cn			Natural Science Foundation of China [31372215, 31172106, 31401981]; Anhui Provincial Natural Science Foundation [1408085QC56]; China Scholarship Council	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); China Scholarship Council(China Scholarship Council)	This work was funded by the Natural Science Foundation of China (Grant No. 31372215, 31172106, 31401981), Anhui Provincial Natural Science Foundation (Grant No. 1408085QC56), and China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; Barelli C, 2008, BEHAVIOUR, V145, P965, DOI 10.1163/156853908784089243; Berman CM, 2008, BEHAVIOUR, V145, P863, DOI 10.1163/156853908784089252; Berman CM, 2002, INT J PRIMATOL, V23, P383, DOI 10.1023/A:1013891730061; Berman CM, 2004, INT J PRIMATOL, V25, P1283, DOI 10.1023/B:IJOP.0000043963.77801.c3; Bertram B.C.R., 1978, P64; BOINSKI S, 1993, AM J PRIMATOL, V30, P85, DOI 10.1002/ajp.1350300202; Bonabeau E, 1997, TRENDS ECOL EVOL, V12, P188, DOI 10.1016/S0169-5347(97)01048-3; Bonanni R, 2010, ANIM BEHAV, V79, P981, DOI 10.1016/j.anbehav.2010.02.021; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; Bourjade M, 2009, ETHOLOGY, V115, P321, DOI 10.1111/j.1439-0310.2009.01614.x; Byrne RW, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P491; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Detrain C, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P331; DEWAAL FBM, 1989, AM J PRIMATOL, V19, P83, DOI 10.1002/ajp.1350190203; Gautrais J, 2007, ANIM BEHAV, V74, P1443, DOI 10.1016/j.anbehav.2007.02.020; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hockings KJ, 2006, CURR BIOL, V16, pR668, DOI 10.1016/j.cub.2006.08.019; Holekamp KE, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P587; Kappeler PM, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P470; King AJ, 2008, CURR BIOL, V18, P1833, DOI 10.1016/j.cub.2008.10.048; Kummer H., 1968, SOCIAL ORG HAMADRYAS; Leca JB, 2003, ANIM BEHAV, V66, P1045, DOI 10.1006/anbe.2003.2276; Li J.H., 1999, TIBETAN MACAQUE SOC; Li JH, 1996, CHINESE SCI BULL, V41, P1377; Little AC, 2007, EVOL HUM BEHAV, V28, P18, DOI 10.1016/j.evolhumbehav.2006.09.002; Lusseau D, 2006, J ANIM ECOL, V75, P14, DOI 10.1111/j.1365-2656.2005.01013.x; Lusseau D, 2007, EVOL ECOL, V21, P357, DOI 10.1007/s10682-006-9105-0; Meunier H, 2006, BEHAVIOUR, V143, P1511, DOI 10.1163/156853906779366982; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nishida T., 1968, Primates, V9, P167, DOI 10.1007/BF01730971; Petit O, 2009, P ROY SOC B-BIOL SCI, V276, P3495, DOI 10.1098/rspb.2009.0983; Petit O, 2010, BEHAV PROCESS, V84, P635, DOI 10.1016/j.beproc.2010.04.009; Pratt SC, 2002, BEHAV ECOL SOCIOBIOL, V52, P117, DOI 10.1007/s00265-002-0487-x; Pratt SC, 2006, P NATL ACAD SCI USA, V103, P15906, DOI 10.1073/pnas.0604801103; Radford AN, 2004, ETHOLOGY, V110, P11, DOI 10.1046/j.1439-0310.2003.00943.x; Rajaratnam SMW, 1999, PHYSIOL BEHAV, V66, P21, DOI 10.1016/S0031-9384(98)00271-6; Ramseyer A, 2009, BEHAVIOUR, V146, P351, DOI 10.1163/156853909X410955; Seeley TD, 2004, BEHAV ECOL SOCIOBIOL, V56, P594, DOI 10.1007/s00265-004-0814-5; Stueckle S, 2008, ANIM BEHAV, V75, P1995, DOI 10.1016/j.anbehav.2007.12.012; Sueur C, 2008, BEHAV PROCESS, V78, P84, DOI 10.1016/j.beproc.2008.01.004; Sueur C, 2010, J EXP BIOL, V213, P1338, DOI 10.1242/jeb.039016; Sueur C, 2009, ANIM BEHAV, V78, P1087, DOI 10.1016/j.anbehav.2009.07.029; Sueur C, 2008, INT J PRIMATOL, V29, P1085, DOI 10.1007/s10764-008-9262-9; Sueur C, 2011, AM J PRIMATOL, V73, P703, DOI 10.1002/ajp.20915; Sueur C, 2010, BEHAV ECOL SOCIOBIOL, V64, P1875, DOI 10.1007/s00265-010-0999-8; Sueur C, 2010, ANIM COGN, V13, P239, DOI 10.1007/s10071-009-0261-9; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Sumpter DJT, 2008, CURR BIOL, V18, P1773, DOI 10.1016/j.cub.2008.09.064; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Sundaresan SR, 2007, OECOLOGIA, V151, P140, DOI 10.1007/s00442-006-0553-6; Van Belle S, 2013, BEHAV ECOL SOCIOBIOL, V67, P31, DOI 10.1007/s00265-012-1421-5; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; Watts DP, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P351; Whitehead H., 2005, ANIM BEHAV, V69, pE1, DOI [10.1016/j.anbehav.2004.11.004, DOI 10.1016/J.ANBEHAV.2004.11.004]; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447; Xia DP, 2012, AM J PRIMATOL, V74, P569, DOI 10.1002/ajp.21985; Zhang M, 2010, CURR ZOOL, V56, P213	64	11	15	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127459	10.1371/journal.pone.0127459	http://dx.doi.org/10.1371/journal.pone.0127459			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992882	gold, Green Published, Green Submitted			2022-12-26	WOS:000354921400121
J	Zimmerman, SM; Michel, F; Hogan, RJ; Lafontaine, ER				Zimmerman, Shawn M.; Michel, Frank; Hogan, Robert J.; Lafontaine, Eric R.			The Autotransporter BpaB Contributes to the Virulence of Burkholderia mallei in an Aerosol Model of Infection	PLOS ONE			English	Article							HUMAN EPITHELIAL-CELLS; MORAXELLA-CATARRHALIS; HAEMOPHILUS-INFLUENZAE; MOLECULAR CHARACTERIZATION; ANTIBODY-RESPONSE; PASSENGER DOMAIN; USPA1 PROTEIN; PSEUDOMALLEI; ADHESIN; IDENTIFICATION	Burkholderia mallei is a highly pathogenic bacterium that causes the zoonosis glanders. Previous studies indicated that the genome of the organism contains eight genes specifying autotransporter proteins, which are important virulence factors of Gram-negative bacteria. In the present study, we report the characterization of one of these autotransporters, BpaB. Database searches identified the bpaB gene in ten B. mallei isolates and the predicted proteins were 99-100% identical. Comparative sequence analyses indicate that the gene product is a trimeric autotransporter of 1,090 amino acids with a predicted molecular weight of 105-kDa. Consistent with this finding, we discovered that recombinant bacteria expressing bpaB produce a protein of >= 300-kDa on their surface that is reactive with a BpaB-specific monoclonal antibody. Analysis of sera from mice infected with B. mallei indicated that animals produce antibodies against BpaB during the course of disease, thus establishing production of the autotransporter in vivo. To gain insight on its role in virulence, we inactivated the bpaB gene of B. mallei strain ATCC 23344 and determined the median lethal dose of the mutant in a mouse model of aerosol infection. These experiments revealed that the bpaB mutation attenuates virulence 8-14 fold. Using a crystal violet-based assay, we also discovered that constitutive production of BpaB on the surface of B. mallei promotes biofilm formation. To our knowledge, this is the first report of a biofilm factor for this organism.	[Zimmerman, Shawn M.; Hogan, Robert J.; Lafontaine, Eric R.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Michel, Frank; Hogan, Robert J.] Univ Georgia, Coll Vet Med, Dept Vet Biosci & Diagnost Imaging, Athens, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Lafontaine, ER (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.	elafon10@uga.edu			DTRA [HDTRA1-12-C-0081, PA 14-740]; Zoetis-Morris Animal Foundation Veterinary Fellowship	DTRA(United States Department of DefenseDefense Threat Reduction Agency); Zoetis-Morris Animal Foundation Veterinary Fellowship	This study was supported by DTRA contract HDTRA1-12-C-0081 awarded to ERL and RJH (PA 14-740) and a Zoetis-Morris Animal Foundation Veterinary Fellowship for Advanced Study to SMZ. Zoetis-Morris Animal Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DTRA contributed to study design and preparation of the manuscript.	Adler NRL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079461; Adler NRL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00151; Alamuri P, 2009, INFECT IMMUN, V77, P632, DOI 10.1128/IAI.01050-08; Arun S, 1999, VET REC, V144, P255, DOI 10.1136/vr.144.10.255; Attia AS, 2005, INFECT IMMUN, V73, P2400, DOI 10.1128/IAI.73.4.2400-2410.2005; Balder R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-250; Balder R, 2009, INFECT IMMUN, V77, P4597, DOI 10.1128/IAI.00212-09; Bondi SK, 2008, EXPERT REV VACCINES, V7, P1357, DOI 10.1586/14760584.7.9.1357; Brett PJ, 1997, EPIDEMIOL INFECT, V118, P137, DOI 10.1017/S095026889600739X; Bullard B, 2005, INFECT IMMUN, V73, P5127, DOI 10.1128/IAI.73.8.5127-5136.2005; Bullard B, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-65; Burtnick MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076767; Burtnick MN, 2010, INFECT IMMUN, V78, P88, DOI 10.1128/IAI.00985-09; Burtnick MN, 2001, MICROBIOL-UK, V147, P111, DOI 10.1099/00221287-147-1-111; Burtnick MN, 1999, ANTIMICROB AGENTS CH, V43, P2648, DOI 10.1128/AAC.43.11.2648; Campos CG, 2013, INFECT IMMUN, V81, P2788, DOI 10.1128/IAI.00526-13; Cao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036283; Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; CARLONE GM, 1986, J CLIN MICROBIOL, V24, P330, DOI 10.1128/JCM.24.3.330-332.1986; Carr-Gregory B, 2007, MED ASPECTS BIOL WAR, P121; Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004; Cutter D, 2002, J INFECT DIS, V186, P1115, DOI 10.1086/344233; DeShazer D, 2007, FEMS MICROBIOL LETT, V277, P64, DOI 10.1111/j.1574-6968.2007.00946.x; Farn JL, 2001, J BACTERIOL, V183, P6717, DOI 10.1128/JB.183.22.6717-6720.2001; Fernandes PJ, 2007, INFECT IMMUN, V75, P3027, DOI 10.1128/IAI.00150-07; Fexby S, 2007, INFECT IMMUN, V75, P30, DOI 10.1128/IAI.01117-06; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Heras B, 2014, P NATL ACAD SCI USA, V111, P457, DOI 10.1073/pnas.1311592111; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; Klemm P, 2004, MOL MICROBIOL, V51, P283, DOI 10.1046/j.1365-2958.2003.03833.x; Laarmann S, 2002, MOL MICROBIOL, V46, P731, DOI 10.1046/j.1365-2958.2002.03189.x; Lafontaine ER, 2000, J BACTERIOL, V182, P1364, DOI 10.1128/JB.182.5.1364-1373.2000; Lafontaine ER, 2001, J BACTERIOL, V183, P1540, DOI 10.1128/JB.183.5.1540-1551.2001; Lafontaine ER, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-92; Lafontaine ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076804; Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005; Lipsitz Rebecca, 2012, Emerg Infect Dis, V18, pe2, DOI 10.3201/eid1812.120638; Lipski SL, 2007, FEMS MICROBIOL LETT, V267, P207, DOI 10.1111/j.1574-6968.2006.00549.x; Lipski SL, 2007, INFECT IMMUN, V75, P314, DOI 10.1128/IAI.01330-06; Liu DF, 2004, INFECT IMMUN, V72, P6961, DOI 10.1128/IAI.72.12.6961-6968.2004; Maroncle NM, 2006, INFECT IMMUN, V74, P6124, DOI 10.1128/IAI.01086-06; Melville S, 2013, MICROBIOL MOL BIOL R, V77, P323, DOI 10.1128/MMBR.00063-12; Neubauer H., 1997, Revue Internationale des Services de Sante des Forces Armees, V70, P258; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Ooi WF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003795; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Parthasarathy N, 2006, DIAGN MICR INFEC DIS, V56, P329, DOI 10.1016/j.diagmicrobio.2006.04.018; Pascual DW, 2013, VIRULENCE, V4, P384, DOI 10.4161/viru.24886; Pearson MM, 2007, INFECT IMMUN, V75, P4316, DOI 10.1128/IAI.01347-06; Pearson MM, 2006, INFECT IMMUN, V74, P1588, DOI 10.1128/IAI.74.3.1588-1596.2006; Reed L.J., 1938, AM J HYG, V27, P793; Roggenkamp A, 2003, J BACTERIOL, V185, P3735, DOI 10.1128/JB.185.13.3735-3744.2003; Romero CM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-228; Sambrook J., 2001, MOL CLONING LAB MANU; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Shaffer TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067881; Sherlock O, 2004, J BACTERIOL, V186, P8058, DOI 10.1128/JB.186.23.8058-8065.2004; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Smith MD, 1997, INFECT IMMUN, V65, P4319, DOI 10.1128/IAI.65.10.4319-4321.1997; Srinivasan A, 2001, NEW ENGL J MED, V345, P256, DOI 10.1056/NEJM200107263450404; Stathopoulos C, 2000, MICROBES INFECT, V2, P1061, DOI 10.1016/S1286-4579(00)01260-0; Stevens JM, 2005, J BACTERIOL, V187, P7857, DOI 10.1128/JB.187.22.7857-7862.2005; Timpe JM, 2003, INFECT IMMUN, V71, P4341, DOI 10.1128/IAI.71.8.4341-4350.2003; Tiyawisutsri R, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-19; Tuanyok A, 2005, FEMS MICROBIOL LETT, V252, P327, DOI 10.1016/j.femsle.2005.09.043; Ulett GC, 2001, MICROBES INFECT, V3, P621, DOI 10.1016/S1286-4579(01)01417-4; Valle J, 2008, J BACTERIOL, V190, P4147, DOI 10.1128/JB.00122-08; van Ulsen P, 2014, BBA-MOL CELL RES, V1843, P1592, DOI 10.1016/j.bbamcr.2013.11.006; Van Zandt KE, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-131; Varga JJ, 2012, VIRULENCE, V3, P510, DOI 10.4161/viru.22056; Waag DM., 2004, BIOL WEAPONS DEFENSE, P209; Wang LQ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002765; Whitlock GC, 2007, FEMS MICROBIOL LETT, V277, P115, DOI 10.1111/j.1574-6968.2007.00949.x; Yang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046828	77	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0126437	10.1371/journal.pone.0126437	http://dx.doi.org/10.1371/journal.pone.0126437			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993100	Green Submitted, Green Published, gold			2022-12-26	WOS:000354921400064
J	Yu, JY; Zhang, B; Peng, L; Wu, CH; Cao, H; Zhong, JF; Hoffman, J; Huang, SH				Yu, Jing-Yi; Zhang, Bao; Peng, Liang; Wu, Chun-Hua; Cao, Hong; Zhong, John F.; Hoffman, Jill; Huang, Sheng-He			Repositioning of Memantine as a Potential Novel Therapeutic Agent against Meningitic E-coli-Induced Pathogenicities through Disease-Associated Alpha7 Cholinergic Pathway and RNA Sequencing-Based Transcriptome Analysis of Host Inflammatory Responses	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; NICOTINIC ACETYLCHOLINE-RECEPTOR; ENDOTHELIAL-CELLS; BACTERIAL-MENINGITIS; NEONATAL SEPSIS; EXPRESSION; SEQ; CYTOSKELETON; PROPHYLAXIS; RESISTANCE	Neonatal sepsis and meningitis (NSM) remains a leading cause worldwide of mortality and morbidity in newborn infants despite the availability of antibiotics over the last several decades. E. coli is the most common gram-negative pathogen causing NSM. Our previous studies show that alpha 7 nicotinic receptor (alpha 7 nAChR), an essential regulator of inflammation, plays a detrimental role in the host defense against NSM. Despite notable successes, there still exists an unmet need for new effective therapeutic approaches to treat this disease. Using the in vitro/in vivo models of the blood-brain barrier (BBB) and RNA-seq, we undertook a drug repositioning study to identify unknown antimicrobial activities for known drugs. We have demonstrated for the first time that memantine (MEM), a FDA-approved drug for treatment of Alzheimer's disease, could very efficiently block E. coli-caused bacteremia and meningitis in a mouse model of NSM in a manner dependent on alpha 7 nAChR. MEM was able to synergistically enhance the antibacterial activity of ampicillin in HBMEC infected with E. coli K1 (E44) and in neonatal mice with E44-caused bacteremia and meningitis. Differential gene expression analysis of RNA-Seq data from mouse BMEC infected with E. coli K1 showed that several E44-increased inflammatory factors, including IL33, IL18rap, MMP10 and Irs1, were significantly reduced by MEM compared to the infected cells without drug treatment. MEM could also significantly up-regulate anti-inflammatory factors, including Tnfaip3, CISH, Ptgds and Zfp36. Most interestingly, these factors may positively and negatively contribute to regulation of NF-kappa B, which is a hallmark feature of bacterial meningitis. Furthermore, we have demonstrated that circulating BMEC (cBMEC) are the potential novel biomarkers for NSM. MEM could significantly reduce E44-increased blood level of cBMEC in mice. Taken together, our data suggest that memantine can efficiently block host inflammatory responses to bacterial infection through modulation of both inflammatory and anti-inflammatory pathways.	[Yu, Jing-Yi; Zhang, Bao; Cao, Hong; Huang, Sheng-He] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Microbiol, Guangdong Prov Key Lab Trop Dis Res, Guangzhou 510515, Guangdong, Peoples R China; [Yu, Jing-Yi; Zhang, Bao; Peng, Liang; Wu, Chun-Hua; Hoffman, Jill; Huang, Sheng-He] Univ So Calif, Childrens Hosp Los Angeles, Keck Sch Med, Saban Res Inst,Dept Pediat, Los Angeles, CA 90027 USA; [Peng, Liang] Guangzhou Med Univ, Affiliated Hosp 2, Dept Clin Lab, Guangzhou 510260, Guangdong, Peoples R China; [Zhong, John F.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Zhong, John F.] Univ So Calif, Sch Dent, Dept Perio Diagnost Sci & Biomed Sci, Los Angeles, CA 93003 USA; [Zhong, John F.] Univ So Calif, Sch Med, Dept Pediat, Los Angeles, CA 93003 USA	Southern Medical University - China; Children's Hospital Los Angeles; University of Southern California; Guangzhou Medical University; University of Southern California; University of Southern California; University of Southern California	Huang, SH (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Microbiol, Guangdong Prov Key Lab Trop Dis Res, Guangzhou 510515, Guangdong, Peoples R China.	shhuang@hsc.usc.edu			Public Health Service [R21NS083967]; China Natural Science Foundation [81370740]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS083967] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was financially supported by Public Health Service grants R21NS083967 (S.H.H.), and China Natural Science Foundation grant 81370740 (S.H.H). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon A, 2004, PEDIATR INFECT DIS J, V23, P295, DOI 10.1097/00006454-200404000-00004; Apte SP, 2006, MED HYPOTHESES, V67, P359, DOI 10.1016/j.mehy.2006.01.043; Aracava Y, 2005, J PHARMACOL EXP THER, V312, P1195, DOI 10.1124/jpet.104.077172; Atif ML, 2008, INFECT CONT HOSP EP, V29, P1066, DOI 10.1086/591858; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Bredfeldt R C, 1995, J Am Board Fam Pract, V8, P95; Butsashvili M, 2009, EUR J EPIDEMIOL, V24, P477, DOI 10.1007/s10654-009-9360-9; Che XJ, 2011, BRAIN PATHOL, V21, P389, DOI 10.1111/j.1750-3639.2010.00463.x; Chen YH, 2002, CELL MICROBIOL, V4, P503, DOI 10.1046/j.1462-5822.2002.00209.x; Chi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035862; Chi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025016; Chi F, 2011, FUTURE MICROBIOL, V6, P953, DOI 10.2217/FMB.11.65; Chiu HC, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-110; Chng ZZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067546; Chu SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105294; Collier MA, 2013, EXPERT REV ANTI-INFE, V11, P1225, DOI 10.1586/14787210.2013.845524; Cucina A, 2000, J SURG RES, V92, P233, DOI 10.1006/jsre.2000.5894; Czyz DM, 2014, MBIO, V5, DOI 10.1128/mBio.01534-14; Daley AJ, 2004, PEDIATR INFECT DIS J, V23, P630, DOI 10.1097/01.inf.0000128782.20060.79; Dhir A, 2015, FUND CLIN PHARMACOL, V29, P72, DOI 10.1111/fcp.12090; Dobelis P, 2011, NAT P, V3, P1; Gui J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046515; Hikansson P, 2008, GENE CHROMOSOME CANC, V47, P267, DOI 10.1002/gcc.20528; Hoffman Olaf, 2009, Ther Adv Neurol Disord, V2, P1, DOI 10.1177/1756285609337975; Huang SH, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/856314; Huang SH, 2000, MICROBES INFECT, V2, P1237, DOI 10.1016/S1286-4579(00)01277-6; Huang SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062164; Huang SH, 2009, ADV DIFFER EQU-NY, DOI 10.1155/2009/389624; JACKSON CJ, 1990, J CELL SCI, V96, P257; Jones RW, 2010, INT J GERIATR PSYCH, V25, P547, DOI 10.1002/gps.2384; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Latiano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062144; Laudenbach V, 2002, FASEB J, V16, P423, DOI 10.1096/fj.01-0532fje; Lederberg J, 2000, SCIENCE, V288, P287, DOI 10.1126/science.288.5464.287; Lee JD, 2006, ACTA TROP, V97, P204, DOI 10.1016/j.actatropica.2005.11.003; Levine E M, 1999, Infect Dis Obstet Gynecol, V7, P210; Li SP, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-58; Lill M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00033; Manning SM, 2011, INT J DEV NEUROSCI, V29, P767, DOI 10.1016/j.ijdevneu.2011.05.005; Michael CA, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00145; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Panigrahi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072791; Pareek TK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00201; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Pomytkin IA, 2015, BEHAV BRAIN RES, V276, P111, DOI 10.1016/j.bbr.2014.04.049; Rodriguez JA, 2013, J THROMB HAEMOST, V11, P1464, DOI 10.1111/jth.12312; Sastre JBL, 2005, ACTA PAEDIATR, V94, P451, DOI 10.1080/08035250410025302; Schneider LS, 2014, J INTERN MED, V275, P251, DOI 10.1111/joim.12191; Schrag SJ, 2006, PEDIATRICS, V118, P570, DOI 10.1542/peds.2005-3083; Simonsen KA, 2014, CLIN MICROBIOL REV, V27, P21, DOI 10.1128/CMR.00031-13; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Vani J, 2010, NEW ENGL J MED, V363, P1676, DOI 10.1056/NEJMc1007642; Zhang HC, 2013, ARTERIOSCL THROM VAS, V33, P1212, DOI 10.1161/ATVBAHA.113.301496; Zhou Hong-Yi, 2011, Expert Rev Clin Pharmacol, V4, P379	54	18	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0121911	10.1371/journal.pone.0121911	http://dx.doi.org/10.1371/journal.pone.0121911			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993608	Green Published, gold, Green Submitted			2022-12-26	WOS:000354918600002
J	Baselga, A; Bonthoux, S; Balent, G				Baselga, Andres; Bonthoux, Sebastien; Balent, Gerard			Temporal Beta Diversity of Bird Assemblages in Agricultural Landscapes: Land Cover Change vs. Stochastic Processes	PLOS ONE			English	Article							FARMLAND BIRDS; CLIMATE-CHANGE; TIME-LAG; RESPONSES; TURNOVER; COMMUNITIES; VEGETATION; DYNAMICS; BIODIVERSITY; ABANDONMENT	Temporal variation in the composition of species assemblages could be the result of deterministic processes driven by environmental change and/or stochastic processes of colonization and local extinction. Here, we analyzed the relative roles of deterministic and stochastic processes on bird assemblages in an agricultural landscape of southwestern France. We first assessed the impact of land cover change that occurred between 1982 and 2007 on (i) the species composition (presence/absence) of bird assemblages and (ii) the spatial pattern of taxonomic beta diversity. We also compared the observed temporal change of bird assemblages with a null model accounting for the effect of stochastic dynamics on temporal beta diversity. Temporal assemblage dissimilarity was partitioned into two separate components, accounting for the replacement of species (i.e. turnover) and for the nested species losses (or gains) from one time to the other (i.e. nestedness-resultant dissimilarity), respectively. Neither the turnover nor the nestedness-resultant components of temporal variation were accurately explained by any of the measured variables accounting for land cover change (r(2)<0.06 in all cases). Additionally, the amount of spatial assemblage heterogeneity in the region did not significantly change between 1982 and 2007, and site-specific observed temporal dissimilarities were larger than null expectations in only 1% of sites for temporal turnover and 13% of sites for nestedness-resultant dissimilarity. Taken together, our results suggest that land cover change in this agricultural landscape had little impact on temporal beta diversity of bird assemblages. Although other unmeasured deterministic process could be driving the observed patterns, it is also possible that the observed changes in presence/absence species composition of local bird assemblages might be the consequence of stochastic processes in which species populations appeared and disappeared from specific localities in a random-like way. Our results might be case-specific, but if stochastic dynamics are generally dominant, the ability of correlative and mechanistic models to predict land cover change effects on species composition would be compromised.	[Baselga, Andres] Univ Santiago de Compostela, Fac Biol, Dept Zool, Santiago De Compostela 15782, Spain; [Bonthoux, Sebastien; Balent, Gerard] INRA, UMR DYNAFOR 1201, F-31320 Castanet Tolosan, France; [Bonthoux, Sebastien] ENSNP, UMR CITERES 7324, F-41000 Blois, France	Universidade de Santiago de Compostela; INRAE	Baselga, A (corresponding author), Univ Santiago de Compostela, Fac Biol, Dept Zool, Rua Lope Gomez de Marzoa S-N, Santiago De Compostela 15782, Spain.	andres.baselga@usc.es	Baselga, Andres/A-6740-2008	Baselga, Andres/0000-0001-7914-7109	French National Institute for Agricultural Research (INRA)	French National Institute for Agricultural Research (INRA)	The authors thank the French National Institute for Agricultural Research (INRA) for supporting this long term research on bird communities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeler DG, 2012, FRESHWATER BIOL, V57, P1782, DOI 10.1111/j.1365-2427.2012.02838.x; BALENT G, 1992, LANDSCAPE ECOL, V6, P195; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1223, DOI 10.1111/j.1466-8238.2011.00756.x; Baselga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032341; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Benedetti-Cecchi L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002777; Berg A, 2002, BIRD STUDY, V49, P153, DOI 10.1080/00063650209461260; Betts MG, 2014, ECOGRAPHY, V37, P517, DOI 10.1111/ecog.00740; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Bonthoux S, 2013, OECOLOGIA, V172, P563, DOI 10.1007/s00442-012-2498-2; Bonthoux S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054179; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Crawley M.J., 2007, R BOOK; Cunningham R, 2014, ECOL APPL, V24, P1275, DOI 10.1890/13-0872.1; Deconchat M, 2001, FORESTRY, V74, P105, DOI 10.1093/forestry/74.2.105; Devictor V, 2009, DIVERS DISTRIB, V15, P122, DOI 10.1111/j.1472-4642.2008.00510.x; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Gil-Tena A, 2009, GLOBAL CHANGE BIOL, V15, P474, DOI 10.1111/j.1365-2486.2008.01730.x; Guilherme JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073619; Hillebrand H, 2010, GLOBAL CHANGE BIOL, V16, P1181, DOI 10.1111/j.1365-2486.2009.02045.x; Bellocq MI, 2011, ECOSCIENCE, V18, P354, DOI 10.2980/18-4-3431; Kampichler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035272; Korhonen JJ, 2010, ECOLOGY, V91, P508, DOI 10.1890/09-0392.1; Lindstrom A, 2013, ECOGRAPHY, V36, P313, DOI 10.1111/j.1600-0587.2012.07799.x; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; R Core Team, 2021, R LANGUAGE ENV STAT; Sanderson FJ, 2013, AGR ECOSYST ENVIRON, V168, P16, DOI 10.1016/j.agee.2013.01.015; Sanderson FJ, 2009, AGR ECOSYST ENVIRON, V129, P37, DOI 10.1016/j.agee.2008.07.001; Schaefer HC, 2008, GLOBAL ECOL BIOGEOGR, V17, P38, DOI 10.1111/j.1466-8238.2007.00341.x; Schaub M, 2012, OECOLOGIA, V168, P97, DOI 10.1007/s00442-011-2070-5; Sirami C, 2008, ECOGRAPHY, V31, P509, DOI 10.1111/j.0906-7590.2008.05403.x; Sirami C, 2007, DIVERS DISTRIB, V13, P42, DOI 10.1111/j.1472-4642.2006.00297.x; Soderstrom B, 2000, CONSERV BIOL, V14, P522, DOI 10.1046/j.1523-1739.2000.98564.x; Stegen JC, 2013, GLOBAL ECOL BIOGEOGR, V22, P202, DOI 10.1111/j.1466-8238.2012.00780.x; Svenning JC, 2011, J ANIM ECOL, V80, P393, DOI 10.1111/j.1365-2656.2010.01771.x; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Ulrich W, 2007, ECOLOGY, V88, P1824, DOI 10.1890/06-1208.1; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wretenberg J, 2010, BIOL CONSERV, V143, P375, DOI 10.1016/j.biocon.2009.11.001	47	41	42	7	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0127913	10.1371/journal.pone.0127913	http://dx.doi.org/10.1371/journal.pone.0127913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010153	Green Submitted, Green Published, gold			2022-12-26	WOS:000355183900164
J	Bourjade, M; Thierry, B; Hausberger, M; Petit, O				Bourjade, Marie; Thierry, Bernard; Hausberger, Martine; Petit, Odile			Is Leadership a Reliable Concept in Animals? An Empirical Study in the Horse	PLOS ONE			English	Article							EQUUS-FERUS-PRZEWALSKII; COLLECTIVE DECISION-MAKING; SOCIAL RELATIONSHIPS; CONSENSUS DECISION; GROUP DEPARTURES; MOVEMENTS; BEHAVIOR; EVOLUTION; DOMINANCE; COORDINATION	Leadership is commonly invoked when accounting for the coordination of group movements in animals, yet it remains loosely defined. In parallel, there is increased evidence of the sharing of group decisions by animals on the move. How leadership integrates within this recent framework on collective decision-making is unclear. Here, we question the occurrence of leadership in horses, a species in which this concept is of prevalent use. The relevance of the three main definitions of leadership - departing first, walking in front travel position, and eliciting the joining of mates - was tested on the collective movements of two semi-free ranging groups of Przewalski horses (Equus ferus przewalskii). We did not find any leader capable of driving most group movements or recruiting mates more quickly than others. Several group members often displayed pre-departure behaviours at the same time, and the simultaneous departure of several individuals was common. We conclude that the decision-making process was shared by several group members a group movement (i.e., partially shared consensus) and that the leadership concept did not help to depict individual departure and leading behaviour across movements in both study groups. Rather, the different proxies of leadership produced conflicting information about individual contributions to group coordination. This study discusses the implications of these findings for the field of coordination and decision-making research.	[Bourjade, Marie] Univ Toulouse Jean Jaures, Unite Rech Interdisciplinaire Octogone, Lab Cognit Commun Dev, Toulouse, France; [Bourjade, Marie] Assoc Takh Cheval Przewalski, Stn Biol Tour Valat, Arles, France; [Thierry, Bernard; Petit, Odile] CNRS, Dept Ecol Physiol & Ethol, Strasbourg, France; [Thierry, Bernard; Petit, Odile] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Hausberger, Martine] Univ Rennes 1, CNRS, Lab Ethol Anim & Humaine, Rennes, France	Universite de Toulouse; Universite de Toulouse - Jean Jaures; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Bourjade, M (corresponding author), Univ Toulouse Jean Jaures, Unite Rech Interdisciplinaire Octogone, Lab Cognit Commun Dev, Toulouse, France.	marie.bourjade@univ-tlse2.fr			GDR of Ethology [2822]; MAVA Foundation; Station Biologique de la Tour du Valat	GDR of Ethology; MAVA Foundation; Station Biologique de la Tour du Valat	Financial and logistic supports came from the GDR of Ethology (2822), the MAVA Foundation and the Station Biologique de la Tour du Valat.	Akos Z, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003446; BERGER J, 1977, BEHAV ECOL SOCIOBIOL, V2, P131, DOI 10.1007/BF00361898; Boinski S., 2000, MOVE WHY ANIMALS TRA; Bonanni R, 2010, ANIM BEHAV, V79, P981, DOI 10.1016/j.anbehav.2010.02.021; Bourjade M, 2010, BEHAV PROCESS, V84, P648, DOI 10.1016/j.beproc.2010.02.027; Bourjade M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004888; Bourjade M, 2009, ETHOLOGY, V115, P321, DOI 10.1111/j.1439-0310.2009.01614.x; BYRNE RW, 1990, AM J PRIMATOL, V20, P313, DOI 10.1002/ajp.1350200409; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Dumont B, 2005, APPL ANIM BEHAV SCI, V95, P55, DOI 10.1016/j.applanim.2005.04.005; Faria JJ, 2010, ANIM BEHAV, V79, P895, DOI 10.1016/j.anbehav.2009.12.039; Feh C, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P83; FEIST JD, 1976, Z TIERPSYCHOL, V41, P337; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Fureix C, 2012, APPL ANIM BEHAV SCI, V138, P216, DOI 10.1016/j.applanim.2012.02.009; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; Hinde RA., 1974, BIOL BASES HUMAN SOC; Holekamp KE, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P587; Johnstone RA, 2011, P NATL ACAD SCI USA, V108, P8373, DOI 10.1073/pnas.1102191108; King AJ, 2007, BIOL LETTERS, V3, P137, DOI 10.1098/rsbl.2007.0017; King AJ, 2011, INT J PRIMATOL, V32, P1245, DOI 10.1007/s10764-011-9526-7; King AJ, 2010, BEHAV PROCESS, V84, P671, DOI 10.1016/j.beproc.2010.03.006; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; King AJ, 2008, CURR BIOL, V18, P1833, DOI 10.1016/j.cub.2008.10.048; King SRB, 2010, APPL ANIM BEHAV SCI, V125, P22, DOI 10.1016/j.applanim.2010.03.006; KRAUSE J, 1992, BEHAV ECOL SOCIOBIOL, V30, P177, DOI 10.1007/BF00166700; Krause J, 2000, FISH FISH, V1, P82, DOI 10.1111/j.1467-2979.2000.tb00001.x; Krueger K, 2014, BEHAV PROCESS, V103, P91, DOI 10.1016/j.beproc.2013.10.007; Kummer H., 1968, SOCIAL ORG HAMADRYAS; Kurvers RHJM, 2009, ANIM BEHAV, V78, P447, DOI 10.1016/j.anbehav.2009.06.002; Lamprecht J, 1996, SOC SCI INFORM, V35, P595, DOI 10.1177/053901896035004001; Leca JB, 2003, ANIM BEHAV, V66, P1045, DOI 10.1006/anbe.2003.2276; Linklater WL, 2000, BIOL REV, V75, P1, DOI 10.1017/S0006323199005411; List C, 2004, TRENDS ECOL EVOL, V19, P168, DOI 10.1016/j.tree.2004.02.004; Meunier H, 2008, PRIMATES, V49, P26, DOI 10.1007/s10329-007-0055-0; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Nakayama S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043747; Nakayama S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036606; Ozogany K, 2015, J STAT PHYS, V158, P628, DOI 10.1007/s10955-014-1131-7; Peterson RO, 2002, CAN J ZOOL, V80, P1405, DOI 10.1139/Z02-124; Petit O, 2009, P ROY SOC B-BIOL SCI, V276, P3495, DOI 10.1098/rspb.2009.0983; Petit O, 2010, BEHAV PROCESS, V84, P635, DOI 10.1016/j.beproc.2010.04.009; Pillot MH, 2010, BEHAV PROCESS, V83, P235, DOI 10.1016/j.beproc.2009.11.006; Pyritz LW, 2011, INT J PRIMATOL, V32, P1268, DOI 10.1007/s10764-011-9524-9; Ramseyer A, 2009, ETHOLOGY, V115, P948, DOI 10.1111/j.1439-0310.2009.01686.x; Ramseyer A, 2009, ANIM BEHAV, V78, P71, DOI 10.1016/j.anbehav.2009.03.017; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Rands SA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-51; Reale D, 2003, ANIM BEHAV, V65, P463, DOI 10.1006/anbe.2003.2100; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; REINHARDT V, 1983, BEHAVIOUR, V83, P251, DOI 10.1163/156853983X00183; Sarova R, 2010, ANIM BEHAV, V79, P1037, DOI 10.1016/j.anbehav.2010.01.019; Schaller G.E., 1963, MOUNTAIN GORILLA ECO; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Souris AC, 2007, APPL ANIM BEHAV SCI, V107, P307, DOI 10.1016/j.applanim.2006.09.023; Stueckle S, 2008, ANIM BEHAV, V75, P1995, DOI 10.1016/j.anbehav.2007.12.012; Sueur C, 2008, BEHAV PROCESS, V78, P84, DOI 10.1016/j.beproc.2008.01.004; Sueur C, 2011, INT J PRIMATOL, V32, P1413, DOI 10.1007/s10764-011-9520-0; Sueur C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000917; Sueur C, 2010, ANIM COGN, V13, P239, DOI 10.1007/s10071-009-0261-9; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Tomasello M, 2007, DEVELOPMENTAL SCI, V10, P121, DOI 10.1111/j.1467-7687.2007.00573.x; Tyler S., 1972, ANIM BEHAV MONOGR, V5, P87, DOI [DOI 10.1016/0003-3472(72)90003-6, 10.1016/0003-3472(72)90003-6]; Van Vugt M, 2008, AM PSYCHOL, V63, P182, DOI 10.1037/0003-066X.63.3.182; Welsh DA, 1975, THESIS DALHOUSIE U; Wolf M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2777; Xia CJ, 2014, BIOL CONSERV, V177, P142, DOI 10.1016/j.biocon.2014.06.021	69	15	15	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126344	10.1371/journal.pone.0126344	http://dx.doi.org/10.1371/journal.pone.0126344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ0QZ	26010442	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900027
J	Singh, V; Sharma, G; Gardas, RL				Singh, Vickramjeet; Sharma, Gyanendra; Gardas, Ramesh L.			Thermodynamic and Ultrasonic Properties of Ascorbic Acid in Aqueous Protic Ionic Liquid Solutions	PLOS ONE			English	Article							VOLUMETRIC PROPERTIES; THIAMINE HYDROCHLORIDE; MOLECULAR-INTERACTIONS; TRANSPORT-PROPERTIES; BIPHASIC SYSTEMS; PLUS SUCROSE; AMINO-ACIDS; SUDAN-I; WATER; BEHAVIOR	In this work, we report the thermodynamic and ultrasonic properties of ascorbic acid (vitamin C) in water and in presence of newly synthesized ammonium based protic ionic liquid (diethylethanolammonium propionate) as a function of concentration and temperature. Apparent molar volume and apparent molar isentropic compression, which characterize the solvation state of ascorbic acid (AA) in presence of protic ionic liquid (PIL) has been determined from precise density and speed of sound measurements at temperatures (293.15 to 328.15) K with 5 K interval. The strength of molecular interactions prevailing in ternary solutions has been discussed on the basis of infinite dilution partial molar volume and partial molar isentropic compression, corresponding volume of transfer and interaction coefficients. Result has been discussed in terms of solute-solute and solute-solvent interactions occurring between ascorbic acid and PIL in ternary solutions (AA + water + PIL).	[Singh, Vickramjeet; Sharma, Gyanendra; Gardas, Ramesh L.] Indian Inst Technol, Dept Chem, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Gardas, RL (corresponding author), Indian Inst Technol, Dept Chem, Madras 600036, Tamil Nadu, India.	gardas@iitm.ac.in	Gardas, Ramesh L./B-2358-2008; singh, vickramjeet/R-3778-2019; Singh, Vickramjeet/AFS-3556-2022	Gardas, Ramesh L./0000-0002-6185-5825; Singh, Vickramjeet/0000-0002-6854-1503; Sharma, Gyanendra/0000-0002-5835-1255	Council of Scientific and Industrial Research (CSIR), India [01(2525)/11/EMR-II]; CSIR	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	The authors are thankful to Council of Scientific and Industrial Research (CSIR, http://www.csirhrdg.res.in/), India for the financial support through grant numbers 01(2525)/11/EMR-II. Dr. Vickramjeet Singh acknowledges the financial support from CSIR through his post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apelblat A, 2007, J MOL LIQ, V131, P7, DOI 10.1016/j.molliq.2006.08.022; Attri P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086530; Attri P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068970; Ayranci G, 2007, J CHEM THERMODYN, V39, P1620, DOI 10.1016/j.jct.2007.04.009; Banik I, 2012, J MOL LIQ, V169, P8, DOI 10.1016/j.molliq.2012.03.006; Banipal PK, 2015, FOOD CHEM, V168, P142, DOI 10.1016/j.foodchem.2014.06.104; Banipal PK, 2013, Z PHYS CHEM, V227, P1707, DOI 10.1524/zpch.2013.0394; Banipal TS, 2013, THERMOCHIM ACTA, V553, P31, DOI 10.1016/j.tca.2012.10.017; Birch GG, 2002, PURE APPL CHEM, V74, P1103, DOI 10.1351/pac200274071103; Chailapakul O, 2008, FOOD CHEM, V109, P876, DOI 10.1016/j.foodchem.2008.01.018; Clayden J., 2001, ORGANIC CHEM; Comunian TA, 2013, FOOD RES INT, V52, P373, DOI 10.1016/j.foodres.2013.03.028; DESNOYER.JE, 1969, J PHYS CHEM-US, V73, P3346, DOI 10.1021/j100844a032; Dhondge SS, 2013, J CHEM THERMODYN, V67, P217, DOI 10.1016/j.jct.2013.08.016; Elyasi M, 2013, FOOD CHEM, V141, P4311, DOI 10.1016/j.foodchem.2013.07.020; Freire MG, 2011, GREEN CHEM, V13, P1536, DOI 10.1039/c1gc15110j; Freire MG, 2010, GREEN CHEM, V12, P1715, DOI 10.1039/c0gc00179a; HAKIN AW, 1993, CAN J CHEM, V71, P925, DOI 10.1139/v93-123; Hayakawa EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085467; HEPLER LG, 1969, CAN J CHEMISTRY, V47, P4613, DOI 10.1139/v69-762; Jamal MA, 2014, FOOD CHEM, V146, P460, DOI 10.1016/j.foodchem.2013.09.076; Jiang XF, 2014, J CHEM THERMODYN, V71, P50, DOI 10.1016/j.jct.2013.11.002; Jiang XF, 2013, J CHEM ENG DATA, V58, P2970, DOI 10.1021/je400395u; Kant S, 2013, J CHEM ENG DATA, V58, P1294, DOI 10.1021/je301362j; Kant S, 2009, J MOL LIQ, V150, P39, DOI 10.1016/j.molliq.2009.09.010; KAULGUD MV, 1978, INDIAN J CHEM A, V16, P955; Kawada H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062717; Keshapolla D, 2014, J MOL LIQ, V199, P330, DOI 10.1016/j.molliq.2014.09.030; Lan W, 2011, CARBOHYD POLYM, V86, P672, DOI 10.1016/j.carbpol.2011.05.013; MCMILLAN WG, 1945, J CHEM PHYS, V13, P276, DOI 10.1063/1.1724036; Monti DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029794; Mourao T, 2014, ACS SUSTAIN CHEM ENG, V2, P2426, DOI 10.1021/sc500444w; Parke SA, 1999, CHEM SENSES, V24, P271, DOI 10.1093/chemse/24.3.271; Pereira JFB, 2010, GREEN CHEM, V12, P1661, DOI 10.1039/c003578e; Ping JF, 2012, FOOD CHEM, V135, P362, DOI 10.1016/j.foodchem.2012.05.013; Pinkert A, 2009, CHEM REV, V109, P6712, DOI 10.1021/cr9001947; Raja S., 2012, SCI TECHNOL HUM VAL, V1, P7; Rusen Feng, 2010, Journal of Environmental Protection, V1, P95, DOI 10.4236/jep.2010.12012; Sahin M, 2011, J CHEM THERMODYN, V43, P177, DOI 10.1016/j.jct.2010.08.017; SAVAGE JJ, 1976, J SOLUTION CHEM, V5, P733, DOI 10.1007/BF00643457; Sdiri S., 2012, FOOD RES INT, V50, P143; Seuvre AM, 2010, FOOD CHEM, V122, P455, DOI 10.1016/j.foodchem.2009.04.101; SHAMIM M, 1979, AUST J CHEM, V32, P2293, DOI 10.1071/CH9792293; Singh V, 2015, FOOD CHEM, V169, P478, DOI 10.1016/j.foodchem.2014.08.023; Singh V, 2014, J CHEM THERMODYN, V71, P37, DOI 10.1016/j.jct.2013.11.021; Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m; Tian MM, 2014, FOOD CHEM, V145, P28, DOI 10.1016/j.foodchem.2013.08.029; Tsuda T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091193; Valente A, 2011, FOOD RES INT, V44, P2237, DOI 10.1016/j.foodres.2011.02.012; Ventura SPM, 2011, J CHEM ENG DATA, V56, P4253, DOI 10.1021/je200714h; Wong SZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066691; Wu B, 2008, J CHEM ENG DATA, V53, P983, DOI 10.1021/je700729p; Wu B, 2009, J CHEM ENG DATA, V54, P1430, DOI 10.1021/je800622e; Yuan JP, 1998, J AGR FOOD CHEM, V46, P5078, DOI 10.1021/jf9805404; Zafarani-Moattar MT, 2011, BIOTECHNOL PROGR, V27, P986, DOI 10.1002/btpr.613; Zhang HJ, 2014, FOOD CHEM, V151, P429, DOI 10.1016/j.foodchem.2013.11.016; Zhu LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047058	57	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0126091	10.1371/journal.pone.0126091	http://dx.doi.org/10.1371/journal.pone.0126091			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26009887	gold, Green Published, Green Submitted			2022-12-26	WOS:000355183900022
J	Zhang, J; Liu, T; Feng, RF; Liu, C; Chi, S				Zhang, Jing; Liu, Tao; Feng, Rongfang; Liu, Cui; Chi, Shan			Genetic Map Construction and Quantitative Trait Locus (QTL) Detection of Six Economic Traits Using an F-2 Population of the Hybrid from Saccharina longissima and Saccharina japonica	PLOS ONE			English	Article							MARKER-ASSISTED SELECTION; SEGREGATION DISTORTION; LINKAGE MAP; LAMINARIA-JAPONICA; PHAEOPHYTA GAMETOPHYTES; MICROSATELLITE MARKERS; GRAIN-YIELD; DNA; GENOME; MAIZE	Saccharina (Laminaria) is one of the most important economic seaweeds. Previously, four genetic linkage maps of Saccharina have been constructed and five QTLs have been identified. However, they were not enough for its breeding. In this work, Saccharina longissima (female) and Saccharina japonica (male), which showed obvious differences in morphology and genetics, were applied in hybridization to yield the F-2 mapping population with 102 individuals. Using these 102 F-2 hybrids, the genetic linkage map of Saccharina was constructed by MapMaker software based on 37 amplified fragment length polymorphisms (AFLPs), 22 sequence-related amplified polymorphisms (SRAPs) and 139 simple sequence repeats (SSRs) markers. Meanwhile, QTL analysis was performed for six economic traits. The linkage map constructed in this research consisted of 422 marker loci (137 AFLPs, 57 SRAPs and 228 SSRs), which formed 45 linkage groups (LGs) with an average marker space of 7.92 cM; they spanned a total length of 2233.1 cM, covering the whole estimated genome size. A total of 29 QTLs were identified for six economic traits, which explained 1.06 to 64.00% of phenotypic variation, including three QTLs for frond length (FL) and raw weight (RW), five QTLs for frond width (FW), two QTLs for frond fascia width (FFW) and frond thickness (FT), and fourteen QTLs for base shape (BS). The results of this research will improve the breeding efficiency and be beneficial for marker-assisted selection (MAS) schemes in Saccharina breeding.	[Zhang, Jing] Qilu Univ Technol, Jinan, Shandong, Peoples R China; [Zhang, Jing; Liu, Tao; Liu, Cui; Chi, Shan] Ocean Univ China, Coll Marine Life Sci, Qingdao, Shandong, Peoples R China; [Feng, Rongfang] Guangdong Inst Microbiol, Guangzhou, Guangdong, Peoples R China	Qilu University of Technology; Ocean University of China; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences	Liu, T (corresponding author), Ocean Univ China, Coll Marine Life Sci, Qingdao, Shandong, Peoples R China.	our_science@sina.com	Zhang, Jing/ABD-1862-2021		National High Technology Joint Research Program of China [2012AA10A406]; National Natural Science Foundation of China [31402300]; Special Fund of Fundamental Scientific Research Business Expense for Higher School of Central Government [201262003]	National High Technology Joint Research Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund of Fundamental Scientific Research Business Expense for Higher School of Central Government	This work was supported by the National High Technology Joint Research Program of China (2012AA10A406), the National Natural Science Foundation of China (Grant No. 31402300) and Special Fund of Fundamental Scientific Research Business Expense for Higher School of Central Government (201262003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1939, SCI REP TOHOKU IMP U, V14, P327; An X.L., 2010, FISH SCI, V29, P115; Barchi L, 2010, GENOME, V53, P805, DOI [10.1139/g10-073, 10.1139/G10-073]; Basten CJ, 2005, QTL CARTOGRAPHER VER; Bidinger FR, 2007, CROP SCI, V47, P969, DOI 10.2135/cropsci2006.07.0465; Billot C, 1998, MOL ECOL, V7, P1778, DOI 10.1046/j.1365-294x.1998.00516.x; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Butcher PA, 2002, THEOR APPL GENET, V104, P1185, DOI 10.1007/s00122-001-0820-1; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Ding WD, 2010, AQUACULT INT, V18, P575, DOI 10.1007/s10499-009-9277-z; Doucleff M, 2004, THEOR APPL GENET, V109, P1178, DOI 10.1007/s00122-004-1728-3; Edwards KJ, 1996, BIOTECHNIQUES, V20, P758; Fang T.C., 1962, B BOT, V10, P197; Fang TC, 1983, J SHANDONG COLL OCEA, V13, P63; Fang TC, 1985, J SHANDONG COLL OCEA, V15, P64; Garvin DF, 2010, GENOME, V53, P1, DOI [10.1139/G09-079, 10.1139/g09-079]; Gong L, 2008, GENOME, V51, P878, DOI 10.1139/G08-072; Gosselin I, 2002, THEOR APPL GENET, V104, P987, DOI 10.1007/s00122-001-0823-y; Guillemaut P, 1992, PLANT MOL BIOL REP, V10, P60, DOI 10.1007/BF02669265; Hong YB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-17; Hong YanBin, 2008, Agricultural Sciences in China, V7, P915, DOI 10.1016/S1671-2927(08)60130-3; Kiani SP, 2009, PLANT BREEDING, V128, P363, DOI 10.1111/j.1439-0523.2009.01628.x; Korol A., 2007, AQUACULTURE GENOME T, P169; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Ky CL, 2000, THEOR APPL GENET, V101, P669, DOI 10.1007/s001220051529; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LEWIS RJ, 1993, J PHYCOL, V29, P363, DOI 10.1111/j.0022-3646.1993.00363.x; Li G, 2001, THEOR APPL GENET, V103, P455, DOI 10.1007/s001220100570; Li YH, 2007, J INTEGR PLANT BIOL, V49, P392, DOI 10.1111/j.1744-7909.2007.00397.x; Liu FL, 2010, MAR BIOTECHNOL, V12, P386, DOI 10.1007/s10126-009-9229-7; Liu FL, 2010, J APPL PHYCOL, V22, P109, DOI 10.1007/s10811-009-9426-9; Liu FL, 2009, J PHYCOL, V45, P1228, DOI 10.1111/j.1529-8817.2009.00729.x; LORIEUX M, 1995, THEOR APPL GENET, V90, P81, DOI 10.1007/BF00220999; Luo L, 2005, HEREDITY, V94, P347, DOI 10.1038/sj.hdy.6800615; McCouch SR, 1997, RICE GENET NEWSLETT, V14, P11, DOI [DOI 10.1007/S10142-013-0328-1, DOI 10.1007/S10681-005-0449-2]; Mohan M, 1997, MOL BREEDING, V3, P87, DOI 10.1023/A:1009651919792; Mu P, 2003, CHINESE SCI BULL, V48, P2718, DOI 10.1360/03wc0180; Nikaido A, 1999, GENES GENET SYST, V74, P55, DOI 10.1266/ggs.74.55; Nunome T, 2001, BREEDING SCI, V51, P19, DOI 10.1270/jsbbs.51.19; PATERSON AH, 1991, GENETICS, V127, P181; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Quarrie SA, 2005, THEOR APPL GENET, V110, P865, DOI 10.1007/s00122-004-1902-7; Rebetzke GJ, 2005, PLANT SOIL, V272, P87, DOI 10.1007/s11104-004-4040-8; Shi YY, 2007, MOL ECOL NOTES, V7, P620, DOI 10.1111/j.1471-8286.2006.01652.x; Sraphet S, 2011, THEOR APPL GENET, V122, P1161, DOI 10.1007/s00122-010-1520-5; STUBER CW, 1987, CROP SCI, V27, P639, DOI 10.2135/cropsci1987.0011183X002700040006x; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Taylor DR, 2003, GENETICA, V117, P27, DOI 10.1023/A:1022308414864; Tseng C. K., 1983, COMMON SEAWEEDS CHIN; Tuberosa R, 2002, ANN BOT-LONDON, V89, P941, DOI 10.1093/aob/mcf134; Upadyayula N, 2006, THEOR APPL GENET, V112, P592, DOI 10.1007/s00122-005-0133-x; Vengadessan V., 2013, ISRN GENET, V2013, P1, DOI [10.5402/2013/471632, DOI 10.5402/2013/471632]; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang CM, 2005, GENET RES, V86, P97, DOI 10.1017/S0016672305007779; Wang GL, 2011, ACTA OCEANOL SIN, V30, P112, DOI 10.1007/s13131-011-0125-4; Wang XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080569; Wang XL, 2005, J INTEGR PLANT BIOL, V47, P753, DOI 10.1111/j.1744-7909.2005.00059.x; Wang XL, 2004, AQUACULTURE, V238, P143, DOI 10.1016/j.aquaculture.2004.05.007; YABU H, 1973, Bulletin of the Faculty of Fisheries Hokkaido University, V23, P171; YABU H, 1991, Japanese Journal of Phycology, V39, P185; Yang GP, 2009, J PHYCOL, V45, P873, DOI 10.1111/j.1529-8817.2009.00720.x; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang J, 2015, J APPL PHYCOL, V27, P479, DOI 10.1007/s10811-014-0301-y; Zhang J, 2011, J APPL PHYCOL, V23, P165, DOI 10.1007/s10811-011-9650-y; Zhang LY, 2010, THEOR APPL GENET, V121, P1071, DOI 10.1007/s00122-010-1372-z; Zhang ZY., 1999, J DALIAN FISHERIES U, V14, P13; Zhou LR, 2004, HYDROBIOLOGIA, V512, P141, DOI 10.1023/B:HYDR.0000020319.36532.eb	70	8	9	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128588	10.1371/journal.pone.0128588	http://dx.doi.org/10.1371/journal.pone.0128588			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010152	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900244
J	Steinway, SN; Dang, H; You, HN; Rountree, CB; Ding, W				Steinway, Steven N.; Dang, Hien; You, Hanning; Rountree, C. Bart; Ding, Wei			The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met(+) Hepatocellular Carcinoma	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; CELL LUNG-CANCER; STEM-CELLS; SIGNALING PATHWAY; BRAIN METASTASIS; CROSS-TALK; RECEPTOR; RESISTANCE; EGFR; EXPRESSION	Background c-Met, a high-affinity receptor for Hepatocyte Growth Factor (HGF), plays a critical role in tumor growth, invasion, and metastasis. Hepatocellular carcinoma (HCC) patients with activated HGF/c-Met signaling have a significantly worse prognosis. Targeted therapies using c-Met tyrosine kinase inhibitors are currently in clinical trials for HCC, although receptor tyrosine kinase inhibition in other cancers has demonstrated early success. Unfortunately, therapeutic effect is frequently not durable due to acquired resistance. Methods We utilized the human MHCC97-H c-Met positive (c-Met(+)) HCC cell line to explore the compensatory survival mechanisms that are acquired after c-Met inhibition. MHCC97-H cells with stable c-Met knockdown (MHCC97-H c-Met KD cells) were generated using a c-Met shRNA vector with puromycin selection and stably transfected scrambled shRNA as a control. Gene expression profiling was conducted, and protein expression was analyzed to characterize MHCC97-H cells after blockade of the c-Met oncogene. A high-throughput siRNA screen was performed to find putative compensatory survival proteins, which could drive HCC growth in the absence of c-Met. Findings from this screen were validated through subsequent analyses. Results We have previously demonstrated that treatment of MHCC97-H cells with a c-Met inhibitor, PHA665752, results in stasis of tumor growth in vivo. MHCC97-H c-Met KD cells demonstrate slower growth kinetics, similar to c-Met inhibitor treated tumors. Using gene expression profiling and siRNA screening against 873 kinases and phosphatases, we identified ErbB3 and TGF-alpha as compensatory survival factors that are upregulated after c-Met inhibition. Suppressing these factors in c-Met KD MHCC97-H cells suppresses tumor growth in vitro. In addition, we found that the PI3K/Akt signaling pathway serves as a negative feedback signal responsible for the ErbB3 upregulation after c-Met inhibition. Furthermore, in vitro studies demonstrate that combination therapy with PHA665752 and Gefitinib (an EGFR inhibitor) significantly reduced cell viability and increased apoptosis compared with either PHA665752 or Gefitinib treatment alone. Conclusion c-Met inhibition monotherapy is not sufficient to eliminate c-Met(+) HCC tumor growth. Inhibition of both c-Met and EGFR oncogenic pathways provides superior suppression of HCC tumor growth. Thus, combination of c-Met and EGFR inhibition may represent a superior therapeutic regimen for c-Met(+) HCC.	[Steinway, Steven N.; Dang, Hien; You, Hanning; Rountree, C. Bart; Ding, Wei] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ding, W (corresponding author), Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA.	wding@hmc.psu.edu		Steinway, Steven/0000-0002-4645-293X	National Institute of Health [R03DK088013]; American Cancer Society [MGO-116519]; Penn State Hershey Four Diamonds Fund; National Institutes of Health [F30 DK093234]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK088013, F30DK093234] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Penn State Hershey Four Diamonds Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by 1. National Institute of Health, R03DK088013: http://grants.nih.gov/grants/funding/r03.htm (CBR); 2. American Cancer Society, Research Scholar Grant, MGO-116519: http://www.cancer.org/research/applyforaresearchgrant/granttypes/research-scholar-grants (CBR); 3. The Penn State Hershey Four Diamonds Fund: http://www.fourdiamonds.org/how-we-help/#how-we-helpresearch-center (CBR); 4. National Institutes of Health, F30 DK093234: http://grants.nih.gov/grants/guide/pa-files/PA-14-150.html (SS).	Accornero P, 2010, J MOL ENDOCRINOL, V44, P115, DOI 10.1677/JME-09-0035; Acunzo M, 2013, P NATL ACAD SCI USA, V110, P8573, DOI 10.1073/pnas.1302107110; Agarwal S, 2009, BRIT J CANCER, V100, P941, DOI 10.1038/sj.bjc.6604937; Benedettini E, 2010, AM J PATHOL, V177, P415, DOI 10.2353/ajpath.2010.090863; Blumenschein GR, 2012, J CLIN ONCOL, V30, P3287, DOI 10.1200/JCO.2011.40.3774; Bozkaya G, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-64; Breindel JL, 2013, CANCER RES, V73, P5053, DOI 10.1158/0008-5472.CAN-12-3775; Ding W, 2010, HEPATOLOGY, V52, P945, DOI 10.1002/hep.23748; Ding W, 2009, HEPATOLOGY, V49, P1277, DOI 10.1002/hep.22743; Dulak AM, 2011, ONCOGENE, V30, P3625, DOI 10.1038/onc.2011.84; El-Serag HB, 2002, J CLIN GASTROENTEROL, V35, pS72, DOI 10.1097/00004836-200211002-00002; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; FIXMAN ED, 1995, ONCOGENE, V10, P237; Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; GRAZIANI A, 1991, J BIOL CHEM, V266, P22087; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Ke AW, 2009, HEPATOLOGY, V49, P491, DOI 10.1002/hep.22639; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Ma PC, 2003, CANCER METAST REV, V22, P309, DOI 10.1023/A:1023768811842; McDermott U, 2010, CANCER RES, V70, P1625, DOI 10.1158/0008-5472.CAN-09-3620; Mueller KL, 2008, CANCER RES, V68, P3314, DOI 10.1158/0008-5472.CAN-08-0132; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Neaud V, 1997, HEPATOLOGY, V26, P1458, DOI 10.1002/hep.510260612; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Ovcharenko D, 2005, RNA, V11, P985, DOI 10.1261/rna.7288405; Pediaditakis P, 2001, HEPATOLOGY, V34, P688, DOI 10.1053/jhep.2001.27811; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Rountree CB, 2009, STEM CELLS, V27, P290, DOI 10.1634/stemcells.2008-0332; Santoro A, 2013, LANCET ONCOL, V14, P55, DOI 10.1016/S1470-2045(12)70490-4; Sequist LV, 2011, J CLIN ONCOL, V29, P3307, DOI 10.1200/JCO.2010.34.0570; Sierra J Rafael, 2011, Ther Adv Med Oncol, V3, pS21, DOI 10.1177/1758834011422557; Society AC, 2010, CANC FACTS FIG 2010; Takami T, 2007, CANCER RES, V67, P9844, DOI 10.1158/0008-5472.CAN-07-1905; Tian J, 1999, BRIT J CANCER, V81, P814, DOI 10.1038/sj.bjc.6690769; Ueki T, 1997, HEPATOLOGY, V25, P862, DOI 10.1002/hep.510250413; Ueki T, 1997, HEPATOLOGY, V25, P619, DOI 10.1002/hep.510250321; Velpula KK, 2012, TRANSL ONCOL, V5, P379, DOI 10.1593/tlo.12235; Wang W, 2012, CLIN CANCER RES, V18, P1663, DOI 10.1158/1078-0432.CCR-11-1171; Wang ZL, 2008, J GASTROINTEST SURG, V12, P327, DOI 10.1007/s11605-007-0310-0; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yau TC SW, 2012, J CLIN ONCOLOGY OFFI; You HN, 2011, HEPATOLOGY, V54, P879, DOI 10.1002/hep.24450; You HN, 2010, HEPATOLOGY, V51, P1635, DOI 10.1002/hep.23544; Zeng ZS, 2008, CANCER LETT, V265, P258, DOI 10.1016/j.canlet.2008.02.049	50	22	23	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0128159	10.1371/journal.pone.0128159	http://dx.doi.org/10.1371/journal.pone.0128159			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000702	Green Published, Green Submitted, gold			2022-12-26	WOS:000354931700106
J	Eltzner, B; Wollnik, C; Gottschlich, C; Huckemann, S; Rehfeldt, F				Eltzner, Benjamin; Wollnik, Carina; Gottschlich, Carsten; Huckemann, Stephan; Rehfeldt, Florian			The Filament Sensor for Near Real-Time Detection of Cytoskeletal Fiber Structures	PLOS ONE			English	Article							FINGERPRINT IMAGES; STRESS FIBERS; CELLS; MECHANISMS; MICROSCOPY; DIFFUSION; STIFFNESS	A reliable extraction of filament data from microscopic images is of high interest in the analysis of acto-myosin structures as early morphological markers in mechanically guided differentiation of human mesenchymal stem cells and the understanding of the underlying fiber arrangement processes. In this paper, we propose the filament sensor (FS), a fast and robust processing sequence which detects and records location, orientation, length, and width for each single filament of an image, and thus allows for the above described analysis. The extraction of these features has previously not been possible with existing methods. We evaluate the performance of the proposed FS in terms of accuracy and speed in comparison to three existing methods with respect to their limited output. Further, we provide a benchmark dataset of real cell images along with filaments manually marked by a human expert as well as simulated benchmark images. The FS clearly outperforms existing methods in terms of computational runtime and filament extraction accuracy. The implementation of the FS and the benchmark database are available as open source.	[Eltzner, Benjamin; Gottschlich, Carsten; Huckemann, Stephan] Univ Gottingen, Inst Math Stochast, D-37077 Gottingen, Germany; [Wollnik, Carina; Rehfeldt, Florian] Univ Gottingen, Inst Phys Biophys 3, D-37077 Gottingen, Germany	University of Gottingen; University of Gottingen	Eltzner, B (corresponding author), Univ Gottingen, Inst Math Stochast, D-37077 Gottingen, Germany.	benjamin.eltzner@mathematik.uni-goettingen.de; rehfeldt@physik3.gwdg.de	Gottschlich, Carsten/E-3948-2013; Rehfeldt, Florian/A-1078-2007	Gottschlich, Carsten/0000-0002-4118-012X; Rehfeldt, Florian/0000-0001-9086-3835	Deutsche Forschungsgemeinschaft collaborative research center [SFB 755]; Open Access Publication Funds of the University of Gottingen; Felix-Bernstein-Institute for Mathematical Statistics in the Biosciences; Niedersachsen Vorab of the Volkswagen Foundation	Deutsche Forschungsgemeinschaft collaborative research center(German Research Foundation (DFG)); Open Access Publication Funds of the University of Gottingen; Felix-Bernstein-Institute for Mathematical Statistics in the Biosciences; Niedersachsen Vorab of the Volkswagen Foundation	All authors were supported by Deutsche Forschungsgemeinschaft collaborative research center SFB 755 "Nanoscale Photonic Imaging" project B8 (http://www.uni-goettingen.de/de/318955.html) and Open Access Publication Funds of the University of Gottingen (http://www.sub.unigoettingen.de/en/electronic-publishing/open-access/open-access-publication-funding/). CG SH were supported by Felix-Bernstein-Institute for Mathematical Statistics in the Biosciences and Niedersachsen Vorab of the Volkswagen Foundation http://www.volkswagenstiftung.de/foerderung/vorab.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2013, J MICROSC-OXFORD, V250, P57, DOI 10.1111/jmi.12018; Bekkers E, 2014, J MATH IMAGING VIS, V49, P583, DOI 10.1007/s10851-013-0488-6; Benes V, 2004, STOCHASTIC GEOMETRY; Chang S, 2001, STUD HEALTH TECHNOL, V84, P901; Ciobanasu Corina, 2012, Int J Cell Biol, V2012, P941292, DOI 10.1155/2012/941292; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dormann D, 2002, CELL MOTIL CYTOSKEL, V52, P221, DOI 10.1002/cm.10048; DUDA RO, 1972, COMMUN ACM, V15, P11, DOI 10.1145/361237.361242; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Faust U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028963; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; Gottschlich C, 2012, IET BIOMETRICS, V1, P105, DOI 10.1049/iet-bmt.2012.0003; Gottschlich C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110214; Gottschlich C, 2012, IEEE T IMAGE PROCESS, V21, P2220, DOI 10.1109/TIP.2011.2170696; Gottschlich C, 2009, IEEE T INF FOREN SEC, V4, P802, DOI 10.1109/TIFS.2009.2033219; Haralock R. M., 1991, COMPUTER ROBOT VISIO; Herberich G, 2010, CONF REC ASILOMAR C, P1359, DOI 10.1109/ACSSC.2010.5757755; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Huckemann S, 2014, ARXIV14043300STATME; Huo X., 2002, LECT NOTES COMPUTATI, P149, DOI DOI 10.1007/978-3-642-56205-1; Lichtenstein N, 2003, CYTOM PART A, V54A, P8, DOI 10.1002/cyto.a.10053; MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; Otsu N, 1975, AUTOMATICA, V11, P285; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007; Rubner Y, 2000, INT J COMPUT VISION, V40, P99, DOI 10.1023/A:1026543900054; Sanchez T, 2012, NATURE, V491, P431, DOI 10.1038/nature11591; Shen L, 2001, LECT NOTES COMPUT SC, V2091, P266; Soine JRD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004076; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Szeliski R., 2010, COMPUTER VISION ALGO, DOI DOI 10.1007/978-3-030-34372-9; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Vallenius T, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130001; WEICKERT J, 1996, COMP SUPPL, V11, P221; Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]; Yoshikawa HY, 2013, J PHYS CHEM B, V117, P4081, DOI 10.1021/jp4008224; Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613	38	43	43	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0126346	10.1371/journal.pone.0126346	http://dx.doi.org/10.1371/journal.pone.0126346			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996921	gold, Green Published, Green Submitted			2022-12-26	WOS:000356444000021
J	Niu, PG; Zhang, YX; Shi, DH; Liu, Y; Chen, YY; Deng, J				Niu, Pei-Guang; Zhang, Yu-Xuan; Shi, Dao-Hua; Liu, Ying; Chen, Yao-Yao; Deng, Jie			Cardamonin Inhibits Metastasis of Lewis Lung Carcinoma Cells by Decreasing mTOR Activity	PLOS ONE			English	Article							OVARIAN-CANCER CELLS; ENDOTHELIAL GROWTH-FACTOR; SIGNALING PATHWAY; MESENCHYMAL TRANSITION; CADHERIN; RAPAMYCIN; INVASION; EXPRESSION; MOTILITY; INSULIN	The mammalian target of rapamycin (mTOR) regulates the motility and invasion of cancer cells. Cardamonin is a chalcone that exhibits anti-tumor activity. The previous study had proved that the anti-tumor effect of cardamonin was associated with mTOR inhibition. In the present study, the anti-metastatic effect of cardamonin and its underlying molecule mechanisms were investigated on the highly metastatic Lewis lung carcinoma (LLC) cells. The proliferation, invasion and migration of LLC cells were measured by MTT, transwell and wound healing assays, respectively. The expression and activation of mTOR-and adhesion-related proteins were assessed by Western blotting. The in vivo effect of cardamonin on the metastasis of the LLC cells was investigated by a mouse model. Treated with cardamonin, the proliferation, invasion and migration of LLC cells were significantly inhibited. The expression of Snail was decreased by cardamonin, while that of E-cadherin was increased. In addition, cardamonin inhibited the activation of mTOR and its downstream target ribosomal S6 kinase 1 (S6K1). Furthermore, the tumor growth and its lung metastasis were inhibited by cardamonin in C57BL/6 mice. It indicated that cardamonin inhibited the invasion and metastasis of LLC cells through inhibiting mTOR. The metastasis inhibitory effect of cardamonin was correlated with down-regulation of Snail and up-regulation of E-cadherin.	[Niu, Pei-Guang; Zhang, Yu-Xuan; Shi, Dao-Hua; Liu, Ying; Chen, Yao-Yao; Deng, Jie] Fujian Prov Maternal & Child Hlth Hosp, Dept Pharm, Fuzhou, Fujian, Peoples R China		Shi, DH (corresponding author), Fujian Prov Maternal & Child Hlth Hosp, Dept Pharm, Fuzhou, Fujian, Peoples R China.	shidh@yeah.net	Daohua, Shi/C-3952-2011	Daohua, Shi/0000-0002-3383-5640	Natural Science Foundation of Fujian Province [2012J01312]	Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This work was supported by the Natural Science Foundation of Fujian Province (NO. 2012J01312). The URL of the funder is http://xmgl.fjkjt.gov.cn/. DHS received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieri M, 2009, MOL IMMUNOL, V46, P866, DOI 10.1016/j.molimm.2008.09.011; Blechschmidt K, 2008, BRIT J CANCER, V98, P489, DOI 10.1038/sj.bjc.6604115; Boffa DJ, 2004, CLIN CANCER RES, V10, P293, DOI 10.1158/1078-0432.CCR-0629-3; Canel M, 2013, J CELL SCI, V126, P393, DOI 10.1242/jcs.100115; Dong C, 2013, ONCOGENE, V32, P1351, DOI 10.1038/onc.2012.169; Ekshyyan O, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-320; El-Naga RN, 2014, TOXICOL APPL PHARM, V274, P87, DOI 10.1016/j.taap.2013.10.031; Goncalves LM, 2014, J MED FOOD, V17, P633, DOI 10.1089/jmf.2013.0061; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Kumar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068597; Lau MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059083; Lau MT, 2012, CANCER LETT, V326, P191, DOI 10.1016/j.canlet.2012.08.016; Lee HB, 2007, J KOREAN MED SCI, V22, P943, DOI 10.3346/jkms.2007.22.6.943; Lee JH, 2006, J PHARMACOL EXP THER, V316, P271, DOI 10.1124/jpet.105.092486; Liao Q, 2010, EUR J PHARMACOL, V641, P179, DOI 10.1016/j.ejphar.2010.05.024; Luan FL, 2003, KIDNEY INT, V63, P917, DOI 10.1046/j.1523-1755.2003.00805.x; Maru S, 2013, J UROLOGY, V189, P1921, DOI 10.1016/j.juro.2012.11.010; Merikallio H, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-104; Niu PG, 2013, PLANTA MED, V79, P452, DOI 10.1055/s-0032-1328325; Park MK, 2013, LIFE SCI, V92, P154, DOI 10.1016/j.lfs.2012.11.009; Pon YL, 2008, CANCER RES, V68, P6524, DOI 10.1158/0008-5472.CAN-07-6302; Schlosshauer PW, 2009, GYNECOL ONCOL, V114, P516, DOI 10.1016/j.ygyno.2009.06.002; Tang Y, 2014, LIFE SCI, V99, P44, DOI 10.1016/j.lfs.2014.01.066; Tian SS, 2014, FITOTERAPIA, V92, P34, DOI 10.1016/j.fitote.2013.09.016; Wander SA, 2013, BREAST CANCER RES TR, V138, P369, DOI 10.1007/s10549-012-2389-6; Wu MJ, 2006, KIDNEY INT, V69, P2029, DOI 10.1038/sj.ki.5000161; Zhou HY, 2011, CURR PROTEIN PEPT SC, V12, P30; Zhou HY, 2010, CRIT REV EUKAR GENE, V20, P1	30	46	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127778	10.1371/journal.pone.0127778	http://dx.doi.org/10.1371/journal.pone.0127778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996501	Green Published, gold, Green Submitted			2022-12-26	WOS:000356444000087
J	Ward, J; Vella, C; Hoare, DJ; Hall, DA				Ward, Jamie; Vella, Claire; Hoare, Derek J.; Hall, Deborah A.			Subtyping Somatic Tinnitus: A Cross-Sectional UK Cohort Study of Demographic, Clinical and Audiological Characteristics	PLOS ONE			English	Article							DORSAL COCHLEAR NUCLEUS; TEMPOROMANDIBULAR DISORDERS; NECK; NEUROSCIENCE; MODULATION; MECHANISMS; RESPONSES; NETWORK; ONSET; HEAD	Somatic tinnitus is the ability to modulate the psychoacoustic features of tinnitus by somatic manoeuvres. The condition is still not fully understood and further identification of this subtype is essential, particularly for the purpose of establishing protocols for both its diagnosis and treatment. This study aimed to investigate the characteristics of somatic tinnitus within a large UK cohort using a largely unselected sample. We believe this to be relatively unique in comparison to current literature on the topic. This was investigated by using a total of 608 participant assessments from a set of recognised tinnitus and audiology measures. Results from a set of chi-square tests of association found that amongst the individuals with somatic tinnitus, a higher proportion had pulsatile tinnitus (different from heartbeat), were under the age of 40, reported variation in the loudness of their tinnitus and reported temporomandibular joint (TMJ) disorder. The same pattern of results was confirmed using a multivariate analysis of the data based on logistic regression. These findings have strong implications towards the profiling of somatic tinnitus as a distinct subtype of general tinnitus.	[Ward, Jamie; Vella, Claire] Univ Sussex, Sch Psychol, Brighton BNI 9RH, E Sussex, England; [Hoare, Derek J.; Hall, Deborah A.] NIHR, Nottingham Hearing Biomed Res Unit, Nottingham NG1 5DU, England; [Hoare, Derek J.; Hall, Deborah A.] Univ Nottingham, Sch Med, Div Clin Neurosci, Otol & Hearing Grp, Nottingham NG7 2UH, England	University of Sussex; University of Nottingham; University of Nottingham	Ward, J (corresponding author), Univ Sussex, Sch Psychol, Brighton BNI 9RH, E Sussex, England.	jamiew@sussex.ac.uk	Ward, Jamie/F-3609-2011	Ward, Jamie/0000-0001-7007-1902; Vella, Claire/0000-0001-7383-1559; Hall, Deborah/0000-0002-3804-1452; Hoare, Derek/0000-0002-8768-1392; Vanneste, Sven/0000-0003-1513-5752	Summer Studentship; National Institute for Health Research (NIHR) Biomedical Research Unit Programme	Summer Studentship; National Institute for Health Research (NIHR) Biomedical Research Unit Programme(National Institute for Health Research (NIHR))	The research was funded by a Summer Studentship (to CV) awarded to the University of Sussex by Action on Hearing Loss. DJH and DAH are supported by the National Institute for Health Research (NIHR) Biomedical Research Unit Programme. However, the views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MD, 2004, CRANIO, V22, P181, DOI 10.1179/crn.2004.024; Adjamian P, 2009, HEARING RES, V253, P15, DOI 10.1016/j.heares.2009.04.001; Afra P, 2009, PSYCHOL RES BEHAV MA, V2, P31; Baguley D, 2013, LANCET, V382, P1600, DOI 10.1016/S0140-6736(13)60142-7; Beauchamp MS, 2008, J NEUROSCI, V28, P13696, DOI 10.1523/JNEUROSCI.3872-08.2008; Bento R F, 1998, Ear Nose Throat J, V77, P814; Coad ML, 2001, OTOL NEUROTOL, V22, P650, DOI 10.1097/00129492-200109000-00016; Davies J, 2014, INT J AUDIOL, V53, P192, DOI 10.3109/14992027.2013.846482; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Field A, 2013, DISCOVERING STAT USI; Hoare DJ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-207; Hoare DJ, 2012, JARO-J ASSOC RES OTO, V13, P543, DOI 10.1007/s10162-012-0323-6; Hoare DJ, 2014, PLOS ONE, V9; Hoekstra CEL, 2014, EAR HEARING, V35, P544, DOI 10.1097/AUD.0000000000000045; Hoffman HJ, 2004, TINNITUS THEORY MANA; Isberg A, 1998, ORAL SURG ORAL MED O, V85, P252, DOI 10.1016/S1079-2104(98)90004-X; KUK FK, 1990, EAR HEARING, V11, P434, DOI 10.1097/00003446-199012000-00005; Landgrebe M, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-42; Langguth B, 2007, PROG BRAIN RES, V166, P525, DOI 10.1016/S0079-6123(07)66050-6; Levine RA, 2007, PROG BRAIN RES, V166, P195, DOI 10.1016/S0079-6123(07)66017-8; Levine RA, 1999, AM J OTOLARYNG, V20, P351, DOI 10.1016/S0196-0709(99)90074-1; Levine RA, 2003, EXP BRAIN RES, V153, P643, DOI 10.1007/s00221-003-1747-3; Levine RA, 1999, SOMATIC MODULATION A; Levine RA, 1995, MECH TINNITUS, P149; Maixner W, 1998, PAIN, V76, P71, DOI 10.1016/S0304-3959(98)00028-1; McCombe A, 2001, CLIN OTOLARYNGOL, V26, P388, DOI 10.1046/j.1365-2273.2001.00490.x; MOLLER AR, 1992, LARYNGOSCOPE, V102, P1165; Nebel MB, 2010, J PAIN, V11, P1083, DOI 10.1016/j.jpain.2010.02.021; Newman C W, 1998, J Am Acad Audiol, V9, P153; NEWMAN CW, 1995, ANN OTO RHINOL LARYN, V104, P718, DOI 10.1177/000348949510400910; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Robinson Shannon K, 2003, Int Tinnitus J, V9, P97; Sanchez TG, 2007, ANN OTO RHINOL LARYN, V116, P30, DOI 10.1177/000348940711600106; Sanchez TG, 2011, TEXTBOOK OF TINNITUS, P363, DOI 10.1007/978-1-60761-145-5_43; Schiffman E, 2014, J ORAL FACIAL PAIN H, V28, P6, DOI 10.11607/jop.1151; Seidman M D, 1999, Ear Nose Throat J, V78, P292; Shore SE, 2008, EUR J NEUROSCI, V27, P155, DOI 10.1111/j.1460-9568.2007.05983.x; Shore SE, 2005, EUR J NEUROSCI, V21, P3334, DOI 10.1111/j.1460-9568.2005.04142.x; Shore SE, 2000, J COMP NEUROL, V419, P271, DOI 10.1002/(SICI)1096-9861(20000410)419:3<271::AID-CNE1>3.0.CO;2-M; Shore S, 2007, PROG BRAIN RES, V166, P107, DOI 10.1016/S0079-6123(07)66010-5; Simmons Richard, 2008, Seminars in Hearing, V29, P361, DOI 10.1055/s-0028-1095895; SPECULAND B, 1984, COMMUNITY DENT ORAL, V12, P197, DOI 10.1111/j.1600-0528.1984.tb01439.x; Vielsmeier V, 2012, PLOS ONE, V7; Vielsmeier V, 2011, OTOLARYNG HEAD NECK, V145, P748, DOI 10.1177/0194599811413376; Won JY, 2013, AUDIOL NEURO-OTOL, V18, P261, DOI 10.1159/000351685; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030	48	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0126254	10.1371/journal.pone.0126254	http://dx.doi.org/10.1371/journal.pone.0126254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996779	Green Published, Green Accepted, gold			2022-12-26	WOS:000356444000019
J	Zeng, Q; Shi, LL; Wen, L; Chen, JZ; Duo, HR; Lei, GC				Zeng, Qing; Shi, Linlu; Wen, Li; Chen, Junzhu; Duo, Hairui; Lei, Guangchun			Gravel Bars Can Be Critical for Biodiversity Conservation: A Case Study on Scaly-Sided Merganser in South China	PLOS ONE			English	Article							GROUP-SIZE; MERGUS-SQUAMATUS; HABITAT EDGES; DISTURBANCE; BIRDS; ABUNDANCE; RESPONSES; RICHNESS; ECOLOGY; MODELS	Gravel bars are characteristic components of river landscapes and are increasingly recognized as key sites for many waterbirds, though detailed studies on the ecological function of gravel bars for waterbirds are rare. In this study, we surveyed the endangered Scaly-sided Merganser Mergus squamatus along a 40 km river section of Yuan River, in Central China, for three consecutive winters. We derived the landscape metrics of river gravel bars from geo-rectified fine resolution (0.6 m) aerial image data. We then built habitat suitability models (Generalized Linear Models-GLMs) to study the effects of landscape metrics and human disturbance on Scaly-sided Merganser presence probability. We found that 1) the Scaly-sided Merganser tended to congregate at river segments with more gravel patches; 2) the Scaly-sided Merganser preferred areas with larger and more contiguous gravel patches; and 3) the number of houses along the river bank (a proxy for anthropogenic disturbance) had significantly negative impacts on the occurrence of the Scaly-sided Merganser. Our results suggest that gravel bars are vital to the Scaly-sided Merganser as shelters from disturbance, as well as sites for feeding and roosting. Therefore, maintaining the exposure of gravel bars in regulated rivers during the low water period in winter might be the key for the conservation of the endangered species. These findings have important implications for understanding behavioral evolution and distribution of the species and for delineating between habitats of different quality for conservation and management.	[Zeng, Qing; Shi, Linlu; Chen, Junzhu; Duo, Hairui; Lei, Guangchun] Beijing Forestry Univ, Sch Nat Conservat, Beijing 100083, Peoples R China; [Wen, Li] NSW Off Environm & Heritage, Water Wetlands & Coasts Sci, Sydney, NSW 2001, Australia	Beijing Forestry University; Office of Environment & Heritage - New South Wales	Lei, GC (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing 100083, Peoples R China.	guangchun8099@gmail.com	ZENG, Qing/V-9563-2019; Guangchun, Lei/ABC-8081-2021	WEN, LI/0000-0003-3783-3826; Zeng, Qing/0000-0002-7471-4941	National Basic Research Program of China (973 Program) [2009CB421103, 2012CB417005]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by National Basic Research Program of China (973 Program) (No. 2009CB421103 & No. 2012CB417005). GL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Barter M, 2014, BIRD CONSERV INT, V24, P406, DOI 10.1017/S0959270913000622; Barton K., 2012, MUMIN MULTIMODEL INF; Beauchamp G, 1998, BIOL REV, V73, P449, DOI 10.1017/S0006323198005246; Belsley D.A., 2005, REGRESSION DIAGNOSTI; BirdLife International, 2012, MERG SQUAM; BirdLife International, 2001, THREAT BIRDS AS BIRD; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CARACO T, 1979, ECOLOGY, V60, P611, DOI 10.2307/1936081; Church M, 2008, DEV EARTH S, V11, P3, DOI 10.1016/S0928-2025(07)11111-1; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Embling CB, 2010, BIOL CONSERV, V143, P267, DOI 10.1016/j.biocon.2009.09.005; Garcia XF, 2012, HYDROBIOLOGIA, V685, P49, DOI 10.1007/s10750-011-0905-z; Gilvear D, 2008, DEV EARTH S, V11, P677, DOI 10.1016/S0928-2025(07)11154-8; He Fen-Qi, 2006, Chinese Journal of Zoology, V41, P52; He FQ, 2002, WATERBIRDS, V25, P462, DOI 10.1675/1524-4695(2002)025[0462:SOTSMW]2.0.CO;2; Helzer CJ, 1999, ECOL APPL, V9, P1448; Hendrickx J, 2008, PERTURB TOOLS EVALUA; HUNT GL, 1972, ECOLOGY, V53, P1051, DOI 10.2307/1935417; Ikuta LA, 2003, BIOL CONSERV, V112, P447, DOI 10.1016/S0006-3207(02)00324-5; Li ZW, 2014, QUATERN INT, V336, P73, DOI 10.1016/j.quaint.2013.12.039; MA, MILL ASS REP 2005; MADSEN J, 1995, IBIS, V137, pS67, DOI 10.1111/j.1474-919X.1995.tb08459.x; Martin AD, 2011, J STAT SOFTW, V42, P1; McGarigal K., FRAGSTATS SPATIAL PA; McGarigal K., SPATIAL PATTERN ANAL; MURKIN HR, 1982, CAN J ZOOL, V60, P2324, DOI 10.1139/z82-299; Naiman RJ, 2000, BIOSCIENCE, V50, P996, DOI 10.1641/0006-3568(2000)050[0996:REAMIT]2.0.CO;2; Nakamura F, 2008, DEV EARTH S, V11, P501, DOI 10.1016/S0928-2025(07)11141-X; Osmundson DB, 2002, ECOL APPL, V12, P1719, DOI 10.1890/1051-0761(2002)012[1719:FSBRIF]2.0.CO;2; R Core Team, 2012, R LANG ENV STAT COMP; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; RIITTERS KH, 1995, LANDSCAPE ECOL, V10, P23, DOI 10.1007/BF00158551; ROBBINS SH, 2004, THESIS U RHODE ISLAN; Sabo JL, 2005, ECOLOGY, V86, P56, DOI 10.1890/04-0668; Sanford JP, 2007, THESIS U MONTANA; Saura S, 2002, INT J REMOTE SENS, V23, P4853, DOI 10.1080/01431160110114493; Schlossberg S, 2008, ECOL APPL, V18, P1325, DOI 10.1890/08-0020.1; Schummer ML, 2003, J WILDLIFE MANAGE, V67, P789, DOI 10.2307/3802686; Selgrath JC, 2007, J EXP MAR BIOL ECOL, V353, P253, DOI 10.1016/j.jembe.2007.09.012; Shao MQ, 2012, PAK J ZOOL, V44, P503; Solovieva D. V., 2002, Wildfowl, V53, P205; Solovyeva DV, 2014, BIRD CONSERV INT, V24, P393, DOI 10.1017/S0959270913000610; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; Torras O, 2008, BIODIVERS CONSERV, V17, P1227, DOI 10.1007/s10531-007-9277-0; Tracy-Smith EK., 2006, THESIS U MISSOURI CO; Venables WN., 2002, MODERN APPL STAT S 4; Ward JV, 1998, BIOL CONSERV, V83, P269, DOI 10.1016/S0006-3207(97)00083-9; Wishart D, 2008, GEOMORPHOLOGY, V94, P131, DOI 10.1016/j.geomorph.2007.05.003; Zeng Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117307; Zhao Zhengjie, 1998, Forktail, V14, P76	52	13	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127387	10.1371/journal.pone.0127387	http://dx.doi.org/10.1371/journal.pone.0127387			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996671	gold, Green Published, Green Submitted			2022-12-26	WOS:000356444000059
J	Zhang, Y; Jia, Q; Prins, HHT; Cao, L; de Boer, WF				Zhang, Yong; Jia, Qiang; Prins, Herbert H. T.; Cao, Lei; de Boer, Willem Fred			Individual-Area Relationship Best Explains Goose Species Density in Wetlands	PLOS ONE			English	Article							HUMAN DISTURBANCE; HABITAT HETEROGENEITY; MAMMALIAN HERBIVORES; POPULATION-DENSITY; AFRICAN ELEPHANT; FORAGE QUALITY; BARNACLE GEESE; BODY-MASS; DIVERSITY; SELECTION	Explaining and predicting animal distributions is one of the fundamental objectives in ecology and conservation biology. Animal habitat selection can be regulated by top-down and bottom-up processes, and is mediated by species interactions. Species varying in body size respond differently to top-down and bottom-up determinants, and hence understanding these allometric responses to those determinants is important for conservation. In this study, using two differently sized goose species wintering in the Yangtze floodplain, we tested the predictions derived from three different hypotheses (individual-area relationship, food resource and disturbance hypothesis) to explain the spatial and temporal variation in densities of two goose species. Using Generalized Linear Mixed Models with a Markov Chain Monte Carlo technique, we demonstrated that goose density was positive correlated with patch area size, suggesting that the individual area-relationship best predicts differences in goose densities. Moreover, the other predictions, related to food availability and disturbance, were not significant. Buffalo grazing probably facilitated greater white-fronted geese, as the number of buffalos was positively correlated to the density of this species. We concluded that patch area size is the most important factor determining the density of goose species in our study area. Patch area size is directly determined by water levels in the Yangtze floodplain, and hence modifying the hydrological regimes can enlarge the capacity of these wetlands for migratory birds.	[Zhang, Yong; Prins, Herbert H. T.; de Boer, Willem Fred] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Zhang, Yong; Jia, Qiang] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China; [Cao, Lei] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China	Wageningen University & Research; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Cao, L (corresponding author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China.	leicao@rcees.ac.cn		Prins, Herbert/0000-0003-1131-5107	National Basic Research Program of China (973 Program) [2012CB956104]; National Natural Science Foundation of China [31370416]; CAS-KNAW Joint PhD Training Programme	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS-KNAW Joint PhD Training Programme	National Basic Research Program of China (973 Program, Grant No. 2012CB956104), www.nsfc.gov.cn, LC; National Natural Science Foundation of China (Grant No. 31370416), www.nsfc.gov.cn, LC; CAS-KNAW Joint PhD Training Programme, www.knaw.nl, YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker ES, 2009, BASIC APPL ECOL, V10, P141, DOI 10.1016/j.baae.2007.10.009; BAZZAZ FA, 1975, ECOLOGY, V56, P485, DOI 10.2307/1934981; Bell RHV., 1970, THE USE OF THE HERB; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Blumstein DT, 2005, J APPL ECOL, V42, P943, DOI 10.1111/j.1365-2664.2005.01071.x; Bos D, 2004, OIKOS, V107, P485, DOI 10.1111/j.0030-1299.2004.13273.x; Boyd DS, 2006, INT J REMOTE SENS, V27, P2631, DOI 10.1080/01431160600554348; Cao L, 2008, BIOL CONSERV, V141, P2301, DOI 10.1016/j.biocon.2008.06.022; Cao Lei, 2011, Chinese Birds, V2, P1; Connor EF, 2000, ECOLOGY, V81, P734, DOI 10.2307/177373; Cromsigt JPGM, 2009, DIVERS DISTRIB, V15, P513, DOI 10.1111/j.1472-4642.2008.00554.x; de Boer WF, 2013, BIOL CONSERV, V159, P468, DOI 10.1016/j.biocon.2012.10.015; de Boer WF, 2011, AMBIO, V40, P68, DOI 10.1007/s13280-010-0088-2; Durant D, 2003, J ANIM ECOL, V72, P220, DOI 10.1046/j.1365-2656.2003.00689.x; Farnsworth KD, 2002, AM NAT, V159, P24, DOI 10.1086/324114; Fernandez-Juricic E, 2000, BIRD STUDY, V47, P13, DOI 10.1080/00063650009461156; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Garcia-Morales R, 2013, CONSERV BIOL, V27, P1096, DOI 10.1111/cobi.12099; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Heuermann N, 2011, OECOLOGIA, V166, P659, DOI 10.1007/s00442-010-1894-8; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Koh CN, 2006, DIVERS DISTRIB, V12, P546, DOI 10.1111/j.1366-9516.2006.00238.x; KREBS CJ, 1995, SCIENCE, V269, P1112, DOI 10.1126/science.269.5227.1112; Laca EA, 2010, ECOL LETT, V13, P311, DOI 10.1111/j.1461-0248.2009.01423.x; Lepczyk CA, 2008, CONSERV BIOL, V22, P405, DOI 10.1111/j.1523-1739.2008.00881.x; Loe LE, 2007, BIOL LETTERS, V3, P109, DOI 10.1098/rsbl.2006.0571; Matthew M.W., 2000, AEROSENSE 2000; Meager JJ, 2012, DIVERS DISTRIB, V18, P294, DOI 10.1111/j.1472-4642.2011.00873.x; Murray CG, 2013, HYDROBIOLOGIA, V716, P131, DOI 10.1007/s10750-013-1558-x; Olff H, 2002, NATURE, V415, P901, DOI 10.1038/415901a; Palomino D, 2007, BIOL CONSERV, V140, P100, DOI 10.1016/j.biocon.2007.07.029; Pretorius Y, 2012, OIKOS, V121, P2110, DOI 10.1111/j.1600-0706.2012.19680.x; Prins HH., 1996, ECOLOGY AND BEHAVIOU; RAPPOLDT C, 1985, ARDEA, V73, P13; Reiter ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081029; RISCH SJ, 1981, ECOLOGY, V62, P1325, DOI 10.2307/1937296; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Rosin ZM, 2012, J ORNITHOL, V153, P747, DOI 10.1007/s10336-011-0791-1; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; SCHOTT JR, 1988, REMOTE SENS ENVIRON, V26, P1, DOI 10.1016/0034-4257(88)90116-2; Searle KR, 2005, J ANIM ECOL, V74, P181, DOI 10.1111/j.1365-2656.2005.00911.x; Shipley LA, 2007, OIKOS, V116, P1964, DOI 10.1111/j.2007.0030-1299.15974.x; Si YL, 2011, ARDEA, V99, P217, DOI 10.5253/078.099.0212; Skorka P, 2009, LANDSCAPE ECOL, V24, P599, DOI 10.1007/s10980-009-9333-0; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tombre IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071912; Van der Wal R, 2000, OECOLOGIA, V123, P108, DOI 10.1007/s004420050995; van Langevelde F, 2008, ECOL MODEL, V213, P273, DOI 10.1016/j.ecolmodel.2007.12.009; Van Wieren SE, 1998, EFFECTS LARGE HERBIV, P185; Wilmshurst JF, 2000, P ROY SOC B-BIOL SCI, V267, P345, DOI 10.1098/rspb.2000.1007; Xu C, 2014, GLOBAL ECOL BIOGEOGR, V23, P436, DOI 10.1111/geb.12108; YDENBERG RC, 1981, J APPL ECOL, V18, P443, DOI 10.2307/2402405; Zhang J, 2013, J BIOGEOGR, V40, P1131, DOI 10.1111/jbi.12063	54	12	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0124972	10.1371/journal.pone.0124972	http://dx.doi.org/10.1371/journal.pone.0124972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996502	Green Published, Green Submitted, gold			2022-12-26	WOS:000356444000007
J	Davis, RA; Doherty, TS				Davis, Robert A.; Doherty, Tim S.			Rapid Recovery of an Urban Remnant Reptile Community following Summer Wildfire	PLOS ONE			English	Article							SMALL MAMMALS; BODY-SIZE; FIRE; HABITAT; BIODIVERSITY; MANAGEMENT; RESPONSES; FRAGMENTATION; DISTURBANCE; WOODLANDS	Reptiles in urban remnants are threatened with extinction by increased fire frequency, habitat fragmentation caused by urban development, and competition and predation from exotic species. Understanding how urban reptiles respond to and recover from such disturbances is key to their conservation. We monitored the recovery of an urban reptile community for five years following a summer wildfire at Kings Park in Perth, Western Australia, using pitfall trapping at five burnt and five unburnt sites. The reptile community recovered rapidly following the fire. Unburnt sites initially had higher species richness and total abundance, but burnt sites rapidly converged, recording a similar total abundance to unburnt areas within two years, and a similar richness within three years. The leaf-litter inhabiting skink Hemiergis quadrilineata was strongly associated with longer unburnt sites and may be responding to the loss of leaf litter following the fire. Six rarely-captured species were also strongly associated with unburnt areas and were rarely or never recorded at burnt sites, whereas two other rarely-captured species were associated with burnt sites. We also found that one lizard species, Ctenotus fallens, had a smaller average body length in burnt sites compared to unburnt sites for four out of the five years of monitoring. Our study indicates that fire management that homogenises large areas of habitat through frequent burning may threaten some species due to their preference for longer unburnt habitat. Careful management of fire may be needed to maximise habitat suitability within the urban landscape.	[Davis, Robert A.; Doherty, Tim S.] Edith Cowan Univ, Sch Nat Sci, Joondalup, WA, Australia; [Davis, Robert A.] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia	Edith Cowan University; University of Western Australia	Davis, RA (corresponding author), Edith Cowan Univ, Sch Nat Sci, Joondalup, WA, Australia.	robert.davis@ecu.edu.au	Doherty, Tim S./G-9354-2015; Davis, Robert/F-6621-2012	Doherty, Tim S./0000-0001-7745-0251; Davis, Robert/0000-0002-9062-5754	Botanic Gardens and Park Authority;  [G0002800]	Botanic Gardens and Park Authority; 	The project was funded by a grant to ECU (CI was RAD) over 5 years. ECU funding number G0002800. The funding source was the Botanic Gardens and Park Authority http://www.bgpa.wa.gov.au. The sponsors provided vegetation data for our analyses and provided some assistance with checking traps, but had no role in the other aspects of data collection, study design, data analysis, decision to publish or preparation of the manuscript.	Anderson L, 2002, AUSTRAL ECOL, V27, P630, DOI 10.1046/j.1442-9993.2002.01224.x; Aronson MFJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3330; Avitabile SC, 2013, LANDSCAPE URBAN PLAN, V117, P81, DOI 10.1016/j.landurbplan.2013.04.017; Baker PJ, 2003, MAMMAL REV, V33, P95, DOI 10.1046/j.1365-2907.2003.00003.x; Bamford M.J., 1995, CALM Science Supplement, V4, P175; BANNISTER P, 1966, J ECOL, V54, P665, DOI 10.2307/2257809; Bureau of Meteorology, 2014, CLIMATE DATA ONLINE; BURROWS ND, 1990, J ENVIRON MANAGE, V31, P229, DOI 10.1016/S0301-4797(05)80036-2; Rodriguez-Caro RC, 2013, EUR J WILDLIFE RES, V59, P911, DOI 10.1007/s10344-013-0764-1; Christie K, 2012, RESTOR ECOL, V20, P740, DOI 10.1111/j.1526-100X.2011.00818.x; Craig MD, 2014, FOREST ECOL MANAG, V318, P142, DOI 10.1016/j.foreco.2014.01.011; Craig MD, 2010, RESTOR ECOL, V18, P300, DOI 10.1111/j.1526-100X.2009.00526.x; Cunningham M, 1998, BIOL CONSERV, V83, P19, DOI 10.1016/S0006-3207(97)00046-3; Davis R. A., 2013, Pacific Conservation Biology, V19, P110; Davis RA, 2013, URBAN ECOSYST, V16, P427, DOI 10.1007/s11252-012-0275-y; Dell J, 1995, BURNING OUR BUSHLAND, P35; Dixon R, 1995, BURNING OUR BUSHLAND, P15; Doherty TS, 2015, INT J WILDLAND FIRE, V24, P534, DOI 10.1071/WF14115; Dorie V, 2014, R PACKAGE VERSION 1; DOUGHTY P, 1994, J HERPETOL, V28, P485, DOI 10.2307/1564962; Doughty P, 2014, CHECKLIST OF THE REP; Driscoll DA, 2008, BIOL CONSERV, V141, P460, DOI 10.1016/j.biocon.2007.10.016; Driscoll DA, 2012, LANDSCAPE ECOL, V27, P829, DOI 10.1007/s10980-012-9734-3; Driscoll DA, 2012, BIODIVERS CONSERV, V21, P1607, DOI 10.1007/s10531-012-0267-5; Driscoll DA, 2010, BIOL CONSERV, V143, P1928, DOI 10.1016/j.biocon.2010.05.026; Elzer AL, 2013, AUSTRAL ECOL, V38, P190, DOI 10.1111/j.1442-9993.2012.02391.x; FRIEND GR, 1993, BIOL CONSERV, V65, P99, DOI 10.1016/0006-3207(93)90439-8; Gardner TA, 2007, BIOL CONSERV, V138, P166, DOI 10.1016/j.biocon.2007.04.017; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Germaine SS, 2001, BIOL CONSERV, V97, P229, DOI 10.1016/S0006-3207(00)00115-4; Gorley C.K., 2006, GETTING STARTED PRIM; Hailey A, 2000, BIOL CONSERV, V92, P321, DOI 10.1016/S0006-3207(99)00099-3; Hellgren EC, 2010, J WILDLIFE MANAGE, V74, P300, DOI 10.2193/2009-090; Hodgson P, 2006, WILDLIFE RES, V33, P591, DOI 10.1071/WR05017; How R., 1994, PACIFIC CONSERVATION, V1, P132; How R. A., 2000, Pacific Conservation Biology, V6, P198; Hu Y, 2013, BIODIVERS CONSERV, V22, P1949, DOI 10.1007/s10531-013-0519-z; Jennings WB, 1999, HERPETOLOGICA, V55, P352; LACY RC, 1995, BIOL CONSERV, V73, P131, DOI 10.1016/0006-3207(95)91940-Y; Letnic M, 2004, J ARID ENVIRON, V59, P85, DOI 10.1016/j.jaridenv.2004.01.014; Lindenmayer DB, 2008, OIKOS, V117, P1086, DOI 10.1111/j.0030-1299.2008.16683.x; Madsen T, 2000, J ANIM ECOL, V69, P952, DOI 10.1046/j.1365-2656.2000.00477.x; McChesney C, 2011, UNPUBLISHED REPORT; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Nimmo DG, 2012, GLOBAL ECOL BIOGEOGR, V21, P1062, DOI 10.1111/j.1466-8238.2011.00747.x; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Ramalho CE, 2014, ECOLOGY, V95, P2466, DOI 10.1890/13-1239.1; Robinson NM, 2013, J APPL ECOL, V50, P1321, DOI 10.1111/1365-2664.12153; Russell KR, 1999, WILDLIFE SOC B, V27, P374; Santos X, 2013, BIOL CONSERV, V168, P90, DOI 10.1016/j.biocon.2013.09.008; Santos-Silva J, 2009, CEP DISCUSSION PAPER; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith Annabel, 2012, Herpetology Notes, V5, P233; Smith AL, 2013, J APPL ECOL, V50, P1178, DOI 10.1111/1365-2664.12119; Snep RPH, 2006, BIOL CONSERV, V127, P345, DOI 10.1016/j.biocon.2005.06.034; Stenhouse RN, 2004, LANDSCAPE URBAN PLAN, V68, P389, DOI 10.1016/S0169-2046(03)00151-8; Valentine LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034448; Valentine LE, 2009, CONSERV BIOL, V23, P103, DOI 10.1111/j.1523-1739.2008.01074.x; Wall M, 2013, ASIAN HERPETOL RES, V4, P9, DOI 10.3724/SP.J.1245.2013.00009; Wikelski M, 1997, ECOLOGY, V78, P2204, DOI 10.2307/2265956; Wilson BA, 2001, WILDLIFE RES, V28, P527, DOI 10.1071/WR00016; Wilson Barbara A., 2014, Pacific Conservation Biology, V20, P57; Zhao MY, 2010, NEURAL COMPUT, V22, P1231, DOI 10.1162/neco.2010.03-09-982	64	17	18	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127925	10.1371/journal.pone.0127925	http://dx.doi.org/10.1371/journal.pone.0127925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992802	Green Published, Green Submitted, gold			2022-12-26	WOS:000354921400140
J	Nieuwenhuizen, RPJ; Bates, M; Szymborska, A; Lidke, KA; Rieger, B; Stallinga, S				Nieuwenhuizen, Robert P. J.; Bates, Mark; Szymborska, Anna; Lidke, Keith A.; Rieger, Bernd; Stallinga, Sjoerd			Quantitative Localization Microscopy: Effects of Photophysics and Labeling Stoichiometry	PLOS ONE			English	Article							SINGLE-MOLECULE; SUPERRESOLUTION MICROSCOPY; RESOLUTION; FLUOROPHORES	Quantification in localization microscopy with reversibly switchable fluorophores is severely hampered by the unknown number of switching cycles a fluorophore undergoes and the unknown stoichiometry of fluorophores on a marker such as an antibody. We overcome this problem by measuring the average number of localizations per fluorophore, or generally per fluorescently labeled site from the build-up of spatial image correlation during acquisition. To this end we employ a model for the interplay between the statistics of activation, bleaching, and labeling stoichiometry. We validated our method using single fluorophore labeled DNA oligomers and multiple-labeled neutravidin tetramers where we find a counting error of less than 17% without any calibration of transition rates. Furthermore, we demonstrated our quantification method on nanobody- and antibody-labeled biological specimens.	[Nieuwenhuizen, Robert P. J.; Rieger, Bernd; Stallinga, Sjoerd] Delft Univ Technol, Quantitat Imaging Grp, Delft, Netherlands; [Bates, Mark] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany; [Szymborska, Anna] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69012 Heidelberg, Germany; [Lidke, Keith A.] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA	Delft University of Technology; Max Planck Society; European Molecular Biology Laboratory (EMBL); University of New Mexico	Rieger, B (corresponding author), Delft Univ Technol, Quantitat Imaging Grp, Delft, Netherlands.	b.rieger@tudelft.nl; s.stallinga@tudelft.nl	Sauer, Markus/C-4378-2017	Sauer, Markus/0000-0002-1692-3219; Nieuwenhuizen, Robert/0000-0003-0243-1173; Szymborska-Mell, Anna/0000-0003-1741-4106	Dutch Technology Foundation STW, Netherlands Organisation for Scientific Research (NWO) - Ministry of Economic Affairs, Agriculture and Innovation; US National Science Foundation CAREER Award [0954836]; US National Institutes of Health [P50GM085273]; Direct For Mathematical & Physical Scien [0954836] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085273] Funding Source: NIH RePORTER	Dutch Technology Foundation STW, Netherlands Organisation for Scientific Research (NWO) - Ministry of Economic Affairs, Agriculture and Innovation; US National Science Foundation CAREER Award(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R.P.J.N. is supported by the Dutch Technology Foundation STW (http://www.stw.nl/), which is part of the Netherlands Organisation for Scientific Research (NWO), which is partly funded by the Ministry of Economic Affairs, Agriculture and Innovation. K.A.L. was supported by US National Science Foundation CAREER Award #0954836 (http://www.nsf.gov) and US National Institutes of Health grant P50GM085273 (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibale P, 2011, NAT METHODS, V8, P527, DOI 10.1038/nmeth.1627; Bates M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108101; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Bates M, 2012, CHEMPHYSCHEM, V13, P99, DOI 10.1002/cphc.201100735; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bollmann S, 2011, PHYS CHEM CHEM PHYS, V13, P12874, DOI 10.1039/c1cp21111k; Bui KH, 2013, CELL, V155, P1233, DOI 10.1016/j.cell.2013.10.055; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Durisic N, 2014, NAT METHODS, V11, P156, DOI [10.1038/NMETH.2784, 10.1038/nmeth.2784]; Ehmann N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5650; Espinoza FA, 2012, B MATH BIOL, V74, P190, DOI 10.1007/s11538-011-9671-3; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Grussmayer KS, 2014, CHEMPHYSCHEM, V15, P734, DOI 10.1002/cphc.201300840; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang F, 2011, BIOMED OPT EXPRESS, V2, P1377, DOI 10.1364/BOE.2.001377; Kask P, 2000, BIOPHYS J, V78, P1703, DOI 10.1016/S0006-3495(00)76722-1; Lando D, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120078; Lee SH, 2012, P NATL ACAD SCI USA, V109, P17436, DOI 10.1073/pnas.1215175109; Mlodzianoski MJ, 2011, OPT EXPRESS, V19, P15009, DOI 10.1364/OE.19.015009; Nan XL, 2013, P NATL ACAD SCI USA, V110, P18519, DOI 10.1073/pnas.1318188110; Nieuwenhuizen RPJ, 2013, NAT METHODS, V10, P557, DOI [10.1038/nmeth.2448, 10.1038/NMETH.2448]; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Puchner EM, 2013, P NATL ACAD SCI USA, V110, P16015, DOI 10.1073/pnas.1309676110; Rawls H.R., 1965, PURE APPL CHEM, V11, P371, DOI [10.1351/pac196511030371, 10.1002/anie.201002307]; Rosch U., 2006, ANGEW CHEM, V118, P7184, DOI [10.1002/ange.200602286, DOI 10.1002/ANGE.200602286]; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Szymborska A, 2013, SCIENCE, V341, P655, DOI 10.1126/science.1240672; Veatch SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031457; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Wang SY, 2014, P NATL ACAD SCI USA, V111, P8452, DOI 10.1073/pnas.1406593111	34	40	40	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0127989	10.1371/journal.pone.0127989	http://dx.doi.org/10.1371/journal.pone.0127989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992915	Green Submitted, Green Published, gold			2022-12-26	WOS:000354921400141
J	Roques, A; Fan, JT; Courtial, B; Zhang, YZ; Yart, A; Auger-Rozenberg, MA; Denux, O; Kenis, M; Baker, R; Sun, JH				Roques, Alain; Fan, Jian-ting; Courtial, Beatrice; Zhang, Yan-zhuo; Yart, Annie; Auger-Rozenberg, Marie-Anne; Denux, Olivier; Kenis, Marc; Baker, Richard; Sun, Jiang-Hua			Planting Sentinel European Trees in Eastern Asia as a Novel Method to Identify Potential Insect Pest Invaders	PLOS ONE			English	Article							EMERALD ASH BORER; BIOLOGICAL INVASIONS; NATURAL ENEMIES; ACCUMULATION; PATHWAYS; ESCAPE; TRADE; RISK	Quarantine measures to prevent insect invasions tend to focus on well-known pests but a large proportion of the recent invaders were not known to cause significant damage in their native range, or were not even known to science before their introduction. A novel method is proposed to detect new potential pests of woody plants in their region of origin before they are introduced to a new continent. Since Asia is currently considered to be the main supplier of insect invaders to Europe, sentinel trees were planted in China during 20072011 as an early warning tool to identify the potential for additional Asian insect species to colonize European trees. Seedlings (1-1.5 m tall) of five broadleaved (Quercus petraea, Q. suber, Q. ilex, Fagus sylvatica, and Carpinus betulus) and two conifer species (Abies alba and Cupressus sempervirens) were planted in blocks of 100 seedlings at two widely separated sites (one in a nursery near Beijing and the other in a forest environment near Fuyang in eastern China), and then regularly surveyed for colonization by insects. A total of 104 insect species, mostly defoliators, were observed on these new hosts, and at least six species were capable of larval development. Although a number of the insects observed were probably incidental feeders, 38 species had more than five colonization events, mostly infesting Q. petraea, and could be considered as being capable of switching to European trees if introduced to Europe. Three years was shown to be an appropriate duration for the experiment, since the rate of colonization then tended to plateau. A majority of the identified species appeared to have switched from agricultural crops and fruit trees rather than from forest trees. Although these results are promising, the method is not appropriate for xylophagous pests and other groups developing on larger trees. Apart from the logistical problems, the identification to species level of the specimens collected was a major difficulty. This situation could be improved by the development of molecular databases.	[Roques, Alain; Courtial, Beatrice; Yart, Annie; Auger-Rozenberg, Marie-Anne; Denux, Olivier] INRA, UR Zool Forestiere 633, Orleans, France; [Fan, Jian-ting] Zhejiang Agr & Forestry Univ, Sch Forestry & Biotechnol, Linan, Peoples R China; [Zhang, Yan-zhuo; Sun, Jiang-Hua] Chinese Acad Sci, Inst Zool, State key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Kenis, Marc] CABI, Delemont, Switzerland; [Baker, Richard] Dept Environm Food & Rural Affairs, York, N Yorkshire, England	INRAE; Zhejiang A&F University; Chinese Academy of Sciences; Institute of Zoology, CAS	Roques, A (corresponding author), INRA, UR Zool Forestiere 633, Orleans, France.	alain.roques@orleans.inra.fr		sun, jianghua/0000-0002-9465-3672; Courtial, Beatrice/0000-0001-9757-5131	EU project ALARM (Assessing large-scale environmental risks with tested methods) [GOCE-CT-2003-506675]; EU project PRATIQUE (Enhancements of pest risk analysis techniques) [KBBE-2007-212459]; EU project ISEFOR (Increasing Sustainability of European Forests: Modelling for Security Against Invasive Pests and Pathogens under Climate Change-collaborative project) [245268]; EU COST project PERMIT (Pathway Evaluation and pest Risk Management In Transport) [FP1002-181110-06882]; EU COST project GLOBAL WARNING (A global network of nurseries as early warning system against alien tree pests) [FP1401]; National Forestry Industry Research Special Funds for Public Welfare Projects in China [20130440]	EU project ALARM (Assessing large-scale environmental risks with tested methods); EU project PRATIQUE (Enhancements of pest risk analysis techniques); EU project ISEFOR (Increasing Sustainability of European Forests: Modelling for Security Against Invasive Pests and Pathogens under Climate Change-collaborative project); EU COST project PERMIT (Pathway Evaluation and pest Risk Management In Transport); EU COST project GLOBAL WARNING (A global network of nurseries as early warning system against alien tree pests); National Forestry Industry Research Special Funds for Public Welfare Projects in China	The authors greatly acknowledge the financial support for this work from the EU projects ALARM (Assessing large-scale environmental risks with tested methods-GOCE-CT-2003-506675), PRATIQUE (Enhancements of pest risk analysis techniques; KBBE-2007-212459), and ISEFOR (Increasing Sustainability of European Forests: Modelling for Security Against Invasive Pests and Pathogens under Climate Change-collaborative project 245268). The EU COST projects PERMIT (Pathway Evaluation and pest Risk Management In Transport-FP1002-181110-06882) and GLOBAL WARNING (A global network of nurseries as early warning system against alien tree pests- FP1401) allowed fruitful discussions about the project design and results. JT Fan was also supported by a grant from National Forestry Industry Research Special Funds for Public Welfare Projects (20130440) in China.	[Anonymous], 2012, EVOL BIOINFORM, V8, P1, DOI 10.4137/EBO.S8532; Aukema JE, 2010, BIOSCIENCE, V60, P886, DOI 10.1525/bio.2010.60.11.5; Baranchikov Y., 2008, Bulletin OEPP, V38, P233, DOI 10.1111/j.1365-2338.2008.01210.x; Blank SM, 2010, EUR J ENTOMOL, V107, P357, DOI 10.14411/eje.2010.045; Britton Kerry O., 2010, New Zealand Journal of Forestry Science, V40, P109; Brown KA, 2008, J APPL ECOL, V45, P1639, DOI 10.1111/j.1365-2664.2008.01550.x; Bunnell DB, 2009, J GREAT LAKES RES, V35, P74, DOI 10.1016/j.jglr.2008.10.002; Burgman M., 2005, RISKS DECISIONS CONS; CABI, 2003, CROP PROTECTION COMP; Cheong Y. L., 2010, Journal of Entomology, V7, P141, DOI 10.3923/je.2010.141.151; CONNOR EF, 1980, ECOL ENTOMOL, V5, P205, DOI 10.1111/j.1365-2311.1980.tb01143.x; Cooke DEL, 2007, MOL ECOL, V16, P3735, DOI 10.1111/j.1365-294X.2007.03430.x; DAISIE, 2009, HDB ALIEN SPECIES EU, DOI [10.1007/978-1-4020-8280-1, DOI 10.1007/978-1-4020-8280-1]; Eom KC, 2006, ANN RES REPORT 2005; Eschen R, 2014, FOREST ECOL MANAG, V315, P103, DOI 10.1016/j.foreco.2013.12.021; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Food and Agriculture Organization of the United Nations, 2004, PEST RISK AN QUAR PE; Genovesi P., 2007, CONV CONS EUR WILDL; Groenteman R, 2015, BIOL INVASIONS, V17, P1299, DOI 10.1007/s10530-014-0804-0; Haack RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096611; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hara H, 2013, APPL ENTOMOL ZOOL, V48, P379, DOI 10.1007/s13355-013-0198-y; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; International Network for Bamboo and Rattan, 1998, INS PESTS BAMB AS; International Plant Protection Convention, 2007, FRAM PEST RISK AN IS; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kenis Marc, 2010, BioRisk, V4, P51; Kirichenko N, 2013, BIOL INVASIONS, V15, P2105, DOI 10.1007/s10530-013-0436-9; Kriticos DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064479; Laroche A, 1996, BIOL CONTROL, V6, P306, DOI 10.1006/bcon.1996.0039; Legalov A.A., 2007, LEAF ROLLING WEEVILS; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Liebhold AM, 2012, FRONT ECOL ENVIRON, V10, P135, DOI 10.1890/110198; Lopez-Vaamonde C., 2010, BIORISK - Biodiversity and Ecosystem Risk Assessment, P45; McCullough DG, 2006, BIOL INVASIONS, V8, P611, DOI 10.1007/s10530-005-1798-4; Paini DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025695; Paini DR, 2010, J APPL ECOL, V47, P290, DOI 10.1111/j.1365-2664.2010.01782.x; Pimentel D, 2011, BIOLOGICAL INVASIONS: ECONOMIC AND ENVIRONMENTAL COSTS OF ALIEN PLANT, ANIMAL, AND MICROBE SPECIES, 2ND EDITION, P1, DOI 10.1201/b10938; Pugh SA, 2011, CAN J FOREST RES, V41, P2165, DOI [10.1139/X11-138, 10.1139/x11-138]; Roques A, 2006, CAN J FOREST RES, V36, P299, DOI 10.1139/x05-277; Roques Alain, 2010, BioRisk, V4, P11; Roques Alain, 2010, New Zealand Journal of Forestry Science, V40, pS77; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Singh SK, 2014, BIOL INVASIONS, V16, P1515, DOI 10.1007/s10530-013-0588-7; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Theurkar SV, 2013, RES J RECENT SC, V2, P1; Tomoshevich M, 2013, FOREST PATHOL, V43, P345, DOI 10.1111/efp.12036; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Williamson MH, 1996, BIOL CONSERV, V78, P163, DOI 10.1016/0006-3207(96)00025-0; Wittenberg R, 2001, INVASIVE ALIEN SPECI; Wolfe LM, 2002, AM NAT, V160, P705, DOI 10.1086/343872; Worner SP, 2006, J APPL ECOL, V43, P858, DOI 10.1111/j.1365-2664.2006.01202.x; Worner Susan P., 2013, NeoBiota, V18, P83; Yuan F, 1997, ACTA U AGR BOREALI O, V25, P27; Yunus A., 1980, B MINISTRY AGR, V153, P1	58	41	44	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0120864	10.1371/journal.pone.0120864	http://dx.doi.org/10.1371/journal.pone.0120864			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993342	Green Published, Green Submitted, gold			2022-12-26	WOS:000354921400005
J	Soares-Bezerra, RJ; Ferreira, NCD; Alberto, AVP; Bonavita, AG; Fidalgo-Neto, AA; Calheiros, AS; Frutuoso, VD; Alves, LA				Soares-Bezerra, Romulo Jose; da Silva Ferreira, Natiele Carla; Pinto Alberto, Anael Viana; Bonavita, Andre Gustavo; Fidalgo-Neto, Antonio Augusto; Calheiros, Andrea Surrage; Frutuoso, Valber da Silva; Alves, Luiz Anastacio			An Improved Method for P2X7R Antagonist Screening	PLOS ONE			English	Article							P2X(7) RECEPTOR ANTAGONISTS; NATURAL-PRODUCTS; DRUG DISCOVERY; FUTURE; ATP; CHANNEL; INJURY; CELLS	ATP physiologically activates the P2X7 receptor (P2X7R), a member of the P2X ionotropic receptor family. When activated by high concentrations of ATP (i.e., at inflammation sites), this receptor is capable of forming a pore that allows molecules of up to 900 Da to pass through. This receptor is upregulated in several diseases, particularly leukemia, rheumatoid arthritis and Alzheimer's disease. A selective antagonist of this receptor could be useful in the treatment of P2X7R activation-related diseases. In the present study, we have evaluated several parameters using in vitro protocols to validate a high-throughput screening (HTS) method to identify P2X7R antagonists. We generated dose-response curves to determine the EC50 value of the known agonist ATP and the ICs50 values for the known antagonists Brilliant Blue G (BBG) and oxidized ATP (OATP). The values obtained were consistent with those found in the literature (0.7 +/- 0.07 mM, 1.3-2.6 mM and 173-285 mu M for ATP, BBG and OATP, respectively). The Z-factor, an important statistical tool that can be used to validate the robustness and suitability of an HTS assay, was 0.635 for PI uptake and 0.867 for LY uptake. No inter-operator variation was observed, and the results obtained using our improved method were reproducible. Our data indicate that our assay is suitable for the selective and reliable evaluation of P2X7 activity in multiwell plates using spectrophotometry-based methodology. This method might improve the high-throughput screening of conventional chemical or natural product libraries for possible candidate P2X7R antagonist or agonist	[Soares-Bezerra, Romulo Jose; da Silva Ferreira, Natiele Carla; Fidalgo-Neto, Antonio Augusto; Alves, Luiz Anastacio] Fiocruz MS, Inst Oswaldo Cruz, Lab Cellular Commun, BR-21045900 Rio De Janeiro, Brazil; [Bonavita, Andre Gustavo] Univ Fed Rio de Janeiro, Lab Integrated Res, Rio de Janeiro, Brazil; [Calheiros, Andrea Surrage; Frutuoso, Valber da Silva] Fiocruz MS, Inst Oswaldo Cruz, Lab Immunopharmacol, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Alves, LA (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Cellular Commun, BR-21045900 Rio De Janeiro, Brazil.	alveslaa@gmail.com	Bonavita, Andre G/J-3471-2014	Bonavita, Andre G/0000-0003-3618-2478	CNPq; FAPERJ; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by CNPq: US$: 10.000 www.cnpq.br; FAPERJ: US$: 5.000 www.faperj.br; CAPES: US$: 75.000 http://www.capes.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto AVP, 2013, N-S ARCH PHARMACOL, V386, P775, DOI 10.1007/s00210-013-0868-x; Alcaraz L, 2003, BIOORG MED CHEM LETT, V13, P4043, DOI 10.1016/j.bmcl.2003.08.033; Alves LA, 2014, BBA-BIOMEMBRANES, V1838, P2578, DOI 10.1016/j.bbamem.2014.05.015; Bartlett R, 2014, PHARMACOL REV, V66, P638, DOI 10.1124/pr.113.008003; Baxter A, 2003, BIOORG MED CHEM LETT, V13, P4047, DOI 10.1016/j.bmcl.2003.08.034; Bhaskaracharya A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093058; Buchanan MS, 2007, J ORG CHEM, V72, P2309, DOI 10.1021/jo062007q; Burnstock G, 2001, HANDB EXP PHARM, V151, P89; Burnstock G, 2009, BRAZ J MED BIOL RES, V42, P3, DOI 10.1590/S0100-879X2008005000037; Burnstock G., 2009, Autonomic & Autacoid Pharmacology, V29, P63, DOI 10.1111/j.1474-8673.2009.00435.x; Burnstock G, 2008, NAT REV DRUG DISCOV, V7, P575, DOI 10.1038/nrd2605; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Cankurtaran-Sayar S, 2009, MOL PHARMACOL, V76, P1323, DOI 10.1124/mol.109.059923; Cascabulho CM, 2008, PARASITOL RES, V103, P829, DOI 10.1007/s00436-008-1063-8; Chong JH, 2010, BIOCHEM BIOPH RES CO, V391, P498, DOI 10.1016/j.bbrc.2009.11.087; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Coutinho-Silva R, 1997, AM J PHYSIOL-CELL PH, V273, pC1793, DOI 10.1152/ajpcell.1997.273.6.C1793; Gorodeski GI, 2009, EXPERT OPIN THER TAR, V13, P1313, DOI 10.1517/14728220903277249; Gunosewoyo H, 2010, EXPERT OPIN THER PAT, V20, P625, DOI 10.1517/13543771003702424; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Lister Martin F, 2007, J Inflamm (Lond), V4, P5, DOI 10.1186/1476-9255-4-5; Ludbrook J, 1997, CLIN EXP PHARMACOL P, V24, P193, DOI 10.1111/j.1440-1681.1997.tb01807.x; Mann J, 2002, NAT REV CANCER, V2, P143, DOI 10.1038/nrc723; Michel AD, 2009, BRIT J PHARMACOL, V156, P1312, DOI 10.1111/j.1476-5381.2009.00135.x; Mitchell W, 2011, CURR OPIN CHEM BIOL, V15, P553, DOI 10.1016/j.cbpa.2011.06.005; Muzzachi S, 2013, BIOL CELL, V105, P399, DOI 10.1111/boc.201200088; Namovic Marian T, 2012, Curr Protoc Pharmacol, VChapter 9, DOI 10.1002/0471141755.ph0915s57; Pan SY, 2010, J PHARM PHARM SCI, V13, P450, DOI 10.18433/J39W2G; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Ralevic V, 1998, PHARMACOL REV, V50, P413; Santos JAA, 2011, J MED FOOD, V14, P920, DOI 10.1089/jmf.2010.0184; Takenouchi T, 2010, ARCH IMMUNOL THER EX, V58, P91, DOI 10.1007/s00005-010-0069-y; Taylor SRJ, 2009, J AM SOC NEPHROL, V20, P1275, DOI 10.1681/ASN.2008060559; Virgilio F, 2005, CURRDRUG TARGETSCARD, V5, P85; Williams M, 2000, BIOCHEM PHARMACOL, V59, P1173, DOI 10.1016/S0006-2952(99)00341-X; Williams M, 1996, CIBA F SYMP, V198, P309; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhu F, 2011, P NATL ACAD SCI USA, V108, P12943, DOI 10.1073/pnas.1107336108	39	8	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0123089	10.1371/journal.pone.0123089	http://dx.doi.org/10.1371/journal.pone.0123089			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993132	gold, Green Submitted, Green Published			2022-12-26	WOS:000354918600004
J	Ansong, E; Ying, Q; Ekoue, DN; Deaton, R; Hall, AR; Kajdacsy-Balla, A; Yang, WC; Gann, PH; Diamond, AM				Ansong, Emmanuel; Ying, Qi; Ekoue, Dede N.; Deaton, Ryan; Hall, Andrew R.; Kajdacsy-Balla, Andre; Yang, Wancai; Gann, Peter H.; Diamond, Alan M.			Evidence That Selenium Binding Protein 1 Is a Tumor Suppressor in Prostate Cancer	PLOS ONE			English	Article							GLUTATHIONE-PEROXIDASE; COLORECTAL-CANCER; TISSUE RESOURCE; GLEASON SCORE; CELLS; EXPRESSION; P53; HSP56; 5-FLUOROURACIL; HIF-1-ALPHA	Selenium-Binding Protein 1 (SBP1, SELENBP1, hSP56) is a selenium-associated protein shown to be at lower levels in tumors, and its lower levels are frequently predictive of a poor clinical outcome. Distinguishing indolent from aggressive prostate cancer is a major challenge in disease management. Associations between SBP1 levels, tumor grade, and disease recurrence following prostatectomy were investigated by duplex immunofluorescence imaging using a tissue microarray containing tissue from 202 prostate cancer patients who experienced biochemical (PSA) recurrence after prostatectomy and 202 matched control patients whose cancer did not recur. Samples were matched by age, ethnicity, pathological stage and Gleason grade, and images were quantified using the Vectra multispectral imaging system. Fluorescent labels were targeted for SBP1 and cytokeratins 8/18 to restrict scoring to tumor cells, and cell-by-cell quantification of SBP1 in the nucleus and cytoplasm was performed. Nuclear SBP1 levels and the nuclear to cytoplasm ratio were inversely associated with tumor grade using linear regression analysis. Following classification of samples into quartiles based on the SBP1 levels among controls, tumors in the lowest quartile were more than twice as likely to recur compared to those in any other quartile. Inducible ectopic SBP1 expression reduced the ability of HCT-116 human tumor cells to grow in soft agar, a measure of transformation, without affecting proliferation. Cells expressing SBP1 also demonstrated a robust induction in the phosphorylation of the p53 tumor suppressor at serine 15. These data indicate that loss of SBP1 may play an independent contributing role in prostate cancer progression and its levels might be useful in distinguishing indolent from aggressive disease.	[Ansong, Emmanuel; Ying, Qi; Ekoue, Dede N.; Deaton, Ryan; Kajdacsy-Balla, Andre; Yang, Wancai; Gann, Peter H.; Diamond, Alan M.] Univ Illinois, Dept Pathol, Chicago, IL 60607 USA; [Hall, Andrew R.] Univ Illinois, Chicago, IL USA; [Ying, Qi] Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Ying, Qi; Yang, Wancai] Xinxiang Med Univ, Dept Pathol, Xinxiang, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Nanjing Agricultural University; Xinxiang Medical University	Ansong, E (corresponding author), Univ Illinois, Dept Pathol, Chicago, IL 60607 USA.	Emmanuel.Ansong@gmail.com	Yang, Wancai/O-7655-2019	Yang, Wancai/0000-0001-7437-9197	National Institutes of Health [R01CA127943]; National Natural Science Foundation of China [91229115, 81272251]; NATIONAL CANCER INSTITUTE [R01CA155301, R01CA127943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Institutes of Health (Grant # R01CA127943) to AMD and grants from National Natural Science Foundation of China (Grant # 91229115 and 81272251) to WY.	Ansong E, 2014, MOL NUTR FOOD RES, V58, P117, DOI 10.1002/mnfr.201300543; BANSAL MP, 1989, CARCINOGENESIS, V10, P541, DOI 10.1093/carcin/10.3.541; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; CARROLL AG, 1993, PROSTATE, V23, P123, DOI 10.1002/pros.2990230206; Chen GA, 2004, J PATHOL, V202, P321, DOI 10.1002/path.1524; Davis CD, 2012, ANNU REV NUTR, V32, P73, DOI 10.1146/annurev-nutr-071811-150740; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Fang WF, 2010, CARCINOGENESIS, V31, P1360, DOI 10.1093/carcin/bgq114; Fitzpatrick JM, 2008, BJU INT, V101, P16, DOI 10.1111/j.1464-410X.2007.07487.x; Geybels MS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju003; Huang C, 2012, CLIN CANCER RES, V18, P3042, DOI 10.1158/1078-0432.CCR-12-0183; Huang KC, 2006, INT J CANCER, V118, P2433, DOI 10.1002/ijc.21671; Jeong JY, 2014, BMB REP, V47, P411, DOI 10.5483/BMBRep.2014.47.7.104; Jeong JY, 2009, BIOCHEM BIOPH RES CO, V379, P583, DOI 10.1016/j.bbrc.2008.12.110; Jerome-Morais A, 2012, PROSTATE, V72, P1006, DOI 10.1002/pros.21506; Kaeser MD, 2004, J BIOL CHEM, V279, P7598, DOI 10.1074/jbc.M311732200; Kajdacsy-Balla A, 2007, J MOL HISTOL, V38, P113, DOI 10.1007/s10735-006-9054-5; Kim H, 2006, PROTEOMICS, V6, P3466, DOI 10.1002/pmic.200500629; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Lee SH, 2014, ONCOL REP, V32, P1427, DOI 10.3892/or.2014.3337; Li TH, 2008, MOL NUTR FOOD RES, V52, P1289, DOI 10.1002/mnfr.200700331; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Loughery J, 2014, NUCLEIC ACIDS RES, V42, P7664, DOI 10.1093/nar/gku501; Melamed J, 2004, CLIN CANCER RES, V10, P4614, DOI 10.1158/1078-0432.CCR-04-0240; Mori S, 2009, ONCOGENE, V28, P2796, DOI 10.1038/onc.2009.139; Nguyen CT, 2012, ASIAN J ANDROL, V14, P349, DOI 10.1038/aja.2011.140; Pohl NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007774; Porat A, 2000, J BIOL CHEM, V275, P14457, DOI 10.1074/jbc.275.19.14457; Rayman MP, 2009, BBA-GEN SUBJECTS, V1790, P1533, DOI 10.1016/j.bbagen.2009.03.014; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Stark JR, 2009, J CLIN ONCOL, V27, P3459, DOI 10.1200/JCO.2008.20.4669; WOHLHUETER RM, 1980, J CELL PHYSIOL, V104, P309, DOI 10.1002/jcp.1041040305; Yang MH, 1998, CANCER RES, V58, P3150; Zhang XP, 2011, P NATL ACAD SCI USA, V108, P8990, DOI 10.1073/pnas.1100600108; Zhuo P, 2009, BIOCHIM BIOPHYS ACTA, V115, P227	35	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127295	10.1371/journal.pone.0127295	http://dx.doi.org/10.1371/journal.pone.0127295			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993660	Green Submitted, Green Published, gold			2022-12-26	WOS:000354917300112
J	Wilkinson, DJ; Bethell, GS; Shukla, R; Kenny, SE; Edgar, DH				Wilkinson, David J.; Bethell, George S.; Shukla, Rajeev; Kenny, Simon E.; Edgar, David H.			Isolation of Enteric Nervous System Progenitor Cells from the Aganglionic Gut of Patients with Hirschsprung's Disease	PLOS ONE			English	Article							CREST-DERIVED CELLS; MIGRATION; TRANSPLANTATION; NEUROGENESIS; MULTIPOTENT; GENERATION; NEURONS; ORIGIN; NERVES; COLON	Enteric nervous system progenitor cells isolated from postnatal human gut and cultured as neurospheres can then be transplanted into aganglionic gut to restore normal patterns of contractility. These progenitor cells may be of future use to treat patients with Hirschprung's disease, a congenital condition characterized by hindgut dysmotility due to the lack of enteric nervous system ganglia. Here we demonstrate that progenitor cells can also be isolated from aganglionic gut removed during corrective surgery for Hirschsprung's disease. Although the enteric nervous system marker calretinin is not expressed in the aganglionic gut region, de novo expression is initiated in cultured neurosphere cells isolated from aganglionic Hirschsprung bowel. Furthermore, expression of the neural markers NOS, VIP and GFAP also increased during culture of aganglionic gut neurospheres which we show can be transplantation into cultured embryonic mouse gut explants to restore a normal frequency of contractility. To determine the origin of the progenitor cells in aganglionic region, we used fluorescence-activated cell sorting to demonstrate that only p75-positive neural crest-derived cells present in the thickened nerve trunks characteristic of the aganglionic region of Hirschsprung gut gave rise to neurons in culture. The derivation of enteric nervous system progenitors in the aganglionic gut region of Hirschprung's patients not only means that this tissue is a potential source of cells for future autologous transplantation, but it also raises the possibility of inducing the differentiation of these endogenous cells in situ to compensate for the aganglionosis.	[Wilkinson, David J.; Bethell, George S.; Kenny, Simon E.; Edgar, David H.] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Shukla, Rajeev] Alder Hey Childrens Hosp NHS Fdn Trust, Dept Pathol, Liverpool, Merseyside, England; [Kenny, Simon E.] Alder Hey Childrens Hosp NHS Fdn Trust, Dept Paediat Surg, Liverpool, Merseyside, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust; University of Liverpool; Alder Hey Children's NHS Foundation Trust	Edgar, DH (corresponding author), Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England.	dhedgar@liv.ac.uk		Shukla, Rajeev/0000-0002-1688-8054; Bethell, George/0000-0002-1302-0735; Kenny, Simon/0000-0002-5917-8554; Wilkinson, David/0000-0001-5165-8230	Action Medical Research UK [RTF/1395]; Action Medical Research [1795] Funding Source: researchfish	Action Medical Research UK; Action Medical Research	DJW was supported by a grant RTF/1395 from Action Medical Research UK (www.action.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbareian SE, 2013, DEV BIOL, V382, P446, DOI 10.1016/j.ydbio.2013.08.006; Almond S, 2007, GUT, V56, P489, DOI 10.1136/gut.2006.094565; Barshack I, 2004, J CLIN PATHOL, V57, P712, DOI 10.1136/jcp.2004.016030; BAUMGARTEN HG, 1973, VIRCHOWS ARCH A, V358, P113, DOI 10.1007/BF00548512; Becker L, 2012, AM J PHYSIOL-GASTR L, V302, pG958, DOI 10.1152/ajpgi.00511.2011; Burns AJ, 2014, NAT REV GASTRO HEPAT, V11, P317, DOI 10.1038/nrgastro.2013.226; Dettmann HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097792; Dyachuk V, 2014, SCIENCE, V345, P82, DOI 10.1126/science.1253281; Erickson CS, 2012, J COMP NEUROL, V520, P620, DOI 10.1002/cne.22755; Espinosa-Medina I, 2014, SCIENCE, V345, P87, DOI 10.1126/science.1253286; Heanue TA, 2011, STEM CELLS, V29, P128, DOI 10.1002/stem.557; Hotta R, 2013, J CLIN INVEST, V123, P1182, DOI 10.1172/JCI65963; Joseph NM, 2011, J CLIN INVEST, V121, P3398, DOI 10.1172/JCI58186; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kapur RP, 2009, SEMIN PEDIAT SURG, V18, P212, DOI 10.1053/j.sempedsurg.2009.07.003; Kenny SE, 2010, SEMIN PEDIATR SURG, V19, P194, DOI 10.1053/j.sempedsurg.2010.03.004; KOBAYASHI H, 1994, GUT, V35, P1605, DOI 10.1136/gut.35.11.1605; Kruger GM, 2003, NEURON, V40, P917, DOI 10.1016/S0896-6273(03)00727-X; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; Lindley RM, 2008, GASTROENTEROLOGY, V135, P205, DOI 10.1053/j.gastro.2008.03.035; Lindley RM, 2009, J PEDIATR SURG, V44, P1249, DOI 10.1016/j.jpedsurg.2009.02.048; Liu MT, 2009, J NEUROSCI, V29, P9683, DOI 10.1523/JNEUROSCI.1145-09.2009; Martin I, 2012, STEM CELL REV REP, V8, P1178, DOI 10.1007/s12015-012-9387-2; Miyahara K, 2013, PEDIATR SURG INT, V29, P9, DOI 10.1007/s00383-012-3201-8; Obermayr F, 2013, NAT REV GASTRO HEPAT, V10, P43, DOI 10.1038/nrgastro.2012.234; Sasselli V, 2012, DEV BIOL, V366, P64, DOI 10.1016/j.ydbio.2012.01.012; Solari V, 2003, PEDIATR SURG INT, V19, P349, DOI 10.1007/s00383-003-1009-2; Theocharatos S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054809; Theocharatos S, 2008, EARLY HUM DEV, V84, P801, DOI 10.1016/j.earlhumdev.2008.09.007; Wang X, 2011, GASTROENTEROLOGY, V141, P992, DOI 10.1053/j.gastro.2011.06.002; YNTEMA CL, 1954, J COMP NEUROL, V101, P515, DOI 10.1002/cne.901010212	31	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0125724	10.1371/journal.pone.0125724	http://dx.doi.org/10.1371/journal.pone.0125724			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992739	Green Submitted, Green Published, gold			2022-12-26	WOS:000354917300023
J	Sheehan, KCF; Lazear, HM; Diamond, MS; Schreiber, RD				Sheehan, Kathleen C. F.; Lazear, Helen M.; Diamond, Michael S.; Schreiber, Robert D.			Selective Blockade of Interferon-alpha and -beta Reveals Their Non-Redundant Functions in a Mouse Model of West Nile Virus Infection	PLOS ONE			English	Article							IFN-GAMMA RECEPTOR; I INTERFERON; MONOCLONAL-ANTIBODIES; DENDRITIC CELLS; T-CELLS; ANTIVIRAL RESPONSE; DIRECT STIMULATION; POSITIVE FEEDBACK; VIRAL-INFECTION; B-CELLS	Although type I interferons (IFNs) were first described almost 60 years ago, the ability to monitor and modulate the functional activities of the individual IFN subtypes that comprise this family has been hindered by a lack of reagents. The major type I IFNs, IFN-beta and the multiple subtypes of IFN-alpha, are expressed widely and induce their effects on cells by interacting with a shared heterodimeric receptor (IFNAR). In the mouse, the physiologic actions of IFN-alpha and IFN-beta have been defined using polyclonal anti-type I IFN sera, by targeting IFNAR using monoclonal antibodies or knockout mice, or using Ifnb(-/-) mice. However, the corresponding analysis of IFN-alpha has been difficult because of its polygenic nature. Herein, we describe two monoclonal antibodies (mAbs) that differentially neutralize murine IFN-beta or multiple subtypes of murine IFN-alpha. Using these mAbs, we distinguish specific contributions of IFN-beta versus IFN-alpha in restricting viral pathogenesis and identify IFN-alpha as the key mediator of the antiviral response in mice infected with West Nile virus. This study thus suggests the utility of these new reagents in dissecting the antiviral and immunomodulatory roles of IFN-beta versus IFN-alpha in murine models of infection, immunity, and autoimmunity.	[Sheehan, Kathleen C. F.; Diamond, Michael S.; Schreiber, Robert D.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Lazear, Helen M.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Sheehan, Kathleen C. F.; Diamond, Michael S.; Schreiber, Robert D.] Washington Univ, Sch Med, Ctr Human Immunol, St Louis, MO USA; [Sheehan, Kathleen C. F.; Diamond, Michael S.; Schreiber, Robert D.] Washington Univ, Sch Med, Immunotherapy Programs, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Schreiber, RD (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	Schreiber@immunology.wustl.edu	Schreiber, Robert/Q-7550-2019; Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165; Lazear, Helen/0000-0002-8649-4579; Schreiber, Robert/0000-0003-1590-2341	 [U54 AI057160];  [R01 CA043059];  [U19 AI083019];  [U19 AI106772];  [R01 AI104972]; NATIONAL CANCER INSTITUTE [R01CA043059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI106772, U19AI083019, U54AI057160, R01AI104972] Funding Source: NIH RePORTER	; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by U54 AI057160 (RDS) http://www.niaid.nih.gov/labsandresources/resources/rce/Pages/default.aspx, R01 CA043059 (RDS) http://www.cancer.gov, U19 AI083019 (MSD) http://www.niaid.nih.gov, U19 AI106772 (MSD) http://www.niaid.nih.gov and the R01 AI104972 (MSD) http://www.niaid.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Axtell RC, 2013, CLIN REV ALLERG IMMU, V44, P114, DOI 10.1007/s12016-011-8296-5; BACH EA, 1995, SCIENCE, V270, P1215, DOI 10.1126/science.270.5239.1215; Barchet W, 2002, J EXP MED, V195, P507, DOI 10.1084/jem.20011666; BELARDELLI F, 1987, J GEN VIROL, V68, P2203, DOI 10.1099/0022-1317-68-8-2203; Biggioggero M, 2010, AUTOIMMUNITY, V43, P248, DOI 10.3109/08916930903510971; Boasso A, 2011, BLOOD, V118, P5152, DOI 10.1182/blood-2011-03-344218; Boasso A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002961; Buontempo PJ, 2006, J INTERF CYTOK RES, V26, P40, DOI 10.1089/jir.2006.26.40; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Carrero JA, 2013, INT IMMUNOL, V25, P663, DOI 10.1093/intimm/dxt050; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Daffis S, 2008, J VIROL, V82, P8465, DOI 10.1128/JVI.00918-08; Daffis S, 2011, J VIROL, V85, P5664, DOI 10.1128/JVI.00232-11; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9; Deonarain R, 2000, J VIROL, V74, P3404, DOI 10.1128/JVI.74.7.3404-3409.2000; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Donlin LT, 2014, J IMMUNOL, V193, P2373, DOI 10.4049/jimmunol.1400486; Dunn GP, 2005, NAT IMMUNOL, V6, P722, DOI 10.1038/ni1213; Ebel GD, 2001, EMERG INFECT DIS, V7, P650; Erlandsson L, 1998, CURR BIOL, V8, P223, DOI 10.1016/S0960-9822(98)70086-7; Fenner JE, 2006, NAT IMMUNOL, V7, P33, DOI 10.1038/ni1287; Fuertes MB, 2013, TRENDS IMMUNOL, V34, P67, DOI 10.1016/j.it.2012.10.004; Fung KY, 2013, SCIENCE, V339, P1088, DOI 10.1126/science.1233321; GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548; GRESSER I, 1976, J EXP MED, V144, P1316, DOI 10.1084/jem.144.5.1316; Hardy MP, 2004, GENOMICS, V84, P331, DOI 10.1016/j.ygeno.2004.03.003; Henry T, 2010, J IMMUNOL, V184, P3755, DOI 10.4049/jimmunol.0902065; Herbeuval JP, 2007, CLIN IMMUNOL, V123, P121, DOI 10.1016/j.clim.2006.09.016; Hertzog PJ, 2013, CYTOKINE GROWTH F R, V24, P217, DOI 10.1016/j.cytogfr.2013.04.002; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Isaacs J D, 1990, Semin Immunol, V2, P449; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Khabar KSA, 2007, BIOCHIMIE, V89, P761, DOI 10.1016/j.biochi.2007.02.008; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; LaFleur DW, 2001, J BIOL CHEM, V276, P39765, DOI 10.1074/jbc.M102502200; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Lazear HM, 2011, J VIROL, V85, P7186, DOI 10.1128/JVI.00396-11; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Le Bon A, 2006, J IMMUNOL, V176, P4682, DOI 10.4049/jimmunol.176.8.4682; Lewerenz M, 1998, J MOL BIOL, V282, P585, DOI 10.1006/jmbi.1998.2026; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Miller JC, 2008, J IMMUNOL, V181, P8492, DOI 10.4049/jimmunol.181.12.8492; MUELLER C, 1994, ACTA ASTRONAUT, V33, P9, DOI 10.1016/0094-5765(94)90102-3; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; NAGANO Y, 1958, CR SOC BIOL, V152, P1627; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Oritani K, 2000, NAT MED, V6, P659, DOI 10.1038/76233; Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Prakash A, 2005, J BIOL CHEM, V280, P18651, DOI 10.1074/jbc.M501289200; Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10; Rizza P, 2010, AUTOIMMUNITY, V43, P204, DOI 10.3109/08916930903510880; Runkel L, 1998, J BIOL CHEM, V273, P8003, DOI 10.1074/jbc.273.14.8003; SalazarMather TP, 1996, J IMMUNOL, V157, P3054; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schreiber G, 2015, TRENDS IMMUNOL, V36, P139, DOI 10.1016/j.it.2015.01.002; SCHREIBER RD, 1984, CONTEMP TOP IMMUNOBI, V13, P171; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; SHEEHAN KCF, 1988, J IMMUNOL, V140, P4231; SHEEHAN KCF, 1989, J IMMUNOL, V142, P3884; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Swann JB, 2007, J IMMUNOL, V178, P7540, DOI 10.4049/jimmunol.178.12.7540; Swiecki M, 2011, J EXP MED, V208, P2367, DOI 10.1084/jem.20110654; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; TANIGUCHI T, 1980, NATURE, V285, P547, DOI 10.1038/285547a0; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; TRINCHIERI G, 1977, NATURE, V270, P611, DOI 10.1038/270611a0; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; van Pesch V, 2004, J VIROL, V78, P8219, DOI 10.1128/JVI.78.15.8219-8228.2004; ZWARTHOFF EC, 1985, NUCLEIC ACIDS RES, V13, P791, DOI 10.1093/nar/13.3.791	86	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128636	10.1371/journal.pone.0128636	http://dx.doi.org/10.1371/journal.pone.0128636			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	26010249	Green Published, gold, Green Submitted			2022-12-26	WOS:000355183900245
J	Giatropoulos, A; Papachristos, DP; Koliopoulos, G; Michaelakis, A; Emmanouel, N				Giatropoulos, Athanassios; Papachristos, Dimitrios P.; Koliopoulos, George; Michaelakis, Antonios; Emmanouel, Nickolaos			Asymmetric Mating Interference between Two Related Mosquito Species: Aedes (Stegomyia) albopictus and Aedes (Stegomyia) cretinus	PLOS ONE			English	Article							COMPETITIVE DISPLACEMENT; AEGYPTI DIPTERA; REPRODUCTIVE ISOLATION; SEXUAL RECEPTIVITY; FEMALE MONOGAMY; AEDINI DIPTERA; CULICIDAE; STRAINS; CLASSIFICATION; SATYRIZATION	Aedes (Stegomyia) albopictus (Skuse) and Aedes (Stegomyia) cretinus Edwards are closely related mosquito species with common morphological features and bio-ecological similarities. Recent mosquito surveillance in Athens, Greece, showed that they are sympatric mosquito species, with Ae. Albopictus developing quite higher population densities than Ae. Cretinus. The potential of mating interference between these species was investigated by reciprocal and homologous mating experiments in cages under laboratory conditions. In non-choice interspecific crosses (groups of males and females) females of both species produced sterile eggs. Insemination rate was 58% for Ae. Cretinus females and only 1% for Ae. Albopictus females. Aedes albopictus males were sexually aggressive and inseminated Ae. Cretinus females (31%) in choice experiments, where males of one species had access to mate with females of both species. Whereas, interspecific mating of Ae. Albopictus females with Ae. Cretinus males in the co-occurrence of Ae. Cretinus females was weaker (4%). Aedes cretinus females from non-choice crossing with Ae. Albopictus or Ae. Cretinus males were paired individually with conspecific males. The percentage of fertile Ae. Cretinus females was 17.5% when had encaged before with Ae. Albopictus males, compared to 100% when Ae. Cretinus females were encaged with conspecific males only. Probable ecological consequences of asymmetric mating between these ecologically homologous species in nature are discussed.	[Giatropoulos, Athanassios; Koliopoulos, George] Benaki Phytopathol Inst, Dept Pesticides Control & Phytopharmacy, Lab Biol Control Pesticides, Athens, Greece; [Giatropoulos, Athanassios; Emmanouel, Nickolaos] Agr Univ Athens, Lab Agr Zool & Entomol, GR-11855 Athens, Greece; [Papachristos, Dimitrios P.; Michaelakis, Antonios] Benaki Phytopathol Inst, Dept Entomol & Agr Zool, Lab Agr Entomol, Athens, Greece	Agricultural University of Athens	Giatropoulos, A (corresponding author), Benaki Phytopathol Inst, Dept Pesticides Control & Phytopharmacy, Lab Biol Control Pesticides, Athens, Greece.	a.giatropoulos@bpi.gr	Papachristos, Dimitrios/AHC-0813-2022; Michaelakis, Antonios/AAL-1594-2020	Papachristos, Dimitrios/0000-0002-0524-0180	Development & demonstration of management plans against - the climate change enhanced-invasive mosquitoes in South Europe - European Commission [LIFE CONOPS LIFE12 ENV/GR/000466]	Development & demonstration of management plans against - the climate change enhanced-invasive mosquitoes in South Europe - European Commission	This study was supported by the Development & demonstration of management plans against - the climate change enhanced-invasive mosquitoes in South Europe (LIFE CONOPS LIFE12 ENV/GR/000466), funded by the European Commission in the framework of the programme LIFE + Environment Policy and Governance (www.conops.gr; http://ec.europa.eu/environment/life/index.htm) (to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; ALI SR, 1971, MOSQ NEWS, V31, P80; Alten B, 2000, J VECTOR ECOL, V25, P146; Bargielowski IE, 2013, P NATL ACAD SCI USA, V110, P2888, DOI 10.1073/pnas.1219599110; Becker N, 2010, MOSQUITOES AND THEIR; Benedict MQ, 2007, METHODS IN ANOPHELES; BLACK WC, 1989, J MED ENTOMOL, V26, P260, DOI 10.1093/jmedent/26.4.260; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042040; Cabrera M, 2007, J AM MOSQUITO CONTR, V23, P1, DOI 10.2987/8756-971X(2007)23[1:AAPMLB]2.0.CO;2; Caglar SS, 2003, J VECTOR ECOL, V28, P12; Clements AN, 1999, BIOLOGY OF MOSQUITOE, VII; CRAIG GB, 1967, SCIENCE, V156, P1499, DOI 10.1126/science.156.3781.1499; Darsie RF, 1997, J AM MOSQUITO CONTR, V13, P247; Darsie RF, 1999, P ENTOMOL SOC WASH, V101, P614; DEBACH P, 1966, ANNU REV ENTOMOL, V11, P183, DOI 10.1146/annurev.en.11.010166.001151; DUHRKOPF RE, 1992, J MED ENTOMOL, V29, P796, DOI 10.1093/jmedent/29.5.796; Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864; Estrada-Franco J. G., 1995, Technical Paper - Pan American Health Organization; FUCHS MS, 1968, LIFE SCI PT 1 PHYSI, V7, P835, DOI 10.1016/0024-3205(68)90114-8; Giatropoulos A.K., 2012, Hellenic Plant Protection Journal, V5, P49; Giatropoulos A, 2012, J MED ENTOMOL, V49, P262, DOI 10.1603/ME11096; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Groning J, 2008, Q REV BIOL, V83, P257, DOI 10.1086/590510; GUBLER DJ, 1970, J MED ENTOMOL, V7, P65, DOI 10.1093/jmedent/7.1.65; GWADZ RW, 1972, J INSECT PHYSIOL, V18, P259, DOI 10.1016/0022-1910(72)90126-6; GWADZ RW, 1970, MOSQ NEWS, V30, P355; HARPER JP, 1994, J AM MOSQUITO CONTR, V10, P88; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225; Helinski MEH, 2012, J INSECT PHYSIOL, V58, P1307, DOI 10.1016/j.jinsphys.2012.07.003; Helinski MEH, 2012, AM J TROP MED HYG, V86, P635, DOI 10.4269/ajtmh.2012.11-0225; HOBBS JH, 1991, J AM MOSQUITO CONTR, V7, P488; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; LEAHY M. G., 1965, MOSQUITO NEWS, V25, P448; LEAHY MG, 1967, EVOLUTION, V21, P41, DOI 10.1111/j.1558-5646.1967.tb00129.x; Lima-Camara TN, 2013, MEM I OSWALDO CRUZ, V108, P18, DOI 10.1590/0074-0276130381; Lounibos LP, 2007, J AM MOSQUITO CONTR, V23, P276, DOI 10.2987/8756-971X(2007)23[276:CDAR]2.0.CO;2; Lounibos LP, 2002, J VECTOR ECOL, V27, P86; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; NASCI RS, 1989, J AM MOSQUITO CONTR, V5, P416; Nazni WA, 2009, SE ASIAN J TROP MED, V40, P40; NIJHOUT HF, 1971, ENTOMOL EXP APPL, V14, P399, DOI 10.1007/BF00539936; Oliva CF, 2014, ACTA TROP, V132, pS12, DOI 10.1016/j.actatropica.2013.11.021; Oliva CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078884; OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554; Polaszek A, 2006, TRENDS PARASITOL, V22, P8, DOI 10.1016/j.pt.2005.11.003; Reinert JF, 2004, ZOOL J LINN SOC-LOND, V142, P289, DOI 10.1111/j.1096-3642.2004.00144.x; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; RIBEIRO JMC, 1986, AM NAT, V128, P513, DOI 10.1086/284584; RIBEIRO JMC, 1988, J MED ENTOMOL, V25, P431, DOI 10.1093/jmedent/25.6.431; ROTH LM, 1948, AM MIDL NAT, V40, P265, DOI 10.2307/2421604; Samanidou-Voyadjoglou A., 2005, European Mosquito Bulletin, V19, P10; Samanidou-Voyadjoglou A., 1998, 4 INT C DIPT, P194; Savage HM, 2005, J MED ENTOMOL, V42, P923, DOI 10.1603/0022-2585(2005)042[0923:COMITA]2.0.CO;2; Shutt B, 2010, MED VET ENTOMOL, V24, P91, DOI 10.1111/j.1365-2915.2009.00849.x; Sokal R.R., 2012, BIOMETRY; SPIELMAN A, 1969, J INSECT PHYSIOL, V15, P1471, DOI 10.1016/0022-1910(69)90168-1; SPIELMAN A, 1979, T ROY SOC TROP MED H, V73, P381, DOI 10.1016/0035-9203(79)90158-5; SPIELMAN A, 1967, BIOL BULL-US, V132, P404, DOI 10.2307/1539644; SPSS, 2004, SPSS 14 FOR WINDOWS; SUTHERST RW, 1987, INT J PARASITOL, V17, P921, DOI 10.1016/0020-7519(87)90009-9; Tripet F, 2011, AM J TROP MED HYG, V85, P265, DOI 10.4269/ajtmh.2011.10-0677; Vanderplank F. L., 1947, Transactions of the Royal Entomological Society of London, V98, P1	66	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0127762	10.1371/journal.pone.0127762	http://dx.doi.org/10.1371/journal.pone.0127762			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001099	Green Published, Green Submitted, gold			2022-12-26	WOS:000354931700082
J	Siarkou, VI; Vorimore, F; Vicari, N; Magnino, S; Rodolakis, A; Pannekoek, Y; Sachse, K; Longbottom, D; Laroucau, K				Siarkou, Victoria I.; Vorimore, Fabien; Vicari, Nadia; Magnino, Simone; Rodolakis, Annie; Pannekoek, Yvonne; Sachse, Konrad; Longbottom, David; Laroucau, Karine			Diversification and Distribution of Ruminant Chlamydia abortus Clones Assessed by MLST and MLVA	PLOS ONE			English	Article							MEMBRANE PROTEIN GENE; VACCINE STRAIN 1B; CHLAMYDOPHILA-ABORTUS; STREPTOCOCCUS-PNEUMONIAE; FAMILY CHLAMYDIACEAE; GENOME SEQUENCE; VARIANT STRAIN; PREGNANT MICE; IDENTIFICATION; DIVERSITY	Chlamydia abortus, an obligate intracellular bacterium, is the most common infectious cause of abortion in small ruminants worldwide and has zoonotic potential. We applied multilocus sequence typing (MLST) together with multiple-locus variable-number tandem repeat analysis (MLVA) to genotype 94 ruminant C. abortus strains, field isolates and samples collected from 1950 to 2011 in diverse geographic locations, with the aim of delineating C. abortus lineages and clones. MLST revealed the previously identified sequence types (STs) ST19, ST25, ST29 and ST30, plus ST86, a recently-assigned type on the Chlamydiales MLST website and ST87, a novel type harbouring the hemN_21 allele, whereas MLVA recognized seven types (MT1 to MT7). Minimum-spanning-tree analysis suggested that all STs but one (ST30) belonged to a single clonal complex, possibly reflecting the short evolutionary timescale over which the predicted ancestor (ST19) has diversified into three single-locus variants (ST86, ST87 and ST29) and further, through ST86 diversification, into one double-locus variant (ST25). ST descendants have probably arisen through a point mutation evolutionmode. Interestingly, MLVA showed that in the ST19 population there was a greater genetic diversity than in other STs, most of which exhibited the same MT over time and geographical distribution. However, the evolutionary pathways of C. abortus STs seem to be diverse across geographic distances with individual STs restricted to particular geographic locations. The ST30 singleton clone displaying geographic specificity and represented by the Greek strains LLG and POS was effectively distinguished from the clonal complex lineage, supporting the notion that possibly two separate host adaptations and hence independent bottlenecks of C. abortus have occurred through time. The combination of MLST and MLVA assays provides an additional level of C. abortus discrimination and may prove useful for the investigation and surveillance of emergent C. abortus clonal populations.	[Siarkou, Victoria I.] Aristotle Univ Thessaloniki, Fac Hlth Sci, Sch Vet Med, Lab Microbiol & Infect Dis, GR-54006 Thessaloniki, Greece; [Vorimore, Fabien; Laroucau, Karine] Univ Paris Est, Bacterial Zoonoses Unit, Hlth Anim Lab, Anses, Maisons Alfort, France; [Vicari, Nadia; Magnino, Simone] Ist Zooprofilattico Sperimentale Lombardia & Emil, Sez Diagnost Pavia, Pavia, Italy; [Rodolakis, Annie] INRA, Infectiol Anim & Sante Publ, F-37380 Nouzilly, France; [Pannekoek, Yvonne] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Sachse, Konrad] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, Jena, Germany; [Longbottom, David] Moredun Res Inst, Edinburgh EH17 7JH, Midlothian, Scotland	Aristotle University of Thessaloniki; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); IZS Lombardia e Emilia; INRAE; University of Amsterdam; Academic Medical Center Amsterdam; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute; Moredun Research Institute	Siarkou, VI (corresponding author), Aristotle Univ Thessaloniki, Fac Hlth Sci, Sch Vet Med, Lab Microbiol & Infect Dis, GR-54006 Thessaloniki, Greece.	vickysi@vet.auth.gr; Karine.LAROUCAU@anses.fr	Vicari, Nadia/HCH-8694-2022; Laroucau, Karine/GSO-1980-2022; Sachse, Konrad/GWC-4999-2022; Longbottom, David/GWZ-8448-2022	Laroucau, Karine/0000-0001-7605-8602; Sachse, Konrad/0000-0003-1230-1786; Longbottom, David/0000-0003-0086-8443; Pannekoek, Yvonne/0000-0003-1154-652X; Vicari, Nadia/0000-0001-8156-0138				Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Aitken ID., 2007, DIS SHEEP, V4, P105, DOI [10.1002/9780470753316.ch16, DOI 10.1002/9780470753316.CH16]; Bouakane A, 2005, VET REC, V157, P771, DOI 10.1136/vr.157.24.771; Bouakane A, 2003, INFECT IMMUN, V71, P7219, DOI 10.1128/IAI.71.12.7219-7222.2003; Boumedine KS, 1998, RES MICROBIOL, V149, P735, DOI 10.1016/S0923-2508(99)80020-5; DENAMUR E, 1991, J GEN MICROBIOL, V137, P2525, DOI 10.1099/00221287-137-11-2525; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Feil EJ, 2000, GENETICS, V154, P1439; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; Futuyma DJ, 2009, EVOLUTION, P255; Joseph SJ, 2012, MOL BIOL EVOL, V29, P3933, DOI 10.1093/molbev/mss198; Kerr K, 2005, RES VET SCI, V78, P1, DOI 10.1016/j.rvsc.2004.08.004; Koeck JL, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-66; Kuo CC, 2011, BERGEYS MANUAL SYSTE, V4, P846; Laroucau K, 2010, VACCINE, V28, P5653, DOI 10.1016/j.vaccine.2010.06.064; Laroucau K, 2009, VET MICROBIOL, V137, P335, DOI 10.1016/j.vetmic.2009.01.029; Longbottom D, 2003, J COMP PATHOL, V128, P217, DOI 10.1053/jcpa.2002.0629; Madoff LC, 1996, P NATL ACAD SCI USA, V93, P4131, DOI 10.1073/pnas.93.9.4131; Martin P, 2003, MOL MICROBIOL, V50, P245, DOI 10.1046/j.1365-2958.2003.03678.x; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pannekoek Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014179; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Pantchev A, 2009, VET J, V181, P145, DOI 10.1016/j.tvjl.2008.02.025; Pearson T, 2009, INFECT GENET EVOL, V9, P1010, DOI 10.1016/j.meegid.2009.05.014; Rattei T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-355; Read TD, 2013, MBIO, V4, DOI 10.1128/mBio.00604-12; Sachse K, 2014, SYST APPL MICROBIOL, V37, P79, DOI 10.1016/j.syapm.2013.12.004; Sait M, 2011, J BACTERIOL, V193, P4276, DOI 10.1128/JB.05290-11; Sait M, 2011, VET MICROBIOL, V151, P284, DOI 10.1016/j.vetmic.2011.03.005; SALINAS J, 1995, VET MICROBIOL, V43, P219, DOI 10.1016/0378-1135(94)00100-B; Siarkou V, 2002, VET MICROBIOL, V85, P145, DOI 10.1016/S0378-1135(01)00506-5; Siarkou V, 1992, THESIS ARISTOTLE U T, DOI 10.12681/eadd/8983; Siarkou VI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019813; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomson NR, 2005, GENOME RES, V15, P629, DOI 10.1101/gr.3684805; Top J, 2008, J CLIN MICROBIOL, V46, P214, DOI 10.1128/JCM.01351-07; Vorimore F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074823; Vorimore F, 2012, J MICROBIOL METH, V90, P241, DOI 10.1016/j.mimet.2012.05.014; Vretou E, 1996, VET MICROBIOL, V51, P275, DOI 10.1016/0378-1135(96)00048-X; Vretou E, 2001, INFECT IMMUN, V69, P607, DOI 10.1128/IAI.69.1.607-612.2001	43	8	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126433	10.1371/journal.pone.0126433	http://dx.doi.org/10.1371/journal.pone.0126433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26001070	Green Published, gold, Green Submitted			2022-12-26	WOS:000354931700019
J	Yaacob, NS; Yankuzo, HM; Devaraj, S; Wong, JKM; Lai, CS				Yaacob, Nik Soriani; Yankuzo, Hassan Muhammad; Devaraj, Sutha; Wong, Jimmy Ka Ming; Lai, Choon-Sheen			Anti-Tumor Action, Clinical Biochemistry Profile and Phytochemical Constituents of a Pharmacologically Active Fraction of S. crispus in NMU-Induced Rat Mammary Tumour Model	PLOS ONE			English	Article							STROBILANTHES-CRISPUS; HUMAN BREAST; CHEMICAL-CONSTITUENTS; MARIGOLD EXTRACT; DIETARY LUTEIN; ORAL TOXICITY; CANCER; CARCINOGENESIS; PREVENTION; INDUCTION	Cancer patients seek alternative remedies such as traditional medicinal plants for safe and effective treatment and help overcome the side effects of conventional therapy. Current knowledge indicates that extracts of Strobilanthes crispus of the Acanthaceae family exhibit potent anticancer properties in vitro and are non-toxic in vivo. S. crispus was also reported to be protective against chemical hepatocarcinogenesis. We previously showed that a bioactive fraction of S. crispus leaves also synergized with tamoxifen to cause apoptosis of human breast cancer cell lines without damaging non-malignant epithelial cells. The present study aimed to evaluate the antitumor effect of S. crispus dichloromethane fraction (F3) using N-methyl-N-Nitrosourea (NMU)-induced rat mammary tumor model. Tumor regression was observed in 75% of the rats following 8-week oral administration of F3 with no secondary tumour formation and no signs of anemia or infection. However, no improvement in the liver and renal function profiles was observed. Major constituents of F3 were identified as lutein, 13(1)-hydroxy-13(2)-oxo-pheophytin a, campesterol, stigmasterol, beta-sitosterol, pheophytin a and 13(2)-hydroxy-pheophytin a. These compounds however, may not significantly contribute to the antitumor effect of F3.	[Yaacob, Nik Soriani; Yankuzo, Hassan Muhammad] Univ Sains Malaysia, Sch Med Sci, Dept Chem Pathol, Kubang Kerian, Kelantan, Malaysia; [Devaraj, Sutha; Wong, Jimmy Ka Ming; Lai, Choon-Sheen] Univ Sains Malaysia, Ctr Drug Res, George Town, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Yaacob, NS (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Chem Pathol, Kubang Kerian, Kelantan, Malaysia.	niksoriani@usm.my; cs_lai@usm.my	Devaraj, Sutha/AAK-5539-2020; Lai, Choon-Sheen/B-6941-2011		Universiti Sains Malaysia Research University Grant [1001/PPSP/853002]; Malaysian Ministry of Education; Universiti Sains Malaysia Fellowship	Universiti Sains Malaysia Research University Grant(Universiti Sains Malaysia); Malaysian Ministry of Education; Universiti Sains Malaysia Fellowship(Universiti Sains Malaysia)	This work was funded by the Universiti Sains Malaysia Research University Grant (no. 1001/PPSP/853002). SD and JKMW are recipients of MyBrain scholarship funded by the Malaysian Ministry of Education. HMY received the Universiti Sains Malaysia Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Henhena N, 2011, J MED PLANTS RES, V5, P3660; Asmah Rahmat, 2006, International Journal of Cancer Research (USA), V2, P47; Bernstein L, J NATL CANC I, V199, P1654; Brummitt RK, 1992, AUTHORS PLANT NAMES; Burkill I, 1935, DICT EC PRODUCTS MAL, P2086; Cameron J.S., 1998, OXFORD TXB CLIN NEPH, P36; Chan MM, 2005, CARCINOGENESIS, V26, P1343, DOI 10.1093/carcin/bgi100; Chang CL, 2013, J DENT SCI, V8, P8, DOI 10.1016/j.jds.2012.09.006; Chang YC, 2012, ARCH TOXICOL, V86, P315, DOI 10.1007/s00204-011-0753-7; Cheng HH, 2001, J NAT PROD, V64, P915, DOI 10.1021/np000595b; Chew BP, 1996, ANTICANCER RES, V16, P3689; Chew BP, 2003, ANTICANCER RES, V23, P3333; Chong HZ, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-35; Nogueira TBDD, 2013, MOLECULES, V18, P11086, DOI 10.3390/molecules180911086; Donaldson MS, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-19; Dubben HH, 1998, RADIOTHER ONCOL, V47, P167, DOI 10.1016/S0167-8140(97)00215-6; Endrini S., 2007, Journal of Medical Sciences (Pakistan), V7, P1098; Fadzelly ABM, 2006, PLANT FOOD HUM NUTR, V61, P7, DOI 10.1007/s11130-006-0002-z; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Ge XX, 2013, ASIAN PAC J CANCER P, V14, P1911, DOI 10.7314/APJCP.2013.14.3.1911; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Goh KL., 2004, MALAYSIAN HERBS, V2, P249; HYNNINEN PH, 1973, ACTA CHEM SCAND, V27, P1478, DOI 10.3891/acta.chem.scand.27-1478; Ina A, 2007, INT J DEV NEUROSCI, V25, P63, DOI 10.1016/j.ijdevneu.2006.09.323; Ismail M, 2000, J NUTR BIOCHEM, V11, P536, DOI 10.1016/S0955-2863(00)00108-X; KEDAR RP, 1994, LANCET, V343, P1318, DOI 10.1016/S0140-6736(94)92466-X; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim YS, 2010, Republic Korean Kongkae Taeho Kongbo, Patent No. [KR20100024793, 20100024793]; Koay YC, 2013, REC NAT PROD, V7, P59; Krishnan P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-259; Kull DR, 1997, J AGR FOOD CHEM, V45, P4201, DOI 10.1021/jf960945t; Lai CS, 2010, J ETHNOPHARMACOL, V127, P486, DOI 10.1016/j.jep.2009.10.009; Lim Kean Tatt, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P948, DOI 10.1016/S2221-1691(13)60005-2; Liza MS, 2010, FOOD BIOPROD PROCESS, V88, P319, DOI 10.1016/j.fbp.2009.02.001; Matsuo A, 1996, PHYTOCHEMISTRY, V42, P427, DOI 10.1016/0031-9422(96)00017-9; Mohd Fadzelly A. B., 2006, International Journal of Cancer Research (USA), V2, P152; Molnar P, 2006, HELV CHIM ACTA, V89, P667, DOI 10.1002/hlca.200690067; Muslim NS, 2010, INT J PHARMACOL, V6, P591, DOI 10.3923/ijp.2010.591.599; Norfarizan-Hanoon NA, 2012, SAINS MALAYS, V41, P403; Nurraihana H., 2013, International Food Research Journal, V20, P2045; Park JS, 1998, J NUTR, V128, P1650, DOI 10.1093/jn/128.10.1650; Putzbach K, 2005, J AGR FOOD CHEM, V53, P671, DOI 10.1021/jf0487506; Rahmat A., 2006, J BIOL SCI, V6, P1005, DOI DOI 10.3923/JBS.2006.1005.1010; RIVERA ES, 1994, CANCER LETT, V86, P223, DOI 10.1016/0304-3835(94)90082-5; Russell W., 2009, PRINCIPLES HUMANE EX, V1959, P238; Sakdarat S, 2009, BIOORGAN MED CHEM, V17, P1857, DOI 10.1016/j.bmc.2009.01.059; Samuel AJSJ, 2010, J ETHNOBIOL ETHNOMED, V6, DOI 10.1186/1746-4269-6-5; Soares-Maia R, 2013, J ENVIRON PATHOL TOX, V32, P2013; Soediro I, 1987, ACTA PHARM INDONES, VXII, P1; Suherman J., 2004, Pakistan Journal of Biological Sciences, V7, P947, DOI 10.3923/pjbs.2004.947.951; Suherman Jaksa, 2005, Journal of Medical Sciences (Pakistan), V5, P130; THOMPSON HJ, 1992, CARCINOGENESIS, V13, P1535, DOI 10.1093/carcin/13.9.1535; Tsubura A, 2011, IN VIVO, V25, P11; Usunomena U., 2012, BR J PHARM TOXICOL, V3, P165; Yaacob NS, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-252; Yaacob NS, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-42; Sun Z, 2007, ASIA PAC J CLIN NUTR, V16, P447	57	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2015	10	5							e0126426	10.1371/journal.pone.0126426	http://dx.doi.org/10.1371/journal.pone.0126426			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7GR	26000968	gold, Green Published, Green Submitted			2022-12-26	WOS:000354931700018
J	Kumar, S; Ratnikov, BI; Kazanov, MD; Smith, JW; Cieplak, P				Kumar, Sonu; Ratnikov, Boris I.; Kazanov, Marat D.; Smith, Jeffrey W.; Cieplak, Piotr			CleavPredict: A Platform for Reasoning about Matrix Metalloproteinases Proteolytic Events	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; IMMUNOGENIC PEPTIDES; CARTILAGE MATRIX; DRUG TARGETS; TUMOR-GROWTH; II COLLAGEN; CANCER; SEQUENCE; DATABASE; CLEAVAGE	CleavPredict (http://cleavpredict.sanfordburnham.org) is a Web server for substrate cleavage prediction for matrix metalloproteinases (MMPs). It is intended as a computational platform aiding the scientific community in reasoning about proteolytic events. CleavPredict offers in silico prediction of cleavage sites specific for 11 human MMPs. The prediction method employs the MMP specific position weight matrices (PWMs) derived from statistical analysis of high-throughput phage display experimental results. To augment the substrate cleavage prediction process, CleavPredict provides information about the structural features of potential cleavage sites that influence proteolysis. These include: secondary structure, disordered regions, transmembrane domains, and solvent accessibility. The server also provides information about subcellular location, co-localization, and co-expression of proteinase and potential substrates, along with experimentally determined positions of single nucleotide polymorphism (SNP), and posttranslational modification (PTM) sites in substrates. All this information will provide the user with perspectives in reasoning about proteolytic events. CleavPredict is freely accessible, and there is no login required.	[Kumar, Sonu; Ratnikov, Boris I.; Smith, Jeffrey W.; Cieplak, Piotr] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Kazanov, Marat D.] Russian Acad Sci, Inst Informat Transmiss Problems, Moscow, Russia	Sanford Burnham Prebys Medical Discovery Institute; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences	Cieplak, P (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	pcieplak@sanfordbumham.org	Kumar, Sonu/GZA-9110-2022; Kumar, Sonu/AAH-2962-2019; Kazanov, Marat D/D-6381-2013; Kumar, Sonu/AAA-1746-2019	Kumar, Sonu/0000-0003-0423-2880; Kazanov, Marat D/0000-0002-2314-5507; 	National Institutes of Health (NIH) grant [R01GM098835]; Russian Foundation grant [15-04-06861a]; Russian Academy of Sciences via program "Molecular and Cellular Biology"; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098835] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Foundation grant; Russian Academy of Sciences via program "Molecular and Cellular Biology"(Russian Academy of Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) grant R01GM098835 (PC) and by the Russian Foundation grant: 15-04-06861a and Russian Academy of Sciences via program "Molecular and Cellular Biology" (MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TL, 2004, BONE, V35, P1107, DOI 10.1016/j.bone.2004.06.019; Belushkin AA, 2014, PROTEOMICS, V14, P42, DOI 10.1002/pmic.201300416; Benito MJ, 2005, ANN RHEUM DIS, V64, P1263, DOI 10.1136/ard.2004.025270; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; Calderone A, 2013, NAT METHODS, V10, P690, DOI 10.1038/nmeth.2561; CARRELL RW, 1985, NATURE, V317, P730, DOI 10.1038/317730a0; Churg A, 2012, EUR RESPIR J, V39, P197, DOI 10.1183/09031936.00121611; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Critchley DR, 2009, NAT CELL BIOL, V11, P538, DOI 10.1038/ncb0509-538; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Dziembowska M, 2012, INT J BIOCHEM CELL B, V44, P709, DOI 10.1016/j.biocel.2012.01.023; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fraser A, 2003, ARTHRITIS RHEUM, V48, P3085, DOI 10.1002/art.11331; Gatto C, 1999, CLIN CANCER RES, V5, P3603; Golubkov VS, 2010, J BIOL CHEM, V285, P35740, DOI 10.1074/jbc.M110.165159; Golubkov VS, 2010, J BIOL CHEM, V285, P27726, DOI 10.1074/jbc.M110.135442; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Hwang IK, 2004, BBA-PROTEINS PROTEOM, V1702, P79, DOI 10.1016/j.bbapap.2004.08.001; Igarashi Y, 2007, NUCLEIC ACIDS RES, V35, pD546, DOI 10.1093/nar/gkl813; Johnson JL, 2006, CARDIOVASC RES, V71, P586, DOI 10.1016/j.cardiores.2006.05.009; Johnson JL, 2006, CIRCULATION, V113, P2435, DOI 10.1161/CIRCULATIONAHA.106.613281; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kato T, 2001, FEBS LETT, V508, P187, DOI 10.1016/S0014-5793(01)02897-6; Kazanov MD, 2011, J PROTEOME RES, V10, P3642, DOI 10.1021/pr200271w; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lambert V, 2003, FASEB J, V17, P2290, DOI 10.1096/fj.03-0113fje; Lark MW, 1997, J CLIN INVEST, V100, P93, DOI 10.1172/JCI119526; Li H, 2001, HUM GENE THER, V12, P515, DOI 10.1089/104303401300042429; Lopez-Aviles S, 2010, CURR BIOL, V20, pR101, DOI 10.1016/j.cub.2010.01.001; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Lorenz IC, 2006, NATURE, V442, P831, DOI 10.1038/nature04975; Lu CT, 2013, NUCLEIC ACIDS RES, V41, pD295, DOI 10.1093/nar/gks1229; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Martin ACR, 2005, BIOINFORMATICS, V21, P4297, DOI 10.1093/bioinformatics/bti694; Martin DC, 1999, LAB INVEST, V79, P225; Murphy G, 2008, NAT CLIN PRACT RHEUM, V4, P128, DOI 10.1038/ncprheum0727; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Newby AC, 2007, TRENDS CARDIOVAS MED, V17, P253, DOI 10.1016/j.tcm.2007.09.001; Obayashi T, 2013, NUCLEIC ACIDS RES, V41, pD1014, DOI 10.1093/nar/gks1014; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Prudova A, 2010, MOL CELL PROTEOMICS, V9, P894, DOI 10.1074/mcp.M000050-MCP201; Ratnikov Boris, 2009, V539, P93, DOI 10.1007/978-1-60327-003-8_6; Ratnikov BI, 2014, P NATL ACAD SCI USA, V111, pE4148, DOI 10.1073/pnas.1406134111; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; Rossetto O, 2000, CLIN CHIM ACTA, V291, P189, DOI 10.1016/S0009-8981(99)00228-4; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Schechter I, 2012, BIOCHEM BIOPH RES CO, V425, P497, DOI 10.1016/j.bbrc.2012.08.015; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Shipley JM, 1996, P NATL ACAD SCI USA, V93, P3942, DOI 10.1073/pnas.93.9.3942; Shiryaev SA, 2013, J BIOL CHEM, V288, P34956, DOI 10.1074/jbc.M113.516153; Shiryaev SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054290; Shiryaev SA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040029, 10.1371/journal.pone.0035759]; Shiryaev SA, 2011, FEBS J, V278, P3277, DOI 10.1111/j.1742-4658.2011.08244.x; Shiryaev SA, 2009, J BIOL CHEM, V284, P30615, DOI 10.1074/jbc.M109.041244; Shiryaev SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004952; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050300; Troeberg L, 2012, BBA-PROTEINS PROTEOM, V1824, P133, DOI 10.1016/j.bbapap.2011.06.020; Vanlaere I, 2009, CLIN MICROBIOL REV, V22, P224, DOI 10.1128/CMR.00047-08; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Witten IH, 2011, MOR KAUF D, P1; Wu W, 2002, ARTHRITIS RHEUM, V46, P2087, DOI 10.1002/art.10428; Wuarin J, 1996, CELL, V85, P785, DOI 10.1016/S0092-8674(00)81261-1; Yip YL, 2004, HUM MUTAT, V23, P464, DOI 10.1002/humu.20021; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	82	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2015	10	5							e0127877	10.1371/journal.pone.0127877	http://dx.doi.org/10.1371/journal.pone.0127877			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK7VW	25996941	Green Published, gold			2022-12-26	WOS:000356444000093
J	Kim, HS; Woo, J; Lee, JH; Joo, HJ; Choi, Y; Kim, H; Moon, WK; Kim, SJ				Kim, Hoe Suk; Woo, Jisu; Lee, Jae Hoon; Joo, Hyun Jung; Choi, YoonSeok; Kim, Hyeonjin; Moon, Woo Kyung; Kim, Seung Ja			In vivo Tracking of Dendritic Cell using MRI Reporter Gene, Ferritin	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; LYMPH-NODES; MELANOMA PATIENTS; CANCER VACCINES; ACTIVATION; MIGRATION; MICE; TRANSPLANTATION; INTERLEUKIN-2; EXPRESSION	The noninvasive imaging of dendritic cells (DCs) migrated into lymph nodes (LNs) can provide helpful information on designing DCs-based immunotherapeutic strategies. This study is to investigate the influence of transduction of human ferritin heavy chain (FTH) and green fluorescence protein (GFP) genes on inherent properties of DCs, and the feasibility of FTH as a magnetic resonance imaging (MRI) reporter gene to track DCs migration into LNs. FTH-DCs were established by the introduction of FTH and GFP genes into the DC cell line (DC2.4) using lentivirus. The changes in the rate of MRI signal decay (R-2*) resulting from FTH transduction were analyzed in cell phantoms as well as popliteal LN of mice after subcutaneous injection of those cells into hind limb foot pad by using a multiple gradient echo sequence on a 9.4 T MR scanner. The transduction of FTH and GFP did not influence the proliferation and migration abilities of DCs. The expression of co-stimulatory molecules (CD40, CD80 and CD86) in FTH-DCs was similar to that of DCs. FTH-DCs exhibited increased iron storage capacity, and displayed a significantly higher transverse relaxation rate (R-2*) as compared to DCs in phantom. LNs with FTH-DCs exhibited negative contrast, leading to a high R-2* in both in vivo and ex vivo T-2*-weighted images compared to DCs. On histological analysis FTH-DCs migrated to the subcapsular sinus and the T cell zone of LN, where they highly expressed CD25 to bind and stimulate T cells. Our study addresses the feasibility of FTH as an MRI reporter gene to track DCs migration into LNs without alteration of their inherent properties. This study suggests that FTH-based MRI could be a useful technique to longitudinally monitor DCs and evaluate the therapeutic efficacy of DC-based vaccines.	[Kim, Hoe Suk; Woo, Jisu; Lee, Jae Hoon; Joo, Hyun Jung; Choi, YoonSeok; Kim, Hyeonjin; Moon, Woo Kyung] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Choi, YoonSeok; Kim, Hyeonjin; Moon, Woo Kyung] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Kim, Seung Ja] Seoul Natl Univ, Seoul Metropolitan Govt, Dept Radiol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Moon, WK (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, 101 Daehak Ro, Seoul 110744, South Korea.	moonwk@snu.ac.kr; winnerkim89@gmail.com	Kim, Hyeonjin/M-3761-2019		Basic Science Research Program through the National Research Foundation of Korea (NRF) - ministry of Education, Science and Technology [2010-0004455]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - ministry of Education, Science and Technology	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the ministry of Education, Science and Technology (2010-0004455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baar J, 1999, Oncologist, V4, P140; Bousso P, 2008, NAT REV IMMUNOL, V8, P675, DOI 10.1038/nri2379; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Briley-Saebo KC, 2010, MAGN RESON MED, V64, P1510, DOI 10.1002/mrm.22519; Chen IY, 2009, MOL IMAGING BIOL, V11, P178, DOI 10.1007/s11307-008-0182-z; Choi SH, 2012, NMR BIOMED, V25, P737, DOI 10.1002/nbm.1788; Choi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052931; Cohen B, 2005, NEOPLASIA, V7, P109, DOI 10.1593/neo.04436; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; de Vries IJM, 2003, CANCER RES, V63, P12; Dekaban GA, 2009, J IMMUNOTHER, V32, P240, DOI 10.1097/CJI.0b013e318197b2a0; Genove G, 2005, NAT MED, V11, P450, DOI 10.1038/nm1208; Jonuleit H, 2000, GENE THER, V7, P249, DOI 10.1038/sj.gt.3301077; Joo HJ, 2012, NMR BIOMED, V25, P570, DOI 10.1002/nbm.1774; Kim HS, 2013, MOL IMAGING BIOL, V15, P48, DOI 10.1007/s11307-012-0567-x; Kim HS, 2010, CANCER RES, V70, P7315, DOI 10.1158/0008-5472.CAN-10-0241; Lin KL, 2014, BLOOD, V123, P1604, DOI 10.1182/blood-2013-09-526020; Liou HL, 2012, JOVE-J VIS EXP, V8, pe3720; Lizee G, 2004, HUM GENE THER, V15, P393, DOI 10.1089/104303404322959542; Long CM, 2009, CANCER RES, V69, P3180, DOI 10.1158/0008-5472.CAN-08-3691; Lucignani G, 2005, EUR J NUCL MED MOL I, V32, P725, DOI 10.1007/s00259-005-1858-0; Morse MA, 2000, CURR OPIN MOL THER, V2, P20; Ottobrini L, 2011, EUR J NUCL MED MOL I, V38, P949, DOI 10.1007/s00259-010-1687-7; Reichardt W, 2008, J IMMUNOL, V181, P4770, DOI 10.4049/jimmunol.181.7.4770; Shen ZH, 1997, J IMMUNOL, V158, P2723; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; VandenDriessche T, 2002, BLOOD, V100, P813, DOI 10.1182/blood.V100.3.813; Verdijk P, 2007, INT J CANCER, V120, P978, DOI 10.1002/ijc.22385; Wuest SC, 2011, NAT MED, V17, P604, DOI 10.1038/nm.2365; Xia HJ, 2009, CELL MOL IMMUNOL, V6, P159, DOI 10.1038/cmi.2009.22	30	20	21	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0125291	10.1371/journal.pone.0125291	http://dx.doi.org/10.1371/journal.pone.0125291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25993535	Green Published, gold, Green Submitted			2022-12-26	WOS:000354921400030
J	Poisot, T; Kefi, S; Morand, S; Stanko, M; Marquet, PA; Hochberg, ME				Poisot, Timothee; Kefi, Sonia; Morand, Serge; Stanko, Michal; Marquet, Pablo A.; Hochberg, Michael E.			A Continuum of Specialists and Generalists in Empirical Communities	PLOS ONE			English	Article							MUTUALISTIC NETWORKS; SPECIES RICHNESS; EVOLUTION; DIVERSITY; ARCHITECTURE; COEXISTENCE; ECOLOGY; SPECIALIZATION; HERBIVORE; PARASITES	Understanding the persistence of specialists and generalists within ecological communities is a topical research question, with far-reaching consequences for the maintenance of functional diversity. Although theoretical studies indicate that restricted conditions may be necessary to achieve co-occurrence of specialists and generalists, analyses of larger empirical (and species-rich) communities reveal the pervasiveness of coexistence. In this paper, we analyze 175 ecological bipartite networks of three interaction types (animal hosts-parasite, plant-herbivore and plant-pollinator), and measure the extent to which these communities are composed of species with different levels of specificity in their biotic interactions. We find a continuum from specialism to generalism. Furthermore, we demonstrate that diversity tends to be greatest in networks with intermediate connectance, and argue this is because of physical constraints in the filling of networks.	[Poisot, Timothee] Univ Montreal, Dept Sci Biol, Montreal, PQ H3C 3J7, Canada; [Poisot, Timothee] Quebec Ctr Biodivers Sci, Montreal, PQ, Canada; [Kefi, Sonia; Hochberg, Michael E.] Univ Montpellier 2, CNRS, IRD, Inst Sci Evolut, F-34095 Montpellier 05, France; [Morand, Serge] CNRS, CIRAD AGIRs, Ctr Infectiol Christophe Merieux Laos, F-75700 Paris, France; [Stanko, Michal] Slovak Acad Sci, Inst Zool, Kosice 04001, Slovakia; [Stanko, Michal] Slovak Acad Sci, Inst Parasitol, Kosice 04001, Slovakia; [Marquet, Pablo A.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Ecol, Santiago, Chile; [Marquet, Pablo A.] Inst Ecol & Biodiversidad, Santiago, Chile; [Marquet, Pablo A.; Hochberg, Michael E.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Marquet, Pablo A.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Lab Internac Cambio Global LINCGlobal, Santiago, Chile; [Hochberg, Michael E.] Wissenschaftskolleg Berlin, D-14193 Berlin, Germany	Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CIRAD; Slovak Academy of Sciences; Slovak Academy of Sciences; Pontificia Universidad Catolica de Chile; The Santa Fe Institute; Pontificia Universidad Catolica de Chile	Poisot, T (corresponding author), Univ Montreal, Dept Sci Biol, Pavillon Marie Victorin,CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	timothee.poisot@umontreal.ca	Marquet, Pablo A/B-7732-2009; Stanko, Michal/AAN-6099-2020; Morand, Serge/M-5433-2018	Marquet, Pablo A/0000-0001-6369-9339; Stanko, Michal/0000-0002-9917-2421; Morand, Serge/0000-0003-3986-7659; Kefi, Sonia/0000-0002-9678-7770; Poisot, Timothee/0000-0002-0735-5184	Slovak Research and Development Agency grant [0267-10]; CRD grant from NSERC; PBEEE post-doctoral scholarship from FQRNT/MELS; Agence Nationale de la Recherche "EvolStress" [ANR-09-BLAN-099-01]; McDonnell Foundation (SCS-Research Award) [JSMF 220020294]	Slovak Research and Development Agency grant; CRD grant from NSERC; PBEEE post-doctoral scholarship from FQRNT/MELS; Agence Nationale de la Recherche "EvolStress"(French National Research Agency (ANR)); McDonnell Foundation (SCS-Research Award)	MS was funded by Slovak Research and Development Agency grant No. 0267-10. TP was supported by a CRD grant from NSERC, and a PBEEE post-doctoral scholarship from FQRNT/MELS. MEH is funded by grants from Agence Nationale de la Recherche "EvolStress" (ANR-09-BLAN-099-01) and the McDonnell Foundation (JSMF 220020294/SCS-Research Award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2006, AM NAT, V167, P329, DOI 10.1086/499382; Abrams PA, 2006, AM NAT, V168, P645, DOI 10.1086/507878; Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Arimura G, 2005, BBA-MOL CELL BIOL L, V1734, P91, DOI 10.1016/j.bbalip.2005.03.001; Barber MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066102; Barber MJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026129; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; DEMEEUS T, 1995, EVOL ECOL, V9, P131, DOI 10.1007/BF01237752; Devictor V, 2008, GLOBAL ECOL BIOGEOGR, V17, P252, DOI 10.1111/j.1466-8238.2007.00364.x; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Dunne JA, 2006, SFI S SCI C, P27; Egas M, 2004, AM NAT, V163, P518, DOI 10.1086/382599; Ferry-Graham LA, 2002, INTEGR COMP BIOL, V42, P265, DOI 10.1093/icb/42.2.265; Flores CO, 2011, P NATL ACAD SCI USA, V108, pE288, DOI 10.1073/pnas.1101595108; Forister ML, 2012, ECOLOGY, V93, P981, DOI 10.1890/11-0650.1; Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Haerter JO, 2014, ISME J, V8, P2317, DOI 10.1038/ismej.2014.80; HASSELL MP, 1986, J ANIM ECOL, V55, P923, DOI 10.2307/4425; HOCHBERG ME, 1990, AM NAT, V136, P517, DOI 10.1086/285111; Lounnas M., 2013, ECOL PROCESS, V2, DOI DOI 10.1186/2192-1709-2-13; McPeek MA, 1996, AM NAT, V148, pS124, DOI 10.1086/285906; Miklos I, 2004, ECOLOGY, V85, P86, DOI 10.1890/03-0101; Ode PJ, 2006, ANNU REV ENTOMOL, V51, P163, DOI 10.1146/annurev.ento.51.110104.151110; Otto SB, 2007, NATURE, V450, P1226, DOI 10.1038/nature06359; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Poisot T, 2014, PEERJ, V2, DOI 10.7717/peerj.251; Poisot T, 2012, ECOL LETT, V15, P1353, DOI 10.1111/ele.12002; Poisot T, 2012, METHODS ECOL EVOL, V3, P537, DOI 10.1111/j.2041-210X.2011.00174.x; Poisot T, 2011, ECOL LETT, V14, P841, DOI 10.1111/j.1461-0248.2011.01645.x; Poullain V, 2008, EVOLUTION, V62, P1, DOI 10.1111/j.1558-5646.2007.00260.x; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Ravigne V, 2009, AM NAT, V174, pE141, DOI 10.1086/605369; SCHOENER TW, 1989, ECOLOGY, V70, P1559, DOI 10.2307/1938088; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Singer MS, 2012, AM NAT, V179, P363, DOI 10.1086/664080; Stanko M, 2002, OECOLOGIA, V131, P289, DOI 10.1007/s00442-002-0889-5; Stouffer DB, 2010, ECOL LETT, V13, P154, DOI 10.1111/j.1461-0248.2009.01407.x; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thrall PH, 2007, TRENDS ECOL EVOL, V22, P120, DOI 10.1016/j.tree.2006.11.007; Van Nouhuys S, 2003, ECOL ENTOMOL, V28, P193, DOI 10.1046/j.1365-2311.2003.00501.x; Wei JN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000852; Weiner J, 2012, THEOR ECOL-NETH, V5, P161, DOI 10.1007/s12080-011-0153-x; Williams RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017645; WILSON DS, 1994, AM NAT, V144, P692, DOI 10.1086/285702; Xin Liu, 2010, Information and Media Technologies, V5, P184	53	10	10	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 20	2015	10	5							e0114674	10.1371/journal.pone.0114674	http://dx.doi.org/10.1371/journal.pone.0114674			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7CV	25992798	Green Submitted, Green Published, gold			2022-12-26	WOS:000354921400003
J	Kim, YM; Kim, WY; Nam, SA; Choi, AR; Kim, H; Kim, YK; Kim, HS; Kim, J				Kim, Yu-mi; Kim, Wan-Young; Nam, Sun Ah; Choi, A-Rum; Kim, Hyang; Kim, Yong-Kyun; Kim, Hak-Soo; Kim, Jin			Role of Prox1 in the Transforming Ascending Thin Limb of Henle's Loop during Mouse Kidney Development	PLOS ONE			English	Article							DEVELOPING RAT-KIDNEY; HOMEOBOX GENE PROX-1; ALDOSE REDUCTASE; UREA TRANSPORTER; EXPRESSION; PROSPERO; TRANSDIFFERENTIATION; PHENOTYPE; PROTEIN; RETINA	The homeobox transcription factor Prox1 is critical to the development of many embryonic organs and tissues, although current understanding of its expression in the developing renal medulla is limited. We examined the functional role of Prox1 during mouse kidney development with particular emphasis on the developing loop of Henle. Our data show that Prox1 is expressed in the transdifferentiating region from the NKCC2-positive thick ascending limb, into the CLC-K1-positive ascending thin limb of Henle's loop beginning at embryonic day 18. From 1 to 14 days of age, Prox1-positive cells gradually disappeared from the papillary tip, and remained in the initial part of inner medulla after 21 days. In this transforming area, no Prox1 was observed in cells undergoing apoptosis but was expressed strongly in the remaining cells, which differentiated into ascending thin limb epithelial cells. In vitro and in vivo approaches showed that Prox1 expression increases where the osmolality is near optimal range, but decreases at below-or above-optimal ranges. Renal hypoosmolality induced by furosemide (NKCC2 inhibitor) inhibited Prox1 expression and delayed maturation of the ascending limb of Henle's loop. Together, these studies suggest that Prox1 appears to be a critical stage specific regulator of specifying ascending thin limb cell fate and that its expression is regulated by osmolality.	[Kim, Yu-mi; Kim, Wan-Young; Nam, Sun Ah; Choi, A-Rum; Kim, Hak-Soo; Kim, Jin] Catholic Univ Korea, Coll Med, Dept Anat, Seoul, South Korea; [Kim, Yu-mi; Kim, Wan-Young; Nam, Sun Ah; Choi, A-Rum; Kim, Hak-Soo; Kim, Jin] Catholic Univ Korea, Coll Med, Cell Death Dis Res Ctr, Seoul, South Korea; [Kim, Hyang] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Sch Med, Div Nephrol, Seoul, South Korea; [Kim, Yong-Kyun] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Korea	Kim, J (corresponding author), Catholic Univ Korea, Coll Med, Dept Anat, Seoul, South Korea.	jinkim@catholic.ac.kr			National Research Foundation (NRF); Ministry of Science, ICT and Future Planning [2014054063]; National Research Foundation of Korea [2012R1A5A2047939]	National Research Foundation (NRF); Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation (NRF), funded by the Ministry of Science, ICT and Future Planning (2014054063) and National Research Foundation of Korea (2012R1A5A2047939). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURGLIN TR, 1994, TRENDS BIOCHEM SCI, V19, P70, DOI 10.1016/0968-0004(94)90035-3; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Glasgow E, 1998, MECH DEVELOP, V76, P175, DOI 10.1016/S0925-4773(98)00121-X; Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642; Hong YK, 2003, CELL TISSUE RES, V314, P85, DOI 10.1007/s00441-003-0747-8; Hong YK, 2002, DEV DYNAM, V225, P351, DOI 10.1002/dvdy.10163; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Jung JY, 2002, AM J PHYSIOL-RENAL, V283, pF481, DOI 10.1152/ajprenal.00332.2001; Karalay O, 2011, P NATL ACAD SCI USA, V108, P5807, DOI 10.1073/pnas.1013456108; Kim J, 1996, AM J PHYSIOL-RENAL, V271, pF831, DOI 10.1152/ajprenal.1996.271.4.F831; Kim YH, 2002, AM J PHYSIOL-RENAL, V282, pF530, DOI 10.1152/ajprenal.00246.2001; Kim YM, 2009, AM J PHYSIOL-RENAL, V296, pF67, DOI 10.1152/ajprenal.00143.2008; Kirjavainen A, 2008, DEV BIOL, V322, P33, DOI 10.1016/j.ydbio.2008.07.004; Kobayashi K, 2001, HISTOCHEM CELL BIOL, V116, P49; Lavado A, 2010, PLOS BIOL, P8; Lee HW, 2007, AM J PHYSIOL-RENAL, V292, pF269, DOI 10.1152/ajprenal.00145.2006; Lee HW, 2011, CELL TISSUE RES, V343, P429, DOI 10.1007/s00441-010-1098-x; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Nachman PH., 2012, BRENNER RECTORS KIDN, V9, P1121; NEISS WF, 1982, ANAT EMBRYOL, V164, P315, DOI 10.1007/BF00315754; Ny A, 2005, NAT MED, V11, P998, DOI 10.1038/nm1285; OLIVER G, 1993, MECH DEVELOP, V44, P3, DOI 10.1016/0925-4773(93)90012-M; Park EY, 2012, HISTOL HISTOPATHOL, V27, P1559, DOI 10.14670/HH-27.1559; Risebro CA, 2009, DEVELOPMENT, V136, P495, DOI 10.1242/dev.030007; Slack JMW, 2001, CURR OPIN GENET DEV, V11, P581, DOI 10.1016/S0959-437X(00)00236-7; Song J, 2004, AM J PHYSIOL-RENAL, V287, pF1076, DOI 10.1152/ajprenal.00075.2004; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Tomarev SI, 1996, DEV DYNAM, V206, P354, DOI 10.1002/(SICI)1097-0177(199608)206:4<354::AID-AJA2>3.0.CO;2-H; Tomarev SI, 1998, BIOCHEM BIOPH RES CO, V248, P684, DOI 10.1006/bbrc.1998.8989; Tosh D, 2002, NAT REV MOL CELL BIO, V3, P187, DOI 10.1038/nrm761; Wang JF, 2005, DEV BIOL, V286, P182, DOI 10.1016/j.ydbio.2005.07.021; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Zinovieva RD, 1996, GENOMICS, V35, P517, DOI 10.1006/geno.1996.0392	34	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2015	10	5							e0127429	10.1371/journal.pone.0127429	http://dx.doi.org/10.1371/journal.pone.0127429			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BT	25993027	Green Published, Green Submitted, gold			2022-12-26	WOS:000354918600062
J	Chen, S; Li, ZF; Hu, MH; Guo, SL; Wu, JW; Wang, B; Hu, W; Sun, YS; Li, H; Liu, MB; Moore, JB; Chen, HY				Chen, Shengen; Li, Zifen; Hu, Maohong; Guo, Shuangli; Wu, Jingwen; Wang, Bin; Hu, Wei; Sun, Yanshuang; Li, Hui; Liu, Mingbin; Moore, Justin B.; Chen, Haiying			Knowledge, Attitudes, and Practices (KAP) Relating to Avian Influenza (H10N8) among Farmers' Markets Workers in Nanchang, China	PLOS ONE			English	Article							LIVE POULTRY MARKETS; A H7N9 VIRUS; HUMAN INFECTION; H5N1; RISK; DIAGNOSIS; OUTBREAK; ANXIETY	Three cases of avian influenza virus H10N8 were reported in Nanchang, China, as of April 2014. To identify the knowledge, attitudes, and practices (KAP) related to H10N8 among farmers' market workers, a cross-sectional survey was conducted in 63 farmers' markets in Nanchang. Using the resulting data, characteristics of poultry and non-poultry workers' knowledge, attitudes, and practice were described. Results suggest that interventions targeting high-risk workers should be developed and implemented by public health agencies to prevent the spread of H10N8. Additionally policies that encourage farmers' market workers to receive influenza vaccine should be developed, adopted, and enforced.	[Chen, Shengen; Li, Zifen; Hu, Maohong; Guo, Shuangli; Wu, Jingwen; Wang, Bin; Hu, Wei; Sun, Yanshuang; Li, Hui; Liu, Mingbin; Chen, Haiying] Nanchang Ctr Dis Control & Prevent, Nanchang, Jiangxi, Peoples R China; [Li, Zifen] Nanchang Univ, Coll Med, Sch Publ Hlth, Nanchang, Jiangxi, Peoples R China; [Moore, Justin B.] Univ S Carolina, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA; [Moore, Justin B.] Univ S Carolina, Arnold Sch Publ Hlth, Columbia, SC 29208 USA	Nanchang University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Chen, HY (corresponding author), Nanchang Ctr Dis Control & Prevent, Nanchang, Jiangxi, Peoples R China.	nccdcchy@126.com	Moore, Justin B/B-9357-2012	Moore, Justin B/0000-0003-4059-0538	Major Science and Technological Project from Department of Science and Technology of Jiangxi Province [20143ACG70004]	Major Science and Technological Project from Department of Science and Technology of Jiangxi Province	This work was supported by Major Science and Technological Project (No. 20143ACG70004, to HC) from Department of Science and Technology of Jiangxi Province (http://www.jxstc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate R, 2006, EMERG INFECT DIS, V12, P1762, DOI 10.3201/eid1211.060671; [Anonymous], 2005, Wkly Epidemiol Rec, V80, P279; [Anonymous], LANCET, V372, P744, DOI [10.1016/S0140-6736(08)61125-3, DOI 10.1016/S0140-6736(08)61125-3]; [Anonymous], 2013, HUM INF INFL A H7N9; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; China National Radio, 2014, THIS YEARS FLU VIR I; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Goodwin R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-166; Grayson ML, 2009, CLIN INFECT DIS, V48, P285, DOI 10.1086/595845; Jia XH, 2009, RATE INFLUENZA VACCI; Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032; Kung NY, 2003, AVIAN DIS, V47, P1037, DOI 10.1637/0005-2086-47.s3.1037; Leung YHC, 2012, EMERG INFECT DIS, V18, P1339, DOI 10.3201/eid1808.111879; Li TG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-4; Liu WD, 2013, J BIOMED RES, V27, P163, DOI 10.7555/JBR.27.20130071; Manabe T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047560; Olsen SJ, 2005, EMERG INFECT DIS, V11, P1601, DOI 10.3201/eid1110.041267; Ortiz JR, 2007, J INFECT DIS, V196, P1685, DOI 10.1086/522158; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; WHO, 2015, WHO RISK ASS HUM INF; World Health Organization, 2015, AV INFL WEEKL UPD NU; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhang QL, 2008, CHI J PUBLIC HLTH, V24, P1370; Zhou XF, 2013, JPN J INFECT DIS, V66, P558, DOI 10.7883/yoken.66.558	27	7	7	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127120	10.1371/journal.pone.0127120	http://dx.doi.org/10.1371/journal.pone.0127120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993111	gold, Green Submitted, Green Published			2022-12-26	WOS:000354917300093
J	van Cleef, BAGL; van Benthem, BHB; Verkade, EJM; van Rijen, MML; Kluytmans-van den Bergh, MFQ; Graveland, H; Bosch, T; Verstappen, KMHW; Wagenaar, JA; Bos, MEH; Heederik, D; Kluytmans, JAJW				van Cleef, Brigitte A. G. L.; van Benthem, Birgit H. B.; Verkade, Erwin J. M.; van Rijen, Miranda M. L.; Kluytmans-van den Bergh, Marjolein F. Q.; Graveland, Haitske; Bosch, Thijs; Verstappen, Koen M. H. W.; Wagenaar, Jaap A.; Bos, Marian E. H.; Heederik, Dick; Kluytmans, Jan A. J. W.			Livestock-Associated MRSA in Household Members of Pig Farmers: Transmission and Dynamics of Carriage, A Prospective Cohort Study	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN RESISTANCE; NASAL CARRIAGE; PREVALENCE; COLONIZATION; EXPOSURE; CC398; ST398	This prospective cohort study describes carriage of livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) in household members from 49 farrowing pig farms in the Netherlands (2010-2011). Of 171 household members, 4% were persistent MRSA nasal carriers, and the MRSA prevalence on any given sampling moment was 10% (range 7-11%). Working in the stables (of which 98% was MRSA-positive, prevalence ratio (PR) = 2.11 per 10 hours), working with sows (PR=1.97), and living with an MRSA-positive pig farmer (PR=4.63) were significant determinants for MRSA carriage. Significant protective factors were carriage of methicillin-susceptible Staphylococcus aureus (MSSA) (PR=0.50), and wearing a facemask when working in the stables (37% decreased prevalence). All MRSA strains during the study period were known livestock-associated types. The bacteriophage phi 3 was not found in household members. Transmission from pigs and the environment appeared to be important determinants; human-to-human transmission could not sufficiently be differentiated. Wearing a facemask when working in the stables and carriage of MSSA are potential interventional targets.	[van Cleef, Brigitte A. G. L.; Verkade, Erwin J. M.; van Rijen, Miranda M. L.; Kluytmans, Jan A. J. W.] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [van Cleef, Brigitte A. G. L.; Verkade, Erwin J. M.; Kluytmans, Jan A. J. W.] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [van Cleef, Brigitte A. G. L.; van Benthem, Birgit H. B.; Bosch, Thijs] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, NL-3720 BA Bilthoven, Netherlands; [Kluytmans-van den Bergh, Marjolein F. Q.] Amphia Hosp, Amphia Acad Infect Dis Fdn, Breda, Netherlands; [Kluytmans-van den Bergh, Marjolein F. Q.] UMC Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Graveland, Haitske; Bos, Marian E. H.; Heederik, Dick] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Graveland, Haitske; Verstappen, Koen M. H. W.; Wagenaar, Jaap A.] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Wagenaar, Jaap A.] Cent Vet Inst Wageningen UR, Lelystad, Netherlands; [Kluytmans, Jan A. J. W.] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Prevent, Amsterdam, Netherlands	Amphia Hospital; Elisabeth-TweeSteden Ziekenhuis (ETZ); Netherlands National Institute for Public Health & the Environment; Amphia Hospital; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University; Wageningen University & Research; Vrije Universiteit Amsterdam	van Cleef, BAGL (corresponding author), Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands.	brivancleef@gmail.com	van den Bergh, Marjolein Kluytmans -/A-7267-2016	van den Bergh, Marjolein Kluytmans -/0000-0002-6576-6408; Heederik, Dick/0000-0002-4550-1437	Netherlands Organisation for Health Research and Development [125020009]	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This work was supported by grant number 125020009 from the Netherlands Organisation for Health Research and Development (ZonMw: www.zonmw.nl). BvC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisdorff B, 2012, EPIDEMIOL INFECT, V140, P1800, DOI 10.1017/S0950268811002378; Bosch T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-40; Broens EM, 2011, PREV VET MED, V102, P41, DOI 10.1016/j.prevetmed.2011.06.005; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; Dall'Antonia M, 2005, J HOSP INFECT, V61, P62, DOI 10.1016/j.jhin.2005.01.008; Davis MF, 2012, LANCET INFECT DIS, V12, P703, DOI 10.1016/S1473-3099(12)70156-1; Francois P, 2003, J CLIN MICROBIOL, V41, P254, DOI 10.1128/JCM.41.1.254-260.2003; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Kilic A, 2010, DIAGN MICR INFEC DIS, V66, P349, DOI 10.1016/j.diagmicrobio.2009.11.010; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Knol MJ, 2012, CAN MED ASSOC J, V184, P895, DOI 10.1503/cmaj.101715; Knox J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049900; Leonas KK., 2003, J TEXT APPAR TECHNOL, V3, P1; McCarthy AJ, 2012, APPL ENVIRON MICROB, V78, P8845, DOI 10.1128/AEM.02398-12; Noss I, 2008, APPL ENVIRON MICROB, V74, P5621, DOI 10.1128/AEM.00619-08; Oppliger A, 2012, APPL ENVIRON MICROB, V78, P8010, DOI 10.1128/AEM.01902-12; Osadebe LU, 2013, ZOONOSES PUBLIC HLTH, V60, P234, DOI 10.1111/j.1863-2378.2012.01527.x; Schouls LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005082; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; van Cleef BAGL, 2014, CLIN MICROBIOL INFEC, V20, pO764, DOI 10.1111/1469-0691.12582; van Cleef BAGL, 2010, EPIDEMIOL INFECT, V138, P756, DOI 10.1017/S0950268810000245; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; van Cleef BAGL, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-34; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; van Griethuysen A, 1999, J CLIN MICROBIOL, V37, P2789, DOI 10.1128/JCM.37.9.2789-2792.1999; van Meurs MLJGM, 2013, INFECTION, V41, P339, DOI 10.1007/s15010-012-0319-5; Verkade E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100823; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Working Party on Infection Prevention of the Netherlands (WIP), 2012, METH RES STAPH AUR M; Xu QF, 2012, EMERG INFECT DIS, V18, P1738, DOI 10.3201/eid1811.111904	35	38	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127190	10.1371/journal.pone.0127190	http://dx.doi.org/10.1371/journal.pone.0127190			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25993665	Green Published, gold			2022-12-26	WOS:000354917300100
J	Matula, R; Svatek, M; Palkova, M; Volarik, D; Vrska, T				Matula, Radim; Svatek, Martin; Palkova, Marcela; Volarik, Daniel; Vrska, Tomas			Mistletoe Infection in an Oak Forest Is Influenced by Competition and Host Size	PLOS ONE			English	Article							LORANTHUS-EUROPAEUS; TROPICAL MISTLETOE; SEED DEPOSITION; DISPERSAL; SPECIFICITY; POPULATION; PARASITISM; EFFICIENCY; VISCACEAE; PATTERNS	Host size and distance from an infected plant have been previously found to affect mistletoe occurrence in woody vegetation but the effect of host plant competition on mistletoe infection has not been empirically tested. For an individual tree, increasing competition from neighbouring trees decreases its resource availability, and resource availability is also known to affect the establishment of mistletoes on host trees. Therefore, competition is likely to affect mistletoe infection but evidence for such a mechanism is lacking. Based on this, we hypothesised that the probability of occurrence as well as the abundance of mistletoes on a tree would increase not only with increasing host size and decreasing distance from an infected tree but also with decreasing competition by neighbouring trees. Our hypothesis was tested using generalized linear models (GLMs) with data on Loranthus europaeus Jacq., one of the two most common mistletoes in Europe, on 1015 potential host stems collected in a large fully mapped plot in the Czech Republic. Because many trees were multistemmed, we ran the analyses for both individual stems and whole trees. We found that the probability of mistletoe occurrence on individual stems was affected mostly by stem size, whereas competition had the most important effects on the probability of mistletoe occurrence on whole trees as well as on mistletoe abundance. Therefore, we confirmed our hypothesis that competition among trees has a negative effect on mistletoe occurrence.	[Matula, Radim; Svatek, Martin; Volarik, Daniel] Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Bot Dendrol & Geobiocoenol, Brno, Czech Republic; [Palkova, Marcela] Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Silviculture, Brno, Czech Republic; [Palkova, Marcela; Vrska, Tomas] Silva Tarouca Res Inst, Dept Forest Ecol, Brno, Czech Republic	Mendel University in Brno; Mendel University in Brno	Matula, R (corresponding author), Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Bot Dendrol & Geobiocoenol, Brno, Czech Republic.	radim.matula@mendelu.cz	Svatek, Martin/C-1890-2014; Volařík, Daniel/AAE-9556-2019; Geršl, Milan/L-2134-2018; Šrámek, Martin/C-1536-2014	Svatek, Martin/0000-0003-2328-4627; Volařík, Daniel/0000-0002-3682-2992; Šrámek, Martin/0000-0003-0259-9902; Matula, Radim/0000-0002-7460-0100; Gersl, Milan/0000-0002-7721-3309	Ministry of Education, Youth and Sports of the Czech Republic [GA526/08/1050, LG12018, CZ.1.07/2.3.00/20.0267]; Faculty of Forestry and Wood Technology of Mendel University in Brno [IGA 11/2010]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Faculty of Forestry and Wood Technology of Mendel University in Brno	This study was funded by projects: GA526/08/1050, "Structure and function of the Quercus-Loranthus complex regarding the potential suppression of the important oak crown killer", LG12018 "Involvement of the Czech Republic in the research of European Forest Institute (EFI)" and CZ.1.07/2.3.00/20.0267 "Coppice forests as the production and biological alternative for the future" of the Ministry of Education, Youth and Sports of the Czech Republic (www.msmt.cz); IGA 11/2010 of the Faculty of Forestry and Wood Technology of Mendel University in Brno (www.ldf.mendelu.cz) - "Spatial and age structure analysis of old oak coppices in the Podyji National Park. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TP, 2007, P ROY SOC B-BIOL SCI, V274, P3039, DOI 10.1098/rspb.2007.0891; [Anonymous], 2014, R LANG ENV STAT COMP; Arruda R, 2006, FLORA, V201, P127, DOI 10.1016/j.flora.2005.07.001; Arruda R, 2012, ACTA BOT BRAS, V26, P264, DOI 10.1590/S0102-33062012000200003; Aukema JE, 2003, FRONT ECOL ENVIRON, V1, P212, DOI 10.1890/1540-9295(2003)001[0212:VVAVMA]2.0.CO;2; Aukema JE, 2004, ECOGRAPHY, V27, P137, DOI 10.1111/j.0906-7590.2004.03640.x; Aukema JE, 2002, ECOLOGY, V83, P3489, DOI 10.1890/0012-9658(2002)083[3489:WDAFEB]2.0.CO;2; Aukema JE, 2002, ECOGRAPHY, V25, P139, DOI 10.1034/j.1600-0587.2002.250202.x; BIGING GS, 1995, FOREST SCI, V41, P360; Bonser SP, 2013, FUNCT ECOL, V27, P876, DOI 10.1111/1365-2435.12064; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Butin HH, 1995, TREE DIS DISORDERS C; Canham CD, 2004, CAN J FOREST RES, V34, P778, DOI [10.1139/x03-232, 10.1139/X03-232]; Carlo TA, 2005, ECOLOGY, V86, P3245, DOI 10.1890/05-0460; Carnegie AJ, 2009, BOTANY, V87, P49, DOI 10.1139/B08-127; Coates KD, 2009, J ECOL, V97, P118, DOI 10.1111/j.1365-2745.2008.01458.x; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Dobbertin M, 2006, FOREST PATHOL, V36, P309, DOI 10.1111/j.1439-0329.2006.00457.x; DONOHUE K, 1995, INT J PLANT SCI, V156, P816, DOI 10.1086/297305; ELIAS P, 1987, EKOL CSFR, V6, P359; Glatzel G, 2009, BOTANY, V87, P10, DOI 10.1139/B08-096; GLATZEL G, 1983, OECOLOGIA, V56, P193, DOI 10.1007/BF00379691; Janik D, 2007, THAYENSIA, V1, P175; Kubat K, 1997, KVETENA CESKE REPUBL, V5, P467; Mathiasen RL, 2008, PLANT DIS, V92, P988, DOI 10.1094/PDIS-92-7-0988; Matula R, 2012, EUR J FOREST RES, V131, P1501, DOI 10.1007/s10342-012-0618-5; MONTEIRO RF, 1992, J TROP ECOL, V8, P307, DOI 10.1017/S026646740000657X; Mourao FA, 2009, ACTA BOT BRAS, V23, P820, DOI 10.1590/S0102-33062009000300023; OVERTON JM, 1994, J ECOL, V82, P711, DOI 10.2307/2261437; Press MC, 2005, NEW PHYTOL, V166, P737, DOI 10.1111/j.1469-8137.2005.01358.x; Reid N, 2009, BOTANY, V87, P1, DOI 10.1139/B08-109; Rist L, 2011, BIOTROPICA, V43, P50, DOI 10.1111/j.1744-7429.2010.00643.x; SARGENT S, 1995, FUNCT ECOL, V9, P197, DOI 10.2307/2390565; Shaw DC, 2004, AUST J BOT, V52, P481, DOI 10.1071/BT03074; Skorka P, 2005, ACTA ORNITHOL, V40, P35, DOI 10.3161/068.040.0109; Skorka Piotr, 2003, Acta Zoologica Cracoviensia, V46, P29; SNOW BK, 1984, IBIS, V126, P39, DOI 10.1111/j.1474-919X.1984.tb03662.x; STERBA H, 1993, FOREST ECOL MANAG, V62, P39, DOI 10.1016/0378-1127(93)90040-T; Teodoro GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065836; Vrska T, 1998, THAYENSIA, V1, P101; Ward MJ, 2007, AUSTRAL ECOL, V32, P113, DOI 10.1111/j.1442-9993.2006.01668.x; Watson DM, 2009, BOTANY, V87, P16, DOI 10.1139/B08-105; Watson DM, 2001, ANNU REV ECOL SYST, V32, P219, DOI 10.1146/annurev.ecolsys.32.081501.114024; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	44	28	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2015	10	5							e0127055	10.1371/journal.pone.0127055	http://dx.doi.org/10.1371/journal.pone.0127055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI7BG	25992920	gold, Green Submitted, Green Published			2022-12-26	WOS:000354917300079
J	Matula, R; Damborska, L; Necasova, M; Gersl, M; Sramek, M				Matula, Radim; Damborska, Lenka; Necasova, Monika; Gersl, Milan; Sramek, Martin			Measuring Biomass and Carbon Stock in Resprouting Woody Plants	PLOS ONE			English	Article							SPROUT DEVELOPMENT; TROPICAL FOREST; TREE; PLANTATIONS; VARIABILITY; ALLOMETRY; WOODLAND; STUMPS; GROWTH; STANDS	Resprouting multi-stemmed woody plants form an important component of the woody vegetation in many ecosystems, but a clear methodology for reliable measurement of their size and quick, non-destructive estimation of their woody biomass and carbon stock is lacking. Our goal was to find a minimum number of sprouts, i.e., the most easily obtainable, and sprout parameters that should be measured for accurate sprout biomass and carbon stock estimates. Using data for 5 common temperate woody species, we modelled carbon stock and sprout biomass as a function of an increasing number of sprouts in an interaction with different sprout parameters. The mean basal diameter of only two to five of the thickest sprouts and the basal diameter and DBH of the thickest sprouts per stump proved to be accurate estimators for the total sprout biomass of the individual resprouters and the populations of resprouters, respectively. Carbon stock estimates were strongly correlated with biomass estimates, but relative carbon content varied among species. Our study demonstrated that the size of the resprouters can be easily measured, and their biomass and carbon stock estimated; therefore, resprouters can be simply incorporated into studies of woody vegetation.	[Matula, Radim; Damborska, Lenka; Necasova, Monika; Sramek, Martin] Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Bot Dendrol & Geobiocoenol, Brno, Czech Republic; [Gersl, Milan] Mendel Univ Brno, Fac Agron, Dept Agr Food & Environm Engn, Brno, Czech Republic	Mendel University in Brno; Mendel University in Brno	Matula, R (corresponding author), Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Bot Dendrol & Geobiocoenol, Brno, Czech Republic.	radim.matula@mendelu.cz	Svatek, Martin/C-1890-2014; Volařík, Daniel/AAE-9556-2019; Geršl, Milan/L-2134-2018; Šrámek, Martin/C-1536-2014	Svatek, Martin/0000-0003-2328-4627; Volařík, Daniel/0000-0002-3682-2992; Šrámek, Martin/0000-0003-0259-9902; Matula, Radim/0000-0002-7460-0100; Gersl, Milan/0000-0002-7721-3309	Ministry of Education, Youth and Sports [LG12018]	Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	This study was funded by project LG12018 of the Ministry of Education, Youth and Sports (www.msmt.cz) titled "Involvement of the Czech Republic in the research of European Forest Institute (EFI)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASKERVILLE G L, 1972, Canadian Journal of Forest Research, V2, P49, DOI 10.1139/x72-009; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Clarke PJ, 2010, NEW PHYTOL, V188, P651, DOI 10.1111/j.1469-8137.2010.03508.x; Crawley MJ, 2013, R BOOK, P557; Dietze MC, 2008, ECOL MONOGR, V78, P331, DOI 10.1890/07-0271.1; Everham EM, 1996, BOT REV, V62, P113, DOI 10.1007/BF02857920; Fang SZ, 2011, BIOMASS BIOENERG, V35, P3104, DOI 10.1016/j.biombioe.2011.04.017; HAASE R, 1995, FOREST ECOL MANAG, V73, P29, DOI 10.1016/0378-1127(94)03509-U; HARRINGTON RA, 1993, FOREST ECOL MANAG, V56, P315, DOI 10.1016/0378-1127(93)90120-C; Hector A, 2011, PHILOS T R SOC B, V366, P3303, DOI 10.1098/rstb.2011.0094; Henry M, 2011, SILVA FENN, V45, P477, DOI 10.14214/sf.38; HYTONEN J, 1987, BIOMASS, V14, P39, DOI 10.1016/0144-4565(87)90021-7; Hytonen J, 1999, BIOMASS BIOENERG, V17, P455, DOI 10.1016/S0961-9534(99)00061-6; Johansson T, 2008, BIOMASS BIOENERG, V32, P944, DOI 10.1016/j.biombioe.2008.01.009; JOHNSON PS, 2002, ECOLOGY SILVICULTURE; Lamlom SH, 2003, BIOMASS BIOENERG, V25, P381, DOI 10.1016/S0961-9534(03)00033-3; Liu ZL, 2011, FOREST ECOL MANAG, V262, P299, DOI 10.1016/j.foreco.2011.03.035; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; Matula R, 2014, J ARID ENVIRON, V100, P72, DOI 10.1016/j.jaridenv.2013.10.014; Matula R, 2012, EUR J FOREST RES, V131, P1501, DOI 10.1007/s10342-012-0618-5; Mosseler A, 2014, FOREST ECOL MANAG, V320, P190, DOI 10.1016/j.foreco.2014.02.027; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Paciorek CJ, 2000, J ECOL, V88, P765, DOI 10.1046/j.1365-2745.2000.00494.x; Paine CET, 2012, METHODS ECOL EVOL, V3, P245, DOI 10.1111/j.2041-210X.2011.00155.x; Pinheiro J., 2014, NLME LINEAR NONLINEA, V3, P1; R Core Team, 2012, R LANG ENV STAT COMP; Robertson KM, 2014, OECOLOGIA, V174, P765, DOI 10.1007/s00442-013-2823-4; Tanentzap AJ, 2012, J ECOL, V100, P171, DOI 10.1111/j.1365-2745.2011.01879.x; Thomas SC, 2007, J ENVIRON MANAGE, V85, P659, DOI 10.1016/j.jenvman.2006.04.022; Verwijst T, 1999, FOREST ECOL MANAG, V121, P137, DOI 10.1016/S0378-1127(98)00562-3; Wright L, 2006, BIOMASS BIOENERG, V30, P706, DOI 10.1016/j.biombioe.2005.08.008; Zewdie M, 2009, BIOMASS BIOENERG, V33, P421, DOI 10.1016/j.biombioe.2008.08.007; Zhang QZ, 2009, FOREST ECOL MANAG, V258, P722, DOI 10.1016/j.foreco.2009.05.009	35	28	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2015	10	2							e0118388	10.1371/journal.pone.0118388	http://dx.doi.org/10.1371/journal.pone.0118388			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CC2ZH	25992920	Green Submitted, gold, Green Published			2022-12-26	WOS:000350213200050
